PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Shah, S; Heddle, JG				Shah, Shama; Heddle, Jonathan G.			Squaring up to DNA: pentapeptide repeat proteins and DNA mimicry	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Review						DNA gyrase; Topoisomerase; Pentapeptide repeat proteins; MfpA; Qnr; DNA mimicry	MEDIATED QUINOLONE RESISTANCE; LIGHT-INDUCED CAROTENOGENESIS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; GLYCOSYLASE INHIBITOR; TOPOISOMERASE-IV; BACILLUS-SUBTILIS; MICROCIN B17; ANTIBIOTIC-RESISTANCE; TRANSFERABLE PLASMID	Pentapeptide repeats are a class of proteins characterized by the presence of multiple repeating sequences five amino acids in length. The sequences fold into a right-handed beta-helix with a roughly square-shaped cross section. Pentapeptide repeat proteins include a number of examples which are thought to function as structural mimics of DNA and act to competitively bind to the type II topoisomerase DNA gyrase, an important antibacterial target. DNA gyrase-targeting pentapeptide repeat proteins can both inhibit DNA gyrase-a potentially useful therapeutic property-and contribute to resistance to quinolone antibacterials (by acting to prevent them forming a lethal complex with the DNA and enzyme). Pentapeptide repeat proteins are therefore of wide interest not only because of their unusual structure, function, and potential as an antibacterial target, but also because knowledge of their mechanism of action may lead to both a greater understanding of the details of DNA gyrase function as well as being a useful template for the design of new DNA gyrase inhibitors. However, many puzzling aspects as to how these DNA mimics function and indeed even their ability to act as DNA mimics itself remains open to question. This review summarizes the current state of knowledge regarding pentapeptide repeat proteins, focusing on those that are thought to mimic DNA, and speculates on potential structure-function relationships which may account for their differing specificities.	[Shah, Shama; Heddle, Jonathan G.] RIKEN, Heddle Initiat Res Unit, Wako, Saitama 3510198, Japan; [Shah, Shama] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Heddle, JG (reprint author), RIKEN, Heddle Initiat Res Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	heddle@riken.jp	Heddle, Jonathan/H-4586-2014		RIKEN Initiative; RIKEN Junior Research Associate	We thank Anthony Maxwell, James Berger, Ting-Yu Lin, and Soshichiro Nagano for critical reading of the manuscript, Soshichiro Nagano for useful discussions and assistance with sequence alignments, and Ting-Yu Lin for elements of Fig. 4. SS and JGH were funded by RIKEN Initiative Research Funding awarded to JGH, and SS was funded as a RIKEN Junior Research Associate.	Xiong XL, 2011, NUCLEIC ACIDS RES, V39, P3917, DOI 10.1093/nar/gkq1296; Wang HC, 2007, DEV COMP IMMUNOL, V31, P672, DOI 10.1016/j.dci.2006.11.001; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Stabler RA, 2005, MICROBIOL-SGM, V151, P2907, DOI 10.1099/mic.0.28099-0; Voloshin ON, 2001, GENE DEV, V15, P415, DOI 10.1101/gad.862901; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Dorman CJ, 2003, CURR OPIN GENET DEV, V13, P179, DOI 10.1016/S0959-437X(03)00025-X; Wang HC, 2014, BIOCHEMISTRY-US, V53, P2865, DOI 10.1021/bi5002689; TAKAHASHI I, 1963, NATURE, V197, P794, DOI 10.1038/197794a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Vetting MW, 2009, ACTA CRYSTALLOGR D, V65, P462, DOI 10.1107/S0907444909008324; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Vetting MW, 2011, ACTA CRYSTALLOGR F, V67, P296, DOI 10.1107/S1744309110053315; Kirby TW, 2002, J MOL BIOL, V320, P771, DOI 10.1061/S0022-2836(02)00460-6; Court R, 2007, J MOL BIOL, V371, P25, DOI 10.1016/jmb.2007.05.037; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Vetting MW, 2011, J BIOL CHEM, V286, P25265, DOI 10.1074/jbc.M111.226936; Nekrasov SV, 2007, J MOL BIOL, V365, P284, DOI 10.1016/jmb.2006.09.087; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; MuroPastor AM, 1997, J MOL BIOL, V268, P589, DOI 10.1006/jmbi.1997.0985; Serrano-Heras G, 2007, NUCLEIC ACIDS RES, V35, P5393, DOI 10.1093/nar/gkm584; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Mustaev A, 2014, J BIOL CHEM, V289, P12300, DOI 10.1074/jbc.M113.529164; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Hegde SS, 2011, ANTIMICROB AGENTS CH, V55, P110, DOI 10.1128/AAC.01158-10; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Leon E, 2010, NUCLEIC ACIDS RES, V38, P5226, DOI 10.1093/nar/gkq277; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377; Wang HC, 2008, P NATL ACAD SCI USA, V105, P20758, DOI 10.1073/pnas.0811233106; Merens A, 2009, J BACTERIOL, V191, P1587, DOI 10.1128/JB.01205-08; Walkinshaw MD, 2002, MOL CELL, V9, P187, DOI 10.1016/S1097-2765(02)00435-5; Putnam CD, 2005, DNA REPAIR, V4, P1410, DOI 10.1016/j.dnarep.2005.08.007; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Tavio MM, 2014, J ANTIMICROB CHEMOTH, V69, P2102, DOI 10.1093/jac/dku102; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Wang HC, 2013, NUCLEIC ACIDS RES, V41, P5127, DOI 10.1093/nar/gkt201; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; Hashimi SM, 2007, ANTIMICROB AGENTS CH, V51, P181, DOI 10.1128/AAC.00918-06; Nakamura Y, 2011, WIRES RNA, V2, P647, DOI 10.1002/wrna.81; Hata M, 2005, ANTIMICROB AGENTS CH, V49, P801, DOI 10.1128/AAC.49.2.801-803.2005; Montero C, 2001, ANTIMICROB AGENTS CH, V45, P3387, DOI 10.1128/AAC.45.12.3387-3392.2001; Parks WM, 2007, BIOCHIMIE, V89, P500, DOI 10.1016/j.biochi.2006.12.005; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; MURPHY KC, 1991, J BACTERIOL, V173, P5808; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647; Wang HC, 2012, NUCLEIC ACIDS RES, V40, P5718, DOI 10.1093/nar/gks177; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; Parsons LX, 2004, PROTEINS, V54, P375, DOI 10.1002/prot.10607; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ghosh M, 2007, J BIOL CHEM, V282, P5682, DOI 10.1074/jbc.M605986200; Laponogov I, 2013, NUCLEIC ACIDS RES, V41, P9911, DOI 10.1093/nar/gkt749; Wang HC, 2014, NUCLEIC ACIDS RES, V42, P1354, DOI 10.1093/nar/gkt964; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Grove A, 2011, CURR ISSUES MOL BIOL, V13, P1; Tao J, 2013, NUCLEIC ACIDS RES, V41, P2370, DOI 10.1093/nar/gks1351; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; Arsene S, 2007, ANTIMICROB AGENTS CH, V51, P3254, DOI 10.1128/AAC.00274-07; GARRIDO MD, 1988, EMBO J, V7, P1853; Ramirez BE, 2000, PROTEIN SCI, V9, P2161; Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468; Asensio JL, 2011, NUCLEIC ACIDS RES, V39, P9779, DOI 10.1093/nar/gkr667; Bateman A, 1998, PROTEIN SCI, V7, P1477; Bates A D, 2005, DNA TOPOLOGY; BELOGUROV AA, 1992, J BACTERIOL, V174, P5079; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P207, DOI 10.1016/0885-5765(87)90034-8; BIRCH RG, 1987, PHYSIOL MOL PLANT P, V30, P199, DOI 10.1016/0885-5765(87)90033-6; BLACK K, 1995, J BACTERIOL, V177, P6440; Buchko GW, 2008, J STRUCT BIOL, V162, P184, DOI 10.1016/j.jsb.2007.11.008; Buchko GW, 2006, PROTEIN SCI, V15, P2579, DOI 10.1110/ps.062407506; Chatterji M, 2002, EMBO REP, V3, P261, DOI 10.1093/embo-reports/kvf038; CONE R, 1980, J BIOL CHEM, V255, P354; DREW HR, 1981, P NATL ACAD SCI-BIOL, V78, P2179, DOI 10.1073/pnas.78.4.2179; Dryden DTF, 2006, TRENDS BIOTECHNOL, V24, P378, DOI 10.1016/j.tibtech.2006.06.004; Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208; Exley RM, 2009, INFECT IMMUN, V77, P45, DOI 10.1128/IAI.00968-08; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fonseca Erica L, 2008, Emerg Infect Dis, V14, P1129, DOI 10.3201/eid1407.080132; FONTES M, 1993, EMBO J, V12, P1265; FRIEDBERG EC, 1975, J VIROL, V16, P315; Galkin VE, 2011, J MOL BIOL, V408, P815, DOI 10.1016/j.jmb.2011.03.046; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571; Guo QL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-33; Heddle J, 2002, ANTIMICROB AGENTS CH, V46, P1805, DOI 10.1128/AAC.46.6.1805-1815.2002; Heddle JG, 2001, J MOL BIOL, V307, P1223, DOI 10.1006/jmbi.2001.4562; Heddle JG, 2000, NUCLEOS NUCLEOT NUCL, V19, P1249, DOI 10.1080/15257770008033048; HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; KOLTER R, 1992, ANNU REV MICROBIOL, V46, P141, DOI 10.1146/annurev.mi.46.100192.001041; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301; Lomovskaya O, 1996, ANTIMICROB AGENTS CH, V40, P1050; Lopez-Rubio JJ, 2002, J BIOL CHEM, V277, P7262, DOI 10.1074/jbc.M110351200; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; McMahon SA, 2009, NUCLEIC ACIDS RES, V37, P4887, DOI 10.1093/nar/gkp478; MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960; Moreno F, 1995, Biotechnology, V28, P307; Nei M., 2000, MOL EVOLUTION PHYLOG; Ni SS, 2011, ACTA CRYSTALLOGR F, V67, P1480, DOI 10.1107/S1744309111037432; Ni SS, 2009, J STRUCT BIOL, V165, P47, DOI 10.1016/j.jsb.2008.09.010; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Papillon J, 2013, NUCLEIC ACIDS RES, V41, P7815, DOI 10.1093/nar/gkt560; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Rodriguez-Martinez JM, 2011, J INFECT CHEMOTHER, V17, P149, DOI 10.1007/s10156-010-0120-2; Romanowski MJ, 2002, PROTEINS, V47, P403, DOI 10.1002/prot.10102; Schrodinger LLC, 2010, PYMOL MOL GRAPHICS S; SUGINO A, 1980, J BIOL CHEM, V255, P6299; Vetting MW, 2007, PROTEIN SCI, V16, P755, DOI 10.1110/ps.062637707; WANG Z, 1989, J BIOL CHEM, V264, P1163; WANG ZG, 1991, GENE, V99, P31; WANG ZG, 1988, J BACTERIOL, V170, P1082; Whitworth DE, 2001, MOL MICROBIOL, V42, P809, DOI 10.1046/j.1365-2958.2001.02679.x; Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488; Williams NL, 1999, BIOCHEMISTRY-US, V38, P14157, DOI 10.1021/bi991478m; Yasuda T, 1998, EMBO J, V17, P3207, DOI 10.1093/emboj/17.11.3207; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	132	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2014	98	23					9545	9560		10.1007/s00253-014-6151-3		16	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AT7TN	WOS:000345140200003		
J	Kurniawan, YN; Kitani, S; Maeda, A; Nihira, T				Kurniawan, Yohanes Novi; Kitani, Shigeru; Maeda, Asa; Nihira, Takuya			Differential contributions of two SARP family regulatory genes to indigoidine biosynthesis in Streptomyces lavendulae FRI-5	APPLIED MICROBIOLOGY AND BIOTECHNOLOGY			English	Article						Streptomyces; gamma-Butyrolactone autoregulator; Secondary metabolism; Indigoidine	BLUE PIGMENT PRODUCTION; BUTYROLACTONE AUTOREGULATOR; COELICOLOR A3(2); ANTIBIOTIC PRODUCTION; SECONDARY METABOLISM; TRANSCRIPTIONAL REGULATOR; VIRGINIAMYCIN PRODUCTION; GAMMA-BUTYROLACTONE; CONJUGAL TRANSFER; ESCHERICHIA-COLI	The Streptomyces antibiotic regulatory protein (SARP) family regulators have been shown to control the production of secondary metabolites in many Streptomyces species as the most downstream regulators in the regulatory cascade. Streptomyces lavendulae FRI-5 produces a blue pigment (indigoidine) together with two types of antibiotics: D-cycloserine and the nucleoside antibiotics. The production of these secondary metabolites is governed by a signaling system consisting of a gamma-butyrolactone, IM-2 [(2R,3R,1'R)-2-1'-hydroxybutyl-3-hydroxymethyl-gamma-butanolide], and its cognate receptor, FarA. Here, we characterized two regulatory genes of the SARP family, farR3 and farR4, which are tandemly located in the proximal region of farA. farR3 is transcribed both as a monocistronic RNA and as a bicistronic farR4-farR3 mRNA, and the expression profile is tightly controlled by the IM-2/FarA system. Loss of farR3 delayed and decreased the production of indigoidine without any changes in the transcriptional profile of other far regulatory genes, indicating that FarR3 positively controls the biosynthesis of indigoidine and is positioned in the downstream region of the IM-2/FarA signaling system. Meanwhile, loss of farR4 induced the early production of IM-2 by increasing transcription of an IM-2 biosynthetic gene, farX, indicating that FarR4 negatively controls the biosynthesis of IM-2. Thus, our results suggested differential contributions of the SARP family regulators to the regulation of secondary metabolism in S. lavendulae FRI-5. This is the first report to show that an SARP family regulator is involved in the biosynthesis of a signaling molecule functioning at the most upstream region of the regulatory cascade for Streptomyces secondary metabolism.	[Kurniawan, Yohanes Novi; Kitani, Shigeru; Maeda, Asa; Nihira, Takuya] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan; [Nihira, Takuya] Mahidol Univ, MU Collaborat Res Ctr Biosci & Biotechnol, Fac Sci, Bangkok 10400, Thailand	Nihira, T (reprint author), Mahidol Univ, MU Collaborat Res Ctr Biosci & Biotechnol, Fac Sci, Rama VI Rd, Bangkok 10400, Thailand.	nihira@icb.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS); National Research Council of Thailand; National Science and Technology Development Agency of Thailand; JSPS [24310157, 24651243, 24780071]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work is a part of the PhD dissertation of Y.N.K. This work was supported in part by a grant for the Joint Program in the Field of Biotechnology from the Japan Society for the Promotion of Science (JSPS), the National Research Council of Thailand, and the National Science and Technology Development Agency of Thailand to T.N.; by a Grant-in-Aid for Scientific Research (B) (No. 24310157) and a Grant-in-Aid for Challenging Exploratory Research (No. 24651243) from JSPS to T.N. and S. K.; by a Grant-in-Aid for Young Scientists (B) (No. 24780071) from JSPS to S. K.; and by a scholarship from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Y.N.K.	Aigle B, 2005, J BACTERIOL, V187, P2491, DOI 10.1128/JB.187.7.2491-2500.2005; Tanaka A, 2007, J MOL BIOL, V369, P322, DOI 10.1016/j.jmb.2007.02.096; Takano E, 2000, J BIOL CHEM, V275, P11010, DOI 10.1074/jbc.275.15.11010; Pulsawat N, 2007, GENE, V393, P31, DOI 10.1016/j.gene.2006.12.035; SATO K, 1989, J FERMENT BIOENG, V68, P170, DOI 10.1016/0922-338X(89)90131-1; KUHN R, 1965, ARCH MIKROBIOL, V51, P71, DOI 10.1007/BF00406851; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Kitani S, 2000, J MICROBIOL BIOTECHN, V10, P535; Pulsawat N, 2009, MICROBIOL-SGM, V155, P1250, DOI 10.1099/mic.0.022467-0; Kitani S, 2001, J BACTERIOL, V183, P4357, DOI 10.1128/JB.183.14.4357-4363.2001; YANAGIMOTO M, 1983, J FERMENT TECHNOL, V61, P545; Liras P, 2008, J IND MICROBIOL BIOT, V35, P667, DOI 10.1007/s10295-008-0351-8; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Yu Q, 2012, ARCH MICROBIOL, V194, P415, DOI 10.1007/s00203-011-0768-8; Wang J, 2011, MOL MICROBIOL, V82, P236, DOI 10.1111/j.1365-2958.2011.07811.x; Paget MSB, 1999, J BACTERIOL, V181, P204; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Kitani S, 2008, GENE, V425, P9, DOI 10.1016/j.gene.2008.07.043; Novakova R, 2011, MICROBIOL-SGM, V157, P1629, DOI 10.1099/mic.0.047795-0; Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; Horinouchi S, 2007, BIOSCI BIOTECH BIOCH, V71, P283, DOI 10.1271/bbb.60627; Arias P, 1999, J BACTERIOL, V181, P6958; HASHIMOTO K, 1992, J FERMENT BIOENG, V73, P449, DOI 10.1016/0922-338X(92)90136-I; Kieser T., 2000, PRACTICAL STREPTOMYC; Kitani S, 1999, J BACTERIOL, V181, P5081; Kitani S, 2010, ARCH MICROBIOL, V192, P211, DOI 10.1007/s00203-010-0550-3; Novakova R, 2010, FOLIA MICROBIOL, V55, P119, DOI 10.1007/s12223-010-0018-5; Sambrook J, 2001, MOL CLONING LAB MANU; Sheldon PJ, 2002, MOL MICROBIOL, V44, P449, DOI 10.1046/j.1365-2958.2002.02886.x; STARR MP, 1966, APPL MICROBIOL, V14, P870; Takahashi H, 2007, J BIOL CHEM, V282, P9073, DOI 10.1074/jbc.M611319200; TAKANO E, 1992, MOL MICROBIOL, V6, P2797, DOI 10.1111/j.1365-2958.1992.tb01459.x; YAMADA Y, 1987, J ANTIBIOT, V40, P496; YANAGIMOTO M, 1988, J FERMENT BIOENG, V66, P1, DOI 10.1016/0385-6380(88)90121-5	34	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0175-7598	1432-0614		APPL MICROBIOL BIOT	Appl. Microbiol. Biotechnol.	DEC	2014	98	23					9713	9721		10.1007/s00253-014-5988-9		9	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AT7TN	WOS:000345140200016		
J	Geiseler, H; Ishii, N; Kaneshima, K; Kanai, T; Itatani, J				Geiseler, Henning; Ishii, Nobuhisa; Kaneshima, Keisuke; Kanai, Teruto; Itatani, Jiro			Long-term passive stabilization of the carrier-envelope phase of an intense infrared few-cycle pulse source	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							LASER-PULSES; GENERATION; STABILITY; OFFSET	We present long-term stability of the carrier-envelope phase of intense infrared few-cycle pulses at 1.6 mu m, generated by optical parametric chirped-pulse amplification. The employed system is based on a passive stabilization scheme that obviates the need for active feedback loops, and requires only control of environmental parameters. The stabilization is demonstrated to last for up to 45 h, during which the carrier-envelope phase drift is measured to be less than . This marks, to the best of our knowledge, the longest demonstrated phase-stable operation of a passively stabilized, amplified few-cycle source to date.	[Geiseler, Henning; Ishii, Nobuhisa; Kaneshima, Keisuke; Kanai, Teruto; Itatani, Jiro] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Geiseler, H (reprint author), Univ Tokyo, Inst Solid State Phys, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778581, Japan.	geiseler@issp.u-tokyo.ac.jp			Japan Society for the Promotion of Science [23226003, 25790063]; Photon Frontier Network Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This research was partially supported by Grant-in-Aid for Scientific Research (S), Grant Number 23226003, and Grant-in-Aid for Young Scientists (B), Grant Number 25790063, of the Japan Society for the Promotion of Science, and by the Photon Frontier Network Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Anderson A, 2011, APPL PHYS B-LASERS O, V103, P531, DOI 10.1007/s00340-011-4592-2; Renault A, 2007, OPT LETT, V32, P2363, DOI 10.1364/OL.32.002363; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Apolonski A, 2000, PHYS REV LETT, V85, P740, DOI 10.1103/PhysRevLett.85.740; PAULUS GG, 1994, J PHYS B-AT MOL OPT, V27, pL703, DOI 10.1088/0953-4075/27/21/003; Fuji T, 2004, OPT LETT, V29, P632, DOI 10.1364/OL.29.000632; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; Nisoli M, 1997, OPT LETT, V22, P522, DOI 10.1364/OL.22.000522; Koke S, 2010, NAT PHOTONICS, V4, P462, DOI [10.1038/NPHOTON.2010.91, 10.1038/nphoton.2010.91]; Paulus GG, 2001, NATURE, V414, P182, DOI 10.1038/35102520; OWENS JC, 1967, APPL OPTICS, V6, P51, DOI 10.1364/AO.6.000051; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Paulus GG, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.253004; Thai A, 2011, OPT LETT, V36, P3918, DOI 10.1364/OL.36.003918; Ishii N, 2012, OPT LETT, V37, P4182, DOI 10.1364/OL.37.004182; Cerullo G, 2011, LASER PHOTONICS REV, V5, P323, DOI 10.1002/lpor.201000013; Hauri CP, 2004, APPL PHYS B-LASERS O, V79, P673, DOI 10.1007/s00340-004-1650-z; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Steinmeyer G, 1999, SCIENCE, V286, P1507, DOI 10.1126/science.286.5444.1507; Hadrich S, 2012, OPT LETT, V37, P4910, DOI 10.1364/OL.37.004910; Lucking F, 2012, OPT LETT, V37, P2076, DOI 10.1364/OL.37.002076; Schatzel MG, 2004, APPL PHYS B-LASERS O, V79, P1021, DOI 10.1007/s00340-004-1663-7	22	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	DEC	2014	117	3					941	946		10.1007/s00340-014-5912-0		6	Optics; Physics, Applied	Optics; Physics	AU0RN	WOS:000345331900023		
J	Wakui, K; Hayasaka, K; Ido, T				Wakui, Kentaro; Hayasaka, Kazuhiro; Ido, Tetsuya			Generation of vacuum ultraviolet radiation by intracavity high-harmonic generation toward state detection of single trapped ions	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							ABSOLUTE FREQUENCY-MEASUREMENT; EXTREME-ULTRAVIOLET; THRESHOLD HARMONICS; REPETITION-RATE; LASER; SPECTROSCOPY; CAVITY; COMBS; TRANSITION; DISPERSION	Vacuum ultraviolet (VUV) radiation around 159 nm is obtained toward direct excitation of a single trapped In-115 + ion. An efficient fluoride-based VUV output coupler is employed for intracavity high-harmonic generation of a Ti:S oscillator. Using this coupler, where we measured its reflectance to be about 90 %, an average power reaching 6.4 mu W is coupled out from a modest fundamental power of 650 mW. When a single comb component out of 1.9 x 10(5) teeth is resonant to the atomic transition, 100s of fluorescence photons per second will be detectable under a realistic condition.	[Wakui, Kentaro; Hayasaka, Kazuhiro; Ido, Tetsuya] Natl Inst Informat & Commun, Koganei, Tokyo 1848795, Japan; [Ido, Tetsuya] Japan Sci & Technol Agcy, PRESTO, Honcho, Saitama 2230012, Japan	Wakui, K (reprint author), Natl Inst Informat & Commun, 4-2-1 Nukui Kitamachi, Koganei, Tokyo 1848795, Japan.	wakui@nict.go.jp			Use-of-UVSOR Facility Program (BL5B) of the Institute for Molecular Science [25-568]	The authors thank H. Hachisu, A. Yamaguchi, Y. Li, S. Nagano, H. Ishijima, M. Kumagai, M. Kajita, Y. Hanado, and M. Sasaki for discussions and support, and E. Sasaki for technical support. Part of this work was supported by the Use-of-UVSOR Facility Program (BL5B, No. 25-568) of the Institute for Molecular Science.	Allison TK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.183903; Herrmann M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052505; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Peik E, 2003, EUROPHYS LETT, V61, P181, DOI 10.1209/epl/i2003-00210-x; Bloom BJ, 2014, NATURE, V506, P71, DOI 10.1038/nature12941; HANSCH TW, 1980, OPT COMMUN, V35, P441, DOI 10.1016/0030-4018(80)90069-3; Jones RJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.193201; Wang YH, 2007, OPT COMMUN, V273, P526, DOI 10.1016/j.optcom.2007.01.068; Herrera-Sancho OA, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.012512; Pupeza I, 2011, OPT EXPRESS, V19, P12108, DOI 10.1364/OE.19.012108; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; DEHMELT HG, 1982, IEEE T INSTRUM MEAS, V31, P83; Pupeza I, 2013, NAT PHOTONICS, V7, P608, DOI [10.1038/nphoton.2013.156, 10.1038/NPHOTON.2013.156]; Ozawa A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.253901; Hammond TJ, 2009, OPT EXPRESS, V17, P8998, DOI 10.1364/OE.17.008998; Yost DC, 2009, NAT PHYS, V5, P815, DOI 10.1038/NPHYS1398; Schliesser A, 2006, OPT EXPRESS, V14, P5975, DOI 10.1364/OE.14.005975; Beck BR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.142501; Gohle C, 2005, NATURE, V436, P234, DOI 10.1038/nature03851; ALLISON R, 1964, J OPT SOC AM, V54, P747, DOI 10.1364/JOSA.54.000747; Rellergert WG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.200802; Kanai T, 2004, J OPT SOC AM B, V21, P370, DOI 10.1364/JOSAB.21.000370; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; Herschbach N, 2012, APPL PHYS B-LASERS O, V107, P891, DOI 10.1007/s00340-011-4790-y; Kolbe D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.063901; Guthohrlein GR, 2001, NATURE, V414, P49, DOI 10.1038/35102129; Ozawa A, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.022507; von Zanthier J, 2000, OPT LETT, V25, P1729; Cingoz A, 2012, NATURE, V482, P68, DOI 10.1038/nature10711; Ruehl A, 2010, OPT LETT, V35, P3015, DOI 10.1364/OL.35.003015; Lee J, 2011, OPT EXPRESS, V19, P23315, DOI 10.1364/OE.19.023315; Thorpe MJ, 2005, OPT EXPRESS, V13, P882, DOI 10.1364/OPEX.13.000882; Campbell CJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.223001; Carlson DR, 2011, OPT LETT, V36, P2991, DOI 10.1364/OL.36.002991; CARUSO AJ, 1981, APPL OPTICS, V20, P1764, DOI 10.1364/AO.20.001764; Hammond TJ, 2011, OPT EXPRESS, V19, P24871, DOI 10.1364/OE.19.024871; Hayasaka K, 2012, APPL PHYS B-LASERS O, V107, P965, DOI 10.1007/s00340-012-4909-9; JOHNSON FS, 1951, J OPT SOC AM, V41, P702, DOI 10.1364/JOSA.41.000702; Katori H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.173005; Mahajan N., 2005, J OPT SOC AM A, V22, P1824; National Research Council, 2009, SCI ASS HIGH POW FRE; Nomura Y, 2011, OPT LETT, V36, P1758, DOI 10.1364/OL.36.001758; Paul J, 2008, OPT LETT, V33, P2482, DOI 10.1364/OL.33.002482; Pronin O, 2011, OPT EXPRESS, V19, P10232, DOI 10.1364/OE.19.010232; Samson J A R, 1967, TECHNIQUES VACUUM UL; Samson J.A.R., 1998, VACUUM ULTRAVIOLET S; Ushijima I., 2014, ARXIV14054071PHYSICS; Wakui K, 2011, PROC SPIE, V8132, DOI 10.1117/12.894949; WATANABE K, 1953, J OPT SOC AM, V43, P32, DOI 10.1364/JOSA.43.000032; Yang YY, 2011, OPT EXPRESS, V19, P1954, DOI 10.1364/OE.19.001954; Yost DC, 2008, OPT LETT, V33, P1099, DOI 10.1364/OL.33.001099; Zheng J., 2014, ARXIV14063921QUANTPH	53	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	DEC	2014	117	3					957	967		10.1007/s00340-014-5914-y		11	Optics; Physics, Applied	Optics; Physics	AU0RN	WOS:000345331900025		
J	Minami, Y				Minami, Yasuo			Surface tension measurement of liquid metal with inelastic light-scattering spectroscopy of a thermally excited capillary wave	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							MOLECULAR-DYNAMICS; VAPOR INTERFACE	Thermally excited capillary waves propagate everywhere on a liquid surface. The relationship between the frequency and wavelength of the capillary wave reflects the surface tension of the liquid, and the lifetime of the capillary wave reflects the shear viscosity of the liquid. By observing a capillary wave with inelastic light-scattering spectroscopy, we can obtain the surface tension and the viscosity from the frequency modulation of the light and the spectral width of the scattered light. In this study, we observed capillary waves on liquid metal using high-resolution spectroscopy, and successfully measured their properties in a non-contact manner. In the experiment, values were obtained at a frequency of about 20 kHz. The values were equivalent to those at 0 Hz, since the properties of liquid metals are constant at least in the frequency region from 0 to several tens of kilohertz.	Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan	Minami, Y (reprint author), Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan.	minamiyasuo@ynu.ac.jp	Minami, Yasuo/H-4834-2013	Minami, Yasuo/0000-0002-3382-9160	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	This work was partly supported by a Grant-in-Aid for the Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Yoshitake Y, 2005, J APPL PHYS, V97, DOI 10.1063/1.1839640; Sakai K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2387864; Hou HY, 2009, COMP MATER SCI, V46, P516, DOI 10.1016/j.commatsci.2009.04.001; Egry I, 2005, INT J THERMOPHYS, V26, P931, DOI 10.1007/s10765-005-6675-y; Fiori L, 2005, J MATER SCI, V40, P2155, DOI 10.1007/s10853-005-1907-x; Gonzalez DJ, 2007, J NON-CRYST SOLIDS, V353, P3560, DOI 10.1016/j.jnoncrysol.2007.05.115; Hsieh PY, 2009, IEEE T MAGN, V45, P319, DOI 10.1109/TMAG.2008.2008547; Kolevzon V, 1997, PHYS REV E, V55, P3134, DOI 10.1103/PhysRevE.55.3134; LANGEVIN D, 1981, J COLLOID INTERF SCI, V80, P412, DOI 10.1016/0021-9797(81)90200-9; Levich V. G., 1962, PHYSICOCHEMICAL HYDR; Minami Y, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3072604; Minami Y, 2006, JPN J APPL PHYS 1, V45, P4469, DOI 10.1143/JJAP.45.4469; Munoz MG, 2003, LANGMUIR, V19, P2147, DOI 10.1021/la0206007; Saiz E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041602; Tay A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3002424	15	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-2171	1432-0649		APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	DEC	2014	117	3					969	972		10.1007/s00340-014-5915-x		4	Optics; Physics, Applied	Optics; Physics	AU0RN	WOS:000345331900026		
J	Yanaba, K; Umezawa, Y; Ito, T; Hayashi, M; Kikuchi, S; Fukuchi, O; Saeki, H; Nakagawa, H				Yanaba, Koichi; Umezawa, Yoshinori; Ito, Toshihiro; Hayashi, Mitsuha; Kikuchi, Sota; Fukuchi, Osamu; Saeki, Hidehisa; Nakagawa, Hidemi			Impact of obesity on the efficacy of ustekinumab in Japanese patients with psoriasis: a retrospective cohort study of 111 patients	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						Psoriasis; Ustekinumab; Obesity; Body mass index; Psoriasis area and severity index	BODY-MASS INDEX; INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; PLAQUE PSORIASIS; CONTROLLED-TRIAL; WEIGHT-LOSS; DOUBLE-BLIND; TNF-ALPHA; MODERATE; POPULATION; PREVALENCE	Obesity is thought to be involved in the pathogenesis of psoriasis, although its impact on the therapeutic response to systemic treatments remains unclear. The aim of this study was to examine the association of body mass index (BMI) with the efficacy of ustekinumab in Japanese patients with psoriasis. Clinical data from a cohort of 111 Japanese patients treated with ustekinumab 45 mg between July 2011 and March 2014 were retrospectively evaluated. The measured outcome was improvement in the psoriasis area and severity index (PASI) score at week 16. Patients with BMI a parts per thousand yen 25 and BMI < 25 had comparable rates of a parts per thousand yen50 and 75 % improvement in PASI (PASI-50 and PASI-75, respectively), whereas patients with BMI a parts per thousand yen 25 had significantly lower PASI-90 and PASI-100 response rates. Patients with BMI a parts per thousand yen 25 also showed significantly lower percent reduction in PASI than those with BMI < 25 at week 16 (85 vs. 74 %, P < 0.004). BMI was negatively correlated with percent reduction in PASI, whereas body weight was not. These results show that a higher BMI, but not body weight, is associated with lower effectiveness of ustekinumab for psoriasis. BMI a parts per thousand yen 25 could therefore be a negative predictor of achieving PASI-90 and PASI-100 in patients with psoriasis when starting ustekinumab.	[Yanaba, Koichi; Umezawa, Yoshinori; Ito, Toshihiro; Hayashi, Mitsuha; Kikuchi, Sota; Fukuchi, Osamu; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, Tokyo 1058641, Japan; [Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan	Yanaba, K (reprint author), Jikei Univ, Sch Med, Dept Dermatol, Minato Ku, 3-25-8 Nishishimbashi, Tokyo 1058641, Japan.	yanaba@jikei.ac.jp			Janssen Pharmaceuticals K K	H. Nakagawa has received consultant and speaker fees from Janssen Pharmaceuticals K K.	Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Wolk K, 2009, ACTA DERM-VENEREOL, V89, P492, DOI 10.2340/00015555-0711; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Naldi L, 2014, BRIT J DERMATOL, V170, P634, DOI 10.1111/bjd.12735; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Gisondi P, 2008, AM J CLIN NUTR, V88, P1242, DOI 10.3945/ajcn.2008.26427; Naldi L, 2008, DERMATOLOGY, V217, P365, DOI 10.1159/000156599; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Hossler EW, 2013, BRIT J DERMATOL, V168, P660, DOI 10.1111/j.1365-2133.2012.11211.x; Jensen P, 2013, JAMA DERMATOL, V149, P795, DOI 10.1001/jamadermatol.2013.722; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Tanaka S, 2001, CLIN ENDOCRINOL, V54, P347, DOI 10.1046/j.1365-2265.2001.1139/cn2155.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Zhu YW, 2009, J CLIN PHARMACOL, V49, P162, DOI 10.1177/0091270008329556; Lebwohl M, 2010, J AM ACAD DERMATOL, V63, P571, DOI 10.1016/j.jaad.2009.11.012; Driessen RJB, 2009, BRIT J DERMATOL, V160, P670, DOI 10.1111/j.1365-2133.2008.09019.x; Iannone F, 2013, SCAND J RHEUMATOL, V42, P41, DOI 10.3109/03009742.2012.715186; Lafuente-Urrez RF, 2014, EUR J DERMATOL, V24, P217, DOI 10.1684/ejd.2014.2278; LINDEGARD B, 1986, DERMATOLOGICA, V172, P298; Sumarac-Dumanovic M, 2009, INT J OBESITY, V33, P151, DOI 10.1038/ijo.2008.216; YIP SY, 1984, J AM ACAD DERMATOL, V10, P965, DOI 10.1016/S0190-9622(84)80314-X	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-3696	1432-069X		ARCH DERMATOL RES	Arch. Dermatol. Res.	DEC	2014	306	10					921	925		10.1007/s00403-014-1495-1		5	Dermatology	Dermatology	AT7DY	WOS:000345098300006		
J	Kakeda, M; Schlapbach, C; Danelon, G; Tang, MM; Cecchinato, V; Yawalkar, N; Uguccioni, M				Kakeda, M.; Schlapbach, Christoph; Danelon, G.; Tang, M. M.; Cecchinato, V.; Yawalkar, N.; Uguccioni, M.			Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis	ARCHIVES OF DERMATOLOGICAL RESEARCH			English	Article						IL-17A/F; AGEP; GPP; Innate immune cells; Mast cells; Neutrophils; Macrophages	IN-VIVO; INFLAMMATION; IDENTIFICATION; LYMPHOMA; MARKER	Acute generalized exanthematous pustulosis (AGEP) and generalized pustular psoriasis (GPP) are rare pustular skin disorders with systemic involvement. IL-17A/F is a proinflammatory cytokine involved in various neutrophilic inflammatory disorders. Here we show that IL-17A/F is highly expressed by innate immune cells such as neutrophils and mast cells in both AGEP and GPP.	[Kakeda, M.; Schlapbach, Christoph; Tang, M. M.; Yawalkar, N.] Inselspital Bern Univ Hosp, Dept Dermatol, CH-3010 Bern, Switzerland; [Kakeda, M.] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Danelon, G.; Cecchinato, V.; Uguccioni, M.] Biomed Res Inst, Bellinzona, Switzerland	Schlapbach, C (reprint author), Inselspital Bern Univ Hosp, Dept Dermatol, CH-3010 Bern, Switzerland.	christoph.schlapbach@insel.ch		Kakeda, Masato/0000-0001-9011-3655	European Union [ADITEC 280873, TIMER 281608]; Swiss National Science Foundation [3100A0-143718/1]; Helmut Horten Foundation	We thank Dagmar Simon for providing us with the ECP antibody. This study was supported by a grant from the European Union FP7 (ADITEC 280873 and TIMER 281608 to M. U.), the Swiss National Science Foundation (3100A0-143718/1 to M. U.) and the Helmut Horten Foundation.	Navarini AA, 2013, J INVEST DERMATOL, V133, P1904, DOI 10.1038/jid.2013.44; Girolomoni G, 2012, BRIT J DERMATOL, V167, P717, DOI 10.1111/j.1365-2133.2012.11099.x; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Schlapbach C, 2009, J AM ACAD DERMATOL, V61, P58, DOI 10.1016/j.jaad.2008.12.033; Zhao LS, 2004, J IMMUNOL METHODS, V293, P207, DOI 10.1016/j.jim.2004.08.009; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Keijsers RRMC, 2014, J INVEST DERMATOL, V134, P1276, DOI 10.1038/jid.2013.526; Vermi W, 2008, J PATHOL, V216, P356, DOI 10.1002/path.2420; Krueger JG, 2012, NAT MED, V18, P1750, DOI 10.1038/nm.3025; Dowlatshahi EA, 2013, BRIT J DERMATOL, V169, P266, DOI 10.1111/bjd.12355; Britschgi M, 2001, J CLIN INVEST, V107, P1433, DOI 10.1172/JCI12118; Song CW, 2008, J IMMUNOL, V181, P6117; Venetz D, 2010, INT J CANCER, V127, P2300, DOI 10.1002/ijc.25236; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Schaerli P, 2004, J IMMUNOL, V173, P2151; Kabashima R, 2011, J EUR ACAD DERMATOL, V25, P485, DOI 10.1111/j.1468-3083.2010.03771.x; Nakamizo S, 2010, BRIT J DERMATOL, V162, P1402, DOI 10.1111/j.1365-2133.2010.09705.x; Sidoroff A, 2001, J CUTAN PATHOL, V28, P113, DOI 10.1034/j.1600-0560.2001.028003113.x; Simon D, 2011, J ALLERGY CLIN IMMUN, V127, P194, DOI 10.1016/j.jaci.2010.11.002	24	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-3696	1432-069X		ARCH DERMATOL RES	Arch. Dermatol. Res.	DEC	2014	306	10					933	938		10.1007/s00403-014-1488-0		6	Dermatology	Dermatology	AT7DY	WOS:000345098300008		
J	Uchida, M; Hirasawa, T; Wachi, M				Uchida, Makoto; Hirasawa, Takashi; Wachi, Masaaki			Characterization of a Corynebacterium glutamicum dnaB mutant that shows temperature-sensitive growth and mini-cell formation	ARCHIVES OF MICROBIOLOGY			English	Article						Corynebacterium glutamicum; dnaB; Mini-cell; Cell division	COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; BREVIBACTERIUM-LACTOFERMENTUM; CORYNEFORM BACTERIA; BACILLUS-SUBTILIS; MICROBIAL-PRODUCTION; RESISTANT MUTANTS; POLAR GROWTH; AMINO-ACIDS; FTSZ GENE	Corynebacterium glutamicum is known to perform a unique form of cell division called post-fission snapping division. In order to investigate the mechanism of cell division of this bacterium, we isolated temperature-sensitive mutants from C. glutamicum wild-type strain ATCC 31831, and found that one of them, M45, produced high frequencies of mini-cells with no nucleoids. Cell pairs composed of an elongated cell, with one nucleoid, connected to a mini-cell, with no nucleoids, were occasionally observed. The temperature sensitivity and mini-cell formation of M45 was complemented by a 2-kb DraI-EcoRI fragment derived from the ATCC 31831 chromosomal DNA, which carried a dnaB homolog encoding a replicative DNA helicase. DNA sequence analysis revealed that M45 carried a missense mutation in the dnaB gene, which caused a substitution of Thr364 to Ile. Microscopic observation after 4E(1),6-diamidino-2-phenylindole staining revealed that the DNA content of single cells was decreased by culturing at the restrictive temperature, suggesting that the mutation affects chromosomal replication. These results suggest that the C. glutamicum dnaB mutant performs an asymmetric cell division even after DNA replication is inhibited, which results in the production of mini-cells.	[Uchida, Makoto; Hirasawa, Takashi; Wachi, Masaaki] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Wachi, M (reprint author), Tokyo Inst Technol, Dept Bioengn, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	thirasawa@bio.titech.ac.jp; mwachi@bio.titech.ac.jp	Wachi, Masaaki/D-1220-2015	Wachi, Masaaki/0000-0002-3655-4035			Lee CS, 2012, J MICROBIOL, V50, P860, DOI 10.1007/s12275-012-2109-2; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Cerdeno-Tarraga AM, 2003, NUCLEIC ACIDS RES, V31, P6516, DOI 10.1093/nar/gkg874; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Lv YY, 2011, J BACTERIOL, V193, P6096, DOI 10.1128/JB.06074-11; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Cole ST, 1998, NATURE, V393, P537; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; RICARD M, 1973, J BACTERIOL, V116, P314; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106; Ginda K, 2013, MOL MICROBIOL, V87, P998, DOI 10.1111/mmi.12146; NAKAYAMA K, 1961, J GEN APPL MICROBIOL, V7, P145, DOI 10.2323/jgam.7.145; UDAKA S, 1960, J BACTERIOL, V79, P754; ARAI K, 1979, P NATL ACAD SCI USA, V76, P4308, DOI 10.1073/pnas.76.9.4308; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; Donovan C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055078; Donovan C, 2012, MOL MICROBIOL, V84, P105, DOI 10.1111/j.1365-2958.2012.08011.x; Donovan C, 2010, J BACTERIOL, V192, P3441, DOI 10.1128/JB.00214-10; DREISEIKELMANN B, 1987, NUCLEIC ACIDS RES, V15, P385, DOI 10.1093/nar/15.2.385; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; GUNTHER E, 1984, MOL GEN GENET, V193, P225, DOI 10.1007/BF00330672; HIRAGA S, 1989, J BACTERIOL, V171, P1496; Hirasawa T, 2003, BIOSCI BIOTECH BIOCH, V67, P2416, DOI 10.1271/bbb.67.2416; HIROTA Y, 1968, J MOL BIOL, V35, P175, DOI 10.1016/S0022-2836(68)80046-4; Honrubia MP, 1998, MOL GEN GENET, V259, P97; Honrubia MP, 2001, MOL GENET GENOMICS, V265, P1022, DOI 10.1007/s004380100497; Jakimowicz D, 2006, J BACTERIOL, V188, P1710, DOI 10.1128/JB.188.5.1710-1720.2006; Kaito C, 2002, FEMS MICROBIOL LETT, V210, P157, DOI 10.1111/j.1574-6968.2002.tb11175.x; Kijima N, 1998, APPL MICROBIOL BIOT, V50, P227; Kinoshita S, 1957, J GEN APPL MICROBIOL, V3, P193, DOI 10.2323/jgam.3.193; Kobayashi M, 1997, BIOCHEM BIOPH RES CO, V236, P383, DOI 10.1006/bbrc.1997.6930; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; Lv YY, 2012, J BACTERIOL, V194, P742, DOI 10.1128/JB.06514-11; Malathi KC, 1999, FEMS MICROBIOL LETT, V175, P193, DOI 10.1111/j.1574-6968.1999.tb13619.x; Ramos A, 2005, MICROBIOL-SGM, V151, P2563, DOI 10.1099/mic.0.28036-0; ROGERS HJ, 1970, J GEN MICROBIOL, V61, P155; Rosario CJ, 2007, J BACTERIOL, V189, P8793, DOI 10.1128/JB.01361-07; SAKAMOTO Y, 1995, MICROBIOL-UK, V141, P641; SANO K, 1970, J GEN APPL MICROBIOL, V16, P373, DOI 10.2323/jgam.16.5_373; SCLAFANI RA, 1981, J BACTERIOL, V146, P418; SHIIO I, 1970, AGR BIOL CHEM TOKYO, V34, P448; TSUCHIDA T, 1975, AGR BIOL CHEM TOKYO, V39, P1319; Wachi M, 1999, APPL MICROBIOL BIOT, V51, P223; Wijayarathna CD, 2001, APPL MICROBIOL BIOT, V55, P466, DOI 10.1007/s002530000533; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	52	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	DEC	2014	196	12					871	879		10.1007/s00203-014-1026-7		9	Microbiology	Microbiology	AT7EA	WOS:000345098500005		
J	Kozono, N; Ikemura, S; Yamashita, A; Harada, T; Watanabe, T; Shirasawa, K				Kozono, Naoya; Ikemura, Satoshi; Yamashita, Akihisa; Harada, Takashi; Watanabe, Tetsuya; Shirasawa, Kenzo			Direct reduction may need to be considered to avoid postoperative subtype P in patients with an unstable trochanteric fracture: a retrospective study using a multivariate analysis	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Femur; Trochanteric fracture; Osteosynthesis; Intramedullary nail; Subtype	INTERNAL-FIXATION; HIP; FAILURE; MORTALITY; FEMUR; DELAY	Introduction It has recently been reported that the cases with an anterior femoral neck cortex posterior to the distal fragment (subtype P) in the lateral view of a postoperative radiograph have a risk of excessive sliding of lag screws compared to those located anterior to the distal fragment (subtype A) or perfectly continuous to the distal fragment (subtype N) following osteosynthesis for the treatment of a trochanteric fracture. The purpose of this study was to investigate factors that influence the postoperative subtype in the lateral view of radiographs. Patients and methods This study reviewed 136 patients who underwent osteosynthesis using an intramedullary hip nail for the treatment of a trochanteric fracture. A closed reduction was performed in 130 patients (95.6 %), while a direct reduction via a small elevator with a small skin incision was performed in the other six patients (4.4 %). The 136 patients were divided into two groups (subtype P and subtype A or N) based on postoperative radiographs taken of the lateral view. Both clinical and radiological factors were analyzed using the univariate and multivariable analyses. Results Thirty-nine patients (29 %) were categorized as subtype P and 97 patients (71 %) were categorized as subtype A or N. A multivariate analysis demonstrated that unstable fractures were associated with a significant risk of postoperative subtype P (Odds ratio: 24.45, P = 0.0024). Conclusions The results of this study suggest that direct reduction via a small elevator with a small skin incision or percutaneous intrafocal pinning may be needed in these cases.	[Kozono, Naoya; Ikemura, Satoshi; Yamashita, Akihisa; Harada, Takashi; Watanabe, Tetsuya; Shirasawa, Kenzo] Shimonoseki City Hosp, Dept Orthopaed Surg, Shimonoseki, Yamaguchi 7508520, Japan	Ikemura, S (reprint author), Shimonoseki City Hosp, Dept Orthopaed Surg, 1-13-1 Koyo Cho, Shimonoseki, Yamaguchi 7508520, Japan.	saikemura@gmail.com					Abram SGF, 2013, BONE JOINT J, V95B, P825, DOI 10.1302/0301-620X.95B6.31018; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; DAVIS TRC, 1990, J BONE JOINT SURG BR, V72, P26; KYLE RF, 1979, J BONE JOINT SURG AM, V61, P216; FIELDING JW, 1966, SURG GYNECOL OBSTETR, V122, P555; Baumgaertner MR, 1997, J BONE JOINT SURG BR, V79B, P969, DOI 10.1302/0301-620X.79B6.7949; Chen CM, 2001, ARCH ORTHOP TRAUM SU, V121, P505, DOI 10.1007/s004020100276; EBBINGHAUS S, 1991, UPSALA J MED SCI, V96, P235; EVANS EM, 1951, J BONE JOINT SURG BR, V33, P192; Ikuta T, 2002, KOSSETSU, V24, P158; JENSEN JS, 1980, ACTA ORTHOP SCAND, V51, P949, DOI 10.3109/17453678008990900; Kawatani Y, 2011, INJURY, V42, pS22, DOI 10.1016/S0020-1383(11)70008-0; Ochi R, 2001, KOSSETSU, V23, P408; Matelic TM, 1996, J ORTHOP TRAUMA, V10, P1, DOI 10.1097/00005131-199601000-00001; Tokunaga M, 2013, KOSSETSU, V35, P98; Tsukada S, 2012, ARCH ORTHOP TRAUM SU, V132, P839, DOI 10.1007/s00402-012-1484-9; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	DEC	2014	134	12					1649	1654		10.1007/s00402-014-2089-2		6	Orthopedics; Surgery	Orthopedics; Surgery	AT9ZJ	WOS:000345282500002		
J	Nishigori, H; Sugawara, J; Obara, T; Nishigori, T; Sato, K; Sugiyama, T; Okamura, K; Yaegashi, N				Nishigori, Hidekazu; Sugawara, Junichi; Obara, Taku; Nishigori, Toshie; Sato, Kineko; Sugiyama, Takashi; Okamura, Kunihiro; Yaegashi, Nobuo			Surveys of postpartum depression in Miyagi, Japan, after the Great East Japan Earthquake	ARCHIVES OF WOMENS MENTAL HEALTH			English	Article						Great East Japan Earthquake; Tsunami; Postpartum depression; Edinburgh Postnatal Depression Scale (EPDS)		This study explores the correlation between the impact of the Great East Japan Earthquake and the incidence of postpartum depression in Miyagi prefecture, Japan. The design used was a cross-sectional study with self-administered questionnaires, 6-9 months after the disaster. The results showed the prevalence of postnatal women with Edinburgh Postnatal Depression Scale (EPDS) score of a parts per thousand yen9 to be 21.3 %. Multivariate analysis showed that exposure to tsunami (odds ratio, 1.80; 95 % confidence interval, 1.16-2.78) was significantly and independently associated with an EPDS score of a parts per thousand yen9. Postnatal women and their children should be treated as a vulnerable population, and a protective framework must be established to prepare for future devastating disasters.	[Nishigori, Hidekazu; Sugawara, Junichi; Sugiyama, Takashi; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 9808573, Japan; [Sugawara, Junichi; Obara, Taku; Nishigori, Toshie; Yaegashi, Nobuo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 9808573, Japan; [Sato, Kineko] Tohoku Univ, Grad Sch Med, Dept Hlth Sci, Sendai, Miyagi 9808573, Japan; [Okamura, Kunihiro] Tohoku Kohsai Hosp, Sendai, Miyagi, Japan; [Sugawara, Junichi] Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Aoba Ku, Sendai, Miyagi 9808573, Japan	Sugawara, J (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Div Fetomaternal Med Sci, Aoba Ku, 2-1 Seiryocho, Sendai, Miyagi 9808573, Japan.	jsugawara@med.tohoku.ac.jp			Health Labour Sciences Research [H24]	This work was supported by the Health Labour Sciences Research Grant Number H24. Jisedai-shitei 006(fukkou).	Qu ZY, 2012, ARCH WOMEN MENT HLTH, V15, P49, DOI 10.1007/s00737-011-0255-x; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Ehrlich M, 2010, J WOMENS HEALTH, V19, P877, DOI 10.1089/jwh.2009.1693; Harville EW, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-21; Hibino Yuri, 2009, Environmental Health and Preventive Medicine, V14, P255, DOI 10.1007/s12199-009-0090-0; Okano T MM, 1996, ARCH PSYCHIAT DIAGN, V7, P525; Suzumiya H., 2004, KOUSEI NO SHIHYO, V51, P1; Xiong Xu, 2010, Am J Disaster Med, V5, P181	8	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	1434-1816	1435-1102		ARCH WOMEN MENT HLTH	Arch. Womens Ment. Health	DEC	2014	17	6					579	581		10.1007/s00737-014-0459-y		3	Psychiatry	Psychiatry	AU0RP	WOS:000345332100013		
J	Goh, M; Yon, KJ; Shimmi, Y; Hirai, T				Goh, Michael; Yon, Kyu Jin; Shimmi, Yukiko; Hirai, Tatsuya			Experiences of Asian psychologists and counselors trained in the USA: an exploratory study	ASIA PACIFIC EDUCATION REVIEW			English	Article						International students; Counseling psychology; Multicultural training; Sojourner experience; Reentry experience	INTERNATIONAL STUDENTS; HONG-KONG; MOTIVATIONS; DIRECTIONS; PROGRAMS	This study qualitatively explored the pre-departure to reentry experiences of Asian international psychologists and counselors trained in the USA. Semi-structured interviews were conducted with 10 participants from four different Asian countries. Inductive analysis with Consensual Qualitative Research methods was used to analyze the interview data. Three domains and 25 themes emerged from the analysis of the data, representing participants' key domains as motivation to study in the USA, various sojourn experiences, and multiple reentry challenges. Findings are discussed in terms of training applications for Asian counseling students as well as the cross-national application of US counseling training. Recommendations for educators, supervisors, and prospective international students are suggested.	[Goh, Michael] Univ Minnesota, Dept Org Leadership Policy & Dev, St Paul, MN USA; [Yon, Kyu Jin] Sogang Univ, Dept Psychol, Seoul 121742, South Korea; [Shimmi, Yukiko] Hitotsubashi Univ, Grad Sch Law, Kunitachi, Tokyo 186, Japan; [Hirai, Tatsuya] Ritsumeikan Asia Pacific Univ, Educ Dev & Learning Support Ctr, Beppu, Oita, Japan	Yon, KJ (reprint author), Sogang Univ, Dept Psychol, D336,35 Baekbeom Ro, Seoul 121742, South Korea.	kjyon@sogang.ac.kr					Abreu JM, 2000, COUNS PSYCHOL, V28, P641, DOI 10.1177/0011000000285003; Abu-Ein M. M., 1995, DISS ABSTR INT, V55, P2319; Adler N. J., 1981, GROUP ORGAN STUD, V6, P341, DOI 10.1177/105960118100600310; ALLEN GJ, 1986, PROF PSYCHOL-RES PR, V17, P91, DOI 10.1037//0735-7028.17.2.91; Altekruse M. K., 1991, COUNS EDUC SUPERV, V30, P178; Mittal M, 2006, J MARITAL FAM THER, V32, P369, DOI 10.1111/j.1752-0606.2006.tb01613.x; Hou ZJ, 2007, APPL PSYCHOL-INT REV, V56, P33; Marsella AJ, 1998, AM PSYCHOL, V53, P1282, DOI 10.1037//0003-066X.53.12.1282; Nilsson JE, 2004, PROF PSYCHOL-RES PR, V35, P306, DOI 10.1037/0735-7028.35.3.306; Nyaupane GP, 2011, INT J TOUR RES, V13, P205, DOI 10.1002/jtr.811; Wang KT, 2012, J COUNS PSYCHOL, V59, P424, DOI 10.1037/a0028532; Li M, 2007, HIGH EDUC, V53, P791, DOI 10.1007/s10734-005-5423-3; Park-Saltzman J, 2012, COUNS PSYCHOL, V40, P895, DOI 10.1177/0011000011429831; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Gaw KF, 2000, INT J INTERCULT REL, V24, P83, DOI 10.1016/S0147-1767(99)00024-3; Arthur N., 2004, COUNSELING INT STUDE; Arthur N., 2003, CANADIAN J COUNSELLI, V37, P173; Arulmani G, 2007, APPL PSYCHOL-INT REV, V56, P69, DOI 10.1111/j.1464-0597.2007.00276.x; Bang K, 2006, ASIA PAC EDUC REV, V7, P11; Bathurst L., 2012, STUDENT LEARNING ABR, P261; Bernard J. M., 2009, FUNDAMENTALS CLIN SU; Butcher A., 2002, J STUD INT EDUC, V6, P354, DOI 10.1177/102831502237641; Butler S. K., 2003, CLIN SUPERVISOR, V22, P125, DOI 10.1300/J001v22n01_09; Coward F. L., 2003, DISS ABSTR INT, V64, P66; Evans C. C., 2010, COMPARISON COUNSELOR; Fischer AR, 1998, COUNS PSYCHOL, V26, P525, DOI 10.1177/0011000098264001; Forrest L., 2008, 10 MINN INT COUNS I; Gama E., 1977, INT J INTERCULTURAL, V1, P46, DOI 10.1016/0147-1767(77)90031-1; Gerstein L. H., 2009, INT HDB CROSS CULTUR; Goh M, 2007, INT J ADV COUNS, V29, P187, DOI [10. 1007/ s10447- 007- 9038- 5, DOI 10.1007/S10447-007-9038-5]; Grant C. S., 1999, DISS ABSTR INT, V59, P5082; Gutierrez F. J., 1982, COUNS EDUC SUPERV, V3, P218, DOI 10.1002/j.1556-6978.1982.tb01705.x; Han Counseling Association, 2008, NEWSLETTER HAN COUNS, V3, P1; Hasan N. A., 2008, STUDYING PSYCHOL US; Heppner P. P., 2008, HDB COUNSELING PSYCH, P68; Heppner P. P., 2005, AM PSYCHOL ASS SOC C, V26, P1; Hood M. A., 1983, PROFESSIONAL INTEGRA; Hurley EJ, 2013, COUNS PSYCHOL, V41, P724, DOI 10.1177/0011000012436432; Inman A. G., 2008, STUDYING PSYCHOL US; Institute of International Education, 2014, OP DOORS 2013 REP IN; Jianvittayakit L., 2012, INTERDISCIPLINARY ST, V12, P172; Kim J., 1997, DISS ABSTR INT, V57, P4783; Kim Juhu, 2005, KEDI Journal of Educational Policy, V2, P7; Kogan M. J., 2000, MONITOR PSYCHOL, V31, P53; Kracen A. C., 2008, STUDYING PSYCHOL US, P151; Krueger R., 1994, FOCUS GROUPS PRACTIC; Leong FTL, 2000, COUNS PSYCHOL, V28, P5, DOI 10.1177/0011000000281001; Leong FTL, 2003, COUNS PSYCHOL, V31, P381, DOI 10.1177/0011000002250636; Leung SA, 2007, APPL PSYCHOL-INT REV, V56, P51; Lin J. G., 1997, COLL STUDENT J, V31, P473; Lloyd M. A., 2014, MASTERS DOCTORAL LEV; Marsella A. J., 2004, COUNS PSYCHOL, V17, P413, DOI [10.1080/09515070412331331246, DOI 10.1080/09515070412331331246]; MARTIN JN, 1984, INT J INTERCULT REL, V8, P115, DOI 10.1016/0147-1767(84)90035-X; Ng K. M., 2006, INT J ADV COUNS, V28, P1, DOI 10.1007/s10447-005-8492-1; Pai H. C., 1997, REENTRY DIFFICULTY L; Patton M. Q., 2002, QUALITATIVE RES EVAL, DOI [10.1037/0735-7028.35.3.306, DOI 10.1037/0735-7028.35.3.306]; Piaget J, 1985, EQUILIBRATION COGNIT; Rasichio R. A., 1987, J COLL STUDENT PERS, V28, P156; Samuel S., 2005, INTEGRATIVE ANTIRACI; Sanchez C. M., 2006, J TEACHING INT BUSIN, V18, P27; Seo YS, 2007, APPL PSYCHOL-INT REV, V56, P107; Sohn S., 2005, KOREAN J COUNSELING, V17, P57; Sussman M. N., 1986, INT J INTERCULTURAL, V10, P235, DOI [10.1016/0147-1767(86)90008-8, DOI 10.1016/0147-1767(86)90008-8]; Thompson C. L., 2006, INT J ADV COUNS, V28, P21, DOI [10.1007/s10447-005-8493-0, DOI 10.1007/S10447-005-8493-0]; Turner-Essel L, 2009, COUNS PSYCHOL, V37, P877, DOI 10.1177/0011000009336149; Watanabe-Muraoka AM, 2007, APPL PSYCHOL-INT REV, V56, P97; Yeh C. J., 2003, COUNS PSYCHOL, V16, P15, DOI DOI 10.1080/0951507031000114058; Ying Y., 2003, COLL STUDENT J, V37, P470; Yoo S. K., 2005, J MENTAL HLTH COUNSE, V27, P266; ZIMMERMANN S, 1995, COMMUN EDUC, V44, P321	70	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1598-1037	1876-407X		ASIA PAC EDUC REV	Asia Pac. Educ. Rev.	DEC	2014	15	4					593	608		10.1007/s12564-014-9347-4		16	Education & Educational Research	Education & Educational Research	AT6UB	WOS:000345073600009		
J	Suenaga, M; Mizunuma, N; Matsusaka, S; Shinozaki, E; Ueno, M; Yamaguchi, T				Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Matsusaka, Satoshi; Shinozaki, Eiji; Ueno, Masashi; Yamaguchi, Toshiharu			Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first-line treatment in Japanese patients with metastatic colorectal cancer	ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY			English	Article						bevacizumab; FOLFOX4; metastatic colorectal cancer; overall survival; progression-free survival	PHASE-II; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; TRIAL; CHEMOTHERAPY; COMBINATION; IRINOTECAN; FOLFIRI; GERCOR	Aims: Past reports have suggested that the addition of bevacizumab (BV) to oxaliplatin combined with 5-fluorouracil (5-FU) and folinic acid (leucovorin) (FOLFOX4) provides a limited survival benefit in metastatic colorectal cancer (mCRC). Our study aimed to evaluate the survival benefits of a FOLFOX4 + BV regimen. Methods: Patients with mCRC who started treatment between April 2005 and July 2008 were evaluated in this retrospective cohort study. Patients received FOLFOX4, or FOLFOX4 + BV after the approval of BV in 2007. The two cohorts treated before and after BV approval were compared. Primary end-points were progression-free survival (PFS), overall survival (OS) and response rate (RR). Results: A total of 213 patients received either FOLFOX4 (n = 128) or FOLFOX4 + BV (n = 85). For FOLFOX4 and FOLFOX4 + BV respectively, median PFS was 9.9 and 17.0 months (HR, 0.58; 95% CI, 0.42-0.82; P = 0.002), median OS was 20.5 and 38.8 months (HR, 0.49; 95% CI, 0.34-0.71; P < 0.001), respectively. Patients who received 5-fluorouracil plus leucovorin (FL) as maintenance therapy during oxaliplatin suspension in both FOLFOX4 (n = 6) and FOLFOX4 + BV (n = 46) groups showed a trend to improved median PFS and median OS. Conclusions: The additive effect and potential survival benefits of adding BV to the FOLFOX4 regimen in first-line treatment of mCRC were demonstrated. Maintenance FL during suspension of oxaliplatin appeared to be an important factor in better survival.	[Suenaga, Mitsukuni; Mizunuma, Nobuyuki; Matsusaka, Satoshi; Shinozaki, Eiji] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo 1358550, Japan; [Ueno, Masashi; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo 1358550, Japan	Suenaga, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	m.suenaga@jfcr.or.jp					Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Welch S, 2010, ANN ONCOL, V21, P1152, DOI 10.1093/annonc/mdp533; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Chibaudel B, 2009, J CLIN ONCOL, V27, P5727, DOI 10.1200/JCO.2009.23.4344; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Loupakis F, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-58; National Cancer Center Center for Cancer Control and Information Services, 2012, CANC STAT JAP	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1743-7555	1743-7563		ASIA-PAC J CLIN ONCO	Asia-Pac. J. Clin. Oncol.	DEC	2014	10	4					322	329		10.1111/ajco.12094		8	Oncology	Oncology	AT8TW	WOS:000345205700005		
J	Lackner, CN; Silverman, JD; Salvato, M; Kampczyk, P; Kartaltepe, JS; Sanders, D; Capak, P; Civano, F; Halliday, C; Ilbert, O; Jahnke, K; Koekemoer, AM; Lee, N; Le Fevre, O; Liu, CT; Scoville, N; Sheth, K; Toft, S				Lackner, C. N.; Silverman, J. D.; Salvato, M.; Kampczyk, P.; Kartaltepe, J. S.; Sanders, D.; Capak, P.; Civano, F.; Halliday, C.; Ilbert, O.; Jahnke, K.; Koekemoer, A. M.; Lee, N.; Le Fevre, O.; Liu, C. T.; Scoville, N.; Sheth, K.; Toft, S.			LATE-STAGE GALAXY MERGERS IN COSMOS TO z similar to 1	ASTRONOMICAL JOURNAL			English	Article						galaxies: active; galaxies: formation; galaxies: interactions; techniques: image processing	ACTIVE GALACTIC NUCLEI; DIGITAL SKY SURVEY; SUPERMASSIVE BLACK-HOLES; DEEP-FIELD-SOUTH; ULTRALUMINOUS INFRARED GALAXIES; EXTRAGALACTIC LEGACY SURVEY; TELESCOPE ADVANCED CAMERA; STELLAR MASS FUNCTION; LESS-THAN 1.5; REDSHIFT SURVEY	The role of major mergers in galaxy and black hole formation is not well-constrained. To help address this, we develop an automated method to identify late-stage galaxy mergers before coalescence of the galactic cores. The resulting sample of mergers is distinct from those obtained using pair-finding and morphological indicators. Our method relies on median-filtering of high-resolution images to distinguish two concentrated galaxy nuclei at small separations. This method does not rely on low surface brightness features to identify mergers, and is therefore reliable to high redshift. Using mock images, we derive statistical contamination and incompleteness corrections for the fraction of late-stage mergers. The mock images show that our method returns an uncontaminated (<10%) sample of mergers with projected separations between 2.2 and 8 kpc out to z similar to 1. We apply our new method to a magnitude-limited (m(FW 814) < 23) sample of 44,164 galaxies from the COSMOS HST/ACS catalog. Using a mass-complete sample with log M-*/M-circle dot > 10.6 and 0.25 < z <= 1.00, we find similar to 5% of systems are late-stage mergers. Correcting for incompleteness and contamination, the fractional merger rate increases strongly with redshift as R-merge proportional to (1 + z)(3.8 +/- 0.9), in agreement both with earlier studies and with dark matter halo merger rates. Separating the sample into star-forming and quiescent galaxies shows that the merger rate for star-forming galaxies increases strongly with redshift, (1 + z)(4.5 +/- 1.3), while the merger rate for quiescent galaxies is consistent with no evolution, (1 + z)(1.1 +/- 1.2). The merger rate also becomes steeper with decreasing stellar mass. Limiting our sample to galaxies with spectroscopic redshifts from zCOSMOS, we find that the star formation rates and X-ray selected active galactic nucleus (AGN) activity in likely late-stage mergers are higher by factors of similar to 2 relative to those of a control sample. Combining our sample with more widely separated pairs, we find that 8 +/- 5% of star formation and 20 +/- 8% of AGN activity are triggered by close encounters (<143 kpc) or mergers, providing additional evidence that major mergers are not the only channels for star formation and black hole growth.	[Lackner, C. N.; Silverman, J. D.] Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan; [Salvato, M.] Max Planck Inst Extraterr Phys, D-84571 Garching, Germany; [Kampczyk, P.] ETH, Dept Phys, Inst Astron, CH-8093 Zurich, Switzerland; [Kartaltepe, J. S.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Sanders, D.; Lee, N.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Capak, P.; Scoville, N.] CALTECH, Pasadena, CA 91125 USA; [Civano, F.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Civano, F.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Ilbert, O.; Le Fevre, O.] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, F-13388 Marseille, France; [Jahnke, K.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Koekemoer, A. M.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Liu, C. T.] CUNY Coll Staten Isl, Astrophys Observ, Staten Isl, NY 10314 USA; [Sheth, K.] Natl Radio Astron Observ, NAASC, Charlottesville, VA 22903 USA; [Toft, S.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark	Lackner, CN (reprint author), Univ Tokyo, Kavli IPMU WPI, Kashiwa, Chiba 2778583, Japan.	claire.lackner@ipmu.jp	Koekemoer, Anton/F-8400-2014	Koekemoer, Anton/0000-0002-6610-2048	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Lundbeck Foundation; Danish National Research Foundation	We thank the referee for insightful comments that greatly improved this work. We also thank Richard Massey and Kevin Bundy for helpful comments on a draft. This work was supported by the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. S. T. acknowledges support from the Lundbeck Foundation. The Dark Cosmology Centre is funded by the Danish National Research Foundation. This research has made use of the NASA/IPAC Infrared Science Archive, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration. This research made use of APLpy, an open-source plotting package for Python hosted at http://aplpy.github.com	Alonso MS, 2007, MON NOT R ASTRON SOC, V375, P1017, DOI 10.1111/j.1365-2966.2007.11367.x; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P356, DOI 10.1086/524362; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Comerford JM, 2009, ASTROPHYS J LETT, V702, pL82, DOI 10.1088/0004-637X/702/1/L82; Patton DR, 2013, MON NOT R ASTRON SOC, V433, pL59, DOI 10.1093/mnrasl/slt058; Woods DF, 2007, ASTRON J, V134, P527, DOI 10.1086/519381; Darg DW, 2010, MON NOT R ASTRON SOC, V401, P1043, DOI 10.1111/j.1365-2966.2009.15686.x; Guo Q, 2008, MON NOT R ASTRON SOC, V384, P2, DOI 10.1111/J.1365-2966.2007.12619.X; Le Fevre O, 2000, MON NOT R ASTRON SOC, V311, P565, DOI 10.1046/j.1365-8711.2000.03083.x; ABRAHAM RG, 1994, ASTROPHYS J, V432, P75, DOI 10.1086/174550; BARNES JE, 1992, ANNU REV ASTRON ASTR, V30, P705; LACEY C, 1993, MON NOT R ASTRON SOC, V262, P627; Lin L, 2010, ASTROPHYS J, V718, P1158, DOI 10.1088/0004-637X/718/2/1158; Moustakas J, 2006, ASTROPHYS J, V642, P775, DOI 10.1086/500964; Lilly SJ, 2009, ASTROPHYS J SUPPL S, V184, P218, DOI 10.1088/0067-0049/184/2/218; Massey R, 2010, MON NOT R ASTRON SOC, V401, P371, DOI 10.1111/j.1365-2966.2009.15638.x; Fakhouri O, 2010, MON NOT R ASTRON SOC, V406, P2267, DOI 10.1111/j.1365-2966.2010.16859.x; de Ravel L, 2009, ASTRON ASTROPHYS, V498, P379, DOI 10.1051/0004-6361/200810569; Salvato M, 2009, ASTROPHYS J, V690, P1250, DOI 10.1088/0004-637X/690/2/1250; Civano F, 2010, ASTROPHYS J, V717, P209, DOI 10.1088/0004-637X/717/1/209; Kitzbichler MG, 2008, MON NOT R ASTRON SOC, V391, P1489, DOI 10.1111/j.1365-2966.2008.13873.x; Ilbert O, 2010, ASTROPHYS J, V709, P644, DOI 10.1088/0004-637X/709/2/644; HERNQUIST L, 1989, NATURE, V340, P687, DOI 10.1038/340687a0; Somerville RS, 2008, MON NOT R ASTRON SOC, V391, P481, DOI 10.1111/j.1365-2966.2008.13805.x; Lotz JM, 2004, ASTRON J, V128, P163, DOI 10.1086/421849; Balogh ML, 1999, ASTROPHYS J, V527, P54, DOI 10.1086/308056; Scarlata C, 2007, ASTROPHYS J SUPPL S, V172, P406, DOI 10.1086/516582; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Bundy K, 2009, ASTROPHYS J, V697, P1369, DOI 10.1088/0004-637X/697/2/1369; Di Matteo T, 2008, ASTROPHYS J, V676, P33, DOI 10.1086/524921; Ilbert O, 2009, ASTROPHYS J, V690, P1236, DOI 10.1088/0004-637X/690/2/1236; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Kauffmann G, 2004, MON NOT R ASTRON SOC, V353, P713, DOI 10.1111/j.1365-2966.2004.08117.x; Di Matteo P, 2007, ASTRON ASTROPHYS, V468, P61, DOI 10.1051/0004-6361:20066959; Brusa M, 2010, ASTROPHYS J, V716, P348, DOI 10.1088/0004-637X/716/1/348; Robaina AR, 2010, ASTROPHYS J, V719, P844, DOI 10.1088/0004-637X/719/1/844; Johansson PH, 2009, ASTROPHYS J LETT, V707, pL184, DOI 10.1088/0004-637X/707/2/L184; Kuchinski LE, 2000, ASTROPHYS J SUPPL S, V131, P441, DOI 10.1086/317371; Lotz JM, 2010, MON NOT R ASTRON SOC, V404, P590, DOI 10.1111/j.1365-2966.2010.16269.x; Lotz JM, 2008, MON NOT R ASTRON SOC, V391, P1137, DOI 10.1111/j.1365-2966.2008.14004.x; Barton EJ, 2000, ASTROPHYS J, V530, P660, DOI 10.1086/308392; De Propris R, 2007, ASTROPHYS J, V666, P212, DOI 10.1086/520488; Koekemoer AM, 2007, ASTROPHYS J SUPPL S, V172, P196, DOI 10.1086/520086; Abraham RG, 2003, ASTROPHYS J, V588, P218, DOI 10.1086/373919; Bordoloi R, 2010, MON NOT R ASTRON SOC, V406, P881, DOI 10.1111/j.1365-2966.2010.16765.x; Ellison SL, 2008, ASTRON J, V135, P1877, DOI 10.1088/0004-6256/135/5/1877; Leauthaud A, 2007, ASTROPHYS J SUPPL S, V172, P219, DOI 10.1086/516598; Jogee S, 2009, ASTROPHYS J, V697, P1971, DOI 10.1088/0004-637X/697/2/1971; Conselice CJ, 2003, ASTRON J, V126, P1183, DOI 10.1086/377318; KEEL WC, 1985, ASTRON J, V90, P708, DOI 10.1086/113779; Fiore F, 2008, ASTROPHYS J, V672, P94, DOI 10.1086/523348; Ellison SL, 2011, MON NOT R ASTRON SOC, V418, P2043, DOI 10.1111/j.1365-2966.2011.19624.x; Hopkins PF, 2009, MON NOT R ASTRON SOC, V397, P802, DOI 10.1111/j.1365-2966.2009.14983.x; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Lotz JM, 2008, ASTROPHYS J, V672, P177, DOI 10.1086/523659; Kartaltepe JS, 2010, ASTROPHYS J, V721, P98, DOI 10.1088/0004-637X/721/1/98; Lotz JM, 2010, MON NOT R ASTRON SOC, V404, P575, DOI 10.1111/j.1365-2966.2010.16268.x; Dey A, 2008, ASTROPHYS J, V677, P943, DOI 10.1086/529516; Jahnke K, 2009, ASTROPHYS J LETT, V706, pL215, DOI 10.1088/0004-637X/706/2/L215; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P1, DOI 10.1086/516585; Bridge CR, 2010, ASTROPHYS J, V709, P1067, DOI 10.1088/0004-637X/709/2/1067; Lambas DG, 2003, MON NOT R ASTRON SOC, V346, P1189, DOI 10.1111/j.1365-2966.2003.07179.x; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V166, P1, DOI 10.1086/505753; Liu X, 2010, ASTROPHYS J LETT, V715, pL30, DOI 10.1088/2041-8205/715/1/L30; Dale DA, 2002, ASTROPHYS J, V576, P159, DOI 10.1086/341632; Lilly SJ, 2007, ASTROPHYS J SUPPL S, V172, P70, DOI 10.1086/516589; Scudder JM, 2012, MON NOT R ASTRON SOC, V426, P549, DOI 10.1111/j.1365-2966.2012.21749.x; Wu H, 1998, ASTRON ASTROPHYS SUP, V132, P181, DOI 10.1051/aas:1998443; Sanders DB, 2007, ASTROPHYS J SUPPL S, V172, P86, DOI 10.1086/517885; Mihos JC, 1996, ASTROPHYS J, V464, P641, DOI 10.1086/177353; BARNES JE, 1991, ASTROPHYS J, V370, pL65, DOI 10.1086/185978; Bournaud F, 2007, ASTROPHYS J, V670, P237, DOI 10.1086/522077; Bell EF, 2006, ASTROPHYS J, V652, P270, DOI 10.1086/508408; Berrier JC, 2006, ASTROPHYS J, V652, P56, DOI 10.1086/507573; Bolzonella M, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/200912801; Bongiorno A, 2012, MON NOT R ASTRON SOC, V427, P3103, DOI 10.1111/j.1365-2966.2012.22089.x; CARLBERG RG, 1994, ASTROPHYS J, V435, P540, DOI 10.1086/174835; Cassata P, 2005, MON NOT R ASTRON SOC, V357, P903, DOI 10.1111/j.1365-2966.2005.08657.x; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Cisternas M, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/57; Civano F, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/30; Conselice CJ, 2003, ASTROPHYS J SUPPL S, V147, P1, DOI 10.1086/375001; Conselice CJ, 2006, ASTROPHYS J, V638, P686, DOI 10.1086/499067; Conselice CJ, 2009, MON NOT R ASTRON SOC, V394, P1956, DOI 10.1111/j.1365-2966.2009.14396.x; Cui J, 2001, ASTRON J, V122, P63, DOI 10.1086/321127; Darg DW, 2010, MON NOT R ASTRON SOC, V401, P1552, DOI 10.1111/j.1365-2966.2009.15786.x; de Ravel L., 2011, ARXIV11045470; Donley JL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/142; Elbaz D, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014687; Ellison SL, 2013, MON NOT R ASTRON SOC, V435, P3627, DOI 10.1093/mnras/stt1562; Elvis M, 2009, ASTROPHYS J SUPPL S, V184, P158, DOI 10.1088/0067-0049/184/1/158; Genzel R, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/101; Grogin NA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/35; Hopkins P. F., 2013, ARXIV13096231; Hung CL, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/129; Ilbert O, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201321100; Kampczyk P, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/43; Kampczyk P, 2007, ASTROPHYS J SUPPL S, V172, P329, DOI 10.1086/516594; Kartaltepe JS, 2007, ASTROPHYS J SUPPL S, V172, P320, DOI 10.1086/519953; Kartaltepe J. S., 2014, ARXIV14012455; Kartaltepe JS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/23; Kennicutt RC, 1998, ASTROPHYS J, V498, P541; KENNICUTT RC, 1984, ASTROPHYS J, V279, pL5, DOI 10.1086/184243; Kocevski DD, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/148; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Koss M, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/57; Koss M, 2012, ASTROPHYS J LETT, V746, DOI 10.1088/2041-8205/746/2/L22; Le Floc'h E, 2005, ASTROPHYS J, V632, P169, DOI 10.1086/432789; Le Floc'h E, 2009, ASTROPHYS J, V703, P222, DOI 10.1088/0004-637X/703/1/222; Li C, 2008, MON NOT R ASTRON SOC, V385, P1915, DOI 10.1111/j.1365-2966.2008.13023.x; Lin LW, 2008, ASTROPHYS J, V681, P232, DOI 10.1086/587928; Lin LW, 2004, ASTROPHYS J, V617, pL9, DOI 10.1086/427183; Liu X, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/94; Lopez-Sanjuan C, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220286; Lopez-Sanjuan C, 2009, ASTRON ASTROPHYS, V501, P505, DOI 10.1051/0004-6361/200911923; Lopez-Sanjuan C, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219085; Lopez-Sanjuan C, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201015839; Lotz JM, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/103; Maier C, 2009, ASTROPHYS J, V694, P1099, DOI 10.1088/0004-637X/694/2/1099; Masjedi M, 2008, ASTROPHYS J, V679, P260, DOI 10.1086/586696; McCracken HJ, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219507; MIHOS JC, 1992, ASTROPHYS J, V400, P153, DOI 10.1086/171980; Moore B, 1996, ASTROPHYS J, V457, P455, DOI 10.1086/176745; Newman AB, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/162; OKE JB, 1974, ASTROPHYS J SUPPL S, V27, P21, DOI 10.1086/190287; Papovich C, 2003, ASTROPHYS J, V598, P827, DOI 10.1086/378976; Patton DR, 2002, ASTROPHYS J, V565, P208, DOI 10.1086/324543; Patton DR, 2000, ASTROPHYS J, V536, P153, DOI 10.1086/308907; Patton DR, 2008, ASTROPHYS J, V685, P235, DOI 10.1086/590542; Pozzetti L, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/200913020; Robaina AR, 2009, ASTROPHYS J, V704, P324, DOI 10.1088/0004-637X/704/1/324; Salvato M, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/61; Sargent MT, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L31; Satyapal S, 2014, MON NOT R ASTRON SOC, V441, P1297, DOI 10.1093/mnras/stu650; Schawinski K, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L31; Schramm M, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/13; SECKER J, 1995, PUBL ASTRON SOC PAC, V107, P496, DOI 10.1086/133580; Shi Y, 2009, ASTROPHYS J, V697, P1764, DOI 10.1088/0004-637X/697/2/1764; Silverman JD, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/2; Smolcic V, 2008, ASTROPHYS J SUPPL S, V177, P14, DOI 10.1086/588028; Tasca LAM, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201321507; TOOMRE A, 1972, ASTROPHYS J, V178, P623, DOI 10.1086/151823; Williams RJ, 2011, ASTROPHYS J LETT, V738, DOI 10.1088/2041-8205/738/2/L25; Xu CK, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/72; ZEPF SE, 1989, ASTROPHYS J, V337, P34, DOI 10.1086/167085	146	7	8	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	DEC	2014	148	6							137	10.1088/0004-6256/148/6/137		27	Astronomy & Astrophysics	Astronomy & Astrophysics	AT9BP	WOS:000345223200033		
J	Aartsen, MG; Ackermann, M; Adams, J; Aguilar, JA; Ahlers, M; Ahrens, M; Altmann, D; Anderson, T; Arguelles, C; Arlen, TC; Auffenberg, J; Bai, X; Barwick, SW; Baum, V; Beatty, JJ; Tjus, JB; Becker, KH; BenZvi, S; Berghaus, P; Berley, D; Bernardini, E; Bernhard, A; Besson, DZ; Binder, G; Bindig, D; Bissok, M; Blaufuss, E; Blumenthal, J; Boersma, DJ; Bohm, C; Bos, F; Bose, D; Boser, S; Botner, O; Brayeur, L; Bretz, HP; Brown, AM; Casey, J; Casier, M; Cheung, E; Chirkin, D; Christov, A; Christy, B; Clark, K; Classen, L; Clevermann, F; Coenders, S; Cowen, DF; Silva, AHC; Danninger, M; Daughhetee, J; Davis, JC; Day, M; de Andre, JPAM; De Clercq, C; De Ridder, S; Desiati, P; de Vries, KD; de With, M; DeYoung, T; Diaz-Velez, JC; Dunkman, M; Eagan, R; Eberhardt, B; Eichmann, B; Eisch, J; Euler, S; Evenson, PA; Fadiran, O; Fazely, AR; Fedynitch, A; Feintzeig, J; Felde, J; Feusels, T; Filimonov, K; Finley, C; Fischer-Wasels, T; Flis, S; Franckowiak, A; Frantzen, K; Fuchs, T; Gaisser, TK; Gallagher, J; Gerhardt, L; Gier, D; Gladstone, L; Glusenkamp, T; Goldschmidt, A; Golup, G; Gonzalez, JG; Goodman, JA; Gora, D; Grandmont, DT; Grant, D; Gretskov, P; Groh, JC; Gross, A; Ha, C; Haack, C; Ismail, AH; Hallen, P; Hallgren, A; Halzen, F; Hanson, K; Hebecker, D; Heereman, D; Heinen, D; Helbing, K; Hellauer, R; Hellwig, D; Hickford, S; Hill, GC; Hoffman, KD; Hoffmann, R; Homeier, A; Hoshina, K; Huang, F; Huelsnitz, W; Hulth, PO; Hultqvist, K; Hussain, S; Ishihara, A; Jacobi, E; Jacobsen, J; Jagielski, K; Japaridze, GS; Jero, K; Jlelati, O; Jurkovic, M; Kaminsky, B; Kappes, A; Karg, T; Karle, A; Kauer, M; Kelley, JL; Kheirandish, A; Kiryluk, J; Klas, J; Klein, SR; Kohne, JH; Kohnen, G; Kolanoski, H; Koob, A; Kopke, L; Kopper, C; Kopper, S; Koskinen, DJ; Kowalski, M; Kriesten, A; Krings, K; Kroll, G; Kroll, M; Kunnen, J; Kurahashi, N; Kuwabara, T; Labare, M; Larsen, DT; Larson, MJ; Lesiak-Bzdak, M; Leuermann, M; Leute, J; Lunemann, J; Macias, O; Madsen, J; Maggi, G; Maruyama, R; Mase, K; Matis, HS; Maunu, R; McNally, F; Meagher, K; Medici, M; Meli, A; Meures, T; Miarecki, S; Middell, E; Middlemas, E; Milke, N; Miller, J; Mohrmann, L; Montaruli, T; Morse, R; Nahnhauer, R; Naumann, U; Niederhausen, H; Nowicki, SC; Nygren, DR; Obertacke, A; Odrowski, S; Olivas, A; Omairat, A; O'Murchadha, A; Palczewski, T; Paul, L; Penek, O; Pepper, JA; Heros, CPD; Pfendner, C; Pieloth, D; Pinat, E; Posselt, J; Price, PB; Przybylski, GT; Putz, J; Quinnan, M; Radel, L; Rameez, M; Rawlins, K; Redl, P; Rees, I; Reimann, R; Resconi, E; Rhode, W; Richman, M; Riedel, B; Robertson, S; Rodrigues, JP; Rongen, M; Rott, C; Ruhe, T; Ruzybayev, B; Ryckbosch, D; Saba, SM; Sander, HG; Sandroos, J; Santander, M; Sarkar, S; Schatto, K; Scheriau, F; Schmidt, T; Schmitz, M; Schoenen, S; Schoneberg, S; Schonwald, A; Schukraft, A; Schulte, L; Schulz, O; Seckel, D; Sestayo, Y; Seunarine, S; Shanidze, R; Sheremata, C; Smith, MWE; Soldin, D; Spiczak, GM; Spiering, C; Stamatikos, M; Stanev, T; Stanisha, NA; Stasik, A; Stezelberger, T; Stokstad, RG; Stossl, A; Strahler, EA; Strom, R; Strotjohann, NL; Sullivan, GW; Taavola, H; Taboada, I; Tamburro, A; Tepe, A; Ter-Antonyan, S; Terliuk, A; Tesic, G; Tilav, S; Toale, PA; Tobin, MN; Tosi, D; Tselengidou, M; Unger, E; Usner, M; Vallecorsa, S; van Eijndhoven, N; Vandenbroucke, J; van Santen, J; Vehring, M; Voge, M; Vraeghe, M; Walck, C; Wallraff, M; Weaver, C; Wellons, M; Wendt, C; Westerhoff, S; Whelan, BJ; Whitehorn, N; Wichary, C; Wiebe, K; Wiebusch, CH; Williams, DR; Wissing, H; Wolf, M; Wood, TR; Woschnagg, K; Xu, DL; Xu, XW; Yanez, JP; Yodh, G; Yoshida, S; Zarzhitsky, P; Ziemann, J; Zierke, S; Zoll, M				Aartsen, M. G.; Ackermann, M.; Adams, J.; Aguilar, J. A.; Ahlers, M.; Ahrens, M.; Altmann, D.; Anderson, T.; Arguelles, C.; Arlen, T. C.; Auffenberg, J.; Bai, X.; Barwick, S. W.; Baum, V.; Beatty, J. J.; Tjus, J. Becker; Becker, K. -H.; BenZvi, S.; Berghaus, P.; Berley, D.; Bernardini, E.; Bernhard, A.; Besson, D. Z.; Binder, G.; Bindig, D.; Bissok, M.; Blaufuss, E.; Blumenthal, J.; Boersma, D. J.; Bohm, C.; Bos, F.; Bose, D.; Boeser, S.; Botner, O.; Brayeur, L.; Bretz, H. -P.; Brown, A. M.; Casey, J.; Casier, M.; Cheung, E.; Chirkin, D.; Christov, A.; Christy, B.; Clark, K.; Classen, L.; Clevermann, F.; Coenders, S.; Cowen, D. F.; Silva, A. H. Cruz; Danninger, M.; Daughhetee, J.; Davis, J. C.; Day, M.; de Andre, J. P. A. M.; De Clercq, C.; De Ridder, S.; Desiati, P.; de Vries, K. D.; de With, M.; DeYoung, T.; Diaz-Velez, J. C.; Dunkman, M.; Eagan, R.; Eberhardt, B.; Eichmann, B.; Eisch, J.; Euler, S.; Evenson, P. A.; Fadiran, O.; Fazely, A. R.; Fedynitch, A.; Feintzeig, J.; Felde, J.; Feusels, T.; Filimonov, K.; Finley, C.; Fischer-Wasels, T.; Flis, S.; Franckowiak, A.; Frantzen, K.; Fuchs, T.; Gaisser, T. K.; Gallagher, J.; Gerhardt, L.; Gier, D.; Gladstone, L.; Gluesenkamp, T.; Goldschmidt, A.; Golup, G.; Gonzalez, J. G.; Goodman, J. A.; Gora, D.; Grandmont, D. T.; Grant, D.; Gretskov, P.; Groh, J. C.; Gross, A.; Ha, C.; Haack, C.; Ismail, A. Haj; Hallen, P.; Hallgren, A.; Halzen, F.; Hanson, K.; Hebecker, D.; Heereman, D.; Heinen, D.; Helbing, K.; Hellauer, R.; Hellwig, D.; Hickford, S.; Hill, G. C.; Hoffman, K. D.; Hoffmann, R.; Homeier, A.; Hoshina, K.; Huang, F.; Huelsnitz, W.; Hulth, P. O.; Hultqvist, K.; Hussain, S.; Ishihara, A.; Jacobi, E.; Jacobsen, J.; Jagielski, K.; Japaridze, G. S.; Jero, K.; Jlelati, O.; Jurkovic, M.; Kaminsky, B.; Kappes, A.; Karg, T.; Karle, A.; Kauer, M.; Kelley, J. L.; Kheirandish, A.; Kiryluk, J.; Klaes, J.; Klein, S. R.; Koehne, J. -H.; Kohnen, G.; Kolanoski, H.; Koob, A.; Koepke, L.; Kopper, C.; Kopper, S.; Koskinen, D. J.; Kowalski, M.; Kriesten, A.; Krings, K.; Kroll, G.; Kroll, M.; Kunnen, J.; Kurahashi, N.; Kuwabara, T.; Labare, M.; Larsen, D. T.; Larson, M. J.; Lesiak-Bzdak, M.; Leuermann, M.; Leute, J.; Luenemann, J.; Macias, O.; Madsen, J.; Maggi, G.; Maruyama, R.; Mase, K.; Matis, H. S.; Maunu, R.; McNally, F.; Meagher, K.; Medici, M.; Meli, A.; Meures, T.; Miarecki, S.; Middell, E.; Middlemas, E.; Milke, N.; Miller, J.; Mohrmann, L.; Montaruli, T.; Morse, R.; Nahnhauer, R.; Naumann, U.; Niederhausen, H.; Nowicki, S. C.; Nygren, D. R.; Obertacke, A.; Odrowski, S.; Olivas, A.; Omairat, A.; O'Murchadha, A.; Palczewski, T.; Paul, L.; Penek, O.; Pepper, J. A.; Heros, C. Perez De Los; Pfendner, C.; Pieloth, D.; Pinat, E.; Posselt, J.; Price, P. B.; Przybylski, G. T.; Puetz, J.; Quinnan, M.; Raedel, L.; Rameez, M.; Rawlins, K.; Redl, P.; Rees, I.; Reimann, R.; Resconi, E.; Rhode, W.; Richman, M.; Riedel, B.; Robertson, S.; Rodrigues, J. P.; Rongen, M.; Rott, C.; Ruhe, T.; Ruzybayev, B.; Ryckbosch, D.; Saba, S. M.; Sander, H. -G.; Sandroos, J.; Santander, M.; Sarkar, S.; Schatto, K.; Scheriau, F.; Schmidt, T.; Schmitz, M.; Schoenen, S.; Schoeneberg, S.; Schoenwald, A.; Schukraft, A.; Schulte, L.; Schulz, O.; Seckel, D.; Sestayo, Y.; Seunarine, S.; Shanidze, R.; Sheremata, C.; Smith, M. W. E.; Soldin, D.; Spiczak, G. M.; Spiering, C.; Stamatikos, M.; Stanev, T.; Stanisha, N. A.; Stasik, A.; Stezelberger, T.; Stokstad, R. G.; Stoessl, A.; Strahler, E. A.; Strom, R.; Strotjohann, N. L.; Sullivan, G. W.; Taavola, H.; Taboada, I.; Tamburro, A.; Tepe, A.; Ter-Antonyan, S.; Terliuk, A.; Tesic, G.; Tilav, S.; Toale, P. A.; Tobin, M. N.; Tosi, D.; Tselengidou, M.; Unger, E.; Usner, M.; Vallecorsa, S.; van Eijndhoven, N.; Vandenbroucke, J.; van Santen, J.; Vehring, M.; Voge, M.; Vraeghe, M.; Walck, C.; Wallraff, M.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whelan, B. J.; Whitehorn, N.; Wichary, C.; Wiebe, K.; Wiebusch, C. H.; Williams, D. R.; Wissing, H.; Wolf, M.; Wood, T. R.; Woschnagg, K.; Xu, D. L.; Xu, X. W.; Yanez, J. P.; Yodh, G.; Yoshida, S.; Zarzhitsky, P.; Ziemann, J.; Zierke, S.; Zoll, M.		IceCube Collaboration	SEARCHES FOR EXTENDED AND POINT-LIKE NEUTRINO SOURCES WITH FOUR YEARS OF ICECUBE DATA	ASTROPHYSICAL JOURNAL			English	Article						astroparticle physics; galaxies: active; galaxies: clusters: general; galaxies: starburst; ISM: supernova remnants; neutrinos	HIGH-ENERGY NEUTRINOS; ACTIVE GALACTIC NUCLEI; GAMMA-RAY EMISSION; SUPERNOVA-REMNANTS; PARTICLE-ACCELERATION; COSMIC-RAYS; FERMI LAT; TELESCOPE; ASTRONOMY; MILAGRO	We present results on searches for point-like sources of neutrinos using four years of IceCube data, including the first year of data from the completed 86 string detector. The total livetime of the combined data set is 1373 days. For an E-2 spectrum, the observed 90% C. L. flux upper limits are similar to 10(-12) TeV-1 cm(-2) s(-1) for energies between 1 TeV and 1 PeV in the northern sky and similar to 10(-11) TeV-1 cm(-2) s(-1) for energies between 100 TeV and 100 PeV in the southern sky. This represents a 40% improvement compared to previous publications, resulting from both the additional year of data and the introduction of improved reconstructions. In addition, we present the first results from an all-sky search for extended sources of neutrinos. We update the results of searches for neutrino emission from stacked catalogs of sources and test five new catalogs; two of Galactic supernova remnants and three of active galactic nuclei. In all cases, the data are compatible with the background-only hypothesis, and upper limits on the flux of muon neutrinos are reported for the sources considered.	[Aartsen, M. G.; Hill, G. C.; Robertson, S.; Whelan, B. J.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Ackermann, M.; Berghaus, P.; Bernardini, E.; Bretz, H. -P.; Silva, A. H. Cruz; Gluesenkamp, T.; Gora, D.; Jacobi, E.; Kaminsky, B.; Karg, T.; Middell, E.; Mohrmann, L.; Nahnhauer, R.; Schoenwald, A.; Shanidze, R.; Spiering, C.; Stoessl, A.; Terliuk, A.; Yanez, J. P.] DESY, D-15735 Zeuthen, Germany; [Adams, J.; Hickford, S.; Macias, O.] Univ Canterbury, Dept Phys & Astron, Christchurch 1, New Zealand; [Aguilar, J. A.; Christov, A.; Montaruli, T.; Rameez, M.; Vallecorsa, S.] Univ Geneva, Dept Phys Nucl & Corpusculaire, CH-1211 Geneva, Switzerland; [Ahlers, M.; Arguelles, C.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Velez, J. C.; Eisch, J.; Fadiran, O.; Feintzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kauer, M.; Kelley, J. L.; Kheirandish, A.; Kopper, C.; Kurahashi, N.; Larsen, D. T.; Maruyama, R.; McNally, F.; Middlemas, E.; Morse, R.; Rees, I.; Riedel, B.; Rodrigues, J. P.; Santander, M.; Tobin, M. N.; Tosi, D.; Vandenbroucke, J.; van Santen, J.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Ahlers, M.; Arguelles, C.; BenZvi, S.; Chirkin, D.; Day, M.; Desiati, P.; Diaz-Velez, J. C.; Eisch, J.; Fadiran, O.; Feintzeig, J.; Gladstone, L.; Halzen, F.; Hoshina, K.; Jacobsen, J.; Jero, K.; Karle, A.; Kauer, M.; Kelley, J. L.; Kheirandish, A.; Kopper, C.; Kurahashi, N.; Larsen, D. T.; Maruyama, R.; McNally, F.; Middlemas, E.; Morse, R.; Rees, I.; Riedel, B.; Rodrigues, J. P.; Santander, M.; Tobin, M. N.; Tosi, D.; Vandenbroucke, J.; van Santen, J.; Weaver, Ch.; Wellons, M.; Wendt, C.; Westerhoff, S.; Whitehorn, N.] Univ Wisconsin, Wisconsin IceCube Particle Astrophys Ctr, Madison, WI 53706 USA; [Ahrens, M.; Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Ahrens, M.; Bohm, C.; Danninger, M.; Finley, C.; Flis, S.; Hulth, P. O.; Hultqvist, K.; Walck, C.; Wolf, M.; Zoll, M.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Altmann, D.; Classen, L.; Kappes, A.; Tselengidou, M.] Univ Erlangen Nurnberg, Erlangen Ctr Astroparticle Phys, D-91058 Erlangen, Germany; [Anderson, T.; Arlen, T. C.; Cowen, D. F.; de Andre, J. P. A. M.; DeYoung, T.; Dunkman, M.; Eagan, R.; Huang, F.; Quinnan, M.; Smith, M. W. E.; Stanisha, N. A.; Tesic, G.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Auffenberg, J.; Bissok, M.; Blumenthal, J.; Gier, D.; Gretskov, P.; Haack, C.; Hallen, P.; Heinen, D.; Hellwig, D.; Jagielski, K.; Koob, A.; Kriesten, A.; Krings, K.; Leuermann, M.; Paul, L.; Penek, O.; Puetz, J.; Reimann, R.; Riedel, B.; Rongen, M.; Schoenen, S.; Schukraft, A.; Vehring, M.; Wallraff, M.; Wichary, C.; Wiebusch, C. H.; Zierke, S.] Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; [Bai, X.] South Dakota Sch Mines & Technol, Dept Phys, Rapid City, SD 57701 USA; [Barwick, S. W.; Yodh, G.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Baum, V.; Eberhardt, B.; Koepke, L.; Luenemann, J.; Schatto, K.; Wiebe, K.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Beatty, J. J.; Davis, J. C.; Pfendner, C.; Stamatikos, M.] Ohio State Univ, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Beatty, J. J.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Tjus, J. Becker; Bos, F.; Eichmann, B.; Fedynitch, A.; Kroll, M.; Saba, S. M.; Schoeneberg, S.; Unger, E.] Ruhr Univ Bochum, Fak Phys & Astron, D-44780 Bochum, Germany; [Becker, K. -H.; Bindig, D.; Fischer-Wasels, T.; Helbing, K.; Hoffmann, R.; Klaes, J.; Kopper, S.; Naumann, U.; Obertacke, A.; Omairat, A.; Posselt, J.; Soldin, D.; Tepe, A.] Univ Wuppertal, Dept Phys, D-42119 Wuppertal, Germany; [Berley, D.; Blaufuss, E.; Cheung, E.; Christy, B.; Felde, J.; Goodman, J. A.; Hellauer, R.; Hoffman, K. D.; Maunu, R.; Meagher, K.; Olivas, A.; Redl, P.; Richman, M.; Schmidt, T.; Sullivan, G. W.; Wissing, H.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Bernhard, A.; Coenders, S.; Gross, A.; Jurkovic, M.; Leute, J.; Resconi, E.; Schulz, O.; Sestayo, Y.] Tech Univ Munich, D-85748 Garching, Germany; [Besson, D. Z.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Binder, G.; Gerhardt, L.; Goldschmidt, A.; Ha, C.; Klein, S. R.; Matis, H. S.; Miarecki, S.; Nygren, D. R.; Przybylski, G. T.; Stezelberger, T.; Stokstad, R. G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Binder, G.; Filimonov, K.; Gerhardt, L.; Ha, C.; Klein, S. R.; Miarecki, S.; Price, P. B.; Woschnagg, K.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Boersma, D. J.; Botner, O.; Euler, S.; Hallgren, A.; Heros, C. Perez De Los; Strom, R.; Taavola, H.] Uppsala Univ, Dept Phys & Astron, S-75120 Uppsala, Sweden; [Bose, D.; Rott, C.] Sungkyunkwan Univ, Dept Phys, Suwon 440746, South Korea; [Boeser, S.; Franckowiak, A.; Hebecker, D.; Homeier, A.; Kowalski, M.; Schulte, L.; Stasik, A.; Strotjohann, N. L.; Usner, M.; Voge, M.] Univ Bonn, Inst Phys, D-53115 Bonn, Germany; [Brayeur, L.; Casier, M.; De Clercq, C.; de Vries, K. D.; Golup, G.; Kunnen, J.; Maggi, G.; Miller, J.; Strahler, E. A.; van Eijndhoven, N.] Vrije Univ Brussel, Dienst ELEM, B-1050 Brussels, Belgium; [Casey, J.; Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Daughhetee, J.; Taboada, I.] Georgia Inst Technol, Ctr Relativist Astrophys, Atlanta, GA 30332 USA; [Clark, K.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Clevermann, F.; Frantzen, K.; Fuchs, T.; Koehne, J. -H.; Milke, N.; Pieloth, D.; Rhode, W.; Ruhe, T.; Scheriau, F.; Schmitz, M.; Ziemann, J.] TU Dortmund, Dept Phys, D-44221 Dortmund, Germany; [Cowen, D. F.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [De Ridder, S.; Feusels, T.; Ismail, A. Haj; Jlelati, O.; Labare, M.; Meli, A.; Ryckbosch, D.; Vraeghe, M.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium; [de With, M.; Kolanoski, H.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Hussain, S.; Kuwabara, T.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Evenson, P. A.; Gaisser, T. K.; Gonzalez, J. G.; Hussain, S.; Kuwabara, T.; Ruzybayev, B.; Seckel, D.; Stanev, T.; Tamburro, A.; Tilav, S.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Fazely, A. R.; Ter-Antonyan, S.; Xu, X. W.] Southern Univ, Dept Phys, Baton Rouge, LA 70813 USA; [Gallagher, J.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Grandmont, D. T.; Grant, D.; Nowicki, S. C.; Odrowski, S.; Sheremata, C.; Wood, T. R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Hanson, K.; Heereman, D.; Meures, T.; O'Murchadha, A.; Pinat, E.] Univ Libre Bruxelles, Fac Sci, B-1050 Brussels, Belgium; [Hoshina, K.] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Ishihara, A.; Mase, K.; Yoshida, S.] Chiba Univ, Dept Phys, Chiba 2638522, Japan; [Japaridze, G. S.] Clark Atlanta Univ, CTSPS, Atlanta, GA 30314 USA; [Kiryluk, J.; Lesiak-Bzdak, M.; Niederhausen, H.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Kohnen, G.] Univ Mons, B-7000 Mons, Belgium; [Koskinen, D. J.; Larson, M. J.; Medici, M.; Sandroos, J.; Sarkar, S.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Madsen, J.; Seunarine, S.; Spiczak, G. M.] Univ Wisconsin, Dept Phys, River Falls, WI 54022 USA; [Palczewski, T.; Pepper, J. A.; Toale, P. A.; Williams, D. R.; Xu, D. L.; Zarzhitsky, P.] Univ Alabama, Dept Phys & Astron, Tuscaloosa, AL 35487 USA; [Rawlins, K.] Univ Alaska Anchorage, Dept Phys & Astron, Anchorage, AK 99508 USA; [Sarkar, S.] Univ Oxford, Dept Phys, Oxford OX1 3NP, England; [Stamatikos, M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Aartsen, MG (reprint author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia.		Koskinen, David/G-3236-2014; Auffenberg, Jan/D-3954-2014; Maruyama, Reina/A-1064-2013; Beatty, James/D-9310-2011; Sarkar, Subir/G-5978-2011; Aguilar Sanchez, Juan Antonio/H-4467-2015; Taavola, Henric/B-4497-2011; 	Strotjohann, Nora Linn/0000-0002-4667-6730; Larsen, Dag Toppe/0000-0002-9898-2174; Koskinen, David/0000-0002-0514-5917; Schukraft, Anne/0000-0002-9112-5479; Auffenberg, Jan/0000-0002-1185-9094; Maruyama, Reina/0000-0003-2794-512X; Groh, John/0000-0001-9880-3634; Sarkar, Subir/0000-0002-3542-858X; Aguilar Sanchez, Juan Antonio/0000-0003-2252-9514; Rott, Carsten/0000-0002-6958-6033; Taavola, Henric/0000-0002-2604-2810; Ter-Antonyan, Samvel/0000-0002-5788-1369	U. S. National Science Foundation-Office of Polar Programs; U. S. National Science Foundation-Physics Division; University of Wisconsin Alumni Research Foundation; Grid Laboratory of Wisconsin (GLOW); University of Wisconsin-Madison; Open Science Grid (OSG); U.S. Department of Energy; National Energy Research Scientific Computing Center; Louisiana Optical Network Initiative (LONI); Natural Sciences and Engineering Research Council of Canada; West-Grid and Compute/Calcul Canada; Swedish Research Council; Swedish Polar Research Secretariat; Swedish National Infrastructure for Computing (SNIC); Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF); Deutsche Forschungsgemeinschaft (DFG); Helmholtz Alliance for Astroparticle Physics (HAP); Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO); FWO Odysseus programme; Flanders Institute to encourage scientific and technological research in industry (IWT); Belgian Federal Science Policy Office (Belspo); University of Oxford, United Kingdom; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); Swiss National Science Foundation (SNSF), Switzerland; National Research Foundation of Korea (NRF); Danish National Research Foundation, Denmark (DNRF)	We acknowledge the support from the following agencies: U. S. National Science Foundation-Office of Polar Programs, U.S. National Science Foundation-Physics Division, University of Wisconsin Alumni Research Foundation, the Grid Laboratory of Wisconsin (GLOW) grid infrastructure at the University of Wisconsin-Madison, the Open Science Grid (OSG) grid infrastructure; U.S. Department of Energy, and National Energy Research Scientific Computing Center, the Louisiana Optical Network Initiative (LONI) grid computing resources; Natural Sciences and Engineering Research Council of Canada, West-Grid and Compute/Calcul Canada; Swedish Research Council, Swedish Polar Research Secretariat, Swedish National Infrastructure for Computing (SNIC), and Knut and Alice Wallenberg Foundation, Sweden; German Ministry for Education and Research (BMBF), Deutsche Forschungsgemeinschaft (DFG), Helmholtz Alliance for Astroparticle Physics (HAP), Research Department of Plasmas with Complex Interactions (Bochum), Germany; Fund for Scientific Research (FNRS-FWO), FWO Odysseus programme, Flanders Institute to encourage scientific and technological research in industry (IWT), Belgian Federal Science Policy Office (Belspo); University of Oxford, United Kingdom; Marsden Fund, New Zealand; Australian Research Council; Japan Society for Promotion of Science (JSPS); the Swiss National Science Foundation (SNSF), Switzerland; National Research Foundation of Korea (NRF); Danish National Research Foundation, Denmark (DNRF).	Aartsen MG, 2013, SCIENCE, V342, P947, DOI 10.1126/science.1242856; Aartsen M. G., 2013, ARXIV13056811 ICECUB; Aartsen MG, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/132; Aartsen MG, 2014, J INSTRUM, V9, DOI 10.1088/1748-0221/9/03/P03009; Aartsen M. G., 2013, NIMPA, V736, P143; Abbasi R, 2010, NUCL INSTRUM METH A, V618, P139, DOI 10.1016/j.nima.2010.03.102; Abbasi R, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/18; Abdo AA, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/159; Abdo AA, 2009, ASTROPHYS J LETT, V700, pL127, DOI 10.1088/0004-637X/700/2/L127; Ackermann M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/171; Adrian-Martinez S, 2014, ASTROPHYS J LETT, V786, DOI 10.1088/2041-8205/786/1/L5; Ahrens J, 2004, NUCL INSTRUM METH A, V524, P169, DOI 10.1016/j.nima.2004.01.065; Alvarez-Muniz J, 2002, ASTROPHYS J, V576, pL33, DOI 10.1086/342978; Anchordoqui L. A., 2014, J HIGH ENERGY ASTROP, V1-2, P1, DOI DOI 10.1016/JJHEAP.2014.01.001; Ackermann M, 2013, SCIENCE, V339, P807, DOI 10.1126/science.1231160; Learned JG, 2000, ANNU REV NUCL PART S, V50, P679, DOI 10.1146/annurev.nucl.50.1.679; Gonzalez-Garcia MC, 2014, ASTROPART PHYS, V57-58, P39, DOI 10.1016/j.astropartphys.2014.04.001; Abdo AA, 2010, SCIENCE, V327, P1103, DOI 10.1126/science.1182787; Murase K, 2008, ASTROPHYS J LETT, V689, pL105, DOI 10.1086/595882; Abdo AA, 2009, ASTROPHYS J LETT, V706, pL1, DOI 10.1088/0004-637X/706/1/L1; Essey W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.141102; Waxman E, 1997, PHYS REV LETT, V78, P2292, DOI 10.1103/PhysRevLett.78.2292; Mucke A, 2003, ASTROPART PHYS, V18, P593, DOI 10.1016/S0927-6505(02)00185-8; Anchordoqui LA, 2010, ANNU REV NUCL PART S, V60, P129, DOI 10.1146/annurev.nucl.012809.104551; Halzen F, 2002, REP PROG PHYS, V65, P1025, DOI 10.1088/0034-4885/65/7/201; Waxman E, 1999, PHYS REV D, V59; Becker JK, 2008, PHYS REP, V458, P173, DOI 10.1016/j.physrep.2007.10.006; Atoyan A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.221102; Neronov A, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.083008; Kalashev OE, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.041103; Aartsen MG, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.101101; GREISEN K, 1966, PHYS REV LETT, V16, P748, DOI 10.1103/PhysRevLett.16.748; Murase K, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.121301; Kappes A, 2007, ASTROPHYS J, V656, P870, DOI 10.1086/508936; Abdo AA, 2007, ASTROPHYS J, V664, pL91, DOI 10.1086/520717; STECKER FW, 1991, PHYS REV LETT, V66, P2697, DOI 10.1103/PhysRevLett.66.2697; Amato E, 2003, ASTRON ASTROPHYS, V402, P827, DOI 10.1051/0004-6361:20030279; Vissani F, 2011, ASTROPART PHYS, V34, P778, DOI 10.1016/j.astropartphys.2011.01.011; De Marco D, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.043004; Abbasi R, 2009, NUCL INSTRUM METH A, V601, P294, DOI 10.1016/j.nima.2009.01.001; Murase K, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.023007; Achterberg A, 2006, ASTROPART PHYS, V26, P155, DOI 10.1016/j.astropartphys.2006.06.007; Guetta D, 2004, ASTROPART PHYS, V20, P429, DOI 10.1016/S0927-6505(03)00211-1; Aartsen MG, 2013, NUCL INSTRUM METH A, V711, P73, DOI 10.1016/j.nima.2013.01.054; Braun J, 2010, ASTROPART PHYS, V33, P175, DOI 10.1016/j.astropartphys.2010.01.005; Auge E., 2013, P 48 RENC MOR LA THU; Becker J. K., 2009, ARXIV09011775; Bednarek W, 2003, ASTRON ASTROPHYS, V407, P1, DOI 10.1051/0004-6361:20030929; Caramete LI, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/200913146; Castro D, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/85; Cavasinni V, 2006, ASTROPART PHYS, V26, P41, DOI 10.1016/j.astropartphys.2006.04.009; Ferrand G, 2012, ADV SPACE RES, V49, P1313, DOI 10.1016/j.asr.2012.02.004; Halzen F, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.063004; Honda M, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.043006; Lacki BC, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/107; Link B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.181101; Link B, 2006, MON NOT R ASTRON SOC, V371, P375, DOI 10.1111/j.1365-2966.2006.10665.x; Loeb A, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2006/05/003; Mandelartz M., 2013, ARXIV13012437; Meszaros P., 2006, RPPH, V69, P2259; Murase K., 2012, JCAP, V02, P028; Neunhoffer T, 2006, ASTROPART PHYS, V25, P220, DOI 10.1016/j.astropartphys.2006.01.002; Neyman J., 1937, RSPTA, V236, P333; Romero GE, 2003, ASTROPHYS J, V586, pL33, DOI 10.1086/374654; Sedov L, 1946, PMM-J APPL MATH MEC, V10, P241; Sironi L, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/75; Szabelski J., 2009, P 31 INT COSM RAY C; Tchernin C, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201321801; Whitehorn N, 2013, COMPUT PHYS COMMUN, V184, P2214, DOI 10.1016/j.cpc.2013.04.008; Wolfe B, 2008, ASTROPHYS J, V687, P193, DOI 10.1086/591723	70	13	14	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							109	10.1088/0004-637X/796/2/109		14	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900038		
J	Casey, CM; Scoville, NZ; Sanders, DB; Lee, N; Cooray, A; Finkelstein, SL; Capak, P; Conley, A; De Zotti, G; Farrah, D; Fu, H; Le Floc'h, E; Ilbert, O; Ivison, RJ; Takeuchi, TT				Casey, C. M.; Scoville, N. Z.; Sanders, D. B.; Lee, N.; Cooray, A.; Finkelstein, S. L.; Capak, P.; Conley, A.; De Zotti, G.; Farrah, D.; Fu, H.; Le Floc'h, E.; Ilbert, O.; Ivison, R. J.; Takeuchi, T. T.			ARE DUSTY GALAXIES BLUE? INSIGHTS ON UV ATTENUATION FROM DUST-SELECTED GALAXIES	ASTROPHYSICAL JOURNAL			English	Article						galaxies: evolution; galaxies: high-redshift; galaxies: starburst; infrared: galaxies; submillimeter: galaxies	STAR-FORMING GALAXIES; SIMILAR-TO 2; LYMAN-BREAK GALAXIES; HIGH-REDSHIFT GALAXIES; FORMATION RATE DENSITY; SUBMILLIMETER-SELECTED GALAXIES; ULTRAVIOLET LUMINOSITY DENSITY; SPECTRAL ENERGY-DISTRIBUTIONS; AZTEC MILLIMETER SURVEY; ACTIVE GALACTIC NUCLEI	Galaxies' rest-frame ultraviolet (UV) properties are often used to directly infer the degree to which dust obscuration affects the measurement of star formation rates (SFRs). While much recent work has focused on calibrating dust attenuation in galaxies selected at rest-frame ultraviolet wavelengths, locally and at high-z, here we investigate attenuation in dusty, star forming galaxies (DSFGs) selected at far-infrared wavelengths. By combining multiwavelength coverage across 0.15-500 mu m in the COSMOS field, in particular making use of Herschel imaging, and a rich data set on local galaxies, we find an empirical variation in the relationship between the rest-frame UV slope (beta) and the ratio of infrared-to-ultraviolet emission (L-IR/L-UV = IRX) as a function of infrared luminosity, or total SFR. Both locally and at high-z, galaxies above SFR greater than or similar to 50 M-circle dot yr(-1) deviate from the nominal IRX-beta relation toward bluer colors by a factor proportional to their increasing IR luminosity. We also estimate contamination rates of DSFGs on high-z dropout searches of << 1% at z less than or similar to 4-10, providing independent verification that contamination from very dusty foreground galaxies is low in Lyman-break galaxy searches. Overall, our results are consistent with the physical interpretation that DSFGs, e.g., galaxies with > 50 M-circle dot yr(-1), are dominated at all epochs by short-lived, extreme burst events, producing many young O and B stars that are primarily, yet not entirely, enshrouded in thick dust cocoons. The blue rest-frame UV slopes of DSFGs are inconsistent with the suggestion that most DSFGs at z similar to 2 exhibit steady-state star formation in secular disks.	[Casey, C. M.; Cooray, A.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Scoville, N. Z.] CALTECH, Pasadena, CA 91125 USA; [Sanders, D. B.; Lee, N.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Finkelstein, S. L.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Capak, P.] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA; [Conley, A.] Univ Colorado, Ctr Astrophys & Space Astron UCB 389, Boulder, CO 80309 USA; [De Zotti, G.] Osserv Astron Padova, I-35122 Padua, Italy; [De Zotti, G.] SISSA, I-34136 Trieste, Italy; [Farrah, D.] Virginia Tech, Dept Phys, Blacksburg, VA 24061 USA; [Fu, H.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Le Floc'h, E.] CEA Saclay, F-91191 Gif Sur Yvette, France; [Ilbert, O.] Aix Marseille Univ, CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille, France; [Ivison, R. J.] Univ Edinburgh, Royal Observ, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Ivison, R. J.] European So Observ, D-85748 Garching, Germany; [Takeuchi, T. T.] Nagoya Univ, Div Particle & Astrophys Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Casey, CM (reprint author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.			De Zotti, Gianfranco/0000-0003-2868-2595	NASA [NAS 5-26555]; ESA Member States; European Southern Observatory, Chile; Kitt Peak National Observatory; Cerro Tololo Inter-American Observatory; National Optical Astronomy Observatory; BMVIT (Austria); ESA-PRODEX (Belgium); CEA/CNES (France); DLR (Germany); ASI/INAF (Italy); CICYT/MCYT (Spain); CSA (Canada); NAOC (China); CEA (France); CNES (France); CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC (UK); UKSA (UK); NASA (USA); McCue Fellowship through the University of California, Irvine's Center for Cosmology; NSF [AST-1313319]; ERC AdG; COSMICISM; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24111707]; Strategic Young Researches Overseas Visits Program for Accelerating Brain Circulation from the MEXT	COSMOS is based on observations with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by AURA Inc, under NASA contract NAS 5-26555; also based on data collected at: the Subaru Telescope, which is operated by the National Astronomical Observatory of Japan; XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA; the European Southern Observatory, Chile; Kitt Peak National Observatory, Cerro Tololo Inter-American Observatory, and the National Optical Astronomy Observatory, which are operated by the Association of Universities for Research in Astronomy, Inc. (AURA) under cooperative agreement with the National Science Foundation; the National Radio Astronomy Observatory, which is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc; and the Canada-France-Hawaii Telescope operated by the National Research Council of Canada, the Centre National de la Recherche Scientifique de France, and the University of Hawaii.; PACS has been developed by a consortium of institutes led by MPE (Germany) and including UVIE (Austria); KU Leuven, CSL, IMEC (Belgium); CEA, LAM (France); MPIA (Germany); INAF-IFSI/OAA/OAP/OAT, LENS, SISSA (Italy); IAC (Spain). This development has been supported by the funding agencies BMVIT (Austria), ESA-PRODEX (Belgium), CEA/CNES (France), DLR (Germany), ASI/INAF (Italy), and CICYT/MCYT (Spain).; SPIRE has been developed by a consortium of institutes led by Cardiff Univ. (UK) and including: Univ. Lethbridge (Canada); NAOC (China); CEA, LAM (France); IFSI, Univ. Padua (Italy); IAC (Spain); Stockholm Observatory (Sweden); Imperial College London, RAL, UCL-MSSL, UKATC, Univ. Sussex (UK); and Caltech, JPL, HNSC, Univ. Colorado (USA). This development has been supported by national funding agencies: CSA (Canada); NAOC (China); CEA, CNES, CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC, UKSA (UK); and NASA (USA).; C.M.C. acknowledges support from a McCue Fellowship through the University of California, Irvine's Center for Cosmology. A.C. acknowledges support from NSF AST-1313319. R.J.I. acknowledges support from ERC AdG, COSMICISM. T.T.T. has been supported by the Grant-in-Aid for the Scientific Research Fund (24111707) commissioned by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. T.T.T. has also been partially supported from Strategic Young Researches Overseas Visits Program for Accelerating Brain Circulation from the MEXT. We are grateful to the anonymous referee for productive comments that improved the paper. We would also like to thank Naveen Reddy, Brian Siana, Mara Salvato, and Douglas Scott for helpful conversations during the manuscript's preparation.	Alavi A, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/143; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Morrissey P, 2007, ASTROPHYS J SUPPL S, V173, P682, DOI 10.1086/520512; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Boissier S, 2007, ASTROPHYS J SUPPL S, V173, P524, DOI 10.1086/516642; Reddy NA, 2010, ASTROPHYS J, V712, P1070, DOI 10.1088/0004-637X/712/2/1070; Marks M, 2012, MON NOT R ASTRON SOC, V422, P2246, DOI 10.1111/j.1365-2966.2012.20767.x; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Bauer AE, 2011, MON NOT R ASTRON SOC, V417, P289, DOI 10.1111/j.1365-2966.2011.19240.x; Heinis S, 2013, MON NOT R ASTRON SOC, V429, P1113, DOI 10.1093/mnras/sts397; Capak P, 2007, ASTROPHYS J SUPPL S, V172, P99, DOI 10.1086/519081; Munoz-Mateos JC, 2009, ASTROPHYS J, V701, P1965, DOI 10.1088/0004-637X/701/2/1965; Scott KS, 2008, MON NOT R ASTRON SOC, V385, P2225, DOI 10.1111/J.1365-2966.2008.12989.x; Papovich C, 2006, ASTROPHYS J, V640, P92, DOI 10.1086/499915; Ivison RJ, 1998, MON NOT R ASTRON SOC, V298, P583, DOI 10.1046/j.1365-8711.1998.01677.x; Burgarella D, 2005, MON NOT R ASTRON SOC, V360, P1413, DOI 10.1111/j.1365-2966.2005.09131.x; CALZETTI D, 1994, ASTROPHYS J, V429, P582, DOI 10.1086/174346; Blain AW, 2004, ASTROPHYS J, V611, P725, DOI 10.1086/422353; Casey CM, 2013, MON NOT R ASTRON SOC, V436, P1919, DOI 10.1093/mnras/stt1673; Buat V, 2005, ASTROPHYS J, V619, pL51, DOI 10.1086/423241; Ivison RJ, 2011, MON NOT R ASTRON SOC, V412, P1913, DOI 10.1111/j.1365-2966.2010.18028.x; Bouwens RJ, 2011, NATURE, V469, P504, DOI 10.1038/nature09717; Ilbert O, 2010, ASTROPHYS J, V709, P644, DOI 10.1088/0004-637X/709/2/644; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Smail I, 2004, ASTROPHYS J, V616, P71, DOI 10.1086/424896; Adelberger KL, 2000, ASTROPHYS J, V544, P218, DOI 10.1086/317183; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Kong X, 2004, MON NOT R ASTRON SOC, V349, P769, DOI 10.1111/j.1365-2966.2004.07556.x; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; Ilbert O, 2009, ASTROPHYS J, V690, P1236, DOI 10.1088/0004-637X/690/2/1236; Stanway ER, 2005, MON NOT R ASTRON SOC, V359, P1184, DOI 10.1111/j.1365-2966.2005.08977.x; Dunne L, 2003, NATURE, V424, P285, DOI 10.1038/nature01792; Reddy NA, 2009, ASTROPHYS J, V692, P778, DOI 10.1088/0004-637X/692/1/778; Wild V, 2011, MON NOT R ASTRON SOC, V417, P1760, DOI 10.1111/j.1365-2966.2011.19367.x; Cortese L, 2006, ASTROPHYS J, V637, P242, DOI 10.1086/498296; Sanders DB, 2003, ASTRON J, V126, P1607, DOI 10.1086/376841; Reddy NA, 2006, ASTROPHYS J, V653, P1004, DOI 10.1086/508851; Brusa M, 2010, ASTROPHYS J, V716, P348, DOI 10.1088/0004-637X/716/1/348; Hathi NP, 2008, ASTROPHYS J, V673, P686, DOI 10.1086/524836; Symeonidis M, 2013, MON NOT R ASTRON SOC, V431, P2317, DOI 10.1093/mnras/stt330; Howell JH, 2010, ASTROPHYS J, V715, P572, DOI 10.1088/0004-637X/715/1/572; Shapley AE, 2003, ASTROPHYS J, V588, P65, DOI 10.1086/373922; NEUGEBAUER G, 1984, ASTROPHYS J, V278, pL1, DOI 10.1086/184209; Armus L, 2009, PUBL ASTRON SOC PAC, V121, P559; Caputi KI, 2007, ASTROPHYS J, V660, P97, DOI 10.1086/512667; Beckwith SVW, 2006, ASTRON J, V132, P1729, DOI 10.1086/507302; Chapman SC, 2004, ASTROPHYS J, V611, P732, DOI 10.1086/422383; Engel H, 2010, ASTROPHYS J, V724, P233, DOI 10.1088/0004-637X/724/1/233; Roseboom IG, 2010, MON NOT R ASTRON SOC, V409, P48, DOI 10.1111/j.1365-2966.2010.17634.x; Finkelstein SL, 2010, ASTROPHYS J, V719, P1250, DOI 10.1088/0004-637X/719/2/1250; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Chary R, 2001, ASTROPHYS J, V556, P562, DOI 10.1086/321609; Hinshaw G, 2009, ASTROPHYS J SUPPL S, V180, P225, DOI 10.1088/0067-0049/180/2/225; Roseboom IG, 2012, MON NOT R ASTRON SOC, V419, P2758, DOI 10.1111/j.1365-2966.2011.19827.x; Peek JEG, 2010, ASTROPHYS J, V719, P415, DOI 10.1088/0004-637X/719/1/415; Conroy C, 2010, ASTROPHYS J, V718, P184, DOI 10.1088/0004-637X/718/1/184; Hopkins AM, 2006, ASTROPHYS J, V651, P142, DOI 10.1086/506610; Seibert M, 2005, ASTROPHYS J, V619, pL55, DOI 10.1086/427843; Dey A, 2008, ASTROPHYS J, V677, P943, DOI 10.1086/529516; Scoville N, 2007, ASTROPHYS J SUPPL S, V172, P1, DOI 10.1086/516585; Bouwens RJ, 2009, ASTROPHYS J, V705, P936, DOI 10.1088/0004-637X/705/1/936; Madau P, 1996, MON NOT R ASTRON SOC, V283, P1388; Meurer GR, 1999, ASTROPHYS J, V521, P64, DOI 10.1086/307523; Casey CM, 2014, PHYS REP, V541, P45, DOI 10.1016/j.physrep.2014.02.009; Bunker AJ, 2003, MON NOT R ASTRON SOC, V342, pL47, DOI 10.1046/j.1365-8711.2003.06664.x; Oesch PA, 2010, ASTROPHYS J LETT, V709, pL16, DOI 10.1088/2041-8205/709/1/L16; Dale DA, 2002, ASTROPHYS J, V576, P159, DOI 10.1086/341632; Aretxaga I, 2011, MON NOT R ASTRON SOC, V415, P3831, DOI 10.1111/j.1365-2966.2011.18989.x; Steidel CC, 1996, ASTROPHYS J, V462, pL17, DOI 10.1088/1538-4357/462/1/L17; Gordon KD, 2000, ASTROPHYS J, V533, P236, DOI 10.1086/308668; Walter F, 2012, NATURE, V486, P233, DOI 10.1038/nature11073; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; Giavalisco M, 2004, ASTROPHYS J, V600, pL103, DOI 10.1086/381244; Ivison RJ, 2012, MON NOT R ASTRON SOC, V425, P1320, DOI 10.1111/j.1365-2966.2012.21544.x; KINNEY AL, 1993, ASTROPHYS J SUPPL S, V86, P5, DOI 10.1086/191771; Boquien M, 2009, ASTROPHYS J, V706, P553, DOI 10.1088/0004-637X/706/1/553; Boquien M, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118624; Bouwens RJ, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/90; Bouwens R. J., 2014, ARXIV14034295; Buat V, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117264; Buat V, 2010, MON NOT R ASTRON SOC, V409, pL1, DOI 10.1111/j.1745-3933.2010.00916.x; Buat V, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219405; Calzetti D, 2001, PUBL ASTRON SOC PAC, V113, P1449, DOI 10.1086/324269; Casey CM, 2012, MON NOT R ASTRON SOC, V425, P3094, DOI 10.1111/j.1365-2966.2012.21455.x; Casey CM, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/139; Casey CM, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/140; Casey CM, 2009, MON NOT R ASTRON SOC, V399, P121, DOI 10.1111/j.1365-2966.2009.15291.x; Castellano M., 2014, ASTRON ASTROPHYS, V566, P19; Chapman SC, 2005, ASTROPHYS J, V622, P772, DOI 10.1086/428082; Chapman SC, 2004, ASTROPHYS J, V614, P671, DOI 10.1086/423833; Chapman SC, 2009, MON NOT R ASTRON SOC, V398, P1615, DOI 10.1111/j.1365-2966.2009.14710.x; Civano F, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/30; Cooray A, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/40; Coppin K. E. K., 2014, ARXIV14076712; Donley JL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/142; Dowell CD, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/75; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Finkelstein SL, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/164; Frayer DT, 2000, ASTRON J, V120, P1668, DOI 10.1086/301571; Fu H, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/134; De Paz AG, 2007, ASTROPHYS J SUPPL S, V173, P185, DOI 10.1086/516636; Goldader JD, 2002, ASTROPHYS J, V568, P651, DOI 10.1086/339165; Gordon KD, 2003, ASTROPHYS J, V594, P279, DOI 10.1086/376774; Goto T, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913182; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Hainline LJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/96; Hao CN, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/124; Hodge JA, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/11; Kawada M., 2007, PASJ, V59, P389; Kriek M, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L16; Le Floc'h E, 2005, ASTROPHYS J, V632, P169, DOI 10.1086/432789; Lee KS, 2012, ASTROPHYS J LETT, V758, DOI 10.1088/2041-8205/758/2/L31; Lee N, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/131; LILLY SJ, 1995, ASTROPHYS J, V455, P108, DOI 10.1086/176560; Lutz D., 2011, ASTRON ASTROPHYS, V532, P90; Magdis GE, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201117649; McCracken HJ, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219507; Meurer GR, 1995, ASTRON J, V110, P2665, DOI 10.1086/117721; Michalowski MJ, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201016308; Michalowski M. J., 2014, ARXIV14052335; Nguyen HT, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014680; Nordon R, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/182; Oesch PA, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/1/75; Oliver SJ, 2012, MON NOT R ASTRON SOC, V424, P1614, DOI 10.1111/j.1365-2966.2012.20912.x; Ouchi M, 2004, ASTROPHYS J, V611, P660, DOI 10.1086/422207; Overzier RA, 2011, ASTROPHYS J LETT, V726, DOI 10.1088/2041-8205/726/1/L7; Penner K, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/28; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Poglitsch A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014535; Reddy N, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/154; Rodighiero G, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L40; Roseboom IG, 2013, MON NOT R ASTRON SOC, V436, P430, DOI 10.1093/mnras/stt1577; Sanders D. B., 2012, APJS, V203, P9; Scoville N, 2013, ASTROPHYS J SUPPL S, V206, DOI 10.1088/0067-0049/206/1/3; Stanway ER, 2007, MON NOT R ASTRON SOC, V376, P727, DOI 10.1111/j.1365-2966.2007.11469.x; Swinbank M., 2013, MNRAS, V438, P1267; Takeuchi TT, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/144; Takeuchi TT, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913476; TINSLEY BM, 1980, ASTROPHYS J, V242, P435, DOI 10.1086/158477; To CH, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/139; Trentham N, 1999, ASTRON J, V117, P2152, DOI 10.1086/300831	141	5	5	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							95	10.1088/0004-637X/796/2/95		15	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900024		
J	Fujii, K; Minamidani, T; Mizuno, N; Onishi, T; Kawamura, A; Muller, E; Dawson, J; Tatematsu, K; Hasegawa, T; Tosaki, T; Miura, RE; Muraoka, K; Sakai, T; Tsukagoshi, T; Tanaka, K; Ezawa, H; Fukui, Y				Fujii, Kosuke; Minamidani, Tetsuhiro; Mizuno, Norikazu; Onishi, Toshikazu; Kawamura, Akiko; Muller, Erik; Dawson, Joanne; Tatematsu, Ken'ichi; Hasegawa, Tetsuo; Tosaki, Tomoka; Miura, Rie E.; Muraoka, Kazuyuki; Sakai, Takeshi; Tsukagoshi, Takashi; Tanaka, Kunihiko; Ezawa, Hajime; Fukui, Yasuo			DENSE MOLECULAR CLUMPS ASSOCIATED WITH THE LARGE MAGELLANIC CLOUD SUPERGIANT SHELLS LMC 4 AND LMC 5	ASTROPHYSICAL JOURNAL			English	Article						galaxies: star formation; ISM: bubbles; ISM: clouds; ISM: structure; Magellanic Clouds; radio lines: ISM	SUBMILLIMETER TELESCOPE EXPERIMENT; PROPAGATING STAR FORMATION; YOUNG STELLAR OBJECTS; INTERSTELLAR-MEDIUM; APERTURE SYNTHESIS; CONSTELLATION-III; RADIO-CONTINUUM; NOBEYAMA 45-M; GIANT SHELLS; ATOMIC GAS	We investigate the effects of supergiant shells (SGSs) and their interaction on dense molecular clumps by observing the Large MagellanicCloud (LMC) star-forming regions N48 and N49, which are located between two SGSs, LMC4 and LMC 5. (CO)-C-12 (J = 3-2, 1-0) and (CO)-C-13(J = 1-0) observations with the ASTE and Mopra telescopes have been carried out toward these regions. A clumpy distribution of dense molecular clumps is revealed with 7 pc spatial resolution. Large velocity gradient analysis shows that the molecular hydrogen densities (n(H-2)) of the clumps are distributed from low to high density (10(3)-10(5) cm(-3)) and their kinetic temperatures (T-kin) are typically high (greater than 50 K). These clumps seem to be in the early stages of star formation, as also indicated from the distribution of Ha, young stellar object candidates, and IR emission. We found that the N48 region is located in the high column density Hi envelope at the interface of the two SGSs and the star formation is relatively evolved, whereas the N49 region is associated with LMC 5 alone and the star formation is quiet. The clumps in the N48 region typically show high n(H-2) and T-kin, which are as dense and warm as the clumps in LMC massive cluster-forming areas (30 Dor, N159). These results suggest that the large-scale structure of the SGSs, especially the interaction of two SGSs, works efficiently on the formation of dense molecular clumps and stars.	[Fujii, Kosuke; Mizuno, Norikazu] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1330033, Japan; [Fujii, Kosuke; Mizuno, Norikazu; Kawamura, Akiko; Muller, Erik; Tatematsu, Ken'ichi; Hasegawa, Tetsuo; Miura, Rie E.; Ezawa, Hajime] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Minamidani, Tetsuhiro] Nobeyama Radio Observ, Nagano 3841305, Japan; [Onishi, Toshikazu] Osaka Prefecture Univ, Dept Phys Sci, Osaka 5998531, Japan; [Dawson, Joanne] CSIRO Astron & Space Sci, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Dawson, Joanne] Macquarie Univ, Dept Phys & Astron, Sydney, NSW 2109, Australia; [Dawson, Joanne] Macquarie Univ, MQ Res Ctr Astron, Sydney, NSW 2109, Australia; [Tosaki, Tomoka] Joetsu Univ Educ, Niigata 9438512, Japan; [Sakai, Takeshi] Univ Electrocommun, Grad Sch Informat & Engn, Chofu, Tokyo 1828585, Japan; [Tsukagoshi, Takashi] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Tanaka, Kunihiko] Keio Univ, Fac Sci & Technol, Dept Phys, Yokohama, Kanagawa 2238522, Japan; [Fukui, Yasuo] Nagoya Univ, Dept Astrophys, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Fujii, K (reprint author), Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1330033, Japan.	kosuke.fujii@nao.ac.jp			MEXT (KAKENHI) [15071202, 15071203, 20001003]; JSPS KAKENHI [14J11419, 22740127]; Commonwealth of Australia for operation as a National Facility managed by CSIRO; National Science Foundation (NSF), National Optical Astronomy Observatories (NOAO); Dean B. McLaughlin fund at the University of Michigan; NSF [9540747]; NASA/Spitzer [1275598]; NASA [NAG5-12595]	We thank the referee, whose thorough reading helped improve the manuscript. K. Fujii thanks Shinya Komugi and Remy Indebetouw for fruitful discussions. A part of this study was financially supported by MEXT Grants-in-Aid for Scientific Research (KAKENHI) grant numbers 15071202, 15071203, 20001003, and JSPS KAKENHI grant Numbers 14J11419, 22740127. The ASTE project is managed by Nobeyama Radio Observatory (NRO), a branch of the National Astronomical Observatory of Japan (NAOJ), in collaboration with University of Chile, and Japanese institutes including University of Tokyo, Nagoya University, Osaka Prefecture University, Ibaraki University, and Hokkaido University. Observations with ASTE were carried out remotely from Japan by using NTT's GEMnet2 and its partner R&E (Research & Education) networks, which are based on the AccessNova collaboration of University of Chile, NTT Laboratories, and NAOJ. The Mopra Telescope is part of the Australia Telescope, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. Cerro Tololo Inter-American Observatory (CTIO) is operated by the Association of Universities for Research in Astronomy Inc. (AURA), under a cooperative agreement with the National Science Foundation (NSF) as part of the National Optical Astronomy Observatories (NOAO). The MCELS is funded through the support of the Dean B. McLaughlin fund at the University of Michigan and through NSF grant 9540747. SAGE research has been funded by NASA/Spitzer grant 1275598 and NASA NAG5-12595.	Hartmann L, 2001, ASTROPHYS J, V562, P852, DOI 10.1086/323863; Meixner M, 2006, ASTRON J, V132, P2268, DOI 10.1086/508185; SCOVILLE NZ, 1974, ASTROPHYS J, V187, pL67, DOI 10.1086/181398; Calzetti D, 2005, ASTROPHYS J, V633, P871, DOI 10.1086/466518; van der Marel RP, 2001, ASTRON J, V122, P1807, DOI 10.1086/323099; MCCRAY R, 1987, ASTROPHYS J, V317, P190, DOI 10.1086/165267; Ezawa H, 2004, P SOC PHOTO-OPT INS, V5489, P763, DOI 10.1117/12.551391; BERTOLDI F, 1992, ASTROPHYS J, V395, P140, DOI 10.1086/171638; Kawamura A, 2009, ASTROPHYS J SUPPL S, V184, P1, DOI 10.1088/0067-0049/184/1/1; Staveley-Smith L, 2003, MON NOT R ASTRON SOC, V339, P87, DOI 10.1046/j.1365-8711.2003.06146.x; MACLOW MM, 1989, ASTROPHYS J, V337, P141, DOI 10.1086/167094; MACLAREN I, 1988, ASTROPHYS J, V333, P821, DOI 10.1086/166791; Hosokawa T, 2007, ASTROPHYS J, V664, P363, DOI 10.1086/518396; Kim S, 2003, ASTROPHYS J SUPPL S, V148, P473, DOI 10.1086/376980; Kawamura A, 1998, ASTROPHYS J SUPPL S, V117, P387, DOI 10.1086/313119; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Ladd N, 2005, PUBL ASTRON SOC AUST, V22, P62, DOI 10.1071/AS04068; CHU YH, 1990, ASTROPHYS J, V365, P510, DOI 10.1086/169505; Rieke GH, 2004, P SOC PHOTO-OPT INS, V5487, P50, DOI 10.1117/12.551965; Schoier FL, 2005, ASTRON ASTROPHYS, V432, P369, DOI 10.1051/0004-6361:20041729; Perez-Gonzalez PG, 2006, ASTROPHYS J, V648, P987, DOI 10.1086/506196; Sorai K, 2000, P SOC PHOTO-OPT INS, V4015, P86, DOI 10.1117/12.390466; Kim S, 1998, ASTROPHYS J, V503, P674, DOI 10.1086/306030; Hughes A, 2007, MON NOT R ASTRON SOC, V382, P543, DOI 10.1111/j.1365-2966.2007.12466.x; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P10, DOI 10.1086/422843; Gruendl RA, 2009, ASTROPHYS J SUPPL S, V184, P172, DOI 10.1088/0067-0049/184/1/172; Pietrzynski G, 2013, NATURE, V495, P76, DOI 10.1038/nature11878; Koyama H, 2000, ASTROPHYS J, V532, P980, DOI 10.1086/308594; Calzetti D, 2007, ASTROPHYS J, V666, P870, DOI 10.1086/520082; Sawada T, 2008, PUBL ASTRON SOC JPN, V60, P445; Ikeda N, 2007, ASTROPHYS J, V665, P1194, DOI 10.1086/519484; Mac Low MM, 1999, ASTROPHYS J, V513, P142, DOI 10.1086/306832; Whitney BA, 2008, ASTRON J, V136, P18, DOI 10.1088/0004-6256/136/1/18; Li AG, 2001, ASTROPHYS J, V554, P778, DOI 10.1086/323147; TENORIOTAGLE G, 1988, ANNU REV ASTRON ASTR, V26, P145; Bica E, 1996, ASTROPHYS J SUPPL S, V102, P57, DOI 10.1086/192251; Book LG, 2009, ASTRON J, V137, P3599, DOI 10.1088/0004-6256/137/3/3599; Book LG, 2008, ASTROPHYS J SUPPL S, V175, P165, DOI 10.1086/523897; Braun J. M., 2000, ARXIVASTROPH0006060; Braun JM, 1997, ASTRON ASTROPHYS, V328, P167; CASTOR JI, 1970, MON NOT R ASTRON SOC, V149, P111; Chen CHR, 2009, ASTROPHYS J, V695, P511, DOI 10.1088/0004-637X/695/1/511; CHERNIN AD, 1995, MON NOT R ASTRON SOC, V275, P313; Chu Y.-H., 1999, IAU S, V190, P28; Cohen M, 2003, MON NOT R ASTRON SOC, V340, P275, DOI 10.1046/j.1365-8711.2003.06303.x; Davies R. D., 1976, MEM ROY ASTRON SOC, V81, P89; Dawson J. R., 2013, PASA, V30, P25; Dawson JR, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/56; Dawson JR, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/127; DICKEY JM, 1994, ASTRON ASTROPHYS, V289, P357; Dobashi K, 1996, ASTROPHYS J, V466, P282, DOI 10.1086/177509; DOMGORGEN H, 1995, ASTRON ASTROPHYS, V296, P523; DOPITA MA, 1985, ASTROPHYS J, V297, P599, DOI 10.1086/163556; Efremov YN, 1998, ASTROPHYS J, V501, pL163, DOI 10.1086/311468; Efremov YN, 1998, MON NOT R ASTRON SOC, V299, P643, DOI 10.1046/j.1365-8711.1998.01745.x; Ehlerova S, 1997, ASTRON ASTROPHYS, V328, P121; Elmegreen BG, 1998, ASTR SOC P, V148, P150; EMERSON DT, 1988, ASTRON ASTROPHYS, V190, P353; Ezawa H, 2008, PROC SPIE, V7012, DOI 10.1117/12.789652; FILIPOVIC MD, 1995, ASTRON ASTROPHYS SUP, V111, P311; Filipovic M. D., 1998, MAGELLANIC CLOUDS OT, P137; Fukui Y, 2008, ASTROPHYS J SUPPL S, V178, P56, DOI 10.1086/589833; Fukui Y, 2010, ANNU REV ASTRON ASTR, V48, P547, DOI 10.1146/annurev-astro-081309-130854; Fukui Y, 2009, ASTROPHYS J, V705, P144, DOI 10.1088/0004-637X/705/1/144; Glatt K, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014187; GOLDREIC.P, 1974, ASTROPHYS J, V189, P441, DOI 10.1086/152821; Henize K., 1956, AP J               S, V2, P315, DOI 10.1086/190025; Ikeda N, 2009, ASTROPHYS J, V691, P1560, DOI 10.1088/0004-637X/691/2/1560; Indebetouw R, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/73; Inoue H., 2008, 19 INT S SPAC TER TE, P281; Kim S, 1999, ASTRON J, V118, P2797, DOI 10.1086/301116; Kohno K, 2005, ASTR SOC P, V344, P242; Marx-Zimmer M, 2000, ASTRON ASTROPHYS, V354, P787; MEABURN J, 1980, MON NOT R ASTRON SOC, V192, P365; Minamidani T, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/3/73; Minamidani T, 2008, ASTROPHYS J SUPPL S, V175, P485, DOI 10.1086/524038; Mizuno N, 2001, PUBL ASTRON SOC JPN, V53, P971; Mizuno Y, 2010, PUBL ASTRON SOC JPN, V62, P51; Ntormousi E, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/13; Points SD, 1999, ASTROPHYS J, V518, P298, DOI 10.1086/307249; Seale JP, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/42; Walter F, 1999, ASTRON J, V118, P273, DOI 10.1086/300906; Weisz DR, 2009, ASTROPHYS J LETT, V691, pL59, DOI 10.1088/0004-637X/691/1/L59; Will JM, 1996, ASTRON ASTROPHYS, V315, P125; Wong T, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/16; Yamaguchi R, 2001, PUBL ASTRON SOC JPN, V53, P959; Yamaguchi R, 2001, ASTROPHYS J, V553, pL185, DOI 10.1086/320678; Yonekura Y, 1997, ASTROPHYS J SUPPL S, V110, P21, DOI 10.1086/312994	88	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							123	10.1088/0004-637X/796/2/123		22	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900052		
J	Gilbert, KM; Kalirai, JS; Guhathakurta, P; Beaton, RL; Geha, MC; Kirby, EN; Majewski, SR; Patterson, RJ; Tollerud, EJ; Bullock, JS; Tanaka, M; Chiba, M				Gilbert, Karoline M.; Kalirai, Jason S.; Guhathakurta, Puragra; Beaton, Rachael L.; Geha, Marla C.; Kirby, Evan N.; Majewski, Steven R.; Patterson, Richard J.; Tollerud, Erik J.; Bullock, James S.; Tanaka, Mikito; Chiba, Masashi			GLOBAL PROPERTIES OF M31'S STELLAR HALO FROM THE SPLASH SURVEY. II. METALLICITY PROFILE	ASTROPHYSICAL JOURNAL			English	Article						galaxies: groups: individual (M31); galaxies: halos; stars: kinematics and dynamics; techniques: spectroscopic	GIANT SOUTHERN STREAM; STAR-FORMATION HISTORY; DIGITAL SKY SURVEY; INTEGRATED-LIGHT SPECTROSCOPY; HIERARCHICAL GALAXY FORMATION; SURFACE BRIGHTNESS PROFILE; DWARF SPHEROIDAL SATELLITE; HUBBLE-SPACE-TELESCOPE; LAMBDA-CDM MODELS; MILKY-WAY	We present the metallicity distribution of red giant branch (RGB) stars in M31's stellar halo, derived from photometric metallicity estimates for over 1500 spectroscopically confirmed RGB halo stars. The stellar sample comes from 38 halo fields observed with the Keck/DEIMOS spectrograph, ranging from 9 to 175 kpc in projected distance from M31's center, and includes 52 confirmed M31 halo stars beyond 100 kpc. While a wide range of metallicities is seen throughout the halo, the metal-rich peak of the metallicity distribution function becomes significantly less prominent with increasing radius. The metallicity profile of M31's stellar halo shows a continuous gradient from 9 to similar to 100 kpc, with a magnitude of similar to-0.01 dex kpc(-1). The stellar velocity distributions in each field are used to identify stars that are likely associated with tidal debris features. The removal of tidal debris features does not significantly alter the metallicity gradient in M31's halo: a gradient is maintained in fields spanning 10-90 kpc. We analyze the halo metallicity profile, as well as the relative metallicities of stars associated with tidal debris features and the underlying halo population, in the context of current simulations of stellar halo formation. We argue that the large-scale gradient in M31's halo implies M31 accreted at least one relatively massive progenitor in the past, while the field to field variation seen in the metallicity profile indicates that multiple smaller progenitors are likely to have contributed substantially to M31's outer halo.	[Gilbert, Karoline M.; Kalirai, Jason S.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Kalirai, Jason S.] Johns Hopkins Univ, Ctr Astrophys Sci, Dept Phys & Astron, Baltimore, MD 21218 USA; [Guhathakurta, Puragra] Univ Calif Santa Cruz, Dept Astron & Astrophys, UCO Lick Observ, Santa Cruz, CA 95064 USA; [Beaton, Rachael L.; Majewski, Steven R.; Patterson, Richard J.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Geha, Marla C.; Tollerud, Erik J.] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Kirby, Evan N.; Bullock, James S.] CALTECH, Pasadena, CA 91125 USA; [Tanaka, Mikito; Chiba, Masashi] Tohoku Univ, Astron Inst, Aoba Ku, Sendai, Miyagi 9808578, Japan	Gilbert, KM (reprint author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	kgilbert@stsci.edu	Patterson, RIchard/F-5690-2013; 	Patterson, RIchard/0000-0003-1494-8399; Tollerud, Erik/0000-0002-9599-310X	NASA through Hubble Fellowship [51273.01, 51316.01]; Space Telescope Science Institute; NASA [NAS 5-26555, HST-GO-12105.03]; NSF [AST-1010039, AST-1009973, AST-1009882, AST-0607726, AST03-07842, AST03-07851, AST06-07726, AST08-07945, AST-0071048]; NASA/JPL [1228235]; David and Lucile Packard Foundation; F.H. Levinson Fund of the Peninsula Community Foundation; Southern California Center for Galaxy Evolution; University of California Office of Research; Graduate Assistance in Areas of National Need (GAANN); Mark C. Pirrung Family Graduate Fellowship from the Jefferson Scholars Foundation; Fellowship Enhancement for Outstanding Doctoral Candidates from the Office of the Vice President of Research at the University of Virginia; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25800098]	Support for this work was provided by NASA through Hubble Fellowship grants 51273.01, and 51316.01 awarded to K.M.G. and E.J.T. by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555. P.G., J.S.B., S.R.M., and R.L.B. acknowledge support from collaborative NSF grants AST-1010039, AST-1009973, AST-1009882, and AST-0607726. This project was also supported by NSF grants AST03-07842, AST03-07851, AST06-07726, AST08-07945, and AST10-09882, NASA grant HST-GO-12105.03 through STScI, NASA/JPL contract 1228235, the David and Lucile Packard Foundation, and the F.H. Levinson Fund of the Peninsula Community Foundation (S.R.M., R.J.P., and R.L.B.). E.N.K acknowledges support from the Southern California Center for Galaxy Evolution, a multicampus research program funded by the University of California Office of Research, and partial support from NSF grant AST-1009973. E.J.T. acknowledges support from a Graduate Assistance in Areas of National Need (GAANN) fellowship. R.L.B. acknowledges receipt of the Mark C. Pirrung Family Graduate Fellowship from the Jefferson Scholars Foundation and a Fellowship Enhancement for Outstanding Doctoral Candidates from the Office of the Vice President of Research at the University of Virginia. M.T. acknowledges support from Grant-in-Aid for Scientific Research (25800098) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The analysis pipeline used to reduce the DEIMOS data was developed at UC Berkeley with support from NSF grant AST-0071048.	Prieto CA, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201424053; An D, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/65; Brown TM, 2008, ASTROPHYS J LETT, V685, pL121, DOI 10.1086/592686; Ibata R, 2001, NATURE, V412, P49, DOI 10.1038/35083506; Yanny B, 2000, ASTROPHYS J, V540, P825, DOI 10.1086/309386; Juric M, 2008, ASTROPHYS J, V673, P864, DOI 10.1086/523619; Girardi L, 2002, ASTRON ASTROPHYS, V391, P195, DOI 10.1051/0004-6361:20020612; Zolotov A, 2010, ASTROPHYS J, V721, P738, DOI 10.1088/0004-637X/721/1/738; McConnachie AW, 2003, MON NOT R ASTRON SOC, V343, P1335, DOI 10.1046/j.1365-8711.2003.06785.x; Johnston KV, 2008, ASTROPHYS J, V689, P936, DOI 10.1086/592228; Majewski SR, 2003, ASTROPHYS J, V599, P1082, DOI 10.1086/379504; Irwin MJ, 2005, ASTROPHYS J, V628, pL105, DOI 10.1086/432718; Bellazzini M, 2003, ASTRON ASTROPHYS, V405, P867, DOI 10.1051/0004-6361:20030455; Kalirai JS, 2006, ASTROPHYS J, V648, P389, DOI 10.1086/505697; VandenBerg DA, 2006, ASTROPHYS J SUPPL S, V162, P375, DOI 10.1086/498451; Font AS, 2006, ASTROPHYS J, V646, P886, DOI 10.1086/505131; Ibata R, 2001, ASTROPHYS J, V551, P294, DOI 10.1086/320060; Venn KA, 2004, ASTRON J, V128, P1177, DOI 10.1086/422734; Stanek KZ, 1998, ASTROPHYS J, V503, pL131, DOI 10.1086/311539; McConnachie AW, 2009, NATURE, V461, P66, DOI 10.1038/nature08327; McCarthy IG, 2012, MON NOT R ASTRON SOC, V420, P2245, DOI 10.1111/j.1365-2966.2011.20189.x; Feltzing S, 2013, NEW ASTRON REV, V57, P80, DOI 10.1016/j.newar.2013.06.001; Bullock JS, 2001, ASTROPHYS J, V548, P33, DOI 10.1086/318681; Demarque P, 2004, ASTROPHYS J SUPPL S, V155, P667, DOI 10.1086/424966; Zolotov A, 2009, ASTROPHYS J, V702, P1058, DOI 10.1088/0004-637X/702/2/1058; ARMANDROFF TE, 1991, ASTRON J, V101, P1329, DOI 10.1086/115769; Fardal MA, 2012, MON NOT R ASTRON SOC, V423, P3134, DOI 10.1111/j.1365-2966.2012.21094.x; Durrell PR, 2001, ASTRON J, V121, P2557, DOI 10.1086/320403; Font AS, 2008, ASTROPHYS J, V673, P215, DOI 10.1086/524102; Gilbert KM, 2009, ASTROPHYS J, V701, P776, DOI 10.1088/0004-637X/701/1/776; Tissera PB, 2012, MON NOT R ASTRON SOC, V420, P255, DOI 10.1111/j.1365-2966.2011.20028.x; Simon JD, 2007, ASTROPHYS J, V670, P313, DOI 10.1086/521816; Springel V, 2008, MON NOT R ASTRON SOC, V391, P1685, DOI 10.1111/j.1365-2966.2008.14066.x; Cooper AP, 2010, MON NOT R ASTRON SOC, V406, P744, DOI 10.1111/j.1365-2966.2010.16740.x; Ibata R, 2007, ASTROPHYS J, V671, P1591, DOI 10.1086/522574; Battaglia G, 2008, MON NOT R ASTRON SOC, V383, P183, DOI 10.1111/j.1365-2966.2007.12532.x; IBATA RA, 1994, NATURE, V370, P194, DOI 10.1038/370194a0; Brown TM, 2006, ASTROPHYS J, V652, P323, DOI 10.1086/508015; Bullock JS, 2005, ASTROPHYS J, V635, P931, DOI 10.1086/497422; Tissera PB, 2014, MON NOT R ASTRON SOC, V439, P3128, DOI 10.1093/mnras/stu181; Ibata R, 2005, ASTROPHYS J, V634, P287, DOI 10.1086/491727; Ferguson AMN, 2002, ASTRON J, V124, P1452, DOI 10.1086/342019; OLSZEWSKI EW, 1991, ASTRON J, V101, P515, DOI 10.1086/115701; Font AS, 2011, MON NOT R ASTRON SOC, V416, P2802, DOI 10.1111/j.1365-2966.2011.19227.x; Seigar MS, 2008, MON NOT R ASTRON SOC, V389, P1911, DOI 10.1111/j.1365-2966.2008.13732.x; ARMANDROFF TE, 1988, ASTRON J, V96, P92, DOI 10.1086/114792; Carrera R, 2013, MON NOT R ASTRON SOC, V434, P1681, DOI 10.1093/mnras/stt1126; Guhathakurta P, 2006, ASTRON J, V131, P2497, DOI 10.1086/499562; Beaton R., 2014, BAAS, V223; Bensby T, 2014, ASTRON ASTROPHYS, V562, DOI [10.1051/0004-6361/201322631, 10.1015/0004-6361/201322631]; Brown TM, 2006, ASTROPHYS J, V636, pL89, DOI 10.1086/500089; Brown TM, 2007, ASTROPHYS J, V658, pL95, DOI 10.1086/515395; Carney BW, 1996, PUBL ASTRON SOC PAC, V108, P900, DOI 10.1086/133811; Carollo D, 2010, ASTROPHYS J, V712, P692, DOI 10.1088/0004-637X/712/1/692; Chapman SC, 2006, ASTROPHYS J, V653, P255, DOI 10.1086/508599; Cole AA, 2004, MON NOT R ASTRON SOC, V347, P367, DOI 10.1111/j.1365-2966.2004.07223.x; Colucci J. E., 2012, ARXIV12107200; Colucci JE, 2009, ASTROPHYS J, V704, P385, DOI 10.1088/0004-637X/704/1/385; Courteau S, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/20; Dalcanton JJ, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/18; Dorman CE, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/147; Dorman CE, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/103; Durrell PR, 2004, ASTRON J, V128, P260, DOI 10.1086/421746; DURRELL PR, 1994, ASTRON J, V108, P2114, DOI 10.1086/117223; Fardal MA, 2007, MON NOT R ASTRON SOC, V380, P15, DOI [10.1111/j.1365-2966.2007.11929.x, 10.1111/J.1365-2966.2007.11929.X]; Ferguson AMN, 2005, ASTROPHYS J, V622, pL109, DOI 10.1086/429371; Font AS, 2006, ASTRON J, V131, P1436, DOI 10.1086/499564; GEISLER D, 1990, PUBL ASTRON SOC PAC, V102, P344, DOI 10.1086/132639; Gilbert KM, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/76; Gilbert KM, 2007, ASTROPHYS J, V668, P245, DOI 10.1086/521094; Gilbert KM, 2009, ASTROPHYS J, V705, P1275, DOI 10.1088/0004-637X/705/2/1275; Gilbert KM, 2006, ASTROPHYS J, V652, P1188, DOI 10.1086/508643; Guhathakurta P., 2005, ASTROPH0502366; Ho N., 2014, ARXIV14054424; Ibata RA, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/128; Ishigaki MN, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/64; Ivezic Z, 2012, ANNU REV ASTRON ASTR, V50, P251, DOI 10.1146/annurev-astro-081811-125504; Kalirai JS, 2006, ASTROPHYS J, V641, P268, DOI 10.1086/498700; Kalirai JS, 2010, ASTROPHYS J, V711, P671, DOI 10.1088/0004-637X/711/2/671; Kalirai JS, 2009, ASTROPHYS J, V705, P1043, DOI 10.1088/0004-637X/705/1/1043; Kirby EN, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/102; Koch A, 2008, ASTROPHYS J, V689, P958, DOI 10.1086/592373; Majewski SR, 2000, ASTRON J, V120, P2550, DOI 10.1086/316836; MOULD J, 1986, ASTROPHYS J, V305, P591, DOI 10.1086/164273; Newman JA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/5; Ostheimer Jr J. C, 2003, THESIS U VIRGINIA; Phillepich A., 2014, ARXIV14077855; Phillepich A., 2014, MNRAS, V444, P237; PRITCHET CJ, 1994, ASTRON J, V107, P1730, DOI 10.1086/116981; Reitzel DB, 1998, ASTRON J, V116, P707, DOI 10.1086/300458; Rich RM, 1996, ASTRON J, V111, P768, DOI 10.1086/117822; Richardson JC, 2009, MON NOT R ASTRON SOC, V396, P1842, DOI 10.1111/j.1365-2966.2009.14788.x; Robertson B, 2005, ASTROPHYS J, V632, P872, DOI 10.1086/452619; Rutledge GA, 1997, PUBL ASTRON SOC PAC, V109, P883, DOI 10.1086/133958; Starkenburg E, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913759; Tanaka M, 2010, ASTROPHYS J, V708, P1168, DOI 10.1088/0004-637X/708/2/1168; Tollerud EJ, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/45; Tolstoy E, 2001, MON NOT R ASTRON SOC, V327, P918, DOI 10.1046/j.1365-8711.2001.04785.x; WHEELER JC, 1989, ANNU REV ASTRON ASTR, V27, P279; Williams BF, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/46; Yanny B, 2003, ASTROPHYS J, V588, P824, DOI 10.1086/374220; Zucker DB, 2007, ASTROPHYS J, V659, pL21, DOI 10.1086/516748	102	9	9	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							76	10.1088/0004-637X/796/2/76		20	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900005		
J	Guzman, AE; Garay, G; Rodriguez, LF; Moran, J; Brooks, KJ; Bronfman, L; Nyman, LA; Sanhueza, P; Mardones, D				Guzman, Andres E.; Garay, Guido; Rodriguez, Luis F.; Moran, James; Brooks, Kate J.; Bronfman, Leonardo; Nyman, Lars-Ake; Sanhueza, Patricio; Mardones, Diego			THE SLOW IONIZED WIND AND ROTATING DISKLIKE SYSTEM THAT ARE ASSOCIATED WITH THE HIGH-MASS YOUNG STELLAR OBJECT G345.4938+01.4677	ASTROPHYSICAL JOURNAL			English	Article						ISM: individual objects (IRAS 16562-3959); ISM: jets and outflows; stars: formation; stars: individual (G345.4938+01.4677); stars: jets	RADIO RECOMBINATION LINES; STAR-FORMING REGIONS; PRINCIPAL QUANTUM NUMBERS; HYPERCOMPACT HII-REGIONS; COLLIMATED JET SOURCE; LARGE PROPER MOTIONS; CEPHEUS-A HW2; H-II REGIONS; MOLECULAR OUTFLOWS; HIGH-VELOCITY	We report the detection, made using ALMA, of the 92 GHz continuum and hydrogen recombination lines (HRLs) H40 alpha, H42 alpha, and H50 beta emission toward the ionized wind associated with the high-mass young stellar object G345.4938+01.4677. This is the luminous central dominating source located in the massive and dense molecular clump associated with IRAS 16562-3959. The HRLs exhibit Voigt profiles, which is a strong signature of Stark broadening. We successfully reproduce the observed continuum and HRLs simultaneously using a simple model of a slow ionized wind in local thermodynamic equilibrium, with no need for a high-velocity component. The Lorentzian line wings imply electron densities of 5 x 10(7) cm(-3) on average. In addition, we detect SO and SO2 emission arising from a compact (similar to 3000 AU) molecular core associated with the central young star. The molecular core exhibits a velocity gradient that is perpendicular to the jet-axis, which we interpret as evidence of rotation. The set of observations toward G345.4938+01.4677 are consistent with it being a young high-mass star associated with a slow photo-ionized wind.	[Guzman, Andres E.; Garay, Guido; Bronfman, Leonardo; Mardones, Diego] Univ Chile, Dept Astron, Santiago, Chile; [Guzman, Andres E.; Moran, James] Harvard Smithsonian Ctr Astrophys, Cambridge, MA USA; [Rodriguez, Luis F.] Ctr Radioastron & Astrofis UNAM, Morelia 58089, Michoacan, Mexico; [Brooks, Kate J.] CSIRO Astron & Space Sci, Epping, NSW 1710, Australia; [Nyman, Lars-Ake] Joint ALMA Observ JAO, Santiago, Chile; [Sanhueza, Patricio] Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; [Sanhueza, Patricio] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Guzman, AE (reprint author), Univ Chile, Dept Astron, Camino Observ 1515, Santiago, Chile.			Guzman, Andres/0000-0003-0990-8990	NASA [NNX12AI55G, NNX10AD68G]; CONICYT [PFB-06]	The authors are grateful to C. Barrett, Y. Contreras, E. Keto, L. Kristensen, and Q. Zhang for useful discussions and proofreading the manuscript. The authors thank an anonymous referee for a careful reading and useful suggestions that improved this article. A.E.G. acknowledges support from NASA Grants NNX12AI55G and NNX10AD68G. L.B., G.G., and D.M. acknowledge support from CONICYT through project PFB-06. This paper makes use of ALMA data ADS/JAO.ALMA#2011.0.00351.S. ALMA is a partnership of ESO (member states), NINS (Japan), NSF (USA), NRC (Canada), and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile.	Alexander J, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/194; Anglada G, 1996, ASTR SOC P, V93, P3; Wu Y, 2004, ASTRON ASTROPHYS, V426, P503, DOI 10.1051/0004-6361:20035767; Hatchell J, 1998, ASTRON ASTROPHYS, V338, P713; Kraus S, 2010, NATURE, V466, P339, DOI 10.1038/nature09174; Shepherd DS, 1998, ASTROPHYS J, V507, P861, DOI 10.1086/306362; Martins F, 2005, ASTRON ASTROPHYS, V436, P1049, DOI 10.1051/0004-6361:20042386; MEZGER PG, 1968, SCIENCE, V160, P29, DOI 10.1126/science.160.3823.29; Robitaille TP, 2007, ASTROPHYS J SUPPL S, V169, P328, DOI 10.1086/512039; Smith MD, 1997, ASTRON ASTROPHYS, V323, P223; MENZEL DH, 1968, NATURE, V218, P756, DOI 10.1038/218756a0; Zhang QZ, 2001, ASTROPHYS J, V552, pL167, DOI 10.1086/320345; Gibb AG, 2003, MON NOT R ASTRON SOC, V339, P1011, DOI 10.1046/j.1365-8711.2003.06251.x; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Keto E, 2006, ASTROPHYS J, V637, P850, DOI 10.1086/498611; Hosokawa T, 2009, ASTROPHYS J, V691, P823, DOI 10.1088/0004-637X/691/1/823; Villuendas E, 1996, ASTR SOC P, V93, P56; Gibb EL, 2004, ASTROPHYS J SUPPL S, V151, P35, DOI 10.1086/381182; van der Tak FFS, 2003, ASTRON ASTROPHYS, V412, P133, DOI 10.1051/0004-6361:20031409; GARDEN RP, 1991, ASTROPHYS J, V374, P540, DOI 10.1086/170143; Pickett HM, 1998, J QUANT SPECTROSC RA, V60, P883, DOI 10.1016/S0022-4073(98)00091-0; Zhang QZ, 2005, ASTROPHYS J, V625, P864, DOI 10.1086/429660; Cesaroni R, 1997, ASTRON ASTROPHYS, V325, P725; Beuther H, 2002, ASTRON ASTROPHYS, V383, P892, DOI 10.1051/0004-6361:20011808; Bell MB, 2000, PUBL ASTRON SOC PAC, V112, P1236, DOI 10.1086/316611; SMIRNOV GT, 1984, ASTRON ASTROPHYS, V135, P116; Hudson RL, 2000, ASTRON ASTROPHYS, V357, P787; Keto E, 2008, ASTROPHYS J LETT, V678, pL109, DOI 10.1086/588657; Sana H, 2012, SCIENCE, V337, P444, DOI 10.1126/science.1223344; Wu JW, 2003, ASTROPHYS J, V592, pL79, DOI 10.1086/377679; BROWN RL, 1978, ANNU REV ASTRON ASTR, V16, P445, DOI 10.1146/annurev.aa.16.090178.002305; Galvan-Madrid R, 2010, ASTROPHYS J, V725, P17, DOI 10.1088/0004-637X/725/1/17; TOFANI G, 1995, ASTRON ASTROPHYS SUP, V112, P299; RODRIGUEZ LF, 1994, ASTROPHYS J, V430, pL65, DOI 10.1086/187439; Keto E, 2008, ASTROPHYS J, V672, P423, DOI 10.1086/522570; Beuther H, 2007, ASTRON ASTROPHYS, V466, P1065, DOI 10.1051/0004-6361:20066742; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883; Benjamin RA, 2003, PUBL ASTRON SOC PAC, V115, P953, DOI 10.1086/376696; Peters T, 2012, MON NOT R ASTRON SOC, V425, P2352, DOI 10.1111/j.1365-2966.2012.21676.x; Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P10, DOI 10.1086/422843; Bronfman L, 2008, ASTROPHYS J, V672, P391, DOI 10.1086/522487; DEYOUNG DS, 1991, SCIENCE, V252, P389, DOI 10.1126/science.252.5004.389; Cabrit S, 2007, LECT NOTES PHYS, V723, P21, DOI 10.1007/978-3-540-68035-2_2; Strelnitski VS, 1996, ASTROPHYS J, V470, P1118, DOI 10.1086/177936; Patel NA, 2005, NATURE, V437, P109, DOI 10.1038/nature04011; Downes TP, 2003, ASTRON ASTROPHYS, V403, P135, DOI 10.1051/0004-6361:20030363; Foster TJ, 2007, ASTROPHYS J, V667, P248, DOI 10.1086/518957; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323; LAMPTON M, 1976, ASTROPHYS J, V208, P177, DOI 10.1086/154592; Su YN, 2004, ASTROPHYS J, V604, P258, DOI 10.1086/381880; Goldsmith PF, 1999, ASTROPHYS J, V517, P209, DOI 10.1086/307195; Zapata LA, 2009, ASTROPHYS J, V698, P1422, DOI 10.1088/0004-637X/698/2/1422; Muller HSP, 2001, ASTRON ASTROPHYS, V370, pL49, DOI 10.1051/0004-6361:20010367; Lumsden SL, 2012, MON NOT R ASTRON SOC, V424, P1088, DOI 10.1111/j.1365-2966.2012.21280.x; Zinnecker H, 2007, ANNU REV ASTRON ASTR, V45, P481, DOI 10.1146/annurev.astro.44.051905.092549; MARTI J, 1993, ASTROPHYS J, V416, P208, DOI 10.1086/173227; Baez-Rubio A, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201219889; Beltran MT, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015049; Beltran MT, 2006, NATURE, V443, P427, DOI 10.1038/nature05074; Beuther H, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321498; Briggs D. S., 1995, THESIS NEW MEXICO I; Bronfman L, 1996, ASTRON ASTROPHYS SUP, V115, P81; Carrasco-Gonzalez C, 2012, ASTROPHYS J LETT, V752, DOI 10.1088/2041-8205/752/2/L29; Carrasco-Gonzalez C, 2010, ASTRON J, V139, P2433, DOI 10.1088/0004-6256/139/6/2433; Caswell JL, 1998, MON NOT R ASTRON SOC, V297, P215; Charnley SB, 1997, ASTROPHYS J, V481, P396, DOI 10.1086/304011; Curiel S, 2006, ASTROPHYS J, V638, P878, DOI 10.1086/498931; CURIEL S, 1989, ASTROPHYS LETT COMM, V27, P299; DEBIEVRE P, 1993, INT J MASS SPECTROM, V123, P149, DOI 10.1016/0168-1176(93)87009-H; Draine BT, 2006, ASTROPHYS J, V636, P1114, DOI 10.1086/498130; Dubernet ML, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220630; Fallscheer C, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/66; Faundez S, 2004, ASTRON ASTROPHYS, V426, P97, DOI 10.1051/0004-6361:20035755; Feigelson ED, 2012, MODERN STATISTICAL METHODS FOR ASTRONOMY: WITH R APPLICATIONS, P1, DOI 10.1017/CBO9781139015653; Fernandez-Lopez M, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/97; Ferrante RF, 2008, ASTROPHYS J, V684, P1210, DOI 10.1086/590362; Franco-Hernandez R, 2009, ASTROPHYS J, V701, P974, DOI 10.1088/0004-637X/701/2/974; Frank A., 2014, PROTOSTARS IN PRESS; Galvan-Madrid R, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201220330; Garay G, 2007, ASTRON ASTROPHYS, V463, P217, DOI 10.1051/0004-6361:20065329; Garay G., 2005, IAU S, V227, P86; Garay G, 2002, ASTROPHYS J, V579, P678, DOI 10.1086/342986; Garay G, 2003, ASTROPHYS J, V587, P739, DOI 10.1086/368310; Gordon M. A., 2009, ASTROPHYSICS SPACE S, V282; GREEN S, 1978, ASTROPHYS J SUPPL S, V37, P169, DOI 10.1086/190523; GRIEM HR, 1967, ASTROPHYS J, V148, P547, DOI 10.1086/149176; Guzman AE, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/51; Guzman AE, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/150; Guzman A. E., 2012, THESIS U CHILE; Guzman AE, 2010, ASTROPHYS J, V725, P734, DOI 10.1088/0004-637X/725/1/734; Herpin F, 2009, ASTRON ASTROPHYS, V504, P853, DOI 10.1051/0004-6361/200811257; HO PTP, 1986, ASTROPHYS J, V304, P501, DOI 10.1086/164184; Hoare M. G., 2007, DIFFUSE MATTER STAR, P61, DOI 10.1007/978-1-4020-5425-9_4; Hunter TR, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/187; Jaffe DT, 1999, ASTROPHYS J, V520, P162, DOI 10.1086/307440; Jimenez-Serra I, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/2/L27; Jimenez-Serra I, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/34; Johnston KG, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201219657; Keto E, 2007, ASTROPHYS J, V666, P976, DOI 10.1086/520320; Kuiper R, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/20; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Lamers H. J. G. L. M., 1999, INTRO STELLAR WINDS; Lang K. R., 1980, ASTROPHYSICAL FORMUL; Larson R. B., 2003, ASP C SER, P65; Li Z.-Y., 2014, PROTOSTARS IN PRESS; Livio M., 2009, PROTOSTELLAR JETS CO, P3, DOI 10.1007/978-3-642-00576-3_1; Lopez C, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201015889; Lugo J, 2004, ASTROPHYS J, V614, P807, DOI 10.1086/423924; Lumsden SL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/11; Maity S, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/184; Marti J, 1998, ASTROPHYS J, V502, P337, DOI 10.1086/305900; CHERNIN LM, 1992, ASTROPHYS J, V387, pL47, DOI 10.1086/186302; Maud LT, 2013, MON NOT R ASTRON SOC, V428, P609, DOI 10.1093/mnras/sts049; Ormel CW, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201117058; Paladini R, 2004, MON NOT R ASTRON SOC, V347, P237, DOI 10.1111/j.1365-2966.2004.07210.x; Petry D, 2012, ASTR SOC P, V461, P849; Qiu KP, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/170; Ray T., 2007, PROTOSTARS PLANETS, VV, P231; Remijan A. J., 2007, BAAS, V39, P963; REYNOLDS SP, 1986, ASTROPHYS J, V304, P713, DOI 10.1086/164209; Richer J. S., 2000, PROTOSTARS PLANETS, P867; Rodriguez LF, 2005, ASTROPHYS J, V626, P953, DOI 10.1086/430268; Rodriguez LF, 2008, ASTRON J, V135, P2370, DOI 10.1088/0004-6256/135/6/2370; RODRIGUEZ LF, 1993, REV MEX ASTRON ASTR, V25, P23; Sanchez-Monge A, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201321134; Sandell G, 2009, ASTROPHYS J LETT, V699, pL31, DOI 10.1088/0004-637X/699/1/L31; Sanhueza P, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/60; Sewillo M, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/44; SIMPSON JP, 1973, ASTROPHYS SPACE SCI, V20, P187, DOI 10.1007/BF00645596; Stepkin SV, 2007, MON NOT R ASTRON SOC, V374, P852, DOI 10.1111/j.1365-2966.2006.11190.x; Tan J. C., 2014, PROTOSTARS IN PRESS; Torrelles JM, 2011, MON NOT R ASTRON SOC, V410, P627, DOI 10.1111/j.1365-2966.2010.17483.x; Vaidya B, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/56; van der Tak F., 2011, IAU S, V280, P449; von Prochazka AA, 2010, PUBL ASTRON SOC PAC, V122, P354; Wakelam V, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016164; WALMSLEY CM, 1990, ASTRON ASTROPHYS SUP, V82, P201; WALMSLEY M, 1995, REV MEX AST ASTR, V1, P137; Wilson TL, 2009, ASTRON ASTROPHYS LIB, P1, DOI 10.1007/978-3-540-85122-6_1; Zhang Q., 2005, IAU S, V227, P135; Zhang QZ, 1997, ASTROPHYS J, V488, P241, DOI 10.1086/304667; Zhang QZ, 2007, ASTROPHYS J, V658, P1152, DOI 10.1086/511381	142	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							117	10.1088/0004-637X/796/2/117		20	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900046		
J	Hori, T; Ueda, Y; Shidatsu, M; Kawamuro, T; Kubota, A; Done, C; Nakahira, S; Tsumura, K; Shirahata, M; Nagayama, T				Hori, Takafumi; Ueda, Yoshihiro; Shidatsu, Megumi; Kawamuro, Taiki; Kubota, Aya; Done, Chris; Nakahira, Satoshi; Tsumura, Kohji; Shirahata, Mai; Nagayama, Takahiro			SUZAKU OBSERVATION OF THE BLACK HOLE BINARY 4U 1630-47 IN THE VERY HIGH STATE (vol 790, pg 20, 2014)	ASTROPHYSICAL JOURNAL			English	Correction									[Hori, Takafumi; Ueda, Yoshihiro; Shidatsu, Megumi; Kawamuro, Taiki] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Kubota, Aya] Shibaura Inst Technol, Dept Elect Informat Syst, Minuma Ku, Saitama 3378570, Japan; [Done, Chris] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Nakahira, Satoshi] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, ISS Sci Project Off, Tsukuba, Ibaraki 3058505, Japan; [Tsumura, Kohji] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Shirahata, Mai] Natl Astron Observ Japan, Natl Inst Nat Sci, Mitaka, Tokyo 1818588, Japan; [Shirahata, Mai] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Dept Space Astron & Astrophys, Sagamihara, Kanagawa 2525210, Japan; [Nagayama, Takahiro] Kagoshima Univ, Fac Sci, Dept Phys, Kagoshima 8900065, Japan	Hori, T (reprint author), Kyoto Univ, Dept Astron, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	hori@kusastro.kyoto-u.ac.jp	XRAY, SUZAKU/A-1808-2009				Hori T, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/20	1	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							146	10.1088/0004-637X/796/2/146		1	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900075		
J	Ohashi, N; Saigo, K; Aso, Y; Aikawa, Y; Koyamatsu, S; Machida, MN; Saito, M; Takahashi, SZ; Takakuwa, S; Tomida, K; Tomisaka, K; Yen, HW				Ohashi, Nagayoshi; Saigo, Kazuya; Aso, Yusuke; Aikawa, Yuri; Koyamatsu, Shin; Machida, Masahiro N.; Saito, Masao; Takahashi, Sanemichi Z.; Takakuwa, Shigehisa; Tomida, Kengo; Tomisaka, Kohji; Yen, Hsi-Wei			FORMATION OF A KEPLERIAN DISK IN THE INFALLING ENVELOPE AROUND L1527 IRS: TRANSFORMATION FROM INFALLING MOTIONS TO KEPLER MOTIONS	ASTROPHYSICAL JOURNAL			English	Article						circumstellar matter; stars: individual (L1527 IRS); stars: low-mass; stars: protostars	CONTROLLED SPASMODIC ACCRETION; MOLECULAR CLOUD CORES; T-TAURI STARS; MAGNETIC BRAKING; PROTOSTELLAR DISKS; EVOLUTION; GAS; PROTOSTARS; ROTATION; COLLAPSE	We report Atacama Large Millimeter/submillimeter Array (ALMA) cycle 0 observations of the (CO)-O-18 (J = 2-1), SO (J(N) = 6(5)-5(4)), and the 1.3 mm dust continuum toward L1527 IRS, a class 0 solar-type protostar surrounded by an infalling and rotating envelope. (CO)-O-18 emission shows strong redshifted absorption against the bright continuum emission associated with L1527 IRS, strongly suggesting infall motions in the (CO)-O-18 envelope. The (CO)-O-18 envelope also rotates with a velocity mostly proportional to r(-1), where r is the radius, whereas the rotation profile at the innermost radius (similar to 54 AU) may be shallower than r(-1), suggestive of formation of a Keplerian disk around the central protostar of similar to 0.3 M-circle dot in dynamical mass. SO emission arising from the inner part of the (CO)-O-18 envelope also shows rotation in the same direction as the (CO)-O-18 envelope. The rotation is, however, rigid-body-like, which is very different from the differential rotation shown by (CO)-O-18. In order to explain the line profiles and the position-velocity (PV) diagrams of (CO)-O-18 and SO observed, simple models composed of an infalling envelope surrounding a Keplerian disk of 54 AU in radius orbiting a star of 0.3 M-circle dot are examined. It is found that in order to reproduce characteristic features of the observed line profiles and PV diagrams, the infall velocity in the model has to be smaller than the free-fall velocity yielded by a star of 0.3 M-circle dot. Possible reasons for the reduced infall velocities are discussed.	[Ohashi, Nagayoshi] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Ohashi, Nagayoshi; Takakuwa, Shigehisa; Yen, Hsi-Wei] Acad Sinica, Inst Astron & Astrophys, Taipei 10617, Taiwan; [Saigo, Kazuya] Natl Inst Nat Sci, Natl Astron Observ Japan, Chile Observ, Mitaka, Tokyo 1818588, Japan; [Aso, Yusuke; Koyamatsu, Shin] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Aikawa, Yuri] Kobe Univ, Dept Earth & Planetary Sci, Kobe, Hyogo 6578501, Japan; [Machida, Masahiro N.] Kyushu Univ, Dept Earth & Planetary Sci, Fac Sci, Fukuoka 8128581, Japan; [Saito, Masao] Joint ALMA Observ, Santiago, Chile; [Takahashi, Sanemichi Z.] Kyoto Univ, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Tomida, Kengo] Princeton Univ, Dept Astron Sci, Princeton, NJ 08544 USA; [Tomida, Kengo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Tomisaka, Kohji] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Ohashi, N (reprint author), Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, 650 N Aohoku Pl, Hilo, HI 96720 USA.	nohashi@naoj.org	Tomisaka, Kohji/E-6508-2013; 	Tomisaka, Kohji/0000-0003-2726-0892; Tomida, Kengo/0000-0001-8105-8113	Subaru Telescope Internship Program; JSPS Research Fellowship for Young Scientists; Ministry of Science and Technology of Taiwan [MOST 102-2119M-001-012-MY3, NSC 102-2119-M-001-012-MY3]; Ministry of Education, Culture, Sports, Science, and Technologies [23540266, 23103004]	This paper makes use of the following ALMA data: ADS/JAO.ALMA#2011.0.00210. S. ALMA is a partnership of ESO (representing its member states), NSF (USA), and NINS (Japan), together with NRC (Canada) and NSC and ASIAA (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, AUI/NRAO, and NAOJ. We thank all the ALMA staff, who made our observations successful. We also thank Takayuki Muto, Takaaki Matsumoto, and Nami Sakai who provided us with fruitful comments on the manuscript. S.K. is supported by the Subaru Telescope Internship Program. K.T. is supported by JSPS Research Fellowship for Young Scientists. S.T. acknowledges a grant from the Ministry of Science and Technology of Taiwan (MOST 102-2119M-001-012-MY3; NSC 102-2119-M-001-012-MY3) in support of this work. This study is supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technologies (23540266, 23103004 (to Y.A.)).	Mellon RR, 2009, ASTROPHYS J, V698, P922, DOI 10.1088/0004-637X/698/1/922; Simon M, 2000, ASTROPHYS J, V545, P1034, DOI 10.1086/317838; Mellon RR, 2008, ASTROPHYS J, V681, P1356, DOI 10.1086/587542; Machida MN, 2011, PUBL ASTRON SOC JPN, V63, P555; Andrews SM, 2007, ASTROPHYS J, V659, P705, DOI 10.1086/511741; Ohashi N, 1997, ASTROPHYS J, V475, P211, DOI 10.1086/303533; Saigo K, 2008, ASTROPHYS J, V674, P997, DOI 10.1086/523888; Sakai N, 2014, NATURE, V507, P78, DOI 10.1038/nature13000; Tobin JJ, 2012, NATURE, V492, P83, DOI 10.1038/nature11610; CASSEN P, 1981, ICARUS, V48, P353, DOI 10.1016/0019-1035(81)90051-8; Garrod RT, 2006, ASTRON ASTROPHYS, V457, P927, DOI 10.1051/0004-6361:20065560; Andrews SM, 2005, ASTROPHYS J, V631, P1134, DOI 10.1086/432712; Tobin JJ, 2008, ASTROPHYS J, V679, P1364, DOI 10.1086/587683; Schoier FL, 2005, ASTRON ASTROPHYS, V432, P369, DOI 10.1051/0004-6361:20041729; Hennebelle P, 2009, ASTRON ASTROPHYS, V506, pL29, DOI 10.1051/0004-6361/200913008; Di Francesco J, 2001, ASTROPHYS J, V562, P770, DOI 10.1086/323854; Machida MN, 2014, MON NOT R ASTRON SOC, V438, P2278, DOI 10.1093/mnras/stt2343; van der Tak FFS, 2007, ASTRON ASTROPHYS, V468, P627, DOI 10.1051/0004-6361:20066820; Caselli P, 2002, ASTROPHYS J, V572, P238, DOI 10.1086/340195; BEICHMAN CA, 1986, ASTROPHYS J, V307, P337, DOI 10.1086/164421; TEREBEY S, 1984, ASTROPHYS J, V286, P529, DOI 10.1086/162628; BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; Kitamura Y, 2002, ASTROPHYS J, V581, P357, DOI 10.1086/344223; HASEGAWA TI, 1993, MON NOT R ASTRON SOC, V261, P83; Aota T., 2014, APJ UNPUB; Dutrey A, 1998, ASTRON ASTROPHYS, V338, pL63; GOLDREIC.P, 1974, ASTROPHYS J, V189, P441, DOI 10.1086/152821; Harsono D, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322646; Joos M, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118730; Kristensen L. E., 2012, ASTRON ASTROPHYS, V542, P8; Krumholz MR, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L11; Kunz MW, 2010, MON NOT R ASTRON SOC, V408, P322, DOI 10.1111/j.1365-2966.2010.17110.x; Li Z.-Y., 1996, ASTROPHYS J LETT, V464, pL1; Li ZY, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/180; Lique F., 2007, JCHPH, V126, P16; Lique F, 2006, ASTRON ASTROPHYS, V450, P399, DOI 10.1051/0004-6361:20054520; Murillo N. M., 2013, ASTRON ASTROPHYS, V560, P103; NEUFELD DA, 1994, ASTROPHYS J, V428, P170, DOI 10.1086/174230; Osterbrock D. E., 2006, ASTROPHYSICS GASEOUS; Pineda JE, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219589; Takakuwa S., 2012, APJ, V745, P52; Tassis K, 2005, ASTROPHYS J, V618, P783, DOI 10.1086/424480; Tassis K, 2005, ASTROPHYS J, V618, P769, DOI 10.1086/424479; Tobin JJ, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/48; Tobin JJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/45; Tomida K, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/6; Tsukamoto Y., 2014, ARXIV14047271; Yen HW, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/1; Yen HW, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/1/22	49	10	10	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							131	10.1088/0004-637X/796/2/131		11	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900060		
J	Watanabe, H; Kitai, R; Otsuji, K				Watanabe, Hiroko; Kitai, Reizaburo; Otsuji, Kenichi			FORMATION AND DECAY OF RUDIMENTARY PENUMBRA AROUND A PORE	ASTROPHYSICAL JOURNAL			English	Article						magnetic fields; Sun: photosphere; sunspots	SOLAR OPTICAL TELESCOPE; MAGNETIC-FLUX TUBES; TEMPORAL EVOLUTION; SUNSPOT PENUMBRAE; HINODE; FIELD; SPECTROPOLARIMETRY; VELOCITY; ORIGIN; FLOWS	We analyze the evolution of a pore in the active region NOAA 10940 using the data obtained by the Hinode satellite on 2007 February 3. The pore we analyzed showed the formation of a rudimentary penumbra structure, succeeded by an abrupt disappearance after about 5 hr. The pore had an approximate radius of 3.5 Mm and a total magnetic flux of 3.0 x 10(19) Mx, which is a little smaller than the necessary magnetic flux for penumbral formation supposed by Rucklidge et al. (1-1.5 x 10(20) Mx). Our observation describes a rare phenomenon which was in the unstable phase between a pore and a sunspot. The area of the dark umbra gradually decreased when the rudimentary penumbral filaments formed the penumbral structure, meaning that the penumbra develops at the expense of the umbral magnetic flux. This statement was confirmed by a rough estimation of the magnetic flux variation observed by the Hinode Fe I magnetogram. Five hours after the formation phase, the decay phase began. In this decaying phase, multiple opposite polarity patches are found to appear in the exterior of the pore (a different location from the penumbra formation site). We interpret these opposite polarities as signatures of the horizontal magnetic field, which preferably appears in the course of the unstable reconfiguration of the magnetic field structure. During the course of the disappearance of the penumbra, the horizontal penumbral field seems to become vertical because of the dark umbral area that recovered by about 10%.	[Watanabe, Hiroko] Kyoto Univ, Unit Synerget Studies Space, Yamashina Ku, Kyoto 6078417, Japan; [Kitai, Reizaburo] Kyoto Univ, Kwasan & Hida Observ, Yamashina Ku, Kyoto 6078417, Japan; [Kitai, Reizaburo] Bukkyo Univ, Kita Ku, Kyoto 6038301, Japan; [Otsuji, Kenichi] Natl Astron Observ, Solar Observ, Mitaka, Tokyo 1818588, Japan	Watanabe, H (reprint author), Kyoto Univ, Unit Synerget Studies Space, Yamashina Ku, Kyoto 6078417, Japan.	watanabe@kwasan.kyoto-u.ac.jp			Japanese MEXT [26400235]	We thank Dr. Suematsu for his help with the deconvolution using the point-spread function of the Hinode SOT. We also thank the members of the Kwasan and Hida Observatories and Unit of Synergetic Studies for Space for fruitful discussions. We are supported by the Grant-in-Aid for JSPS Fellows, and by the grant-in-aid from the Japanese MEXT (PI: R. Kitai, No. 26400235). This work has made extensive use of the Hinode Solar Optical Telescope. We are grateful to the developers and observers of Hinode. Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as a domestic partner and NASA and STFC (UK) as international partners. It is operated by these agencies in cooperation with ESA and NSC (Norway).	Hurlburt NE, 2000, MON NOT R ASTRON SOC, V314, P793, DOI 10.1046/j.1365-8711.2000.03407.x; Brummell NH, 2008, ASTROPHYS J, V686, P1454, DOI 10.1086/591640; Leka KD, 1998, ASTROPHYS J, V507, P454, DOI 10.1086/306297; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Sobotka M, 1999, ASTROPHYS J, V511, P436, DOI 10.1086/306671; Cameron R, 2007, ASTRON ASTROPHYS, V474, P261, DOI 10.1051/0004-6361:20078140; Weiss NO, 2004, ASTROPHYS J, V600, P1073, DOI 10.1086/380091; Thomas JH, 2002, NATURE, V420, P390, DOI 10.1038/nature01174; Rubio LRB, 2008, ASTROPHYS J, V676, P698, DOI 10.1086/527366; Chae J. C., 2007, PASJ, V59, P619; Criscuoli S, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201117698; Kitai R., 2014, PASJ IN PRESS; Louis RE, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/109; Petrovay K, 1997, ASTROPHYS J, V485, P398, DOI 10.1086/304404; Rempel M, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/5; Rempel M, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/62; Rezaei R, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117485; RICHARDS.WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; RUCKLIDGE AM, 1995, MON NOT R ASTRON SOC, V273, P491; Shimizu T, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L18; Shine R. A., 1987, NASA C PUBLICATION, V2483, P133; SIMON GW, 1970, SOL PHYS, V13, P85, DOI 10.1007/BF00963944; Sobotka M, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322148; Sobotka M, 2013, J PHYS CONF SER, V440, DOI 10.1088/1742-6596/440/1/012049; Tildesley MJ, 2004, MON NOT R ASTRON SOC, V350, P657, DOI 10.1111/j.1365-2966.2004.07678.x; Suematsu Y, 2008, SOL PHYS, V249, P197, DOI 10.1007/s11207-008-9129-4; Wang HM, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/76; Watanabe H, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/49; Wedemeyer-Bohm S, 2008, ASTRON ASTROPHYS, V487, P399, DOI 10.1051/0004-6361:200809819	30	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	DEC 1	2014	796	2							77	10.1088/0004-637X/796/2/77		7	Astronomy & Astrophysics	Astronomy & Astrophysics	AT4AI	WOS:000344878900006		
J	Kanazawa, H; Yoshida, N; Yamamoto, H; Hara, M; Hasegawa, M; Matsuzawa, S; Shinnabe, A; Iino, Y				Kanazawa, Hiromi; Yoshida, Naohiro; Yamamoto, Hiroki; Hara, Mariko; Hasegawa, Masayo; Matsuzawa, Shingo; Shinnabe, Akihiro; Iino, Yukiko			Risk factors associated with severity of eosinophilic otitis media	AURIS NASUS LARYNX			English	Article						Eosinophilic otitis media; Severity score; Bronchial asthma; Obesity	ASTHMA RESEARCH-PROGRAM; CHRONIC RHINOSINUSITIS; BRONCHIAL-ASTHMA; EUSTACHIAN-TUBE; PHENOTYPE; OBESITY; MICE	Objective: Eosinophilic otitis media (EOM) is an intractable otitis media associated with bronchial asthma. Clinical characteristics of EOM are apparent, but severe EOM, which is unresponsive to ongoing treatments, can occur. The present study aimed to investigate potential risk factors associated with the severity of EOM. Methods: We scored the EOM severity of 26 patients according to quantity of middle ear effusion (MEE), thickness of the middle ear mucosa, use of topical and oral corticosteroids, and use of antibiotics, all measured over a 3-month period. The scores for four 3-month periods (1 year) were averaged. We analyzed the prevalence of clinical variables by partial regression: sex, age, body mass index (BMI), duration of bronchial asthma, association of aspirin-intolerant asthma, Lund-Mackay score for sinusitis, mastoid pneumatization, width of the bony Eustachian tube at the tympanic orifice, percentage of eosinophils and immunoglobulin E in peripheral blood, and association of allergic rhinitis. Duration of bronchial asthma was defined as the period from onset of bronchial asthma to the age of first consultation at our hospital. Samples of MEE were taken for bacterial culture. Results: The average severity score was 6.6 (out of 16). The severity score in the pathogen-positive MEE group was significantly higher than that in the pathogen-negative MEE group (p < 0.05). The score was not significantly different between the seasons. Linear multiple regression analysis showed that BMI and the duration of bronchial asthma significantly affected the EOM severity score (p < 0.05). The presence of aspirin intolerant asthma tended to be correlated with the severity score. The Lund-Mackay score tended to be negatively correlated with it. Conclusions: There is a significant association between the severity of EOM and obesity, as well as with the duration of bronchial asthma. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kanazawa, Hiromi; Yoshida, Naohiro; Yamamoto, Hiroki; Hara, Mariko; Hasegawa, Masayo; Matsuzawa, Shingo; Shinnabe, Akihiro; Iino, Yukiko] Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol, Saitama 3308503, Japan	Kanazawa, H (reprint author), Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	hkanazawa@jichi.ac.jp					Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Nagamine H, 2002, AURIS NASUS LARYNX, V29, P19, DOI 10.1016/S0385-8146(01)00124-9; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Lin DC, 2011, AM J RHINOL ALLERGY, V25, P205, DOI 10.2500/ajra.2011.25.3613; Iino Y, 2012, OTOL NEUROTOL, V33, P1218, DOI 10.1097/MAO.0b013e318263d5b8; Chung WJ, 2012, KOREAN J RADIOL, V13, P363, DOI 10.3348/kjr.2012.13.3.363; Kanazawa H, 2013, J INT ADV OTOL, V9, P353; [Anonymous], 2000, WHO TECH REP SER, V894, P1; Celedon JC, 2001, AM J RESP CRIT CARE, V164, P1835; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Iino Y, 2008, OTOL NEUROTOL, V29, P949, DOI 10.1097/MAO.0b013e318185fb0d; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P103, DOI 10.1016/j.jaci.2004.10.007; Iino Y, 2011, AURIS NASUS LARYNX, V38, P456, DOI 10.1016/j.anl.2010.11.016; Iino Y, 2006, ARCH OTOLARYNGOL, V132, P1109, DOI 10.1001/archotol.132.10.1109; Beuther DA, 2006, AM J RESP CRIT CARE, V174, P112, DOI 10.1164/rccm.200602-231PP; DJERIC D, 1985, ACTA OTO-LARYNGOL, V99, P543; Fukutomi Y, 2011, CLIN EXP ALLERGY, V42, P738; Iino Y, 2006, ANN ALLERG ASTHMA IM, V97, P761; Ishitoya Junichi, 2010, Allergol Int, V59, P239, DOI 10.2332/allergolint.10-RAI-0231; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Talay F, 2008, ALLERGY ASTHMA PROC, V29, P475, DOI 10.2500/aap.2008.29.3157; The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma, 2003, EUR RESP J, V22, P470; Youkou A, 2011, INTERNAL MED, V50, P1911, DOI 10.2169/internalmedicine.50.5474	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					513	517		10.1016/j.anl.2014.08.003		5	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000004		
J	Ogi, K; Takabayashi, T; Sakashita, M; Susuki, D; Yamada, T; Manabe, Y; Fujieda, S				Ogi, Kazuhiro; Takabayashi, Tetsuji; Sakashita, Masafumi; Susuki, Dai; Yamada, Takechiyo; Manabe, Yasuhiro; Fujieda, Shigeharu			Effect of Asian sand dust on Japanese cedar pollinosis	AURIS NASUS LARYNX			English	Article						Asian sand dust; Seasonal allergic rhinitis; Japanese cedar pollen	ALLERGIC RHINITIS; STORM EVENTS; HOSPITAL ADMISSIONS; DESERT DUST; AIR-POLLUTION; TAIWAN; ASTHMA; TAIPEI; EXPOSURE; ASSOCIATION	Objective: Asian sand dust (ASD), originating in the deserts of Mongolia and China, spreads over large areas and is associated with adverse effects on human health in East Asia, including asthma, heart disease, and some allergic diseases. However, the effect of ASD on patients with seasonal allergic rhinitis caused by Japanese cedar pollen (SAR-JCP), the most common form of allergic rhinitis, remains unclear. The aim of this study was to investigate the effect of ASD on SAR-JCP patients. Methods: A total of 41 patients with SAR-JCP recorded nasal and ocular allergic symptom scores in a diary. We assessed the influence of ASD events on patients with SAR-JCP during the JCP season and before and after the JCP season. Results: ASD events did not influence nasal and ocular allergy symptoms during the JCP season. Scores for sneezing and runny nose were significantly increased by ASD events in the pre-JCP season. Ocular symptom scores were significantly increased by ASD events in the post-JCP season. Conclusion: Our results suggest that ASD may exacerbate allergy symptoms even before mass scattering of JCP, which usually does not cause allergic symptoms in patients with SAR-JCP. ASD also induced conjunctivitis symptoms after the JCP season. However, we did not observe any adverse effects of ASD on allergic symptoms during the JCP season. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ogi, Kazuhiro; Manabe, Yasuhiro] Shinseikai Toyama Hosp, Div Otorhinolaryngol, Toyama 9390243, Japan; [Takabayashi, Tetsuji; Sakashita, Masafumi; Susuki, Dai; Yamada, Takechiyo; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Sensory & Locomotor Med, Div Otorhinolaryngol Head & Neck Surg, Fukui 9101193, Japan	Ogi, K (reprint author), Shinseikai Toyama Hosp, Div Otorhinolaryngol, Toyama 9390243, Japan.	ogikazu@shinseikai.or.jp					Chiu HF, 2008, INHAL TOXICOL, V20, P777, DOI 10.1080/08958370802005308 ; Fujieda S, 2012, AURIS NASUS LARYNX, V39, P553, DOI 10.1016/j.anl.2011.12.006; Sakashita M, 2008, CLIN EXP ALLERGY, V38, P1875, DOI 10.1111/j.1365-2222.2008.03114.x; Ichinose T, 2008, ARCH ENVIRON CON TOX, V55, P348, DOI 10.1007/s00244-007-9128-8; He M, 2010, INHAL TOXICOL, V22, P1012, DOI 10.3109/08958378.2010.510151; Sugimoto N, 2006, APPL OPTICS, V45, P7468, DOI 10.1364/AO.45.007468; Uno I, 2009, NAT GEOSCI, V2, P557, DOI 10.1038/NGEO583; Yamada P, 2012, ECOTOX ENVIRON SAFE, V84, P9, DOI 10.1016/j.ecoenv.2012.05.021; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Ostro B, 2009, ENVIRON HEALTH PERSP, V117, P475, DOI 10.1289/ehp.11848; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Yanagisawa R, 2007, EXP BIOL MED, V232, P1109, DOI 10.3181/0612-RM-311; Sakashita M, 2010, INT ARCH ALLERGY IMM, V151, P255, DOI 10.1159/000242363; Yang CY, 2005, INHAL TOXICOL, V17, P817, DOI 10.1080/08958370500241254; Chen YS, 2005, J TOXICOL ENV HEAL A, V68, P1457, DOI 10.1080/15287390590967388; Chang CC, 2006, J TOXICOL ENV HEAL A, V69, P229, DOI 10.1080/15287390500227415; Ichinose T, 2006, J TOXICOL ENV HEAL A, V69, P1571, DOI 10.1080/15287390500470833; Tamari M, 2013, ALLERGOL INT, V62, P21, DOI 10.2332/allergolint.13-RAI-0539; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Chen YS, 2004, ENVIRON RES, V95, P151, DOI 10.1016/j.envres.2003.08.008; Hiyoshi K, 2005, ENVIRON RES, V99, P361, DOI 10.1016/j.envres.2005.03.008; Gyan K, 2005, INT J BIOMETEOROL, V49, P371, DOI 10.1007/s00484-005-0257-3; Watanabe Masanari, 2011, Allergology International, V60, P267, DOI 10.2332/allergolint.10-OA-0239; Okubo Kimihiro, 2011, Allergology International, V60, P171, DOI [10.2332/allergolint. 11-RAI-0334, 10.2332/allergolint.11-RAI-0334]; Chen PS, 2010, ENVIRON HEALTH PERSP, V118, P1211, DOI 10.1289/ehp.0901782; Kim BG, 2001, ATMOS ENVIRON, V35, P727, DOI 10.1016/S1352-2310(00)00344-7; Taylor DA, 2002, ENVIRON HEALTH PERSP, V110, pA80, DOI 10.1289/ehp.110-a80; Watanabe Masanari, 2011, Allergology International, V60, P517, DOI 10.2332/allergolint.10-OA-0298; Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1; Duce AR, 1980, SCIENCE, V209, P1522; Husar RB, 2001, J GEOPHYS RES, V106, P18316; Ichinose T, 2009, INHAL TOXCOL, V12, P985; Kobayashi Fumihisa, 2010, Earozoru Kenkyu, V25; Lai LW, 2008, INT J ENVIRON HEAL R, V18, P429, DOI 10.1080/09603120802272227; Middleton N, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-39; Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3; Qian ZA, 2002, J DESERT RES, V22, P2; Tomita K, 2013, ALLERGY, V68, P92, DOI 10.1111/all.12066; Yamada T, 2014, J ALLERGY CLIN IMMUN, V133, P632, DOI 10.1016/j.jaci.2013.11.002; Yamamoto H, 2010, ALLERGY ASTHMA PROC, V31, P296, DOI 10.2500/aap.2010.31.3355; Yang CY, 2006, J TOXICOL ENV HEAL A, V69, P1673, DOI 10.1080/15287390600630096	42	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					518	522		10.1016/j.anl.2014.05.020		5	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000005		
J	Shiga, H; Yamamoto, J; Kitamura, M; Nakagawa, H; Matsubasa, T; Seo, A; Miwa, T				Shiga, Hideaki; Yamamoto, Junpei; Kitamura, Miwa; Nakagawa, Hideaki; Matsubasa, Tomoko; Seo, Atsuko; Miwa, Takaki			Combinations of two odorants of smell identification test for screening of olfactory impairment	AURIS NASUS LARYNX			English	Article						Odorant; Open Essence; Screening for olfactory impairment; Smell identification test card	JAPANESE PATIENTS; DISTURBANCE; CARD	Objective: To determine whether combinations of two odorants of the Open Essence smell identification test can be used to screen for olfactory impairment in Japanese people. Methods: A total of 243 Japanese subjects (142 males, 101 females; mean age, 37.5 years; age range, 2062 years) were enrolled in the study. The main outcome measures were the results of olfactory testing by using the full 12 odorants (condensed milk, cooking gas, curry, cypress wood (Japanese cypress, hinoki), India ink, Japanese orange (mikan), menthol, perfume, roasted garlic, rose, sweaty-smelling clothes, and wood) of the Open Essence test as well as combinations of two odorants of the Open Essence test, and the results of self-reported questionnaires addressing awareness of a smell disorder, history of sinunasal disease, self-reported nasal obstruction, and history of smoking. Results: In screening with combinations of two odorants, the highest positive likelihood ratio (19.1) was obtained with the cypress wood and India ink odorants. All subjects correctly identified the curry odorant. Combinations of other odorants also had high positive likelihood ratios (India ink and sweatysmelling clothes, 17.6; perfume and sweaty-smelling clothes, 14.7; cypress wood and roasted garlic, 14.1; cypress wood and rose, 13.2; cypress wood and perfume, 11.0; cypress wood and wood, 10.7). Conclusion: The combination of cypress wood and India ink odorants may be useful for detecting individuals with olfactory impairment among subjects who can correctly identify the curry odorant. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Shiga, Hideaki; Yamamoto, Junpei; Kitamura, Miwa; Miwa, Takaki] Kanazawa Med Univ, Dept Otorhinolaryngol, Uchinada, Ishikawa 9200293, Japan; [Nakagawa, Hideaki] Kanazawa Med Univ, Dept Epidemiol & Publ Hlth, Uchinada, Ishikawa 9200293, Japan; [Nakagawa, Hideaki] Kanazawa Med Univ Hosp, Hlth Control Ctr, Kanazawa, Ishikawa 9200293, Japan; [Matsubasa, Tomoko; Seo, Atsuko] Tokyo Gas Corp Ltd, Tokyo 1058527, Japan	Shiga, H (reprint author), Kanazawa Med Univ, Dept Otorhinolaryngol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	shigah@kanazawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [C21592174, C25462670]	This research was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (C21592174 and C25462670 to H.S.).	Kobayashi M, 2006, CHEM SENSES, V31, P335, DOI 10.1093/chemse/bjj037; Saito S, 2006, CHEM SENSES, V31, P379, DOI 10.1093/chemse/bjj042; Fujio H, 2012, ANN OTO RHINOL LARYN, V121, P413; Hashimoto Y, 2004, CHEM SENSES, V29, P565, DOI 10.1093/chemse/bjh061; Kobayashi M, 2004, ACTA OTO-LARYNGOL, V124, P74, DOI 10.1080/03655230410017715; Miwa Takaki, 2004, Nihon Jibiinkoka Gakkai Kaiho, V107, P956; Nishida Kohei, 2010, Nihon Jibiinkoka Gakkai Kaiho, V113, P751; Okutani F, 2013, AURIS NASUS LARYNX, V40, P76, DOI 10.1016/j.anl.2012.02.007; Saito S, 1999, TASTES AROMAS CHEM S, P75; Shiga H, 2009, ACTA OTO-LARYNGOL, V129, P91, DOI 10.1080/00016480902915699; Tsuchida A, 2008, JPN J TASTE SMELL RE, V15, P523; ZUSHO H, 1983, Rhinology (Utrecht), V21, P281	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					523	527		10.1016/j.anl.2014.08.011		5	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000006		
J	Matsunobu, T; Kurioka, T; Miyagawa, Y; Araki, K; Tamura, A; Niwa, K; Tomifuji, M; Yamashita, T; Shiotani, A				Matsunobu, Takeshi; Kurioka, Takaomi; Miyagawa, Yoshihiro; Araki, Koji; Tamura, Atsushi; Niwa, Katsuki; Tomifuji, Masayuki; Yamashita, Taku; Shiotani, Akihiro			Minimally invasive surgery of sialolithiasis using sialendoscopy	AURIS NASUS LARYNX			English	Article						Sialendoscopy; Salivary gland; Sialolithiasis; Transoral stone removal; Gland preservation	EXPERIENCE; DIAGNOSIS; MANAGEMENT	Objective: The introduction of minimally invasive surgical procedures using sialendoscopy has significantly reduced the rate of major salivary gland removal due to sialolithiasis. The present study assessed the utility of sialendoscopy and identified potential factors influencing successful sialendoscopic salivary stone retrieval. Methods: Medical records of sialendoscopic procedures performed at the Department of Otolaryngology of the National Defense Medical College in Japan from November 2007 to January 2014 were retrospectively reviewed. We identified 78 patients diagnosed with sialolithiasis and treated with sialendoscopy (SE). Factors analyzed included stone location, size, symptom duration, surgical methods, and complications. Results: The mean age at presentation was 41 years (range, 11-76 years) with a male-to-female gender ratio of 1:1.89. In total, 73 submandibular and 5 parotid endoscopies were performed. Stone size ranged from 2 to 20 mm in diameter. Submandibular stones were removed either by SE alone (9.6%), by transoral stone removal (19.2%), or a combined approach (57.5%). Only 13.7% (10/73) of the cases required submandibular gland removal. Stone size and shape were significant predictors for successful endoscopic stone removal, and stone size and location were significant predictors for submandibular gland removal. Conclusion: Sialendoscopy is a reasonable, minimally invasive treatment option for sialolithiasis that avoids salivary gland removal. The present results indicate that sialendoscopy is the first treatment of choice for submandibular gland sialolithiasis. Complete surgical excision is becoming uncommon as a first-line treatment, but it remains indispensable in certain cases. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Matsunobu, Takeshi; Kurioka, Takaomi; Miyagawa, Yoshihiro; Araki, Koji; Tamura, Atsushi; Niwa, Katsuki; Tomifuji, Masayuki; Yamashita, Taku; Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 3598513, Japan	Matsunobu, T (reprint author), Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	takeshim@ndmc.ac.jp					Marchal F, 2001, ARCH OTOLARYNGOL, V127, P66; Koch M, 2010, OTOLARYNG HEAD NECK, V142, P98, DOI 10.1016/j.otohns.2009.10.022; Marchal F, 2003, ARCH OTOLARYNGOL, V129, P951, DOI 10.1001/archotol.129.9.951; Escudier MP, 2003, BRIT J SURG, V90, P482, DOI 10.1002/bjs.4067; Zenk J, 2012, OTOLARYNG HEAD NECK, V147, P858, DOI 10.1177/0194599812452837; Marchal F, 2001, LARYNGOSCOPE, V111, P264, DOI 10.1097/00005537-200102000-00015; Walvekar RR, 2008, LARYNGOSCOPE, V118, P776, DOI 10.1097/MLG.0b013e318165e355; Walvekar RR, 2009, AM J OTOLARYNG, V30, P153, DOI 10.1016/j.amjoto.2008.03.007; Nahlieli O, 2003, ORAL SURG ORAL MED O, V95, P396, DOI 10.1067/moe.2003.145; Serbetci E, 2010, ANN OTO RHINOL LARYN, V119, P155; Nahlieli O, 2000, LARYNGOSCOPE, V110, P988, DOI 10.1097/00005537-200006000-00020; Escudier MP, 1999, BRIT DENT J, V186, P463, DOI 10.1038/sj.bdj.4800141a; Capaccio P, 2011, EUR ARCH OTO-RHINO-L, V68, P1081; Geisthoff Urban W, 2009, Otolaryngol Clin North Am, V42, P1029, DOI 10.1016/j.otc.2009.08.004; Harrison John D, 2009, Otolaryngol Clin North Am, V42, P927, DOI 10.1016/j.otc.2009.08.012; Koch M, 2008, HNO, V56, P835; Koch M, 2009, LARYNGOSCOPE, V119, P1696, DOI 10.1002/lary.20522; Nahlieli O, 2006, J AM DENT ASSOC, V137, P1397; Zenk J, 1999, HNO, V47, P963, DOI 10.1007/s001060050476	19	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					528	531		10.1016/j.anl.2014.05.009		4	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000007		
J	Akai, A; Yamamura, Y; Nonaka, M; Yoshihara, T				Akai, Aki; Yamamura, Yukie; Nonaka, Manabu; Yoshihara, Toshio			(TcO4-)-Tc-99m accumulation in scintigraphy and expression of Na+/I- symporter in salivary gland tumors	AURIS NASUS LARYNX			English	Article						Sodium-iodide symporter; (TcO4-)-Tc-99m scintigraphy; Warthin's tumor; Real-time PCR	SODIUM-IODIDE SYMPORTER; LEMON JUICE STIMULATION; WARTHINS TUMOR; RADIOIODINE THERAPY; CANCER; TISSUE; GENE	Objective: Warthin's tumors and oncocytomas show exceptionally good (TcO4-)-Tc-99m (Tc) accumulation images in Tc scintigraphy. However, the mechanism of Tc accumulation in these tumors remains unclear. Sodium-iodide symporter (NIS) is a plasma membrane protein expressed in the thyroid, lactating breast, stomach and salivary glands; it facilitates uptake of I and Tc. We hypothesized that Warthin's tumor cells and oncocytomas may also express NIS, which would promote uptake of Tc. We examined NIS localization and the mechanism of Tc accumulation in various salivary gland tissues. Methods: Immunohistological localization of NIS was performed for 19 tumors from 18 patients who underwent preoperative Tc scintigraphy. Expression of mRNA for NIS in the normal salivary gland, Warthin's tumors and pleomorphic adenomas was analyzed by real-time PCR. Results: In normal salivary glands, striated duct cells were strongly immunostained by anti-NIS antibodies. In Warthin's tumors, eosinophilic epithelial cells exhibited positive immunostaining, but their staining was varied among the cases. Furthermore, all Tc-positive specimens were NIS-positive, and all Tc-negative specimens were NIS-negative. Real-time PCR showed that NIS mRNA expression was detectable in normal salivary glands and Warthin's tumor cells. The expression was significantly higher in normal salivary glands compared with Warthin's tumor cells and pleomorphic adenoma. Conclusion: IC-positive salivary glands expressed NIS. Our findings suggest that Tc accumulation in Warthin's tumors and oncocytomas is due to poorer Tc excretory function compared with normal salivary gland tissues, in addition to active uptake of (TcO4-)-Tc-99m via NIS. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Akai, Aki; Yamamura, Yukie; Nonaka, Manabu; Yoshihara, Toshio] Tokyo Womens Med Univ, Dept Otolaryngol, Shinjuku Ku, Tokyo 1628666, Japan	Yamamura, Y (reprint author), Tokyo Womens Med Univ, Dept Otolaryngol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yukie@fd5.so-net.ne.jp					Spitzweg C, 2000, CANCER RES, V60, P6526; Filetti S, 1999, EUR J ENDOCRINOL, V141, P443, DOI 10.1530/eje.0.1410443; Scholz IV, 2005, GENE THER, V12, P272, DOI 10.1038/sj.gt.3302410; Tazebay UH, 2000, NAT MED, V6, P871; Vayre L, 1999, EUR J ENDOCRINOL, V141, P382, DOI 10.1530/eje.0.1410382; Moon DH, 2001, NUCL MED BIOL, V28, P829; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; MISHKIN FS, 1981, SEMIN NUCL MED, V11, P258, DOI 10.1016/S0001-2998(81)80023-2; Teymoortash A, 2005, VIRCHOWS ARCH, V446, P585, DOI 10.1007/s00428-005-1276-5; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; GATES GA, 1967, LARYNGOSCOPE, V77, P861, DOI 10.1288/00005537-196705000-00013; Haraguchi S, 1985, Nihon Jibiinkoka Gakkai Kaiho, V88, P520; Ikarashi Fumio, 1997, Auris Nasus Larynx, V24, P405, DOI 10.1016/S0385-8146(97)10007-4; Miyake H, 2001, EUR RADIOL, V11, P2472, DOI 10.1007/s003300100839; Murata Y, 1998, J NUCL MED, V39, P43; Nishiyama Y, 1998, Nihon Jibiinkoka Gakkai Kaiho, V101, P615; Ozawa Nozomi, 2006, Radiat Med, V24, P41, DOI 10.1007/BF02489988; Shinohara S, 2001, Nihon Jibiinkoka Gakkai Kaiho, V104, P852; Spitzweg C, 1999, J CLIN ENDOCR METAB, V84, P4178, DOI 10.1210/jc.84.11.4178	19	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					532	538		10.1016/j.anl.2014.08.002		7	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000008		
J	Kobayashi, K; Takenouchi, S; Mitani, H; Yoshida, T				Kobayashi, Kenya; Takenouchi, Shigeo; Mitani, Hiroki; Yoshida, Tuyoshi			Recurrence pattern after conservative surgery for papillary thyroid carcinoma	AURIS NASUS LARYNX			English	Article						Papillary thyroid carcinoma; Conservative surgery; Pattern of recurrence; Risk-based treatment	RETROSPECTIVE ANALYSIS; NODAL METASTASES; LOW-RISK; CANCER; SURVIVAL; SYSTEM; POLICY; WELL	Objective: Risk-based treatment represents the optimal management strategy for papillary thyroid carcinoma; however, the optimal extent of thyroidectomy and neck dissection remains controversial. This study aims to clarify the pattern of recurrence after conservative surgery in patients with papillary thyroid carcinoma. Methods: We retrospectively reviewed 93 patients with papillary thyroid carcinoma treated with conservative surgery. We analyzed recurrence rate, recurrence pattern, risk factors for recurrence, salvage treatment, and disease-free survival (DFS) in patients stratified according to risk. Results: The recurrence rate was significantly lower in the low-risk group compared with the high-risk group (14% vs 34%; p < 0.01). The recurrence pattern also differed between the two groups, with ipsilateral lateral neck recurrence being more common in the low-risk group (9%), while contralateral lateral neck recurrence was more common in the high-risk group (18%). Patients with contralateral thyroid lobe metastasis and/or direct contralateral thyroid lobe invasion showed a significantly higher rate of contralateral lateral neck metastasis than patients negative for both these features. The overall 5-year DFS was 81% in all patients. Advanced T and N classification, large primary tumor (>= 4 cm), extrathyroidal invasion, and high-risk group were significantly associated with poorer 5-year DFS in univariate analysis. Conclusion: Conservative surgery may represent a good treatment option for patients with low-risk papillary thyroid carcinoma. Tumor recurrence patterns differ between risk groups, with contralateral thyroid lobe lesions and direct contralateral lobe invasion being risk factors for contralateral lateral neck recurrence. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kobayashi, Kenya; Takenouchi, Shigeo; Yoshida, Tuyoshi] Takeda Gen Hosp, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Kobayashi, Kenya] Tokyo Univ Hosp, Dept Otolaryngol Head & Neck Surg, Tokyo 1138655, Japan; [Mitani, Hiroki] Canc Inst Hosp, Dept Head & Neck Surg, Shizuoka, Japan	Kobayashi, K (reprint author), Tokyo Univ Hosp, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kenyajp@hotmail.com					Haigh PI, 2005, ANN SURG ONCOL, V12, P81, DOI 10.1245/ASO.2005.03.027; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Wanebo H, 1998, ANN SURG, V227, P912, DOI 10.1097/00000658-199806000-00015; Hotomi M, 2012, WORLD J SURG, V36, P1231, DOI 10.1007/s00268-012-1518-z; HAY ID, 1987, SURGERY, V102, P1088; Sugitani I, 2004, SURGERY, V135, P139, DOI 10.1016/S0039-6060(03)00384-2; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Hurtado-López Luis Mauricio, 2011, Cir Cir, V79, P118; Ito Y, 2012, J THYROID RES, V2012; Shigematsu N, 2005, ENDOCR J, V52, P479, DOI 10.1507/endocrj.52.479; Sugitani I, 2010, SURG TODAY, V40, P199, DOI 10.1007/s00595-009-4034-5; Tanaka K, 2005, SURG TODAY, V35, P714, DOI 10.1007/s00595-005-3021-8; The Japanese Society of Thyroid Surgery, 2010, GUID MAN THYR TUM	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					548	551		10.1016/j.anl.2014.05.012		4	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000011		
J	Ishikawa, K; Yagi-Nakanishi, S; Nakanishi, Y; Kondo, S; Tsuji, A; Endo, K; Wakisaka, N; Murono, S; Yoshizaki, T				Ishikawa, Kazuya; Yagi-Nakanishi, Sayaka; Nakanishi, Yosuke; Kondo, Satoru; Tsuji, Akira; Endo, Kazuhira; Wakisaka, Naohiro; Murono, Shigeyuki; Yoshizaki, Tomokazu			Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue	AURIS NASUS LARYNX			English	Article						Interleukin-33; ST2; Tongue squamous cell carcinoma; Inflammation; Mast cell; Malignant potential	HUMAN MAST-CELLS; MATRIX METALLOPROTEINASE-1; TUMOR ANGIOGENESIS; GENE-EXPRESSION; RECEPTOR ST2; IL-1 FAMILY; CYTOKINE; CANCER; INFLAMMATION; MICE	Objective: The aim of this study was to clarify the role of IL-33 in tumor progression. Methods: Surgical specimens from 81 patients with squamous cell carcinoma of the tongue were studied using immunohistochemistry. Primary tumor sections were analyzed for IL-33 and ST2 expression. To examine the influence of IL-33 on the microenvironment of the tumor, we determined the mast cell density (MCD) and microvessel density of the stroma. Results: Patients with high IL-33 expression had a significantly worse prognosis (p = 0.004). IL-33 expression was significantly elevated in patients with local and riodal recurrence (p = 0.014 and p = 0.019). ST2 expression was also associated with a worse prognosis:(p = 0.024) and was significantly elevated in patients with nodal recurrence (p = 0.004). MCD was associated with worse prognosis (p = 0.038) and correlated significantly with IL-33 expression (r = 0.626, p < 0.001). Micovessels in the stroma were significantly increased in the high IL-33 group (p < 0.001). Conclusion: These data suggest that the IL-33/ST2 axis contributes to tumor aggressiveness and affects the tumor microenvironment. Immunohistochemical evaluation of IL-33 and 5T2 is useful for identifying patients at a high risk for poor prognosis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ishikawa, Kazuya; Yagi-Nakanishi, Sayaka; Nakanishi, Yosuke; Kondo, Satoru; Tsuji, Akira; Endo, Kazuhira; Wakisaka, Naohiro; Murono, Shigeyuki; Yoshizaki, Tomokazu] Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol & Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan	Yoshizaki, T (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Otolaryngol & Head & Neck Surg, Takara Machi 13-1, Kanazawa, Ishikawa 9208640, Japan.	tomoy@med.kanazawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24791760]	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 24791760.	Alkhabuli Juma O, 2007, Libyan J Med, V2, P30, DOI 10.4176/070110; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimizu Y, 2008, AURIS NASUS LARYNX, V35, P381, DOI 10.1016/j.anl.2007.12.002; Crivellato E, 2009, EUR CYTOKINE NETW, V20, P197, DOI 10.1684/ecn.2009.0167; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Jovanovic I, 2011, EUR J IMMUNOL, V41, P1902, DOI 10.1002/eji.201141417; Schmieder A, 2012, CYTOKINE, V60, P514, DOI 10.1016/j.cyto.2012.06.286; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Qiu CA, 2013, IMMUNOLOGY, V138, P76, DOI 10.1111/imm.12020; Marvie P, 2010, J CELL MOL MED, V14, P1726, DOI 10.1111/j.1582-4934.2009.00801.x; Sun PH, 2011, DIGEST DIS SCI, V56, P3596, DOI 10.1007/s10620-011-1760-5; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Hallett MA, 2012, CANCER RES, V72, P6338, DOI 10.1158/0008-5472.CAN-12-3544; Aoki S, 2010, MOL CELL BIOCHEM, V335, P75, DOI 10.1007/s11010-009-0244-9; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Kamekura R, 2012, CLIN EXP ALLERGY, V42, P218, DOI 10.1111/j.1365-2222.2011.03867.x; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Piemonte ED, 2010, J ORAL PATHOL MED, V39, P513, DOI 10.1111/j.1600-0714.2010.00901.x; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Hirota K, 2012, HISTOPATHOLOGY, V61, P1065, DOI 10.1111/j.1365-2559.2012.04341.x; Hong SN, 2012, DIGEST DIS SCI, V57, P1486, DOI 10.1007/s10620-012-2053-3; Liithi AU, 2009, IMMUNITY, V31, P84; Michailidou EZ, 2012, INT J ORAL MAX SURG, V41, P1467, DOI 10.1016/j.ijom.2011.12.038; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Nakanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062066; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Sobin LH, 1997, TNM CLASSIFICATION M, P4; Yoshizaki T, 2001, INT J CANCER, V95, P44, DOI 10.1002/1097-0215(20010120)95:1<44::AID-IJC1008>3.0.CO;2-M	35	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					552	557		10.1016/j.anl.2014.08.007		6	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000012		
J	Hamahata, A; Beppu, T; Shirakura, S; Hatanaka, A; Yamaki, T; Saitou, T; Sakurai, H				Hamahata, Atsumori; Beppu, Takesi; Shirakura, Satoshi; Hatanaka, Akio; Yamaki, Takashi; Saitou, Takashi; Sakurai, Hiroyuki			Tongue pressure in patients with tongue cancer resection and reconstruction	AURIS NASUS LARYNX			English	Article						Tongue pressure; Tongue carcinoma; Surgical flaps	SPEECH; GLOSSECTOMY	Objective: Assessment of tongue function following tongue reconstruction is important to evaluate patient status. To assess tongue function in patients who had undergone tongue reconstruction, the surgical team used a simple, hand-held tongue pressure measurement device to measure tongue power. Methods: Tongue power of 30 patients (25 males, 5 females: average age: 53.6 +/- 15.0 years) was calculated using a hand-held tongue pressure measurement device, six months postoperation. The defects were classified into minimal glossectomy (MG) (n = 8), near-half partial glossectomy of the mobile tongue (PG) (n = 5), hemi-glossectomy (HG) (n = 4), more than half partial glossectomy of the mobile tongue (SG-MT) (n = 7), and subtotal glossectomy (SG) (n = 6). As seen in other tongue assessments, a simple articulatory test, food evaluation, and speech intelligibility assessment were also performed: resulting correlations were statistically calculated using tongue pressure values. Results: The tongue pressure values were 94.0 +/- 14.5% in MG, 48.5 +/- 13.2(a) % in PG, 40.4 +/- 18.7(a) % in HG, 19.3 +/- 7.7(a,b)% in SG-MT, and 15.3 +/- 5.6(a,b)% in SG (a: <0.05 vs. MG, b: <0.05 vs. PG). The Pearson r was 0.77, 0.67, and 0.74 when correlated with simple articulatory test, food evaluation, and speech intelligibility assessment, respectively. Conclusion: Tongue pressure measurement in patients with tongue cancer resection and reconstruction facilitated determination of patients' tongue function status. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Hamahata, Atsumori; Saitou, Takashi] Saitama Canc Ctr, Div Plast & Reconstruct Surg, Saitama, Japan; [Beppu, Takesi; Shirakura, Satoshi; Hatanaka, Akio] Saitama Canc Ctr, Div Head & Neck Surg, Saitama, Japan; [Yamaki, Takashi; Sakurai, Hiroyuki] Tokyo Womens Med Univ, Dept Plast & Reconstruct Surgery, Tokyo, Japan	Hamahata, A (reprint author), Saitama Canc Ctr, Div Plast & Reconstruct Surg, 818 Komuro Inamachi Kitaadachigunn, Saitama, Japan.	a.hamahata@cancer-c.pref.saitama.jp					McConnel FMS, 1998, ARCH OTOLARYNGOL, V124, P625; PAULOSKI BR, 1994, HEAD NECK-J SCI SPEC, V16, P313, DOI 10.1002/hed.2880160404; Crow HC, 1996, J GERONTOL A-BIOL, V51, pM247; Utanohara Y, 2008, DYSPHAGIA, V23, P286, DOI 10.1007/s00455-007-9142-z; Chuanjun Chen, 2002, J Oral Maxillofac Surg, V60, P404, DOI 10.1053/joms.2002.31228; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Kan N, 2002, PROSTHODONT RES PRAC, V1, P16; ROBBINS AM, 1995, ADV OTO-RHINO-LARYNG, V50, P160; ROBBINS J, 1995, J GERONTOL A-BIOL, V50, pM257; Sarukawa S, 2013, JPN J HEAD NECK CANC, V39, P374; Shaker R, 1988, Dysphagia, V3, P79, DOI 10.1007/BF02412424; Wakumoto M, 1996, J ORAL REHABIL, V23, P764, DOI 10.1046/j.1365-2842.1996.d01-186.x; Wong RK, 2007, HEAD NECK-J SCI SPEC, V29, P758, DOI 10.1002/hed.20566; Yoshioka Fumi, 2004, Journal of Medical and Dental Sciences, V51, P19	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					563	567		10.1016/j.anl.2014.05.023		5	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000014		
J	Nomura, F; Kishimoto, S				Nomura, Fuminori; Kishimoto, Seiji			Synovial sarcoma of the temporomandibular joint and infratemporal fossa	AURIS NASUS LARYNX			English	Article						Synovial sarcoma; Head and neck; Temporomandibular joint; Infratemporal fossa; Surgery	CHILDREN; TRIAL; NECK; HEAD	Objective: Synovial sarcoma in the head and neck region is rare, and is difficult to resect with adequate safety margins because of its anatomical complexity. We herein report our experiences with synovial sarcoma in this region, and review the literature regarding the management of such cases. Method: We retrospectively examined four cases of synovial sarcoma arising from the temporomandibular joint (TMJ) area and infratemporal fossa. Result: Only one patient remains alive without disease, while the other three patients have died. Conclusion: The local control of these tumors has improved because of the progress in the surgical operation methods, while it is expected that there is still a high rate of deaths due to distant metastasis increase. The development of strong chemotherapy is needed for the use after the initial treatment and surgery. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nomura, Fuminori; Kishimoto, Seiji] Tokyo Med & Dent Univ, Dept Head & Neck Surg, Tokyo 1138519, Japan	Nomura, F (reprint author), Tokyo Med & Dent Univ, Dept Head & Neck Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	wq93329@tb3.so-net.ne.jp					Andrassy RJ, 2001, J AM COLL SURGEONS, V192, P305, DOI 10.1016/S1072-7515(00)00806-1; Italiano A, 2009, ANN ONCOL, V20, P425, DOI 10.1093/annonc/mdn678; Kawai A, 1998, NEW ENGL J MED, V338, P153, DOI 10.1056/NEJM199801153380303; Enzinger FM, 2006, SOFT TISSUE TUMORS, P1483; Harb WJ, 2007, HEAD NECK-J SCI SPEC, V29, P731, DOI 10.1002/hed.20564; Koda H, 2007, LARYNGOSCOPE, V117, P1533, DOI 10.1097/MLG.0b0l3e31806dd040; MOORE DM, 1987, ARCH OTOLARYNGOL, V113, P311; Pai S, 1983, J SURG ONCOL, V54, P82; Pappo AS, 2005, J CLIN ONCOL, V23, P4031, DOI 10.1200/JCO.2005.03.209; Sugahara S, 2012, RADIOTHER ONCOL, V105, P226, DOI 10.1016/j.radonc.2012.09.010; Sun Y, 2011, J BIOL CHEM, V286, P18623, DOI 10.1074/jbc.M110.176693; van de Rijn M, 1999, AM J SURG PATHOL, V23, P106, DOI 10.1097/00000478-199901000-00012	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					572	575		10.1016/j.anl.2014.07.001		4	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000016		
J	Sugimoto, H; Ito, M; Hatano, M; Yoshizaki, T				Sugimoto, Hisashi; Ito, Makoto; Hatano, Miyako; Yoshizaki, Tomokazu			Persistent stapedial artery with stapes ankylosis	AURIS NASUS LARYNX			English	Article						Persistent stapedial artery; Malleus-stapedotomy	MIDDLE-EAR; ANOMALIES	The persistent stapedial artery (PSA) is a very rare, congenital, vascular anomaly. It presents as a pulsatile middle ear mass and sometimes causes conductive hearing loss. The diagnosis of the presence of a PSA is always accidental, because it is so rare and difficult to predict. CT findings include the absence of the foramen spinosum and a soft-tissue prominence in the region of the tympanic segment of the facial nerve. The risks of surgery include facial palsy, hemiplegia caused by coagulation of the PSA, and bleeding due to injury of the carotid artery during surgery in cases of aberrant internal carotid. In this article we report a case of PSA with stapes ankylosis for which we performed malleus-stapedotomy using a Teflon wire piston. We did not coagulate the PSA. Nevertheless the PSA attached to the prosthesis, the patient presented significant improvement in hearing level and had no complaint of pulsating tinnitus. Thus, we have shown that attachment of the prosthesis to the PSA does not necessarily disturb improvement of hearing level after malleus-stapedotomy for otosclerosis with PSA. Based on our experience, many cases can be treated by stapedotomy using a prosthesis and without coagulating the PSA. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Sugimoto, Hisashi; Hatano, Miyako; Yoshizaki, Tomokazu] Kanazawa Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ito, Makoto] Jichi Med Univ, Jichi Childrens Med Ctr Tochigi, Shimotsuke, Tochigi 3290498, Japan	Ito, M (reprint author), Jichi Med Univ, Jichi Childrens Med Ctr Tochigi, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	makoto-ito@jichi.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19591961]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (#19591961).	Hitier M, 2013, SURG RADIOL ANAT, V35, P883, DOI 10.1007/s00276-013-1127-z; MOREANO EH, 1994, LARYNGOSCOPE, V104, P309; GOVAERTS PJ, 1993, ANN OTO RHINOL LARYN, V102, P724; HOGG ID, 1972, ANN OTO RHINOL LARYN, V81, P860; KELEMEN G, 1958, ARCHIV OTOLARYNGOL, V67, P668; Murphy MP, 1995, INT TINNITUS J, V1, P147; PIRODDA A, 1994, J LARYNGOL OTOL, V108, P237; Silbergleit R, 2000, AM J NEURORADIOL, V21, P572; STEFFEN TN, 1968, LARYNGOSCOPE, V78, P171, DOI 10.1288/00005537-196802000-00001; Thiers FA, 2000, AM J NEURORADIOL, V21, P1551	10	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					582	585		10.1016/j.anl.2014.05.024		4	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000018		
J	Nishiike, S; Tatsumi, K; Shikina, T; Masumura, C; Inohara, H				Nishiike, Suetaka; Tatsumi, Ke-ita; Shikina, Takashi; Masumura, Chisako; Inohara, Hidenori			Thyroid-stimulating hormone-secreting ectopic pituitary adenoma of the nasopharynx	AURIS NASUS LARYNX			English	Article						Hyperthyroidism; TSH; Ectopic pituitary adenoma; Rathke's pouch; Extracranial	TUMOR	Thyroid-stimulating hormone-secreting ectopic pituitary adenoma of the nasopharynx is highly unusual, with only three reported cases in the world literature. We describe the clinical presentation and radiologic findings in one patient with such rare lesions. A 46-year-old male with typical symptoms of Grave's disease was found to have a mass on magnetic resonance imaging. An otolaryngologic examination revealed a nasopharyngeal mass lesion, which was endoscopically resected. The results of immunohistochemical staining for thyroid-stimulating hormone were positive. After the resection, the patient's TSH was within normal limits. The clinical significance of the case and a brief literature review are presented. (C0 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishiike, Suetaka; Shikina, Takashi; Masumura, Chisako; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Suita, Osaka, Japan; [Nishiike, Suetaka] Osaka Rosai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Sakai, Osaka 5918025, Japan; [Tatsumi, Ke-ita] Osaka Univ, Grad Sch Med, Dept Lab Med, Suita, Osaka, Japan	Nishiike, S (reprint author), Osaka Rosai Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kita Ku, 1179-3 Nagasonecho, Sakai, Osaka 5918025, Japan.	snishiike@orh.go.jp					BeckPeccoz P, 1996, ENDOCR REV, V17, P610, DOI 10.1210/er.17.6.610; Collie RB, 2005, OTOLARYNG HEAD NECK, V133, P453, DOI 10.1016/j.otohns.2004.10.015; Cooper DS, 1996, THYROID, V6, P337, DOI 10.1089/thy.1996.6.337; Hori A, 1999, ACTA NEUROPATHOL, V98, P262; Kienitz T, 2007, EUR J ENDOCRINOL, V157, P39, DOI 10.1530/EJE-07-0098; LANGFORD L, 1995, ANN OTO RHINOL LARYN, V104, P167; LLOYD RV, 1986, AM J SURG PATHOL, V10, P546, DOI 10.1097/00000478-198608000-00004; Luk ISC, 1996, HUM PATHOL, V27, P605, DOI 10.1016/S0046-8177(96)90170-7; Pasquini E, 2003, EUR J ENDOCRINOL, V148, P253, DOI 10.1530/eje.0.1480253	9	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	DEC	2014	41	6					586	588		10.1016/j.anl.2014.07.004		3	Otorhinolaryngology	Otorhinolaryngology	AT9SI	WOS:000345266000019		
J	Nakano, S; Dadashipour, M; Asano, Y				Nakano, Shogo; Dadashipour, Mohammad; Asano, Yasuhisa			Structural and functional analysis of hydroxynitrile lyase from Baliospermum montanum with crystal structure, molecular dynamics and enzyme kinetics	BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS			English	Article						Hydroxynitrile lyase; High benzyl affinity; Broad substrate specificity; Crystal structure; Molecular dynamics simulation; Enzyme kinetics	MANIHOT-ESCULENTA; HEVEA-BRASILIENSIS; ESCHERICHIA-COLI; MECHANISM; DETERMINANTS; CYANOHYDRINS; EXPRESSION; MUTANTS; PROGRAM; COMPLEX	Hydroxynitrile lyases (HNLs) catalyze degradation of cyanohydrins to hydrogen cyanide and the corresponding ketone or aldehyde. HNLs can also catalyze the reverse reaction, i.e., synthesis of cyanohydrins. Although several crystal structures of S-selective hydroxynitrile lyases (S-HNLs) have been reported, it remains unknown whether and how dynamics at the active site of S-HNLs influence their broad substrate specificity and affinity. In this study, we analyzed the structure, dynamics and function of S-HNL from Baliospermum montanum (BmHNL), which has an alpha/beta hydrolase fold. Two crystal structures of BmHNL, apo1 and apo2, were determined at 2.55 and 1.9 angstrom, respectively. Structural comparison between BmHNL (apo2) and S-HNL from Hevea brasiliensis with (S)-mandelonitrile bound to the active site revealed that hydrophobic residues at the entrance region of BmHNL formed hydrophobic interactions with the benzene ring of the substrate. The flexible structures of these hydrophobic residues were confirmed by a 15 ns molecular dynamics simulation. This flexibility regulated the size of the active site cavity, enabling binding of various substrates to BmHNL. The high affinity of BmHNL toward substrates containing a benzene ring was also confirmed by comparing the kinetics of BmHNL and S-HNL from Manihot esculenta. Taken together, the results indicated that the flexibility and placement of the residues are important for the broad substrate specificity of S-HNLs. (C) 2014 Elsevier B.V. All rights reserved.	[Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; JST, ERATO, Asano Act Enzyme Mol Project, Imizu, Toyama 9390398, Japan	Asano, Y (reprint author), Toyama Prefectural Univ, Biotechnol Res Ctr, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	asano@pu-toyama.ac.jp			Photon Factory (PF) [2013G004]	X-ray data for the apo2 crystal were collected at the synchrotron facilities of the Photon Factory (PF) using beamline BL-17A (proposal no. 2013G004). The authors are grateful to the beamline staff and Dr. Yusuke Yamada for their assistance. The authors appreciate Dr. Yuta Miki, Dr. Masafumi Kameya, Dr. Seiji Okazaki, Dr. Kimiyasu Isobe, and Dr. Hidenobu Komeda for fruitful discussions and critical reading of the manuscript.	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Asano Y, 2011, PROTEIN ENG DES SEL, V24, P607, DOI 10.1093/protein/gzr030; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Schmidt A, 2008, J BIOL CHEM, V283, P21827, DOI 10.1074/jbc.M801056200; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Nakano S, 2014, J BIOL CHEM, V289, P10445, DOI 10.1074/jbc.M113.540773; Andexer JN, 2012, CHEMBIOCHEM, V13, P1932, DOI 10.1002/cbic.201200239; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Swart M, 2007, J MOL MODEL, V13, P1245, DOI 10.1007/s00894-007-0239-y; Gruber K, 2004, J BIOL CHEM, V279, P20501, DOI 10.1074/jbc.M401575200; Gregory RJH, 1999, CHEM REV, V99, P3649, DOI 10.1021/cr9902906; Asano Y, 2005, BIOSCI BIOTECH BIOCH, V69, P2349, DOI 10.1271/bbb.69.2349; Buhler H, 2005, CHEMBIOCHEM, V6, P711, DOI 10.1002/cbic.200400302; C.C.G. Inc, 2012, MOL OP ENV MOE; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cui FC, 2010, J PHYS CHEM B, V114, P9622, DOI 10.1021/jp100373e; Dadashipour M, 2011, J BIOTECHNOL, V153, P100, DOI 10.1016/j.jbiotec.2011.02.004; Dadashipour M, 2011, ACS CATAL, V1, P1121, DOI 10.1021/cs200325q; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Dreveny I, 2009, BIOCHEMISTRY-US, V48, P3370, DOI 10.1021/bi802162s; Franz E., 2006, STATE ART APPL STERE; Gartler G, 2007, J BIOTECHNOL, V129, P87, DOI 10.1016/j.jbiotec.2006.12.009; Holt J, 2009, CURR ORG SYNTH, V6, P15; Lauble H, 2002, PROTEIN SCI, V11, P65, DOI 10.1101/ps.33702; Lauble H, 2001, ACTA CRYSTALLOGR D, V57, P194, DOI 10.1107/S0907444900015766; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Purkarthofer T, 2007, APPL MICROBIOL BIOT, V76, P309, DOI 10.1007/s00253-007-1025-6; Semba H, 2008, BIOSCI BIOTECH BIOCH, V72, P1457, DOI 10.1271/bbb.70765; Semba H, 2010, METHODS MOL BIOL, V643, P133, DOI 10.1007/978-1-60761-723-5_10; Trummler K, 1997, J BIOL CHEM, V272, P4770; von Langermann J, 2014, CHEMBIOCHEM, V15, P1931, DOI 10.1002/cbic.201402081; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235	37	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-9639	0006-3002		BBA-PROTEINS PROTEOM	BBA-Proteins Proteomics	DEC	2014	1844	12					2059	2067		10.1016/j.bbapap.2014.09.004		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	AT8KR	WOS:000345182800001		
J	Bosch, TCG; Adamska, M; Augustin, R; Domazet-Loso, T; Foret, S; Fraune, S; Funayama, N; Grasis, J; Hamada, M; Hatta, M; Hobmayer, B; Kawai, K; Klimovich, A; Manuel, M; Shinzato, C; Technau, U; Yum, S; Miller, DJ				Bosch, Thomas C. G.; Adamska, Maja; Augustin, Rene; Domazet-Loso, Tomislav; Foret, Sylvain; Fraune, Sebastian; Funayama, Noriko; Grasis, Juris; Hamada, Mayuko; Hatta, Masayuki; Hobmayer, Bert; Kawai, Kotoe; Klimovich, Alexander; Manuel, Michael; Shinzato, Chuya; Technau, Uli; Yum, Seungshic; Miller, David J.			How do environmental factors influence life cycles and development? An experimental framework for early-diverging metazoans	BIOESSAYS			English	Article						Cnidaria; corals; environmental genomics; holobiont; hydra; sponges; symbiosis	CORAL ACROPORA-MILLEPORA; REEF-BUILDING CORAL; INNATE IMMUNITY; CLIMATE-CHANGE; CAENORHABDITIS-ELEGANS; ANIMAL DEVELOPMENT; GENETIC-STRUCTURE; SYMBIOTIC CORALS; ALGAL SYMBIOSIS; SPONGE LARVA	Ecological developmental biology (eco-devo) explores the mechanistic relationships between the processes of individual development and environmental factors. Recent studies imply that some of these relationships have deep evolutionary origins, and may even pre-date the divergences of the simplest extant animals, including cnidarians and sponges. Development of these early diverging metazoans is often sensitive to environmental factors, and these interactions occur in the context of conserved signaling pathways and mechanisms of tissue homeostasis whose detailed molecular logic remain elusive. Efficient methods for transgenesis in cnidarians together with the ease of experimental manipulation in cnidarians and sponges make them ideal models for understanding causal relationships between environmental factors and developmental mechanisms. Here, we identify major questions at the interface between animal evolution and development and outline a road map for research aimed at identifying the mechanisms that link environmental factors to developmental mechanisms in early diverging metazoans.	[Bosch, Thomas C. G.; Augustin, Rene; Fraune, Sebastian; Grasis, Juris; Hamada, Mayuko; Klimovich, Alexander] Univ Kiel, Kiel, Germany; [Adamska, Maja] Univ Bergen, Sars Ctr, Bergen, Norway; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Zagreb, Croatia; [Domazet-Loso, Tomislav] Catholic Univ Croatia, Zagreb, Croatia; [Foret, Sylvain] Australian Natl Univ, Canberra, ACT, Australia; [Funayama, Noriko; Kawai, Kotoe] Kyoto Univ, Kyoto, Japan; [Grasis, Juris] San Diego State Univ, San Diego, CA 92182 USA; [Hamada, Mayuko; Shinzato, Chuya] Grad Univ, OIST, Okinawa, Japan; [Hatta, Masayuki] Ochanomizu Univ, Tokyo 112, Japan; [Hobmayer, Bert] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Hobmayer, Bert] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Manuel, Michael] Univ Paris 06, Paris, France; [Technau, Uli] Univ Vienna, Vienna, Austria; [Yum, Seungshic] KIOST, Geoje, South Korea; [Miller, David J.] James Cook Univ, Townsville, Qld 4811, Australia	Bosch, TCG (reprint author), Univ Kiel, Kiel, Germany.	tbosch@zoologie.uni-kiel.de; david.miller@jcu.edu.au	Manager, MEEL/C-4732-2015; Shinzato, Chuya/G-2958-2015; Adamska, Maja/L-3306-2015; FORET, Sylvain/B-9207-2012; Fraune, Sebastian/B-7970-2010; 	Adamska, Maja/0000-0002-4223-8450; Technau, Ulrich/0000-0003-4472-8258			Pratchett MS, 2008, CORAL REEFS, V27, P541, DOI 10.1007/s00338-008-0357-8; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Riesgo A, 2014, MOL BIOL EVOL, V31, P1102, DOI 10.1093/molbev/msu057; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Purcell JE, 2009, MAR ECOL PROG SER, V375, P139, DOI 10.3354/meps07785; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Gorbunov MY, 2002, LIMNOL OCEANOGR, V47, P309; Keshavmurthy S, 2012, MOL ECOL, V21, P4393, DOI 10.1111/j.1365-294X.2012.05704.x; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Heyward AJ, 2012, SCIENCE, V335, P1064, DOI 10.1126/science.1216055; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Bosch TCG, 2014, TRENDS IMMUNOL, V35, P495, DOI 10.1016/j.it.2014.07.008; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Gilbert SF, 2012, EVOL DEV, V14, P20, DOI 10.1111/j.1525-142X.2011.00519.x; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Maldonado M, 2003, MAR BIOL, V143, P427, DOI 10.1007/s00227-003-1100-1; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Bosch TCG, 2012, BIOL BULL-US, V223, P78; Bottger A, 2006, EUR J CELL BIOL, V85, P1107, DOI 10.1016/j.ejcb.2006.05.007; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; Gilbert SF, 2001, DEV BIOL, V233, P1, DOI 10.1006/dbio.2001.0210; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Conaco C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-209; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Mendola D, 2008, MAR BIOTECHNOL, V10, P622, DOI 10.1007/s10126-008-9102-0; Bosch TCG, 2013, ANNU REV MICROBIOL, V67, P499, DOI 10.1146/annurev-micro-092412-155626; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Kimes NE, 2013, ENVIRON MICROBIOL, V15, P2082, DOI 10.1111/1462-2920.12130; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Meyer E, 2012, BIOL BULL-US, V223, P44; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Leys SP, 2002, J COMP PHYSIOL A, V188, P199, DOI 10.1007/s00359-002-0293-y; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; MORSE DE, 1994, BIOL BULL, V186, P172, DOI 10.2307/1542051; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Franzenburg S, 2012, P NATL ACAD SCI USA, V109, P19374, DOI 10.1073/pnas.1213110109; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Funayama N, 2013, DEV GENES EVOL, V223, P23, DOI 10.1007/s00427-012-0417-5; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Nijhout HF, 1999, BIOSCIENCE, V49, P181, DOI 10.2307/1313508; Boehm AM, 2013, BIOESSAYS, V35, P994, DOI 10.1002/bies.201300075; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Kenyon C, 2010, ANN NY ACAD SCI, V1204, P156, DOI 10.1111/j.1749-6632.2010.05640.x; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Rivera AS, 2012, J EXP BIOL, V215, P1278, DOI 10.1242/jeb.067140; Hemmrich G, 2012, MOL BIOL EVOL, V29, P3267, DOI 10.1093/molbev/mss134; Hume B, 2013, MAR POLLUT BULL, V72, P313, DOI 10.1016/j.marpolbul.2012.11.032; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; Benito-Gutierrez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071599; Berumen ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P989, DOI 10.1007/s00265-007-0526-8; Boehm AM, 2012, P NATL ACAD SCI USA, V109, P19697, DOI 10.1073/pnas.1209714109; Carla' EC, 2003, TISSUE CELL, V35, P213, DOI 10.1016/S0040-8166(03)00028-4; Chalker B.E., 1977, P 3 INT COR REEF S, P417; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Erwin D, 2013, CAMBRIAN EXPLOSION C; Flatt T, 2011, MECH LIFE HIST EVOLU, V13; Fraune Sebastian, 2011, Communicative & Integrative Biology, V4, P369, DOI 10.4161/cib.4.4.15159; Fraune S, 2010, P NATL ACAD SCI USA, V107, P18067, DOI 10.1073/pnas.1008573107; Fuchs B, 2014, CURR BIOL, V24, P263, DOI 10.1016/j.cub.2013.12.003; Gilbert SF, 2008, ECOLOGICAL DEV BIOL; Hodgins-Davis A, 2012, GENOME BIOL EVOL, V4, P1188; Holland LZ, 2014, J EXP ZOOL PART B, DOI [10.1002/jez.b.22569, DOI 10.1002/JEZ.B.22569]; Howells EJ, 2013, MOL ECOL, V22, P3693, DOI 10.1111/mec.12342; Hyman L. H., 1940, INVERTEBRATES PROTOZ; Hyman LH, 1928, BIOL BULL-US, V54, P65, DOI 10.2307/1536982; Keesing JK, 2012, MAR FRESHWATER RES, V63, P403, DOI 10.1071/MF11216; LEITZ T, 1993, MAR BIOL, V115, P173, DOI 10.1007/BF00346332; Lewontin R., 2008, GENE ORGANISM ENV BA; Loomis SH, 2009, PHYSIOL BIOCHEM ZOOL, V82, P388, DOI 10.1086/589901; Ludeman DA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-3; Madin JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046637; Mason B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050371; McDonald JI, 2003, J EXP MAR BIOL ECOL, V296, P13, DOI 10.1016/S0022-0981(03)00302-2; MEAD KS, 1995, ZYGOTE, V3, P95; Mendola D, 2007, BIOLOGY LETT, V3, P595, DOI 10.1098/rsbl.2007.0357; Muller WA, 2002, CAN J ZOOL, V80, P1755, DOI 10.1139/Z02-130; MUSCATINE LEONARD, 1963, SCIENCE, V142, P956, DOI 10.1126/science.142.3594.956; PALUMBI SR, 1984, SCIENCE, V225, P1478, DOI 10.1126/science.225.4669.1478; Piraino S, 2004, CAN J ZOOL, V82, P1748, DOI 10.1139/Z04-174; Reitzel AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012805; Roff D. A., 1992, EVOLUTION LIFE HIST; Schwaiger M, 2014, GENOME RES, V24, P639, DOI 10.1101/gr.162529.113; Sharp KH, 2012, BIOL BULL-US, V223, P66; SIMPSON TL, 1974, T AM MICROSC SOC, V93, P544, DOI 10.2307/3225157; Sorek M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2942; Sorek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043264; Sorek Michal, 2012, Scientific Reports, V2, P1; Sorek M, 2014, MAR GENOM, V14, P47, DOI 10.1016/j.margen.2014.01.003; Stearns S. C., 1992, EVOLUTION LIFE HIST; Steele RE, 1996, DEV GENES EVOL, V206, P247, DOI 10.1007/s004270050050; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Tran C, 2012, BIOL BULL-US, V222, P128; Veron JEN, 1995, CORALS SPACE TIME BI; Vize PD, 2009, BIOL BULL-US, V216, P131; Waddington CH, 1940, ORGANISERS GENES; Whalan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030386; Young Graham A., 2010, Palaeoworld, V19, P212, DOI 10.1016/j.palwor.2010.09.014; Yu JKS, 2010, ZOOLOGY, V113, P1, DOI 10.1016/j.zool.2009.06.001	122	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0265-9247	1521-1878		BIOESSAYS	Bioessays	DEC	2014	36	12					1185	1194		10.1002/bies.201400065		10	Biochemistry & Molecular Biology; Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	AT4OA	WOS:000344918000014		
J	Ohsawa, T; Osawa, T				Ohsawa, Takafumi; Osawa, Takeshi			Quantifying effects of legal and non-legal designations of alien plant species on their control and profile	BIOLOGICAL INVASIONS			English	Article						Invasive alien species; Legal regulations; Identifications; Plants; Weed risk assessment (WRA)	WEED RISK-ASSESSMENT; CONSERVATION; MODEL; TOOL	Invasive alien species (IAS) pose serious threats to native ecosystems worldwide. In some regions, laws and/or lists related to alien species have been made, but their effects on actual measures against alien species have been little studied. In Japan the IAS act, which came into force in 2005, lists many harmful species under the heading "Designated IAS". The importation, domestication, sale or release of these species is tightly regulated. In addition, other species are named as alerted alien species (AASs) on the "alien species alert list" to raise public awareness. In this paper we examined the situation in Japan as case study that is exposed to threats from alien species under such laws in recent year to evaluate the effects of that for public interesting. We conducted a survey of the effects of the legal designation and other classification of alien plant species, examining a number of aspects, including research publications, eradications and public awareness. In our analysis, the degree of harmfulness of IASs was considered on the basis of weed risk assessment (WRA). The results show that legal classification of IASs has led to increases in research focused on the designated species, eradication efforts and public awareness. Similar results were also apparent for some AASs, but there was a great deal of variability among the many sub-categories of AASs. This may be partly because AAS sub-categories are based on different premises, and partly because the identification of AASs is not necessarily linked to legal controls that affect the behavior of individuals.	[Ohsawa, Takafumi] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS B3H 4R2, Canada; [Osawa, Takeshi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan	Ohsawa, T (reprint author), Dalhousie Univ, Sch Resource & Environm Studies, 6100 Univ Ave,Suite 5010, Halifax, NS B3H 4R2, Canada.	aa56258@hotmail.co.jp			Japan Society for the Promotion of Science [24710038]	We would like to thank the editor as well as two anonymous reviewers for their advice on a previous version of this paper. This study was partially supported by a Grant-in-aid for young scientists (No. 24710038) from the Japan Society for the Promotion of Science. The views and opinions expressed in this article represent solely those of the authors and do not represent the views of any organization.	Agresti A, 2002, CATEGORICAL DATA ANA, P734; Gallo T, 2011, BIOSCIENCE, V61, P459, DOI 10.1525/bio.2011.61.6.8; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Smith AL, 2014, BIOL INVASIONS, V16, P1325, DOI 10.1007/s10530-013-0585-x; Sampei Y, 2009, GLOBAL ENVIRON CHANG, V19, P203, DOI 10.1016/j.gloenvcha.2008.10.005; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Nishida T, 2009, BIOL INVASIONS, V11, P1319, DOI 10.1007/s10530-008-9340-0; Osawa T, 2013, ECOL COMPLEX, V15, P26, DOI 10.1016/j.ecocom.2013.01.009; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Cohen J., 2003, APPL MULTIPLE REGRES; Dawson W, 2009, BIOL CONSERV, V142, P1018, DOI 10.1016/j.biocon.2009.01.013; FAO, 2005, PROC WEED RISK ASS; Hotta M, 1974, EVOLUTIONARY BIOL PL; Japanese National Institute for Agro-Environmental Sciences, 2008, CHEM COMP WEED RISK; McGeoch MA, 2012, ECOL APPL, V22, P959, DOI 10.1890/11-1252.1; Minato M, 1966, EARTH SCI, V85, P2; Mito Toshikazu, 2004, Global Environmental Research, V8, P171; Mito T, 2006, ASSESSMENT CONTROL B; Mizutani T, 2010, APPL ENTOMOL ZOOL, V45, P65, DOI 10.1303/aez.2010.65; Muranaka K, 2005, JPN J CONSERV ECOL, V10, P19; National Institute for Agro-Environmental Science, 2008, RISK AN WEEDN AL INV; Ohsawa T, 2011, ALPINE BOT, V121, P49, DOI 10.1007/s00035-010-0083-z; Osawa T, 2011, B JPN ASS BOT GARD, V6, P135; OSAWA T, 2012, HOZEN SEITAIGAKU KEN, V17, P271; Osawa T, 2011, MAG JPN LANDSC CONTR, V446, P2; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Roberts W, 2011, CURR OPIN ENV SUST, V3, P60, DOI 10.1016/j.cosust.2010.11.007; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Takada Kenta, 2011, Insects, V2, P336, DOI 10.3390/insects2030336; The Japanese Ministry of Agriculture Forestry and Fishery, 2013, PLANT QUAR NOT; The Japanese Ministry of the Environment, 2012, REP RES PROJ ISS INV; The Japanese Ministry of the Environment, 2011, REP ENF INV AL SPEC; The Japanese Ministry of the Environment, 2005, INF CAUT AL AL SPEC	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1387-3547	1573-1464		BIOL INVASIONS	Biol. Invasions	DEC	2014	16	12					2669	2680		10.1007/s10530-014-0695-0		12	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	AT7BG	WOS:000345090600015		
J	Shirai, J; Yamaoka, M; Imamiya, E; Nakamura, M; Tarui, N; Hashimoto, T; Ikeura, Y				Shirai, Junya; Yamaoka, Masayoshi; Imamiya, Eikoh; Nakamura, Minoru; Tarui, Naoki; Hashimoto, Tadatoshi; Ikeura, Yoshinori			3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis (vol 20, pg 5668, 2012)	BIOORGANIC & MEDICINAL CHEMISTRY			English	Correction									[Shirai, Junya; Yamaoka, Masayoshi; Imamiya, Eikoh; Nakamura, Minoru; Tarui, Naoki; Hashimoto, Tadatoshi; Ikeura, Yoshinori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan	Shirai, J (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, 2-17-85 Jusohonmachi, Osaka 5328686, Japan.						Shirai J, 2012, BIOORGAN MED CHEM, V20, P5668, DOI 10.1016/j.bmc.2012.08.011	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	DEC 1	2014	22	23					6726	6726		10.1016/j.bmc.2014.10.019		1	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AU0BE	WOS:000345287300019		
J	Ohmi, M; Shishido, Y; Inoue, T; Ando, K; Fujiuchi, A; Yamada, A; Watanabe, S; Kawamura, K				Ohmi, Masashi; Shishido, Yuji; Inoue, Tadashi; Ando, Kazuo; Fujiuchi, Akiyoshi; Yamada, Akiko; Watanabe, Shuzo; Kawamura, Kiyoshi			Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						TRPM8 antagonist; Sulfonamide; RQ-00203078; Wet-dog shakes; Cold allodynia	COLD; INHIBITION; RATS; DISCOVERY; CHANNELS	A novel series of 2-pyridyl-benzensulfonamide derivatives have been identified as selective and orally active TRPM8 antagonists via high throughput screening (HTS). Exploration of the structure-activity relationships of compound 1 has led to the identification of RQ-00203078 (compound 36) as a highly selective, potent and orally available TRPM8 antagonist. RQ-00203078 demonstrated excellent in vivo activity in a dose dependent manner with an ED50 value of 0.65 mg/kg in the icilin-induced wet-dog shakes model in rats after oral administration and may become an important pharmacological tool for fully assessing the potential therapeutic use of the targets activated by cold stimulation. (C) 2014 Elsevier Ltd. All rights reserved.	[Ohmi, Masashi; Shishido, Yuji; Inoue, Tadashi; Ando, Kazuo; Fujiuchi, Akiyoshi; Yamada, Akiko; Watanabe, Shuzo; Kawamura, Kiyoshi] RaQualia Pharma Inc, Res & Dev, Taketoyo, Aichi 4702341, Japan	Ohmi, M (reprint author), RaQualia Pharma Inc, Res & Dev, 5-2 Taketoyo, Taketoyo, Aichi 4702341, Japan.	masashi.ohmi@raqualia.com; kiyoshi.kawamura@raqualia.com					Lashinger ESR, 2008, AM J PHYSIOL-RENAL, V295, pF803, DOI 10.1152/ajprenal.90269.2008; Horne DB, 2014, J MED CHEM, V57, P2989, DOI 10.1021/jm401955h; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Okamoto Y, 2012, INT J ONCOL, V40, P1431, DOI 10.3892/ijo.2012.1340; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Sugano K, 2006, J PHARM SCI-US, V95, P2115, DOI 10.1002/jps.20628; Winchester WJ, 2014, J PHARMACOL EXP THER, V351, P259, DOI 10.1124/jpet.114.216010; Calvo RR, 2012, BIOORG MED CHEM LETT, V22, P1903, DOI 10.1016/j.bmcl.2012.01.060; Gleeson MP, 2011, CURR TOP MED CHEM, V11, P358; Tamayo NA, 2012, J MED CHEM, V55, P1593, DOI 10.1021/jm2013634; Tanaka H, 2007, BIOORG MED CHEM LETT, V17, P6079, DOI 10.1016/j.bmc1.2007.09.053; Branum S. T., 2009, Int, Patent Appl., Patent No. [WO 2009/012430, 2009012430]; Chaudhari SS, 2013, BIOORGAN MED CHEM, V21, P6542, DOI 10.1016/j.bmc.2013.08.031; DeFalco J, 2011, CURR TOP MED CHEM, V11, P2237; Fernandez-Pena C., 2013, OPEN PAIN J, V6, P154; Inoue T., 2010, Sulfamoylbenzoic acid derivatives and related compounds as TRPM8 antagonists and their preparation and use for the treatment of diseases, Patent No. [W02010125831A1, 2010125831]; Kawamura K., 2012, [No title captured], Patent No. [WO2012042915, 2012042915]; Parks DJ, 2011, J MED CHEM, V54, P233, DOI 10.1021/jm101075v; TSE SYH, 1986, PSYCHOPHARMACOLOGY, V90, P322; WEI ET, 1983, PSYCHOPHARMACOLOGY, V81, P111, DOI 10.1007/BF00429002; WEI ET, 1983, J PHARM PHARMACOL, V35, P110	22	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	DEC 1	2014	24	23					5364	5368		10.1016/j.bmcl.2014.10.074		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AT7NW	WOS:000345125500003		
J	Akahoshi, A; Doi, Y; Sisido, M; Watanabe, K; Ohtsuki, T				Akahoshi, Akiya; Doi, Yoshio; Sisido, Masahiko; Watanabe, Kazunori; Ohtsuki, Takashi			Photo-dependent protein biosynthesis using a caged aminoacyl-tRNA	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Caged aminoacyl-tRNA; Site-specific incorporation; Non-natural amino acid; Translation; Photocleavable group	ELONGATION-FACTOR TU; GENE-EXPRESSION; INTERFERENCE; ACIDS; STREPTAVIDIN; ANALOGS; BINDING; SYSTEMS	Translation systems with four-base codons provide a powerful strategy for protein engineering and protein studies because they enable site-specific incorporation of non-natural amino acids into proteins. In this study, a caged aminoacyl-tRNA with a four-base anticodon was synthesized. The caged aminoacyl-tRNA contains a photocleavable nitroveratryloxycarbonyl (NVOC) group. This study showed that the caged aminoacyl-tRNA was not deacylated, did not bind to EF-Tu, and was activated by light. Photo-dependent translation of an mRNA containing the four-base codon was demonstrated using the caged aminoacyl-tRNA. (C) 2014 Elsevier Ltd. All rights reserved.	[Akahoshi, Akiya; Doi, Yoshio; Sisido, Masahiko; Watanabe, Kazunori; Ohtsuki, Takashi] Okayama Univ, Dept Biotechnol, Okayama 7008530, Japan	Ohtsuki, T (reprint author), Okayama Univ, Dept Biotechnol, 3-1-1 Tsushimanaka, Okayama 7008530, Japan.	ohtsuk@okayama-u.ac.jp			Research on Innovative Areas 'Nanomedicine Molecular Science' from MEXT, Japan [26107711]	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Nanomedicine Molecular Science' (Grant number 26107711) from MEXT, Japan.	Akahoshi A, 2011, BIOCHEM BIOPH RES CO, V414, P625, DOI 10.1016/j.bbrc.2011.09.137; ROBERTSON SA, 1991, J AM CHEM SOC, V113, P2722, DOI 10.1021/ja00007a055; Le DD, 2013, J AM CHEM SOC, V135, P2879, DOI 10.1021/ja3108214; Sisido M, 2005, METHODS, V36, P270, DOI 10.1016/j.ymeth.2005.04.009; Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072; Endoh T, 2009, J CONTROL RELEASE, V137, P241, DOI 10.1016/j.jconrel.2009.04.015; Endoh T, 2008, BIOCONJUGATE CHEM, V19, P1017, DOI 10.1021/bc800020n; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; Ogasawara S, 2011, BIOORG MED CHEM LETT, V21, P5457, DOI 10.1016/j.bmcl.2011.06.119; Hohsaka T, 1999, J AM CHEM SOC, V121, P34, DOI 10.1021/ja9813109; Kajihara D, 2006, NAT METHODS, V3, P923, DOI 10.1038/NMETH945; Shah S, 2005, ANGEW CHEM INT EDIT, V44, P1328, DOI 10.1002/anie.200461458; Ando H, 2001, NAT GENET, V28, P317, DOI 10.1038/ng583; Mikat V, 2007, RNA, V13, P2341, DOI 10.1261/rna.753407; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Hohsaka T, 1996, J AM CHEM SOC, V118, P9778, DOI 10.1021/ja9614225; Arita M, 2006, NUCLEIC ACIDS RES, V34, P5291, DOI 10.1093/nar/gkl526; Doi Y, 2007, J AM CHEM SOC, V129, P14458, DOI 10.1021/ja075557u; Govan JM, 2013, NUCLEIC ACIDS RES, V41, P10518, DOI 10.1093/nar/gkt806; Kawakami T., 2012, NUCL ACIDS, V2012; Matsushita-Ishiodori Y, 2012, ACCOUNTS CHEM RES, V45, P1039, DOI 10.1021/ar200227n; Matsushita-Ishiodori Y, 2011, BIOCONJUGATE CHEM, V22, P2222, DOI 10.1021/bc200095a; Nakata H, 2009, ANAL BIOCHEM, V390, P121, DOI 10.1016/j.ab.2009.03.049; Ohtsuki T, 2005, FEBS LETT, V579, P6769, DOI 10.1016/j.febslet.2005.11.010; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; Stepanov VG, 2002, EXTREMOPHILES, V6, P485, DOI 10.1007/s00792-002-0285-4	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	DEC 1	2014	24	23					5369	5372		10.1016/j.bmcl.2014.10.053		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AT7NW	WOS:000345125500004		
J	Kuang, X; Li, W; Kanno, Y; Mochizuki, M; Inouye, Y; Koike, K				Kuang, Xingzhu; Li, Wei; Kanno, Yuichiro; Mochizuki, Michiru; Inouye, Yoshio; Koike, Kazuo			Cycloartane-type triterpenes from Euphorbia fischeriana stimulate human CYP3A4 promoter activity	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Euphorbia fischeriana; Cycloartane; CYP3A4; Promoter; Pregnane X receptor	PREGNANE-X-RECEPTOR; CONSTITUENTS; ACTIVATION; INHIBITORS; APOPTOSIS	A chemical study of the roots of Euphorbia fischeriana resulted in the isolation of seven triterpenes (1-7), including two new compounds: (24R, S)-3 beta-24,31-epoxy-24-methylcycloartane (1) and (24R, S)-3 beta, 31-dihydroxy-24-methoxy-24-methylcycloartane (2). Their structures were elucidated through extensive spectroscopic analyses. Cycloartanes 1-4 showed significant human CYP3A4 promoter activity through a series of luciferase reporter assays. Of these compounds, 3 and 4 activated the pregnane X receptor (PXR) and induced CYP3A4 mRNA expression in human primary hepatocytes. However, despite showing the most potent human CYP3A4 promoter activity via a PXR-independent pathway, 2 did not affect CYP3A4 mRNA expression in human primary hepatocytes. This difference is correlated to substitutions in C-24 and C-25 of the cycloartane structure. (C) 2014 Elsevier Ltd. All rights reserved.	[Kuang, Xingzhu; Li, Wei; Kanno, Yuichiro; Mochizuki, Michiru; Inouye, Yoshio; Koike, Kazuo] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2478510, Japan	Li, W (reprint author), Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2478510, Japan.	liwei@phar.toho-u.ac.jp			MEXT KAKENHI [23790104, 25460175]	The research was partially supported by MEXT KAKENHI (Grant numbers 23790104 and 25460175).	Sasaki T, 2013, PHYTOCHEMISTRY, V95, P333, DOI 10.1016/j.phytochem.2013.07.022; Li W, 2013, BIOORG MED CHEM LETT, V23, P5836, DOI 10.1016/j.bmcl.2013.08.102; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Goodwin B, 1999, MOL PHARMACOL, V56, P1329; Sun YX, 2011, CHEM BIODIVERS, V8, P1205, DOI 10.1002/cbdv.201000115; [Anonymous], 1985, TRADITIONAL CHINESE, V4, P5651; Fahmi OA, 2010, DRUG METAB DISPOS, V38, P1605, DOI 10.1124/dmd.110.033126; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; Puapairoj P, 2005, PLANTA MED, V71, P208, DOI 10.1055/s-2005-837818; BOAR RB, 1975, PHYTOCHEMISTRY, V14, P1143, DOI 10.1016/S0031-9422(00)98584-4; Chen Jiezhong, 2014, Ann Transl Med, V2, P7, DOI 10.3978/j.issn.2305-5839.2013.03.02; Cho JY, 2013, J AGR FOOD CHEM, V61, P4563, DOI 10.1021/jf400524b; Corsaro M. M., 1994, PHYTOCHEMISTRY, V35, P515; Ferreira MJU, 2001, NAT PROD LETT, V15, P363; Kanno Y, 2014, DRUG METAB DISPOS, V42, P1084, DOI 10.1124/dmd.114.057810; Liu FJ, 2008, BIOCHEM J, V409, P243, DOI 10.1042/BJ20070613; Long C, 2012, J NAT PROD, V75, P34, DOI 10.1021/np200441h; Qiu F, 2012, J NAT PROD, V75, P432, DOI [10.1021/np200878s, 10.1021/np20087Bs]; Schuetz EG, 2004, MOL PHARMACOL, V65, P279, DOI 10.1124/mol.65.2.279; TALAPATRA B, 1983, PHYTOCHEMISTRY, V22, P2559, DOI 10.1016/0031-9422(83)80164-2; TANAKA R, 1988, PHYTOCHEMISTRY, V27, P2273; Toume K, 2011, J NAT PROD, V74, P249, DOI 10.1021/np100784t; Xu HY, 2013, EUR J PHARMACOL, V700, P13, DOI 10.1016/j.ejphar.2012.11.015; Yalcin FN, 2012, PHYTOCHEMISTRY, V73, P119, DOI 10.1016/j.phytochem.2011.09.011; Zhou CX, 2013, ORG LETT, V15, P2734, DOI 10.1021/ol401066j	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	DEC 1	2014	24	23					5423	5427		10.1016/j.bmcl.2014.10.032		5	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AT7NW	WOS:000345125500016		
J	Sakamoto, T; Koga, Y; Hikota, M; Matsuki, K; Murakami, M; Kikkawa, K; Fujishige, K; Kotera, J; Omori, K; Morimoto, H; Yamada, K				Sakamoto, Toshiaki; Koga, Yuichi; Hikota, Masataka; Matsuki, Kenji; Murakami, Michino; Kikkawa, Kohei; Fujishige, Kotomi; Kotera, Jun; Omori, Kenji; Morimoto, Hiroshi; Yamada, Koichiro			The discovery of avanafil for the treatment of erectile dysfunction: A novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						PDE5; PDE6; Erectile dysfunction; Avanafil		Novel pyrimidine-5-carboxamide derivatives bearing a 3-chloro-4-methoxybenzylamino group at the 4-position were identified as potent and highly selective phosphodiesterase 5 inhibitors. Among them, we successfully found 10j (avanafil) which exhibited a potent relaxant effect on isolated rabbit cavernosum (EC30 = 2.1 nM) and a high isozyme selectivity. (C) 2014 Elsevier Ltd. All rights reserved.	[Sakamoto, Toshiaki; Koga, Yuichi; Hikota, Masataka; Matsuki, Kenji; Morimoto, Hiroshi; Yamada, Koichiro] Mitsubishi Tanabe Pharma Corp, Med Chem Res Labs 2, Toda, Saitama 3358505, Japan; [Murakami, Michino; Kikkawa, Kohei] Mitsubishi Tanabe Pharma Corp, Pharmacol Res Labs 2, Toda, Saitama 3358505, Japan; [Fujishige, Kotomi; Kotera, Jun; Omori, Kenji] Mitsubishi Tanabe Pharma Corp, Adv Med Res Labs, Toda, Saitama 3358505, Japan; [Omori, Kenji] Nagoya Univ, Grad Sch Pharmaceut Sci, Lab Target & Drug Discovery, Ind & Acad Cooperat Res Project,Chikusa Ku, Nagoya, Aichi 4648601, Japan	Morimoto, H (reprint author), Mitsubishi Tanabe Pharma Corp, Med Chem Res Labs 2, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan.	morimoto.hiroshi@md.mt-pharma.co.jp					Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Bruzziches R, 2013, EXPERT OPIN PHARMACO, V14, P1333, DOI 10.1517/14656566.2013.799665; Goldstein I, 2012, J SEX MED, V9, P1122, DOI 10.1111/j.1743-6109.2011.02629.x; Giuliano F, 2010, INT J CLIN PRACT, V64, P240, DOI 10.1111/j.1742-1241.2009.02254.x; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Kedia George T, 2013, Ther Adv Urol, V5, P35, DOI 10.1177/1756287212466282; Kotera J, 2012, J UROLOGY, V188, P668, DOI 10.1016/j.juro.2012.03.115; Marmor MF, 1999, SURV OPHTHALMOL, V44, P153, DOI 10.1016/S0039-6257(99)00079-X; Peterson C., 2006, J SEX MED S3, V3, P253; Sakamoto T, 2014, BIOORG MED CHEM LETT, V24, P5175, DOI 10.1016/j.bmcl.2014.09.082	10	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	DEC 1	2014	24	23					5460	5465		10.1016/j.bmcl.2014.10.008		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	AT7NW	WOS:000345125500024		
J	Takekawa, M; Park, G; Soda, S; Ike, M				Takekawa, Masashi; Park, Giri; Soda, Satoshi; Ike, Michihiko			Simultaneous anammox and denitrification (SAD) process in sequencing batch reactors	BIORESOURCE TECHNOLOGY			English	Article						Anaerobic ammonium oxidation; Denitrification; C/N ratio	ANAEROBIC AMMONIUM OXIDATION; FLUIDIZED-BED REACTOR; NITROGEN-REMOVAL; OXIDIZING BACTERIA; C/N RATIO; NITRITE; NITRATE; CARBON; LIMITATION; CARRIER	This study investigated nitrogen removal by the simultaneous anaerobic ammonium oxidation (anammox) and heterotrophic denitrification (SAD) process in a sequencing batch reactor (SBR) inoculated with suspended activated sludge and immobilized anammox sludge at various total organic carbon/nitrate (C/N) ratios. Synthetic wastewater containing nitrate 100 mg-N L-1, ammonium 70 mg-N L-1, and acetate 50-250 mg-C L-1 was fed to the SBR. Nitrite reduced from nitrate by heterotrophic denitrification was accumulated and removed with ammonium in each cycle operation of the SBR. The SAD process removed nitrate and ammonium effectively (T-N removal, 58-94%) by the high anammox contribution (ca. 80-100%) under low C/N ratios (0.5-1.0). At high C/N ratios of 1.2-2.5, the SAD process maintained T-N removal 67-79% with predominance of heterotrophic denitrification instead of anammox reaction. Results demonstrated that the SAD process performs high nitrogen removal effectively from wastewater with widely different C/N ratios. (C) 2014 Elsevier Ltd. All rights reserved.	[Takekawa, Masashi; Park, Giri; Soda, Satoshi; Ike, Michihiko] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan	Ike, M (reprint author), Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ike@see.eng.osaka-u.ac.jp					Strous M, 1999, NATURE, V400, P446; Tokutomi T, 2010, WATER RES, V44, P4195, DOI 10.1016/j.watres.2010.05.021; Fujii T, 2002, J BIOSCI BIOENG, V94, P412, DOI 10.1263/jbb.94.412; Third KA, 2001, SYST APPL MICROBIOL, V24, P588, DOI 10.1078/0723-2020-00077; Quan LM, 2011, BIODEGRADATION, V22, P1155, DOI 10.1007/s10532-011-9471-3; Isaka K, 2007, APPL MICROBIOL BIOT, V76, P1457, DOI 10.1007/s00253-007-1106-6; Sumino T, 2006, J BIOSCI BIOENG, V102, P346, DOI 10.1263/jbb.102.346; Kartal B, 2008, FEMS MICROBIOL ECOL, V63, P46, DOI 10.1111/j.1574-6941.2007.00408.x; van Dongen U, 2001, WATER SCI TECHNOL, V44, P153; Strous M, 1999, APPL ENVIRON MICROB, V65, P3248; Magri A, 2012, BIORESOURCE TECHNOL, V114, P231, DOI 10.1016/j.biortech.2012.03.077; Du R, 2014, BIORESOURCE TECHNOL, V162, P316, DOI 10.1016/j.biortech.2014.03.041; Dapena-Mora A, 2007, ENZYME MICROB TECH, V40, P859, DOI 10.1016/j.enzmictec.2006.06.018; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589; Lotti T, 2014, WATER RES, V60, P1, DOI 10.1016/j.watres.2014.04.017; Furukawa K, 2006, WATER SCI TECHNOL, V53, P83, DOI 10.2166/wst.2006.175; Gao F, 2012, BIORESOURCE TECHNOL, V114, P54, DOI 10.1016/j.biortech.2012.02.113; Her JJ, 1995, BIORESOURCE TECHNOL, V54, P45, DOI 10.1016/0960-8524(95)00113-1; Isaka K., 2014, J JPN SOC WATER ENV, V37, P341; Kartal B, 2007, SYST APPL MICROBIOL, V30, P39, DOI 10.1016/j.syapm.2006.03.004; Kornaros M, 1996, WATER ENVIRON RES, V68, P934, DOI 10.2175/106143096X127947; Kumar M., 2008, J HAZARD MATER, V178, P1; Michinaka A., 2014, J JPN SOC WATER ENV, V37, P333; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1111/j.1574-6941.1995.tb00281.x; Oh J, 1999, J ENVIRON ENG-ASCE, V125, P234, DOI 10.1061/(ASCE)0733-9372(1999)125:3(234); Paredes D, 2007, ENG LIFE SCI, V7, P565, DOI 10.1002/elsc.200700030; Soda S., 2011, P 11 INT AN S IANAS, P201; Takekawa M., 2014, J ENV CONSERV ENG, V43, P293; Van De Graaf Astrid A., 1996, Microbiology (Reading), V142, P2187; Volcke EIP, 2006, WATER SCI TECHNOL, V53, P45, DOI 10.2166/wst.2006.109; Yamamoto T, 2006, J BIOSCI BIOENG, V102, P497, DOI 10.1263/jbb.102.497; Zhang L, 2010, J BIOSCI BIOENG, V110, P441, DOI 10.1016/j.jbiosc.2010.05.008; Zhong YM, 2013, WORLD J MICROB BIOT, V29, P51, DOI 10.1007/s11274-012-1157-4	33	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	DEC	2014	174						159	166		10.1016/j.biortech.2014.10.021		8	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AT5YD	WOS:000345014900021		
J	Sakai, T; Ohkuma, Y; Kohno, H; Hayashi, T; Watanabe, A; Tsuneoka, H				Sakai, Tsutomu; Ohkuma, Yasuhiro; Kohno, Hideo; Hayashi, Takaaki; Watanabe, Akira; Tsuneoka, Hiroshi			Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							ENDOTHELIAL GROWTH-FACTOR; EPITHELIUM-DERIVED FACTOR; MACULAR DEGENERATION; FOLLOW-UP; RANIBIZUMAB; VERTEPORFIN; EFFICACY	Purpose To compare the 3-year visual outcome after double therapy of photodynamic therapy (PDT) with intravitreal bevacizumab (IVB) and triple therapy of PDT combined with IVB and subtenon triamcinolone acetonide (STTA) injections for polypoidal choroidal vasculopathy (PCV). Design Retrospective, comparative, interventional case series. Methods Medical records for 36 eyes in 36 patients (33 men, 3 women; mean age 73.5 years old; range 63-82 years old) with treatment-naive subfoveal PCV were reviewed retrospectively. Of the 36 eyes, 17 were treated with double therapy and 19 with triple therapy. Results The change in visual acuity after triple therapy was significantly better than that after double therapy (p<0.05). At 36 months, improvement in visual acuity was seen in 5 eyes (29.4%) in the double therapy group and 10 eyes (52.6%) in the triple therapy group. Retreatment using the initial treatment was performed for six eyes (35.3%) in the double therapy group and five eyes (26.3%) in the triple therapy group, and treatment-free period was significantly longer in the triple therapy group (p<0.05). The mean number of additional antivascular endothelial growth factor therapy was higher in the double therapy group. Post-treatment vitreous haemorrhage or retinal pigment epithelium tear occurred only in the double therapy group, in one eye (5.9%) and one eye (5.9%), respectively. Conclusions Initial therapy consisting of a single session of PDT combined with IVB and STTA improves vision in treatment-naive subfoveal PCV. Compared with double therapy, this triple therapy may be more effective for PCV.	[Sakai, Tsutomu; Ohkuma, Yasuhiro; Kohno, Hideo; Hayashi, Takaaki; Watanabe, Akira; Tsuneoka, Hiroshi] Jikei Univ, Sch Med, Dept Ophthalmol, Tokyo 1058461, Japan	Sakai, T (reprint author), Jikei Univ, Sch Med, Dept Ophthalmol, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	tstmski@jikei.ac.jp			Vehicle Racing Commemorative Foundation	This study was supported by grants from the Vehicle Racing Commemorative Foundation.	Akaza E, 2011, JPN J OPHTHALMOL, V55, P39, DOI 10.1007/s10384-010-0886-x; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478; Tsuchiya D, 2009, RETINA-J RET VIT DIS, V29, P960, DOI 10.1097/IAE.0b013e3181a3b7c5; Lai TYY, 2010, J OCUL PHARMACOL TH, V26, P91, DOI 10.1089/jop.2009.0073; Tong JP, 2006, AM J OPHTHALMOL, V141, P456, DOI 10.1016/j.ajo.2005.10.012; Koh A, 2012, RETINA-J RET VIT DIS, V32, P1453, DOI 10.1097/IAE.0b013e31824f91e8; Kokame GT, 2010, BRIT J OPHTHALMOL, V94, P297, DOI 10.1136/bjo.2008.150029; Ciardella AP, 2004, SURV OPHTHALMOL, V49, P25, DOI 10.1016/j.survophthal.2003.10.007; Gomi F, 2008, OPHTHALMOLOGY, V115, P141, DOI 10.1016/j.ophtha.2007.02.031; Spaide RF, 2002, RETINA-J RET VIT DIS, V22, P529, DOI 10.1097/00006982-200210000-00001; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Akaza E, 2008, RETINA-J RET VIT DIS, V28, P717, DOI 10.1097/IAE.0b013e31816577cb; Kikuchi M, 2007, OPHTHALMOLOGY, V114, P1722, DOI 10.1016/j.ophtha.2006.12.021; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Matsuoka M, 2004, BRIT J OPHTHALMOL, V88, P809, DOI 10.1136/bjo.2003.032466; Kim M, 2011, OPHTHALMOLOGICA, V226, P205, DOI 10.1159/000330793; Cheng CK, 2011, RETINA-J RET VIT DIS, V31, P846, DOI 10.1097/IAE.0b013e3181f84fdf; Hikichi T, 2013, BRIT J OPHTHALMOL, V97, P617, DOI 10.1136/bjophthalmol-2012-302652; Gomi F, 2010, AM J OPHTHALMOL, V150, P48, DOI 10.1016/j.ajo.2010.02.008; Kang HM, 2013, AM J OPHTHALMOL, V156, P652, DOI 10.1016/j.ajo.2013.05.038; Kang HM, 2014, AM J OPHTHALMOL, V157, P598, DOI 10.1016/j.ajo.2013.11.015; Leal S, 2010, RETINA-J RET VIT DIS, V30, P1197, DOI 10.1097/IAE.0b013e3181d37486; Lee YA, 2012, AM J OPHTHALMOL, V154, P872, DOI 10.1016/j.ajo.2012.03.051; Luttrull JK, 2007, RETINA-J RET VIT DIS, V27, P688, DOI 10.1097/IAE.0b013e318030e999; Moon SW, 2011, OPHTHALMOLOGICA, V225, P169, DOI 10.1159/000323811; Nakata I, 2013, GRAEF ARCH CLIN EXP, V251, P1073, DOI 10.1007/s00417-012-2137-y; Sagong M, 2012, AM J OPHTHALMOL, V153, P873, DOI 10.1016/j.ajo.2011.09.031; Sato T, 2010, AM J OPHTHALMOL, V149, P947, DOI 10.1016/j.ajo.2009.12.038; Tano Y, 2008, OPHTHALMOLOGY, V115, P585, DOI 10.1016/j.ophtha.2007.10.018; Wakabayashi T, 2012, BRIT J OPHTHALMOL, V96, P394, DOI 10.1136/bjo.2011.204123; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001; Yoshizawa C, 2013, JPN J OPHTHALMOL, V57, P68, DOI 10.1007/s10384-012-0206-8	34	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	DEC	2014	98	12					1642	1648		10.1136/bjophthalmol-2014-305189		7	Ophthalmology	Ophthalmology	AU0AB	WOS:000345284300008		
J	Fukuda, K; Ishida, W; Tanaka, H; Harada, Y; Fukushima, A				Fukuda, Ken; Ishida, Waka; Tanaka, Hiroshi; Harada, Yosuke; Fukushima, Atsuki			Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							HUMAN CONJUNCTIVAL FIBROBLASTS; EPITHELIAL-CELLS; TNF-ALPHA; DRY EYE; INDUCED EXPRESSION; BARRIER FUNCTION; BINDING PROTEIN; SOLUBLE CD14; MULTICENTER; OPC-12759	Background/aims The dry-eye drug rebamipide has mucin secretagogue activity in and anti-inflammatory effects on corneal epithelial cells. Corneal stromal fibroblasts (transdifferentiated keratocytes) function as immune modulators in the pathogenesis of chronic ocular allergic inflammation and in innate immune responses at the ocular surface. The possible anti-inflammatory effects of rebamipide on human corneal stromal fibroblasts were examined. Methods Serum-deprived cells were incubated for 1 h with rebamipide and then for various times in the additional absence or presence of cytokines or bacterial lipopolysaccharide (LPS). The release of chemokines into culture supernatants was determined with ELISAs. The intracellular abundance of chemokine mRNAs was quantitated by reverse transcription and real-time PCR analysis. Degradation of the nuclear factor kappa B (NF kappa B) inhibitor I kappa B alpha was detected by immunoblot analysis. Results Rebamipide suppressed the release of interleukin (IL)-8 and the upregulation of IL-8 mRNA induced by tumour necrosis factor alpha (TNF-alpha) or LPS in corneal fibroblasts. It also inhibited eotaxin-1 (CCL-11) expression at the protein and mRNA levels induced by the combination of TNF-alpha and IL-4. In addition, rebamipide attenuated the degradation of I kappa B alpha induced by TNF-alpha or LPS. Conclusions Rebamipide inhibited the synthesis of chemokines by corneal fibroblasts in association with suppression of NF kappa B signalling. Rebamipide may therefore prove effective for the treatment of corneal stromal inflammation associated with allergy or bacterial infection.	[Fukuda, Ken; Ishida, Waka; Harada, Yosuke; Fukushima, Atsuki] Kochi Med Sch, Dept Ophthalmol & Visual Sci, Nankoku, Kochi 7838505, Japan; [Tanaka, Hiroshi] Machida Hosp, Kochi, Japan; [Tanaka, Hiroshi] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Fukuda, K (reprint author), Kochi Med Sch, Dept Ophthalmol & Visual Sci, Oko Cho, Nankoku, Kochi 7838505, Japan.	k.fukuda@kochi-u.ac.jp			Otsuka Pharmaceutical Co. in Japan	The study received funding from Otsuka Pharmaceutical Co., which manufactures rebamipide eyedrops in Japan. The sponsor had no role in the study design; in the collection, analysis, or interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication.	Adachi T, 2010, INVEST OPHTH VIS SCI, V51, P3954, DOI 10.1167/iovs.09-4161; Gohil P, 2011, ACTA PHARMACEUT, V61, P427, DOI 10.2478/v10007-011-0033-3; Fukuda K, 2005, INVEST OPHTH VIS SCI, V46, P3095, DOI 10.1167/iovs.04-1365; Kinoshita S, 2012, OPHTHALMOLOGY, V119, P2471, DOI 10.1016/j.ophtha.2012.06.052; Leonardi A, 2003, INVEST OPHTH VIS SCI, V44, P183, DOI 10.1167/iovs.02-0420; Choe JY, 2010, INFLAMM RES, V59, P1019, DOI 10.1007/s00011-010-0221-5; Kinoshita S, 2013, OPHTHALMOLOGY, V120, P1158, DOI 10.1016/j.ophtha.2012.12.022; Kinoshita S, 2014, AM J OPHTHALMOL, V157, P576, DOI 10.1016/j.ajo.2013.11.010; Fukuda K, 2010, J ALLERGY CLIN IMMUN, V125, P493, DOI 10.1016/j.jaci.2009.10.041; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; Kumagai N, 2005, INVEST OPHTH VIS SCI, V46, P114, DOI 10.1167/iovs.04-0922; Tanaka H, 2013, BRIT J OPHTHALMOL, V97, P912, DOI 10.1136/bjophthalmol-2012-302868; Fujitsu Y, 2005, INVEST OPHTH VIS SCI, V46, P797, DOI 10.1167/iovs.04-1016; Fujitsu Y, 2003, EXP EYE RES, V76, P107, DOI 10.1016/S0014-4835(02)00248-8; Fukagawa K, 2000, INT ARCH ALLERGY IMM, V121, P144, DOI 10.1159/000024310; Fukuda Ken, 2010, Cornea, V29 Suppl 1, pS62; Fukuda K, 2006, INVEST OPHTH VIS SCI, V47, P2857, DOI 10.1167/iovs.05-1261; Fukuda K, 2010, JPN J OPHTHALMOL, V54, P241, DOI 10.1007/s10384-009-0787-z; Fukuda Ken, 2006, Allergol Int, V55, P121, DOI 10.2332/allergolint.55.121; Kimura K, 2013, INVEST OPHTH VIS SCI, V54, P2752, DOI 10.1167/iovs.12-11294; Kumagai N, 2006, PROG RETIN EYE RES, V25, P165, DOI 10.1016/j.preteyeres.2005.09.002; Kumagai N, 2000, INVEST OPHTH VIS SCI, V41, P1448; Ueta M, 2013, J OCUL PHARMACOL TH, V29, P688, DOI 10.1089/jop.2012.0054; Ueta M, 2014, ALLERGOL INT, V63, P75, DOI 10.2332/allergolint.13-OA-0605; Ueta M, 2004, J IMMUNOL, V173, P3337	25	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	DEC	2014	98	12					1751	1755		10.1136/bjophthalmol-2014-305425		5	Ophthalmology	Ophthalmology	AU0AB	WOS:000345284300028		
J	He, ZQ; Takeda, M				He, Zhuqing; Takeda, Makio			The influence of developmental days on body size and allometry of head width in male Loxoblemmus angulatus (Orthoptera: Gryllidae)	CANADIAN ENTOMOLOGIST			English	Article							SEXUAL-DIMORPHISM; ACHETA-DOMESTICUS; HOUSE CRICKETS; GROUND-HOPPER; MALE CHOICE; EVOLUTION; SELECTION; INSECTS; BEHAVIOR; BEETLE	Male crickets belonging to the genus Loxoblemmus Saussure (Orthoptera:Gryllidae) often exhibit exaggerated facial structures with characteristic projections. Whether these structures are stable within a single species is not certified. We collected Loxoblemmus angulatus Bey-Bienko and reared the second generation under 16:8, 14:10, and 12:12 light:dark photoperiods. Body morphology of adults was measured and development days were recorded. The results showed that short daytime photoperiod made them develop slowly. Males became larger after longer developmental days. Head width was wider in males and horns on head were more exaggerated in large individuals than in small ones. Head width was allometric against pronotum width. Our study shows that the male head morphology in L. angulatus is strongly influenced by development days and it is not suitable as taxonomic characters.	[He, Zhuqing] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Takeda, Makio] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Takeda, M (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, 1-1 Rokko Dai, Kobe, Hyogo 6578501, Japan.	mtakeda@kobe-u.ac.jp					MASAKI S, 1972, EVOLUTION, V26, P587, DOI 10.2307/2407055; Montealegre ZF, 2009, J EXP BIOL, V212, P257, DOI 10.1242/jeb.022731; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Dale J, 2007, P R SOC B, V274, P2971, DOI 10.1098/rspb.2007.1043; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; MASAKI S, 1987, EVOL BIOL, V21, P349; Hochkirch A, 2008, EVOL DEV, V10, P350, DOI 10.1111/j.1525-142X.2008.00243.x; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Whitman Douglas W., 2008, Journal of Orthoptera Research, V17, P117, DOI 10.1665/1082-6467-17.2.117; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Hochkirch A, 2007, EVOL ECOL, V21, P727, DOI 10.1007/s10682-006-9147-3; Gray DA, 1997, ANIM BEHAV, V54, P1553, DOI 10.1006/anbe.1997.0584; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Bohonak AJ, 2002, RMA SOFTWARE REDUCED; BORGIA G, 1981, ANIM BEHAV, V29, P71, DOI 10.1016/S0003-3472(81)80153-4; Chopard L., 1969, ORTHOPTERA, V1; Esperk T, 2007, ECOL ENTOMOL, V32, P243, DOI 10.1111/j.1365-2311.2007.00872.x; Gorochov A. V., 1983, BIOLOGICHESKIE NAUKI, V1, P49; Gorochov A.V., 2001, ZOOSYSTEMATICA ROSSI, V9, P316; GREEN AJ, 1992, ANIM BEHAV, V43, P170, DOI 10.1016/S0003-3472(05)80086-7; HIEBER CS, 1983, EVOLUTION, V37, P987, DOI 10.2307/2408412; Hcchkirch Axel, 2008, Journal of Orthoptera Research, V17, P189, DOI 10.1665/1082-6467-17.2.189; Hochkirch A, 2009, BIOL J LINN SOC, V97, P118, DOI 10.1111/j.1095-8312.2008.01199.x; Huxley J.S, 1993, PROBLEMS RELATIVE GR; Iba M, 1995, ZOOL SCI, V12, P695, DOI 10.2108/zsj.12.695; Ichikawa A., 2006, ORTHOPTERA JAPANESE; Ingrisch S, 1998, ENTOMOL SCAND, V29, P315; JOHNSON LK, 1984, BEHAV ECOL SOCIOBIOL, V15, P183, DOI 10.1007/BF00292973; Judge KA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003980; Kim H, 2011, J ETHOL, V29, P435, DOI 10.1007/s10164-011-0277-x; Masaki S., 1966, JAPANESE J ENTOMOLOG, V34, P277; Masaki S., 1963, JAPANESE J ENTOMOLOG, V31, P249; Plaistow SJ, 2005, ECOL ENTOMOL, V30, P692, DOI 10.1111/j.0307-6946.2005.00740.x; Tanaka Seiji, 1999, Entomological Science, V2, P173; TANAKA S, 1976, Applied Entomology and Zoology, V11, P27; WAGNER WE, 1995, ANIM BEHAV, V49, P1269, DOI 10.1006/anbe.1995.0159; Walker SE, 2008, CAN J ZOOL, V86, P253, DOI 10.1139/Z08-001; Walker T.J., 1989, P1; Yin H. S., 1995, SYNOPSIS CLASSIFICAT	41	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0008-347X	1918-3240		CAN ENTOMOL	Can. Entomol.	DEC	2014	146	6					590	597		10.4039/tce.2014.10		8	Entomology	Entomology	AT7MN	WOS:000345121600002		
J	Brucher, BLDM; Kitajima, M; Siewert, JR				Bruecher, Bjoern L. D. M.; Kitajima, Masaki; Siewert, Joerg Ruediger			Undervalued Criteria in the Evaluation of Multimodal Trials for Upper GI Cancers	CANCER INVESTIGATION			English	Article						Upper gastrointestinal tract; Esophageal carcinoma; Anticancer therapy; Neoadjuvant therapy; Multimodal therapy	SQUAMOUS-CELL CARCINOMA; RESECTABLE ESOPHAGEAL CANCER; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; MULTICHANNEL INTRALUMINAL IMPEDANCE; LYMPHATIC VESSEL INVASION; LABEL PHASE-3 TRIAL; GASTRIC-CANCER; PREOPERATIVE CHEMOTHERAPY; BARRETTS-ESOPHAGUS	Global economies and their health systems face a huge challenge from cancer: 1 in 3 women and 1 in 2 men will develop cancer in their lifetime. In the less developed countries, the volume of cancer patients will overwhelm the existing healthcare systems. Even in developed regions, patients with upper gastrointestinal (GI) cancer usually present with locally advanced tumors that their prognosis is poor. A detailed knowledge of anatomy, embryology, epidemiology, tumor classifications and tumor growth is key understanding and evaluating the relevant research. We review undervalued criteria necessary to evaluate the response to multimodal therapy for upper GI cancers.	[Bruecher, Bjoern L. D. M.] Theodor Billroth Acad, Munich, Germany; [Bruecher, Bjoern L. D. M.] Theodor Billroth Acad, Richmond, VA USA; [Bruecher, Bjoern L. D. M.] Theodor Billroth Acad, Sacramento, CA USA; [Bruecher, Bjoern L. D. M.] Theodor Billroth Acad, Int Consortium Res Excellence, INCORE, Munich, Germany; [Bruecher, Bjoern L. D. M.] Theodor Billroth Acad, Int Consortium Res Excellence, INCORE, Richmond, VA USA; [Bruecher, Bjoern L. D. M.] Theodor Billroth Acad, Int Consortium Res Excellence, INCORE, Sacramento, CA USA; [Bruecher, Bjoern L. D. M.] Bon Secours Canc Inst, Richmond, VA USA; [Kitajima, Masaki] Int Univ Hlth & Welfare, Tokyo, Japan; [Siewert, Joerg Ruediger] Univ Freiburg, D-79106 Freiburg, Germany	Brucher, BLDM (reprint author), Bon Secours Canc Inst, Theodor Billroth Acad, Richmond, VA 23230 USA.	b-bruecher@gmx.de					Ancona E, 1995, ACTA CHIR ITAL, V51, P308; Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Fiorica F, 2004, GUT, V53, P925, DOI 10.1136/gut.2003.025080; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Urschel JD, 2002, AM J SURG, V183, P274, DOI 10.1016/S0002-9610(02)00795-X; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; NYGAARD K, 1992, WORLD J SURG, V16, P1104; OHNO S, 1995, J AM COLL SURGEONS, V180, P577; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; Tepper J, 2008, J CLIN ONCOL, V26, P1086, DOI 10.1200/JCO.2007.12.9593; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Clark PI, 2000, BRIT J CANCER, V83, P1; Greil R, 2007, LANCET ONCOL, V8, P189, DOI 10.1016/S1470-2045(07)70053-0; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Blot WJ, 1999, SEMIN ONCOL, V26, P2; Lee JH, 2012, YONSEI MED J, V53, P248, DOI 10.3349/ymj.2012.53.2.248; Azuma T, 2004, J GASTROENTEROL, V39, P97, DOI 10.1007/s00535-003-1279-4; Hampel H, 2005, ANN INTERN MED, V143, P199; Jemal A, 2005, CA-CANCER J CLIN, V55, P10; Siewert JR, 1998, BRIT J SURG, V85, P1457; Brucher BLDM, 2004, EJSO, V30, P963, DOI 10.1016/j.ejso.2004.06.008; Schneider JME, 2009, OBES SURG, V19, P1522, DOI 10.1007/s11695-008-9624-6; Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H; Hiripi E, 2012, ACTA ONCOL, V51, P906, DOI 10.3109/0284186X.2012.673732; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Kitagawa Y, 1996, CLIN CANCER RES, V2, P909; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Gaddy JA, 2013, INFECT IMMUN, V81, P2258, DOI 10.1128/IAI.01271-12; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Teoh AYB, 2013, ANN ONCOL, V24, P165, DOI 10.1093/annonc/mds206; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; BLASER MJ, 1995, CANCER RES, V55, P2111; Graham A, 2005, J ANAT, V207, P479; Kelsen DP, 2007, J CLIN ONCOL, V25, P3719, DOI 10.1200/JCO.2006.10.4760; Urschel JD, 2003, AM J SURG, V185, P538, DOI 10.1016/S0002-9610(03)00066-7; Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Kuper MA, 2010, SURG ENDOSC, V24, P1996, DOI 10.1007/s00464-010-0893-5; Law S, 2004, ANN SURG, V240, P791, DOI 10.1097/01.sla.0000143123.245561c; Kasama K, 2012, OBES SURG, V22, P677, DOI 10.1007/s11695-012-0610-7; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Ectors N, 2005, ARCH PATHOL LAB MED, V129, P183; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Lagergren J, 2005, GUT, V54, pI1, DOI 10.1136/gut.2004.041517; Brucher BLDM, 2006, CANCER-AM CANCER SOC, V106, P2119, DOI 10.1002/cncr.21850; Jemal A, 2004, CA-CANCER J CLIN, V54, P8; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Stein HJ, 2005, ANN SURG, V242, P566, DOI 10.1097/01.sla.0000184211.75970.85; Baba M, 1999, Jpn J Thorac Cardiovasc Surg, V47, P199; Baba M, 2000, DIS ESOPHAGUS, V13, P136; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bhansali MS, 1996, ANN ONCOL, V7, P355; Boige V, 2007, ASCO M, V25, P4510; Brucher BLDM, 2009, CHIRURG, V80, P1011, DOI 10.1007/s00104-009-1733-9; Brucher BLDM, 2009, INT J COLORECTAL DIS, V24, P69, DOI 10.1007/s00384-008-0562-5; Brucher BLDM, 2012, CANCER INVEST, V30, P209, DOI 10.3109/07357907.2012.654871; Brucher BLDM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-331; Brucher BLDM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-186; Brucher BLDM, 2009, ANN SURG ONCOL, V16, P878, DOI 10.1245/s10434-009-0315-x; Brucher BLDM, 2011, WORLD J SURG, V25, P745; Brucher BLDM, 2001, CANCER-AM CANCER SOC, V92, P2228, DOI 10.1002/1097-0142(20011015)92:8<2228::AID-CNCR1567>3.0.CO;2-4; Clara M, 1955, ENTWICKLUNGSGESCHICH; Bancewicz J, 2002, LANCET, V359, P1727; Corning HK, 1925, LEHRBUCH ENTWICKLUNG; Ebihara Y, 2004, EUR J CARDIO-THORAC, V26, P1223, DOI 10.1016/j.ejcts.2004.08.019; Edge S, 2010, AJCC CANC STAGING MA, P103; Ferlay J., 2008, GLOBOCAN 2008 CANC I; Fietkau R, 1999, STRAHLENTHER ONKOL, V175, P251, DOI 10.1007/BF02742406; Halperin E. C., 2008, PEREZ BRADYS PRINCIP; HESKETH PJ, 1989, CANCER, V64, P526, DOI 10.1002/1097-0142(19890715)64:2<526::AID-CNCR2820640228>3.0.CO;2-B; Hohenberger W, 2003, STRAHLENTHER ONKOL, V179, P271; Huang Q, 2011, J DIGEST DIS, V12, P420, DOI 10.1111/j.1751-2980.2011.00535.x; Ito Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-304; Kelsen D, 2001, J CLIN ONCOL, V19, P283; Kitajima M, 2002, NEW ENGL J MED, V347, P1705, DOI 10.1056/NEJMe020130; Koide N, 1998, HEPATO-GASTROENTEROL, V45, P1619; Kok TC, 1997, P ASCO, V17, pA984; Komanduri S, 2011, ANN NY ACAD SCI, V1232, P248, DOI 10.1111/j.1749-6632.2011.06055.x; Kubik S, 1990, AK TUELLE THERAPIE O; Langmann J, 1985, MED EMBRYOLOGIE; Lauren T., 1965, ACTA PATHOL MIC SC, V64, P31; Law S, 1997, J THORAC CARDIOV SUR, V114, P210, DOI 10.1016/S0022-5223(97)70147-8; Liebermann-Meffert D, 2001, DIS ESOPHAGUS, V14, P81, DOI 10.1046/j.1442-2050.2001.00160.x; Liebermann-Meffert D, 2005, SHACKELFORDS SURG AL; Lorenzen S, 2008, BRIT J CANCER, V99, P1020, DOI 10.1038/sj.bjc.6604659; MAIPANG T, 1994, J SURG ONCOL, V56, P191, DOI 10.1002/jso.2930560314; Malthaner RA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001556.pub2; Malthaner RA, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-35; MARSHALL BJ, 1985, MED J AUSTRALIA, V143, P319; Matsuhisa Takeshi, 2012, Helicobacter, V17, P396, DOI 10.1111/j.1523-5378.2012.00967.x; MCGREGOR DH, 1976, CANCER, V37, P1556, DOI 10.1002/1097-0142(197603)37:3<1556::AID-CNCR2820370345>3.0.CO;2-E; Mobius C, 2007, WORLD J SURG, V31, P1768, DOI 10.1007/s00268-006-0373-1; O'Rahilly R, 2001, HUMAN EMBRYOLOGY TER; ROTH JA, 1992, CHIRURG, V63, P683; ROTH JA, 1988, J THORAC CARDIOV SUR, V96, P242; Ruffato A, 2013, ANN THORAC SURG, V95, P1147, DOI 10.1016/j.athoracsur.2012.12.040; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sarbia M, 2007, BRIT J CANCER, V97, P1404, DOI 10.1038/sj.bjc.6604037; SCHLAG P, 1992, CHIRURG, V63, P709; NEUHAUS P, 1992, ARCH SURG-CHICAGO, V127, P1446; Schneider JH, 2009, OBES SURG, V19, P595, DOI 10.1007/s11695-009-9809-7; Schneider JH, 2010, J GASTROINTEST SURG, V14, P17, DOI 10.1007/s11605-009-1017-1; Shimkin MB, 1977, CONTRARY NATURE; Shridhar Ravi, 2013, J Gastrointest Cancer, V44, P375, DOI 10.1007/s12029-013-9511-9; Siewert JR, 2005, CHIRURG, V76, P1033, DOI 10.1007/s00104-005-1096-9; Solaymani-Dodaran M, 2004, GUT, V53, P1070, DOI 10.1136/gut.2003.028076; Solaymani-Dodaran M, 2013, GASTROENTEROLOGY, V144, P1375, DOI 10.1053/j.gastro.2013.02.050; Spence JR, 2001, DEV DYNAM, V240, P501; Stilidi I, 2006, J CLIN ONCOL, V24, P4055; Swift GH, 1998, MOL CELL BIOL, V18, P5109; Tanaka K, 2012, JPN J CLIN ONCOL, V42, P212, DOI 10.1093/jjco/hyr198; Thiagarajan Prarthana, 2012, Recent Results Cancer Res, V196, P115, DOI 10.1007/978-3-642-31629-6_8; Thirion P, 2007, J CLIN ONCOL, V25, P4512; Twaddell WS, 2011, ANN NY ACAD SCI, V1232, P265, DOI 10.1111/j.1749-6632.2011.06056.x; Von Rahden BHA, 2006, VIRCHOWS ARCH, V448, P862, DOI 10.1007/s00428-006-0185-6; von Rahden BHA, 2005, J CLIN ONCOL, V23, P874, DOI 10.1200/JCO.12.151; Wang Chunli, 2001, Zhonghua Zhongliu Zazhi, V23, P254; Website American Cancer Society, 2014, SURV RAT CANC ES STA; YANG PC, 1988, CANCER, V61, P612, DOI 10.1002/1097-0142(19880201)61:3<612::AID-CNCR2820610332>3.0.CO;2-Q; Yuasa N, 2006, WORLD J SURG, V30, P364, DOI 10.1007/s00268-005-0434-x; Zhou J, 2003, WORLD J GASTROENTERO, V9, P9; Ziogas DE, 2010, ANN SURG ONCOL, V17, P343, DOI 10.1245/s10434-009-0747-3	134	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0735-7907	1532-4192		CANCER INVEST	Cancer Invest.	DEC	2014	32	10					497	506		10.3109/07357907.2014.958497		10	Oncology	Oncology	AU0IJ	WOS:000345306400001		
J	Takayama, K; Taki, W; Toma, N; Nakahara, I; Maeda, M; Tanemura, H; Kuroiwa, T; Imai, K; Sakamoto, M; Nakagawa, I; Masuo, O; Myouchin, K; Wada, T; Suzuki, H				Takayama, Katsutoshi; Taki, Waro; Toma, Naoki; Nakahara, Ichiro; Maeda, Masayuki; Tanemura, Hiroshi; Kuroiwa, Terumasa; Imai, Keisuke; Sakamoto, Masahiko; Nakagawa, Ichiro; Masuo, Osamu; Myouchin, Kaoru; Wada, Takeshi; Suzuki, Hidenori			Effect of Pitavastatin on Preventing Ischemic Complications with Carotid Artery Stenting: A Multicenter Prospective Study-EPOCH-CAS Study	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Statin therapy; Carotid artery stenting; Diffusion-weighted imaging; Pitavastatin; Ischemic complication	LEAD-IN PHASE; BRAIN-LESIONS; REVASCULARIZATION ENDARTERECTOMY; HIGH-RISK; TRIAL; PLAQUE; STABILIZATION; ANGIOPLASTY; PROTECTION; STENOSIS	Periprocedural ischemic stroke is one problem associated with carotid artery stenting (CAS). This study was designed to assess whether preoperative statin therapy reduces the risk of periprocedural ischemic complications with CAS. In this prospective study at 11 centers, patients with carotid artery stenosis (symptomatic a parts per thousand yen50 %, asymptomatic a parts per thousand yen80 %) and a high risk of carotid endarterectomy but without previous statin treatments were divided into two groups by low-density lipoprotein cholesterol (LDL-C) levels. With LDL-C a parts per thousand yen120 mg/dl, the pitavastatin-treated (PS) group received pitavastatin at 4 mg/day. With LDL-C < 120 mg/dl, the non-PS group received no statin therapy. After 4 weeks, both groups underwent CAS. Frequencies of new ipsilateral ischemic lesions on diffusion-weighted imaging within 72 h after CAS and cerebrovascular events (transient ischemic attack, stroke, or death) within 30 days were assessed. Among the 80 patients enrolled, 61 patients (PS group, n = 31; non-PS group, n = 30) fulfilled the inclusion criteria. New ipsilateral ischemic lesions were identified in 8 of 31 patients (25.8 %) in the PS group and 16 of 30 patients (53.3 %) in the non-PS group (P = 0.028). Cerebrovascular events occurred in 0 patients in the PS group and in 3 of 30 patients (10.0 %) in the non-PS group (P = 0.071). Multivariate analyses demonstrated the pitavastatin treatment (beta = 0.74, 95 % confidence interval 0.070-1.48, P = 0.042) to be an independent factor for decreasing post-CAS ischemic lesions. Pretreatment with pitavastatin significantly reduced the frequency of periprocedural ischemic complications with CAS.	[Takayama, Katsutoshi; Myouchin, Kaoru] Ishinkai Yao Gen Hosp, Dept Radiol & Intervent Neuroradiol, Osaka 5810036, Japan; [Taki, Waro; Toma, Naoki; Tanemura, Hiroshi; Suzuki, Hidenori] Mie Univ, Dept Neurosurg, Grad Sch Med, Tsu, Mie 514, Japan; [Nakahara, Ichiro] Kokura Mem Hosp, Dept Neurosurg, Fukuoka, Japan; [Maeda, Masayuki] Mie Univ, Dept Radiol, Grad Sch Med, Tsu, Mie 514, Japan; [Kuroiwa, Terumasa] Osaka Med Coll, Dept Neurosurg, Takatsuki, Osaka 569, Japan; [Imai, Keisuke] Kyoto First Red Cross Hosp, Dept Neurol, Kyoto, Japan; [Sakamoto, Masahiko; Wada, Takeshi] Nara Med Univ, Dept Radiol, Kashihara, Nara 634, Japan; [Nakagawa, Ichiro] Nara Med Univ, Dept Neurosurg, Kashihara, Nara 634, Japan; [Masuo, Osamu] Wakayama Med Univ, Dept Neurol Surg, Wakayama, Japan	Takayama, K (reprint author), Ishinkai Yao Gen Hosp, Dept Radiol & Intervent Neuroradiol, 1-41 Numa Yao, Osaka 5810036, Japan.	takayamaneuroivs@par.odn.ne.jp		Nakahara, Ichiro/0000-0001-8909-2949			Verzini F, 2011, J VASC SURG, V53, P71, DOI 10.1016/j.jvs.2010.08.024; Watanabe K, 2005, J AM COLL CARDIOL, V46, P2022, DOI 10.1016/j.jacc.2005.04.070; Hobson RW, 2004, J VASC SURG, V40, P1106, DOI 10.1016/j.jvs.2004.10.022; Bonati LH, 2010, LANCET NEUROL, V9, P353, DOI 10.1016/S1474-4422(10)70057-0; Pasceri V, 2004, CIRCULATION, V110, P674, DOI 10.1161/01.CIR.0000137828.06205.87; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Yoshimura S, 2011, STROKE, V42, P3132, DOI 10.1161/STROKEAHA.111.615708; Russjan A, 2012, CEREBROVASC DIS, V33, P30, DOI 10.1159/000332088; Hopkins LN, 2010, J STROKE CEREBROVASC, V19, P153, DOI 10.1016/j.jstrokecerebrovasdis.2010.01.001; Nakamura T, 2008, J CARDIOVASC PHARM, V51, P365, DOI 10.1097/FJC.0b013e318165dcad; Davignon J, 2012, BRIT J CLIN PHARMACO, V73, P518, DOI 10.1111/j.1365-2125.2011.04139.x; Stojanov D, 2012, AM J NEURORADIOL, V33, P708, DOI 10.3174/ajnr.A2840; Kastrup A, 2006, STROKE, V37, P2312, DOI 10.1161/01.STR.0000236492.86303.85; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Schnaudigel S, 2008, STROKE, V39, P1911, DOI 10.1161/STROKEAHA.107.500603; Bosiers M, 2007, EUR J VASC ENDOVASC, V33, P135, DOI 10.1016/j.ejvs.2006.09.019; Groschel K, 2006, RADIOLOGY, V240, P145, DOI 10.1148/radiol.2401050603; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Jansen O, 2009, STROKE, V40, P841, DOI 10.1161/STROKEAHA.108.534289; Lal BK, 2009, J VASC SURG, V50, P1224, DOI 10.1016/j.jvs.2009.09.003; Sasaki Makoto, 2007, Magn Reson Med Sci, V6, P133, DOI 10.2463/mrms.6.133; Takayama K, 2011, JPN J RADIOL, V29, P51, DOI 10.1007/s11604-010-0518-x; Tanemura H, 2013, STROKE, V44, P105, DOI 10.1161/STROKEAHA.112.663138; Yamada K, 2010, ATHEROSCLEROSIS, V208, P161, DOI 10.1016/j.atherosclerosis.2009.06.024	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	DEC	2014	37	6					1436	1443		10.1007/s00270-013-0813-x		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AT2ZX	WOS:000344804600005		
J	Kariya, S; Komemushi, A; Nakatani, M; Yoshida, R; Kono, Y; Tanigawa, N				Kariya, Shuji; Komemushi, Atsushi; Nakatani, Miyuki; Yoshida, Rie; Kono, Yumiko; Tanigawa, Noboru			Intranodal Lymphangiogram: Technical Aspects and Findings	CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY			English	Article						Chylothorax; Intranodal lymphangiogram; Pulmonary embolization; Thoracic duct embolization	THORACIC-DUCT EMBOLIZATION; CHYLOTHORAX; MANAGEMENT	To report the technical results and imaging findings of intranodal lymphangiogram (INL). we studied four patients (three men, one woman) who had persistent chylous leakage despite conservative treatment after esophageal cancer surgery. Their mean age was 68 years (range 61-74 years). The inguinal or femoral lymph node was punctured under ultrasound guidance using a 60-mm-long, 23-gauge needle. If the lipiodol injected via the needle showed granular nodules on fluoroscopy, lipiodol injection was continued manually at a rate of 1 mL/3 min for INL. If the cisterna chyli was detectable on the lymphangiogram, it was punctured percutaneously via the abdomen by a needle under fluoroscopy, and thoracic duct embolization was performed. INL was successful in all patients. Lymphaticovenous anastomoses at the femoral or pelvic region were confirmed in all four patients. In one case, a different ipsilateral lymph node was punctured because major flow of lipiodol into the veins through a lymphaticovenous anastomosis occurred. Catheter cannulation and embolization were successful for three of the four patients. In unsuccessful procedures, the cisterna chyli was not visualized, and puncture was not possible. INL succeeded in all patients. Lipiodol leaked into the vein through a lymphaticovenous anastomosis at the femoral or pelvic region in all patients.	[Kariya, Shuji; Komemushi, Atsushi; Nakatani, Miyuki; Yoshida, Rie; Kono, Yumiko; Tanigawa, Noboru] Kansai Med Univ, Dept Radiol, Hirakata, Osaka 5731010, Japan	Kariya, S (reprint author), Kansai Med Univ, Dept Radiol, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	kariyas@hirakata.kmu.ac.jp; komemush@takii.kmu.ac.jp; nakatanm@hirakata.kmu.ac.jp; yagir@hirakata.kmu.ac.jp; kohnoy@hirakata.kmu.ac.jp; tanigano@hirakata.kmu.ac.jp					Itkin M, 2010, J THORAC CARDIOV SUR, V139, P584, DOI 10.1016/j.jtcvs.2009.11.025; Cope C, 2002, J VASC INTERV RADIOL, V13, P1139, DOI 10.1016/S1051-0443(07)61956-3; Nadolski GJ, 2012, J VASC INTERV RADIOL, V23, P613, DOI 10.1016/j.jvir.2012.01.078; Cope C, 1999, J VASC INTERV RADIOL, V10, P1248, DOI 10.1016/S1051-0443(99)70227-7; Guermazi A, 2003, RADIOGRAPHICS, V23, P1541, DOI 10.1148/rg.236035704; HALL RC, 1967, J AMER MED ASSOC, V202, P1136, DOI 10.1001/jama.202.13.1136; KOEHLER PR, 1967, CIRCULATION, V35, P401; TAKAHASH.M, 1967, RADIOLOGY, V89, P633	8	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0174-1551	1432-086X		CARDIOVASC INTER RAD	Cardiovasc. Interv. Radiol.	DEC	2014	37	6					1606	1610		10.1007/s00270-014-0888-z		5	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AT2ZX	WOS:000344804600029		
J	Satsuma, A; Matsuoka, M; Matsuda, H				Satsuma, Atsushi; Matsuoka, Masaya; Matsuda, Hirokazu			Special issue of the Seventh Tokyo Conference on Advanced Catalytic Science and Technology (TOCAT7) Preface	CATALYSIS SURVEYS FROM ASIA			English	Editorial Material									[Satsuma, Atsushi] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Matsuoka, Masaya] Osaka Prefecture Univ, Sakai, Osaka 591, Japan; [Matsuda, Hirokazu] Daicel Corp, Osaka, Japan	Satsuma, A (reprint author), Nagoya Univ, Nagoya, Aichi 4648601, Japan.	satsuma@apchem.nagoya-u.ac.jp; matsumac@chem.osakafu-u.ac.jp; hk_matsuda@jp.daicel.com						0	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1571-1013	1574-9266		CATAL SURV ASIA	Catal. Surv. Asia	DEC	2014	18	4			SI		99	100		10.1007/s10563-014-9181-z		2	Chemistry, Physical	Chemistry	AT7BL	WOS:000345091100001		
J	Hirata, H				Hirata, Hirohito			Recent Research Progress in Automotive Exhaust Gas Purification Catalyst	CATALYSIS SURVEYS FROM ASIA			English	Article						Exhaust gas purification catalyst; Platinum group metals decrease; Platinum group metals substitution; Metal support interaction; Platinum group metals cluster; Bimetallic cluster	BIMETALLIC CLUSTERS; SPECTROSCOPY	In automotive catalysis, the exhaust gas purification catalyst is expected to maintain a high level of importance for the next several decades. Current exhaust gas purification catalysts contain platinum group metals (PGM; Pt, Pd and Rh), and exhaust gas purification reactions occur on the PGM surface. The total demand for PGM is increasing yearly due to the introduction of stricter exhaust gas regulations and the increase in automobile production. Given the limited global PGM resources, catalysts with decreased PGM content or alternative technologies are needed. In this manuscript, the latest results of our research towards the aforementioned needs are introduced.	Toyota Motor Co Ltd, Adv Mat Engn Div, Shizuoka 4101193, Japan	Hirata, H (reprint author), Toyota Motor Co Ltd, Adv Mat Engn Div, 1200 Mishuku, Shizuoka 4101193, Japan.	hirohito_hirata@mail.toyota.co.jp					Tanabe T, 2012, CATAL TODAY, V184, P219, DOI 10.1016/j.cattod.2011.10.005; Nagai Y, 2006, J CATAL, V242, P103, DOI 10.1016/j.jcat.2006.06.002; Anderson JA, 2006, APPL CATAL B-ENVIRON, V64, P189, DOI 10.1016/j.apcatb.2005.12.007; Aoki Y, 2011, SAE PAPER NO 2011 01; Carrondo MAAF de CT, 1976, J CHEM SOC CHEM COMM, V410; Kabashima N, 2014, 113TH CATALYSIS SOCI; Nagata N, 2013, 23RD NORTH AMERICAN; Nagata N, 2012, 110TH CATALYSIS SOCI; Nagata N, 2012, 109TH CATALYSIS SOCI; Ohashi M, 2006, CHEM LETT, V35, P954, DOI 10.1246/cl.2006.954; Osaki M, 2012, 109TH CATALYSIS SOCI; Shirakawa S, 2012, 110TH CATALYSIS SOCI; Shirakawa S., 2013, EUROPACAT XI S10 T8; Tanabe T, 2011, APPL CATAL B-ENVIRON, V105, P41, DOI 10.1016/j.apcatb.2011.03.033; TOSHIMA N, 1989, CHEM LETT, P1769, DOI 10.1246/cl.1989.1769; TOSHIMA N, 1991, J PHYS CHEM-US, V95, P7448, DOI 10.1021/j100172a061; Yoshida T, 2006, SAE PAPER NO 2006 01	17	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1571-1013	1574-9266		CATAL SURV ASIA	Catal. Surv. Asia	DEC	2014	18	4			SI		128	133		10.1007/s10563-014-9170-2		6	Chemistry, Physical	Chemistry	AT7BL	WOS:000345091100003		
J	Setoyama, T				Setoyama, Tohru			The Contribution of Catalysis for the Realization of GSC in the Twenty-First Century	CATALYSIS SURVEYS FROM ASIA			English	Article						GSC; Diversification; Inter-conversion; Artificial photosynthesis	METHANE; WATER	The drastic climate change on global scale is becoming very serious. To curb the anthropogenic CO2 emissions will be one of the most important issues for the human society in the twenty-first century. The chemical industry can contribute to this issue from the viewpoint of green sustainable chemistry. We have been establishing various innovative catalyst technologies and can still continue further efforts. Considering the existence of huge infrastructure of the conventional processes based on fossil resources, it would be very difficult to turn into new technologies based on sustainable resources quickly and straightforwardly. Thus it may be good to apply more practical strategies along the realistic time line. Here we propose a strategy comprised of establishing more energy-effective chemical processes based on fossil resources in short term, utilizing biomasses as chemical feedstocks in large scale in middle term, and pursuit of the artificial photosynthesis as a final goal in long term. In this article, several topics in each category are introduced.	Mitsubishi Chem Corp, Aoba Ku, Yokohama, Kanagawa 2278502, Japan	Setoyama, T (reprint author), Mitsubishi Chem Corp, Aoba Ku, 1000 Kamoshida Cho, Yokohama, Kanagawa 2278502, Japan.	1908182@cc.m-kagaku.co.jp					FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Xie KC, 2010, ENERGY, V35, P4349, DOI 10.1016/j.energy.2009.05.029; Sanfilippo D, 2006, CATAL TODAY, V111, P133, DOI 10.1016/j.cattod.2005.10.012; Caro J, 2008, MICROPOR MESOPOR MAT, V115, P215, DOI 10.1016/j.micromeso.2008.03.008; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; [Anonymous], 2012, WORLD EN OUTL; Fritzmann C, 2007, DESALINATION, V216, P1, DOI 10.1016/j.desal.2006.12.009; Sutton D, 2001, FUEL PROCESS TECHNOL, V73, P155, DOI 10.1016/S0378-3820(01)00208-9; Maeda K, 2005, J AM CHEM SOC, V127, P8286, DOI 10.1021/ja0518777; Haas T, 2005, APPL CATAL A-GEN, V280, P83, DOI 10.1016/j.apcata.2004.08.027; Hayashi M, 2010, World Patent, Patent No. [WO 2010/128644 A1, 2010128644]; KELLER GE, 1982, J CATAL, V73, P9, DOI 10.1016/0021-9517(82)90075-6; LEE JS, 1988, CATAL REV, V30, P249, DOI 10.1080/01614948808078620; Morgen M, 1999, CHEM IND, P166; Muller U, 2014, TOCAT 7 P PL 2; Ookoshi T, 2012, [No title captured], Patent No. [WO 2012-102347-A1, 2012102347]; S Sugita, 2012, [No title captured], Patent No. [2012- 39272, 201239272]; S Sugita, [No title captured], Patent No. [JP 2010- 43366, 201043366]; S Sugita, [No title captured], Patent No. [US 8376148, 8376148]; Shultz H., 1999, APPL CATAL A-GEN, V186, P3; Yamashita A, 2013, [No title captured], Patent No. [JP 2013-253061, 2013253061]	21	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1571-1013	1574-9266		CATAL SURV ASIA	Catal. Surv. Asia	DEC	2014	18	4			SI		183	192		10.1007/s10563-014-9180-0		10	Chemistry, Physical	Chemistry	AT7BL	WOS:000345091100008		
J	Perez, CV; Pellizzari, EH; Cigorraga, SB; Galardo, MN; Naito, M; Lustig, L; Jacobo, PV				Valeria Perez, Cecilia; Herminia Pellizzari, Eliana; Beatriz Cigorraga, Selva; Noel Galardo, Maria; Naito, Munekazu; Lustig, Livia; Veronica Jacobo, Patricia			IL17A impairs blood-testis barrier integrity and induces testicular inflammation	CELL AND TISSUE RESEARCH			English	Article						IL17A; Blood-testis barrier; Sertoli cells; Cell adhesion molecules; Testicular inflammation	NECROSIS-FACTOR-ALPHA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; IL-17 FAMILY CYTOKINES; SERTOLI TIGHT JUNCTION; AUTOIMMUNE ORCHITIS; RAT TESTIS; CELL-JUNCTIONS; IN-VITRO; DISRUPTION; EXPRESSION	Experimental autoimmune orchitis is a useful model for studying testicular inflammation and germ/immune cell interactions. Th17 cells and their hallmark cytokine IL17A were reported to be involved in the development of autoimmune orchitis. The aim of the present work is to investigate the pathogenic role of IL17A in rat testis. In vitro experiments were performed in order to analyze effects of IL17A on Sertoli cell tight junctions. The addition of IL17A to normal rat Sertoli cell cultures induced a significant decline in transepithelial electrical resistance and a reduction of occludin expression and redistribution of occludin and claudin 11, altering the Sertoli cell tight junction barrier. Intratesticular injection of 1 mu g of recombinant rat IL17A to Sprague-Dawley rats induced increased blood-testis barrier permeability, as shown by the presence of biotin tracer in the seminiferous tubule adluminal compartment, and delocalization of occludin and claudin 11. Results showed that IL17A induced focal inflammatory cell infiltration in the interstitium and germ cell sloughing in adjacent seminiferous tubules. Moreover, an increase in TUNEL+ apoptotic germ cells was also observed. Inflammatory ED1+ macrophages were the main population infiltrating the interstitium following IL17A injection. This correlated with an increase in mRNA expression of the monocyte chemoattractant protein Ccl2, its receptor Ccr2 and the vascular cell adhesion molecule Vcam1. Overall results suggest a relevant role of IL17A in the development of testicular inflammation, facilitating the recruitment of immune cells to the testicular interstitium and inducing impairment of blood-testis barrier function.	[Valeria Perez, Cecilia; Naito, Munekazu; Lustig, Livia; Veronica Jacobo, Patricia] Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina; [Herminia Pellizzari, Eliana; Beatriz Cigorraga, Selva; Noel Galardo, Maria] Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol CONICET, Buenos Aires, DF, Argentina; [Naito, Munekazu] Tokyo Med Univ, Dept Anat, Tokyo 1608402, Japan	Perez, CV (reprint author), Paraguay 2155,Piso 10,C1121ABG, Buenos Aires, DF, Argentina.	ceciliaperez77@yahoo.com.ar			Universidad de Buenos Aires [20020100100447]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [11220110100930, 11220080100806]	This work was supported by the Universidad de Buenos Aires (grant number 20020100100447) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (grant numbers 11220110100930, 11220080100806). We are grateful to Shuichi Hirai for his suggestions and excellent assistance in PCR experiments. We thank Cecilia Garcia for her technical assistance in histological procedures and the Instituto Nacional de Microbiologia "A. Malbran", Division Vacunas Bacterianas, for their generous donation of Bordetella pertussis.	Song XY, 2013, CELL SIGNAL, V25, P2335, DOI 10.1016/j.cellsig.2013.07.021; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; RUSSELL LD, 1987, GAMETE RES, V17, P43, DOI 10.1002/mrd.1120170106; Guazzone VA, 2003, J REPROD IMMUNOL, V60, P143, DOI 10.1016/j.jri.2003.08.001; Sarkar O, 2008, BIOL REPROD, V78, P445, DOI 10.1095/biolreprod.107.064501; Meroni SB, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740195; Ni JB, 2013, INFLAMMATION, V36, P53, DOI 10.1007/s10753-012-9519-5; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Theas MS, 2008, HUM REPROD, V23, P1865, DOI 10.1093/humrep/den240; Jacobo P, 2011, AUTOIMMUN REV, V10, P201, DOI 10.1016/j.autrev.2010.09.026; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Huppert J, 2010, FASEB J, V24, P1023, DOI 10.1096/fj.09-141978; Rival C, 2006, J REPROD IMMUNOL, V70, P43, DOI 10.1016/j.jri.2005.10.006; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496; Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865; Gerdprasert O, 2002, MOL HUM REPROD, V8, P518, DOI 10.1093/molehr/8.6.518; Duan YG, 2011, INT J ANDROL, V34, pE536, DOI 10.1111/j.1365-2605.2010.01137.x; Cheng CY, 2013, SPERMATOGENESIS, V3; Chung SSW, 1999, J CELL PHYSIOL, V181, P258, DOI 10.1002/(SICI)1097-4652(199911)181:2<258::AID-JCP8>3.0.CO;2-Q; DONCEL GF, 1989, AM J REPROD IMMUNOL, V20, P44; Grima J, 1998, J BIOL CHEM, V273, P21040, DOI 10.1074/jbc.273.33.21040; Jacobo P, 2011, REPRODUCTION, V141, P249, DOI 10.1530/REP-10-0362; Lustig L, 2006, AUTOIMMUNE DISEASES, 4TH EDITION, P841, DOI 10.1016/B978-012595961-2/50063-9; Marks BR, 2009, SEMIN IMMUNOL, V21, P164, DOI 10.1016/j.smim.2009.03.001; Marwaha AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00129; Perez CV, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101709; Perez C.V., 2013, SPERMATOGENESIS, V3, P23870, DOI DOI 10.4161/SPMG.23870; SHARPE RM, 1984, J ENDOCRINOL, V102, P319, DOI 10.1677/joe.0.1020319; Suescun MO, 2003, BIOL REPROD, V68, P2114, DOI 10.1095/biolreprod.102.011189	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2014	358	3					885	898		10.1007/s00441-014-1995-5		14	Cell Biology	Cell Biology	AT6YT	WOS:000345083700020		
J	Tanaka, SS; Nishinakamura, R				Tanaka, Satomi S.; Nishinakamura, Ryuichi			Regulation of male sex determination: genital ridge formation and Sry activation in mice	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Six1; Six4; Sox9; Transcriptional network; Nr5a1/Ad4BP/Sf1	STEROIDOGENIC FACTOR-I; PRIMORDIAL GERM-CELLS; MULLERIAN-INHIBITING SUBSTANCE; HEART TUBE FORMATION; DETERMINING GENE SRY; FETAL LEYDIG-CELLS; DM-DOMAIN GENE; TRANSCRIPTION FACTOR; TESTIS DEVELOPMENT; WILMS-TUMOR	Sex determination is essential for the sexual reproduction to generate the next generation by the formation of functional male or female gametes. In mammals, primary sex determination is commenced by the presence or absence of the Y chromosome, which controls the fate of the gonadal primordium. The somatic precursor of gonads, the genital ridge is formed at the mid-gestation stage and gives rise to one of two organs, a testis or an ovary. The fate of the genital ridge, which is governed by the differentiation of somatic cells into Sertoli cells in the testes or granulosa cells in the ovaries, further determines the sex of an individual and their germ cells. Mutation studies in human patients with disorders of sex development and mouse models have revealed factors that are involved in mammalian sex determination. In most of mammals, a single genetic trigger, the Y-linked gene Sry (sex determination region on Y chromosome), regulates testicular differentiation. Despite identification of Sry in 1990, precise mechanisms underlying the sex determination of bipotential genital ridges are still largely unknown. Here, we review the recent progress that has provided new insights into the mechanisms underlying genital ridge formation as well as the regulation of Sry expression and its functions in male sex determination of mice.	[Tanaka, Satomi S.; Nishinakamura, Ryuichi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, Kumamoto 8600811, Japan	Tanaka, SS (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Kidney Dev, 2-2-1 Honjo, Kumamoto 8600811, Japan.	stanaka@kumamoto-u.ac.jp; ryuichi@kumamoto-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Japan Society for Promotion of Science; Takeda Science Foundation	We thank Yuka Fujimoto for her contributions to the analysis of the Six1 and Six4 double-mutant mouse embryo. This work was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan, the Japan Society for Promotion of Science, and the Takeda Science Foundation.	Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.0.CO;2-R; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Tamura M, 2001, MECH DEVELOP, V102, P135, DOI 10.1016/S0925-4773(01)00298-2; Cui SY, 2004, DEVELOPMENT, V131, P4095, DOI 10.1242/dev.01266; DeFalco T, 2011, DEV BIOL, V352, P14, DOI 10.1016/j.ydbio.2011.01.011; Eggers S, 2012, CHROMOSOME RES, V20, P215, DOI 10.1007/s10577-012-9274-3; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014; Cool J, 2008, SEX DEV, V2, P128, DOI 10.1159/000143430; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Hatano O, 1996, GENES CELLS, V1, P663, DOI 10.1046/j.1365-2443.1996.00254.x; Cutting A, 2013, DEV DYNAM, V242, P380, DOI 10.1002/dvdy.23944; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Seeherunvong T, 2004, AM J MED GENET A, V127A, P149, DOI 10.1002/ajmg.a.20630; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Blackless M, 2000, AM J HUM BIOL, V12, P151, DOI 10.1002/(SICI)1520-6300(200003/04)12:2<151::AID-AJHB1>3.0.CO;2-F; Sekido R, 2013, SEX DEV, V7, P21, DOI 10.1159/000342221; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Hara K, 2009, DEV BIOL, V330, P427, DOI 10.1016/j.ydbio.2009.04.012; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Schepers G, 2003, J BIOL CHEM, V278, P28101, DOI 10.1074/jbc.M304067200; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; Combes AN, 2009, DEV BIOL, V326, P112, DOI 10.1016/j.ydbio.2008.10.040; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; DiNapoli L, 2006, DEVELOPMENT, V133, P1519, DOI 10.1242/dev.02303; Nachtigal MW, 1998, CELL, V93, P445, DOI 10.1016/S0092-8674(00)81172-1; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Polanco JC, 2010, HUM MOL GENET, V19, P506, DOI 10.1093/hmg/ddp520; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Tanaka SS, 2000, GENE DEV, V14, P841; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Kusaka M, 2010, ENDOCRINOLOGY, V151, P5893, DOI 10.1210/en.2010-0915; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Ruggiu M, 1997, NATURE, V389, P73; HACKER A, 1995, DEVELOPMENT, V121, P1603; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Qin YJ, 2005, HUM MOL GENET, V14, P1221, DOI 10.1093/hmg/ddi133; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Harikae K, 2013, DEV DYNAM, V242, P330, DOI 10.1002/dvdy.23872; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Ungewitter EK, 2013, SEX DEV, V7, P7, DOI 10.1159/000338612; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Achermann JC, 1999, NAT GENET, V22, P125; Archambeault DR, 2010, P NATL ACAD SCI USA, V107, P10526, DOI 10.1073/pnas.1000318107; Giordani J, 2007, P NATL ACAD SCI USA, V104, P11310, DOI 10.1073/pnas.0611299104; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Shimamura R, 1997, CLIN CANCER RES, V3, P2571; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; Schmahl J, 2000, DEVELOPMENT, V127, P65; Shima Y, 2012, ENDOCRINOLOGY, V153, P417, DOI 10.1210/en.2011-1407; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/ydbio.2004.07.011; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/reprod/126.5.589; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Biason-Lauber A, 2009, AM J HUM GENET, V84, P658, DOI 10.1016/j.ajhg.2009.03.016; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Ono M, 2013, NAT REV ENDOCRINOL, V9, P79, DOI 10.1038/nrendo.2012.235; Aleck KA, 1999, AM J MED GENET, V85, P2, DOI 10.1002/(SICI)1096-8628(19990702)85:1<2::AID-AJMG2>3.0.CO;2-G; Cupp AS, 2003, BIOL REPROD, V68, P2033, DOI 10.1095/biolreprod.102.012617; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Kashimada K, 2011, FASEB J, V25, P3561, DOI 10.1096/fj.11-184333; Katoh-Fukui Y, 2012, ENDOCRINOLOGY, V153, P913, DOI 10.1210/en.2011-1055; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; HARLEY VR, 1994, MOL REPROD DEV, V39, P184; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.10.010; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Ludbrook LM, 2012, ENDOCRINOLOGY, V153, P1948, DOI 10.1210/en.2011-1428; Katoh-Fukui Y, 2005, BLOOD, V106, P1612, DOI 10.1182/blood-2004-08-3367; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Pilon N, 2003, BIOL REPROD, V68, P1098, DOI 10.1095/biolrepod.102.010884; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Mallet D, 2004, J CLIN ENDOCR METAB, V89, P4829, DOI 10.1210/jc.2004-0670; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Arboleda VA, 2014, GENETICS, V197, P885, DOI 10.1534/genetics.113.160259; Bernard P, 2012, ENDOCRINOLOGY, V153, P901, DOI 10.1210/en.2011-1347; Bhandari RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043380; Bhandari RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019935; Bland ML, 2004, MOL ENDOCRINOL, V18, P941, DOI 10.1210/me.2003-0333; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; Clement TM, 2011, BIOL REPROD, V85, P277, DOI 10.1095/biolreprod.110.090282; Correa SM, 2012, PLOS GENET, V8, P11, DOI 10.1371/journal.pgen.1002569; Czech DP, 2014, ENDOCRINOLOGY, V155, P2602, DOI 10.1210/en.2013-2158; Desclozeaux M, 1998, BBA-GENE STRUCT EXPR, V1397, P247, DOI 10.1016/S0167-4781(98)00041-4; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Fatchiyah Zubair M, 2006, BIOCHEM BIOPH RES CO, V341, P1036; Fujimoto Y, 2013, DEV CELL, V26, P416, DOI 10.1016/j.devcel.2013.06.018; Graves JAM, 2001, REPROD FERT DEVELOP, V13, P665, DOI 10.1071/RD01093; HONDA S, 1993, J BIOL CHEM, V268, P7494; Hoyle C, 2002, MOL ENDOCRINOL, V16, P747, DOI 10.1210/me.16.4.747; Hu YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003629; Hughes I A, 2006, J Pediatr Urol, V2, P148, DOI 10.1016/j.jpurol.2006.03.004; JAGER RJ, 1992, HUM GENET, V90, P350; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Kanai Y, 2000, MECH DEVELOP, V96, P223, DOI 10.1016/S0925-4773(00)00397-X; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kobayashi H, 2007, MECH DEVELOP, V124, P290, DOI 10.1016/j.mod.2007.01.002; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Li B, 2006, J MOL BIOL, V360, P310, DOI 10.1016/j.jmb.2006.04.046; Li BR, 2001, J BIOL CHEM, V276, P46480, DOI 10.1074/jbc.C100388200; Merchant-Larios H, 1981, Prog Clin Biol Res, V59B, P383; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Miyamoto Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-44; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; MOROHASHI K, 1993, MOL ENDOCRINOL, V7, P1196, DOI 10.1210/me.7.9.1196; Munger SC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003630; Munger SC, 2009, GENE DEV, V23, P2521, DOI 10.1101/gad.1835809; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; PARMACEK MS, 1994, MOL CELL BIOL, V14, P1870; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; PONTIGGIA A, 1994, EMBO J, V13, P6115; SCHMITT-NEY M, 1995, AM J HUM GENET, V56, P862; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; SHINODA K, 1995, DEV DYNAM, V204, P22; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Sock E, 2001, MOL CELL BIOL, V21, P6951, DOI 10.1128/MCB.21.20.6951-6959.2001; Toyooka Y, 1998, INT J DEV BIOL, V42, P1143; Tremblay Jacques J., 2001, Biology of Reproduction, V64, P1191, DOI 10.1095/biolreprod64.4.1191; Tremblay JJ, 2001, MOL ENDOCRINOL, V15, P1636, DOI 10.1210/me.15.9.1636; Wei P, 2012, J NEUROCHEM, V121, P717, DOI 10.1111/j.1471-4159.2012.07648.x; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Yamauchi Y, 2014, SCIENCE, V343, P69, DOI 10.1126/science.1242544	198	4	4	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	DEC	2014	71	24					4781	4802		10.1007/s00018-014-1703-3		22	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AT6ZM	WOS:000345085600006		
J	Arimura, Y; Shimizu, K; Koyanagi, M; Yagi, J				Arimura, Yutaka; Shimizu, Kazuhiko; Koyanagi, Madoka; Yagi, Junji			Effects of protein tyrosine phosphatase-PEST are reversed by Akt in T cells	CELLULAR SIGNALLING			English	Article						Protein Tyrosine Phosphatase (PTP); PIP-PEST; Cell death; Growth factor signaling; Akt	PTP-PEST; LYMPHOCYTE-ACTIVATION; PROGRAMMED NECROSIS; NEGATIVE REGULATOR; CATALYTIC-ACTIVITY; KINASE P50(CSK); SH3 DOMAIN; IN-VIVO; ASSOCIATION; SUBSTRATE	T cell activation is regulated by a balance between phosphorylation and dephosphorylation that is under the control of kinases and phosphatases. Here, we examined the role of a non-receptor-type protein tyrosine phosphatase, PTP-PEST, using retrovirus-mediated gene transduction into murine T cells. Based on observations of vector markers (GFP or Thy1.1), exogenous PTP-PEST-positive CD4(+) T cells appeared within 2 days after gene transduction; the percentage of PIP-PEST-positive cells tended to decrease during a resting period in the presence of IL-2 over the next 2 days. These vector markers also showed much lower expression intensities, compared with control cells, suggesting a correlation between the percent reduction and the low marker expression intensity. A catalytically inactive PIP-PEST mutant also showed the same tendency, and stepwise deletion mutants gradually lost their ability to induce the above phenomenon. On the other hand, these PIP-PEST-transduced cells did not have an apoptotic phenotype. No difference in the total cell numbers was found in the wells of a culture plate containing VEC- and PIP-PEST-transduced T cells. Moreover, serine/threonine kinase Akt, but not the anti-apoptotic molecules Bc1-2 and Bcl-XL, reversed the phenotype induced by PTP-PEST. We discuss the novel mechanism by which Ala interferes with PIP-PEST. (C) 2014 Elsevier Inc. All rights reserved.	[Arimura, Yutaka; Koyanagi, Madoka] Nippon Vet & Life Sci Univ, Musashino, Tokyo 1808602, Japan; [Arimura, Yutaka; Shimizu, Kazuhiko; Yagi, Junji] Tokyo Womens Med Univ, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan	Arimura, Y (reprint author), Nippon Vet & Life Sci Univ, 1-7-1 Kyonan, Musashino, Tokyo 1808602, Japan.	arimura2013@nvlu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23570173]	This study was supported by grants from our university and the Ministry of Education, Culture, Sports, Science and Technology (#23570173). We are grateful to Dr.J.F. Cote for the PIP-PEST expression vectors (pcDNA3.1). We thank Dr. T. Kitamura for the pMXs retrovirus vector and Plat-E retrovirus packaging cells. We also thank Naoko Kodama for great technical help and Masato Yoshikawa for providing animal care.	Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; Wu Y, 1998, J BIOL CHEM, V273, P30487, DOI 10.1074/jbc.273.46.30487; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tanuma N, 2001, BLOOD, V98, P3030, DOI 10.1182/blood.V98.10.3030; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Miyazaki T, 1998, GENE DEV, V12, P770, DOI 10.1101/gad.12.6.770; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Spencer S, 1997, J CELL BIOL, V138, P845, DOI 10.1083/jcb.138.4.845; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Nishiya N, 1999, J BIOL CHEM, V274, P9847, DOI 10.1074/jbc.274.14.9847; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Wang B, 2001, MOL CELL BIOL, V21, P1077, DOI 10.1128/MCB.21.4.1077-1088.2001; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Charest A, 1996, J BIOL CHEM, V271, P8424; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Arimura Y, 2008, MOL IMMUNOL, V45, P3074, DOI 10.1016/j.molimm.2008.03.019; Arimura Y, 2004, J BIOL CHEM, V279, P11408, DOI 10.1074/jbc.M309063200; Arimura Y, 2010, J LEUKOCYTE BIOL, V87, P493, DOI 10.1189/jlb.0708440; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Badour Karen, 2004, Journal of Experimental Medicine, V199, P99; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; Chen J, 2004, ONCOGENE, V23, P3659, DOI 10.1038/sj.onc.1207471; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Cote JF, 1999, J BIOL CHEM, V274, P20550, DOI 10.1074/jbc.274.29.20550; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GARTON AJ, 1994, EMBO J, V13, P3763; Halle M, 2007, MOL CELL BIOL, V27, P1172, DOI 10.1128/MCB.02462-05; Halle M, 2007, CELL CYCLE, V6, P2773; Hinton SD, 2010, BIOCHEM J, V427, P349, DOI 10.1042/BJ20091383; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Li J, 1998, EMBO J, V17, P7320, DOI 10.1093/emboj/17.24.7320; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Playford MP, 2006, J BIOL CHEM, V281, P34104, DOI 10.1074/jbc.M606277200; Shen Y, 2000, J BIOL CHEM, V275, P1405, DOI 10.1074/jbc.275.2.1405; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Tanuma N, 2000, J BIOL CHEM, V275, P28216	58	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	DEC	2014	26	12					2721	2729		10.1016/j.cellsig.2014.08.014		9	Cell Biology	Cell Biology	AT7HQ	WOS:000345107700015		
J	Akada, M; Harada, K; Negishi, M; Katoh, H				Akada, Mai; Harada, Kohei; Negishi, Manabu; Katoh, Hironori			EphB6 promotes anoikis by modulating EphA2 signaling	CELLULAR SIGNALLING			English	Article						EphA2; EphB6; Ephexin4; Anoikis; Heterotypic interaction	RECEPTOR TYROSINE KINASE; BREAST-CARCINOMA CELLS; RHO-GTPASES; CANCER; MIGRATION; GROWTH; ACTIVATION; EXPRESSION; RAC1; PHOSPHORYLATION	Anoikis is a specific type of apoptosis induced by detachment of epithelial cells from extracellular matrix, and acquiring resistance to anoikis is an important step that enables cancer cells to metastasize. EphA2, which is overexpressed in a variety of human cancers, is phosphorylated by Akt on serine 897 and mediates ligand ephrin-independent promotion of anoikis resistance through the RhoG activator Ephexin4. EphB6 is frequently silenced in invasive and metastatic cancers; however, its role in cancer progression is poorly understood. Here we show that EphB6 interacts with EphA2 and suppresses EphA2-mediated promotion of anoikis resistance in MCF7 breast cancer cells. On the other hand, knockdown of EphB6 promotes anoikis resistance. We further show that expression of EphB6 decreases serine 897 phosphorylation of EphA2 and suppresses EphA2-Ephexin4 interaction and the RhoG activation. These findings implicate EphB6 as a negative regulator of EphA2 oncogenic signaling. (C) 2014 Elsevier Inc. All rights reserved.	[Akada, Mai; Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Pharmaceut Sci, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan; [Harada, Kohei; Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan	Katoh, H (reprint author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hirokato@pharm.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23370085]; Suzuken Memorial Foundation	We thank Dr. J. Miyazaki and Dr. T. Saito for the EYFP expression plasmid. This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (Scientific Research (B) 23370085) of Japan and by a grant from the Suzuken Memorial Foundation. The authors declare that they have no competing interests.	Gurniak CB, 1996, ONCOGENE, V13, P777; Harada K, 2011, EXP CELL RES, V317, P1701, DOI 10.1016/j.yexcr.2011.05.014; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Tang XX, 1999, CLIN CANCER RES, V5, P1491; Matsuoka H, 2005, J BIOL CHEM, V280, P29355, DOI 10.1074/jbc.M500010200; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Murga C, 2002, ONCOGENE, V21, P207; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Oricchio E, 2011, CELL, V147, P554, DOI 10.1016/j.cell.2011.09.035; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Kaenel P, 2012, CELL ADHES MIGR, V6, P138, DOI 10.4161/cam.20154; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Kawai H, 2013, FEBS OPEN BIO, V3, P78, DOI 10.1016/j.fob.2013.01.002; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yezcr.2006.09.006; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fox BP, 2006, BIOCHEM BIOPH RES CO, V340, P268, DOI 10.1016/j.bbrc.2005.11.174; Fox BP, 2011, CANCER GENOM PROTEOM, V8, P185; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Freywald A, 2002, J BIOL CHEM, V277, P3823, DOI 10.1074/jbc.M108011200; Fujimoto S, 2009, MOL BIOL CELL, V20, P4941, DOI 10.1091/mbc.E09-03-0200; Hafner C, 2003, INT J ONCOL, V23, P1553; Matsuoka H, 1997, BIOCHEM BIOPH RES CO, V235, P487, DOI 10.1006/bbrc.1997.6812; Miao H., 2014, ONCOGENE, V33; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Seiradake E., 2010, NAT STRUCT MOL BIOL, V4, P398; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000	48	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	DEC	2014	26	12					2879	2884		10.1016/j.cellsig.2014.08.031		6	Cell Biology	Cell Biology	AT7HQ	WOS:000345107700032		
J	Abdullah, R; Saka, S				Abdullah, Rosnah; Saka, Shiro			Hydrolysis behavior of various crystalline celluloses treated by cellulase of Tricoderma viride	CELLULOSE			English	Article						Cellulose; Cellulase; Crystalline structure; Hydrolysis; Trichoderma viride	X-RAY-DIFFRACTION; ENZYMATIC-HYDROLYSIS; CELLOBIOHYDROLASE; SACCHARIFICATION; RESOLUTION; MECHANISM; SIZE; DECOMPOSITION; PRETREATMENT; CONVERSION	Cellobiose and glucose are valuable products that can be obtained from enzymatic hydrolysis of cellulose. This study discusses changes in the crystalline form of celluloses to enhance the production of sugars and examines the effect on structural properties during enzymatic hydrolysis. Various crystalline celluloses consisting of group I (cell I, cell IIII, cell IVI) and group II (cell II, cell IIIII, cell IVII) of similar DPs were prepared as starting materials. The similar DP values allowed a more direct comparison of the hydrolysis yields. The outcomes were analyzed and evaluated based on the residues and supernatants obtained from the treatment. As a result: (1) action of the cellulase of Trichoderma viride decreased both DP and crystallinity, with greater changes in group II celluloses, (2) the polymorphic interconversion process that occurred for cell IIII, cell IVI, cell IIIII and cell IVII during the treatment was independent of the enzymatic hydrolysis, thus, the hydrolysis behaviors depended on the starting material of the celluloses, and (3) higher sugar production was obtained from cell IIII and group II. Therefore, the hydrolysis behavior of the various crystalline celluloses depended on the particular polymorph of the starting material.	[Abdullah, Rosnah; Saka, Shiro] Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Saka, S (reprint author), Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Kyoto 6068501, Japan.	saka@energy.kyoto-u.ac.jp			Kyoto University Global GCOE program of 'Energy Science in the Age of Global Warming'	The authors are thankful for the support that was given by the Kyoto University Global GCOE program of 'Energy Science in the Age of Global Warming', for the completion of this work.	OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; Wada M, 2008, BIOMACROMOLECULES, V9, P2898, DOI 10.1021/bm8006709; [Anonymous], 1988, T222OM88 TAPPI; WEIMER PJ, 1991, APPL ENVIRON MICROB, V57, P3101; Abdullah R, 2013, CELLULOSE, V20, P2321, DOI 10.1007/s10570-013-0022-4; Kadam KL, 2004, BIOTECHNOL PROGR, V20, P698, DOI 10.1021/bp034316x; Andersson S, 2003, J WOOD SCI, V49, P531, DOI 10.1007/s10086-003-0518-x; French AD, 2013, CELLULOSE, V20, P583, DOI 10.1007/s10570-012-9833-y; Bommarius AS, 2008, METAB ENG, V10, P370, DOI 10.1016/j.ymben.2008.06.008; EVANS R, 1989, J APPL POLYM SCI, V37, P3291, DOI 10.1002/app.1989.070371202; Mormann W, 2002, CARBOHYD POLYM, V50, P201, DOI 10.1016/S0144-8617(02)00016-4; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Cao Y, 2005, ENZYME MICROB TECH, V36, P314, DOI 10.1016/j.enzmictec.2004.09.002; FAN LT, 1980, BIOTECHNOL BIOENG, V22, P177, DOI 10.1002/bit.260220113; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Cao Y, 2002, CARBOHYD RES, V337, P1291; Isogai A, 1998, CELLULOSE, V5, P309, DOI 10.1023/A:1009272632367; Kumar S, 2010, BIORESOURCE TECHNOL, V101, P1337, DOI 10.1016/j.biortech.2009.09.035; Wada M, 2010, POLYM DEGRAD STABIL, V95, P543, DOI 10.1016/j.polymdegradstab.2009.12.014; Schacht C, 2008, J SUPERCRIT FLUID, V46, P299, DOI 10.1016/j.supflu.2008.01.018; Langan P, 2001, BIOMACROMOLECULES, V2, P410, DOI 10.1021/mb005612q; Igarashi K, 2007, FEBS J, V274, P1785, DOI 10.1111/j.1742-4658.2007.05727.x; LEE SB, 1983, BIOTECHNOL BIOENG, V25, P33, DOI 10.1002/bit.260250105; Sulzenbacher G, 1997, BIOCHEMISTRY-US, V36, P5902, DOI 10.1021/bi962963+; SASAKI T, 1979, BIOTECHNOL BIOENG, V21, P1031, DOI 10.1002/bit.260210608; Wada M, 2004, MACROMOLECULES, V37, P8548, DOI 10.1021/ma0485585; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; French AD, 2014, CELLULOSE, V21, P885, DOI 10.1007/s10570-013-0030-4; Hsu TA., 1996, HDB BIOETHANOL PRODU, P179; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; LOEB L, 1955, J POLYM SCI, V15, P343, DOI 10.1002/pol.1955.120158003; LOKHANDE HT, 1977, J POLYM SCI POL LETT, V15, P97, DOI 10.1002/pol.1977.130150207; Mittal A., 2011, BIOTECHNOL BIOFUELS, V4, P1; NISHIMURA H, 1987, J APPL POLYM SCI, V33, P867, DOI 10.1002/app.1987.070330315; Park S, 2010, BIOTECHNOL BIOFUELS, V3, P1; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Reese ET, 1957, TEXT RES J, V27, P626, DOI 10.1177/004051755702700806; Vanderghem C, 2010, APPL BIOCHEM BIOTECH, V160, P2300, DOI 10.1007/s12010-009-8724-7; vanWyk JPH, 1997, BIOTECHNOL TECH, V11, P443, DOI 10.1023/A:1018485226767; Ward RJ, 2011, ROUTES TO CELLULOSIC ETHANOL, P135, DOI 10.1007/978-0-387-92740-4_9; Yang J, 2010, BIORESOURCE TECHNOL, V101, P4930, DOI 10.1016/j.biortech.2009.09.079	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0969-0239	1572-882X		CELLULOSE	Cellulose	DEC	2014	21	6					4049	4058		10.1007/s10570-014-0410-4		10	Materials Science, Paper & Wood; Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	AT2ZF	WOS:000344802700017		
J	Takaichi, S; Saito, T; Tanaka, R; Isogai, A				Takaichi, Satoshi; Saito, Tsuguyuki; Tanaka, Reina; Isogai, Akira			Improvement of nanodispersibility of oven-dried TEMPO-oxidized celluloses in water	CELLULOSE			English	Article						Carbonyl group; NaBH4 reduction; Nanodispersibility; 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO); TEMPO-oxidized cellulose	MEDIATED OXIDATION; NATIVE CELLULOSE; CARBONYL GROUPS; NANOCELLULOSES; ACID	Never-dried 2,2,6,6,-tetramethylpiperidinyl-1-oxyl (TEMPO)-oxidized wood celluloses (TOCs) with carboxylate contents of 1.0-1.7 mmol/g can be converted to TEMPO-oxidized cellulose nanofibrils (TOCNs) with homogeneous widths of a parts per thousand 3 nm by mechanical disintegration treatment in water. However, oven-dried TOCs have low nanodispersibility in water. In this study, when TOC was reduced with NaBH4 under suitable conditions, almost all C6-aldehydes and C2/C3 ketones present in the TOCs were converted to hydroxyl groups. The NaBH4-reduced TOCs had sufficiently high nanodispersibility (similar to that of never-dried TOCs) in water even after oven drying at 105 A degrees C for 3 h. Thus, interfibrillar hemiacetal linkages are probably formed between hydroxyl groups and either C6-aldehydes or C2/C3 ketones present on the crystalline microfibril surfaces of TOCs during heating, resulting in low nanodispersibility. The heat-induced discoloration of TOCs can also be avoided by using NaBH4-reduced TOCs. Heating of the oven-dried TOCs in water at 80 A degrees C for 0.5-3 h improves their nanodispersibility, presumably because the interfibrillar hemiacetal linkages formed by oven drying are broken during the hot-water treatment. A semi-quantitative method to determine C6-aldehydes and C2/C3 ketones present in dried TOCs is proposed, in which the specific UV absorbance spectra of TOCN films heated at 105 A degrees C for 3 h are used. The presence of C6-aldehydes and C2/C3 ketones in TOCs can be determined by UV absorption peaks of the TOCN films at a parts per thousand 260 and a parts per thousand 290 nm, respectively.	[Takaichi, Satoshi; Saito, Tsuguyuki; Tanaka, Reina; Isogai, Akira] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Isogai, A (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aisogai@mail.ecc.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (JST)	This research was supported by Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Agency (JST).	ALBERTSSON U, 1962, ANAL CHIM ACTA, V27, P434, DOI 10.1016/S0003-2670(00)88534-7; Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970; Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b; Bode JW, 2001, J ORG CHEM, V66, P6410, DOI 10.1021/jo015791h; Tsuchikama K, 2011, J ORG CHEM, V76, P6981, DOI 10.1021/jo200882k; Chiou WH, 2012, ORG BIOMOL CHEM, V10, P2518, DOI 10.1039/c2ob06984a; LEWIN M, 1962, J POLYM SCI, V58, P1023, DOI 10.1002/pol.1962.1205816663; Palombo E, 2005, TETRAHEDRON, V61, P9545, DOI 10.1016/j.tet.2005.07.087; Kim UJ, 2004, CARBOHYD POLYM, V56, P7, DOI 10.1016/j.carbpol.2003.10.013; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Okita Y, 2010, BIOMACROMOLECULES, V11, P1696, DOI 10.1021/bm100214b; Isogai A, 2013, J WOOD SCI, V59, P449, DOI 10.1007/s10086-013-1365-z; Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268; REESE ET, 1950, J BACTERIOL, V59, P485; Csuk R, 2012, EUR J MED CHEM, V56, P237, DOI 10.1016/j.ejmech.2012.08.032; Veelaert S, 1997, CARBOHYD POLYM, V33, P153, DOI 10.1016/S0144-8617(97)00046-5; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Shinoda R, 2012, BIOMACROMOLECULES, V13, P842, DOI 10.1021/bm2017542; Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337; Potthast A, 2003, BIOMACROMOLECULES, V4, P743, DOI 10.1021/bm025759c; Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769; Kinney WA, 2000, ORG LETT, V2, P2921, DOI 10.1021/ol0059495; Hesse M, 1979, SPEKTROSCOPISCHE MET, P1; Hirota M, 2010, ANGEW CHEM, V42, P7836; Iwabuchi Y, 2008, J SYN ORG CHEM JPN, V66, P1076; LEONARD NJ, 1950, J AM CHEM SOC, V72, P5388, DOI 10.1021/ja01168a007; Pretsch E, 1989, TABLES SPECTRAL DATA, pU5; Shingh RB, 1978, TALANTA, V25, P619; Takaichi S, 2013, CELLULOSE, V20, P1979, DOI 10.1007/s10570-013-9932-4	31	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0969-0239	1572-882X		CELLULOSE	Cellulose	DEC	2014	21	6					4093	4103		10.1007/s10570-014-0444-7		11	Materials Science, Paper & Wood; Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	AT2ZF	WOS:000344802700021		
J	Nodera, H; Manto, M				Nodera, Hiroyuki; Manto, Mario			Cerebellum Tunes the Excitability of the Motor System: Evidence from Peripheral Motor Axons	CEREBELLUM			English	Article							NUCLEUS INTERPOSITUS; DENTATE NUCLEUS; CORTEX; STIMULATION	Cerebellum is highly connected with the contralateral cerebral cortex. So far, the motor deficits observed in acute focal cerebellar lesions in human have been mainly explained on the basis of a disruption of the cerebello-thalamo-cortical projections. Cerebellar circuits have also numerous anatomical and functional interactions with brainstem nuclei and projects also directly to the spinal cord. Cerebellar lesions alter the excitability of peripheral motor axons as demonstrated by peripheral motor threshold-tracking techniques in cerebellar stroke. The biophysical changes are correlated with the functional scores. Nerve excitability measurements represent an attractive tool to extract the rules underlying the tuning of excitability of the motor pathways by the cerebellum and to discover the contributions of each cerebellar nucleus in this key function, contributing to early plasticity and sensorimotor learning.	[Nodera, Hiroyuki] Tokushima Univ Hosp, Dept Neurol, Tokushima, Japan; [Manto, Mario] FNRS ULB Erasme, Unite Etud Mouvement, B-1070 Brussels, Belgium	Manto, M (reprint author), FNRS ULB Erasme, Unite Etud Mouvement, 808 Route Lennik, B-1070 Brussels, Belgium.	mmanto@ulb.ac.be			FNRS-Belgium	MM is supported by the FNRS-Belgium.	DILAZZARO V, 1995, ELECTROMYOGR MOTOR C, V97, P259; Ruigrok TJH, 2011, CEREBELLUM, V10, P464, DOI 10.1007/s12311-010-0164-y; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; ASANUMA C, 1980, BRAIN RES, V191, P245, DOI 10.1016/0006-8993(80)90327-3; BANTLI H, 1975, PFLUG ARCH EUR J PHY, V357, P237, DOI 10.1007/BF00585978; BANTLI H, 1975, BRAIN RES, V88, P86, DOI 10.1016/0006-8993(75)90952-X; Ben Taib Nordeyn Oulad, 2009, J Neurosurg, V111, P796, DOI 10.3171/2008.2.17679; Ben-Taib NO, 2004, CEREBELLUM, V3, P21, DOI 10.1080/14734220410028660; FOX JE, 1982, J NEUROL NEUROSUR PS, V45, P1165, DOI 10.1136/jnnp.45.12.1165; Kuypers HGJM, 1981, HDB PHYSL 1, VII, P597, DOI DOI 10.1002/CPHY.CP010213; Ben Taib NO, 2013, NEURAL PLAST, DOI 10.1155/2013/613197; Ruigrok TJ, 2013, HDB CEREBELLUM CEREB, P497; SHINODA Y, 1982, NEUROSCI LETT, V34, P111, DOI 10.1016/0304-3940(82)90161-6; Tamburin S, 2004, CLIN NEUROPHYSIOL, V115, P348, DOI 10.1016/S1388-2457(03)00357-2; TSUKAHARA N, 1983, BRAIN RES, V274, P249, DOI 10.1016/0006-8993(83)90702-3	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	DEC	2014	13	6					663	665		10.1007/s12311-014-0578-z		3	Neurosciences	Neurosciences & Neurology	AU0AF	WOS:000345284700001		
J	Anami, H; Aihara, Y; Kawashima, A; Yamaguchi, K; Nagahara, A; Okada, Y				Anami, Hidenori; Aihara, Yasuo; Kawashima, Akitsugu; Yamaguchi, Koji; Nagahara, Ayumi; Okada, Yoshikazu			A case report of a pediatric traumatic aneurysm with arteriovenous (A-V) fistula CASE-BASED UPDATE	CHILDS NERVOUS SYSTEM			English	Article						Traumatic intracranial aneurysm; Subarachnoid hemorrhage; Anterior inferior cerebral artery; Arteriovenous (A-V) fistula; Clipping	INFERIOR CEREBELLAR ARTERY; INTRACRANIAL ANEURYSMS; CEREBRAL-ARTERY; VERTEBRAL ARTERY; POSTERIOR-FOSSA; BASILAR ARTERY; FALSE ANEURYSM; CHILDHOOD; SECONDARY; INJURY	Traumatic intracranial aneurysms (TICAs) are rare, representing less than 5 % of all intracranial aneurysms. Most TICAs are located within the anterior circulation, and less than 10 % of TICAs occur in the posterior circulation. Histopathologically, most TICAs are false aneurysms and have a high risk of rupture or re-bleeding. When they are discovered, careful observation or treatment may be required. Once they are enlarged, they have a high risk of rupture, and immediate treatment is essential. For the first time in the literature, we report a rare case of an 8-year-old boy with a TICA in anterior inferior cerebellar artery (AICA) and arteriovenous (A-V) fistula after severe head trauma. Trapping of AICA and resection of the aneurysm was performed. Postoperatively, he has peripheral facial palsy but is otherwise neurologically normal. Surgical treatment for traumatic aneurysms is challenging because most of TICAs are histopathologically pseudoaneurysms. It may be technically difficult to perform direct surgery of aneurysms especially located in the posterior circulation, but when the treatment is successful, the outcome was favorable.	[Anami, Hidenori; Aihara, Yasuo; Kawashima, Akitsugu; Yamaguchi, Koji; Nagahara, Ayumi; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1628666, Japan	Aihara, Y (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yaihara@nij.twmu.ac.jp			Department of Neurosurgery, Tokyo Women's Medical University	This study was supported by research funds of the Department of Neurosurgery, Tokyo Women's Medical University.	Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BANK WO, 1978, AM J ROENTGENOL, V130, P975; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; COCKRILL HH, 1977, J NEUROSURG, V46, P377, DOI 10.3171/jns.1977.46.3.0377; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; Kim B, 2003, INTERV NEURORADIOL, V9, P199; MCDONALD EJ, 1976, AM J ROENTGENOL, V126, P792; MEGURO K, 1985, NEUROSURGERY, V16, P666; MORARD M, 1991, NEUROSURGERY, V29, P438; NAGASHIMA C, 1977, J NEUROSURG, V46, P681, DOI 10.3171/jns.1977.46.5.0681; Nishioka T, 2002, ACTA NEUROCHIR, V144, P839, DOI 10.1007/s00701-002-0952-3; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; Senegor M, 1991, TRAUMATIC PERICALLOS; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; Sure U, 1999, CHILD NERV SYST, V15, P354, DOI 10.1007/s003810050411; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; WORTZMAN D, 1980, SURG NEUROL, V13, P329	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2014	30	12					2003	2008		10.1007/s00381-014-2551-z		6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AT4AO	WOS:000344879700003		
J	Shimizu, K; Mineharu, Y; Imamura, H; Asai, K; Imai, Y; Ichimura, K; Sakai, N				Shimizu, Kampei; Mineharu, Yohei; Imamura, Hirotoshi; Asai, Katsunori; Imai, Yukihiro; Ichimura, Koichi; Sakai, Nobuyuki			Intracranial germinomas in a father and his son	CHILDS NERVOUS SYSTEM			English	Article						Intracranial; Germ cell tumor; Germinoma; Familial; Gene; Pathologically confirmed	GERM-CELL TUMORS; TESTICULAR SEMINOMA; 2 BROTHERS; MUTATIONS; KIT; COMMON	Background Primary intracranial germ cell tumors (IGCTs) represent an uncommon category of neoplasms, and familial occurrence is rare. We present the first report of parent-child patients with pathologically confirmed pure germinomas. Case report A 36-year-old Japanese man presented with diabetes insipidus and hypopituitarism. Magnetic resonance imaging (MRI) revealed a mass lesion in the pituitary stalk, which was diagnosed as a pure germinoma by open craniotomy tumor biopsy. Seven years later, his 13-year-old son also presented with diabetes insipidus. MRI revealed mass lesions in the pituitary stalk and the pineal region. He underwent endoscopic tumor biopsy for the pineal lesion, which was diagnosed as a pure germinoma. Both the father and his son were treated with combined radiochemotherapeutic regimens and achieved complete remission after one to two cycles of chemotherapy. Conclusion Although there have been three previous case reports of familial germinoma, all of these involved sibling pairs. The present report represents the first parent-child cases. This type of familial occurrence suggests the possibility that germline mutations may also be involved in the development of IGCTs.	[Shimizu, Kampei; Mineharu, Yohei; Imamura, Hirotoshi; Asai, Katsunori; Sakai, Nobuyuki] Gen Hosp, Kobe City Med Ctr, Dept Neurosurg, Kobe, Hyogo, Japan; [Imai, Yukihiro] Gen Hosp, Kobe City Med Ctr, Dept Pathol, Kobe, Hyogo, Japan; [Mineharu, Yohei; Asai, Katsunori; Sakai, Nobuyuki] Inst Biomed Res & Innovat IBRI, Div Neuroendovasc Therapy, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Ichimura, Koichi] Natl Canc Ctr, Res Inst, Div Brain Tumor Translat Res, Tokyo 104, Japan	Mineharu, Y (reprint author), Inst Biomed Res & Innovat IBRI, Div Neuroendovasc Therapy, Chuo Ku, 2-2 Minatojima Minamimach, Kobe, Hyogo 6500047, Japan.	mineharu@kuhp.kyoto-u.ac.jp		Imai, Yukihiro/0000-0002-5067-1545			Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Sakuma Y, 2004, CANCER SCI, V95, P716, DOI 10.1111/j.1349-7006.2004.tb03251.x; Reuter VE, 2005, MODERN PATHOL, V18, pS51, DOI 10.1038/modpathol.3800309; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; CALAMINUS G, 1994, NEUROPEDIATRICS, V25, P26, DOI 10.1055/s-2008-1071577; Iwato M, 2000, CANCER RES, V60, P2113; Calaminus G, 2005, NEUROPEDIATRICS, V36, P71, DOI 10.1055/s-2005-837582; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Fukushima S, 2014, ACTA NEUROPATHOL, V127, P911, DOI 10.1007/s00401-014-1247-5; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Kanamori M, 2009, J NEUROS-PEDIATR, V4, P506, DOI 10.3171/2009.7.PEDS08288; AOYAMA I, 1994, SURG NEUROL, V41, P313, DOI 10.1016/0090-3019(94)90181-3; Committee of Brain Tumor Registry of Japan, 2014, NEUROL MED CHIR S, V54, P17; Horvath A, 2009, CANCER RES, V69, P5301, DOI 10.1158/0008-5472.CAN-09-0884; Kamakura Y, 2006, J NEUROSURG, V104, P173, DOI 10.3171/ped.2006.104.3.173; Kawabata Y, 2008, J NEURO-ONCOL, V88, P161, DOI 10.1007/s11060-008-9542-4; KIDO G, 1984, Neurological Surgery, V12, P975; Maity A, 2004, J NEURO-ONCOL, V70, P83, DOI 10.1023/B:NEON.0000040829.35787.95; NAKASU S, 1983, SURG NEUROL, V20, P147, DOI 10.1016/0090-3019(83)90467-6; Nitta N, 2013, NEUROL MED-CHIR, V53, P703, DOI 10.2176/nmc.cr2012-0143; PEAT DS, 1994, J CLIN PATHOL, V47, P771, DOI 10.1136/jcp.47.8.771; TRENTINI G P, 1985, Applied Pathology, V3, P129; WAKAI S, 1980, J NEUROSURG, V53, P239, DOI 10.3171/jns.1980.53.2.0239	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2014	30	12					2143	2146		10.1007/s00381-014-2461-0		4	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AT4AO	WOS:000344879700028		
J	Jia, WT; Sonoda, Y; Saito, R; Endo, T; Watanabe, M; Tominaga, T				Jia, Wenting; Sonoda, Yukihiko; Saito, Ryuta; Endo, Toshiki; Watanabe, Mika; Tominaga, Teiji			Intracerebral cystic rhabdoid papillary meningioma in an 11-year-old patient	CHILDS NERVOUS SYSTEM			English	Article						Cystic lesion; Intracerebral meningioma; Rhabdoid papillary meningioma	EXPRESSION; TRANSFORMATION; CHILD	Introduction Rhabdoid papillary meningioma is a rare meningioma variant categorized as WHO grade III. We report an 11-year-old girl with an intracerebral rhabdoid papillary meningioma. Materials and methods An 11-year-old girl presented to our hospital with a short history of severe headache and vomiting. MRI revealed a left frontal intracerebral cystic lesion with rim enhancement. The tumor, including the cyst wall, was totally removed. Since the histological diagnosis was rhabdoid papillary meningioma, she was treated with postoperative radiotherapy. She is currently undergoing routine follow-up without any symptoms of recurrence. Conclusion We discuss the clinical picture of this patient with reference to the published literature on this uncommon diagnosis.	[Jia, Wenting; Sonoda, Yukihiko; Saito, Ryuta; Endo, Toshiki; Watanabe, Mika; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Jia, Wenting; Sonoda, Yukihiko; Saito, Ryuta; Endo, Toshiki; Watanabe, Mika; Tominaga, Teiji] Tohoku Univ Hosp, Div Pathol, Sendai, Miyagi, Japan	Sonoda, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sono@nsg.med.tohoku.ac.jp					GERMANO IM, 1994, J NEUROSURG, V80, P447, DOI 10.3171/jns.1994.80.3.0447; Buccoliero AM, 2011, NEUROPATHOLOGY, V31, P59, DOI 10.1111/j.1440-1789.2010.01113.x; Chaturvedi S, 2008, CLIN NEUROPATHOL, V27, P248; Dutta D, 2009, J CLIN NEUROSCI, V16, P1073, DOI 10.1016/j.jocn.2008.07.085; Eom KS, 2009, CLIN NEUROL NEUROSUR, V111, P619, DOI 10.1016/j.clineuro.2009.05.002; Ferrante L, 1989, Br J Neurosurg, V3, P189, DOI 10.3109/02688698909002794; Hojo H, 2001, AM J SURG PATHOL, V25, P964, DOI 10.1097/00000478-200107000-00018; Kepes JJ, 1998, AM J SURG PATHOL, V22, P231, DOI 10.1097/00000478-199802000-00012; Liu M, 2007, J CLIN NEUROSCI, V14, P856, DOI 10.1016/j.jocn.2006.06.003; Martinez-Lage J, 2006, CHILD NERV SYST, V22, P325, DOI 10.1007/s00381-004-1094-0; Morina Arsim, 2010, Med Arh, V64, P123; NAUTA HJW, 1979, J NEUROL NEUROSUR PS, V42, P529, DOI 10.1136/jnnp.42.6.529; Nozza P, 2005, ACTA NEUROPATHOL, V110, P205, DOI 10.1007/s00001-005-1048-y; Perry A, 2007, WHO CLASSIFICATION T, P164; Perry A, 1998, AM J SURG PATHOL, V22, P1482, DOI 10.1097/00000478-199812000-00005; Rittierodt M, 2001, J NEUROIMMUNOL, V120, P129, DOI 10.1016/S0165-5728(01)00425-8; Tian Q, 2014, CHILD NERV SYST, V3, P189; Vaquero J, 2002, NEUROPATH APPL NEURO, V28, P418, DOI 10.1046/j.1365-2990.2002.00407.x; Wakabayashi K, 2005, ACTA NEUROPATHOL, V110, P196, DOI 10.1007/s00401-005-1037-1; Wu YT, 2011, NEUROPATHOLOGY, V31, P599, DOI 10.1111/j.1440-1789.2011.01201.x; ZEE CS, 1995, NEUROSURGERY, V36, P482	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2014	30	12					2151	2155		10.1007/s00381-014-2470-z		5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AT4AO	WOS:000344879700030		
J	Srikulnath, K; Matsubara, K; Uno, Y; Nishida, C; Olsson, M; Matsuda, Y				Srikulnath, Kornsorn; Matsubara, Kazumi; Uno, Yoshinobu; Nishida, Chizuko; Olsson, Mats; Matsuda, Yoichi			Identification of the linkage group of the Z sex chromosomes of the sand lizard (Lacerta agilis, Lacertidae) and elucidation of karyotype evolution in lacertid lizards	CHROMOSOMA			English	Article							BIRDS; DIFFERENTIATION; SQUAMATA; REPTILES; ORIGIN; GENOME; TESTUDINES; HOMOLOGY; MAMMALS; SNAKES	The sand lizard (Lacerta agilis, Lacertidae) has a chromosome number of 2n = 38, with 17 pairs of acrocentric chromosomes, one pair of microchromosomes, a large acrocentric Z chromosome, and a micro-W chromosome. To investigate the process of karyotype evolution in L. agilis, we performed chromosome banding and fluorescent in situ hybridization for gene mapping and constructed a cytogenetic map with 86 functional genes. Chromosome banding revealed that the Z chromosome is the fifth largest chromosome. The cytogenetic map revealed homology of the L. agilis Z chromosome with chicken chromosomes 6 and 9. Comparison of the L. agilis cytogenetic map with those of four Toxicofera species with many microchromosomes (Elaphe quadrivirgata, Varanus salvator macromaculatus, Leiolepis reevesii rubritaeniata, and Anolis carolinensis) showed highly conserved linkage homology of L. agilis chromosomes (LAG) 1, 2, 3, 4, 5(Z), 7, 8, 9, and 10 with macrochromosomes and/or macrochromosome segments of the four Toxicofera species. Most of the genes located on the microchromosomes of Toxicofera were localized to LAG6, small acrocentric chromosomes (LAG11-18), and a microchromosome (LAG19) in L. agilis. These results suggest that the L. agilis karyotype resulted from frequent fusions of microchromosomes, which occurred in the ancestral karyotype of Toxicofera and led to the disappearance of microchromosomes and the appearance of many small macrochromosomes.	[Srikulnath, Kornsorn; Uno, Yoshinobu; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet,Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Srikulnath, Kornsorn] Kasetsart Univ, Dept Genet, Lab Anim Cytogenet & Comparat Genom, Fac Sci, Bangkok 10900, Thailand; [Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, CASTNAR,NRU KU, Bangkok, Thailand; [Matsubara, Kazumi] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Nishida, Chizuko] Hokkaido Univ, Dept Nat Hist Sci, Fac Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Olsson, Mats] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Olsson, Mats] Univ Gothenburg, Dept Zool, S-40530 Gothenburg, Sweden	Matsuda, Y (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet,Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kornsorn.s@ku.ac.th; yoimatsu@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23113004, 22370081]	This work was financially supported by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23113004) and Scientific Research (B) (No. 22370081) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Srikulnath K, 2009, CYTOGENET GENOME RES, V125, P213, DOI 10.1159/000230005; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Kawagoshi T, 2012, CHROMOSOME RES, V20, P95, DOI 10.1007/s10577-011-9267-7; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; LANG JW, 1994, J EXP ZOOL, V270, P28, DOI 10.1002/jez.1402700105; OLMO E, 1987, CHROMOSOMA, V96, P33, DOI 10.1007/BF00285880; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; Ciofi C, 1997, APPL ANIM BEHAV SCI, V51, P251, DOI 10.1016/S0168-1591(96)01108-2; CREE A, 1995, NATURE, V375, P543, DOI 10.1038/375543a0; De Smet WHO, 1981, ACTA ZOOL PATHOL ANT, V76, P73; Ezaz T, 2010, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; Ezaz T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-899; Gamble T, 2014, EVOLUTION, V68, P1027, DOI 10.1111/evo.12328; HEAD G, 1987, NATURE, V329, P198, DOI 10.1038/329198a0; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Kawagoshi T, 2009, CYTOGENET GENOME RES, V125, P125, DOI 10.1159/000227837; Kawai A, 2009, CHROMOSOMA, V118, P43, DOI 10.1007/s00412-008-0176-2; Leache AD, 2009, CYTOGENET GENOME RES, V127, P166, DOI 10.1159/000293285; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; ODIERNA G, 1987, Amphibia-Reptilia, V8, P373, DOI 10.1163/156853887X00144; Odierna Gaetano, 1995, Amphibia-Reptilia, V16, P293, DOI 10.1163/156853895X00091; Odierna G., 1993, Amphibia-Reptilia, V14, P1, DOI 10.1163/156853893X00147; Olmo E, 2005, CHROMOREP REPTILE CH; Olmo E., 1992, Revista Espanola de Herpetologia, V6, P81; Pokorna M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-90; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Shedlock Andrew M., 2009, P375; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; Uetz P, 2014, TIGR REPTILE DATABAS; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027	34	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-5915	1432-0886		CHROMOSOMA	Chromosoma	DEC	2014	123	6					563	575		10.1007/s00412-014-0467-8		13	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	AT7RX	WOS:000345136100004		
J	Imai, T; Kuwahara, K; Nishihara, A; Nakagawa, T; Yamamoto, S; Honda, T; Miyamoto, T; Kochi, T; Eguchi, M; Uehara, A; Kuroda, R; Omoto, D; Nagata, T; Pham, NM; Kurotani, K; Nanri, A; Akter, S; Kabe, I; Mizoue, T; Sone, T; Dohi, S				Imai, Teppei; Kuwahara, Keisuke; Nishihara, Akiko; Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru; Miyamoto, Toshiaki; Kochi, Takeshi; Eguchi, Masafumi; Uehara, Akihiko; Kuroda, Reiko; Omoto, Daisuke; Nagata, Tomohisa; Ngoc Minh Pham; Kurotani, Kayo; Nanri, Akiko; Akter, Shamima; Kabe, Isamu; Mizoue, Tetsuya; Sone, Tomofumi; Dohi, Seitaro		Japan Epidemiol Collaboration	Association of overtime work and hypertension in a Japanese working population: A cross-sectional study	CHRONOBIOLOGY INTERNATIONAL			English	Article						Cross-sectional study; hypertension; Japan; long working hours	ACUTE MYOCARDIAL-INFARCTION; BODY-MASS INDEX; CORONARY-HEART-DISEASE; BLOOD-PRESSURE; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; EPIDEMIOLOGIC EVIDENCE; RISK-FACTORS; JOB STRAIN; METAANALYSIS	Long working hours have been associated with an increased risk of cardiovascular disease, but its relationship with hypertension remains unclear. The objective of this study is to examine the relationship between overtime and presence of hypertension using data from a large-scale multi-company study in Japan. Participants were 52 365 workers of four companies that provided both health-checkup data and self-reported data on overtime worked. Hypertension was defined as systolic blood pressure >= 140 mmHg, diastolic blood pressure >= 90 mmHg, and/or the use of antihypertensive drug. Logistic regression analysis was performed to determine the odds ratio for hypertension for each category of overtime work (<45, 45-79, 80-99 or >= 100 h/month) with adjustments for age, sex, company, smoking status and body mass index. The prevalence of hypertension tended to decrease with increasing overtime work: 17.5, 12.0, 11.1 and 9.1% for the shortest (<45 h/month) through the longest overtime category (>= 100 h/month). The age-, sex- and company-adjusted odds ratios (95% confidence interval) were 1.00 (reference), 0.81 (0.75-0.86), 0.73 (0.62-0.86), 0.58 (0.44-0.76), respectively (p for linear trend <0.001). In a sub-cohort, the inverse association remained statistically significant after an additional adjustment for other potential confounders. Results of the present large-scale study among Japanese workers suggest an inverse association between overtime work and presence of hypertension.	[Imai, Teppei; Nishihara, Akiko] Azbil Corp, Chiyoda Ku, Tokyo 1006419, Japan; [Kuwahara, Keisuke; Kurotani, Kayo; Nanri, Akiko; Akter, Shamima; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Tokyo, Japan; [Nakagawa, Tohru; Yamamoto, Shuichiro; Honda, Toru] Hitachi Ltd, Ibaraki, Japan; [Miyamoto, Toshiaki] Nippon Steel & Sumitomo Met Corp Kimitsu Works, Chiba, Japan; [Kochi, Takeshi; Eguchi, Masafumi; Kabe, Isamu] Furukawa Elect Corp, Tokyo, Japan; [Uehara, Akihiko] YAMAHA Corp, Shizuoka, Japan; [Kuroda, Reiko] Univ Tokyo, Div Environm Hlth & Safety, Tokyo, Japan; [Omoto, Daisuke] Mitsubishi Heavy Ind Co Ltd, Aichi, Japan; [Nagata, Tomohisa] Univ Occupat & Environm Hlth, Dept Occupat Hlth Practice & Management, Fukuoka, Japan; [Ngoc Minh Pham] Thai Nguyen Univ Med & Pharm, Fac Publ Hlth, Dept Epidemiol, Buon Ma Thuot, Thai Nguyen Pro, Vietnam; [Sone, Tomofumi] Natl Inst Publ Hlth, Director Planning & Coordinat, Saitama, Japan; [Dohi, Seitaro] Mitsui Chem Inc, Tokyo, Japan	Imai, T (reprint author), Azbil Corp, Chiyoda Ku, Tokyo Bldg,2-7-3 Marunouchi, Tokyo 1006419, Japan.	t.imai.pz@azbil.com			Industrial Health Foundation (Japan Epidemiology Collaboration on Occupational Health Study working group); Occupational Health Promotion Foundation	This research was supported by the Industrial Health Foundation (Japan Epidemiology Collaboration on Occupational Health Study working group) and a grant from the Occupational Health Promotion Foundation. The authors declare that no competing interests are present. TI, A Nishihara, T Nakagawa, SY, TH, T Miyamoto, TK, ME, AU, DO, IK, and SD are health professionals in the corporations.	Artazcoz L, 2009, J EPIDEMIOL COMMUN H, V63, P521, DOI 10.1136/jech.2008.082123; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Schluter PJ, 2012, INT J NURS STUD, V49, P701, DOI 10.1016/j.ijnurstu.2012.01.005; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Uchiyama S, 2005, J OCCUP HEALTH, V47, P102, DOI 10.1539/joh.47.102; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Nakanishi N, 2001, J EPIDEMIOL COMMUN H, V55, P316, DOI 10.1136/jech.55.5.316; Sokejima S, 1998, BRIT MED J, V317, P775; Hori A, 2014, CIRC J, V78, P1160, DOI 10.1253/circj.CJ-13-1067; Iwasaki K, 2006, IND HEALTH, V44, P537, DOI 10.2486/indhealth.44.537; Guo XF, 2013, SLEEP MED, V14, P324, DOI 10.1016/j.sleep.2012.12.001; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; Virtanen M, 2012, AM J EPIDEMIOL, V176, P586, DOI 10.1093/aje/kws139; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Wada K, 2006, OCCUP MED-OXFORD, V56, P578, DOI 10.1093/occmed/kql106; Cosgrove MP, 2012, OCCUP MED-OXFORD, V62, P167, DOI 10.1093/occmed/kqs002; Fukuoka Y, 2005, INT J CARDIOL, V100, P29, DOI 10.1016/j.ijcard.2004.04.003; Itani O, 2013, J OCCUP HEALTH, V55, P11; Kuwahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095732; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lee Sangheon, 2007, WORKING TIME WORLD T; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Nagai Michiaki, 2010, Curr Cardiol Rev, V6, P54, DOI 10.2174/157340310790231635; Nakamura K, 2012, AM J HYPERTENS, V25, P979, DOI 10.1038/ajh.2012.37; Pimenta AM, 2009, J HYPERTENS, V27, P34, DOI 10.1097/HJH.0b013e3283163c3c; Taris TW, 2011, INT J BEHAV MED, V18, P352, DOI 10.1007/s12529-010-9103-z; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Yang H, 2006, HYPERTENSION, V48, P744, DOI 10.1161/01.HYP.0000238327.41911.52	31	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.	DEC	2014	31	10					1108	1114		10.3109/07420528.2014.957298		7	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	AT9GY	WOS:000345237200003		
J	Richter, I; Behera, SK; Doi, T; Taguchi, B; Masumoto, Y; Xie, SP				Richter, Ingo; Behera, Swadhin K.; Doi, Takeshi; Taguchi, Bunmei; Masumoto, Yukio; Xie, Shang-Ping			What controls equatorial Atlantic winds in boreal spring?	CLIMATE DYNAMICS			English	Article						Equatorial Atlantic; Surface winds; Interannual variability; Atlantic Nino; Gill model; Lindzen-Nigam model; Bjerknes feedback; Double ITCZ	SEA-SURFACE TEMPERATURE; ATMOSPHERIC BOUNDARY-LAYER; TROPICAL PACIFIC; INTERANNUAL VARIABILITY; COLD-TONGUE; MODEL; OCEAN; GRADIENTS; BIASES; ENSO	The factors controlling equatorial Atlantic winds in boreal spring are examined using both observations and general circulation model (GCM) simulations from the coupled model intercomparison phase 5. The results show that the prevailing surface easterlies flow against the attendant pressure gradient and must therefore be maintained by other terms in the momentum budget. An important contribution comes from meridional advection of zonal momentum but the dominant contribution is the vertical transport of zonal momentum from the free troposphere to the surface. This implies that surface winds are strongly influenced by conditions in the free troposphere, chiefly pressure gradients and, to a lesser extent, meridional advection. Both factors are linked to the patterns of deep convection. Applying these findings to GCM errors indicates, that, consistent with the results of previous studies, the persistent westerly surface wind bias found in most GCMs is due mostly to precipitation errors, in particular excessive precipitation south of the equator over the ocean and deficient precipitation over equatorial South America. Free tropospheric influences also dominate the interannual variability of surface winds in boreal spring. GCM experiments with prescribed climatological sea-surface temperatures (SSTs) indicate that the free tropospheric influences are mostly associated with internal atmospheric variability. Since the surface wind anomalies in boreal spring are crucial to the development of warm SST events (Atlantic Ninos), the results imply that interannual variability in the region may rely far less on coupled air-sea feedbacks than is the case in the tropical Pacific.	[Richter, Ingo; Behera, Swadhin K.; Doi, Takeshi; Masumoto, Yukio] JAMSTEC, Res Inst Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Richter, Ingo; Behera, Swadhin K.; Doi, Takeshi] JAMSTEC, Applicat Lab, Yokohama, Kanagawa 2360001, Japan; [Taguchi, Bunmei] JAMSTEC, Earth Simulator Ctr, Yokohama, Kanagawa 2360001, Japan; [Xie, Shang-Ping] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Richter, I (reprint author), JAMSTEC, Res Inst Global Change, Kanazawa Ku, 3173-5 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	richter@jamstec.go.jp	Xie, Shang-Ping/C-1254-2009; Doi, Takeshi/C-1989-2013		NOAA	The authors thank the three anonymous reviewers for their constructive comments. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison which provides coordinating support and led development of software infrastructure for CMIP, and the climate modeling groups for making available their model output. SPX is supported by NOAA.	Ahlgrimm M, 2006, J ATMOS SCI, V63, P998, DOI 10.1175/JAS3669.1; Richter I, 2008, CLIM DYNAM, V31, P587, DOI 10.1007/s00382-008-0364-z; Chang CY, 2008, J CLIMATE, V21, P4766, DOI 10.1175/2008JCLI2138.1; Richter I, 2014, CLIM DYNAM, V42, P171, DOI 10.1007/s00382-012-1624-5; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Richter I, 2013, NAT GEOSCI, V6, P43, DOI [10.1038/ngeo1660, 10.1038/NGEO1660]; Chiang JCH, 2001, J ATMOS SCI, V58, P1371, DOI 10.1175/1520-0469(2001)058<1371:RROEHA>2.0.CO;2; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; Richter I, 2012, CLIM DYNAM, V38, P985, DOI 10.1007/s00382-011-1038-9; WALLACE JM, 1989, J CLIMATE, V2, P1492, DOI 10.1175/1520-0442(1989)002<1492:TIOSST>2.0.CO;2; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; Xie SP, 2004, GEOPHYS MONOGR SER, V147, P121; Davey MK, 2002, CLIM DYNAM, V18, P403, DOI 10.1007/s00382-001-0188-6; WALLACE JM, 1992, J CLIMATE, V5, P561, DOI 10.1175/1520-0442(1992)005<0561:SVDOWS>2.0.CO;2; Stevens B, 2002, J CLIMATE, V15, P30, DOI 10.1175/1520-0442(2002)015<0030:ERFABL>2.0.CO;2; EMANUEL KA, 1994, Q J ROY METEOR SOC, V120, P1111, DOI 10.1002/qj.49712051902; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1256/smsqj.44904; Xie SP, 2004, B AM METEOROL SOC, V85, P195, DOI 10.1175/BAMS-85-2-195; SERVAIN J, 1982, J PHYS OCEANOGR, V12, P457, DOI 10.1175/1520-0485(1982)012<0457:EORFIT>2.0.CO;2; Chan KM, 2013, J GEOPHYS RES-ATMOS, V118, P12422, DOI 10.1002/2013JD020147; DESER C, 1993, J CLIMATE, V6, P64, DOI 10.1175/1520-0442(1993)006<0064:DOTSMB>2.0.CO;2; Woodruff SD, 2011, INT J CLIMATOL, V31, P951, DOI 10.1002/joc.2103; Chelton DB, 2001, J CLIMATE, V14, P1479, DOI 10.1175/1520-0442(2001)014<1479:OOCBSW>2.0.CO;2; Sobel AH, 2000, J CLIMATE, V13, P4378, DOI 10.1175/1520-0442(2000)013<4378:MTPIAS>2.0.CO;2; Stockdale TN, 2006, J CLIMATE, V19, P6047, DOI 10.1175/JCLI3947.1; Chang CY, 2007, J CLIMATE, V20, P1053, DOI 10.1175/JCLI4047.1; Chang P, 2006, NATURE, V443, P324, DOI 10.1038/nature05053; Wahl S, 2011, CLIM DYNAM, V36, P891, DOI 10.1007/s00382-009-0690-9; Back LE, 2009, J CLIMATE, V22, P6477, DOI 10.1175/2009JCLI2393.1; Keenlyside NS, 2007, J CLIMATE, V20, P131, DOI 10.1175/JCLI3992.1; Back LE, 2009, J CLIMATE, V22, P4182, DOI 10.1175/2009JCLI2392.1; Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; de Szoeke SP, 2005, J ATMOS SCI, V62, P426, DOI 10.1175/JAS-3381.1; Dunbar S, 2006, D18053 JET PROP LAB; Foltz GR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045522; Lubbecke JF, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005964; Lubbecke JF, 2012, J CLIMATE, V25, P4294, DOI 10.1175/JCLI-D-11-00553.1; McGauley M, 2004, J CLIMATE, V17, P3907, DOI 10.1175/1520-0442(2004)017<3907:LCOTAB>2.0.CO;2; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; Okumura Y, 2004, J CLIMATE, V17, P3588; Philander S.G., 1990, INT GEOPHYS SERIES, V46; Richter I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044461; Tozuka T, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006717; ZEBIAK SE, 1993, J CLIMATE, V6, P1567, DOI 10.1175/1520-0442(1993)006<1567:AIITEA>2.0.CO;2; Zermeno-Diaz DM, 2013, J CLIMATE, V26, P8154, DOI 10.1175/JCLI-D-12-00226.1	47	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	DEC	2014	43	11			SI		3091	3104		10.1007/s00382-014-2170-0		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AT3UY	WOS:000344862200012		
J	Maeda, TM; Kimura, CK; Takahashi, KT; Ichimura, KI				Maeda, T. M.; Kimura, C. K.; Takahashi, K. T.; Ichimura, K. I.			Increase in skin perfusion pressure after maggot debridement therapy for critical limb ischaemia	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Article							LARVAE	Skin perfusion pressure (SPP) is the perfusion pressure at the skin level, and it can serve as an index of peripheral circulation in the skin and subcutaneous tissue. We report a 78-year-old man with critical limb ischaemia who, despite having undergone several catheter interventions, still had severe ulcers with exposed bone on his right foot. We performed transmetatarsal amputation. The tissue around the surgical site became necrotic several days later, and did not respond to conservative therapy. Therefore, we opted for maggot debridement therapy (MDT), given that maggots favour necrotic tissue. After the therapy, SPP around the ulcer increased from 12 to 54mmHg on the dorsal aspect, and from 17 to 44mmHg on the plantar aspect. Wound healing was successfully activated by MDT, leading to complete healing within 2.5months after MDT. We believe that MDT probably contributed to increase the blood supply to the ischaemic wound.	[Maeda, T. M.; Kimura, C. K.; Takahashi, K. T.] Hakodate Gen Cent Hosp, Dept Plast & Reconstruct Surg, Hakodate, Hokkaido, Japan; [Ichimura, K. I.] Hokkaido Univ Hosp, Dept Plast & Reconstruct Surg, Sapporo, Hokkaido 060, Japan	Maeda, TM (reprint author), Hakodate Gen Cent Hosp, Dept Plast & Reconstruct Surg, 33-2 Honmachi, Hakodate, Hokkaido, Japan.	takumaeda1105@yellow.plala.or.jp					Mumcuoglu KY, 2001, J MED ENTOMOL, V38, P161, DOI 10.1603/0022-2585-38.2.161; Bexfield A, 2010, BRIT J DERMATOL, V162, P554, DOI 10.1111/j.1365-2133.2009.09530.x; Dumville JC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b773; Igari Kimihiro, 2013, Ann Vasc Dis, V6, P145, DOI 10.3400/avd.oa.13-00036; Malvezzi L, 1992, J VASC SURG, V15, P9; MALVEZZI L, 1992, J VASC SURG, V15, P823; Mumcuoglu K Y, 2001, Am J Clin Dermatol, V2, P219, DOI 10.2165/00128071-200102040-00003; Nordstrom A, 2009, CLIN EXP DERMATOL, V34, pE683, DOI 10.1111/j.1365-2230.2009.03405.x; SHERMAN RA, 1988, MED VET ENTOMOL, V2, P225, DOI 10.1111/j.1365-2915.1988.tb00188.x; Zhang Z, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-24	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	DEC	2014	39	8					911	914		10.1111/ced.12454		4	Dermatology	Dermatology	AT9DB	WOS:000345227100010		
J	Matsushita, A; Seike, M; Hagiwara, T; Sato, A; Ohtsu, H				Matsushita, A.; Seike, M.; Hagiwara, T.; Sato, A.; Ohtsu, H.			Close relationship between T helper (Th)17 and Th2 response in murine allergic contact dermatitis	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Article							IL-17-DEFICIENT MICE; CELLS; IL-17; EXPRESSION; RECEPTOR; HYPERSENSITIVITY; INTERLEUKIN-17; KERATINOCYTES; ELICITATION; SUPPRESSION	BackgroundRepeated exposure to allergens induces chronic allergic lesions in the skin and a shift in the cutaneous cytokine milieu to T helper (Th)2. AimTo assess the relationships between Th17 and Th2 response during allergic contact dermatitis (ACD) in mice. MethodsACD was induced in C57BL/6 mice by single or repeated epicutaneous challenge of 2,4,6-trinitro-1-chlorobenzene. Relationships between Th17 and Th2 response were analyzed by immunohistochemical observations and activity of cytokines on days 8 (first challenge), 18 (11th challenge), 28 (21st challenge) and 38 (31st challenge). ResultsOn day 8, tissue levels of interleukin (IL)-17 and IL-22 were high, whereas tissue levels of IL-4 and serum IgE concentration were low. Following acute contact dermatitis, mice developed chronic eczematous lesions on day 18, and gradually improved on days 28 and 38. Tissue IL-4 and serum IgE levels corresponded to the development and improvement of chronic eczematous lesions. Numbers of Th17 cells and tissue levels of IL-17 and IL-22 rapidly decreased as IL-4 and IgE levels increased on day 18. As levels of IL-4 and IgE decreased, the number of Th17 cells and tissue levels of IL-17 and IL-22 increased again on days 28 and 38. On day 18, tissue levels of Th17 response-inducing cytokines (IL-6, IL-23 and transforming growth factor-) were high, and IL-23-expressing cells appeared in abundance, when Th2 response was extremely high. IL-17 injection decreased tissue IL-4 and serum IgE levels. ConclusionsTh17 correlates closely with Th2 in murine chronic ACD induced by repeated epicutaneous challenge.	[Matsushita, A.; Seike, M.; Hagiwara, T.] Sagami Womens Jr Coll, Dept Food & Nutr Sci, Sagamihara, Kanagawa 2520383, Japan; [Sato, A.; Ohtsu, H.] Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 980, Japan	Seike, M (reprint author), Sagami Womens Jr Coll, Dept Food & Nutr Sci, Bunkyo Ku, Minami Ku, Sagamihara, Kanagawa 2520383, Japan.	m-seike@star.sagami-wu.ac.jp			Ministry of Education, Science and Culture of Japan	This work was supported by a grant-in-aid from the Ministry of Education, Science and Culture of Japan.	Komiyama Y, 2006, J IMMUNOL, V177, P566; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Hsieh ST, 1996, J NEUROCYTOL, V25, P513, DOI 10.1007/BF02284819; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107; Kitagaki H, 1997, J IMMUNOL, V159, P2484; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402; Seike M, 2010, ALLERGY, V65, P319, DOI 10.1111/j.1398-9995.2009.02240.x; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Nakae S, 2003, J IMMUNOL, V171, P6173; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; NIKAEIN A, 1991, J INVEST DERMATOL, V96, P3, DOI 10.1111/1523-1747.ep12514646; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	DEC	2014	39	8					924	931		10.1111/ced.12425		8	Dermatology	Dermatology	AT9DB	WOS:000345227100014		
J	Moriuchi, R; Kikuchi, K; Ito, T; Shimizu, S				Moriuchi, R.; Kikuchi, K.; Ito, T.; Shimizu, S.			Acquired plantar port-wine stain showing a red parallel ridge pattern under dermoscopy	CLINICAL AND EXPERIMENTAL DERMATOLOGY			English	Letter									[Moriuchi, R.; Kikuchi, K.; Ito, T.; Shimizu, S.] Sapporo City Gen Hosp, Dept Dermatol, Chuo Ku, Sapporo, Hokkaido 0608604, Japan	Moriuchi, R (reprint author), Sapporo City Gen Hosp, Dept Dermatol, Chuo Ku, North 11,West 13, Sapporo, Hokkaido 0608604, Japan.	parallelridge@yahoo.co.jp					Abe R, 2010, J DERMATOL SCI, V57, P183, DOI 10.1016/j.jdermsci.2009.12.010; Saida T, 2004, ARCH DERMATOL, V140, P1233, DOI 10.1001/archderm.140.10.1233; Bernabeu-Wittel J, 2011, J AM ACAD DERMATOL, V65, P238, DOI 10.1016/j.jaad.2009.12.043; Tanioka M, 2011, J DERMATOL, V38, P41, DOI 10.1111/j.1346-8138.2010.01128.x; Toyonaga E, 2013, JAMA DERMATOL, V149, P109, DOI 10.1001/archdermatol.2012.3201	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6938	1365-2230		CLIN EXP DERMATOL	Clin. Exp. Dermatol.	DEC	2014	39	8					944	945		10.1111/ced.12409		2	Dermatology	Dermatology	AT9DB	WOS:000345227100016		
J	Ozarda, Y; Ichihara, K; Aslan, D; Aybek, H; Ari, Z; Taneli, F; Coker, C; Akan, P; Sisman, AR; Bahceci, O; Sezgin, N; Demir, M; Yucel, G; Akbas, H; Ozdem, S; Polat, G; Erbagci, AB; Orkmez, M; Mete, N; Evliyaoglu, O; Kiyici, A; Vatansev, H; Ozturk, B; Yucel, D; Kayaalp, D; Dogan, K; Pinar, A; Gurbilek, M; Cetinkaya, CD; Akin, O; Serdar, M; Kurt, I; Erdinc, S; Kadicesme, O; Ilhan, N; Atali, DS; Bakan, E; Polat, H; Noyan, T; Can, M; Bedir, A; Okuyucu, A; Deger, O; Agac, S; Ademoglu, E; Kaya, A; Nogay, T; Eren, N; Dirican, M; Tuncer, G; Aykus, M; Gunes, Y; Ozmen, SU; Kawano, R; Tezcan, S; Demirpence, O; Degirmen, E				Ozarda, Yesim; Ichihara, Kiyoshi; Aslan, Diler; Aybek, Hulya; Ari, Zeki; Taneli, Fatma; Coker, Canan; Akan, Pinar; Sisman, Ali Riza; Bahceci, Onur; Sezgin, Nurzen; Demir, Meltem; Yucel, Gultekin; Akbas, Halide; Ozdem, Sebahat; Polat, Gurbuz; Erbagci, Ayse Binnur; Orkmez, Mustafa; Mete, Nuriye; Evliyaoglu, Osman; Kiyici, Aysel; Vatansev, Husamettin; Ozturk, Bahadir; Yucel, Dogan; Kayaalp, Damla; Dogan, Kubra; Pinar, Asli; Gurbilek, Mehmet; Cetinkaya, Cigdem Damla; Akin, Okhan; Serdar, Muhittin; Kurt, Ismail; Erdinc, Selda; Kadicesme, Ozgur; Ilhan, Necip; Atali, Dilek Sadak; Bakan, Ebubekir; Polat, Harun; Noyan, Tevfik; Can, Murat; Bedir, Abdulkerim; Okuyucu, Ali; Deger, Orhan; Agac, Suret; Ademoglu, Evin; Kaya, Aysem; Nogay, Turkan; Eren, Nezaket; Dirican, Melahat; Tuncer, GulOzlem; Aykus, Mehmet; Gunes, Yeliz; Ozmen, Sevda Unalli; Kawano, Reo; Tezcan, Sehavet; Demirpence, Ozlem; Degirmen, Elif			A multicenter nationwide reference intervals study for common biochemical analytes in Turkey using Abbott analyzers	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						biochemical parameters; common reference intervals; multicenter study; regional differences; Turkey	APPROVED RECOMMENDATION 1987; HIGH-DENSITY-LIPOPROTEINS; ELEVATED HEPATIC LIPASE; REFERENCE VALUES; WORLDWIDE MULTICENTER; SERUM CREATININE; POPULATION	Background: A nationwide multicenter study was organized to establish reference intervals (RIs) in the Turkish population for 25 commonly tested biochemical analytes and to explore sources of variation in reference values, including regionality. Methods: Blood samples were collected nationwide in 28 laboratories from the seven regions (>= 400 samples/region, 3066 in all). The sera were collectively analyzed in Uludag University in Bursa using Abbott reagents and analyzer. Reference materials were used for standardization of test results. After secondary exclusion using the latent abnormal values exclusion method, RIs were derived by a parametric method employing the modified Box-Cox formula and compared with the RIs by the non-parametric method. Three-level nested ANOVA was used to evaluate variations among sexes, ages and regions. Associations between test results and age, body mass index (BMI) and region were determined by multiple regression analysis (MRA). Results: By ANOVA, differences of reference values among seven regions were significant in none of the 25 analytes. Significant sex-related and age-related differences were observed for 10 and seven analytes, respectively. MRA revealed BMI-related changes in results for uric acid, glucose, triglycerides, high-density lipoprotein (HDL)-cholesterol, alanine aminotransferase, and.-glutamyltransferase. Their RIs were thus derived by applying stricter criteria excluding individuals with BMI >28 kg/m(2). Ranges of RIs by non-parametric method were wider than those by parametric method especially for those analytes affected by BMI. Conclusions: With the lack of regional differences and the well-standardized status of test results, the RIs derived from this nationwide study can be used for the entire Turkish population.	[Ichihara, Kiyoshi; Kawano, Reo] Yamaguchi Univ, Grad Sch Med, Dept Lab Sci, Fac Hlth Sci, Ube, Yamaguchi 755, Japan; [Aslan, Diler; Aybek, Hulya] Pamukkale Univ, Sch Med, Dept Med Biochem, Denizli, Turkey; [Ari, Zeki; Taneli, Fatma] Celal Bayar Univ, Sch Med, Dept Med Biochem, Manisa, Turkey; [Coker, Canan; Akan, Pinar; Sisman, Ali Riza] Dokuz Eylul Univ, Sch Med, Dept Med Biochem, Izmir, Turkey; [Bahceci, Onur] Servergazi State Hosp, Denizli, Turkey; [Sezgin, Nurzen] Baskent Univ, Adana Res Ctr, Adana, Turkey; [Demir, Meltem] Medicalpk Hosp, Antalya, Turkey; [Yucel, Gultekin; Akbas, Halide; Ozdem, Sebahat] Akdeniz Univ, Sch Med, Dept Med Biochem, TR-07058 Antalya, Turkey; [Polat, Gurbuz] Mersin Univ, Sch Med, Dept Med Biochem, Mersin, Turkey; [Erbagci, Ayse Binnur; Orkmez, Mustafa] Gaziantep Univ, Sch Med, Dept Med Biochem, Gaziantep, Turkey; [Mete, Nuriye; Evliyaoglu, Osman] Dicle Univ, Sch Med, Dept Med Biochem, Diyarbakir, Turkey; [Kiyici, Aysel; Vatansev, Husamettin; Ozturk, Bahadir] Selcuk Univ, Sch Med, Dept Med Biochem, Konya, Turkey; [Yucel, Dogan; Kayaalp, Damla; Dogan, Kubra] Ankara Teaching & Res Hosp, Ankara, Turkey; [Pinar, Asli] Hacettepe Univ, Sch Med, Dept Med Biochem, Ankara, Turkey; [Gurbilek, Mehmet; Cetinkaya, Cigdem Damla] Necmettin Erbakan Univ, Sch Med, Dept Med Biochem, Konya, Turkey; [Akin, Okhan] Kecioren Teaching & Res Hosp, Ankara, Turkey; [Serdar, Muhittin; Kurt, Ismail] Gulhane Mil Med Acad, Dept Med Biochem, Ankara, Turkey; [Erdinc, Selda; Kadicesme, Ozgur] Kars State Hosp, Kars, Turkey; [Ilhan, Necip; Atali, Dilek Sadak] Invitrolab Lab, Elazig, Turkey; [Bakan, Ebubekir; Polat, Harun] Ataturk Univ, Sch Med, Dept Med Biochem, Erzurum, Turkey; [Noyan, Tevfik] Ordu Univ, Dept Med Biochem, Sch Med, Ordu, Turkey; [Can, Murat] Bulent Ecevit Univ, Dept Med Biochem, Sch Med, Zonguldak, Turkey; [Bedir, Abdulkerim; Okuyucu, Ali] Ondokuz Mayis Univ, Dept Med Biochem, Sch Med, Samsun, Turkey; [Deger, Orhan; Agac, Suret] Karadeniz Teknik Univ, Sch Med, Dept Med Biochem, Trabzon, Turkey; [Ademoglu, Evin; Kaya, Aysem] Istanbul Univ, Inst Cardiol, Istanbul, Turkey; [Nogay, Turkan] Luleburgaz State Hosp, Kirklareli, Turkey; [Eren, Nezaket] Sisli Etfal Teaching & Res Hosp, Istanbul, Turkey; [Ozarda, Yesim; Dirican, Melahat; Tuncer, GulOzlem; Aykus, Mehmet; Gunes, Yeliz; Ozmen, Sevda Unalli] Uludag Univ, Sch Med, Dept Med Biochem, Bursa, Turkey; [Tezcan, Sehavet; Demirpence, Ozlem; Degirmen, Elif] Batman Reg Hosp, Batman, Turkey	Ozarda, Y (reprint author), Uludag Univ, Sch Med, Dept Med Biochem, Bursa, Turkey.	yesim@uludag.edu.tr	Serdar, Muhittin/D-2493-2015; Vatansev, Husamettin/P-9097-2014; 	Evliya, Osman/0000-0002-5780-9068	Uludag Universty [UAP(T)-2011/48]; IFCC C-RIDL; Japan Society for the Promotion of Science [24256003:2012-2014]; Abbott Diagnostics; Becton Dickinson	This study was supported by Research Fund of Uludag Universty (UAP(T)-2011/48), IFCC C-RIDL, Scientific Research Fund (No: 24256003:2012-2014) provided by the Japan Society for the Promotion of Science, Abbott Diagnostics and Becton Dickinson. We had invaluable input from the IFCC C-RIDL and the Turkish National Biochemical Association. We are very grateful to Uludag University Central Laboratory, We are thankful to David Ambruster from Abbott Diagnostics for his kind cooperation to realize this study. The final manuscript was edited with generous support by Prof. A. Myron Johnson.	SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P645; Onat A, 2012, NUTR METAB CARDIOVAS, V22, P643, DOI 10.1016/j.numecd.2010.10.010; Ichihara K, 2014, CLIN CHIM ACTA, V432, P108, DOI 10.1016/j.cca.2014.01.025; Mahley RW, 2005, AM J CARDIOL, V96, P547, DOI 10.1016/j.amjcard.2005.04.018; Onat A, 2001, ATHEROSCLEROSIS, V156, P1, DOI 10.1016/S0021-9150(01)00500-7; Ilcol YO, 2006, CLIN CHEM LAB MED, V44, P867, DOI 10.1515/CCLM.2006.139; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Bersot TP, 1999, J LIPID RES, V40, P432; Inal TC, 2010, CROAT MED J, V51, P124, DOI 10.3325/cmj.2010.51.124; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Wang XJ, 2011, CLIN CHIM ACTA, V412, P1793, DOI 10.1016/j.cca.2011.05.033; Ceriotti F, 2009, ANN CLIN BIOCHEM, V46, P8, DOI 10.1258/acb.2008.008170; Ceriotti F, 2010, CLIN CHEM LAB MED, V48, P1593, DOI 10.1515/CCLM.2010.315; [Anonymous], 2012, 151892012 ISO; MAHLEY RW, 1995, J LIPID RES, V36, P839; Ceriotti F, 2008, CLIN CHEM, V54, P1261; Ceriotti Ferruccio, 2007, Clin Biochem Rev, V28, P115; Ceriotti F, 2009, CLIN BIOCHEM, V42, P297, DOI 10.1016/j.clinbiochem.2008.09.017; CLSI and IFCC, 2008, C28P3 CLSI, V28, P1; DYBKAER R, 1987, J CLIN CHEM CLIN BIO, V25, P657; Ichihara K, 2013, CLIN CHEM LAB MED, V51, P1007, DOI 10.1515/cclm-2013-0248; Ichihara K, 2010, CLIN CHEM LAB MED, V48, P1537, DOI 10.1515/CCLM.2010.319; Ichihara K, 2013, CLIN CHEM LAB MED, V48, P1593; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; Koseoglu M, 2004, TURK J BIOCHEM, V35, P215; Lo YC, 2012, EJIFCC; Mahley RW, 2000, J LIPID RES, V41, P1290; Martensson A, 2004, SCAND J CLIN LAB INV, V64, P439, DOI 10.1080/00365510410002832; Mazzachi B C, 2000, Clin Lab, V46, P53; Ozarda Ilcol Y, 2004, TURK J BIOCHEM, V29, P183; Ozarda Y, 2009, CELL BIOCHEM FUNCT, V27, P568, DOI 10.1002/cbf.1610; Ozarda Y, 2013, CLIN CHEM LAB MED, V51, P1027, DOI 10.1515/cclm-2013-0249; Petit Clerc C, 1987, CLIN CHIM ACTA, V170, pS1, DOI 10.1016/0009-8981(87)90150-1; Petit Clerc C, 1987, CLIN BIOCHEM, V25, P337; SOLBERG HE, 1988, J CLIN CHEM CLIN BIO, V26, P593; SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P337; SOLBERG HE, 1991, EUR J CLIN CHEM CLIN, V29, P531; Yadav D, 2013, CLIN CHIM ACTA, V426, P145, DOI 10.1016/j.cca.2013.06.004; Yamamato Y, 2013, CLIN CHEM LAB MED, V51, P1	40	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	DEC	2014	52	12					1823	1833		10.1515/cclm-2014-0228		11	Medical Laboratory Technology	Medical Laboratory Technology	AT6BK	WOS:000345023500026		
J	Iida, Y; Kawai, K; Tsuno, NH; Ishihara, S; Yamaguchi, H; Sunami, E; Kitayama, J; Watanabe, T				Iida, Yuuki; Kawai, Kazushige; Tsuno, Nelson H.; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki			Proximal Shift of Colorectal Cancer Along With Aging	CLINICAL COLORECTAL CANCER			English	Article						Adenoma; Elderly; Gender; Proximal colon	COLON-CANCER; MICROSATELLITE INSTABILITY; AGE; CARCINOGENESIS; ESTROGEN; TRENDS; RISK; BILE; EXPRESSION; HORMONES	This study reviewed 1059 patients with colorectal cancers (CRCs) to evaluate the age-related changes in the clinicopathologic features, according to the gender. The presence of concomitant adenoma was the only independent age-related factor in men (P = .0044), whereas the presence of right-sided CRC was the only one in women (P < .0001). The results suggest the oncologic background difference between men and women among the elderly. Introduction: Although several reports have documented the increased incidence of right-sided colorectal cancer (CRC) in the elderly, especially in women, the gender-specific, age-related changes in the characteristics of CRCs, especially related to the cancer localization, have not been fully investigated. This study evaluated the age-related changes in the clinicopathologic features of CRCs, according to the gender. Materials and Methods: A total of 1059 consecutive patients with CRCs who were admitted to the authors' surgical department between February 2005 and June 2012 were retrospectively reviewed. The patients were divided into male (n = 632) and female (n = 427) groups and then according to the age group, and the correlation between the age group and the other clinicopathologic features was analyzed by univariate and multivariate analysis. Results: The number of concomitant adenomas found was significantly increased along with increasing age in men, and the presence of concomitant adenoma was the only independent age-related factor of male CRC in the multivariate analysis (P = .0044). In contrast, in women, the location of the CRC progressively shifted to the right side (proximal colon) with increasing age, and the presence of right-sided CRC was the only independent factor of female CRC in the multivariate analysis (P < .0001). Conclusion: There was a significant gender-specific difference in the age-related changes in the characteristics of CRC. Increasing the number of concomitant adenomas and the shift of CRC localization to the proximal colon were the gender-specific characteristics of male and female CRC, respectively.	[Iida, Yuuki; Kawai, Kazushige; Ishihara, Soichiro; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg Oncol, Tokyo 1138655, Japan; [Tsuno, Nelson H.] Univ Tokyo, Fac Med, Dept Transfus Med, Tokyo 1138655, Japan	Iida, Y (reprint author), Univ Tokyo, Fac Med, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yiida-tky@umin.ac.jp					Newcomb PA, 2008, ADV EXP MED BIOL, V617, P259, DOI 10.1007/978-0-387-69080-3_24; Okamoto M, 2002, GASTROINTEST ENDOSC, V55, P548, DOI 10.1067/mge.2002.122335; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Singh H, 2008, AM J GASTROENTEROL, V103, P1249, DOI 10.1111/j.1572-0241.2007.01726.x; Arai T, 2007, PATHOL INT, V57, P303, DOI 10.1111/j.1440-1827.2007.02101.x; Debruyne PR, 2001, MUTAT RES-FUND MOL M, V480, P359, DOI 10.1016/S0027-5107(01)00195-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI 10.1053/j.gastro.2009.12.064; Barnes EL, 2012, CLIMACTERIC, V15, P250, DOI 10.3109/13697137.2012.659450; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Papaxoinis K, 2010, EUR J GASTROEN HEPAT, V22, P614, DOI 10.1097/MEG.0b013e328335ef50; McCashland TM, 2001, AM J GASTROENTEROL, V96, P882; Kakar S, 2003, CANCER, V97, P1421, DOI 10.1002/cncr.11206; MCMICHAEL AJ, 1980, J NATL CANCER I, V65, P1201; MCMICHAEL AJ, 1985, J NATL CANCER I, V75, P185; LYNN J, 1973, ANN SURG, V178, P514, DOI 10.1097/00000658-197310000-00014; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Arai T, 2000, J CLIN GASTROENTEROL, V31, P67, DOI 10.1097/00004836-200007000-00016; Gervaz P, 2004, J SURG ONCOL, V88, P261, DOI 10.1002/jso.20156; Henderson KD, 2010, AM J EPIDEMIOL, V171, P415, DOI 10.1093/aje/kwp434; Ito Y, 2012, JPN J CLIN ONCOL, V42, P974, DOI 10.1093/jjco/hys132; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321; Shah AB, 2012, ANZ J SURG, V82, P258, DOI 10.1111/j.1445-2197.2011.05995.x; Sobin LH, 2010, TNM CLASSIFICATION M	25	1	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1533-0028	1938-0674		CLIN COLORECTAL CANC	Clin. Colorectal Canc.	DEC	2014	13	4					213	218		10.1016/j.clcc.2014.06.005		6	Oncology	Oncology	AT8RP	WOS:000345200100002		
J	Tokoro, T; Okuno, K; Hida, J; Ueda, K; Yoshifuji, T; Daito, K; Sugiura, F				Tokoro, Tadao; Okuno, Kiyotaka; Hida, Jin-chi; Ueda, Kazuki; Yoshifuji, Takehito; Daito, Koji; Sugiura, Fumiaki			Prognostic Factors for Patients With Advanced Colorectal Cancer and Symptomatic Brain Metastases	CLINICAL COLORECTAL CANCER			English	Article						Intracerebral metastases; Prognosis; Systemic chemotherapy; Recursive partitioning analysis; Stereotactic surgery	RADIATION-THERAPY; CARCINOMA; SURVIVAL; RADIOSURGERY; MANAGEMENT; TUMORS; COLON	Patients with advanced colorectal cancer (CRC) have increased risks of brain metastases (BMs), which are associated with poor clinical outcomes. In a study of 25 patients with multiple brain lesions, we identified prognostic factors relevant to local treatment for BMs. After BMs onset, continued systemic chemotherapy might improve survival in cases of advanced CRC. Background: Increased rates of long-term survival after CRC diagnosis are accompanied by increases in the incidence of BMs. Here, we retrospectively evaluated the outcomes of patients with BMs from CRC. Materials and Methods: We reviewed the records of 1364 patients with CRC treated between January 1999 and December 2010 at Kinki University Hospital in Japan. Twenty-five of these patients developed BMs. Log-rank tests and Cox regression analyses were used to assess potential prognostic factors for survival. Results: Among the patients with BMs, BMs developed a median of 25.3 (range, 11.4-111) months after primary CRC surgery. There was a median of 2 BMs per patient. Eleven patients had solitary BMs. Concomitant extracerebral metastases, particularly lung metastases, were found in 23 patients. Twenty-three patients were receiving systemic chemotherapy at the time of diagnosis with BMs. After the development of BMs, the median survival time (MST) was 2.8 months. The MST was 4.8 months among patients who underwent neurosurgical resection (n = 6) or stereotactic surgery (n = 9, including combined therapy in 2 patients) and 1.5 months among patients who underwent whole-brain radiotherapy only or best supportive care (n = 12). In multivariate analysis, single BMs and additional systemic chemotherapy after BMs diagnosis were significantly associated with overall survival (P = .022 and .023, respectively). Conclusion: Our results suggest that advancements in continuing systemic chemotherapy prolong survival among patients with BMs from CRC. Clinicians should be especially aware of BMs in patients with lung metastases.	[Tokoro, Tadao; Okuno, Kiyotaka; Hida, Jin-chi; Ueda, Kazuki; Yoshifuji, Takehito; Daito, Koji; Sugiura, Fumiaki] Kinki Univ, Fac Med, Dept Surg, Osaka, Japan	Tokoro, T (reprint author), 377-2 Oohono Higashi, Osaka 5898511, Japan.	tokoro@surg.med.kindai.ac.jp					Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Nieder C, 2009, ONCOLOGY-BASEL, V76, P369, DOI 10.1159/000210026; Alden TD, 1996, DIS COLON RECTUM, V39, P541, DOI 10.1007/BF02058708; Aprile G, 2009, J CANCER RES CLIN, V135, P451, DOI 10.1007/s00432-008-0468-1; Farnell GF, 1996, CANCER, V78, P711, DOI 10.1002/(SICI)1097-0142(19960815)78:4<711::AID-CNCR3>3.0.CO;2-H; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Golden DW, 2008, J NEUROSURG, V109, P77, DOI 10.3171/JNS/2008/109/12/S13; Jung M, 2011, J NEURO-ONCOL, V101, P49, DOI 10.1007/s11060-010-0214-9; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Mege D, 2013, ANTICANCER RES, V33, P5645; Ko FC, 1999, DIS COLON RECTUM, V42, P1467, DOI 10.1007/BF02235049; NOORDIJK EM, 1994, INT J RADIAT ONCOL, V29, P711; Tan WS, 2009, WORLD J SURG, V33, P817, DOI 10.1007/s00268-009-9919-3; Noura S, 2012, J SURG ONCOL, V106, P144, DOI 10.1002/jso.23055; Kruser TJ, 2008, CANCER, V113, P158, DOI 10.1002/cncr.23531; Schouten LJ, 2002, CANCER, V94, P2698, DOI 10.1002/cncr.10541; Amichetti M, 2005, TUMORI, V91, P163; FLOYD CE, 1966, ANN SURG, V163, P829, DOI 10.1097/00000658-196606000-00003; PATCHELL RA, 1990, NEW ENGL J MED, V322, P494, DOI 10.1056/NEJM199002223220802; Hammoud MA, 1996, ANN SURG ONCOL, V3, P453, DOI 10.1007/BF02305763; Go PH, 2011, CANCER-AM CANCER SOC, V117, P3630, DOI 10.1002/cncr.25940; CAIRNCROSS JG, 1980, ANN NEUROL, V7, P529, DOI 10.1002/ana.410070606; Fabi A, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-10; Fokas E, 2011, CLIN COLORECTAL CANC, V10, P121, DOI 10.1016/j.clcc.2011.03.009; Jamal A, 2009, CA-CANCER J CLIN, V59, P225; Sobin LH, 2009, TNM CLASSIFICATION M; Sundermeyer Mark L, 2005, Clin Colorectal Cancer, V5, P108, DOI 10.3816/CCC.2005.n.022; Suzuki Y, 2013, DIS COLON RECTUM, V57, P56; Tillibert S, 2005, CURR OPIN ONCOL, V17, P588; WINSTON KR, 1980, CANCER, V45, P2639, DOI 10.1002/1097-0142(19800515)45:10<2639::AID-CNCR2820451025>3.0.CO;2-O	30	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1533-0028	1938-0674		CLIN COLORECTAL CANC	Clin. Colorectal Canc.	DEC	2014	13	4					226	231		10.1016/j.clcc.2014.09.008		6	Oncology	Oncology	AT8RP	WOS:000345200100004		
J	Sato, Y; Tsujikawa, T; Oh, M; Mori, T; Kiyono, Y; Fujieda, S; Kimura, H; Okazawa, H				Sato, Yoshitaka; Tsujikawa, Tetsuya; Oh, Myungmi; Mori, Tetsuya; Kiyono, Yasushi; Fujieda, Shigeharu; Kimura, Hirohiko; Okazawa, Hidehiko			Assessing Tumor Hypoxia in Head and Neck Cancer by PET With Cu-62-Diacetyl-Bis(N-4-Methylthiosemicarbazone)	CLINICAL NUCLEAR MEDICINE			English	Article						tumor hypoxia; PET; Cu-62-ATSM; head and neck cancer	POSITRON-EMISSION-TOMOGRAPHY; MODULATED RADIATION-THERAPY; TISSUE OXYGENATION; CERVICAL-CANCER; LUNG-CANCER; CU-ATSM; IN-VIVO; CU-64-ATSM; CU-60-ATSM; TRACER	Purpose: The aim of this study was to investigate the potential of PET imaging with a hypoxia-selective tracer Cu-62-diacetyl-bis(N-4-methylthiosemicarbazone) (Cu-62-ATSM) for evaluating the prognosis of patients with head and neck cancer (HNC). Methods: Twenty-five patients with HNC including stage II to IV underwent both Cu-62-ATSM and F-18-FDG PET before the initiation of treatment. Volumes of interest were placed on the tumor and sternocleidomastoid muscles to obtain SUVmax and to calculate the tumor-to-muscle activity ratio (TMR). The PET results were correlated with clinical follow-up, and the receiver operating characteristic analysis was used to determine the optimal cutoff values. Progression-free survival (PFS) and cause-specific survival (CSS) were statistically analyzed. Results: Patients were followed up for periods ranging from 4 to 32 months. Twelve patients died from local recurrence or metastasis of a primary cancer, and 2 had recurrence of the 13 remaining patients. Mean (SD) periods of PFS and CSS were 15.5 (12.5) and 18.6 (11.0) months, respectively. Optimal cutoff values for each PET index were as follows: SUVs of Cu-62-ATSM (SUVATSM) and FDG were 3.6 and 7.9; TMRs of ATSM (TMRATSM) and FDG were 3.2 and 5.6. When the cutoff for TMRATSM was set at 3.2, patients with a greater TMRATSM had significantly worse PFS (P = 0.014) and CSS (P = 0.031). Two-year PFS and CSS rates were 73% and 80% for patients with a lower TMRATSM (<= 3.2); however, they were 20% and 33% for those with hypoxic tumors (TMRATSM, >3.2), respectively. F-18-FDG-related indices did not show any significant difference in either PFS or CSS. Conclusions: Pretreatment Cu-62-ATSM PET is useful for predicting the prognosis of patients with HNC.	[Sato, Yoshitaka; Tsujikawa, Tetsuya; Mori, Tetsuya; Kiyono, Yasushi; Okazawa, Hidehiko] Univ Fukui, Biomed Imaging Res Ctr, Fac Med Sci, Fukui 910Y1193, Japan; [Sato, Yoshitaka; Kimura, Hirohiko] Univ Fukui, Dept Radiol, Fac Med Sci, Fukui 910Y1193, Japan; [Oh, Myungmi; Fujieda, Shigeharu] Univ Fukui, Dept Otolaryngol, Fac Med Sci, Fukui 910Y1193, Japan	Tsujikawa, T (reprint author), Univ Fukui, Biomed Imaging Res Ctr, 23-3 Matsuoka Shimoaizuki,Eiheiji Cho, Fukui 910Y1193, Japan.	awaji@u-fukui.ac.jp			Japan Society for the Promotion of Science [21390342, 24249065]; Japan Advances Molecular Imaging Program	Supported by the grants-in-aid for scientific research from the Japan Society for the Promotion of Science (21390342, 24249065) and the Japan Advances Molecular Imaging Program.	Adam MF, 1999, HEAD NECK-J SCI SPEC, V21, P146, DOI 10.1002/(SICI)1097-0347(199903)21:2<146::AID-HED8>3.0.CO;2-U; Dehdashti F, 2003, EUR J NUCL MED MOL I, V30, P844, DOI 10.1007/s00259-003-1130-4; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Minagawa Y, 2011, ANN NUCL MED, V25, P339, DOI 10.1007/s12149-011-0471-5; Dietz DW, 2008, DIS COLON RECTUM, V51, P1641, DOI 10.1007/s10350-008-9420-3; Chao KSC, 2001, INT J RADIAT ONCOL, V49, P1171, DOI 10.1016/S0360-3016(00)01433-4; Kamibayashi T, 2008, MOL IMAGING BIOL, V10, P162, DOI 10.1007/s11307-008-0132-9; Fujibayashi Y, 1999, NUCL MED BIOL, V26, P117, DOI 10.1016/S0969-8051(98)00049-3; Ryu IS, 2013, J NUCL MED, V54, P1032, DOI 10.2967/jnumed.112.116053; van Loon J, 2010, EUR J NUCL MED MOL I, V37, P1663, DOI 10.1007/s00259-010-1437-x; Ikawa M, 2009, MITOCHONDRION, V9, P144, DOI 10.1016/j.mito.2009.01.011; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; Holland JP, 2009, Q J NUCL MED MOL IM, V53, P193; Dubois LJ, 2011, P NATL ACAD SCI USA, V108, P14620, DOI 10.1073/pnas.1102526108; Lewis JS, 2008, J NUCL MED, V49, P1177, DOI 10.2967/jnumed.108.051326; Dehdashti F, 2003, INT J RADIAT ONCOL, V55, P1233, DOI 10.1016/S0360-3016(02)04477-2; Lewis JS, 2001, J NUCL MED, V42, P655; Lohith TG, 2009, J NUCL MED, V50, P1948, DOI 10.2967/jnumed.109.069021; Yoshii Y, 2010, NUCL MED BIOL, V37, P395, DOI 10.1016/j.nucmedbio.2009.12.011; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; Yasuda K, 2013, INT J RADIAT ONCOL, V85, P142, DOI 10.1016/j.ijrobp.2012.03.029; Hicks RJ, 2005, EUR J NUCL MED MOL I, V32, P1384, DOI 10.1007/s00259-005-1880-2; Lee NY, 2008, INT J RADIAT ONCOL, V70, P2, DOI 10.1016/j.ijrobp.2007.06.039; Lehtio K, 2001, J NUCL MED, V42, P1643; Takahashi N, 2000, ANN NUCL MED, V14, P323, DOI 10.1007/BF02988690; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Lewis JS, 1999, J NUCL MED, V40, P177; Komar G, 2008, J NUCL MED, V49, P1944, DOI 10.2967/jnumed.108.053785; Dehdashti F, 2008, J NUCL MED, V49, P201, DOI 10.2967/jnumed.107.048520; Wong TZ, 2008, AM J ROENTGENOL, V190, P427, DOI 10.2214/AJR.07.2876; Bowen SR, 2011, NUCL MED BIOL, V38, P771, DOI 10.1016/j.nucmedbio.2011.02.002; Lee ST, 2007, SEMIN NUCL MED, V37, P451, DOI 10.1053/j.semnuclmed.2007.07.00.1; DEGRADO TR, 1994, J NUCL MED, V35, P1398; Grassi I, 2014, CLIN NUCL MED, V39, pE59, DOI 10.1097/RLU.0b013e3182a756f0; Isozaki M, 2011, EUR J NUCL MED MOL I, V38, P1075, DOI 10.1007/s00259-011-1734-z; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kositwattanarerk A, 2012, CLIN NUCL MED, V37, P252, DOI 10.1097/RLU.0b013e31823eaadb; Lewis JS, 2002, J NUCL MED, V43, P1557; Lim R, 2012, J NUCL MED, V53, P1506; Postema EJ, 2009, EUR J NUCL MED MOL I, V36, P1565, DOI 10.1007/s00259-009-1154-5	40	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	DEC	2014	39	12					1027	1032				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT8AZ	WOS:000345157400003		
J	Nakamura, S; Inami, S; Murai, K; Takano, M; Takano, H; Asai, K; Yasutake, M; Shimizu, W; Mizuno, K				Nakamura, Shunichi; Inami, Shigenobu; Murai, Koji; Takano, Masamichi; Takano, Hitoshi; Asai, Kuniya; Yasutake, Masahiro; Shimizu, Wataru; Mizuno, Kyoichi			Relationship between cholesterol crystals and culprit lesion characteristics in patients with stable coronary artery disease: an optical coherence tomography study	CLINICAL RESEARCH IN CARDIOLOGY			English	Article						Cholesterol crystals; Plaque rupture; Vulnerable plaque; Coronary artery disease; Diabetes	PLAQUE RUPTURE; MYOCARDIAL-INFARCTION; VULNERABLE PLAQUE; MORTALITY; THERAPY; EVENTS	Aims Some recent studies have reported the role of cholesterol crystals (ChCs) in plaque rupture in patients with coronary artery disease. We used optical coherence tomography (OCT) to investigate the characteristics of coronary plaques that were associated with derived ChCs. Methods We evaluated 101 subjects with stable coronary artery disease who underwent OCT. We compared the OCT findings of the culprit lesions with ChCs to those without ChCs and investigated the background characteristics. Results ChCs were observed in culprit lesions of 39 patients. The frequencies of spotty calcification, microchannel structure, and lipid-rich plaque were significantly higher in patients with ChCs than those without ChCs (64.1 vs. 27.4 %, p<0.001; 69.2 vs. 38.7 %, p = 0.003; 53.8 vs. 29.0 %, p = 0.01, respectively). On the other hand, the frequencies of thrombus, disruption, and thin-cap fibroatheroma did not differ significantly between patients with and without ChCs (15.3 vs. 24.1 %, p = 0.3; 33.3 vs. 17.7 %, p = 0.07; and 33.3 vs. 24.1 %, p = 0.3, respectively). Among the possible clinical factors, multivariate analysis showed an elevated level of glycated hemoglobin as the sole significant factor associated with ChCs. Conclusion ChCs are frequently associated with the major findings of vulnerable plaque, and are often seen in poorly controlled diabetic patients. Thus, ChCs might be one of the features of vulnerable plaque.	[Nakamura, Shunichi; Inami, Shigenobu; Murai, Koji; Takano, Masamichi; Asai, Kuniya; Yasutake, Masahiro; Shimizu, Wataru; Mizuno, Kyoichi] Nippon Med Sch, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1130022, Japan; [Takano, Hitoshi] Chiba Hokusoh Hosp, Nippon Med Sch, Ctr Cardiovasc, Chiba, Japan	Inami, S (reprint author), Nippon Med Sch, Dept Cardiovasc Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1130022, Japan.	s-nakamura@nms.ac.jp; sigenobu@nms.ac.jp					Suh WM, 2011, CIRC-CARDIOVASC IMAG, V4, P169, DOI 10.1161/CIRCIMAGING.110.958777; Takarada S, 2009, ATHEROSCLEROSIS, V202, P491, DOI 10.1016/j.atherosclerosis.2008.05.014; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Tanaka A, 2009, EUR HEART J, V30, P1348, DOI 10.1093/eurheartj/ehp122; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Abela GS, 2010, J CLIN LIPIDOL, V4, P156, DOI 10.1016/j.jacl.2010.03.003; Vedre A, 2009, ATHEROSCLEROSIS, V203, P89, DOI 10.1016/j.atherosclerosis.2008.06.027; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P339, DOI 10.1016/j.jcmg.2008.10.017; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262; Abela GS, 2005, CLIN CARDIOL, V28, P413, DOI 10.1002/clc.4960280906; Abela GS, 2011, AM J CARDIOL, V107, P1710, DOI 10.1016/j.amjcard.2011.02.336; Frink RJ, 2010, J INVASIVE CARDIOL, V22, P406; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; GARCIA MJ, 1974, DIABETES, V23, P105; Kato K, 2012, JACC-CARDIOVASC INTE, V5, P1150, DOI 10.1016/j.jcin.2012.06.019; BYINGTON RP, 1995, CIRCULATION, V92, P2419; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	25	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-0684	1861-0692		CLIN RES CARDIOL	Clin. Res. Cardiol.	DEC	2014	103	12					1015	1021		10.1007/s00392-014-0748-5		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AU0DL	WOS:000345293500007		
J	Okubo, T; Tsuchida, A				Okubo, Tsuneo; Tsuchida, Akira			Drying dissipative structures of arrowroot starch	COLLOID AND POLYMER SCIENCE			English	Article						Gelation; Arrowroot starch; Drying pattern; Dissipative structure; Broad ring; Sharpness parameter	THERMOSENSITIVE GEL SPHERES; POLY(RIBOADENYLIC ACID); POLY(ETHYLENE GLYCOL); AQUEOUS-SOLUTIONS; POTASSIUM-SALTS; SODIUM-SALTS; CRYSTALLIZATION; SUSPENSIONS; PATTERNS; POLY(N-ISOPROPYLACRYLAMIDE)	Macroscopic and microscopic drying patterns of arrowroot starch (ARS) in diluted aqueous solution and gel state were investigated on a cover glass in order to know the molecular information of ARS and their interaction with the substrate. Thickness profiles of the dried film showed coexistence of the rather sharp broad ring and the very broad accumulation at the outside edge and the inner region, respectively. The sharpness parameters, S values from the outside peaks decreased sharply from 100 to 3 as initial concentration increased from 0.04 to 3 wt%. Furthermore, very low S values between one and two originating from the round hills were also observed at low concentrations, 0.04 to 0.2 wt%. The results support that stable gelation of ARS molecules does not take place at the ARS concentrations lower than ca. 2 wt% at 20 A degrees C. It is highly plausible that ARS molecules existing near the substrate surface are adsorbed strongly on the substrate. Gelation of ARS molecules took place rapidly above 2 wt%. The S values increased sharply from 3 to 15 with increasing temperature from 5 to 20 A degrees C, and kept constant around 15 at the higher temperatures up to 50 A degrees C. Convectional diffusion of ARS decreased in the order of ARS > gelatin > poly (N-butyl acrylate), when comparison was made at the same weight percent at the lower concentrations than ca. 2 wt%. Above the concentration, stable gel structures of ARS were formed.	[Okubo, Tsuneo] Inst Colloidal Org, Uji, Kyoto 6110012, Japan; [Tsuchida, Akira] Gifu Univ, Dept Appl Chem, Gifu 5011193, Japan	Okubo, T (reprint author), Inst Colloidal Org, Hatoyama 3-1-112, Uji, Kyoto 6110012, Japan.	okubotsu@ybb.ne.jp					Hoover R, 2001, CARBOHYD POLYM, V45, P253, DOI 10.1016/S0144-8617(00)00260-5; Okubo T, 2014, COLLOID POLYM SCI, V292, P1419, DOI 10.1007/s00396-014-3200-5; Yamaguchi T, 2005, COLLOID POLYM SCI, V283, P1123, DOI 10.1007/s00396-004-1258-1; Srichuwong S, 2005, CARBOHYD POLYM, V60, P529, DOI 10.1016/j.carbpol.2005.03.004; Okubo T, 2011, COLLOID SURFACE B, V87, P11, DOI 10.1016/j.colsurfb.2011.03.022; Okubo T, 2012, COLLOID POLYM SCI, V290, P1901, DOI 10.1007/s00396-012-2727-6; Fujii S, 2014, COLLOID POLYM SCI, V289, P807; Ida T, 2008, J APPL CRYSTALLOGR, V41, P393, DOI 10.1107/S0021889807067659; Okubo T, 2006, MOL COLLOIDAL ELECTR, P573; Okubo T, 2013, COLLOID POLYM SCI, V291, P1019, DOI 10.1007/s00396-012-2825-5; Okubo T, 2011, COLLOID POLYM SCI, V289, P1729, DOI 10.1007/s00396-011-2495-8; Okubo T, 2014, COLLOID POLYM SCI, V292, P133, DOI 10.1007/s00396-013-3053-3; Okubo T, 2011, COLLOID SURFACE B, V87, P439, DOI 10.1016/j.colsurfb.2011.06.006; Okubo T, 2010, COLLOID POLYM SCI, V288, P245, DOI 10.1007/s00396-009-2177-y; Okubo T, 2008, NANOPARTICLES SYNTHE, P256; Okubo T, 2011, COLLOID POLYM SCI, V289, P1205, DOI 10.1007/s00396-011-2444-6; Okubo T, 2010, COLLOID POLYM SCI, V288, P189, DOI 10.1007/s00396-009-2152-7; Okubo T, 2013, COLLOID POLYM SCI, V291, P2447, DOI 10.1007/s00396-013-2972-3; Okubo T, 2012, COLLOID POLYM SCI, V290, P867, DOI 10.1007/s00396-012-2602-5; Okubo T, 2011, COLLOID POLYM SCI, V289, P807, DOI 10.1007/s00396-011-2402-3; Okubo T, 2009, COLLOID POLYM SCI, V287, P1155, DOI 10.1007/s00396-009-2075-3; Okubo T, COLLOID POLYM SCI, V291, P2805; Okubo T, 2012, COLLOID POLYM SCI, V290, P411, DOI 10.1007/s00396-011-2561-2; Okubo T, 2006, COLLOID POLYM SCI, V285, P339, DOI 10.1007/S00396-006-1577-5; Okubo T, 2007, COLLOID POLYM SCI, V285, P999, DOI 10.1007/s00396-007-1645-5; Okubo T, 2010, COLLOID POLYM SCI, V288, P981, DOI 10.1007/s00396-010-2218-6; Okubo T, 2010, COLLOID POLYM SCI, V288, P1551, DOI 10.1007/s00396-010-2239-4; Okubo T, 2011, COLLOID POLYM SCI, V289, P159, DOI 10.1007/s00396-010-2324-5; Okubo T, 2010, COLLOID POLYM SCI, V288, P1435, DOI 10.1007/s00396-010-2281-z; Okubo T, 2005, LANGMUIR, V21, P9889, DOI 10.1021/la050692a; Okubo T, 2010, MACROMOL SYMP, V288, P67, DOI 10.1002/masy.201050209; Okubo T, 2014, COLLOID POLYM SCI, V292, P381, DOI 10.1007/s00396-013-3082-y; Okubo T, 2013, COLLOID POLYM SCI, V291, P1887, DOI 10.1007/s00396-013-2930-0; Okubo T, 2009, COLLOID POLYM SCI, V287, P933, DOI 10.1007/s00396-009-2049-5; Peroni TS, 2006, FOOD SCI TECHNOL INT, V12, P505	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2014	292	12					3187	3193		10.1007/s00396-014-3370-1		7	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AT4AQ	WOS:000344880000013		
J	Tomoda, K; Yabuki, N; Terada, H; Makino, K				Tomoda, Keishiro; Yabuki, Natsumi; Terada, Hiroshi; Makino, Kimiko			Application of polymeric nanoparticles prepared by an antisolvent diffusion with preferential solvation for iontophoretic transdermal drug delivery	COLLOID AND POLYMER SCIENCE			English	Article						PLGA; Nanoparticle; Transdermal; Iontophoresis; Antisolvent diffusion; Indomethacin; Preferential solvation	PENETRATION ENHANCERS; PLGA NANOPARTICLES; SKIN PENETRATION; PERMEATION ENHANCEMENT; HAIR-FOLLICLES; IN-VIVO; COMBINATION; TRANSPORT; SYSTEM; FABRICATION	Indomethacin-loaded poly(lactide-co-glycolide) (PLGA) nanoparticles with an average diameter of 100 nm were prepared by using a combination of an antisolvent diffusion method with preferential solvation (bare nanoparticles). Polyvinyl alcohol (PVA)-coated indomethacin-loaded PLGA nanoparticles with an average diameter of 100 nm were also prepared by emulsification and the solvent evaporation method (PVA-coated nanoparticles). Bare nanoparticles do not have a hydrophilic stabilizer on the surface; therefore, they have high hydrophobicity and negative charges. Electrophoretic mobility of bare nanoparticles at 5 mM NaCl solution was about 68 times higher than that of PVA-coated nanoparticles. Permeability of bare nanoparticles through rat skin was significantly higher than that of PVA-coated nanoparticles when iontophoresis was applied ex vivo. Indomethacin amount inside the skin after the permeation study by using bare nanoparticles was much higher than that by using PVA-coated nanoparticles. Indomethacin transition to circulation and accumulation in muscle by the transdermal delivery of indomethacin-loaded PLGA nanoparticles were significantly enhanced by using the combination of bare nanoparticles and iontophoresis in vivo. As for transdermal route of nanoparticles, both bare and PVA-coated nanoparticles were revealed to penetrate through the transfollicular pathway, and the migration of nanoparticles to follicles was enhanced by the application of iontophoresis. PLGA nanoparticles prepared by the antisolvent diffusion with preferential solvation are beneficial for iontophoretic transdermal delivery of therapeutic agents.	[Tomoda, Keishiro; Yabuki, Natsumi; Terada, Hiroshi; Makino, Kimiko] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan; [Tomoda, Keishiro; Terada, Hiroshi; Makino, Kimiko] Tokyo Univ Sci, Ctr Drug Delivery Res, Noda, Chiba 278, Japan; [Tomoda, Keishiro; Terada, Hiroshi; Makino, Kimiko] Tokyo Univ Sci, Ctr Phys Pharmaceut, Noda, Chiba 278, Japan	Makino, K (reprint author), Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 278, Japan.	makino@rs.noda.tus.ac.jp			Program for Development of the Strategic Research Center in Private Universities by MEXT	This work was supported by the Program for Development of the Strategic Research Center in Private Universities, which is supported by MEXT (2010-2014).	Mitragotri S, 2000, PHARMACEUT RES, V17, P1354, DOI 10.1023/A:1007522114438; Chen HB, 2009, J CONTROL RELEASE, V139, P63, DOI 10.1016/j.jconrel.2009.05.031; Liu W, 2008, INT J PHARMACEUT, V364, P135, DOI 10.1016/j.ijpharm.2008.08.013; Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025; Tomoda K, 2011, COLLOID SURFACE B, V88, P706, DOI 10.1016/j.colsurfb.2011.08.004; Tomoda K, 2014, COLLOID SURFACE A, V457, P88, DOI 10.1016/j.colsurfa.2014.05.010; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Sapra B, 2008, AAPS J, V10, P120, DOI 10.1208/s12248-008-9012-0; Tomoda K, 2012, COLLOID SURFACE B, V92, P50, DOI 10.1016/j.colsurfb.2011.11.016; Sonavane G, 2008, COLLOID SURFACE B, V65, P1, DOI 10.1016/j.colsurfb.2008.02.013; Henry S, 1998, J PHARM SCI, V87, P922, DOI 10.1021/js980042+; Tomoda K, 2012, COLLOID SURFACE B, V97, P84, DOI 10.1016/j.colsurfb.2012.04.002; Fang JY, 1999, J CONTROL RELEASE, V60, P1, DOI 10.1016/S0168-3659(99)00055-3; Toll R, 2004, J INVEST DERMATOL, V123, P168, DOI 10.1111/j.0022-202X.2004.22717.x; Lademann J, 2007, EUR J PHARM BIOPHARM, V66, P159, DOI 10.1016/j.ejpb.2006.10.019; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; PRAUSNITZ MR, 1993, P NATL ACAD SCI USA, V90, P10504, DOI 10.1073/pnas.90.22.10504; Prow TW, 2011, ADV DRUG DELIVER REV, V63, P470, DOI 10.1016/j.addr.2011.01.012; Naik A, 1995, J CONTROL RELEASE, V37, P299, DOI 10.1016/0168-3659(95)00088-7; BEHL CR, 1980, J INVEST DERMATOL, V75, P346, DOI 10.1111/1523-1747.ep12531118; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; Bounoure F, 2008, J DERMATOL SCI, V52, P170, DOI 10.1016/j.jdermsci.2008.06.009; Drakulic BJ, 2008, INT J PHARMACEUT, V363, P40, DOI 10.1016/j.ijpharm.2008.06.032; Ghafourian T, 2004, J CONTROL RELEASE, V99, P113, DOI 10.1016/j.jconrel.2004.06.010; GOODMAN M, 1989, INT J PHARM, V57, P29, DOI 10.1016/0378-5173(89)90260-3; Grossberg GT, 2010, INT J CLIN PRACT, V64, P651, DOI 10.1111/j.1742-1241.2009.02330.x; Guy RH, 1996, PHARMACEUT RES, V13, P1765, DOI 10.1023/A:1016060403438; Lee S, 2007, BIOL PHARM BULL, V30, P393, DOI 10.1248/bpb.30.393; MASADA T, 1989, INT J PHARM, V49, P57, DOI 10.1016/0378-5173(89)90152-X; Miyazaki N., 2003, J PHARM PHARM SCI, V6, P238; Mudry B, 2006, J CONTROL RELEASE, V111, P362, DOI 10.1016/j.jconrel.2005.12.020; Mudry B, 2007, J CONTROL RELEASE, V122, P165, DOI 10.1016/j.jconrel.2007.07.004; OHSHIMA H, 1994, J COLLOID INTERF SCI, V163, P474, DOI 10.1006/jcis.1994.1126; Sugino M, 2009, YAKUGAKU ZASSHI, V129, P1453; Tsujimoto H., 2004, J SOC POWDER TECHNOL, V41, P867; Ueda H, 1995, J CONTROL RELEASE, V37, P291, DOI 10.1016/0168-3659(95)00087-9; Wiechers J W, 1990, Drug Des Deliv, V6, P87; Xiong JY, 2004, J CHEM PHYS, V121, P12626, DOI 10.1063/1.1808419; Xiong JY, 2005, J PHYS CHEM B, V109, P13877, DOI 10.1021/jp0446480	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0303-402X	1435-1536		COLLOID POLYM SCI	Colloid Polym. Sci.	DEC	2014	292	12					3195	3203		10.1007/s00396-014-3342-5		9	Chemistry, Physical; Polymer Science	Chemistry; Polymer Science	AT4AQ	WOS:000344880000014		
J	Aonuma, S				Aonuma, Satoru			Momotaro as Proletarian: A Study of Revolutionary Symbolism in Japan	COMMUNICATION AND CRITICAL-CULTURAL STUDIES			English	Article						Folklore; Japanese Rhetoric; Marxism; Proletarian Literature; Rhetorical Subversion		This article discusses the ideological working of Momotaro, a popular Japanese folktale in which an imaginary hero liberates his people from evil demons in a distant land. During the 1930s and 1940s, this folktale was used by the imperial authorities to justify the war against demonic Anglo-Americans. Little known is that the same story was also appropriated by Japanese orator-communists challenging imperialism and war capitalism. The article critically examines how the folk hero acquired class consciousness and became proletarian, critiquing the dominant ideology.	[Aonuma, Satoru] Tsuda Coll, Kodaira, Tokyo 1878577, Japan	Aonuma, S (reprint author), Tsuda Coll, Dept English, 2-1-1 Tsuda Machi, Kodaira, Tokyo 1878577, Japan.	aonuma@tsuda.ac.jp					Adams Robert J., 1967, ASIAN ETHNOGRAPHY, V30, P99; [Anonymous], 1983, MOMOTARO NO UNMEI; [Anonymous], 2011, KARASHIDANES BL 0314; Greene RW, 1998, CRIT STUD MASS COMM, V15, P21; [Anonymous], 1927, AKAITORI, P40; ANTONI K, 1991, ASIAN FOLKLORE STUD, V50, P155, DOI 10.2307/1178189; Apter D. E., 1984, STATE POLITICS SOCIA; Artz Lee, 2006, MARXISM COMMUNICATIO; Aune James Arnt, 1994, RHETORIC MARXISM, P15; Bascom William R., 1953, J AM FOLKLORE, V66, P283; Branham Robert James, 1994, ARGUMENTATION ADVOCA, V30, P131; Burke Kenneth, 1989, LEGACY KENNETH BURKE, P10; Chung Hilary, 1996, PARTY SPIRIT SOCIALI, V6, P3; Cloud D. L., 2005, MANAGEMENT COMMUNICA, V18, P509, DOI [10.1177/0893318904273688, DOI 10.1177/0893318904273688]; Cloud DL, 1998, WESTERN J COMM, V62, P387; Colbert Evelyn S., 1952, LEFT WING JAPANESE P, P7; Condit C., 1993, CRAFTING EQUALITY AM; Dewherst Martin, 1996, PARTY SPIRIT SOCIALI, V6, P24; Dower John W., 1986, WAR MERCY RACE POWER; Eagleton Terry, 2005, FIGURES DISSENT CRIT, P87; Eagleton Terry, 1981, WALTER BENJAMIN REVO; Eder Matthias, 1969, ASIAN ETHNOGRAPHY, V28, P19; Eguchi Kiyoshi, 1927, AKAITORI, P48; Gaikotsu, 1929, MEIJI ENZETSU SHI; Goto-Jones Christopher, 2006, LEFT SHAPING JAPANES, P5; Gouldner Alvin W., 1976, DIALECTIC IDEOLOGY T, P31; Gramsci Antonio, 1985, SELECTIONS CULTURAL, P189; Greene RW, 2006, PHILOS RHETORIC, V39, P85, DOI 10.1353/par.2006.0008; Hashimoto Mitsuhiro, 2000, HIKAKU BUNKA KENKYU, V49, P61; Hirano Ken, 1963, SHOWA BUNGAKU SHI; Honda Shugo, 1985, TENKO BUNGAKU RON; Honjo Mutsuo, 1931, SHONEN SENKI, P8; Howard Robert Glenn, THEORY VERNACULAR RH; Howell Dana Prescott, 1992, DEV SOVIET FOLKLORIS; Ishii S., 1992, COMMUNICATION Q, V40, P391; Kakita Hideki, 2003, THESIS U IOWA; Kawai Y., 2009, J INT INTERCULTURAL, V2, P16; Kersten Rikki, 2006, LEFT SHAPING JAPANES; Kondo Eizo, 1930, PROLETARIA YUBENGAKU; Koyama Hirotaka, 1956, NIHON MARUKUSUSHUGI; Krauss E. S., 1984, CONFLICT IN JAPAN; Kublin Hyman, 1952, J POLIT, V14, P269; Kumagai Takashi, 1956, BUNGAKU KYOUIKU; Kurihara Yukio, 1971, PROLETARIA BUNGAKU S; Leff Michael C., 1995, TEXTS CONTEXT CRITIC; Lenin Vladimir I., 1917, IMPERIALISM HIGHEST; Lenin Vladimir I., WHAT IS TO BE DONE, P34; Lentricchia Frank, 1983, CRITICISM SOCIAL CHA, P28; Marcuse Herbert, 1972, COUNTERREVOLUTION RE, P80; Matsuzawa Hiroaki, 1973, NIHON MARUKUSUSHUGI; MCGEE MC, 1980, COMMUN MONOGR, V47, P23; McGee Michael Calvin, 1980, Q J SPEECH, V66, P14; Miki Kiyoshi, 1967, MIKI KIYOSHI ZENSHU, P139; Morrison John L., 1976, W SPEECH, V36, P89; Nakazawa Miyori, 1989, THESIS NW U; Nimura Kazuo, 1990, FORMATION LABOUR MOV, VII; Niwano Makoto, 2004, ZA MOMOTARO, V2; Odagiri Hideo, 1990, SHAKAIBUNGAKU SHAKAI; Ohkouchi Kazuo, 1972, KOUTOKU SHUSUI KATAY; Ohtsuru Kimihiko, 2008, OHTSURU KIMIHIK 0727; Okabe Roichi, 1973, Q J SPEECH, V59, P188; Okuda Hiroko, 2005, INT INTERCULTURAL CO, V28, P14; Oliver Robert T., 1962, CULTURE COMMUNICATIO, P155; Packard III George R., 1966, PROTEST IN TOKYO; Phillips Jerry, MARXISM UTOPIA SOCIA; Saito Momoe, 1996, ADVENTURE MOMOTARO P; Sakuragi Toshiyuki, 1992, HOWARD J COMMUNICATI, V4, P105; Silverberg Miriam, 1990, CHANGING SONG MARXIS, P47; Steinhoff Patricia, 1989, DEMOCRACY IN JAPAN, P172; Suzuki Takeshi, 2000, ARGUMENTATION ADVOCA, V41, P102; Tsurumi Kazuko, 1975, JAPAN Q, V22, P224; Volosinov V. N., 1986, MARXISM PHILOS LANGU, P23; WILKIE RW, 1976, PHILOS RHETORIC, V9, P232; Williams David Cratis, 1990, ARGUMENTATION THEORY, P165; Yamauchi Akito, 2010, J HIST KYUSHU U, V147, P111; Yuichi Asao, 1991, PROLETARIA BUNGAKU U, P10; Zompetti JP, 1997, WESTERN J COMM, V61, P66	77	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1479-1420	1479-4233		COMMUN CRIT-CULT STU	Commun. Crit.-Cult. Stud.	DEC	2014	11	4					382	400		10.1080/14791420.2014.959452		19	Cultural Studies; Communication	Cultural Studies; Communication	AU1HB	WOS:000345370500005		
J	Ogura, T; Murakami, H				Ogura, T.; Murakami, H.			A rank test based on the moments of order statistics of the modified Makeham distribution	COMPUTATIONAL STATISTICS			English	Article						Modified Makeham distribution; Moments of order statistics; Rank sum test; Two-sample problem	RECURRENCE RELATIONS; 2-SAMPLE	Single moments of order statistics from the modified Makeham distribution (MMD) are derived, an identity about the single moments of order statistics is given, and the specific expected value and variance of the single moments of order statistics from the MMD are calculated. In this study, the order statistic from the MMD was applied to the rank sum test in a two-sample problem. The exact critical values of the designated statistics were evaluated. Simulations were used to investigate the power of these statistics for the two-sided alternative with several population distributions. The powers of the statistics were compared with the Wilcoxon rank sum statistic, the Lepage statistic, the modified Baumgartner statistic, the Savage test and the normal score test. The Edgeworth expansion was used to evaluate the upper tail probability for the preferred statistic, given finite sample sizes.	[Ogura, T.] Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie, Japan; [Murakami, H.] Natl Def Acad, Dept Math, Yokosuka, Kanagawa 239, Japan	Ogura, T (reprint author), Mie Univ Hosp, Clin Res Support Ctr, Tsu, Mie, Japan.	t-ogura@clin.medic.mie-u.ac.jp; murakami@gug.math.chuo-u.ac.jp			JSPS, KAKENHI [23700349, 26730025]	The authors would like to thank the editor and the two referees for their valuable comments and suggestions. The author also appreciates that this research is supported by the Grant-in-Aid for Young Scientists B of JSPS, KAKENHI Numbers 23700349 and 26730025.	Nadarajah S, 2008, STAT PROBABIL LETT, V78, P196, DOI 10.1016/j.spl.2007.05.022; LEPAGE Y, 1971, BIOMETRIKA, V58, P213, DOI 10.2307/2334333; BICKEL PJ, 1974, ANN STAT, V2, P1, DOI 10.1214/aos/1176342609; SMITH PJ, 1995, AM STAT, V49, P217, DOI 10.2307/2684642; Arnold B. C., 2008, 1 COURSE ORDER STAT; BALAKRISHNAN N, 1988, COMMUN STAT THEORY, V17, P2657, DOI 10.1080/03610928808829763; Barlow RE, 1975, STAT THEORY RELIABIL; Baumgartner W, 1998, BIOMETRICS, V54, P1129, DOI 10.2307/2533862; Chakraborti S, 2010, NONPARAMETRIC STAT I; Cox D, 1990, ANAL SURVIVAL DATE; David H. A., 2003, ORDER STAT; DHILLON BS, 1979, IEEE T RELIAB, V28, P150; Genc AI, 2012, STAT PAP, V53, P117, DOI 10.1007/s00362-010-0320-y; Hajek J., 1999, THEORY RANK TESTS; Kosznik S, 2007, COMPUTAT METH SCI TE, V13, P113; Kosznik S, 2003, THESIS GDANSK PG; Kosznik S, 2006, RODZINA ROZKLADOW MA; Kosznik S, 2011, COMPUTAT METH SCI TE, V17, P35; Marshall AW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-68477-2; Murakami H, 2006, J JAPANESE SOC COMPU, V19, P1, DOI 10.5183/jjscs1988.19.1; Neuhauser M, 2001, J NONPARAMETR STAT, V13, P729, DOI 10.1080/10485250108832874; Raqab MZ, 2004, STATISTICS, V38, P29, DOI 10.1080/0233188032000158781; TERRY ME, 1952, ANN MATH STAT, V23, P346, DOI 10.1214/aoms/1177729381; Thomas PY, 2008, STAT PAP, V49, P139, DOI 10.1007/s00362-006-0377-9	24	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0943-4062	1613-9658		COMPUTATION STAT	Comput. Stat.	DEC	2014	29	6					1691	1711		10.1007/s00180-014-0513-2		21	Statistics & Probability	Mathematics	AT7EH	WOS:000345099200015		
J	Koyamaa, Y; Shinbori, A; Tanaka, Y; Hori, T; Nose, M; Oimatsu, S				Koyamaa, Yukinobu; Shinbori, Atsuki; Tanaka, Yoshimasa; Hori, Tomoaki; Nose, Masahito; Oimatsu, Satoshi			An Interactive Data Language software package to calculate ionospheric conductivity by using numerical models	COMPUTER PHYSICS COMMUNICATIONS			English	Article						Geophysics and Atmospheric Science; Ionosphere; Conductivity; Numerical models; IDL; TDAS; UDAS; IUGONET	LONG-TERM TRENDS; PARAMETERS; FIELD	The Inter-university Upper atmosphere Global Observation NETwork (IUGONET) project focuses on handling ground-based observational data of the upper atmosphere. To this end, the project members have been developing a data analysis software package which is based on Interactive Data Language (IDL). Filling the spatial gaps in observational data requires the use of numerical models. In this paper, we discuss an IDL software package for global ionospheric conductivity by integration of 3rd party numerical models. The model can be used to create further derived models. (C) 2014 Elsevier B.V. All rights reserved.	[Koyamaa, Yukinobu; Nose, Masahito] Kyoto Univ, Grad Sch Sci, Data Anal Ctr Geomagnetism & Space Magnetism, Kyoto 6068501, Japan; [Shinbori, Atsuki] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6068501, Japan; [Tanaka, Yoshimasa] Natl Inst Polar Res, Space & Upper Atmospher Sci Grp, Tokyo, Japan; [Hori, Tomoaki] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Oimatsu, Satoshi] Kyoto Univ, Grad Sch Sci, Solar Planetary Electromagnetism Lab, Kyoto 6068501, Japan	Koyamaa, Y (reprint author), Kyoto Univ, Grad Sch Sci, Data Anal Ctr Geomagnetism & Space Magnetism, Kyoto 6068501, Japan.	ykoyama@kugi.kyoto-u.ac.jp			Solar-Terrestrial Environment Laboratory, Nagoya University; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This research is supported by the joint research of the Solar-Terrestrial Environment Laboratory, Nagoya University. The IUGONET project is supported by the Special Educational Research Budget (Research Promotion) [FY2009] and the Special Budget (Project) [FY2010 and later years] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	BELYAEV PP, 1990, J ATMOS TERR PHYS, V52, P781, DOI 10.1016/0021-9169(90)90010-K; Bilitza D, 2008, ADV SPACE RES, V42, P599, DOI 10.1016/j.asr.2007.07.048; MAEDA KI, 1977, J ATMOS TERR PHYS, V39, P1041, DOI 10.1016/0021-9169(77)90013-7; Finlay CC, 2010, GEOPHYS J INT, V183, P1216, DOI 10.1111/j.1365-246X.2010.04804.x; ASHER RL, 1995, CHEM PHYS LETT, V234, P113, DOI 10.1016/0009-2614(95)00005-O; Banks P.M., 1973, AERONOMY A; Cnossen I, 2008, J ATMOS SOL-TERR PHY, V70, P1512, DOI 10.1016/j.jastp.2008.05.003; Danilov AD, 1999, ANN GEOPHYS-ATM HYDR, V17, P1239, DOI 10.1007/s00585-999-1239-2; Foppiano AJ, 1999, J ATMOS SOL-TERR PHY, V61, P717, DOI 10.1016/S1364-6826(99)00025-5; Hall C.M., ANN GEOPHYS; Mikhailov A.V., 2000, ANN GEOPHYS, V18; Oimatsu S., 2012, THESIS KYOTO U; Picone J.M., 2002, J ATMOS TERR PHYS, V107, P1468; Robre R.G., 1989, GEOPHYS RES LETT, V16, P1441; Volland H, 1995, HDB ATMOSPHERIC ELEC, V2	15	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-4655	1879-2944		COMPUT PHYS COMMUN	Comput. Phys. Commun.	DEC	2014	185	12					3398	3405		10.1016/j.cpc.2014.08.011		8	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	AT3GX	WOS:000344824900032		
J	Batsaikhan, N; Buuveibaatar, B; Chimed, B; Enkhtuya, O; Galbrakh, D; Ganbaatar, O; Lkhagvasuren, B; Nandintsetseg, D; Berger, J; Calabrese, JM; Edwards, AE; Fagan, WF; Fuller, TK; Heiner, M; Ito, TY; Kaczensky, P; Leimgruber, P; Lushchekina, A; Milner-Gulland, EJ; Mueller, T; Murray, MG; Olson, KA; Reading, R; Schaller, GB; Stubbe, A; Stubbe, M; Walzer, C; Von Wehrden, H; Whitten, T				Batsaikhan, Nyamsuren; Buuveibaatar, Bayarbaatar; Chimed, Bazaar; Enkhtuya, Oidov; Galbrakh, Davaa; Ganbaatar, Oyunsaikhan; Lkhagvasuren, Badamjav; Nandintsetseg, Dejid; Berger, Joel; Calabrese, Justin M.; Edwards, Ann E.; Fagan, William F.; Fuller, Todd K.; Heiner, Michael; Ito, Takehiko Y.; Kaczensky, Petra; Leimgruber, Peter; Lushchekina, Anna; Milner-Gulland, E. J.; Mueller, Thomas; Murray, Martyn G.; Olson, Kirk A.; Reading, Richard; Schaller, George B.; Stubbe, Annagret; Stubbe, Michael; Walzer, Chris; Von Wehrden, Henrik; Whitten, Tony			Conserving the World's Finest Grassland Amidst Ambitious National Development	CONSERVATION BIOLOGY			English	Article							CONSERVATION; ECOSYSTEM		[Batsaikhan, Nyamsuren; Ganbaatar, Oyunsaikhan; Nandintsetseg, Dejid; Stubbe, Michael] Natl Univ Mongolia, Dept Zool, Sch Biol & Biotechnol, Ulaanbaatar, Mongol Peo Rep; [Buuveibaatar, Bayarbaatar; Edwards, Ann E.] Wildlife Conservat Soc, Mongolia Program, Ulaanbaatar, Mongol Peo Rep; [Chimed, Bazaar] Ochir WWF Mongolia Program, Ulaanbaatar, Mongol Peo Rep; [Enkhtuya, Oidov; Galbrakh, Davaa] Nat Conservancy Mongolia Program Off, Ulaanbaatar, Mongol Peo Rep; [Ganbaatar, Oyunsaikhan] Protected Areas Adm, Khovd, Mongol Peo Rep; [Lkhagvasuren, Badamjav] Mongolian Acad Sci, Inst Biol, Mammalian Ecol Lab, Ulaanbaatar, Mongol Peo Rep; [Nandintsetseg, Dejid; Kaczensky, Petra; Walzer, Chris] Univ Vet Med, Res Inst Wildlife Ecol, A-1210 Vienna, Austria; [Berger, Joel] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Berger, Joel; Schaller, George B.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Calabrese, Justin M.; Leimgruber, Peter; Mueller, Thomas; Murray, Martyn G.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Fagan, William F.; Mueller, Thomas] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Fuller, Todd K.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Heiner, Michael] Nature Conservancy, Boulder, CO 80302 USA; [Ito, Takehiko Y.] Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan; [Lushchekina, Anna] Russian Acad Sci, Inst Ecol & Evolut, Moscow, Russia; [Milner-Gulland, E. J.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Mueller, Thomas] Senckenberg Gesell Nat Forsch, Biodivers Climate Res Ctr, D-60325 Frankfurt, Germany; [Murray, Martyn G.] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; [Murray, Martyn G.; Olson, Kirk A.; Whitten, Tony] Fauna & Flora Int, Cambridge CB1 2JD, England; [Reading, Richard] Denver Zool Fdn, Denver, CO 80205 USA; [Schaller, George B.] Panthera, New York, NY 10001 USA; [Stubbe, Annagret] Univ Halle Wittenberg, Inst Biol, Dept Zool, D-06099 Halle, Germany; [Von Wehrden, Henrik] Leuphana Univ Luneburg, Ctr Methods, D-21335 Luneburg, Germany	Olson, KA (reprint author), Fauna & Flora Int, Jupiter House,4th Floor,Stn Rd, Cambridge CB1 2JD, England.	kirk.olson@fauna-flora.org	Calabrese, Justin/B-9131-2012; Ito, Takehiko/M-7221-2015				Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Olson KA, 2011, CONSERV LETT, V4, P304, DOI 10.1111/j.1755-263X.2011.00180.x; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; von Wehrden H, 2012, ECOL APPL, V22, P393, DOI 10.1890/11-0802.1; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Reading RP, 2001, J ZOOL, V254, P381, DOI 10.1017/S0952836901000887; Laurance WF, 2013, NATURE, V495, P308, DOI 10.1038/495308a; Fleming C. H., 2014, AM NATURALIST, V183; Hartlam-Brooks H. L. A., 2011, ORYX, V45, P210; Hibbert R. A., 1968, ORYX, V9, P196; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; Ito TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056995; Olson E., 1997, NATL GRASSLANDS MANA	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0888-8892	1523-1739		CONSERV BIOL	Conserv. Biol.	DEC	2014	28	6					1736	1739		10.1111/cobi.12297		4	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	AT2WF	WOS:000344794200031		
J	Yoshimura, K; Maekura, R; Hiraga, T; Miki, K; Kitada, S; Miki, M; Tateishi, Y; Mori, M				Yoshimura, Kenji; Maekura, Ryoji; Hiraga, Toru; Miki, Keisuke; Kitada, Seigo; Miki, Mari; Tateishi, Yoshitaka; Mori, Masahide			Identification of Three Exercise-induced Mortality Risk Factors in Patients with COPD	COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE			English	Article						Exercise capacity; exercise-induced hypoxemia; progressive respiratory acidosis; survival rate; sympathetic overactivity	OBSTRUCTIVE PULMONARY-DISEASE; OXYGEN-THERAPY; SURVIVAL; PROGNOSIS; DYSPNEA; VENTILATION; PREDICTORS; CAPACITY; FAILURE; LIFE	The survival rate of chronic obstructive pulmonary disease (COPD) patients with severely reduced exercise capacity is extremely low. We recently identified three life-threatening pathophysiological conditions during cardiopulmonary exercise testing (CPET): (1) exercise-induced hypoxemia, (2) sympathetic overactivity, and (3) progressive respiratory acidosis at low-intensity exercise. The present prospective observation study aimed to determine whether these parameters constitute risk factors of mortality in moderate-to-very severe COPD. Ninety-six COPD patients were followed-up, monthly, for > 3 years. Subsequently, spirometry and CPET were performed to examine parameters of exercise-induced hypoxemia ([PaO2 slope, mmHg/L.min(-1)] = Decrease in PaO2/Delta VO2 (Difference in Delta VO2 between at rest and at peak exercise)), progression of acidosis ([Delta pH/Delta VO2/L.min(-1)] = Decrease in pH/Delta VO2), and sympathetic overactivity ([Delta norepinephrine(NE)/Delta VO2, ng/mL/L.min(-1)] = increase in NE/Delta VO2). Univariate analysis revealed a significant association between the three conditions with increased mortality. Kaplan-Meier analysis showed that the quartile combining the steepest PaO2 slope (<=-55 mmHg/Delta VO2 [L/min]), steepest decrease in arterial blood pH (<= -1.72/Delta VO2 [L/min]), and most rapid increase in plasma NE level (>= 5.2 ng/Delta VO2 [L/min]) during incremental exercise was associated with higher all-cause mortality. These conditions showed cumulative effects on COPD patients' survival. Multivariate analyses revealed that these three life-threatening factors are also independent predictors of mortality based on age, heart rate and PaO2 at rest, body mass index, and forced expiratory volume in 1 s. Thus, these new exercise-induced mortality risk factors may lead to more efficient pulmonary rehabilitation programs for COPD patients based on patient-specific exercise-induced pathophysiological profiles.	[Yoshimura, Kenji; Maekura, Ryoji; Hiraga, Toru; Miki, Keisuke; Kitada, Seigo; Miki, Mari; Tateishi, Yoshitaka; Mori, Masahide] Natl Hosp Org Toneyama Hosp, Dept Resp Med, Toyonaka, Osaka 5600045, Japan	Maekura, R (reprint author), Natl Hosp Org Toneyama Hosp, Dept Resp Med, 5-1-1 Toneyama, Toyonaka, Osaka 5600045, Japan.	rmaekura@toneyama.go.jp			Health and Labour Sciences Research Grants, Clinical Research, H20-translational research-general-002	This study was funded by the Health and Labour Sciences Research Grants, Clinical Research, H20-translational research-general-002.	O'Donnell DE, 2006, J APPL PHYSIOL, V101, P1025, DOI 10.1152/japplphysiol.01470.2005; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Nici L, 2000, CLIN CHEST MED, V21, P693, DOI 10.1016/S0272-5231(05)70178-7; Nishimura K, 2002, CHEST, V121, P1434, DOI 10.1378/chest.121.5.1434; Roca J, 1997, EUR RESPIR J, V10, P2662; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; ANTHONISEN NR, 1986, AM REV RESPIR DIS, V133, P14; Hiraga T, 2003, CLIN PHYSIOL FUNCT I, V23, P324, DOI 10.1046/j.1475-0961.2003.00514.x; Foucher P, 1998, CHEST, V113, P1580, DOI 10.1378/chest.113.6.1580; Domingo-Salvany A, 2002, AM J RESP CRIT CARE, V166, P680, DOI 10.1164/rccm.2112043; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Borrill ZL, 2005, BRIT J CLIN PHARMACO, V59, P379, DOI 10.1111/j.1365-2125.2004.02261.x; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Garcia-Rio F, 2012, CHEST, V142, P338, DOI 10.1378/chest.11-2014; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; Chu CM, 2004, THORAX, V59, P1020, DOI 10.1136/thx.2004.024307; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Oga T, 2003, AM J RESP CRIT CARE, V167, P544, DOI 10.1164/rccm.200206-583OC; Celli BR, 2006, EUR RESPIR J, V27, P242, DOI 10.1183/09031936.06.00129305; Chailleux E, 1996, CHEST, V109, P741, DOI 10.1378/chest.109.3.741; Global Initiative for Chronic Obstructive Lung Disease ( GOLD), 2007, AM REV RESP DIS; Hirotani A, 2003, J NUCL MED, V44, P325; Maekura R, RESPIR CARE IN PRESS; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Miki K, 2012, RESPIROLOGY, V17, P149, DOI 10.1111/j.1440-1843.2011.02086.x; Nocturnal Oxygen Therapy Trial Group, 1980, ANN INTERN MED, V93, P391; van Gestel Arnoldus J R, 2010, J Thorac Dis, V2, P215, DOI 10.3978/j.issn.2072-1439.2010.02.04.5; Yoshimura K, 2012, INT J CHRONIC OBSTR, V7, P109, DOI 10.2147/COPD.S28677	30	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1541-2555	1541-2563		COPD	COPD-J. Chronic Obstr. Pulm. Dis.	DEC	2014	11	6					615	626		10.3109/15412555.2014.898038		12	Respiratory System	Respiratory System	AT3XZ	WOS:000344870100003		
J	Nojima, Y; Yasuoka, Y; Kume, K; Adachi, H; Hattori, S; Matsutera, R; Kohama, Y; Sasaki, T				Nojima, Yuhei; Yasuoka, Yoshinori; Kume, Kiyoshi; Adachi, Hidenori; Hattori, Susumu; Matsutera, Ryo; Kohama, Yasuaki; Sasaki, Tatsuya			Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis	CORONARY ARTERY DISEASE			English	Article						drug-eluting stent; heterogeneous drug-eluting stent; homogeneous drug-eluting stent; in-stent restenosis; switching types (drug coating or generation) of drug-eluting stent	CONVENTIONAL BALLOON ANGIOPLASTY; ANGIOGRAPHIC FOLLOW-UP; BARE-METAL STENTS; RANDOMIZED-TRIAL; ARTERY-DISEASE; VASCULAR BRACHYTHERAPY; IMPLANTATION; RESISTANCE; ATHERECTOMY; MECHANISMS	ObjectivesWe treated patients experiencing drug-eluting stent (DES) restenosis with plain old balloon angioplasty (POBA), implantation of the same type of DES [homogeneous drug-eluting stent (HOMO-DES)], or implantation of a different type of DES [heterogeneous drug-eluting stent (HETERO-DES)], and compared the efficacy and safety of these procedures for the prevention of repeated in-stent restenosis (ISR).BackgroundIn patients with de-novo coronary lesions, DES implantation is associated with a markedly reduced restenosis rate as compared with that associated with a bare metal stent and POBA. However, the optimal management strategy for patients with DES ISR remains unknown.Patients and methodsWe identified 191 consecutive DES ISR lesions from 183 patients who required clinically driven revascularization and divided them into three groups according to the treatment: 38 lesions were treated with POBA, 38 with HOMO-DES, and 115 with HETERO-DES.ResultsThe incidence of target lesion revascularization (TLR) was 42.1% (16/38), 15.8% (6/38), and 16.5% (19/115) in the POBA, HOMO-DES, and HETERO-DES groups (POBA vs. HOMO, HETERO-DES; P=0.002, respectively). Multivariate analysis indicated that diabetes [odds ratio (OR), 3.4], hemodialysis (OR, 7.74), nonfocal ISR patterns (OR, 3.35), previous myocardial infarction (OR, 3.26), and POBA (OR, 8.84) were independent predictors of TLR.ConclusionA strategy involving repeated DES implantation was superior to POBA for preventing recurrent restenosis. Treatment with a different type or generation of DES does not appear to reduce the incidence of TLR. Moreover, we identified certain useful factors for facilitating appropriate and early triage in the patients with repeated DES ISR.	[Nojima, Yuhei; Yasuoka, Yoshinori; Kume, Kiyoshi; Adachi, Hidenori; Hattori, Susumu; Matsutera, Ryo; Kohama, Yasuaki; Sasaki, Tatsuya] Osaka Minami Med Ctr, Dept Cardiovasc Med, Kawachi Nagano, Osaka 5868521, Japan	Nojima, Y (reprint author), Osaka Minami Med Ctr, Dept Cardiovasc Med, 2-1 Kidohigashi Machi, Kawachi Nagano, Osaka 5868521, Japan.	yuhei_nojima727zoso@yahoo.co.jp					Stone GW, 2006, JAMA-J AM MED ASSOC, V295, P1253, DOI 10.1001/jama.295.11.1253; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Albiero R, 2004, J AM COLL CARDIOL, V43, P943, DOI 10.1016/j.jacc.2003.09.054; Kimura T, 2002, CIRCULATION, V105, P2986, DOI 10.1161/01.CIR.0000019743.11941.3B; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Radke PW, 2003, EUR HEART J, V24, P266, DOI 10.1016/50195-668X(02)00202-6; Mehilli J, 2010, J AM COLL CARDIOL, V55, P2710, DOI 10.1016/j.jacc.2010.02.009; Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264; Mehran R, 1999, CIRCULATION, V100, P1872; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Kim YH, 2006, AM J CARDIOL, V98, P1451, DOI 10.1016/j.amjcard.2006.07.027; Huang SL, 2003, CANCER BIOL THER, V2, P222; Huang S, 2001, DRUG RESIST UPDATE, V4, P378, DOI 10.1054/drup.2002.0227; KUNTZ RE, 1992, CIRCULATION, V86, P1827; Wohrle J, 2012, J AM COLL CARDIOL, V60, P1733, DOI 10.1016/j.jacc.2012.07.040; Park DW, 2006, J AM COLL CARDIOL, V48, P2432, DOI 10.1016/j.jacc.2006.08.033; Waksman R, 2000, CIRCULATION, V101, P1895; Sousa JE, 2001, CIRCULATION, V104, P2007, DOI 10.1161/hc4201.098056; Cosgrave J, 2006, J AM COLL CARDIOL, V47, P2399, DOI 10.1016/j.jacc.2006.02.046; Colombo A, 2003, CIRCULATION, V107, P2178, DOI 10.1161/01.CIR.0000070592.04766.36; Cosgrave J, 2007, AM HEART J, V153, P354, DOI 10.1016/j.ahj.2006.12.009; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Elezi S, 1999, CATHETER CARDIO INTE, V48, P151, DOI 10.1002/(SICI)1522-726X(199910)48:2<151::AID-CCD6>3.0.CO;2-C; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Garg S, 2007, CATHETER CARDIO INTE, V70, P9, DOI 10.1002/ccd.21106; KUNTZ RE, 1993, J AM COLL CARDIOL, V21, P15; Kuriyama N, 2011, JACC-CARDIOVASC INTE, V4, P123, DOI 10.1016/j.jcin.2010.09.013; Lemos PA, 2004, CIRCULATION, V109, P2500, DOI 10.1161/01.CIR.0000130173.63105.4E; Mishkel GJ, 2007, J AM COLL CARDIOL, V49, P181, DOI 10.1016/j.jacc.2006.08.049; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071	34	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	DEC	2014	25	8					638	644		10.1097/MCA.0000000000000159		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT4XI	WOS:000344945000003		
J	Morita, S; Mizuno, Y; Harada, E; Kashiwagi, Y; Yoshimura, M; Murohara, T; Yasue, H				Morita, Sumio; Mizuno, Yuji; Harada, Eisaku; Kashiwagi, Yusuke; Yoshimura, Michihiro; Murohara, Toyoaki; Yasue, Hirofumi			Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, suppresses coronary spasm	CORONARY ARTERY DISEASE			English	Article						coronary spasm; endothelial dysfunction; inflammation; insulin resistance; peroxisome proliferator-activated receptor; pioglitazone	INSULIN-RESISTANCE; ENDOTHELIAL FUNCTION; VASOSPASTIC ANGINA; MYOSIN PHOSPHATASE; ARTERY SPASM; RISK-FACTORS; RHO-KINASE; ATHEROSCLEROSIS; ACETYLCHOLINE; INFLAMMATION	ObjectiveWe examined whether a peroxisome proliferator-activated receptor (PPAR-) agonist, pioglitazone, suppresses coronary spasm.BackgroundPatients with coronary spastic angina (CSA) also have endothelial dysfunction and inflammation. Activation of PPAR- improves endothelial dysfunction and inflammation.Participants and methodsThe study participants included 73 consecutive CSA patients (47 men and 26 women, mean age 63.610.4 years) who were admitted to our institution with a suspicion of CSA because of episodes of chest discomfort occurring mostly at rest in whom coronary spasm was induced by an intracoronary acetylcholine injection and a repeat acetylcholine provocation injection was administered after 6 months of follow-up. Thirty-six of the patients were administered pioglitazone15-30mg/day added on calcium channel blockers (CCBs) (pioglitazone group) and 37 were administered CCBs alone (control group). Clinical and laboratory data were also examined before and after 6 months of follow-up and the results between the two groups were compared.ResultsCoronary spasm was suppressed in 18/36 patients (50.0%) in the pioglitazone group (P<0.001) and 8/37 patients (21.6%) in the control group (P=0.008) after 6 months of treatment. Coronary spasm was thus significantly reduced in the pioglitazone group compared with the control group (P=0.011). The levels of total white blood cell count and high-sensitivity C-reactive protein decreased significantly (P<0.001 and P<0.001, respectively) in the pioglitazone group, whereas these levels did not differ in the control group (P=0.15 and 0.39, respectively) after the treatment.ConclusionPioglitazone added on CCBs significantly reduced coronary spasm compared with CCBs alone after 6 months of treatment. Pioglitazone may thus prove to be a novel therapy for coronary spasm.	[Morita, Sumio; Mizuno, Yuji; Harada, Eisaku; Kashiwagi, Yusuke; Yasue, Hirofumi] Kumamoto Kinoh Hosp, Div Cardiovasc Med, Kumamoto Aging Res Inst, Kumamoto 8608518, Japan; [Kashiwagi, Yusuke; Yoshimura, Michihiro] Jikei Univ, Dept Internal Med, Div Cardiol, Sch Med, Tokyo, Japan; [Morita, Sumio; Murohara, Toyoaki] Nagoya Univ, Sch Med, Dept Cardiol, Nagoya, Aichi 466, Japan	Yasue, H (reprint author), Kumamoto Kinoh Hosp, Div Cardiovasc Med, Kumamoto Aging Res Inst, 6-8-1 Yamamuro, Kumamoto 8608518, Japan.	yasue@juryo.or.jp	Murohara, Toyoaki/M-4958-2014		Japan Heart Foundation, Tokyo; Japan Vascular Disease Research Foundation, Kyoto, Japan	This study was supported in part by the Japan Heart Foundation, Tokyo, and the Japan Vascular Disease Research Foundation, Kyoto, Japan.	Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Plutzky J, 2011, CIRC RES, V108, P1002, DOI 10.1161/CIRCRESAHA.110.226860; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Maseri A, 2009, CIRC J, V73, P394; Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687; Hirashima O, 2000, J AM COLL CARDIOL, V35, P1860, DOI 10.1016/S0735-1097(00)00616-1; Kugiyama K, 1996, CIRCULATION, V94, P266; VITA JA, 1990, CIRCULATION, V81, P491; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001; Nakano T, 2002, CIRCULATION, V105, P2024, DOI 10.1161/01.CIR.0000014613.36469.3F; Yasue H, 2008, J AM COLL CARDIOL, V51, P1742, DOI 10.1016/j.jacc.2007.12.049; Morikawa Y, 2013, CORONARY ARTERY DIS, V24, P177, DOI 10.1097/MCA.0b013e32835cbef5; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Campia U, 2006, CIRCULATION, V113, P867, DOI 10.1161/CIRCULATIONAHA.105.549618; Kaul S, 2010, CIRCULATION, V121, P1868, DOI 10.1161/CIR.0b013e3181d34114; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI [10.2337/dc12-0413, 10.2337/dc12-041.3]; Itoh T, 2007, CIRC J, V71, P1074, DOI 10.1253/circj.71.1074; Ogawa H, 2010, CIRC J, V74, P1745, DOI 10.1253/circj.CJ-10-74-0802; Kashiwagi Y, 2013, CORONARY ARTERY DIS, V24, P559, DOI 10.1097/MCA.0000000000000024; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; SHINOZAKI K, 1995, CIRCULATION, V92, P1749; Takano H, 2009, CIRC J, V73, P214; Wakino S, 2004, CIRC RES, V95, pE45, DOI 10.1161/01.RES.0000142313.68389.92; WATERS D, 1993, CIRCULATION, V87, P38; YASUE H, 1990, CIRCULATION, V81, P482	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	DEC	2014	25	8					671	677		10.1097/MCA.0000000000000144		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT4XI	WOS:000344945000008		
J	Akutsu, Y; Kobayashi, Y; Sambe, T; Kurihara, T; Kaneko, K; Kodama, Y; Li, HL; Suyama, J; Hamazaki, Y; Iwasaki, J; Gokan, T; Itabashi, K; Oguchi, K; Uchida, N; Kobayashi, S				Akutsu, Yasushi; Kobayashi, Youichi; Sambe, Takehiko; Kurihara, Toshikazu; Kaneko, Kyouichi; Kodama, Yusuke; Li, Hui-Ling; Suyama, Jumpei; Hamazaki, Yuji; Iwasaki, Junya; Gokan, Takehiko; Itabashi, Kazuo; Oguchi, Katsuji; Uchida, Naoki; Kobayashi, Shinichi			Five-year follow-up of a giant coronary aneurysm using virtual coronary angioscopy	CORONARY ARTERY DISEASE			English	Editorial Material							KAWASAKI-DISEASE		[Akutsu, Yasushi; Sambe, Takehiko; Kurihara, Toshikazu; Uchida, Naoki; Kobayashi, Shinichi] Showa Univ, Karasuyama Hosp, Dept Internal Med Cardiol, Clin Res Inst Clin Pharmacol & Therapeut, Tokyo 1578577, Japan; [Akutsu, Yasushi; Kobayashi, Youichi; Kaneko, Kyouichi; Kodama, Yusuke; Li, Hui-Ling; Hamazaki, Yuji] Showa Univ, Sch Med, Div Cardiol, Dept Med, Tokyo 142, Japan; [Iwasaki, Junya; Itabashi, Kazuo] Showa Univ, Sch Med, Dept Pediat, Tokyo 142, Japan; [Suyama, Jumpei; Gokan, Takehiko] Showa Univ, Sch Med, Dept Radiol, Tokyo 142, Japan; [Sambe, Takehiko; Oguchi, Katsuji; Uchida, Naoki] Showa Univ, Sch Med, Dept Pharmacol, Tokyo 142, Japan	Akutsu, Y (reprint author), Showa Univ, Karasuyama Hosp, Dept Internal Med Cardiol, Clin Res Inst Clin Pharmacol & Therapeut,Setagaya, 6-11-11 Kita Karasuyama, Tokyo 1578577, Japan.	hzn01233@s02.itscom.net					Akagi T, 2005, PEDIATR CARDIOL, V26, P206, DOI 10.1007/s00246-004-0964-2; Suda K, 2011, CIRCULATION, V123, P1836, DOI 10.1161/CIRCULATIONAHA.110.978213; Schroeder S, 2002, HEART, V87, P205, DOI 10.1136/heart.87.3.205	3	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0954-6928	1473-5830		CORONARY ARTERY DIS	Coronary Artery Dis.	DEC	2014	25	8					727	729		10.1097/MCA.0000000000000157		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT4XI	WOS:000344945000016		
J	Zhang, C; Li, YP; Hou, YH; Tang, N; Ohmura, K; Koizumi, Y; Chiba, A				Zhang, Chen; Li, Yunping; Hou, Yuhang; Tang, Ning; Ohmura, Kazuyo; Koizumi, Yuichiro; Chiba, Akihiko			Corrosion resistance of Cu- and Fe-modified Ni-30Co-16Cr-15Mo alloy in aqueous hydrofluoric acid	CORROSION SCIENCE			English	Article						Nickel; Cobalt; SEM; XRD; Acid corrosion; Passive films	18CR-8NI STAINLESS STEELS; BEHAVIOR; COPPER; ENVIRONMENT; NICKEL	The effect of Cu and Fe addition on the corrosion resistance of Ni-30Co-16Cr-15Mo in hydrofluoric acid was investigated by immersion testing at 100 degrees C. Microstructural observation revealed that adding 15 wt.% Fe gives rise to a significantly deteriorated corrosion resistance that is characterized by preferential dissolution along grain boundaries, especially in cold-forged sample. Meanwhile, alloy modified with 15 wt.% Fe and 2 wt.% Cu exhibited a tremendous improvement in corrosion resistance, even after cold forging. This is probably attributed to the rapid formation of a Cu-rich passive film, which is ascribable to the noble nature and high reorganising ability of Cu. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.	[Zhang, Chen; Hou, Yuhang] Tohoku Univ, Sch Engn, Sendai, Miyagi 9808577, Japan; [Li, Yunping; Tang, Ning; Ohmura, Kazuyo; Koizumi, Yuichiro; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Li, YP (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	lyping@imr.tohoku.ac.jp	Li, Yunping/A-8109-2011; Koizumi, Yuichiro/C-2697-2011	Li, Yunping/0000-0002-4657-2923; Koizumi, Yuichiro/0000-0001-7061-7135	Regional Innovation Cluster Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan	This research was mainly supported by a Regional Innovation Cluster Program 2010 of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ye HZ, 2008, J MATER PROCESS TECH, V200, P12, DOI 10.1016/j.jmatprotec.2007.10.066; Hou YH, 2014, CORROS SCI, V89, P258, DOI 10.1016/j.corsci.2014.09.004; Liu SJ, 2007, POLYM TEST, V26, P232, DOI 10.1016/j.polymertesting.2006.10.008; PAWEL SJ, 1994, CORROSION, V50, P963; Jakupi P, 2011, CORROS SCI, V53, P1670, DOI 10.1016/j.corsci.2011.01.028; Genuino HC, 2012, J IND ENG CHEM, V18, P1529, DOI 10.1016/j.jiec.2012.03.001; [Anonymous], 1968, INC CORR ENG B, V5; Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005; Bale CW, 2009, CALPHAD, V33, P295, DOI 10.1016/j.calphad.2008.09.009; Hong JH, 2012, CORROS SCI, V54, P174, DOI 10.1016/j.corsci.2011.09.012; Pardo A, 2006, CORROS SCI, V48, P1075, DOI 10.1016/j.corsci.2005.05.002; Li YP, 2014, CORROS SCI, V78, P101, DOI 10.1016/j.corsci.2013.09.004; Critchlow GW, 2006, INT J ADHES ADHES, V26, P577, DOI 10.1016/j.ijadhadh.2005.09.003; Tomio A, 2014, CORROS SCI, V81, P144, DOI 10.1016/j.corsci.2013.12.013; BIRNBAUM HK, 1963, J APPL PHYS, V34, P2175, DOI 10.1063/1.1702711; Crook P., 2007, CORR 2007 C EXP NASH; Crook P., 2005, CORROSION NICKEL NIC; GREENE ND, 1970, CORROSION, V26, P533; GREENE ND, 1961, J ELECTROCHEM SOC, V108, P836, DOI 10.1149/1.2428234; Liu Y, 2008, CORROS SCI, V50, P1475, DOI 10.1016/j.corsci.2008.01.021; Lu GX, 2003, ENERGY ABSORPTION ST; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; Rabier J., 1976, J DE PHYS C, V7, P578; Rebak RB, 2001, MATER CORROS, V52, P289, DOI 10.1002/1521-4176(200104)52:4<289::AID-MACO289>3.0.CO;2-0; San Nalan Oya, 2011, CORROS SCI, V53, P2216; Thermo-Calc Software, NI BAS ALL DAT TCW 5; WILDE BE, 1969, CORROSION, V25, P300; Yanagihara K., 2012, JIM AUT M SEPT EH U	28	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	DEC	2014	89						81	92		10.1016/j.corsci.2014.08.010		12	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT6OT	WOS:000345059400010		
J	Lee, JS; Fushimi, K; Nakanishi, T; Hasegawa, Y; Park, YS				Lee, Jun-Seob; Fushimi, Koji; Nakanishi, Takayuki; Hasegawa, Yasuchika; Park, Yong-Soo			Corrosion behaviour of ferrite and austenite phases on super duplex stainless steel in a modified green-death solution	CORROSION SCIENCE			English	Article						Stainless steel; Potentiostatic; SEM; Anodic dissolution	GALVANIC CORROSION; PITTING CORROSION; SULFURIC-ACID; TEMPERATURE; DISSOLUTION; ALLOYS; MICROSTRUCTURE; PRECIPITATION; CHLORIDE	Corrosion behaviour of super duplex stainless steel (SDSS) in acidic chloride solution was investigated electrochemically. Potentiostatic polarisations of SDSS at -0.377 and -0.447 V-SHE resulted in selective dissolution of gamma- and alpha-phases, respectively, and were utilized for fabricating single-phase electrodes. Potentiodynamic polarisation curve of SDSS could be calculated from those of single-phase electrodes. The higher corrosion current density and less noble corrosion potential of alpha-phase characterised by galvanic connection with gamma-phase indicated that alpha- and gamma-phases were functioned as the anode and the cathode, respectively, in the corrosion of SDSS. (C) 2014 Elsevier Ltd. All rights reserved.	[Lee, Jun-Seob] Hokkaido Univ, Grad Sch Chem Sci & Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Fushimi, Koji; Nakanishi, Takayuki; Hasegawa, Yasuchika] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Park, Yong-Soo] Yonsei Univ, Dept Mat Sci & Engn, Seoul 120749, South Korea	Fushimi, K (reprint author), Hokkaido Univ, Fac Engn, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	kfushimi@eng.hokudai.ac.jp	Fushimi, Koji/E-6642-2014	Fushimi, Koji/0000-0002-8945-0969			Agarwal DC, 1997, MATER CORROS, V48, P542, DOI 10.1002/maco.19970480810; de Assis KS, 2012, CORROS SCI, V59, P71, DOI 10.1016/j.corsci.2012.02.014; Luo H, 2012, ELECTROCHIM ACTA, V64, P211, DOI 10.1016/j.electacta.2012.01.025; Vignal V, 2013, CORROS SCI, V67, P109, DOI 10.1016/j.corsci.2012.10.009; Le DP, 2008, CORROS SCI, V50, P1195, DOI 10.1016/j.corsci.2007.11.027; Xiang HL, 2009, ACTA METALL SIN, V45, P1456; Fushimi K, 2013, ELECTROCHIM ACTA, V113, P741, DOI 10.1016/j.electacta.2013.03.021; Tsai WT, 2007, CORROS SCI, V49, P3659, DOI 10.1016/j.corsci.2007.03.035; Ha H, 2007, ELECTROCHIM ACTA, V52, P2175, DOI 10.1016/j.electacta.2006.08.034; Zanotto F, 2014, CORROS SCI, V80, P205, DOI 10.1016/j.corsci.2013.11.028; Alvarez SM, 2011, CORROS SCI, V53, P1748, DOI 10.1016/j.corsci.2011.01.050; Ortiz N, 2013, CORROS SCI, V69, P236, DOI 10.1016/j.corsci.2012.12.008; Cervo R, 2010, J MATER SCI, V45, P4369, DOI [10.1007/s10853-010-4310-1, 10.1007/s10853-010-4311-0]; YAU YH, 1987, CORROSION, V43, P366; Tan H, 2009, MATER CHARACT, V60, P1049, DOI 10.1016/j.matchar.2009.04.009; Ghosh SK, 2008, MATER CHARACT, V59, P1776, DOI 10.1016/j.matchar.2008.04.008; Atrens A, 1997, J ELECTROCHEM SOC, V144, P3697, DOI 10.1149/1.1838078; Deng B, 2010, J ALLOY COMPD, V493, P461, DOI 10.1016/j.jallcom.2009.12.127; Fu Y, 2005, ACTA METALL SIN, V41, P302; Fushimi K, 2013, ELECTROCHIM ACTA, V114, P83, DOI 10.1016/j.electacta.2013.09.162; HAYES FH, 1985, J LESS-COMMON MET, V114, P89, DOI 10.1016/0022-5088(85)90393-5; Jiang DW, 2012, J IRON STEEL RES INT, V19, P50, DOI 10.1016/S1006-706X(12)60059-4; Lo I.H., 2006, CORROS SCI, V49, P3659; NILSSON JO, 1992, MATER SCI TECH SER, V8, P685; Nobell M.F.i., 2003, THESIS ROYAL I TECHN; Okamoto H., 1992, P C APPL STAINL STEE, P360; Olson J., 1986, DUPL STAINL STEELS S, P219; Pardal JM, 2010, MATER RES-IBERO-AM J, V13, P401, DOI 10.1590/S1516-14392010000300020; Perteneder E., 1986, DUPL STAINL STEELS S, P48; Kumar BS, 2013, ADV MATER RES-SWITZ, V794, P583, DOI 10.4028/www.scientific.net/AMR.794.583; SYMNIOTIS E, 1995, CORROSION, V51, P571; SYMNIOTIS E, 1990, CORROSION, V46, P2; The International Molybdenum Association (IMOA), 2009, PRACT GUID FABR DUPL, P1; Tsai WT, 2008, CORROSION, V64, P155, DOI 10.5006/1.3280684; YAU YH, 1991, CORROSION, V47, P352	35	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	DEC	2014	89						111	117		10.1016/j.corsci.2014.08.014		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT6OT	WOS:000345059400013		
J	Hou, YH; Li, YP; Zhang, C; Koizumi, Y; Chiba, A				Hou, Yuhang; Li, Yunping; Zhang, Chen; Koizumi, Yuichiro; Chiba, Akihiko			Effects of cold working on corrosion resistance of Co-modified Ni-16Cr-15Mo alloy in hydrofluoric acid solution	CORROSION SCIENCE			English	Article						Interfaces; Alloys; Acid solutions; Acid corrosion; Cobalt; Nickel	STACKING-FAULT ENERGY; NI-BASED ALLOYS; PITTING CORROSION; MECHANICAL-BEHAVIOR; STAINLESS-STEELS; SULFURIC-ACID; CU ALLOYS; NICKEL; WATER; DEFORMATION	We examined the effects of cold working on the corrosion resistances of Ni-30Co-16Cr-15Mo and Ni-16Cr-15Mo in 5.2 M HF acid solution at 100 degrees C. After cold working, the Ni-30Co-16Cr-15Mo samples exhibited a more significant increase in hardness compared to Ni-16Cr-15Mo as well as a more localised microstructure that contained a greater number of planar slipping bands and mechanical twinning. Both alloys exhibited a decrease in corrosion resistance, with the decrease being much greater in the case of Ni-30Co-16Cr-15Mo. The difference in the corrosion resistances of the alloys was ascribable to the differences in their microstructures. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.	[Hou, Yuhang; Zhang, Chen] Tohoku Univ, Sch Engn, Sendai, Miyagi 9808577, Japan; [Li, Yunping; Koizumi, Yuichiro; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Li, YP (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	lyping@imr.tohoku.ac.jp	Li, Yunping/A-8109-2011; Koizumi, Yuichiro/C-2697-2011	Li, Yunping/0000-0002-4657-2923; Koizumi, Yuichiro/0000-0001-7061-7135	Ministry of Education, Culture, Sports, Science and Technology of Japan	This research was mainly supported by a Regional Innovation Cluster Program 2010 of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nakhaie D, 2014, CORROS SCI, V80, P290, DOI 10.1016/j.corsci.2013.11.039; Honesty NR, 2013, CORROS SCI, V67, P67, DOI 10.1016/j.corsci.2012.10.002; Ye HZ, 2008, J MATER PROCESS TECH, V200, P12, DOI 10.1016/j.jmatprotec.2007.10.066; Chen T, 2013, CORROS SCI, V77, P230, DOI 10.1016/j.corsci.2013.08.007; Wang YX, 2011, CORROS SCI, V53, P2761, DOI 10.1016/j.corsci.2011.05.011; Liu SJ, 2007, POLYM TEST, V26, P232, DOI 10.1016/j.polymertesting.2006.10.008; Alvarez SM, 2013, CORROS SCI, V69, P130, DOI 10.1016/j.corsci.2012.11.033; PAWEL SJ, 1994, CORROSION, V50, P963; Vignal V, 2013, CORROS SCI, V68, P275, DOI 10.1016/j.corsci.2012.11.013; Li WJ, 2013, CORROS SCI, V68, P25, DOI 10.1016/j.corsci.2012.10.027; Alizadeh M, 2013, CORROS SCI, V70, P170, DOI 10.1016/j.corsci.2013.01.026; Lu ZP, 2012, CORROS SCI, V58, P211, DOI 10.1016/j.corsci.2012.01.029; Zhang XQ, 2014, ELECTROCHIM ACTA, V125, P543, DOI 10.1016/j.electacta.2014.01.143; Cheng CQ, 2013, CORROS SCI, V70, P235, DOI 10.1016/j.corsci.2013.01.035; Youssef K, 2011, ACTA MATER, V59, P5758, DOI 10.1016/j.actamat.2011.05.052; Hou J, 2011, CORROS SCI, V53, P1137, DOI 10.1016/j.corsci.2010.11.022; Yang YG, 2013, CORROS SCI, V73, P250, DOI 10.1016/j.corsci.2013.04.013; Ter-Ovanessian B, 2013, CORROS SCI, V67, P11, DOI 10.1016/j.corsci.2012.09.048; Genuino HC, 2012, J IND ENG CHEM, V18, P1529, DOI 10.1016/j.jiec.2012.03.001; [Anonymous], 1968, INC CORR ENG B, V5; Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005; Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1767, DOI 10.1016/j.electacta.2005.02.103; Jakupi P, 2011, ELECTROCHIM ACTA, V56, P6251, DOI 10.1016/j.electacta.2010.07.064; Li YP, 2014, CORROS SCI, V78, P101, DOI 10.1016/j.corsci.2013.09.004; Critchlow GW, 2006, INT J ADHES ADHES, V26, P577, DOI 10.1016/j.ijadhadh.2005.09.003; Avramovic Z, 2004, CORROS SCI, V46, P2793, DOI 10.1016/j.corsci.2004.03.010; Bouchaud B, 2013, CORROS SCI, V68, P176, DOI 10.1016/j.corsci.2012.11.010; Kamoutsi H, 2014, CORROS SCI, V80, P139, DOI 10.1016/j.corsci.2013.11.021; Li Y., 2013, MAT SCI ENG A-STRUCT, V581A, P161; Li YP, 2013, SCRIPTA MATER, V68, P171, DOI 10.1016/j.scriptamat.2012.10.007; Li YP, 2011, J MATER RES, V26, P3098, DOI 10.1557/jmr.2011.369; Ortiz MR, 2013, CORROS SCI, V68, P72, DOI 10.1016/j.corsci.2012.10.037; Rebak RB, 2001, MATER CORROS, V52, P289, DOI 10.1002/1521-4176(200104)52:4<289::AID-MACO289>3.0.CO;2-0; Shkatulyak N., 2013, INT J NONFERROUS MET, V2, P35; Suzuki T, 2013, MAT SCI ENG A-STRUCT, V563, P117, DOI 10.1016/j.msea.2012.11.041; Wu XX, 2013, MATER DESIGN, V47, P372, DOI 10.1016/j.matdes.2012.12.006; Yanagihara K., 2012, JIM AUT M SEPT EH U; Zhang Y, 2009, SCRIPTA MATER, V60, P211, DOI 10.1016/j.scriptamat.2008.10.005	38	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-938X	1879-0496		CORROS SCI	Corrosion Sci.	DEC	2014	89						258	267		10.1016/j.corsci.2014.09.004		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT6OT	WOS:000345059400029		
J	Yoshitaka, S; Egi, M; Kanazawa, T; Toda, Y; Morita, K				Yoshitaka, Shiho; Egi, Moritoki; Kanazawa, Tomoyuki; Toda, Yuichiro; Morita, Kiyoshi			The association of plasma gamma-aminobutyric acid concentration with postoperative delirium in critically ill patients	CRITICAL CARE AND RESUSCITATION			English	Article							CEREBROSPINAL-FLUID; RISK-FACTORS; GABA; MECHANISMS; RECEPTORS; PROPOFOL; DISEASE; SYSTEM	Objective: Delirium is a common complication in postoperative, critically ill patients. The mechanism of postoperative delirium is not well understood but many studies have shown significant associations between benzodiazepine use, alcohol withdrawal and cirrhosis, and an increased risk of delirium. We aimed to investigate a possible link with alterations of gamma-aminobutyric acid (GABA) activity. Design, setting and participants: A prospective observational investigation of 40 patients >20 years old who had undergone elective surgery with general anaesthesia and were expected to need postoperative intensive care for more than 48 hours. We assessed postoperative delirium using the confusion assessment method in the intensive care unit at 1 hour after the operation and on postoperative Day (POD) 1 and POD 2. We collected blood samples for measurement of plasma GABA concentrations before the operation and on POD 1 and 2. Main outcome measures: Postoperative delirium and perioperative plasma GABA concentrations in patients with and without delirium. Results: Postoperative delirium occurred in 13 of the patients. Patients with delirium had significantly higher Acute Physiology and Chronic Health Evaluation IF scores than patients without delirium. The mean plasma GABA concentration on POD 2 was significantly lower in patients with delirium than in those without delirium. After adjustment of relevant variables, plasma GABA concentration on POD 2 was independently associated with postoperative delirium. Conclusions: Plasma GABA level on POD 2 has a significant independent association with postoperative delirium.	[Yoshitaka, Shiho; Egi, Moritoki; Kanazawa, Tomoyuki; Toda, Yuichiro; Morita, Kiyoshi] Okayama Univ, Sch Med, Dept Anesthesiol & Resuscitol, Okayama 700, Japan	Egi, M (reprint author), Okayama Univ, Sch Med, Dept Anesthesiol & Resuscitol, Okayama 700, Japan.						KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Guenther U, 2011, CURR OPIN ANESTHESIO, V24, P670, DOI 10.1097/ACO.0b013e32834c7b44; Steiner LA, 2011, EUR J ANAESTH, V28, P628, DOI 10.1097/EJA.0b013e328349b7f5; KURODA H, 1982, J NEUROL NEUROSUR PS, V45, P257, DOI 10.1136/jnnp.45.3.257; Flacker JM, 1999, J GERONTOL A-BIOL, V54, pB239, DOI 10.1093/gerona/54.6.B239; Mayo-Smith MF, 2004, ARCH INTERN MED, V164, P1405, DOI 10.1001/archinte.164.13.1405; ROBERTS E, 1950, J BIOL CHEM, V187, P55; Malcolm RJ, 2003, J CLIN PSYCHIAT, V64, P36; Greenfield LJ, 2013, SEIZURE-EUR J EPILEP, V22, P589, DOI 10.1016/j.seizure.2013.04.015; Alagiakrishnan K, 2004, POSTGRAD MED J, V80, P388, DOI 10.1136/pgmj.2003.017236; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; van den Boogaard M, 2012, CRIT CARE MED, V40, P112, DOI 10.1097/CCM.0b013e31822e9fc9; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; McPherson JA, 2013, CRIT CARE MED, V41, P405, DOI 10.1097/CCM.0b013e31826ab49b; BOHLEN P, 1979, BRAIN RES, V167, P297, DOI 10.1016/0006-8993(79)90824-2; Brown KE, 2013, MED HYPOTHESES, V81, P536, DOI 10.1016/j.mehy.2013.06.027; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; FERENCI P, 1988, LIVER, V8, P225; Frontera Jennifer A, 2012, Continuum (Minneap Minn), V18, P611, DOI 10.1212/01.CON.0000415431.07019.c2; PETTY F, 1994, CLIN CHEM, V40, P296; Powell-Tuck J, 2004, J ROY SOC MED, V97, P425; Vanlersberghe C., 2008, V182, P227; Yoshitaka S, J CRIT CARE, V28, P236; ZUKIN SR, 1974, P NATL ACAD SCI USA, V71, P4802, DOI 10.1073/pnas.71.12.4802	25	0	0	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit Care Resusc.	DEC	2014	16	4					269	273				5	Critical Care Medicine	General & Internal Medicine	AT5IU	WOS:000344977900006		
J	Fujiwara, K; Monk, B; Devouassoux-Shisheboran, M				Fujiwara, Keiichi; Monk, Bradley; Devouassoux-Shisheboran, Mojgan			Adenocarcinoma of the Uterine Cervix: Why Is it Different?	CURRENT ONCOLOGY REPORTS			English	Article						Cervical cancer of the uterus; Adenocarcinomas; Squamous cell carcinoma; Clinicopathological and molecular difference; Prognosis	SQUAMOUS-CELL CARCINOMA; GYNECOLOGIC-ONCOLOGY-GROUP; COMBINATION CHEMOTHERAPY; PHASE-III; CONCURRENT CHEMORADIOTHERAPY; ENDOCERVICAL ADENOCARCINOMAS; IMMUNOHISTOCHEMICAL ANALYSIS; NEOADJUVANT CHEMOTHERAPY; HUMAN-PAPILLOMAVIRUS; PROGNOSTIC-FACTORS	Adenocarcinoma (AC) of the uterine cervix is the second most frequent tumor type following squamous cell carcinoma (SCC). According to the National Comprehensive Cancer Network (NCCN) guidelines, there is no difference in the treatment strategy between SCC and AC. However, there are a number of studies that suggest a worse prognosis for AC compared to SCC. In this comprehensive review, we will try to find the reason why AC is different from SCC, and then discuss what we need to do to improve the prognosis of AC. Uterine cervical AC is clearly different from SCC based on its molecular pathogenesis, histological appearance, and clinical behavior. Therefore, it will be necessary to make a different treatment strategy, particularly for patients with locally advanced and metastatic or recurrent disease. It is most important to intensify our research into the molecular profile of AC, so that we can develop more appropriate targeted therapies. Because of its rarity, international collaboration among clinical trials with translational components will be key to increasing cure rates and improving survivorship.	[Fujiwara, Keiichi] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka City, Saitama, Japan; [Monk, Bradley] Creighton Univ Sch Med, Dign Hlth St Josephs Hosp & Med Ctr, Univ Arizona Canc Ctr, Div Gynecol Oncol,Dept Obstet & Gynecol, Phoenix, AZ 85013 USA; [Devouassoux-Shisheboran, Mojgan] Hosp Civils Lyon, Dept Pathol, Lyon, France	Fujiwara, K (reprint author), Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, 1397-1 Yamane, Hidaka City, Saitama, Japan.	fujiwara@saitama-med.ac.jp			Roche/Genentech	Dr. Bradley Monk has received grants from Roche/Genentech.	Ramirez PT, 2011, CANCER-AM CANCER SOC, V117, P1928, DOI 10.1002/cncr.25739; Rotman M, 2006, INT J RADIAT ONCOL, V65, P169, DOI 10.1016/j.ijrobp.2005.10.019; Monk BJ, 2007, GYNECOL ONCOL, V105, P427, DOI 10.1016/j.ygyno.2006.12.027; Castellsague X, 2006, J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Toita T, 2012, GYNECOL ONCOL, V126, P211, DOI 10.1016/j.ygyno.2012.04.036; Shimada M, 2006, GYNECOL ONCOL, V101, P234, DOI 10.1016/j.ygyno.2005.10.004; Tornesello ML, 2013, GYNECOL ONCOL, V128, P442, DOI 10.1016/j.ygyno.2012.11.017; McCusker ME, 2003, GYNECOL ONCOL, V88, P333, DOI 10.1016/S0090-8258(02)00150-6; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Moore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170; Curtin JP, 2001, J CLIN ONCOL, V19, P1275; Mikami Y, 2004, MODERN PATHOL, V17, P962, DOI 10.1038/modpathol.3800148; Sherman ME, 2005, CANCER, V103, P1258, DOI 10.1002/cncr.20877; Wang SS, 2004, CANCER, V100, P1035, DOI 10.1002/cncr.20064; Kim HS, 2013, EJSO-EUR J SURG ONC, V39, P115, DOI 10.1016/j.ejso.2012.09.003; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Silver SA, 2001, AM J SURG PATHOL, V25, P379, DOI 10.1097/00000478-200103000-00013; Mikami Y, 2013, ADV ANAT PATHOL, V20, P227, DOI 10.1097/PAP.0b013e31829c2d66; Park KJ, 2011, AM J SURG PATHOL, V35, P633, DOI 10.1097/PAS.0b013e31821534b9; McCluggage WG, 2008, INT J GYNECOL PATHOL, V27, P92, DOI 10.1097/pgp.0b013e31815698e7; Katsumata N, 2013, BRIT J CANCER, V108, P1957, DOI 10.1038/bjc.2013.179; EIFEL PJ, 1995, GYNECOL ONCOL, V59, P38, DOI 10.1006/gyno.1995.1265; GILKS CB, 1989, AM J SURG PATHOL, V13, P717, DOI 10.1097/00000478-198909000-00001; Galic V, 2012, GYNECOL ONCOL, V125, P287, DOI 10.1016/j.ygyno.2012.01.012; Baalbergen A, 2004, GYNECOL ONCOL, V92, P262, DOI 10.1016/j.ygyno.2003.09.001; Kojima A, 2007, AM J SURG PATHOL, V31, P664, DOI 10.1097/01.pas.0000213434.91868.b0; Gien LT, 2010, GYNECOL ONCOL, V116, P140, DOI 10.1016/j.ygyno.2009.09.040; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Takekida S, 2010, INT J GYNECOL CANCER, V20, P1563, DOI 10.1111/IGC.0b013e3181a81221; [Anonymous], 2014, NCCN CLIN PRACTICE G; Aoki D, 2014, J OBSTET GYNAECOL RE, V40, P338, DOI 10.1111/jog.12360; Rajkumar T, 2006, INT J CANCER, V118, P1481; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Chao A, 2006, INT J CANCER, V119, P91, DOI 10.1002/ijc.21813; Davy MLJ, 2003, OBSTET GYNECOL, V101, P38, DOI 10.1016/S0029-7844(02)02275-5; EIFEL PJ, 1990, CANCER, V65, P2507, DOI 10.1002/1097-0142(19900601)65:11<2507::AID-CNCR2820651120>3.0.CO;2-9; Hirai Y, 2004, AM J OBSTET GYNECOL, V191, P1173, DOI 10.1016/j.ajog.2004.04.015; HOPKINS MP, 1991, OBSTET GYNECOL, V77, P912; Huang YT, 2011, INT J RADIAT ONCOL, V80, P429, DOI 10.1016/j.ijrobp.2010.02.009; Irie T, 2000, EUR J SURG ONCOL, V26, P464, DOI 10.1053/ejso.1999.0923; JONES MW, 1993, INT J GYNECOL PATHOL, V12, P1, DOI 10.1097/00004347-199301000-00001; Kasamatsu T, 2002, GYNECOL ONCOL, V85, P327, DOI 10.1006/gyno.2002.6624; Kastritis E, 2005, GYNECOL ONCOL, V99, P376, DOI 10.1016/j.ygyno.2005.06.024; Kuji S, 2014, J GYNECOL ONCOL, V25, P90, DOI 10.3802/jgo.2014.25.2.90; Kurman RJ, 2014, WHO CLASSIFICATION T; Nagai Y, 2012, ANTICANCER RES, V32, P1475; Nagao S, 2005, GYNECOL ONCOL, V96, P805, DOI 10.1016/j.ygyno.2004.11.044; Ramirez Pedro T, 2007, Gynecol Oncol, V104, P9, DOI 10.1016/j.ygyno.2006.10.032; Tang J, 2012, GYNECOL ONCOL, V125, P297, DOI 10.1016/j.ygyno.2012.01.033; Wistuba II, 1999, GYNECOL ONCOL, V74, P519, DOI 10.1006/gyno.1999.5485; Wright AA, 2013, CANCER-AM CANCER SOC, V119, P3776, DOI 10.1002/cncr.28288; Zhou C, 1998, AM J SURG PATHOL, V22, P113, DOI 10.1097/00000478-199801000-00015	53	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1523-3790	1534-6269		CURR ONCOL REP	Curr. Oncol. Rep.	DEC	2014	16	12							416	10.1007/s11912-014-0416-y		9	Oncology	Oncology	AU0RX	WOS:000345332900004		
J	Seino, Y; Allen, JE				Seino, Yutomo; Allen, Jacqui E.			Treatment of aging vocal folds: surgical approaches	CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY			English	Review						aging; glottal incompetence; glottis; laryngoplasty; presbylaryngis; thyroplasty	INJECTION LARYNGOPLASTY; MEDIALIZATION THYROPLASTY; VOICE DISORDERS; HYALURONIC-ACID; GLOTTIC INCOMPETENCE; PARALYSIS; AGE; AUGMENTATION; OUTCOMES; POPULATION	Purpose of reviewAging may affect the voice through either physiological or pathological changes. Globally society is aging and the working lifetime is extending. Increasing numbers of elderly will present with voice issues. This review examines current thinking regarding surgical treatment of the aging voice.Recent findingsThe mainstay of surgical treatment remains injection laryngoplasty and medialization thyroplasty. In-office injection laryngoplasty is increasingly common. Data suggest that patients with vocal fold atrophy do not achieve as much benefit from augmentation treatments as other causes of glottal incompetence. In addition the timing of injection laryngoplasty may influence the rate of subsequent medialization thyroplasty. Disease-specific treatments can provide some benefit to voice, such as deep brain stimulation in Parkinson's disease. Novel treatments including growth factor therapy are entering clinical practice and will provide new options for the clinician in future.SummaryVoice disorders affect approximately 20% of the elderly population. Causes include neurologic, malignant, iatrogenic and benign vocal fold disorders. These should be ruled out before accepting dysphonia is age-related in nature. Treatment should be specific to recognized vocal disorders but may also address physiologic changes in the glottis. Injection laryngoplasty and thyroplasty remain effective options for treating glottal incompetence but novel therapies are showing promising results.	[Seino, Yutomo] Kitasato Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Sagamihara, Kanagawa 228, Japan; [Allen, Jacqui E.] Univ Auckland, Fac Med & Hlth Sci, Auckland 1142, New Zealand	Allen, JE (reprint author), Univ Auckland, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1142, New Zealand.	jeallen@voiceandswallow.co.nz					Alghonaim Y, 2013, J OTOLARYNGOL-HEAD N, V42, DOI 10.1186/1916-0216-42-24; Rosen CA, 2009, LARYNGOSCOPE, V119, P1033, DOI 10.1002/lary.20126; Choi J, 2012, J LARYNGOL OTOL, V126, P260, DOI 10.1017/S0022215111002702; Mallur PS, 2010, CLIN EXP OTORHINOLAR, V3, P177, DOI 10.3342/ceo.2010.3.4.177; Sulica L, 2010, LARYNGOSCOPE, V120, P319, DOI 10.1002/lary.20737; Prendes BL, 2012, LARYNGOSCOPE, V122, P2227, DOI 10.1002/lary.23473; Ohno T, 2009, ANN OTO RHINOL LARYN, V118, P735; Gartner-Schmidt J, 2011, LARYNGOSCOPE, V121, P585, DOI 10.1002/lary.21122; Woo SH, 2013, J VOICE, V27, P236, DOI 10.1016/j.jvoice.2012.11.001; Turley R, 2009, OTOLARYNG HEAD NECK, V140, P33, DOI 10.1016/j.otohns.2008.10.010; Roy N, 2007, LARYNGOSCOPE, V117, P628, DOI 10.1097/MLG.0b013e3180306da1; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Hirano S, 2012, LARYNGOSCOPE, V122, P327, DOI 10.1002/lary.22393; Zealear DL, 2009, LARYNGOSCOPE, V119, P1737, DOI 10.1002/lary.20587; Upton DC, 2013, ANN OTO RHINOL LARYN, V122, P541; Carroll TL, 2011, LARYNGOSCOPE, V121, P313, DOI 10.1002/lary.21258; Wen MH, 2013, OTOLARYNG HEAD NECK, V149, P900, DOI 10.1177/0194599813508082; Long JL, 2010, OTOLARYNG HEAD NECK, V142, P438, DOI 10.1016/j.otohns.2009.11.020; Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15; Davids T, 2012, LARYNGOSCOPE, V122, P332, DOI 10.1002/lary.22397; Birkent H, 2013, LARYNGOSCOPE, V123, P1759, DOI 10.1002/lary.24010; Bielamowicz S, 2004, ARCH OTOLARYNGOL, V130, P1114, DOI 10.1001/archotol.130.9.1114; Buckmire RA, 2011, J VOICE, V25, P288, DOI 10.1016/j.jvoice.2009.12.003; Conoyer JM, 2006, ANN OTO RHINOL LARYN, V115, P837; Golub JS, 2006, J AM GERIATR SOC, V54, P1736, DOI 10.1111/j.1532-5415.2006.00915.x; Gregory ND, 2010, J VOICE, V26, P254; Hawkshaw MJ, 2012, J VOICE, V26, P769, DOI 10.1016/j.jvoice.2012.05.004; Imaizumi M, 2013, ANN OTO RHINOL LARYN, V122, P737; Johns MM, 2011, OTOLARYNG HEAD NECK, V145, P1, DOI 10.1177/0194599811404640; Kwon TK, 2010, LARYNGOSCOPE, V120, P326, DOI 10.1002/lary.20749; Long JL, 2010, CURR OPIN OTOLARYNGO, V18, P512; Mesallam TA, 2011, CLIN EXP OTORHINOLAR, V4, P142, DOI 10.3342/ceo.2011.4.3.142; Reiter Rudolf, 2012, J Voice, V26, P785, DOI 10.1016/j.jvoice.2011.11.007; Rosen CA, 2008, OPERATIVE TECHNIQUES; Schneider-Stickler B, 2013, EUR ARCH OTO-RHINO-L, V270, P1689, DOI 10.1007/s00405-013-2416-1; Selber J, 2003, J VOICE, V17, P88, DOI 10.1016/S0892-1997(03)00025-0; Shah RN, 2013, LARYNGOSCOPE, V123, P1742, DOI 10.1002/lary.23983; Szkielkowska A, 2013, MED SCI MONITOR, V19, P276, DOI 10.12659/MSM.883888; Tan ML, 2011, J VOICE, V25, P619, DOI 10.1016/j.jvoice.2010.08.001; Ting JY, 2012, J VOICE, V26, P797, DOI 10.1016/j.jvoice.2012.02.004; Tsunoda Koichi, 2005, Laryngoscope, V115, P1, DOI 10.1097/01.mlg.0000183966.72921.31; Tsunoda K, 1999, LARYNGOSCOPE, V109, P504, DOI 10.1097/00005537-199903000-00030; Verma SP, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.10.006; Woo SH, 2013, YONSEI MED J, V54, P1516, DOI 10.3349/ymj.2013.54.6.1516	44	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1068-9508	1531-6998		CURR OPIN OTOLARYNGO	Curr. Opin. Otolaryngol. Head Neck Surg.	DEC	2014	22	6					466	471		10.1097/MOO.0000000000000099		6	Otorhinolaryngology	Otorhinolaryngology	AT4QX	WOS:000344926800007		
J	Ohno, T; Hirano, S				Ohno, Tsunehisa; Hirano, Shigeru			Treatment of aging vocal folds: novel approaches	CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY			English	Review						aging vocal fold; growth factor therapy; regenerative medicine; tissue engineering	HEPATOCYTE GROWTH-FACTOR; AGE-RELATED-CHANGES; FACTOR THERAPY; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; HYALURONIC-ACID; STROMAL CELLS; CANINE MODEL; REGENERATION; COLLAGEN	Purpose of reviewThis article aims to review previous research reports and to summarize current strategies for the treatment of the aging vocal fold using regenerative medicine and tissue engineering, with a particular focus on growth factor therapy.Recent findingsPrevious studies have elucidated age-related histological and gene expression changes in key extracellular matrix components, such as collagen and hyaluronan, in the lamina propria of the aging vocal fold. On the basis of these findings, our research group has focused on growth factor therapy to restore extracellular matrix distribution in the aging vocal fold to a younger state. Results from recent studies with basic fibroblast growth factor and hepatocyte growth factor provided preliminary evidence of the regenerative effects of growth factor therapy on treatment of the aging vocal fold. In addition, a clinical trial using basic fibroblast growth factor revealed improvements of maximum phonation time, mean flow rate, and acoustic parameters in atrophied vocal folds. These positive findings suggest that the administration of basic fibroblast growth factor may become a useful tool for the treatment of the aging vocal fold.SummaryRegenerative medicine and tissue engineering are innovative strategies for the treatment of aging vocal folds, and recent reports have also confirmed the therapeutic potential of growth factor therapy for the treatment of the aging vocal fold. More recently, the clinical application of basic fibroblast growth factor was reported with encouraging outcomes. Continued basic research and clinical investigations will be required to develop strategies to overcome age-related voice disorders.	[Ohno, Tsunehisa] Kurashiki Cent Hosp, Dept Otolaryngol Head & Neck Surg, Kurashiki, Okayama, Japan; [Hirano, Shigeru] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan	Hirano, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, 54 Shogoin Kawaharamachi, Kyoto 6068507, Japan.	hirano@ent.kuhp.kyoto-u.ac.jp					Hirano S, 2004, LARYNGOSCOPE, V114, P2161, DOI 10.1097/01.mlg.0000149450.37640.db; Palmon A, 2001, J PERIODONTAL RES, V36, P65, DOI 10.1034/j.1600-0765.2001.360201.x; Ohno T, 2009, ANN OTO RHINOL LARYN, V118, P735; HELDIN P, 1989, BIOCHEM J, V258, P919; Hammond TH, 2000, ANN OTO RHINOL LARYN, V109, P913; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Gray SD, 1999, LARYNGOSCOPE, V109, P845, DOI 10.1097/00005537-199906000-00001; Hirano S, 2012, LARYNGOSCOPE, V122, P327, DOI 10.1002/lary.22393; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Matsumoto K, 2001, KIDNEY INT, V59, P2023; Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915; Hirano S, 2005, ANN OTO RHINOL LARYN, V114, P304; Ueki T, 1999, NAT MED, V5, P226; Chan RW, 1999, LARYNGOSCOPE, V109, P1142, DOI 10.1097/00005537-199907000-00026; Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15; Sato K, 1997, ANN OTO RHINOL LARYN, V106, P44; Kanemaru S, 2013, LARYNGOSCOPE, V123, P2728, DOI 10.1002/lary.24060; Ohno T, 2009, LARYNGOSCOPE, V119, P1424, DOI 10.1002/lary.20497; Suehiro A, 2011, LARYNGOSCOPE, V121, P1726, DOI 10.1002/lary.21816; Butler JE, 2001, LARYNGOSCOPE, V111, P907, DOI 10.1097/00005537-200105000-00029; Dias Garcia RI, 2012, J VOICE, V26; Ding H, 2001, J GERONTOL A-BIOL, V56, pB145; Ford C, 2004, ARCH OTOLARYNGOL, V130, P1117, DOI 10.1001/archotol.130.9.1117; Graupp M, 2014, J VOICE, V28, P420, DOI 10.1016/j.jvoice.2013.11.005; Gray SD, 1993, MOL CELLULAR STRUCTU, P1; Gugatschka M, 2012, J VOICE, V26; Hirano M., 1985, COVER BODY THEORY VO, P1; Hirano M., 1981, ASHA REP, V11, P11; Hirano S, 2004, ANN OTO RHINOL LARYN, V113, P777; Hirano S, 2008, LARYNGOSCOPE, V118, P2254, DOI 10.1097/MLG.0b013e3181845720; Hom David B, 2002, Facial Plast Surg, V18, P41, DOI 10.1055/s-2002-19826; Kanemaru S, 2005, ANN OTO RHINOL LARYN, V114, P907; Kishirnoto Y, 2009, ANN OTO RHINOL LARYN, V118, P613; Manuel JA, 2006, MATRIX BIOL, V25, P505, DOI 10.1016/j.matbio.2006.07.008; Mizuno S, 2005, FASEB J, V19, P580, DOI 10.1096/fj.04-1535fje; Ohno S, 2009, ANN OTO RHINOL LARYN, V118, P805; Ohno T, 2008, ANN OTO RHINOL LARYN, V117, P696; Ohno T, 2009, ANN OTO RHINOL LARYN, V118, P559; Ohno T, 2007, ANN OTO RHINOL LARYN, V116, P762; Ramig LO, 2001, FOLIA PHONIATR LOGO, V53, P252, DOI 10.1159/000052680	41	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1068-9508	1531-6998		CURR OPIN OTOLARYNGO	Curr. Opin. Otolaryngol. Head Neck Surg.	DEC	2014	22	6					472	476		10.1097/MOO.0000000000000096		5	Otorhinolaryngology	Otorhinolaryngology	AT4QX	WOS:000344926800008		
J	Takahashi, M; Koide, K; Mizuhashi, F				Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi			Influence of sheet material shape on the thickness and fit of mouthguards	DENTAL TRAUMATOLOGY			English	Article						mouthguard; sheet material shape; thickness; fit; vacuum formation		The aim of this study was to evaluate the influence of sheet material shape on the thickness and fit of mouthguards. Mouthguards were fabricated using ethylene vinyl acetate sheets (4.0mm thick) and a vacuum-forming machine. The working model was trimmed to a height of 20mm at the incisor and 15mm at the first molar. Three forming conditions were compared: Square sheets were fabricated while being secured by the clamping frames attached to the forming machine; round sheets were fabricated while secured by a circle tray; and square sheets were fabricated while secured by a circle tray. Each condition was defined when the sheet sagged by 15mm below the level of the clamp. The thickness of the sheet was determined for the incisal and molar portion. Additionally, the difference in fit according to the forming conditions was analyzed. Differences in the material thickness or the fit due to forming conditions were analyzed using one-way analysis of variance (anova). Round sheets resulted in the thinnest mouthguard at the incisor and molar region and produced the best fit. For square sheets, no significant difference in thickness was observed between the clamping frame and circle tray methods. The fit of the mouthguard at the first molar was better when using square sheets fabricated by a circle tray than those fabricated by the clamping frame. In conclusion, when molding a mouthguard using square sheets, the thickness reduction was less and fit was better with using a circle tray, which may be clinically useful.	[Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi] Nippon Dent Univ Sch Life Dent Niigata, Dept Removable Prosthodont, Niigata 9518580, Japan	Takahashi, M (reprint author), Nippon Dent Univ Sch Life Dent Niigata, Dept Removable Prosthodont, Chuo Ku, 1-8 Hamaura Cho, Niigata 9518580, Japan.	mutsumit@ngt.ndu.ac.jp					Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Bemelmanns P, 2001, INT J SPORTS MED, V22, P149, DOI 10.1055/s-2001-11342; DelsRossi G, 2007, DENT TRAUMATOL, V23, P149; DELSROSSI G, 2008, DENT TRAUMTOL, V24, P197; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Iinuma M, 2003, J SPORTS DENT, V6, P16; Ishijima T, 1992, J JPN PROSTHODONT SO, V36, P116; JOHNSEN D C, 1991, Dental Clinics of North America, V35, P657; Kawarai C, 2002, J SPORTS DENT, V5, P25; Kawarai C, 2004, J SPORTS DENT, V7, P36; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Maeda Y, 2006, MANUAL CONJUGATED FO, P21; Maeda Y, 2007, HYOGO DENT ASS, V667, P28; Mizuhashi F, 2012, DENT TRAUMATOL, V28, P291, DOI 10.1111/j.1600-9657.2011.01091.x; Mizuhashi F, 2012, DENT TRAUMATOL, V22, P23; Morii H., 1998, NIHON U DENT J, V72, P331; Nishida J, 2006, JPN J SPORTS DENT, V9, P25; Otani R, 2007, J GIFU DENT SOC, V34, P55; Padilla R, 1996, J Calif Dent Assoc, V24, P30; Takahashi F, 2003, J SPORTS DENT, V6, P30; Takahashi F, 2008, J SPORTS DENT, V11, P64; Takahashi F, 2004, J SPORTS DENT, V7, P12; Takahashi F, 2003, J SPORTS DENT, V6, P36; Takahashi M, 2012, J PROSTHODONT RES, V56, P194, DOI 10.1016/j.jpor.2011.11.002; Takahashi M, 2011, ANN JPN PROTHODONT S, V3, P135; Takeuchi M., 2008, PRACTICE SPORTS DENT, P10; Takeuchi M, 2006, EFFECTIVELY THERMOFO, p[24, 54]; Tunc SE, 2013, DENT TRAUMATOL, V29, P378; Westerman B, 1995, AUST DENT J, V40, P389; Yamada J, 2003, J SPORTS DENT, V6, P42; Yamada Junko, 2007, J Prosthodont, V16, P452, DOI 10.1111/j.1532-849X.2007.00222.x; Yasui T, 2001, DENT PRODUCTS NEWS, V124, P13	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	DEC	2014	30	6					455	460		10.1111/edt.12112		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU0US	WOS:000345340900007		
J	Mizuhashi, F; Koide, K; Takahashi, M				Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi			Assessing change in mouthguard thickness according to the thickness of the original mouthguard sheet	DENTAL TRAUMATOLOGY			English	Article						Mouthguard; Thickness; Sheet condition		The aim of this study was to examine changes in thickness and differences in rate of change of mouthguard thickness according to the thickness of the original sheet used to form the mouthguard. The material used in this study was Sports Mouthguard (3.0, 3.8, and 5.0mm thicknesses, ethylene vinyl acetate sheet). The sheets were heated until they hung 15mm from the baseline and were then vacuum formed. The thickness of the mouthguard was measured, and the rate of change of thickness was calculated. The differences in thickness and rate of change of thickness at the labial surface of the central incisor and buccal surface of the first molar according to the thickness of sheet were analyzed by one-way anova, and that of the occlusal surface of the first molar was analyzed by the Kruskal-Wallis test. The results showed that the thickness of mouthguard increased as the thickness of sheet increased (P<0.05 or P<0.01). The thickness of the sheet did not affect the rate of change of thickness at the central incisor and occlusal surface of the first molar. Adequate thickness could be obtained using the original sheet with a thickness >3.8mm at the buccal surface of the first molar and >3.0mm at the occlusal surface of the first molar. At the central incisor, the necessary thickness of the original sheet was calculated as 5.6mm. These results would be useful for selecting the appropriate mouthguard sheet material.	[Mizuhashi, Fumi; Koide, Kaoru; Takahashi, Mutsumi] Nippon Dent Univ Sch Life Dent Niigata, Dept Removable Prosthodont, Niigata 9518580, Japan	Mizuhashi, F (reprint author), Nippon Dent Univ Sch Life Dent Niigata, Dept Removable Prosthodont, Chuo Ku, 18 Hamaura Cho, Niigata 9518580, Japan.	fumichan@ngt.ndu.ac.jp					Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Tran D, 2001, DENT TRAUMATOL, V17, P260, DOI 10.1034/j.1600-9657.2001.170604.x; Chi Howard H, 2007, Compend Contin Educ Dent, V28, P36; Del Rossi G, 2007, DENT TRAUMATOL, V23, P149, DOI 10.1111/j.1600-9657.2006.00436.x; Hoffmann J, 1999, ENDOD DENT TRAUMATOL, V15, P157; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Low Danny, 2002, Ann R Australas Coll Dent Surg, V16, P153; Nishizawa Y, 2004, OSTEOPOROSIS JAPAN, V12, P191; Padilla R, 1996, J Calif Dent Assoc, V24, P30; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; Santos Filho Paulo César de Freitas, 2007, J Contemp Dent Pract, V8, P89; Spinas E, 2007, Eur J Paediatr Dent, V8, P193; Takahashi F, 2003, J SPORTS DENT, V6, P30; Takahashi F, 2004, J SPORTS DENT, V7, P12	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	DEC	2014	30	6					468	471		10.1111/edt.12115		4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU0US	WOS:000345340900009		
J	Takahashi, M; Koide, K; Mizuhashi, F				Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi			Differences in the thickness of mouthguards fabricated from ethylene vinyl acetate copolymer sheets with differently arranged v-shaped grooves: part 2-effect of shape on the working model	DENTAL TRAUMATOLOGY			English	Article						mouthguard; thickness; sheet material shape; working model shape; ethylene vinyl acetate sheet	VACUUM-FORMING PROCESS; MOUTH GUARDS; FIT	The aim of this study was to evaluate the change in thickness of a working model mouthguard sheet due to different shape. Mouthguards were fabricated with ethylene vinyl acetate (EVA) sheets (4.0mm thick) using a vacuum-forming machine. Two shapes of the sheet were compared: normal sheet or v-shaped groove 10-40mm from the anterior end. Additionally, two shapes of the working model were compared; the basal plane was vertical to the tooth axis of the maxillary central incisor (condition A), and the occlusal plane was parallel to the basal plane (condition B). Sheets were heated until they sagged 15mm below the clamp. Postmolding thickness was determined for the incisal portion (incisal edge and labial surface) and molar portion (cusp and buccal surface). Differences in the change in thickness due to the shape of the sheets and model were analyzed using two-way anova followed by a Bonferroni's multiple comparison tests. The thickness of the mouthguard sheet with v-shaped grooves was more than that of the normal sheet at all measuring points under condition A and condition B (P<0.01). The thickness of condition B was less than that of condition A, there the incisal portion in the normal sheet and the incisal edge in the sheet with v-shaped grooves (P<0.01). The present results suggested that thickness after molding was secured by the use of the sheet with v-shaped grooves. In particular, the model with the undercut on the labial surface may be clinically useful.	[Takahashi, Mutsumi; Koide, Kaoru; Mizuhashi, Fumi] Nippon Dent Univ Sch Life Dent Niigata, Dept Removable Prosthodont, Niigata, Niigata, Japan	Takahashi, M (reprint author), 1-8,Hamaura Cho,Chuo Ku, Niigata 9518580, Japan.	mutsumit@ngt.ndu.ac.jp					Westerman B, 2002, DENT TRAUMATOL, V18, P24, DOI 10.1034/j.1600-9657.2002.180103.x; Takahashi M, 2013, J PROSTHODONT RES, V57, P169, DOI 10.1016/j.jpor.2013.01.004; Bemelmanns P, 2001, INT J SPORTS MED, V22, P149, DOI 10.1055/s-2001-11342; DelsRossi G, 2007, DENT TRAUMATOL, V23, P149; DELSROSSI G, 2008, DENT TRAUMTOL, V24, P197; DORNEY B, 1994, PHILLIP J, V9, P311; Geary JL, 2008, DENT TRAUMATOL, V24, P350, DOI 10.1111/j.1600-9657.2007.00550.x; Maeda Masahiko, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P211, DOI 10.2186/jjps.52.211; Mizuhashi F, 2012, DENT TRAUMATOL, V28, P291, DOI 10.1111/j.1600-9657.2011.01091.x; Mizuhashi F, 2013, DENT TRAUMATOL, V29, P307, DOI 10.1111/edt.12004; O'Malley Margaret, 2012, J Ir Dent Assoc, V58, P205; Padilla R, 1996, J Calif Dent Assoc, V24, P30; Padilla R R, 1999, J Calif Dent Assoc, V27, P200; PARK JB, 1994, J PROSTHET DENT, V72, P373, DOI 10.1016/0022-3913(94)90556-8; RANALLI D N, 1991, Dental Clinics of North America, V35, P627; Takahashi F, 2008, J SPORTS DENT, V11, P64; Takahashi F, 2004, J SPORTS DENT, V7, P12; Takahashi M, 2011, J SPORTS DENT, V14, P47; Takeuchi M, 2006, EFFECTIVELY THERMOFO, p[24, 54]; Westerman B, 1995, AUST DENT J, V40, P389; Yonehata Y, 2003, J PROSTHET DENT, V89, P23, DOI 10.1067/mpr.2003.62	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	DEC	2014	30	6					472	476		10.1111/edt.12123		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU0US	WOS:000345340900010		
J	Tsukiboshi, M; Tsukiboshi, T				Tsukiboshi, Mitsuhiro; Tsukiboshi, Taisuke			Bone morphology after delayed tooth replantation - case series	DENTAL TRAUMATOLOGY			English	Article						replantation; decoronation; ankylosis; bone resorption	PERIODONTAL-LIGAMENT CELLS; MATURE PERMANENT INCISORS; BALANCED SALT-SOLUTION; ROOT RESORPTION; STORAGE MEDIA; BIO-OSS(R) COLLAGEN; MONKEY TEETH; MILK; DOG; EXTRACTION	The purpose of this report was to describe the morphological changes in the alveolar bone after delayed replantation of avulsed teeth using three dimensional cone-beam computed tomography in 11 during the time period 2003-2012. The radiographic observations revealed the following: Delayed replantation results in ankylosis-related replacement root resorption; the resorption is delayed or arrested around the cervical area superior to the alveolar crest. The buccal bone is reduced in thickness but not the palatal bone. The buccal bone resorption of the alveolar crest progresses approximately to the root canal space of the ankylosed root. Delayed replantation does not completely maintain the bone volume. The buccal profile of alveolar bone in the maxillary anterior region is depending on teeth with viable periodontal ligament.	[Tsukiboshi, Mitsuhiro; Tsukiboshi, Taisuke] Tsukiboshi Dent Clin, Amagun, Aichi 4970050, Japan	Tsukiboshi, M (reprint author), Tsukiboshi Dent Clin, 6-8 Gakuto, Amagun, Aichi 4970050, Japan.	moonstar@guitar.ocn.ne.jp					ANDERSSON L, 1987, ENDOD DENT TRAUMATOL, V3, P288; ANDREASEN JO, 1981, INT J ORAL MAXILLOF, V10, P43, DOI 10.1016/S0300-9785(81)80007-5; ANDREASEN JO, 1981, INT J ORAL MAXILLOF, V10, P54, DOI 10.1016/S0300-9785(81)80008-7; Andreasen JO, 1992, ATLAS REPLANTATION T, P15; Andreasen JO, 1988, REV ROOT RESORPTION, P9; Andreasen JO, 1994, TXB COLOR ATLAS TRAU, V3rd, P383; Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x; Araujo M, 2008, INT J PERIODONT REST, V28, P123; Nevins M, 2006, INT J PERIODONT REST, V26, P19; Cohenca N, 2007, DENT TRAUMATOL, V23, P87, DOI 10.1111/j.1600-9657.2006.00454.x; Filippi A, 2001, DENT TRAUMATOL, V17, P93, DOI 10.1034/j.1600-9657.2001.017002093.x; Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x; Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P76; BOYDE A, 1984, BRIT DENT J, V156, P216, DOI 10.1038/sj.bdj.4805313; Sapir S, 2008, DENT TRAUMATOL, V24, P131, DOI 10.1111/j.1600-9657.2006.00506.x; ANDREASEN JO, 1980, SWED DENT J, V4, P101; Schropp L, 2003, INT J PERIODONT REST, V23, P313; Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P9, DOI 10.1111/j.1600-0501.2010.01937.x; Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x; BLOMLOF L, 1981, SCAND J DENT RES, V89, P251; ANDERSSON L, 1989, ENDOD DENT TRAUMATOL, V5, P38; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x; ANDREASEN JO, 1987, ENDOD DENT TRAUMATOL, V3, P269; BLOMLOF L, 1980, SCAND J DENT RES, V88, P436; BLOMLOF L, 1983, J DENT RES, V62, P912, DOI 10.1177/00220345830620081301; Blomlöf L, 1981, Swed Dent J Suppl, V8, P1; BLOMLOF L, 1980, SCAND J DENT RES, V88, P441; Cho MI, 2000, PERIODONTOL 2000, V24, P9, DOI 10.1034/j.1600-0757.2000.2240102.x; Courts F J, 1983, Pediatr Dent, V5, P183; Day Peter F, 2008, J Orthod, V35, P143, DOI 10.1179/146531207225022590; Enlow DH, 1975, HDB FACIAL GROWTH, P10; HILTZ J, 1991, ENDOD DENT TRAUMATOL, V7, P69; Iseri H, 1991, TANDLAEGEBLADET, V95, P839; Jone SJ, 1988, INITIATING FACTORS D, P335; LINDSKOG S, 1982, ACTA ODONTOL SCAND, V40, P435, DOI 10.3109/00016358209025118; Lindskog SF, 2007, TRAUMATIC INJURIES T, P137; MACNEIL RL, 1993, J PERIODONTOL, V64, P95; MALMGREN B, 1984, SCAND J DENT RES, V92, P391; Malmgren B, 2000, J Calif Dent Assoc, V28, P846; Malmgren B, 2002, DENT TRAUMATOL, V18, P28, DOI 10.1034/j.1600-9657.2002.180104.x; Oswald R J, 1980, J Endod, V6, P546, DOI 10.1016/S0099-2399(80)80148-8; PATIL S, 1994, INT ENDOD J, V27, P1, DOI 10.1111/j.1365-2591.1994.tb00220.x; SODER PO, 1977, SCAND J DENT RES, V85, P164; Ten Cate A R, 1996, Oral Dis, V2, P55; TROPE M, 1992, ENDOD DENT TRAUMATOL, V8, P183; Wesselink P, 1988, INITIATION FACTORS D, P329	47	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	DEC	2014	30	6					477	483		10.1111/edt.12111		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU0US	WOS:000345340900011		
J	Atoh, M				Atoh, Makoto			World Population Policies: Their Origin, Evolution, and Impact	DEVELOPING ECONOMIES			English	Book Review									[Atoh, Makoto] Hlth Labor & Welf Stat Assoc, Tokyo, Japan	Atoh, M (reprint author), Hlth Labor & Welf Stat Assoc, Tokyo, Japan.						May John, 2012, WORLD POPULATION POL	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	DEC	2014	52	4					376	379		10.1111/deve.12058		4	Economics; Planning & Development	Business & Economics; Public Administration	AU0XQ	WOS:000345345900004		
J	Kudo, Y				Kudo, Yuya			The Limits of Institutional Reform in Development: Changing Rules for Realistic Solutions	DEVELOPING ECONOMIES			English	Book Review									[Kudo, Yuya] JETRO, Inst Dev Econ, Chiba, Japan	Kudo, Y (reprint author), JETRO, Inst Dev Econ, Chiba, Japan.						Andrews M., 2013, LIMITS I REFORM DEV	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1533	1746-1049		DEV ECON	Dev. Econ.	DEC	2014	52	4					382	383		10.1111/deve.12060		2	Economics; Planning & Development	Business & Economics; Public Administration	AU0XQ	WOS:000345345900006		
J	Tanimizu, N; Kobayashi, S; Ichinohe, N; Mitaka, T				Tanimizu, Naoki; Kobayashi, Seiji; Ichinohe, Norihisa; Mitaka, Toshihiro			Downregulation of miR122 by grainyhead-like 2 restricts the hepatocytic differentiation potential of adult liver progenitor cells	DEVELOPMENT			English	Article						Tissue stem/progenitor cells; Bipotential; Postnatal development; Hepatocyte; Cholangiocyte; Transcription factor	ENRICHED TRANSCRIPTION FACTORS; MOUSE-LIVER; STEM-CELLS; CLONAL IDENTIFICATION; IN-VITRO; INJURY; MICE; CHOLANGIOCYTES; ORGANOGENESIS; HEPATOBLASTS	Late fetal and adult livers are reported to contain bipotential liver stem/progenitor cells (LPCs), which share surface markers, including epithelial cell adhesion molecule (EpCAM), with cholangiocytes and differentiate into both hepatocytes and cholangiocytes. However, recent results do not necessarily support the idea that LPCs contribute significantly to cellular turnover and regeneration by supplying new hepatocytes. Here, we examined the colony-forming capability of EpCAM(+) cells isolated from mouse livers between E17 and 11 weeks of age. We found that the number of bipotential colonies was greatly reduced between 1 and 6 weeks, indicating that the number of LPCs decreases during postnatal development. Moreover, bipotential colonies derived from adult LPCs contained substantially fewer albumin(+) cells than those from neonatal LPCs. We further examined the differentiation potential of neonatal and adult LPCs by transplantation and found that neonatal cells differentiated into mature hepatocytes in recipient livers more frequently than adult LPCs. Since we previously reported that the transcription factor grainyhead-like 2 (GRHL2) expressed in EpCAM(+) cells inhibits hepatocytic differentiation, we examined whether targets of GRHL2 might block hepatocytic differentiation. DNA and microRNA microarrays revealed that miR122, the expression of which correlates with hepatocytic differentiation, was greatly reduced in adult as compared with neonatal EpCAM(+) cells. Indeed, GRHL2 negatively regulates the promoter/enhancer activity of the Mir122 gene. Our results indicate that neonatal but not adult EpCAM(+) LPCs have great potential to produce albumin(+) hepatocytes. GRHL2 suppresses transcription of miR122 and thereby restricts the differentiation potential of adult LPCs.	[Tanimizu, Naoki; Kobayashi, Seiji; Ichinohe, Norihisa; Mitaka, Toshihiro] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Dev & Regenerat,Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Tanimizu, N (reprint author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Dev & Regenerat,Chuo Ku, S 1,W 17, Sapporo, Hokkaido 0608556, Japan.	tanimizu@sapmed.ac.jp	Mitaka, Toshihiro/K-9424-2013	Mitaka, Toshihiro/0000-0001-9467-4871	Ministry of Education, Culture, Sports, Science and Technology, Japan [22790386, 21390365, 24390304]	This work is supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan, Grants-in-Aid for Young Scientists (B) for N.T. [22790386] and Grants-in-Aid for Scientific Research (B) for T.M. [21390365, 24390304].	Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Laudadio I, 2012, GASTROENTEROLOGY, V142, P119, DOI 10.1053/j.gastro.2011.09.001; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Tanimizu N, 2013, J CELL SCI, V126, P5239, DOI 10.1242/jcs.133082; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Hikichi T, 2013, P NATL ACAD SCI USA, V110, P6412, DOI 10.1073/pnas.1220200110; Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001; Oertel M, 2003, HEPATOLOGY, V37, P994, DOI 10.1053/jhep.2003.50183; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066	29	4	4	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	DEC	2014	141	23					4448	4456		10.1242/dev.113654		9	Developmental Biology	Developmental Biology	AT6DP	WOS:000345029600004		
J	Matsui, Y; Takehara, A; Tokitake, Y; Ikeda, M; Obara, Y; Morita-Fujimura, Y; Kimura, T; Nakano, T				Matsui, Yasuhisa; Takehara, Asuka; Tokitake, Yuko; Ikeda, Makiko; Obara, Yuka; Morita-Fujimura, Yuiko; Kimura, Tohru; Nakano, Toru			The majority of early primordial germ cells acquire pluripotency by AKT activation	DEVELOPMENT			English	Article						EGCs; PGCs; LIF; bFGF; AKT	LEUKEMIA INHIBITORY FACTOR; EMBRYONIC STEM-CELLS; MICE; EXPRESSION; DERIVATION; CULTURE; DIFFERENTIATION; PROLIFERATION; REQUIREMENT; GENERATION	Primordial germ cells (PGCs) are undifferentiated germ cells in embryos, the fate of which is to become gametes; however, mouse PGCs can easily be reprogrammed into pluripotent embryonic germ cells (EGCs) in culture in the presence of particular extracellular factors, such as combinations of Steel factor (KITL), LIF and bFGF (FGF2). Early PGCs form EGCs more readily than do later PGCs, and PGCs lose the ability to form EGCs by embryonic day (E) 15.5. Here, we examined the effects of activation of the serine/threonine kinase AKT in PGCs during EGC formation; notably, AKT activation, in combination with LIF and bFGF, enhanced EGC formation and caused similar to 60% of E10.5 PGCs to become EGCs. The results indicate that the majority of PGCs at E10.5 could acquire pluripotency with an activated AKT signaling pathway. Importantly, AKT activation did not fully substitute for bFGF and LIF, and AKT activation without both LIF and bFGF did not result in EGC formation. These findings indicate that AKT signal enhances and/or collaborates with signaling pathways of bFGF and of LIF in PGCs for the acquisition of pluripotency.	[Matsui, Yasuhisa; Takehara, Asuka; Tokitake, Yuko; Ikeda, Makiko; Obara, Yuka] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Matsui, Yasuhisa; Tokitake, Yuko; Nakano, Toru] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Morita-Fujimura, Yuiko] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci FRIS, Sendai, Miyagi 9808578, Japan; [Kimura, Tohru] Kitasato Univ, Sch Sci, Sagamihara, Kanagawa 2520373, Japan; [Nakano, Toru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Matsui, Y (reprint author), Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan.	ymatsui@idac.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; CREST from Japan Science and Technology Agency (JST); MEXT of Japan	Y.M. and T.N. were partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; and by CREST from Japan Science and Technology Agency (JST). T.K. was supported by Grants-in-Aid for Scientific Research from MEXT of Japan.	Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Leitch HG, 2013, DEVELOPMENT, V140, P2495, DOI 10.1242/dev.091603; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Koshimizu U, 1996, DEVELOPMENT, V122, P1235; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Leitch HG, 2013, STEM CELL REP, V1, P66, DOI 10.1016/j.stemcr.2013.03.004; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Leitch HG, 2014, DEV BIOL, V385, P155, DOI 10.1016/j.ydbio.2013.11.014; Magni P, 2007, MOL ENDOCRINOL, V21, P1163, DOI 10.1210/me.2006-0270; Matsui Y, 2009, DEV GROWTH DIFFER, V51, P657, DOI 10.1111/j.1440-169X.2009.01125.x; Morita-Fujimura Y, 2009, DEV GROWTH DIFFER, V51, P567, DOI 10.1111/j.1440-169X.2009.01119.x; Nagamatsu G, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096792; Okamura D, 2008, DEV BIOL, V317, P576, DOI 10.1016/j.ydbio.2008.03.002	34	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	DEC	2014	141	23					4457	4467		10.1242/dev.113779		11	Developmental Biology	Developmental Biology	AT6DP	WOS:000345029600005		
J	Shi, DB; Komatsu, K; Hirao, M; Toyooka, Y; Koyama, H; Tissir, F; Goffinet, AM; Uemura, T; Fujimori, T				Shi, Dongbo; Komatsu, Kouji; Hirao, Mayumi; Toyooka, Yayoi; Koyama, Hiroshi; Tissir, Fadel; Goffinet, Andre M.; Uemura, Tadashi; Fujimori, Toshihiko			Celsr1 is required for the generation of polarity at multiple levels of the mouse oviduct	DEVELOPMENT			English	Article						Celsr1/Flamingo; Planar cell polarity; Cilia; Epithelial morphogenesis; Oviduct; Cell shape	PLANAR CELL POLARITY; NEURAL-TUBE DEFECTS; BASAL BODIES; EPITHELIAL MORPHOGENESIS; ASYMMETRIC LOCALIZATION; OVUM TRANSPORT; VAN-GOGH; DROSOPHILA; CILIA; AXIS	The oviduct is an important organ in reproduction where fertilization occurs, and through which the fertilized eggs are carried to the uterus in mammals. This organ is highly polarized, where the epithelium forms longitudinal folds along the ovary-uterus axis, and the epithelial multicilia beat towards the uterus to transport the ovulated ova. Here, we analyzed the postnatal development of mouse oviduct and report that multilevel polarities of the oviduct are regulated by a planar cell polarity (PCP) gene, Celsr1. In the epithelium, Celsr1 is concentrated in the specific cellular boundaries perpendicular to the ovary-uterus axis from postnatal day 2. We found a new feature of cellular polarity in the oviduct - the apical surface of epithelial cells is elongated along the ovary-uterus axis. In Celsr1-deficient mice, the ciliary motion is not orchestrated along the ovary-uterus axis and the transport ability of beating cilia is impaired. Epithelial cells show less elongation and randomized orientation, and epithelial folds show randomized directionality and ectopic branches in the mutant. Our mosaic analysis suggests that the geometry of epithelial cells is primarily regulated by Celsr1 and as a consequence the epithelial folds are aligned. Taken together, we reveal the characteristics of the multilevel polarity formation processes in the mouse oviduct epithelium and suggest a novel function of the PCP pathway for proper tissue morphogenesis.	[Shi, Dongbo; Komatsu, Kouji; Hirao, Mayumi; Toyooka, Yayoi; Koyama, Hiroshi; Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Aichi 4448787, Japan; [Shi, Dongbo; Uemura, Tadashi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Komatsu, Kouji; Uemura, Tadashi; Fujimori, Toshihiko] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Toyooka, Yayoi; Koyama, Hiroshi; Fujimori, Toshihiko] Grad Univ Adv Studies, Okazaki, Aichi 4448787, Japan; [Tissir, Fadel; Goffinet, Andre M.] Univ Louvain, Sch Med, Inst Neurosci, B-1200 Brussels, Belgium	Fujimori, T (reprint author), Natl Inst Basic Biol, Div Embryol, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	fujimori@nibb.ac.jp		Shi, Dongbo/0000-0002-4408-3042	Centers of Research Excellence in Science (CREST) grant; Ministry of Education, Culture, Sports, Science and Technology (MEXT) grant (Kakenhi); Mitsubishi Foundation; National Institute for Basic Biology	This work was supported by a Centers of Research Excellence in Science (CREST) grant and a Ministry of Education, Culture, Sports, Science and Technology (MEXT) grant (Kakenhi) to T.U. and T.F.; a grant of The Mitsubishi Foundation to T.U.; and a grant from the National Institute for Basic Biology to T.F. D.S. was a Research Fellow of the Japan Society for the Promotion of Science (JSPS).	AGDUHR ERIK, 1927, ACTA ZOOL [STOCKHOLM], V8, P1; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Taniguchi K, 2011, SCIENCE, V333, P339, DOI 10.1126/science.1200940; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; Vladar EK, 2012, CURR BIOL, V22, P2203, DOI 10.1016/j.cub.2012.09.046; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Hirota Y, 2010, DEVELOPMENT, V137, P3037, DOI 10.1242/dev.050120; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Werner ME, 2011, J CELL BIOL, V195, P19, DOI 10.1083/jcb.201106110; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Kusaka M, 2010, ENDOCRINOLOGY, V151, P5893, DOI 10.1210/en.2010-0915; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Adler PN, 2012, CURR TOP DEV BIOL, V101, P1, DOI 10.1016/B978-0-12-394592-1.00001-6; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Wake MH, 1998, J EXP ZOOL, V282, P477; Bakst MR, 1998, J EXP ZOOL, V282, P618, DOI 10.1002/(SICI)1097-010X(199811/12)282:4/5<618::AID-JEZ11>3.3.CO;2-D; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Wang YC, 2012, NATURE, V484, P390, DOI 10.1038/nature10938; Taylor J, 1998, GENETICS, V150, P199; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; HALBERT SA, 1976, SCIENCE, V191, P1052, DOI 10.1126/science.1251215; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; Behringer R, 2014, MANIPULATING MOUSE E; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147; Chae J, 1999, DEVELOPMENT, V126, P5421; CONDIC ML, 1991, DEVELOPMENT, V111, P23; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Formstone CJ, 2001, MECH DEVELOP, V109, P91, DOI 10.1016/S0925-4773(01)00515-9; FRISTROM D, 1988, TISSUE CELL, V20, P645, DOI 10.1016/0040-8166(88)90015-8; GIBBONS IR, 1961, J BIOPHYS BIOCHEM CY, V11, P179, DOI 10.1083/jcb.11.1.179; Hadjantonakis AK, 1997, GENOMICS, V45, P97, DOI 10.1006/geno.1997.4892; HALBERT SA, 1989, BIOL REPROD, V40, P1131, DOI 10.1095/biolreprod40.6.1131; Jain R, 2010, AM J RESP CELL MOL, V43, P731, DOI 10.1165/rcmb.2009-0328OC; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; May-Simera HL, 2010, DEV BIOL, V345, P215, DOI 10.1016/j.ydbio.2010.07.013; Shi DB, 2011, GENES CELLS, V16, P282, DOI 10.1111/j.1365-2443.2011.01484.x; Stewart C Allison, 2012, Results Probl Cell Differ, V55, P247, DOI 10.1007/978-3-642-30406-4_14; STRONG LC, 1949, J HERED, V40, P329; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Yamanouchi H, 2010, BIOL REPROD, V82, P528, DOI 10.1095/biolreprod.109.078329; Zar J. H., 2010, BIOSTATISTICAL ANAL	56	3	3	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	DEC	2014	141	23					4558	4568		10.1242/dev.115659		11	Developmental Biology	Developmental Biology	AT6DP	WOS:000345029600014		
J	Nakagawa, S; Shimada, M; Yanaka, K; Mito, M; Arai, T; Takahashi, E; Fujita, Y; Fujimori, T; Standaert, L; Marine, JC; Hirose, T				Nakagawa, Shinichi; Shimada, Masayuki; Yanaka, Kaori; Mito, Mari; Arai, Takashi; Takahashi, Eiki; Fujita, Youko; Fujimori, Toshihiko; Standaert, Laura; Marine, Jean-Christophe; Hirose, Tetsuro			The lncRNA Neat1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice	DEVELOPMENT			English	Article						Neat1; Paraspeckles; Corpus luteum; Progesterone; Sfpq; Stochastic failure	LONG NONCODING RNA; NUCLEAR-BODIES; SPLICING FACTOR; GROWTH-FACTOR; PARASPECKLES; TRANSCRIPTION; EXPRESSION; RETENTION; REGULATOR; ELEMENT	Neat1 is a non-protein-coding RNA that serves as an architectural component of the nuclear bodies known as paraspeckles. Although cell-based studies indicate that Neat1 is a crucial regulator of gene expression, its physiological relevance remains unclear. Here, we find that Neat1 knockout (KO) mice stochastically fail to become pregnant despite normal ovulation. Unilateral transplantation of wildtype ovaries or the administration of progesterone partially rescued the phenotype, suggesting that corpus luteum dysfunction and concomitant low progesterone were the primary causes of the decreased fertility. In contrast to the faint expression observed in most of the adult tissues, Neat1 was highly expressed in the corpus luteum, and the formation of luteal tissue was severely impaired in nearly half of the Neat1 KO mice. These observations suggest that Neat1 is essential for the formation of the corpus luteum and for the subsequent establishment of pregnancy under a suboptimal condition that has not yet been identified.	[Nakagawa, Shinichi; Yanaka, Kaori; Mito, Mari] RIKEN, RNA Biol Lab, Wako, Saitama 3510198, Japan; [Shimada, Masayuki] Hiroshima Univ, Grad Sch Biosphere Sci, Lab Reprod Endocrinol, Higashihiroshima 7398528, Japan; [Arai, Takashi; Takahashi, Eiki] RIKEN, Brain Sci Inst, Res Resources Ctr, Support Unit Anim Resources Dev, Wako, Saitama 3510198, Japan; [Fujita, Youko] Womens Clin Oizumi Gakuen, Tokyo 1780063, Japan; [Fujimori, Toshihiko] NIBB, Div Embryol, Okazaki, Aichi 4448787, Japan; [Standaert, Laura; Marine, Jean-Christophe] VIB, Lab Mol Canc Biol, Ctr Biol Dis, B-3000 Leuven, Belgium; [Standaert, Laura; Marine, Jean-Christophe] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Canc Biol, B-3000 Leuven, Belgium; [Hirose, Tetsuro] Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan	Nakagawa, S (reprint author), RIKEN, RNA Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nakagawas@riken.jp	Nakagawa, Shinichi/I-4192-2014; Marine, Jean Christophe/J-2237-2015		Ministry of Education, Science, Sports, and Culture of Japan (MEXT); Japan Society for the Promotion of Science	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT); and by Grants-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science. Deposited in PMC for immediate release.	Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Nakagawa S, 2014, BBA-GENE REGUL MECH, V1839, P215, DOI 10.1016/j.bbagrm.2013.10.009; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Ferrara N, 1998, NAT MED, V4, P336, DOI 10.1038/nm0398-336; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; King SR, 2012, FRONT BIOSCI-LANDMRK, V17, P824, DOI 10.2741/3959; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1280, DOI 10.1210/en.143.4.1280; FREEMAN ME, 1974, ENDOCRINOLOGY, V94, P875; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; BARKLEY MS, 1978, BIOL REPROD, V19, P291, DOI 10.1095/biolreprod19.2.291; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Urban RJ, 2000, MOL ENDOCRINOL, V14, P774, DOI 10.1210/me.14.6.774	29	5	5	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	DEC	2014	141	23					4618	4627		10.1242/dev.110544		10	Developmental Biology	Developmental Biology	AT6DP	WOS:000345029600020		
J	Kamiya, C; Ohta, N; Ogura, Y; Yoshida, K; Horie, T; Kusakabe, TG; Satake, H; Sasakura, Y				Kamiya, Chisato; Ohta, Naoyuki; Ogura, Yosuke; Yoshida, Keita; Horie, Takeo; Kusakabe, Takehiro G.; Satake, Honoo; Sasakura, Yasunori			Nonreproductive Role of Gonadotropin-Releasing Hormone in the Control of Ascidian Metamorphosis	DEVELOPMENTAL DYNAMICS			English	Article						GnRH; ascidian; metamorphosis	CIONA-INTESTINALIS; NERVOUS-SYSTEM; GNRH-RECEPTORS; PROTOCHORDATE; LARVAE; MIGRATION; PROTEIN; GENES; HETERODIMERIZATION; PROGRESSION	Background: Gonadotropin-releasing hormones (GnRHs) are neuropeptides that play central roles in the reproduction of vertebrates. In the ascidian Ciona intestinalis, GnRHs and their receptors are expressed in the nervous systems at the larval stage, when animals are not yet capable of reproduction, suggesting that the hormones have non-reproductive roles. Results: We showed that GnRHs in Ciona are involved in the animals metamorphosis by regulating tail absorption and adult organ growth. Absorption of the larval tail and growth of the adult organs are two major events in the metamorphosis of ascidians. When larvae were treated with GnRHs, they completed tail absorption more frequently than control larvae. cAMP was suggested to be a second messenger for the induction of tail absorption by GnRHs. tGnRH-3 and tGnRH-5 (the t indicates tunicate) inhibited the growth of adult organs by arresting cell cycle progression in parallel with the promotion of tail absorption. Conclusions: This study provides new insights into the molecular mechanisms of ascidian metamorphosis conducted by non-reproductive GnRHs. Developmental Dynamics 243:1524-1535, 2014. (c) 2014 Wiley Periodicals, Inc.	[Kamiya, Chisato; Ogura, Yosuke; Yoshida, Keita; Horie, Takeo; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka 4150025, Japan; [Ohta, Naoyuki] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto, Japan; [Kusakabe, Takehiro G.] Konan Univ, Inst Integrat Neurobiol, Kobe, Hyogo, Japan; [Kusakabe, Takehiro G.] Konan Univ, Dept Biol, Kobe, Hyogo, Japan; [Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, Osaka, Japan	Sasakura, Y (reprint author), Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Shizuoka 4150025, Japan.	sasakura@kurofune.shimoda.tsukuba.ac.jp			JSPS [21112004]; MEXT [23681039]; Toray Science and Technology Grant [DDS01702]; Suntory Foundation for Life Sciences [CDE22022, CDE23017]	Grant sponsor: JSPS; Grant number: 21112004; Grant sponsor: MEXT; Grant number: 23681039; Grant sponsor: Toray Science and Technology Grant; Grant number: DDS01702; Grant sponsor: Suntory Foundation for Life Sciences; Grant numbers: CDE22022, CDE23017.	Adams BA, 2003, ENDOCRINOLOGY, V144, P1907, DOI 10.1210/en.2002-0216; Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Kah O, 2007, GEN COMP ENDOCR, V153, P346, DOI 10.1016/j.ygcen.2007.01.030; Imai A, 1996, J CLIN ENDOCR METAB, V81, P3249, DOI 10.1210/jc.81.9.3249; Sasakura Y, 2010, MOL GENET GENOMICS, V283, P99, DOI 10.1007/s00438-009-0500-4; Park MK, 2013, GEN COMP ENDOCR, V181, P259, DOI 10.1016/j.ygcen.2012.09.023; Eri R, 1999, DEVELOPMENT, V126, P5809; Ogura Y, 2011, DEVELOPMENT, V138, P577, DOI 10.1242/dev.053132; Lemaire P, 2011, DEVELOPMENT, V138, P2143, DOI 10.1242/dev.048975; Abraham E, 2010, ENDOCRINOLOGY, V151, P332, DOI 10.1210/en.2009-0548; Ogasawara M, 1999, J EXP ZOOL, V285, P158, DOI 10.1002/(SICI)1097-010X(19990815)285:2<158::AID-JEZ8>3.0.CO;2-0; Limonta P, 2003, FRONT NEUROENDOCRIN, V24, P279, DOI 10.1016/j.yfrne.2003.10.003; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Takamura K, 1998, DEV GENES EVOL, V208, P1, DOI 10.1007/s004270050147; Joly JS, 2007, DEV DYNAM, V236, P1832, DOI 10.1002/dvdy.21124; Chambon JP, 2002, DEVELOPMENT, V129, P3105; Millar RP, 2008, FRONT NEUROENDOCRIN, V29, P17, DOI 10.1016/j.yfrne.2007.06.002; Wu S, 2006, MOL CELL ENDOCRINOL, V257-8, P47, DOI 10.1016/j.mce.2006.06.010; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; CLONEY RA, 1982, AM ZOOL, V22, P817; Kusakabe TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041955; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Kawada T, 2011, ENDOCRINOLOGY, V152, P2416, DOI 10.1210/en.2010-1348; Hamada M, 2011, DEV BIOL, V352, P202, DOI 10.1016/j.ydbio.2011.01.006; Kimura Y, 2003, DEV BIOL, V258, P129, DOI 10.1016/S0012-1606(03)00118-0; Kusakabe T, 2003, GENE, V322, P77, DOI 10.1016/j.gene.2003.08.013; Matsuoka T, 2005, GENESIS, V41, P61; Nakayama A, 2005, ZOOL SCI, V22, P301, DOI 10.2108/zsj.22.301; Nakayama-Ishimura A, 2009, DEV BIOL, V326, P357, DOI 10.1016/j.ydbio.2008.11.026; Okada T, 1999, DEV GROWTH DIFFER, V41, P759; Sakai T, 2010, MOL BIOL EVOL, V27, P1097, DOI 10.1093/molbev/msp319; Sakai T, 2012, ENDOCRINOLOGY, V153, P1841, DOI 10.1210/en.2011-1668; Sasakura Y, 2005, P NATL ACAD SCI USA, V102, P15134, DOI 10.1073/pnas.0503640102; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Shimazaki A, 2006, DEV DYNAM, V235, P562, DOI 10.1002/dvdy.20657; Shirae-Kurabayashi M, 2006, DEVELOPMENT, V133, P2683, DOI 10.1242/dev.02446; Tello JA, 2005, ENDOCRINOLOGY, V146, P4061, DOI 10.1210/en.2004-1558; Terakado K, 2001, GEN COMP ENDOCR, V124, P277, DOI 10.1006/gcen.2001.7728; Yu B, 2011, FERTIL STERIL, V95, P465, DOI 10.1016/j.fertnstert.2010.08.045; Zega G, 2005, DEV BIOL, V282, P246, DOI 10.1016/j.ydbio.2005.03.012	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	DEC	2014	243	12					1524	1535		10.1002/dvdy.24176		12	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	AU0JD	WOS:000345308300003		
J	Nakamura, J; Yoshida, K; Sasakura, Y; Fujiwara, S				Nakamura, Jun; Yoshida, Keita; Sasakura, Yasunori; Fujiwara, Shigeki			Chondroitin 6-O-Sulfotransferases are Required for Morphogenesis of the Notochord in the Ascidian Embryo	DEVELOPMENTAL DYNAMICS			English	Article						Ascidian; chondroitin sulfate; morphogenesis; notochord; sulfotransferase	CIONA-INTESTINALIS; SULFATE-E; GENE-EXPRESSION; CONVERGENT EXTENSION; CELL-ADHESION; LEPRECAN GENE; BRACHYURY; MOVEMENT; BINDING; GROWTH	Background: Chondroitin sulfate (CS) is a sulfated polysaccharide chain that binds to various core proteins to form proteoglycans. The amount and position of sulfate groups in CS are variable among different tissues, and are determined by specific sulfotransferases. Although the ascidians are the closest relatives of vertebrates, the functions of their sulfotransferases have not been studied. Results: The genome of the ascidian Ciona intestinalis contains eight genes encoding proteins similar to chondroitin 6-O-sulfotransferases (C6STs), which appear to have independently diverged in the ascidian lineage during evolution. Among them, Ci-C6ST-like1 and Ci-C6ST-like7 were predominantly expressed in the developing notochord. In addition, they were weakly expressed in the neural tube. The disruption of either one of them affected the convergent extension movement of notochordal cells. Presumptive notochord cells coming from both sides of the embryo did not intercalate. The results suggest that both of them are necessary. In some cases, the anterior neural tube failed to close. Forced expression of Ci-C6ST-like1 or Ci-C6ST-like7 in the notochord restored the normal intercalation of notochordal cells, indicating that the effects of morpholino oligos are specific. Conclusions:Ci-C6ST-like1 and Ci-C6ST-like7 are required for the morphogenesis of the notochord in the ascidian embryo. Developmental Dynamics 243:1637-1645, 2014. (c) 2014 Wiley Periodicals, Inc.	[Nakamura, Jun; Fujiwara, Shigeki] Kochi Univ, Dept Appl Sci, Kochi 7808520, Japan; [Yoshida, Keita; Sasakura, Yasunori] Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda, Japan; [Fujiwara, Shigeki] Kochi Univ, Syst Glycobiol Res Ctr, Nankoku, Kochi, Japan	Fujiwara, S (reprint author), Kochi Univ, Dept Appl Sci, 2-5-1 Akebono Cho, Kochi 7808520, Japan.	tatataa@kochi-u.ac.jp			Japan Society for the Promotion of Science [22570214, 25440192]	Grant sponsor: The Japan Society for the Promotion of Science; Grant number: 22570214, Grant number: 25440192.	Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Ueoka C, 2000, J BIOL CHEM, V275, P37407, DOI 10.1074/jbc.M002538200; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Hemmerich S, 2001, GLYCOBIOLOGY, V11, P75, DOI 10.1093/glycob/11.1.75; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Sasakura Y, 1998, INT J DEV BIOL, V42, P573; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sasakura Y, 2001, DEV GROWTH DIFFER, V43, P573; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Jiang D, 2005, CURR BIOL, V15, P79; Niwano T, 2009, BIOL CELL, V101, P645, DOI 10.1042/BC20090042; Yasuo H, 2007, DEV BIOL, V302, P92, DOI 10.1016/j.ydbio.2006.08.075; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Keys DN, 2002, DEV BIOL, V246, P329, DOI 10.1006/dbio.2002.0656; Satou Y, 2005, ZOOL SCI, V22, P837, DOI 10.2108/zsj.22.837; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Shimizu K, 2011, J NEUROSCI, V31, P4944, DOI 10.1523/JNEUROSCI.0154-11.2011; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Ishii M, 2008, GLYCOBIOLOGY, V18, P602, DOI 10.1093/glycob/cwn040; Veeman MT, 2008, DEVELOPMENT, V135, P33, DOI 10.1242/dev.010892; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Corbo JC, 1997, DEVELOPMENT, V124, P589; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; DOMOWICZ M, 1995, DEV BIOL, V171, P655, DOI 10.1006/dbio.1995.1312; Dunn MP, 2009, DEV BIOL, V328, P561, DOI 10.1016/j.ydbio.2009.02.007; Hotta K, 2000, DEV BIOL, V224, P69, DOI 10.1006/dbio.2000.9765; IIDA J, 1992, J CELL BIOL, V118, P431, DOI 10.1083/jcb.118.2.431; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; Miya T, 1997, DEVELOPMENT, V124, P5149; Mizumoto S, 2009, BIOCHEM J, V419, P387, DOI 10.1042/BJ20081639; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; SANDELL LJ, 1994, MICROSC RES TECHNIQ, V28, P470, DOI 10.1002/jemt.1070280603; Satou Y, 2002, GENE, V287, P83, DOI 10.1016/S0378-1119(01)00826-5; Shi WY, 2009, DEVELOPMENT, V136, P23, DOI 10.1242/dev.029157; Tetsukawa A, 2010, COMP BIOCHEM PHYS B, V157, P205, DOI 10.1016/j.cbpb.2010.06.009; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Willis CM, 2009, GENET MOL RES, V8, P1331, DOI 10.4238/vol8-4gmr673	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1058-8388	1097-0177		DEV DYNAM	Dev. Dyn.	DEC	2014	243	12					1637	1645		10.1002/dvdy.24213		9	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	AU0JD	WOS:000345308300013		
J	Nishimura, S; Nagasaki, M; Okudaira, S; Aoki, J; Ohmori, T; Ohkawa, R; Nakamura, K; Igarashi, K; Yamashita, H; Eto, K; Uno, K; Hayashi, N; Kadowaki, T; Komuro, I; Yatomi, Y; Nagai, R				Nishimura, Satoshi; Nagasaki, Mika; Okudaira, Shinichi; Aoki, Junken; Ohmori, Tsukasa; Ohkawa, Ryunosuke; Nakamura, Kazuhiro; Igarashi, Koji; Yamashita, Hiroshi; Eto, Koji; Uno, Kansei; Hayashi, Naoto; Kadowaki, Takashi; Komuro, Issei; Yatomi, Yutaka; Nagai, Ryozo			ENPP2 Contributes to Adipose Tissue Expansion and Insulin Resistance in Diet-Induced Obesity	DIABETES			English	Article							LYSOPHOSPHATIDIC ACID; BLOOD-VESSELS; IN-VIVO; AUTOTAXIN; MICE; DIFFERENTIATION; INFLAMMATION; EXPRESSION; CELLS; IDENTIFICATION	Body weight is tightly regulated by food intake and energy dissipation, and obesity is related to decreased energy expenditure (EE). Herein, we show that nucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2, autotaxin) is an adipose-derived, secreted enzyme that controls adipose expansion, brown adipose tissue (BAT) function, and EE. In mice, Enpp2 was highly expressed in visceral white adipose tissue and BAT and is downregulated in hypertrophied adipocytes/adipose tissue. Enpp2(+/-) mice and adipocyte-specific Enpp2 knockout mice fed a high-fat diet showed smaller body weight gains and less insulin resistance than control mice fed the same diet. BAT was functionally more active and EE was increased in Enpp2-deficient mice. In humans, ENPP2 expression in subcutaneous fat and ENPP2 levels in serum were reduced in obese subjects. Taken together, our results establish ENPP2 as an adipose-derived, secreted enzyme that regulates adipose obesity and systemic metabolism. They also suggest ENPP2 could be a useful therapeutic target for the treatment of metabolic disease.	[Nishimura, Satoshi; Nagasaki, Mika; Yamashita, Hiroshi; Uno, Kansei; Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Nishimura, Satoshi; Kadowaki, Takashi] Univ Tokyo, Translat Syst Biol & Med Initiat, Tokyo, Japan; [Nishimura, Satoshi; Ohmori, Tsukasa; Nagai, Ryozo] Jichi Med Univ, Ctr Mol Med, Res Div Cell & Mol Med, Shimotsuke, Tochigi, Japan; [Nagasaki, Mika; Uno, Kansei; Hayashi, Naoto] Univ Tokyo, Tokyo, Japan; [Okudaira, Shinichi; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Biochem, Miygai, Japan; [Ohkawa, Ryunosuke; Nakamura, Kazuhiro; Yatomi, Yutaka] Tokyo Univ Hosp, Dept Clin Lab, Tokyo 113, Japan; [Igarashi, Koji] Tosoh Corp, Reagent Dev Dept, AIA Res Grp, Biosci Div, Ayase, Kanagawa, Japan; [Eto, Koji] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Kadowaki, Takashi] Univ Tokyo, Dept Metab Dis, Tokyo, Japan	Nishimura, S (reprint author), Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan.	snishi-tky@umin.ac.jp			Japan Society for the Promotion of Science; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Translational Systems Biology and Medicine Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Global Centers of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation	This study was supported by research fellowships from the Japan Society for the Promotion of Science Research Fellowships for Young Scientists (S.N.); the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) (S.N. and R.N.); Grants-in-Aid for Scientific Research (R.N.); grants from the Translational Systems Biology and Medicine Initiative (T. L. and R.N.) and the Global Centers of Excellence Program (T. K. and R.N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a research grant from the National Institute of Biomedical Innovation (R.N.).	Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Liu DX, 1999, FASEB J, V13, P2318; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Boucher J, 2005, DIABETOLOGIA, V48, P569, DOI 10.1007/s00125-004-1660-8; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004.0219; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Federico L, 2012, MOL ENDOCRINOL, V26, P786, DOI 10.1210/me.2011-1229; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Dennis J, 2008, MOL CELL NEUROSCI, V37, P412, DOI 10.1016/j.mcn.2007.10.018; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Camp HS, 2001, ENDOCRINOLOGY, V142, P3207, DOI 10.1210/en.142.7.3207; Pagès G, 2000, Ann N Y Acad Sci, V905, P159; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B	27	7	7	AMER DIABETES ASSOC	ALEXANDRIA	1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA	0012-1797	1939-327X		DIABETES	Diabetes	DEC	2014	63	12					4154	4164		10.2337/db13-1694		11	Endocrinology & Metabolism	Endocrinology & Metabolism	AU0ST	WOS:000345335500026		
J	Tanaka, S; Suzuki, K; Aoki, C; Niitani, M; Kato, K; Tomotsune, T; Aso, Y				Tanaka, Seiichi; Suzuki, Kunihiro; Aoki, Chie; Niitani, Mai; Kato, Kanako; Tomotsune, Takanori; Aso, Yoshimasa			Add-On Treatment with Teneligliptin Ameliorates Glucose Fluctuations and Improves Glycemic Control Index in Japanese Patients with Type 2 Diabetes on Insulin Therapy	DIABETES TECHNOLOGY & THERAPEUTICS			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; GLUCAGON-LIKE PEPTIDE-1; IV INHIBITOR; DPP-4 INHIBITOR; SITAGLIPTIN; MELLITUS; HYPERGLYCEMIA; POTENT; VILDAGLIPTIN; METFORMIN	Background: This study investigated whether teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, ameliorated glucose fluctuations in hospitalized Japanese patients with type 2 diabetes receiving insulin therapy, with or without other antidiabetes drugs, and using continuous glucose monitoring (CGM). Patients and Methods: Twenty-six patients with type 2 diabetes were admitted for glycemic control. After admission, patients continued to be treated with optimal dietary therapy plus insulin therapy, with or without other antidiabetes drugs, until they achieved stable glycemic control. CGM measurements were made for 7 consecutive days. On Days 1-3, patients received insulin with or without other antidiabetes drugs, and on Days 4-7, teneligliptin 20 mg once daily at breakfast was added to ongoing therapy. Doses of insulin were fixed during the study. Levels of serum glycated albumin (GA), 1,5-anhydro-d-glucitol (1,5-AG), and high-sensitivity C-reactive protein (hsCRP) were measured. Results: Add-on treatment with teneligliptin led to significant improvements in 24-h mean glucose levels, the proportion of time in normoglycemia, mean amplitude of glycemic excursions, and total area under the curve within 2 h after each meal. The proportion of time in hypoglycemia and hsCRP levels did not increase significantly compared with before teneligliptin. Values of 1,5-AG and GA were significantly improved by treatment with teneligliptin. Conclusions: Addition of teneligliptin to insulin therapy led to a significant improvement in diurnal glycemic control and significant reductions in glucose fluctuations in 24-h periods without increasing hypoglycemia in Japanese patients with type 2 diabetes on insulin therapy, with or without other antidiabetes agents.	[Tanaka, Seiichi; Suzuki, Kunihiro; Aoki, Chie; Niitani, Mai; Kato, Kanako; Tomotsune, Takanori; Aso, Yoshimasa] Dokkyo Med Univ, Dept Endocrinol & Metab, Shimotsugagun, Tochigi 3210293, Japan	Suzuki, K (reprint author), Dokkyo Med Univ, Dept Endocrinol & Metab, 880 Kitakobayashi, Shimotsugagun, Tochigi 3210293, Japan.	kuni-s@dokkyomed.ac.jp					Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Kim HS, 2013, DIABETES TECHNOL THE, V15, P810, DOI 10.1089/dia.2013.0038; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Aso Y, 2013, TRANSL RES, V162, P309, DOI 10.1016/j.trsl.2013.07.011; Satoh-Asahara N, 2013, METABOLISM, V62, P347, DOI 10.1016/j.metabol.2012.09.004; Fravel MA, 2011, AM J HEALTH-SYST PH, V68, P500, DOI 10.2146/ajhp080085; Mori Y, 2011, DIABETES TECHNOL THE, V13, P699, DOI 10.1089/dia.2011.0025; Nabeno M, 2013, BIOCHEM BIOPH RES CO, V434, P191, DOI 10.1016/j.bbrc.2013.03.010; Moreno G, 2013, J AM GERIATR SOC, V61, P2027, DOI 10.1111/jgs.12513; Kadowaki T, 2013, DIABETES OBES METAB, V15, P810, DOI 10.1111/dom.12092; Eckhardt M, 2007, J MED CHEM, V50, P6450, DOI 10.1021/jm701280z; Mori Y, 2013, DIABETES TECHNOL THE, V15, P237, DOI 10.1089/dia.2012.0214; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Xu L, 2008, DIABETES OBES METAB, V10, P1212, DOI 10.1111/j.1463-1326.2008.00887.x; Vilsboll T, 2010, DIABETES OBES METAB, V12, P167, DOI 10.1111/j.1463-1326.2009.01173.x; Katsuno T, 2013, ENDOCR J, V60, P733; Kothny W, 2013, DIABETES OBES METAB, V15, P252, DOI 10.1111/dom.12020; Lukashevich Valentina, 2013, Vasc Health Risk Manag, V9, P21, DOI 10.2147/VHRM.S39300; Metzler WJ, 2008, PROTEIN SCI, V17, P240, DOI 10.1110/ps.073253208; Osonoi T, 2014, EXPERT OPIN PHARMACO, V15, P1325, DOI 10.1517/14656566.2014.920323; Sakamoto M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-92; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; Zhang ZY, 2011, J MED CHEM, V54, P510, DOI 10.1021/jm101016w	27	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1520-9156	1557-8593		DIABETES TECHNOL THE	Diabetes Technol. Ther.	DEC 1	2014	16	12					840	845		10.1089/dia.2014.0095		6	Endocrinology & Metabolism	Endocrinology & Metabolism	AU3GH	WOS:000345499900005		
J	Hori, T; Kato, T; Komiya, A; Fuse, H; Nunomura, S; Fukuoka, J; Nomoto, K				Hori, Takashi; Kato, Tomonori; Komiya, Akira; Fuse, Hideki; Nunomura, Sayuri; Fukuoka, Junya; Nomoto, Kazuhiro			Primary Melanoma of the Urinary Bladder Identified by Urine Cytology: A Rare Case Report	DIAGNOSTIC CYTOPATHOLOGY			English	Letter							PRIMARY MALIGNANT-MELANOMA; CELL MELANOMA; METASTASES		[Hori, Takashi; Nomoto, Kazuhiro] Toyama Univ Hosp, Pathol Lab, Toyama 9300194, Japan; [Kato, Tomonori; Komiya, Akira; Fuse, Hideki] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Urol, Toyama 930, Japan; [Nunomura, Sayuri; Fukuoka, Junya] Nagasaki Univ, Dept Pathol, Grad Sch Biomed Sci, Nagasaki 852, Japan	Hori, T (reprint author), Toyama Univ Hosp, Pathol Lab, 2630 Sugitani, Toyama 9300194, Japan.	thpath@med.u-toyama.ac.jp					AINSWORTH AM, 1976, CANCER, V37, P1928, DOI 10.1002/1097-0142(197604)37:4<1928::AID-CNCR2820370444>3.0.CO;2-W; ANICHKOV NM, 1982, J UROLOGY, V128, P813; Schindler K, 2012, MELANOMA RES, V22, P320, DOI 10.1097/CMR.0b013e32835566c0; Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G; DETORRES I, 1995, J UROLOGY, V154, P525, DOI 10.1016/S0022-5347(01)67094-0; El Ammari JE, 2011, CASE REP UROL; GOLDSCHMIDT P, 1988, BRIT J UROL, V61, P359, DOI 10.1111/j.1464-410X.1988.tb13975.x; Gupta R, 2007, INT UROL NEPHROL, V39, P833, DOI 10.1007/s11255-006-9086-5; IRONSIDE JW, 1985, BRIT J UROL, V57, P593, DOI 10.1111/j.1464-410X.1985.tb05880.x; Khalbuss WE, 2001, ACTA CYTOL, V45, P631; KOJIMA T, 1992, ARCH PATHOL LAB MED, V116, P1213; LANGEWELKER U, 1993, UROL INT, V50, P226; LUND L, 1992, SCAND J UROL NEPHROL, V26, P205; Martinez-Giron R, 2008, CYTOPATHOLOGY, V19, P402, DOI 10.1111/j.1365-2303.2008.00607.x; Mihajlovic M, 2012, INT J CLIN EXP PATHO, V5, P739; MOURAD WA, 1993, ULTRASTRUCT PATHOL, V17, P463; NIEDERBERGER CS, 1993, UROLOGY, V41, P72, DOI 10.1016/0090-4295(93)90250-E; Pacella M, 2006, INT J UROL, V13, P635, DOI 10.1111/j.1442-2042.2006.01375.x; Sathiyamoorthy S, 2013, DIAGN CYTOPATHOL, V41, P997, DOI 10.1002/dc.22878; SU CT, 1962, J UROLOGY, V87, P365; Sundersingh S, 2011, INDIAN J PATHOL MICR, V54, P422, DOI 10.4103/0377-4929.81612; Tainio HM, 1999, SCAND J UROL NEPHROL, V33, P406; VansAhlen H, 1992, UROLOGY, V40, P550; Wheelock MC, 1942, J UROLOGY, V48, P628; WILLIS AJ, 1980, J UROLOGY, V123, P278	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-1039	1097-0339		DIAGN CYTOPATHOL	Diagn. Cytopathol.	DEC	2014	42	12					1091	1095		10.1002/dc.23074		5	Medical Laboratory Technology; Pathology	Medical Laboratory Technology; Pathology	AT8WU	WOS:000345210700012		
J	Chiba, M; Yoshida, T; Komatsu, M				Chiba, Mitsuro; Yoshida, Tatsuya; Komatsu, Masafumi			From Low-Residue Diets to Plant-Based Diets in Inflammatory Bowel Disease	DIGESTIVE DISEASES AND SCIENCES			English	Letter									[Chiba, Mitsuro; Yoshida, Tatsuya; Komatsu, Masafumi] Akita City Hosp, Div Gastroenterol, Akita 0100933, Japan	Chiba, M (reprint author), Akita City Hosp, Div Gastroenterol, 4-30 Matsuoka Machi, Akita 0100933, Japan.	acd00517@akita-city-hp.jp; acd00386@akita-city-hp.jp; ac990892@akita-city-hp.jp					Le Leu R, 2013, DIGEST DIS SCI, V58, P3475, DOI 10.1007/s10620-013-2844-1; Hamer HM, 2008, ALIMENT PHARM THERAP, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Park Y, 2011, ARCH INTERN MED, V171, P1061, DOI 10.1001/archinternmed.2011.18; Chiba M, 2011, INFLAMM BOWEL DIS, V17, pE82, DOI 10.1002/ibd.21745; Chiba M, 2010, WORLD J GASTROENTERO, V16, P2484, DOI 10.3748/wjg.v16.i20.2484; HELLER SN, 1978, AM J CLIN NUTR, V31, P1510; Report of the Working Group on Arteriosclerosis of the National Heart Lung and Blood Institute, 1981, ARTERIOSCLEROSIS, V2; Tuso Philip J, 2013, Perm J, V17, P61, DOI 10.7812/TPP/12-085	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	DEC	2014	59	12					3129	3130		10.1007/s10620-014-3399-5		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU0OG	WOS:000345322100038		
J	Kawada, T				Kawada, Tomoyuki			Risk of Peptic Ulcer Bleeding in Patients with Chronic Kidney Disease and End-Stage Renal Disease Receiving Peritoneal or Hemodialysis	DIGESTIVE DISEASES AND SCIENCES			English	Letter							DIALYSIS		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Lau JY, 2011, DIGESTION, V84, P102, DOI 10.1159/000323958; Drew DA, 2014, AM J KIDNEY DIS, V63, P547, DOI 10.1053/j.ajkd.2014.01.009; Dong R, 2014, WORLD J GASTROENTERO, V20, P11370, DOI 10.3748/wjg.v20.i32.11370; Huang KW, 2014, DIGEST DIS SCI, V59, P807, DOI 10.1007/s10620-013-2973-6	4	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	DEC	2014	59	12					3131	3132		10.1007/s10620-014-3401-2		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AU0OG	WOS:000345322100039		
J	Ware, JA; Urquhart, BL; Sugiyama, Y; Zamek-Gliszczynski, MJ				Ware, Joseph A.; Urquhart, Bradley L.; Sugiyama, Yuichi; Zamek-Gliszczynski, Maciej J.			Breast Cancer Resistance Protein Substrate and Inhibition Evaluation: Why, When, and How?	DRUG METABOLISM AND DISPOSITION			English	Letter							SULFASALAZINE; BCRP; POLYMORPHISMS; TRANSPORTERS; DISPOSITION; ABSORPTION; CURCUMIN; HUMANS; ABCG2; PROBE		[Ware, Joseph A.] Genentech Inc, Clin Pharmacol, San Francisco, CA 94080 USA; [Urquhart, Bradley L.] Univ Western Ontario, London, ON, Canada; [Sugiyama, Yuichi] RIKEN Innovat Ctr, Yokohama, Kanagawa, Japan; [Zamek-Gliszczynski, Maciej J.] GlaxoSmithKline, Drug Metab & Pharmacokinet, Res Triangle Pk, NC USA	Ware, JA (reprint author), Genentech Res & Early Dev, 1 DNA Way,MS-463A, San Francisco, CA 94080 USA.	ware.joseph@gene.com	Urquhart, Brad/E-4221-2015	Urquhart, Brad/0000-0001-8324-1472			Urquhart BL, 2008, PHARMACOGENET GENOM, V18, P439, DOI 10.1097/FPC.0b013e3282f974dc; Zaher H, 2006, MOL PHARMACEUT, V3, P55, DOI 10.1021/mp050113v; Kusuhara H, 2012, BRIT J PHARMACOL, V166, P1793, DOI 10.1111/j.1476-5381.2012.01887.x; Englund G, 2006, EUR J PHARM SCI, V29, P269, DOI 10.1016/j.ejps.2006.04.010; Yamasaki Y, 2008, CLIN PHARMACOL THER, V84, P95, DOI 10.1038/sj.clpt.6100459; Kalvass JC, 2013, CLIN PHARMACOL THER, V94, P80, DOI 10.1038/clpt.2013.34; Pang KS, 2003, DRUG METAB DISPOS, V31, P1507, DOI 10.1124/dmd.31.12.1507; Shukla S, 2009, PHARM RES-DORD, V26, P480, DOI 10.1007/s11095-008-9735-8; Adkison KK, 2010, J PHARM SCI-US, V99, P1046, DOI 10.1002/jps.21860; Poirier A, 2014, DRUG METAB DISPOS, V42, P1466, DOI 10.1124/dmd.114.058248; Zamek-Gliszczynski MJ, 2012, DRUG METAB DISPOS, V40, P1825, DOI 10.1124/dmd.112.046508; Zamek-Gliszczynski MJ, 2013, CLIN PHARMACOL THER, V94, P64, DOI 10.1038/clpt.2013.45	12	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	DEC	2014	42	12					1979	1980		10.1124/dmd.114.060970		2	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT8AP	WOS:000345156500001		
J	Uno, Y; Uehara, S; Hosokawa, M; Imai, T				Uno, Yasuhiro; Uehara, Shotaro; Hosokawa, Masakiyo; Imai, Teruko			Systematic Identification and Characterization of Carboxylesterases in Cynomolgus Macaques	DRUG METABOLISM AND DISPOSITION			English	Article							HUMAN LIVER CARBOXYLESTERASE; CATALYTIC-PROPERTIES; PURIFICATION; IRINOTECAN; METABOLISM; ACTIVATION; EXPRESSION; ISOZYMES; ESTERASE; COCAINE	Carboxylesterase (CES) is important for detoxification of a wide range of drugs and xenobiotics and catalyzes cholesterol and fatty acid metabolism. Cynomolgus macaques are widely used in drug metabolism studies; however, cynomolgus CES has not been fully investigated at molecular levels, partly due to the lack of gene information. In this study, we isolated and characterized cDNAs for CES homologous to human CES1, CES2, and CES5A in cynomolgus macaques. By genome analysis, in the cynomolgus macaque genome, three gene sequences were found for CES1(v1-3) and CES2(v1-3), whereas one gene sequence was found for CES5A. Cynomolgus CES1, CES2, and CES5A genes were located in the genomic regions corresponding to the human genes. We successfully identified CES1v1, CES1v2, CES2v1, CES2v3, and CES5A cDNAs from cynomolgus liver. Sequence analysis showed that amino acid sequences of each CES were highly homologous to that of the human homolog. All five CESs had sequences characteristic for CES enzymes, including the catalytic triad and oxyanion hole loop. By quantitative polymerase chain reaction, the most abundant expression of CES mRNAs among the 10 tissue types analyzed was observed in liver (CES1v1 and CES2v3 mRNAs), jejunum (CES2v1 mRNAs), and kidney (CES1v2 and CES5A mRNA), the organs important for drug metabolism and excretion. The results indicated that cynomolgus macaques express at least five CES genes, which potentially encode intact CES proteins.	[Uno, Yasuhiro; Uehara, Shotaro] Shin Nippon Biomed Labs, Pharmacokinet & Bioanal Ctr, Kainan 6420017, Japan; [Hosokawa, Masakiyo] Chiba Inst Sci, Fac Pharmaceut Sci, Lab Drug Metab & Biopharmaceut, Choshi, Japan; [Imai, Teruko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto, Japan	Uno, Y (reprint author), Shin Nippon Biomed Labs, Pharmacokinet & Bioanal Ctr, Genome Res Grp, 16-1 Minami Akasaka, Wakayama 6420017, Japan.	uno-yasuhiro@snbl.co.jp					Alexson SEH, 2002, DRUG METAB DISPOS, V30, P643, DOI 10.1124/dmd.30.6.643; Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4; Bosron WF, 2002, NAT STRUCT BIOL, V9, P4, DOI 10.1038/nsb0102-4; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Miyazaki M, 2006, CHEM BIOL, V13, P1071, DOI 10.1016/j.chembiol.2006.08.013; Pindel EV, 1997, J BIOL CHEM, V272, P14769, DOI 10.1074/jbc.272.23.14769; Xu G, 2002, CLIN CANCER RES, V8, P2605; Potter PM, 1998, CANCER RES, V58, P3627; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; Holmes RS, 2008, COMP BIOCHEM PHYS D, V3, P195, DOI 10.1016/j.cbd.2008.05.002; HOSOKAWA M, 1987, MOL PHARMACOL, V31, P579; Miller AD, 1999, PROTEIN EXPRES PURIF, V17, P16, DOI 10.1006/prep.1999.1121; Satoh T, 2002, DRUG METAB DISPOS, V30, P488, DOI 10.1124/dmd.30.5.488; Taketani M, 2007, LIFE SCI, V81, P924, DOI 10.1016/j.lfs.2007.07.026; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Uno Y, 2006, MOL PHARMACOL, V70, P477, DOI 10.1124/mol.106.022673; Williams ET, 2010, MOL PHYLOGENET EVOL, V57, P23, DOI 10.1016/j.ympev.2010.05.018; Williams ET, 2011, DRUG METAB DISPOS, V39, P2305, DOI 10.1124/dmd.111.041335	19	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	DEC	2014	42	12					2002	2006		10.1124/dmd.114.059972		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT8AP	WOS:000345156500005		
J	Namisaki, T; Schaeffeler, E; Fukui, H; Yoshiji, H; Nakajima, Y; Fritz, P; Schwab, M; Nies, AT				Namisaki, Tadashi; Schaeffeler, Elke; Fukui, Hiroshi; Yoshiji, Hitoshi; Nakajima, Yoshiyuki; Fritz, Peter; Schwab, Matthias; Nies, Anne T.			Differential Expression of Drug Uptake and Efflux Transporters in Japanese Patients with Hepatocellular Carcinoma	DRUG METABOLISM AND DISPOSITION			English	Article							MULTIDRUG-RESISTANCE PROTEIN; P-GLYCOPROTEIN; OCT1 SLC22A1; TARGETED THERAPIES; DOWN-REGULATION; UP-REGULATION; LIVER-CANCER; STEM-CELLS; GENE; MRP2	Targeted chemotherapy for hepatocellular carcinoma (HCC) is impaired by intrinsic and/or acquired drug resistance. Because drugs used in HCC therapy (e.g., anthracyclines or the tyrosine kinase inhibitor sorafenib) are substrates of uptake and/or efflux transporters, variable expression of these transporters at the plasma membrane of tumor cells may contribute to drug resistance and subsequent clinical response. In this study, the variability of expression of uptake transporters [organic cation transporter (OCT) 1 and OCT3] and efflux transporters [multidrug resistance 1 (MDR1)/P-glycoprotein, multidrug resistance protein (MRP) 1, MRP2, and breast cancer resistance protein (BCRP)], selected for their implication in transporting drugs used in HCC therapy, was investigated. HCC and corresponding nontumor tissue samples were collected from 24 Japanese patients at the time of surgery. Protein expression was determined by immunohistochemistry. Expression data were correlated with clinicopathological characteristics and patients' outcome (median follow-up, 53 months). Generally, expression was highly variable among individual tumor samples. Yet median expression of OCT1, OCT3, and MDR1 in HCC was significantly lower (1.4-, 2.7-, and 2-fold, respectively) than in nontumor tissue, while expression of MRP2 persisted and BCRP showed a trend of increased levels in HCC. Patients with low BCRP expression had significantly shorter overall and recurrence-free survival times. Results suggest different expression patterns of drug transporters in HCC, which are associated only in part with clinicopathological characteristics. Detailed information on expression of drug transporters in HCC may be promising for individualization and optimization of drug therapy for liver cancer.	[Namisaki, Tadashi; Schaeffeler, Elke; Fritz, Peter; Schwab, Matthias; Nies, Anne T.] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Namisaki, Tadashi; Schaeffeler, Elke; Fritz, Peter; Schwab, Matthias; Nies, Anne T.] Univ Tubingen, Tubingen, Germany; [Namisaki, Tadashi; Fukui, Hiroshi; Yoshiji, Hitoshi] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara 634, Japan; [Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 634, Japan; [Schwab, Matthias] Univ Tubingen Hosp, Inst Expt & Clin Pharmacol & Toxicol, Dept Clin Pharmacol, Tubingen, Germany	Nies, AT (reprint author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-70376 Stuttgart, Germany.	anne.nies@ikp-stuttgart.de			Wilhelm-Sander-Stiftung, Munchen, Germany [2010.059.1]; Robert Bosch Stiftung, Stuttgart, Germany; European Union [FP7 PITN-GA-2009-238132]	This work was supported by the Wilhelm-Sander-Stiftung, Munchen, Germany [Grant no. 2010.059.1]; by the Robert Bosch Stiftung, Stuttgart, Germany; and by the European Union [Grant FP7 PITN-GA-2009-238132].	Akimoto M, 2006, WORLD J GASTROENTERO, V12, P868; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Kato A, 2001, J SURG ONCOL, V78, P110, DOI 10.1002/jso.1129; Swift B, 2013, DRUG METAB DISPOS, V41, P1179, DOI 10.1124/dmd.112.048181; Herraez E, 2012, MOL PHARMACEUT, V9, P2565, DOI 10.1021/mp300178a; Zen Y, 2007, AM J PATHOL, V170, P1750, DOI 10.2353/ajpath.2007.060798; Zollner G, 2005, LIVER INT, V25, P367, DOI 10.1111/j.1478-3231.2005.01033.x; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Cui YH, 1999, MOL PHARMACOL, V55, P929; Herraez E, 2013, HEPATOLOGY, V58, P1065, DOI 10.1002/hep.26425; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Okabe H, 2001, CANCER RES, V61, P2129; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Nies AT, 2001, INT J CANCER, V94, P492, DOI 10.1002/ijc.1498; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Ng IOL, 2000, AM J CLIN PATHOL, V113, P355; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; Larbcharoensub N, 2011, HISTOPATHOLOGY, V59, P235, DOI 10.1111/j.1365-2559.2011.03935.x; Baguley BC, 2010, METHODS MOL BIOL, V596, P1, DOI 10.1007/978-1-60761-416-6_1; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; DeGorter MK, 2012, ANNU REV PHARMACOL, V52, P249, DOI 10.1146/annurev-pharmtox-010611-134529; Sukowati CHC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-160; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Chu X, 2013, CLIN PHARMACOL THER, V94, P126, DOI 10.1038/clpt.2013.78; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Sun ZG, 2010, TUMORI, V96, P90; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Llovet JM, 2012, J HEPATOL, V56, P908; Fox J, 2012, J STAT SOFTW, V49, P1; Heise M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-109; Hirohashi S, 2000, WHO CLASSIFICATION T, P158; Schaeffeler E, 2011, GENOME MED, V3, DOI 10.1186/gm298; Scheffer GL, 2000, CANCER RES, V60, P5269; Singletary SE, 2003, CANCER, V98, P2740, DOI 10.1002/cncr.11865; Wright SR, 1998, CLIN CANCER RES, V4, P2279	41	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	DEC	2014	42	12					2033	2040		10.1124/dmd.114.059832		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT8AP	WOS:000345156500009		
J	Ito, Y; Fukami, T; Yokoi, T; Nakajima, M				Ito, Yusuke; Fukami, Tatsuki; Yokoi, Tsuyoshi; Nakajima, Miki			An Orphan Esterase ABHD10 Modulates Probenecid Acyl Glucuronidation in Human Liver	DRUG METABOLISM AND DISPOSITION			English	Article							UDP-GLUCURONOSYLTRANSFERASE ISOFORMS; SERINE HYDROLASE ABHD6; HUMAN SERUM-ALBUMIN; CARBOXYLIC-ACID; ARYLACETAMIDE DEACETYLASE; COVALENT BINDING; HYDROLYSIS; ENZYME; DRUGS; METABOLITES	Probenecid, a widely used uricosuric agent, is mainly metabolized to probenecid acyl glucuronide (PRAG), which is considered a causal substance of severe allergic or anaphylactoid reactions. PRAG can be hydrolyzed (deglucuronidated) to probenecid. The purpose of this study was to identify enzymes responsible for probenecid acyl glucuronidation and PRAG deglucuronidation in human livers and to examine the effect of deglucuronidation in PRAG formation. In human liver homogenates (HLHs), the intrinsic clearance (CLint) of PRAG deglucuronidation was much greater (497-fold) than that of probenecid acyl glucuronidation. Evaluation of PRAG formation by recombinant UDP-glucuronosyltransferase (UGT) isoforms and an inhibition study using HLHs as an enzyme source demonstrated that multiple UGT isoforms, including UGT1A1, UGT1A9, and UGT2B7, catalyzed probenecid acyl glucuronidation. We found that recombinant alpha/beta hydrolase domain containing 10 (ABHD10) substantially catalyzed PRAG deglucuronidation activity, whereas carboxylesterases did not. Similar inhibitory patterns by chemicals between HLHs and recombinant ABHD10 supported the major contribution of ABHD10 to PRAG deglucuronidation in human liver. Interestingly, it was demonstrated that the CLint value of probenecid acyl glucuronidation in HLHs was increased by 1.7-fold in the presence of phenylmethylsulfonyl fluoride, which potently inhibited ABHD10 activity. In conclusion, we found that PRAG deglucuronidation catalyzed by ABHD10 suppressively regulates PRAG formation via multiple UGT enzymes in human liver. The balance of activities by these enzymes is important for the formation of PRAG, which may be associated with the adverse reactions observed after probenecid administration.	[Ito, Yusuke; Fukami, Tatsuki; Yokoi, Tsuyoshi; Nakajima, Miki] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan	Fukami, T (reprint author), Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan.	tatsuki@p.kanazawa-u.ac.jp	Fukami, Tatsuki/C-8907-2015; Nakajima, Miki/C-3990-2015		Japan Society for the Promotion of Science [23590174]	This research was supported in part by the Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research 23590174].	SMITH PC, 1992, DRUG METAB DISPOS, V20, P962; Kato Y, 2012, DRUG METAB DISPOS, V40, P240, DOI 10.1124/dmd.111.042150; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Sawamura R, 2010, DRUG METAB DISPOS, V38, P1857, DOI 10.1124/dmd.110.034173; Fukami T, 2010, DRUG METAB DISPOS, V38, P2173, DOI 10.1124/dmd.110.034454; Jinno N, 2013, BIOL PHARM BULL, V36, P1509; DUBOISPRESLE N, 1995, MOL PHARMACOL, V47, P647; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Fallon JK, 2013, J PROTEOME RES, V12, P4402, DOI 10.1021/pr4004213; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; Miners JO, 2011, DRUG METAB DISPOS, V39, P644, DOI 10.1124/dmd.110.037036; Fukami T, 2012, DRUG METAB PHARMACOK, V27, P466, DOI 10.2133/dmpk.DMPK-12-RV-042; Yamaori S, 2006, DRUG METAB PHARMACOK, V21, P147, DOI 10.2133/dmpk.21.147; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Iwamura A, 2012, J BIOL CHEM, V287, P9240, DOI 10.1074/jbc.M111.271288; Soars MG, 2002, J PHARMACOL EXP THER, V301, P382, DOI 10.1124/jpet.301.1.382; Kuehl GE, 2005, DRUG METAB DISPOS, V33, P1027, DOI 10.1124/dmd.104.002527; Ohtsuki S, 2012, DRUG METAB DISPOS, V40, P83, DOI 10.1124/dmd.111.042259; Kobayashi Y, 2012, DRUG METAB DISPOS, V40, P1080, DOI 10.1124/dmd.112.044537; Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257; HEYMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P609, DOI 10.1515/bchm2.1967.348.1.609; Fujiwara R, 2010, J PHARM SCI-US, V99, P442, DOI 10.1002/jps.21830; Sato Y, 2014, DRUG METAB DISPOS, V42, P885, DOI 10.1124/dmd.113.056291; Tachibana M, 2005, DRUG METAB DISPOS, V33, P803, DOI 10.1124/dmd.104.003178; Bernard P, 1999, MOL PHARMACOL, V56, P526; Gregory PA, 2004, MOL PHARMACOL, V65, P953, DOI 10.1124/mol.65.4.953; HILLECKE NA, 1965, J AMER MED ASSOC, V193, P740; Hioki T, 2011, DRUG METAB DISPOS, V39, P1345, DOI 10.1124/dmd.111.038141; Ishii Y, 2000, MOL PHARMACOL, V57, P940; ISRAILI ZH, 1972, J MED CHEM, V15, P709, DOI 10.1021/jm00277a004; IWATSUBO K, 1965, JPN J PHARMACOL, V15, P244, DOI 10.1254/jjp.15.244; Johnson G, 2000, MOL IMMUNOL, V37, P707, DOI 10.1016/S0161-5890(00)00104-8; Labar G, 2007, CHEMBIOCHEM, V8, P1293, DOI 10.1002/cbic.200700139; LEVVY GA, 1952, BIOCHEM J, V52, P464; MINAGAWA T, 1995, BIOCHEM PHARMACOL, V49, P1361, DOI 10.1016/0006-2952(95)00071-7; Oda S, 2012, DRUG METAB DISPOS, V40, P1620, DOI 10.1124/dmd.112.045625; PEREL JM, 1970, LIFE SCI, V9, P1337, DOI 10.1016/0024-3205(70)90041-X; Preuss CV, 1996, BIOCHEM PHARMACOL, V51, P1661, DOI 10.1016/0006-2952(96)00134-7; Ramirez J, 2008, PHARMACOGENOMICS J, V8, P152, DOI 10.1038/sj.tpj.6500454; ROWE BJ, 1984, J PHARMACOL EXP THER, V230, P237; Sakaguchi K, 2004, ARCH BIOCHEM BIOPHYS, V424, P219, DOI 10.1016/j.abb.2004.02.004; Sallustio BC, 1997, DRUG METAB DISPOS, V25, P55; SMITH PC, 1990, J PHARMACOL EXP THER, V252, P218; Southwood HT, 2007, CHEM RES TOXICOL, V20, P1520, DOI 10.1021/tx700188x; SPAHNLANGGUTH H, 1992, DRUG METAB REV, V24, P5; Suzuki E, 2010, DRUG METAB DISPOS, V38, P1538, DOI 10.1124/dmd.110.032938; VOLLAND C, 1991, DRUG METAB DISPOS, V19, P1080	48	2	2	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0090-9556	1521-009X		DRUG METAB DISPOS	Drug Metab. Dispos.	DEC	2014	42	12					2109	2116		10.1124/dmd.114.059485		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT8AP	WOS:000345156500017		
J	Yamano, M; Hamamoto, H; Kawada, Y; Goto, S				Yamano, Makoto; Hamamoto, Hideki; Kawada, Yoshifumi; Goto, Shusaku			Heat flow anomaly on the seaward side of the Japan Trench associated with deformation of the incoming Pacific plate	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						Japan Trench; Pacific plate; heat flow; thermal structure; subduction zone; hydrothermal circulation	NORTHEASTERN JAPAN; SEISMOGENIC ZONE; OKI EARTHQUAKE; OCEANIC PLATE; FORE-ARC; REFLECTION; VOLCANISM; REGION; SANRIKU; FLEXURE	Extensive heat flow measurements were conducted on the seaward side of the Japan Trench for investigation of the extent and the origin of high heat flow previously found on the incoming Pacific plate. The obtained data combined with the existing data showed that high and variable heat flow values are pervasively distributed seawards of the northern half of the trench and within about 150 km of the trench axis. In this anomalous zone, the average heat flow is 60 to 70 mW/m(2), appreciably higher than the value typical for the seafloor age of about 135 m.y. The occurrence of the anomalous heat flow along the trench indicates that it results from processes closely related to deformation of the incoming plate. Heating by intra-plate "petit-spot" volcanism and/or fluid flow along normal faults developed on the trench slope may yield local heat flow peaks but cannot raise regional average heat flow. The most probable cause of the observed widespread anomalous heat flow is efficient vertical heat transport by hydrothermal circulation in a permeable layer in the oceanic crust, which is gradually developed by fracturing due to plate bending. Similar heat flow and temperature structure anomalies on the seaward side of the trench may exist in other subduction zones. (C) 2014 Elsevier B.V. All rights reserved.	[Yamano, Makoto; Kawada, Yoshifumi] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Hamamoto, Hideki] Ctr Environm Sci Saitama, Kisai, Saitama 3470115, Japan; [Goto, Shusaku] AIST, Inst Georesources & Environm, Tsukuba, Ibaraki 3058567, Japan	Yamano, M (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	yamano@eri.u-tokyo.ac.jp			JSPS/MEXT KAKENHI Grant [19340125, 21107003]	We are grateful to the officers, crew, scientists, and technicians for their assistance on the cruises during which we made heat flow measurements, KH-07-3 (R/V Hakuho-maru), KR07-06, KR08-10, KR09-16, KR10-12 (R/V Kairei), KT-08-25, and KT-09-8 (R/V Tansei-maru). We also thank G. Fujie, S. Kodaira, Y. Nakamura, and K. Kawamura for helpful discussions, and P. Fulton and an anonymous reviewer for valuable comments on the first version of the manuscript. MCS reflection profiles were provided by the JAM-STEC Crustal Structure Data Base Site. This work was supported by JSPS/MEXT KAKENHI Grant Numbers 19340125 and 21107003.	Hirano N, 2008, BASIN RES, V20, P543, DOI 10.1111/j.1365-2117.2008.00363.x; Nishimura T, 2004, GEOPHYS J INT, V157, P901, DOI 10.1111/j.1365-246X.2004.02159.x; Hamamoto H, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024138; Grevemeyer I, 2005, EARTH PLANET SC LETT, V236, P238, DOI 10.1016/j.epsl.2005.04.048; Hirano N, 2011, GEOCHEM J, V45, P157; Tajima F, 2013, TECTONOPHYSICS, V586, P15, DOI 10.1016/j.tecto.2012.09.014; Stein CA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018478; Fulton PM, 2013, SCIENCE, V342, P1214, DOI 10.1126/science.1243641; Yamano M, 2008, INT J EARTH SCI, V97, P345, DOI 10.1007/s00531-007-0280-1; ANDERSON RN, 1977, J GEOPHYS RES, V82, P3391, DOI 10.1029/JB082i023p03391; Kobayashi K, 1998, GEOPHYS J INT, V134, P356, DOI 10.1046/j.1365-246x.1998.00569.x; Fujie G, 2013, GEOPHYS RES LETT, V40, P88, DOI 10.1029/2012GL054340; Nakanishi M, 2011, MOD APPR SOL EARTH S, V8, P1, DOI 10.1007/978-90-481-8885-7_1; Hirano N, 2006, SCIENCE, V313, P1426, DOI 10.1126/science.1128235; Moore JC, 2001, GEOLOGY, V29, P183, DOI 10.1130/0091-7613(2001)029<0183:ULOTSZ>2.0.CO;2; Kawada Y, 2014, GEOCHEM GEOPHY GEOSY, V15, P1580, DOI 10.1002/2014GC005285; Tanioka Y, 1997, ISL ARC, V6, P261, DOI 10.1111/j.1440-1738.1997.tb00176.x; Wada I, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002570; Davis E.E., 1989, HDB SEAFLOOR HEAT FL, P145; Fujie G., 2013, JAP GEOSC UN M 2013; Fujie G, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013764; Hasterok D, 2011, EARTH PLANET SC LETT, V311, P386, DOI 10.1016/j.epsl.2011.09.044; Hirano N, 2001, GEOPHYS RES LETT, V28, P2719, DOI 10.1029/2000GL012426; Ito A, 2004, EARTH PLANET SC LETT, V223, P163, DOI 10.1016/j.epsl.2004.04.007; Kinoshita M, 2006, EARTH PLANET SC LETT, V245, P498, DOI 10.1016/j.epsl.2006.02.006; Labani R., GEOCHEM GEOPHY UNPUB; Miura S, 2005, TECTONOPHYSICS, V407, P165, DOI 10.1016/j.tecto.2005.08.001; Nakanishi M, 1998, J GEOPHYS RES-SOL EA, V103, P12453, DOI 10.1029/98JB00754; Oleskevich DA, 1999, J GEOPHYS RES-SOL EA, V104, P14965, DOI 10.1029/1999JB900060; Sacks I.S., 2000, P OCEAN DRILLING PRO, V186, P1; SASS JH, 1984, J VOLCANOL GEOTH RES, V20, P145, DOI 10.1016/0377-0273(84)90071-4; Tsuru T, 2000, J GEOPHYS RES-SOL EA, V105, P16403, DOI 10.1029/2000JB900132; Vacquier V., 1966, B EARTHQ RES I TOKYO, V44, P531; Von Herzen R., 1959, J GEOPHYS RES, V64, P1557, DOI 10.1029/JZ064i010p01557; Von Herzen R, 2001, J GEOPHYS RES-SOL EA, V106, P6817, DOI 10.1029/2000JB900469; Yamanaka Y., 2004, J GEOPHYS RES, V109; Yamano M., 2004, GEOTHERMAL GRADIENT	37	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	DEC 1	2014	407						196	204		10.1016/j.epsl.2014.09.039		9	Geochemistry & Geophysics	Geochemistry & Geophysics	AT8JH	WOS:000345179300017		
J	Shimpo, M; Fukkoshi, Y; Akamatsu, R				Shimpo, Misa; Fukkoshi, Yuko; Akamatsu, Rie			Correlations between self-efficacy in resisting six temptations and dietary energy and macronutrient intake at each meal	EATING BEHAVIORS			English	Article						Self-efficacy; Diet; Energy intake; Macronutrient intake	WEIGHT-LOSS; MAINTENANCE; BEHAVIOR; ADULTS	Self-efficacy in relation to eating behavior for weight control is commonly defined as having the confidence to control urges to overeat in high-risk situations. Prior researchers have suggested that self-efficacy plays a mediating role in eating behavior for weight loss and maintenance. The current study examined the relationship between self-efficacy in resisting certain temptations and daily dietary intake at each meal. Participants were 83 men and 122 women registered at the health management website "Asken". They administered questionnaires about self-efficacy and dietary records. As results of multiple regression analysis, self-efficacy in resisting negative emotions was negatively related to lunch energy intake in men (beta = -0.308, p = 0.023) and total (beta = -0.302, p = 0.003), breakfast (beta = -0.334, p = 0.004), and snacking (beta = -0.232, p = 0.022) energy intake in women. Also, self-efficacy in resisting rewards was negatively related to lunch energy intake in men (beta = -0.218, p = 0.040). In men, self-efficacy in resisting hunger was positively related to protein intake (beta = 0.148, p = 0.021) and relaxation was negatively related to lipid intake (beta = -0.211, p = 0.009). Self-efficacy in resisting some temptations, especially negative emotions, and dietary intakes were negatively related. Future research is needed to confirm these results and assess the prospective effects of self-efficacy. (C) 2014 Elsevier Ltd. All rights reserved.	[Shimpo, Misa; Akamatsu, Rie] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan; [Shimpo, Misa] Japan Soc Promot Sci, Tokyo, Japan	Akamatsu, R (reprint author), 2-1-1 Otsuka,Bunkyo Ku, Tokyo 1128610, Japan.	g1370511@edu.cc.ocha.ac.jp; fukko4yuko@gmail.com; akamatsu.rie@ocha.ac.jp					Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Riebe D, 2005, PREV MED, V40, P769, DOI 10.1016/j.ypmed.2004.09.023; Byrne SM, 2002, J PSYCHOSOM RES, V53, P1029, DOI 10.1016/S0022-3999(02)00487-7; Glasofer DR, 2013, INT J EAT DISORDER, V46, P663, DOI 10.1002/eat.22160; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Bas M, 2009, APPETITE, V52, P209, DOI 10.1016/j.appet.2008.09.017; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191; Grogan SC, 1997, APPETITE, V28, P19, DOI 10.1006/appe.1996.0067; Carels RA, 2006, PSYCHOL HEALTH, V21, P65, DOI 10.1080/14768320500102277; CLARK MM, 1991, J CONSULT CLIN PSYCH, V59, P739, DOI 10.1037//0022-006X.59.5.739; Costanzo PR, 1999, INT J EAT DISORDER, V26, P205, DOI 10.1002/(SICI)1098-108X(199909)26:2<205::AID-EAT10>3.0.CO;2-2; HEATHERTON TF, 1991, PSYCHOL BULL, V110, P86, DOI 10.1037//0033-2909.110.1.86; Ministry of Education Culture Sports Science and Technology; the Government of Japan, 2010, STAND TABL FOOD COMP; Ministry of Health Labour and Welfare (a), ANN REP NAT NUTR SUR; Ministry of Health Labour and Welfare (b), JAP DIET REF INT; Nothwehr F, 2008, HEALTH EDUC BEHAV, V35, P698, DOI 10.1177/1090198106296771; Roach JB, 2003, J AM DIET ASSOC, V103, P1357, DOI 10.1053/S0002-8223(03)01072-1; STANTON AL, 1990, ADDICT BEHAV, V15, P461, DOI 10.1016/0306-4603(90)90033-T; Tamaura Y., 2010, Japanese Journal of Nutrition and Dietetics, V68, P87, DOI 10.5264/eiyogakuzashi.68.87; Wingo BC, 2013, J NUTR EDUC BEHAV, V45, P314, DOI 10.1016/j.jneb.2012.12.004	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1471-0153	1873-7358		EAT BEHAV	Eat. Behav.	DEC	2014	15	4					563	566		10.1016/j.eatbeh.2014.08.012		4	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	AU1TJ	WOS:000345402700010		
J	Namerikawa, T; Hosoda, Y				Namerikawa, Toru; Hosoda, Yasuhiko			H-infinity Filter-Based Short-Term Electric Load Prediction Considering Characteristics of Load Curve	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						electric load prediction; H-infinity filter; characteristics of load curve; estimation; prediction		This paper deals with H filter-based short-term electric load prediction taking into consideration the characteristics of the load curve. We propose a predictive method to forecast the future electric load demand for 36 h from 12:00 PM, and evaluate the peak and bottom of the load curves on the next day. We propose a load model, estimate the unknown parameters of the model by means of an H filter using the data separated for nonworking days and weekdays, with the same pattern of the previous data chosen and assigned to the model parameters. The simulation results show the effectiveness of the proposed prediction methodology.	[Namerikawa, Toru] Keio Univ, Dept Syst Design & Engn, Fac Sci & Technol, Tokyo 108, Japan; [Hosoda, Yasuhiko] Keio Univ, Grad Sch Engn, Tokyo 108, Japan	Namerikawa, T (reprint author), Keio Univ, Dept Syst Design & Engn, Fac Sci & Technol, Tokyo 108, Japan.		Namerikawa, Toru/H-4110-2012	Namerikawa, Toru/0000-0001-9907-4234			ABUELMAGED MA, 1982, T SYST CYBERNET, P370; MOGHRAM I, 1989, IEEE T POWER SYST, V4, P1484, DOI 10.1109/59.41700; Basar T., 1995, H OPTIMAL CONTROL RE; CHRISTIAANSE WR, 1971, IEEE T POWER AP SYST; HAIDA T, 2009, T IEEJ B, V129, P1477; HAMADI HMA, 2004, T ELECT POWER SYST R, P47; Iizaka T., 2004, Transactions of the Institute of Electrical Engineers of Japan, Part B, V124-B, DOI 10.1541/ieejpes.124.347; Iizaka T., 2001, Transactions of the Institute of Electrical Engineers of Japan, Part C, V121-C; Ishida T., 1994, Transactions of the Institute of Electrical Engineers of Japan, Part B, V114-B; Ishioka O., 2000, Transactions of the Institute of Electrical Engineers of Japan, Part B, V120-B; ITO S, 2010, T IEEJ B, V130, P329; KATAYAMA T, 2010, APPL KALMAN FILTERS; Kawauchi S., 2004, Transactions of the Institute of Electrical Engineers of Japan, Part B, V124-B, DOI 10.1541/ieejpes.124.77; OHMI N, 2006, T IEEJ B, V126, P202; Onoda T., 1997, Journal of Japanese Society for Artificial Intelligence, V12; *SUBCOMM INV TECHN, 1989, TECHNICAL REPORT OF; YOKOKAWA A, 2010, SMART GRID STRUCTURA; Yukita K., 2004, Transactions of the Institute of Electrical Engineers of Japan, Part B, V124-B, DOI 10.1541/ieejpes.124.355; Zheng TX, 2000, ELECTR POW SYST RES, V54, P11, DOI 10.1016/S0378-7796(99)00063-2	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					1	10		10.1002/ecj.11558		10	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700001		
J	Sako, T; Tokumo, K; Yoshie, O				Sako, Takashi; Tokumo, Koutaro; Yoshie, Osamu			Rubbing Detection of Sliding Bearings in Early Stage by Frequency Modulation Analysis	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						cepstrum; sliding bearing; machine diagnosis; rubbing; vibration; machine condition monitoring		It is important in maintenance to detect rubbing of sliding bearings in the early stage. An experiment on mild rubbing conditions was conducted, and the changes in vibration were examined. Importantly, a newly found fact is that peaks in the spectral domain with respect to the rotational period occur as a result of rubbing. Consequently, cepstrum analysis was shown to be effective for the detection of rubbing in the early stage. A device that can follow the level of the quefrency was developed based upon this idea. Utilizing the device is a highly efficient way to monitor the condition of a sliding bearing.	[Sako, Takashi] Waseda Univ, Grad Sch, Tokyo, Japan; [Yoshie, Osamu] Waseda Univ, Grad Sch Sci, Tokyo, Japan; [Yoshie, Osamu] Waseda Univ, Grad Sch Informat & Ind Syst, Tokyo, Japan	Sako, T (reprint author), Waseda Univ, Grad Sch, Tokyo, Japan.						Courrech J., 1987, NEW TECHNIQUES FAULT, P83; El Badaoui M, 2001, J MECH DESIGN, V123, P422, DOI 10.1115/1.1349420; Hans KH, 2010, SOUND VIB JST, V44, P10; Morita N, 2005, IEEJ RES REP ROTATIN, VRM-05, P101; Okamoto K, 2008, P JAP I MAR ENG C, V78, P39; Randall RB, 1980, 2 INT C VIBR ROT MAC, P169; Sato N, 1989, T IEEJ C, V109-C, P145; Wada M., 1990, Journal of the Japan Society of Precision Engineering, V56	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					11	23		10.1002/ecj.11559		13	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700002		
J	Shirai, K; Amano, Y				Shirai, Kenji; Amano, Yoshinori			Mathematical Analysis of Manufacturing Lead Time: Applications to Deadline Scheduling in Manufacturing Systems	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						manufacturing lead time; manufacturing lead time compatibility constraint; stochastic differential equations of log-normal type; martingale; risk-neutral integral		In this paper, we apply a stochastic differential equation (SDE) as a mathematical model that describes the manufacturing process from input of materials to the end of the process. We utilize the risk-neutral principle in stochastic calculus based on the SDE. We extend the mathematical model to allow for objective evaluation. In order to improve the lead time in a manufacturing process, we introduce an evaluation equation that satisfies a certain compatibility constraint with respect to the lead time; this compatibility constraint with lead time refers to a strategy that eliminates irrelevant processes from the overall process, and results in improvements to the process. We assume a probability density function of log-normal type, which is the probability density function from the input materials to the end of the process. The present paper evaluates a certain compatibility constraint with lead time by applying risk neutrality and the martingale measure of the stochastic integral under this assumption. After the evaluation value is calculated by the evaluation equation, a process control system evaluates each subprocess and performs rescheduling to improve the utilization efficiency of the entire manufacturing process. Thus, a front-end process is used to cancel requests to the process, and follows the instructions in the process control systems. However, the present paper gives only a simulation evaluation in which the parameters are calculated, and does not discuss compatibility between an evaluation value based on the calculated manufacturing lead time compatibility constraint and a real system. However, the paper offers an idea for finding bottleneck subprocesses in a manufacturing process, and for use as a software tool for process synchronization.	[Shirai, Kenji] Niigata Univ Int & Informat Studies, Niigata, Japan; [Amano, Yoshinori] Kyohnan Elecs Co Ltd, Toyota, Japan	Shirai, K (reprint author), Niigata Univ Int & Informat Studies, Niigata, Japan.						BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Lee HL, 1997, SLOAN MANAGE REV, V38, P93; [Anonymous], 2009, J FACULTY MANAGEMENT, P183; Dolgui A, 2002, INT J PROD ECON, V78, P145, DOI 10.1016/S0925-5273(00)00180-8; Hiiragi S, 2012, SIGNIFICANCE SHORTEN; Kondo H, 2008, REPORTS RIAM S MATH, VME-S7, P146; Matsui M, 2000, J JPN IND MANAGE ASS, V51, P124; Takefusa A, 2003, SACSIS2003 S, P121; Wilmott P., 1998, DERIVATIVES	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					24	34		10.1002/ecj.11586		11	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700003		
J	Miyauchi, Y; Ishizawa, H; Koyama, S; Tezuka, S; Hara, H				Miyauchi, Yuki; Ishizawa, Hiroaki; Koyama, Shouhei; Tezuka, Shin-ichirou; Hara, Hitoshi			Development of a Glucose Measuring System Using a Confocal Optical System	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						glucose; confocal; near-infrared absorption; blood	SPECTROSCOPY; BLOOD	Our research team has developed a confocal optical system using a near-infrared laser that is capable of reducing the effects of scattering when measuring glucose concentration. We have measured the light reflection of our samples, and because our system has the depth resolution offered by a confocal optical system, it is able to limit the length of the light path and to detect light absorption at each depth level of the samples, thereby restricting the point of measurement. This report details the use of this system for a basic experiment involving measuring blood samples and predicting glucose concentration levels. The results show a high correlation between the glucose concentration and near-infrared light absorption. We also demonstrate the potential for calculating glucose concentrations in living organisms using our system.	[Miyauchi, Yuki; Ishizawa, Hiroaki; Koyama, Shouhei] Shinshu Univ, Matsumoto, Nagano, Japan; [Tezuka, Shin-ichirou; Hara, Hitoshi] Yokogawa Elect Corp, Tokyo, Japan	Miyauchi, Y (reprint author), Shinshu Univ, Matsumoto, Nagano, Japan.						Aijima T, 1992, CHEMOMETRICS NEW SPE, P114; Amaral C. E. F., 2008, MED ENG PHYS, V30, P541, DOI DOI 10.1016/J.MEDENGPHY.2007.06.003; Nishiyama N, 2005, IEEE J SEL TOP QUANT, V11, P990, DOI 10.1109/JSTQE.2005.853841; Malin SF, 1999, CLIN CHEM, V45, P1651; HEISE HM, 1989, ANAL CHEM, V61, P2009, DOI 10.1021/ac00193a004; Oliver NS, 2009, DIABETIC MED, V26, P197, DOI 10.1111/j.1464-5491.2008.02642.x; ROBINSON MR, 1992, CLIN CHEM, V38, P1618; Berger AJ, 1997, SPECTROCHIM ACTA A, V53, P287, DOI 10.1016/S0584-8539(96)01779-5; Fishbache Ch, 1997, FRESEN J ANAL CHEM, V359, P78; Fujita K, 2004, IEEJ T EIS, V124, P1759, DOI 10.1541/ieejeiss.124.1759; Hashima M, 2001, OPTICAL COMMUNICATIO, P19; International Diabetes Federation, 2009, ATL FOR; International Diabetes Federation, 2008, INT DIAB FED GUID MA, P11; Kadowaki T, 1996, FUNDAM CLIN, V30-5, P1125; Kawada S, 2005, SPECTROSCOPICAL SOC, V38, P33; Kiyono H, 2010, DIABETES, V53, P450; Martini FH, 1991, COLOR STRUCTURAL ATL, P69; Masuko A, 1996, JPN J MED PHARM SCI, V35-4, P921; Miyauchi Y, 2010, SICE ANN C 2010, P3427; Miyauchi Y, 2010, 49 ANN C JSMBE; Miyauchi Y., 2011, SICE 2011 - 50th Annual Conference of the Society of Instrument and Control Engineers of Japan; Nishimura G, 2009, I JPN COLL ANGIOL, V49, P139; Ozaki S, 1996, SPECTROSCOPICAL SOC, V32, P11; PATTERSON M S, 1991, Lasers in Medical Science, V6, P379, DOI 10.1007/BF02042460; Polonky KS, 1988, J CLIN INVEST, P442; Shaffer RE, 1996, ANAL CHEM, V68, P2663, DOI 10.1021/ac960049g; Smith JL, 2006, PURSUIT NONINVASIVE; Tamura K, 2007, IEEJ T ELECT INFORM, V127, P686, DOI 10.1541/ieejeiss.127.686; Tamura M, 2004, KOGAKU, V33, P380; WHO, 2010, DIAB PROGR; Yamakoshi K, 1996, JAPAN SOC PRECISION, V62, P1525	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					35	41		10.1002/ecj.11589		7	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700004		
J	Maenaka, K; Chan, ACK; Ohkochi, S; Nakamura, T; Kitamura, H; Kimura, J; Higuchi, K				Maenaka, Kazusuke; Chan, Alex Chun Kit; Ohkochi, Sayaka; Nakamura, Toshiaki; Kitamura, Hirokazu; Kimura, Junichi; Higuchi, Kohei			A Low-Power Miniaturized 315 MHz Transceiver Module for Biosignal Transmission	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						low power consumption; wireless radio; miniature size; biosignal; sensor; wearable		In this paper we describe a small-sized and extremely low-power consumption transceiver module for a wireless sensor network, especially suitable for biosignal transmission. Currently, many types of transceiver modules such as Bluetooth, ZigBee, and low-power radio modules for 315 MHz are available on the market. However, when we consider an extremely small and light system including a battery and transceiver module for a wireless sensor network mounted on the human body, almost all the transceiver modules on the market consume too much power and are too large for assembly. In this study we concentrated on creating an extremely low-power consumption and small/lightweight transceiver module for the 315 MHz radio band. As a result, we successfully designed and fabricated a transceiver module with a size of 11 x 11 x 1.5 mm(3) including a bipolar ASIC for the radio circuit and an eight-bit microcontroller. The operation currents of the receiver and transmitter are 2 mA and 1 mA, respectively, for a supply voltage of 2.5 V. These results are generally sufficient for many uses for wireless sensor network systems, and not only for biosignal applications.	[Maenaka, Kazusuke] Univ Hyogo, Grad Sch Engn, Circuit & Syst Dept, Div Elect Engn, Kobe, Hyogo 6500044, Japan; [Maenaka, Kazusuke; Ohkochi, Sayaka] Japan Sci & Technol Agcy, Tokyo, Japan; [Nakamura, Toshiaki; Kitamura, Hirokazu; Kimura, Junichi] Panasonic Corp, Tokyo, Japan; [Chan, Alex Chun Kit] Japan Sci & Technol Agcy, Erato Maenaka Sensing Fus Project, Sensor Syst Grp, Tokyo, Japan; [Higuchi, Kohei] Japan Sci & Technol Agcy, Erato Maenaka Sensing Fus Project, Tokyo, Japan	Maenaka, K (reprint author), Univ Hyogo, Grad Sch Engn, Circuit & Syst Dept, Div Elect Engn, Kobe, Hyogo 6500044, Japan.				JST ERATO Sensing Fusion Project	This investigation was supported by the JST ERATO Sensing Fusion Project, and is the result of joint research by the University of Hyogo Electronic Circuit Research Laboratory and Panasonic Electronic Devices. The authors thank the members of the Sensing Fusion Project, as well as Director Wada, and also Director Okada of Panasonic Electronic Devices for their cooperation in development and prototyping.	[Anonymous], 2008, BIRTH LIV REC, P91; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; [Anonymous], 1950, 14 RAD MAN COMM; [Anonymous], 2005, STD21 ARIB RCR; Gabriel C, 1996, 203320001 AFB DC; Kwak KS, 2011, 802156 IEEE; Maenaka K, 2011, P 28 SENS SYN D, VD2- 2, P177; Maenaka K, 2008, IEEJ T E, V128-E, P419, DOI 10.1541/ieejsmas.128.419; Otto C., 2006, J MOBILE MULTIMEDIA, V1, P307; Penders J, 2008, P 5 INT WORKSH WEAR, P94; RF World, 2009, LOW POW RF DAT COMM	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					42	51		10.1002/ecj.11590		10	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700005		
J	Kudo, H; Arakawa, T; Mitsubayashi, K				Kudo, Hiroyuki; Arakawa, Takahiro; Mitsubayashi, Kohji			Status of Soft Contact Lens Biosensor Development for Tear Sugar Monitoring: A Review	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						glucose; noninvasive; tear; biosensor	GLUCOSE; HYPERGLYCEMIA	Noninvasive and continuous glucose monitoring is of increasing significance since diabetes mellitus has become a global problem, not only in developed countries. Usually, continuous glucose monitors use the relationship between blood glucose and other body fluids. In particular, we focused on the relationship between blood glucose and tear glucose. A soft contact lens (SCL) biosensor has been developed for the assessment of blood glucose by real-time tear sugar monitoring. The SCL biosensor has film electrodes on the rounded surface of a polydimethyl siloxane (PDMS) contact lens, and glucose oxidase (GOD) is immobilized on the sensing region of the electrodes. In this paper, the status of SCL biosensor development and the application of the SCL biosensor in the real-time monitoring of tear glucose are reviewed.	[Kudo, Hiroyuki; Arakawa, Takahiro; Mitsubayashi, Kohji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan	Kudo, H (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.						Lane JD, 2006, CURR EYE RES, V31, P895, DOI 10.1080/02713680600976552; Kudo H, 2006, BIOSENS BIOELECTRON, V22, P558, DOI 10.1016/j.bios.2006.05.006; DAUM KM, 1982, INVEST OPHTH VIS SCI, V22, P509; Baca JT, 2007, CLIN CHEM, V53, P1370, DOI 10.1373/clinchem.2006.078543; Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003; Jin Z, 1997, ANAL CHEM, V69, P1326, DOI 10.1021/ac960724m; Badugu R, 2004, J FLUORESC, V14, P617, DOI 10.1023/B:JOFL.0000039349.89929.da; Chu MX, 2011, TALANTA, V83, P960, DOI 10.1016/j.talanta.2010.10.055; Chu MX, 2011, BIOMED MICRODEVICES, V13, P603, DOI 10.1007/s10544-011-9530-x; GASSET AR, 1968, AM J OPHTHALMOL, V65, P414; Iguchi S, 2007, BIOMED MICRODEVICES, V9, P603, DOI 10.1007/s10544-007-9073-3; LEWIS J. G., 1958, BRIT JOUR OPHTHALMOL, V42, P754, DOI 10.1136/bjo.42.12.754; Michail D, 1937, CR SOC BIOL, V125, P1095; Yan QY, 2011, ANAL CHEM, V83, P8341, DOI 10.1021/ac201700c	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					52	56		10.1002/ecj.11591		5	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700006		
J	Matsumoto, A; Miyahara, Y				Matsumoto, Akira; Miyahara, Yuji			Current Development Status and Perspectives of Self-Regulated Insulin Delivery Systems: A Review	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						polymer gel; phenylboronic acid; glucose; insulin; diabetes	GLUCOSE-SENSING MOIETY; PHYSIOLOGICAL PH; BEARING	Diabetes is not an infectious disease but its increasingly rapid and worldwide spread has been recognized as pandemic. Despite the necessity for continuous and accurate glycemic control in the management of insulin-dependent diabetes mellitus, the current palliative treatment relies almost solely on patient self-injection of insulin, which not only impinges on the QOL of patients but also fails to precisely control the dose of insulin, where an overdose must be strictly avoided since it can otherwise cause serious hypoglycemia. The development of self-regulated insulin delivery systems is a long-standing challenge for materials science, for which the exploitation of glucose oxidase and sugar-binding lectin are two prevalent strategies to achieve the function of glucose sensitivity. These protein-based components, however, are inappropriate for long-term use and storage due to their denaturing and cytotoxic natures, and they are hardly suitable for any implantable applications. Thus, they have not yet been put in clinical use to date. This review intends to provide an overview of the current efforts to develop a thoroughly synthetic alternative making use of a phenylboronic acid-derived polyacrylamide gel.	[Matsumoto, Akira; Miyahara, Yuji] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan	Matsumoto, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.						Matsumoto A, 2004, BIOMACROMOLECULES, V5, P1038, DOI 10.1021/bm0345413; JAMES TD, 1995, NATURE, V374, P345, DOI 10.1038/374345a0; LORAND JP, 1959, J ORG CHEM, V24, P769, DOI 10.1021/jo01088a011; Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1; Matsumoto A, 2012, ANGEW CHEM INT EDIT, V51, P2124, DOI 10.1002/anie.201106252; Matsumoto A, 2004, MACROMOLECULES, V37, P1502, DOI 10.1021/ma035382i; Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d; SWAIN CG, 1968, J AM CHEM SOC, V90, P4328, DOI 10.1021/ja01018a024; Matsumoto A, 2010, CHEM COMMUN, V46, P2203, DOI 10.1039/b920319b; Matsumoto A, 2003, BIOMACROMOLECULES, V4, P1410, DOI 10.1021/bm034139o; ARONOFF S, 1975, CARBOHYD RES, V40, P299, DOI 10.1016/S0008-6215(00)82611-7; BOESEKEN J, 1949, ADV CARBOHYD CHEM, V4, P189; FOSTER AB, 1957, ADV CARBOHYD CHEM, V12, P81; SINGHAL RP, 1991, J CHROMATOGR, V543, P17, DOI 10.1016/S0021-9673(01)95752-8	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					57	61		10.1002/ecj.11592		5	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700007		
J	Asayama, R; Wang, JQ; Fujiwara, O; Nagaoka, T; Watanabe, S				Asayama, Ryota; Wang, Jianqing; Fujiwara, Osamu; Nagaoka, Tomoaki; Watanabe, Soichi			Statistical Outliers in Voxel SARs and Their Effect of Whole-Body Average SARs in Pregnant Woman and Child for Far-Field Exposure	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						far-field exposure; pregnant woman; 3-year-old child; voxel SAR; statistical outliers; whole-body average SARs	GHZ; MHZ	The World Health Organization (WHO) recommended the necessity of electromagnetic (FM) dosimetry evaluation of pregnant women with fetus and of children as an urgent research subject in 2006, with emphasis on studies of whole-body average specific absorption rates (WBA-SARs) in various numerical models of pregnant woman and children for the purpose of determining the safety limits of WBA-SARs. The current safety limits were determined on the basis of behavior abnormalities in healthy adult animals in radio-frequency FM exposure and FM absorption characteristics at resonant frequencies, but not in experiments using pregnant and young animals. In this investigation, we calculated the voxel SARs and WBA-SARs in anatomically detailed models of pregnant woman and 3-year-old children at their resonant frequencies. The histograms and cumulative relative distributions of the voxel SARs were also derived to determine statistical outliers in the voxel SARs for pregnant woman and 3-year-old child models. We found that the mean voxel SARs agree with the WBA-SARs, and that median voxel SARs in the pregnant woman and 3-year-old child models are 47% and 55% of their means, respectively, and the peak voxel SARs are 70 times the mean in both cases. This suggests the possibility that finite-difference time-domain (FDTD)-calculated WBA-SARs may be overestimated due to the existence of statistical outliers. It was also found that although the total number ratio of voxel SARs for the outliers is 0.36% for the pregnant woman model and 0.34% for the 3-year-old child model, WBA-SARs excluding these outliers are less than those in the pregnant woman and 3-year-old child models by 6.8% and 5.7%, respectively.	[Asayama, Ryota; Wang, Jianqing; Fujiwara, Osamu] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi, Japan; [Nagaoka, Tomoaki; Watanabe, Soichi] Natl Inst Informat & Commun Technol, Tokyo, Japan	Asayama, R (reprint author), Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi, Japan.						Conil E, 2008, PHYS MED BIOL, V53, P1511, DOI 10.1088/0031-9155/53/6/001; Dimbylow P, 2007, PHYS MED BIOL, V52, P6639, DOI 10.1088/0031-9155/52/22/006; Nagaoka T, 2007, PHYS MED BIOL, V52, P6731, DOI 10.1088/0031-9155/52/22/012; Fujiwara O., 1992, Journal of the Institute of Electronics, Information and Communication Engineers, V75; Gabriel C., 1996, ALOETR19960037 BROOK; Hirata A, 2007, BIOELECTROMAGNETICS, V28, P484, DOI 10.1002/bem.20335; Hirata A, 2009, IEEJ T EIS, V129, P2102; Ministry of Posts and Telecommunications Telecommunications Technology Council Reply, 1990, PROT GUID HUM BOD EX; Miwa H, 2011, IEEJ T FM, V131, P89, DOI 10.1541/ieejfms.131.89; Nagaoka T, 2005, DEV CHILD VOXEL MODE, P39; Nagaya Yoshio, 2008, IEICE Transactions on Communications, VJ91-B; World Health Organization, 2006, 2006 WHO RES AG RAD	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					62	69		10.1002/ecj.11593		8	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700008		
J	Kimishima, M; Nakayama, Y; Kogami, Y				Kimishima, Masayuki; Nakayama, Yoshikazu; Kogami, Yoshinori			RF-SiP Reflectometer Technology for RF Testers	ELECTRONICS AND COMMUNICATIONS IN JAPAN			English	Article						RF tester; SIP; reflectometer; network analyzer; directional coupler; isolation amplifier	TRANSMISSION; CMOS	Technologies of small size reflectometers constructed in the form of RF functional systems in packages (SiPs) for RF testers are described. As primary concerns, focusing on the directivity and dynamic range of the reflectometer performance, we propose the construction and core circuit topologies to realize a very small reflectometer SiP that satisfies the functions of vector network analysis for RF testers. The reflectometer features a very small size, less than 1/50 of our conventional hybrid form reflectometer, and has good performance for RF testers.	[Kimishima, Masayuki] Utsunomiya Univ, Grad Sch Engn, ADVANTEST CORP, ATE Unit Dev Grp, Utsunomiya, Tochigi, Japan; [Nakayama, Yoshikazu] Utsunomiya Univ, ATE Unit Dev Grp, ADVANTEST CORP, Utsunomiya, Tochigi, Japan; [Kogami, Yoshinori] Utsunomiya Univ, Grad Sch Engn, Utsunomiya, Tochigi, Japan	Kimishima, M (reprint author), Utsunomiya Univ, Grad Sch Engn, ADVANTEST CORP, ATE Unit Dev Grp, Utsunomiya, Tochigi, Japan.						BEYER JB, 1984, IEEE T MICROW THEORY, V32, P268, DOI 10.1109/TMTT.1984.1132664; Mirzaei A, 2011, IEEE J SOLID-ST CIRC, V46, P950, DOI 10.1109/JSSC.2011.2109570; Davidson A, 1989, 34 AUT RF TECHN GROU; GILBERT B, 1968, IEEE J SOLID-ST CIRC, VSC 3, P365, DOI 10.1109/JSSC.1968.1049925; Kim SS, 2004, IEEE MICROW WIREL CO, V14, P440, DOI 10.1109/LMWC.2004.832079; Kimishima M, 2012, IEICE T ELECTRON, VE95C, P1147, DOI 10.1587/transele.E95.C.1147; Kimishima M, 2011, 2011 CHINA JAPAN JOI; Kimishima M, 2010, 2010 IEEE INT TEST C; Kimura S, 1996, IEEE T MICROW THEORY, V44, P2076, DOI 10.1109/22.543965; Lai JW, 2009, IEEE J SOLID-ST CIRC, V44, P2911, DOI 10.1109/JSSC.2009.2028920; Levy R., 1963, IEEE Transactions on Microwave Theory and Techniques, VMTT-11, DOI 10.1109/TMTT.1963.1125647; LEVY R, 1964, IEEE T MICROW THEORY, VMT12, P275, DOI 10.1109/TMTT.1964.1125809; Lim K, 2011, IEEE J SOLID-ST CIRC, V46, P1648, DOI 10.1109/JSSC.2011.2144090; MEYER RG, 1986, IEEE J SOLID-ST CIRC, V21, P534, DOI 10.1109/JSSC.1986.1052568; SHELTON JP, 1966, IEEE T MICROW THEORY, VMT14, P7, DOI 10.1109/TMTT.1966.1126145; Schellenberg J, 1999, IEEE MTT S INT MICR, P1733, DOI 10.1109/MWSYM.1999.780306; Shimozawa M, 2006, IEICE J C, VJ89-C, P217; Soares R, 1988, GAAS MESFET CIRCUIT, P39; Wong T. T. Y., 1993, FUNDAMENTALS DISTRIB; Yoshimoto A, 2007, IEEE VTS VEH TECHNOL, P1137, DOI 10.1109/VETECF.2007.246	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1942-9533	1942-9541		ELECTR COMMUN JPN	Electr. Commun. Jpn.	DEC	2014	97	12					70	85		10.1002/ecj.11621		16	Engineering, Electrical & Electronic	Engineering	AU0MI	WOS:000345316700009		
J	Agboola, JI				Agboola, Julius Ibukun			Technological Innovation and Developmental Strategies for Sustainable Management of Aquatic Resources in Developing Countries	ENVIRONMENTAL MANAGEMENT			English	Article						Technology; Developing countries; Strategies; Aquatic resources; Sustainable management	ENVIRONMENTAL-MANAGEMENT; RENEWABLE ENERGY; DISASTERS	Sustainable use and allocation of aquatic resources including water resources require implementation of ecologically appropriate technologies, efficient and relevant to local needs. Despite the numerous international agreements and provisions on transfer of technology, this has not been successfully achieved in developing countries. While reviewing some challenges to technological innovations and developments (TID), this paper analyzes five TID strategic approaches centered on grassroots technology development and provision of localized capacity for sustainable aquatic resources management. Three case studies provide examples of successful implementation of these strategies. Success requires the provision of localized capacity to manage technology through knowledge empowerment in rural communities situated within a framework of clear national priorities for technology development.	[Agboola, Julius Ibukun] United Nations Univ, Inst Adv Study Sustainabil, Operating Unit Ishikawa Kanazawa, Kanazawa, Ishikawa 9200962, Japan; [Agboola, Julius Ibukun] Lagos State Univ, Dept Fisheries, Fac Sci, Ctr Environm & Sci Educ CESE, Ojo, Lagos, Nigeria	Agboola, JI (reprint author), Lagos State Univ, Dept Fisheries, Fac Sci, Ctr Environm & Sci Educ CESE, Ojo, Lagos, Nigeria.	jb_agboola@yahoo.com			United Nations University Institute for Advanced Study on Sustainability (UNU IAS), Japan	Much of this work has been inspired through my participation as an invited early career speaker at the 17th Asian Symposium on Ecotechnology on November 11-13, 2010 at Unazuki International Hall "Selene,'' Kurobe, Japan, and open discussions with lecturers and speakers, particularly with the works of Dipak Gyawali and M. S Swaminathan. I have enjoyed a fellowship support from the United Nations University Institute for Advanced Study on Sustainability (UNU IAS), Japan.	Aerni P, 2001, 13 CTR INT DEV; African Ministerial Council on Science and Technology (AMCOST), 2010, SEC US AFR IND KNOWL; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Allenby B, 2005, SCIENCE, V309, P1034, DOI 10.1126/science.1111534; Kennelly SJ, 2002, FISH FISH, V3, P340, DOI 10.1046/j.1467-2979.2002.00090.x; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Evans L, 2011, J ENVIRON MANAGE, V92, P1938, DOI 10.1016/j.jenvman.2011.03.010; Maclean N, 2000, FISH FISH, V1, P146, DOI 10.1046/j.1467-2979.2000.00017.x; Sundaravadivel M, 2001, CRIT REV ENV SCI TEC, V31, P351, DOI 10.1080/20016491089253; Kesavan PC, 2008, PHILOS T R SOC B, V363, P877, DOI 10.1098/rstb.2007.2189; Agboola JI, 2009, WATER RESOUR MANAG, V23, P2761, DOI 10.1007/s11269-009-9407-4; Pelc R, 2002, MAR POLICY, V26, P471, DOI 10.1016/S0308-597X(02)00045-3; Liu D, 2009, FRONT ECOL ENVIRON, V7, P261, DOI 10.1890/070110; [Anonymous], 1991, ECOL ECON, DOI 10.1016/0921-8009(91)90032-A; DAHLMAN CJ, 1987, WORLD DEV, V15, P759, DOI 10.1016/0305-750X(87)90058-1; LALL S, 1992, WORLD DEV, V20, P165, DOI 10.1016/0305-750X(92)90097-F; COHEN WM, 1989, ECON J, V99, P569, DOI 10.2307/2233763; Beharrel M, 2002, P WORKSH AS WETL BRI, P582; Biggs S, 1998, WORLD DEV, V26, P239, DOI 10.1016/S0305-750X(97)10041-9; Chambers R, 1997, WHOSE REALITY COUNTS; Chambers R, 1995, 24 PLA INT I ENV DEV; Clarke AAD, 2006, HUMAN ECOLOGICAL FOO; Clery D, 2011, SCIENCE, V331, P136, DOI 10.1126/science.331.6014.136; Costa-Pierce BA, 2002, WORLD AQUACULT, V33, P4; Dahlman C, 1983, FINANC DEV, V20, P6; Dey MM, 2000, SPECIAL EDITION AQUA, V4; Esposto S, 2009, TECHNOL SOC, V31, P257; Esteban M, 2008, INNOVATION RESPONDIN; Evenson R.E., 1995, HDB DEV EC, VIII; FAO, 2010, STAT WORLD FISH AQ, P197; Food and Agriculture Organization of the United Nations (FAO), 2007, STAT WORLD FISH AQ; Ghose AK, 2003, JOBS INCOMES GLOBALI; Gommes R, 1998, SUSTAINABLE DEV DIME; Guan JC, 2006, TECHNOL FORECAST SOC, V73, P666, DOI 10.1016/j.techfore.2005.05.009; Hoffman K, 1990, MANAGING INT TECHNOL; Kesavan PC, 2006, PHILOS T R SOC A, V364, P2191, DOI 10.1098/rsta.2006.1822; Konstapel K, 1995, FISHERIES DEV COUNTR; Lall S, 2004, WORLD BANK NEPAD TIC; Lehmann V, 2000, BIOTECHNOL DEV MONIT, P18; Luken R, 2008, J CLEAN PROD, V16, pS67, DOI 10.1016/j.jclepro.2007.10.006; Marlerba F, 1992, ECON J, V102, P845; Measham TG, 2007, AUST GEOGR, V38, P145, DOI 10.1080/00049180701392758; Okurut TO, 2000, THESIS WAGENINGEN U; Pavitt Keith, 1993, IND CORP CHANGE, V2, P157, DOI DOI 10.1093/ICC/2.1.157; Pelkey N, 1996, COASTAL RESOUR RES N, V5, P17; Ramanathan R, 2002, ECOL ECON, V42, P117, DOI 10.1016/S0921-8009(02)00043-5; Redford KH, 2000, CONSERV BIOL, V14, P1567; Reisman A, 2005, OMEGA-INT J MANAGE S, V33, P189, DOI 10.1016/j.omega.2004.04.004; Robert HK, 2004, TREATMENT WETLANDS; Sachs JD, 2000, WELTWIRTSCH ARCH, V136, P579, DOI 10.1007/BF02707644; Soerensen HC, 2008, KEY NOTE PAPER IPCC; Swaminathan MS, 1994, REACHING UNREACHED E; Tougiani A., 2009, GeoJournal, V74, P377, DOI 10.1007/s10708-008-9228-7; UNIDO, 2005, IND DEV REP 2005; United Nations Conference on Trade and Development ( UNCTAD), 2000, WATER SCI TECHNOL, VVI; United Nations Conference on Trade and Development ( UNCTAD), 2000, WATER SCI TECHNOL, VV; United Nations Conference on Trade and Development ( UNCTAD), 2000, WATER SCI TECHNOL, VIV; United Nations (UN), 2001, UNTADITEIPCMISC 5, VE-01.II.D.28; Wetzel RG, 2000, WATER SCI TECH, V44, P1; World Bank, 2002, GLOB GROWTH POV BUIL	60	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-152X	1432-1009		ENVIRON MANAGE	Environ. Manage.	DEC	2014	54	6					1237	1248		10.1007/s00267-014-0358-z		12	Environmental Sciences	Environmental Sciences & Ecology	AT7EN	WOS:000345099900001		
J	Saitanis, CJ; Bari, SM; Burkey, KO; Stamatelopoulos, D; Agathokleous, E				Saitanis, Costas J.; Bari, Shafiqul M.; Burkey, Kent O.; Stamatelopoulos, Dimitris; Agathokleous, Evgenios			Screening of Bangladeshi winter wheat (Triticum aestivum L.) cultivars for sensitivity to ozone	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						SPAD; Chlorophyll; Carotenoids; Cluster analysis; Principal component analysis; Biplot	OPEN-TOP CHAMBERS; MODERN GREEK CULTIVARS; PHASEOLUS-VULGARIS L.; LONG-TERM EXPOSURE; SPRING WHEAT; LEAF CHLOROPHYLL; ELEVATED OZONE; STOMATAL CONDUCTANCE; ABSORPTION-SPECTRA; CARBON-DIOXIDE	The sensitivity to ozone of ten Bangladeshi wheat cultivars was tested by exposing plants to eight ozone exposure regimes (50, 60, 80, 100, 120, 135, 150, and 200 ppb for 14, 11, 8, 6, 5, 4, 3, and 1 days, respectively, for 8 h/day) in controlled environment chambers. Visible leaf injury, dry weight, chlorophyll, carotenoid content, leaf greenness (SPAD value), quantum yield of photosynthesis, and stomatal resistance were measured to evaluate response. Shoot biomass, total chlorophyll, leaf greenness, and carotenoid content were reduced in ozone-exposed plants. Based on the results of principal component analysis (PCA)-biplot analysis, the order of sensitivity to ozone was: Akbar>>Sufi >= Bijoy >= Shatabdi> Bari-26 >= Gourab>Bari-25 >= Prodip >= Sourav>>Kanchan. The most important parameters to discriminate cultivars with respect to ozone sensitivity were visible injury and chlorophyll b/a ratio, whereas quantum yield of photosynthesis was less important. Differences in stomatal resistance were not a significant factor in ozone response. Regression of cultivars' PCA scores against year of release revealed no trend, suggesting that ozone tolerance was not incorporated during cultivar breeding.	[Saitanis, Costas J.; Stamatelopoulos, Dimitris] Agr Univ Athens, Lab Ecol & Environm Sci, GR-11855 Athens, Greece; [Bari, Shafiqul M.] Hajee Mohammad Danesh Sci & Technol Univ, Fac Agr, Dept Agroforestry, Dinajpur 5200, Bangladesh; [Burkey, Kent O.] USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA; [Agathokleous, Evgenios] Hokkaido Univ, Silviculture & Forest Ecol Studies, Sapporo, Hokkaido 0608589, Japan	Saitanis, CJ (reprint author), Agr Univ Athens, Lab Ecol & Environm Sci, Iera Odos 75, GR-11855 Athens, Greece.	saitanis@aua.gr			Greek State Scholarships Foundation (IKY) [18504a]	The authors thank the Greek State Scholarships Foundation (IKY) for supporting the 1 year postdoctoral scholarship (Ref. 18504a) of the co-author Shafiqul Bari in the Agricultural University of Athens, Greece, where the experiments were conducted. The authors thank all the four unknown reviewers for their valuable suggestions.	Akhtar A, 2010, ENVIRON POLLUT, V158, P1763; Uddling J, 2007, PHOTOSYNTH RES, V91, P37, DOI 10.1007/s11120-006-9077-5; Avnery S, 2011, ATMOS ENVIRON, V45, P2284, DOI 10.1016/j.atmosenv.2010.11.045; Danielsson H, 2003, ATMOS ENVIRON, V37, P475, DOI 10.1016/S1352-2310(02)00924-X; FUKSHANSKY L, 1993, PHOTOCHEM PHOTOBIOL, V57, P538, DOI 10.1111/j.1751-1097.1993.tb02332.x; Salvatori E, 2013, ENVIRON EXP BOT, V87, P79, DOI 10.1016/j.envexpbot.2012.09.008; Biswas DK, 2008, GLOBAL CHANGE BIOL, V14, P46, DOI 10.1111/j.1365-2486.2007.01477.x; Azad AK, 1998, ATMOS ENVIRON, V32, P1991, DOI 10.1016/S1352-2310(97)00508-6; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Fuhrer J, 1997, ENVIRON POLLUT, V97, P91, DOI 10.1016/S0269-7491(97)00067-5; Oksanen E, 2013, ENVIRON POLLUT, V177, P189, DOI 10.1016/j.envpol.2013.02.010; Dentener F, 2006, ENVIRON SCI TECHNOL, V40, P3586, DOI 10.1021/es0523845; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; LEFOHN AS, 1987, ATMOS ENVIRON, V21, P561, DOI 10.1016/0004-6981(87)90038-2; Bindi M, 2002, EUR J AGRON, V17, P319, DOI 10.1016/S1161-0301(02)00069-2; Singh AA, 2014, ENVIRON SCI POLLUT R, V21, P2628, DOI 10.1007/s11356-013-2188-6; Burkey KO, 2012, ENVIRON POLLUT, V166, P167, DOI 10.1016/j.envpol.2012.03.020; Goumenaki E, 2010, ENVIRON EXP BOT, V69, P259, DOI 10.1016/j.envexpbot.2010.04.011; Saitanis CJ, 2001, CHEMOSPHERE, V42, P945, DOI 10.1016/S0045-6535(00)00158-2; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87; Fuhrer J, 2003, ENVIRON INT, V29, P141, DOI 10.1016/S0160-4120(02)00157-5; Barma NCD, 2011, WHEAT PRODUCTION SEE, P1; BARNES JD, 1990, NEW PHYTOL, V116, P707, DOI 10.1111/j.1469-8137.1990.tb00557.x; Biswas DK, 2009, AGR ECOSYST ENVIRON, V134, P168, DOI 10.1016/j.agee.2009.06.009; Burkey KO, 1996, PHOTOSYNTH RES, V50, P149, DOI 10.1007/BF00014885; Burkey KO, 2009, FIELD CROP RES, V111, P207, DOI 10.1016/j.fcr.2008.12.005; Caregnato FF, 2013, CHEMOSPHERE, V93, P320, DOI 10.1016/j.chemosphere.2013.04.084; Cohen J., 1988, STAT POWER ANAL BEHA; DETEMMERMAN L, 1992, ENVIRON POLLUT, V77, P1, DOI 10.1016/0269-7491(92)90151-Y; Emberson LD, 2009, ATMOS ENVIRON, V43, P1945, DOI 10.1016/j.atmosenv.2009.01.005; FANGMEIER A, 1994, ENVIRON POLLUT, V83, P317, DOI 10.1016/0269-7491(94)90153-8; Gepstein S, 1988, SENESCENCE AGING PLA, P85; Hasan MK, 2006, THESIS BANGLADESH AG; Kaliakatsou E, 2010, ENVIRON POLLUT, V158, P1948, DOI 10.1016/j.envpol.2009.10.033; Lorenzini G, 2004, ABIOTIC STRESSES PLA, P256; MCCLENDON JH, 1990, PHOTOCHEM PHOTOBIOL, V51, P203, DOI 10.1111/j.1751-1097.1990.tb01704.x; MIKKELSEN TN, 1995, ENVIRON POLLUT, V87, P197, DOI 10.1016/0269-7491(94)P2607-B; MIYAKE H, 1989, NEW PHYTOL, V111, P187, DOI 10.1111/j.1469-8137.1989.tb00681.x; OJANPERA K, 1992, NEW PHYTOL, V120, P39, DOI 10.1111/j.1469-8137.1992.tb01056.x; Ollerenshaw JH, 1999, ENVIRON POLLUT, V106, P67, DOI 10.1016/S0269-7491(99)00060-3; Pandit DB, 2007, BANGLADESH J AGR RES, V32, P473; Pleijel H, 2011, ENVIRON POLLUT, V159, P897, DOI 10.1016/j.envpol.2010.12.020; Pleijel H, 2006, ENVIRON EXP BOT, V56, P63, DOI 10.1016/j.envexpbot.2005.01.004; Saitanis CJ, 2003, CHEMOSPHERE, V51, P913, DOI 10.1016/S0045-6535(03)00041-9; Saitanis CJ, 2002, J AGRON CROP SCI, V188, P51, DOI 10.1046/j.1439-037x.2002.00539.x; Salam A, 2008, AIR QUAL ATMOS HLTH, V1, P101, DOI 10.1007/s11869-008-0017-8; Sarkar A, 2010, ENVIRON EXP BOT, V69, P328, DOI 10.1016/j.envexpbot.2010.04.016; Sikder HA, 2013, ATMOS RES, V122, P378, DOI 10.1016/j.atmosres.2012.09.011; SUTINEN S, 1990, NEW PHYTOL, V115, P345, DOI 10.1111/j.1469-8137.1990.tb00461.x; VELISSARIOU D, 1992, AGR ECOSYST ENVIRON, V38, P79, DOI 10.1016/0167-8809(92)90169-C; Wang QB, 2004, J PLANT NUTR, V27, P557, DOI 10.1081/PLN-120028878	51	3	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2014	21	23					13560	13571		10.1007/s11356-014-3286-9		12	Environmental Sciences	Environmental Sciences & Ecology	AT9YP	WOS:000345280200046		
J	Geng, Y; Liu, ZX; Xue, B; Dong, HJ; Fujita, T; Chiu, A				Geng, Yong; Liu, Zuoxi; Xue, Bing; Dong, Huijuan; Fujita, Tsuyoshi; Chiu, Anthony			Emergy-based assessment on industrial symbiosis: a case of Shenyang Economic and Technological Development Zone	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Emergy analysis; Industrial symbiosis; Industrial park; China	LIFE-CYCLE ASSESSMENT; PARK LEVEL; EMISSION REDUCTION; CIRCULAR ECONOMY; CHINA; MANAGEMENT; INDICATOR	Industrial symbiosis is the sharing of services, utility, and by-product resources among industries. This is usually made in order to add value, reduce costs, and improve the environment, and therefore has been taken as an effective approach for developing an eco-industrial park, improving resource efficiency, and reducing pollutant emission. Most conventional evaluation approaches ignored the contribution of natural ecosystem to the development of industrial symbiosis and cannot reveal the interrelations between economic development and environmental protection, leading to a need of an innovative evaluation method. Under such a circumstance, we present an emergy analysis-based evaluation method by employing a case study at Shenyang Economic and Technological Development Zone (SETDZ). Specific emergy indicators on industrial symbiosis, including emergy savings and emdollar value of total emergy savings, were developed so that the holistic picture of industrial symbiosis can be presented. Research results show that nonrenewable inputs, imported resource inputs, and associated services could be saved by 89.3, 32.51, and 15.7 %, and the ratio of emergy savings to emergy of the total energy used would be about 25.58 %, and the ratio of the emdollar value of total emergy savings to the total gross regional product (GRP) of SETDZ would be 34.38 % through the implementation of industrial symbiosis. In general, research results indicate that industrial symbiosis could effectively reduce material and energy consumption and improve the overall eco-efficiency. Such a method can provide policy insights to industrial park managers so that they can raise appropriate strategies on developing eco-industrial parks. Useful strategies include identifying more potential industrial symbiosis opportunities, optimizing energy structure, increasing industrial efficiency, recovering local ecosystems, and improving public and industrial awareness of eco-industrial park policies.	[Geng, Yong] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China; [Geng, Yong; Liu, Zuoxi; Xue, Bing] Chinese Acad Sci, Inst Appl Ecol, Key Lab Pollut Ecol & Environm Engn, Shenyang 110016, Liaoning Provin, Peoples R China; [Liu, Zuoxi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Dong, Huijuan; Fujita, Tsuyoshi] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Chiu, Anthony] De La Salle Univ, Dept Ind Engn, Manila 1004, Philippines	Geng, Y (reprint author), Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, Shanghai 200240, Peoples R China.	ygeng@sjtu.edu.cn			Natural Science Foundation of China [71033004, 71325006, 41101126, 71311140172]; Ministry of Science and Technology of China [2011BAJ06B01]	This work was supported by Natural Science Foundation of China (71033004, 71325006, 41101126, and 71311140172), Ministry of Science and Technology of China (2011BAJ06B01).	Geng Y, 2009, J IND ECOL, V13, P15, DOI 10.1111/j.1530-9290.2008.00071.x; Geng Y, 2010, SCI TOTAL ENVIRON, V408, P5273, DOI 10.1016/j.scitotenv.2010.07.081; Ulgiati S, 2002, J CLEAN PROD, V10, P335, DOI 10.1016/S0959-6526(01)00044-0; Mu HF, 2011, ECOL ENG, V37, P335, DOI 10.1016/j.ecoleng.2010.11.026; Geng Y, 2008, INT J SUST DEV WORLD, V15, P231, DOI 10.3843/SusDev.15.3:6; Huang SL, 2003, LANDSCAPE URBAN PLAN, V63, P61, DOI 10.1016/S0169-2046(02)00152-4; Geng Y, 2013, J CLEAN PROD, V58, P82, DOI 10.1016/j.jclepro.2013.06.034; Geng Y, 2010, J CLEAN PROD, V18, P993, DOI 10.1016/j.jclepro.2010.03.003; Van Berkel R, 2009, J ENVIRON MANAGE, V90, P1544, DOI 10.1016/j.jenvman.2008.11.010; Hashimoto S, 2010, RESOUR CONSERV RECY, V54, P704, DOI 10.1016/j.resconrec.2009.11.013; Hau JL, 2004, ECOL MODEL, V178, P215, DOI 10.1016/j.ecolmodel.2003.12.016; Taskhiri MS, 2011, RESOUR CONSERV RECY, V55, P730, DOI 10.1016/j.resconrec.2011.03.001; Ingwersen WW, 2011, J IND ECOL, V15, P550, DOI 10.1111/j.1530-9290.2011.00333.x; Rugani B, 2012, INT J LIFE CYCLE ASS, V17, P795, DOI 10.1007/s11367-012-0403-1; Rugani B, 2012, ENVIRON SCI TECHNOL, V46, P4701, DOI 10.1021/es203440n; Geng Y, 2012, J CLEAN PROD, V23, P216, DOI 10.1016/j.jclepro.2011.07.005; Chertow MR, 2005, ENVIRON SCI TECHNOL, V39, P6535, DOI 10.1021/es050050+; Geng Y, 2013, SCIENCE, V339, P1526, DOI 10.1126/science.1227059; Geng Y, 2013, RENEW SUST ENERG REV, V18, P95, DOI 10.1016/j.rser.2012.10.015; Chertow MR, 2007, J IND ECOL, V11, P11, DOI 10.1162/jiec.2007.1110; Ulgiati S, 2011, ECOL INDIC, V11, P1185, DOI 10.1016/j.ecolind.2010.12.021; Dong HJ, 2013, ENERG POLICY, V57, P298, DOI 10.1016/j.enpol.2013.01.057; Xi FM, 2011, ENERG POLICY, V39, P5999, DOI 10.1016/j.enpol.2011.06.063; Chertow MR, 2000, ANNU REV ENERG ENV, V25, P313, DOI 10.1146/annurev.energy.25.1.313; Bastlanoni S, 2005, INT J ENERG RES, V29, P53, DOI 10.1002/er.1036; Budihardjo S, 2013, J HUM RESOUR SUSTAIN, V1, P14; Dong HJ, 2014, ENERGY, V64, P277, DOI 10.1016/j.energy.2013.11.005; Geng Y, 2007, WASTE MANAGE, V27, P141, DOI 10.1016/j.wasman.2006.07.013; Geng Y, 2013, J MATER CYCLES WASTE, V15, P310, DOI 10.1007/s10163-013-0118-9; Geng Y, 2010, J CLEAN PROD, V18, P1502, DOI 10.1016/j.jclepro.2010.06.028; Geng Y, 2003, ENVIRON MANAGE, V31, P784, DOI 10.1007/s00267-002-2854-9; Geng Y, 2009, J CLEAN PROD, V17, P1289, DOI 10.1016/j.jclepro.2009.03.009; Geng Y, 2007, REG ENVIRON CHANGE, V7, P123, DOI 10.1007/s10113-007-0026-4; Geng Y, 2012, ENVIRON SCI TECHNOL, V46, P107, DOI 10.1021/es204293x; Li H, 2013, LECT NOTES ELECT ENG, V209, P199; Li Y, 2010, THESIS DONGHUA U LIB; Odum H. T., 2000, HDB EMERGY EVALUATIO; Odum H. T., 1996, ENV ACCOUNTING EMERG; ODUM HT, 1988, SCIENCE, V242, P1132, DOI 10.1126/science.242.4882.1132; Ren W., 2012, URBAN CLIM, V1, P55; SETDZ, 2013, ENV PROT EM RED REP; Shenyang Municipality, 2011, SHEN YEARL BOOK 2010; Song Y, 2014, NATL IND PARKS DEV R; Sun LN, 2013, ECOL ENG, V53, P115, DOI 10.1016/j.ecoleng.2012.12.023; Ulgiati S, 2013, EMERGY SYNTHESIS, P557; Wang LM, 2005, ECOL MODEL, V189, P233, DOI 10.1016/j.ecolmodel.2005.02.005; Yan MR, 2013, ENERGIES, V6, P973, DOI 10.3390/en6020973; Yang J, 2012, SCI WORLD J, DOI 10.1100/2012/917830	48	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2014	21	23					13572	13587		10.1007/s11356-014-3287-8		16	Environmental Sciences	Environmental Sciences & Ecology	AT9YP	WOS:000345280200047		
J	Dasgupta, S; Cao, A; Mauer, B; Yan, BZ; Uno, S; McElroy, A				Dasgupta, Subham; Cao, Austin; Mauer, Brittany; Yan, Beizhan; Uno, Seiichi; McElroy, Anne			Genotoxicity of oxy-PAHs to Japanese medaka (Oryzias latipes) embryos assessed using the comet assay	ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH			English	Article						Oryzias latipes; Comet assay; Acenaphthenequinone; 7,12-Benz[a]anthracenquinone; Fish embryos	POLYCYCLIC AROMATIC-HYDROCARBONS; LAMBDA-TRANSGENIC MEDAKA; CANCER-RISK ASSESSMENT; DNA-DAMAGE; ZEBRAFISH EMBRYOS; INDIVIDUAL CELLS; MODEL ORGANISM; SEDIMENTS; EXPOSURE; IDENTIFICATION	Polycyclic aromatic hydrocarbons (PAHs) have long been recognized as important environmental toxicants. Despite a plethora of information on the fate and effects of parent PAHs, relatively little is known about the environmental fate and toxicity of ketone- and quinone-substituted PAH oxidation products (termed oxy-PAHs), particularly in the aquatic environment. This study begins to fill that gap using embryos of the Japanese medaka (Oryzias latipes) as a model species. The genotoxic potential of two environmentally relevant oxy-PAHs, acenaphthenequinone and 7,12-benz[a]anthracenquinone,was assessed using the comet assay. We found that both oxy-PAHs could cause significant increases in DNA damage after only 48 h of exposure at the lowest concentrations tested (5 mu g/L). Comparisons of the genotoxic potential between these oxy-PAHs and their corresponding parent PAHs (acenaphthene and benz[a]anthracene) and a well-known mutagenic PAH, benzo[a]pyrene, indicated similar potencies among all five of these compounds, particularly after longer (7 day) exposures. This study demonstrates the mutagenic potential of oxy-PAHs to an in vivo fish embryo model and points out the need for further study of their environmental occurrence and biologic effects.	[Dasgupta, Subham; Cao, Austin; Mauer, Brittany; McElroy, Anne] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Yan, Beizhan] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Uno, Seiichi] Kagoshima Univ, Fac Fisheries, Educ & Res Ctr Marine Resources & Environm, Kagoshima 8900056, Japan	McElroy, A (reprint author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	Anne.McElroy@Stonybrook.edu					Machala M, 2001, ENVIRON TOXICOL CHEM, V20, P2736, DOI 10.1897/1551-5028(2001)020<2736:AHRMAE>2.0.CO;2; Layshock JA, 2010, ENVIRON TOXICOL CHEM, V29, P2450, DOI 10.1002/etc.301; FERNANDEZ P, 1992, ENVIRON SCI TECHNOL, V26, P817, DOI 10.1021/es00028a024; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Nimrod AC, 1998, AQUAT TOXICOL, V44, P141, DOI 10.1016/S0166-445X(98)00062-9; WILSON SC, 1993, ENVIRON POLLUT, V81, P229, DOI 10.1016/0269-7491(93)90206-4; Bandowe BAM, 2010, ENVIRON POLLUT, V158, P2888, DOI 10.1016/j.envpol.2010.06.012; TIFFIN GJ, 1991, J REPROD FERTIL, V93, P125; Hu J, 2012, ENVIRON SCI TECHNOL, V46, P4607, DOI 10.1021/es300020e; PASHIN YV, 1979, ENVIRON HEALTH PERSP, V30, P185, DOI 10.2307/3429123; MENZIE CA, 1992, ENVIRON SCI TECHNOL, V26, P1278, DOI 10.1021/es00031a002; Wessel N, 2007, AQUAT TOXICOL, V85, P133, DOI 10.1016/j.aquatox.2007.08.007; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Kosmehl T, 2006, ENVIRON TOXICOL CHEM, V25, P2097, DOI 10.1897/05-460R.1; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Billiard SM, 2008, TOXICOL SCI, V105, P5, DOI 10.1093/toxsci/kfm303; Kosmehl T, 2008, MUTAT RES-GEN TOX EN, V650, P1, DOI 10.1016/j.mrgentox.2007.09.009; Knecht AL, 2013, TOXICOL APPL PHARM, V271, P266, DOI 10.1016/j.taap.2013.05.006; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; De Boeck M, 2000, MUTAT RES-GEN TOX EN, V469, P181, DOI 10.1016/S1383-5718(00)00075-9; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451; SPORSTOL S, 1983, ENVIRON SCI TECHNOL, V17, P282, DOI 10.1021/es00111a008; SHIMA A, 1994, ENVIRON HEALTH PERSP, V102, P33; Wang L, 2006, TOXICOL SCI, V93, P331, DOI 10.1093/toxsci/kfl/072; Lundstedt S, 2007, AMBIO, V36, P475, DOI 10.1579/0044-7447(2007)36[475:SFATHO]2.0.CO;2; Kosmehl T, 2007, J SOIL SEDIMENT, V7, P377, DOI 10.1065/jss2007.11.261; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Umbuzeiro GA, 2008, MUTAT RES-GEN TOX EN, V652, P72, DOI 10.1016/j.mrgentox.2007.12.007; Baird WM, 2005, ENVIRON MOL MUTAGEN, V45, P106, DOI 10.1002/em.20095; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Brack W, 2003, ENVIRON TOXICOL CHEM, V22, P2228, DOI 10.1897/02-450; Brorstrom-Lunden E., 2010, RESULTS SWEDISH NATL; Brown JS, 2004, ECOL INDIC, V3, P263, DOI 10.1016/j.ecolind.2003.11.004; Cachot J, 2007, ENVIRON SCI TECHNOL, V41, P7830, DOI 10.1021/es071082v; Cerniglia Carl E., 1992, Biodegradation, V3, P351, DOI 10.1007/BF00129093; Chung SW, 2008, TOXICOL SCI, V101, P152, DOI 10.1093/toxsci/kfm252; Elonen GE, 1998, ENVIRON TOXICOL CHEM, V17, P472, DOI 10.1897/1551-5028(1998)017<0472:CTOTPD>2.3.CO;2; Farmer PB, 2003, MUTAT RES-REV MUTAT, V544, P397, DOI 10.1016/j.mrrev.2003.09.002; Fisher S, 2010, QUANTIFICATION OXYGE; Gurbani D, 2013, INT J HYGIENE ENV HL; HANNAH JB, 1982, ARCH ENVIRON CON TOX, V11, P727; Hook SE, 2004, AQUAT TOXICOL, V66, P1, DOI 10.1016/j.aquatox.2003.06.002; HOSE JE, 1982, ARCH ENVIRON CON TOX, V11, P167; KOCHANY J, 1994, SCI TOTAL ENVIRON, V144, P17, DOI 10.1016/0048-9697(94)90424-3; Lampi MA, 2001, STP ASTM, V1403, P211; Lee B-K, 2010, AIR POLLUTION, DOI [10.5772/10045, DOI 10.5772/10045]; Lee R, 2000, MAR ENVIRON RES, V50, P553, DOI 10.1016/S0141-1136(00)00110-0; Lee RF, 1999, AM SOC TEST MATER, V1364, P341, DOI 10.1520/STP15813S; Lynes K, 2006, THESIS CARLETON U CA; McElroy AE, 2000, AM SOC TEST MATER, V1381, P239, DOI 10.1520/STP14427S; McElroy AE, 2006, MAR ENVIRON RES, V62, pS273, DOI 10.1016/j.marenvres.2006.04.019; McElroy AE, 2006, NEW APPROACHES ASSES; Morin B, 2011, ANAL BIOANAL CHEM, V399, P2235, DOI 10.1007/s00216-010-4602-y; Muir WM, 2001, AM NAT, V158, P1, DOI 10.1086/320860; National Research Council Agency USEP, 1983, POL AR HYDR EV SOURC; Neff J. M., 1979, POLYCYCLIC AROMATIC; NIKOLAOU K, 1984, SCI TOTAL ENVIRON, V32, P103, DOI 10.1016/0048-9697(84)90125-6; Olive PL, 1990, RADIAT RES, V178, pAV35; Pies C, 2008, J SOIL SEDIMENT, V8, P312, DOI 10.1007/s11368-008-0031-3; Sabti AI- K, 1995, MUTAT RES-GEN TOX EN, V343, p121 ; SASAKI J, 1995, ENVIRON SCI TECHNOL, V29, P1324, DOI 10.1021/es00005a027; Strober W., 2001, CURRENT PROTOCOLS IM; United States. Agency for Toxic Substances and Disease Registry Research Triangle Institute, 1995, TOX PROF POL AR HYDR; Wcisło E., 1998, Polish Journal of Environmental Studies, V7, P267; Willett KL, 2000, TOXICOL SCI, V58, P68, DOI 10.1093/toxsci/58.1.68; Winn RN, 2005, TECHNIQUES AQUATIC T, V2, P705; Zaccaria KJ, 2013, INT J TOXICOL, V32, P236, DOI 10.1177/1091581813492829; Zainol M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp826	69	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0944-1344	1614-7499		ENVIRON SCI POLLUT R	Environ. Sci. Pollut. Res.	DEC	2014	21	24					13867	13876		10.1007/s11356-014-2586-4		10	Environmental Sciences	Environmental Sciences & Ecology	AU0LN	WOS:000345314500015		
J	Suzuki, T; Kosugi, Y; Hosaka, M; Nishimura, T; Nakae, D				Suzuki, Toshinari; Kosugi, Yuki; Hosaka, Mitsugu; Nishimura, Tetsuji; Nakae, Dai			OCCURRENCE AND BEHAVIOR OF THE CHIRAL ANTI-INFLAMMATORY DRUG NAPROXEN IN AN AQUATIC ENVIRONMENT	ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY			English	Article						Naproxen; Enantiomeric fraction; Chiral inversion; Sewage treatment plant	PERSONAL CARE PRODUCTS; MUNICIPAL WASTE-WATER; PERFORMANCE LIQUID-CHROMATOGRAPHY; SEWAGE-TREATMENT PLANT; SURFACE WATERS; RIVER WATER; ACIDIC PHARMACEUTICALS; 2-ARYLPROPIONIC ACIDS; CLOFIBRIC ACID; IBUPROFEN	The present study reports on the occurrence and chiral behavior of the anti-inflammatory drug (S)-naproxen (NAP)(S)-2-(6-methoxynaphthalen-2-yl)propionic acidin an aquatic environment under both field and laboratory conditions. In influents and effluents of sewage treatment plants (STPs) in the Tama River basin (Tokyo), (S)-NAP was detected at concentrations of 0.03 mu gL(-1) to 0.43 mu gL(-1) and 0.01 mu gL(-1) to 0.11 mu gL(-1), respectively. The concentrations of a major metabolite, 6-O-desmethyl NAP (DM-NAP) were up to 0.47 mu gL(-1) and 0.56 mu gL(-1) in influents and effluents, respectively. (R)-naproxen was not detected in STP influents, although it was present in effluents, and the enantiomeric faction (= S/[S+R]) of NAP ranged from 0.88 to 0.91. Under laboratory conditions with activated sludge from STPs, rapid degradation of (S)-NAP to DM-NAP and chiral inversion of (S)-NAP to (R)-NAP were observed. During river die-away experiments, degradation and chiral inversion of NAP were extremely slow. In addition, chiral inversion of (S)-NAP to (R)-NAP was not observed during photodegradation experiments. In the river receiving STP discharge, NAP and DM-NAP concentrations reached 0.08 mu gL(-1) and 0.16 mu gL(-1), respectively. The enantiomeric faction of NAP in the river ranged from 0.84 to 0.98 and remained almost unchanged with the increasing contribution of rainfall to the river water. These results suggest that the absence and decrease of (R)-NAP in river waters could indicate the inflow of untreated sewage. Environ Toxicol Chem 2014;33:2671-2678. (c) 2014 SETAC	[Suzuki, Toshinari; Kosugi, Yuki; Hosaka, Mitsugu; Nakae, Dai] Metropolitan Inst Publ Hlth, Div Environm Sci, Tokyo, Japan; [Nishimura, Tetsuji] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo, Japan	Suzuki, T (reprint author), Metropolitan Inst Publ Hlth, Div Environm Sci, Tokyo, Japan.	toshinari_suzuki@member.metro.tokyo.jp			Health and Labor Sciences Research Grant from the Ministry of Health and Welfare, Japan [H24-Iyaku-Shitei-013]	The authors thank the staff of the sewage treatment plants for their help with sample collection. The present research was supported in part by Health and Labor Sciences Research Grant No. H24-Iyaku-Shitei-013 from the Ministry of Health and Welfare, Japan.	Garrison AW, 2006, ENVIRON SCI TECHNOL, V40, P16, DOI 10.1021/es063022f; Kimura K, 2007, ENVIRON SCI TECHNOL, V41, P3708, DOI 10.1021/es061684z; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Janak K, 2005, ENVIRON SCI TECHNOL, V39, P1987, DOI 10.1021/es0484909; Vieno NM, 2005, ENVIRON SCI TECHNOL, V39, P8220, DOI 10.1021/es051124k; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Zhang SY, 2007, CHEMOSPHERE, V66, P1057, DOI 10.1016/j.chemosphere.2006.06.067; Buser HR, 1999, ENVIRON SCI TECHNOL, V33, P2529, DOI 10.1021/es981014w; Bosca F, 2001, PHOTOCHEM PHOTOBIOL, V74, P637, DOI 10.1562/0031-8655(2001)074<0637:POTNAI>2.0.CO;2; Felis E, 2007, WATER SCI TECHNOL, V55, P281, DOI 10.2166/wsat.2007.417; Fono LJ, 2005, ENVIRON SCI TECHNOL, V39, P9244, DOI 10.1021/es047965t; Lin AYC, 2005, ENVIRON TOXICOL CHEM, V24, P1303, DOI 10.1897/04-236R.1; ANDERSEN JV, 1992, J CHROMATOGR-BIOMED, V577, P362, DOI 10.1016/0378-4347(92)80260-W; HARRISON IT, 1970, J MED CHEM, V13, P203, DOI 10.1021/jm00296a008; Tixier C, 2003, ENVIRON SCI TECHNOL, V37, P1061, DOI 10.1021/es025834r; Jones WJ, 2007, ENVIRON SCI TECHNOL, V41, P8301, DOI 10.1021/es071409s; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Lindqvist N, 2005, WATER RES, V39, P2219, DOI 10.1016/j.watres.2005.04.003; Jones OAH, 2002, WATER RES, V36, P5013, DOI 10.1016/S0043-1354(02)00227-0; Packer JL, 2003, AQUAT SCI, V65, P342, DOI 10.1007/s00027-003-0671-8; Nakada N, 2008, ENVIRON SCI TECHNOL, V42, P6347, DOI 10.1021/es7030856; HUTT AJ, 1983, J PHARM PHARMACOL, V35, P693; Quintana JB, 2005, WATER RES, V39, P2654, DOI 10.1016/j.watres.2005.04.068; Carballa M, 2004, WATER RES, V38, P2918, DOI 10.1016/j.watres.2004.03.029; Zipper C, 1998, ENVIRON SCI TECHNOL, V32, P2070, DOI 10.1021/es970880q; Vieno NM, 2007, ENVIRON SCI TECHNOL, V41, P5077, DOI 10.1021/es062720x; Da-Fang Z, 2003, ACTA PHARMACOL SIN, V24, P442; GOTO J, 1982, J CHROMATOGR, V239, P559, DOI 10.1016/S0021-9673(00)82013-0; He A, 2003, PHARMAZIE, V58, P420; Kallenborn R., 2001, CHIRAL ENV POLLUTANT; Mark JB, 2009, ENVIRON SCI TECHNOL, V43, P597; Nakada Norihide, 2005, Environ Sci, V12, P359; Organisation for Economic Development and Co-Operation, 1992, TEST 301 READ BIOD 2; Qurie M, 2014, CLEAN-SOIL AIR WATER, V42, P594, DOI 10.1002/clen.201300179; Renner R, 1996, ENVIRON SCI TECHNOL, V30, pA17; Strong M, 1999, FOOD DRUG LAW J, V54, P463; SUGAWARA Y, 1978, CHEM PHARM BULL, V26, P3312; TOMLINSO.RV, 1972, BIOCHEM BIOPH RES CO, V46, P552, DOI 10.1016/S0006-291X(72)80174-8	39	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-7268	1552-8618		ENVIRON TOXICOL CHEM	Environ. Toxicol. Chem.	DEC	2014	33	12					2671	2678		10.1002/etc.2741		8	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	AU0NE	WOS:000345319100004		
J	Toyoda, H; Kumada, T; Takaguchi, K; Shimada, N; Tanaka, J				Toyoda, H.; Kumada, T.; Takaguchi, K.; Shimada, N.; Tanaka, J.			Changes in hepatitis C virus genotype distribution in Japan	EPIDEMIOLOGY AND INFECTION			English	Article						Birth year; distribution; genotypes; hepatitis C virus	INTRAVENOUS-DRUG-USERS; MOLECULAR EPIDEMIOLOGY; INFECTION; SYSTEM; 1B	Genotypes are associated with the natural course of hepatitis C virus (HCV) infection and response to antiviral therapy for HCV. HCV genotype 1b has been the dominant genotype in Japan, where the prevention of HCV transmission through blood transfusion or nosocomial infection has been established since 1990. The distribution of HCV genotype was investigated based on patient's birth year in 5515 HCV-infected Japanese individuals at three institutions from different areas of Japan. At all three institutions, the proportion of HCV genotype 1b decreased and was <50% in individuals born after 1970. By contrast, the percentage of HCV genotype 2b increased in subsequent birth cohorts after 1920-1929. Significant changes in HCV genotype distribution were observed across Japan regardless of area.	[Toyoda, H.; Kumada, T.] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu 5038502, Japan; [Takaguchi, K.] Kagawa Prefectural Cent Hosp, Dept Internal Med, Takamatsu, Kagawa, Japan; [Shimada, N.] Shinmatsudo Cent Gen Hosp, Dept Gastroenterol & Hepatol, Matsudo, Chiba, Japan; [Tanaka, J.] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Prevent, Hiroshima, Japan	Toyoda, H (reprint author), Ogaki Municipal Hosp, Dept Gastroenterol, 4-86 Minaminokawa, Ogaki, Gifu 5038502, Japan.	hmtoyoda@spice.ocn.ne.jp					Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884; Chlabicz S, 2008, J CLIN VIROL, V42, P156, DOI 10.1016/j.jcv.2008.02.001; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; Roman F, 2008, WORLD J GASTROENTERO, V14, P1237, DOI 10.3748/wjg.14.1237; Bourliere M, 2002, J VIRAL HEPATITIS, V9, P62, DOI 10.1046/j.1365-2893.2002.00319.x; Bojovic K, 2013, BIOMED PHARMACOTHER, V67, P517, DOI 10.1016/j.biopha.2013.03.010; Mathei C, 2005, EUR J CLIN MICROBIOL, V24, P514, DOI 10.1007/s10096-005-1376-9; Moriya T, 1999, INTERVIROLOGY, V42, P153, DOI 10.1159/000024974; Ohno T, 1997, J CLIN MICROBIOL, V35, P201; Rosen HR, 1999, AM J GASTROENTEROL, V94, P3015; Tanaka H, 1998, J Epidemiol, V8, P244	13	3	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	DEC	2014	142	12					2624	2628		10.1017/S0950268814000478		5	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	AT4OY	WOS:000344920800019		
J	Suzuki, M; Camacho, A; Ariyoshi, K				Suzuki, M.; Camacho, A.; Ariyoshi, K.			Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs	EPIDEMIOLOGY AND INFECTION			English	Article						Influenza vaccine effectiveness; non-influenza respiratory virus; test-negative design; virus interference	INFECTION	A hypothetical influenza infection-induced non-specific immunity may reduce the risk of subsequent non-influenza respiratory virus (NIRV) infection and bias the influenza vaccine effectiveness (VE) estimates in test-negative designs (TNDs). We conducted a simulation study using a simple TND model and explored the degree of bias in the VE estimates. The bias was marginal during the usual seasons and most of the time during pandemics; the bias only became large when the influenza infection attack rate increased to pandemic levels (>50%), the true VE was low to moderate, and the non-specific immunity almost completely protected from NIRV infections and lasted at least half the influenza season.	[Suzuki, M.; Ariyoshi, K.] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 8528523, Japan; [Camacho, A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Suzuki, M (reprint author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Sakamoto 1-12-4, Nagasaki 8528523, Japan.	mosuzuki@nagasaki-u.ac.jp			'Improvement of Research Environment for Young Researchers' programme; Medical Research Council UK [MR/J01432X/1]	This work was supported by the 'Improvement of Research Environment for Young Researchers' programme, organized by the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by the Medical Research Council UK [A.C., MR/J01432X/1].	ANESTAD G, 1982, LANCET, V1, P502; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Sundaram ME, 2013, CLIN INFECT DIS, V57, P789, DOI 10.1093/cid/cit379; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Kelly H, 2011, PEDIATR INFECT DIS J, V30, P107, DOI 10.1097/INF.0b013e318201811c; Cowling BJ, 2012, EPIDEMIOLOGY, V23, P930, DOI 10.1097/EDE.0b013e31826b300e; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; De Serres G, 2013, EUROSURVEILLANCE, V18; Kelly H, 2010, EUROSURVEILLANCE, V15; Linde A, 2009, EUROSURVEILLANCE, V14; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Wu JT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001103; Yin JK, 2012, VACCINE, V30, P3209, DOI 10.1016/j.vaccine.2012.02.048	16	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0950-2688	1469-4409		EPIDEMIOL INFECT	Epidemiol. Infect.	DEC	2014	142	12					2642	2646		10.1017/S0950268814000107		5	Public, Environmental & Occupational Health; Infectious Diseases	Public, Environmental & Occupational Health; Infectious Diseases	AT4OY	WOS:000344920800021		
J	Gagne, NO				Gagne, Nana Okura			Romance and sexuality in Japanese Latin dance clubs	ETHNOGRAPHY			English	Article						dance; sexuality; fantasy; gender ideology; Japan	SALSA; TRANSFORMATION; DIFFERENCE; EMOTIONS	In urban Japan, it is not just public expressions of affection or touch between adult men and women that are uncommon, but opportunities for dancing among adults are very limited in Japanese daily life. This article explores the choreography of parasexuality' - delimited yet intensified sensuality - that is created through sensual touching among salsa dancers. While public expression of intimacy is highly charged and best avoided in Tokyo, I argue that the bracketed pleasure zone' of Latin dance legitimates and intensifies sensual interactions in the form of explicitly tactile parasexuality' for both men and women. What marks salsa as a romantic fantasy space is the disembeddeness of sensuality and sexuality from everyday routines, on the one hand, and participants' individual expression of aesthetic pursuits that liberates them from the responsibilities of everyday gender ideology, on the other hand.	Univ Tokyo, Inst Social Sci, Tokyo 1138654, Japan	Gagne, NO (reprint author), Univ Tokyo, Inst Social Sci, Tokyo 1138654, Japan.	gagne@iss.u-tokyo.ac.jp					Allison A., 1994, NIGHTWORK SEXUALITY; Allan AJ, 2009, GENDER EDUC, V21, P145, DOI 10.1080/09540250802213172; Wade L, 2011, ETHNOGRAPHY, V12, P224, DOI 10.1177/1466138111398231; Kapchan D, 2006, AM ETHNOL, V33, P361, DOI 10.1525/ae.2006.33.3.361; Bailey P., 1990, GENDER HIST, V2, P148, DOI 10.1111/j.1468-0424.1990.tb00091.x; Bauman Z., 2000, LIQUID MODERNITY; Ben-Ari E, 1998, CULTURE JAPAN SEEN I; Borland K, 2009, J AM FOLKLORE, V122, P466; Bosse J, 2008, DANCE RES J, V40, P45; Buffington R, 2005, J LATIN AM CULTURAL, V14, P8; Butler J., 1999, GENDER TROUBLE FEMIN; DESMOND JC, 1994, CULT CRIT, P33; Enriquez Arana E, 2007, THESIS BOWLING GREEN; Erickson Julia A., 2011, DANCE ME BALLROOM DA; Filmer P, 1999, BODY SOC, V5, P1, DOI 10.1177/1357034X99005001001; Gagne I, 2013, GIRLS SEXUALITIES ME; Gagne N, 2010, ASIAN ANTHR, V9, P29; Giddens Anthony, 1993, TRANSFORMATION INTIM; Giddens Anthony, 1991, MODERNITY SELF IDENT; Goldstein-Gidoni O, 2002, JAPAN FORUM, V14, P63, DOI 10.1080/09555800120109032; Gonzalez LS, 1999, CULT STUD, V13, P237, DOI 10.1080/095023899335266; Hewer P, 2010, J CONSUM BEHAV, V9, P113, DOI 10.1002/cb.308; Isobe R, 2012, ODOTTEHA KENAI KUNI; Iwao S., 1993, JAPANESE WOMAN TRADI; Johnson T, 2009, 2009 C LAT AM STUD A; Karatsu R, 2003, J POP CULT, V36, P416, DOI 10.1111/1540-5931.00014; Kelsky Karen, 2001, WOMEN VERGE JAPANESE; Kinsella Sharon, 2000, ADULT MANGA CULTURE; Louis L, 1992, BUTTERFLIES NIGHT; Marion J, 2006, THESIS U CALIFORNIA; Nagai Y, 1991, SHAKO DANSU NIHONJIN; Nagai Y, 2004, DANSU HORU; Ogasawara Y, 1998, OFFICE LADIES SALARI; Olszewski B, 2008, BODY SOC, V14, P63, DOI 10.1177/1357034XO8090698; Paechter C, 2006, GENDER EDUC, V18, P253, DOI 10.1080/09540250600667785; Pusnik M, 2010, ANTHROPOL NOTEB, V16, P107; Reed SA, 2002, CULT ANTHROPOL, V17, P246, DOI 10.1525/can.2002.17.2.246; Renta R, 2004, CTR J, V2, P138; Robertson J., 1998, TAKARAZUKA SEXUAL PO; Roman-Velazquez P, 1999, POP MUSIC, V18, P115, DOI 10.1017/S0261143000008758; Savigliano M, 1994, RE MADE JAPAN EVERYD; Skinner J, 2007, IDENTITIES-GLOB STUD, V14, P485, DOI 10.1080/10702890701578480; Skinner J, 2008, DANCE RES J, V40, P65; Thomas DA, 2002, CULT ANTHROPOL, V17, P512, DOI 10.1525/can.2002.17.4.512; Urquía N., 2005, Leisure Studies, V24, P385, DOI 10.1080/02614360500200698; Watanabe K, 2004, EDO 300NEN YOSHIWARA; Wieschiolek H., 2003, SPORT DANCE EMBODIED; Wulff H, 2003, SPORT DANCE EMBODIED	48	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1466-1381	1741-2714		ETHNOGRAPHY	Ethnography	DEC	2014	15	4					446	468		10.1177/1466138113490605		23	Anthropology; Sociology	Anthropology; Sociology	AU0SL	WOS:000345334700003		
J	Sassa, N; Kato, K; Abe, S; Iwano, S; Ito, S; Ikeda, M; Shimamoto, K; Yamamoto, S; Yamamoto, T; Gotoh, M; Naganawa, S				Sassa, Naoto; Kato, Katsuhiko; Abe, Shinji; Iwano, Shingo; Ito, Shinji; Ikeda, Mitsuru; Shimamoto, Kazuhiro; Yamamoto, Seiichi; Yamamoto, Tokunori; Gotoh, Momokazu; Naganawa, Shinji			Evaluation of C-11-choline PET/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot study	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						C-11-Choline PET/CT; Urothelial carcinoma; Upper urinary tract; Renal pelvis; Ureter	EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; RADICAL RETROPUBIC PROSTATECTOMY; CHOLINE KINASE-ACTIVITY; BLADDER-CANCER; PSA FAILURE; LOCALIZATION; SPECTROSCOPY; CHEMOTHERAPY; RECURRENCE; SURVIVAL	We conducted a pilot study to prospectively evaluate the efficacy of PET/CT with C-11-choline (choline PET/CT) for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract (UUT-UC). Enrolled in this study were 16 patients (9 men, 7 women; age range 51 - 83 years, mean +/- SD 69 +/- 10.8 years) with suspected UUT-UC. The patients were examined by choline PET/CT, and 13 underwent laparoscopic nephroureterectomy and partial cystectomy. Lymphadenectomy and chemotherapy were also performed as necessary in some of the patients. Of the 16 patients, 12 were confirmed to have UUT-UC (7 renal pelvis carcinoma and 5 ureteral carcinoma), 1 had malignant lymphoma (ureter), 1 had IgG4-related disease (ureter), and 2 had other benign diseases (ureter). Of the 16 study patients, 13 showed definite choline uptake in urothelial lesions, and of these, 11 had UUT-UC, 1 had malignant lymphoma, and 1 had IgG4-related disease. Three patients without choline uptake comprised one with UUT-UC and two with benign diseases. Of the 12 patients with UUT-UC, 3 had distant metastases, 2 had metastases only in the regional lymph nodes, and 7 had no metastases. Distant metastases and metastases in the regional lymph nodes showed definite choline uptake. The outcome in patients with UUT-UC, which was evaluated 592 - 1,530 days after surgery, corresponded to the patient classification based on the presence or absence of metastases and locoregional or distant metastases. Choline uptake determined as SUVmax 10 min after administration was significantly higher than at 20 min in metastatic tumours of UUT-UC (p < 0.05), whereas there was no statistically significant difference between the SUVmax values at 10 and those at 20 min in primary tumours of UUT-UC. This study suggests that choline PET/CT is a promising tool for the primary diagnosis and staging of UUT-UC.	[Sassa, Naoto; Yamamoto, Tokunori; Gotoh, Momokazu] Nagoya Univ, Grad Sch Med, Dept Urol, Nagoya, Aichi 4618673, Japan; [Kato, Katsuhiko; Ikeda, Mitsuru; Shimamoto, Kazuhiro; Yamamoto, Seiichi] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Nagoya, Aichi 4618673, Japan; [Abe, Shinji] Nagoya Univ Hosp, Dept Radiol Technol, Nagoya, Aichi, Japan; [Iwano, Shingo; Ito, Shinji; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4618673, Japan	Kato, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, 1-20 Daikominami 1 chome, Nagoya, Aichi 4618673, Japan.	katokt@med.nagoya-u.ac.jp	Ikeda, Mitsuru/B-5163-2010; Kato, Katsuhiko/D-7965-2013; Naganawa, Shinji/I-1572-2012; IWANO, Shingo/I-7355-2014	Ikeda, Mitsuru/0000-0002-5695-3527; Kato, Katsuhiko/0000-0002-2083-9319; Naganawa, Shinji/0000-0002-0214-613X; 			Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jana S, 2006, SEMIN NUCL MED, V36, P51, DOI 10.1053/j.semnuclmed.2.005.09.001; Schoder H, 2004, SEMIN NUCL MED, V34, P274, DOI 10.1053/j.semnuclmed.2004.06.004; Lodde M, 2010, BJU INT, V106, P658, DOI 10.1111/j.1464-410X.2010.09212.x; Testa C, 2007, RADIOLOGY, V244, P797, DOI 10.1148/radiol.2443061063; Farsad M, 2005, J NUCL MED, V46, P1642; Rigatti P, 2011, EUR UROL, V60, P935, DOI 10.1016/j.eururo.2011.07.060; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Schilling D, 2008, BJU INT, V102, P446, DOI 10.1111/j.1464-410X.2008.07592.x; Giovacchini G, 2010, J UROLOGY, V184, P938, DOI 10.1016/j.juro.2010.04.084; Budiharto T, 2011, EUR UROL, V60, P125, DOI 10.1016/j.eururo.2011.01.015; Contractor K, 2011, CLIN CANCER RES, V17, P7673, DOI 10.1158/1078-0432.CCR-11-2048; Fuccio C, 2011, EUR J RADIOL, V80, pE50, DOI 10.1016/j.ejrad.2010.07.023; Scattoni V, 2007, EUR UROL, V52, P423, DOI 10.1016/j.eururo.2007.03.032; Ackerstaff E, 2001, CANCER RES, V61, P3599; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Swinnen G, 2010, EUR UROL, V57, P641, DOI 10.1016/j.eururo.2009.05.014; Reske SN, 2006, J NUCL MED, V47, P1249; de Jong IJ, 2002, EUR J NUCL MED MOL I, V29, P1283, DOI 10.1007/s00259-002-0881-7; Rosenblatt R, 2012, EUR UROL, V61, P1229, DOI 10.1016/j.eururo.2011.12.010; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Kibel AS, 2009, J CLIN ONCOL, V27, P4314, DOI 10.1200/JCO.2008.20.6722; MACARA IG, 1989, MOL CELL BIOL, V9, P325; Martini T, 2012, ADV UROL, V2012; Martorana G, 2006, J UROLOGY, V176, P954, DOI 10.1016/j.juro.2006.04.015; RATNAM S, 1995, ARCH BIOCHEM BIOPHYS, V323, P313, DOI 10.1006/abbi.1995.9959; Scosyrev E, 2012, CANCER-AM CANCER SOC, V118, P72, DOI 10.1002/cncr.26238; Sobin LH, 2009, UROLOGICAL TUMORS, P258; Suter G, 2004, WHO CLASSIFICATION T, P110; Winter A, 2010, UROL INT, V84, P418, DOI 10.1159/000296298	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	DEC	2014	41	12					2232	2241		10.1007/s00259-014-2871-y		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT7TG	WOS:000345139500007		
J	Fukuda, Y; Miura, S; Fujimi, K; Yano, M; Nishikawa, H; Yanagisawa, J; Hiratsuka, M; Shiraishi, T; Iwasaki, A; Saku, K				Fukuda, Yusuke; Miura, Shin-ichiro; Fujimi, Kanta; Yano, Masaya; Nishikawa, Hiroaki; Yanagisawa, Jun; Hiratsuka, Masafumi; Shiraishi, Takeshi; Iwasaki, Akinori; Saku, Keijiro			Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY			English	Article						Bosentan; cardiac rehabilitation; pulmonary hypertension; pulmonary Langerhans cell histiocytosis	ARTERIAL-HYPERTENSION; EXERCISE	Pulmonary hypertension (PH), which is classified as group 5 in the clinical classification of PH, is sometimes a complication of Pulmonary langerhans cell histiocytosis (PLCH), and is associated with high mortality. A 36-year-old woman had suffered from severe dyspnea 9 years previously and was diagnosed with PLCH and was on a waiting list for a lung transplant. Right heart failure had been observed and the mean pulmonary artery pressure was over 40mmHg. The patient was diagnosed as PLCH with PH. After combined treatment with exercise rehabilitation and bosentan for 6 months, the cardiothoracic ratio, brain natriuretic peptide, and bodyweight were significantly decreased (cardiothoracic ratio from 43 to 38%, brain natriuretic peptide from 284 to10 pg/ml and bodyweight from 63 to 58kg). Six-minute walk test also improved from 214 to 275 meters and the SF36 score for screening of depressive and anxiety disorders was improved. This is the report demonstrating the efficacy and safety of cardiac rehabilitation in combination with bosentan in a single patient with PLCH associated with PH.	[Fukuda, Yusuke; Miura, Shin-ichiro; Fujimi, Kanta; Yano, Masaya; Nishikawa, Hiroaki; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 81401, Japan; [Yanagisawa, Jun; Hiratsuka, Masafumi; Shiraishi, Takeshi; Iwasaki, Akinori] Fukuoka Univ, Sch Med, Dept Gen Thorac Breast & Pediat Surg, Fukuoka 81401, Japan	Fukuda, Y (reprint author), 7-45-1 Nanakuma,Jonan Ku, Fukuoka 8140180, Japan.	zfukusuke@minf.med.fukuoka-u.ac.jp					Desai SA, 2008, J CARDIOPULM REHABIL, V28, P12, DOI 10.1097/01.HCR.0000311502.57022.73; Oikawa M, 2005, J AM COLL CARDIOL, V45, P1849, DOI 10.1016/j.jacc.2005.02.065; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Paolillo S, 2012, EUR J PREV CARDIOL, V19, P960, DOI 10.1177/1741826711426635; Le Pavec J, 2012, CHEST, V142, P1150, DOI 10.1378/chest.11-2490; Chan L, 2012, CHEST, V143, P333; Kiakouama L, 2010, EUR RESPIR J, V36, P202, DOI 10.1183/09031936.00004810; Lederer DJ, 2011, AM J RESP CRIT CARE, V184, P1055, DOI 10.1164/rccm.201104-0728OC; Vassallo R, 2004, CLIN CHEST MED, V25, P561, DOI 10.1016/j.ccm.2004.04.005; Williams RB, 2011, CIRCULATION, V123, pE639, DOI 10.1161/CIRCULATIONAHA.110.017285	11	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2047-4873	2047-4881		EUR J PREV CARDIOL	Eur. J. Prev. Cardiol.	DEC	2014	21	12					1481	1483		10.1177/2047487313497603		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT9CF	WOS:000345224900004		
J	Inohara, T; Kohsaka, S; Okamura, T; Watanabe, M; Nakamura, Y; Higashiyama, A; Kadota, A; Okuda, N; Murakami, Y; Ohkubo, T; Miura, K; Okayama, A; Ueshima, H				Inohara, Taku; Kohsaka, Shun; Okamura, Tomonori; Watanabe, Makoto; Nakamura, Yasuyuki; Higashiyama, Aya; Kadota, Aya; Okuda, Nagako; Murakami, Yoshitaka; Ohkubo, Takayoshi; Miura, Katsuyuki; Okayama, Akira; Ueshima, Hirotsugu		NIPPON Data 80 90 Res Grp	Cumulative impact of axial, structural, and repolarization ECG findings on long-term cardiovascular mortality among healthy individuals in Japan: National Integrated Project for Prospective Observation of Non-Communicable Disease and its Trends in the Aged, 1980 and 1990	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY			English	Article						Cardiovascular outcomes; cohort study; electrocardiography; NIPPON DATA80; NIPPON DATA90	CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; LEFT-VENTRICULAR HYPERTROPHY; T-WAVE ABNORMALITIES; 24-YEAR FOLLOW-UP; NIPPON DATA80; GENERAL-POPULATION; ELECTROCARDIOGRAPHIC ABNORMALITIES; ASYMPTOMATIC ADULTS; PROGNOSTIC VALUE	Aims Various cohort studies have shown a close association between long-term cardiovascular disease (CVD) outcomes and individual electrocardiographic (ECG) abnormalities such as axial, structural, and repolarization changes. The combined effect of these ECG abnormalities, each assumed to be benign, has not been thoroughly investigated. Methods and Results Community-dwelling Japanese residents from the National Integrated Project for Perspective Observation of Non-Communicable Disease and its Trends in the Aged, 1980-2004 and 1990-2005 (NIPPON DATA80 and 90), were included in this study. Baseline ECG findings were classified using the Minnesota Code and categorized into axial (left axis deviation, clockwise rotation), structural (left ventricular hypertrophy, atrial enlargement), and repolarization (minor and major ST-T changes) abnormalities. The hazard ratios of the cumulative impacts of ECG findings on long-term CVD death were estimated by stratified Cox proportional hazard models, including adjustments for cohort strata. In all, 16,816 participants were evaluated. The average age was 51.213.5 years; 42.7% participants were male. The duration of follow up was 300,924 person-years (mean 17.9 +/- 5.8 years); there were 1218 CVD deaths during that time. Overall, 4203 participants (25.0%) had one or more categorical ECG abnormalities: 3648 (21.7%) had a single abnormality, and 555 (3.3%) had two or more. The risk of CVD mortality increased as the number of abnormalities accumulated (single abnormality HR 1.29, 95% CI 1.13-1.48; 2 abnormalities HR 2.10, 95% CI 1.73-2.53). Conclusions Individual ECG abnormalities had an additive effect in predicting CVD outcome risk in our large-scale cohort study.	[Inohara, Taku; Kohsaka, Shun; Okamura, Tomonori] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Watanabe, Makoto] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Nakamura, Yasuyuki] Kyoto Womens Univ, Kyoto, Japan; [Higashiyama, Aya] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; [Kadota, Aya] Osaka Kyoiku Univ, Kashiwara, Japan; [Okuda, Nagako] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Murakami, Yoshitaka; Miura, Katsuyuki; Ueshima, Hirotsugu] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo, Japan; [Okayama, Akira] First Inst Hlth Promot & Hlth Care, Tokyo, Japan	Kohsaka, S (reprint author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kohsaka@cpnet.med.keio.ac.jp	Okamura, Tomonori/L-1693-2013		Ministry of Health, Labor, and Welfare; Ministry of Health, Labor, and Welfare [7A-2]	This study was supported by a grant-in-aid by from the Ministry of Health, Labor, and Welfare under the auspices of the Japanese Association for Cerebro-Cardiovascular Disease Control, a research grant for cardiovascular diseases (7A-2) from the Ministry of Health, Labor, and Welfare, and research grants from Health and Labor Sciences (Comprehensive Research on Aging and Health H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014; Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus H22-Jyunkankitou-Seisyu-Sitei-017 and H25-Jyunkankitou-Seisyu-Sitei-022)	Okamura T, 2004, AM HEART J, V147, P1024, DOI 10.1016/j.ahj.2003.12.020; Okamura T, 2007, ATHEROSCLEROSIS, V190, P216, DOI 10.1016/j.atherosclerosis.2006.01.024; Prineas RJ, 2002, AM J CARDIOL, V90, P1391, DOI 10.1016/S0002-9149(02)02881-3; De Bacquer D, 1998, HEART, V80, P570; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Bakhoya VN, 2014, EUR J PREV CARDIOL, V21, P500, DOI 10.1177/2047487312460022; Larsen CT, 2002, EUR HEART J, V23, P315, DOI 10.1053/euhj.2001.2774; Chou R, 2011, ANN INTERN MED, V155, P375, DOI [10.7326/0003-4819-155-6-201109200-00006, 10.1059/0003-4819-155-6-201109200-00006]; Brown DW, 2000, AM HEART J, V140, P848, DOI 10.1067/mhj.2000.111112; Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978; Machado DB, 2006, AM J CARDIOL, V97, P1176, DOI 10.1016/j.amjcard.2005.11.036; Sigurdsson E, 1996, J AM COLL CARDIOL, V27, P1140, DOI 10.1016/0735-1097(95)00614-1; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Greenland P, 2003, AM J CARDIOL, V91, P1068, DOI 10.1016/S0002-9149(03)00150-4; Ohsawa M, 2007, CIRC J, V71, P814, DOI 10.1253/circj.71.814; Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; Higashiyama A, 2010, J EPIDEMIOL, V20, pS537, DOI 10.2188/jea.JE20090222; Horibe H, 2005, J EPIDEMIOL, V15, P125, DOI 10.2188/jea.15.125; Jones RC, 2004, AM J MED, V117, P380, DOI 10.1016/j.amjmed.2004.06.004; Kadota A, 2011, ATHEROSCLEROSIS, V215, P209, DOI 10.1016/j.atherosclerosis.2010.11.033; Kadowaki S, 2008, DIABETOLOGIA, V51, P575, DOI 10.1007/s00125-007-0915-6; LIAO YL, 1988, J AM COLL CARDIOL, V12, P1494; Ministry of Health, 2007, ORD IND SAF HLTH; Nakamura K, 2006, HYPERTENS RES, V29, P353, DOI 10.1291/hypres.29.353; Nakamura Y, 2012, CIRCULATION, V125, P1226, DOI 10.1161/CIRCULATIONAHA.111.070045; Ueshima H, 2006, CIRC J, V70, P1249; Okamura T, 2006, ATHEROSCLEROSIS, V184, P143, DOI 10.1016/j.atherosclerosis.2005.03.042; Okayama A, 2006, J HYPERTENS, V24, P459, DOI 10.1097/01.hjh.0000209981.43983.cf; Rumana N, 2011, AM J CARDIOL, V107, P1718, DOI 10.1016/j.amjcard.2011.02.335; Saito I, 2000, INT J EPIDEMIOL, V29, P837, DOI 10.1093/ije/29.5.837; STROGATZ DS, 1987, J CHRON DIS, V40, P149, DOI 10.1016/0021-9681(87)90066-X; SUTHERLAND SE, 1993, CIRCULATION, V88, P2685; Teramoto Tamio, 2013, J Atheroscler Thromb, V20, P517; Ueshima H, 2004, STROKE, V35, P1836, DOI 10.1161/01.STR.0000131747.84423.74; Berg AO, 2004, ANN INTERN MED, V140, P569; WHO, 2008, GLOB BURD DIS 2004 U; Woodward M, 2005, EPIDEMIOLOGY STUDY D	38	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2047-4873	2047-4881		EUR J PREV CARDIOL	Eur. J. Prev. Cardiol.	DEC	2014	21	12					1501	1508		10.1177/2047487313500568		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT9CF	WOS:000345224900007		
J	Ducrocq, G; Bhatt, DL; Labreuche, J; Corbalan, R; Porath, A; Gao, R; Panchenko, E; Liau, CS; Ikeda, Y; Goto, S; Amarenco, P; Steg, PG				Ducrocq, G.; Bhatt, D. L.; Labreuche, J.; Corbalan, R.; Porath, A.; Gao, R.; Panchenko, E.; Liau, C. S.; Ikeda, Y.; Goto, S.; Amarenco, P.; Steg, P. G.			Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY			English	Article						Geographic differences; atherothrombotic disease; ischemic outcomes; bleeding	ACUTE CORONARY SYNDROMES; CARDIOVASCULAR EVENT RATES; EURO HEART SURVEY; BODY-MASS INDEX; SECONDARY PREVENTION; STABLE OUTPATIENTS; INCOME COUNTRIES; MIDDLE-INCOME; GLOBAL BURDEN; MANAGEMENT	Aims There are major differences in the prevalence and management of patients with atherothrombotic disease including coronary artery disease (CAD), cerebrovascular disease (CVD) and peripheral artery disease (PAD) across different geographical regions. There is, however, little data allowing comparisons of management and outcomes across broad geographic regions. We aimed to describe geographical differences in baseline characteristics, management and outcomes in stable outpatients with established atherothrombotic disease. Methods and results From the REACH Registry of atherothrombosis, patients with documented CAD, PAD or CVD and with 4-year follow-up were included. Baseline characteristics, treatments and 4-year outcomes were recorded. Event rates were compared between geographical regions and were adjusted for risk scores predicting ischemic and bleeding events. The analyses of baseline characteristics and medications according to geographical region showed marked differences. For the composite primary outcome (cardiovascular death, non-fatal myocardial infarction (MI) and non-fatal stroke), rates ranged from 12.1% in Japan to 18.2% in Eastern Europe. After adjustment, substantial variations remained: taking North America as a reference, patients from Western Europe and Japan had a lower risk of primary outcome event (hazard ratio (HR) 0.93; p=0.045, and HR=0.67; p<0.001 respectively) whereas patients from Eastern Europe had a higher risk (HR=1.24; p<0.001). There were no obvious differences between patients from North America and those from Latin America, the Middle East and Asia. Conclusion There are important variations in the outcomes of patients with atherothrombotic across geographic regions. These observations have important implications for public health and clinical research.	[Ducrocq, G.; Labreuche, J.; Amarenco, P.; Steg, P. G.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Ducrocq, G.; Labreuche, J.; Amarenco, P.; Steg, P. G.] Hop Bichat Paris, AP HP, Paris, France; [Ducrocq, G.; Labreuche, J.; Amarenco, P.; Steg, P. G.] INSERM, U698, F-75877 Paris 18, France; [Bhatt, D. L.] Harvard Univ, Brigham & Womens Hosp, VA Boston Healthcare Syst, Sch Med, Cambridge, MA 02138 USA; [Corbalan, R.] Pontificia Univ Catolica Chile, Santiago, Chile; [Porath, A.] Ben Gurion Univ Negev, Dept Epidemiol, IL-84105 Beer Sheva, Israel; [Gao, R.] Cardiovasc Inst, Beijing, Peoples R China; [Gao, R.] Fuwai Hosp, Beijing, Peoples R China; [Panchenko, E.] Cardiol Res Ctr, Moscow, Russia; [Liau, C. S.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Ikeda, Y.] Kokura Mem Hosp, Fukuoka, Japan; [Goto, S.] Tokai Univ, Hiratsuka, Kanagawa 25912, Japan	Ducrocq, G (reprint author), INSERM, U698, 46 Rue Henri Huchard, F-75877 Paris 18, France.	gregory.ducrocq@bch.aphp.fr			Astra Zeneca; Departement Hospitalo-Universitaire FIRE of Universite Paris-Diderot and Assistance Publique - Hopitaux de Paris	This analysis was supported by Astra Zeneca and by the Departement Hospitalo-Universitaire FIRE of Universite Paris-Diderot and Assistance Publique - Hopitaux de Paris.	Dallongeville J, 2012, EUR J PREV CARDIOL, V19, P241, DOI 10.1177/1741826710394305; Goyal A, 2010, CIRCULATION, V122, P1167, DOI 10.1161/CIRCULATIONAHA.109.919274; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Fox KAA, 2000, EUR HEART J, V21, P1440, DOI 10.1053/euhj.2000.2185; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; WORTH RM, 1975, AM J EPIDEMIOL, V102, P481; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Lenzen MJ, 2005, EUR HEART J, V26, P1169, DOI 10.1093/eurheartj/ehi238; Barba C, 2004, LANCET, V363, P157; Bueno H, 2011, EUR HEART J, V32, P1583, DOI 10.1093/eurheartj/ehq388; Daly CA, 2008, INT J CARDIOL, V125, P311, DOI 10.1016/j.ijcard.2007.01.103; Ducrocq G, 2010, EUR HEART J, V31, P1257, DOI 10.1093/eurheartj/ehq021; Ohman EM, 2006, AM HEART J, V151, p786e1; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Venkitachalam L, 2012, CIRCULATION, V125, P1858, DOI 10.1161/CIRCULATIONAHA.111.064378; Wilson PWF, 2012, AM J MED, V125, P695, DOI 10.1016/j.amjmed.2012.01.014	27	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2047-4873	2047-4881		EUR J PREV CARDIOL	Eur. J. Prev. Cardiol.	DEC	2014	21	12					1509	1516		10.1177/2047487313501278		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT9CF	WOS:000345224900008		
J	Udell, JA; Steg, PG; Scirica, BM; Eagle, KA; Ohman, EM; Goto, S; Alsheikh-Ali, AA; Porath, A; Corbalan, R; Umez-Eronini, AA; Hoffman, EB; Wilson, PWF; Bhatt, DL				Udell, Jacob A.; Steg, Ph Gabriel; Scirica, Benjamin M.; Eagle, Kim A.; Ohman, E. Magnus; Goto, Shinya; Alsheikh-Ali, Alawi A.; Porath, Avi; Corbalan, Ramon; Umez-Eronini, Amarachi A.; Hoffman, Elaine B.; Wilson, Peter W. F.; Bhatt, Deepak L.		Reduction Atherothrombosis	Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY			English	Article						Cardiovascular; cohort; diabetes; metabolic syndrome; risk factors	CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; RANDOMIZED-TRIALS; EVENTS; METAANALYSIS; MEN; ATHEROSCLEROSIS; MANAGEMENT; DURATION; PREVENTION	Background The incidence of metabolic syndrome (MetS), diabetes mellitus (DM), and their coexistence is increasing but whether MetS increases cardiovascular risk beyond component risk factors is controversial. Design We compared the risk of cardiovascular death, myocardial infarction, or stroke among patients with MetS, newly detected DM, established DM, or coexistent MetS and DM in the global REduction of Atherothrombosis for Continued Health (REACH) registry. Methods Outpatients with or at risk for atherothrombosis were recruited between 1 December 2003 and 31 December 2004 and followed up to 4 years for cardiovascular events. Risk was compared in patients with or without MetS or DM after adjustment for age, sex, risk factors, vascular disease, fasting blood glucose, therapy, and region. Results Among 44,548 REACH participants, 17,887 (40%) were without MetS or DM; 6459 had MetS (15%); 12,059 had established DM (27%); 7503 had both (17%); and 640 had newly detected DM (1%). Presence of MetS was not associated with higher cardiovascular events (12.6%, adjusted HR 0.98, 95% CI 0.89-1.08). In addition, once DM was evident, patients with coexistent MetS had similar increased risk (16.1%, adjusted HR 1.33, 95% CI 1.21-1.47) as DM alone (16.7%, adjusted HR 1.36, 95% CI 1.24-1.48). Newly detected DM was associated with increased cardiovascular risk (18.5%, adjusted HR 1.26, 95% CI 1.02-1.57), similar to longstanding DM. MetS was associated with incident DM (adjusted OR 1.94). Conclusions In the REACH registry, presence of newly detected DM but not metabolic syndrome was associated with an increased risk of cardiovascular events.	[Udell, Jacob A.] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada; [Steg, Ph Gabriel] Univ Paris Diderot, DHU Fire, AP HP, Paris, France; [Steg, Ph Gabriel] INSERM, U698, Paris, France; [Scirica, Benjamin M.; Umez-Eronini, Amarachi A.; Hoffman, Elaine B.; Bhatt, Deepak L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Eagle, Kim A.] Univ Michigan, Cardiovasc Ctr, Ann Arbor, MI 48109 USA; [Ohman, E. Magnus] Duke Univ, Durham, NC USA; [Goto, Shinya] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Alsheikh-Ali, Alawi A.] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; [Alsheikh-Ali, Alawi A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Porath, Avi] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Corbalan, Ramon] Pontificia Univ Catolica Chile, Santiago, Chile; [Wilson, Peter W. F.] Emory Univ, Sch Med, Atlanta VA Med Ctr, Atlanta, GA USA	Bhatt, DL (reprint author), 1400 VFW Pkwy, Boston, MA 02132 USA.	DLBHATTMD@post.harvard.edu			Sanofi-Aventis (Bridgewater, NJ, USA); Bristol-Myers Squibb (New York, NY, USA); Waksman Foundation (Tokyo, Japan)	The REACH Registry was supported by Sanofi-Aventis (Bridgewater, NJ, USA), Bristol-Myers Squibb (New York, NY, USA), and the Waksman Foundation (Tokyo, Japan).	American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Kearney PM, 2008, LANCET, V371, P117; Fox CS, 2004, DIABETES CARE, V27, P704, DOI 10.2337/diacare.27.3.704; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Liu J, 2007, AM HEART J, V153, P552, DOI 10.1016/j.ahj.2007.01.003; Wen CP, 2011, EUR J CARDIOV PREV R, V18, P561, DOI 10.1177/1741826710389422; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Wassink AMJ, 2008, EUR HEART J, V29, P213, DOI 10.1093/eurheartj/ehm582; Butler J, 2006, J AM COLL CARDIOL, V47, P1595, DOI 10.1016/j.jacc.2005.12.046; Wannamethee SG, 2011, ARCH INTERN MED, V171, P404, DOI 10.1001/archinternmed.2011.2; KANNEL WB, 1979, CIRCULATION, V59, P8; Malik S, 2011, DIABETES CARE, V34, P2285, DOI 10.2337/dc11-0816; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Bayturan O, 2010, ARCH INTERN MED, V170, P478, DOI 10.1001/archinternmed.2009.551; Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; [Anonymous], 2011, LANCET, V378, P99; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; Lemieux I, 2000, CIRCULATION, V102, P179; [Anonymous], 2000, LANCET, V355, P253; Collins R, 2009, LANCET, V373, P1849; Tuomilehto J, 2007, EUR J CARDIOV PREV R, V14, P192; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; EPSTEIN FH, 1967, CIRCULATION, V36, P609; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kondo T, 2011, EUR J CARDIOV PREV R, V18, P574, DOI 10.1177/1741826710389529; Natarajan S, 2005, ARCH INTERN MED, V165, P430, DOI 10.1001/archinte.165.4.430; Scirica BM, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.006; Udell JA, 2012, CLIN CARDIOL, V35, P722, DOI 10.1002/clc.22032	36	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2047-4873	2047-4881		EUR J PREV CARDIOL	Eur. J. Prev. Cardiol.	DEC	2014	21	12					1531	1540		10.1177/2047487313500541		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT9CF	WOS:000345224900010		
J	Kidoa, T; Kido, T; Nakamura, M; Kawaguchi, N; Nishiyama, Y; Ogimoto, A; Miyagawa, M; Mochizuki, T				Kidoa, Tomoyuki; Kido, Teruhito; Nakamura, Masashi; Kawaguchi, Naoto; Nishiyama, Yoshiko; Ogimoto, Akiyoshi; Miyagawa, Masao; Mochizuki, Teruhito			Three-dimensional phase-sensitive inversion recovery sequencing in the evaluation of left ventricular myocardial scars in ischemic and non-ischemic cardiomyopathy: Comparison to three-dimensional inversion recovery sequencing	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Magnetic resonance imaging; Late gadolinium enhancement; Myocardial scar; Phase-sensitive inversion-recovery	CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; EMISSION-COMPUTED-TOMOGRAPHY; DELAYED CONTRAST ENHANCEMENT; CORONARY-ARTERY-DISEASE; MR-IMAGING TECHNIQUE; HYPERTROPHIC CARDIOMYOPATHY; HEART-DISEASE; INFARCTION; PROGNOSIS	Background: Late gadolinium enhancement (LGE) magnetic resonance imaging (MRI) is a useful technique for detecting myocardial fibrosis. LGE images are typically acquired using the inversion recovery (IR) method. Recently, phase-sensitive inversion recovery (PSIR) technology has been developed. The purpose of this study was to evaluate free-breathing 3D PSIR sequencing in comparison with breath-held 3D IR sequencing for the detection of myocardial fibrosis. Methods: One hundred twenty-three patients with suspected ischemic cardiac disease (n = 27) or non-ischemic cardiomyopathy (hypertrophic cardiomyopathy, n= 29; dilated cardiomyopathy, n= 22; sarcoidosis, n= 21; arrhythmia, n= 9; myocarditis, n=4; amyloidosis, n= 3; and others, n= 8) were evaluated by LGE-MRI, which was performed first with the IR sequence and then with the PSIR sequence, using a 3 T MRI scanner. Image quality was scored by two independent readers using a four-point scale. The 3D LGE volume was analyzed quantitatively and compared between both sequencing methods. Results: There was no significant difference in overall image quality (p = 0.19). LGE was detected in 73 patients, who were evaluated visually. Ultimately, 58 patients with acceptable image quality were enrolled in further quantitative analyses (volume assessment). Although quantification of LGE volume revealed a strong correlation between both methods, larger LGE volumes were detected with PSIR compared to IR in patients suspected of non-ischemic cardiomyopathy (39.5 +/- 25.9 cm(3) for PSIR and 32.8 +/- 23.9 cm(3) for IR, p <0.001). The LGE volume did not differ significantly in patients suspected of ischemic cardiac disease (17.9 +/- 12.7 cm(3) for PSIR and 17.5 +/- 11.1 cm(3) for IR, p = 0.34). Conclusions: 3D PSIR is suitable for detection of LGE and may be an option in cases with IR images of unacceptable quality but overestimates LGE volume in non-ischemic cardiomyopathy. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kidoa, Tomoyuki; Kido, Teruhito; Nakamura, Masashi; Kawaguchi, Naoto; Nishiyama, Yoshiko; Miyagawa, Masao; Mochizuki, Teruhito] Ehime Univ, Grad Sch Med, Dept Radiol, Toon City, Ehime 7910295, Japan; [Ogimoto, Akiyoshi] Ehime Univ, Grad Sch Med, Dept Cardiovasc Internal Med, Toon City, Ehime 7910295, Japan	Kidoa, T (reprint author), Ehime Univ, Grad Sch Med, Dept Radiol, Toon City, Ehime 7910295, Japan.	tomozo0421@gmail.com					Syed IS, 2010, JACC-CARDIOVASC IMAG, V3, P155, DOI 10.1016/j.jcmg.2009.09.023; Klein C, 2004, J MAGN RESON IMAGING, V20, P588, DOI 10.1002/jmri.20164; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Klem I, 2006, J AM COLL CARDIOL, V47, P1630, DOI 10.1016/j.jacc.2005.10.074; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Bello D, 2005, J AM COLL CARDIOL, V45, P1104, DOI 10.1016/j.jacc.2004.12.057; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Klein C, 2007, J CARDIOVASC MAGN R, V9, P653, DOI 10.1080/10976640601105614; Kim RJ, 1999, CIRCULATION, V100, P1992; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258; BERNSTEIN MA, 1989, MED PHYS, V16, P813, DOI 10.1118/1.596304; Simonetti OP, 2001, RADIOLOGY, V218, P215; Nakamori S, 2012, CIRC J, V76, P914, DOI 10.1253/circj.CJ-11-1043; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; NOLL DC, 1991, IEEE T MED IMAGING, V10, P154, DOI 10.1109/42.79473; Dewey M, 2006, RADIOLOGY, V239, P703, DOI 10.1148/radiol.2393050586; Edelman RR, 2004, RADIOLOGY, V232, P653, DOI 10.1148/radiol.2323031558; Goldfarb JW, 2005, MAGNET RESON MED, V53, P367, DOI 10.1002/mrm.20369; Gupta A, 2004, RADIOLOGY, V233, P921, DOI 10.1148/radiol.2333032004; Huber AM, 2005, RADIOLOGY, V237, P854, DOI 10.1148/radiol.2373041483; Hundley W. G., 2010, J AM COLL CARDIOL, V55, P2614, DOI DOI 10.1016/J.JACC.2009.11.011; Kellman P, 2005, MAGNET RESON MED, V53, P194, DOI 10.1002/mrm.20333; Kellman P, 2002, MAGNET RESON MED, V47, P372, DOI 10.1002/mrm.10051; Kino A, 2011, INT J CARDIOVAS IMAG, V27, P527, DOI 10.1007/s10554-010-9640-1; Kino A, 2009, AM J ROENTGENOL, V193, P381; Kuhl HP, 2003, J AM COLL CARDIOL, V41, P1341, DOI 10.1016/S0735-1097(03)00158-X; Moon JC, 2010, J AM COLL CARDIOL, V56, P875; Morita K, 2013, ACAD RADIOL, V20, P752, DOI 10.1016/j.acra.2013.01.014; Oshinski JN, 2001, CIRCULATION, V104, P2838, DOI 10.1161/hc4801.100351; Peukert D, 2007, ACAD RADIOL, V14, P788, DOI 10.1016/j.acra.2007.03.006; Shehata Monda L, 2008, Top Magn Reson Imaging, V19, P43, DOI 10.1097/RMR.0b013e31816fcb22; Spiewak M, 2010, EUR J RADIOL, V74, P149; Viallon M, 2011, J MAGN RESON IMAGING, V34, P1374, DOI 10.1002/jmri.22783; Wagner A, 2006, J AM COLL CARDIOL, V47, P2027, DOI 10.1016/j.jacc.2006.01.059; Wu KC, 2009, JACC-CARDIOVASC IMAG, V2, P843, DOI 10.1016/j.jcmg.2009.02.013; Yin G, 2013, J MAGN RESON IMAGING, V38, P72, DOI 10.1002/jmri.23962	39	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	DEC	2014	83	12					2159	2166		10.1016/j.ejrad.2014.09.014		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT4WA	WOS:000344940600009		
J	Nagata, K; Iida, N; Kanazawa, H; Fujiwara, M; Mogi, T; Mitsushima, T; Lefor, AT; Sugimoto, H				Nagata, Koichi; Iida, Nao; Kanazawa, Hidenori; Fujiwara, Masanori; Mogi, Tomohiro; Mitsushima, Toru; Lefor, Alan T.; Sugimoto, Hideharu			Effect of listening to music and essential oil inhalation on patients undergoing screening CT colonography: A randomized controlled trial	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Music; Aroma; Colonography; Computed tomography; Relaxation	COLONOSCOPY; ANXIETY; EXPERIENCE; REQUIREMENTS; AROMATHERAPY; METAANALYSIS; ENDOSCOPY; SEDATION; COMFORT	Objective: To prospectively evaluate the effect of listening to music and inhaling aroma oil on patients undergoing screening computed tomography colonography. Materials and methods: Two hundred and twenty four participants were randomly allocated to one of the four groups including: (1) combined music and aroma, (2) music alone, (3) aroma alone, and (4) control. The visual analog scale for pain and a questionnaire were used for subjective outcomes. We also used a pre-test-post-test design to compare the differences in blood pressure and heart rate as objective outcomes. Results: There were no statistical differences between the control group and other groups in the visual analog scale or changes in heart rate. Changes in blood pressure were similar. Participants reported good overall experiences. There were no differences in terms of overall satisfaction, pain rating, willingness to repeat the computed tomography colonography procedure in the future, or preference between colonoscopy and computed tomography colonography. More participants using music and/or aroma requested music and/or aroma during the next computed tomography colonography (P < 0.0001). Conclusion: Although audio and olfactory intervention had little effect on perceived pain or discomfort and vital signs, participants who listened to music and inhaled aroma during the computed tomography colonography preferred music and aroma during the next computed tomography colonography. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nagata, Koichi] Kameda Med Ctr, Dept Radiol, Chiba 2968602, Japan; [Nagata, Koichi; Kanazawa, Hidenori; Sugimoto, Hideharu] Jichi Med Univ, Dept Radiol, Shimotsuke, Tochigi 3290498, Japan; [Nagata, Koichi] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Canc Screening Technol Div, Kita Ku, Tokyo 1040045, Japan; [Iida, Nao; Mogi, Tomohiro] Kameda Med Ctr Makuhari, Dept Radiol, Mihama Ku, Chiba 2618501, Japan; [Mitsushima, Toru] Kameda Med Ctr Makuhari, Dept Radiol, Dept Gastroenterol, Mihama Ku, Chiba 2618501, Japan; [Lefor, Alan T.] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi 3290498, Japan	Nagata, K (reprint author), Jichi Med Univ, Dept Radiol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	Nagata7@aol.com; n.iida-xray@kameda.jp; r0713hk@jichi.ac.jp; m_fujiwara@kameda.jp; mogi-xray@kameda.jp; mitsushima@kameda.jp; alefor@jichi.ac.jp; sugimoto@jichi.ac.jp		Lefor, Alan/0000-0001-6673-5630			Akerkar GA, 2001, GASTROINTEST ENDOSC, V54, P310, DOI 10.1067/mge.2001.117595; Andrada JMLC, 2004, EUR J GASTROEN HEPAT, V16, P1381, DOI 10.1097/00042737-200412000-00024; Ovayolu N, 2006, WORLD J GASTROENTERO, V12, P7532; Costa A, 2010, DIGEST LIVER DIS, V42, P871, DOI 10.1016/j.dld.2010.03.016; Rudin D, 2007, ENDOSCOPY, V39, P507, DOI 10.1055/s-2007-966362; Peng SM, 2009, J ALTERN COMPLEM MED, V15, P53, DOI 10.1089/acm.2008.0243; Muzzarelli L, 2006, GASTROENTEROL NURS, V29, P466, DOI 10.1097/00001610-200611000-00005; Stirling L, 2007, J ADV NURS, V60, P494, DOI 10.1111/j.1365-2648.2007.04461.x; Pendse DA, 2013, EUR J RADIOL, V82, P1159, DOI 10.1016/j.ejrad.2012.04.011; Stea S, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/726341; Tam WWS, 2008, WORLD J GASTROENTERO, V14, P5336, DOI 10.3748/wjg.14.5336; Bosworth HB, 2006, AM J MED, V119, P791, DOI 10.1016/j.amjmed.2006.02.013; Bechtold ML, 2006, WORLD J GASTROENTERO, V12, P7309; Binek J, 2003, DIGESTION, V68, P5, DOI 10.1159/000073219; Bruzzi JF, 2003, EUR RADIOL, V13, P2264, DOI 10.1007/s00330-003-2012-7; Byers J F, 1997, Am J Crit Care, V6, P183; DUBOIS JM, 1995, CHEST, V108, P129, DOI 10.1378/chest.108.1.129; Jensch S, 2010, EUR RADIOL, V20, P146, DOI 10.1007/s00330-009-1517-0; Kim JT, 2007, OBES SURG, V17, P920, DOI 10.1007/s11695-007-9170-7; Nagata K, 2007, INT J COLORECTAL DIS, V22, P69, DOI 10.1007/s00384-006-0113-x; Nagata K, 2014, AJR AM J RO IN PRESS; Nagata K, 2009, ACAD RADIOL, V16, P780, DOI 10.1016/j.acra.2008.12.027; Ni C. H., 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/927419, DOI 10.1155/2013/927419]; Olapour Alireza, 2013, Anesth Pain Med, V3, P203, DOI 10.5812/aapm.9570; Puttler K, 2009, J ALTERN COMPLEM MED, V15, P381, DOI 10.1089/acm.2008.0257; SLIFER KJ, 1991, AM J ROENTGENOL, V156, P403; Smith CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009215; Sosna J, 2006, RADIOLOGY, V239, P457, DOI 10.1148/radiol.2392050287; Taylor SA, 2003, AM J ROENTGENOL, V181, P913; von Wagner C, 2012, RADIOLOGY, V263, P723, DOI 10.1148/radiol.12111523	30	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	DEC	2014	83	12					2172	2176		10.1016/j.ejrad.2014.09.016		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT4WA	WOS:000344940600011		
J	Ikeda, Y; Yoshimura, N; Hori, Y; Horii, Y; Ishikawa, H; Yamazaki, M; Noto, Y; Aoyama, H				Ikeda, Yohei; Yoshimura, Norihiko; Hori, Yoshiro; Horii, Yosuke; Ishikawa, Hiroyuki; Yamazaki, Motohiko; Noto, Yoshiyuki; Aoyama, Hidefumi			Analysis of decrease in lung perfusion blood volume with occlusive and non-occlusive pulmonary embolisms	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Computed tomography; Angiography; Dual energy; Perfusion; Pulmonary embolism	DUAL-ENERGY CT; COMPUTED-TOMOGRAPHY; HYPERTENSION; ANGIOPLASTY; ANGIOGRAPHY	Purpose: The aim of this study was to determine if lung perfusion blood volume (lung PBV) with non-occlusive pulmonary embolism (PE) differs quantitatively and visually from that with occlusive PE and to investigate if lung PBV with non-occlusive PE remains the same as that without PE. Materials and methods: Totally, 108 patients suspected of having acute PE underwent pulmonary dualenergy computed tomography angiography (DECTA) between April 2011 and January 2012. Presence of PE on DECTA was evaluated by one radiologist. Two radiologists visually evaluated the PE distribution (segmental or subsegmental) and its nature (occlusive or non-occlusive) on DECTA and classified perfusion in lung PBV as "decreased," "slightly decreased," and "preserved". Two radiologists used a lung PBV application to set a region of interest (ROI) in the center of the lesion and measured HU values of an iodine map. In the same slice as the ROI of the lesion and close to the lesion, another ROI was set in the normal perfusion area without PE, and HUs were measured. The proportion of lesions was compared between the occlusive and non-occlusive groups. HUs were compared among the occlusive, non-occlusive, and corresponding normal groups. Results: Twenty-five patients had 80 segmental or subsegmental lesions. There were 37 and 43 lesions in the occlusive and non-occlusive groups, respectively. The proportion of decreased lesions was 73.0% (27137) in the occlusive group, while that of preserved lesions in the non-occlusive group was 76.7% (33143). There was a significant difference in the proportion of lesions (P< 0.001) between the two groups. HUs of the iodine map were significantly higher in the non-occlusive group than in the occlusive group (33.8 +/- 8.2 HU vs. 11.9 +/- 6.1 HU, P < 0.001). There was no significant difference in HUs for the entire lesion between the non-occlusive (33.8 +/- 8.2 HU) and corresponding normal group (34.5 +/- 6.8 HU; P= 0.294). Conclusion: Iodine perfusion tended to be visually and quantitatively preserved in lungs with nonocclusive PE. Lung PBV is required to evaluate pulmonary blood flow. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ikeda, Yohei; Yoshimura, Norihiko; Horii, Yosuke; Ishikawa, Hiroyuki; Aoyama, Hidefumi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Radiol, Niigata 95021, Japan; [Noto, Yoshiyuki] Niigata Univ, Med & Dent Hosp, Dept Radiol, Niigata 95021, Japan; [Yamazaki, Motohiko] Niigata City Gen Hosp, Dept Radiol, Niigata, Japan; [Hori, Yoshiro] Showa Univ, Fujigaoka Hosp, Dept Radiol, Shinagawa, Japan	Ikeda, Y (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Radiol, Niigata 95021, Japan.	ypfranky1@ybb.ne.jp					Thieme SF, 2012, EUR J RADIOL, V81, P360, DOI 10.1016/j.ejrad.2010.11.037; Thieme SF, 2009, AM J ROENTGENOL, V193, P144, DOI 10.2214/AJR.08.1653; Lee CW, 2011, EUR RADIOL, V21, P54, DOI 10.1007/s00330-010-1903-7; Kang MJ, 2010, RADIOGRAPHICS, V30, P685, DOI 10.1148/rg.303095101; Fedullo P, 2011, AM J RESP CRIT CARE, V183, P1605, DOI 10.1164/rccm.201011-1854CI; Andreassen AK, 2013, HEART, V99, P1415, DOI 10.1136/heartjnl-2012-303549; Kataoka M, 2012, CIRC-CARDIOVASC INTE, V5, P756, DOI 10.1161/CIRCINTERVENTIONS.112.971390; Stein PD, 2006, AM J MED, V119, P1048, DOI 10.1016/j.amjmed.2006.05.060; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Thieme SF, 2008, EUR J RADIOL, V68, P369, DOI 10.1016/j.ejrad.2008.07.031; Clark AR, 2014, RESP PHYSIOL NEUROBI, V190, P1, DOI 10.1016/j.resp.2013.09.005; Hagspiel KD, 2012, CLIN RADIOL, V67, P69, DOI 10.1016/j.crad.2010.12.021; Hoey ETD, 2011, AM J ROENTGENOL, V196, P524, DOI 10.2214/AJR.10.4842; Hong YJ, 2013, AM J ROENTGENOL, V200, P812, DOI 10.2214/AJR.12.8697; Piazza G, 2006, CIRCULATION, V114, P28; Wildberger JE, 2005, EUR RADIOL, V15, P919, DOI 10.1007/s00330-005-2643-y	17	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	DEC	2014	83	12					2260	2267		10.1016/j.ejrad.2014.08.015		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT4WA	WOS:000344940600021		
J	Nishio, M; Matsumoto, S; Seki, S; Koyama, H; Ohno, Y; Fujisawa, Y; Sugihara, N; Yoshikawa, T; Sugimura, K				Nishio, Mizuho; Matsumoto, Sumiaki; Seki, Shinichiro; Koyama, Hisanobu; Ohno, Yoshiharu; Fujisawa, Yasuko; Sugihara, Naoki; Yoshikawa, Takeshi; Sugimura, Kazuro			Emphysema quantification on low-dose CT using percentage of low-attenuation volume and size distribution of low-attenuation lung regions: Effects of adaptive iterative dose reduction using 3D processing	EUROPEAN JOURNAL OF RADIOLOGY			English	Article						Low-dose CT; Iterative reconstruction; COPD; Quantitative evaluation	FILTERED BACK-PROJECTION; QUANTITATIVE COMPUTED-TOMOGRAPHY; CHRONIC OBSTRUCTIVE PULMONARY; MICROSCOPIC MORPHOMETRY; MULTIDETECTOR CT; IMAGE QUALITY; RECONSTRUCTION; CHEST; RADIATION; DISEASE	Purpose: To evaluate the effects of adaptive iterative dose reduction using 3D processing (AIDR 3D) for quantification of two measures of emphysema: percentage of low-attenuation volume (LAV%) and size distribution of low-attenuation lung regions. Method and materials: : Fifty-two patients who underwent standard-dose (SDCT) and low-dose CT (LDCT) were included. SDCT without AIDR 3D, LDCT without AIDR 3D, and LDCT with AIDR 3D were used for emphysema quantification. First, LAV% was computed at 10 thresholds from -990 to -900 HU. Next, at the same thresholds, linear regression on a log-log plot was used to compute the power law exponent (D) for the cumulative frequency-size distribution of low-attenuation lung regions. Bland-Altman analysis was used to assess whether AIDR 3D improved agreement between LDCT and SDCT for emphysema quantification of LAV% and D. Results: The mean relative differences in LAV% between LDCT without AIDR 3D and SDCT were 3.73%-88.18% and between LDCT with AIDR 3D and SDCT were -6.61% to 0.406%. The mean relative differences in D between LDCT without AIDR 3D and SDCT were 8.22%-19.11% and between LDCT with AIDR 3D and SDCT were 1.82%-4.79%. AIDR 3D improved agreement between LDCT and SDCT at thresholds from -930 to -990 HU for LAV% and at all thresholds for D. Conclusion: AIDR 3D improved the consistency between LDCT and SDCT for emphysema quantification of LAV% and D. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nishio, Mizuho; Matsumoto, Sumiaki; Ohno, Yoshiharu; Yoshikawa, Takeshi] Kobe Univ, Adv Biomed Imaging Res Ctr, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Nishio, Mizuho; Matsumoto, Sumiaki; Ohno, Yoshiharu; Yoshikawa, Takeshi] Kobe Univ, Grad Sch Med, Dept Radiol, Div Funct & Diagnost Imaging Res,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Seki, Shinichiro; Koyama, Hisanobu; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Div Radiol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Fujisawa, Yasuko; Sugihara, Naoki] Toshiba Med Syst Corp, Otawara, Tochigi 3248550, Japan	Nishio, M (reprint author), Kobe Univ, Adv Biomed Imaging Res Ctr, Grad Sch Med, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	nmizuho@med.kobe-u.ac.jp; sumatsu@med.kobe-u.ac.jp; sshin@med.kobe-u.ac.jp; hkoyama@med.kobe-u.ac.jp; yosirad@kobe-u.ac.jp; yasuko1.fujisawa@toshiba.co.jp; naoki.sugihara@toshiba.co.jp; yoshikaw@med.kobe-u.ac.jp; sugimura@med.kobe-u.ac.jp			Toshiba Medical Systems Corporation	M. Nishio, S. Matsumoto, Y. Ohno, T. Yoshikawa, and K. Sugimura have received research grants from Toshiba Medical Systems Corporation. Y. Fujisawa and N. Sugihara are employees of Toshiba Medical Systems Corporation. S. Seki and H. Koyama have no conflict of interest.	Willemink MJ, 2013, EUR RADIOL, V23, P1632, DOI 10.1007/s00330-012-2764-z; Gervaise A, 2012, EUR RADIOL, V22, P295, DOI 10.1007/s00330-011-2271-7; Nishio M, 2012, AM J ROENTGENOL, V199, P595, DOI 10.2214/AJR.11.8174; Heyer CM, 2007, RADIOLOGY, V245, P577, DOI 10.1148/radiol.2452061919; Madani A, 2006, RADIOLOGY, V238, P1036, DOI 10.1148/radiol.2382042196; Ohno Y, 2012, AM J ROENTGENOL, V199, pW477, DOI 10.2214/AJR.11.8275; Kilic K, 2011, AM J NEURORADIOL, V32, P1578, DOI 10.3174/ajnr.A2585; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Leipsic J, 2010, AM J ROENTGENOL, V195, P1095, DOI 10.2214/AJR.09.4050; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Kalra MK, 2004, RADIOLOGY, V230, P619, DOI 10.1148/radiol.2303021726; BLAND JM, 1995, BRIT MED J, V310, P170; Baumueller S, 2012, EUR RADIOL, V22, P2597, DOI 10.1007/s00330-012-2524-0; Newell John D Jr, 2008, Proc Am Thorac Soc, V5, P915, DOI 10.1513/pats.200804-034QC; Willemink MJ, 2013, EUR RADIOL, V23, P1623, DOI 10.1007/s00330-012-2765-y; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Baker ME, 2012, AM J ROENTGENOL, V199, P8, DOI 10.2214/AJR.11.7421; BLAND JM, 1986, LANCET, V1, P307; Gierada DS, 2007, AM J ROENTGENOL, V188, P42, DOI 10.2214/AJR.05.1498; Koyama H, 2010, ACAD RADIOL, V17, P163, DOI 10.1016/j.acra.2009.08.009; Madani A, 2008, RADIOLOGY, V248, P1036, DOI 10.1148/radiol.2483071434; Mets OM, 2012, LUNG, V190, P133, DOI 10.1007/s00408-011-9353-9; Mets OM, 2012, EUR RADIOL, V22, P2103, DOI 10.1007/s00330-012-2489-z; Nishio M, 2014, AM J ROENTGENOL, V202, pW453, DOI 10.2214/AJR.13.10781; Prakash P, 2010, RADIOLOGY, V256, P261, DOI 10.1148/radiol.10091487; Zaporozhan J, 2006, J COMPUT ASSIST TOMO, V30, P460, DOI 10.1097/00004728-200605000-00018	29	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0720-048X	1872-7727		EUR J RADIOL	Eur. J. Radiol.	DEC	2014	83	12					2268	2276		10.1016/j.ejrad.2014.09.011		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT4WA	WOS:000344940600022		
J	Koyasu, S; Iima, M; Umeoka, S; Morisawa, N; Porter, DA; Ito, J; Le Bihan, D; Togashi, K				Koyasu, Sho; Iima, Mami; Umeoka, Shigeaki; Morisawa, Nobuko; Porter, David A.; Ito, Juichi; Le Bihan, Denis; Togashi, Kaori			The clinical utility of reduced-distortion readout-segmented echo-planar imaging in the head and neck region: initial experience	EUROPEAN RADIOLOGY			English	Article						Diffusion magnetic resonance imaging; Echo-planar imaging; Parotid gland; Head and neck neoplasms; Magnetic resonance imaging	APPARENT DIFFUSION-COEFFICIENT; BENIGN PAROTID TUMORS; GLAND TUMORS; DIAGNOSTIC-ACCURACY; SALIVARY-GLANDS; MR NEUROGRAPHY; WEIGHTED MRI; PREDICTION; BRAIN	To evaluate whether readout-segmented echo-planar imaging (RS-EPI) diffusion weighted image (DWI) can diminish image distortion in the head and neck area, compared with single-shot (SS)-EPI DWI. We conducted phantom and patient studies using 3 T magnetic resonance imaging (MRI) with a 16-channel coil. For the phantom study, we evaluated distortion and signal homogeneity in gel phantoms. For the patient study, 29 consecutive patients with clinically suspicious parotid lesions were prospectively enrolled. RS-EPI and SS-EPI DWI were evaluated by two independent readers for identification of organ/lesion and distortion, using semiquantitative scales and quantitative scores. Apparent diffusion coefficient (ADC) values and contrast-noise ratios of parotid tumours (if present; n = 15) were also compared. The phantom experiments showed that RS-EPI provided less distorted and more homogeneous ADC maps than SS-EPI. In the patient study, RS-EPI was found to provide significantly less distortion in almost all organs/lesions (p < 0.05), according to both semiquantitative scales and quantitative scores. There was no significant difference in ADC values and contrast-noise ratios between the two DWI techniques. The distortion in DWI was significantly reduced with RS-EPI in both phantom and patient studies. The RS-EPI technique provided more homogenous images than SS-EPI, and can potentially offer higher image quality in the head and neck area. aEuro cent The distortion in DWI is significantly reduced with RS-EPI compared with SS-EPI. aEuro cent Structures in the head and neck were identified more clearly using RS-EPI. aEuro cent No significant difference in ADC values was found between the techniques.	[Koyasu, Sho; Iima, Mami; Umeoka, Shigeaki; Morisawa, Nobuko; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, Kyoto 6068507, Japan; [Porter, David A.] Siemens AG, MED MR PLM AW Neurol, D-91052 Erlangen, Germany; [Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan; [Le Bihan, Denis] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Sakyo Ku, Kyoto 6068507, Japan; [Le Bihan, Denis] CEA Saclay Ctr, Neurospin, F-91191 Gif Sur Yvette, France	Umeoka, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	umeoka@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science	The authors of this manuscript declare relationships with the following companies: David A. Porter is an employee of Siemens AG, Erlangen, Germany. This study has received funding by a Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science (Sho Koyasu, Mami Iima). No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. None of study subjects or cohorts have been previously reported. Methodology: prospective, observational study, performed at one institution.	Habermann CR, 2009, AM J NEURORADIOL, V30, P591, DOI 10.3174/ajnr.A1412; Albergotti WG, 2012, LARYNGOSCOPE, V122, P1954, DOI 10.1002/lary.23396; Bogner W, 2012, RADIOLOGY, V263, P64, DOI 10.1148/radiol.12111494; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Chhabra A, 2011, AM J ROENTGENOL, V197, P583, DOI 10.2214/AJR.10.6012; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Kato H, 2011, J MAGN RESON IMAGING, V34, P904, DOI 10.1002/jmri.22729; Yabuuchi H, 2008, RADIOLOGY, V249, P909, DOI 10.1148/radiol.2493072045; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Iima M, 2014, INVEST RADIOL, V49, P485, DOI 10.1097/RLI.0000000000000040; Witt RL, 2002, LARYNGOSCOPE, V112, P2141, DOI 10.1097/00005537-200212000-00004; Yoshino N, 2001, RADIOLOGY, V221, P837, DOI 10.1148/radiol.2213010131; Forbes KP, 2002, RADIOLOGY, V225, P551, DOI 10.1148/radiol.2252011479; Eida S, 2007, AM J NEURORADIOL, V28, P116; Fleiss JL, 2003, STAT METHODS RATES P; HELLER KS, 1988, AM J SURG, V156, P294, DOI 10.1016/S0002-9610(88)80295-2; Iima M, 2012, AM J NEURORADIOL, V33, P1321, DOI 10.3174/ajnr.A2969; Juan CJ, 2009, RADIOLOGY, V253, P144, DOI 10.1148/radiol.2531082228; Klinke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031766; Lavdas I, 2013, J MAGN RESON IMAGING, V38, P173, DOI 10.1002/jmri.23950; O'Brien CJ, 2003, HEAD NECK-J SCI SPEC, V25, P946, DOI 10.1002/hed.10312; Parwani AV, 2003, CANCER CYTOPATHOL, V99, P166, DOI 10.1002/cncr.11207; Taha MS, 2013, EUR ARCH OTORHINOLAR, DOI 10.1007/s00405-013-2782-8; Takahara T, 2008, RADIOLOGY, V249, P653, DOI 10.1148/radiol.2492071826; Thoeny HC, 2004, J MAGN RESON IMAGING, V20, P786, DOI 10.1002/jmri.20196; Vandecaveye V, 2006, BRIT J RADIOL, V79, P681, DOI 10.1259/bjr/89661809; Yoshikawa T, 2006, RADIOGRAPHICS, V26, pS133, DOI 10.1148/rg.26si065511	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	DEC	2014	24	12					3088	3096		10.1007/s00330-014-3369-5		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT7TZ	WOS:000345141300012		
J	Gondo, T; Hricak, H; Sala, E; Zheng, JT; Moskowitz, CS; Bernstein, M; Eastham, JA; Vargas, HA				Gondo, Tatsuo; Hricak, Hedvig; Sala, Evis; Zheng, Junting; Moskowitz, Chaya S.; Bernstein, Melanie; Eastham, James A.; Vargas, Hebert Alberto			Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3+4 prostate cancer	EUROPEAN RADIOLOGY			English	Article						Prostate cancer; Active surveillance; Multiparametric MRI; Diffusion-weighted imaging; Dynamic contrast-enhanced MRI	ACTIVE SURVEILLANCE; LOW-RISK; GRADE; INTERMEDIATE; CANDIDATES; AGREEMENT; OUTCOMES; UPDATE; SYSTEM; MEN	The aim of this study was to assess the diagnostic performance of pre-treatment 3-Tesla (3T) multiparametric magnetic resonance imaging (mpMRI) for predicting Gleason score (GS) downgrading after radical prostatectomy (RP) in patients with GS 3 + 4 prostate cancer (PCa) on biopsy. We retrospectively reviewed 304 patients with biopsy-proven GS 3 + 4 PCa who underwent mpMRI before RP. On T2-weighted imaging and three mpMRI combinations (T2-weighted imaging + diffusion-weighted imaging [DWI], T2-weighted imaging + dynamic contrast-enhanced-MRI [DCE-MRI], and T2-weighted imaging + DWI + DCE-MRI), two radiologists (R1/R2) scored the presence of a dominant tumour using a 5-point Likert scale (1 = definitely absent to 5 = definitely present). Diagnostic performance in identifying downgrading was evaluated via areas under the curves (AUCs). Predictive accuracies of multivariate models were calculated. In predicting downgrading, T2-weighted imaging + DWI (AUC = 0.89/0.85 for R1/R2) performed significantly better than T2-weighted imaging alone (AUC = 0.72/0.73; p < 0.001/p = 0.02 for R1/R2), while T2-weighted imaging + DWI + DCE-MRI (AUC = 0.89/0.84 for R1/R2) performed no better than T2-weighted imaging + DWI (p = 0.48/p > 0.99 for R1/R2). On multivariate analysis, the clinical + mpMRI model incorporating T2-weighted imaging + DWI (AUC = 0.92/0.88 for R1/R2) predicted downgrading significantly better than the clinical model (AUC = 0.73; p < 0.001 for R1/R2). mpMRI improves the ability to identify a subgroup of patients with Gleason 3 + 4 PCa on biopsy who are candidates for active surveillance. DCE-MRI (compared to T2 + DWI) offered no additional benefit to the prediction of downgrading. aEuro cent Diagnostic performance of T2-weighted-imaging + DWI was better than T2-weighted-imaging alone. aEuro cent Diagnostic performance of T2-weighted-imaging + DWI was similar to T2-weighted-imaging + DWI + DCE-MRI. aEuro cent Combining clinical and T2-weighted-imaging + DWI features best predicted GS downgrading. aEuro cent mpMRI might prevent overtreatment by increasing eligibility for PCa active surveillance.	[Gondo, Tatsuo; Bernstein, Melanie; Eastham, James A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10065 USA; [Gondo, Tatsuo] Tokyo Med Univ, Dept Urol, Tokyo 1608402, Japan; [Hricak, Hedvig; Sala, Evis; Vargas, Hebert Alberto] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Zheng, Junting; Moskowitz, Chaya S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA	Vargas, HA (reprint author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10065 USA.	vargasah@mskcc.org			Sidney Kimmel Center for Prostate and Urologic Cancers	This work was supported by the Sidney Kimmel Center for Prostate and Urologic Cancers. We are grateful to Ada Muellner, M.S., for editing the manuscript.	Adam M, 2014, J UROL; Bjurlin MA, 2013, J UROLOGY, V189, P2039, DOI 10.1016/j.juro.2013.02.072; Klotz L, 2013, CURR OPIN ENDOCRINOL, V20, P204, DOI 10.1097/MED.0b013e328360332a; Lee DH, 2013, JPN J CLIN ONCOL, V43, P553, DOI 10.1093/jjco/hyt041; Turkbey B, 2013, RADIOLOGY, V268, P144, DOI 10.1148/radiol.13121325; Donati OF, 2013, RADIOLOGY, V268, P440, DOI 10.1148/radiol.13122149; Rosenkrantz AB, 2013, AM J ROENTGENOL, V201, pW612, DOI 10.2214/AJR.12.10173; Borofsky MS, 2013, UROLOGY, V81, P1279, DOI 10.1016/j.urology.2012.12.026; Vargas HA, 2012, RADIOLOGY, V265, P478, DOI 10.1148/radiol.12120041; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Hambrock T, 2011, RADIOLOGY, V259, P453, DOI 10.1148/radiol.11091409; Freedland SJ, 2007, UROLOGY, V69, P495, DOI 10.1016/j.urology.2006.10.036; Fridlyand J, 2013, NAT REV DRUG DISCOV, V12, P743, DOI 10.1038/nrd4101; Cooperberg MR, 2011, J CLIN ONCOL, V29, P228, DOI 10.1200/JCO.2010.31.4252; Tosoian JJ, 2013, J UROLOGY, V190, P1218, DOI 10.1016/j.juro.2013.04.071; Ross HM, 2012, AM J SURG PATHOL, V36, P1346, DOI 10.1097/PAS.0b013e3182556dcd; Lawrentschuk N, 2011, NAT REV UROL, V8, P312, DOI 10.1038/nrurol.2011.50; Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050; Bul M, 2012, BJU INT, V110, P1672, DOI 10.1111/j.1464-410X.2012.11434.x; Margel D, 2012, J UROLOGY, V187, P1247, DOI 10.1016/j.juro.2011.11.112; Moussa AS, 2009, BJU INT, V103, P43, DOI 10.1111/j.1464-410X.2008.08059.x; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Van der Kwast TH, 2013, NAT REV UROL, V10, P473, DOI 10.1038/nrurol.2013.112; Verma S, 2011, AM J ROENTGENOL, V196, P374, DOI 10.2214/AJR.10.4441; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Vargas HA, 2012, J UROLOGY, V188, P1732, DOI 10.1016/j.juro.2012.07.024; Donohue JF, 2006, J UROLOGY, V176, P991, DOI 10.1016/j.juro.2006.04.048; Eggener SE, 2013, J UROLOGY, V189, pS19, DOI 10.1016/j.juro.2012.11.023; LESAFFRE E, 1989, COMMUN STAT THEORY, V18, P2989, DOI 10.1080/03610928908830072; Mullins JK, 2013, BJU INT, V111, P1037, DOI 10.1111/j.1464-410X.2012.11641.x; Whitson JM, 2013, UROL ONCOL-SEMIN ORI, V31, P442, DOI 10.1016/j.urolonc.2011.02.010	32	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	DEC	2014	24	12					3161	3170		10.1007/s00330-014-3367-7		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT7TZ	WOS:000345141300020		
J	Kaneko, K; Choi, I; Nakagawa, M; Shinozaki, K; Uike, N				Kaneko, Koichiro; Choi, Ilseung; Nakagawa, Makoto; Shinozaki, Kenji; Uike, Naokuni			Does tumoral In-111-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing Y-90-ibritumomab radioimmunotherapy?	EUROPEAN RADIOLOGY			English	Article						Y-90-ibritumomab radioimmunotherapy; Pretreatment In-111-ibritumomab imaging; Tumoral In-111-ibritumomab accumulation; Therapeutic responses; Progression-free survival	NON-HODGKINS-LYMPHOMA; IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY; FOLLICULAR LYMPHOMA; TRIAL; RESPONSES	The aim of this study was to determine whether tumoral In-111-ibritumomab accumulation on pre-treatment imaging correlates with therapeutic responses and progression-free survival (PFS) in patients with non-Hodgkin's lymphoma (NHL) undergoing Y-90-ibritumomab radioimmunotherapy (RIT). This was a retrospective study of 39 patients with low-grade B-cell NHL treated with RIT. We classified the patients into positive and negative groups according to the presence or absence of tumoral In-111-ibritumomab accumulation on pre-treatment In-111-ibritumomab examinations. We then determined the correlation between the In-111-ibritumomab imaging findings and the patients' therapeutic responses and PFS. Tumoral In-111-ibritumomab accumulation was positive in 64.1 % and negative in 35.9 % of the patients. The In-111-positive patients had a significantly higher overall response rate (ORR) compared to the In-111-negative patients (100.0 % vs. 78.6 %, p = 0.02). The In-111-negative patients with advanced disease (stages III/IV) had a significantly lower ORR (40 %) and a significantly higher rate of progressive disease (40.0 %) compared to those of the In-111-negative patients with limited disease (stages I/II) (100 % and 0 %, p = 0.009 each). However, these two groups had similar 2-year PFS rates (65.0 % vs. 50.0 %, p = 0.80). In-111-ibritumomab imaging findings seem to correlate with ORR and the progressive disease rate after RIT, but not with PFS. aEuro cent All 39 NHL patients had tumoral accumulation on pretreatment FDG-PET/CT aEuro cent 64.1 % of NHL patients had tumoral accumulation on a pretreatment (111) In-ibritumomab examination aEuro cent (90) Y-ibritumomab RIT resulted in high overall response and complete remission rates aEuro cent (111) In-ibritumomab avidity of lymphoma lesions could predict a strong therapeutic effect aEuro cent (111) In-ibritumomab imaging findings did not correlate with progression-free survival.	[Kaneko, Koichiro; Shinozaki, Kenji] Natl Hosp Org, Dept Radiol, Kyushu Natl Canc Ctr, Minami Ku, Fukuoka 8111395, Japan; [Choi, Ilseung; Uike, Naokuni] Natl Hosp Org, Div Hematol, Kyushu Natl Canc Ctr, Minami Ku, Fukuoka 8111395, Japan; [Nakagawa, Makoto] Koga Hosp 21, PET Imaging Ctr, Kurume, Fukuoka 8390801, Japan	Kaneko, K (reprint author), Natl Hosp Org, Dept Radiol, Kyushu Natl Canc Ctr, Minami Ku, 3-3-1 Notame, Fukuoka 8111395, Japan.	kkaneko-kyu@umin.ac.jp					Andrade Campos MM, 2012, J ONCOL, DOI [10.1155/2012/412742, DOI 10.1155/2012/412742]; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Lopci E, 2012, EUR J NUCL MED MOL I, V39, P864, DOI 10.1007/s00259-012-2079-y; Wiseman GA, 2002, BLOOD, V99, P4336, DOI 10.1182/blood.V99.12.4336; Witzig TE, 2007, CANCER, V109, P1804, DOI 10.1002/cncr.22617; Conti PS, 2005, J NUCL MED, V46, P1812; Iagaru A, 2008, J NUCL MED, V49, P1809, DOI 10.2967/jnumed.108.052928; Witzig TE, 2002, J CLIN ONCOL, V20, P3262, DOI 10.1200/JCO.2002.11.017; CARBONE PP, 1971, CANCER RES, V31, P1860; Fisher RI, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.23797; Gokhale AS, 2005, INT J RADIAT ONCOL, V63, P194, DOI 10.1016/j.ijrobp.2005.01.017; Gordon LI, 2004, BLOOD, V103, P4429, DOI 10.1182/blood-2003-11-3883; Lopci E, 2010, ANN ONCOL, V21, P1877, DOI 10.1093/annonc/mdq024; Nakagawa M, 2012, JPN J RADIOL, V30, P642, DOI 10.1007/s11604-012-0103-6; Oriuchi Noboru, 2008, Kaku Igaku, V45, P99; Otte A, 2008, HELL J NUCL MED, V11, P12; Stevens Patrick L, 2012, Am J Blood Res, V2, P86; Witzig TE, 2002, J CLIN ONCOL, V20, P2453, DOI 10.1200/JCO.2002.11.076; Witzig TE, 1999, J CLIN ONCOL, V17, P3793; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4; Zinzani PL, 2010, CL LYMPH MYELOM LEUK, V10, P258, DOI 10.3816/CLML.2010.n.054	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	DEC	2014	24	12					3191	3198		10.1007/s00330-014-3378-4		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT7TZ	WOS:000345141300023		
J	Nakajo, M; Nakajo, M; Kajiya, Y; Goto, Y; Jinguji, M; Tanaka, S; Fukukura, Y; Tani, A; Higashi, M				Nakajo, Masatoyo; Nakajo, Masayuki; Kajiya, Yoriko; Goto, Yuko; Jinguji, Megumi; Tanaka, Sadao; Fukukura, Yoshihiko; Tani, Atsushi; Higashi, Michiyo			Correlations of F-18-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci	EUROPEAN RADIOLOGY			English	Article						Colorectal cancer; FLT; PET/CT; Ki-67; TK-1	POSITRON-EMISSION-TOMOGRAPHY; IMAGING PROLIFERATION; F-18-FLT PET; IN-VIVO; CELL-PROLIFERATION; THORACIC TUMORS; BREAST-CANCER; LUNG-TUMORS; TRACER; 3'-DEOXY-3'-F-18-FLUOROTHYMIDINE	To examine correlations of F-18-fluorothymidine (FLT) uptake with pathological tumour size and immunohistochemical Ki-67, and thymidine kinase 1 (TK-1) expressions in primary and metastatic node colorectal cancer foci. Thirty primary cancers (PCs) and 37 metastatic nodes (MNs) were included. FLT uptake was assessed by visual scores (non-visible: 0-1 and visible: 2-4), standardized uptake value (SUV), and correlated with size, Ki-67, and TK-1. SUV was measured in visible lesions. FLT heterogeneity was assessed by visual scores (no heterogeneous uptake: 0 and heterogeneous uptake: 1-4). Forty-two lesions were visible. The visible group showed significantly higher values than the non-visible group in size, Ki-67, and TK-1 (each p < 0.05). Size correlated significantly with visual score (PC; rho = 0.74 and MN; rho = 0.63), SUVmax (PC; rho = 0.49, and MN; rho = 0.76), and SUVmean (PC; rho = 0.40 and MN; rho = 0.76) (each p < 0.05). Visual score correlated significantly with size (rho = 0.86), Ki-67max (rho = 0.35), Ki-67mean (rho = 0.38), TK-1max (rho = 0.35) and TK-1mean (rho = 0.25) (each p < 0.05). No significant correlations were found between FLT uptake and Ki-67 or TK-1 in 42 visible lesions (each p > 0.05). Heterogeneous FLT uptake was noted in 73 % (22/30) of PCs. FLT uptake correlated with size. Heterogeneous FLT distribution in colorectal cancers may be one of the causes of weak or lack of FLT uptake/Ki-67 or TK-1 correlation. aEuro cent FLT uptake correlated well with tumour size in colorectal cancer aEuro cent Weak or lack of FLT uptake/Ki-67 and TK-1 correlations were observed aEuro cent Immunohistochemical Ki-67 and TK-1 expressions are not always correlated with FLT uptake.	[Nakajo, Masatoyo; Nakajo, Masayuki; Jinguji, Megumi; Fukukura, Yoshihiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima 8928512, Japan; [Nakajo, Masatoyo; Nakajo, Masayuki; Kajiya, Yoriko; Tani, Atsushi] Nanpuh Hosp, Dept Radiol, Kagoshima 8928512, Japan; [Goto, Yuko; Higashi, Michiyo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 8908544, Japan; [Tanaka, Sadao] Nanpuh Hosp, Dept Pathol, Kagoshima 8928512, Japan	Nakajo, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, 8-35-1 Sakuragaoka, Kagoshima 8928512, Japan.	toyo.nakajo@dolphin.ocn.ne.jp					Ullrich R, 2008, CLIN CANCER RES, V14, P2049, DOI 10.1158/1078-0432.CCR-07-1553; Vesselle H, 2002, CLIN CANCER RES, V8, P3315; Menda Y, 2009, J NUCL MED, V50, P1028, DOI 10.2967/jnumed.108.058495; Buck AK, 2003, J NUCL MED, V44, P1426; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433; Kim SJ, 2008, J NUCL MED, V49, P2057, DOI 10.2967/jnumed.108.053215; Westerterp M, 2007, EUR J NUCL MED MOL I, V34, P392, DOI 10.1007/s00259-006-0224-1; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Kenny LM, 2005, CANCER RES, V65, P10104, DOI 10.1158/0008-5472.CAN-04-4297; McKinley ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058938; Oh SJ, 2004, NUCL MED BIOL, V31, P803, DOI 10.1016/j.nucmedbio.2004.01.008; Wagner M, 2003, CANCER RES, V63, P2681; Krieger-Hinck N, 2006, ANTICANCER RES, V26, P3467; Hoshikawa H, 2011, MOL IMAGING BIOL, V13, P172, DOI 10.1007/s11307-010-0331-z; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Schwartz JL, 2003, J NUCL MED, V44, P2027; Tian JH, 2008, J NUCL MED, V49, P186, DOI 10.2967/jnumed.107.044966; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Rasey JS, 2002, J NUCL MED, V43, P1210; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; van Westreenen HL, 2005, J NUCL MED, V46, P400; Chen W, 2005, J NUCL MED, V46, P945; Apisarnthanarax S, 2006, CLIN CANCER RES, V12, P4590, DOI 10.1158/1078-0432.CCR-05-2720; Wang H, 2009, J NUCL MED, V50, P1857, DOI 10.2967/jnumed.109.064238; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Barthel H, 2005, EUR J NUCL MED MOL I, V32, P257, DOI 10.1007/s00259-004-1611-0; Brockenbrough J Scott, 2011, J Nucl Med, V52, P1181, DOI 10.2967/jnumed.111.089482; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Dittmann H, 2003, EUR J NUCL MED MOL I, V30, P1407, DOI 10.1007/s00259-003-1257-3; Francis DL, 2003, EUR J NUCL MED MOL I, V30, P988, DOI 10.1007/s00259-003-1187-0; HOANG C, 1989, VIRCHOWS ARCH A, V414, P423, DOI 10.1007/BF00718626; Kameyama R, 2009, EUR J NUCL MED MOL I, V36, P382, DOI 10.1007/s00259-008-0970-3; Krempser AR, 2013, ANN NUCL MED, V27, P924, DOI 10.1007/s12149-013-0773-x; Muijs CT, 2011, RADIOTHER ONCOL, V98, P357, DOI 10.1016/j.radonc.2010.12.008; Nakajo M, 2013, EUR J NUCL MED MOL I, V40, P1223, DOI 10.1007/s00259-013-2424-9; Simon Ronald, 2003, Expert Rev Mol Med, V5, P1; Smyczek-Gargya B, 2004, EUR J NUCL MED MOL I, V31, P720, DOI 10.1007/s00259-004-1462-8; Troost EGC, 2010, J NUCL MED, V51, P713, DOI 10.2967/jnumed.109.071910; Wieder HA, 2007, EUR J NUCL MED MOL I, V34, P878, DOI 10.1007/s00259-006-0292-2; Yamamoto Y, 2009, NUCL MED COMMUN, V30, P841, DOI 10.1097/MNM.0b013e328330294d; Yap CS, 2006, CHEST, V129, P393, DOI 10.1378/chest.129.2.393	41	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	DEC	2014	24	12					3199	3209		10.1007/s00330-014-3379-3		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT7TZ	WOS:000345141300024		
J	Omeri, AK; Okada, F; Takata, S; Ono, A; Nakayama, T; Ando, Y; Sato, H; Hiramatsu, K; Mori, H				Omeri, Ahmad Khalid; Okada, Fumito; Takata, Shoko; Ono, Asami; Nakayama, Tomoko; Ando, Yumiko; Sato, Haruka; Hiramatsu, Kazufumi; Mori, Hiromu			Comparison of high-resolution computed tomography findings between Pseudomonas aeruginosa pneumonia and Cytomegalovirus pneumonia	EUROPEAN RADIOLOGY			English	Article						Computed tomography; Pseudomonas aeruginosa; Cytomegalovirus (CMV) pneumonia; Nosocomial infection; Ventilator-associated pneumonia	VENTILATOR-ASSOCIATED PNEUMONIA; BONE-MARROW-TRANSPLANTATION; THIN-SECTION CT; IMMUNOCOMPROMISED PATIENTS; PULMONARY INFECTIONS; ACQUIRED PNEUMONIA; EXPRESSION; SPECTRUM; CULTURE	To compare pulmonary high-resolution CT (HRCT) findings in patients with Pseudomonas aeruginosa pneumonia to HRCT findings in patients with Cytomegalovirus (CMV) pneumonia. We studied 124 patients (77 men, 47 women; age range, 20-89 years; mean age, 65.4 years) with P. aeruginosa pneumonia and 44 patients (22 men, 22 women; age range, 36-86 years; mean age, 63.2 years) with CMV pneumonia. CT findings of consolidation (p < 0.005), bronchial wall thickening (p < 0.001), cavity (p < 0.05), and pleural effusion (p < 0.001) were significantly more frequent in patients with P. aeruginosa pneumonia than in those with CMV pneumonia. Centrilobular nodules, a crazy-paving appearance, and nodules were significantly more frequent in patients with CMV pneumonia than in those with P. aeruginosa pneumonia (all p < 0.001). Pulmonary HRCT findings, such as bronchial wall thickening, crazy-paving appearance, and nodules may be useful in distinguishing between P. aeruginosa pneumonia and CMV pneumonia. aEuro cent Distinguishing Pseudomonas aeruginosa pneumonia from Cytomegalovirus pneumonia is important. aEuro cent Characteristic features of underlying conditions are present in each pneumonia species. aEuro cent Bronchial wall thickening and cavities are more frequent in Pseudomonas aeruginosa pneumonia. aEuro cent Nodules and a crazy-paving appearance are more frequent in Cytomegalovirus pneumonia.	[Omeri, Ahmad Khalid; Okada, Fumito; Takata, Shoko; Ono, Asami; Sato, Haruka; Mori, Hiromu] Oita Univ, Dept Radiol, Fac Med, Oita 8795593, Japan; [Nakayama, Tomoko] Oita Red Cross Hosp, Dept Radiol, Oita, Japan; [Ando, Yumiko] Oita Nishibeppu Natl Hosp, Dept Radiol, Oita, Japan; [Hiramatsu, Kazufumi] Oita Univ Hosp, Hosp Infect Control Ctr, Oita, Japan	Omeri, AK (reprint author), Oita Univ, Dept Radiol, Fac Med, 1-1 Idaigaoka,Hasama Machi, Oita 8795593, Japan.	dr_ahmadkhalidomeri@yahoo.com					Angelici E, 1996, J MED MICROBIOL, V45, P149; Ichikado K, 2000, RADIOLOGY, V216, P531; Beardsley JR, 2006, CHEST, V130, P787, DOI 10.1378/chest.130.3.787; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; MCGUINNESS G, 1994, RADIOLOGY, V192, P451; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121; Takizawa Y, 2008, RHEUMATOLOGY, V47, P1373, DOI 10.1093/rheumatology/ken231; Florescu Diana F., 2011, Infectious Disorders - Drug Targets, V11, P354; Fagon JY, 1996, CLIN INFECT DIS, V23, P538; Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Arai Y, 2012, PATHOL INT, V62, P628, DOI 10.1111/j.1440-1827.2012.02849.x; Collins J, 2000, AM J ROENTGENOL, V175, P811; Demirkazik FB, 2008, DIAGN INTERV RADIOL, V14, P75; Escuissato DL, 2005, AM J ROENTGENOL, V185, P608; Gasparetto EL, 2004, BRIT J RADIOL, V77, P724, DOI 10.1259/bjr/70800575; Groskin SA, 1993, LUNG RADIOLOGIC PATH, P194; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Horger MS, 2006, AJR, V187, P636; IANNINI PB, 1974, JAMA-J AM MED ASSOC, V230, P558, DOI 10.1001/jama.230.4.558; Jokoh T, 1999, RADIOLOGY, V211, P155; Kang EY, 1996, J COMPUT ASSIST TOMO, V20, P295, DOI 10.1097/00004728-199603000-00024; Lipchik RJ, 1996, RADIOL CLIN N AM, V34, P47; Moon J H, 2000, Korean J Radiol, V1, P73; Muller NL, 2002, DIS LUNG RADIOLOGIC, P66; Okada F, 2012, BRIT J RADIOL, V85, P1533, DOI 10.1259/bjr/54468236; PENNINGT.JE, 1973, AM J MED, V55, P155, DOI 10.1016/0002-9343(73)90163-0; RENNER RR, 1972, RADIOLOGY, V105, P555; Robinson TE, 2009, PEDIATR PULM, V44, P1107, DOI 10.1002/ppul.21107; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1089; Shah RM, 2002, J THORAC IMAG, V17, P53, DOI 10.1097/00005382-200201000-00007; Tanaka N, 1996, J COMPUT ASSIST TOMO, V20, P600, DOI 10.1097/00004728-199607000-00019; Vogel MN, 2007, BRIT J RADIOL, V80, P516, DOI 10.1259/bjr/39696316; Watanabe A, 2008, INTERNAL MED, V47, P215; WINERMURAM HT, 1995, RADIOLOGY, V195, P247; Worthy SA, 1997, RADIOGRAPHICS, V17, P1359	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	DEC	2014	24	12					3251	3259		10.1007/s00330-014-3326-3		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT7TZ	WOS:000345141300030		
J	Yamasaki, Y; Nagao, M; Yamamura, K; Yonezawa, M; Matsuo, Y; Kawanami, S; Kamitani, T; Higuchi, K; Sakamoto, I; Shiokawa, Y; Yabuuchi, H; Honda, H				Yamasaki, Yuzo; Nagao, Michinobu; Yamamura, Kenichiro; Yonezawa, Masato; Matsuo, Yoshio; Kawanami, Satoshi; Kamitani, Takeshi; Higuchi, Ko; Sakamoto, Ichiro; Shiokawa, Yuichi; Yabuuchi, Hidetake; Honda, Hiroshi			Quantitative assessment of right ventricular function and pulmonary regurgitation in surgically repaired tetralogy of Fallot using 256-slice CT: comparison with 3-Tesla MRI	EUROPEAN RADIOLOGY			English	Article						Tetralogy of Fallot; Right ventricular function; Pulmonary regurgitation; Multislice computed tomography; Magnetic resonance imaging	CONGENITAL HEART-DISEASE; CARDIAC COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; VALVE-REPLACEMENT; CORONARY-ANGIOGRAPHY; IMAGE QUALITY; 3.0 TESLA; ECHOCARDIOGRAPHY; REPRODUCIBILITY; GUIDELINES	To compare 256-slice cardiac computed tomography (CCT) with cardiac magnetic resonance (CMR) imaging to assess right ventricular (RV) function and pulmonary regurgitant fraction (PRF) in patients with repaired tetralogy of Fallot (TOF). Thirty-three consecutive patients with repaired TOF underwent retrospective ECG-gated CCT and 3-Tesla CMR. RV and left ventricular (LV) end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV) and ejection fraction (EF) were measured using CCT and CMR. PRF-CCT (%) was defined as (RVSV -aEuro parts per thousand LVSV)/RVSV. PRF-CMR (%) was measured by the phase-contrast method. Repeated measurements were performed to determine intra- and interobserver variability. CCT measurements, including PRF, correlated highly with the CMR reference (r = 0.71-0.96). CCT overestimated RVEDV (mean difference, 17.1 +/- 2.9 ml), RVESV (12.9 +/- 2.1 ml) and RVSV (4.2 +/- 2.0 ml), and underestimated RVEF (-2.6 +/- 1.0 %) and PRF (-9.1 +/- 2.0 %) compared with CMR. The limits of agreement between CCT and CMR were in a good range for all measurements. The variability in CCT measurements was lower than those in CMR. The estimated effective radiation dose was 7.6 +/- 2.6 mSv. 256-slice CCT can assess RV function and PRF with relatively low dose radiation exposure in patients with repaired TOF, but overestimates RV volume and underestimates PRF. aEuro cent 256-slice CT assessment of RV function is highly reproducible in repaired TOF. aEuro cent Pulmonary regurgitation can be evaluated by biventricular systolic volume difference. aEuro cent CT overestimates RV volume and underestimates pulmonary regurgitation, compared with MRI.	[Yamasaki, Yuzo; Yonezawa, Masato; Matsuo, Yoshio; Kamitani, Takeshi; Higuchi, Ko; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Nagao, Michinobu; Kawanami, Satoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, Fukuoka 8128582, Japan; [Yamamura, Kenichiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Higashi Ku, Fukuoka 8128582, Japan; [Sakamoto, Ichiro] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Higashi Ku, Fukuoka 8128582, Japan; [Shiokawa, Yuichi] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Higashi Ku, Fukuoka 8128582, Japan; [Yabuuchi, Hidetake] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan	Nagao, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Imaging & Diag, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	minagao@radiol.med.kyushu-u.ac.jp			Bayer Healthcare Japan, Modest, Research Grant; Philips Electronics Japan, Modest, Research Grant; Japan Society for the Promotion of Science (JSPS) KAKENHI [25461831]	The scientific guarantor of this publication is Hiroshi Honda. The authors of this manuscript declare relationships with the following companies: Nagao M. and Kawanami S: Bayer Healthcare Japan, Modest, Research Grant; Philips Electronics Japan, Modest, Research Grant; Higuchi K.: Philips Electronics Japan, Employee. This study has received funding by the Japan Society for the Promotion of Science (JSPS) KAKENHI (25461831). No complex statistical methods were necessary for this paper. Institutional review board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: prospective, diagnostic study, performed at one institution.	Ammash Naser M, 2007, Congenit Heart Dis, V2, P386, DOI 10.1111/j.1747-0803.2007.00131.x; Mooij CF, 2008, J MAGN RESON IMAGING, V28, P67, DOI 10.1002/jmri.21407; Mercer-Rosa L, 2012, CIRC-CARDIOVASC IMAG, V5, P637, DOI 10.1161/CIRCIMAGING.112.972588; Gutberlet M, 2006, INVEST RADIOL, V41, P154, DOI 10.1097/01.rli.0000195840.50230.10; Oda S, 2011, ACAD RADIOL, V18, P991, DOI 10.1016/j.acra.2011.03.007; Alfakih K, 2003, J MAGN RESON IMAGING, V18, P25, DOI 10.1002/jmri.10329; Lee C, 2012, J AM COLL CARDIOL, V60, P1005, DOI 10.1016/j.jacc.2012.03.077; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Hou Y, 2012, AM J ROENTGENOL, V199, P588, DOI 10.2214/AJR.11.7557; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Maffei E, 2012, EUR RADIOL, V22, P1041, DOI 10.1007/s00330-011-2345-6; Lotz J, 2005, J MAGN RESON IMAGING, V21, P604, DOI 10.1002/jmrt.20275; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Seneviratne SK, 2010, CIRC-CARDIOVASC IMAG, V3, P375, DOI 10.1161/CIRCIMAGING.109.892638; Guo YK, 2010, INT J CARDIOL, V139, P254, DOI 10.1016/j.ijcard.2008.10.031; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690; van Straten A, 2004, RADIOLOGY, V233, P824, DOI 10.1148/radiol.2333030804; Kerl JM, 2008, RADIOLOGY, V247, P356, DOI 10.1148/radiol.2472070856; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Jensen CJ, 2010, EUR J RADIOL, V74, P484, DOI 10.1016/j.ejrad.2009.03.027; Kondo M, 2014, ACAD RADIOL, V21, P648, DOI 10.1016/j.acra.2014.01.022; Michaely HJ, 2006, INVEST RADIOL, V41, P133, DOI 10.1097/01.rli.0000192023.96494.af; Mueller M, 2010, EUR J ECHOCARDIOGR, V11, P786, DOI 10.1093/ejechocard/jeq067; Ochiai R, 2011, CIRC J, V75, P2220, DOI 10.1253/circj.CJ-10-1209; Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X; Takx RAP, 2012, EUR J RADIOL, V81, pE598, DOI 10.1016/j.ejrad.2011.07.001	28	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	DEC	2014	24	12					3289	3299		10.1007/s00330-014-3344-1		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT7TZ	WOS:000345141300034		
J	de Kleuver, M; Lewis, SJ; Germscheid, NM; Kamper, SJ; Alanay, A; Berven, SH; Cheung, KM; Ito, M; Lenke, LG; Polly, DW; Qiu, Y; van Tulder, M; Shaffrey, C				de Kleuver, Marinus; Lewis, Stephen J.; Germscheid, Niccole M.; Kamper, Steven J.; Alanay, Ahmet; Berven, Sigurd H.; Cheung, Kenneth M.; Ito, Manabu; Lenke, Lawrence G.; Polly, David W.; Qiu, Yong; van Tulder, Maurits; Shaffrey, Christopher			Optimal surgical care for adolescent idiopathic scoliosis: an international consensus	EUROPEAN SPINE JOURNAL			English	Review						Adolescent idiopathic scoliosis; Surgery; Optimal care; Delphi; Consensus	PEDICLE SCREW INSTRUMENTATION; SPINAL DEFORMITY SURGERY; HALO-FEMORAL TRACTION; PULMONARY-FUNCTION; CURVE CORRECTION; TRANSFUSION REQUIREMENTS; HYBRID INSTRUMENTATION; FUSION SURGERY; ANCHOR DENSITY; FOLLOW-UP	The surgical management of adolescent idiopathic scoliosis (AIS) has seen many developments in the last two decades. Little high-level evidence is available to support these changes and guide treatment. This study aimed to identify optimal operative care for adolescents with AIS curves between 40A degrees and 90A degrees Cobb angle. From July 2012 to April 2013, the AOSpine Knowledge Forum Deformity performed a modified Delphi survey where current expert opinion from 48 experienced deformity surgeons, representing 29 diverse countries, was gathered. Four rounds were performed: three web-based surveys and a final face-to-face meeting. Consensus was achieved with a parts per thousand yen70 % agreement. Data were analyzed qualitatively and quantitatively. Consensus of what constitutes optimal care was reached on greater than 60 aspects including: preoperative radiographs; posterior as opposed to anterior (endoscopic) surgical approaches; use of intraoperative spinal cord monitoring; use of local autologous bone (not iliac crest) for grafts; use of thoracic and lumbar pedicle screws; use of titanium anchor points; implant density of < 80 % for 40A degrees-70A degrees curves; and aspects of postoperative care. Variability in practice patterns was found where there was no consensus. In addition, there was consensus on what does not constitute optimal care, including: routine pre- and intraoperative traction; routine anterior release; use of bone morphogenetic proteins; and routine postoperative CT scanning. International consensus was found on many aspects of what does and does not constitute optimal operative care for adolescents with AIS. In the absence of current high-level evidence, at present, these expert opinion findings will aid health care providers worldwide define appropriate care in their regions. Areas with no consensus provide excellent insight and priorities for future research.	[de Kleuver, Marinus] Vrije Univ Amsterdam, Med Ctr, Dept Orthopaed Surg, NL-1081 HZ Amsterdam, Netherlands; [Lewis, Stephen J.] Toronto Western Hosp, Dept Surg, Toronto, ON M5T 2S8, Canada; [Germscheid, Niccole M.] AOSpine Int, Res Dept, Davos, Switzerland; [Kamper, Steven J.] Univ Sydney, George Inst, Musculoskeletal Div, Sydney, NSW 2006, Australia; [Alanay, Ahmet] Istanbul Bilim Univ, Sch Med, Dept Orthopaed & Traumatol, Istanbul, Turkey; [Berven, Sigurd H.] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Cheung, Kenneth M.] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Ito, Manabu] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Lenke, Lawrence G.] Washington Univ, Dept Orthopaed Surg, St Louis, MO USA; [Polly, David W.] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Qiu, Yong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Spine Surg, Nanjing 210008, Jiangsu, Peoples R China; [van Tulder, Maurits] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Shaffrey, Christopher] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA	de Kleuver, M (reprint author), Vrije Univ Amsterdam, Med Ctr, Dept Orthopaed Surg, De Boelelaan 1117, NL-1081 HZ Amsterdam, Netherlands.	m.dekleuver@vumc.nl	Alanay, Ahmet/D-7634-2015		AOSpine International through the AOSpine Knowledge Forum Deformity; AOSpine International	This study received financial support from AOSpine International through the AOSpine Knowledge Forum Deformity. All co-authors and invited panelists, disclose that they were provided with only necessary travel funds from the study sponsor (AOSpine International) to participate in the final consensus meeting which was integral to the study design. No other funding was received by any of the authors.	Anand N, 1998, J SPINAL DISORD, V11, P532; Bharucha NJ, 2013, SPINE J, V13, P375, DOI 10.1016/j.spinee.2012.05.029; Clements DH, 2009, SPINE, V34, P2147, DOI 10.1097/BRS.0b013e3181adb35d; Roussouly P, 2013, EUR SPINE J, V22, pS203, DOI 10.1007/s00586-012-2571-x; Takahashi J, 2010, SPINE, V35, P347, DOI 10.1097/BRS.0b013e3181b77f0a; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Helgeson MD, 2010, SPINE, V35, P177, DOI 10.1097/BRS.0b013e3181c77f8c; Horton WC, 2005, SPINE, V30, P427, DOI 10.1097/01.brs.0000153698.94091.f8; Daffner SD, 2010, SPINE, V35, P1165, DOI 10.1097/BRS.0b013e3181d88e78; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169; Quan GMY, 2010, SPINE, V35, P562, DOI 10.1097/BRS.0b013e3181b4af34; Hempfing A, 2007, EUR SPINE J, V16, P515, DOI 10.1007/s00586-006-0229-2; Gebhart S, 2014, SPINE, V39, pE104, DOI 10.1097/BRS.0000000000000075; Yang S, 2011, EUR SPINE J, V20, P1039, DOI 10.1007/s00586-011-1808-4; Fischer CR, 2011, EUR SPINE J, V20, P1048, DOI 10.1007/s00586-011-1730-9; Langeloo DD, 2003, SPINE, V28, P1043, DOI 10.1097/00007632-200305150-00017; Hamzaoglu A, 2008, SPINE, V33, P979, DOI 10.1097/BRS.0b013e31816c8b17; Ughwanogho E, 2012, SPINE, V37, pE473, DOI 10.1097/BRS.0b013e318238bbd9; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Aubin CE, 2007, EUR SPINE J, V16, P57, DOI 10.1007/s00586-006-0063-6; Vedantam R, 2000, SPINE, V25, P82, DOI 10.1097/00007632-200001010-00015; Pastorelli F, 2011, EUR SPINE J, V20, P105, DOI 10.1007/s00586-011-1756-z; Thuet ED, 2010, SPINE, V35, P1880, DOI 10.1097/BRS.0b013e3181e53434; Sakai Y, 2008, J SPINAL DISORD TECH, V21, P181, DOI 10.1097/BSD.0b013e318074d388; Bowen RE, 2010, SPINE, V35, P246, DOI 10.1097/BRS.0b013e3181bdf22a; Blank J, 2003, J SPINAL DISORD TECH, V16, P508, DOI 10.1097/00024720-200312000-00004; Chen JY, 2013, SPINE, V38, pE946, DOI 10.1097/BRS.0b013e318297bfd4; Clement JL, 2013, EUR SPINE J, V22, P2414, DOI 10.1007/s00586-013-2852-z; Copley LAB, 1999, SPINE, V24, P219, DOI 10.1097/00007632-199902010-00005; Crawford AH, 2013, SPINE, V38, P1199, DOI 10.1097/BRS.0b013e31828ce597; Diab M, 2012, SPINE, V37, P966, DOI 10.1097/BRS.0b013e31823bbf0b; DODD CAF, 1988, J BONE JOINT SURG BR, V70, P431; Dold A, 2012, CAN J SUR S, V3, pS38, DOI [10.1503/cjs.012212, DOI 10.1503/CJS.012212]; Ersen Omer, 2012, Musculoskelet Surg, V96, P107, DOI 10.1007/s12306-012-0203-6; Fletcher ND, 2012, SPINE, V37, P200, DOI 10.1097/BRS.0b013e318216106c; Greggi T, 2010, J SPINAL DISORD TECH, V23, pE63, DOI 10.1097/BSD.0b013e3181d268b9; Halanski MA, 2013, J SPINAL DISORD TECH, V26, P252, DOI 10.1097/BSD.0b013e318241e3cf; Hassan N, 2011, TRANSFUSION, V51, P2133, DOI 10.1111/j.1537-2995.2011.03175.x; Huang TH, 2014, SPINE J, V14, P1545, DOI 10.1016/j.spinee.2013.09.026; Hung HL, 2008, EVAL PROGRAM PLANN, V31, P191, DOI 10.1016/j.evalprogplan.2008.02.005; Ilharreborde B, 2008, J PEDIATR ORTHOPED, V28, P347, DOI 10.1097/BPO.0b013e318168d1d4; Jain A, 2013, J BONE JOINT SURG AM, V95A, P1265, DOI [10.2106/JBJS.L.01118, 10.2106/JBJS.L01118]; Jaquith Bradley P, 2012, J Child Orthop, V6, P137, DOI 10.1007/s11832-012-0400-8; Lamerain M, 2014, EUR SPINE J, V23, P1190, DOI 10.1007/s00586-014-3168-3; Larson AN, 2014, SPINE, V39, P571, DOI 10.1097/BRS.0000000000000204; Lewis SJ, 2011, SPINE, V36, P1627, DOI 10.1097/BRS.0b013e318216124e; Mac-Thiong JM, 2004, SPINE, V29, P1549, DOI 10.1097/01.BRS.0000131421.66635.AF; Min K, 2013, EUR SPINE J, V22, P345, DOI 10.1007/s00586-012-2533-3; Mollmann M, 2007, BRIT J ANAESTH, V99, P597, DOI 10.1093/bja/aem248; Newton PO, 2003, SPINE, V28, pS249, DOI 10.1097/01.BRS.0000092475.04293.F5; Prince DE, 2014, J PEDIATR ORTHOPED, V34, P22, DOI 10.1097/BPO.0b013e318288b3c1; Roach JW, 2011, J PEDIATR ORTHOPED, V31, pS77, DOI 10.1097/BPO.0b013e3181f73bfd; Salmingo RA, 2013, CLIN BIOMECH, V28, P122, DOI 10.1016/j.clinbiomech.2012.12.001; Suk SI, 2008, SPINE, V33, P1061, DOI 10.1097/BRS.0b013e31816f2888; Wang XY, 2012, EUR SPINE J, V21, P1082, DOI 10.1007/s00586-011-2089-7; Yaszay B, 2009, J SPINAL DISORD TECH, V22, P278, DOI 10.1097/BSD.0b013e31816d2530; Yilmaz G, 2012, J PEDIATR ORTHOPED, V32, P490, DOI 10.1097/BPO.0b013e318250c629; Zhang HQ, 2011, INT ORTHOP, V35, P1037, DOI 10.1007/s00264-010-1111-8	58	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2014	23	12					2603	2618		10.1007/s00586-014-3356-1		16	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU0SC	WOS:000345333500005		
J	Takahashi, J; Ikegami, S; Kuraishi, S; Shimizu, M; Futatsugi, T; Kato, H				Takahashi, Jun; Ikegami, Shota; Kuraishi, Shuugo; Shimizu, Masayuki; Futatsugi, Toshimasa; Kato, Hiroyuki			Skip pedicle screw fixation combined with Ponte osteotomy for adolescent idiopathic scoliosis	EUROPEAN SPINE JOURNAL			English	Article						Adolescent idiopathic scoliosis; Ponte osteotomy; Correction rate; Thoracic kyphosis; Rod material	SCHEUERMANNS KYPHOSIS; POSTERIOR; INSTRUMENTATION	This study aimed to determine whether Ponte osteotomy combined with skip pedicle screw fixation (SPSF) can improve the correction rate and restore thoracic kyphosis for patients with adolescent idiopathic scoliosis. Surgical time, blood loss, preoperative Cobb angle of the main thoracic curve, flexibility, Cobb angle at 1 year after surgery, thoracic curve correction rate, and Cincinnati correction index (CCI) were determined for both the Ponte (n = 17) and non-Ponte (control; n = 21) groups. Furthermore, kyphotic angles at T5-T12 before and 1 year after the surgery were measured. The following measurements were obtained for the Ponte and control groups, respectively: surgical time, 236 +/- A 13 and 187 +/- A 9 min; blood loss, 1,141 +/- A 150 and 745 +/- A 120 g; preoperative Cobb angle of the main thoracic curve, 52.5A degrees A A +/- A 10.4A degrees and 51.5A degrees A A +/- A 9.2A degrees; flexibility, 31.7 +/- A 13.2 and 45.1 +/- A 12.3 % (p = 0.003); thoracic curve correction rate, 62.0 +/- A 2.5 and 63.6 +/- A 2.5 %; CCI, 2.2 +/- A 0.2 and 1.5 +/- A 0.1 (p = 0.003); preoperative kyphotic angle at T5-T12, 11.3A degrees A A +/- A 11.2A degrees and 13.0A degrees A A +/- A 9.0A degrees; and kyphotic angle at T5-T12 at 1 year after the surgery, 21.8A degrees A A +/- A 1.7A degrees and 24.2A degrees A A +/- A 1.9A degrees. Ponte osteotomy was combined with SPSF in case of rigid curve. CCI was significantly greater in the Ponte group. Postoperative thoracic kyphotic angles were identical in both groups.	[Takahashi, Jun; Ikegami, Shota; Kuraishi, Shuugo; Shimizu, Masayuki; Futatsugi, Toshimasa; Kato, Hiroyuki] Shinshu Univ, Sch Med, Dept Orthopaed Surg, Nagano 3908621, Japan	Takahashi, J (reprint author), Shinshu Univ, Sch Med, Dept Orthopaed Surg, Matsumotoshi Asahi 3-1-1, Nagano 3908621, Japan.	jtaka@shinshu-u.ac.jp					Vora V, 2007, SPINE, V32, P1869, DOI 10.1097/BRS.0b013e318108b912; Takahashi J, 2010, SPINE, V35, P347, DOI 10.1097/BRS.0b013e3181b77f0a; Quan GMY, 2010, SPINE, V35, P562, DOI 10.1097/BRS.0b013e3181b4af34; Hempfing A, 2007, EUR SPINE J, V16, P515, DOI 10.1007/s00586-006-0229-2; Cheung KMC, 2010, J BONE JOINT SURG AM, V92A, P169, DOI 10.2106/JBJS.H.01831; El Masry MA, 2007, EUR SPINE J, V16, P1600, DOI 10.1007/s00586-007-0411-1; Geck MJ, 2007, J SPINAL DISORD TECH, V20, P586; Halanski MA, 2013, J SPINAL DISORD TECH, V26, P252, DOI 10.1097/BSD.0b013e318241e3cf; Lonner BS, 2007, SPINE, V32, P2644; Mukaiyama K, 2013, J ORTHOP SCI, V18, P687, DOI 10.1007/s00776-013-0424-z; Newton PO, 2010, SPINE, V35, P1365, DOI 10.1097/BRS.0b013e3181dccd63; Shah SA, 2013, SPINE DEFORMITY, V1, P196, DOI DOI 10.1016/J.JSPD.2013.03.002; SUK SI, 1995, SPINE, V20, P1399, DOI 10.1097/00007632-199506000-00012; Zhang Guoying, 2012, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V26, P1197	14	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2014	23	12					2689	2695		10.1007/s00586-014-3505-6		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU0SC	WOS:000345333500014		
J	Omi, H; Yokoyama, T; Ono, A; Numasawa, T; Wada, K; Fujisawa, Y				Omi, Hirotsugu; Yokoyama, Toru; Ono, Atsushi; Numasawa, Takuya; Wada, Kanichiro; Fujisawa, Yoichi			Can MRI predict subsequent pseudarthrosis resulting from osteoporotic thoracolumbar vertebral fractures?	EUROPEAN SPINE JOURNAL			English	Article						Short inversion time inversion-recovery (STIR); Magnetic resonance imaging (MRI); Osteoporotic vertebral fracture; Bone union; Kyphosis	RANDOMIZED-TRIAL; VACUUM; VERTEBROPLASTY; PSEUDARTHROSIS; COLLAPSE; CLEFT; SPINE; WOMEN	The purpose of this study was to assess the ability of short inversion time inversion-recovery (STIR) in magnetic resonance imaging for predicting the prognosis of osteoporotic vertebral fractures. We analyzed 63 vertebrae of 56 patients who had osteoporotic vertebral fracture (Th10-L2) prospectively. Image finding of a homogeneous high signal change on a fractured vertebra was evaluated and all vertebrae were divided into "homogenous high signal change group" or "non-homogenous high signal change group". On the other hand, image finding of linear black signal area was evaluated and all vertebrae were divided into "linear black signal area group" or "non-linear black signal area group". Sixteen and 24 vertebrae were included in the homogenous high signal change group or the linear black signal area group, respectively. The 16 homogenous high signal change cases did not result in non-union, and 47 non-homogenous high signal change cases resulted in 14 non-unions, a significant difference. Twenty-four linear black signal area and 39 non-linear black signal area cases resulted in 10, and 4 non-unions, respectively, also a significant difference. The kyphosis progression rate of the linear black signal area group (mean 35 %) was significantly higher than that of non-linear black signal area group (mean 23 %). The visual analog scale of back pain of the linear black signal area group (mean 35 mm) was significantly higher than that of the non-linear black signal area group (mean 23 mm). STIR was useful for predicting bone union, kyphosis, and back pain in patients with osteoporotic vertebral fracture.	[Omi, Hirotsugu] Takaoka Seishikai Orthopaed Hosp, Takaoka, Toyama 9330039, Japan; [Yokoyama, Toru; Fujisawa, Yoichi] Odate Municipal Gen Hosp, Dept Orthopaed Surg, Odate, Akita, Japan; [Ono, Atsushi; Wada, Kanichiro] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Hirosaki, Aomori, Japan; [Numasawa, Takuya] Publ Noheji Hosp, Dept Orthopaed Surg, Aomori, Japan	Omi, H (reprint author), Takaoka Seishikai Orthopaed Hosp, Oote Machi 8-31, Takaoka, Toyama 9330039, Japan.	omi0403@gmail.com					Hasegawa K, 1998, SPINE, V23, P2201, DOI 10.1097/00007632-199810150-00011; Yu CW, 2007, AM J NEURORADIOL, V28, P42; Kallmes DF, 2009, NEW ENGL J MED, V361, P569, DOI 10.1056/NEJMoa0900563; Linn J, 2009, SPINE, V34, pE88, DOI 10.1097/BRS.0b013e318193ca06; Mirovsky Y, 2005, AM J NEURORADIOL, V26, P1634; Buchbinder R, 2009, NEW ENGL J MED, V361, P557, DOI 10.1056/NEJMoa0900429; Edidin AA, 2011, J BONE MINER RES, V26, P1617, DOI 10.1002/jbmr.353; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Theodorou DJ, 2001, RADIOLOGY, V221, P787, DOI 10.1148/radiol.2213991129; BABA H, 1995, PARAPLEGIA, V33, P281; Ito Z, 2006, OSTEOPOROSIS INT, V17, P1584, DOI 10.1007/s00198-006-0123-0; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Spiegl UJA, 2009, EUR SPINE J, V18, P1287, DOI 10.1007/s00586-009-1045-2; Tsujio T, 2011, SPINE, V36, P1229, DOI 10.1097/BRS.0b013e3181f29e8d; Harada A, 2010, J ORTHOP SCI, V15, P79, DOI 10.1007/s00776-009-1411-2; Hashidate H, 2006, J ORTHOP SCI, V11, P28, DOI 10.1007/s00776-005-0967-8; Kado DM, 2009, ANN INTERN MED, V150, P681; Kanchiku T, 2014, J SPINAL DISORD TECH, V27, pE61, DOI 10.1097/BSD.0b013e318292b509; Kanchiku Tsukasa, 2003, J Orthop Sci, V8, P463, DOI 10.1007/s00776-003-0665-3; Kanchiku T, 2003, SPINE, V28, P2522, DOI 10.1097/01.BRS.0000092384.29767.85; Lin WC, 2011, SPINE, V36, P1244, DOI 10.1097/BRS.0b013e3181eb9b6c; Niimi R, 2014, OSTEOPOROSIS INT, V25, P605, DOI 10.1007/s00198-013-2456-9	22	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	DEC	2014	23	12					2705	2710		10.1007/s00586-014-3490-9		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	AU0SC	WOS:000345333500017		
J	Ando, K; Nishimura, R; Seo, C; Tsujino, D; Sakamoto, M; Utsunomiya, K				Ando, Kiyotaka; Nishimura, Rimei; Seo, Chiaki; Tsujino, Daisuke; Sakamoto, Masaya; Utsunomiya, Kazunori			Comparing postprandial efficacy in type 2 diabetic patients receiving mitiglinide and sitagliptin by using continuous glucose monitoring: a pilot study	EXPERT OPINION ON PHARMACOTHERAPY			English	Review						clinical trial; continuous glucose monitoring; mitiglinide; postprandial glucose; sitagliptin; type 2 diabetes	DIPEPTIDYL PEPTIDASE-4 INHIBITOR; INSULIN-SECRETION; MELLITUS; HYPERGLYCEMIA; TOLERANCE; MORTALITY	Objective: To compare postprandial efficacy in type 2 diabetic patients given mitiglinide and sitagliptin, both of which are known to improve postprandial hyperglycemia, by using continuous glucose monitoring (CGM). Methods: Eleven patients with type 2 diabetes were given mitiglinide 10 mg three times a daily or sitagliptin 50 mg once a day for 1 month and were hospitalized for 4 days and evaluated by CGM. On discharge, they were crossed over to the other regimen for 1 month of treatment/4 days of evaluation. The CGM data were used to compare each parameter for glycemic variability. Results: The patients were 60 +/- 10 (mean +/- SD) years old, and had HbA1c value 7.3 +/- 0.9%. The pre-meal glucose levels before lunch were significantly lower with mitiglinide than with sitagliptin (116 +/- 26/131 +/- 34 mg/dl, p = 0.022). The AUC measuring over 140 mg/dl 3 h after breakfast (mitiglinide 4812 +/- 4219/sitagliptin 7807 +/- 6391 mg/dl +/- min, p = 0.042) and lunch (mitiglinide 5658 +/- 5856/sitagliptin 8492 +/- 7161, p = 0.050) was significantly lower with mitiglinide than with sitagliptin. Conclusions: A CGM-based comparison showed that mitiglinide and sitagliptin were different in their glucose-lowering effects, where mitiglinide significantly improved hyperglycemia after breakfast and lunch, and significantly lowered pre-meal glucose levels before lunch, compared to sitagliptin.	[Ando, Kiyotaka; Nishimura, Rimei; Seo, Chiaki; Tsujino, Daisuke; Sakamoto, Masaya; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Div Dept Internal Med, Minato Ku, Tokyo 1058471, Japan; [Nishimura, Rimei] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Nishimura, R (reprint author), Jikei Univ, Sch Med, Div Dept Internal Med, Minato Ku, 3-19-18 Nishishimbashi, Tokyo 1058471, Japan.	rimei@jikei.ac.jp			Kissei; MSD	R Nishimura, D Tsujino, M Sakamoto and K Utsunomiya have received speaking fees from Kissei, Ono and MSD. K Ando has received speaking fees from Kissei. C Seo has received speaking fees from MSD. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Esposito K, 2004, CIRCULATION, V110, P214, DOI 10.1161/01.CIR.0000134501.57864.66; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Reimann F, 2001, BRIT J PHARMACOL, V132, P1542, DOI 10.1038/sj.bjp.0703962; Boyne MS, 2003, DIABETES, V52, P2790, DOI 10.2337/diabetes.52.11.2790; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; SERVICE FJ, 1970, DIABETES, V19, P644; Scheen AJ, 2010, DIABETES OBES METAB, V12, P648, DOI 10.1111/j.1463-1326.2010.01212.x; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Cherrington AD, 2009, FRONT BIOSCI-LANDMRK, V14, P1169; Cheyne E H, 2002, Diabetes Technol Ther, V4, P607, DOI 10.1089/152091502320798222; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Borch-Johnsen K, 1999, LANCET, V354, P617; Herman GA, 2011, BRIT J CLIN PHARMACO, V71, P429, DOI 10.1111/j.1365-2125.2010.03852.x; Iwamoto Y, 2010, ENDOCR J, V57, P383; Jung JA, 2013, ADV THER, V30, P1018, DOI 10.1007/s12325-013-0072-x; Malaisse Willy J, 2003, Treat Endocrinol, V2, P401, DOI 10.2165/00024677-200302060-00004; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Sanusi Himawan, 2009, Acta Med Indones, V41, P205; Seo C, 2013, DIABETES TECHNOL THE, V15, P378, DOI 10.1089/dia.2012.0262	22	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-6566	1744-7666		EXPERT OPIN PHARMACO	Expert Opin. Pharmacother.	DEC	2014	15	17					2479	2485		10.1517/14656566.2014.970531		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT3WW	WOS:000344865800002		
J	Jakovljevic, MB; Getzen, TE; Torbica, A; Anegawa, T				Jakovljevic, Mihajlo B.; Getzen, Thomas E.; Torbica, Aleksandra; Anegawa, Tomofumi			10th World IHEA and ECHE joint congress: Health Economics in the Age of Longevity	EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH			English	Article							CARE; EXPENDITURES	The 10th consecutive World Health Economics conference was organized jointly by International Health Economics Association and European Conference on Health Economics Association and took place at The Trinity College, Dublin, Ireland in July 2014. It has attracted broad participation from the global professional community devoted to health economics teaching, research and policy applications. It has provided a forum for lively discussion on hot contemporary issues such as health expenditure projections, reimbursement regulations, health technology assessment, universal insurance coverage, demand and supply of hospital services, prosperity diseases, population aging and many others. The high-profile debate fostered by this meeting is likely to inspire further methodological advances worldwide and spreading of evidence-based policy practice from OECD towards emerging markets.	[Jakovljevic, Mihajlo B.] Univ Kragujevac, Fac Med Sci, Kragujevac 34000, Serbia; [Getzen, Thomas E.] Temple Univ, Risk Insurance & Healthcare Management Dept, Philadelphia, PA 19122 USA; [Torbica, Aleksandra] Univ Bocconi, Ctr Res Hlth & Social Care Management CERGAS, I-20136 Milan, Italy; [Anegawa, Tomofumi] Keio Univ, Grad Sch Business Adm, Kohoku Ku, Yokohama, Kanagawa 2238526, Japan	Jakovljevic, MB (reprint author), Univ Kragujevac, Fac Med Sci, Svetozara Markovica 69, Kragujevac 34000, Serbia.	sidartagothama@gmail.com			Ministry of Science Education and Technological Development of the Republic of Serbia [175014]	The Ministry of Science Education and Technological Development of the Republic of Serbia through Grant No175014 financed the corresponding author's attendance of 10th iHEA global event. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Anegawa T., IRYO TO SHAKAI, V12, P49; [Anonymous], 2014, Nobelprize.org. Nobel Media AB 2014, Patent No. 140009; Arsenijevic J, 2013, SOC SCI MED, V78, P17, DOI 10.1016/j.socscimed.2012.11.014; [Anonymous], EUHEA 2016 KNOW ROP; Getzen TE, 2000, J HEALTH ECON, V19, P259, DOI 10.1016/S0167-6296(99)00032-6; Kawaguchi H, 2014, HEALTH CARE MANAG SC, V17, P101, DOI 10.1007/s10729-013-9248-9; Wagstaff A, 2012, J HEALTH ECON, V31, P406, DOI 10.1016/j.jhealeco.2012.03.002; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Kolstad JT, 2013, AM ECON REV, V103, P2875, DOI 10.1257/aer.103.7.2875; Ciani O, 2012, HEALTH POLICY, V108, P194, DOI 10.1016/j.healthpol.2012.09.017; Coughlan D, 2014, VALUE HEALTH, V17, P90, DOI [10.1016/j.jval.2013.10.004, 10.1016/j.jval.2013.10.094]; Fattore Giovanni, 2006, Health Care Manag Sci, V9, P251, DOI 10.1007/s10729-006-9092-2; International Health Economics Association, 2014, NOBEL MEDIA AB 2014; Jakovljevic MB, 2014, EXPERT REV PHARM OUT, V14, P181, DOI 10.1586/14737167.2014.881254; Mullner RM, 2009, ENCY HLTH SERVICES R; Ogura S, 1994, AGING US JAPAN, P139	16	0	0	EXPERT REVIEWS	LONDON	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND	1473-7167	1744-8379		EXPERT REV PHARM OUT	Expert Rev. Pharmacoecon. Outcomes Res.	DEC	2014	14	6					781	783		10.1586/14737167.2014.967220		3	Health Care Sciences & Services; Health Policy & Services; Pharmacology & Pharmacy	Health Care Sciences & Services; Pharmacology & Pharmacy	AT4SK	WOS:000344931900004		
J	Zhang, BB; Wang, DG; Xuan, C; Sun, GL; Deng, KF				Zhang, Bei-bei; Wang, Dao-gang; Xuan, Chao; Sun, Gui-li; Deng, Kai-feng			Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls	FAMILIAL CANCER			English	Article						Cancer; RAD51; Polymorphism; Meta-analysis	DNA-REPAIR GENES; STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION REPAIR; ACUTE MYELOID-LEUKEMIA; SINGLE-NUCLEOTIDE POLYMORPHISMS; SPORADIC COLORECTAL-CANCER; OVARIAN-CANCER; POLISH WOMEN; 135G-GREATER-THAN-C POLYMORPHISM; MUTATION CARRIERS	The RAD51 gene is essential for the repair of damaged DNA related to tumor development. Although a number of genetic studies have attempted to link the 135G/C polymorphism of RAD51 gene to the risk of cancer, the results were inconclusive. The present study aimed at investigating the pooled association using the more comprehensive meta-analysis. The PubMed, EBSCO, and BIOSIS databases were searched to identify eligible studies which were published in English before March 2014. Data were extracted using standardized methods. The association was assessed by odds ratio (OR) with 95 % confidence interval (CI). Begg's test was used to measure publication bias. Sensitivity analyses were also performed to assess the stability of the results. A total of 45 eligible studies with 28,956 patients and 28,372 controls were included in this meta-analysis. Overall, significant association was detected between 135G/C polymorphism and increased cancer risk (C allele vs. G allele: OR 1.23, 95 % CI 1.18-1.28; CC vs. GG: OR 2.41, 95 % CI 2.12-2.74; CC vs. CG: OR 3.86, 95 % CI 3.41-4.37; recessive model: OR 3.57, 95 % CI 3.19-4.00). In further stratified analysis, significantly elevated cancer risk was observed among Caucasians but not Asians. Subgroup analysis by different cancers also showed their significant associations in breast cancer, hematologic malignances, ovarian cancer, colorectal cancer and endometrial cancer, but not in head and neck cancer. Our results indicated that the RAD51 135G/C polymorphism was a candidate for susceptibility of cancer. The effect of the variants on the expression levels and the possible functional role of the variants in different cancers should be addressed in further studies.	[Zhang, Bei-bei] Mie Univ, Grad Sch Med, Tsu, Mie 514, Japan; [Wang, Dao-gang] Guangxi Univ Chinese Med, Dept Gastroenterol, Affiliated Hosp 1, Nanning, Peoples R China; [Xuan, Chao] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Clin Lab, Qingdao 266071, Peoples R China; [Sun, Gui-li] Guangxi Med Univ, Affiliated Hosp 3, Dept Endocrinol, Nanning, Peoples R China; [Deng, Kai-feng] Guangxi Med Univ, Dept Clin Lab, Affiliated Hosp 4, Liuzhou, Peoples R China	Wang, DG (reprint author), Guangxi Univ Chinese Med, Dept Gastroenterol, Affiliated Hosp 1, Nanning, Peoples R China.	sdqdmu@126.com					Jara L, 2010, BREAST CANCER RES TR, V122, P813, DOI 10.1007/s10549-009-0709-2; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Zhang LH, 2012, ONCOL LETT, V3, P351, DOI 10.3892/ol.2011.463; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Xuan C, 2012, INT J COLORECTAL DIS, V27, P11, DOI 10.1007/s00384-011-1265-x; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Alexander FE, 2001, CANCER RES, V61, P2542; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wang LE, 2004, CANCER RES, V64, P5560, DOI 10.1158/0008-5472.CAN-03-2181; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Mendoza J, 2013, BRIT J CANCER, V109, P68, DOI 10.1038/bjc.2013.303; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Auranen A, 2005, INT J CANCER, V117, P611, DOI 10.1002/ijc.21047; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Dudas A, 2004, MUTAT RES-REV MUTAT, V566, P131, DOI 10.1016/j.mrrev.2003.07.001; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Dhillon VS, 2011, UROL ONCOL-SEMIN ORI, V29, P641, DOI 10.1016/j.urolonc.2009.08.013; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Voso MT, 2007, ANN ONCOL, V18, P1523, DOI 10.1093/annonc/mdm191; Jakubowska A, 2007, CANCER EPIDEM BIOMAR, V16, P270, DOI 10.1158/1055-9965.EPI-06-0562; Krupa R, 2009, EXP MOL PATHOL, V87, P32, DOI 10.1016/j.yexmp.2009.04.005; Costa S, 2007, BREAST CANCER RES TR, V103, P209, DOI 10.1007/s10549-006-9364-z; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Webb PM, 2005, CANCER EPIDEM BIOMAR, V14, P319, DOI 10.1158/1055-9965.EPI-04-0335; Bhatla D, 2008, LEUKEMIA, V22, P265, DOI 10.1038/sj.leu.2405000; Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Cheng D, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-18; Dixon K, 2004, SEMIN CANCER BIOL, V14, P441, DOI 10.1016/j.semcancer.2004.06.007; Fabiani E, 2009, LEUKEMIA RES, V33, P1068, DOI 10.1016/j.leukres.2008.10.012; Figueroa JD, 2007, CARCINOGENESIS, V28, P1788, DOI 10.1093/carcin/bgm132; Finch SC, 2007, BEST PRACT RES CL HA, V20, P109, DOI 10.1016/j.beha.2006.10.009; Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5; Gresner P, 2012, GENE, V504, P166, DOI 10.1016/j.gene.2012.05.030; Hamdy MS, 2011, J INVEST MED, V59, P1124, DOI 10.231/JIM.0b013e3182281da3; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; He YZ, 2014, TUMOR BIOL, V35, P615, DOI 10.1007/s13277-013-1085-4; Jakubowska A, 2009, EUR J CANCER, V45, P837, DOI 10.1016/j.ejca.2008.10.021; Jara L, 2007, CANCER GENET CYTOGEN, V178, P65, DOI 10.1016/j.cancergencyto.2007.05.024; Kawabata M, 2005, ACTA MED OKAYAMA, V59, P1; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; KRIVOKUCA AM, 2013, FAMILIAL CANC; Krupa R, 2011, MOL BIOL REP, V38, P1163, DOI 10.1007/s11033-010-0214-z; Lisby M, 2009, DNA REPAIR, V8, P1068, DOI 10.1016/j.dnarep.2009.04.007; Liu L, 2011, LEUKEMIA RES, V35, P1020, DOI 10.1016/j.leukres.2011.01.014; Lu JC, 2007, CARCINOGENESIS, V28, P988, DOI 10.1093/carcin/bgl225; Mohindra A, 2002, HUM MOL GENET, V11, P2189, DOI 10.1093/hmg/11.18.2189; Mucha Bartosz, 2012, Pol Przegl Chir, V84, P358, DOI 10.2478/v10035-012-0060-x; Pasaje CFA, 2011, J MED VIROL, V83, P1892, DOI 10.1002/jmv.22122; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Poplawski T, 2006, MUTAT RES-FUND MOL M, V601, P83, DOI 10.1016/j.mrfmmm.2006.06.002; Richardson C, 2005, CANCER LETT, V218, P127, DOI 10.1016/j.canlet.2004.08.009; Rollinson S, 2007, LEUKEMIA RES, V31, P169, DOI 10.1016/j.leukres.2006.05.028; Romanowicz H, 2010, POL J PATHOL, V61, P206; Romanowicz-Makowska H., 2006, Experimental Oncology, V28, P156; Romanowicz-Makowska H, 2012, J OBSTET GYNAECOL RE, V38, P918, DOI 10.1111/j.1447-0756.2011.01811.x; Romanowicz-Makowska H, 2012, POL J PATHOL, V63, P193, DOI 10.5114/PJP.2012.31505; Romanowicz-Makowska H, 2012, ARCH MED SCI, V8, P1065, DOI 10.5114/aoms.2012.32417; Romanowicz-Makowska H, 2012, EUR J GYNAECOL ONCOL, V33, P145; Romanowicz-Makowska H, 2012, EUR J GYNAECOL ONCOL, V33, P406; Seedhouse C, 2004, CLIN CANCER RES, V10, P2675, DOI 10.1158/1078-0432.CCR-03-0372; Sliwinski T, 2005, BREAST CANCER RES TR, V94, P105, DOI 10.1007/s10549-005-0672-5; Smolarz B, 2013, POL J PATHOL, V64, P39, DOI 10.5114/PJP.2013.34602; Sun HM, 2011, BREAST CANCER RES TR, V125, P157, DOI 10.1007/s10549-010-0922-z; Synowiec E, 2008, MUTAT RES-FUND MOL M, V648, P65, DOI 10.1016/j.mrfmmm.2008.09.014; Tarasov VA, 2006, P AC SCI USSR BIOL S, V406, P66; Vispe S, 1997, BIOCHIMIE, V79, P587, DOI 10.1016/S0300-9084(97)82007-X; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075153; Wang ZW, 2010, BREAST CANCER RES TR, V124, P765, DOI 10.1007/s10549-010-0885-0; Werbrouck J, 2008, MUTAT RES-GEN TOX EN, V656, P74, DOI 10.1016/j.mrgentox.2008.07.013; Xuan C, 2013, ANN HUM GENET, V77, P191, DOI 10.1111/ahg.12016; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Yu KD, 2011, BREAST CANCER RES TR, V126, P365, DOI 10.1007/s10549-010-0937-5; Zeljic K, 2014, ORAL DIS, V20, P416, DOI 10.1111/odi.12144; Zhang BB, 2013, EUR J CANCER CARE, V22, P617, DOI 10.1111/ecc.12067; Zhao MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087259	78	4	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-9600	1573-7292		FAM CANCER	Fam. Cancer	DEC	2014	13	4					515	526		10.1007/s10689-014-9729-0		12	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	AT7CG	WOS:000345093500001		
J	Watari, S; Murata, M; Baba, T; Oda, S; Ishitani, M; Mishiro, K; Uchida, Y				Watari, S.; Murata, M.; Baba, T.; Oda, S.; Ishitani, M.; Mishiro, K.; Uchida, Y.			Fisheries resource management of the daggertooth pike conger, Muraenesox cinereus, using existing limited datasets in the western Seto Inland Sea, Japan	FISHERIES MANAGEMENT AND ECOLOGY			English	Article						age composition; demersal stock; fishing mortality coefficient; stock assessment; trawl fisheries; yield per recruit		The daggertooth pike conger, Muraenesox cinereus (Forsskal), has become an important fish resource in the western Seto Inland Sea, Japan, since the 1990s. However, introducing sustainable fisheries resource management for this species is difficult in this region because stock assessments have not been performed, and official fisheries statistics for this stock were discontinued after 2007. This study used existing limited data sets to compile the first report for fisheries resource management for this M.cinereus stock. Yield-per-recruit analyses showed that increasing fishing pressure above current levels would provide only a minimal increase in expected catch levels. Hence, the current harvest level is considered to represent the upper limit of fishing pressure. Age composition in a given year could potentially be used to forecast landing abundance for the following 2years. This study provides a basis for establishing effective fisheries resource management strategies for M.cinereus.	[Watari, S.] Fisheries Res Agcy, Natl Res Inst Fisheries & Environm Inland Sea, Hiroshima, Japan; [Murata, M.; Baba, T.] Yamaguchi Prefectural Fisheries Res Ctr, Coastal Sea Res Div, Yamaguchi, Japan; [Oda, S.; Ishitani, M.] Fukuoka Fisheries & Marine Technol Res Ctr, Buzenkai Lab, Fukuoka, Japan; [Ishitani, M.] Hamagen Co Ltd, Fukuoka, Japan; [Mishiro, K.] Oita Prefecture Eastern Region Bur, Oita, Japan; [Uchida, Y.] Yamaguchi Prefectural Govt, Dept Agr Forestry & Fisheries, Yamaguchi, Japan	Watari, S (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, 2-12-4 Fukuura, Yokohama, Kanagawa 2368648, Japan.	swatari@affrc.go.jp			Fisheries Agency; Fisheries Research Agency, Japan	We thank Dr. Norio Yamashita and Dr. Shiroh Yonezaki from the Fisheries Research Agency for providing valuable suggestions about the manuscript. This work was supported by the Fisheries Agency and the Fisheries Research Agency, Japan.	MACE PM, 1994, CAN J FISH AQUAT SCI, V51, P110, DOI 10.1139/f94-013; GULLAND JA, 1973, FISH B-NOAA, V71, P325; Efron B., 1993, INTRO BOOTSTRAP; Fisheries Agency and Fisheries Research Agency of Japan, 2013, MAR FISH STOCK ASS E; Hebert M. E., 2010, 2010091 CAN SCI ADV; Imoto Y, 2007, NIPPON SUISAN GAKK, V73, P684, DOI 10.2331/suisan.73.684; Kaneda Y, 2005, FISHERIES FISHING ME; Kitanishi S, 2013, NIPPON SUISAN GAKK, V79, P869; Masaki Y., 1983, REPORTS GROUNDFISH S, P51; Oda S., 2011, B FUKUOKA FISHERIES, V21, P35; Okaichi T., 1996, LIVING RESOURCES ENV; Otaki H., 1961, B SEIKAI REG FISH RE, V21, P47; Otaki H., 1964, B SEIKAI REG FISH RE, V32, P59; Takai T., 1959, Journal of the Shimonoseki College of Fisheries, V8, P209; TANAKA SYOITI, 1960, BULL TOKAI REG FISH RES LAB, V28, P1; Ueda Y., 2010, KAIYO MONTHLY, V42, P253; Ueta Y., 1993, FISH POPULATION BIOL, P134; Ueta Y, 2011, NIPPON SUISAN GAKK, V77, P61; Ueta Y., 2008, B TOKUSHIMA PREF FIS, V6, P85; Ueta Y., 1992, FISH POPULATION BIOL, P92; Watari S, 2013, FISHERIES SCI, V79, P367, DOI 10.1007/s12562-013-0605-x; Watari S, 2011, NIPPON SUISAN GAKK, V77, P799	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0969-997X	1365-2400		FISHERIES MANAG ECOL	Fisheries Manag. Ecol.	DEC	2014	21	6					470	479		10.1111/fme.12096		10	Fisheries	Fisheries	AU0MU	WOS:000345318000005		
J	Inokuchi, G; Yajima, D; Hayakawa, M; Motomura, A; Chiba, F; Torimitsu, S; Makino, Y; Iwase, H				Inokuchi, Go; Yajima, Daisuke; Hayakawa, Mutsumi; Motomura, Ayumi; Chiba, Fumiko; Torimitsu, Suguru; Makino, Yohsuke; Iwase, Hirotaro			Postmortem dynamic cerebral angiography for detecting aneurysm and bleeding sites in cases of subarachnoid hemorrhage	FORENSIC SCIENCE MEDICINE AND PATHOLOGY			English	Article						Postmortem computed tomography (PMCT); Postmortem computed tomography angiography (PMCTA); Subarachnoid hemorrhage (SAH); Traumatic subarachnoid hemorrhage (tSAH); Vertebral artery injury	MINIMALLY INVASIVE AUTOPSY; VERTEBRAL ARTERY RUPTURE; CT-ANGIOGRAPHY; DIAGNOSIS; TRAUMA	One of the advantages of postmortem imaging is its ability to obtain diagnostic findings in a non-destructive manner when autopsy is either difficult or may destroy forensic evidence. In recent years, efforts have been made to incorporate computed tomography (CT) based postmortem angiography into forensic pathology; however, it is not currently clear how well the modality can determine sites of bleeding in cases of subarachnoid hemorrhage. Therefore, in this study, we investigated the utility of postmortem cerebral angiography using multi-detector row CT (MDCT) by injecting a contrast medium through a catheter inserted into the internal carotid and vertebral arteries of 10 subarachnoid hemorrhage cases. While postmortem MDCT angiography (PMCTA) was capable of detecting aneurysms in a non-destructive manner, it was sometimes difficult to identify the aneurysm and bleeding sites because of a large amount of contrast medium leaking into the extravascular space. To overcome this problem, we developed the novel contrast imaging method "dynamic cerebral angiography," which involves scanning the same area multiple times while injecting contrast medium to enable real-time observation of the contrasted vasculature. Using multiphase contrast images acquired by this method, we successfully captured the moment when contrast medium leaked from the hemorrhage site. This method will be useful for identifying exact bleeding sites on PMCTA.	[Inokuchi, Go; Yajima, Daisuke; Hayakawa, Mutsumi; Motomura, Ayumi; Chiba, Fumiko; Torimitsu, Suguru; Makino, Yohsuke; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan	Inokuchi, G (reprint author), Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	goinokuchi@chiba-u.jp					Burke M, 2012, FORENSIC SCI MED PAT, V8, P367, DOI 10.1007/s12024-012-9347-9; Saunders SL, 2011, INT J LEGAL MED, V125, P609, DOI 10.1007/s00414-011-0559-4; Chew KL, 2012, FORENSIC SCI MED PAT, V8, P436, DOI 10.1007/s12024-012-9329-y; Grabherr S, 2011, INT J LEGAL MED, V125, P791, DOI 10.1007/s00414-010-0526-5; KARHUNEN PJ, 1990, FORENSIC SCI INT, V44, P107, DOI 10.1016/0379-0738(90)90240-Y; Flach PM, 2010, ARCH PATHOL LAB MED, V134, P115, DOI 10.1043/2008-0503-CRR3.1; Roberts ISD, 2011, CLIN RADIOL, V66, P645, DOI 10.1016/j.crad.2011.01.007; Ross S, 2008, AM J ROENTGENOL, V190, P1380, DOI 10.2214/AJR.07.3082; Chen CJ, 2004, AM J NEURORADIOL, V25, P769; Palmiere C, 2012, FORENSIC SCI INT, V222, P33, DOI 10.1016/j.forsciint.2012.04.031; Saunders SL, 2011, FORENSIC SCI MED PAT, V7, P271, DOI 10.1007/s12024-010-9208-3; Matsumoto M, 2007, AM J NEURORADIOL, V28, P299; Bolliger SA, 2010, AM J ROENTGENOL, V195, P1051, DOI 10.2214/AJR.10.4600; Grabherr S, 2007, AM J ROENTGENOL, V188, P832, DOI 10.2214/AJR.06.0787; Grabherr S, 2008, AM J ROENTGENOL, V190, P345, DOI 10.2214/AJR.07.2261; Ikegaya H, 2008, AM J FOREN MED PATH, V29, P276, DOI 10.1097/PAF.0b013e318174f0e2; Iwase Hirotaro, 2009, Legal Medicine, V11, P168, DOI 10.1016/j.legalmed.2009.02.032; Kaiser C, 2008, FORENSIC SCI INT, V182, pe15; Kathuria S, 2011, EUR J RADIOL, V79, P328, DOI 10.1016/j.ejrad.2010.01.020; Opeskin K, 1998, AM J FOREN MED PATH, V19, P206, DOI 10.1097/00000433-199809000-00002; Saukko P, 2004, KNIGHTS FORENSIC PAT	21	3	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1547-769X	1556-2891		FORENSIC SCI MED PAT	Forensic Sci. Med. Pathol.	DEC	2014	10	4					487	495		10.1007/s12024-014-9572-5		9	Medicine, Legal; Pathology	Legal Medicine; Pathology	AT3ZH	WOS:000344874800003		
J	Sesana, A; Weber, WJ; Killow, CJ; Perreur-Lloyd, M; Robertson, DI; Ward, H; Fitzsimons, ED; Bryant, J; Cruise, AM; Dixon, G; Hoyland, D; Smith, D; Bogenstahl, J; McNamara, PW; Gerndt, R; Flatscher, R; Hechenblaikner, G; Hewitson, M; Gerberding, O; Barke, S; Brause, N; Bykov, I; Danzmann, K; Enggaard, A; Gianolio, A; Hansen, TV; Heinzel, G; Hornstrup, A; Jennrich, O; Kullmann, J; Moller-Pedersen, S; Rasmussen, T; Reiche, J; Sodnik, Z; Suess, M; Armano, M; Sumner, T; Bender, PL; Akutsu, T; Sathyaprakash, BS				Sesana, A.; Weber, W. J.; Killow, C. J.; Perreur-Lloyd, M.; Robertson, D. I.; Ward, H.; Fitzsimons, E. D.; Bryant, J.; Cruise, A. M.; Dixon, G.; Hoyland, D.; Smith, D.; Bogenstahl, J.; McNamara, P. W.; Gerndt, R.; Flatscher, R.; Hechenblaikner, G.; Hewitson, M.; Gerberding, O.; Barke, S.; Brause, N.; Bykov, I.; Danzmann, K.; Enggaard, A.; Gianolio, A.; Hansen, T. Vendt; Heinzel, G.; Hornstrup, A.; Jennrich, O.; Kullmann, J.; Moller-Pedersen, S.; Rasmussen, T.; Reiche, J.; Sodnik, Z.; Suess, M.; Armano, M.; Sumner, T.; Bender, P. L.; Akutsu, T.; Sathyaprakash, B. S.		DECIGO Working Grp	Space-based detectors	GENERAL RELATIVITY AND GRAVITATION			English	Article						LISA Pathfinder; Optical bench Interferometer; Spaceborne precision metrology; Interferometry; Phasemeter; Gravitational waves	LISA PATHFINDER; MISSION; BINARIES	The parallel session C5 on Space-Based Detectors gave a broad overview over the planned space missions related to gravitational wave detection. Overviews of the revolutionary science to be expected from LISA was given by Alberto Sesana and Sasha Buchman. The launch of LISA Pathfinder (LPF) is planned for 2015. This mission and its payload "LISA Technology Package" will demonstrate key technologies for LISA. In this context, reference masses in free fall for LISA, and gravitational physics in general, was described by William Weber, laser interferometry at the picometre level and the optical bench of LPF was presented by Christian Killow and the performance of the LPF optical metrology system by Paul McNamara. While LPF will not yet be sensitive to gravitational waves, it may nevertheless be used to explore fundamental physics questions, which was discussed by Michele Armano. Some parts of the LISA technology that are not going to be demonstrated by LPF, but under intensive development at the moment, were presented by Oliver Jennrich and Oliver Gerberding. Looking into the future, Japan is studying the design of a mid-frequency detector called DECIGO, which was discussed by Tomotada Akutsu. Using atom interferometry for gravitational wave detection has also been recently proposed, and it was critically reviewed by Peter Bender. In the nearer future, the launch of GRACE Follow-On (for Earth gravity observation) is scheduled for 2017, and it will include a Laser Ranging Interferometer as technology demonstrator. This will be the first inter-spacecraft laser interferometer and has many aspects in common with the LISA long arm, as discussed by Andrew Sutton.	[Sesana, A.] Max Planck Inst Gravitat Phys, D-14476 Golm, Germany; [Weber, W. J.] Univ Trento, Dept Phys, I-38123 Povo, TN, Italy; [Weber, W. J.] Ist Nazl Fis Nucl, Trento Inst Fundamental Phys & Applicat, I-38123 Povo, TN, Italy; [Killow, C. J.; Perreur-Lloyd, M.; Robertson, D. I.; Ward, H.] Univ Glasgow, Sch Phys & Astron, Inst Gravitat Res, SUPA, Glasgow G12 8QQ, Lanark, Scotland; [Fitzsimons, E. D.; Gerndt, R.; Flatscher, R.; Hechenblaikner, G.] Airbus Def & Space GmbH, D-88090 Immenstaad, Germany; [Bryant, J.; Cruise, A. M.; Dixon, G.; Hoyland, D.; Smith, D.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Bogenstahl, J.; Gerberding, O.; Barke, S.; Brause, N.; Bykov, I.; Danzmann, K.; Heinzel, G.; Kullmann, J.; Reiche, J.] Leibniz Univ Hannover, Inst Gravitat Phys, D-30167 Hannover, Germany; [McNamara, P. W.; Gianolio, A.; Jennrich, O.; Sodnik, Z.; Suess, M.] European Space Agcy, European Space Res & Technol Ctr, NL-2200 AG Noordwijk, Netherlands; [Hewitson, M.] Albert Einstein Inst, Max Planck Inst Gravitat Phys, D-30167 Hannover, Germany; [Enggaard, A.; Hansen, T. Vendt; Rasmussen, T.] Axcon ApS, DK-2800 Lyngby, Denmark; [Hornstrup, A.; Moller-Pedersen, S.] Tech Univ Denmark, DTU Space, Natl Space Inst, DK-2800 Lyngby, Denmark; [Armano, M.] European Space Agcy, European Space Astron Ctr, Madrid, Spain; [Sumner, T.] Univ London Imperial Coll Sci Technol & Med, London, England; [Akutsu, T.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Sathyaprakash, B. S.] Cardiff Univ, Sch Phys & Astron, Cardiff CF10 3AX, S Glam, Wales	Sathyaprakash, BS (reprint author), Cardiff Univ, Sch Phys & Astron, Cardiff CF10 3AX, S Glam, Wales.	B.Sathyaprakash@astro.cf.ac.uk	Dixon, George/K-5501-2014; Weber, William/H-4351-2012	Weber, William/0000-0003-1536-2410	Japan Aerospace Exploration Agency (JAXA); Japan Society for the Promotion of Science (JSPS); Global COE Program of the graduated school of science in Kyoto University; Research Center for the Early Universe (RESCEU) at the University of Tokyo	This research was supported by the Japan Aerospace Exploration Agency (JAXA), by the Japan Society for the Promotion of Science (JSPS), Grant-in-aid for scientific research, by the Global COE Program of the graduated school of science in Kyoto University, and by the Research Center for the Early Universe (RESCEU) at the University of Tokyo.	Amaro-Seoane P., 2013, GW NOTES, V6, P4; Malbon RK, 2007, MON NOT R ASTRON SOC, V382, P1394, DOI 10.1111/j.1365-2966.2007.12317.x; Sugarbaker A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.113002; Robertson DI, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/8/085006; Willemenot E, 2000, REV SCI INSTRUM, V71, P302, DOI 10.1063/1.1150197; Graham PW, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.171102; Seto N, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.221103; Antonucci F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.181101; Nelemans G, 2001, ASTRON ASTROPHYS, V375, P890, DOI 10.1051/0004-6361:20010683; Dolesi R, 2003, CLASSICAL QUANT GRAV, V20, pS99, DOI 10.1088/0264-9381/20/10/312; Rummel R, 2011, J GEODESY, V85, P777, DOI 10.1007/s00190-011-0500-0; Antonucci F, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/9/094002; Ashby N., 2009, P INT ASTRON UNION, V5, P414; Barack L, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.082005; Cavalleri A, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/9/094017; Cavalleri A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.140601; Esteban JJ, 2011, OPT EXPRESS, V19, P15937, DOI 10.1364/OE.19.015937; Fitzsimons ED, 2013, APPL OPTICS, V52, P2527, DOI 10.1364/AO.52.002527; Gair JR, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.104014; Gerberding O., 2012, ASP C SERIES, V467, P271; Gerberding O, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/23/235029; Heinzel G, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/9/094008; Jennrich O., 2011, ESASRE2011; Kawamura S, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/9/094011; Killow CJ, 2013, APPL OPTICS, V52, P177, DOI 10.1364/AO.52.000177; Magueijo J, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.043527; McNamara PW, 2005, CLASSICAL QUANT GRAV, V22, pS243, DOI 10.1088/0264-9381/22/10/016; Nissanke S, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/131; Racca GD, 2010, SPACE SCI REV, V151, P159, DOI 10.1007/s11214-009-9602-x; Seoane P A, 2013, ARXIV13055720; Sesana A, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.044036; Shaddock D. A., 2006, AIP C P, V873, P689; Stroeer A, 2006, CLASSICAL QUANT GRAV, V23, P809; Sumner TJ, 2013, ASTR SOC P, V467, P129; Sutton AJ, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/7/075008; Volonteri M., 2003, APJ, V582, P599; Volonteri M., 2009, ARXIV09120525; Weber WJ, 2003, P SOC PHOTO-OPT INS, V4856, P31, DOI 10.1117/12.458564; Wiese DN, 2009, J GEODESY, V83, P569, DOI 10.1007/s00190-008-0274-1	39	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-7701	1572-9532		GEN RELAT GRAVIT	Gen. Relativ. Gravit.	DEC	2014	46	12							1793	10.1007/s10714-014-1793-0		13	Astronomy & Astrophysics; Physics, Multidisciplinary; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	AT3AA	WOS:000344804900001		
J	Goto, KT; Anbar, AD; Gordon, GW; Romaniello, SJ; Shimoda, G; Takaya, Y; Tokumaru, A; Nozaki, T; Suzuki, K; Machida, S; Hanyu, T; Usui, A				Goto, Kosuke T.; Anbar, Ariel D.; Gordon, Gwyneth W.; Romaniello, Stephen J.; Shimoda, Gen; Takaya, Yutaro; Tokumaru, Ayaka; Nozaki, Tatsuo; Suzuki, Katsuhiko; Machida, Shiki; Hanyu, Takeshi; Usui, Akira			Uranium isotope systematics of ferromanganese crusts in the Pacific Ocean: Implications for the marine U-238/U-235 isotope system	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							FE-MN CRUSTS; CO-RICH CRUST; OSMIUM ISOTOPE; EXTRACTION CHROMATOGRAPHY; ACIDIC MEDIA; SEAWATER; FRACTIONATION; U-234/U-238; SEDIMENTS; RATIOS	Variations of U-238/U-235 ratio (delta U-238) in sedimentary rocks have been proposed as a possible proxy for the paleo-oceanic redox conditions, although the marine delta U-238 system is not fully understood. Here we investigate the spatial variation of delta U-238 in modern ferromanganese (Fe-Mn) crusts by analyzing U isotopes in the surface (0-3 mm depth) layer of 19 Fe-Mn crusts collected from 6 seamounts in the Pacific Ocean. delta U-238 values in the surface layers show little variation and range from -0.59 parts per thousand to -0.69 parts per thousand. The uniformity of delta U-238 values is consistent with the long residence time of U in modern seawater, although the delta U-238 values are lighter than that of present-day seawater by similar to 0.24 parts per thousand. The light delta U-238 values are consistent with the isotope offset observed in previously reported adsorption experiment of U to Mn oxide. These results indicate that removal of U from seawater to Mn oxide is responsible for the second largest U isotope fractionation in the modern marine system, and could contribute to isotopically heavy U to seawater. Depth profiles of U isotopes (delta U-234 and delta U-238) in two Fe-Mn crusts (MR12-03_D06-R01 and MC10_CB07_B), dated by Os isotope stratigraphy, were investigated to reconstruct the evolution of the oceanic redox state during the Cenozoic. The delta U-238 depth profiles show very limited ranges (-0.57 parts per thousand to -0.67 parts per thousand for MR12-03_D06-R01 and -0.56 parts per thousand to -0.69 parts per thousand for MC10_CB07_B), and have values that are similar to those of the surface layers of Fe-Mn crusts. The absence of any resolvable variation in the delta U-238 depth profiles may suggest that the relative amounts of oxic and reducing U sinks have not varied significantly over the past 45 Myr. However, the delta U-234 depth profiles of the same samples show evidence for the possible redistribution of U-234 after deposition. Therefore, the depth profile of delta U-238 in Fe-Mn crusts may have been also overprinted by later chemical exchange with pore-water or seawater, and may not reflect the paleo-oceanic environmental changes. To assess the potential role of U removal by Mn oxides on seawater delta U-238, we calculated seawater delta U-238 with different U sink fluxes into Mn oxides using a simple mass balance model. The results of these calculations suggest that seawater delta U-238 could have varied significantly throughout Earth's history due to changes in the accumulation rate of Mn oxides. (C) 2014 Elsevier Ltd. All rights reserved.	[Goto, Kosuke T.; Shimoda, Gen] AIST, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Anbar, Ariel D.; Gordon, Gwyneth W.; Romaniello, Stephen J.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Anbar, Ariel D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Takaya, Yutaro; Nozaki, Tatsuo; Suzuki, Katsuhiko] JAMSTEC, Res & Dev Ctr Submarine Resources, Yokosuka, Kanagawa 2370061, Japan; [Tokumaru, Ayaka] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Machida, Shiki] Waseda Univ, Dept Resources & Environm Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Hanyu, Takeshi] JAMSTEC, Dept Solid Earth Geochem, Yokosuka, Kanagawa 2370061, Japan; [Usui, Akira] Kochi Univ, Dept Geol, Kochi, Kochi 7808520, Japan	Goto, KT (reprint author), AIST, Geol Survey Japan, Cent 7,1-1-1 Higashi, Tsukuba, Ibaraki 3058567, Japan.	k.goto@aist.go.jp			Sasakawa Scientific Research Grant from the Japan Science Society [25-704]; Fukada Geological Institute; Japan Society for the Promotion of Science [21840069, 2034015]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20109006]; Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits	We thank YK08-09, NT09-02 Leg 2, YK10-05, KY11-02 Leg 1, and MR12-03 cruise members for providing Fe-Mn crust samples; Jun-Ichi Kimura and Qing Chang for their help in Re-Os analysis. Reviews by Sune G. Nielsen, one anonymous reviewer, and associate editor Timothy J. Shaw improved the manuscript. This work was partly supported by the Sasakawa Scientific Research Grant from the Japan Science Society (No. 25-704 to K.T.G.), the Fukada Grant-in-Aid from the Fukada Geological Institute, the Grant in Aid from Japan Society for the Promotion of Science (No. 21840069 to T.N. and No. 2034015 to K.S.), the Grant in Aid from Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 20109006 to K.S.), and the Japan Society for the Promotion of Science Institutional Program for Young Researcher Overseas Visits.	Chabaux F, 2003, REV MINERAL GEOCHEM, V52, P533, DOI 10.2113/0520533; RICHTER FM, 1992, EARTH PLANET SC LETT, V109, P11, DOI 10.1016/0012-821X(92)90070-C; Sims KWW, 2002, GEOCHIM COSMOCHIM AC, V66, P3481, DOI 10.1016/S0016-7037(02)00909-2; Condon DJ, 2010, GEOCHIM COSMOCHIM AC, V74, P7127, DOI 10.1016/j.gca.2010.09.019; Wen X, 1997, MAR GEOL, V136, P277, DOI 10.1016/S0025-3227(96)00064-3; Bopp CJ, 2010, ENVIRON SCI TECHNOL, V44, P5927, DOI 10.1021/es100643v; [Anonymous], 2000, MAR SCI SER; Levasseur S, 2004, EARTH PLANET SC LETT, V224, P91, DOI 10.1016/j.epsl.2004.05.010; Brennecka GA, 2011, P NATL ACAD SCI USA, V108, P17631, DOI 10.1073/pnas.1106039108; Stirling CH, 2007, EARTH PLANET SC LETT, V264, P208, DOI 10.1016/j.epsl.2007.09.019; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Ling HF, 1997, EARTH PLANET SC LETT, V146, P1, DOI 10.1016/S0012-821X(96)00224-5; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; DePaolo DJ, 2006, EARTH PLANET SC LETT, V248, P394, DOI 10.1016/j.epsl.2006.06.004; Henderson GM, 1999, EARTH PLANET SC LETT, V170, P169, DOI 10.1016/S0012-821X(99)00104-1; ELDERFIELD H, 1981, GEOCHIM COSMOCHIM AC, V45, P513, DOI 10.1016/0016-7037(81)90184-8; Siebert C, 2003, EARTH PLANET SC LETT, V211, P159, DOI 10.1016/S0012-821X(03)00189-4; Li JS, 2008, SCI CHINA SER D, V51, P1452, DOI 10.1007/s11430-008-0100-x; Montoya-Pino C, 2010, GEOLOGY, V38, P315, DOI 10.1130/G30652.1; HORWITZ EP, 1993, ANAL CHIM ACTA, V281, P361, DOI 10.1016/0003-2670(93)85194-O; Brennecka GA, 2010, EARTH PLANET SC LETT, V291, P228, DOI 10.1016/j.epsl.2010.01.023; HORWITZ EP, 1992, ANAL CHIM ACTA, V266, P25, DOI 10.1016/0003-2670(92)85276-C; CHEN JH, 1981, ANAL CHEM, V53, P2060, DOI 10.1021/ac00236a027; Gall L, 2013, EARTH PLANET SC LETT, V375, P148, DOI 10.1016/j.epsl.2013.05.019; KIGOSHI K, 1971, SCIENCE, V173, P47, DOI 10.1126/science.173.3991.47; Schauble EA, 2007, GEOCHIM COSMOCHIM AC, V71, P2170, DOI 10.1016/j.gca.2007.02.004; Maher K, 2004, GEOCHIM COSMOCHIM AC, V68, P4629, DOI 10.1016/j.gca.2004.04.024; KLINKHAMMER GP, 1991, GEOCHIM COSMOCHIM AC, V55, P1799, DOI 10.1016/0016-7037(91)90024-Y; Burton KW, 1999, EARTH PLANET SC LETT, V171, P185, DOI 10.1016/S0012-821X(99)00139-9; Koschinsky A, 2003, MAR GEOL, V198, P331, DOI 10.1016/S0025-3227(03)00122-1; Woodhouse OB, 1999, EARTH PLANET SC LETT, V173, P223, DOI 10.1016/S0012-821X(99)00233-2; Maynard JB, 2010, ECON GEOL, V105, P535; Koschinsky A, 1997, GEOCHIM COSMOCHIM AC, V61, P4079, DOI 10.1016/S0016-7037(97)00231-7; CHABAUX F, 1995, GEOCHIM COSMOCHIM AC, V59, P633, DOI 10.1016/0016-7037(94)00379-Z; Clark SK, 2008, ENVIRON SCI TECHNOL, V42, P7850, DOI 10.1021/es801814v; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; KU TL, 1977, DEEP-SEA RES, V24, P1005, DOI 10.1016/0146-6291(77)90571-9; Asael D, 2013, CHEM GEOL, V362, P193, DOI 10.1016/j.chemgeo.2013.08.003; Kendall B, 2013, CHEM GEOL, V362, P105, DOI 10.1016/j.chemgeo.2013.08.010; Levasseur S, 1998, SCIENCE, V282, P272, DOI 10.1126/science.282.5387.272; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; Weyer S, 2008, GEOCHIM COSMOCHIM AC, V72, P345, DOI 10.1016/j.gca.2007.11.012; Nielsen SG, 2009, EARTH PLANET SC LETT, V278, P297, DOI 10.1016/j.epsl.2008.12.010; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Brennecka GA, 2011, ENVIRON SCI TECHNOL, V45, P1370, DOI 10.1021/es103061v; Klemm V, 2005, EARTH PLANET SC LETT, V238, P42, DOI 10.1016/j.epsl.2005.07.016; Chabaux F, 1997, GEOCHIM COSMOCHIM AC, V61, P3619, DOI 10.1016/S0016-7037(97)00187-7; Hiess J, 2012, SCIENCE, V335, P1610, DOI 10.1126/science.1215507; Romaniello SJ, 2013, CHEM GEOL, V362, P305, DOI 10.1016/j.chemgeo.2013.10.002; Bopp C. J., 2009, GEOLOGY, V31, P611; Claude C, 2005, GEOCHIM COSMOCHIM AC, V69, P4845, DOI 10.1016/j.gca.2005.05.016; Dunk R. M., 2002, CHEM GEOL, V190, P185; Esat TM, 2010, GEOCHIM COSMOCHIM AC, V74, P7008, DOI 10.1016/j.gca.2010.09.007; Esat TM, 2006, GEOCHIM COSMOCHIM AC, V70, P4140, DOI 10.1016/j.gca.2006.06.013; FLEISCHER RL, 1980, SCIENCE, V207, P979, DOI 10.1126/science.207.4434.979; Glasby G.P., 2006, MARINE GEOCHEMISTRY, P371, DOI 10.1007/3-540-32144-6_11; HALBACH P, 1986, GEOL RUNDSCH, V75, P235, DOI 10.1007/BF01770191; Henderson GM, 1999, EARTH PLANET SC LETT, V169, P99, DOI 10.1016/S0012-821X(99)00065-5; Horner TJ, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002987; Klemm V, 2008, EARTH PLANET SC LETT, V273, P175, DOI 10.1016/j.epsl.2008.06.028; KU TL, 1965, J GEOPHYS RES, V70, P3457, DOI 10.1029/JZ070i014p03457; Kuleshov VN, 2011, DOKL EARTH SCI, V441, P1611, DOI 10.1134/S1028334X1112004X; Meng XW, 2008, SCI CHINA SER D, V51, P1446, DOI 10.1007/s11430-008-0101-9; MO T, 1973, GEOCHIM COSMOCHIM AC, V37, P35, DOI 10.1016/0016-7037(73)90242-1; Neff U, 1999, GEOCHIM COSMOCHIM AC, V63, P2211, DOI 10.1016/S0016-7037(99)00135-0; Nielsen SG, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002003; Noordmann J., 2011, MINERAL MAG, V75, P1548; Nozaki T, 2012, GEOSTAND GEOANAL RES, V36, P131, DOI 10.1111/j.1751-908X.2011.00125.x; Oda H, 2011, GEOLOGY, V39, P227, DOI 10.1130/G31610.1; Peucker-Ehrenbrink B, 2000, TERRA NOVA, V12, P205, DOI 10.1046/j.1365-3121.2000.00295.x; Peucker-Ehrenbrink B., 2001, GEOCHEM GEOPHYS GEOS, V2; Ravizza G, 2003, EARTH PLANET SC LETT, V210, P151, DOI 10.1016/S0012-821X(03)00137-7; Sims KWW, 1999, GEOCHIM COSMOCHIM AC, V63, P4119, DOI 10.1016/S0016-7037(99)00313-0; Tokumaru A., 2012, MINERAL MAG, V76, P2461; Verbruggen A., 2008, PREPARATION CERTIFIC; von Blanckenburg F, 1996, GEOCHIM COSMOCHIM AC, V60, P4957, DOI 10.1016/S0016-7037(96)00310-9; von Blanckenburg F, 1996, EARTH PLANET SC LETT, V141, P213, DOI 10.1016/0012-821X(96)00059-3; YAMADA M, 1984, MAR GEOL, V54, P263, DOI 10.1016/0025-3227(84)90042-2	78	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037	1872-9533		GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	DEC 1	2014	146						43	58		10.1016/j.gca.2014.10.003		16	Geochemistry & Geophysics	Geochemistry & Geophysics	AT4XP	WOS:000344946000004		
J	Jeong, SW; Park, SS; Fukuoka, H				Jeong, Sueng Won; Park, Sung-Sik; Fukuoka, Hiroshi			Shear behavior of waste rock materials in drained and undrained ring shear tests	GEOSCIENCES JOURNAL			English	Article						ring shear test; abandoned mines; waste rock materials; shear stress; grain crushing	LANDSLIDES; PREFECTURE; APPARATUS; RAINFALL; DYNAMICS; JAPAN; SANDS; SOILS; MINE	The denudation processes in abandoned mines pose environmental and social problems. Insufficient remediation and cleanup modify the physicochemical properties near the mine sites. In addition, large amounts of sediment and debris can flow downward due to heavy rainfall. Here, the shear characteristics of mine deposits are presented rather than their chemical contaminants, which include heavy metals. Drained and undrained ring shear tests were performed on waste rock materials that were collected from pyrophyllite mine deposits in the mountainous region of Korea. These samples were classified as gravelly sandy soils (i.e., with an effective grain size of D-10 = 0.3 mm and a uniformity coefficient of c(u) = 5). The following three tests were performed: (i) shear stress measurement with shearing time for a given shear velocity (i.e., 0.1 mm/sec), (ii) shear stress as a function of shear velocity, and (iii) shear stress as a function of normal stress. The fully saturated samples were subjected to different normal stresses (i.e., 25 and 100 kPa) and shear velocities (i.e., 0.01, 0.1, 1, and 100 mm/sec). The waste materials exhibited a strain-softening behavior regardless of the drainage and shear velocity condition. In addition, the shear stress was strongly influenced by the shear velocity and increased with increasing shear velocity and normal stress in the post-failure stage. Using grain size distribution analyses, we show that significant grain crushing occurs in the shear zone during shearing. Under relatively high shear velocity conditions (i.e., >;100 mm/sec), the grain crushing effect is more significant and results in rapid mass movements.	[Jeong, Sueng Won] Korea Inst Geosci & Mineral Resources, Taejon 305350, South Korea; [Park, Sung-Sik] Kyungpook Natl Univ, Dept Civil Engn, Taegu 702701, South Korea; [Fukuoka, Hiroshi] Niigata Univ, Res Inst Nat Hazards & Disaster Recovery, Niigata 9502181, Japan	Jeong, SW (reprint author), Korea Inst Geosci & Mineral Resources, Taejon 305350, South Korea.	suengwon@hotmail.com			KIGAM [14-3212, 14-3215]; Regional Technology Innovation Program by Ministry of Land, Infrastructure and Transport of Korean government [12-RTIP-B01]	The authors would like to thank the KIGAM research project (14-3212, 14-3215) for their support. The authors highly appreciated the detailed, valuable comments of the reviewers and editor regarding our paper. This research was supported by a grant (12-RTIP-B01) from Regional Technology Innovation Program by Ministry of Land, Infrastructure and Transport of Korean government.	Sassa K, 2004, LANDSLIDES, V1, P7, DOI 10.1007/s10346-003-0004-y; Leroueil S, 2001, GEOTECHNIQUE, V51, P197, DOI 10.1680/geot.51.3.197.39365; Leroueil S, 1996, LANDSLIDES, P53; Hungr O, 2005, S-P BKS GEOPHYS SCI, P135; Fukuoka H, 2007, LANDSLIDES, V4, P63, DOI 10.1007/s10346-006-0053-0; Neiva AMR, 2014, J GEOCHEM EXPLOR, V136, P102, DOI 10.1016/j.gexplo.2013.10.014; Li YR, 2013, ENG GEOL, V154, P106, DOI 10.1016/j.enggeo.2012.12.015; Feda J, 2002, ENG GEOL, V63, P93, DOI 10.1016/S0013-7952(01)00072-2; Ferreira da Silva E., 2009, SCI TOTAL ENVIRON, V497, P5620; FUKUOKA H, 1991, US FOR SERV T R PSW, V130, P33; Fukuoka H, 2006, LANDSLIDES, V3, P239, DOI 10.1007/s10346-006-0043-2; IGUS-WGL, 1995, B INT ASS ENG GEOL, V52, P75; Jeong S.W, 2011, J KOREAN SOC CIVIL E, V33, P181; Jeong SW, 2013, MAR GEORESOUR GEOTEC, V31, P190, DOI 10.1080/1064119X.2012.676155; Jiao YY, 2013, ENG GEOL, V159, P36, DOI 10.1016/j.enggeo.2013.03.021; LAMBE T.W, 1979, SOIL MECH SI VERSION, V3; Meju MA, 2000, J APPL GEOPHYS, V44, P115, DOI 10.1016/S0926-9851(00)00011-2; Okada Y, 2004, ENG GEOL, V75, P325, DOI 10.1016/j.enggeo.2004.07.001; Sassa K, 2003, GEOTECH TEST J, V26, P1; Sassa K., 2007, PROGR LANDSLIDE SCI; Wafid M.A, 2004, LANDSLIDES, V1, P101; Wang F., 2000, J NATURAL DISASTER S, V22, P87, DOI 10.2328/jnds.22.87; Wang FW, 2002, ENG GEOL, V63, P169, DOI 10.1016/S0013-7952(01)00080-1; Wang GH, 2010, EARTH SURF PROC LAND, V35, P407, DOI 10.1002/esp.1937; Wang GH, 2002, CAN GEOTECH J, V39, P821, DOI 10.1139/T02-032	25	0	0	GEOLOGICAL SOCIETY KOREA	SEOUL	NEW BLD RM 813, KSTC, 835-4, YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-4806	1598-7477		GEOSCI J	Geosci. J.	DEC	2014	18	4					459	468		10.1007/s12303-014-0030-x		10	Geosciences, Multidisciplinary	Geology	AT9YQ	WOS:000345280300008		
J	Ito, H; Morishita, R; Iwamoto, I; Nagata, K				Ito, Hidenori; Morishita, Rika; Iwamoto, Ikuko; Nagata, Koh-ichi			Establishment of an In Vivo Electroporation Method into Postnatal Newborn Neurons in the Dentate Gyrus	HIPPOCAMPUS			English	Article						hippocampus; neuron; in vivo electroporation; dendrite; spine	HIPPOCAMPAL NEUROGENESIS; UTERO ELECTROPORATION; ADULT NEUROGENESIS; GENE-TRANSFER; MIGRATION; CELLS; ANTIDEPRESSANTS; PRECURSORS; MATURATION; FOREBRAIN	Electroporation-mediated gene transfer has been developed for the analysis of mammalian brain development in vivo. Indeed, in utero electroporation method is widely used for the investigation of the mouse embryonic cortical development while in vivo electroporation using neonatal mouse brain is employed for the analysis of the rostral migratory stream (RMS) and postnatal olfactory neurogenesis. In the present study, we established a stable gene-transfer method to dentate gyrus (DG) neurons by carefully determining the in vivo electroporation conditions, such as position and direction of electrode, voltage for electric pulses, and interval between electroporation and sample preparation. Consequently, GFP-positive cells in DG were observed to extend branched dendrites and long axons into the molecular layer and the hilus, respectively, 21 days after electrporation. They were morphologically identified as dentate granule neurons with many protrusions on dendrites, and some of them had wide head and thin neck that resembled matured mushroom spines. Expression of GFP in dentate neurons sustained for at least 9 months after electroporation under our experimental conditions. Taken together, the method developed here could be a powerful new tool for the analysis of the postnatal DG development. (c) 2014 Wiley Periodicals, Inc.	[Ito, Hidenori; Morishita, Rika; Iwamoto, Ikuko; Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi 4800392, Japan	Nagata, K (reprint author), Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, 713-8 Kamiya, Kasugai, Aichi 4800392, Japan.	knagata@inst-hsc.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [23590124, 25461658, 24390271, 25122722, 25670488]; Takeda Science Foundation	Grant sponsor: Ministry of Education, Science, Technology, Sports and Culture of Japan; Grant numbers: 23590124, 25461658, 24390271, 25122722, 25670488; Grant sponsor: Takeda Science Foundation.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P343, DOI 10.1002/cne.903010303; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Snyder JS, 2011, NEUROBIOL AGING, V32, P1149, DOI 10.1016/j.neurobiolaging.2009.05.022; Jinno S, 2011, HIPPOCAMPUS, V21, P467, DOI 10.1002/hipo.20762; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Huang YS, 2013, BIOL PSYCHIAT, V74, P62, DOI 10.1016/j.biopsych.2013.01.005; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Tomita K, 2011, HUM MOL GENET, V20, P2834, DOI 10.1093/hmg/ddr194; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; SERESS L, 1981, J ANAT, V133, P181; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Nishimura YV, 2012, MED MOL MORPHOL, V45, P1, DOI 10.1007/s00795-011-0557-0; Choe Y, 2013, J NEUROSCI, V33, P6766, DOI 10.1523/JNEUROSCI.0128-13.2013; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Tabata H, 2008, DEV GROWTH DIFFER, V50, P507, DOI [10.1111/j.1440-169X.2008.01043.x, 10.1111/j.1440-169x.2008.01043.x]; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Boutin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001883; Chesler AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001517; Fernandez ME, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-13; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Fung SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025194; vansPraag H, 1999, NAT NEUROSCI, V2, P266; Walton NM, 2012, TRANSL PSYCHIAT, V10, pe135; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	DEC	2014	24	12					1449	1457		10.1002/hipo.22325		9	Neurosciences	Neurosciences & Neurology	AU0TE	WOS:000345336600005		
J	Xu, XB; He, Y; Song, C; Ke, X; Fan, SJ; Peng, WJ; Tan, R; Kawata, M; Matsuda, KI; Pan, BX; Kato, N				Xu, Xiao-Bin; He, Ye; Song, Chen; Ke, Xin; Fan, Shi-Jun; Peng, Wei-Jie; Tan, Ruei; Kawata, Mitsuhiro; Matsuda, Ken-Ichi; Pan, Bing-Xing; Kato, Nobumasa			Bisphenol A Regulates the Estrogen Receptor Alpha Signaling in Developing Hippocampus of Male Rats Through Estrogen Receptor	HIPPOCAMPUS			English	Article						phosphorylation; nuclear translocation; ICI 182780; environmental estrogen; spatial learning	MESSENGER-RNA; PERINATAL EXPOSURE; GENE-EXPRESSION; SEX-DIFFERENCES; PROTEIN-LEVELS; ICI 182,780; ESTRADIOL; PHOSPHORYLATION; MICE; CORTEX	Bisphenol A (BPA), one of the most common environmental endocrine disruptors, has been recognized to have wide adverse effects on the brain development and behavior. These adversities are related to its ability to bind estrogen receptor (ER) with subsequent alteration of its expression in the target areas. However, very little is known about whether BPA exposure also affects ER phosphorylation and its translocation to nucleus during postnatal development, two critical steps for its function. Here, we found that during development from postnatal day 7 (P7) to P21, the alpha subtype of ER (ER) in the hippocampus of male rats experienced remarkable alterations in terms of its expression, phosphorylation and translocation to nucleus. Exposure to low level of BPA had bidirectional, development-dependent effects on the expression of ER mRNA and protein, but decreased ER phosphorylation and impaired its translocation to nucleus throughout the period investigated. Treatment with low dose of ICI 182,780 (ICI), an ER antagonist to block the binding of ER with BPA, reversed the altered ER following BPA exposure, highlighting critical involvement of ER. Moreover, ICI treatment rescued the hippocampus-dependent behavioral deficits in the adult rats experiencing early-life BPA exposure. Overall, our results indicate that BPA interferes with the ER signaling in the developing hippocampus in an ER-dependent manner, which may underlie its adverse behavioral and cognitive outcomes in adult animals. (c) 2014 Wiley Periodicals, Inc.	[Xu, Xiao-Bin; He, Ye; Song, Chen; Ke, Xin; Fan, Shi-Jun; Pan, Bing-Xing] Nanchang Univ, Inst Life Sci, Lab Fear & Anxiety Disorder, Nanchang 330031, Peoples R China; [He, Ye; Peng, Wei-Jie] Nanchang Univ, Dept Pharmacol, Nanchang 330031, Peoples R China; [Tan, Ruei; Kato, Nobumasa] Showa Univ, Sch Med, Dept Psychiat, Tokyo 1578577, Japan; [Kawata, Mitsuhiro; Matsuda, Ken-Ichi] Kyoto Prefectural Univ, Dept Anat & Neurobiol, Kyoto 6028566, Japan	Xu, XB (reprint author), Nanchang Univ, Nanchang 330031, Peoples R China.	xuxiaobin70@hotmail.com; panbingxing@ncu.edu.cn			973 Basic Research Program of China [2014CB846100]; National Natural Science Foundation of China [81071096, 31160208, 31260244, 91332123]; Program for New Century Excellent Talents in Universities of China; major scientific project of Jiangxi Province; "555 talent project"	Grant sponsor: National 973 Basic Research Program of China; Grant number: 2014CB846100; Grant sponsor: National Natural Science Foundation of China; Grant numbers: 81071096, 31160208, 31260244, 91332123; Grant sponsor: Program for New Century Excellent Talents in Universities of China; Grant sponsor: "555 talent project" and the major scientific project of Jiangxi Province.	Alfinito PD, 2008, ENDOCRINOLOGY, V149, P5219, DOI 10.1210/en.2008-0532; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Tian YH, 2010, SYNAPSE, V64, P432, DOI 10.1002/syn.20746; Xu XH, 2010, TOXICOL APPL PHARM, V249, P188, DOI 10.1016/j.taap.2010.09.007; Rodgers SP, 2010, ENDOCRINOLOGY, V151, P1194, DOI 10.1210/en.2009-1245; Cao JY, 2013, TOXICOL SCI, V133, P157, DOI 10.1093/toxsci/kft035; Brede C, 2003, FOOD ADDIT CONTAM, V20, P684, DOI 10.1080/02652030210134236; Xu X, 2007, NEUROSCI RES, V58, P149, DOI 10.1016/j.neures.2007.02.011; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Ivanova T, 2000, CELL TISSUE RES, V300, P231, DOI 10.1007/s004410000199; Hart SA, 2007, J NEUROSCI, V27, P2102, DOI 10.1523/JNEUROSCI.5436-06.2007; OKEEFE JA, 1995, MOL BRAIN RES, V30, P115, DOI 10.1016/0169-328X(94)00284-L; Bohacek J, 2009, J NEUROENDOCRINOL, V21, P640, DOI 10.1111/j.1365-2826.2009.01882.x; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Nakamura D, 2010, TOXICOL LETT, V194, P16, DOI 10.1016/j.toxlet.2010.02.002; McEwen BS, 1995, CIBA F SYMP, V191, P52; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Xu XH, 2013, CHEMOSPHERE, V91, P1073, DOI 10.1016/j.chemosphere.2012.12.065; Rune GM, 2002, NEUROSCIENCE, V113, P167, DOI 10.1016/S0306-4522(02)00152-5; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; Chao HH, 2012, HISTOCHEM CELL BIOL, V137, P249, DOI 10.1007/s00418-011-0894-z; Bagamasbad P, 2011, GEN COMP ENDOCR, V170, P3, DOI 10.1016/j.ygcen.2010.03.013; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Edginton AN, 2009, ENVIRON HEALTH PERSP, V117, P645, DOI 10.1289/ehp.0800073; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565; Iivonen S, 2006, NEUROSCIENCE, V137, P1143, DOI 10.1016/j.neuroscience.2005.10.023; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Gundlah C, 2000, MOL BRAIN RES, V76, P191, DOI 10.1016/S0006-8993(99)02475-0; Eilam-Stock T, 2012, BEHAV NEUROSCI, V126, P175, DOI 10.1037/a0025959; BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439; Gardener HE, 2001, HORM BEHAV, V39, P121, DOI 10.1006/hbeh.2000.1638; Hatanaka Y, 2003, PATHOL INT, V53, P693, DOI 10.1046/j.1440-1827.2003.01547.x; Hatsumi T, 2006, EXP BIOL MED, V231, P311; Lahooti H, 1995, J STEROID BIOCHEM, V55, P305, DOI 10.1016/0960-0760(95)00188-3; LE GP, 1994, J BIOL CHEM, V269, P4458; McCarthy MM, 1997, BRAIN RES BULL, V44, P487, DOI 10.1016/S0361-9230(97)00230-X; NANCY LW, 2007, MOL ENDOCRINOL, V21, P2311; Papaconstantinou AD, 2001, TOXICOL SCI, V63, P173, DOI 10.1093/toxsci/63.2.173; Papaconstantinou AD, 2000, TOXICOL SCI, V56, P332, DOI 10.1093/toxsci/56.2.332; SONG RX, 2006, ENDOCR-RELAT CANCER, V13, pS1; [王亚民 WANG Ya-min], 2009, [生物物理学报, Acta Biophysica Sinica], V25, P423; Watanabe M, 2012, TOXICOL LETT, V210, P95, DOI 10.1016/j.toxlet.2012.01.020; Wilson ME, 2011, HORM BEHAV, V59, P353, DOI 10.1016/j.yhbeh.2010.08.004; Xu XB, 2011, NEUROTOXICOL TERATOL, V33, P458, DOI 10.1016/j.ntt.2011.06.002	46	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	DEC	2014	24	12					1570	1580		10.1002/hipo.22336		11	Neurosciences	Neurosciences & Neurology	AU0TE	WOS:000345336600015		
J	Kosaki, Y; Lin, TCE; Horne, MR; Pearce, JM; Gilroy, KE				Kosaki, Yutaka; Lin, Tzu-Ching Esther; Horne, Murray R.; Pearce, John M.; Gilroy, Kerry E.			The Role of the Hippocampus in Passive and Active Spatial Learning	HIPPOCAMPUS			English	Article						spatial learning; S-S versus S-R association; passive learning; length discrimination; hippocampus	NICTITATING-MEMBRANE RESPONSE; AMYGDALA LESIONS; CAUDATE-NUCLEUS; DORSAL STRIATUM; MEMORY-SYSTEMS; RATS; NAVIGATION; PLACE; ENVIRONMENT; DISCRIMINATION	Rats with lesions of the hippocampus or sham lesions were required in four experiments to escape from a square swimming pool by finding a submerged platform. Experiments 1 and 2 commenced with passive training in which rats were repeatedly placed on the platform in one cornerthe correct cornerof a pool with distinctive walls. A test trial then revealed a strong preference for the correct corner in the sham but not the hippocampal group. Subsequent active training of being required to swim to the platform resulted in both groups acquiring a preference for the correct corner in the two experiments. In Experiments 3 and 4, rats were required to solve a discrimination between different panels pasted to the walls of the pool, by swimming to the middle of a correct panel. Hippocampal lesions prevented a discrimination being formed between panels of different lengths (Experiment 3), but not between panels showing lines of different orientations (Experiment 4); rats with sham lesions mastered both problems. It is suggested that an intact hippocampus is necessary for the formation of stimulus-goal associations that permit successful passive spatial leaning. It is further suggested that an intact hippocampus is not necessary for the formation of stimulus-response associations, except when they involve information about length or distance. (c) 2014 The Authors. Hippocampus Published by Wiley Periodicals, Inc.	[Kosaki, Yutaka; Lin, Tzu-Ching Esther; Horne, Murray R.; Pearce, John M.; Gilroy, Kerry E.] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Kosaki, Y (reprint author), Keio Univ, Adv Res Ctr, Tokyo, Japan.	y.kosaki@cantab.net			United Kingdom Biotechnology and Biological Sciences Research Council; Wellcome Trust	Grant sponsors: United Kingdom Biotechnology and Biological Sciences Research Council, the Wellcome Trust.	Aggleton JP, 2001, PHILOS T ROY SOC B, V356, P1467; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; White NM, 2006, LEARN MEMORY, V13, P119, DOI 10.1101/lm.138806; Pearce JM, 2004, J EXP PSYCHOL ANIM B, V30, P135, DOI 10.1037/0097-7403.30.2.135; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; KEITH JR, 1988, PSYCHOBIOLOGY, V16, P146; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Hollup SA, 2001, J NEUROSCI, V21, P4505; Pearce JM, 1998, NATURE, V396, P75, DOI 10.1038/23941; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; MULLER RU, 1987, J NEUROSCI, V7, P1935; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Kosaki Y, 2013, J EXP PSYCHOL ANIM B, V39, P342, DOI 10.1037/a0032570; Sheynikhovich D, 2009, PSYCHOL REV, V116, P540, DOI 10.1037/a0016170; O'Reilly RC, 2000, HIPPOCAMPUS, V10, P389, DOI 10.1002/1098-1063(2000)10:4<389::AID-HIPO5>3.0.CO;2-P; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pearce JM, 2009, Q J EXP PSYCHOL, V62, P1665, DOI 10.1080/17470210902805589; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; RUDY JW, 1989, BEHAV BRAIN RES, V34, P97, DOI 10.1016/S0166-4328(89)80093-2; NADEL L, 1980, PHYSIOL PSYCHOL, V8, P218; Devan BD, 1999, J NEUROSCI, V19, P2789; Chai SC, 2004, BEHAV NEUROSCI, V118, P770, DOI 10.1037/0735-7044.118.4.770; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; Gilroy KE, 2014, J EXP PSYCHOL ANIM B, V40, P212, DOI 10.1037/xan0000017; Honey RC, 2014, NEUROBIOL LEARN MEM, V108, P96, DOI 10.1016/j.nlm.2013.06.002; Horne MR, 2010, BEHAV NEUROSCI, V124, P623, DOI 10.1037/a0020824; Horne MR, 2012, J EXP PSYCHOL ANIM B, V38, P139, DOI 10.1037/a0027288; JACOBS WJ, 1989, J EXP PSYCHOL ANIM B, V15, P36, DOI 10.1037//0097-7403.15.1.36; JACOBS WJ, 1989, J EXP PSYCHOL ANIM B, V15, P286, DOI 10.1037/0097-7403.15.3.286; Jones PM, 2007, BEHAV NEUROSCI, V121, P1258, DOI 10.1037/0735-7044.121.6.1258; McGregor A, 2004, BEHAV NEUROSCI, V118, P1011, DOI 10.1037/0735-7044.118.5.1011; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 1990, WATERMAZE SOFTWARE C; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; Paxinos G., 2005, RAT BRAIN STEREOTAXI; SOLOMON PR, 1975, J COMP PHYSIOL PSYCH, V89, P1192, DOI 10.1037/h0077183; SUTHERLAND RJ, 1982, BEHAV NEURAL BIOL, V36, P103, DOI 10.1016/S0163-1047(82)90101-7; White N. M., 2008, MEMORY SYSTEMS, P9; WHITE NM, 1993, BEHAV BRAIN RES, V55, P269, DOI 10.1016/0166-4328(93)90122-7	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	DEC	2014	24	12					1633	1652		10.1002/hipo.22343		20	Neurosciences	Neurosciences & Neurology	AU0TE	WOS:000345336600021		
J	Wang, YL; Bai, L; Lin, Y; Guan, H; Zhu, NH; Chen, YL; Li, YF; Gao, SC; Zhao, SH; Fan, JL; Liu, EQ				Wang, Yanli; Bai, Liang; Lin, Yan; Guan, Hua; Zhu, Ninghong; Chen, Yulong; Li, Yafeng; Gao, Shoucui; Zhao, Sihai; Fan, Jianglin; Liu, Enqi			Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects	HISTOLOGY AND HISTOPATHOLOGY			English	Article						Atorvastatin; Probucol; Cilostazol; Atherosclerosis; Hypercholesterolemia	CHOLESTEROL-FED RABBITS; ENDOTHELIAL-CELLS; TRANSGENIC RABBITS; ATHEROSCLEROSIS; MANAGEMENT; RISK; SEE	Statins are often prescribed for treatment of cardiovascular diseases, although there are still many patients who cannot be effectively treated by statins alone. Both probucol and cilostazol exhibit anti-atherogenic effects. In the current study, we attempted to investigate whether a probucol and cilostazol combination had any add-on effects on atorvastatin. To examine this hypothesis, we fed Japanese white rabbits with a cholesterol-rich diet supplemented with atorvastatin alone (Statin group), probucol and cilostazol (PC group), atorvastatin, probucol and cilostazol (APC group), and compared their effects on plasma lipids and aortic atherosclerosis. All three drug-treated groups had lowered total cholesterol levels compared with the vehicle group but high-density lipoproteins cholesterol levels of the atorvastatin group were higher than other groups. Although aortic atherosclerosis was significantly reduced in all drug-treated groups, the most prominent atheroprotective effect was seen in APC group (APC: 67% reduction> PC: 43% reduction> Statin group: 42% reduction over the vehicle). Morphometric analysis revealed that the reduced aortic atherosclerosis in all three groups was mainly attributed to the reduction of intimal macrophages and smooth muscle cells. These results suggest that a combination of probucol and cilostazol with statin enhances statin's anti-atherogenic functions, which may be beneficial for those patients who are less responsive to statin therapy alone.	[Wang, Yanli; Bai, Liang; Lin, Yan; Guan, Hua; Zhu, Ninghong; Chen, Yulong; Li, Yafeng; Gao, Shoucui; Zhao, Sihai; Liu, Enqi] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian 710049, Shaanxi, Peoples R China; [Wang, Yanli; Bai, Liang; Lin, Yan; Guan, Hua; Zhu, Ninghong; Chen, Yulong; Li, Yafeng; Gao, Shoucui; Zhao, Sihai; Liu, Enqi] Xi An Jiao Tong Univ, Lab Anim Ctr, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan	Liu, EQ (reprint author), Xi An Jiao Tong Univ, Sch Med, Res Inst Atherosclerot Dis, Xian, Peoples R China.	liuenqi@mail.xjtu.edu.cn			National Natural Science Foundation of China [81070250, 81270348]; National Science and Technology Support Program [2012BAI39B02]; Public Service Platform Grant of Shaanxi Province [2012FWPT-03]; Otsuka Pharmaceutical Co., Ltd.	This work was partly supported by the National Natural Science Foundation of China (81070250, 81270348), by National Science and Technology Support Program (No. 2012BAI39B02), by a Public Service Platform Grant of Shaanxi Province (2012FWPT-03), and by Otsuka Pharmaceutical Co., Ltd.	Zhao SH, 2008, THROMB RES, V123, P281, DOI 10.1016/j.thromres.2008.04.011; Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Miida T, 2008, ATHEROSCLEROSIS, V200, P329, DOI 10.1016/j.atherosclerosis.2007.12.031; Kim MJ, 2005, HYPERTENSION, V45, P552, DOI 10.1161/01.HYP.0000158263.64320.eb; Chen YL, 2013, THROMB RES, V132, P565, DOI 10.1016/j.thromres.2013.09.007; Hirano K, 2005, ARTERIOSCL THROM VAS, V25, P2422, DOI 10.1161/01.ATV.0000185834.98941.3d; Liang JY, 2006, CIRCULATION, V113, P1993, DOI 10.1161/CIRCULATIONAHA.105.596031; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Fan JL, 2003, PHARMACOL THERAPEUT, V99, P261, DOI 10.1016/S0163-7258(03)00069-X; Deng YM, 2004, CIRCULATION, V110, P1855, DOI 10.1161/01.CIR.0000142610.10530.25; Roberts WC, 1997, AM J CARDIOL, V80, P106, DOI 10.1016/S0002-9149(97)00298-1; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; Brunzell JD, 2008, J AM COLL CARDIOL, V51, P1512, DOI [10.1016/j.jacc.2008.02.034, 10.1016/j.jucc.2008.02.03]; Yamashita S, 2009, ATHEROSCLEROSIS, V207, P16, DOI 10.1016/j.atherosclerosis.2009.04.002; Maron DJ, 2000, CIRCULATION, V101, P207; Nakaya K, 2010, ATHEROSCLEROSIS, V213, P135, DOI 10.1016/j.atherosclerosis.2010.07.024; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI 10.1093/eurheartj/ehr158; Yamamoto S, 2011, CIRCULATION, V124, P1382, DOI 10.1161/CIRCULATIONAHA.110.009704; Zhang C, 2010, J COMP PATHOL, V142, P122, DOI [10.1016/j.jcpa.2009.08.159, 10.1016/j.jcpa.2009.07.159]; Yamashita S, 2008, J ATHEROSCLER THROMB, V15, P292; Arca M, 2012, PANMINERVA MED, V54, P105; Fan J, 2000, J Atheroscler Thromb, V7, P26; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Niimi M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-166; Okutsu R, 2009, ATHEROSCLEROSIS, V204, P405, DOI 10.1016/j.atherosclerosis.2008.10.042; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Rosamond W., 2008, CIRCULATION, V117, pe125; Weintraub WS, 2006, CAN J CARDIOL, V22, p56B; Yamamoto A, 2008, J ATHEROSCLER THROMB, V15, P304; Yamazaki D, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-9	32	1	1	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	DEC	2014	29	12					1593	1600				8	Cell Biology; Pathology	Cell Biology; Pathology	AT7ND	WOS:000345123500011		
J	Chekirbane, A; Tsujimura, M; Kawachi, A; Lachaal, F; Isoda, H; Tarhouni, J				Chekirbane, Anis; Tsujimura, Maki; Kawachi, Atsushi; Lachaal, Fethi; Isoda, Hiroko; Tarhouni, Jamila			Use of a time-domain electromagnetic method with geochemical tracers to explore the salinity anomalies in a small coastal aquifer in north-eastern Tunisia	HYDROGEOLOGY JOURNAL			English	Article						Salinization; Geophysical methods; Geochemical tracers; Coastal aquifers; Tunisia	SEAWATER INTRUSION; SALTWATER INTRUSION; GROUNDWATER; TRANSIENT; SOUNDINGS; CONFIGURATION; SALINIZATION; DELINEATION; INTERFACE; PENINSULA	The study area is a small coastal plain in north-eastern Tunisia. It is drained by an ephemeral stream network and is subject to several pollutant discharges such as oilfield brine coming from a neighboring oil company and wastewater from SomA cent a city, located in the upstream of the plain. Furthermore, a hydraulic head near the coastal part of the aquifer is below sea level, suggesting that seawater intrusion may occur. A time-domain electromagnetic (TDEM) survey, based on 28 soundings, was conducted in Wadi Al Ayn and Daroufa plains to delineate the saline groundwater. Based on longitudinal and transversal resistivity two-dimensional pseudosections calibrated with boring data, the extent of saline water was identified. Geochemical tracers were combined with the resistivity dataset to differentiate the origin of groundwater salinization. In the upstream part of the plain, the infiltration of oilfield brine through the sandy bed of Wadi Al Ayn seems to have a considerable effect on groundwater salinization. However, in the coastal part of the aquifer, groundwater salinization is due to seawater intrusion and the saltwater is reaching an inland extent around 1.3 km from the shoreline. The contribution ratios of saline water bodies derived from the inverted chloride data vary for the oilfield brine from 1 to 13 % and for the seawater from 2 to 21 %.	[Chekirbane, Anis; Lachaal, Fethi] Borj Cedria Technopk, Water Res & Technol Ctr, Soliman 8020, Tunisia; [Tsujimura, Maki] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Kawachi, Atsushi; Isoda, Hiroko] Univ Tsukuba, Alliance Res North Africa ARENA, Tsukuba, Ibaraki 3058577, Japan; [Tarhouni, Jamila] Univ Carthage, Natl Agron Inst Tunisia INAT, Tunis Mahrajene 1082, Tunisia	Chekirbane, A (reprint author), Borj Cedria Technopk, Water Res & Technol Ctr, Route Tourist Soliman BP 273, Soliman 8020, Tunisia.	anischkirbene@gmail.com			Science and Technology Research Partnership for Sustainable Development (SATREPS) program - Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA), Japan	This work was supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS) program, funded by the Japan Science and Technology Agency (JST) and the Japan International Cooperation Agency (JICA), Japan. The authors would also like to thank the anonymous reviewers for their constructive comments.	Abdalla OAE, 2010, HYDROGEOL J, V18, P1437, DOI 10.1007/s10040-010-0606-0; Adepelumi AA, 2009, ENVIRON GEOL, V56, P927, DOI 10.1007/s00254-008-1194-3; Kouzana L, 2010, J AFR EARTH SCI, V58, P242, DOI 10.1016/j.jafrearsci.2010.03.005; FITTERMAN DV, 1986, GEOPHYSICS, V51, P995, DOI 10.1190/1.1442158; Stuyfzand PJ, 1999, HYDROGEOL J, V7, P15, DOI 10.1007/s100400050177; Bauer-Gottwein P, 2010, J HYDROL, V380, P318, DOI 10.1016/j.jhydrol.2009.11.007; MILLS T, 1988, GROUND WATER, V26, P771, DOI 10.1111/j.1745-6584.1988.tb00428.x; Duque C, 2008, J HYDROL, V349, P536, DOI 10.1016/j.jhydrol.2007.11.031; GOLDMAN M, 1991, GEOEXPLORATION, V28, P153, DOI 10.1016/0016-7142(91)90046-F; Danielsen JE, 2003, J APPL GEOPHYS, V53, P181, DOI 10.1016/j.jappgeo.2003.08.004; Archie GE, 1942, T AM I MIN MET ENG, V146, P54; Kouzana L, 2009, CR GEOSCI, V341, P21, DOI 10.1016/j.crte.2008.09.008; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Kafri U, 1997, ENVIRON GEOL, V31, P42; Ben Moussa A, 2010, CARBONATE EVAPORITE, V25, P161, DOI 10.1007/s13146-010-0020-7; Maliki MA, 2000, CR ACAD SCI II A, V331, P1; Ben Hamouda MF, 2011, ENVIRON EARTH SCI, V63, P889, DOI 10.1007/s12665-010-0758-1; FROHLICH RK, 1994, J APPL GEOPHYS, V32, P139, DOI 10.1016/0926-9851(94)90016-7; Yechieli Y, 2001, HYDROGEOL J, V9, P367; Appelo C.A.J., 2005, GEOCHEMISTRY GROUNDW; Ben Hamouda MF, 2010, P 21 SALTW INTR M JU; Bernd CR, 1993, GEOCHEMICAL TECHNIQU; CCI CapBon, 2011, CHAMBR COMM IND CAPB; Chattouti F, 2006, THESIS U CARTHAGE BI; Chekirbane A, 2013, THESIS U TSUKUBA JAP; Christensen N.B., 1998, EUROPEAN J ENV ENG G, V31, P75; Clark I., 1997, ENV ISOTOPES HYDROLO; Colleuil B, 1976, THESIS NICE U FRANCE; Custodio E, 1987, STUDIES REPORTS HYDR, P396; Ennabli M, 1980, THESIS NICE U FRANCE; Ernstson K, 2006, GROUNDWATER GEOPHYS, P447; Everett M, 2005, HYDROGEOPHYSICS; Finkl Jr CW, 1994, J COASTAL RES, V12, P372; Freeze R.A., 1979, GROUNDWATER, P604; Herckenrath D, 2012, GROUND WATER, DOI [10.1111/j.1745-6584.2012.00974, DOI 10.1111/J.1745-6584.2012.00974]; Hudak FH, 2001, ENVIRON INT, V26, P497; Jemai S, 1996, THESIS INAT TUNISIA; Kafri U, 2005, J APPL GEOPHYS, V57, P167, DOI 10.1016/j.jappgeo.2004.09.001; Kaufman AA, 1983, FREQUENCY TRANSIENT, P685; Kerrou J, 2008, THESIS NEUCHATEL U S; Khlaifi I, 1998, THESIS U TUNIS E1 MA; Land LA, 2004, GROUND WATER, V24, P59; Levi E, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006459; MacInnes S., 2001, STEMINV DOCUMENTATIO; MACNAE JC, 1984, GEOPHYSICS, V49, P934, DOI 10.1190/1.1441739; MCCRACKEN KG, 1986, GEOPHYSICS, V51, P819, DOI 10.1190/1.1442134; McNeill J.D., 1990, GEOTECHNICAL ENV GEO, P191; Paine JG, 2003, WATER RESOUR RES, V39, DOI 10.1029/2001WR000710; Paniconi C, 2001, PHYS CHEM EARTH PT B, V26, P345, DOI 10.1016/S1464-1909(01)00017-X; Paniconi C, 2004, TRANSPORT POROUS MED, V43, P3; Piper AM, 1944, T AM GEOPHYS UNION, V25, P914; Rekaya M, 1989, CONTEXTE HYDROGEOLOG; Rhoades J. D., 1992, 48 FAO; Rouatbi R, 1968, ETUDE HYDROGEOLOGIQU; Salem H Ben, 1992, THESIS U TUNIS TUNIS; Slama F, 2010, THESIS NEUCHATEL U S; STEWART M, 1986, GROUND WATER, V24, P351, DOI 10.1111/j.1745-6584.1986.tb01011.x; Thomsen R, 2004, HYDROGEOL J, V12, P550, DOI 10.1007/s10040-004-0345-1; Trabelsi F, 2013, HYDROL PROCESS, V27, P2004, DOI 10.1002/hyp.9354; Zghibi A, 2011, HYDROL PROCESS, V25, P1822, DOI 10.1002/hyp.7948; Zonge KL, 1992, PRACTICAL GEOPHYSICS	61	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1431-2174	1435-0157		HYDROGEOL J	Hydrogeol. J.	DEC	2014	22	8					1777	1794		10.1007/s10040-014-1180-7		18	Geosciences, Multidisciplinary; Water Resources	Geology; Water Resources	AU0AN	WOS:000345285600005		
J	Iwasaki, Y; Nakamura, K; Horino, H; Kawashima, S				Iwasaki, Yumi; Nakamura, Kimihito; Horino, Haruhiko; Kawashima, Shigeto			Assessment of factors influencing groundwater-level change using groundwater flow simulation, considering vertical infiltration from rice-planted and crop-rotated paddy fields in Japan	HYDROGEOLOGY JOURNAL			English	Article						Groundwater recharge/water budget; Paddy field; HYDRUS-1D; MODFLOW; Japan	WATER-BALANCE; HYDRAULIC CONDUCTIVITY; MODEL; RECHARGE; AREA; IRRIGATION; MOVEMENT; SURFACE; PLAIN; RIVER	Assessing factors that influence groundwater levels such as land use and pumping strategy, is essential to adequately manage groundwater resources. A transient numerical model for groundwater flow with infiltration was developed for the Tedori River alluvial fan (140 km(2)), Japan. The main water input into the groundwater body in this area is irrigation water, which is significantly influenced by land use, namely paddy and upland fields. The proposed model consists of two models, a one-dimensional (1-D) unsaturated-zone water flow model (HYDRUS-1D) for estimating groundwater recharge and a 3-D groundwater flow model (MODFLOW). Numerical simulation of groundwater flow from October 1975 to November 2009 was performed to validate the model. Simulation revealed seasonal groundwater level fluctuations, affected by paddy irrigation management. However, computational accuracy was limited by the spatiotemporal data resolution of the groundwater use. Both annual groundwater levels and recharge during the irrigation periods from 1975 to 2009 showed long-term decreasing trends. With the decline in rice-planted paddy field area, groundwater recharge cumulatively decreased to 61 % of the peak in 1977. A paddy-upland crop-rotation system could decrease groundwater recharge to 73-98 % relative to no crop rotation.	[Iwasaki, Yumi; Nakamura, Kimihito; Kawashima, Shigeto] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Horino, Haruhiko] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Iwasaki, Y (reprint author), Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	iwa.j.pou@gmail.com			Ministry of Agriculture, Forestry and Fisheries of Japan	This research was supported by a subsidy from the Ministry of Agriculture, Forestry and Fisheries of Japan entitled "Normal hydrological cycle in the Tedori River Alluvial Fan areas as a basis for irrigation water". The authors thank the Ishikawa Prefectural government and Ishikawa Prefectural University for providing statistical datasets.	Chen SK, 2002, J HYDROL, V260, P206, DOI 10.1016/S0022-1694(01)00615-1; Chen SK, 2002, J HYDROL, V268, P259, DOI 10.1016/S0022-1694(02)00180-4; Furman A, 2008, VADOSE ZONE J, V7, P741, DOI 10.2136/vzj2007.0065; Raneesh KY, 2013, WATER RESOUR MANAG, V27, P1517, DOI 10.1007/s11269-012-0252-5; Anan M, 2007, PADDY WATER ENVIRON, V5, P41, DOI 10.1007/s10333-006-0059-1; Phogat V, 2010, PADDY WATER ENVIRON, V8, P333, DOI 10.1007/s10333-010-0213-7; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Twarakavi NKC, 2008, VADOSE ZONE J, V7, P757, DOI 10.2136/vzj2007.0082; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Tournebize J, 2006, PADDY WATER ENVIRON, V4, P39, DOI 10.1007/s10333-005-0028-0; Bhadra A, 2013, PADDY WATER ENVIRON, V11, P331, DOI 10.1007/s10333-012-0324-4; Boggard TA, 2002, EARTH SURF PROCESS L, V27, P1177, DOI [10.1002/esp.419, DOI 10.1002/ESP.419]; Campbell G.S., 1985, SOIL PHYS BASIC TRAN; CHEN ZQ, 1994, WATER RESOUR RES, V30, P523, DOI 10.1029/93WR02885; Doherty J., 2004, PEST MODEL INDEPENDE; Don NC, 2006, AGR WATER MANAGE, V84, P295, DOI 10.1016/j.agwat.2006.03.006; Elhassan AM, 2001, T JSIDRE, V215, P21; Feddes R.A., 1978, SIMULATION MONOGRAPH; Fukushima A, 2003, REP KYUSYU BR CROP S, V69, P33; Futamata K, 2005, INFLUENCE RIVER STRE; Harbaugh A. W., 2000, 0092 US GEOL SURV; Harbaugh AW, 2005, US GEOL SURV TECH ME; Harbaugh AW, 1996, 96485 US GEOL SURV; He B, 2008, HYDROGEOL J, V16, P1215, DOI 10.1007/s10040-008-0298-x; Hokuriku Regional Agricultural Administration Office, 1977, HYDR GEOL GROUNDW IS; Horino H, 1989, T JSIDRE, V144, P9; Imaizumi M, 2006, PADDY WATER ENVIRON, V4, P251, DOI 10.1007/s10333-006-0056-4; Ishikawa Prefecture, 2012, LIST AMOUNT INTAKE W; Ishikawa Prefecture, 2010, ENV WHITE BOOK 2009; Iwasaki Y, 2013, PADDY WATER ENVIRON, V11, P551, DOI 10.1007/s10333-012-0348-9; Iwasaki Y., 2013, Journal of Japan Society of Hydrology and Water Resources, V26, P99, DOI 10.3178/jjshwr.26.99; Japan Meteorological Agency, 2008, GLOB WARM PROJ 7; Kaushal KG, 2009, AGR WATER MANAGE, V96, P1705, DOI [10.1016/j.agwat.2009.06.018, DOI 10.1016/J.AGWAT.2009.06.018]; Kayane I, 1980, GEOJOURNAL, V4, P173, DOI 10.1007/BF00705524; Khan S, 2010, PADDY WATER ENVIRON, V8, P23, DOI 10.1007/s10333-009-0171-0; Kotoda K, 1989, IAHS PUBL, V177, P271; Kukal SS, 2002, AGR WATER MANAGE, V57, P49, DOI 10.1016/S0378-3774(02)00037-9; Leterme B, 2013, P 4 INT C HYDRUS SOF, P235; Lin L, 2014, PADDY WATER ENVIRON, V12, P17, DOI 10.1007/s10333-013-0354-6; Liu CW, 2001, AGR SYST, V68, P41, DOI 10.1016/S0308-521X(00)00062-7; Maruyama T, 2014, PADDY WATER ENVIRON, V12, P163, DOI 10.1007/s10333-013-0373-3; Maruyama T., 2012, Journal of Japan Society of Hydrology and Water Resources, V25, DOI 10.3178/jjshwr.25.20; Matsuno Y, 2006, PADDY WATER ENVIRON, V4, P189, DOI 10.1007/s10333-006-0048-4; Mitsuno T, 1982, J JSIDRE, V50, P1; Morita K, 2008, PLANNING NORMAL DISC; Murashima K, 2009, ANN REP 2008; Nakumura S, 2007, 48 JAP SOC BREED CRO, P51; Noto F, 2013, PADDY WATER ENVIRON, V11, P463, DOI [10.1007/s10333-012-0337-z, DOI 10.1007/S10333-012-0337-Z]; Noto F, 2013, PADDY WATER ENVIRON, V11, P113, DOI [10.1007/s10333-011-0297-8, DOI 10.1007/S10333-011-0297-8]; Okumaya T, 2011, CLARIFYING HYDROGEOL; Satoh T, 2002, HOKURIKU SAKUMOTSU G, V37, P4; Shibayama M, 2011, PLANT PROD SCI, V14, P30, DOI 10.1626/pps.14.30; SHIMADA S, 1990, JPN J CROP SCI, V59, P257; Simunek J, 2008, VADOSE ZONE J, V7, P581, DOI 10.2136/vzj2008.0012; Sugio S, 1999, J GROUNDW HYDROL, V41, P253; TAKEDA G, 1976, Japanese Journal of Crop Science, V45, P357; Tsuchihara T, 2010, APPL HYDROL, V22, P11; Tsujimoto T, 2005, J RIVER ENG, V11, P529; Watanabe S, 2002, J GROUNDW HYDROL, V44, P199; Xu X, 2012, J HYDROL, V412-413, P70, DOI [10.1016/j.kydrol.2011.07.002, DOI 10.1016/J.KYDROL.2011.07.002]; Zhu Y, 2012, J HYDROL, V475, P188, DOI 10.1016/j.jhydrol.2012.09.048	61	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1431-2174	1435-0157		HYDROGEOL J	Hydrogeol. J.	DEC	2014	22	8					1841	1855		10.1007/s10040-014-1171-8		15	Geosciences, Multidisciplinary; Water Resources	Geology; Water Resources	AU0AN	WOS:000345285600009		
J	Tabara, Y; Takahashi, Y; Kawaguchi, T; Setoh, K; Terao, C; Yamada, R; Kosugi, S; Sekine, A; Nakayama, T; Matsuda, F				Tabara, Yasuharu; Takahashi, Yoshimitsu; Kawaguchi, Takahisa; Setoh, Kazuya; Terao, Chikashi; Yamada, Ryo; Kosugi, Shinji; Sekine, Akihiro; Nakayama, Takeo; Matsuda, Fumihiko		Nagahama Study Grp	Association of Serum-Free Fatty Acid Level With Reduced Reflection Pressure Wave Magnitude and Central Blood Pressure The Nagahama Study	HYPERTENSION			English	Article						aortic blood pressure; free fatty acid; insulin resistance; pulse wave analysis	CENTRAL AORTIC PRESSURE; PULSE PRESSURE; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; CENTRAL HEMODYNAMICS; AUGMENTATION INDEX; SYSTOLIC PRESSURE; 2ND PEAK; INSULIN; VELOCITY	Central blood pressure (BP) has been suggested to be a better predictor of cardiovascular disease risk than brachial BP. Given that central BP and arterial waveform are both influenced by insulin resistance, major initiators of insulin resistance, such as serum-free fatty acid (FFA), are suspected of potentially being involved in central hemodynamics. To confirm that insulin signaling is an important modulator of central hemodynamics, we investigated this hypothesis in a large-scale general population. Brachial BP and radial arterial waveform were measured simultaneously in 9393 middle-aged to elderly individuals. The augmentation index was calculated from the radial waveform as the ratio of the height of the late systolic peak to that of the first peak. Central systolic BP was defined as the absolute pressure of the late systolic peak of the waveform. Differences in central and brachial pulse pressure (PP) were considered to represent PP amplification. PP amplification differed significantly among serum FFA level quartiles (Q1, 7.8 +/- 5.3; Q2, 8.6 +/- 5.0; Q3, 9.3 +/- 5.7; Q4, 10.3 +/- 6.1 mm Hg; P<0.001), and the maximum difference in combination with diabetes mellitus status was 4.9 mm Hg. Multivariate analysis adjusted for major covariates indicated that higher serum FFA was an independent determinant for higher PP amplification (beta=0.145, P<0.001) and lower augmentation index (beta=-0.122, P<0.001) and central systolic BP (beta=-0.044, P<0.001), whereas the association between FFA and PP amplification significantly decreased (beta=0.022, P<0.001) after further adjustment for augmentation index. Serum FFA is an overlooked factor favorably influencing central hemodynamics. A low-magnitude reflection pressure wave might be involved in this paradoxical relationship.	[Tabara, Yasuharu; Kawaguchi, Takahisa; Setoh, Kazuya; Terao, Chikashi; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan; [Tabara, Yasuharu; Nakayama, Takeo] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto 6068507, Japan; [Kosugi, Shinji] Kyoto Univ, Sch Publ Hlth, Dept Med Eth & Med Genet, Kyoto 6068507, Japan; [Sekine, Akihiro] Kyoto Univ, Med Res Support Ctr, Kyoto 6068507, Japan	Tabara, Y (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Sakyo Ku, Shogoinkawaramachi 53, Kyoto 6068507, Japan.	tabara@genome.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science & Technology in Japan; Takeda Science Foundation	This study was supported by a University Grant and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science & Technology in Japan and a research grant from the Takeda Science Foundation.	Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Pini R, 2008, J AM COLL CARDIOL, V51, P2432, DOI 10.1016/j.jacc.2008.03.031; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Boutouyrie P, 1999, CIRCULATION, V100, P1387; Takazawa K, 2007, HYPERTENS RES, V30, P219, DOI 10.1291/hypres.30.219; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Boutouyrie P, 2010, HYPERTENSION, V55, P1314, DOI 10.1161/HYPERTENSIONAHA.109.148999; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Miyashita H, 2010, AM J HYPERTENS, V23, P260, DOI 10.1038/ajh.2009.255; Chirinos JA, 2011, HYPERTENSION, V57, P1108, DOI 10.1161/HYPERTENSIONAHA.110.166348; London GM, 2010, NEPHROL DIAL TRANSPL, V25, P3815, DOI 10.1093/ndt/gfq614; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Lacy PS, 2004, J HYPERTENS, V22, P1937, DOI 10.1097/00004872-200410000-00016; Shrestha I, 2009, HYPERTENS RES, V32, P869, DOI 10.1038/hr.2009.121; Maple-Brown LJ, 2005, J HYPERTENS, V23, P1403, DOI 10.1097/01.hjh.0000173524.80802.5a; Pauca AL, 2004, BRIT J ANAESTH, V92, P651, DOI 10.1093/bja/aeh121; Agnoletti D, 2013, ATHEROSCLEROSIS, V230, P315, DOI 10.1016/j.atherosclerosis.2013.07.054; Tabara Y, 2011, J HYPERTENS, V29, P1948, DOI 10.1097/HJH.0b013e32834abd06; Chirinos JA, 2013, DIABETES CARE, V36, P2359, DOI 10.2337/dc12-1463; Ding FH, 2013, AM J HYPERTENS, V26, P118, DOI 10.1093/ajh/hps003; Kohara K, 2009, J HUM HYPERTENS, V23, P538, DOI 10.1038/jhh.2008.154; Odaira M, 2011, AM J HYPERTENS, V24, P881, DOI 10.1038/ajh.2011.56; Tabara Y, 2013, INT J CARDIOL, V168, P2673, DOI 10.1016/j.ijcard.2013.03.028; Tamminen M, 2002, DIABETES CARE, V25, P2314, DOI 10.2337/diacare.25.12.2314; Tomita H, 2008, HYPERTENS RES, V31, P493, DOI 10.1291/hypres.31.493; Westerbacka J, 1999, HYPERTENSION, V33, P1118; Zhou WG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088722	30	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	DEC	2014	64	6					1212	U109		10.1161/HYPERTENSIONAHA.114.04277		12	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7PL	WOS:000345129900018		
J	Rawat, DK; Alzoubi, A; Gupte, R; Chettimada, S; Watanabe, M; Kahn, AG; Okada, T; McMurtry, IF; Gupte, SA				Rawat, Dhawjbahadur K.; Alzoubi, Abdallah; Gupte, Rakhee; Chettimada, Sukrutha; Watanabe, Makino; Kahn, Andrea G.; Okada, Takao; McMurtry, Ivan F.; Gupte, Sachin A.			Increased Reactive Oxygen Species, Metabolic Maladaptation, and Autophagy Contribute to Pulmonary Arterial Hypertension-Induced Ventricular Hypertrophy and Diastolic Heart Failure	HYPERTENSION			English	Article						dehydroepiandrosterone; free radicals; heart function tests; lung	PENTOSE-PHOSPHATE PATHWAY; DEHYDROGENASE-DERIVED NADPH; FATTY-ACID OXIDATION; CARDIOVASCULAR-DISEASE; FAILING HEART; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; SUPEROXIDE-PRODUCTION; PYRIDINE-NUCLEOTIDES; GLUCOSE-METABOLISM; NAD(P)H OXIDASE	Pulmonary arterial hypertension (PAH) is a debilitating and deadly disease with no known cure. Heart failure is a major comorbidity and a common cause of the premature death of patients with PAH. Increased asymmetrical right ventricular hypertrophy and septal wall thickening compress the left ventricular cavity and elicit diastolic heart failure. In this study, we used the Sugen5416/hypoxia/normoxia-induced PAH rat to determine whether altered pyridine nucleotide signaling in the failing heart contributes to 1) increased oxidative stress, 2) changes in metabolic phenotype, 3) autophagy, and 4) the PAH-induced failure. We found that increased reactive oxygen species, metabolic maladaptation, and autophagy contributed to the pathogenesis of right ventricular remodeling and hypertrophy that lead to left ventricular diastolic dysfunction. In addition, arterial elastance increased in PAH rats. Glucose-6-phosphate dehydrogenase is a major source of pyridine molecule (nicotinamide adenine dinucleotide phosphate), which is a substrate for nicotinamide adenine dinucleotide phosphate oxidases in the heart. Dehydroepiandrosterone, a 17-ketosteroid that reduces pulmonary hypertension and right ventricular hypertrophy, inhibited glucose-6-phosphate dehydrogenase, decreased oxidative stress, increased glucose oxidation and acetyl-coA, and reduced autophagy in the hearts of PAH rats. It also decreased arterial stiffness and improved left ventricular diastolic function. These findings demonstrate that pyridine nucleotide signaling, at least partly, mediates PAH-induced diastolic heart failure, and that reduction of glucose-6-phosphate dehydrogenase-derived nicotinamide adenine dinucleotide phosphate is beneficial to improve left ventricle diastolic function.	[Rawat, Dhawjbahadur K.; Gupte, Rakhee; Chettimada, Sukrutha; Gupte, Sachin A.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Alzoubi, Abdallah; McMurtry, Ivan F.] Univ S Alabama, Coll Med, Dept Pharmacol, Mobile, AL 36688 USA; [Alzoubi, Abdallah; McMurtry, Ivan F.; Gupte, Sachin A.] Univ S Alabama, Coll Med, Dept Lung Biol, Mobile, AL USA; [McMurtry, Ivan F.] Univ S Alabama, Coll Med, Dept Internal Med, Mobile, AL USA; [Kahn, Andrea G.] Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA; [Watanabe, Makino; Okada, Takao] Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan	Gupte, SA (reprint author), New York Med Coll, Dept Pharmacol, BSB 546,15 Dana Rd, Valhalla, NY 10595 USA.	s_gupte@nymc.edu			National Heart, Lung, and Blood Institute [RO1-HL-085352]	This work was supported by National Heart, Lung, and Blood Institute grant RO1-HL-085352 (to S.A. Gupte).	Alzoubi A, 2013, AM J PHYSIOL-HEART C, V304, pH1708, DOI 10.1152/ajpheart.00746.2012; Burgoyne JR, 2012, CIRC RES, V111, P1091, DOI 10.1161/CIRCRESAHA.111.255216; Gupte SA, 2006, J MOL CELL CARDIOL, V41, P340, DOI 10.1016/j.yjmcc.2006.05.003; Gupte RS, 2007, J CARD FAIL, V13, P497, DOI 10.1016/j.cardfail.2007.04.003; Alexander PB, 2011, P NATL ACAD SCI USA, V108, P15828, DOI 10.1073/pnas.1111312108; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Piao L, 2010, J MOL MED-JMM, V88, P47, DOI 10.1007/s00109-009-0524-6; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Balteau M, 2011, CARDIOVASC RES, V92, P237, DOI 10.1093/cvr/cvr230; Nediani C, 2007, J MOL CELL CARDIOL, V42, P826, DOI 10.1016/j.yjmcc.2007.01.009; de la Roque ED, 2012, EUR RESPIR J, V40, P1420, DOI 10.1183/09031936.00011511; Shao D, 2012, J MOL CELL CARDIOL, V52, P550, DOI 10.1016/j.yjmcc.2011.09.009; Kasner M, 2012, AM J RESP CRIT CARE, V186, P181, DOI 10.1164/rccm.201110-1860OC; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; Hardegree EL, 2013, CIRC-HEART FAIL, V6, P748, DOI 10.1161/CIRCHEARTFAILURE.112.000098; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Nakamura S, 2004, CIRCULATION, V110, P1787, DOI 10.1161/01.CIR.0000143072.36782.51; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Gupte SA, 2003, AM J PHYSIOL-HEART C, V285, pH2316, DOI 10.1152/ajpheart.00229.2003; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Hill MF, 1996, AM J PATHOL, V148, P291; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Mannic T, 2013, ENDOCRINOLOGY, V154, P1271, DOI 10.1210/en.2012-1784; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Ussher JR, 2012, CIRC RES, V111, P628, DOI 10.1161/CIRCRESAHA.111.246371; Chen XW, 2011, J MOL CELL CARDIOL, V50, P460, DOI 10.1016/j.yjmcc.2010.11.012; Homma N, 2008, AM J PHYSIOL-LUNG C, V295, pL71, DOI 10.1152/ajplung.90251.2008; de La Roque ED, 2012, ANN ENDOCRINOL-PARIS, V73, P20, DOI 10.1016/j.ando.2011.12.005; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Maejima Y, 2011, J MOL CELL CARDIOL, V50, P408, DOI 10.1016/j.yjmcc.2010.12.018; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Nakamura M, 2012, CIRC RES, V111, P604, DOI 10.1161/CIRCRESAHA.111.247924; Assad RS, 2011, J THORAC CARDIOVASC, V142; Assad RS, 2011, J THORAC CARDIOV SUR, V142, P1108, DOI 10.1016/j.jtcvs.2011.08.007; Ata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039009; Barst RJ, 2008, ANN THORAC MED, V3, P1, DOI 10.4103/1817-1737.37832; Bronicki RA, PEDIAT CRIT CARE MED, V11, pS15; Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127; Gupte RS, 2010, J BIOL CHEM, V285, P19561, DOI 10.1074/jbc.M109.092916; Gupte SA, 2006, PULM PHARMACOL THER, V19, P303, DOI 10.1016/j.pupt.2005.08.002; Gupte SA, 2008, ANTIOXID REDOX SIGN, V10, P1137, DOI 10.1089/ars.2007.1995; Gupte SA, 2002, J MOL CELL CARDIOL, V34, P679, DOI 10.1006/jmcc.2002.2008; Hampl V, 2003, EUR RESPIR J, V21, P862, DOI 10.1183/09031936.03.00084503; Hariharan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051632; Hecker PA, 2013, CIRC-HEART FAIL, V6, P118, DOI 10.1161/CIRCHEARTFAILURE.112.969576; Hecker PA, 2013, AM J PHYSIOL-HEART C, V304, pH491, DOI 10.1152/ajpheart.00721.2012; Hemnes AR, 2008, INT J CLIN PRACT, V62, P11, DOI 10.1111/j.1742-1241.2008.01812.x; Lei B, 2004, J MOL CELL CARDIOL, V36, P567, DOI 10.1016/j.yjmcc.2004.02.004; Mair KM, 2014, BRIT J PHARMACOL, V171, P567, DOI 10.1111/bph.12281; Moens AL, 2006, ARTERIOSCL THROM VAS, V26, P2439, DOI 10.1161/01.ATV.0000243924.00970.cb; Nishiyama Y, 1998, AM HEART J, V135, P115, DOI 10.1016/S0002-8703(98)70351-5; Noch E, 2012, MOL CANCER THER, V11, P14, DOI 10.1158/1535-7163.MCT-11-0517; Qipshidze N, 2012, AM J PHYSIOL-HEART C, V302, pH688, DOI 10.1152/ajpheart.00777.2011; Serpillon S, 2009, AM J PHYSIOL-HEART C, V297, pH153, DOI 10.1152/ajpheart.01142.2008; Ucar A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2090; Vimercati C, 2014, AM J PHYSIOL-HEART C, V306, pH709, DOI 10.1152/ajpheart.00783.2013; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053951	60	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	DEC	2014	64	6					1266	U230		10.1161/HYPERTENSIONAHA.114.03261		13	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7PL	WOS:000345129900025		
J	Monfredi, O; Lyashkov, AE; Johnsen, AB; Inada, S; Schneider, H; Wang, RX; Nirmalan, M; Wisloff, U; Maltsev, VA; Lakatta, EG; Zhang, HG; Boyett, MR				Monfredi, Oliver; Lyashkov, Alexey E.; Johnsen, Anne-Berit; Inada, Shin; Schneider, Heiko; Wang, Ruoxi; Nirmalan, Mahesh; Wisloff, Ulrik; Maltsev, Victor A.; Lakatta, Edward G.; Zhang, Henggui; Boyett, Mark R.			Biophysical Characterization of the Underappreciated and Important Relationship Between Heart Rate Variability and Heart Rate	HYPERTENSION			English	Article						autonomic nervous system; ion channels; physiology; sinoatrial node	SINOATRIAL NODE; CARDIOVASCULAR CONTROL; MYOCARDIAL-INFARCTION; PACEMAKER ACTIVITY; SPECTRAL-ANALYSIS; CELLS; MORTALITY; HUMANS; RISK; MICE	Heart rate (HR) variability (HRV; beat-to-beat changes in the R-wave to R-wave interval) has attracted considerable attention during the past 30+ years (PubMed currently lists >17 000 publications). Clinically, a decrease in HRV is correlated to higher morbidity and mortality in diverse conditions, from heart disease to fetal distress. It is usually attributed to fluctuation in cardiac autonomic nerve activity. We calculated HRV parameters from a variety of cardiac preparations (including humans, living animals, Langendorff-perfused heart, and single sinoatrial nodal cell) in diverse species, combining this with data from previously published articles. We show that regardless of conditions, there is a universal exponential decay-like relationship between HRV and HR. Using 2 biophysical models, we develop a theory for this and confirm that HRV is primarily dependent on HR and cannot be used in any simple way to assess autonomic nerve activity to the heart. We suggest that the correlation between a change in HRV and altered morbidity and mortality is substantially attributable to the concurrent change in HR. This calls for re-evaluation of the findings from many articles that have not adjusted properly or at all for HR differences when comparing HRV in multiple circumstances.	[Monfredi, Oliver; Schneider, Heiko; Nirmalan, Mahesh; Boyett, Mark R.] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England; [Monfredi, Oliver; Lyashkov, Alexey E.; Maltsev, Victor A.; Lakatta, Edward G.] NIA, Lab Cardiovasc Sci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Johnsen, Anne-Berit; Wisloff, Ulrik] Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Inada, Shin] Natl Cerebral & Cardiovasc Ctr, Lab Biomed Sci & Informat Management, Osaka, Japan; [Wang, Ruoxi; Zhang, Henggui] Univ Manchester, Biol Phys Grp, Manchester, Lancs, England	Monfredi, O (reprint author), Univ Manchester, Core Technol Facil, Inst Cardiovasc Sci, 46 Grafton St, Manchester M13 9NT, Lancs, England.	oliver.monfredi@manchester.ac.uk		Boyett, Mark/0000-0003-3931-2020	British Cardiovascular Society; British Heart Foundation [RG/11/18/29257]; Intramural Research Program of the National Institutes of Health, National Institute on Aging; Engineering and Physical Science Research Council UK [EP/J00958X/1, EP/I029826/1]; K.G. Jebson Foundation	Grants were received from British Cardiovascular Society (O. Monfredi) and British Heart Foundation (RG/11/18/29257) (M. R. Boyett). This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging. Other grants were received from the Engineering and Physical Science Research Council UK (EP/J00958X/1; EP/I029826/1) (H. Zhang) and the K.G. Jebson Foundation (A.-B. Johnsen and U. Wisloff).	AlAni M, 1996, EUR J APPL PHYSIOL O, V74, P397; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Bogdanov KY, 2006, CIRC RES, V99, P979, DOI 10.1161/01.RES.000247933.66532.0b; ANUMONWO JMB, 1991, CIRC RES, V68, P1138; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; Mangin L, 1998, J CARDIOVASC PHARM, V32, P601, DOI 10.1097/00005344-199810000-00012; [Anonymous], 1996, EUR HEART J, V17, P354; Sacha J, 2008, INT J CARDIOL, V128, P444, DOI 10.1016/j.ijcard.2007.06.047; Huikuri HV, 2009, PHILOS T R SOC A, V367, P1223, DOI 10.1098/rsta.2008.0294; AHMED MW, 1994, J AM COLL CARDIOL, V24, P1082; Vinogradova TM, 2000, CIRC RES, V87, P760; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Dekker JM, 2000, CIRCULATION, V102, P1239; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Uechi M, 1998, CIRC RES, V82, P416; Zaza A, 2001, CARDIOVASC RES, V50, P434, DOI 10.1016/S0008-6363(01)00240-1; Abildstrom SZ, 2003, J CARDIOVASC ELECTR, V14, P168; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151; Laude D, 2008, CLIN EXP PHARMACOL P, V35, P454, DOI 10.1111/j.1440-1681.2008.04895.x; CASOLO G, 1989, AM J CARDIOL, V64, P1162, DOI 10.1016/0002-9149(89)90871-0; JensenUrstad K, 1997, ACTA PHYSIOL SCAND, V160, P235; Tsuji H, 1996, J AM COLL CARDIOL, V28, P1539, DOI 10.1016/S0735-1097(96)00342-7; Maltsev VA, 2009, AM J PHYSIOL-HEART C, V296, pH594, DOI 10.1152/ajpheart.01118.2008; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Gehrmann J, 2000, AM J PHYSIOL-HEART C, V279, pH733; TSUJI H, 1994, CIRCULATION, V90, P878; Zhang H, 2000, AM J PHYSIOL-HEART C, V279, pH397; Tardif JC, 2009, BRIT MED BULL, V90, P71, DOI 10.1093/bmb/ldp016; Beckers F, 2004, TRANSPLANTATION, V78, P1523, DOI 10.1097/01.TP.0000141093.04132.41; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; Bissonnette JM, 2007, AUTON NEUROSCI-BASIC, V136, P82, DOI 10.1016/j.autneu.2007.04.007; Claria F, 2008, PHYSIOL MEAS, V29, P401, DOI 10.1088/0967-3334/29/3/010; COUMEL P, 1994, J CARDIOVASC ELECTR, V5, P899, DOI 10.1111/j.1540-8167.1994.tb01130.x; CRAFT N, 1995, AM J PHYSIOL-HEART C, V268, pH1441; Dekker JM, 1997, AM J EPIDEMIOL, V145, P899; Diedrich A, 2002, CIRCULATION, V106, P2238, DOI 10.1161/01.CIR.0000035241.76918.6C; Ecker PM, 2006, AM J PHYSIOL-HEART C, V290, pH192, DOI 10.1152/ajpheart.00032.2005; Hales S., 1733, STAT ESSAYS HAEMASTA; HAYANO J, 1991, AM J CARDIOL, V67, P199, DOI 10.1016/0002-9149(91)90445-Q; Heathers JAJ, 2012, EXP PHYSIOL, V97, P556, DOI 10.1113/expphysiol.2011.063867; JONGSMA HJ, 1983, J MOL CELL CARDIOL, V15, P123, DOI 10.1016/0022-2828(83)90288-2; Kurata Y, 2008, BIOPHYS J, V95, P951, DOI 10.1529/biophysj.107.112854; Monfredi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067247; Radaelli A, 1996, EUR HEART J, V17, P462; Ramaekers D, 1996, PACE, V19, P2112, DOI 10.1111/j.1540-8159.1996.tb03286.x; SACKNOFF DM, 1994, AM HEART J, V127, P1275, DOI 10.1016/0002-8703(94)90046-9; SEALS DR, 1989, J APPL PHYSIOL, V66, P1886; Wu TW, 2006, PHARMACOLOGY, V76, P170, DOI 10.1159/000091495; Yaniv Y, 2013, J MOL CELL CARDIOL, V62, P80, DOI 10.1016/j.yjmcc.2013.04.026; Zhang HG, 2002, J CARDIOVASC ELECTR, V13, P465, DOI 10.1046/j.1540-8167.2002.00465.x	50	11	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	DEC	2014	64	6					1334	U386		10.1161/HYPERTENSIONAHA.114.03782		26	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7PL	WOS:000345129900034		
J	Otsuka, T; Ishiguro, K; Yoshioka, T; Sawada, H; Okuno, HG				Otsuka, Takuma; Ishiguro, Katsuhiko; Yoshioka, Takuya; Sawada, Hiroshi; Okuno, Hiroshi G.			Multichannel Sound Source Dereverberation and Separation for Arbitrary Number of Sources Based on Bayesian Nonparametrics	IEEE-ACM TRANSACTIONS ON AUDIO SPEECH AND LANGUAGE PROCESSING			English	Article						Bayesian nonparametrics; blind dereverberation; blind source separation; Markov chain Monte Carlo method; microphone; array processing; underdetermined mixtures	BLIND SOURCE SEPARATION; AUDIO SOURCE SEPARATION; SPEECH DEREVERBERATION; MIXTURES; SIGNALS; MODEL	Multichannel signal processing using a microphone array provides fundamental functions for coping with multi-source situations, such as sound source localization and separation, that are needed to extract the auditory information for each source. Auditory uncertainties about the degree of reverberation and the number of sources are known to degrade performance or limit the practical application of microphone array processing. Such uncertainties must therefore be overcome to realize general and robust microphone array processing. These uncertainty issues have been partly addressed-existing methods focus on either source number uncertainty or the reverberation issue, where joint separation and dereverberation has been achieved only for the overdetermined conditions. This paper presents an all-round method that achieves source separation and dereverberation for an arbitrary number of sources including underdetermined conditions. Our method uses Bayesian nonparametrics that realize an infinitely extensible modeling flexibility so as to bypass the model selection in the separation and dereverberation problem, which is caused by the source number uncertainty. Evaluation using a dereverberation and separation task with various numbers of sources including underdetermined conditions demonstrates that (1) our method is applicable to the separation and dereverberation of underdetermined mixtures, and that (2) the source extraction performance is comparable to that of a state-of-the-art method suitable only for overdetermined conditions.	[Otsuka, Takuma; Ishiguro, Katsuhiko; Yoshioka, Takuya] NTT Corp, NTT Commun Sci Labs, Kyoto 6190237, Japan; [Sawada, Hiroshi] NTT Corp, NTT Serv Evolut Labs, Yokosuka, Kanagawa 2390847, Japan; [Okuno, Hiroshi G.] Waseda Univ, Grad Program Embodiment Informat, Tokyo 1690072, Japan	Otsuka, T (reprint author), NTT Corp, NTT Commun Sci Labs, Kyoto 6190237, Japan.	otsuka.takuma@lab.ntt.co.jp; ishiguro.katsuhiko@lab.ntt.co.jp; yoshioka.takuya@lab.ntt.co.jp; sawada.hiroshi@lab.ntt.co.jp; okuno@aoni.waseda.jp			JSPS KAKENHI [24220006, 236577]; Kyoto University; NTT Research Collaboration Program	This work was supported in part by JSPS KAKENHI Grants 24220006 and 236577, and in part by a Kyoto University and NTT Research Collaboration Program. This work was done while T. Otsuka and H. G. Okuno were with the Graduate School of Informatics, Kyoto University. The associate editor coordinating the review of this manuscript and approving it for publication was Dr. Emmanuel Vincent.	Aldous D., 1985, ECOLE ETE PROBABILIT, V1117, P1, DOI 10.1007/BFb0099421; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Lebart K, 2001, ACUSTICA, V87, P359; Gershman SJ, 2012, J MATH PSYCHOL, V56, P1, DOI 10.1016/j.jmp.2011.08.004; Huang YTA, 2005, IEEE T SPEECH AUDI P, V13, P882, DOI 10.1109/TSA.2005.851941; Takeda R, 2012, NEURAL COMPUT, V24, P234, DOI 10.1162/NECO_a_00219; Yilmaz O, 2004, IEEE T SIGNAL PROCES, V52, P1830, DOI [10.1109/TSP.2004.828896, 10.1109/TSP.2004.V8896]; Vincent E, 2006, IEEE T AUDIO SPEECH, V14, P1462, DOI 10.1109/TSA.2005.858005; Conradsen K, 2003, IEEE T GEOSCI REMOTE, V41, P4, DOI 10.1109/TGRS.2002.808066; Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653; ESCOBAR MD, 1995, J AM STAT ASSOC, V90, P577, DOI 10.2307/2291069; Sawada H, 2011, IEEE T AUDIO SPEECH, V19, P516, DOI 10.1109/TASL.2010.2051355; Lee I, 2007, SIGNAL PROCESS, V87, P1859, DOI 10.1016/j.sigpro.2007.01.010; Park T, 2009, J COMPUT GRAPH STAT, V18, P283, DOI 10.1198/jcgs.2009.08108; Mandel MI, 2010, IEEE T AUDIO SPEECH, V18, P382, DOI 10.1109/TASL.2009.2029711; Araki S, 2010, INT CONF ACOUST SPEE, P5, DOI 10.1109/ICASSP.2010.5496283; Araki S, 2009, LECT NOTES COMPUT SC, V5441, P742, DOI 10.1007/978-3-642-00599-2_93; Buchner H, 2010, SIGNALS COMMUN TECHN, P311, DOI 10.1007/978-1-84996-056-4_10; Comon P, 2010, HANDBOOK OF BLIND SOURCE SEPARATION: INDEPENDENT COMPONENT ANALYSIS AND APPLICATIONS, P1; Duong NQK, 2010, IEEE T AUDIO SPEECH, V18, P1830, DOI 10.1109/TASL.2010.2050716; Gorokhov A, 1997, IEEE T CIRCUITS-I, V44, P813, DOI 10.1109/81.622984; Habets EAP, 2008, IEEE T AUDIO SPEECH, V16, P1433, DOI 10.1109/TASL.2008.2002071; Hyvarinen A., 2001, INDEPENDENT COMPONEN; Lovell D., 2012, P WORKSH BIG LEARN N; Mizumoto T., 2011, P IEEE RAS INT C ROB, P2130, DOI 10.1109/ICRA.2011.5979849; Ono N., 2011, P WASPAA OCT, P189; Otsuka T, 2014, IEEE-ACM T AUDIO SPE, V22, P493, DOI 10.1109/TASLP.2013.2294582; Otsuka T., 2012, P 26 AAAI C ART INT, P2038; Sawada H., 2007, P IEEE INT WORKSH MA, P45; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302; Togami M., 2012, Proceedings of the 2012 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP 2012), DOI 10.1109/ICASSP.2012.6288809; Togami M, 2013, IEEE T AUDIO SPEECH, V21, P1369, DOI 10.1109/TASL.2013.2250960; Williamson S., 2013, P 30 INT C MACH LEAR, P98; Yoshioka T, 2011, IEEE T AUDIO SPEECH, V19, P69, DOI 10.1109/TASL.2010.2045183	34	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2329-9290			IEEE-ACM T AUDIO SPE	IEEE-ACM Trans. Audio Speech Lang.	DEC	2014	22	12					2218	2232		10.1109/TASLP.2014.2363790		15	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	AT5PE	WOS:000344993800002		
J	Zhao, HC; Peng, LH; Takahashi, T; Hayashi, T; Shimizu, K; Yamamoto, T				Zhao, Huichao; Peng, Lihui; Takahashi, Tsuyoshi; Hayashi, Takuya; Shimizu, Kazuyoshi; Yamamoto, Toshihiro			Support Vector Regression-Based Data Integration Method for Multipath Ultrasonic Flowmeter	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Computational fluid dynamics (CFD); flow measurement; flow profile; multipath ultrasonic flowmeter; support vector regression (SVR)	MACHINES; FLOW	This paper presents a support vector regression (SVR)-based data integration method for a 4-path ultrasonic flowmeter, which is able to estimate accurately the mean cross-sectional flow velocity under complex flow profiles. While installed in the pipeline with complex configurations, such as single-elbow or out-plane double-elbow, the performance of multipath ultrasonic flowmeter will degenerate due to the strong nonlinear relationships between the flow velocities on different individual sound paths and the mean flow velocity on the cross section, particularly when the straight pipe length is not guaranteed. The presented SVR-based method is of an excellent nonlinear mapping and generalization ability. The cases while the Reynolds number in the range of 3.25 x 10(3) - 3.25 x 10(5) were simulated using computational fluid dynamics and the flow profiles located on the cross sections of 5 and 10 times pipe diameter downstream a single elbow and an out-plane double-elbow were extracted to construct the data set for SVR training and test. It is found that the error of the estimated cross-sectional mean flow velocity obtained by the SVR-based data integration method is within +/- 0.5% without the requirement of a flow conditioner, which is significantly better than the results from the traditional integration method with constant weights. The presented SVR-based data integration method is helpful to extend the limitation of straight pipe length for the installation of multipath ultrasonic flowmeter, which is attractive for the practical applications of multipath ultrasonic flowmeter.	[Zhao, Huichao; Peng, Lihui] Tsinghua Univ, Dept Automat, TNLIST, Beijing 100084, Peoples R China; [Takahashi, Tsuyoshi] Tokyo Keiso Co Ltd, Ultrason Flowmeter Tech Dept, Tokyo 1058558, Japan; [Hayashi, Takuya; Yamamoto, Toshihiro] Tokyo Keiso Co Ltd, Semicond Flowmeter Tech Dept, Tokyo 1058558, Japan; [Shimizu, Kazuyoshi] Tokyo Keiso Co Ltd, Project Promot Div, Tokyo 1058558, Japan	Zhao, HC (reprint author), Tsinghua Univ, Dept Automat, TNLIST, Beijing 100084, Peoples R China.	lihuipeng@tsinghua.edu.cn					Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Shin KS, 2005, EXPERT SYST APPL, V28, P127, DOI 10.1016/j.eswa.2004.08.009; Hilgenstock A, 1996, FLOW MEAS INSTRUM, V7, P161, DOI 10.1016/S0955-5986(97)88066-1; [Anonymous], 2006, R1371 OIML; [Anonymous], 1991, 60041 IEC; Pellegrini M, 2011, PROG NUCL ENERG, V53, P916, DOI 10.1016/j.pnucene.2011.02.005; Ruppel C, 2004, FLOW MEAS INSTRUM, V15, P167, DOI 10.1016/j.flowmeasinst.2003.12.004; Zhao HC, 2014, IEEE SENS J, V14, P362, DOI 10.1109/JSEN.2013.2282466; Kim KJ, 2003, NEUROCOMPUTING, V55, P307, DOI 10.1016/S0925-2312(03)00372-2; Brown G, 2006, LAT TRADE, V14, P18; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Crawford N, 2009, P I MECH ENG E-J PRO, V223, P27, DOI 10.1243/09544089JPME206; Hojholt P., 1986, P INT C FLOW MEAS MI; Jakirlic S, 2002, AIAA J, V40, P1984, DOI 10.2514/2.1560; Lansing J., 2007, AGA 9 MEASUREMENT GA; Lunde P, 2000, GERG PROJECT ULTRASO; Luntta E, 1999, FLOW MEAS INSTRUM, V10, P35, DOI 10.1016/S0955-5986(98)00035-1; Moore PI, 2000, MEAS SCI TECHNOL, V11, P1802, DOI 10.1088/0957-0233/11/12/321; Peng LH, 2012, IEEE SENS J, V12, P2866, DOI 10.1109/JSEN.2012.2204738; Salami L. A., 1984, Transactions of the Institute of Measurement and Control, V6, DOI 10.1177/014233128400600403; Sanderson ML, 2002, FLOW MEAS INSTRUM, V13, P125, DOI 10.1016/S0955-5986(02)00043-2; Smorgrav S., 2009, P 27 N SEA FLOW MEAS, P235; Vapnik V. N., 1995, NATURE STAT LEARNING; Voser A., 1999, THESIS EIDGENOSSISCH; Yeh T. T., 2001, P IEEE INSTR MEAS TE, P1741; Yeh TT, 2001, IEEE IMTC P, P1741, DOI 10.1109/IMTC.2001.929499	26	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	DEC	2014	63	12					2717	2725		10.1109/TIM.2014.2326276		9	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AT6RW	WOS:000345067400002		
J	Amagai, Y; Fujiki, H				Amagai, Yasutaka; Fujiki, Hiroyuki			Improved Electrothermal Simulation for Low-Frequency Characterization of a Single-Junction Thermal Converter	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						AC-DC difference; electrical variable measurement; numerical analysis; thermal converter; thermal voltage converter	AC-DC TRANSFER; VOLTAGE CONVERTERS; TRANSFER STANDARDS; DIFFERENCE; PERFORMANCE	We perform a numerical simulation for the low-frequency characterization of a single-junction thermal converter down to 1 Hz using an improved electrothermal model. The low-frequency characterization of a thermal converter below 10 Hz is of great importance for linking ac-dc transfer standards and low-frequency ac voltage standards based on sampling methods. One feature of our model is the incorporation of the heat capacity for the thermocouple, which has previously been neglected to reproduce an accurate thermal time constant. Our model also includes the temperature dependence of the Seebeck coefficient in the thermocouple in addition to the temperature-dependent material parameters of the heater. To verify the simulation results, the calculated results are compared with the experimental results, which shows that our improved model well reproduces the measured data below 1 Hz. The estimated uncertainty of the simulated ac-dc transfer differences is 49 mu V/V at 4 Hz. These results suggest that our model is a useful predictive tool at low frequencies.	[Amagai, Yasutaka; Fujiki, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan	Amagai, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	y-amagai@aist.go.jp					Amagai Y, 2012, IEEJ T ELECTR ELECTR, V7, P350, DOI 10.1002/tee.21739; Amagai Y, 2012, IEEE T INSTRUM MEAS, V61, P786, DOI 10.1109/TIM.2011.2170490; Amagai Y., 2012, CPEM, P440; Kampik M, 2000, IEEE T INSTRUM MEAS, V49, P429, DOI 10.1109/19.843091; Avramov-Zamurovic S, 1998, IEEE T INSTRUM MEAS, V47, P87, DOI 10.1109/19.728796; Bubanja V, 2000, J ENG MATH, V38, P33, DOI 10.1023/A:1004637514734; Budovsky I, 2001, IEEE T INSTRUM MEAS, V50, P101, DOI 10.1109/19.903885; Henderson D, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/12/124006; HERMACH FL, 1952, J RES NAT BUR STAND, V48, P121, DOI 10.6028/jres.048.018; IEEE, 2008, 10572007 IEEE; Ihlenfeld WGK, 2003, IEEE T INSTRUM MEAS, V52, P371, DOI 10.1109/TIM.2003.811575; INGLIS BD, 1978, IEEE T INSTRUM MEAS, V27, P440, DOI 10.1109/TIM.1978.4314734; INGLIS BD, 1992, METROLOGIA, V29, P191, DOI 10.1088/0026-1394/29/2/007; KINARD JR, 1995, IEEE T INSTRUM MEAS, V44, P383, DOI 10.1109/19.377859; KLONZ M, 1995, IEEE T INSTRUM MEAS, V44, P379, DOI 10.1109/19.377858; KLONZ M, 1989, IEEE T INSTRUM MEAS, V38, P335, DOI 10.1109/19.192301; Laiz H, 1999, IEEE T INSTRUM MEAS, V48, P1155, DOI 10.1109/19.816130; Laiz H., 1999, MICROELECTRON J, V30, P1152; Lipe TE, 1996, IEEE T INSTRUM MEAS, V45, P913, DOI 10.1109/19.543985; Oldham NM, 1997, IEEE T INSTRUM MEAS, V46, P352, DOI 10.1109/19.571854; Sasaki H, 1999, IEEE T INSTRUM MEAS, V48, P408, DOI 10.1109/19.769612; SASAKI H, 1993, IEEE T INSTRUM MEAS, V42, P603, DOI 10.1109/19.278635; Swerlein R. L., 1997, P PROGR LIST DESCR A, P17; Widdis F.C., 1962, Proceedings of the Institution of Electrical Engineers. C. Institution Monographs, V109	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	DEC	2014	63	12					3011	3018		10.1109/TIM.2014.2313952		8	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	AT6RW	WOS:000345067400032		
J	Bharti, D; Kumar, A; Mahla, RS; Kumar, S; Ingle, H; Shankar, H; Joshi, B; Raut, AA; Kumar, H				Bharti, Deepak; Kumar, Ashish; Mahla, Ranjeet Singh; Kumar, Sushil; Ingle, Harshad; Shankar, Hari; Joshi, Beenu; Raut, Ashwin Ashok; Kumar, Himanshu			The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis	IMMUNOGENETICS			English	Article						Single-nucleotide polymorphism(SNP); Pulmonary tuberculosis (PTB); IP-10; IFN gamma; TNF alpha; Tribes	MYCOBACTERIUM-TUBERCULOSIS; RESPONSES; CELLS; IP-10; OPPORTUNITIES; DIAGNOSIS	Mycobacterium tuberculosis (MTB) is the causative agent of pulmonary tuberculosis (PTB), a major health problem that leads to 1.5 million deaths annually. Host genetic factors play a significant role in disease resistance/susceptibility by altering immunity against MTB. Toll-like receptor (TLR) sensors such as TLR2, TLR4, TLR8, and TLR9 are known to play a pivotal role in PTB via modulating sensor expression and/or effector responses. Single-nucleotide polymorphism (SNP) rs187084 (T-1486C) of the TLR9 promoter is associated with various autoimmune disorders and cancers. A recent bioinformatic analysis predicted that the T-1486C SNP is involved in PTB, although its potential role is unclear. To investigate the role of T-1486C in PTB, we stimulated PBMCs with the H37Rv whole cell lysate. We found that the presence of the "C" allele increases the transcriptional activity of the TLR9, which in turn induces high levels of Interferon gamma-induced protein 10 (IP-10), a biomarker for PTB. However, the expression of protective cytokines such as IFN gamma and TNF alpha was observed significantly less with "C" allele in comparison to "T" allele. We further selected three different tribe populations showing differential susceptibility to PTB and performed genotypic analyses for the TLR9 promoter. We found a significantly lower minor allele frequency (MAF) of T-1486C in the Baiga tribe, wherein fewer PTB cases were reported, than that in the Gond and Korku tribes. Collectively, these data suggest that the minor "C" allele at rs187084 locus may be associated with susceptibility to PTB, which may explain the relatively lower PTB rates observed in Baiga tribe members.	[Bharti, Deepak; Kumar, Ashish; Mahla, Ranjeet Singh; Kumar, Sushil; Ingle, Harshad; Kumar, Himanshu] Indian Inst Sci Educ & Res IISER, Immunol Lab, Dept Biol Sci, Bhopal 460023, Madhya Pradesh, India; [Shankar, Hari; Joshi, Beenu] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Raut, Ashwin Ashok] Natl Inst High Secur Anim Dis, OIE Reference Lab Avian Influenza, Pathogen Lab, Bhopal 462022, Madhya Pradesh, India; [Kumar, Himanshu] Osaka Univ, Host Def Lab, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Kumar, Himanshu] IISER, Immunol Lab, Dept Biol Sci, Bhopal 462066, Madhya Pradesh, India	Kumar, H (reprint author), IISER, Immunol Lab, Dept Biol Sci, Indore Bypass Rd, Bhopal 462066, Madhya Pradesh, India.	hkumar@iiserb.ac.in	Kumar, Sushil/E-1762-2015; 	Kumar, Sushil/0000-0003-0547-745X; MAHLA, RANJEET SINGH/0000-0002-5525-8442	Department of Science and technology (DST) [SR/S2/RJN-55/2009, BT/PR6009/GBD/27/382/2012]; Department of Biotechnology (DBT), Government of India [MPCST3657/CST/BTA]; IISER, Bhopal, India	Authors would like to thank the sequencing facility of Department of Biological Sciences, IISER Bhopal. D. B. would like to thank for PDF support from IISER Bhopal. We would also like to thank Raunaq Singh Nagi for reading our manuscript and for helpful suggestions. This work is supported by research grants number SR/S2/RJN-55/2009 and BT/PR6009/GBD/27/382/2012 from Department of Science and technology (DST) and Department of Biotechnology (DBT), Government of India (H. K.); MPCST3657/CST/BTA (D.B.) and Intramural Research Grant of IISER, Bhopal, India.	Aabye MG, 2013, EUR RESPIR J, V42, P495, DOI 10.1183/09031936.00129412; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Hong JY, 2014, J INFECTION, V68, P252, DOI 10.1016/j.jinf.2013.09.033; Kumar H, 2013, INT REV IMMUNOL, V32, P113, DOI 10.3109/08830185.2013.775803; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/erm.11.97, 10.1586/ERM.11.97]; Bao Y, 2014, CELL RES, V24, P161, DOI 10.1038/cr.2013.155; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Guillerey C, 2012, BLOOD, V120, P90, DOI 10.1182/blood-2012-02-410936; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1081/jem.20051782; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4; Pothlichet J, 2013, INT REV IMMUNOL, V32, P157, DOI 10.3109/08830185.2013.777064; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Schmidt CW, 2008, ENVIRON HEALTH PERSP, V116, pA478; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028256; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Lin PL, 2007, J INVEST DERM SYMP P, V12, P22, DOI 10.1038/sj.jidsymp.5650027; Matsumura T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1677; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Yadav R, 2010, Indian J Tuberc, V57, P114	23	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	DEC	2014	66	12					675	681		10.1007/s00251-014-0806-1		7	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	AT5UN	WOS:000345007900001		
J	Saito, M; Abe, N; Ishida, A; Nakagawa, S; Matsuoka, H				Saito, Mikako; Abe, Natsuki; Ishida, Ayano; Nakagawa, Shota; Matsuoka, Hideaki			Concentration-dependent effects of spermine on apoptosis and consequent generation of multilayer myotube sheets from mouse embryoid bodies in vitro	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Article						Spermine; Apoptosis; Differentiation; Mouse embryoid body; Multilayer myotube sheet	PHOSPHATIDYLSERINE EXPOSURE; AMINE OXIDASE; CELL-DEATH; ANNEXIN-V; DNA; FRAGMENTATION; CASPASES	The concentration-dependent effect of spermine was investigated on the spermine-induced generation of multilayer myotube sheets (MMTS) from mouse embryoid bodies (EBs). During spermine treatment for 24 h, a monolayer cell sheet that had already grown radially from the periphery of an EB was exfoliated. The exfoliation was inhibited by z-VAD.fmk, indicating the occurrence of apoptosis, and inhibited also by aminoguanidine, indicating the involvement of amine oxidase. Following the exfoliation, the cell growth restarted from the fresh periphery of EB in a spermine-free medium and finally formed MMTS. To analyze the contribution of apoptosis to the cell death causing exfoliation, the numbers of apoptotic, necrotic, and 2nd apoptotic cells were counted by staining with Annexin V-Cyanine-3 (AVC3) and 7-aminoactinomycin (7AAC). AVC3-positive, 7AAC-positive, and AVC3/7AAC doubly positive cells were assigned as apoptotic, necrotic, and 2nd necrotic cells, respectively. The relative number of apoptotic and 2nd necrotic cells (N (A) + N (A/7)) to the total number of dying cells (N (T)) was 84 similar to 94%, which was independent of spermine concentration in the range from 0.1 to 2.0 mM. The MMTS generation rate at the final stage, however, was dependent on the spermine concentration. It was 60 similar to 80% in the range from 0.1 to 1.5 mM, while it decreased sharply to 1% at 2 mM. This suggests another role of spermine in the MMTS generation in addition to the induction of apoptosis. This 2nd role seems to be inhibited at a spermine concentration higher than a critical limit between 1.5 and 2.0 mM.	[Saito, Mikako; Abe, Natsuki; Ishida, Ayano; Nakagawa, Shota; Matsuoka, Hideaki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan	Saito, M (reprint author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	mikako@cc.tuat.ac.jp	Saito, Mikako/E-6788-2013		CREST of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology	This work was partially funded by a grant to H. Matsuoka from CREST of Japan Science and Technology Agency on the research subject The High Throughput Creation of Disease Model Cells and the Analysis of Their Function. The work was also supported in part by the Strategic Research Promotion Program, the Ministry of Education, Culture, Sports, Science, and Technology, on the research subject "Development of Next Generation Bioresources."	Sharmin S, 2001, BIOCHEM BIOPH RES CO, V282, P228, DOI 10.1006/bbrc.2001.4569; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Enari M, 1998, NATURE, V391, P43; FADOK VA, 1992, J IMMUNOL, V148, P2207; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Slee EA, 1996, BIOCHEM J, V315, P21; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Salvesen GS, 2008, ADV EXP MED BIOL, V615, P13, DOI 10.1007/978-1-4020-6554-5_2; Atamaniuk J, 2006, CLIN CHEM, V52, P523, DOI 10.1373/clinchem.2005.058883; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Grancara S, 2014, AMINO ACIDS, V46, P671, DOI 10.1007/s00726-013-1591-0; Niu G, 2010, J NUCL MED, V51, P1659, DOI 10.2967/jnumed.110.078584; KUNIMOTO S, 1985, J ANTIBIOT, V38, P899; Sasaki T, 2008, DIFFERENTIATION, V76, P1023, DOI 10.1111/j.1432-0436.2008.00294.x; Sasaki T, 2008, YAKUGAKU ZASSHI, V128, P461, DOI 10.1248/yakushi.128.461; Schiller M, 2005, APOPTOSIS, V10, P1151, DOI 10.1007/s10495-005-1188-5; Zhang L, 2014, J STROKE CEREBROVASC, V23, P829, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.007	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	DEC	2014	50	10					973	981		10.1007/s11626-014-9799-1		9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	AU1PC	WOS:000345391600009		
J	Okada, M; Ishkitiev, N; Yaegaki, K; Imai, T; Tanaka, T; Fukuda, M; Ono, S; Haapasalo, M				Okada, M.; Ishkitiev, N.; Yaegaki, K.; Imai, T.; Tanaka, T.; Fukuda, M.; Ono, S.; Haapasalo, M.			Hydrogen sulphide increases hepatic differentiation of human tooth pulp stem cells compared with human bone marrow stem cells	INTERNATIONAL ENDODONTIC JOURNAL			English	Article						adult stem cells; bone marrow; dental pulp; hepatic differentiation; hydrogen sulphide; serum-free medium	IN-VITRO; PASSAGE; PCR; TRANSPLANTATION; APOPTOSIS; TRACT; BLOOD; TEETH; MICE	AimTo determine the differences in stem cell properties, in hepatic differentiation and in the effects of hydrogen sulphide (H2S) on hepatic differentiation between human bone marrow stem cells (hBMC) and stem cells from human exfoliated primary tooth pulp (SHED). MethodologyCD117(+) cells were magnetically separated and subjected to hepatic differentiation. CD117(+) cell lineages were characterized for transcription factors indicative of stem cells by qRT-PCR. For the last 9days of the differentiation, the test cells were exposed to 0.1ngmL(-1) H2S. Immunocytochemistry and flow cytometry of albumin, alpha-fetoprotein and carbamoyl phosphate synthetase were carried out after differentiation. Urea concentration and glycogen synthesis were also determined. ResultsGenes expressed in SHED were also expressed in BMC. No difference in expression level of hepatic markers was shown by immunofluorescence. SHED showed more positive cells than hBMC (P<0.01). H2S increased the number of positive cells in both cultures (P<0.01). Urea concentration and glycogen synthesis increased significantly after H2S exposure (P<0.001 and P<0.05, respectively). Real-time PCR data were analysed by RT2 profiler RT-PCR Array Data Analysis version 3.5 (Qiagen), and ELISA data were analysed by Bonferroni's multiple comparison using Windows spss version 16 (SPSS Inc, Chicago, IL, USA). Bonferroni's multiple comparison test was also carried out after angle transformation for the percentage data of flow cytometer using Windows spss((R)) version 16 (SPSS Inc). Statistical significance was accepted at P<0.05. ConclusionsStem cells from human exfoliated primary tooth pulp and BMC have similar properties. The level of hepatic differentiation in SHED compared with BMC was the same or higher. H2S increased the level ofhepaticdifferentiation.	[Okada, M.; Ishkitiev, N.; Yaegaki, K.; Imai, T.; Tanaka, T.; Fukuda, M.] Nippon Dent Univ Tokyo, Dept Oral Hlth, Tokyo 1028159, Japan; [Ono, S.] Nippon Dent Univ, Dept Community & Prevent Dent, Niigata, Japan; [Haapasalo, M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada	Yaegaki, K (reprint author), Nippon Dent Univ Tokyo, Dept Oral Hlth, 1-9-20 Chiyoda Ku, Tokyo 1028159, Japan.	yaegaki-k@tky.ndu.ac.jp	Ishkitiev, Nikolay/I-4654-2012	Ishkitiev, Nikolay/0000-0002-4351-5579			Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Fuller JA, 2013, J MED VIROL, V85, P924, DOI 10.1002/jmv.23455; Calenic B, 2013, J PERIODONTAL RES, V48, P322, DOI 10.1111/jre.12011; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Hirata TM, 2010, J ENDODONT, V36, P1139, DOI 10.1016/j.joen.2010.03.002; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Tichelli A, 2012, CURR PROBL DERMATOL, V43, P132, DOI 10.1159/000335271; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Smit PM, 2013, PEDIATR RES, V73, P355, DOI 10.1038/pr.2012.176; SIENA S, 1989, BLOOD, V74, P1905; Moraleda JM, 2006, TRANSPL IMMUNOL, V17, P74, DOI 10.1016/j.trim.2006.09.030; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Pournasr B, 2011, ARCH IRAN MED, V14, P244, DOI 0011144/AIM.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ii H, 2010, J PERIODONTOL, V81, P1691, DOI 10.1902/jop.2010.100116; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Ruparel NB, 2013, J ENDODONT, V39, P357, DOI 10.1016/j.joen.2012.10.027; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Ishkitiev N, 2012, J ENDODONT, V38, P475, DOI 10.1016/j.joen.2011.12.011; Crowder SW, 2013, FASEB J, V27, P2788, DOI 10.1096/fj.13-228288; CUDKOWICZ G, 1964, ANN NY ACAD SCI, V114, P571; Dong XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063405; Gronthos S, 2002, J DENT RES, V81, P531; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Ishiwata I, 2000, Hum Cell, V13, P185; Ishkitiev N, 2013, REGEN MED, V8, P597, DOI 10.2217/rme.13.42; Ishkitiev N, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/017103; Leeb C, 2011, CELL PROLIFERAT, V44, P9, DOI 10.1111/j.1365-2184.2010.00725.x; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Moghbeli-Nejad S, 2012, J ASSIST REPROD GEN, V29, P53, DOI 10.1007/s10815-011-9626-5; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Streeter Eloise, 2013, Med Gas Res, V3, P9, DOI 10.1186/2045-9912-3-9; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Yaegaki K, 2008, J PERIODONTAL RES, V43, P391, DOI 10.1111/j.1600-0765.2007.01052.x; Zhang FB, 2005, BIOCHEM BIOPH RES CO, V336, P784, DOI 10.1016/j.bbrc.2005.08.177	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0143-2885	1365-2591		INT ENDOD J	Int. Endod. J.	DEC	2014	47	12					1142	1150		10.1111/iej.12262		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU0OU	WOS:000345323700007		
J	Liang, JG; Narahara, H; Koresawa, H; Suzuki, H				Liang, Jianguo; Narahara, Hiroyuki; Koresawa, Hiroshi; Suzuki, Hiroshi			Verification and evaluation of automatically designed cooling channels for block-laminated molds	INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY			English	Article						Cooling channel; Automatic design; Block-laminatedmold; Rapid prototyping; Laser sintering		This study discusses an automatic design method of injection mold cooling channels using a genetic algorithms (GA) and a finite element method (FEM), combined with an evaluation function based on unsteady-state heat transfer and linear static deformation. The uniformity of cooling and the deformation effect were observed in the injection mold with the automatically designed cooling channel through a verification experiment. The genetic algorithm was applied in the following steps: the generation of finite elements of individuals expressing different cooling channel shapes, the definition of the fitness function to evaluate individuals, the genetic operation for individuals, and the automatic generation of the cooling channel shape. Finally, based on a molding experiment, the cooling and deformation effects were investigated. Results of resin cooling uniformity, temperature distribution of molding parts, and deformation of mold were demonstrated.	[Liang, Jianguo; Narahara, Hiroyuki; Koresawa, Hiroshi; Suzuki, Hiroshi] Kyushu Inst Technol, Fukuoka, Japan	Liang, JG (reprint author), Kyushu Inst Technol, Fukuoka, Japan.	liangjianguo20@hotmail.com; nara@mse.kyutech.ac.jp; koresawa@mse.kyutech.ac.jp; suzuki@mse.kyutech.ac.jp			KAKENHI [21560128]	This work is partly supported by KAKENHI (21560128).	Chen TY, 1997, INT J NUMER METH ENG, V40, P1323, DOI 10.1002/(SICI)1097-0207(19970415)40:7<1323::AID-NME117>3.0.CO;2-T; Yao DG, 2002, POLYM ENG SCI, V42, P2471, DOI 10.1002/pen.11133; Sachs E, 2000, POLYM ENG SCI, V40, P1232, DOI 10.1002/pen.11251; Galante M, 1996, INT J NUMER METH ENG, V39, P361, DOI 10.1002/(SICI)1097-0207(19960215)39:3<361::AID-NME854>3.3.CO;2-T; Jensen E, THESIS PURDUE U; Koresawa H, 2001, ANTEC, P937; Matsumori T, 2008, J JPN SOC MECH ENG C, V74, P239; Matsumoto T, 2000, J JAPAN SOC MECH E A, V66, P14; Park SJ, 1998, J MANUF SCI E-T ASME, V120, P287, DOI 10.1115/1.2830126; Takafuji A, 2003, SEIKEI KAKOU, V15, P357; Yoneyama T, 2001, J JPN SOC PREC ENG, V67, P1991	11	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-3768	1433-3015		INT J ADV MANUF TECH	Int. J. Adv. Manuf. Technol.	DEC	2014	75	9-12					1751	1761		10.1007/s00170-014-6260-2		11	Automation & Control Systems; Engineering, Manufacturing	Automation & Control Systems; Engineering	AT7AN	WOS:000345088400044		
J	Kim, HI; Kim, YJ; Lee, KH; Jeong, HY; Ikeda, Y				Kim, H. I.; Kim, Y. J.; Lee, K. H.; Jeong, H. Y.; Ikeda, Y.			INVESTIGATION ON THE FLAME CHARACTERISTICS IN A PCCI ENGINE USING ENDOSCOPE SYSTEM WITH MICRO-CASSEGRAIN	INTERNATIONAL JOURNAL OF AUTOMOTIVE TECHNOLOGY			English	Article						Partial Charge Compression Ignition (PCCI); Combustion flame/Visualization; Endoscope; Emission; Brake Mean Effective Pressure (BMEP); Rate of Heat Release (RoHR)		Diesel engines are most frequently used in vehicles because of their high efficiency and durability. However, nitrogen oxide (NOx) and particulate matter (PM) from diesel engines are became problem. Recently, the premixed charged compression ignition (PCCI) technique has been studied specifically to reduce NOx and PM emissions simultaneously. While the PCCI engine has the advantage of reducing NOx and PM emissions, control of the combustion phase is difficult. Therefore, it is very important to understand the flame developing process and heat release pattern in a real PCCI engine. However, most research into the characteristics of PCCI combustion has used an optical access engine. This paper describes the combustion characteristics obtained using a micro-Cassegrain sensor and discusses how the sensor can be used to directly detect the flame characteristics for future control of PCCI combustion. From this research, the differences of flame characteristics between PCCI engine and conventional diesel engine were clarified.	[Kim, H. I.; Kim, Y. J.; Lee, K. H.] Hanyang Univ, Dept Mech Engn, Gyeonggi 426791, South Korea; [Jeong, H. Y.] Doosan Engine Corp, Changwon Si 642370, Gyeongnam, South Korea; [Ikeda, Y.] Imagineering Inc, Chuo Ku, Kobe, Hyogo 6500047, Japan	Lee, KH (reprint author), Hanyang Univ, Dept Mech Engn, Gyeonggi 426791, South Korea.	hylee@hanyang.ac.kr			Hanyang University [HY-2012-P]	This work was supported by the research fund of Hanyang University (HY-2012-P).	Bression G., 2008, 2008010034 SAE; Brooks T, 2005, 2005013833 SAE; Gothekar S., 2007, 200726012 SAE; Iwabuchi Y., 1999, 1999010185 SAE; Jeong D. B., 2008, SPRING C KSAE, V1, P292; Jeong H. Y, 2008, MILCOM 2008 NOV, P541; Kim H., 2009, 2009010926 SAE; Kim H. M., 2008, 7 THERM FLUID ENG C; Kim K, 2008, ENERG FUEL, V22, P3687, DOI 10.1021/ef8003224; Kim YJ, 2011, INT J AUTO TECH-KOR, V12, P639, DOI 10.1007/s12239-011-0074-0; Montgomery D. C., 1997, DESIGN ANAL EXPT; Najt PM, 1983, 830264 SAE; Noguchi M, 1979, 790840 SAE; Onishi S, 1979, 790501 SAE; Tatschl R.Priesching, 2007, 2007240048 SAE; Yun HH, 2008, 2008010639 SAE; Zhao F, 2003, HOMOGENEOUS CHARGE C	17	0	0	KOREAN SOC AUTOMOTIVE ENGINEERS-KSAE	SEOUL	#1301, PARADISE VENTURE TOWER, 52-GIL 21, TEHERAN-RO, GANGNAM-GU, SEOUL 135-919, SOUTH KOREA	1229-9138	1976-3832		INT J AUTO TECH-KOR	Int. J. Automot. Technol.	DEC	2014	15	7					1063	1070		10.1007/s12239-014-0110-y		8	Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	AT7ID	WOS:000345108900003		
J	Oikawa, S; Matsui, Y; Sakurai, T				Oikawa, S.; Matsui, Y.; Sakurai, T.			CHARACTERISTICS OF COLLISION DAMAGE MITIGATION BRAKING SYSTEM FOR PEDESTRIAN PROTECTION	INTERNATIONAL JOURNAL OF AUTOMOTIVE TECHNOLOGY			English	Article						Pedestrian safety; Vehicle travel velocity; Collision damage mitigation braking system; Pedestrian protection		The vehicle travel velocity at pedestrian contact is considered to be an important parameter that affects the crash outcome. To reduce vehicle/pedestrian impact velocity, a collision damage mitigation braking system (CDMBS) using a sensor for pedestrian protection could be an effective countermeasure. The first purpose of this study is to clarify the relation between vehicle travel velocity and pedestrian injury severity due to differences in pedestrians' ages in actual traffic accidents. The accident analyses were performed using vehicle-pedestrian accident data in 2009 from the database of the Institute for Traffic Accident Research and Data Analysis (ITARDA) in Japan. The result revealed that the fatality risk became higher with the increase in vehicle travel velocity. The second purpose of this study is to determine the safety performance of production vehicles equipped with the CDMBS for pedestrian protection. It was found that the CDMBS was highly effective in reducing the impact velocity from 50 km/h (vehicle travel velocity) to below 17 km/h, that could result in a significant decrease in fatality risk to be 2% or less. Additionally, the authors investigated a detectable zone with respect to a pedestrian's position in relation to the vehicle. It was shown that the detectable zones for production vehicles tested were limited to be inside the vehicle front width.	[Oikawa, S.; Matsui, Y.] Natl Traff Safety & Environm Lab, Vehicle Safety Res Dept, Chofu, Tokyo 1820012, Japan; [Sakurai, T.] Iwaki Meisei Univ, Coll Sci & Engn, Mech Engn & Syst Course, Iwaki, Fukushima 9708551, Japan	Matsui, Y (reprint author), Natl Traff Safety & Environm Lab, Vehicle Safety Res Dept, 7-42-27 Jindaiji Higashi Machi, Chofu, Tokyo 1820012, Japan.	ymatsui@ntsel.go.jp					Cabinet Office, 2009, WHIT PAP TRAFF SAF; European Enhanced Vehicle-safety Committee, 1998, IMPR TEST METH EV PE; Institute for Traffic Accident Research and Data Analysis of Japan (ITARDA), 1995, ITARDA INF 4; Institute for Traffic Accident Research and Data Analysis of Japan (ITARDA), 2013, ANN TRAFF ACC REP 20; Institute for Traffic Accident Research and Data Analysis of Japan (ITARDA), 2010, ANN TRAFF ACC REP 20; Kuzumaki S., 2009, J SOC AUTOMOT ENG JP, V63, P11; Makabe S., 2012, J SOC AUTOMOTIVE ENG, V66, P88; Matsui Y, 2004, INT J CRASHWORTHINES, V9, P129, DOI 10.1533/ijcr.2004.0280; Matsui Yasuhiro, 2011, International Journal of Vehicle Safety, V5, DOI 10.1504/IJVS.2011.045785; Matsui Y., 2011, 22 ESV C; Matsui Y, 2013, SAE INT J TRANSPORTA, V1, P297; Matsui Y, 2013, TRAFFIC INJ PREV, V14, pS58, DOI 10.1080/15389588.2013.796372; Research Institute of Human Engineering for Quality Life, 1997, JAP BOD SIZ DAT 1992; Shibata E, 2009, J SOC AUTOMOT ENG JP, V63, P93	14	1	1	KOREAN SOC AUTOMOTIVE ENGINEERS-KSAE	SEOUL	#1301, PARADISE VENTURE TOWER, 52-GIL 21, TEHERAN-RO, GANGNAM-GU, SEOUL 135-919, SOUTH KOREA	1229-9138	1976-3832		INT J AUTO TECH-KOR	Int. J. Automot. Technol.	DEC	2014	15	7					1129	1136		10.1007/s12239-014-0117-4		8	Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	AT7ID	WOS:000345108900010		
J	Ueki, Y; Hayashida, K; Komada, Y; Nakamura, M; Kobayashi, M; Iimori, M; Inoue, Y				Ueki, Yoichiro; Hayashida, Kenichi; Komada, Yoko; Nakamura, Masaki; Kobayashi, Mina; Iimori, Makio; Inoue, Yuichi			Factors Associated with Duration Before Receiving Definitive Diagnosis of Narcolepsy among Japanese Patients Affected with the Disorder	INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE			English	Article						Cataplexy; Definitive diagnosis; Early diagnosis; Narcolepsy; Quality of life	QUALITY-OF-LIFE; IDIOPATHIC HYPERSOMNIA; DAYTIME SLEEPINESS; RISK-FACTORS; HEALTH; MODAFINIL; POPULATION; KNOWLEDGE; AWARENESS; CHILDREN	Background Narcolepsy (NA) is a sleep disorder characterized by excessive daytime sleepiness and an increased propensity of rapid eye movement sleep. If left untreated, NA can lead to academic underachievement or job loss because of dozing off or mistakes caused by inattentiveness due to sleepiness. Purpose Although untreated narcolepsy patients may suffer from many social disadvantages due to excessive daytime sleepiness, mostly it takes a long time to receive a definitive diagnosis of the disorder. This retrospective study investigated factors related to the period until definitive diagnosis among patients with narcolepsy in Japan. Methods We enrolled 181 consecutive patients (108 men, 73 women; mean age 37.6+/-16.6 years old; narcolepsy with cataplexy/narcolepsy without cataplexy=131: 50). Multivariate logistic regression analysis was performed with period until definitive diagnosis as the dependent variable and descriptive clinical variables as the independent variables. Results The mean period until receiving the diagnosis among the participants was 9.9+/-10.1 years. More than half of the patients first learned about the disorder from information provided by the media. Multivariate logistic analysis indicated that adult onset (p < 0.01), onset in 1995 or later (p < 0.001), and first learning about the disorder from a sleep disorder specialist physician or a general practitioner (p < 0.001) were associated with a time taken for receiving a definitive diagnosis less than or equal to the median value (7 years). Conclusion Improving access to information about the concept of the disorder and the medical institutions specialized in sleep disorders, especially via the Internet, would be necessary to promote early diagnosis of the disorder.	[Ueki, Yoichiro; Iimori, Makio; Inoue, Yuichi] Tokyo Med Univ, Dept Psychiat, Shinjuku Ku, Tokyo 1600023, Japan; [Ueki, Yoichiro; Komada, Yoko; Nakamura, Masaki; Kobayashi, Mina; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1600023, Japan; [Ueki, Yoichiro; Hayashida, Kenichi; Komada, Yoko; Nakamura, Masaki; Kobayashi, Mina; Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan; [Ueki, Yoichiro; Hayashida, Kenichi] Sleep & Stress Clin, Tokyo, Japan	Inoue, Y (reprint author), Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan.	inoue@somnology.com					Aizawa R, 2008, SLEEP BIOL RHYTHMS, V6, P201, DOI 10.1111/j.1479-8425.2008.00362.x; Alaia SL, 1992, LOSS GRIEF CARE, V5, P1; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Fukuda K, 2001, PSYCHIAT CLIN NEUROS, V55, P231, DOI 10.1046/j.1440-1819.2001.00837.x; FARQUHAR JW, 1977, LANCET, V1, P1192; Ozaki A, 2012, SLEEP MED, V13, P200, DOI 10.1016/j.sleep.2011.07.014; Stein MA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e60; Broughton RJ, 1997, NEUROLOGY, V49, P444; ALDRICH MS, 1991, TRENDS NEUROSCI, V14, P235, DOI 10.1016/0166-2236(91)90121-A; Pancioli AM, 1998, JAMA-J AM MED ASSOC, V279, P1288, DOI 10.1001/jama.279.16.1288; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Mosca L, 2004, CIRCULATION, V109, P573, DOI 10.1161/01.CIR.0000115222.69428.C9; Wing YK, 2008, J NEUROL NEUROSUR PS, V79, P1262, DOI 10.1136/jnnp.2007.143420; Billiard M, 2007, SLEEP MED REV, V11, P377, DOI 10.1016/j.smrv.2007.04.001; Komada Y, 2009, TOHOKU J EXP MED, V219, P11, DOI 10.1620/tjem.219.11; Beusterien KM, 1999, SLEEP, V22, P757; BROUGHTON R, 1981, CAN J NEUROL SCI, V8, P299; BROUGHTON WA, 1994, SLEEP, V17, pS45; DAHL RE, 1994, J AM ACAD CHILD PSY, V33, P834, DOI 10.1097/00004583-199407000-00009; Daniels E, 2001, J SLEEP RES, V10, P75, DOI 10.1046/j.1365-2869.2001.00234.x; Daniels LE, 1934, MEDICINE, V13, P1; Dauvilliers Y., 1998, Journal of Sleep Research, V7, P56; Dodel R, 2007, SLEEP MED, V8, P733, DOI 10.1016/j.sleep.2006.10.010; JOHNS MW, 1991, SLEEP, V14, P540; Juby AG, 2001, OSTEOPOROSIS INT, V12, P617, DOI 10.1007/s001980170060; Moldofsky H, 2000, SLEEP MED, V1, P109, DOI 10.1016/S1389-9457(99)00014-3; Morrish E, 2004, SLEEP MED, V5, P37, DOI 10.1016/j.sleep.2003.06.002; Mukai J, 2003, SLEEP BIOL RHYTHMS, V1, P229, DOI [10.1046/j.1446-9235.2003.00047.x, DOI 10.1046/J.1446-9235.2003.00047.X]; Oka Y, 2008, JPN J SLEEP MED, V2, P187; Ozaki Akiko, 2008, J Clin Sleep Med, V4, P572; PARKES D, 1994, SLEEP, V17, pS93; Rye DB, 1998, NEUROLOGY, V50, P459; SCHARF MB, 1985, J CLIN PSYCHIAT, V46, P222; Spruyt K, 2005, J SLEEP RES, V14, P163, DOI 10.1111/j.1365-2869.2005.00458.x; YOSS RE, 1957, P STAFF M MAYO CLIN, V32, P320	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1070-5503	1532-7558		INT J BEHAV MED	Int. J. Behav. Med.	DEC	2014	21	6					966	970		10.1007/s12529-013-9371-5		5	Psychology, Clinical	Psychology	AU1QR	WOS:000345395700011		
J	Kono, AK; Croisille, P; Nishii, T; Nishiyama, K; Kyotani, K; Shigeru, M; Takamine, S; Fujiwara, S; Sugimura, K				Kono, Atsushi K.; Croisille, Pierre; Nishii, Tatsuya; Nishiyama, Koya; Kyotani, Katsusuke; Shigeru, Mayumi; Takamine, Sachiko; Fujiwara, Sei; Sugimura, Kazuro			Cardiovascular magnetic resonance tagging imaging correlates with myocardial dysfunction and T2 mapping in idiopathic dilated cardiomyopathy	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Strain; Tagging; Dilated cardiomyopathy; Dyssynchrony; T2 mapping	SPATIAL MODULATION; APICAL ROTATION; LEFT-VENTRICLE; QUANTIFICATION; MOTION; EDEMA; INFARCTION; FIBROSIS; SYSTOLE; STRAIN	To evaluate the details of myocardial dysfunction in dilated cardiomyopathy (DCM) patients using tagging images and the correlation of tagging imaging with tissue characteristics. Circumferential strain (Ecc) derived from tagging images was measured in 15 normal (NML) subjects (15 males; mean age 28.5 years) and 12 DCM patients (7 males; mean age 48.9 years). The following parameters were compared: (1) the magnitude of peak Ecc (Ecc*); (2) the coefficient of variation of the time of Ecc* (CVtime*), which indexes dyssynchrony; and (3) descriptive findings of time-Ecc curves. We also evaluated the correlations of Ecc* in DCM patients with ejection fraction (EF), myocardial T2 values, and late gadolinium enhancement (LGE). Mean Ecc*s in DCM patients and NML subjects were -12.7 and -23.5 %, respectively (P < 0.0001). Mean CVtime*s were 15.2 and 4.5 %, respectively (P = 0.0002). The findings of pre-systolic extension and systolic stretch in the septum were observed in 6 (50 %) and 10 (83.3 %) DCM patients and in none of the NML participants. Ecc* was correlated with EF (P < 0.0001, R (2) = 0.90) and T2 values (P = 0.018, R (2) = 0.44) but not with LGE (P = 0.072, R (2) = 0.28). Tagging images revealed the reduction of myocardial function as well as dyssynchrony in DCM patients. Myocardial dysfunction occurred coincidently with myocardial inflammation.	[Kono, Atsushi K.] Kobe Univ Hosp, Dept Radiol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kono, Atsushi K.] Erasmus MC, Dept Radiol, NL-3015 CE Rotterdam, Netherlands; [Kono, Atsushi K.; Nishii, Tatsuya; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Croisille, Pierre] Univ St Etienne, Dept Radiol, CREATIS, CNRS,UMR 5220,INSERM,U1044, Lyon, France; [Nishiyama, Koya; Kyotani, Katsusuke] Kobe Univ Hosp, Div Radiol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Shigeru, Mayumi; Takamine, Sachiko; Fujiwara, Sei] Kobe Univ, Grad Sch Med, Div Cardiovasc & Resp Med,Dept Internal Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Kono, AK (reprint author), Kobe Univ Hosp, Dept Radiol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ringonotegami@mac.com	Croisille, Pierre/H-4928-2014	Croisille, Pierre/0000-0003-4019-3460	Japanese Society for Magnetic Resonance in Medicine; Bayer Schering Pharma	The author (AKK) received an award from the Japanese Society for Magnetic Resonance in Medicine and Bayer Schering Pharma. This study was partially funded by this award. I would like to express my gratitude to my family for the support of my fellowship and to Professor Gabriel P. Krestin at Erasmus Medical Center for his insightful comments and suggestions.	Akar FG, 2005, TRENDS CARDIOVAS MED, V15, P259, DOI 10.1016/j.tcm.2005.08.002; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kim RJ, 1996, CIRCULATION, V94, P3318; Verhaert D, 2011, JACC-CARDIOVASC IMAG, V4, P269, DOI 10.1016/j.jcmg.2010.09.023; Young AA, 2001, CARDIOVASC RES, V49, P308, DOI 10.1016/S0008-6363(00)00248-0; AXEL L, 1989, RADIOLOGY, V171, P841; Arts T, 2010, IEEE T MED IMAGING, V29, P1114, DOI 10.1109/TMI.2009.2037955; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Russel IK, 2009, J CARD FAIL, V15, P717, DOI 10.1016/j.cardfail.2009.04.007; Kanzaki H, 2006, BASIC RES CARDIOL, V101, P465, DOI 10.1007/s00395-006-0603-6; Jeung MY, 2012, RADIOGRAPHICS, V32, P1381, DOI 10.1148/rg.325115098; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; AXEL L, 1989, RADIOLOGY, V172, P349; Kuijpers D, 2003, CIRCULATION, V107, P1592, DOI 10.1161/01.CIR.0000060544.41744.7C; MacGowan GA, 1997, CIRCULATION, V96, P535; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Nelson GS, 2000, CIRCULATION, V101, P2703; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Croisille P, 1999, CIRCULATION, V99, P284; Del-Canto I, 2013, J MAGN RESON IMAGING; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Gotte MJW, 2001, J AM COLL CARDIOL, V37, P808, DOI 10.1016/S0735-1097(00)01186-4; Han YC, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-2; Jeserich M, 2012, CLIN CARDIOL, V35, P371, DOI 10.1002/clc.21979; Kuijer JPA, 2002, J CARDIOV MAGN RESON, V4, P341, DOI 10.1081/JCMR-120013299; MAEHASHI N, 1991, JPN HEART J, V32, P1; McCrohon J. A., 2003, Circulation, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C; MEINERTZ T, 1984, AM J CARDIOL, V53, P902, DOI 10.1016/0002-9149(84)90522-8; Moore C C, 2000, Top Magn Reson Imaging, V11, P359, DOI 10.1097/00002142-200012000-00005; Shehata ML, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-55; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-53; Zwanenburg JJM, 2005, J AM COLL CARDIOL, V46, P2215, DOI 10.1016/j.jacc.2005.08.047	34	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	DEC	2014	30			2	SI		145	152		10.1007/s10554-014-0523-8		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AT7DQ	WOS:000345097400009		
J	Kato, K; Sakai, Y; Ishibashi, I; Kobayashi, Y				Kato, Ken; Sakai, Yoshiaki; Ishibashi, Iwao; Kobayashi, Yoshio			Recurrent mid-ventricular takotsubo cardiomyopathy	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Editorial Material									[Kato, Ken; Kobayashi, Yoshio] Chiba Univ, Dept Cardiovasc Med, Grad Sch Med, Chiba, Japan; [Sakai, Yoshiaki; Ishibashi, Iwao] Chiba Emergency Med Ctr, Dept Cardiol, Chiba, Japan	Kato, K (reprint author), Chiba Univ, Dept Cardiovasc Med, Grad Sch Med, Chiba, Japan.	kkatou0424@yahoo.co.jp						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	DEC	2014	30	8					1417	1418		10.1007/s10554-014-0469-x		2	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AT7CC	WOS:000345093100001		
J	Tatsumi, K; Tanaka, H; Matsumoto, K; Sawa, T; Miyoshi, T; Imanishi, J; Motoji, Y; Mochizuki, Y; Fukuda, Y; Shinke, T; Hirata, K				Tatsumi, Kazuhiro; Tanaka, Hidekazu; Matsumoto, Kensuke; Sawa, Takuma; Miyoshi, Tatsuya; Imanishi, Junichi; Motoji, Yoshiki; Mochizuki, Yasuhide; Fukuda, Yuko; Shinke, Toshiro; Hirata, Ken-ichi			Global endocardial area change rate for the assessment of left ventricular relaxation and filling pressure: using 3-dimensional speckle-tracking study	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Filling pressure; Heart failure; 3-dimensional speckle-tracking echocardiography; Left ventricular relaxation	MITRAL ANNULAR VELOCITY; SYSTOLIC HEART-FAILURE; SOCIETY-OF-CARDIOLOGY; TISSUE DOPPLER; STRAIN-RATE; DIASTOLIC FUNCTION; ECHOCARDIOGRAPHY; CATHETERIZATION; RECOMMENDATIONS; CARDIOMYOPATHY	Early diastolic mitral inflow and annulus velocities ratio (E/e') is the parameter used to estimate left ventricular (LV) filling pressure, but their use for patients with reduced ejection fraction (EF) (< 50 %) is controversial. LV endocardial area change rate with 3-dimensional (3-D) speckle-tracking can be used to evaluate the entire LV diastolic function, we tested the hypothesis that the early diastolic area change rate (E-ACR) represents LV relaxation, and E and E-ACR ratio (E/E-ACR) can accurately predict LV filling pressure in patients with reduced and preserved EF (a parts per thousand yen50 %). We studied 125 patients with EF of 40 +/- A 17 %. E-ACR of all patients was measured using the global area change rate, and LV relaxation time constant (tau, n = 53) and pulmonary capillary wedge pressure (PCWP, n = 125) were measured by cardiac catheterization. E-ACR significantly correlated with tau (r = -0.60, p < 0.001). In the retrospective group (n = 101), E/E-ACR correlated with PCWP for patients with reduced EF as well as those with preserved EF (n = 79 and 22, r = 0.62 and 0.81, both p < 0.001). In overall patients, E/E-ACR a parts per thousand yen94 cm was a better predictor of elevated mean PCWP (> 12 mmHg) (sensitivity: 69 %, specificity: 87 %, areas under the curves = 0.82; p < 0.001) and was a more accurate predictor than E/e' (p = 0.001) for the retrospective group. For the validation group (n = 24), E/E-ACR a parts per thousand yen94 cm was similarly predictive for elevated mean PCWP (sensitivity: 60 %, specificity: 100 %, positive predictive value: 100 %, negative predictive value: 78 %). In conclusions, global E-ACR by 3-D speckle-tracking proved to be dependent on LV relaxation. Moreover, E/E-ACR was found to be a powerful predictor of LV filling pressure regardless of EF.	[Tatsumi, Kazuhiro; Tanaka, Hidekazu; Matsumoto, Kensuke; Sawa, Takuma; Miyoshi, Tatsuya; Imanishi, Junichi; Motoji, Yoshiki; Mochizuki, Yasuhide; Fukuda, Yuko; Shinke, Toshiro; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med,Chuo Ku, Kobe, Hyogo 6500017, Japan	Tanaka, H (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tanakah@med.kobe-u.ac.jp					Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Kasner M, 2010, EUR J ECHOCARDIOGR, V11, P743, DOI 10.1093/ejechocard/jeq060; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Ommen SR, 2000, CIRCULATION, V102, P1788; Seo Y, 2011, JACC-CARDIOVASC IMAG, V4, P358, DOI 10.1016/j.jcmg.2010.12.007; Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1; Geske JB, 2007, CIRCULATION, V116, P2702, DOI 10.1161/CIRCULATIONAHA.107.698985; Sundereswaran L, 1998, AM J CARDIOL, V82, P352, DOI 10.1016/S0002-9149(98)00346-4; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480; Nagueh SF, 1998, CIRCULATION, V98, P1644; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Mullens W, 2009, CIRCULATION, V119, P62, DOI 10.1161/CIRCULATIONAHA.108.779223; Dokainish H, 2004, CIRCULATION, V109, P2432, DOI 10.1161/01.CIR.0000127882.58426.7A; Ha JW, 2001, CIRCULATION, V104, P976, DOI 10.1161/hc3401.095705; Dini FL, 2009, EUR J ECHOCARDIOGR, V10, P562, DOI 10.1093/ejechocard/jep001; Dokainish H, 2008, AM J CARDIOL, V101, P1504, DOI 10.1016/j.amjcard.2008.01.037; Makita Y, 2011, ECHOCARDIOGR-J CARD, V28, P606, DOI 10.1111/j.1540-8175.2011.01414.x; Meluzin J, 2011, EUR J ECHOCARDIOGR, V12, P11, DOI 10.1093/ejechocard/jeq088; Nishimura RA, 2014, 2014 AHA ACC GUIDELI; Olson JJ, 2006, J AM SOC ECHOCARDIOG, V19, P83, DOI 10.1016/j.echo.2005.07.005; Wada Y, 2012, CIRC J, V76, P675, DOI 10.1253/circj.CJ-11-0703	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	DEC	2014	30	8					1473	1481		10.1007/s10554-014-0486-9		9	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	AT7CC	WOS:000345093100010		
J	Ohno, Y; Yamada, M; Yamaguchi, R; Hisaka, A; Suzuki, H				Ohno, Yoshiyuki; Yamada, Maiko; Yamaguchi, Ryo; Hisaka, Akihiro; Suzuki, Hiroshi			Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy	INTERNATIONAL JOURNAL OF CLINICAL PHARMACY			English	Article						Aprepitant; Chemotherapy; CYP2C9; Interaction; Prothrombin time; Warfarin		Case We describe two cases in which treatment with aprepitant persistently altered antithrombotic control in patients receiving warfarin. A 60-year-old man received 5 weekly cycles of chemotherapy. Aprepitant was administered as a 3-day regimen from the second cycle of chemotherapy. In each of the chemotherapy cycles that included aprepitant, the therapeutic international normalized ratio (INR) decreased markedly to < 1.6, and slowly recovered over several weeks. A 47-year-old woman was treated with 4 weekly cycles of chemotherapy. Aprepitant was administered as a 3-day regimen. On day 8 of the first cycle of chemotherapy, the patient's INR fell markedly to 1.1. Although warfarin dosage was steadily increased over the four subsequent cycles of chemotherapy, therapeutic target range was not recovered. INR gradually returned to normal during the 2 months after the final cycle of chemotherapy. Conclusion To our knowledge, this is the first case report to document the effects of aprepitant in cancer patients receiving anticoagulation therapy.	[Ohno, Yoshiyuki; Yamada, Maiko; Yamaguchi, Ryo; Suzuki, Hiroshi] Univ Tokyo, Tokyo Univ Hosp, Dept Pharm, Fac Med,Bunkyo Ku, Tokyo 1138655, Japan; [Hisaka, Akihiro] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan	Ohno, Y (reprint author), Univ Tokyo, Tokyo Univ Hosp, Dept Pharm, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yohno-tky@umin.ac.jp					Miners JO, 1998, BRIT J CLIN PHARMACO, V45, P525, DOI 10.1046/j.1365-2125.1998.00721.x; Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242; Horn JR, 2007, ANN PHARMACOTHER, V41, P674, DOI 10.1345/aph.1H423; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Harder S, 1996, CLIN PHARMACOKINET, V30, P416; Inoue H, 2013, CIRC J, V77, P2264, DOI 10.1253/circj.CJ-13-0290; Depre M, 2005, EUR J CLIN PHARMACOL, V61, P341, DOI 10.1007/s00228-005-0907-8; Le AT, 1997, ANN PHARMACOTHER, V31, P1006; Sellam J, 2007, JOINT BONE SPINE, V74, P446, DOI 10.1016/j.jbspin.2006.12.006; Shadle CR, 2004, J CLIN PHARMACOL, V44, P215, DOI 10.1177/0091270003262950	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	2210-7703	2210-7711		INT J CLIN PHARM-NET	Int. J. Clin. Phar,.	DEC	2014	36	6					1134	1137		10.1007/s11096-014-0022-y		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT6DB	WOS:000345028100007		
J	Beppu, N; Matsubara, N; Noda, M; Yamano, T; Doi, H; Kamikonya, N; Yamanaka, N; Yanagi, H; Tomita, N				Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Yamano, Tomoki; Doi, Hiroshi; Kamikonya, Norihiko; Yamanaka, Naoki; Yanagi, Hidenori; Tomita, Naohiro			The timing of surgery after preoperative short-course S-1 chemoradiotherapy with delayed surgery for T3 lower rectal cancer	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Rectal cancer; Radiotherapy; Interval; Oncologic outcome; Pathological assessment	LONG-COURSE CHEMORADIATION; SHORT-COURSE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL	The purpose of this study was to analyze the influence of variations in clinical practice regarding the timing of surgery with short-course chemoradiotherapy with delayed surgery (SCRT-delay) for lower rectal cancer. A total of 171 patients with T3 N0-2 lower rectal cancer treated with SCRT-delay (25 Gy/10 fractions/5 days (S-1); days 1-10) were retrospectively evaluated. The median waiting period of 30 days was used as a discriminator (group A: waiting period, a parts per thousand currency sign30 days; group B: waiting period, a parts per thousand yen31 days). Preoperative treatment responses and oncological outcomes were analyzed. The mean waiting periods for groups A and B were 24.4 +/- 5.3 and 41.4 +/- 12.3 days, respectively. There were no statistically significant differences between the two groups in any of the clinical variables. The clinicopathological outcomes were as follows: T downstaging (43.5 vs 37.2 %; p = 0.400), negative yp N (67.1 vs 75.6 %; p = 0.218), pCR (7.1 vs 1.2 %; p = 0.119). The 5-year local recurrence-free survival (89.3 vs 87.6 %; p = 0.956), the recurrence-free survival (82.2 vs 78.8 %; p = 0.662), and the overall survival (88.5 vs 84.4 %; p = 0.741), all of which were similar between the two groups. The longer waiting period did not increase the tumor downstaging and not improve the oncological outcomes for T3 lower rectal cancer treated with SCRT-delay. In addition, considering that the impaired leukocyte response occurred during the sub-acute period, any time after the sub-acute period (day 12) up to 30 days after radiotherapy would be a suitable waiting period.	[Beppu, Naohito; Matsubara, Nagahide; Noda, Masashi; Yamano, Tomoki; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Doi, Hiroshi; Kamikonya, Norihiko] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; [Yamanaka, Naoki; Yanagi, Hidenori] Meiwa Hosp, Dept Surg, Nishinomiya, Hyogo 6638186, Japan	Beppu, N (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	n_beppu@yahoo.co.jp					Garcia-Aguilar J, 2011, ANN SURG, V254, P97, DOI 10.1097/SLA.0b013e3182196e1f; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; [Anonymous], 1997, N ENGL J MED, V336, P980; Appelt AL, 2013, INT J RADIAT ONCOL, V85, P74, DOI 10.1016/j.ijrobp.2012.05.017; Minsky BD, 2012, J CLIN ONCOL, V30, P3777, DOI 10.1200/JCO.2012.45.0551; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; Park IJ, 2012, J CLIN ONCOL, V30, P1770, DOI 10.1200/JCO.2011.39.7901; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Doi H, 2013, J RADIAT RES, V54, P1118, DOI 10.1093/jrr/rrt058; Glehen O, 2003, BRIT J SURG, V90, P996, DOI 10.1002/bjs.4162; Ngan SY, 2012, J CLIN ONCOL, V30, P3827, DOI 10.1200/JCO.2012.42.9597; Birgisson H, 2005, J CLIN ONCOL, V23, P8697, DOI 10.1200/JCO-2005.02.9017; Faria S, 2014, COLORECTAL DIS, V16, P66; Fukushima M, 2010, OPTIM METHOD SOFTW, V25, P1, DOI 10.1080/10556780903312936; Veenhof AAFA, 2007, INT J COLORECTAL DIS, V22, P507, DOI 10.1007/s00384-006-0195-5	15	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	DEC	2014	29	12					1459	1466		10.1007/s00384-014-1997-5		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AT7ES	WOS:000345100400003		
J	Mukai, T; Fukunaga, Y; Ueno, M; Nagayama, S; Fujimoto, Y; Konishi, T; Akiyoshi, T; Ono, R; Yamaguchi, T				Mukai, Toshiki; Fukunaga, Yosuke; Ueno, Masashi; Nagayama, Satoshi; Fujimoto, Yoshiya; Konishi, Tsuyoshi; Akiyoshi, Takashi; Ono, Riki; Yamaguchi, Toshiharu			Needlescopic surgery for left-sided colorectal cancer	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Colorectal cancer; Minimally invasive surgery; Needlescopic surgery; Reduced port surgery	RANDOMIZED CONTROLLED-TRIAL; COLON-CANCER; OPEN COLECTOMY; OUTCOMES	Laparoscopic surgery has become the standard for colorectal cancers, but more minimally invasive surgery is continuously pursued. In June 2011, our institution started needlescopic surgery (NS). The aims of this study are to describe this technique and to investigate its feasibility for left-sided colorectal cancer surgery. From June 2011 to June 2013, 105 sigmoid colon and upper/middle rectal cancer patients underwent NS in our institution, involving one 5-mm port and three 3-mm ports, with the exception of an umbilical 12-mm port. A 10-mm scope is used through the umbilical 12-mm port, which will be extended to a small skin incision for specimen extraction. After dissection of the left colon, a 5-mm scope is inserted through the right lower 5-mm port and a linear stapler is inserted through the umbilical 12-mm port for rectal transection. The specimen is then extracted through umbilical incision, and the anastomosis is carried out by the double-staple technique. TNM staging is stage 0/I/II/III/IV = 0/31/32/31/11. Fifty-one patients underwent sigmoidectomy and 54 patients underwent anterior resection. There was no conversion to open surgery, but one patient required a change to a 5-mm port from one of the 3-mm ports. Mean operating time was 193 min and mean estimated blood loss was 12 ml. There were ten (9 %) postoperative complications: two anastomotic leaks requiring reoperation, two anastomotic hemorrhages, and one wound infection. There was no mortality. NS for left-sided colorectal cancer was a technically and oncologically feasible technique for selected patients.	[Mukai, Toshiki; Fukunaga, Yosuke; Ueno, Masashi; Nagayama, Satoshi; Fujimoto, Yoshiya; Konishi, Tsuyoshi; Akiyoshi, Takashi; Ono, Riki; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr,Koto Ku, Tokyo 1358550, Japan	Fukunaga, Y (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr,Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	YosukeF@aol.com					Liang JT, 2007, ANN SURG ONCOL, V14, P109, DOI 10.1245/s10434-006-9135-4; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Gagner M, 1998, SURG LAPAROSC ENDOSC, V8, P171, DOI 10.1097/00019509-199806000-00002; Bona S, 2012, MINIM INVASIVE SURG, V2012, DOI DOI 10.1155/2012/482079; Holder-Murray J, 2011, INT J SURG ONCOLOGY, DOI [10.1155/2011/490917, DOI 10.1155/2011/490917]; Morimasa T, 2010, SURG TODAY, V40, P909; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Rieder E, 2010, SURG ONCOL, V20, P211; Santoro E, 2008, SURG ENDOSC, V22, P1248, DOI 10.1007/s00464-007-9601-5; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7	12	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	DEC	2014	29	12					1501	1505		10.1007/s00384-014-2007-7		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	AT7ES	WOS:000345100400008		
J	Endo, M; Mukawa, T; Sato, N; Maezawa, D; Ohtsu, Y; Kuroda, A; Wakabayashi, M; Asakura, K				Endo, M.; Mukawa, T.; Sato, N.; Maezawa, D.; Ohtsu, Y.; Kuroda, A.; Wakabayashi, M.; Asakura, K.			Coexistence effect of UVA absorbers to increase their solubility and stability of supersaturation	INTERNATIONAL JOURNAL OF COSMETIC SCIENCE			English	Article						formulation skin care; suncare; texture; UV protection; solubility; stability of supersaturation	SKIN; SUNSCREENS	Synopsis ObjectiveSunscreens containing UVA absorbers in high concentrations are expected to be developed, since recent studies have suggested the possibility of involvement of UVA ray in skin cancer and early skin aging. Solubility and stability of supersaturation of UVA absorbers in UVB absorber were determined in the absence and the presence of cosmetic oil. Coexistence effect of UVA absorbers was analyzed to dissolve them in high concentrations. MethodsTwo UVA absorbers, diethylamino hydroxybenzoyl hexyl benzoate (DHHB) and butyl methoxydibenzoylmethane (BMDM), a UVB absorber, 2-ethylhexyl methoxycinnamate (EHMC), and a cosmetic oil, 2-ethylhexyl ester of oligomer of hydroxystearic acid (EH-O-HSA), were used. Their solutions were prepared at 80 degrees C and cooled to 5 degrees C. The solid DHHB and/or BMDM were added to it, and the time evolution of concentrations of the UVA absorbers in the solution phase was monitored. ResultsAt the saturation in the absence of EH-O-HSA at 5 degrees C, weight ratio of DHHB and BMDM to EHMC was 0.39/1.00 and 0.22/1.00, respectively. Addition of EH-O-HSA slightly changed the solubility of DHHB and BMDM. When the weight ratio of EH-O-HSA to EHMC was 0.20/1.00, weight ratio of DHHB and BMDM to EHMC was 0.35/1.00 and 0.25/1.00, respectively at the saturation at 5 degrees C. In the presence of EH-O-HSA, a strong coexistence effect of DHHB and BMDM was found on their solubility. A thermodynamically stable saturated solution at 5 degrees C having the composition that DHHB: BMDM: EHMC: EH-O-HSA = 0.47: 0.46: 1.00: 0.20 was obtained by the simultaneous addition of solid DHHB and BMDM into the initial solution. ConclusionThe solution type composite having the highest concentrations of DHHB and BMDM prepared in this study exhibited critical wavelength at 368nm that was just below the border for sunscreens being qualified as Broad Spectrum' protection under the new rule launched by US FDA. Resume ObjectifNous nous attendons au developpement accru des ecrans solaires contenant des absorbeurs UVA a des concentrations elevees, car des etudes recentes ont suggere la possibilite de participation des rayons UVA dans le developpement de cancer de la peau et dans le vieillissement premature de la peau. La solubilite et la stabilite de la sursaturation d'un filtre UVA dans un filtre UVB ont ete determinees en l'absence et en la presence d'une huile cosmetique. On a analyse l'effet de la coexistence de filtres UVA afin de les dissoudre a des concentrations elevees. MethodesDeux filtres UVA, le diethylamino hydroxybenzoyl hexyl benzoate (DHHB) et le methoxydibenzoylmethane de butyle (BMDM), un filtre des rayons UVB, le methoxycinnamate de 2-ethylhexyle (EHMC), et une huile cosmetique, l'ester 2-ethylhexylique de l'oligomere de l'acide hydroxystearique (EH-O -HSA), ont ete utilises. Les solutions ont ete preparees a 80 degrees C et refroidies a 5 degrees C. Le DHHB et/ou BMDM ont ete ajoutes en l'etat solide, et l'evolution temporelle de la concentration des filtres UVA dans la phase en solution a ete controlee. ResultatsLors de la saturation en l'absence d'EH-O-HSA a 5 degrees C, le rapport ponderal de DHHB et BMDM a EHMC etait 0.39/1.00 et 0.22/1.00, respectivement. L'ajout d'EH-O-HSA a legerement modifie la solubilite du DHHB et BMDM. Lorsque le rapport ponderal du EH-O-HSA etait de EHMAC 0.20/1.00, le rapport ponderal de DHHB et BMDM a EHMC etait 0.35/1.00 et 0.25/1.00, respectivement a la saturation a 5 degrees C. En presence de EH-O-HSA, un fort effet de la coexistence de DHHB et BMDM a ete trouve sur leur solubilite. Une solution saturee thermodynamiquement stable a 5 degrees C ayant la composition DHHB: BMDM: EHMC: EH-O-HSA=0,47: 0,46: 1,00: 0,20 a ete obtenue par l'addition simultanee de DHHB solide et BMDM dans la solution initiale. ConclusionLa composition ayant les plus fortes concentrations de DHHB et BMDM preparee dans cette etude presente une absorption a la longueur d'onde critique a 368 nm qui etait juste en dessous de la frontiere pour les ecrans solaires etant qualifies de protection a large spectre en vertu de la nouvelle regle lancee par la FDA americaine.	[Endo, M.; Mukawa, T.; Sato, N.; Maezawa, D.] Para Hermosa Co Ltd, R&D Ctr, Yokohama, Kanagawa 2360004, Japan; [Maezawa, D.; Kuroda, A.; Wakabayashi, M.; Asakura, K.] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan; [Ohtsu, Y.] Kishi Kasei Co Ltd, R&D Ctr, Yokohama, Kanagawa 2360004, Japan; [Kuroda, A.] Kuroda Consulting Inc, Yokohama Res Ctr, Yokohama, Kanagawa 2260011, Japan	Asakura, K (reprint author), Keio Univ, Fac Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 2238522, Japan.	asakura@applc.keio.ac.jp	Asakura, Kouichi/E-8045-2014				Velasco MVR, 2008, INT J PHARMACEUT, V363, P50, DOI 10.1016/j.ijpharm.2008.06.031; Wang F, 2014, JAMA DERMATOL, V150, P401, DOI 10.1001/jamadermatol.2013.8417; [Anonymous], 2011, FED REG, V76, P35620; Nohynek GJ, 2007, CRIT REV TOXICOL, V37, P251, DOI 10.1080/10408440601177780; Touitou E, 2008, CLIN DERMATOL, V26, P375, DOI 10.1016/j.clindermatol.2008.01.014; [Anonymous], 2006, OFFICIAL J EUR UNI L, V265, P39; Asakura K., 2012, Japan Patent, Patent No. [2012-63180, 5667765, 5667765 A]; Ayala F., 2013, ISRN DERMATOL, V842359, P1; Bonda C. A., 2009, US Patent, Patent No. [2009/246157, 201263180, 2012-63180]; Elsner Peter, 2007, J Dtsch Dermatol Ges, V5, P166, DOI 10.1111/j.1610-0387.2007.06099.x; Fujikake K, 2014, SKIN PHARMACOL PHYS, V27, P254, DOI 10.1159/000356298; Goedel W., 2007, US Patent, Patent No. [2007/28401, 2009246157, 2009/246157]; Goedel W., 2007, US Patent, Patent No. [US 2007/31352, 200728401, 2007/28401]; Hakim V., 1991, NEW TRENDS NONLINEAR, V237, P327; Hansenne I., 1997, US Patent, Patent No. [5667765 A, 5793932, S 57-93932]; Herzog B, 2002, Int J Cosmet Sci, V24, P170, DOI 10.1046/j.1467-2494.2002.00137.x; Higaki Y., 1982, Japan Patent, Patent No. [S 57-93932, 6312673, 6312673 B2]; Japan Oil Chem. Soc, 2013, JOCS STAND METH AN F; Joly P, 2010, J OLEO SCI, V59, P89, DOI 10.5650/jos.59.89; Kuroda A, 2008, J PHYS CHEM B, V112, P1163, DOI 10.1021/jp076254p; McCormick PG, 2012, INT J COSMETIC SCI, V34, P291, DOI 10.1111/j.1468-2494.2012.00717.x; Richard H., 2001, US Patent, Patent No. [6312673 B2, 8198335, 8198335 B2]; US Food and Drug Administration, 2011, Register, V76, P35620, Patent No. [200731352, US 2007/31352]	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-5463	1468-2494		INT J COSMETIC SCI	Int. J. Cosmetic Sci.	DEC	2014	36	6					546	552		10.1111/ics.12154		7	Chemistry, Applied; Dermatology	Chemistry; Dermatology	AT6AQ	WOS:000345021400006		
J	Gunawardhana, N; Ogumori, Y; Yoshio, M; Nakamura, H				Gunawardhana, Nanda; Ogumori, Yoshiyuki; Yoshio, Masaki; Nakamura, Hiroyoshi			Fabrication of a Dual-ion Intercalation Cell Composing of a Graphite Cathode (MCMB) and a TiO2(B) Anode	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Dual-ion; Intercalation; TiO2(B) Anode; Graphite Cathode; safety	ELECTROCHEMICAL INTERCALATION; LI-ION; SUPERCAPACITOR; BATTERY; PERFORMANCE; CAPACITORS; VOLTAGE; SYSTEM	A novel ion intercalation cell was fabricated using a MCMB cathode and a TiO2(B) anode which delivers 142 Wh Kg(-1) as energy density in the voltage region of 1.0-4.0 V. During the charging process, the ceiling potential of cathode reaches to 5.4 V while the bottom potential of anode drops down to 1.4 V Vs Li/Li+. The average working voltage of this device is 3.1 V which is significantly higher than that of other hybrid capacitors. The better rate performance of the fabricated cell mainly attribute to the structural features of TiO2(B) electrode due to fast lithium insertion/de-insertion processes through the open channel parallel to the b-axis of TiO2(B). The ion intercalation mechanism is discussed using 4-electrode cell and ex-situ XRD data. XRD data revealed that peak position of MCMB does not fully come back to its original position after first charge/discharge process of the cell indicating structural changes of the graphite cathode. The fabricated cell is inherently safer than lithium ion batteries especially at low temperate and at high charge discharge rates.	[Gunawardhana, Nanda] Univ Peradeniya, Int Res Ctr, Peradeniya 20400, Sri Lanka; [Gunawardhana, Nanda; Ogumori, Yoshiyuki; Nakamura, Hiroyoshi] Saga Univ, Dept Chem & Appl Chem, Saga 8408502, Japan; [Yoshio, Masaki] Saga Univ, Adv Res Ctr, Saga 8400047, Japan	Gunawardhana, N (reprint author), Univ Peradeniya, Int Res Ctr, Peradeniya 20400, Sri Lanka.	nandagunawardhana@pdn.ac.lk; nakamura@cc.saga-u.ac.jp			Fukuoka Industry and Science Foundation	Partial financial support from Fukuoka Industry and Science Foundation is gratefully acknowledged.	Ishihara T, 2011, J POWER SOURCES, V196, P6956, DOI 10.1016/j.jpowsour.2010.11.075; Wang HY, 2006, ELECTROCHEM COMMUN, V8, P1481, DOI 10.1016/j.elecom.2006.07.016; Ruch PW, 2007, ELECTROCHIM ACTA, V53, P1074, DOI 10.1016/j.electacta.2007.01.069; Seel JA, 2000, J ELECTROCHEM SOC, V147, P892, DOI 10.1149/1.1393288; Meister P, 2014, ELECTROCHIM ACTA, V130, P625, DOI 10.1016/j.electacta.2014.03.070; Brousse T, 2006, J POWER SOURCES, V158, P571, DOI 10.1016/j.jpowsour.2005.09.020; Ishihara T, 2007, ELECTROCHEM SOLID ST, V10, pA74, DOI 10.1149/1.2424263; Sivakkumar SR, 2010, ELECTROCHIM ACTA, V55, P3330, DOI 10.1016/j.electacta.2010.01.059; Aida T, 2007, ELECTROCHEM SOLID ST, V10, pA93, DOI 10.1149/1.2435511; Du Pasquier A, 2003, J POWER SOURCES, V115, P171, DOI 10.1016/S0378-7753(02)00718-8; Sasidharan M, 2011, CHEM COMMUN, V47, P6921, DOI 10.1039/c1cc11902h; Carlin R. T., 1994, J ELECCTROCHEM SOC, V47, pL43; Du Pasquier A, 2004, J POWER SOURCES, V136, P160, DOI 10.1016/j.jpowsour.2004.05.023; Gunawardhana N., 2011, J POWER SOURCES, V1, P119; Gunawardhana N., 2011, J POWER SOURCES, V196, P7896; Gunawardhana N, 2014, INT J ELECTROCHEM SC, V9, P195; Gunawardhana N., 2012, INT C POW EN SYST IC, V56, P58; Jurcakova H., 2010, CARBON, V48, P1767; Khomenko V., 2003, J POWER SOURCES, V177; Lee J. W., 2010, APPL CHEM ENG, V21, P265; Naoi Katsuhiko, 2008, Electrochemical Society Interface, V17; Thapa A. K., 2011, ELECTROCHIM ACTA, V55, P7305; Yoshio M, 2006, ELECTROCHEM SOLID ST, V9, pA561, DOI 10.1149/1.2357987	23	0	0	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	DEC	2014	9	12					6975	6984				10	Electrochemistry	Electrochemistry	AT9QR	WOS:000345261900024		
J	Hassan, S; Suzuki, M; Abd El-Moneim, A				Hassan, Sameh; Suzuki, Masaaki; Abd El-Moneim, Ahmed			Facile Synthesis of MnO2/graphene Electrode by Two-steps Electrodeposition for Energy Storage Application	INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE			English	Article						Electrophoretic deposition; Manganese dioxide; Supercapacitor; Nickel foam; Graphene	CHEMICAL-VAPOR-DEPOSITION; CARBON NANOWALLS; SEAWATER ELECTROLYSIS; OXYGEN EVOLUTION; ELECTROCHEMICAL CAPACITORS; OXIDE ANODES; ELECTROPHORETIC DEPOSITION; HYDROGEN-PRODUCTION; GRAPHENE OXIDE; SUPERCAPACITOR	MnO2/graphene electrode was developed via anodic deposition of nanostructured MnO2 film on electrophoretically reduced graphene oxide (EPD-rGO) film. The electrodeposited MnO2, EPD-rGO and MnO2/EPD-rGO electrodes were characterized and investigated for supercapacitor application using scanning electron microscopy, transmission electron microscopy, X-ray diffraction, fourier transform infrared spectroscopy, cyclic voltammetry, galvanostatic charge/discharge, and electrochemical impedance spectroscopy. The electrophoretic deposition enables the development of rGO film composed of overlapped platelets of defective graphene sheets. The MnO2/EPD-rGO electrode shows better specific capacitance and rate capability than MnO2 electrode; it exhibits specific capacitance of 822 Fg(-1) and better cyclic stability at a current density of 1 mA cm(-2). The large surface area and defective nature of EPD-rGO film in conjunction with an efficient utilization of MnO2 nanoparticles facilitated rapid ion transport and electrochemical cyclic stability, and hence offering the potential of the unique capacitive behavior. The obtained results indicate electrophoretic deposition could set a facile base for providing graphene-based materials, at room temperature without using harsh and toxic chemicals or high synthesis temperature.	[Hassan, Sameh; Abd El-Moneim, Ahmed] Egypt Japan Univ Sci & Technol, Dept Mat Sci & Engn, Alexandria 21934, Egypt; [Suzuki, Masaaki] Tokyo Inst Technol, Dept Chem Engn, Meguro Ku, Tokyo 1528552, Japan	Hassan, S (reprint author), Menoufiya Univ, Fac Sci, Dept Phys, Shibin Al Kawm, Egypt.	ahmed.abdelmoneim@ejust.edu.eg			Missions Sector-Higher Education Ministry, Egypt; Materials Science and Engineering Department at E-JUST	The authors gratefully acknowledge the Missions Sector-Higher Education Ministry, Egypt for financial support through this work and Materials Science and Engineering Department at E-JUST. Also we thank Mr. K. Hori and J. Koki of the Center for Advanced Material Analysis in Tokyo Tech. for assistance with TEM observations.	Yu GH, 2011, NANO LETT, V11, P4438, DOI 10.1021/nl2026635; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Zhao X, 2011, NANOSCALE, V3, P839, DOI 10.1039/c0nr00594k; Liu R, 2010, ACS NANO, V4, P4299, DOI 10.1021/nn1010182; Shiji K, 2005, DIAM RELAT MATER, V14, P831, DOI 10.1016/j.diamond.2004.10.021; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Li ZP, 2011, J MATER CHEM, V21, P3397, DOI 10.1039/c0jm02650f; Hassan S, 2014, J POWER SOURCES, V246, P68, DOI 10.1016/j.jpowsour.2013.06.085; Yan J, 2010, CARBON, V48, P3825, DOI 10.1016/j.carbon.2010.06.047; Hashimoto K, 1999, MAT SCI ENG A-STRUCT, V267, P200, DOI 10.1016/S0921-5093(99)00092-1; Chen S, 2010, ACS NANO, V4, P2822, DOI 10.1021/nn901311t; Snook GA, 2011, J POWER SOURCES, V196, P1, DOI 10.1016/j.jpowsour.2010.06.084; Burke A, 2000, J POWER SOURCES, V91, P37, DOI 10.1016/S0378-7753(00)00485-7; Mori S, 2011, DIAM RELAT MATER, V20, P1129, DOI 10.1016/j.diamond.2011.06.021; Wei WF, 2011, CHEM SOC REV, V40, P1697, DOI 10.1039/c0cs00127a; Sarkar P, 1996, J AM CERAM SOC, V79, P1987, DOI 10.1111/j.1151-2916.1996.tb08929.x; Chen L, 2010, J POWER SOURCES, V195, P3742, DOI 10.1016/j.jpowsour.2009.12.036; Zhao YQ, 2012, MATER LETT, V76, P127, DOI 10.1016/j.matlet.2012.02.097; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Wu YH, 2002, ADV MATER, V14, P64, DOI 10.1002/1521-4095(20020104)14:1<64::AID-ADMA64>3.0.CO;2-G; Lu Q, 2011, J POWER SOURCES, V196, P4088, DOI 10.1016/j.jpowsour.2010.12.059; Celzard A, 2002, J POWER SOURCES, V108, P153, DOI 10.1016/S0378-7753(02)00030-7; Wu YH, 2004, J MATER CHEM, V14, P469, DOI 10.1039/b311682d; Ocana M, 2000, COLLOID POLYM SCI, V278, P443, DOI 10.1007/s003960050537; Inagaki M, 2010, J POWER SOURCES, V195, P7880, DOI 10.1016/j.jpowsour.2010.06.036; Wojtoniszak M, 2012, COLLOID SURFACE B, V89, P79, DOI 10.1016/j.colsurfb.2011.08.026; El-Moneim AA, 2011, INT J HYDROGEN ENERG, V36, P13398, DOI 10.1016/j.ijhydene.2011.07.100; Hassan S, 2014, RSC ADV, V4, P20479, DOI 10.1039/c4ra01132e; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Van der Biest OO, 1999, ANNU REV MATER SCI, V29, P327, DOI 10.1146/annurev.matsci.29.1.327; [Anonymous], 2012, AM J MAT SCI; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; Hassan S, 2014, J POWER SOURCES, V249, P21, DOI 10.1016/j.jpowsour.2013.10.097; Sawangphruk M, 2013, CARBON, V60, P109, DOI 10.1016/j.carbon.2013.03.062; Miller JR, 2008, SCIENCE, V321, P651, DOI 10.1126/science.1158736; Yan J, 2009, J POWER SOURCES, V194, P1202, DOI 10.1016/j.jpowsour.2009.06.006; Boccaccini AR, 2002, CURR OPIN SOLID ST M, V6, P251, DOI 10.1016/S1359-0286(02)00080-3; El-Moneim AA, 2005, MATER TRANS, V46, P309, DOI 10.2320/matertrans.46.309; Conway B. E., 1999, ELECTROCHEMICAL SUPE; El-Moneim A. A., 2009, MAT T, V66, P1969; El-Moneim AA, 2012, INT J ELECTROCHEM SC, V7, P671; El-Moneim AA, 2010, ECS TRANSACTIONS, V25, P127, DOI 10.1149/1.3422589; Hashimoto K., 2006, ECS T, V1, P491, DOI 10.1149/1.2215532; Hassan S., 2012, ELEKTRON ELEKTROTECH, V2, P18; Julien CM, 2004, SPECTROCHIM ACTA A, V60, P689, DOI 10.1016/S1386-1425(03)00279-8; Karuppuchamy S., 2006, J OLEO SCI, V55, P263; Kobayashi K, 2007, J APPL PHYS, V101, DOI 10.1063/1.2728781; Tanaka K, 2005, JPN J APPL PHYS 1, V44, P2074, DOI 10.1143/JJAP.44.2074; Tuken T, 2004, PROG ORG COAT, V50, P115, DOI 10.1016/j.porgcoat.2004.01.002; Xingyou Lang, 2011, Nature Nanotechnology, V6, DOI 10.1038/nnano.2011.13	50	3	3	ESG	BELGRADE	BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA	1452-3981			INT J ELECTROCHEM SC	Int. J. Electrochem. Sci.	DEC	2014	9	12					8340	8354				15	Electrochemistry	Electrochemistry	AT9QR	WOS:000345261900130		
J	Arai, Y; Zarit, SH				Arai, Yumiko; Zarit, Steven H.			Determining a cutoff score of caregiver burden for predicting depression among family caregivers in a large population-based sample	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Letter									[Arai, Yumiko] Natl Ctr Geriatr & Gerontol, Dept Gerontol Policy, Obu, Japan; [Zarit, Steven H.] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA	Arai, Y (reprint author), Natl Ctr Geriatr & Gerontol, Dept Gerontol Policy, Obu, Japan.	yarai903@ncgg.go.jp					Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Schreiner AS, 2006, AGING MENT HEALTH, V10, P107, DOI 10.1080/13607860500312142; Arai Y, 2014, AGING MENT HEALTH, V18, P81, DOI 10.1080/13607863.2013.787045; Arais Y, 2003, JPN J GERIAT, V40, P497; Shima S, 1985, JPN J CLIN PSYCHIAT, V27, P717	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	DEC	2014	29	12					1313	1315		10.1002/gps.4174		3	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	AT8YJ	WOS:000345214600017		
J	Bourner, G; De la Salle, B; George, T; Tabe, Y; Baum, H; Culp, N; Keng, TB				Bourner, G.; De la Salle, B.; George, T.; Tabe, Y.; Baum, H.; Culp, N.; Keng, T. B.		ICSH	ICSH guidelines for the verification and performance of automated cell counters for body fluids	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Article						Automated cell counts; body fluids; cerebrospinal fluid; verification	HEMATOLOGY ANALYZER	One of the many challenges facing laboratories is the verification of their automated Complete Blood Count cell counters for the enumeration of body fluids. These analyzers offer improved accuracy, precision, and efficiency in performing the enumeration of cells compared with manual methods. A patterns of practice survey was distributed to laboratories that participate in proficiency testing in Ontario, Canada, the United States, the United Kingdom, and Japan to determine the number of laboratories that are testing body fluids on automated analyzers and the performance specifications that were performed. Based on the results of this questionnaire, an International Working Group for the Verification and Performance of Automated Cell Counters for Body Fluids was formed by the International Council for Standardization in Hematology (ICSH) to prepare a set of guidelines to help laboratories plan and execute the verification of their automated cell counters to provide accurate and reliable results for automated body fluid counts. These guidelines were discussed at the ICSH General Assemblies and reviewed by an international panel of experts to achieve further consensus.	[Bourner, G.] Gamma Dynacare Med Labs, Brampton, ON L6T 5M3, Canada; [De la Salle, B.] UK Natl External Qual Assessment Scheme Gen Haema, Watford, England; [George, T.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Tabe, Y.] Juntendo Univ, Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Tabe, Y.] Japanese Soc Lab Hematol, Standardizat Comm, Tokyo, Japan; [Baum, H.] Reg Kliniken Holding RKH GmbH, Inst Lab Med, Ludwigsburg, Germany; [Culp, N.] Trillium Diagnost, Bangor, ME USA; [Keng, T. B.] Sullivan Nicolaides Pathol, Brisbane, Qld, Australia	Bourner, G (reprint author), Gamma Dynacare Med Labs, 115 Midair Ct, Brampton, ON L6T 5M3, Canada.	gbourner@rogers.com					Goubard A, 2011, J CLIN PATHOL, V64, P1123, DOI 10.1136/jcp.2010.084285; Keuren JFW, 2013, CLIN CHEM LAB MED, V51, P1285, DOI 10.1515/cclm-2012-0549; Riedl JA, 2010, J CLIN PATHOL, V63, P538, DOI 10.1136/jcp.2009.072975; Danise P, 2013, INT J LAB HEMATOL, V35, P608, DOI 10.1111/ijlh.12093; Williams JE, 2011, LABMEDICINE, V42, P395, DOI 10.1309/V1HMLAYJRY01RT; Aulesa C, 2003, Lab Hematol, V9, P214; Barnes P W, 2004, Lab Hematol, V10, P127, DOI 10.1532/LH96.04023; Clinical and Laboratory Standards Institute (CLSI), 2003, EV LIN QUANT MEAS PR; Clinical Laboratory Standards Institute (CLSI), 2005, DEF EST VER REF RANG; Clinical Laboratory Standards Institute (CLSI), 2004, EV PREC PERF MANC QU; Clinical Laboratory Standards Institute (CLSI), 2010, VAL VER QUAL ASS AUT; Clinical Laboratory Standards Institute (CLSI), 2002, EST US PAT SAMPL APP; Clinical Laboratory Standards Institute (CLSI), 2006, H56A CLSI; Clinical Laboratory Standards Institute (CLSI), 2005, US VER PERF PREC TRU; CLSI, 2012, EV DET CAP CLIN LAB	15	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	DEC	2014	36	6					598	612		10.1111/ijlh.12196		15	Hematology	Hematology	AT9BJ	WOS:000345222500007		
J	Suzuki, S; Kudo, H; Koyama, T				Suzuki, S.; Kudo, H.; Koyama, T.			Assessment of spontaneous platelet aggregation using laser light scattering in healthy subjects: an attempt to standardize	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY			English	Article						Platelet; aggregation; spontaneous platelet aggregation (SPA); P-selectin; activated glycoprotein IIb; IIIa	TRANSMISSION AGGREGOMETRY; RICH PLASMA; COUNT; AGGREGABILITY; RELEASE; VOLUME; COLD	IntroductionWhen measuring platelet aggregation using laser light scattering, small aggregates forming without the addition of agonists may be observed. This event is called spontaneous platelet aggregation (SPA)'. The platelet hyperactivity observed in arterial thrombotic diseases can be detected with relative ease by measuring SPA. Standardization is urgently needed because of differences between measurement conditions among various laboratories. MethodsWe conducted a systematic study of factors that affect SPA measurement, compared SPA results to flow cytometry detection of surface antigens expressed on activated platelet membranes (P-selectin, activated glycoprotein IIb/IIIa), and determined conditions that yield stable measurements. Results and ConclusionsWe evaluated results from 125 healthy volunteers and established conditions for a stable measurement of SPA. As the occurrence of SPA tended to increase with age, we determined conditions valid for subjects aged 20-60years. Blood should be collected using a syringe, and the sample should be prepared after allowing the whole blood to rest for 30min after collection. To isolate platelet-rich plasma, a 2-mL tube should be used and centrifuged at 150g. The sample should be stored at room temperature, the platelet count of the sample should be (250 +/- 10)x10(9)/L, and the measurement should be completed within 90min of blood collection.	[Suzuki, S.; Koyama, T.] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Lab Mol Genet Hematol, Bunkyo Ku, Tokyo 1138519, Japan; [Suzuki, S.; Kudo, H.] Bunkyo Gakuin Univ, Fac Hlth Sci Technol, Dept Clin Lab Med, Bunkyo Ku, Tokyo, Japan	Koyama, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	koyama.lmg@tmd.ac.jp					Adcock DM, 2008, H21A5 CLSI, V5th; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Cattaneo M, 2007, HAEMATOL-HEMATOL J, V92, P694, DOI 10.3324/haematol.10999; BORN GVR, 1962, NATURE, V194, P927, DOI 10.1038/194927b0; Merolla M, 2012, INT J LAB HEMATOL, V34, P81, DOI 10.1111/j.1751-553X.2011.01360.x; Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9; Michelson AD, 1996, BLOOD, V87, P4925; Sobol AB, 2000, DIABETES RES CLIN PR, V50, P1, DOI 10.1016/S0168-8227(00)00160-1; KAPLAN KL, 1981, BLOOD, V57, P199; Cattaneo M, 2009, SEMIN THROMB HEMOST, V35, P158, DOI 10.1055/s-0029-1220324; OZAKI Y, 1994, ANAL BIOCHEM, V218, P284, DOI 10.1006/abio.1994.1180; ANSTALL HB, 1962, TRANSFUSION, V2, P44; Eto K, 1998, CARDIOVASC RES, V40, P223, DOI 10.1016/S0008-6363(98)00114-X; Fukuda K, 1997, DIABETES, V46, P488, DOI 10.2337/diabetes.46.3.488; Fusegawa Y, 2006, THROMB RES, V117, P615, DOI 10.1016/j.thromres.2005.05.011; Hara K, 2012, TRANSL RES, V159, P15, DOI 10.1016/j.trsl.2011.07.007; KATTLOVE HE, 1972, BLOOD-J HEMATOL, V40, P688; KATTLOVE HE, 1971, BLOOD-J HEMATOL, V38, P39; Linnemann B, 2008, J THROMB HAEMOST, V6, P677, DOI 10.1111/j.1538-7836.2008.02891.x; Mani H, 2005, J CLIN PATHOL, V58, P747, DOI 10.1136/jcp.2004.022129; Matsuo T, 2000, THROMB RES, V99, P109, DOI 10.1016/S0049-3848(00)00211-5; Ozaki K, 2008, J JPN SOC LAB HEMATO, V9, P401; Satoh K, 2004, PLATELETS, V15, P61, DOI 10.1080/09537100410001637193; Satoh K, 2008, J JPN SOC LAB HEMATO, V9, P167; Shimizu M, 2003, J JPN SOC LAB HEMATO, V4, P99; Sixma J J, 1972, Adv Exp Med Biol, V34, P79; SIXMA JJ, 1970, THROMB DIATH HAEMOST, V24, P206; THOMPSON CB, 1982, BRIT J HAEMATOL, V50, P509, DOI 10.1111/j.1365-2141.1982.tb01947.x; THOMPSON NT, 1986, THROMB RES, V41, P615, DOI 10.1016/0049-3848(86)90358-0; Toshima H, 2008, PLATELETS, V19, P293, DOI 10.1080/09537100701883457; World Health Organization, 2002, WHODILLAB991	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-5521	1751-553X		INT J LAB HEMATOL	Int. J. Lab. Hematol.	DEC	2014	36	6					676	685		10.1111/ijlh.12208		10	Hematology	Hematology	AT9BJ	WOS:000345222500014		
J	Kita, Y; Ago, Y; Higashino, K; Asada, K; Takano, E; Takuma, K; Matsuda, T				Kita, Yuki; Ago, Yukio; Higashino, Kosuke; Asada, Kazuki; Takano, Erika; Takuma, Kazuhiro; Matsuda, Toshio			Galantamine promotes adult hippocampal neurogenesis via M-1 muscarinic and alpha 7 nicotinic receptors in mice	INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY			English	Article						Acetylcholine receptor; galantamine; hippocampus; insulin-like growth factor 2 (IGF2); neurogenesis	NEURAL STEM-CELLS; ACETYLCHOLINE-RECEPTORS; ALZHEIMERS-DISEASE; ALLOSTERIC POTENTIATION; DENTATE GYRUS; IN-VIVO; PREPULSE INHIBITION; GROWTH-FACTOR; NEUROTROPHIC FACTOR; TREATMENT STRATEGY	Galantamine, an inhibitor of acetylcholinesterase, promotes hippocampal neurogenesis, but the exact mechanism for this is not known. In the present study, we examined the mechanisms underlying the effects of acute galantamine on neurogenesis in the mouse hippocampus. Galantamine (3 mg/kg) increased the number of 5-bromo-2'-deoxyuridine (BrdU)-positive cells in the subgranular zone of the dentate gyrus. This effect was blocked by the muscarinic receptor antagonist scopolamine and the preferential M-1 muscarinic receptor antagonist telenzepine, but not by the nicotinic receptor antagonists mecamylamine and methyllycaconitine. Galantamine did not alter the ratio of neuronal nuclei (NeuN)-or glial fibrillary acidic protein (GFAP)-positive cells to BrdU-labeled cells in the subgranular zone and granule cell layer. Galantamine (1, 3 mg/kg) promoted the survival of 2-wk-old newly divided cells in mice in the granule cell layer of the dentate gyrus, whereas it did not affect the survival of newly divided cells at 1 and 4 wk. Galantamine-induced increases in cell survival were blocked by the alpha 7 nicotinic receptor antagonist methyllycaconitine, but not by scopolamine. Bilateral injection of recombinant IGF2 into the dentate gyrus of the hippocampus mimicked the effects of galantamine. The effects of galantamine were blocked by direct injection of the IGF1 receptor antagonist JB1. These findings suggest that galantamine promotes neurogenesis via activation of the M-1 muscarinic and alpha 7 nicotinic acetylcholine receptors. The present study also suggests that IGF2 is involved in the effects of galantamine on the survival of 2-wk-old immature cells in the granule cell layer.	[Kita, Yuki; Ago, Yukio; Higashino, Kosuke; Asada, Kazuki; Takano, Erika; Takuma, Kazuhiro; Matsuda, Toshio] Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Matsuda, Toshio] Osaka Univ, United Grad Sch Child Dev, Kanazawa Univ, Hamamatsu Univ Sch Med,Chiba Univ, Suita, Osaka 5650871, Japan; [Matsuda, Toshio] Univ Fukui, Suita, Osaka 5650871, Japan	Matsuda, T (reprint author), Osaka Univ, Lab Med Pharmacol, Grad Sch Pharmaceut Sci, 1-6 Yamada Oka, Suita, Osaka 5650871, Japan.	matsuda@phs.osaka-u.ac.jp			KAKENHI [23390139, 25460099]	This study was supported in part by KAKENHI (23390139 and 25460099).	Ago Y, 2011, SYNAPSE, V65, P1373, DOI 10.1002/syn.20969; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Harrist A, 2004, SYNAPSE, V54, P200, DOI 10.1002/syn.20081; Aasebo IEJ, 2011, EUR J NEUROSCI, V33, P1094, DOI 10.1111/j.1460-9568.2011.07608.x; Kita Y, 2013, PSYCHOPHARMACOLOGY, V225, P543, DOI 10.1007/s00213-012-2841-7; Ma W, 2000, EUR J NEUROSCI, V12, P1227, DOI 10.1046/j.1460-9568.2000.00010.x; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; NORDBERG A, 1995, ALZ DIS ASSOC DIS, V9, P21, DOI 10.1097/00002093-199505000-00006; Ago Y, 2013, NEUROPSYCHOPHARMACOL, V38, P1535, DOI 10.1038/npp.2013.52; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Csernansky JG, 2005, NEUROPSYCHOPHARMACOL, V30, P2135, DOI 10.1038/sj.npp.1300761; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Jin K, 2006, BRAIN RES, V1085, P183, DOI 10.1016/j.brainres.2006.02.081; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Coronas V, 2000, NEUROSCIENCE, V98, P213, DOI 10.1016/S0306-4522(00)00143-3; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Noda Y, 2010, INT J NEUROPSYCHOPH, V13, P1343, DOI 10.1017/S1461145710000222; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; Ago Y, 2011, J PHARMACOL SCI, V116, P6, DOI 10.1254/jphs.11R01CR; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; Schilstrom B, 2007, NEUROPSYCHOPHARMACOL, V32, P43, DOI 10.1038/sj.npp.1301087; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Berger F, 1998, J NEUROSCI, V18, P6871; Frielingsdorf H, 2007, NEUROBIOL DIS, V26, P47, DOI 10.1016/j.nbd.2006.11.015; Perry E, 2000, EUR J PHARMACOL, V393, P215, DOI 10.1016/S0014-2999(00)00064-9; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; Agis-Balboa RC, 2011, EMBO J, V30, P4071, DOI 10.1038/emboj.2011.293; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Dajas-Bailador FA, 2003, MOL PHARMACOL, V64, P1217, DOI 10.1124/mol.64.5.1217; Erb C, 2001, J NEUROCHEM, V77, P638, DOI 10.1046/j.1471-4159.2001.00287.x; Koda K, 2011, BRIT J PHARMACOL, V162, P763, DOI 10.1111/j.1476-5381.2010.01080.x; Koda K, 2008, PSYCHOPHARMACOLOGY, V196, P293, DOI 10.1007/s00213-007-0962-1; Maelicke A, 2001, BIOL PSYCHIAT, V49, P279, DOI 10.1016/S0006-3223(00)01109-4; Matsuda T, 2013, BIOL PHARM BULL, V36, P1871; Shruster A, 2014, BEHAV BRAIN RES, V261, P193, DOI 10.1016/j.bbr.2013.12.028; Tanaka K, 2009, NEUROSCI LETT, V462, P235, DOI 10.1016/j.neulet.2009.07.024; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Wadenberg MLG, 2011, INT J NEUROPSYCHOPH, V14, P644, DOI 10.1017/S1461145710000921; Yano K, 2009, BRIT J PHARMACOL, V156, P173, DOI 10.1111/j.1476-5381.2008.00037.x	60	3	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1461-1457	1469-5111		INT J NEUROPSYCHOPH	Int. J. Neuropsychopharmacol.	DEC	2014	17	12					1957	1968		10.1017/S1461145714000613		12	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AT5TX	WOS:000345006100006		
J	Sasaki, T; Kojima, T; Kanaya, K; Yamada, K; Shibahara, M; Oikawa, N; Sugihara, S				Sasaki, Tsutomu; Kojima, Takao; Kanaya, Kunihiro; Yamada, Kyouhei; Shibahara, Masataka; Oikawa, Naoki; Sugihara, Shunichi			Reliability, validity, and factor structure of the cognitive behavioral rating scale for stroke patients	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						behavior; cognition; rehabilitation; stroke	MINI-MENTAL-STATE; TRAUMATIC BRAIN-INJURY; POSTSTROKE DEPRESSION; SUBACUTE STROKE; METACOGNITION; ATTENTION; NEGLECT; PERFORMANCE; VALIDATION; ADMISSION	The aim of this study was to explore the reliability, validity, and factor structure of a newly developed Cognitive Behavioral Rating Scale (CBRS), designed to assess cognitive function through observation. The study included 180 stroke patients and 58 orthopedic patients. The CBRS and the Functional Independence Measure (FIM) were administered. Data on discharge disposition were also collected. The inter-rater reliability, construct validity, concurrent validity, predictive validity, and factor structure of the CBRS were evaluated. The interclass correlation coefficient was 0.736 (P < 0.0001). Cronbach's a for the CBRS was 0.92. Patients with stroke showed a significantly higher total CBRS score than those with orthopedic problems (P < 0.0001). Spearman's rank correlation coefficient (r(s)) was -0.70 (P < 0.01) for the total FIM score and the CBRS, and -0.72 (P < 0.01) for the cognitive FIM and the CBRS. The return-to-home group had a significantly lower CBRS total score than the not-to-home group (P < 0.01). The CBRS comprised three factors: (i) 'language and performance', (ii) 'control of performance', and (iii) 'space-self relation.' The CBRS appears to have a high reliability and validity for the assessment of cognitive function. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Sasaki, Tsutomu] Shinshu Univ, Div Occupat Therapy, Sch Hlth Sci, Fac Med, Matsumoto, Nagano 3908621, Japan; [Kojima, Takao; Shibahara, Masataka; Sugihara, Shunichi] Sapporo Shuyukai Hosp, Dept Rehabil, Sapporo, Hokkaido, Japan; [Yamada, Kyouhei] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Kanaya, Kunihiro; Oikawa, Naoki] Hitsujigaoka Hosp, Dept Rehabil, Sapporo, Hokkaido, Japan; [Kanaya, Kunihiro] Sasson Sugata Clin, Dept Rehabil Med, Otaru, Hokkaido, Japan; [Yamada, Kyouhei] Hokkaido Chitose Inst Rehabil Technol, Chitose, Japan	Sasaki, T (reprint author), Shinshu Univ, Div Occupat Therapy, Sch Hlth Sci, Fac Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tusasaki@shinshu-u.ac.jp					Jaillard A, 2009, STROKE, V40, P2473, DOI 10.1161/STROKEAHA.108.541144; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Kagan I, 2010, P NATL ACAD SCI USA, V107, P7933, DOI 10.1073/pnas.1002825107; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641; Robinson RG, 2010, CAN J PSYCHIAT, V55, P341; Adunsky A, 2002, ARCH GERONTOL GERIAT, V35, P153, DOI 10.1016/S0167-4943(02)00018-3; Hoffmann M, 2006, COGN BEHAV NEUROL, V19, P85, DOI 10.1097/01.wnn.0000213903.59827.50; Azouvi P, 2003, ARCH PHYS MED REHAB, V84, P51, DOI 10.1053/apmr.2003.50062; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; ALBERT ML, 1973, NEUROLOGY, V23, P658; Herrmann N, 1998, STROKE, V29, P618; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Karnath HO, 2000, NEUROLOGY, V55, P1298; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; FOLSTEIN MF, 1977, J NEUROL NEUROSUR PS, V40, P1018, DOI 10.1136/jnnp.40.10.1018; Heilman KM, 2008, CORTEX, V44, P975, DOI 10.1016/j.cortex.2007.10.010; Rabadi MH, 2008, ARCH PHYS MED REHAB, V89, P441, DOI 10.1016/j.apmr.2007.11.014; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015; Arnadottir G, 1990, BRAIN BEHAV ASSESSIN, P218; Arnadottir G, 2010, J REHABIL MED, V42, P903, DOI 10.2340/16501977-0621; Arnadottir G, 2009, NEUROREHAB NEURAL RE, V23, P579, DOI 10.1177/1545968308324223; Budson AE, 2005, NEUROPSYCHOLOGIA, V43, P860, DOI 10.1016/j.neuropsychologia.2004.09.011; Davis C, 2008, BRAIN LANG, V105, P50, DOI 10.1016/j.bandl.2008.01.012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glaser B, 1992, BASICS GROUNDED THEO; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Hasegawa C, 2011, NEUROCASE, V17, P518, DOI 10.1080/13554794.2010.547506; Kimura M, 2000, STROKE, V31, P1482; Kojima T, 2013, HOKKAIDO J OCCUP THE, V29, P199; Kojima T, 2012, HOKKAIDO J OCCUP THE, V29, P93; MuCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI 10.1080/09602019108402257; Shinagawa Y, 2007, INT J GERIATR PSYCH, V22, P951, DOI 10.1002/gps.1768; Toyokura Minoru, 2006, Tokai J Exp Clin Med, V31, P29; Ventre-Dominey J, 2007, NEUROPSYCHOLOGIA, V45, P435, DOI 10.1016/j.neuropsychologia.2006.06.031; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P966, DOI 10.1016/j.apmr.2007.12.031; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108	41	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2014	37	4					343	348		10.1097/MRR.0000000000000078		6	Rehabilitation	Rehabilitation	AT4NM	WOS:000344916100009		
J	Tanaka, K; Koga, M; Sato, K; Suzuki, R; Minematsu, K; Toyoda, K				Tanaka, Koji; Koga, Masatoshi; Sato, Kazuaki; Suzuki, Rieko; Minematsu, Kazuo; Toyoda, Kazunori			Three-dimensional analysis of the left atrial appendage for detecting paroxysmal atrial fibrillation in acute ischemic stroke	INTERNATIONAL JOURNAL OF STROKE			English	Article						atrial fibrillation; ejection fraction; ischemic stroke; left atrial appendage; real-time three-dimensional transesophageal echocardiography; volume measurement	TRANSESOPHAGEAL ECHOCARDIOGRAPHY; SINUS RHYTHM; MORPHOLOGY; TIME; THROMBUS; RISK	Background Atrial fibrillation impairs left atrial appendage function and the thrombus formation in the left atrial appendage is a major cause of cardioembolic stroke. Aims To evaluate the association between the volume of the left atrial appendage measured by real-time three-dimensional transesophageal echocardiography and presence of paroxysmal atrial fibrillation in patients with cerebral infarction or transient ischemic attack. Methods Real-time three-dimensional transesophageal echocardiography was performed to measure left atrial appendage end-diastolic and end-systolic volumes to calculate left atrial appendage ejection fraction. Patients with normal sinus rhythm at the time of real-time three-dimensional transesophageal echocardiography were divided into groups with and without paroxysmal atrial fibrillation. Volumetric data were corrected with the body surface area. Results Of 146 patients registered, 102 (29 women, 72.2 +/- 10.7 years) were normal sinus rhythm at the examination. In 23 patients with paroxysmal atrial fibrillation, left atrial appendage end-diastolic volume (4.78 +/- 3.00 ml/m(2) vs. 3.14 +/- 2.04 ml/m(2), P = 0.003) and end-systolic volume (3.10.2.47 ml/m(2) vs. 1.39 +/- 1.56 ml/m(2), P < 0.001) were larger and left atrial appendage ejection fraction (37.3 +/- 19.1% vs. 57.1 +/- 17.5%, P < 0.001) was lower than in the other 79 patients without paroxysmal atrial fibrillation. The optimal cutoff for left atrial appendage peak flow velocity to predict paroxysmal atrial fibrillation was 39.0 cm/s (sensitivity, 54.6%; specificity, 89.7%; c-statistic, 0.762). The cutoffs for left atrial appendage end-diastolic volume, end-systolic volume, and ejection fraction were 4.52 ml/m(2) (sensitivity, 47.8%; specificity, 82.3%; c-statistic, 0.694), 1.26 ml/m(2) (sensitivity, 91.3%; specificity, 60.3%; c-statistic, 0.806), and 47.9% (sensitivity, 78.3%; specificity, 74.7%; c-statistic, 0.774), respectively. In multivariate analysis, all these parameters were independently associated with paroxysmal atrial fibrillation after adjusting for sex, age, diabetes mellitus, and previous stroke. Conclusions Left atrial appendage volumetric analysis by real-time three-dimensional transesophageal echocardiography is a promising method for detecting paroxysmal atrial fibrillation in acute cerebral infarction or transient ischemic attack.	[Tanaka, Koji; Sato, Kazuaki; Suzuki, Rieko; Minematsu, Kazuo; Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Koga, Masatoshi] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan	Koga, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	koga@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	Japan Society for the Promotion of Science [24591084]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI grant number 24591084).	Di Biase L, 2012, J AM COLL CARDIOL, V60, P531, DOI 10.1016/j.jacc.2012.04.032; Cabrera JA, 2008, EUR HEART J, V29, P356, DOI 10.1093/eurheartj/ehm606; Kamel H, 2013, STROKE, V44, P528, DOI 10.1161/STROKEAHA.112.679100; GARCIAFERNANDEZ MA, 1992, AM HEART J, V124, P955, DOI 10.1016/0002-8703(92)90978-5; Chen OD, 2012, CHINESE MED J-PEKING, V125, P3416, DOI 10.3760/cma.j.issn.0366-6999.2012.19.010; Shah SJ, 2008, J AM SOC ECHOCARDIOG, V21, P1362, DOI 10.1016/j.echo.2008.09.024; Nakajima H, 2010, AM J CARDIOL, V106, P885, DOI 10.1016/j.amjcard.2010.05.014; Stahrenberg R, 2011, STROKE, V42, P3643, DOI 10.1161/STROKEAHA.111.632836; [Anonymous], 1990, STROKE, V21, P637; Kumar V, 2012, ECHOCARDIOGR-J CARD, V29, P112, DOI 10.1111/j.1540-8175.2011.01535.x; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; ROY D, 1986, AM HEART J, V112, P1039, DOI 10.1016/0002-8703(86)90318-2; WOLF PA, 1991, STROKE, V22, P983; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Nucifora G, 2011, CIRC-CARDIOVASC IMAG, V4, P514, DOI 10.1161/CIRCIMAGING.111.963892; POLLICK C, 1991, CIRCULATION, V84, P223; Okada Y, 2010, EUR J NEUROL, V17, P326, DOI 10.1111/j.1468-1331.2009.02813.x; Budge LP, 2008, J INTERV CARD ELECTR, V23, P87, DOI 10.1007/s10840-008-9281-7; Goldberg YH, 2010, EUR J ECHOCARDIOGR, V11, P290, DOI 10.1093/ejechocard/jep216; GRIMM RA, 1995, AM HEART J, V130, P174, DOI 10.1016/0002-8703(95)90253-8; Pozzoli M, 1991, J Am Soc Echocardiogr, V4, P435; Ren JF, 2013, J AM COLL CARDIOL, V61, P689, DOI 10.1016/j.jacc.2012.09.061; Shimizu T, 2013, J STROKE CEREBROVASC, V22, P1370, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.020; Stahrenberg R, 2010, STROKE, V41, P2884, DOI 10.1161/STROKEAHA.110.591958; Taguchi Y, 2010, INTERNAL MED, V49, P1727, DOI 10.2169/internalmedicine.49.3580; Valocik G, 2002, Eur J Echocardiogr, V3, P207, DOI 10.1053/euje.2002.0149	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	DEC	2014	9	8					1045	1051		10.1111/ijs.12268		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT4NN	WOS:000344916300019		
J	Koga, M; Toyoda, K; Kimura, K; Yamamoto, H; Sasaki, M; Hamasaki, T; Kitazono, T; Aoki, J; Seki, K; Homma, K; Sato, S; Minematsu, K				Koga, Masatoshi; Toyoda, Kazunori; Kimura, Kazumi; Yamamoto, Haruko; Sasaki, Makoto; Hamasaki, Toshimitsu; Kitazono, Takanari; Aoki, Junya; Seki, Kenta; Homma, Kazunari; Sato, Shoichiro; Minematsu, Kazuo		THAWS Investigators	THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0.6 mg/kg (THAWS) Trial	INTERNATIONAL JOURNAL OF STROKE			English	Article						acute ischemic stroke; clinical trials; diffusion-weighted imaging; fluid-attenuated inversion recovery imaging; thrombolysis; unclear-onset time	ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; UNKNOWN-ONSET; REPERFUSION THERAPY; SYMPTOM ONSET; TIME; OCCLUSION; OUTCOMES; SAFETY	Rationale Because of lack of information regarding timing of stroke, patients who suffer stroke during sleep are generally ineligible for intravenous thrombolysis, although many of these patients could potentially recover with this treatment. Magnetic resonance image findings with positive diffusion-weighted imaging and no marked parenchymal hyperintensity on fluid-attenuated inversion recovery (negative pattern) can identify acute ischemic stroke patients within 4.5 h from symptom onset. Aims The THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0.6 mg/kg trial aims to determine the efficacy and safety of intravenous thrombolysis with alteplase at 0.6 mg/kg body weight, the approved dose for Japanese stroke patients, using magnetic resonance image-based selection in ischemic stroke patients with unclear time of symptom onset, and compare findings with standard treatment. Design This is an investigator-initiated, multicenter, prospective, randomized, open-treatment, blinded-end-point clinical trial. The design is similar to the Efficacy and Safety of MRI-based Thrombolysis in Wake-up Stroke trial. Patients with unclear-onset time of stroke symptoms beyond 4.5 h and within 12 h after the time of the last-known-well period and within 4.5 h after symptom recognition, who showed a negative fluid-attenuated inversion recovery pattern, are randomized to either intravenous thrombolysis or standard treatment. Study outcomes The primary efficacy end-point is modified Rankin Scale 0-1 at 90 days. The safety outcome measures are symptomatic intracranial hemorrhage at 22-36 h, and major bleeding and mortality at 90 days. Discussion This trial may help determine if low-dose alteplase at 0.6 mg/kg should be recommended as a routine clinical strategy for ischemic stroke patients with unclear-onset time.	[Koga, Masatoshi] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan; [Toyoda, Kazunori; Seki, Kenta; Homma, Kazunari; Sato, Shoichiro; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Kimura, Kazumi; Aoki, Junya] Kawasaki Med Univ, Dept Stroke Med, Kurashiki, Okayama, Japan; [Yamamoto, Haruko] Natl Cerebral & Cardiovasc Ctr, Dept Adv Med Technol Dev, Suita, Osaka 5658565, Japan; [Sasaki, Makoto] Iwate Med Univ, Adv Med Res Ctr, Morioka, Iwate 020, Japan; [Hamasaki, Toshimitsu] Osaka Univ, Grad Sch Med, Dept Biomed Stat, Suita, Osaka, Japan; [Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Clin Sci & Med, Fukuoka 812, Japan	Koga, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	koga@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015; Hamasaki, Toshimitsu/N-3851-2015	Toyoda, Kazunori/0000-0002-8346-9845; Hamasaki, Toshimitsu/0000-0002-4928-1160	Mihara Cerebrovascular Disorder Research Promotion Fund; Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center	Mihara Cerebrovascular Disorder Research Promotion Fund, and Intramural Research Fund for Cardiovascular Diseases of National Cerebral and Cardiovascular Center (H23-4-3; maintenance of the administration infrastructure for international multicenter studies of clinical stroke; P. I., K. Toyoda).	Thomalla G, 2014, INT J STROKE, V9, P829, DOI 10.1111/ijs.12011; Kang DW, 2012, INT J STROKE, V7, P311, DOI 10.1111/j.1747-4949.2012.00779.x; Ostrem JL, 2004, STROKE, V35, pE30, DOI 10.1161/01.STR.0000113783.45745.BE; Ebinger M, 2012, EUR J NEUROL, V19, P348, DOI 10.1111/j.1468-1331.2011.03504.x; Barreto AD, 2009, STROKE, V40, P827, DOI 10.1161/STROKEAHA.108.528034; Kang DW, 2012, STROKE, V43, P3278, DOI 10.1161/STROKEAHA.112.675926; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Serena J, 2003, CEREBROVASC DIS, V16, P128, DOI 10.1159/000070592; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Aoki J, 2010, J NEUROL SCI, V293, P39, DOI 10.1016/j.jns.2010.03.011; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Yamaguchi T, 2006, STROKE, V37, P1810, DOI 10.1161/01.STR.0000227191.01792e3; Aoki J, 2011, CEREBROVASC DIS, V31, P435, DOI 10.1159/000323850; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Mackey J, 2011, NEUROLOGY, V76, P1662, DOI 10.1212/WNL.0b013e318219fb30; Cho AH, 2008, CEREBROVASC DIS, V25, P572, DOI 10.1159/000132204; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Thomalla G, 2009, ANN NEUROL, V65, P724, DOI 10.1002/ana.21651; Todo K, 2006, CEREBROVASC DIS, V21, P367, DOI 10.1159/000091545; Aoki Junya, 2013, Cerebrovasc Dis Extra, V3, P35, DOI 10.1159/000348552; Breuer L, 2010, INT J STROKE, V5, P68, DOI 10.1111/j.1747-4949.2010.00410.x; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; EBINGER M, 2009, STROKE, V41, P250; Koton S, 2012, NEUROEPIDEMIOLOGY, V39, P149, DOI 10.1159/000341242; MARSH EE, 1990, ARCH NEUROL-CHICAGO, V47, P1178; MINEMATSU K, 1992, NEUROLOGY, V42, P235; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; Toyoda K, 2009, STROKE, V40, P3591, DOI 10.1161/STROKEAHA.109.562991	29	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	DEC	2014	9	8					1117	1124		10.1111/ijs.12360		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT4NN	WOS:000344916300029		
J	Rusinol, M; Frinken, V; Karatzas, D; Bagdanov, AD; Llados, J				Rusinol, Marcal; Frinken, Volkmar; Karatzas, Dimosthenis; Bagdanov, Andrew D.; Llados, Josep			Multimodal page classification in administrative document image streams	INTERNATIONAL JOURNAL ON DOCUMENT ANALYSIS AND RECOGNITION			English	Article						Digital mail room; Multimodal page classification; Visual and textual document description	RETRIEVAL	In this paper, we present a page classification application in a banking workflow. The proposed architecture represents administrative document images by merging visual and textual descriptions. The visual description is based on a hierarchical representation of the pixel intensity distribution. The textual description uses latent semantic analysis to represent document content as a mixture of topics. Several off-the-shelf classifiers and different strategies for combining visual and textual cues have been evaluated. A final step uses an -gram model of the page stream allowing a finer-grained classification of pages. The proposed method has been tested in a real large-scale environment and we report results on a dataset of 70,000 pages.	[Rusinol, Marcal; Karatzas, Dimosthenis; Bagdanov, Andrew D.; Llados, Josep] Univ Autonoma Barcelona, Comp Vis Ctr, Dept Ciencies Comp, E-08193 Barcelona, Spain; [Frinken, Volkmar] Kyushu Univ, Dept Adv Informat Technol, Kyushu, Japan	Rusinol, M (reprint author), Univ Autonoma Barcelona, Comp Vis Ctr, Dept Ciencies Comp, Edifici O, E-08193 Barcelona, Spain.	marcal@cvc.uab.es; vfrinken@ait.kyushu-u.ac.jp; dimos@cvc.uab.es; bagdanov@cvc.uab.es; josep@cvc.uab.es	Bagdanov, Andrew/K-3932-2014; Karatzas, Dimosthenis/C-7142-2008	Bagdanov, Andrew/0000-0001-6408-7043; Karatzas, Dimosthenis/0000-0001-8762-4454	Spanish Ministry of Education and Science [TIN2011-24631, TIN2012-37475-C02-02, RYC-2009-05031, RYC-2012-11776]; People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7) under REA [600388]; Agency of Competitiveness for Companies of the Government of Catalonia, ACCIO; CREST project from Japan Society for the Promotion of Science (JSPS)	This work has been partially supported by the Spanish Ministry of Education and Science under projects TIN2011-24631, TIN2012-37475-C02-02, RYC-2009-05031 and RYC-2012-11776; by the People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7/2007-2013) under REA grant agreement no. 600388, and by the Agency of Competitiveness for Companies of the Government of Catalonia, ACCIO; and by the CREST project from Japan Society for the Promotion of Science (JSPS).	Aggarwal C., 2012, MINING TEXT DATA CHA; Gordo A, 2013, PATTERN RECOGN, V46, P1898, DOI 10.1016/j.patcog.2012.12.004; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Odone F, 2005, IEEE T IMAGE PROCESS, V14, P169, DOI 10.1109/TIP.2004.840701; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Heroux P, 1998, INT C PATT RECOG, P926; Augereau O., 2014, P 11 IAPR INT WORKSH; Bagdanov A. D., 2001, Proceedings of Sixth International Conference on Document Analysis and Recognition, DOI 10.1109/ICDAR.2001.953759; Cesarini F., 2001, Proceedings of Sixth International Conference on Document Analysis and Recognition, DOI 10.1109/ICDAR.2001.953962; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Chen N., 2006, INT J DOC ANAL RECOG, V10, P1; Dengel A, 1996, INT J IMAG SYST TECH, V7, P271, DOI 10.1002/(SICI)1098-1098(199624)7:4<271::AID-IMA2>3.0.CO;2-5; Dimmick D., 1991, STRUCTURED FORMS DAT; Doermann D, 1998, COMPUT VIS IMAGE UND, V70, P287, DOI 10.1006/cviu.1998.0692; Duda R., 2000, PATTERN CLASSIFICATI; Erol B., 2006, ELECT IMAGING; Ford G., 2003, P 2003 S DOC IM UND, P199; Gaceb D, 2014, J REAL-TIME IMAGE PR, V9, P329, DOI 10.1007/s11554-011-0227-4; Gordo A., 2010, INT C PATT REC, P1920; Gordo A., 2012, Proceedings of the 10th IAPR International Workshop on Document Analysis Systems (DAS 2012), DOI 10.1109/DAS.2012.30; Gordo A., 2010, P 9 IAPR INT WORKSH, P377, DOI 10.1145/1815330.1815379; Gordo A., 2013, INT C DOC AN REC; Hamza H, 2008, PROCEEDINGS OF THE 8TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS, P175, DOI 10.1109/DAS.2008.43; Meilender T., 2009, P DOC REC RETR; Misue K., 1995, US Patent, Patent No. [US 5463773 A, 5463773]; Porter M., 2001, SNOWBALL LANGUAGE ST; Rangoni Y, 2012, INT J DOC ANAL RECOG, V15, P45, DOI 10.1007/s10032-011-0151-y; REHUREK R, 2011, P 33 EUR C INF RETR, V6611, P289; Rusinol M, 2012, INT C PATT RECOG, P521; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Sarkar P, 2006, P INT C PATT REC; Schmidtler M., 2006, NATURAL LANGUAGE PRO, P123; Sebsatiani F., 2002, J ACM COMPUTING SURV, V34, P1; Shin C., 2001, International Journal on Document Analysis and Recognition, V3, DOI 10.1007/PL00013566; Sidiropoulos P, 2011, PATTERN RECOGN, V44, P739, DOI 10.1016/j.patcog.2010.09.014; van Beusekom J., 2006, P INT C DOC IM AN LI; van der Heijden F., 2004, CLASSIFICATION PARAM; Yang Y., 1997, P 14 INT C MACH LEAR, V97, P412; Yang Y., 1999, P 22 ANN INT ACM SIG, P42, DOI 10.1145/312624.312647; Young S., 1998, CUEDFINFENGTR38 CAMB	41	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1433-2833	1433-2825		INT J DOC ANAL RECOG	Int. J. Doc. Anal. Recognit.	DEC	2014	17	4					331	341		10.1007/s10032-014-0225-8		11	Computer Science, Artificial Intelligence	Computer Science	AT7CO	WOS:000345094500002		
J	Noailles, T; Tanaka, C; Lintz, F; Collon, S; Bargoin, K; Gouin, F				Noailles, Thibaut; Tanaka, Chiaki; Lintz, Francois; Collon, Sylvie; Bargoin, Kevin; Gouin, Francois			Acetabular reconstruction using a free fibular autograft in total hip arthroplasty revisions	INTERNATIONAL ORTHOPAEDICS			English	Article						Fibular autograft; Acetabular reconstruction; Segmentary bone loss; Revision of total hip arthroplasty; Aseptic acetabular loosening	50 YEARS OLD; FOLLOW-UP; REINFORCEMENT DEVICE; CEMENTED CUP; BONE-GRAFT; HYDROXYAPATITE GRANULES; PATIENTS YOUNGER; ALLOGRAFT; DEFECTS; CLASSIFICATION	Purpose Acetabular reconstruction for segmentary bone loss aims for primary stability and long-lasting integration. The use of a fibular autograft has been described after tumour resection and in traumatology. The hypothesis of this study is that it offers a mechanically reliable solution with good functional results and acceptable morbidity. Methods This is a two center retrospective study of 26 operated hips. Indication was mechanical loosening in every case. The operative technique included fibular grafting of a segmental bone loss associated with an acetabular metal reinforcement. Results Mean follow up was 88 months (three to 165). The PMA score increased from 8.5 (five to 12) to 15 (six to 18) (p < 0.001). Acetabular migration was 2 mm (0-4) vertically and 1 mm (0-2) medially. Three graft failures were observed. No major morbidity was observed. Conclusion Fibular autograft after mechanical loosening and segmentary bone loss in total hip arthroplasty revisions offers a mechanically reliable solution for acetabular reconstruction. The results seem to be at least equivalent to other techniques.	[Noailles, Thibaut; Lintz, Francois; Collon, Sylvie; Bargoin, Kevin; Gouin, Francois] Univ Hosp, Nantes, France; [Tanaka, Chiaki] Kyoto City Hosp, Kyoto, Japan	Gouin, F (reprint author), Univ Hosp, 1 Pl Alexis Ricordeau, Nantes, France.	francois.gouin@chu-nantes.fr	gouin, francois/L-1478-2015				Abuhassan Freih Odeh, 2010, Strategies Trauma Limb Reconstr, V5, P149, DOI 10.1007/s11751-010-0093-9; Kerboull M, 2000, CLIN ORTHOP RELAT R, P155; Tanaka C, 2003, J ARTHROPLASTY, V18, P719, DOI 10.1054/S0883-5403(03)00149-9; Chen XD, 2005, INT ORTHOP, V29, P277, DOI 10.1007/s00264-005-0674-2; Schreurs BW, 2001, CLIN ORTHOP RELAT R, P202; Busch VJJF, 2011, J BONE JOINT SURG AM, V93A, P367, DOI [10.2106/JBJS.I.01532, 10.2106/JBJSJ.01532]; Schreurs BW, 2004, J BONE JOINT SURG AM, V86A, P2385; Sakai T, 2010, J BONE JOINT SURG BR, V92B, P1215, DOI 10.1302/0301-620X.92B9.24555; Akiyama H, 2011, J BONE JOINT SURG BR, V93B, P1194, DOI 10.1302/0301-620X.93B9.26598; Garbuz D, 1996, CLIN ORTHOP RELAT R, P98; Kawanabe K, 2007, J BONE JOINT SURG BR, V89B, P26, DOI 10.1302/0301-620X.89B1.18037; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451; Robertson DD, 1998, J COMPUT ASSIST TOMO, V22, P444, DOI 10.1097/00004728-199805000-00018; Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023; TAYLOR GI, 1975, PLAST RECONSTR SURG, V55, P533, DOI 10.1097/00006534-197505000-00002; Buttaro MA, 2008, CLIN ORTHOP RELAT R, V466, P2482, DOI 10.1007/s11999-008-0442-x; Beckmann NA, 2014, J ARTHROPLASTY, V29, P229, DOI 10.1016/j.arth.2013.04.035; Bohm P, 1999, ACTA ORTHOP SCAND, V70, P240, DOI 10.3109/17453679908997800; Bumbasirevic M, 2014, INT ORTHOP, V38, P1277, DOI 10.1007/s00264-014-2281-6; Campbell DG, 2001, J ARTHROPLASTY, V16, P83, DOI 10.1054/arth.2001.19157; Cook SD, 2003, CLIN ORTHOP RELAT R, P195, DOI 10.1097/01.blo.0000096809.78689.b4; DANTONIO JA, 1989, CLIN ORTHOP RELAT R, P126; Dua A, 2010, HIP INT, V20, P143; Eward WC, 2010, CLIN ORTHOP RELAT R, V468, P590, DOI 10.1007/s11999-009-1053-x; Hamadouche M, 2011, INT ORTHOP, V35, P283, DOI 10.1007/s00264-010-1145-y; JASTY M, 1990, J BONE JOINT SURG BR, V72, P63; Massin P, 1998, REV CHIR ORTHOP, V84, P51; MATHOULIN C, 1993, REV CHIR ORTHOP, V79, P492; Moreland JR, 1980, P 8 OP SCI M HIP SOC; Nagoya S, 2000, J BONE JOINT SURG BR, V82B, P1121, DOI 10.1302/0301-620X.82B8.11004; PAPROSKY WG, 1994, CLIN ORTHOP RELAT R, P147; Paprosky Wayne G, 2002, Am J Orthop (Belle Mead NJ), V31, P481; Pereira GCT, 2007, INT ORTHOP, V31, P445, DOI 10.1007/s00264-006-0220-x; Saini R, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-14; Traina F, 2005, INT ORTHOP, V29, P135, DOI 10.1007/s00264-005-0640-z	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	DEC	2014	38	12					2447	2453		10.1007/s00264-014-2439-2		7	Orthopedics	Orthopedics	AU0RO	WOS:000345332000003		
J	Hernigou, J; Alves, A; Homma, Y; Guissou, I; Hernigou, P				Hernigou, Jacques; Alves, Alexandra; Homma, Yashiuro; Guissou, Isaac; Hernigou, Philippe			Anatomy of the ilium for bone marrow aspiration: map of sectors and implication for safe trocar placement	INTERNATIONAL ORTHOPAEDICS			English	Article						Ilium map for bone marrow aspiration; Ilium sectors; Mesenchymal stem cells; Iliac crest; Ilium thickness	MERALGIA-PARESTHETICA; COMPLICATION; ACETABULUM; GRAFT	Purpose The bony anatomy of the human ilium has been well described from a qualitative perspective; however, there are little quantitative data to help the surgeon to perform bone marrow aspiration from the iliac crest in the thickest part of the ilium. The minimum thickness of the spongiousus bone in an iliac wing (transverse thickness between the two tables) is an important factor in ensuring the safe placement of a trocar between the two tables of the iliac wing. For example, with an 8-gauge (3.26 mm) trocar, one can consider that if the transverse thickness of the spongiousus bone of the iliac wing is < 3 mm, it will be difficult to insert the trocar safely between the two tables. Methods For this study, we measured spongiousus bone thickness on 48 iliac wings to map the ilium in six sectors, which were defined by drawing lines from equidistant points spaced along the rim of the iliac crest to the centre of the hip. These sectors can be transposed in the same manner to any patient. To evaluate the risks to reach vascular or neurologic structures, 410 trocars were introduced in the different sectors of 20 iliac bones of ten cadavers. Results A map was constructed indicating the thickness of the spongiousus bone in each sector. The thickness data was used to create a map that identifies the sites where bone marrow can be obtained with a trocar of 3-mm diameter according to the thickness of the spongiousus bone. Sectors 2, 3 and 6 appear to be more favourable for accommodating a 3-mm diameter trocar. Sectors 1, 4 and 5 comprise the areas with the thinnest parts of the iliac crest, with some areas being thinner than the trocar diameter. The sector system reliably predicted safe and unsafe areas for trocar placement. In cadavers, dissection demonstrated nine vascular or neurologic lesions created when trocars were introduced into sectors 1, 5 and 6. Conclusion Using the sector system, trocars can be directed away from neural and vascular structures and towards zones that are likely to contain larger bone marrow stock.	[Hernigou, Jacques; Alves, Alexandra; Guissou, Isaac; Hernigou, Philippe] Hop Henri Mondor, F-94010 Creteil, France; [Homma, Yashiuro] Juntendo Univ, Tokyo, Japan	Hernigou, P (reprint author), Hop Henri Mondor, F-94010 Creteil, France.	philippe.hernigou@wanadoo.fr					JUDET R, 1964, J BONE JOINT SURG AM, V46, P1615; Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Bain BJ, 2003, BRIT J HAEMATOL, V121, P949, DOI 10.1046/j.1365-2141.2003.04329.x; Antoniades J, 2012, CLIN ORTHOP RELAT R, V470, P3537, DOI 10.1007/s11999-012-2574-2; Hauser DL, 1997, J ARTHROPLASTY, V12, P804, DOI 10.1016/S0883-5403(97)90012-7; Hernigou J, 2014, INT ORTHOP; KAHN B, 1979, CLIN ORTHOP RELAT R, P204; MASSEY EW, 1980, J TRAUMA, V20, P342; RUBENSTEIN J, 1982, J CAN ASSOC RADIOL, V33, P137; SMITH SE, 1984, J BONE JOINT SURG AM, V66A, P1306; WEIKEL AM, 1977, PLAST RECONSTR SURG, V60, P572, DOI 10.1097/00006534-197710000-00012	12	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	DEC	2014	38	12					2585	2590		10.1007/s00264-014-2353-7		6	Orthopedics	Orthopedics	AU0RO	WOS:000345332000024		
J	Kong, DX; Yamori, T; Yamazaki, K; Dan, SG				Kong, Dexin; Yamori, Takao; Yamazaki, Kanami; Dan, Shingo			In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA	INVESTIGATIONAL NEW DRUGS			English	Article						Phosphatidylinositol 3-kinase inhibitor; PIK3CA; Hotspot mutation; Apoptosis; Autophagy	BREAST-CANCER CELLS; 3-KINASE/MAMMALIAN TARGET; RAPAMYCIN INHIBITOR; ANTITUMOR-ACTIVITY; LINE PANEL; NVP-BEZ235; JFCR39; POTENT; IDENTIFICATION; APOPTOSIS	Background As accumulating evidences suggest close involvement of phosphatidylinositol 3-kinase (PI3K) in cancer, novel PI3K inhibitors such as ZSTK474, GDC-0941, NVP-BEZ235 and BKM-120 have been developed for cancer therapy. A high frequency of hotspot mutations known as E542K, E545K and H1047R in the PIK3CA gene, which encodes the catalytic subunit of PI3K alpha, has been found in various types of human cancers. The hotspot PIK3CA mutations also lead to resistance to therapeutics targeting epidermal growth factor receptor (EGFR), further suggesting that inhibition of hotspot mutant PIK3CA be required for a PI3K inhibitor as anticancer drug candidate. Methods To investigate the activity of the novel PI3K inhibitors on the hotspot mutant PIK3CA, we determined the inhibition against the respective recombinant mutant PI3K alpha s by biochemical assay. We further examined the activity at cellular background by determining the effect on phosphorylation of Akt (Ser473), and that on the growth of cancer cells. In addition, apoptosis and autophagy in cells with or without hotspot PIK3CA mutation induced by the four inhibitors were investigated. Results Our results indicated that each inhibitor exhibit comparable activity on the hotspot mutant PI3K alpha to that on the wild type, which was further demonstrated by the cell-based assays. No clear correlation was shown between the PIK3CA genetic status and the sensitivity for apoptosis or autophagy induction. Interestingly, among the 4 PI3K inhibitors, BKM-120 is the weakest in PI3K inhibitory potency, but induces most potent apoptosis, suggesting that BKM-120 might have a unique mode of action. Conclusions Our result shows that the PI3K inhibitors exhibit potent activity on both hotspot mutant and wild type PI3K alpha, suggesting they might be used to treat patients with or without PIK3CA mutation when approved.	[Kong, Dexin] Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Sch Pharmaceut Sci, Tianjin 300070, Peoples R China; [Kong, Dexin] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China; [Kong, Dexin; Yamori, Takao; Yamazaki, Kanami; Dan, Shingo] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Koto Ku, Tokyo 1358550, Japan	Kong, DX (reprint author), Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Sch Pharmaceut Sci, 22 Qixiangtai RD, Tianjin 300070, Peoples R China.	kongdexin@tijmu.edu.cn; sdan@jfcr.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [20015048]; Japan Society for the Promotion of Science [221S0001, BR131302, S-12105]; National Natural Science Foundation of China [81373441]; Natural Science Foundation of Tianjin [12JCZDJC25800]	We thank Mr. S. Isoyama, Ms. Y. Nishimura, Ms. Y. Ohashi, Ms. Y. Mukai, Ms. M. Okamura, Ms. M. Seki, and Ms. N. Tamaki for their assistance in cell-based assays. ZSTK474 was kindly provided by Zenyaku Kogyo Co. Ltd. This work was supported in part by a grants-in-aid of the Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. Yamori and S. Dan (20015048); a grants-in-aid for Scientific Research (A) from Japan Society for the Promotion of Science to T. Yamori and S. Dan (221S0001); grants from National Natural Science Foundation of China (81373441), the Natural Science Foundation of Tianjin (12JCZDJC25800), and Japan Society for the Promotion of Science (BR131302, S-12105).	Brachmann SM, 2012, MOL CANCER THER, V11, P1747, DOI 10.1158/1535-7163.MCT-11-1021; Whyte DB, 2006, BIOCHEM BIOPH RES CO, V340, P469, DOI 10.1016/j.bbrc.2005.12.025; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Yaguchi SI, 2006, J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Yang XH, 2001, CANCER RES, V61, P348; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Kong D, 2009, CURR MED CHEM, V16, P2839; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Kong DX, 2012, BIOORGAN MED CHEM, V20, P1947, DOI 10.1016/j.bmc.2012.01.017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Yamori T, 1999, CANCER RES, V59, P4042; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Kong DX, 2010, ACTA PHARMACOL SIN, V31, P1189, DOI 10.1038/aps.2010.150; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Kong D, 2009, EUR J CANCER, V45, P857, DOI 10.1016/j.ejca.2008.12.007; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Kong DX, ACTA PHARM SIN, V31, P1189; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Nakatsu N, 2007, MOL PHARMACOL, V72, P1171, DOI 10.1124/mol.107.038836; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sugita H, 2008, BIOCHEM BIOPH RES CO, V377, P941, DOI 10.1016/j.bbrc.2008.10.083; Zou CYY, 2009, MOL CANCER THER, V8, P1157, DOI 10.1158/1535-7163.MCT-08-1008	36	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	DEC	2014	32	6					1134	1143		10.1007/s10637-014-0152-z		10	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	AT7UI	WOS:000345142300009		
J	Hasegawa, M; Miyamoto, N; Miyazaki, S; Wakabayashi, H; Sudo, A				Hasegawa, Masahiro; Miyamoto, Noriki; Miyazaki, Shinichi; Wakabayashi, Hiroki; Sudo, Akihiro			Longitudinal Magnetic Resonance Imaging of Pseudotumors Following Metal-on-Metal Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total hip arthroplasty; metal-on-metal; pseudotumor; magnetic resonance imaging; complications	ASYMPTOMATIC PATIENTS; PREVALENCE; PROSTHESES; BEARINGS; FAILURE; COHORT; COMMON	The purpose of the study was to determine the natural history of pseudotumors following metal-on-metal total hip arthroplasty (THA) using magnetic resonance imaging (MRI). Initial MRI was conducted at a mean of 36 months postoperatively. Follow-up MRI was performed at a mean of 20 months after the detection of 24 asymptomatic pseudotumors. Pseudotumor size was determined on MRI. The mean pseudotumor size changed from 729 mm(2) to 877 mm(2). Pseudotumors increased in size in eight and decreased in six. Ten hips showed no changes. The bigger the pseudotumor size, the more likely the size would increase. In conclusion, pseudotumors frequently change in size. A single MRI study in the clinical decision-making process should be avoided and a longitudinal study should be performed. (C) 2014 Elsevier Inc. All rights reserved.	[Hasegawa, Masahiro; Miyamoto, Noriki; Miyazaki, Shinichi; Wakabayashi, Hiroki; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan	Hasegawa, M (reprint author), Mie Univ, Grad Sch Med, Dept Orthopaed Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.						Matthies AK, 2012, CLIN ORTHOP RELAT R, V470, P1895, DOI 10.1007/s11999-011-2201-7; Williams DH, 2011, J BONE JOINT SURG AM, V93A, P2164, DOI 10.2106/JBJS.J.01884; Schmalzried TP, 2011, ORTHOP CLIN N AM, V42, P271, DOI 10.1016/j.ocl.2010.12.004; Mahendra G, 2009, ACTA ORTHOP, V80, P653, DOI 10.3109/17453670903473016; Hart AJ, 2012, J BONE JOINT SURG AM, V94A, P317, DOI 10.2106/JBJS.J.01508; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Almousa SA, 2013, CLIN ORTHOP RELAT R, V471, P3814, DOI 10.1007/s11999-013-2944-4; Nawabi DH, 2014, CLIN ORTHOP RELAT R, V472, P471, DOI 10.1007/s11999-013-2788-y; Chang EY, 2012, RADIOLOGY, V265, P848, DOI 10.1148/radiol.12120852; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Nawabi DH, 2013, J BONE JOINT SURG AM, V95A, P895, DOI 10.2106/JBJS.K.01476; Bisschop R, 2013, J BONE JOINT SURG AM, V95A, P1554, DOI 10.2106/JBJS.L.00716; Hasegawa M, 2012, J ARTHROPLASTY, V27, P990, DOI 10.1016/j.arth.2011.12.016; Ebreo D, 2013, BONE JOINT J, V95B, P1035, DOI 10.1302/0301-620X.95B8.31377; Hayter CL, 2012, J MAGN RESON IMAGING, V35, P1013, DOI 10.1002/jmri.23523; Wynn-Jones H, 2011, ACTA ORTHOP, V82, P301, DOI 10.3109/17453674.2011.579518; Bernstein M, 2012, INT ORTHOP, V36, P1807, DOI 10.1007/s00264-012-1570-1; Campe CB, 2013, MAGN RESON IMAGING C, V21, P155, DOI 10.1016/j.mric.2012.09.005; Canadian Hip Resurfacing Study Group, 2011, J BONE JOINT SURG S2, V93, P118; Cuckler JM, 2004, J ARTHROPLASTY, V19, P41, DOI 10.1016/j.arth.2004.09.006; Hasegawa M, 2013, ORTHOPEDICS, V36, pE606, DOI 10.3928/01477447-20130426-23; Levine Brett, 2010, Orthopedics, V33, P797, DOI 10.3928/01477447-20100924-04; Lombardi AV, 2012, J BONE JOINT SURG BR, V94B, P14, DOI 10.1302/0301-620X.94B11.30680; van der Weegen W, 2014, J ARTHROPLASTY, V29, P416, DOI 10.1016/j.arth.2013.06.021	28	3	3	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2236	2238		10.1016/j.arth.2014.05.006		3	Orthopedics	Orthopedics	AT7YP	WOS:000345150900002		
J	Nishii, T; Sakai, T; Takao, M; Yoshikawa, H; Sugano, N				Nishii, Takashi; Sakai, Takashi; Takao, Masaki; Yoshikawa, Hideki; Sugano, Nobuhiko			Is Ultrasound Screening Reliable for Adverse Local Tissue Reaction After Hip Arthroplasty?	JOURNAL OF ARTHROPLASTY			English	Article						total hip arthroplasty; adverse local tissue reaction; ultrasound; MRI; reliability	ON-METAL BEARINGS; SOFT-TISSUE; ION LEVELS; PSEUDOTUMORS; RESURFACINGS; DIAGNOSIS; SPECTRUM; SOCIETY; MRI	There is increasing awareness of prevalence of adverse local tissue reaction (ALTR) surrounding metal-on-metal (MoM) and highly cross-linked polyethylene (HXLPE) bearings, and sensitive and simple screening modalities for ALTR are required. We examined reliability of ultrasound screening for ALTR in 131 hips of 105 patients who received both ultrasound and MRI examinations after hip arthroplasty with MoM or HXLPE bearings. Using the MRI results as reference, sensitivity, specificity and accuracy of ultrasound were 74%, 92% and 84% around MoM bearings, and 90%, 83%, and 85% around HXLPE bearings. Ultrasound detected ALTR in 11 hips that were not shown with MRI. Ultrasound examination is assumed to be a reliable screening tool for detecting clinically important ALTR lesions developing in the anterior region around MoM or HXLPE bearings. (C) 2014 Elsevier Inc. All rights reserved.	[Nishii, Takashi; Sugano, Nobuhiko] Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, Suita, Osaka 5650871, Japan; [Sakai, Takashi; Takao, Masaki; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan	Nishii, T (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.				Ministry of Education, Science and Culture of Japan	This study was funded by Grant-in-Aid for Scientific Research, the Ministry of Education, Science and Culture of Japan.	Matthies AK, 2012, CLIN ORTHOP RELAT R, V470, P1895, DOI 10.1007/s11999-011-2201-7; Williams DH, 2011, J BONE JOINT SURG AM, V93A, P2164, DOI 10.2106/JBJS.J.01884; Malek IA, 2012, J BONE JOINT SURG BR, V94B, P1045, DOI 10.1302/0301-620X.94B8.27626; Browne JA, 2010, CLIN ORTHOP RELAT R, V468, P2313, DOI 10.1007/s11999-010-1419-0; Chen CA, 2011, J MAGN RESON IMAGING, V33, P1121, DOI 10.1002/jmri.22534; Anderson H, 2011, SKELETAL RADIOL, V40, P303, DOI 10.1007/s00256-010-1000-7; Lindgren JU, 2011, J BONE JOINT SURG BR, V93B, P1427, DOI 10.1302/0301-620X.93B10.27645; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Hayter CL, 2012, AM J ROENTGENOL, V199, P884, DOI 10.2214/AJR.11.8203; Klauser AS, 2012, EUR RADIOL, V22, P1140, DOI 10.1007/s00330-011-2356-3; Hauptfleisch J, 2012, SKELETAL RADIOL, V41, P149, DOI 10.1007/s00256-011-1329-6; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; Cooper HJ, 2013, J BONE JOINT SURG AM, V95A, P865, DOI 10.2106/JBJS.L.01042; Griffin WL, 2012, J ARTHROPLASTY, V27, P32, DOI 10.1016/j.arth.2012.03.020; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Amstutz HC, 2010, J BONE JOINT SURG AM, V92A, P2663, DOI 10.2106/JBJS.I.01715; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P738, DOI 10.1302/0301-620X.91B6.21682; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Potter HG, 2004, J BONE JOINT SURG AM, V86A, P1947; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; Garbuz DS, 2014, CLIN ORTHOP RELAT R, V472, P417, DOI 10.1007/s11999-013-3181-6; Nishii T, 2012, J ARTHROPLASTY, V27, P895, DOI 10.1016/j.arth.2011.09.015; Coulter G, 2012, J BONE JOINT SURG BR, V94B, P315, DOI 10.1302/0301-620X.94B3.28185; Fang CSJ, 2008, SKELETAL RADIOL, V37, P715, DOI 10.1007/s00256-008-0492-x; Iagnocco A, 2011, SEMIN ULTRASOUND CT, V32, P66, DOI 10.1053/j.sult.2010.11.004; Lombardi AV, 2012, J BONE JOINT SURG BR, V94B, P14, DOI 10.1302/0301-620X.94B11.30680; Sabah SA, 2011, J ARTHROPLASTY, V26, P71, DOI 10.1016/j.arth.2009.11.008; Sofka Carolyn M, 2006, HSS J, V2, P73, DOI 10.1007/s11420-005-0131-1	32	2	2	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2239	2244		10.1016/j.arth.2014.04.030		6	Orthopedics	Orthopedics	AT7YP	WOS:000345150900003		
J	Tezuka, T; Inaba, Y; Kobayashi, N; Sato, M; Mitsugi, N; Saito, T				Tezuka, Taro; Inaba, Yutaka; Kobayashi, Naomi; Sato, Masaaki; Mitsugi, Naoto; Saito, Tomoyuki			Long-Term Results of Porous-Coated Anatomic Total Hip Arthroplasty for Patients With Osteoarthritis of the Hip	JOURNAL OF ARTHROPLASTY			English	Article						porous-coated anatomic prosthesis; osteoarthritis of the hip; total hip arthroplasty; long-term results; polyethylene wear	CONCISE FOLLOW-UP; ACETABULAR COMPONENT; CONSECUTIVE SERIES; POLYETHYLENE WEAR; REPLACEMENT; PROSTHESIS; CEMENT; 10-YEAR	Between 1986 and 1997, 136 porous-coated anatomic (PCA) total hip arthroplasties were performed for patients with osteoarthritis of the hip, and data were available for 60 hips at final follow-up (mean follow-up, 15.2 years). Of these, 18 hips had undergone revision: 12 for the acetabular component, 10 for the femoral component, and 4 for both components. Survival rate at 23 years postoperatively was 60% for the acetabular component and 82% for the femoral component. Multivariate Cox proportional hazards regression showed that annual polyethylene wear rate, size, and abduction angle of the acetabular component were significantly associated with acetabular component revision surgery, and that annual polyethylene wear rate and filling ratio of the femur were associated with femoral component revision surgery. (C) 2014 Elsevier Inc. All rights reserved.	[Tezuka, Taro; Inaba, Yutaka; Kobayashi, Naomi; Sato, Masaaki; Mitsugi, Naoto; Saito, Tomoyuki] Yokohama City Univ, Dept Orthopaed Surg, Yokohama, Kanagawa 2360004, Japan	Inaba, Y (reprint author), Yokohama City Univ, Dept Orthopaed Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.						Engh CA, 1997, J BONE JOINT SURG AM, V79A, P177; Shinar AA, 1997, J BONE JOINT SURG AM, V79A, P159; CALLAGHAN JJ, 1988, J BONE JOINT SURG AM, V70A, P337; Kawamura H, 2001, J BONE JOINT SURG AM, V83A, P1333; Kim YH, 2005, J BONE JOINT SURG BR, V87B, P623, DOI 10.1302/0301-620X.87B5.15554; Xenos JS, 1999, J BONE JOINT SURG AM, V81A, P74; Bojescul JA, 2003, J BONE JOINT SURG AM, V85A, P1079; BOURNE RB, 1994, J BONE JOINT SURG AM, V76A, P1464; Kim YH, 2003, J BONE JOINT SURG AM, V85A, P1682; Little NJ, 2009, CLIN ORTHOP RELAT R, V467, P2895, DOI 10.1007/s11999-009-0845-3; KIM YH, 1993, J BONE JOINT SURG BR, V75, P6; Patil S, 2003, J BONE JOINT SURG AM, V85A, P56; Loughead JM, 2012, J BONE JOINT SURG AM, V94A, P151, DOI [10.2106/JBJS.J.01553, 10.2106/JBJSJ.01553]; HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737; BARTEL DL, 1986, J BONE JOINT SURG AM, V68A, P1041; WIXSON RL, 1991, J BONE JOINT SURG AM, V73A, P257; Astion DJ, 1996, J BONE JOINT SURG AM, V78A, P755; Burt CF, 1998, J BONE JOINT SURG AM, V80A, P952; DeLee JG, 1976, CLIN ORTHOP RELAT RE, V20; Dorr LD, 1986, TECHNIQUES ORTHOP, V1, P22, DOI 10.1097/00013611-198610000-00007; Gruen TA, 1979, CLIN ORTHOP RELAT RE, P17; Healy WL, 2002, J ARTHROPLASTY, V17, P856, DOI 10.1054/arth.2002.34822; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Maric Z, 1992, CLIN ORTHOP RELAT RE, P116; OWEN TD, 1994, J BONE JOINT SURG BR, V76B, P258; SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849	26	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2251	2255		10.1016/j.arth.2013.11.015		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900005		
J	Minoda, Y; Yoshida, T; Sugimoto, K; Baba, S; Ikebuchi, M; Nakamura, H				Minoda, Yukihide; Yoshida, Taku; Sugimoto, Kazutaka; Baba, Shinogo; Ikebuchi, Mitssuhiko; Nakamura, Hiroaki			Detection of Small Periprosthetic Bone Defects after Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; bone defect; tomography; plain radiography; computed tomography	REPLACEMENT; OSTEOLYSIS; ASSOCIATION; TRENDS; CONES	Large bone defect around total knee prostheses is among the most critical challenges in revision surgery. However, it is difficult to detect bone defects around a prosthesis in early stage. We compared the efficacy of the detection of small bone defects between fluoroscopically guided plain radiography, CT, MRI, and a novel tomographic technique (tomosynthesis) using the six pig knee models. No bone defects were detected with plain radiography and MRI. The sensitivity and specificity of CT were 61.5% and 64.1%, respectively. The sensitivity and specificity of tomosynthesis were 85.4% and 87.2%, respectively. The radiation dose of tomosynthesis was 6% of that of CT. The cost of tomosynthesis was 28% of that of CT. Tomosynthesis was superior in terms of diagnosis, radiation dose, and cost. (C) 2014 Elsevier Inc. All rights reserved.	[Minoda, Yukihide; Yoshida, Taku; Ikebuchi, Mitssuhiko; Nakamura, Hiroaki] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka 5458585, Japan; [Sugimoto, Kazutaka] Sonodakai Joint Replacement Ctr Hosp, Tokyo, Japan; [Baba, Shinogo] Shimadzu Co Ltd, Kyoto, Japan	Minoda, Y (reprint author), Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.						Vessely MB, 2006, J ARTHROPLASTY, V21, P826, DOI 10.1016/j.arth.2005.10.017; Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495; Graves SE, 2004, MED J AUSTRALIA, V180, pS31; Kurtz SM, 2011, INT ORTHOP, V35, P1783, DOI 10.1007/s00264-011-1235-5; Haidukewych GJ, 2011, J AM ACAD ORTHOP SUR, V19, P311; Koh IJ, 2013, CLIN ORTHOP RELAT R, V471, P1441, DOI 10.1007/s11999-012-2622-y; Howard JL, 2011, J BONE JOINT SURG AM, V93A, P478, DOI [10.2106/JBJS.I.01322, 10.2106/JBJS.l.01322]; Robertsson O, 2010, ACTA ORTHOP, V81, P82, DOI 10.3109/17453671003685442; Khatod M, 2008, ACTA ORTHOP, V79, P812, DOI 10.1080/17453670810016902; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Kurmis Timothy P, 2008, J Orthop Surg Res, V3, P47, DOI 10.1186/1749-799X-3-47; MINTZ AD, 1989, J BONE JOINT SURG AM, V71A, P1343; Miura H, 2004, J BONE JOINT SURG AM, V86A, P47; Nadaud MC, 2004, J ARTHROPLASTY, V19, P110, DOI 10.1016/j.arth.2003.08.005; Reish Timothy G, 2006, J Knee Surg, V19, P259; Solomon LB, 2012, J ARTHROPLASTY, V27, P1069, DOI 10.1016/j.arth.2011.09.012	16	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2280	2284		10.1016/j.arth.2014.05.013		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900011		
J	Tamura, S; Takao, M; Sakai, T; Nishii, T; Sugano, N				Tamura, Satoru; Takao, Masaki; Sakai, Takashi; Nishii, Takashi; Sugano, Nobuhiko			Spinal Factors Influencing Change in Pelvic Sagittal Inclination From Supine Position to Standing Position in Patients Before Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						pelvic sagittal inclination; total hip arthroplasty; compression fracture; age; lumbar spondylolisthesis	ACETABULAR CUP NAVIGATION; TILT; SPONDYLOLISTHESIS; IMPINGEMENT; REPLACEMENT; RADIOGRAPHS; ALIGNMENT; BALANCE; MOTION	In some atypical patients, pelvic sagittal inclination (PSI) changes posteriorly by > 10 degrees from supine to standing position before total hip arthroplasty (THA). Several studies have suggested PSI in standing position is related to lumbar degeneration. The purpose of this study was to investigate spinal factors influencing changes in PSI from supine to standing position before THA. Participants comprised 163 consecutive patients who had undergone THA. Presence of compression fractures, presence of lumbar spondylolisthesis, thoracic kyphosis angle, lumbar lordosis angle, S1 anterior tilt angle and T4 plumb line position were investigated as spinal factors. Presence of compression fractures, age, presence of lumbar spondylolisthesis and small S1 anterior tilt angle were independently associated with posterior change in PSI from supine to standing position in patients before THA. (C) 2014 Elsevier Inc. All rights reserved.	[Tamura, Satoru; Nishii, Takashi; Sugano, Nobuhiko] Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, Suita, Osaka 5650871, Japan; [Takao, Masaki; Sakai, Takashi] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan	Sugano, N (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.						Sugano N, 2012, J ARTHROPLASTY, V27, P1562, DOI 10.1016/j.arth.2012.01.029; Babisch JW, 2008, J BONE JOINT SURG AM, V90A, P357, DOI 10.2106/JBJS.F.00628; Widmer KH, 2007, INT ORTHOP, V31, pS29, DOI 10.1007/s00264-007-0429-3; Nishihara S, 2003, CLIN ORTHOP RELAT R, P140, DOI 10.1097/01.blo.0000069891.31220.fd; Malik A, 2007, J BONE JOINT SURG AM, V89A, P1832, DOI 10.2106/JBJS.F.01313; OFFIERSKI CM, 1983, SPINE, V8, P316, DOI 10.1097/00007632-198304000-00014; DiGioia AM, 2006, CLIN ORTHOP RELAT R, P272, DOI 10.1097/01.blo.0000238862.92356.45; Murphy WS, 2013, CLIN ORTHOP RELAT R, V471, P417, DOI 10.1007/s11999-012-2581-3; Imai N, 2013, CLIN ORTHOP RELAT R, V471, P1271, DOI 10.1007/s11999-012-2700-1; Sturesson B, 2000, SPINE, V25, P214, DOI 10.1097/00007632-200001150-00012; Lembeck B, 2005, ACTA ORTHOP, V76, P517, DOI 10.1080/17453670510041501; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; Hammerberg EM, 2003, J SPINAL DISORD TECH, V16, P44; EASTELL R, 1991, J BONE MINER RES, V6, P207; Miki H, 2012, J ARTHROPLASTY, V27, P1641, DOI 10.1016/j.arth.2012.03.002; Sugano N, 2007, J BONE JOINT SURG BR, V89B, P455, DOI 10.1302/0301-620X.89B4.18458; Barrack Robert L, 2003, J Am Acad Orthop Surg, V11, P89; Barrey C, 2007, NEUROSURGERY, V61, P981, DOI 10.1227/01.NEU.0000280112.98151.6D; Eckman K, 2006, CLIN ORTHOP RELAT R, P154, DOI 10.1097/01.blo.0000238809.72164.54; Hirano K, 2012, ORTHOPEDICS, V35, pE1073, DOI 10.3928/01477447-20120621-25; Labelle H, 2005, SPINE, V30, pS27, DOI 10.1097/01.brs.0000155560.92580.90; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P699, DOI 10.1007/s00586-011-1938-8; Morvan Gérard, 2011, Eur Spine J, V20 Suppl 5, P602, DOI 10.1007/s00586-011-1927-y; Steppacher SD, 2009, J ORTHOP RES, V27, P1583, DOI 10.1002/jor.20929	25	2	2	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2294	2297		10.1016/j.arth.2013.11.014		4	Orthopedics	Orthopedics	AT7YP	WOS:000345150900014		
J	Konno, T; Onodera, T; Nishio, Y; Kasahara, Y; Iwasaki, N; Majima, T				Konno, Takuya; Onodera, Tomohiro; Nishio, Yusuke; Kasahara, Yasuhiko; Iwasaki, Norimasa; Majima, Tokifumi			Correlation Between Knee Kinematics and Patellofemoral Contact Pressure in Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; medial pivot pattern; patello-femoral contact stress; kinematics pattern; Mobile bearing insert	FEMORAL COMPONENT; JOINT KINEMATICS; EPICONDYLAR AXIS; PATELLA; FLEXION; MODEL; COMPLICATIONS; BIOMECHANICS; REPLACEMENT; ALIGNMENT	The aim of this study is to evaluate the relationship between patellofemoral contact stress and intraoperative knee kinematic patterns after mobile bearing total knee arthroplasty (TKA). Medial osteoarthritic knees of forty-six posterior-stabilized total knee prostheses were evaluated using a computed tomography-guided navigation system. Subjects were divided into two groups based on intraoperative knee kinematic patterns: the medial pivot group (n = 19) and the non-medial pivot group (n = 27). Mean intraoperative patellofemoral contact stress was significantly lower in the medial pivot group than in the non-medial pivot group (1.7 MPa vs. 3.2 MPa, P < 0.05). An intraoperative medial pivot pattern results in reduced patello-femoral contact stress. (C) 2014 Elsevier Inc. All rights reserved.	[Konno, Takuya; Onodera, Tomohiro; Nishio, Yusuke; Kasahara, Yasuhiko; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido, Japan; [Majima, Tokifumi] Int Univ Hlth & Welf Hosp, Dept Orthoped Surg, Nasushiobara City 3292763, Japan	Majima, T (reprint author), Int Univ Hlth & Welf Hosp, Dept Orthoped Surg, 537-3 Iguchi, Nasushiobara City 3292763, Japan.						Li G, 2004, J ORTHOPAED RES, V22, P801, DOI 10.1016/j.orthres.2003.11.011; Berger RA, 1998, CLIN ORTHOP RELAT R, P144; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Banks SA, 2004, J ARTHROPLASTY, V19, P809, DOI 10.1016/j.arth.2004.04.011; Waters TS, 2003, J BONE JOINT SURG AM, V85A, P212; Wood DJ, 2002, J BONE JOINT SURG AM, V84A, P187; Sawaguchi N, 2010, J ARTHROPLASTY, V25, P920, DOI 10.1016/j.arth.2009.07.024; Skwara A, 2009, ARCH ORTHOP TRAUM SU, V129, P901, DOI 10.1007/s00402-008-0757-9; Asano T, 2005, J ARTHROPLASTY, V20, P1060, DOI 10.1016/j.arth.2004.08.005; Sharma A, 2008, J BIOMECH, V41, P642, DOI 10.1016/j.jbiomech.2007.09.027; Elias JJ, 2004, J BIOMECH, V37, P295, DOI 10.1016/S0021-9290(03)00306-3; Matsuda S, 1997, J ARTHROPLASTY, V12, P790, DOI 10.1016/S0883-5403(97)90010-3; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Campbell DG, 2006, J BONE JOINT SURG BR, V88B, P734, DOI 10.1302/0301-620X.88B6; Victor J, 2009, J BONE JOINT SURG AM, V91A, P150, DOI 10.2106/JBJS.I.00498; Armstrong AD, 2003, J ARTHROPLASTY, V18, P458, DOI 10.1016/S0883-5403(03)00145-1; Benjamin JB, 1998, J ARTHROPLASTY, V13, P693, DOI 10.1016/S0883-5403(98)80015-6; Bischoff JE, 2009, J BIOMECH, V42, P1678, DOI 10.1016/j.jbiomech.2009.04.018; BOYD AD, 1993, J BONE JOINT SURG AM, V75A, P674; Dennis DA, 2003, CLIN ORTHOP RELAT R, P37, DOI 10.1097/01.blo.0000092986.12414.b5; Fuchs S, 2005, KNEE, V12, P9, DOI 10.1021/S0968-0160(02)00045-5; Fuchs S, 2000, INT ORTHOP, V24, P191, DOI 10.1007/s002640000140; Harwin SF, 1998, J ARTHROPLASTY, V13, P753, DOI 10.1016/S0883-5403(98)90026-2; HEEGAARD J, 1995, J BIOMECH, V28, P1265, DOI 10.1016/0021-9290(95)00059-Q; Heegaard JH, 2001, CLIN BIOMECH, V16, P415, DOI 10.1016/S0268-0033(01)00020-1; Kainz H, 2012, INT ORTHOP, V36, P73, DOI 10.1007/s00264-011-1270-2; Kingsley R, 2004, J ARTHROPLASTY, V19, P956; Lee TQ, 1997, CLIN ORTHOP RELAT R, P257; Majima T, 2012, J BONE JOINT SUR S25, V94, P135; Matsuda S, 2000, ORTHOPEDICS, V23, P213; Miyazaki Y, 2011, J ARTHROPLASTY, V26, P1038, DOI 10.1016/j.arth.2010.08.015; Nishio Y, 2014, J ARTHROPLASTY, V29, P702, DOI 10.1016/j.arth.2013.06.035; RANAWAT CS, 1986, CLIN ORTHOP RELAT R, P93; RHOADS DD, 1993, CLIN ORTHOP RELAT R, P122; Skwara A, 2008, ARCH ORTHOP TRAUMA S, V129, P901; Stiehl JB, 2001, J ARTHROPLASTY, V16, P706, DOI 10.1054/arth.2001.24443; Wurm S, 2013, J ORTHOP SCI, V18, P61, DOI 10.1007/s00776-012-0326-5; Xu CM, 2007, KNEE, V14, P183, DOI 10.1016/j.knee.2007.01.005	38	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2305	2308		10.1016/j.arth.2014.07.020		4	Orthopedics	Orthopedics	AT7YP	WOS:000345150900016		
J	Kawahara, S; Okazaki, K; Matsuda, S; Nakahara, H; Okamoto, S; Iwamoto, Y				Kawahara, Shinya; Okazaki, Ken; Matsuda, Shuichi; Nakahara, Hiroyuki; Okamoto, Shigetoshi; Iwamoto, Yukihide			Internal Rotation of Femoral Component Affects Functional Activities After TKA-Survey With The 2011 Knee Society Score	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty (TKA); The 2011 Knee Society Knee Scoring System (KSS); internal rotation of the femoral component; functional activities; satisfaction	PATELLAR TRACKING; POSTOPERATIVE ALIGNMENT; PATIENT SATISFACTION; OUTCOME MEASURE; DISTAL FEMUR; ARTHROPLASTY; REPLACEMENT; SYSTEM; AXIS; MALROTATION	The 2011 Knee Society Knee Scoring System (KSS) was developed as a new patient-derived outcome measure to better characterize satisfaction, expectations, and physical activities after total knee arthroplasty. The rotational alignment of the femoral and tibial components was assessed with computed tomography in 75 patients (92 knees), and its effect on the scores of the KSS was evaluated. Internal rotation of the femoral component relative to the surgical epicondylar axis significantly decreased the score of functional activities and slightly decreased the score of satisfaction. Femoral component malrotation did not affect the scores of symptoms and expectations. Tibial component malrotation did not affect any of the scores of the 2011 KSS. Surgeons should avoid internal rotation of the femoral component to preserve functional activities. (C) 2014 Elsevier Inc. All rights reserved.	[Kawahara, Shinya; Okazaki, Ken; Matsuda, Shuichi; Nakahara, Hiroyuki; Okamoto, Shigetoshi; Iwamoto, Yukihide] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 8128582, Japan	Okazaki, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.			Okazaki, Ken/0000-0003-1274-8406			Akagi M, 2004, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000118442.93383.16; Akagi M, 2005, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000160027.52481.32; Akagi M, 2001, CLIN ORTHOP RELAT R, P147; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Berger RA, 1998, CLIN ORTHOP RELAT R, P144; Noble PC, 2012, CLIN ORTHOP RELAT R, V470, P20, DOI 10.1007/s11999-011-2152-z; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Brander V, 2007, CLIN ORTHOP RELAT R, P21, DOI 10.1097/BLO.0b013e318126c032; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709; Miner AL, 2003, J ARTHROPLASTY, V18, P286, DOI 10.1054/arth.2003.50046; Scott CEH, 2010, J BONE JOINT SURG BR, V92B, P1253, DOI 10.1302/0301-620X.92B9.24394; Devers BN, 2011, J ARTHROPLASTY, V26, P178, DOI 10.1016/j.arth.2010.02.008; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Fukagawa S, 2011, KNEE SURG SPORT TR A, V19, P99, DOI 10.1007/s00167-010-1164-7; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88; Mizu-Uchi H, 2008, J BONE JOINT SURG BR, V90B, P1025, DOI 10.1302/0301-620X.90B8.20265; LAURIN CA, 1978, J BONE JOINT SURG AM, V60, P55; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P542, DOI 10.1007/s11999-009-1046-9; Matsuda S, 2013, CLIN ORTHOP RELAT R, V471, P127, DOI 10.1007/s11999-012-2533-y; Yoshino N, 2001, J ARTHROPLASTY, V16, P493, DOI 10.1054/arth.2001.23621; Scuderi GR, 2012, CLIN ORTHOP RELAT R, V470, P3, DOI 10.1007/s11999-011-2135-0; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Akagi M, 1999, CLIN ORTHOP RELAT R, P155; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Healy WL, 2008, J BONE JOINT SURG AM, V90A, P2245, DOI 10.2106/JBJS.H.00274; Harmer AR, 2009, ARTHRIT RHEUM-ARTHR, V61, P184, DOI 10.1002/art.24420; Conaghan PG, 2007, ARTHRIT RHEUM-ARTHR, V57, P1363, DOI 10.1002/art.23091; Bullens PHJ, 2001, J ARTHROPLASTY, V16, P740, DOI 10.1054/arth.2001.23922; TUGWELL P, 1987, J RHEUMATOL, V14, P446; McHorney CA, 1997, J CLIN EPIDEMIOL, V50, P451, DOI 10.1016/S0895-4356(96)00424-6; Elson DW, 2006, J ARTHROPLASTY, V21, P1047, DOI 10.1016/j.arth.2005.12.010; Thompson JA, 2011, J ORTHOP RES, V29, P969, DOI 10.1002/jor.21344; ANOUCHI YS, 1993, CLIN ORTHOP RELAT R, P170; Barrack BL, 2001, CLIN ORTHOP RELAT R, V392, P46; Kawano T, 2002, J ARTHROPLASTY, V17, P942, DOI 10.1054/arth.2002.34826; Khanna G, 2011, J BONE JOINT SURG AM, V93; Kwon SK, 2010, J ARTHROPLASTY, V25, P1125, DOI 10.1016/j.arth.2009.10.015; LEWIS P, 1994, CLIN ORTHOP RELAT R, P11; Matsuda S, 2001, Am J Knee Surg, V14, P152; Nagamine R, 1994, CLIN ORTHOP RELAT R, V304, P262; Su Edwin P, 2010, Orthopedics, V33, P658, DOI 10.3928/01477447-20100722-48; Verlinden C, 2010, J BONE JOINT SURG BR, V92B, P737, DOI 10.1302/0301-620X.92B5.22603; WASIELEWSKI RC, 1994, CLIN ORTHOP RELAT R, P31	44	4	4	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2319	2323		10.1016/j.arth.2013.11.017		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900019		
J	Fujimoto, E; Sasashige, Y; Tomita, T; Iwamoto, K; Masuda, Y; Hisatome, T				Fujimoto, Eisaku; Sasashige, Yoshiaki; Tomita, Tetsuya; Iwamoto, Keiji; Masuda, Yasuji; Hisatome, Takashi			Significant Effect of the Posterior Tibial Slope on the Weight-Bearing, Midflexion In Vivo Kinematics After Cruciate-Retaining Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						kinematics; cruciate-retaining total knee arthroplasty; 2D/3D registration; posterior cruciate ligament; tibial slope; range of motion; flexion angle	FLUOROSCOPIC ANALYSIS; MULTICENTER ANALYSIS; CONDYLAR OFFSET; FLEXION; TKA	The purpose of the present study was to compare weight bearing (WB) and non-WB conditions, and to evaluate the effect of the posterior tibial slope (PTS) on the in vivo kinematics of 21 knees after posterior cruciate ligament-retaining total knee arthroplasty during midflexion using 2-dimensional/3-dimensional registration. During WB, medial pivot and bicondylar rollback were observed. During non-WB, both the medial and lateral condyles moved significantly more anteriorly as compared to the WB state. These patients were divided into 2 groups according to their PTS. The large PTS group showed a significant posterior displacement of the medial femoral condyle as compared with the small PTS group, but no significant difference was observed at the lateral femoral condyle during both WB and non-WB. The PTS influenced knee kinematics through gravity (124/125). (C) 2014 Elsevier Inc. All rights reserved.	[Fujimoto, Eisaku; Sasashige, Yoshiaki; Masuda, Yasuji; Hisatome, Takashi] Chugoku Rousai Hosp, Dept Orthoped Surg, Kure, Hiroshima 7370193, Japan; [Tomita, Tetsuya; Iwamoto, Keiji] Osaka Univ, Grad Sch Med, Dept Orthoped Biomat Sci, Suita, Osaka, Japan	Fujimoto, E (reprint author), Chugoku Rousai Hosp, Dept Orthoped Surg, 1-5-1 Hirotagaya, Kure, Hiroshima 7370193, Japan.						Victor J, 2005, J BONE JOINT SURG BR, V87B, P646, DOI 10.1302/0301-620X.87B5.15602; Bellemans J, 2002, J BONE JOINT SURG BR, V84B, P50, DOI 10.1302/0301-620X.84B1.12432; Shimizu N, 2011, J ARTHROPLASTY, V26, P1031, DOI 10.1016/j.arth.2011.01.008; Bertin KC, 2002, J ARTHROPLASTY, V17, P1040, DOI 10.1054/arth.2002.35793; Dennis DA, 1998, CLIN ORTHOP RELAT R, P47; Han HS, 2008, KNEE SURG SPORT TR A, V16, P373, DOI 10.1007/s00167-008-0486-1; Banks SA, 1997, J ARTHROPLASTY, V12, P297, DOI 10.1016/S0883-5403(97)90026-7; Massin P, 2006, J ARTHROPLASTY, V21, P889, DOI 10.1016/j.arth.2005.10.019; Dennis DA, 2004, CLIN ORTHOP RELAT R, P180, DOI 10.1097/01.blo.0000148777.98244.84; Yoshiya S, 2005, J ARTHROPLASTY, V20, P777, DOI 10.1016/j.arth.2004.11.012; Victor J, 2006, CLIN ORTHOP RELAT R, P53, DOI 10.1097/01.blo.0000238792.36725.1e; Komistek RD, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000062384.79828.3b; Ostermeier S, 2006, CLIN BIOMECH, V21, P525, DOI 10.1016/j.clinbiomech.2005.12.019; Bellemans J, 2005, KNEE SURG SPORT TR A, V13, P193, DOI 10.1007/s00167-004-0557-x; Zuffi S, 1999, IEEE T MED IMAGING, V18, P981, DOI 10.1109/42.811310; Dennis DA, 2005, J BIOMECH, V38, P241, DOI 10.1016/j.jbiomech.2004.02.042; Dennis DA, 2003, CLIN ORTHOP RELAT R, P114, DOI 10.1097/01.blo.0000062385.79828.72; Fujimoto E, 2012, KNEE SURG SPORTS TRA; Horiuchi H, 2012, J ARTHROPLASTY, V27, P1196, DOI 10.1016/j.arth.2012.01.017; Kitagawa A, 2010, J ARTHROPLASTY, V25, P964, DOI 10.1016/j.arth.2009.07.008; Komistek RD, 2008, J ARTHROPLASTY, V23, P41, DOI 10.1016/j.arth.2007.01.016; Mahfouz MR, 2004, J BONE JOINT SURG AM, V86A, P56; Seon JK, 2011, KNEE SURG SPORT TR A, V19, P2016, DOI 10.1007/s00167-011-1434-z; STIEHL JB, 1995, J BONE JOINT SURG BR, V77B, P884; Stiehl JB, 1999, CLIN ORTHOP RELAT R, P139; Takatsu T, 1998, Bull Hosp Jt Dis, V57, P195; Yamazaki Takaharu, 2005, Nihon Hoshasen Gijutsu Gakkai Zasshi, V61, P79; Zelle J, 2010, MED ENG PHYS, V32, P700, DOI 10.1016/j.medengphy.2010.04.013	28	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2324	2330		10.1016/j.arth.2013.10.018		7	Orthopedics	Orthopedics	AT7YP	WOS:000345150900020		
J	Morishita, M; Ishida, K; Matsumoto, T; Kuroda, R; Kurosaka, M; Tsumura, N				Morishita, Masayuki; Ishida, Kazunari; Matsumoto, Tomoyuki; Kuroda, Ryosuke; Kurosaka, Masahiro; Tsumura, Nobuhiro			Intraoperative Platelet-Rich Plasma Does Not Improve Outcomes of Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						platelet-rich plasma; total knee arthroplasty; bleeding; postoperative recovery; functional score	REDUCE BLOOD-LOSS; MAXILLOFACIAL SURGERY; CURRENT KNOWLEDGE; FIBRIN SEALANT; GEL; OSTEOARTHRITIS; PERSPECTIVES; HEMOGLOBIN; MANAGEMENT; BIOLOGY	This randomized controlled study was conducted to assess the effects of platelet-rich plasma (PRP) on outcomes of total knee arthroplasty (TKA). Forty patients who underwent unilateral TKA were evaluated prospectively; 20 received intraoperative PRP and 20 served as control subjects. The results showed no significant differences in reduction of bleeding, range of motion, swelling around the knee joint, muscle power recovery, pain, Knee Society Scores, and Knee Injury and Osteoarthritis Outcome Score between the 2 groups. Additionally, no distinct clinical characteristics were found in patients who received intraoperative PRP. Therefore, we conclude that intraoperative PRP does not improve outcomes of TKA. (C) 2014 Elsevier Inc. All rights reserved.	[Morishita, Masayuki; Ishida, Kazunari; Tsumura, Nobuhiro] Hyogo Rehabil Ctr Hosp, Dept Orthopaed Surg, Kobe, Hyogo, Japan; [Matsumoto, Tomoyuki; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Kobe, Hyogo, Japan; [Ishida, Kazunari] Kobe Kaisei Hosp, Dept Orthopaed Surg, Kobe, Hyogo 6570068, Japan	Ishida, K (reprint author), Kobe Kaisei Hosp, Dept Orthopaed Surg, Nada Ku, 3-11-15 Shinohara Kita, Kobe, Hyogo 6570068, Japan.						Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Sehat KR, 2004, J BONE JOINT SURG BR, V86B, P561, DOI 10.1302/0301-620X.86B4.14508; Ishida K, 2011, INT ORTHOP, V35, P1639, DOI 10.1007/s00264-010-1205-3; Bierbaum BE, 1999, J BONE JOINT SURG AM, V81A, P2; Gardner MJ, 2007, INT ORTHOP, V31, P309, DOI 10.1007/s00264-006-0174-z; Hee HT, 2003, EUR SPINE J, V12, P400, DOI 10.1007/s00586-003-0548-5; Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850; Gidwani S, 2004, BRIT MED J, V329, P1220, DOI 10.1136/bmj.329.7476.1220; Simonpieri A, 2012, CURR PHARM BIOTECHNO, V13, P1231; NADLER SB, 1962, SURGERY, V51, P224; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88; Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546; Tsumara N, 2006, J BONE JOINT SURG BR, V88B, P49, DOI 10.1302/0301-620X.88B1.16653; Del Corso M, 2012, CURR PHARM BIOTECHNO, V13, P1207; DiIorio TM, 2012, CLIN ORTHOP RELAT R, V470, P138, DOI 10.1007/s11999-011-1972-1; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Esler CNA, 2003, J BONE JOINT SURG BR, V85B, P215, DOI 10.1302/0301-620X.85B2.13357; Horstmann WG, 2011, KNEE SURG SPORT TR A, V19, P115, DOI 10.1007/s00167-010-1207-0; DELROSSI AJ, 1990, J THORAC CARDIOV SUR, V100, P281; Bloomfield MR, 2012, J ARTHROPLASTY, V27, P695, DOI 10.1016/j.arth.2011.09.014; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; GROSS JB, 1983, ANESTHESIOLOGY, V58, P277, DOI 10.1097/00000542-198303000-00016; Berghoff WJ, 2006, ORTHOPEDICS, V29, P590; Eby Ben W, 2002, J Oral Implantol, V28, P297, DOI 10.1563/1548-1336(2002)028<0297:PPHWAS>2.3.CO;2; Everts PAM, 2006, ACTA ANAESTH SCAND, V50, P593, DOI 10.1111/j.1399-6576.2006.01005.x; Levy O, 1999, J BONE JOINT SURG AM, V81A, P1580; Peerbooms JC, 2009, ACTA ORTHOP, V80, P557, DOI 10.3109/17453670903350081; Wang GJ, 2001, J BONE JOINT SURG AM, V83A, P1503; Waters Jonathan H, 2004, J Extra Corpor Technol, V36, P250	30	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2337	2341		10.1016/j.arth.2014.04.007		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900022		
J	Kuriyama, S; Hyakuna, K; Inoue, S; Tamaki, Y; Ito, H; Matsuda, S				Kuriyama, Shinichi; Hyakuna, Katsufumi; Inoue, Satoshi; Tamaki, Yasuyuki; Ito, Hiromu; Matsuda, Shuichi			Tibial Rotational Alignment Was Significantly Improved by Use of a CT-Navigated Control Device in Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; rotational alignment; tibial component; developed instrument; CT-based navigation system	REPLACEMENT; PAIN; COMPONENTS; VARIABILITY; REFERENCES; FAILURE; AXIS	This study compared the accuracy of three methods to set tibial component rotational alignment: (1) conventional method, the anteroposterior (AP) axis was determined by the surgeon using anatomical landmarks; (2) partial-navigation method, the tibia was prepared according to the AP axis using a CT-based navigation system and the component was manually positioned; (3) full-navigation method, the tibial component was positioned and fixed with cement under the control of navigation using a newly developed instrument. The conventional method showed considerable deviation (range, -18.6 degrees to 14.7 degrees), and the partial-navigation method also showed considerable deviation (-11.3 degrees to 8.1 degrees). In contrast, the full-navigation method significantly improved the accuracy of alignment (-2.9 degrees to 2.1 degrees). The tibial component can become malaligned during cement fixation, even after proper bone preparation. (C) 2014 Elsevier Inc. All rights reserved.	[Kuriyama, Shinichi; Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan; [Hyakuna, Katsufumi; Inoue, Satoshi; Tamaki, Yasuyuki] Japanese Red Cross Soc Wakayama Med Ctr, Dept Orthopaed Surg, Wakayama, Japan	Kuriyama, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.						Akagi M, 2004, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000118442.93383.16; Akagi M, 2005, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000160027.52481.32; Nicoll D, 2010, J BONE JOINT SURG BR, V92B, P1238, DOI 10.1302/0301-620X.92B9.23516; Hofmann S, 2003, ORTHOPADE, V32, P469, DOI 10.1007/s00132-003-0503-5; Siston RA, 2006, CLIN ORTHOP RELAT R, P65, DOI 10.1097/01.blo.0000229335.36900.a0; Berger RA, 1998, CLIN ORTHOP RELAT R, P144; BERGER RA, 1993, CLIN ORTHOP RELAT R, P40; Chauhan SK, 2004, J BONE JOINT SURG BR, V86B, P372, DOI 10.1320/0301-620X.86B3.14643; Bedard M, 2011, CLIN ORTHOP RELAT R, V469, P2346, DOI 10.1007/s11999-011-1889-8; Barrack RL, 2001, CLIN ORTHOP RELAT R, P46; Mizu-Uchi H, 2008, J BONE JOINT SURG BR, V90B, P1025, DOI 10.1302/0301-620X.90B8.20265; Kim YH, 2007, J BONE JOINT SURG BR, V89B, P471, DOI 10.1302/0301-620X.89B4.18878; Graw BP, 2010, CLIN ORTHOP RELAT R, V468, P2734, DOI 10.1007/s11999-010-1330-8; Matziolis G, 2007, J BONE JOINT SURG AM, V89A, P236, DOI 10.2106/JBJS.F.00386; Akagi M, 1999, CLIN ORTHOP RELAT R, P155; Liabaud B, 2013, KNEE, V20, P412, DOI 10.1016/j.knee.2013.02.001; Murakami AM, 2012, J BONE JOINT SURG BR, V94B, P1209, DOI 10.1302/0301-620X.94B9.28489; ELIAS SG, 1990, CLIN ORTHOP RELAT R, P98; LEWIS P, 1994, CLIN ORTHOP RELAT R, P11; Matsuda S, 2001, Am J Knee Surg, V14, P152; Matziolis G, 2012, KNEE SURG SPORT TR A, V20, P1083, DOI 10.1007/s00167-011-1696-5; MERKOW RL, 1985, J BONE JOINT SURG AM, V67A, P1321; Nagamine R, 1994, CLIN ORTHOP RELAT R, V304, P262; Vince KG, 2012, J BONE JOINT SURG BR, V94B, P103, DOI 10.1302/0301-620X.94B11.30793; WASIELEWSKI RC, 1994, CLIN ORTHOP RELAT R, P31	25	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2352	2356		10.1016/j.arth.2014.06.016		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900025		
J	Okamoto, N; Nakamura, E; Nishioka, H; Karasugi, T; Okada, T; Mizuta, H				Okamoto, Nobukazu; Nakamura, Eiichi; Nishioka, Hiroaki; Karasugi, Tatsuki; Okada, Tatsuya; Mizuta, Hiroshi			In Vivo Kinematic Comparison Between Mobile-Bearing and Fixed-Bearing Total Knee Arthroplasty During Step-Up Activity	JOURNAL OF ARTHROPLASTY			English	Article						total knee arthroplasty; kinematics; mobile-bearing; fixed-bearing	PROSTHESES; DESIGN; REPLACEMENTS; ROTATION; WEAR	Mobile-bearing total knee arthroplasty (TKA) expects high conformity and low contact stress. It is designed to correct the rotational mismatch between femoral and tibial components. We examined the difference in weight-bearing knee kinematics in patients with mobile-bearing and fixed-bearing TKA performing step-up activities. We randomly assigned 40 knees (37 patients) to mobile-bearing TKA (n = 20) or fixed-bearing TKA (n = 20). Using fluoroscopic imaging we evaluated knee kinematics during step-up activity one year after surgery. The total extent of rotation was not different for the two TKAs. Due to the axial rotation of the polyethylene insert, patients with mobile-bearing TKA had a wider range of absolute axial rotation. The position of the medial and the lateral condyles was significantly more posterior in the fixed-bearing TKA. There were only minor kinematic differences between the two TKAs. The polyethylene insert in the mobile-bearing TKA moved as designed especially with respect to the self-alignment feature. (C) 2014 Published by Elsevier Inc.	[Okamoto, Nobukazu; Nakamura, Eiichi; Nishioka, Hiroaki; Karasugi, Tatsuki; Okada, Tatsuya; Mizuta, Hiroshi] Kumamoto Univ, Dept Orthopaed Surg, Fac Life Sci, Kumamoto, Japan	Okamoto, N (reprint author), 1-1-1 Honjo, Kumamoto, Japan.						Akagi M, 2005, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000160027.52481.32; Matsuda S, 2010, KNEE SURG SPORT TR A, V18, P1311, DOI 10.1007/s00167-010-1143-z; Dennis DA, 2006, CLIN ORTHOP RELAT R, P70, DOI 10.1097/01.blo.0000238776.27316.d6; Harrington MA, 2009, J ARTHROPLASTY, V24, P24, DOI 10.1016/j.arth.2009.04.031; EWALD FC, 1989, CLIN ORTHOP RELAT R, P9; Kelly NH, 2011, CLIN ORTHOP RELAT R, V469, P123, DOI 10.1007/s11999-010-1557-4; Banks SA, 2004, J ARTHROPLASTY, V19, P809, DOI 10.1016/j.arth.2004.04.011; Sawaguchi N, 2010, J ARTHROPLASTY, V25, P920, DOI 10.1016/j.arth.2009.07.024; Hasegawa M, 2009, KNEE SURG SPORT TR A, V17, P237, DOI 10.1007/s00167-008-0662-3; Engh GA, 2009, J ARTHROPLASTY, V24, P28, DOI 10.1016/j.arth.2009.03.010; Ranawat CS, 2004, CLIN ORTHOP RELAT R, P184; McEwen HMJ, 2005, J BIOMECH, V38, P357, DOI 10.1016/j.jbiomech.2004.02.015; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; Kim D, 2012, KNEE SURG SPORT TR A, V20, P337, DOI 10.1007/s00167-011-1750-3; Mahoney OM, 2012, CLIN ORTHOP RELAT R, V470, P33, DOI 10.1007/s11999-011-2114-5; Banks SA, 2004, CLIN ORTHOP RELAT R, P187, DOI 10.1097/01.blo.0000138956.04316.ac; BARTEL DL, 1995, CLIN ORTHOP RELAT R, P76; Catani F, 2009, J ORTHOP RES, V27, P1569, DOI 10.1002/jor.20941; Cheng CK, 2003, CLIN BIOMECH, V18, P231, DOI 10.1016/S0268-0033(02)00189-4; D'Lima DD, 2000, CLIN ORTHOP RELAT R, P151; Fantozzi S, 2004, KNEE SURG SPORT TR A, V12, P144, DOI 10.1007/s00167-003-0384-5; Garling EH, 2007, J BIOMECH, V40, pS25, DOI 10.1016/j.jbiomech.2007.02.013; Shi K, 2008, J ARTHROPLASTY, V23, P164, DOI 10.1016/j.arth.2007.01.009; Wolterbeek N, 2012, CLIN BIOMECH, V27, P398, DOI 10.1016/j.clinbiomech.2011.10.013	24	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2393	2396		10.1016/j.arth.2014.02.022		4	Orthopedics	Orthopedics	AT7YP	WOS:000345150900033		
J	Shimizu, N; Tomita, T; Yamazaki, T; Yoshikawa, H; Sugamoto, K				Shimizu, Norimasa; Tomita, Tetsuya; Yamazaki, Takaharu; Yoshikawa, Hideki; Sugamoto, Kazuomi			In Vivo Movement of Femoral Flexion Axis of a Single-Radius Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						single-radius TKA; posterior stabilized; kinematics; paradoxical movement; femoral roll back	KINEMATIC ANALYSIS; BENDING MOTION; RELATIVE MOVEMENTS; WEIGHT-BEARING; REPLACEMENT; PROSTHESIS; FEMUR; FLUOROSCOPY; INSTABILITY; POSITION	The objective of this study was to investigate in vivo femoro-tibial motion using the movement of femoral flexion axis of a single-radius TKA. We examined 20 clinically successful knees with a single-radius posterior stabilized TKA to evaluate the kinematics of deep knee flexion using 2-3-dimensional registration techniques. The mean knee flexion range of motion was 117.8 degrees. The mean rotation of the femoral component was 7.6 degrees external rotation. The mean knee flexion angle at initial post-cam engagement was 55.2 degrees. No paradoxical movement of femoral component was shown until 70 degrees flexion, afterward the femoral component rolled back with flexion. The data showed that the design of this prosthesis might contribute to reduce the paradoxical anterior femoral movement and provide stability in mid-flexion ranges. (C) 2014 Elsevier Inc. All rights reserved.	[Shimizu, Norimasa; Tomita, Tetsuya; Sugamoto, Kazuomi] Grad Sch Med, Dept Orthopaed Biomat Sci, Suita, Osaka, Japan; [Yamazaki, Takaharu] Grad Sch Med, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan	Tomita, T (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Biomat Sci, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.						Shimizu N, 2011, J ARTHROPLASTY, V26, P1031, DOI 10.1016/j.arth.2011.01.008; Mahoney OM, 2002, J ARTHROPLASTY, V17, P416, DOI 10.1054/arth.2002.32168; Futai K, 2011, KNEE SURG SPORT TR A, V19, P914, DOI 10.1007/s00167-010-1262-6; Iwaki H, 2000, J BONE JOINT SURG BR, V82B, P1189, DOI 10.1302/0301-620X.82B8.10717; [Anonymous], 2004, J BONE JOINT SURG A, V86-A, P1328; HOLLISTER AM, 1993, CLIN ORTHOP RELAT R, P259; Pinskerova V, 2004, J BONE JOINT SURG BR, V86B, P925, DOI 10.1302/0301-620x.86b6.14589; Laskin RS, 2002, CLIN ORTHOP RELAT R, P169, DOI 10.1097/01.blo.0000030494.43495.e4; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328; [Anonymous], 2005, CLIN ORTHOPS REL RES; Heyse TJ, 2010, ARCH ORTHOP TRAUM SU, V130, P1, DOI 10.1007/s00402-009-0927-4; Pinskerova V, 2000, ORTHOPADE, V29, pS3, DOI 10.1007/PL00003679; Zuffi S, 1999, IEEE T MED IMAGING, V18, P981, DOI 10.1109/42.811310; Churchill DL, 1998, CLIN ORTHOP RELAT R, P111; Dennis DA, 2007, CLIN ORTHOP RELAT R, P53, DOI 10.1097/BLO.0b013e31812f85d; Sharkey PF, 2002, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000036002.13841.32; Dennis DA, 2003, CLIN ORTHOP RELAT R, P37, DOI 10.1097/01.blo.0000092986.12414.b5; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136; Hill PF, 2000, J BONE JOINT SURG BR, V82B, P1196, DOI 10.1302/0301-620X.82B8.10716; Horiuchi H, 2012, J ARTHROPLASTY, V27, P1196, DOI 10.1016/j.arth.2012.01.017; Kessler O, 2007, CLIN BIOMECH, V22, P52, DOI 10.1016/j.clinbiomech.2006.07.011; Kurita M, 2012, INT ORTHOP, V36, P2465, DOI 10.1007/s00264-012-1673-8; Ostermeier S, 2011, ACTA ORTHOP, V82, P339, DOI 10.3109/17453674.2011.574564; Pagnano MT, 1998, CLIN ORTHOP RELAT R, P39; Roberts VI, 2007, J BONE JOINT SURG BR, V89B, P1452, DOI 10.1302/0301-620X.89B11.19783; Schwab JH, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000185449.51246.d6; Tamaki M, 2008, J ARTHROPLASTY, V23, P879, DOI 10.1016/j.arth.2008.04.009; Tamaki M, 2009, J ARTHROPLASTY, V24, P972, DOI 10.1016/j.arth.2008.06.012; Uvehammer J, 2000, J ORTHOPAED RES, V18, P856, DOI 10.1002/jor.1100180603; Watanabe T, 2004, J ORTHOPAED RES, V22, P1044, DOI 10.1016/j.orthres.2003.12.013; Yamazaki T, 2005, EUR J RADIOL, V53, P84, DOI 10.1016/j.ejrad.2003.09.018; Yamazaki T, 2004, IEEE T MED IMAGING, V23, P602, DOI 10.1109/TMI.2004.826051	32	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2407	2411		10.1016/j.arth.2013.12.001		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900036		
J	Maruyama, M; Tensho, K; Wakabayashi, S; Hisa, K				Maruyama, Masaaki; Tensho, Keiji; Wakabayashi, Shinji; Hisa, Kenji			Standing Versus Supine Radiographs to Evaluate Femoral Head Penetration in the Polyethylene Liner After Total Hip Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						standing radiograph; femoral head penetration; polyethylene liner wear; total hip arthroplasty	CROSS-LINKED POLYETHYLENE; CONTROLLED-TRIAL; WEAR	The linear penetration rates for ceramic femoral heads on conventional and highly cross-linked polyethylene were measured and compared with radiographs taken in the standing and supine position taken three weeks postoperatively and at final follow-up. Seventy-five patients (83 hips) with conventional polyethylene (group-1) and two hundred and seventy five patients (300 hips) with highly cross-linked polyethylene (group-2) were studied. Follow-up periods were 14.5 years in group-1 and 8.6 years in group-2. The average penetration rates in group-1 were 0.17 mm/year in supine position and 0.18 mm/year in standing position (P < 0.05). On the other hand, the rates in group-2 were 0.03 mm/year and 0.04 mm/year respectively (P < 0.05). Although there were statistical differences between groups, 0.01 mm differences are probably not clinically relevant. (C) 2014 Elsevier Inc. All rights reserved.	[Maruyama, Masaaki] Shinonoi Gen Hosp, Dept Orthoped Surg, Nagano 3888004, Japan; [Tensho, Keiji] Shinshu Univ, Dept Orthoped Surg, Sch Med, Matsumoto, Nagano 3908621, Japan; [Wakabayashi, Shinji] Chushin Matsumoto Hosp, Dept Orthoped Surg, Matsumoto Med Ctr, Matsumoto, Nagano 3990021, Japan; [Hisa, Kenji] IMS Miyoshi Gen Hosp, Dept Orthoped Surg, Miyoshi, Saitama 3540041, Japan	Maruyama, M (reprint author), Shinonoi Gen Hosp, Dept Orthoped Surg, 666-1 Ai, Nagano 3888004, Japan.						McCalden RW, 2009, J BONE JOINT SURG AM, V91A, P773, DOI 10.2106/JBJS.H.00244; Glyn-Jones S, 2008, J ARTHROPLASTY, V23, P337, DOI 10.1016/j.arth.2006.12.117; Lachiewicz PF, 2009, CLIN ORTHOP RELAT R, V467, P3290, DOI 10.1007/s11999-009-1038-9; Glyn-Jones S, 2008, J BONE JOINT SURG BR, V90B, P556, DOI 10.1302/0301-620X.90B5.20545; D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P143, DOI 10.1097/01.blo.0000194090.77500.b4; Bragdon CR, 2006, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000224012.50292.67; Capello WN, 2011, CLIN ORTHOP RELAT R, V469, P825, DOI 10.1007/s11999-010-1556-5; Digas Georgios, 2005, Acta Orthop Suppl, V76, P3; Digas G, 2004, CLIN ORTHOP RELAT RE, V429; Hamaji H, 2008, J ORTHOP SCI, V13, P425, DOI 10.1007/s00776-008-1263-1; Maruyama M., 1993, B HOSP JOINT DIS, V53, P37; Maruyama M, 2013, 12 ASS FRANC JAP ORT; Maruyama M, 2000, CLIN ORTHOP RELAT R, P183; Moore KD, 2008, J BONE JOINT SURG AM, V90A, P2499, DOI 10.2106/JBJS.G.01304; Moore KD, 2000, J BONE JOINT SURG AM, V82A, P62; Sychterz CJ, 1999, CLIN ORTHOP RELAT R, P117; Vandenbussche E, 2010, ACTA ORTHOP, V81, P563, DOI 10.3109/17453674.2010.519163; Wroblewski M, 2004, J ORTHOP SCI, V9, P253, DOI 10.1007/s00776-004-0777-4	18	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2415	2419		10.1016/j.arth.2014.02.010		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900038		
J	Iwase, T; Ito, T; Morita, D				Iwase, Toshiki; Ito, Tadashi; Morita, Daigo			Massive Bone Defect Compromises Postoperative Cup Survivorship of Acetabular Revision Hip Arthroplasty with Impaction Bone Grafting	JOURNAL OF ARTHROPLASTY			English	Article						impaction bone grafting; allograft; acetabulum; revision total hip arthroplasty; survival rate	FOLLOW-UP; REINFORCEMENT DEVICE; CEMENTED CUP; RECONSTRUCTION; REPLACEMENT; ALLOGRAFTS; MANAGEMENT; COMPONENTS; AUGMENTS; SURVIVAL	We evaluated 66 acetabular revision arthroplasties using cemented cup with impaction bone grafting (IBG) to detect the extent that bone defect affects the outcome. We defined the maximum acetabular defect distance (MADD), which indicates the greatest depth of the grafted layer. Cup survival analysis with aseptic loosening as the endpoint revealed that the "MADD <= 20 mm" group showed higher survivorship than the "MADD > 20 mm" group (95% vs. 74%, P = 0.034), and that the simple-wall-defect group (none or one mesh used) showed higher survivorship than the complex-wall-defect group (two meshes used) (96% vs. 73%, P = 0.044). A favorable indication for acetabular IBG reconstruction is cases in which those cups can be placed at <= 20 mm MADD with a simple wall defect. (C) 2014 Elsevier Inc. All rights reserved.	[Iwase, Toshiki; Ito, Tadashi; Morita, Daigo] Hamamatsu Med Ctr, Dept Orthopaed Surg, Hamamatsu, Shizuoka, Japan	Iwase, T (reprint author), Hamamatsu Med Ctr, Dept Orthopaed Surg, Naka Ku, 328 Tomitsuka Cho, Hamamatsu, Shizuoka 4328580, Japan.	tossy.iwase@gmail.com					Kerboull M, 2000, CLIN ORTHOP RELAT R, P155; Garcia-Cimbrelo E, 2010, CLIN ORTHOP RELAT R, V468, P3304, DOI 10.1007/s11999-010-1395-4; Slooff TJJH, 1996, CLIN ORTHOP RELAT R, P108; Borland WS, 2012, ACTA ORTHOP, V83, P347, DOI 10.3109/17453674.2012.718518; Busch VJJF, 2011, J BONE JOINT SURG AM, V93A, P367, DOI [10.2106/JBJS.I.01532, 10.2106/JBJSJ.01532]; Gill K, 2013, HIP INT, V23, P522, DOI 10.5301/hipint.5000053; Okano K, 2010, J ARTHROPLASTY, V25, P594, DOI 10.1016/j.arth.2009.04.003; van der Donk S, 2002, CLIN ORTHOP RELAT R, P131; SLOOFF TJJH, 1984, ACTA ORTHOP SCAND, V55, P593, DOI 10.3109/17453678408992402; Kawanabe K, 2007, J BONE JOINT SURG BR, V89B, P26, DOI 10.1302/0301-620X.89B1.18037; Mandziak DG, 2007, J ARTHROPLASTY, V22, P1000, DOI 10.1016/j.arth.2007.06.001; Akiyama H, 2011, J ORTHOP SCI, V16, P26, DOI 10.1007/s00776-010-0007-1; Lachiewicz PE, 2013, J BONE JOINT SURG AM, V95A, P543, DOI [10.2106/JBJS.L.00758, 10.2106/JBJS.L.0758]; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451; [Anonymous], 2013, TREATMENT OSTEOARTHR; van Haaren EH, 2007, J BONE JOINT SURG BR, V89B, P296, DOI 10.1302/0301-620X.89B3.18080; GIE GA, 1993, J BONE JOINT SURG BR, V75, P14; Comba F, 2006, J BONE JOINT SURG BR, V88B, P865, DOI 10.1302/0301-620X.88B7.17227; Buttaro MA, 2008, CLIN ORTHOP RELAT R, V466, P2482, DOI 10.1007/s11999-008-0442-x; Hooten JP, 1996, J BONE JOINT SURG BR, V78B, P270; Schreurs BW, 2009, J BONE JOINT SURG BR, V91B, P1148, DOI 10.1302/0301-620X.91B9.21750; Civinini R, 2008, INT ORTHOP, V32, P189, DOI 10.1007/s00264-006-0307-4; Board TN, 2006, J BONE JOINT SURG BR, V88B, P852, DOI 10.1302/0301-620X.88B7.17425; DANTONIO JA, 1989, CLIN ORTHOP RELAT R, P126; DELEE JG, 1976, CLIN ORTHOP RELAT R, P20; Fukui K, 2011, HIP INT, V21, P311, DOI 10.5301/HIP.2011.8395; GROSS AE, 1995, CLIN ORTHOP RELAT R, P151; Herrera A, 2006, J ARTHROPLASTY, V21, P857, DOI 10.1016/j.arth.2005.08.026; HODGKINSON JP, 1988, CLIN ORTHOP RELAT R, P105; Ito H, 2010, J ARTHROPLASTY, V25, P1307, DOI 10.1016/j.arth.2009.10.012; Iwase T, 2010, ARCH ORTHOP TRAUM SU, V130, P433, DOI 10.1007/s00402-009-0904-y; Iwase T, 2012, ARCH ORTHOP TRAUM SU, V132, P1487, DOI 10.1007/s00402-012-1561-0; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Pagnano W, 1996, J Bone Joint Surg Am, V78, P1004; Rees HW, 2012, J ARTHROPLASTY, V27, P41, DOI 10.1016/j.arth.2011.04.004	35	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2424	2429		10.1016/j.arth.2014.04.001		6	Orthopedics	Orthopedics	AT7YP	WOS:000345150900040		
J	Fuji, T; Wang, CJ; Fujita, S; Kawai, Y; Kimura, T; Tachibana, S				Fuji, T.; Wang, C. -J.; Fujita, S.; Kawai, Y.; Kimura, T.; Tachibana, S.			Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, for Thromboprophylaxis After Total Hip Arthroplasty in Japan and Taiwan	JOURNAL OF ARTHROPLASTY			English	Article						edoxaban; factor Xa inhibitor; thromboembolic events; total hip arthroplasty; enoxaparin	TOTAL KNEE ARTHROPLASTY; VENOUS THROMBOEMBOLISM; REPLACEMENT; PREVENTION; WARFARIN	Edoxaban, an oral direct factor Xa inhibitor, has proven antithrombotic efficacy. In a multicenter, phase II study, 264 total hip arthroplasty (THA) patients randomly received edoxaban 15 or 30 mg once daily or enoxaparin 2000 IU (20-mg) twice daily for 11-14 days. Thromboembolic event incidences were 3.8% (3/78), 2.8% (2/72), and 4.1% (3/74) for edoxaban 15-mg, 30-mg, and enoxaparin, respectively (P = 1.00). Edoxaban-induced prolongation of prothrombin time, international normalized ratio, and activated partial thromboplastin time were proportional to plasma edoxaban concentration. Major or clinically relevant non-major bleeding incidences were 2.2% (2/89), 1.2% (1/85), and 2.3% (2/87) for edoxaban 15-mg, 30-mg, and enoxaparin, respectively (P = 1.00). Once-daily edoxaban showed similar efficacy and safety to enoxaparin for prevention of thromboembolic events in patients undergoing THA. (c) 2014 The Authors. Published by Elsevier Inc.	[Fuji, T.] Osaka Hosp, Dept Orthopaed Surg, Japan Community Hlth Care Org, Osaka, Japan; [Wang, C. -J.] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Orthoped Surg, Kaohsiung, Taiwan; [Fujita, S.] Takarazuka Daiichi Hosp, Dept Orthoped Surg, Takarazuka, Hyogo, Japan; [Kawai, Y.] Int Univ Hlth & Welf, Tokyo, Japan; [Kimura, T.] Daiichi Sankyo Co Ltd, Clin Planning Dept, Tokyo, Japan; [Tachibana, S.] Mishuku Hosp, Tokyo, Japan	Fuji, T (reprint author), 4-2-78 Fukushima,Fukushima Ku, Osaka 5530003, Japan.				Daiichi Sankyo Co., Ltd. (Tokyo, Japan)	This study (ClinicalTrials.gov Identifier: NCT01203098) was sponsored by Daiichi Sankyo Co., Ltd. (Tokyo, Japan). The study sponsors were involved in the design of the study and the collection and analysis of the data. The authors would like to acknowledge writing assistance provided by Sameena Azmi, PhD, as well as editorial assistance by Innovex Medical Communications and by Scarlett Geunes-Boyer, PhD, of AlphaBioCom, LLC.	Eriksson BI, 2006, CIRCULATION, V114, P2374, DOI 10.1161/CIRCULATIONAHA.106.642074; Fuji T, 2008, J ORTHOP SCI, V13, P442, DOI 10.1007/s00776-008-1264-0; Raskob G, 2010, THROMB HAEMOSTASIS, V104, P642, DOI 10.1160/TH10-02-0142; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Turpie AGG, 2007, ARTERIOSCL THROM VAS, V27, P1238, DOI 10.1161/ATVBAHA.107.139402; Fuji T, 2008, INT ORTHOP, V32, P443, DOI 10.1007/s00264-007-0360-7; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Fujita S, 2000, CLIN ORTHOP RELAT R, P168; Furugohri T, 2008, J THROMB HAEMOST, V6, P1542, DOI 10.1111/j.1538-7836.2008.03064.x; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Matsushima N, 2013, CLIN PHARM DRUG DEV, V2, P358, DOI 10.1002/cpdd.53	15	5	5	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2439	2446		10.1016/j.arth.2014.05.029		8	Orthopedics	Orthopedics	AT7YP	WOS:000345150900042		
J	Tanikawa, H; Sato, T; Nagafuchi, M; Takeda, K; Oshida, J; Okuma, K				Tanikawa, Hidenori; Sato, Tomoyuki; Nagafuchi, Mari; Takeda, Kentaro; Oshida, Junya; Okuma, Kazunari			Comparison of Local Infiltration of Analgesia and Sciatic Nerve Block in Addition to Femoral Nerve Block for Total Knee Arthroplasty	JOURNAL OF ARTHROPLASTY			English	Article						sciatic nerve block; local infiltration of analgesia; femoral nerve block; total knee arthroplasty; rehabilitation	RANDOMIZED CONTROLLED-TRIAL; POSTOPERATIVE ANALGESIA; SINGLE-INJECTION; PERIARTICULAR INFILTRATION; ULTRASOUND GUIDANCE; EPIDURAL ANALGESIA; PAIN-CONTROL; FUNCTIONAL RECOVERY; BRACHIAL-PLEXUS; CLINICAL-TRIAL	We conducted a prospective randomized controlled trial to test the null hypothesis that there is no difference between sciatic nerve block (SNB) and local infiltration of analgesia (LIA) regarding postoperative analgesia after total knee arthroplasty (TKA), when administrated in addition to femoral nerve block (FNB). Forty-six patients scheduled for TKA were randomized into two groups: concomitant administration of FNB and SNB or FNB and LIA. Average pain scores during the first 21 days after surgery were similar in the two groups and remained at low level. There was no significant difference in the need for adjuvant analgesics, patient satisfaction level, the time to achieve rehabilitation goals, and length of hospital stay. The LIA offers a potentially safer alternative to SNB as an adjunct to FNB. (c) 2014 Elsevier Inc. All rights reserved.	[Tanikawa, Hidenori; Takeda, Kentaro; Okuma, Kazunari] Saitama City Hosp, Dept Orthopaed Surg, Saitama 3368522, Japan; [Sato, Tomoyuki; Nagafuchi, Mari; Oshida, Junya] Saitama City Hosp, Dept Anesthesiol, Saitama 3368522, Japan	Tanikawa, H (reprint author), Saitama City Hosp, Dept Orthopaed Surg, Midori Ku, 2460 Mimuro, Saitama 3368522, Japan.						Allen HW, 1998, ANESTH ANALG, V87, P93, DOI 10.1097/00000539-199807000-00020; Wegener JT, 2011, REGION ANESTH PAIN M, V36, P481, DOI 10.1097/AAP.0b013e318228c33a; Mahadevan D, 2012, J ARTHROPLASTY, V27, P1806, DOI 10.1016/j.arth.2012.05.018; Spreng UJ, 2010, BRIT J ANAESTH, V105, P675, DOI 10.1093/bja/aeq232; Andersen LO, 2008, ACTA ORTHOP, V79, P806, DOI 10.1080/17453670810016894; Affas F, 2011, ACTA ORTHOP, V82, P441, DOI 10.3109/17453674.2011.581264; Koh IJ, 2010, KNEE SURG SPORT TR A, V18, P916, DOI 10.1007/s00167-010-1051-2; Gomez-Cardero P, 2010, CLIN ORTHOP RELAT R, V468, P1242, DOI 10.1007/s11999-009-1202-2; Singelyn FJ, 1998, ANESTH ANALG, V87, P88, DOI 10.1097/00000539-199807000-00019; Capdevila X, 1999, ANESTHESIOLOGY, V91, P8, DOI 10.1097/00000542-199907000-00006; Busch CA, 2006, J BONE JOINT SURG AM, V88A, P959, DOI 10.2106/JBJS.E.00344; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Ritter MA, 1999, J BONE JOINT SURG BR, V81B, P301, DOI 10.1302/0301-620X.81B2.9110; Perlas A, 2008, REGION ANESTH PAIN M, V33, P259, DOI 10.1016/j.rapm.2007.10.010; Morin AM, 2005, REGION ANESTH PAIN M, V30, P434, DOI 10.1016/j.rapm.2005.05.006; Salinas FV, 2006, ANESTH ANALG, V102, P1234, DOI 10.1213/01.ane.0000198675.20279.81; Casati A, 2007, BRIT J ANAESTH, V98, P823, DOI 10.1093/bja/aem100; Sharma S, 2010, CLIN ORTHOP RELAT R, V468, P135, DOI 10.1007/s11999-009-1025-1; Wang H, 2002, REGION ANESTH PAIN M, V27, P139, DOI 10.1053/rapm.2002.29253; Gibbs DMR, 2012, J BONE JOINT SURG BR, V94B, P1154, DOI 10.1302/0301-620X.94B9.28611; Auroy Y, 2002, ANESTHESIOLOGY, V97, P1274, DOI 10.1097/00000542-200211000-00034; Mariano ER, 2010, CAN J ANESTH, V57, P919, DOI 10.1007/s12630-010-9364-7; Ashraf A, 2013, KNEE, V20, P324, DOI 10.1016/j.knee.2013.04.009; Toftdahl K, 2007, ACTA ORTHOP, V78, P172, DOI 10.1080/17453670710013645; Chinachoti Thitima, 2012, Journal of the Medical Association of Thailand, V95, P1536; Vendittoli PA, 2006, J BONE JOINT SURG AM, V88A, P282, DOI 10.2106/JBJS.E.00173; Schinsky MF, 2001, J ARTHROPLASTY, V16, P1048, DOI 10.1054/arth.2001.26591; Fischer HBJ, 2008, ANAESTHESIA, V63, P1105, DOI 10.1111/j.1365-2044.2008.05565.x; Wasserstein D, 2013, J ARTHROPLASTY, V28, P1121, DOI 10.1016/j.arth.2012.08.018; Davies AF, 2004, BRIT J ANAESTH, V93, P368, DOI 10.1093/bja/aeh224; Andersen KV, 2010, ACTA ORTHOP, V81, P606, DOI 10.3109/17453674.2010.519165; Ben-David B, 2004, ANESTH ANALG, V98, P747; Carli F, 2010, BRIT J ANAESTH, V105, P185, DOI 10.1093/bja/aeq112; HORLOCKER TT, 1994, ANESTH ANALG, V79, P495; Andersen LO, 2008, ACTA ANAESTH SCAND, V52, P1331, DOI 10.1111/j.1399-6576.2008.01777.x; Cook P, 2003, J ARTHROPLASTY, V18, P583, DOI 10.1016/S0883-5403(03)00198-0; Duarte Victor M, 2006, J Perianesth Nurs, V21, P311, DOI 10.1016/j.jopan.2006.05.011; Hirst GC, 1996, REGION ANESTH, V21, P292; McNamee DA, 2002, ACTA ANAESTH SCAND, V46, P95, DOI 10.1034/j.1399-6576.2002.460117.x; Nielsen KC, 2003, CAN J ANAESTH, V50, P57; Ong Johnny C A, 2010, J Orthop Surg (Hong Kong), V18, P203; Orebaugh SL, 2007, REGION ANESTH PAIN M, V32, P448, DOI 10.1016/j.rapm.2007.05.004; Paauwe JJ, 2008, ANAESTHESIA, V63, P948, DOI 10.1111/j.1365-2044.2008.05538.x; TIERNEY E, 1987, CAN J ANAESTH, V34, P455; Weber A, 2002, EUR J ANAESTH, V19, P834, DOI 10.1017/S0265021502221353; WilliamsRusso P, 1996, CLIN ORTHOP RELAT R, P199; Yang WT, 1998, AM J ROENTGENOL, V171, P1631	47	1	2	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2462	2467		10.1016/j.arth.2014.04.011		6	Orthopedics	Orthopedics	AT7YP	WOS:000345150900046		
J	Fukui, K; Kaneuji, A; Fukushima, M; Matsumoto, T				Fukui, Kiyokazu; Kaneuji, Ayumi; Fukushima, Mana; Matsumoto, Tadami			Inversion of the Acetabular Labrum Triggers Rapidly Destructive Osteoarthritis of the Hip: Representative Case Report and Proposed Etiology	JOURNAL OF ARTHROPLASTY			English	Article						inversion; acetabular labrum; rapidly destructive osteoarthritis of the hip; joint-space narrowing; subchondral insufficiency fracture	SUBCHONDRAL INSUFFICIENCY FRACTURE; FINITE-ELEMENT MODEL; BONE-MINERAL DENSITY; FEMORAL-HEAD; JOINT; ARTHROPATHY; DIAGNOSIS; ARTHRITIS; ARTHROSIS; SEAL	The pathophysiology of rapidly destructive osteoarthritis (OA) of the hip is unknown. This study documented cases of inversion of the acetabular labrum, which has clinicoradiologic features similar to those of initial-stage rapidly destructive hip OA. Our study was based on a prospective review of data for 9 patients with rapidly destructive hip OA. Intraoperative findings showed that the anterosuperior portion of the acetabular labrum had inverted into the articular space, along with many fragments of articular cartilage, in all patients. Subchondral insufficiency fractures of the femoral heads were seen just under the inverted labra in 8 of the 9 patients. Inversion of the acetabular labrum may be involved in rapid joint-space narrowing and subchondral insufficiency fracture in rapidly destructive hip OA. (c) 2014 Elsevier Inc. All rights reserved.	[Fukui, Kiyokazu; Kaneuji, Ayumi; Matsumoto, Tadami] Kanazawa Med Univ, Dept Orthopaed Surg, Uchinada, Ishikawa 9200293, Japan; [Fukushima, Mana] Kanazawa Med Univ, Dept Pathol & Med Lab, Uchinada, Ishikawa 9200293, Japan	Fukui, K (reprint author), Kanazawa Med Univ, Dept Orthopaed Surg, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.						Crawford MJ, 2007, CLIN ORTHOP RELAT R, P16, DOI 10.1097/BLO.0b013e31815b181f; Yamamoto T, 1999, ARTHRITIS RHEUM, V42, P2719, DOI 10.1002/1529-0131(199912)42:12<2719::AID-ANR31>3.0.CO;2-X; Richette P, 2009, CLIN EXP RHEUMATOL, V27, P337; Ferguson SJ, 2000, CLIN BIOMECH, V15, P463, DOI 10.1016/S0268-0033(99)00099-6; Lin J, 2001, J WOMEN HEALTH GEN-B, V10, P699, DOI 10.1089/15246090152563588; Yamamoto T, 2002, AM J ROENTGENOL, V178, P435; Yamamoto T, 2000, ARTHRITIS RHEUM, V43, P2423, DOI 10.1002/1529-0131(200011)43:11<2423::AID-ANR8>3.0.CO;2-Z; Yamamoto T, 2000, AM J SURG PATHOL, V24, P464, DOI 10.1097/00000478-200003000-00017; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; Ferguson SJ, 2000, J BIOMECH, V33, P953, DOI 10.1016/S0021-9290(00)00042-7; ROBINSON DR, 1975, J CLIN INVEST, V56, P1181, DOI 10.1172/JCI108195; Yamamoto T, 2000, OSTEOARTHR CARTILAGE, V8, P303, DOI 10.1053/joca.1999.0305; MASSIE WK, 1950, J BONE JOINT SURG AM, V32-A, P519; Bobechko WP, 1973, P 12 C INT SOC ORTH, P18; DAVIES AM, 1991, BRIT J RADIOL, V64, P305; Forestier F, 1957, THESIS PARIS; Irwin LR, 1998, J ARTHROPLASTY, V13, P642, DOI 10.1016/S0883-5403(98)80007-7; KOMIYA S, 1992, CLIN ORTHOP RELAT R, P273; Lequesne M, 1970, RHUMATOLOGIE, V2, P51; MENKES CJ, 1976, ARTHRITIS RHEUM, V19, P329, DOI 10.1002/1529-0131(197605/06)19:3+<329::AID-ART1780190706>3.0.CO;2-Z; Okano K, 2014, J BONE MINER METAB, V32, P312, DOI 10.1007/s00774-013-0501-6; POSTEL M, 1970, CLIN ORTHOP RELAT R, P138; ROSENBERG ZS, 1992, RADIOLOGY, V182, P213; STAITE ND, 1990, ARTHRITIS RHEUM, V33, P253, DOI 10.1002/art.1780330215; Verhaegen MJA, 1999, ARCH ORTHOP TRAUM SU, V119, P115, DOI 10.1007/s004020050371; Wiberg G., 1939, ACTA CHIR SCAND, V83, P29; Yamamoto T, 2008, ANN RHEUM DIS, V67, P150, DOI 10.1136/ard.2006.066878; YOSHIKAWA T, 1994, J BONE MINER RES, V9, P1053	28	0	0	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2468	2472		10.1016/j.arth.2014.06.017		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900047		
J	Tamaki, T; Nimura, A; Oinuma, K; Shiratsuchi, H; Iida, S; Akita, K				Tamaki, Tatsuya; Nimura, Akimoto; Oinuma, Kazuhiro; Shiratsuchi, Hideaki; Iida, Satoshi; Akita, Keiichi			An Anatomic Study of the Impressions on the Greater Trochanter: Bony Geometry Indicates the Alignment of the Short External Rotator Muscles	JOURNAL OF ARTHROPLASTY			English	Article						total hip arthroplasty; anatomy; short external rotator muscles; anterior approach; greater trochanter	TOTAL HIP-ARTHROPLASTY; INCISION ANTERIOR APPROACH; FRACTURES; FEMUR	In this study, 44 hip regions from 25 embalmed cadavers were dissected to identify the bony landmarks on the greater trochanter, which indicate the individual short external rotator muscle insertions. Micro-computed tomography (micro-CT) images were obtained to identify the bony impressions on the greater trochanter. Then, the soft tissues were removed and their insertions were identified to assess correlation with micro-CT images. Bony landmarks indicating the insertions and the running course of the piriformis muscle, the obturator internus muscle, and the obturator externus muscle were identified on the greater trochanter in all specimens. These findings could be helpful for preserving muscles during capsular release in the anterior approach because the alignment of the short external rotator muscles can be estimated preoperatively using CT images. (c) 2014 Elsevier Inc. All rights reserved.	[Tamaki, Tatsuya; Nimura, Akimoto; Akita, Keiichi] Tokyo Med & Dent Univ, Unit Clin Anat, Grad Sch Med & Dent Sci, Tokyo 1138519, Japan; [Tamaki, Tatsuya; Oinuma, Kazuhiro; Shiratsuchi, Hideaki] Funabashi Orthoped Hosp, Funabashi, Chiba, Japan; [Iida, Satoshi] Matsudo City Hosp, Dept Orthoped Surg, Matsudo, Chiba, Japan	Akita, K (reprint author), Tokyo Med & Dent Univ, Unit Clin Anat, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.						Kennon RE, 2003, J BONE JOINT SURG AM, V85A, P39; Papadakis SA, 2005, SURG RADIOL ANAT, V27, P223, DOI 10.1007/s00276-005-0316-9; WINQUIST RA, 1984, J BONE JOINT SURG AM, V66A, P529; Matta JM, 2005, CLIN ORTHOP RELAT R, P115, DOI 10.1097/01.blo.0000194309.70518.cb; Ricci WM, 2006, J ORTHOP TRAUMA, V20, P663, DOI 10.1097/01.bot.0000248472.53154.14; Burghardt AJ, 2011, CLIN ORTHOP RELAT R, V469, P2179, DOI 10.1007/s11999-010-1766-x; Ito Y, 2012, CLIN ORTHOP RELAT R, V470, P1690, DOI 10.1007/s11999-012-2266-y; KEMPF I, 1985, J BONE JOINT SURG AM, V67A, P709; Kim YS, 2008, CLIN ORTHOP RELAT R, V466, P294, DOI 10.1007/s11999-007-0056-8; Matsuura M, 2010, CLIN ORTHOP RELAT R, V468, P3201, DOI 10.1007/s11999-010-1349-x; Meneghini RM, 2006, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000238859.46615.34; Nogler M, 2006, J ARTHROPLASTY, V21, P1206, DOI 10.1016/j.arth.2006.08.003; Oinuma Kazuhiro, 2007, Oper Orthop Traumatol, V19, P310, DOI 10.1007/s00064-007-1209-3; Siguier T, 2004, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000136651.21191.9f	14	1	1	CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS	PHILADELPHIA	CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA	0883-5403	1532-8406		J ARTHROPLASTY	J. Arthroplast.	DEC	2014	29	12					2473	2477		10.1016/j.arth.2013.11.008		5	Orthopedics	Orthopedics	AT7YP	WOS:000345150900048		
J	Oshibe, T; Hayase, T; Funamoto, K; Shirai, A				Oshibe, Takashi; Hayase, Toshiyuki; Funamoto, Kenichi; Shirai, Atsushi			Numerical Analysis for Elucidation of Nonlinear Frictional Characteristics of a Deformed Erythrocyte Moving on a Plate in Medium Subject to Inclined Centrifugal Force	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						inclined centrifuge microscope; nonlinear frictional characteristics; deformed erythrocyte; material-coated glass plate; angle of attack; flow force; equilibrium state; numerical analysis; Navier-Stokes equation; lubrication theory	ENDOTHELIAL GLYCOCALYX	Complex interactions between blood cells, plasma proteins, and glycocalyx in the endothelial surface layer are crucial in microcirculation. To obtain measurement data of such interactions, we have previously performed experiments using an inclined centrifuge microscope, which revealed that the nonlinear velocity-friction characteristics of erythrocytes moving on an endothelia-cultured glass plate in medium under inclined centrifugal force are much larger than those on plain or material-coated glass plates. The purpose of this study was to elucidate the nonlinear frictional characteristics of an erythrocyte on plain or material-coated glass plates as the basis to clarify the interaction between the erythrocyte and the endothelial cells. We propose a model in which steady motion of the cell is realized as an equilibrium state of the force and moment due to inclined centrifugal force and hydrodynamic flow force acting on the cell. Other electrochemical effects on the surfaces of the erythrocyte and the plate are ignored for the sake of simplicity. Numerical analysis was performed for a three-dimensional flow of a mixture of plasma and saline around a rigid erythrocyte model of an undeformed biconcave shape and a deformed shape with a concave top surface and a flat bottom surface. A variety of conditions for the concentration of plasma in a medium, the velocity of the cell, and the minimum gap width and the angle of attack of the cell from the plate, were examined to obtain the equilibrium states. A simple flat plate model based on the lubrication theory was also examined to elucidate the physical meaning of the model. The equilibrium angle of attack was obtained only for the deformed cell model and was represented as a power function of the minimum gap width. A simple flat plate model qualitatively explains the power function relation of the frictional characteristics, but it cannot explain the equilibrium relation, confirming the computational result that the deformation of the cell is necessary for the equilibrium. The frictional characteristics obtained from the present computation qualitatively agree with those of former experiments, showing the validity of the proposed model.	[Oshibe, Takashi] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Hayase, Toshiyuki; Funamoto, Kenichi; Shirai, Atsushi] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Hayase, T (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	hayase@ifs.tohoku.ac.jp			 [23650252]	Part of this study was supported by a Grant-in-Aid for Challenging Exploratory Research (23650252). Computation in this study was performed at the Advanced Fluid Information Research Center, Institute of Fluid Science, Tohoku University.	Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Chappell D, 2009, CARDIOVASC RES, V83, P388, DOI 10.1093/cvr/cvp097; Squire JM, 2001, J STRUCT BIOL, V136, P239, DOI 10.1006/jsbi.2002.4441; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Schmid-Schonbein GW, 1999, ANNU REV BIOMED ENG, V1, P73, DOI 10.1146/annurev.bioeng.1.1.73; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6; Fung YC, 1996, BIOMECHANICS CIRCULA; Hayase T., 2006, 29 ANN C JAP SOC BIO, P47; Hayase T., 2005, 2005 SUMM BIOENG C V, P1; Hayase T., 2013, 8 INT C MULT FLOW JE, P1; Kandori T, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2948420; Lighthill S. J., 1975, MATH BIOFLUIDDYNAMIC; Oka S., 1984, BIORHEOLOGY; SCHLICHTING H., 1979, BOUNDARY LAYER THEOR; SUTERA SP, 1983, BLOOD CELLS, V9, P485	16	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2014	136	12							121003	10.1115/1.4028723		9	Biophysics; Engineering, Biomedical	Biophysics; Engineering	AT7ZU	WOS:000345154300003		
J	Hagiwara, D; Takahashi, H; Watanabe, A; Takahashi-Nakaguchi, A; Kawamoto, S; Kamei, K; Gonoi, T				Hagiwara, Daisuke; Takahashi, Hiroki; Watanabe, Akira; Takahashi-Nakaguchi, Azusa; Kawamoto, Susumu; Kamei, Katsuhiko; Gonoi, Tohru			Whole-Genome Comparison of Aspergillus fumigatus Strains Serially Isolated from Patients with Aspergillosis	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							OXIDATIVE STRESS-RESPONSE; PULMONARY ASPERGILLOSIS; MULTISPECIES CURATION; AZOLE RESISTANCE; CYP51A GENE; SUSCEPTIBILITY; DNA; ITRACONAZOLE; MUTATIONS; VIRULENCE	The emergence of azole-resistant strains of Aspergillus fumigatus during treatment for aspergillosis occurs by a mutation selection process. Understanding how antifungal resistance mechanisms evolve in the host environment during infection is of great clinical importance and biological interest. Here, we used next-generation sequencing (NGS) to identify mutations that arose during infection by A. fumigatus strains sequentially isolated from two patients, one with invasive pulmonary aspergillosis (IPA) (five isolations) and the other with aspergilloma (three isolations). The serial isolates had identical microsatellite types, but their growth rates and conidia production levels were dissimilar. A whole-genome comparison showed that three of the five isolates from the IPA patient carried a mutation, while 22 mutations, including six nonsynonymous ones, were found among three isolates from the aspergilloma patient. One aspergilloma isolate carried the cyp51A mutation P216L, which is reported to confer azole resistance, and it displayed an MIC indicating resistance to itraconazole. This isolate harbored five other nonsynonymous mutations, some of which were found in the afyap1 and aldA genes. We further identified a large deletion in the aspergilloma isolate in a region containing 11 genes. This finding suggested the possibility that genomic deletions can occur during chronic infection with A. fumigatus. Overall, our results revealed dynamic alterations that occur in the A. fumigatus genome within its host during infection and treatment.	[Hagiwara, Daisuke; Takahashi, Hiroki; Watanabe, Akira; Takahashi-Nakaguchi, Azusa; Kawamoto, Susumu; Kamei, Katsuhiko; Gonoi, Tohru] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Watanabe, Akira; Kamei, Katsuhiko] Chiba Univ Hosp, Div Control & Treatment Infect Dis, Chiba, Japan	Hagiwara, D (reprint author), Chiba Univ, Med Mycol Res Ctr, Chiba, Japan.	dhagi@chiba-u.jp	Takahashi, Hiroki/M-9169-2015		MEXT Special Budget for Research Projects; National BioResource Project for Pathogenic Microbes - Ministry of Education, Culture, Sports, Science and Technology, Japan; NEKKEN; The Project on Controlling Aspergillosis and the Related Emerging Mycoses	This study was supported by the MEXT Special Budget for Research Projects, The Project on Controlling Aspergillosis and the Related Emerging Mycoses, in part by the National BioResource Project for Pathogenic Microbes funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.nbrp.jp/), and in part by a Cooperative Research Grant of NEKKEN (2013).	Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Natesan SK, 2012, DIAGN MICR INFEC DIS, V74, P272, DOI 10.1016/j.diagmicrobio.2012.06.030; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Howard SJ, 2013, MYCOSES, V56, P434, DOI 10.1111/myc.12047; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Hornsey M, 2011, J ANTIMICROB CHEMOTH, V66, P1499, DOI 10.1093/jac/dkr168; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Camps SMT, 2012, ANTIMICROB AGENTS CH, V56, P10, DOI 10.1128/AAC.05088-11; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Ormerod KL, 2013, G3-GENES GENOM GENET, V3, P675, DOI 10.1534/g3.113.005660; Chen J, 2005, J ANTIMICROB CHEMOTH, V55, P31, DOI 10.1093/jac/dkh507; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Denning DW, 2001, CLIN MICROBIOL INFEC, V7, P25, DOI 10.1111/j.1469-0691.2001.tb00006.x; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Asano Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1800, DOI 10.1271/bbb.70133; Denning DW, 1997, ANTIMICROB AGENTS CH, V41, P1364; Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003; Vermeulen E, 2013, CURR OPIN INFECT DIS, V26, P493, DOI 10.1097/QCO.0000000000000005; Shimizu K, 2001, GENETICS, V157, P591; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Howard SJ, 2011, MED MYCOL, V49, pS90, DOI 10.3109/13693786.2010.508469; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Aronesty E, 2013, OPEN BIOINFORMATICS, V7, P1, DOI DOI 10.2174/1875036201307010001; Camps SMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050034; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; DENNING DW, 1991, J MED VET MYCOL, V29, P339; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Gillece JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028550; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Kikuchi K, 2014, J INFECT CHEMOTHER, V20, P336, DOI 10.1016/j.jiac.2014.01.003; Klaassen CHW, 2009, MED MYCOL, V47, pS27, DOI 10.1080/13693780802382244; Lelièvre L, 2013, Med Mal Infect, V43, P139, DOI 10.1016/j.medmal.2013.02.010; LOUDON KW, 1993, J CLIN MICROBIOL, V31, P1117; Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13; Qiao JJ, 2008, MED MYCOL, V46, P773, DOI 10.1080/13693780802054215; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Tashiro M, 2012, ANTIMICROB AGENTS CH, V56, P4870, DOI 10.1128/AAC.00514-12	46	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	DEC	2014	52	12					4202	4209		10.1128/JCM.01105-14		8	Microbiology	Microbiology	AT9BM	WOS:000345222900013		
J	Srilohasin, P; Chaiprasert, A; Tokunaga, K; Nishida, N; Prammananan, T; Smittipat, N; Mahasirimongkol, S; Chaiyasirinroje, B; Yanai, H; Palittapongarnpim, P				Srilohasin, Prapaporn; Chaiprasert, Angkana; Tokunaga, Katsushi; Nishida, Nao; Prammananan, Therdsak; Smittipat, Nat; Mahasirimongkol, Surakameth; Chaiyasirinroje, Boonchai; Yanai, Hideki; Palittapongarnpim, Prasit			Genetic Diversity and Dynamic Distribution of Mycobacterium tuberculosis Isolates Causing Pulmonary and Extrapulmonary Tuberculosis in Thailand	JOURNAL OF CLINICAL MICROBIOLOGY			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; BEIJING GENOTYPE; POPULATION-STRUCTURE; FAMILY; IDENTIFICATION; ASSOCIATION; RESISTANCE; EMERGENCE; MIGRATION; COUNTRIES	This study examined the genetic diversity and dynamicity of circulating Mycobacterium tuberculosis strains in Thailand using nearly neutral molecular markers. The single nucleotide polymorphism (SNP)-based genotypes of 1,414 culture-positive M. tuberculosis isolates from 1,282 pulmonary tuberculosis (PTB) and 132 extrapulmonary TB (EPTB) patients collected from 1995 to 2011 were characterized. Among the eight SNP cluster groups (SCG), SCG2 (44.1%), which included the Beijing (BJ) genotype, and SCG1 (39.4%), an East African Indian genotype, were dominant. Comparisons between the genotypes of M. tuberculosis isolates causing PTB and EPTB in HIV-negative cases revealed similar prevalence trends although genetic diversity was higher in the PTB patients. The identification of 10 reported sequence types (STs) and three novel STs was hypothesized to indicate preferential expansion of the SCG2 genotype, especially the modern BJ ST10 (15.6%) and ancestral BJ ST19 (13.1%). An association between SCG2 and SCG1 genotypes and particular patient age groups implies the existence of different genetic advantages among the bacterial populations. The results revealed that increasing numbers of young patients were infected with M. tuberculosis SCGs 2 and 5, which contrasts with the reduction of the SCG1 genotype. Our results indicate the selection and dissemination of potent M. tuberculosis genotypes in this population. The determination of heterogeneity and dynamic population changes of circulating M. tuberculosis strains in countries using the Mycobacterium bovis BCG (bacillus Calmette-Guerin) vaccine are beneficial for vaccine development and control strategies.	[Srilohasin, Prapaporn; Chaiprasert, Angkana] Mahidol Univ, Dept Microbiol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Nishida, Nao] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Prammananan, Therdsak; Smittipat, Nat] Minist Sci & Technol, Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Mahasirimongkol, Surakameth] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Med Genet Sect, Nonthaburi, Thailand; [Chaiyasirinroje, Boonchai; Yanai, Hideki] Res Inst TB, TB HIV Res Project, Chiang Rai, Thailand; [Yanai, Hideki] Japan Anti TB Assoc, Fukujuji Hosp, Tokyo, Japan; [Palittapongarnpim, Prasit] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand	Chaiprasert, A (reprint author), Mahidol Univ, Dept Microbiol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.	angkana.cha@mahidol.ac.th			Japan Science and Technology Agency (JST); National Science and Technology Development Agency (NSTDA) [P-12-01777]; Mahidol University Research Fund; Siriraj Graduate Thesis Scholarship; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0315/2551]; Chalermprakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University; Ministry of Health, Labor and Welfare of Japan	This study was supported by grants from a collaborative research project of the Japan Science and Technology Agency (JST) and National Science and Technology Development Agency (NSTDA) (grant no. P-12-01777), the Mahidol University Research Fund, Siriraj Graduate Thesis Scholarship, and the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (grant no. PHD/0315/2551) to P.S. (student) and A.C. (advisor). A.C. was also supported by a Chalermprakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University. Sample collections in Chiang Rai were supported by various sources including funding from Ministry of Health, Labor and Welfare of Japan.	Yorsangsukkamol J, 2009, TUBERCULOSIS, V89, P304, DOI 10.1016/j.tube.2009.05.001; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Faksri K, 2011, TUBERCULOSIS, V91, P594, DOI 10.1016/j.tube.2011.08.005; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Buu TN, 2009, INT J TUBERC LUNG D, V13, P900; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Lari N, 2009, CLIN MICROBIOL INFEC, V15, P538, DOI 10.1111/j.1469-0691.2009.02712.x; HERMANS PWM, 1995, J INFECT DIS, V171, P1504; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Abebe F, 2006, CLIN EXP IMMUNOL, V145, P389, DOI 10.1111/j.1365-2249.2006.03162.x; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234; Razanamparany VR, 2002, J CLIN MICROBIOL, V40, P3964, DOI 10.1128/JCM.40.11.3964-3969.2002; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Phyu S, 2009, J CLIN MICROBIOL, V47, P335, DOI 10.1128/JCM.01812-08; Batieha A, 1998, J TROP PEDIATRICS, V44, P288, DOI 10.1093/tropej/44.5.288; Bonah Christian, 2005, Stud Hist Philos Biol Biomed Sci, V36, P696, DOI 10.1016/j.shpsc.2005.09.003; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792; Cheunoy W, 2009, APMIS, V117, P286, DOI 10.1111/j.1600-0463.2009.02438.x; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Faksri K, 2011, INFECT GENET EVOL, V11, P1142, DOI 10.1016/j.meegid.2011.04.007; Fenner L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003318; Gomes T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074517; HILL EB, 1972, J BACTERIOL, V112, P1033; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; LAURO D, 1988, INT MIGR, V26, P301; NGUYEN VAT, 2012, PLOS ONE, V0007; PALITTAPONGARNPIM P, 1993, TUBERCLE LUNG DIS, V74, P204, DOI 10.1016/0962-8479(93)90013-N; Palittapongarnpim P, 1997, INT J TUBERC LUNG D, V1, P370; Pang Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-354; Payanandana V, 1999, BATTLE TB NATL TUBER; Pheiffer C, 2005, MICROBIOL-SGM, V151, P1139, DOI 10.1099/mic.0.27518-0; Prodinger WM, 2001, EMERG INFECT DIS, V7, P483; Rienthong D, 2005, INT J TUBERC LUNG D, V9, P576; Srilohasin P, 2014, J CLIN MICROBIOL, V52, P1962, DOI 10.1128/JCM.00153-14; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	41	3	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	DEC	2014	52	12					4267	4274		10.1128/JCM.01467-14		8	Microbiology	Microbiology	AT9BM	WOS:000345222900022		
J	Tsukamoto, K; Panei, CJ; Shishido, M; Noguchi, D; Pearce, J; Kang, HM; Jeong, OM; Lee, YJ; Nakanishi, K; Ashizawa, T				Tsukamoto, Kenji; Panei, Carlos Javier; Shishido, Makiko; Noguchi, Daigo; Pearce, John; Kang, Hyun-Mi; Jeong, Ok Mi; Lee, Youn-Jeong; Nakanishi, Koji; Ashizawa, Takayoshi			SYBR Green-Based Real-Time Reverse Transcription-PCR for Typing and Subtyping of All Hemagglutinin and Neuraminidase Genes of Avian Influenza Viruses and Comparison to Standard Serological Subtyping Tests (vol 50, pg 37, 2012)	JOURNAL OF CLINICAL MICROBIOLOGY			English	Correction									[Tsukamoto, Kenji; Panei, Carlos Javier; Shishido, Makiko; Noguchi, Daigo] Natl Inst Anim Hlth, Res Team Zoonot Dis, Tsukuba, Ibaraki 305, Japan; [Pearce, John] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Kang, Hyun-Mi; Jeong, Ok Mi; Lee, Youn-Jeong] Natl Vet Res & Quarantine Serv, Avian Dis Div, Anyangsi, Gyeonggido, South Korea; [Nakanishi, Koji] Livestock Hyg Serv Ctr Shiga Prefecture, Omihachiman, Shiga, Japan; [Ashizawa, Takayoshi] Tyuou Livestock Hyg Serv Ctr Chiba Prefecture, Sakura, Chiba, Japan	Tsukamoto, K (reprint author), Natl Inst Anim Hlth, Res Team Zoonot Dis, Tsukuba, Ibaraki 305, Japan.						LEE YJ, 2012, SYBR GREEN BASED REA, V50, P37	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0095-1137	1098-660X		J CLIN MICROBIOL	J. Clin. Microbiol.	DEC	2014	52	12					4453	4453		10.1128/JCM.02779-14		1	Microbiology	Microbiology	AT9BM	WOS:000345222900074		
J	Takeda, M; Kasai, T; Enomoto, Y; Takano, M; Morita, K; Nakai, T; Iizuka, N; Maruyama, H; Ohbayashi, C				Takeda, Maiko; Kasai, Takahiko; Enomoto, Yasunori; Takano, Masato; Morita, Kohei; Nakai, Tokiko; Iizuka, Norishige; Maruyama, Hiroshi; Ohbayashi, Chiho			Comparison of genomic abnormality in malignant mesothelioma by the site of origin	JOURNAL OF CLINICAL PATHOLOGY			English	Article							PLEURAL MESOTHELIOMA; DELTA-CATENIN; FISH ANALYSIS; LUNG-CANCER; E-CADHERIN; EXPRESSION; GENE; HYBRIDIZATION; PERITONEAL; CARCINOMA	Aims Malignant mesothelioma (MM) results from the accumulation of a number of acquired genetic events at the onset. In MM, the most frequent changes are losses in 9p21, 1p36, 22q12 and 14q32, and gains in 5p, 7p and 8q24 by comparative genomic hybridisation analysis. We have examined various genomic losses and gains in MM and benign mesothelial proliferation by fluorescence in situ hybridisation (FISH) analysis. 9p21 deletion was reported to be less frequent in peritoneal than in pleural MMs. This study analysed various genomic losses and gains in MM by the site of origin using FISH analysis. Materials and methods We performed FISH analysis using paraffin-embedded tissues from 54 cases (40 pleural and 14 peritoneal) of MMs and compared the frequency of genomic abnormality by the site of origin. Results 9p21 deletion was shown in 34 of 40 cases (85%) of pleural MMs, and was less frequent in five of 14 cases (36%) of peritoneal MMs (p<0.001) by FISH analysis. By contrast, 5p15 and 7p12 amplification was more significantly frequent in peritoneal than in pleural MMs. No difference between the two sites of MM in other genes was found. Conclusions 9p21 homozygous deletion assessed by FISH has been reported to be useful for differentiating MM from reactive mesothelial proliferation, but it should be noted that 9p21 deletion was less frequent in peritoneal MM. Our study suggests that the pathway of the genetic abnormality might vary between pleural and peritoneal MM.	[Takeda, Maiko; Kasai, Takahiko; Enomoto, Yasunori; Takano, Masato; Morita, Kohei; Nakai, Tokiko; Ohbayashi, Chiho] Nara Med Univ, Dept Diagnost Pathol, Kashihara, Nara 6348521, Japan; [Kasai, Takahiko] Univ Occupat & Environm Hlth, Dept Pathol & Oncol, Kitakyushu, Fukuoka 807, Japan; [Iizuka, Norishige] Kishiwada City Hosp, Dept Lab Med & Pathol, Kashihara, Osaka, Japan; [Maruyama, Hiroshi] Hoshigaoka Med Ctr, Dept Pathol, Hirakata, Osaka, Japan	Takeda, M (reprint author), Nara Med Univ, Dept Diagnost Pathol, Shijo Cho 840, Kashihara, Nara 6348521, Japan.	maikot@naramed-u.ac.jp					Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472/CAN-05-3907; Yoshikawa Y, 2012, CANCER SCI, V103, P868, DOI 10.1111/j.1349-7006.2012.02223.x; Burger MJ, 2002, INT J CANCER, V100, P228, DOI 10.1002/ijc.10468; Trupiano JK, 2004, MODERN PATHOL, V17, P476, DOI 10.1038/modpathol.3800067; Krismann M, 2002, J PATHOL, V197, P363, DOI 10.1002/path.1128; Takeda M, 2010, PATHOL INT, V60, P395, DOI 10.1111/j.1440-1827.2010.02534.x; Nemoto H, 2012, CANCER GENET-NY, V205, P594, DOI 10.1016/j.cancergen.2012.08.005; Singhal S, 2003, CLIN CANCER RES, V9, P3080; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742; Ivanov SV, 2009, INT J CANCER, V124, P589, DOI 10.1002/ijc.23949; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Takeda M, 2012, J CLIN PATHOL, V65, P77, DOI 10.1136/jclinpath-2011-200208; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Bjorkqvist AM, 1998, BRIT J CANCER, V77, P260, DOI 10.1038/bjc.1998.42; Enomoto Y, 2012, PATHOL INT, V62, P226, DOI 10.1111/j.1440-1827.2011.02778.x; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; BROWNE K, 1983, BRIT J IND MED, V40, P145; Bubendorf L, 2005, AM J CLIN PATHOL, V123, P516, DOI 10.1309/F5ADJUWVD2WFL8J5; Chinosea S, 2008, MODERN PATHOL, V21, P242; Chung Y, 2007, ANN SURG ONCOL, V14, P3260, DOI 10.1245/s10434-007-9511-8; Fang Y, 2004, J CANCER RES CLIN, V138, P1769; Hesdorffer ME, 2008, CURR TREAT OPTION ON, V9, P180, DOI 10.1007/s11864-008-0072-2; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jean D, 2011, AM J PATHOL, V178, P881, DOI 10.1016/j.ajpath.2010.10.039; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Musti M, 2006, CANCER GENET CYTOGEN, V170, P9, DOI 10.1016/j.jcancergencyto.2006.04.011; Sandberg AA, 2001, CANCER GENET CYTOGEN, V127, P93, DOI 10.1016/S0165-4608(01)00432-0; Takeshima Y, 2009, HISTOPATHOLOGY, V54, P667, DOI 10.1111/j.1365-2559.2009.03298.x; Travis WD, 2004, WHO CLASSIFICATION T	30	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	DEC	2014	67	12					1038	1043		10.1136/jclinpath-2014-202465		6	Pathology	Pathology	AT9ZA	WOS:000345281400004		
J	Tsugiyuki, O; Nakada, M; Miyano, Y				Tsugiyuki, Okuya; Nakada, Masayuki; Miyano, Yasushi			Temperature dependence of longitudinal tensile strength in unidirectional carbon fiber-reinforced plastic	JOURNAL OF COMPOSITE MATERIALS			English	Article						Carbon fiber-reinforced plastics; resin-impregnated carbon fiber strand; tensile strength; temperature dependence	FATIGUE LIFE; CFRP; COMPOSITES; PREDICTION; BEHAVIOR	This paper is concerned with the characteristics of the temperature-dependent tensile strength along the longitudinal direction of the unidirectional carbon fiber-reinforced plastic. The temperature-dependent tensile strength of the unidirectional carbon fiber-reinforced plastic was evaluated using resin-impregnated carbon fiber strand (carbon fiber-reinforced plastic strand) specimens with highly reliable co-cured tabs developed by the authors. The tensile strength of carbon fiber-reinforced plastic strand was measured at three constant temperatures below the glass transition temperature of the matrix resin for 50 specimens at each temperature. The results showed that the tensile strength of the unidirectional carbon fiber-reinforced plastic has a Weibull distribution at each temperature. The shape parameter of the tensile strength does not change with the temperatures and the scale parameter decreases clearly with increasing temperature. The degradation rate of the tensile strength of the unidirectional carbon fiber-reinforced plastic by the temperature raise against that of the viscoelastic modulus of the matrix resin agrees well with the predicted results based on the Rosen's strength analysis.	[Tsugiyuki, Okuya] Kanazawa Inst Technol, Grad Sch Engn, Kanazawa, Ishikawa, Japan; [Nakada, Masayuki; Miyano, Yasushi] Kanazawa Inst Technol, Mat Syst Res Lab, Kanazawa, Ishikawa, Japan	Tsugiyuki, O (reprint author), Ikebukurohoncho,Toshimaku, Tokyo 1700011, Japan.	okuya.vct@jupiter.ocn.ne.jp					Miyano Y, 1999, ADV COMPOS MATER, V8, P235, DOI 10.1163/156855199X00236; ROSEN BW, 1964, AIAA J, V2, P1985; ABOUDI J, 1989, COMPOS STRUCT, V12, P243, DOI 10.1016/0263-8223(89)90074-3; Miyano Y, 1997, J COMPOS MATER, V31, P619; GATES TS, 1992, EXP MECH, V32, P68, DOI 10.1007/BF02317988; Miyano Y, 2000, MECH TIME-DEPEND MAT, V4, P127, DOI 10.1023/A:1009882709870; MIYANO Y, 1986, J COMPOS MATER, V20, P520, DOI 10.1177/002199838602000602; MIYANO Y, 1994, J COMPOS MATER, V28, P1250; Nakada M, 2002, J COMPOS MATER, V36, P2567, DOI [10.1106/002199802027292, 10.1106/00219980202792]; Okuya T, J REINF PLAST COMPOS, V30; SULLIVAN JL, 1990, COMPOS SCI TECHNOL, V39, P207, DOI 10.1016/0266-3538(90)90042-4	11	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	DEC	2014	48	28					3569	3573		10.1177/0021998313512349		5	Materials Science, Composites	Materials Science	AU0TH	WOS:000345336900010		
J	Yokoi, A; Endo, K; Ozawa, T; Miyaki, M; Matsuo, K; Nozawa, K; Manabe, M; Takagi, Y				Yokoi, Aya; Endo, Koji; Ozawa, Toshiaki; Miyaki, Masahiro; Matsuo, Keiko; Nozawa, Kazumi; Manabe, Motomu; Takagi, Yutaka			A cleanser based on sodium laureth carboxylate and alkyl carboxylates washes facial sebum well but does not induce dry skin	JOURNAL OF COSMETIC DERMATOLOGY			English	Article						transepidermal water loss; detergents; moisturizing; efficacy test; sebum; stratum corneum	SEBACEOUS GLAND; PENETRATION; IRRITATION; HYDRATION; RECOVERY; SULFATE; DAMAGE	BackgroundBecause excess sebum and/or metabolites of sebum induce skin problems, cleansers that can remove those kinds of sebum are sought after. However, many people, especially who have little facial sebum, are afraid to wash off sebum well because that may induce dry skin. This concern may be caused by the result that cleansers with a high cleansing ability tend to decrease not only facial sebum but also natural moisturizing factors and intercellular lipids that are essential for cutaneous function. Recently, we have developed a new cleanser based on sodium laureth carboxylate and alkyl carboxylates (AEC/soap) that cleans sebum well without penetrating the stratum corneum. ObjectivesThis trial was aim to clarify the effects of sebum removal by AEC/soap-based cleanser on the induction of dry skin. MethodsWe designed a controlled single blind parallel trial. Thirty female subjects with mild dry skin were assigned randomly to two groups: one group used AEC/soap-based cleanser while the other group kept using their usual facial cleanser twice a day for 4weeks in the winter season. ResultsUsing a colored artificial sebum mixture, it was demonstrated that this cleanser washed sebum well. Following usage of this cleanser, their dry skin improved rather than worsen which was indicated by instrumental analysis and visual assessment. These improvements were recognized by subjects. ConclusionsThese results suggest that AEC/soap-based cleanser washes off facial sebum well, but it has little effect on the induction of dry skin because of less penetration into stratum corneum.	[Yokoi, Aya; Manabe, Motomu] Akita Univ Hosp, Akita, Japan; [Endo, Koji; Ozawa, Toshiaki; Miyaki, Masahiro; Matsuo, Keiko; Takagi, Yutaka] Kao Corp, Global R&D Skin Care Prod Res, Tokyo 1318501, Japan; [Nozawa, Kazumi] Interface Inc, Akita, Japan	Takagi, Y (reprint author), Kao Corp, Global R&D Skin Care Prod Res, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.	takagi.yutaka@kao.co.jp			Kao Corporation	This study was supported financially by Kao Corporation. We thank our colleagues in the Global R&D, Kao Corporation, and the colleagues in Interface, Inc. for their kind help during the study.	Youn SW, 2005, SKIN RES TECHNOL, V11, P189, DOI 10.1111/j.1600-0846.2005.00119.x; Ro BI, 2005, J INVEST DERM SYMP P, V10, P194, DOI 10.1111/j.1087-0024.2005.10104.x; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Sunwoo Yujin, 2006, Journal of Physiological Anthropology, V25, P229, DOI 10.2114/jpa2.25.229; Ottaviani M, 2006, J INVEST DERMATOL, V126, P2430, DOI 10.1038/sj.jid.5700434; Barany E, 1999, CONTACT DERMATITIS, V40, P98, DOI 10.1111/j.1600-0536.1999.tb05999.x; Clarys P, 1997, CONTACT DERMATITIS, V36, P240, DOI 10.1111/j.1600-0536.1997.tb00209.x; de Jongh CM, 2006, BRIT J DERMATOL, V154, P651, DOI 10.1111/j.1365-2133.2005.06989.x; Imokawa G, 1974, J JAP OIL CHEM SOC, V23, P719; Isoda K, 2014, SKIN RES TE IN PRESS, DOI [10.1111/srt.12183, DOI 10.1111/SRT.12183]; JOIRIS E, 1957, CR SOC BIOL, V151, P1049; KLIGMAN AM, 1986, J SOC COSMET CHEM, V37, P369; Moore PN, 2003, J COSMET SCI, V54, P143; OHSAWA K, 1984, Journal of Toxicological Sciences, V9, P151; Ozawa T, 2009, Japanese Patent, Patent No. [JP2009275012, 2009275012]; Ozawa T., 2012, FRAGRANCE J, V8, P21; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; PROTTEY C, 1975, J SOC COSMET CHEM, V26, P29; SERUP J, 1989, CLIN EXP DERMATOL, V14, P277, DOI 10.1111/j.1365-2230.1989.tb01979.x; Sunwoo Yujin, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P7, DOI 10.2114/jpa2.25.7; Swarna Ekanayake M., 2003, J INVEST DERMATOL, V120, P915; Takagi Y, 2005, DERMATOLOGY, V211, P128, DOI 10.1159/000086442; WILHELM KP, 1991, ARCH DERMATOL, V127, P1806, DOI 10.1001/archderm.127.12.1806	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1473-2130	1473-2165		J COSMET DERMATOL-US	J. Cosmet. Dermatol.	DEC	2014	13	4					245	252		10.1111/jocd.12118		8	Dermatology	Dermatology	AU0FX	WOS:000345300100002		
J	Albuquerque, MTP; Valera, MC; Nakashima, M; Nor, JE; Bottino, MC				Albuquerque, M. T. P.; Valera, M. C.; Nakashima, M.; Nor, J. E.; Bottino, M. C.			Tissue-engineering-based Strategies for Regenerative Endodontics	JOURNAL OF DENTAL RESEARCH			English	Review						tissue scaffolds; regeneration; nanofibers; dental pulp; dentin; stem cells	PULP STEM-CELLS; COLONY-STIMULATING FACTOR; IMMATURE PERMANENT TEETH; DENTAL-PULP; NANOFIBROUS SCAFFOLDS; APICAL PERIODONTITIS; CALCIUM HYDROXIDE; REVASCULARIZATION; PULPECTOMY; HYDROGEL	Stemming from in vitro and in vivo pre-clinical and human models, tissue-engineering-based strategies continue to demonstrate great potential for the regeneration of the pulp-dentin complex, particularly in necrotic, immature permanent teeth. Nanofibrous scaffolds, which closely resemble the native extracellular matrix, have been successfully synthesized by various techniques, including but not limited to electrospinning. A common goal in scaffold synthesis has been the notion of promoting cell guidance through the careful design and use of a collection of biochemical and physical cues capable of governing and stimulating specific events at the cellular and tissue levels. The latest advances in processing technologies allow for the fabrication of scaffolds where selected bioactive molecules can be delivered locally, thus increasing the possibilities for clinical success. Though electrospun scaffolds have not yet been tested in vivo in either human or animal pulpless models in immature permanent teeth, recent studies have highlighted their regenerative potential both from an in vitro and in vivo (i.e., subcutaneous model) standpoint. Possible applications for these bioactive scaffolds continue to evolve, with significant prospects related to the regeneration of both dentin and pulp tissue and, more recently, to root canal disinfection. Nonetheless, no single implantable scaffold can consistently guide the coordinated growth and development of the multiple tissue types involved in the functional regeneration of the pulp-dentin complex. The purpose of this review is to provide a comprehensive perspective on the latest discoveries related to the use of scaffolds and/or stem cells in regenerative endodontics. The authors focused this review on bioactive nanofibrous scaffolds, injectable scaffolds and stem cells, and pre-clinical findings using stem-cell-based strategies. These topics are discussed in detail in an attempt to provide future direction and to shed light on their potential translation to clinical settings.	[Albuquerque, M. T. P.; Valera, M. C.; Bottino, M. C.] Indiana Univ, Sch Dent, Div Dent Biomat, Dept Restorat Dent, Indianapolis, IN 46202 USA; [Albuquerque, M. T. P.] Univ Estadual Paulista, Sao Jose dos Campos Dent Sch, Dept Restorat Dent, BR-12245000 Sao Paulo, Brazil; [Nakashima, M.] Natl Ctr Geriatr & Gerontol, Res Inst, Ctr Adv Med Dent & Oral Dis, Dept Dent Regenerat Med, Obu, Aichi 4748511, Japan; [Nor, J. E.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA	Bottino, MC (reprint author), Indiana Univ, Sch Dent, Div Dent Biomat, Dept Restorat Dent, Indianapolis, IN 46202 USA.	mbottino@iu.edu			American Association of Endodontists Foundation; IUSD; National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) [DE023552]; Indiana University Purdue University (IUPUI/OVCR); NIH/NIDCR [R01DE21410]; Ministry of Health, Labour and Welfare [23-10]; budget for promoting science and technology in Japan	This article is derived from a symposium presentation at the 92nd General Session & Exhibition of the International Association for Dental Research (IADR), which was held June 25-28, 2014, in Cape Town, South Africa. The authors gratefully acknowledge the contributions of the anonymous reviewers who provided stimulating and helpful comments on a former version of this manuscript. M.C.B. thanks colleagues from the Indiana University School of Dentistry (IUSD), Drs. Krzysztof Kamocki and Richard L. Gregory, for their collaboration on the electrospun nanofibrous scaffolds research. Appreciation is expressed to Drs. Jeffrey A. Platt, Ygal Ehrlich, and Kenneth J. Spolnik (IUSD) for stimulating discussions. M.C.B. also acknowledges funding from the American Association of Endodontists Foundation, start-up funds from IUSD, the National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research (NIDCR) (Grant #DE023552), and an International Development Funds (IDF) Grant from Indiana University Purdue University (IUPUI/OVCR). J.E.N. acknowledges NIH/NIDCR Grant #R01DE21410. M.N. acknowledges the Research Grant for Longevity Sciences (23-10) from the Ministry of Health, Labour and Welfare (M.N.), and the budget for promoting science and technology in Japan. Thanks also go to Dr. Koichiro Iohara for his assistance in editing Figure 4. The authors apologize for not citing all relevant references due to a perceived lack of fit or space limitations. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Akkouch A, 2013, J BIOMATER APPL, V28, P922; Martin G, 2013, J ENDODONT, V39, P138, DOI 10.1016/j.joen.2012.09.015; Baylan N, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045011; Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009; Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535; Huang GTJ, 2009, REGEN MED, V4, P697, DOI [10.2217/rme.09.45, 10.2217/RME.09.45]; Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003; Galler KM, 2008, TISSUE ENG PT A, V14, P2051, DOI 10.1089/ten.tea.2007.0413; Ishimatsu H, 2009, J ENDODONT, V35, P858, DOI 10.1016/j.joen.2009.03.049; Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.TEA.2010.0615, 10.1089/ten.tea.2010.0615]; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; Galler KM, 2011, REGEN MED, V6, P191, DOI [10.2217/rme.11.3, 10.2217/RME.11.3]; Iohara K, 2014, EXP GERONTOL, V52, P39, DOI 10.1016/j.exger.2014.01.020; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Nagy MM, 2014, J ENDODONT, V40, P192, DOI 10.1016/j.joen.2013.10.027; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Rosa V, 2013, J DENT RES, V92, P970, DOI 10.1177/0022034513505772; Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.TEA.2011.0222, 10.1089/ten.tea.2011.0222]; Feng K, 2010, J CONTROL RELEASE, V146, P363, DOI 10.1016/j.jconrel.2010.05.035; Shimizu E, 2012, J ENDODONT, V38, P1293, DOI 10.1016/j.joen.2012.06.017; Iohara K, 2013, STEM CELL TRANSL MED, V2, P521, DOI 10.5966/sctm.2012-0132; Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005; Jeeruphan T, 2012, J ENDODONT, V38, P1330, DOI 10.1016/j.joen.2012.06.028; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Coyac BR, 2013, J DENT RES, V92, P648, DOI 10.1177/0022034513488599; Ishizaka R, 2013, BIOMATERIALS, V34, P1888, DOI 10.1016/j.biomaterials.2012.10.045; Cavalcanti BN, 2013, DENT MATER, V29, P97, DOI 10.1016/j.dental.2012.08.002; Ishizaka R, 2012, BIOMATERIALS, V33, P2109, DOI 10.1016/j.biomaterials.2011.11.056; Ravichandran R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385102; Nagata JY, 2014, J ENDODONT, V40, P778, DOI 10.1016/j.joen.2014.01.038; Iwaya S, 2011, DENT TRAUMATOL, V27, P55, DOI 10.1111/j.1600-9657.2010.00963.x; Dobie K, 2002, CONNECT TISSUE RES, V43, P387, DOI 10.1080/03008200290000574; Bose R, 2009, J ENDODONT, V35, P1343, DOI 10.1016/j.joen.2009.06.021; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518; Casagrande L, 2010, J DENT RES, V89, P603, DOI 10.1177/0022034510364487; Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080; Casagrande L, 2011, ODONTOLOGY, V99, P1, DOI 10.1007/s10266-010-0154-z; Bottino MC, 2013, J DENT RES, V92, P963, DOI 10.1177/0022034513505770; Galler KM, 2011, J ENDODONT, V37, P1536, DOI 10.1016/j.joen.2011.08.027; Kim JJ, 2014, J BIOMATER APPL, V28, P1069, DOI 10.1177/0885328213495903; Becerra P, 2014, J ENDODONT, V40, P133, DOI 10.1016/j.joen.2013.07.017; Zhang HM, 2012, TISSUE ENG PT A, V18, P677, DOI [10.1089/ten.TEA.2011.0269, 10.1089/ten.tea.2011.0269]; Ruparel NB, 2012, J ENDODONT, V38, P1372, DOI 10.1016/j.joen.2012.06.018; Murakami M, 2013, BIOMATERIALS, V34, P9036, DOI 10.1016/j.biomaterials.2013.08.011; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022; Bottino MC, 2014, J TISSUE EN IN PRESS; Bottino MC, 2014, CLIN ORAL I IN PRESS; Damle SG, 2012, J CLIN PEDIATR DENT, V36, P263; Diogenes A, 2013, ENDOD TOP, V28, P2; Diogenes Anibal R, 2014, J Endod, V40, pS52, DOI 10.1016/j.joen.2014.01.015; Gupte MJ, 2012, J DENT RES, V91, P227, DOI 10.1177/0022034511417441; Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286; Lu B., 2013, DRUG DISCOV TODAY, V19, P801; Nakashima M, 2011, Adv Dent Res, V23, P313, DOI 10.1177/0022034511405323; Nakashima Misako, 2014, J Endod, V40, pS26, DOI 10.1016/j.joen.2014.01.020; Palasuk J, 2014, J ENDODONT, V40, P1879, DOI 10.1016/j.joen.2014.07.017; Sakai V T, 2011, Adv Dent Res, V23, P325, DOI 10.1177/0022034511405325; Sundararaj SC, 2014, ACTA BIOMATER, V10, P115, DOI 10.1016/j.actbio.2013.09.031; Yang X, 2014, J BIOMED MA IN PRESS	60	12	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	DEC	2014	93	12			SI		1222	1231		10.1177/0022034514549809		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU0UN	WOS:000345340400006		
J	Kitagawa, R; Kitagawa, H; Izutani, N; Hirose, N; Hayashi, M; Imazato, S				Kitagawa, R.; Kitagawa, H.; Izutani, N.; Hirose, N.; Hayashi, M.; Imazato, S.			Development of an Antibacterial Root Canal Filling System Containing MDPB	JOURNAL OF DENTAL RESEARCH			English	Article						root canal filling materials; antibacterial agents; resins; quaternary ammonium compounds; endodontics; Enterococcus faecalis	GUTTA-PERCHA/AH PLUS; SEALING ABILITY; ENDODONTIC INFECTIONS; INCORPORATING MDPB; FLUID FILTRATION; DENTIN PRIMER; BOND STRENGTH; MONOMER MDPB; APICAL SEAL; ADHESIVE	An antibacterial monomer 12-methacryloyloxydodecylpyridinum bromide (MDPB)-containing experimental, chemically cured primer was prepared to develop a new resin-based root canal filling system. This study investigated the antibacterial effects of the MDPB-containing primer (experimental primer [EP]) against Enterococcus faecalis and assessed the in vitro bonding and sealing abilities of the filling system, consisting of EP and a Bis-GMA-based sealer resin. Antibacterial effects of EP were evaluated by contact with planktonic or adherent bacteria for 30 or 60 sec, and the viable bacterial number was counted. The antibacterial effects against E. faecalis in dentinal tubules were also assessed, according to a root canal infection model. Bonding and sealing abilities of the experimental filling system were examined by microtensile bond strength tests and leakage tests based on fluid filtration methods. Significantly greater reduction in viable bacteria in planktonic and adherent form was obtained by short-period contact with EP compared with the control primer (without MDPB) or with the proprietary (Epiphany) primer (p < .05). Significantly greater bactericidal effects of the EP inside the dentinal tubule of root, as opposed to the control primer or Epiphany primer, were confirmed according to a root canal infection model (p < .05), and 100% killing of E. faecalis could be obtained by the application of EP after irrigation with a 5% sodium hypochlorite solution. The experimental endodontic filling system demonstrated significantly greater bond strength to root dentin than Epiphany sealer system (Epiphany primer and Epiphany Root Canal Sealant; p < .05), showing formation of resin tags and a hybridized layer. Leakage tests clarified that the experimental system provided excellent sealing. This study confirmed that the MDPB-containing experimental antibacterial primer has the ability to effectively disinfect the root canal. Additionally, the experimental root canal filling system employing this primer and the Bis-GMA-based sealer resin is useful for achieving good sealing, suggesting its possible benefit for successful endodontic treatments.	[Kitagawa, R.; Kitagawa, H.; Izutani, N.; Hirose, N.; Hayashi, M.] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Osaka, Japan; [Hirose, N.; Imazato, S.] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Osaka, Japan	Imazato, S (reprint author), Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Osaka, Japan.	imazato@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [19209060, 25893121, 26293409]	This work was supported in part by a Grant-in-Aid for Scientific Research (nos. 19209060, 25893121, 26293409) from the Japan Society for the Promotion of Science. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Neelakantan P, 2011, INT ENDOD J, V44, P491, DOI 10.1111/j.1365-2591.2010.01848.x; Ma JZ, 2011, J ENDODONT, V37, P1380, DOI 10.1016/j.joen.2011.06.018; Izutani N, 2010, INT ENDOD J, V43, P637, DOI 10.1111/j.1365-2591.2010.01716.x; Yoshida Y, 2004, J DENT RES, V83, P454; Versiani MA, 2006, INT ENDOD J, V39, P464, DOI 10.1111/j.1365-2591.2006.01105.x; HAAPASALO M, 1987, J DENT RES, V66, P1375, DOI 10.1177/00220345870660081801; Imazato S, 2004, OPER DENT, V29, P369; Imazato S, 2007, DENT MATER, V23, P170, DOI 10.1016/j.dental.2006.01.005; Antonucci JM, 2012, DENT MATER, V28, P219, DOI 10.1016/j.dental.2011.10.004; Bouillaguet S, 2003, DENT MATER, V19, P199, DOI 10.1016/S0109-5641(02)00030-1; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147; IMAZATO S, 1994, J DENT RES, V73, P1437; Gomes BPFA, 2004, ORAL MICROBIOL IMMUN, V19, P71, DOI 10.1046/j.0902-0055.2003.00116.x; Imazato S, 1997, J DENT RES, V76, P768; Imazato S, 2009, DENT MATER J, V28, P11; Imazato S, 1999, BIOMATERIALS, V20, P899, DOI 10.1016/S0142-9612(98)00247-6; Li F, 2009, J DENT RES, V88, P372, DOI 10.1177/0022034509334499; Wu HX, 2009, DENT MATER, V25, P1484, DOI 10.1016/j.dental.2009.06.019; Siqueira JF, 2005, J ENDODONT, V31, P488, DOI 10.1097/01.don.0000157990.86638.49; Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x; Biggs SG, 2006, J ENDODONT, V32, P759, DOI 10.1016/j.joen.2005.08.013; Carvalho Fabíola Galbiatti de, 2012, J Appl Oral Sci, V20, P568; Costa JA, 2010, INT ENDOD J, V43, P698, DOI 10.1111/j.1365-2591.2010.01766.x; Imazato S, 2014, DENT MATER, V30, P97, DOI 10.1016/j.dental.2013.06.003; Matsuo T, 2003, J ENDODONT, V29, P194, DOI 10.1097/00004770-200303000-00008; Ozer F, 2003, J DENT, V31, P111, DOI 10.1016/S0300-5712(03)00006-X; Paque F, 2007, INT ENDOD J, V40, P722, DOI 10.1111/j.1365-2591.2007.01298.x; Raina R, 2007, J ENDODONT, V33, P944, DOI 10.1016/j.joen.2007.05.003; Schmalz G, 2004, J ENDODONT, V30, P352, DOI 10.1097/00004770-200405000-00011; Tay FR, 2005, J ENDODONT, V31, P514, DOI 10.1097/01.don.0000152298.81097.b7	30	2	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	DEC	2014	93	12			SI		1277	1282		10.1177/0022034514549808		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU0UN	WOS:000345340400014		
J	Morasso, P; Casadio, M; De Santis, D; Nomura, T; Rea, F; Zenzeri, J				Morasso, Pietro; Casadio, Maura; De Santis, Dalia; Nomura, Taishin; Rea, Francesco; Zenzeri, Jacopo			Stabilization strategies for unstable dynamics	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Motor cognition; Motor control; Unstable tasks; Control strategies; Stiffness control; Intermittent feedback control	HUMAN ANKLE STIFFNESS; POSTURE; REPRESENTATION; MOVEMENT; BODY; STABILITY; IMPEDANCE; MODEL; SWAY	The stabilization of the human standing posture was originally attributed to the stiffness of the ankle muscles but direct measurements of the ankle stiffness ruled out this hypothesis, leaving open the possibility for a feedback stabilization strategy driven by proprioceptive signals. This solution, however, could be implemented with two different kinds of control mechanisms, namely continuous or intermittent feedback. The debate is now settled and the latter solution seems to be the most plausible one. Moreover, stabilization of unstable dynamics is not limited to bipedal standing. Indeed many manipulation tasks can be described in the same framework and thus a very general protocol for addressing this kind of problems is the use of haptic virtual reality where instability is generated by some kind of divergent or saddle-like force field. Several studies demonstrated that human subjects can choose to adopt a stiffness or feedback strategy as a combination of biomechanical and task constraints and can learn to switch from one strategy to the other if it is feasible or to use one or the other is infeasible. Understanding such mechanisms is relevant, for example, for the design of novel ergonomic man-machine interfaces in difficult, unstable tasks. (C) 2014 Elsevier Ltd. All rights reserved.	[Morasso, Pietro; De Santis, Dalia; Rea, Francesco; Zenzeri, Jacopo] IIT, Dept Robot Brain & Cognit Sci, I-16163 Genoa, Italy; [Casadio, Maura] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Genoa, Italy; [Nomura, Taishin] Osaka Univ, Grad Sch Engn Sci, Dept Bioengn, Toyonaka, Osaka 560, Japan	Morasso, P (reprint author), IIT, RBCS, Via Morego 30, I-16163 Genoa, Italy.	pietro.morasso@iit.it; maura.casadio@unige.it; dalia.desantis@iit.it; taishin@bpe.es.osaka-u.ac.jp; Francesco.rea@iit.it; jacopo.zenzeri@iit.it	Nomura, Taishin/J-8408-2012	Nomura, Taishin/0000-0002-6545-2097	RBCS Dept. of the Istituto Italiano di Tecnologia; ACIRAS Project of Regione Liguria [FP7-270138, W911QY-12-C-0078]; Project DoD, USA; JSPS [26242041]; REMAKE [FP7-PEOPLE-2012-CIG-334201]; DARWIN EU Project	This research was supported by the RBCS Dept. of the Istituto Italiano di Tecnologia; ACIRAS Project of Regione Liguria, DARWIN EU Project (Grant No: FP7-270138), W911QY-12-C-0078 Project DoD, USA, "Consequences of Loading on Postural-Focal Dynamics'', all to Prof. Morasso; JSPS grant-in-aid (# 26242041) to Prof. Nomura; FP7-PEOPLE-2012-CIG-334201 (REMAKE) to Prof. Casadio.	Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Bottaro A, 2005, HUM MOVEMENT SCI, V24, P588, DOI 10.1016/j.humov.2005.07.006; Howard IS, 2010, J NEUROPHYSIOL, V104, P2082, DOI 10.1152/jn.00299.2010; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/s004220050150; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211; FLASH T, 1990, EXP BRAIN RES, V82, P315; Loram ID, 2005, J PHYSIOL-LONDON, V564, P281, DOI 10.1113/jphysiol.2004.073437; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; BIZZI E, 1984, J NEUROSCI, V4, P2738; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; Fletcher J, 2013, PERFORM RES, V18, P1, DOI 10.1080/13528165.2013.867168; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Haggard P., 2005, HIGHER ORDER MOTOR D, P261; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HUNTER IW, 1982, J BIOMECH, V15, P747, DOI 10.1016/0021-9290(82)90089-6; KEARNEY RE, 1982, J BIOMECH, V15, P753, DOI 10.1016/0021-9290(82)90090-2; Lakoff G., 1999, PHILOS FLESH EMBODIE; Loram ID, 2006, J PHYSIOL-LONDON, V577, P417, DOI 10.1113/jphysiol.2006.118786; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; MARSDEN CD, 1972, NATURE, V238, P140, DOI 10.1038/238140a0; Martiny CF, 1998, J MATH SYSTEMS ESTIM, V8, P1; Morasso P, 2013, INT J MACHINE CONSCI, V5, P75; Morasso P, 2013, OS JAP ANN INT C IEE; Pfeifer R, 1998, Z NATURFORSCH C, V53, P480; Saha DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030301; VISALBERGHI E, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P138; Zenzeri J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099087	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	DEC	2014	24	6					803	814		10.1016/j.jelekin.2014.10.006		12	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	AT7NR	WOS:000345125000005		
J	Nakajima, Y; Keeratihattayakorn, S; Yoshinari, S; Tadano, S				Nakajima, Yasuhiro; Keeratihattayakorn, Saran; Yoshinari, Satoshi; Tadano, Shigeru			An EMG-CT method using multiple surface electrodes in the forearm	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Forearm; Surface electromyography; Muscle activity; Optimization; Conductive model	INDEPENDENT COMPONENT ANALYSIS; ACTION-POTENTIAL TRAINS; SINGLE MOTOR UNITS; ELECTROMYOGRAPHIC SIGNALS; CROSS-TALK; MUSCLES; TISSUES; RESISTANCE; SEPARATION; ARRAY	Electromyography computed tomography (EMG-CT) method is proposed for visualizing the individual muscle activities in the human forearm. An EMG conduction model was formulated for reverse-estimation of muscle activities using EMG signals obtained with multi surface electrodes. The optimization process was calculated using sequential quadratic programming by comparing the estimated EMG values from the model with the measured values. The individual muscle activities in the deep region were estimated and used to produce an EMG tomographic image. For validation of the method, isometric contractions of finger muscles were examined for three subjects, applying a flexion load (4.9, 7.4 and 9.8 N) to the proximal interphalangeal joint of the middle finger. EMG signals in the forearm were recorded during the tasks using multiple surface electrodes, which were bound around the subject's forearm. The EMG-CT method illustrates the distribution of muscle activities within the forearm. The change in amplitude and area of activated muscles can be observed. The normalized muscle activities of all three subjects appear to increase monotonically with increases in the load. Kinesiologically, this method was able to estimate individual muscle activation values and could provide a novel tool for studying hand function and development of an examination for evaluating rehabilitation. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakajima, Yasuhiro; Yoshinari, Satoshi] Hokkaido Res Org, Ind Res Inst, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Keeratihattayakorn, Saran; Tadano, Shigeru] Hokkaido Univ, Fac Engn, Div Human Mech Syst & Design, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Tadano, S (reprint author), Hokkaido Univ, Fac Engn, Div Human Mech Syst & Design, Kita Ku, Kita 13-Jo,Nishi 8-Chome, Sapporo, Hokkaido 0608628, Japan.	tadano@eng.hokudai.ac.jp	Tadano, Shigeru/G-5944-2011				Blok JH, 2002, REV SCI INSTRUM, V73, P1887, DOI 10.1063/1.1455134; Roeleveld K, 1997, ACTA PHYSIOL SCAND, V161, P465, DOI 10.1046/j.1365-201X.1997.00247.x; Nakamura H, 2004, J ELECTROMYOGR KINES, V14, P423, DOI 10.1016/j.jelekin.2004.01.004; Merletti R, 2003, J ELECTROMYOGR KINES, V13, P37, DOI 10.1016/S1050-6411(02)00082-2; Cheney M, 1999, SIAM REV, V41, P85, DOI 10.1137/S0036144598333613; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; BUCHTHAL F, 1980, PHYSIOL REV, V60, P90; Lowery MM, 2003, J APPL PHYSIOL, V94, P1324, DOI 10.1152/japplphysiol.00698.2002; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Drost G, 2006, J ELECTROMYOGR KINES, V16, P586, DOI 10.1016/j.jelekin.2006.09.005; PERRY J, 1981, PHYS THER, V61, P7; DE LUCA CJ, 1988, ELECTROEN CLIN NEURO, V69, P568, DOI 10.1016/0013-4694(88)90169-1; BURGER HC, 1961, PHYS MED BIOL, V5, P431, DOI 10.1088/0031-9155/5/4/304; Butler TJ, 2005, J PHYSIOL-LONDON, V567, P301, DOI 10.1113/jphysiol.2005.089201; Garcia GA, 2005, IEEE ENG MED BIOL, V24, P63, DOI 10.1109/MEMB.2005.1463398; GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537; JOHANSON ME, 1990, J HAND SURG-AM, V15A, P587; Kuiken TA, 2001, IEEE T NEUR SYS REH, V9, P346, DOI 10.1109/7333.1000114; LINDSTROM LH, 1977, P IEEE, V65, P653, DOI 10.1109/PROC.1977.10544; MAIER MA, 1995, EXP BRAIN RES, V103, P108, DOI 10.1007/BF00241969; Nakajima Y, 2008, P 13 INT C BIOL MED, P1904; Nakajima Y, 2009, J BIOMECHANICAL SCI, V4, P212; Nakamura H, 2004, J ELECTROMYOGR KINES, V14, P433, DOI 10.1016/j.jelekin.2004.01.005; SCHWAN HP, 1953, P IRE, V41, P1735, DOI 10.1109/JRPROC.1953.274358; STALBERG E, 1980, J NEUROL NEUROSUR PS, V43, P469, DOI 10.1136/jnnp.43.6.469; Stoykov NS, 2002, IEEE T BIO-MED ENG, V49, P763, DOI 10.1109/TBME.2002.800754; WINTER DA, 1994, J ELECTROMYOGR KINES, V4, P15, DOI 10.1016/1050-6411(94)90023-X; Yano H, 2001, NICT J, V48, P9	28	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	DEC	2014	24	6					875	880		10.1016/j.jelekin.2014.07.010		6	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	AT7NR	WOS:000345125000014		
J	Shimose, R; Ushigome, N; Tadano, C; Sugawara, H; Yona, M; Matsunaga, A; Muro, M				Shimose, Ryota; Ushigome, Nobuyuki; Tadano, Chigaya; Sugawara, Hitoshi; Yona, Masae; Matsunaga, Atsuhiko; Muro, Masuo			Increase in rate of force development with skin cooling during isometric knee extension	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Cutaneous input; Cold receptors; Skin temperature; Electromyography; Quadriceps	HUMAN SKELETAL-MUSCLE; TRAINING-INDUCED CHANGES; TORQUE DEVELOPMENT; CONTRACTILE PROPERTIES; ANTAGONIST MUSCLES; OLDER WOMEN; H-REFLEX; TEMPERATURE; STRENGTH; EMG	Rate of force development (RFD) plays an important role when performing rapid and forceful movements. Cold-induced afferent input with transient skin cooling (SC) can modulate neural drive. However, the relationship between RFD and SC is unknown. The purpose of this study was to investigate whether SC increases RFD during isometric knee extension. Fifteen young healthy men (25 +/- 8 yrs old) contracted their quadriceps muscle as fast and forcefully as possible with or without SC. Skin cooling was administered to the front of the thigh. Torque and electromyographic activity were measured simultaneously. Peak torque was not affected by SC. Skin cooling induced a significant increase in RFD at the phase 0-30 and 0-50 ms. The root mean square of the electromyography of vastus medialis, rectus femoris and vastus lateralis at the phases 0-30-50-100 ms increased significantly or tended to increase with SC. These results suggest that SC may increase neural drive and improve RFD in the very early phases of contraction. (C) 2014 Elsevier Ltd. All rights reserved.	[Shimose, Ryota] Sagamihara Chuo Hosp, Dept Rehabil, Chuo Ku, Sagamihara, Kanagawa, Japan; [Ushigome, Nobuyuki] Toho Univ, Omori Med Ctr, Dept Rehabil, Ota Ku, Tokyo, Japan; [Tadano, Chigaya; Muro, Masuo] Toho Univ, Fac Med, Sch Med, Dept Exercise Physiol & Biomech,Ota Ku, Tokyo, Japan; [Sugawara, Hitoshi] Toho Univ, Dept Phys Therapy, Ota Ku, Tokyo, Japan; [Yona, Masae] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Exercise Physiol, Hachioji, Tokyo 19203, Japan; [Matsunaga, Atsuhiko] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Minami Ku, Sagamihara, Kanagawa 228, Japan	Shimose, R (reprint author), 6-4-20 Fujimi,Chuo Ku, Sagamihara, Kanagawa 2520236, Japan.	ryota.shimose.17@gmail.com					Bojsen-Moller J, 2005, J APPL PHYSIOL, V99, P986, DOI 10.1152/japplphysiol.01305.2004; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295; Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; De Ruiter CJ, 2006, MED SCI SPORT EXER, V38, P1843, DOI 10.1249/01.mss.0000227644.14102.50; Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003; de Ruiter CJ, 2004, J APPL PHYSIOL, V97, P1693, DOI 10.1152/japplphysiol.00230.2004; VIITASALO JT, 1981, ACTA PHYSIOL SCAND, V111, P97, DOI 10.1111/j.1748-1716.1981.tb06710.x; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; PETROFSKY JS, 1980, EUR J APPL PHYSIOL O, V44, P189, DOI 10.1007/BF00421098; Korhonen MT, 2006, J APPL PHYSIOL, V101, P906, DOI 10.1152/japplphysiol.00299.2006; Barry BK, 2005, EXP BRAIN RES, V162, P122, DOI 10.1007/s00221-004-2127-3; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; BIGLANDRITCHIE B, 1992, J APPL PHYSIOL, V73, P2457; Oksa J, 2002, J APPL PHYSIOL, V92, P354; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; Chang SHJ, 2005, ARCH PHYS MED REHAB, V86, P1843, DOI 10.1016/j.apmr.2005.03.006; ZHOU S, 1995, EUR J APPL PHYSIOL O, V70, P138, DOI 10.1007/BF00361541; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Kido A, 2004, CAN J PHYSIOL PHARM, V82, P238, DOI 10.1139/Y04-017; Klass M, 2008, J APPL PHYSIOL, V104, P739, DOI 10.1152/japplphysiol.00550.2007; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Blazevich AJ, 2008, MUSCLE NERVE, V38, P1133, DOI 10.1002/mus.21021; Holtermann A, 2007, EUR J APPL PHYSIOL, V101, P301, DOI 10.1007/s00421-007-0503-y; Dewhurst S, 2010, EUR J APPL PHYSIOL, V108, P451, DOI 10.1007/s00421-009-1245-9; Dewhurst S, 2005, EUR J APPL PHYSIOL, V94, P491, DOI 10.1007/s00421-005-1384-6; Girard O, 2009, J APPL PHYSIOL, V107, P359; MASAKADO Y, 1991, EXP BRAIN RES, V86, P426; OKSA J, 1995, AVIAT SPACE ENVIR MD, V66, P26; RANATUNGA KW, 1987, J PHYSIOL-LONDON, V390, P383; Rissanen S, 1996, EUR J APPL PHYSIOL O, V73, P163, DOI 10.1007/BF00262826; Sahaly R, 2003, EUR J APPL PHYSIOL, V89, P79, DOI 10.1007/s00421-002-0762-6; SCHMIDTBLEICHER D, 1981, EUR J APPL PHYSIOL O, V46, P221, DOI 10.1007/BF00423398; WINKEL J, 1991, EUR J APPL PHYSIOL O, V63, P345, DOI 10.1007/BF00364460; Yona M, 1997, JPN J PHYSIOL, V47, P341, DOI 10.2170/jjphysiol.47.341	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	DEC	2014	24	6					895	901		10.1016/j.jelekin.2014.08.002		7	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	AT7NR	WOS:000345125000017		
J	Kondo, N; Rostila, M; Yngwe, MA				Kondo, Naoki; Rostila, Mikael; Yngwe, Monica Aberg			Rising inequality in mortality among working-age men and women in Sweden: a national registry-based repeated cohort study, 1990-2007	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							NORDIC WELFARE STATES; HEALTH INEQUALITIES; INCOME INEQUALITY; RELATIVE DEPRIVATION; SOCIOECONOMIC DISPARITIES; EUROPEAN COUNTRIES; TRENDS; POPULATION; CANCER; EXPLANATION	Background In the past two decades, health inequality has persisted or increased in states with comprehensive welfare. Methods We conducted a national registry-based repeated cohort study with a 3-year follow-up between 1990 and 2007 in Sweden. Information on all-cause mortality in all working-age Swedish men and women aged between 30 and 64 years was collected. Data were subjected to temporal trend analysis using joinpoint regression to statistically confirm the trajectories observed. Results Among men, age-standardised mortality rate decreased by 38.3% from 234.9 to 145 (per 100 000 population) over the whole period in the highest income quintile, whereas the reduction was only 18.3% (from 774.5 to 632.5) in the lowest quintile. Among women, mortality decreased by 40% (from 187.4 to 112.5) in the highest income group, but increased by 12.1% (from 280.2 to 314.2) in the poorest income group. Joinpoint regression identified that the differences in age-standardised mortality between the highest and the lowest income quintiles decreased among men by 18.85 annually between 1990 and 1994 (p trend=0.02), whereas it increased later, with a 2.88 point increase per year (p trend <0.0001). Among women, it continuously increased by 9.26/ year (p trend <0.0001). In relative terms, age-adjusted mortality rate ratios showed a continuous increase in both genders. Conclusions Income-based inequalities among working-age male and female Swedes have increased since the late 1990s, whereas in absolute terms the increase was less remarkable among men. Structural and behavioural factors explaining this trend, such as the economic recession in the early 1990s, should be studied further.	[Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Rostila, Mikael] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Rostila, Mikael; Yngwe, Monica Aberg] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden	Kondo, N (reprint author), Univ Tokyo, Sch Publ Hlth, Bunkyo Ku, Floor 3,Med Bldg 3,7-3-1 Hongo, Tokyo 1130033, Japan.	naoki-kondo@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan [25253052]; Ministry of Health, Labour and WElfare, Japan [H24-chikyukibo-ippan-009]; Stiftelsen Riksbankens Jubileumsfond	Ministry of Education, Culture, Sports, Science and Technology, MEXT, Japan (No: 25253052), Ministry of Health, Labour and WElfare, Japan (H24-chikyukibo-ippan-009); Stiftelsen Riksbankens Jubileumsfond.	Aberg Yngwe M, 2007, HLTH INEQUALITIES WE, P135; Yngwe MA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-664; Anghel B, 2011, IZA DISCUSSION PAPER, V5825, P1; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Khang YH, 2005, INT J EPIDEMIOL, V34, P630, DOI 10.1093/ije/dyi043; Lahelma E, 2002, SOC SCI MED, V55, P609, DOI 10.1016/S0277-9536(01)00191-5; Kondo N, 2008, SOC SCI MED, V67, P982, DOI 10.1016/j.socscimed.2008.06.002; Lundberg O, 2001, SCAND J PUBLIC HEALT, P31; Kondo N, 2008, J EPIDEMIOL COMMUN H, V62, P869, DOI 10.1136/jech.2007.070334; Lynch JW, 2000, BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Granados JAT, 2008, DEMOGRAPHY, V45, P323, DOI 10.1353/dem.0.0008; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Khang YH, 2005, INT J EPIDEMIOL, V34, P1291, DOI 10.1093/ije/dyi224; Smith JP, 2007, J HUM RESOUR, V42, P739; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q; Mackenbach JP, 2013, INT J PUBLIC HEALTH, V58, P811, DOI 10.1007/s00038-013-0509-7; Eckersley R, 2006, INT J EPIDEMIOL, V35, P252, DOI 10.1093/ije/dyi235; Kondo N, 2012, J EPIDEMIOL, V22, P2, DOI 10.2188/jea.JE20110116; Gerdtham UG, 2005, SOC SCI MED, V60, P205, DOI 10.1016/j.socscimed.2004.05.004; Vingard E, 2005, SCAND J PUBLIC HEALT, V33, P370, DOI 10.1080/14034940510005860; Avendano M, 2005, AM J EPIDEMIOL, V161, P52, DOI 10.1093/aje/kwi011; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Fritzell J., 2007, HLTH INEQUALITIES WE; Fritzell J, 2014, CHANGING INEQUALITIE, P641; Harper S, 2008, AM J EPIDEMIOL, V167, P889, DOI 10.1093/aje/kwn016; Kondo N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4471; Kondo N, 2009, J EPIDEMIOL COMMUN H, V63, P461, DOI 10.1136/jech.2008.078642; Kravdal H, 2014, EUR J PUBLIC HEALTH, V24, P270, DOI 10.1093/eurpub/ckt082; Krokstad S, 2002, J EPIDEMIOL COMMUN H, V56, P375, DOI 10.1136/jech.56.5.375; Marmot MG, 2010, FAIR SOC HLTH LIVES; National Cancer Institute, 2013, JOINP REGR PROGR VER; Rostila M, 2012, ORATTVISA HALSAN SOC; Ruhm CJ, 1995, J HEALTH ECON, V14, P583, DOI 10.1016/0167-6296(95)00024-0; Saito M, 2012, SOC SCI MED, V75, P940, DOI 10.1016/j.socscimed.2012.04.006; Statistics Sweden, 2013, POP STAT; Wada K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1191; Yngwe MA, 2005, SOC SCI MED, V61, P627, DOI 10.1016/j.socscimed.2004.12.017	39	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	DEC	2014	68	12					1145	1150		10.1136/jech-2013-203619		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AT3RE	WOS:000344850600006		
J	Heianza, Y; Suzuki, A; Fujihara, K; Tanaka, S; Kodama, S; Hanyu, O; Sone, H				Heianza, Yoriko; Suzuki, Akiko; Fujihara, Kazuya; Tanaka, Shiro; Kodama, Satoru; Hanyu, Osamu; Sone, Hirohito			Impact on short-term glycaemic control of initiating diabetes care versus leaving diabetes untreated among individuals with newly screening-detected diabetes in Japan	JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH			English	Article							UNIVERSAL HEALTH-CARE; MICROVASCULAR COMPLICATIONS; TYPE-2; ASSOCIATION; MELLITUS; HBA(1C); DISEASE; DROPOUT	Background The impact of early initiation of diabetes care soon after the identification of hyperglycaemia rather than leaving diabetes untreated on changes in glycaemic control has not been fully clarified. We aimed to quantify the effect of initiating and continuing diabetes care compared with not starting management of diabetes on short-term changes in glycaemic control among the Japanese with newly screening-detected diabetes. Methods We retrospectively reviewed data from a nationwide claims database to assess histories of physician-diagnosed diabetes or hyperglycaemia, as well as the use of antidiabetic agents, blood testing for hyperglycaemia or dietary advice among individuals without a history of diabetes care. Changes in glycated haemoglobin (HbA1c) concentrations were evaluated using baseline data and data from a health examination during the following year. Results Among 1393 individuals with newly screening-detected diabetes, 62% (n=864) did not initiate diabetes management during the follow-up period; 49.2% (n=425) of the untreated group had poor glycaemic control (HbA1c =7%) at the baseline examination. Only 38% (n=529) began diabetes management in medical settings. Individuals who remained untreated had a 1.87 (95% CI 1.38 to 2.52) or 1.63 (1.10 to 2.41) times higher risk of absolute increases in HbA1c >= 0.5% or >= 1%, respectively, compared with the treated patients, a difference that was significant. Making more frequent clinic visits especially after the first visit was dose-dependently associated with improved HbA1c levels compared with no diabetes management. Conclusions In comparison with a lack of management of diabetes, immediately initiating and continuing diabetes care after identification of hyperglycaemia in a screening setting would contribute to clinically meaningful, improved glycaemic control in the Japanese.	[Heianza, Yoriko; Suzuki, Akiko; Fujihara, Kazuya; Kodama, Satoru; Hanyu, Osamu; Sone, Hirohito] Niigata Univ, Fac Med, Dept Internal Med, Niigata 9518510, Japan; [Fujihara, Kazuya] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Ibaraki, Japan; [Tanaka, Shiro] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan	Sone, H (reprint author), Niigata Univ, Fac Med, Dept Internal Med, Chuoh Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	sone@med.niigata-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science	work is financially supported in part by the Ministry of Health, Labour and Welfare, Japan. HS and YH are recipients of a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	American Association of Diabetes Educator, 2012, DIABETES ED, V38, P142; American Diabetes Association, 2013, DIABETES CARE S1, V36, pS11, DOI DOI 10.2337/DC13-S011; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; GRABER AL, 1992, DIABETES CARE, V15, P1477, DOI 10.2337/diacare.15.11.1477; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Bonora E, 2011, DIABETES CARE, V34, pS184, DOI 10.2337/dc11-s216; Sattar N, 2012, DIABETOLOGIA, V55, P1564, DOI 10.1007/s00125-012-2510-8; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Stratton IM, 2000, BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Morrison F, 2011, ARCH INTERN MED, V171, P1542, DOI 10.1001/archinternmed.2011.400; Healy SJ, 2013, DIABETES CARE, V36, P2960, DOI 10.2337/dc13-0108; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Sone H, 2006, INTERNAL MED, V45, P589, DOI 10.2169/internalmedicine.45.1609; [Anonymous], 2014, J EPIDEMIOL COMMUNIT, V68, P1189, DOI [10.1136/jech-2014-204054, DOI 10.1136/JECH-2014-204054]; Echouffo-Tcheugui JB, 2011, EPIDEMIOL REV, V33, P63, DOI 10.1093/epirev/mxq020; Heianza Y, 2012, DIABETES CARE, V35, P1050, DOI 10.2337/dc11-1793; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; KAWAHARA R, 1994, DIABETES RES CLIN PR, V24, P181, DOI 10.1016/0168-8227(94)90114-7; Kimura S, 2010, J EPIDEMIOL, V20, P413, DOI 10.2188/jea.JE20090066; Koproski J, 1997, DIABETES CARE, V20, P1553, DOI 10.2337/diacare.20.10.1553; Ministry of Health Labour and Welfare, 2011, NAT HLTH NUTR SURV J; Preiss D, 2011, LANCET, V378, P106, DOI 10.1016/S0140-6736(11)60819-2; Nathan DM, 2005, NEW ENGL J MED, V353, P2643; The Diabetes Control and Complications Trial Research Group, 1993, N ENGL J MED, V329, P977; World Health Organization, 2014, US GLYC HAEM HBA1C D	27	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0143-005X	1470-2738		J EPIDEMIOL COMMUN H	J. Epidemiol. Community Health	DEC	2014	68	12					1189	1195		10.1136/jech-2014-204054		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AT3RE	WOS:000344850600012		
J	Eke, EC; Czapiga, MJ; Viparelli, E; Shimizu, Y; Imran, J; Sun, T; Parker, G				Eke, Esther C.; Czapiga, M. J.; Viparelli, E.; Shimizu, Y.; Imran, J.; Sun, T.; Parker, G.			Coevolution of width and sinuosity in meandering rivers	JOURNAL OF FLUID MECHANICS			English	Article						river dynamics; sediment transport	BEND THEORY; HYDRAULIC GEOMETRY; UPSTREAM INFLUENCE; CHANNEL BENDS; FLOW; MIGRATION; AMPLITUDE; SIMULATION; EVOLUTION; MODEL	This research implements a recently proposed framework for wander migration, in order to explore the coevolution of planform and channel width in a freely meandering river. In the model described here, width evolution is coupled to channel migration through two submodels, one describing bank erosion and the other describing bank deposition. Hank erosion is modelled as erosion of purely non-cohesive bank material damped by natural armouring due to basal slump blocks, and bank deposition is modelled in terms of a floss dependent rate of vegetal encroachment. While these two submodels are specified independently, the two banks interact through the medium of the intervening channel; the morphodynamics of which is described by a fully nonlinear depth-averaged morphodynamics model. Since both banks are allowed to migrate independently, channel width is free to vary locally as a result of differential bank migration. Through a series of numerical runs, we demonstrate coevolution of local curvature, width and streamwise slope as the channel migrates over time The correlation between the local curvature, width and bed elevation is characterized, and the nature of this relationship is explored by varying the governing parameters. The results show that, by varying a parameter representing the ratio between a reference bank erosion rate and a reference bank deposition rate, the model is able to reproduce the broad range of river width curvature correlations observed in nature. This research represents a step towards providing general metrics for predicting width V aria non patterns in river systems.	[Eke, Esther C.; Czapiga, M. J.; Parker, G.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; [Viparelli, E.; Imran, J.] Univ S Carolina, Dept Civil & Environm Engn, Columbia, SC 29201 USA; [Shimizu, Y.] Hokkaido Univ, Lab Hydraul Res, Sapporo, Hokkaido 0600814, Japan; [Sun, T.] Chevron Energy Technol Co, Houston, TX 77382 USA; [Parker, G.] Univ Illinois, Dept Geol, Urbana, IL 61801 USA	Eke, EC (reprint author), Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA.	eeke2@illinois.edu		Eke, Esther/0000-0003-1962-0552	US National Science Foundation [EAR-0120914]; National Center for Earth-surface Dynamics; Science and Technology Center	This research represents a contribution of the National Center for Earth-surface Dynamics, a Science and Technology Center funded by the US National Science Foundation (agreement EAR-0120914). We thank R. Luchi for valuable advice on the research and the text.	Motta D, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011601; Lanzoni S, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000416; Ruther N, 2007, GEOMORPHOLOGY, V89, P308, DOI 10.1016/j.geomorph.2006.12.009; PARKER G, 1979, J HYDR ENG DIV-ASCE, V105, P1185; Wu FC, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001941; Seminara G, 2001, J FLUID MECH, V438, P213; Camporeale C, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2006JF000694; Darby SE, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000722; PARKER G, 1982, J FLUID MECH, V115, P303, DOI 10.1017/S0022112082000767; Sun T, 1996, WATER RESOUR RES, V32, P2937, DOI 10.1029/96WR00998; Mosselman E, 1998, HYDROL PROCESS, V12, P1357, DOI 10.1002/(SICI)1099-1085(19980630)12:8<1357::AID-HYP619>3.3.CO;2-Z; Motta D, 2012, GEOMORPHOLOGY, V163, P10, DOI 10.1016/j.geomorph.2011.06.036; Hooke JM, 2008, GEOMORPHOLOGY, V100, P3, DOI 10.1016/j.geomorph.2007.04.034; HOWARD AD, 1984, WATER RESOUR RES, V20, P1659, DOI 10.1029/WR020i011p01659; HICKIN EJ, 1984, J HYDRAUL ENG-ASCE, V110, P1557; Frascati A, 2010, EARTH SURF PROC LAND, V35, P791, DOI 10.1002/esp.1974; Repetto R, 2002, J FLUID MECH, V457, P79, DOI 10.1017/S0022112001007595; Seminara G, 1998, WATER RESOUR RES, V34, P1585, DOI 10.1029/98WR00372; PARKER G, 1986, J FLUID MECH, V162, P139, DOI 10.1017/S0022112086001970; Hooke J, 2003, T I BRIT GEOGR, V28, P238, DOI 10.1111/1475-5661.00089; ENGELUND F, 1974, J HYDR ENG DIV-ASCE, V100, P1631; BLONDEAUX P, 1985, J FLUID MECH, V157, P449, DOI 10.1017/S0022112085002440; Karlstrom L, 2013, J GEOPHYS RES-EARTH, V118, P1897, DOI 10.1002/jgrf.20135; Parker G, 1998, J HYDRAUL ENG-ASCE, V124, P985, DOI 10.1061/(ASCE)0733-9429(1998)124:10(985); LEOPOLD LB, 1960, GEOL SOC AM BULL, V71, P769, DOI 10.1130/0016-7606(1960)71[769:RM]2.0.CO;2; Asahi K, 2013, J GEOPHYS RES-EARTH, V118, P2208, DOI 10.1002/jgrf.20150; Camporeale C, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000185; Zolezzi G, 2001, J FLUID MECH, V438, P183; Wu FC, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000160; IKEDA S, 1981, J FLUID MECH, V112, P363, DOI 10.1017/S0022112081000451; Luchi R, 2011, J FLUID MECH, V681, P311, DOI 10.1017/jfm.2011.200; Luchi R, 2010, EARTH SURF PROC LAND, V35, P902, DOI 10.1002/esp.1947; Seminara G, 2006, J FLUID MECH, V554, P271, DOI 10.1017/S0022112006008925; Hooke JM, 2007, GEOMORPHOLOGY, V84, P277, DOI 10.1016/j.geomorph.2006.06.005; Blanckaert K, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001137; STRUIKSMA N, 1985, J HYDRAUL RES, V23, P57; Parker G, 2011, EARTH SURF PROC LAND, V36, P70, DOI 10.1002/esp.2113; PARKER G, 1985, WATER RESOUR RES, V21, P1361, DOI 10.1029/WR021i009p01361; COLOMBINI M, 1987, J FLUID MECH, V181, P213, DOI 10.1017/S0022112087002064; Nagata N, 2000, J HYDRAUL ENG-ASCE, V126, P243, DOI 10.1061/(ASCE)0733-9429(2000)126:4(243); Wilkerson GV, 2011, J HYDRAUL ENG-ASCE, V137, P739, DOI 10.1061/(ASCE)HY.1943-7900.0000352; Lauer JW, 2008, GEOMORPHOLOGY, V96, P123, DOI 10.1016/j.geomorph.2007.08.003; ASCE Task Committee on Hydraulics Bank Mechanics and Modeling of River Width Adjustment, 1998, J HYDRAULIC ENG, V124, P881, DOI DOI 10.1061/(ASCE)0733-9429(1998)124:9(881); Beck S., 1983, 832 SWE ALB RES COUN; Beck S. M., 1988, THESIS U MINNESOTA; Bittner L., 1994, THESIS U ILLINOIS; Blanckaert K., 2010, J GEOPHYS RES-EARTH, V115; Brice J. C., 1975, AIRPHOTO INTERPRETAT; Brice J.C., 1982, STREAM CHANNEL STABI; COURANT R, 1952, COMMUN PUR APPL MATH, V5, P243, DOI 10.1002/cpa.3160050303; Crosato A., 1990, 903 DELFT U TECHN; Darby SE, 1996, J HYDRAUL ENG-ASCE, V122, P443, DOI 10.1061/(ASCE)0733-9429(1996)122:8(443); De Vries M., 1965, P 11 C INT ASS HYDR, P381; Duan JG, 2010, J HYDROL, V391, P36, DOI 10.1016/j.jhydrol.2010.07.005; Einstein H. A., 1950, TECH B, V1026; Eke E, 2014, J GEOPHYS RES-EARTH, V119, P1455, DOI 10.1002/2013JF003020; Eke E., 2013, U ILLINOIS URBANA CH; Frascati A, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001101; Frascati A, 2013, J GEOPHYS RES-EARTH, V118, P1641, DOI 10.1002/jgrf.20084; Guneralp I, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048134; Hack J. T, 1965, 50413 US GEOL SURV; Hasegawa K., 1977, P HOKK BRANCH JAP SO, P197; Howard A., 1992, FLOODPLAIN PROCESSES, P15; Howard A. D., 1996, LOWLAND FLOODPLAIN R, P2; Ikeda S., 1976, P JAPAN SOC CIVIL EN, V255, P63; Imran J, 1999, J FLUID MECH, V400, P295, DOI 10.1017/S0022112099006515; Johannesson H., 1989, WATER RESOUR MONOGR, V12, P181, DOI DOI 10.1029/WM012P0181; KITANIDIS PK, 1984, J FLUID MECH, V144, P217, DOI 10.1017/S0022112084001580; Konsoer K., 2014, THESIS U ILLINOIS UR; Konsoer K, 2013, J GEOPHYS RES-EARTH, V118, P216, DOI 10.1029/2012JF002422; Konsoer K. M., 2012, 2012 FALL M AGU SAN; Lagasse P., 2004, 533 NHCRP; Langendoen EJ, 2008, J HYDRAUL ENG-ASCE, V134, P905, DOI 10.1061/(ASCE)0733-9429(2008)134:7(905); Li C, 2015, J HYDRAUL RES, V53, P36, DOI 10.1080/00221686.2014.939113; Luchi R, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011117; MacDonald T., 1991, INVENTORY ANAL STREA; Mosselman E, 2000, PHYS CHEM EARTH PT B, V25, P699, DOI 10.1016/S1464-1909(00)00088-5; Nelson J. M., 1989, WATER RESOUR MONOGR, V12, P321, DOI DOI 10.1029/WM012P0321; Pittaluga MB, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007298; Ottevanger W, 2012, GEOMORPHOLOGY, V163, P45, DOI 10.1016/j.geomorph.2011.04.049; Parker G, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000549; PARKER G, 1983, J HYDRAUL ENG-ASCE, V109, P1323; Peyret A. B, 2011, THESIS U TEXAS AUSTI; PIZZUTO JE, 1994, GEOL SOC AM BULL, V106, P1494, DOI 10.1130/0016-7606(1994)106<1494:CATCDP>2.3.CO;2; Rozovskii I. L., 1957, FLOW WATER BENDS OPE, P233; Science Stillwater, 2007, PHYS MOD EXP GUID RI; Smith D., 1984, WATER RESOUR RES, V20, P1301, DOI [10.1029/WR020i009p01301, DOI 10.1029/WR020I009P01301]; Smith V. B, 2012, THESIS U TEXAS AUSTI; Solari L., 2005, S RIV COAST EST MORP; Stolum HH, 1996, SCIENCE, V271, P1710, DOI 10.1126/science.271.5256.1710; Zolezzi G., 2012, REV GEOPHYS, V50	91	2	2	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	DEC	2014	760						127	174		10.1017/jfm.2014.556		48	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AT4MM	WOS:000344913500006		
J	Deguchi, K; Matsubara, N; Nagata, M				Deguchi, Kengo; Matsubara, Naoyoshi; Nagata, Masato			Suction-shear-Coriolis instability in a flow between parallel plates	JOURNAL OF FLUID MECHANICS			English	Article						bifurcation; boundary layer stability; transition to turbulence	COUETTE-POISEUILLE FLOW; BOUNDARY-LAYER; HYDRODYNAMIC STABILITY; COHERENT STRUCTURES; REYNOLDS-NUMBER; CHANNEL FLOW; CROSS-FLOW; TRANSITION; CYLINDERS; TURBULENCE	A rotating fluid flow between differentially translating parallel plates, which induce uniform suction and injection, is studied as a canonical model of swirling flow where suction, shear and Coriolis effects compete. This relatively simple modelling yields several reduced equations that are valid for asymptotically large suction, shear and/or rotation rates. The linear stability problems derived from the full Navier-Stokes and reduced problems are numerically solved and compared. In addition to Taylor-vortex modes, transverse-roll-type instabilities are found in Rayleigh-stable and -unstable parameter regions when weak suction is applied. These instabilities, separated by the so-called Rayleigh line, are characterised by vortices attached to the suction wall. Another type of instability, which exists beyond the Rayleigh line and shows inviseid motion in the fluid core, is found when suction is sufficiently strong. The relation of this instability to the stability results by Gallet, Doering & Spiegel (Phys. Fluids, Vol. 22, 2010, 034105) is discussed. Our nonlinear analyses indicate subcritical and supercritical bifurcations of finite-amplitude solutions for the near-wall and fluid-core instabilities, respectively.	[Deguchi, Kengo] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Deguchi, Kengo; Matsubara, Naoyoshi; Nagata, Masato] Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Kyoto 6068501, Japan; [Nagata, Masato] Tianjin Univ, Dept Mech, Tianjin 300072, Peoples R China	Deguchi, K (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Math, South Kensington Campus, London SW7 2AZ, England.	k.deguchi@imperial.ac.uk; nagata.masato.45x@st.kyoto-u.ac.jp					Fransson JHM, 2003, PHYS FLUIDS, V15, P436, DOI 10.1063/1.1533076; Taylor GI, 1923, PHILOS T R SOC LOND, V223, P289, DOI 10.1098/rsta.1923.0008; Doering CR, 2000, PHYS FLUIDS, V12, P1955, DOI 10.1063/1.870443; Rincon F, 2007, ASTRON ASTROPHYS, V463, P817, DOI 10.1051/0004-6361:20066544; Ji HT, 2006, NATURE, V444, P343, DOI 10.1038/nature05323; MIN K, 1994, PHYS FLUIDS, V6, P144, DOI 10.1063/1.868077; JOHNSTON JP, 1972, J FLUID MECH, V56, P533, DOI 10.1017/S0022112072002502; Fransson JHM, 2003, J FLUID MECH, V482, P51, DOI 10.1017/S0022112003003926; Deguchi K, 2014, J FLUID MECH, V752, P602, DOI 10.1017/jfm.2014.282; Gallet B, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3319824; PARK DS, 1995, J FLUID MECH, V283, P249, DOI 10.1017/S0022112095002308; ORSZAG SA, 1971, J FLUID MECH, V50, P689, DOI 10.1017/S0022112071002842; Avila M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.124501; Paoletti MS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.024501; Nicoud F, 1997, PHYS REV E, V56, P3000, DOI 10.1103/PhysRevE.56.3000; HOCKING LM, 1975, Q J MECH APPL MATH, V28, P341, DOI 10.1093/qjmam/28.3.341; SHEPPARD DM, 1972, PHYS FLUIDS, V15, P241, DOI 10.1063/1.1693900; HAINS FD, 1971, PHYS FLUIDS, V14, P1620, DOI 10.1063/1.1693655; Guha A, 2010, J FLUID MECH, V656, P417, DOI 10.1017/S0022112010001242; Hall P, 2010, J FLUID MECH, V661, P178, DOI 10.1017/S0022112010002892; Dubrulle B, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2008999; Deguchi K, 2013, J FLUID MECH, V721, P58, DOI 10.1017/jfm.2013.27; HALL P, 1991, J FLUID MECH, V227, P641, DOI 10.1017/S0022112091000289; Boyd J.P., 2001, CHEBYSHEV FOURIER SP; COWLEY SJ, 1985, J FLUID MECH, V156, P83, DOI 10.1017/S0022112085002002; Deguchi K, 2013, J FLUID MECH, V720, P582, DOI 10.1017/jfm.2013.51; Deguchi K, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.184502; Drazin PG, 1981, HYDRODYNAMIC STABILI; HALL P, 1988, J FLUID MECH, V193, P243, DOI 10.1017/S0022112088002137; Khapko T, 2013, J FLUID MECH, V717, DOI 10.1017/jfm.2013.20; Lahey PM, 2002, CHEM ENG SCI, V57, P5161, DOI 10.1016/S0009-2509(02)00420-7; Luchini P, 1996, J FLUID MECH, V327, P101, DOI 10.1017/S0022112096008476; Messing R, 2010, J FLUID MECH, V658, P117, DOI 10.1017/S0022112010001576; MILINAZZO FA, 1985, J FLUID MECH, V160, P281, DOI 10.1017/S0022112085003482; NAGATA M, 1986, J FLUID MECH, V169, P229, DOI 10.1017/S0022112086000605; Rayleigh Lord, 1917, P ROY SOC LOND A MAT, V93, P148, DOI 10.1098/rspa.1917.0010	36	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	DEC	2014	760						212	242		10.1017/jfm.2014.600		31	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AT4MM	WOS:000344913500008		
J	Kirillov, ON; Stefani, F; Fukumoto, Y				Kirillov, O. N.; Stefani, F.; Fukumoto, Y.			Local instabilities in magnetized rotational flows: a short-wavelength approach	JOURNAL OF FLUID MECHANICS			English	Article						geophysical and geological flows; instability; MHD and electrohydrodynamics	HELICAL MAGNETOROTATIONAL INSTABILITY; DIFFERENTIAL ROTATION; DIMENSIONLESS NUMBERS; STABILITY ANALYSIS; SHEAR INSTABILITY; FIELDS; MHD; MAGNETOHYDRODYNAMICS; HYDROMAGNETICS; DISKS	We perform a local stability analysis of rotational flows in the presence of a constant vertical magnetic field and an azimuthal magnetic field with a general radial dependence. Employing the short-wavelength approximation we develop a unified framework for the investigation of the standard, helical and azimuthal version of the magnetorotational instability (MRI), as well as of current-driven kink-type instabilities. Considering the viscous and resistive setup, our main focus is on the case of small magnetic Prandtl numbers which applies e.g. to liquid-metal experiments but also to the colder parts of accretion disks. We show that the inductionless versions of MRI that were previously thought to be restricted to comparatively steep rotation profiles extend well to the Keplerian case if only the azimuthal field slightly deviates from its current-free (in the fluid) profile. We find an explicit criterion separating the pure azimuthal inductionless MRI from the regime where this instability is mixed with the Tayler instability. We further demonstrate that for particular parameter configurations the azimuthal MRI originates as a result of a dissipation-induced instability of Chandrasekhar's equipartition solution of ideal magnetohydrodynamics.	[Kirillov, O. N.; Stefani, F.] Helmholtz Zentrum Dresden Rossendorf, D-01314 Dresden, Germany; [Fukumoto, Y.] Inst Math Ind, Nishi Ku, Fukuoka 8190395, Japan	Kirillov, ON (reprint author), Helmholtz Zentrum Dresden Rossendorf, POB 510119, D-01314 Dresden, Germany.	o.kirillov@hzdr.de	Stefani, Frank/B-3287-2010; Kirillov, Oleg/A-4473-2008	Stefani, Frank/0000-0002-8770-4080; Kirillov, Oleg/0000-0002-6150-9308	Helmholtz-Gemeinschaft Deutscher Forschungszentren (HGF); Deutsche Forschungsgemeinschaft [SPP 1488]	This work was supported by Helmholtz-Gemeinschaft Deutscher Forschungszentren (HGF) in frame of the Helmholtz Alliance LIMTECH, as well as by Deutsche Forschungsgemeinschaft in frame of the SPP 1488 (PlanetMag). F.S. acknowledges fruitful discussions with M. Gellert, R. Hollerbach, and G. Rudiger. We thank an anonymous referee for helpful comments.	ACHESON DJ, 1978, PHILOS T R SOC A, V289, P459, DOI 10.1098/rsta.1978.0066; Altmeyer S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046308; Seilmayer M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.244501; Liu W, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056302; Kirillov ON, 2010, ZAMM-Z ANGEW MATH ME, V90, P462, DOI 10.1002/zamm.200900315; Shi JM, 2010, ASTROPHYS J, V708, P1716, DOI 10.1088/0004-637X/708/2/1716; Fromang S, 2007, ASTRON ASTROPHYS, V476, P1113, DOI 10.1051/0004-6361:20077942; Gailitis A, 2000, PHYS REV LETT, V84, P4365, DOI 10.1103/PhysRevLett.84.4365; Monchaux R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.044502; Ji H, 2013, PHYS TODAY, V66, P27; Weber N, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/043034; Done C, 2007, ASTRON ASTROPHYS REV, V15, P1, DOI 10.1007/s00159-007-0006-1; Nornberg MD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.074501; BRANDENBURG A, 1995, ASTROPHYS J, V446, P741, DOI 10.1086/175831; Kirillov ON, 2010, ASTROPHYS J, V712, P52, DOI 10.1088/0004-637X/712/1/52; Hollerbach R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.124501; Rudiger G, 2010, ASTRON NACHR, V331, P121, DOI 10.1002/asna.200911249; Priede J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066314; HOWARD LN, 1962, J FLUID MECH, V14, P463, DOI 10.1017/S0022112062001366; FRIEDLANDER S, 1995, CHAOS, V5, P416, DOI 10.1063/1.166112; BAYLY BJ, 1988, PHYS FLUIDS, V31, P56, DOI 10.1063/1.867002; Hattori Y, 2003, PHYS FLUIDS, V15, P3151, DOI 10.1063/1.1606446; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; Stefani F, 2008, ZAMM-Z ANGEW MATH ME, V88, P930, DOI 10.1002/zamm.200800102; Lesur G, 2007, MON NOT R ASTRON SOC, V378, P1471, DOI 10.1111/j.1365-2966.2007.11888.x; Herault J, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036321; ACHESON DJ, 1973, REP PROG PHYS, V36, P159, DOI 10.1088/0034-4885/36/2/002; TAYLER RJ, 1973, MON NOT R ASTRON SOC, V161, P365; BALBUS SA, 1992, ASTROPHYS J, V400, P610, DOI 10.1086/172022; Sisan DR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.114502; Seilmayer M, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.024505; Stefani F, 2012, MAGNETOHYDRODYNAMICS, V48, P103; Hollerbach R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.044502; Stefani F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.184502; Kirillov ON, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.061103; Armitage P. J., 2011, ANNU REV ASTRON ASTR, V49, P67; Bilharz H, 1944, Z ANGEW MATH MECH, V24, P77, DOI 10.1002/zamm.19440240205; Bogoyavlenskij OI, 2004, J MATH PHYS, V45, P381, DOI 10.1063/1.1629137; CHANDRASEKHAR S, 1960, P NATL ACAD SCI USA, V46, P253, DOI 10.1073/pnas.46.2.253; CHANDRASEKHAR S., 1961, HYDRODYNAMIC HYDROMA; CHANDRASEKHAR S, 1956, P NATL ACAD SCI USA, V42, P273, DOI 10.1073/pnas.42.5.273; DOBROKHOTOV SY, 1992, MATH NOTES+, V51, P47, DOI 10.1007/BF01229434; ECKHARDT B, 1995, CHAOS SOLITON FRACT, V5, P2073, DOI 10.1016/0960-0779(95)00016-W; ECKHOFF KS, 1981, J DIFFER EQUATIONS, V40, P94, DOI 10.1016/0022-0396(81)90012-7; ECKHOFF KS, 1987, PHYS FLUIDS, V30, P3673, DOI 10.1063/1.866404; Fleming TP, 2000, ASTROPHYS J, V530, P464, DOI 10.1086/308338; Friedlander S., 2003, HDB MATH FLUID DYNAM, V2, P289, DOI 10.1016/S1874-5792(03)80010-1; Fuchs H., 1999, ASTRON NACHR, V320, P127; Goedbloed H., 2010, ADV MAGNETOHYDRODYNA; Golovin SV, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/23/235501; Ji HT, 2001, MON NOT R ASTRON SOC, V325, pL1, DOI 10.1046/j.1365-8711.2001.04647.x; Kagan D, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/21; Kapyla PJ, 2011, MON NOT R ASTRON SOC, V413, P901, DOI 10.1111/j.1365-2966.2010.18184.x; Kirillov ON, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/83; Kirillov O. N., 2013, DE GRUYTER STUDIES M, V14; Kirillov ON, 2009, P R SOC A, V465, P2703, DOI 10.1098/rspa.2009.0055; Kirillov ON, 2014, FLUID DYN RES, V46, DOI 10.1088/0169-5983/46/3/031403; Kirillov ON, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036304; Kirillov ON, 2012, ACTA APPL MATH, V120, P177, DOI 10.1007/s10440-012-9689-z; Krolik JH, 1998, ACTIVE GALACTIC NUCL; KRUEGER ER, 1966, J FLUID MECH, V24, P521, DOI 10.1017/S002211206600079X; LANDMAN MJ, 1987, PHYS FLUIDS, V30, P2339, DOI 10.1063/1.866124; LIFSCHITZ A, 1991, PHYS FLUIDS A-FLUID, V3, P2644, DOI 10.1063/1.858153; LIFSCHITZ A, 1991, PHYS LETT A, V157, P481, DOI 10.1016/0375-9601(91)91023-7; Lifschitz A.E., 1989, MAGNETOHYDRODYNAMICS; Marcus PS, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.084501; Michael D. H., 1954, MATHEMATIKA, V1, P45; MONTGOMERY D, 1993, PLASMA PHYS CONTR F, V35, pB105, DOI 10.1088/0741-3335/35/SB/008; Muller U, 2000, NATURWISSENSCHAFTEN, V87, P381, DOI 10.1007/s001140050746; Ogilvie GI, 1996, MON NOT R ASTRON SOC, V279, P152; Oishi JS, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/18; Petitdemange L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034395; Rudiger G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016319; Rudiger G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.068301; Rudiger G, 2013, MAGNETIC PROCESSES A; Spruit H. C., ASTRON ASTROPHYS, V381, P923; Squire J, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.025006; Stefani F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/295; Stefani F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066303; Umurhan OM, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913169; VELIKHOV EP, 1959, SOV PHYS JETP-USSR, V9, P995; Vishik M, 1998, Q APPL MATH, V56, P377	82	6	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0022-1120	1469-7645		J FLUID MECH	J. Fluid Mech.	DEC	2014	760						591	633		10.1017/jfm.2014.614		43	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AT4MM	WOS:000344913500022		
J	Okada, Y				Okada, Yasuhiko			Functions of Chisan dams in large-scale granular mass-flow experiments on Sakurajima volcano pumiceous clasts	JOURNAL OF FOREST RESEARCH			English	Article						Chisan dams; Granular mass flows; Large-scale model flume experiments; Peak impact load; Sediment captured		We investigated the fundamental behaviour of Chisan (check) dams in response to the presence or absence of impounded sediment with different levels of saturation. Large-scale model flume experiments were conducted by use of a model Chisan dam that had been backfilled with pumiceous clasts taken from the Sakurajima volcano in Kagoshima prefecture, Japan. In these experiments, the miniature dam was situated midway down the flume under different backfill sediment conditions and the basal pore-fluid pressure, normal flow depth, and impact load of the granular mass were carefully monitored. Saturated sediment with a volume of 0.6 m(3) was released along the slope of the flume segment at 30A degrees and excess pore-fluid pressure was generated, corresponding to a sediment velocity of approximately 4.8 m s(-1). Direct collision of the sediment with the Chisan dam meant the peak impact loads of granular mass against the back surface of the dam exceeded 157 N in experiments without backfill sediment but were as low as 32.1 N in experiments with sediment. Accordingly, placing the backfill sediment substantially reduced peak impact loads. The sediment captured by the Chisan dams was also calculated. For experiments using saturated backfill sediment, the dam captured only 35 % of the material, indicating that most of the granular mass passed over the dam. However, in experiments without backfill sediment or with unsaturated backfill sediment, over 90 % was captured. Although Chisan dams with unsaturated backfill sediment lacked pocket space, almost equivalent granular masses were trapped in these experiments. On the basis of these results, we suggest that Chisan dams with unsaturated backfill sediment could effectively counter debris flow, reducing sediment loads along the streams draining Sakurajima volcano.	Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Okada, Y (reprint author), Forestry & Forest Prod Res Inst, Matsunosato 1, Tsukuba, Ibaraki 3058687, Japan.	okada10@ffpri.affrc.go.jp			Kyushu Regional Forest Office, the Forestry Agency, the Ministry of Agriculture, Forestry and Fisheries, Japan	The author would like to express the most sincere appreciation to Professor Sumio Matsuura (Disaster Prevention Research Institute, Kyoto University) for his valuable advice, suggestions, and encouragement. Effective discussion with Dr Hirotaka Ochiai and Messrs Ushio Kurokawa and Takashi Miyamae (Forestry and Forest Products Research Institute) is also extremely valuable. The author would like to sincerely thank to the staff of Kyouwa Giken Inc. for their help in managing the experimental environment. Finally, it is noted that this work was carried out with financial support from the Kyushu Regional Forest Office, the Forestry Agency, the Ministry of Agriculture, Forestry and Fisheries, Japan.	Iverson RM, 1997, REV GEOPHYS, V35, P245, DOI 10.1029/97RG00426; Cruden DM, 1996, LANDSLIDES INVESTIGA, P501; Gonda Y, 2009, INT J EROS CONTROL E, V2, P15; Horii N, 2002, SPEC RES REP IND SAF, V25, P17; Hubl J, 2009, P 11 INT S WAT MAN H, P137; Ishikawa N, 2008, P INTERPRAEVENT, P343; Ishikawa N, 2010, P INTERPRAEVENT, P207; Kagawa T., 1978, P JAPAN SOC CIVIL EN, V275, P69; Mizuyama T., 2008, INT J EROSION CONTRO, V1, P38, DOI DOI 10.13101/IJECE.1.38; Okada Y, 2008, ENG GEOL, V97, P1, DOI 10.1016/j.enggeo.2007.10.004; The Japanese Geotechnical Society, 2000, METH GUID SOIL TESTS; The Nihon Chisan Chisui Kyokai, 2009, GUID CHIS SLOP CONS	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	DEC	2014	19	6					493	500		10.1007/s10310-014-0443-4		8	Forestry	Forestry	AT7CQ	WOS:000345094700003		
J	Hirata, R; Ito, S; Araki, MG; Mitsuda, Y; Takagi, M				Hirata, Ryoko; Ito, Satoshi; Araki, Masatake G.; Mitsuda, Yasushi; Takagi, Masahiro			Growth recovery of young hinoki (Chamaecyparis obtusa) subsequent to late weeding	JOURNAL OF FOREST RESEARCH			English	Article						Growth analysis; Net assimilation rate; Relative growth rate; Shade-leaf		The effects of late weeding treatment on the growth of young hinoki (Chamaecyparis obtusa) during the sixth growing season after planting were examined. Furthermore, the contribution toward hinoki growth recovery of crown productivity (NAR) and biomass allocation to crown (CAR) were determined. In the late weeding plot, no decline in height growth was observed subsequent to weeding, and growth in diameter at breast height (DBH) and crown projection area (CPA) began to recover subsequent to weeding; however, DBH and CPA were reduced and experienced a 1- to 1.5-year growth delay compared to values associated with the weeding plot at the end of the second year subsequent to weeding. Relative growth rate (RGR) and NAR in the late weeding plot recovered and possessed similar values to those of the weeding plot in the second year subsequent to weeding. CAR values of the late weeding plot were similar to those of the weeding plot both before and after weeding. These results suggested that the recovery of NAR rather than that of CAR was primarily responsible for the recovery of RGR. The present study demonstrated that hinoki were able to quickly acclimate to an environment dramatically altered by late weeding and recover growth rate within a short period of time. The present study also showed that delays in crown expansion associated with late weeding may have impeded subsequent matter production. Therefore, it was concluded that late weeding treatments should be employed only when the associated delays in growth are taken into account.	[Hirata, Ryoko; Ito, Satoshi; Mitsuda, Yasushi; Takagi, Masahiro] Miyazaki Univ, Fac Agr, Miyazaki 8892192, Japan	Ito, S (reprint author), Miyazaki Univ, Fac Agr, 1-1 Gakuen Kibanadai Nishi, Miyazaki 8892192, Japan.	s.ito@cc.miyazaki-u.ac.jp			Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries under the Agriculture, Forestry and Fisheries Research Council Secretariat (AFFRC) of Japan [21020]; JSPS [25252029]	We would like to thank the staff of the Tano Forest Science Station at the University of Miyazaki for their assistance during field surveys. The present study was supported in part by the Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries under the Agriculture, Forestry and Fisheries Research Council Secretariat (AFFRC) of Japan (No. 21020), and Grant-in-Aid for Scientific Research from JSPS (No. 25252029).	Morikawa Y, 1986, TREE PHYSIOL, V2, P105; Evans GC, 1972, QUANTITATIVE ANAL PL; Forestry Agency, 2013, ANN REP TRENDS FOR F; Fukata H, 2006, B KOCHI PREFECT FOR, V31, P24; Han QM, 2014, J FOREST RES-JPN, V19, P184, DOI 10.1007/s10310-013-0405-2; Hirata R., 2012, Journal of the Japanese Forest Society, V94, P135, DOI 10.4005/jjfs.94.135; Kawanabe S, 1968, B KYOTO U FOR, V40, P111; Kinjou T, 2012, KYUSHU J FOR RES, V65, P24; Muramoto Y, 1998, JPN J FOR ENV, V40, P27; R Core Team, 2012, R LANG ENV STAT COMP; SAKURA T, 1980, Journal of the Japanese Forestry Society, V62, P371; Sato D, 1983, IKURIN; Shidei T, 1974, HINOKI RIN; Shinozaki K., 1964, JAPANESE J ECOL, V14, P97; Tanaka T, 1994, JPN SOC FOREST ENV, V36, P22; Tange T., 1991, Journal of the Japanese Forestry Society, V73, P288; Tsutsumi T, 1994, ZOURINGAKU; Yukutake K, 2006, SCAND FOR EC, V41, P429	18	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	DEC	2014	19	6					514	522		10.1007/s10310-014-0450-5		9	Forestry	Forestry	AT7CQ	WOS:000345094700005		
J	Ueda, A; Kobayashi, M				Ueda, Akira; Kobayashi, Masahide			Effects of mating on the termination of aggregation by the oak borer, Platypus quercivorus (Murayama) (Curculionidae: Platypodinae) during host colonization	JOURNAL OF FOREST RESEARCH			English	Article						Attractiveness; Mass attack; Oak wilt; Platypodidae; Platypus quercivorus	DOUGLAS-FIR BEETLE; SOUTHERN PINE-BEETLE; BALSAM BARK BEETLE; HIGH-RISK STANDS; COLEOPTERA-SCOLYTIDAE; ANTIAGGREGATION PHEROMONE; SECONDARY ATTRACTION; IPS-TYPOGRAPHUS; DENDROCTONUS; ATTACK	We conducted a field experiment to determine whether logs bored by male Platypus quercivorus beetle were less attractive to conspecifics after beetles had mated. Bored (with male beetles) and unbored logs were placed in a beetle-infested forest and enclosed within a cage. For half of the bored logs, female beetles were released to mate with the male beetles. Log attractiveness was determined by assessing the number of beetles captured on adhesive paper placed on each cage enclosing the log. On the logs on which female beetles were released, the number of beetles captured decreased distinctly after release, and did not differ from the number captured on the unbored logs. In contrast, the number of beetles captured on logs with only unpaired males was higher than the number captured on the unbored logs. This result confirms that the attractiveness of logs bored by male P. quercivorus beetles declines after mating occurs. To our knowledge, this is the first evidence for the relaxation of aggregation pheromone following mating for beetles in the subfamily Platypodinae.	[Ueda, Akira] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Chuo Ku, Kumamoto 8600862, Japan; [Kobayashi, Masahide] Kyoto Prefectural Univ, Sakyo Ku, Kyoto 6060823, Japan	Ueda, A (reprint author), Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Chuo Ku, Kurokami 4-11-16, Kumamoto 8600862, Japan.	akira@ffpri.affrc.go.jp					BYERS JA, 1984, J CHEM ECOL, V10, P861, DOI 10.1007/BF00987969; BYERS JA, 1981, J CHEM ECOL, V7, P1135, DOI 10.1007/BF00987633; BIRGERSSON G, 1984, J CHEM ECOL, V10, P1029, DOI 10.1007/BF00987511; Elliott EW, 1975, J CHEM ECOL, V1, P283, DOI 10.1007/BF00988829; GORE WE, 1977, J CHEM ECOL, V3, P429, DOI 10.1007/BF00988186; Holsten EH, 2003, J ECON ENTOMOL, V96, P31, DOI 10.1603/0022-0493-96.1.31; Ito S., 1998, Journal of the Japanese Forestry Society, V80, P229; Ito S., 1998, Journal of the Japanese Forestry Society, V80, P170; Kim J, 2009, J AGR FOOD CHEM, V57, P1406, DOI 10.1021/jf8032717; Kinuura H, 2002, J FOR RES, V7, P7, DOI DOI 10.1007/BF02762592; Kitajima H, 2004, APPL ENTOMOL ZOOL, V39, P7, DOI 10.1303/aez.2004.7; Kobayashi M., 2005, Journal of the Japanese Forest Society, V87, P435; Kobayashi M, 2001, APPL FOR SCI, V10, P79; Kobayashi M, 2001, J FOREST RES, V6, P153, DOI 10.1007/BF02767086; Kobayashi M, 2003, JPN J APPL ENTOMOL Z, V47, P53, DOI 10.1303/jjaez.2003.53; Kubono Takanori, 2002, Mycoscience, V43, P255, DOI 10.1007/s102670200037; Leufven A, 1986, CAN J BOT, V65, P1038; LINDGREN BS, 1988, J APPL ENTOMOL, V105, P289; MADRID F, 1972, Zeitschrift fuer Angewandte Entomologie, V72, P73; MCGREGOR MD, 1984, J FOREST, V82, P613; Milligan R. H., 1982, Insect pheromones and their application. Proceedings of a workshop held at Mount Albert Research Centre, Auckland, New Zealand, 10-12 February 1981, P37; MILLIGAN R H, 1982, New Zealand Journal of Forestry, V27, P236; MILLIGAN RH, 1988, J APPL ENTOMOL, V106, P113; NIJHOLT WW, 1973, CAN ENTOMOL, V105, P583; NIJHOLT WW, 1970, CAN ENTOMOL, V102, P894; R Core Team, 2013, R LANG ENV STAT COMP; RENWICK JAA, 1970, CONTRIB BOYCE THOMPS, V24, P283; RICHERSON JV, 1979, ENVIRON ENTOMOL, V8, P360; Ross DW, 1995, CAN ENTOMOL, V127, P805; ROSS DW, 1994, CAN J FOREST RES, V24, P2184, DOI 10.1139/x94-281; Ross DW, 2002, J ECON ENTOMOL, V95, P778, DOI 10.1603/0022-0493-95.4.778; RUDINSKY JA, 1974, ENVIRON ENTOMOL, V3, P90; SAS Institute, 1998, STATVIEW POWERPC VER; SASAKAWA M, 1981, Kontyu, V49, P461; SCHLYTER F, 1989, J CHEM ECOL, V15, P2263, DOI 10.1007/BF01014114; STOCK AJ, 1990, CAN ENTOMOL, V122, P935; STOCK AJ, 1983, CAN ENTOMOL, V115, P539; Tokoro Masahiko, 2007, Bulletin of the Forestry and Forest Products Research Institute, V6, P49; Ueda A, 2003, APPL FOR SCI, V12, P137; Ueda A., 2001, Journal of the Japanese Forestry Society, V83, P77; Ueda Akira, 2005, Bulletin of the Forestry and Forest Products Research Institute, V4, P39; Ueda Akira, 2004, Bulletin of the Forestry and Forest Products Research Institute, V3, P99; Ueda A, 2001, J FOR RES, V6, P173, DOI 10.1007/BF02767089; YTSMA G, 1989, J CHEM ECOL, V15, P1171, DOI 10.1007/BF01014820; YTSMA G, 1986, J APPL ENTOMOL, V102, P210; Zang Q-H, 2003, AGR FOREST ENTOMOL, V5, P145; Zang Q-H, 2001, J CHEM ECOL, V27, P995; Zang Q-H, 2003, OIKOS, V101, P299	48	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-6979	1610-7403		J FOREST RES-JPN	J. For. Res.	DEC	2014	19	6					523	528		10.1007/s10310-014-0446-1		6	Forestry	Forestry	AT7CQ	WOS:000345094700006		
J	Hasuike, T				Hasuike, Takashi			Risk-control approach for bottleneck transportation problem with randomness and fuzziness	JOURNAL OF GLOBAL OPTIMIZATION			English	Article						Bottleneck transportation problem; Risk-control; Multiobjective programming problem; Strict algorithm	SHORTEST-PATH PROBLEM; INTERVAL DATA; TIME; OPTIMIZATION; ALGORITHM	Solving transportation problems is essential in engineering and supply chain management, where profitability depends on optimal traffic flow. This study proposes risk-control approaches for two bottleneck transportation problems with random variables and preference levels to objective functions with risk parameters. Each proposed model is formulated as a multiobjective programming problem using robust-based optimization derived from stochastic chance constraints. Since it is impossible to obtain a transportation pattern that optimizes all objective functions, our proposed models are numerically solved by introducing an aggregation function for the multiobjective problem. An exact algorithm that performs deterministic equivalent transformations and introduces auxiliary problems is also developed.	Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan	Hasuike, T (reprint author), Osaka Univ, Grad Sch Informat Sci & Technol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	thasuike@ist.osaka-u.ac.jp					Bertsimas D, 2003, MATH PROGRAM, V98, P49, DOI 10.1007/s10107-003-0396-4; Yu G, 1998, COMPUT OPER RES, V25, P457; Montemanni R, 2004, COMPUT OPER RES, V31, P1667, DOI 10.1016/S0305-0548(03)00114-X; Ben-Tal A, 1999, OPER RES LETT, V25, P1, DOI 10.1016/S0167-6377(99)00016-4; Atamturk A, 2007, OPER RES, V55, P662, DOI 10.1287/opre.1070.0428; Averbakh I, 2004, DISCRETE APPL MATH, V138, P289, DOI 10.1016/S0166-218X(03)00462-1; Bellman R.E., 1970, MANAGE SCI, V17, P141, DOI DOI 10.1287/MNSC.17.4.B141; Ben-Tal A., 2001, LECT MODERN CONVEX O; Branda M, 2012, ANN OPER RES, V193, P3, DOI 10.1007/s10479-010-0811-1; Gabrel V, 2013, ANN OPER RES, V207, P97, DOI 10.1007/s10479-011-1004-2; GARFINKE.RS, 1971, NAV RES LOGIST Q, V18, P465, DOI 10.1002/nav.3800180404; Ge Y, 2011, KYBERNETIKA, V47, P560; Ge Y., 2012, P 8 KOR JAP WORKSH, P135; GEETHA S, 1994, J OPER RES SOC, V45, P583; Ghaoui L.E., 1997, J MATRIX ANAL APPL, V18, P1035; Gupta Kavita, 2013, Opsearch, V50, DOI 10.1007/s12597-013-0125-6; HAMMER PL, 1969, NAV RES LOGIST Q, V16, P345; Hasuike T, 2013, INFORM SCIENCES, V221, P520, DOI 10.1016/j.ins.2012.09.025; Hochbaum DS, 1999, OPER RES LETT, V24, P25, DOI 10.1016/S0167-6377(98)00053-4; Kall P, 1994, STOCHASTIC PROGRAMMI; Montemanni R., 2005, 4OR-Q J OPER RES, V3, P315, DOI DOI 10.1007/S10288-005-0066-X; Prekopa A, 2003, HDBK OPER R, V10, P267; RUSSELL RA, 1983, NAV RES LOG, V30, P13, DOI 10.1002/nav.3800300103; SRINIVASAN V, 1976, NAV RES LOG, V23, P567, DOI 10.1002/nav.3800230402; Szwarc W, 1971, NAV RES LOGIST Q, V18, P463; Zimmermann H.-J., 1978, Fuzzy Sets and Systems, V1, DOI 10.1016/0165-0114(78)90031-3	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-5001	1573-2916		J GLOBAL OPTIM	J. Glob. Optim.	DEC	2014	60	4			SI		663	678		10.1007/s10898-014-0208-9		16	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	AT6YP	WOS:000345083300006		
J	Joshita, S; Umemura, T; Ota, M; Tanaka, E				Joshita, Satoru; Umemura, Takeji; Ota, Masao; Tanaka, Eiji			AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis	JOURNAL OF HEPATOLOGY			English	Letter							SUSCEPTIBILITY		[Joshita, Satoru; Umemura, Takeji; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 3908621, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 3908621, Japan	Joshita, S (reprint author), Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	joshita@shinshu-u.ac.jp					Trivedi PJ, 2014, J HEPATOL, V60, P1249, DOI 10.1016/j.jhep.2014.01.029; [Anonymous], 2014, HEPATOL RES, V44, P71; Poupon R, 2008, J HEPATOL, V49, P1038, DOI 10.1016/j.jhep.2008.07.027; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Umemura T, 2012, HEPATOLOGY, V55, P506, DOI 10.1002/hep.24705; EASL Clinical Practice Guidelines, 2009, J HEPATOL, V51, P237; Joshita S, 2010, J HEPATOL, V53, P537, DOI 10.1016/j.jhep.2010.03.017; Joshita S, 2014, DIS MARKERS, V2014, P8	8	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-8278	1600-0641		J HEPATOL	J. Hepatol.	DEC	2014	61	6					1443	1445				4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AT7KQ	WOS:000345115600039		
J	Nanba, K; Tsuiki, M; Nakao, K; Nanba, A; Usui, T; Tagami, T; Hirokawa, Y; Okuno, H; Suzuki, T; Shimbo, T; Shimatsu, A; Naruse, M				Nanba, K.; Tsuiki, M.; Nakao, K.; Nanba, A.; Usui, T.; Tagami, T.; Hirokawa, Y.; Okuno, H.; Suzuki, T.; Shimbo, T.; Shimatsu, A.; Naruse, M.			A subtype prediction score for primary aldosteronism	JOURNAL OF HUMAN HYPERTENSION			English	Article							PRIMARY HYPERALDOSTERONISM; HYPERTENSIVE PATIENTS; PREVALENCE; DIAGNOSIS; SOCIETY; GUIDELINES; MODERATE; ADENOMA	Primary aldosteronism (PA) is the most common cause of endocrine hypertension. Although adrenal venous sampling (AVS) is recommended as the gold standard procedure for subtype classification in PA, it is a specialized technique with limited availability. The objective of this study was to develop a scoring system that predicted PA subtype using clinical characteristics. Seventy-one patients with PA were studied. The subjects were diagnosed as having either unilateral (n = 32) or bilateral disease (n = 39) based on AVS, surgery and/or the postoperative clinical course. Variables associated with laterality in the univariate analysis were entered into multivariable logistic regression models and the regression coefficients were used to construct a subtype prediction score. The diagnostic significance of the score was then evaluated using receiver operating characteristic (ROC) curve analysis. The subtype prediction score was calculated as follows: serum potassium <= 3.4 mEq l(-1), 2 points; plasma aldosterone concentration >= 165 pg ml(-1), 3 points; and aldosterone to renin ratio >= 1000 in a post-captopril challenge test (plasma renin activity in ng ml(-1) h(-1)), 3 points. ROC curve analysis for the ability to discriminate between unilateral and bilateral PA showed that a score of 5 points had 75% sensitivity and 95% specificity, and a score of 3 points had a sensitivity of 97% and a specificity of 59%. The area under the ROC curve was 0.920 (95% confidence interval, 0.859-0.979). Our subtype prediction score could discriminate between unilateral and bilateral PA and is useful for selecting patients who should undergo AVS before surgery.	[Nanba, K.; Tsuiki, M.; Nakao, K.; Nanba, A.; Usui, T.; Tagami, T.; Shimatsu, A.; Naruse, M.] Natl Hosp Org, Kyoto Med Ctr, Dept Endocrinol Metab & Hypertens, Kyoto 6128555, Japan; [Hirokawa, Y.] Natl Hosp Org Kyoto, Med Ctr, Dept Radiol, Kyoto 6128555, Japan; [Okuno, H.] Natl Hosp Org Kyoto, Med Ctr, Dept Urol, Kyoto 6128555, Japan; [Suzuki, T.; Shimbo, T.] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo, Japan	Naruse, M (reprint author), Natl Hosp Org, Kyoto Med Ctr, Dept Endocrinol Metab & Hypertens, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	mnaruse@kyotolan.hosp.go.jp			National Hospital Organization; Ministry of Health, Labor and Welfare, Japan	This study was supported, in part, by grants-in-aid for the study of PA from the National Hospital Organization, and for the study of Adrenal Hormone Disorders from the Ministry of Health, Labor and Welfare, Japan.	Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2012, J CLIN ENDOCR METAB, V97, P1606, DOI 10.1210/jc.2011-2830; Rossi GP, 2006, HYPERTENSION, V48, P232, DOI 10.1161/01.HYP.0000230444.01215.6a; Nanba K, 2013, J CLIN ENDOCR METAB, V98, P1567, DOI 10.1210/jc.2012-3726; Young WF, 2007, CLIN ENDOCRINOL, V66, P607, DOI 10.1111/j.1365-2265.2007.02775.x; Nishimoto K, 2010, J CLIN ENDOCR METAB, V95, P2296, DOI 10.1210/jc.2009-2010; Kupers EM, 2012, J CLIN ENDOCR METAB, V97, P3530, DOI 10.1210/jc.2012-1917; Williams JS, 2006, J HUM HYPERTENS, V20, P129, DOI 10.1038/sj.jhh.1001948; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; Calhoun DA, 2002, HYPERTENSION, V40, P892, DOI 10.1161/01.HYP.0000040261.30455.B6; Rossi GP, 2008, J NEPHROL, V21, P455; Burton TJ, 2012, J CLIN ENDOCR METAB, V97, P100, DOI 10.1210/jc.2011-1537; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Sukor N, 2009, J CLIN ENDOCR METAB, V94, P2437, DOI 10.1210/jc.2008-2803; Strauch B, 2003, J HUM HYPERTENS, V17, P349, DOI 10.1038/sj.jhh.1001554; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Nishikawa T, 2011, ENDOCR J, V58, P711; BIGLIERI EG, 1989, J STEROID BIOCHEM, V32, P199, DOI 10.1016/0022-4731(89)90164-7; Ito Y, 2011, HYPERTENS RES, V34, P98, DOI 10.1038/hr.2010.166; Nanba K, 2012, J CLIN ENDOCR METAB, V97, P1688, DOI 10.1210/jc.2011-2504; Nishikawa T, 2000, BIOMED PHARMACOTHER, V54, p83S, DOI 10.1016/S0753-3322(00)80019-0; NOMURA K, 1990, J CLIN ENDOCR METAB, V71, P825; Sonoyama T, 2011, J CLIN ENDOCR METAB, V96, P2771, DOI 10.1210/jc.2011-0573; Westerdahl C, 2011, SCAND J PRIM HEALTH, V29, P57, DOI 10.3109/02813432.2011.554015	24	2	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9240	1476-5527		J HUM HYPERTENS	J. Hum. Hypertens.	DEC	2014	28	12					716	720		10.1038/jhh.2014.20		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7LL	WOS:000345118200004		
J	Eguchi, K; Hoshide, S; Shimada, K; Kario, K				Eguchi, K.; Hoshide, S.; Shimada, K.; Kario, K.			How many clinic BP readings are needed to predict cardiovascular events as accurately as ambulatory BP monitoring?	JOURNAL OF HUMAN HYPERTENSION			English	Article						multiple clinic BP readings; ambulatory BP; stroke; cardiovascular disease (CVD) events	TREATED HYPERTENSIVE PATIENTS; BLOOD-PRESSURE-MEASUREMENTS; AMERICAN-HEART-ASSOCIATION; WHITE-COAT HYPERTENSION; 10-YEAR FOLLOW-UP; SYSTOLIC HYPERTENSION; PROGNOSTIC VALUE; OLDER PATIENTS; MORNING SURGE; STROKE	We tested the hypothesis that multiple clinic blood pressure (BP) readings over an extended baseline period would be as predictive as ambulatory BP (ABP) for cardiovascular disease (CVD). Clinic and ABP monitoring were performed in 457 hypertensive patients at baseline. Clinic BP was measured monthly and the means of the first 3, 5 and 10 clinic BP readings were taken as the multiple clinic BP readings. The subjects were followed up, and stroke, HARD CVD, and ALL CVD events were determined as outcomes. In multivariate Cox regression analyses, ambulatory systolic BP (SBP) best predicted three outcomes independently of baseline and multiple clinic SBP readings. The mean of 10 clinic SBP readings predicted stroke (hazards ratio (HR) = 1.39, 95% confidence interval (CI) = 1.02-1.90, P = 0.04) and ALL CVD (HR = 1.41, 95% CI = 1.13-1.74, P = 0.002) independently of baseline clinic SBP. Clinic SBPs by three and five readings were not associated with any CVD events, except that clinic SBP by three readings was associated with ALL CVD (P = 0.015). Besides ABP values, the mean of the first 10 clinic SBP values was a significant predictor of stroke and ALL CVD events. It is important to take more than several clinic BP readings early after the baseline period for the risk stratification of future CVD events.	[Eguchi, K.; Hoshide, S.; Kario, K.] Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Shimada, K.] Shinoyama City Hosp, Dept Cardiovasc Med, Oyama, Japan	Eguchi, K (reprint author), Jichi Med Univ, Sch Med, Dept Med, Div Cardiovasc Med, 3311-1 Shimotsuke, Shimotsuke, Tochigi, Japan.	ke112@jichi.ac.jp					Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS5, DOI DOI 10.2337/DIACARE.27.2007.S5; Ohkubo T, 1997, AM J HYPERTENS, V10, P1201, DOI 10.1016/S0895-7061(97)00274-4; Kario K, 1996, HYPERTENSION, V27, P130; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Eguchi K, 2008, AM J HYPERTENS, V21, P443, DOI 10.1038/ajh.2008.4; Lewington S, 2002, LANCET, V360, P1903; Ohkubo T, 2000, J HYPERTENS, V18, P847, DOI 10.1097/00004872-200018070-00005; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Verdecchia P, 2000, HYPERTENSION, V35, P844; Ohkubo T, 2005, J AM COLL CARDIOL, V46, P508, DOI 10.1016/j.jacc.2005.03.070; Dolan E, 2005, HYPERTENSION, V46, P156, DOI 10.1161/01.HYP.0000170138.56903.7a; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Dolan E, 2009, J HYPERTENS, V27, P876, DOI 10.1097/HJH.0b013e328322cd62; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; MANCIA G, 1994, J HYPERTENS, V12, P469; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75; Eguchi K, 2003, STROKE, V34, P2471, DOI 10.1161/01.STR.0000089684.41902.CD; Mancia G, 2000, HYPERTENSION, V36, P894; [Anonymous], 1999, J HYPERTENS, V17, P151; Verdecchia P, 2005, HYPERTENSION, V45, P203, DOI 10.1161/01.HYP.0000151623.49780.89; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/01.hjh.0000125406.50839.15; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; VERDECCHIA P, 1994, HYPERTENSION, V24, P793; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Eguchi K, 2011, BLOOD PRESS MONIT, V16, P142, DOI 10.1097/MBP.0b013e328346d669; Eguchi K, 2007, ARCH INTERN MED, V167, P388, DOI 10.1001/archinte.167.4.388; Eguchi K, 2007, AM J HYPERTENS, V20, P1268, DOI 10.1016/j.amjhyper.2007.08.012; Eguchi K, 2010, HYPERTENS RES, V33, P737, DOI 10.1038/hr.2010.61; IMAI Y, 1992, AM J HYPERTENS, V5, P719; Mancia G, 2012, HYPERTENSION, V60, P1400, DOI 10.1161/HYPERTENSIONAHA.112.199562; National Institute for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY; Powers BJ, 2011, ANN INTERN MED, V154, P781, DOI 10.7326/0003-4819-154-12-201106210-00005	44	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9240	1476-5527		J HUM HYPERTENS	J. Hum. Hypertens.	DEC	2014	28	12					731	735		10.1038/jhh.2014.8		5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7LL	WOS:000345118200007		
J	Ohara, N; Jang, S; Kure, S; Chen, ZQR; Kavvas, ML				Ohara, Noriaki; Jang, SuHyung; Kure, Shuichi; Chen, Z. Q. Richard; Kavvas, M. Levent			Modeling of Interannual Snow and Ice Storage in High-Altitude Regions by Dynamic Equilibrium Concept	JOURNAL OF HYDROLOGIC ENGINEERING			English	Article						Inland glacier; Interannual snow and ice storage; Dynamic equilibrium; Climate change; Pamir Mountains; Water resources	WATER-RESOURCES; GLACIER; BALANCE; MOUNTAINS; CLIMATE	The energy and mass balance model for terrestrial ice and snow is an essential tool for the future projection of interannual snow and ice storage including glaciers. However, the snow models in the hydrologic engineering field have barely considered the long-term behavior of the snow and ice storage because the time scale of glacier dynamics is much longer than those of river flow and seasonal snowmelt. This paper proposes an appropriate treatment for inland glaciers as systems in dynamic equilibrium that stay constant under a static climate condition. It is conjectured that the snow and ice vertical movement from high-elevation areas to valleys (lower elevation areas) by means of wind redistribution, avalanches, and glacial motion may be considered as an equilibrator of the snow and ice storage system because it stimulates snow and ice ablation. In order to demonstrate this concept, a simple dynamic equilibrium model for regional to global scales is proposed and applied to the Pamirs. The interannual snow and ice storage in the Pamir Mountains may lose about half of their volume by the end of 21st century by the anticipated global warming based on nine selected general circulation model (GCM) projections. (C) 2014 American Society of Civil Engineers.	[Ohara, Noriaki] Univ Wyoming, Dept Civil & Architectural Engn, Laramie, WY 82071 USA; [Jang, SuHyung; Kavvas, M. Levent] Univ Calif Davis, Dept Civil & Environm Engn, Hydrol Res Lab, Davis, CA 95616 USA; [Kure, Shuichi] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 9808576, Japan; [Chen, Z. Q. Richard] Calif Dept Water Resources, Sacramento, CA 95821 USA	Ohara, N (reprint author), Univ Wyoming, Dept Civil & Architectural Engn, 1000 E Univ Ave, Laramie, WY 82071 USA.	nohara1@uwyo.edu; shjang@ucdavis.edu; kure@irides.tohoku.ac.jp; zhqchen@sbcglobal.net; leventkavvas@sbcglobal.net	Kure, Shuichi/J-5842-2015				Aizen VB, 2007, GLOBAL PLANET CHANGE, V56, P341, DOI 10.1016/j.gloplacha.2006.07.020; Kure S, 2013, HYDROL PROCESS, V27, P4057, DOI 10.1002/hyp.9535; HALL DK, 1995, REMOTE SENS ENVIRON, V54, P127, DOI 10.1016/0034-4257(95)00137-P; Huss M, 2010, HYDROL EARTH SYST SC, V14, P815, DOI 10.5194/hess-14-815-2010; Singh P, 2005, J HYDROL, V300, P140, DOI 10.1016/j.jhydrol.2004.06.005; Rees HG, 2006, HYDROL PROCESS, V20, P2157, DOI 10.1002/hyp.6209; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Benn DI, 2000, QUATERN INT, V65-6, P15, DOI 10.1016/S1040-6182(99)00034-8; BETS Consulting Services, 2010, 2356 ADB KHATL PROV; Brouwer C., 1986, 3 FAO; Chen J, 1990, IAHS PUBL, V193, P127; Cuffey K.M., 2010, PHYS GLACIERS; De Smedt B, 2003, ANN GLACIOL-SER, V37, P143, DOI 10.3189/172756403781815654; Dolgoushin LD, 1975, INT ASS HYDROLOGICAL, V104, P292; Getinsa Ingenieria S. L., 2010, HEC HMS HYDROLOGIC M; Hirabayashi Y, 2010, J HYDROL, V390, P245, DOI 10.1016/j.jhydrol.2010.07.001; Hoelzle M., 2010, GEOPH RES ABSTR, V12; Hoinkes H., 1970, Z GLETSCHERKUNDE GLA, P37; HUYBRECHTS P, 1989, GLAC QUAT G, V6, P373; Intergovernmental Panel on Climate Change (IPCC), 2007, AR4 IPCC; KONOVALOV VG, 1994, J GLACIOL, V40, P149; KRUSS P, 1984, J GLACIOL, V30, P212; Kure S, 2013, HYDROL PROCESS, V27, P4071, DOI 10.1002/hyp.9536; Makhmadaliev B., 2008, 2 NATL COMMUNICATION; Martinec J., 2008, WINSRM VERSION 1 11; Muller F., 1976, GEOGRAPHISCHES I PUB, V57; Nakicenovic N, 2000, SPECIAL REPORT EMISS; National Snow and Ice Data Center, 1999, WORLD GLAC INV; Ohara N, 2011, J HYDROL ENG, V16, P1071, DOI 10.1061/(ASCE)HE.1943-5584.0000209; Solomon, 2010, GLACIERSWATER RESOUR; State Agency for Hydrometeorology, 2003, GLAC TAJ; Zemp M., 2008, GLOB GLAC CHANG FACT	32	1	1	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	1084-0699	1943-5584		J HYDROL ENG	J. Hydrol. Eng.	DEC	2014	19	12								10.1061/(ASCE)HE.1943-5584.0000988		11	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	AU0QT	WOS:000345329500008		
J	Roush, GC; Fagard, RH; Salles, GF; Pierdomenico, SD; Reboldi, G; Verdecchia, P; Eguchi, K; Kario, K; Hoshide, S; Polonia, J; de la Sierra, A; Hermida, RC; Dolan, E; Zamalloa, H				Roush, George C.; Fagard, Robert H.; Salles, Gil F.; Pierdomenico, Sante D.; Reboldi, Gianpaolo; Verdecchia, Paolo; Eguchi, Kazuo; Kario, Kazuomi; Hoshide, Satoshi; Polonia, Jorge; de la Sierra, Alejandro; Hermida, Ramon C.; Dolan, Eamon; Zamalloa, Hernan		ABC-H Investigators	Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13 844 patients with hypertension	JOURNAL OF HYPERTENSION			English	Review						blood pressure determination; blood pressure monitoring/ambulatory; cardiovascular diseases; cohort studies; prospective studies; stroke; survival analysis	PREDICTS CARDIOVASCULAR EVENTS; EUROPEAN-SOCIETY; COST-EFFECTIVENESS; SLEEP-APNEA; RISK; DISEASE; METAANALYSIS; VARIABILITY; RECOMMENDATIONS; MANAGEMENT	Background and method: To determine which SBP measure best predicts cardiovascular events (CVEs) independently, a systematic review was conducted for cohorts with all patients diagnosed with hypertension, 1+ years follow-up, and coronary artery disease and stroke outcomes. Lead investigators provided ad hoc analyses for each cohort. Meta-analyses gave hazard ratios from clinic SBP (CSBP), daytime SBP (DSBP), and night-time SBP (NSBP). Coefficients of variation of SBP measured dispersion. Nine cohorts (n = 13 844) were from Europe, Brazil, and Japan. For sleep-wake SBP classification, seven cohorts used patient-specific information. Results: Overall, NSBP's dispersion exceeded DSBP's dispersion by 22.6% with nonoverlapping confidence limits. Within all nine cohorts, dispersion for NSBP exceeded that for CSBP and DSBP. For each comparison, P = 0.004 that this occurred by chance. Considered individually, increases in NSBP, DSBP, and CSBP each predicted CVEs: hazard ratios (95% confidence intervals) = 1.25 (1.22-1.29), 1.20 (1.15-1.26), and 1.11 (1.06-1.16), respectively. However, after simultaneous adjustment for all three SBPs, hazard ratios were 1.26 (1.20-1.31), 1.01 (0.94-1.08), and 1.00 (0.95-1.05), respectively. Cohorts with baseline antihypertensive treatment and cohorts with patient-specific information for night-day BP classification gave similar results. Within most cohorts, simultaneously adjusted hazard ratios were greater for NSBP than for DSBP and CSBP: P = 0.023 and 0.012, respectively, that this occurred by chance. Conclusion: In hypertensive patients, NSBP had greater dispersion than DSBP and CSBP in all cohorts. On simultaneous adjustment, compared with DSBP and CSBP, increased NSBP independently predicted higher CVEs in most cohorts, and, overall, NSBP independently predicted CVEs, whereas CSBP and DSBP lost their predictive ability entirely.	[Roush, George C.; Zamalloa, Hernan] UCONN Sch Med, Farmington, CT USA; [Fagard, Robert H.] Univ Leuven, Hypertens Unit, UZ, Leuven, Belgium; [Salles, Gil F.] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, Brazil; [Pierdomenico, Sante D.] Univ Gabriele dAnnunzio, Dipartimento Med & Sci Invecchiamento, Chieti, Italy; [Reboldi, Gianpaolo] Univ Perugia, Dept Internal Med, I-06100 Perugia, Italy; [Verdecchia, Paolo] Osped Assisi, Assisi, Italy; [Eguchi, Kazuo; Kario, Kazuomi; Hoshide, Satoshi] Jichi Med Univ, Sch Med, Shimotsuke, Tochigi, Japan; [Polonia, Jorge] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [de la Sierra, Alejandro] Univ Barcelona, Hosp Mutua Terrassa, Dept Internal Med, Terrassa, Spain; [Hermida, Ramon C.] Univ Vigo, Bioengn & Chronobiol Labs, Vigo 36310, Spain; [Dolan, Eamon] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England	Roush, GC (reprint author), St Vincents Med Ctr, UCONN Sch Med, ABC H, 2800 Main St, Bridgeport, CT 06606 USA.	groush@gcr0.com	FMUP, CINTESIS/C-6631-2014; Polonia, Jorge/J-8288-2013; 	FMUP, CINTESIS/0000-0001-7248-2086; Polonia, Jorge/0000-0002-0133-7217			Altman DG, 2003, BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Head GA, 2012, J HYPERTENS, V30, P253, DOI 10.1097/HJH.0b013e32834de621; Boggia J, 2011, HYPERTENSION, V57, P397, DOI 10.1161/HYPERTENSIONAHA.110.156828; Sachdeva A, 2006, HYPERTENSION, V48, P527, DOI 10.1161/01.HYP.0000240268.37379.7c; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wilson PWF, 1998, CIRCULATION, V97, P1837; Hermida RC, 2013, CHRONOBIOL INT, V30, P355, DOI 10.3109/07420528.2013.750490; Conen D, 2008, J HYPERTENS, V26, P1290, DOI 10.1097/HJH.0b013e3282f97854; Pickering TG, 2008, J AM SOC HYPERTENS, V2, P119, DOI 10.1016/j.jash.2008.04.002; Lewington S, 2002, LANCET, V360, P1903; Fagard R, 1996, J HYPERTENS, V14, P557, DOI 10.1097/00004872-199605000-00003; Tsioufis C, 2011, J HUM HYPERTENS, V25, P281, DOI 10.1038/jhh.2010.113; Roush GC, 2014, J CLIN HYPERTENS, V16, P561, DOI 10.1111/jch.12354; HLA KM, 1994, ANN INTERN MED, V120, P382; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Salles GF, 2008, ARCH INTERN MED, V168, P2340, DOI 10.1001/archinte.168.21.2340; Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Fagard RH, 2010, HYPERTENSION, V56, P56, DOI 10.1161/HYPERTENSIONAHA.110.151654; Franklin SS, 2001, CIRCULATION, V103, P1245; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Dolan E, 2009, J HYPERTENS, V27, P876, DOI 10.1097/HJH.0b013e328322cd62; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Hermida RC, 2010, CHRONOBIOL INT, V27, P1629, DOI 10.3109/07420528.2010.510230; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/01.hjh.0000059016.82022.ca; Kario K, 2009, HYPERTENS RES, V32, P428, DOI 10.1038/hr.2009.56; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Mesquita-Bastos J, 2010, BLOOD PRESS MONIT, V15, P240, DOI 10.1097/MBP.0b013e32833c8b08; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; de la Sierra A, 2012, J HYPERTENS, V30, P713, DOI 10.1097/HJH.0b013e328350bb40; Kario K, 2001, J AM COLL CARDIOL, V38, P238, DOI 10.1016/S0735-1097(01)01325-0; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Redon J, 2008, HYPERTENSION, V51, P41, DOI 10.1161/HYPERTENSIONAHA.107.101337; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Borenstein M, 2009, INTRO METAANALYSIS; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; de Zambotti M, 2013, CLIN AUTON RES, V23, P49, DOI 10.1007/s10286-012-0178-2; Dzielinska Z, 2009, BLOOD PRESS MONIT, V14, P99, DOI 10.1097/MBP.0b013e32832b9df3; Eguchi K, 2009, J HYPERTENS, V27, P2265, DOI 10.1097/HJH.0b013e328330a938; Gordis L, 2004, EPIDEMIOLOGY, P156; Krakoff LR, 2006, HYPERTENSION, V47, P29, DOI 10.1161/01.HYP.0000197195.84725.66; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; National Institute for Health and Clinical Excellence, 2011, HYP CLIM MAN PRIM HY; Reh W, 1996, COMPUT STAT DATA AN, V22, P449, DOI 10.1016/0167-9473(96)83707-8; Schwartz GL, 2000, AM J HYPERTENS, V13, P1203, DOI 10.1016/S0895-7061(00)01198-5; Sokal RR, 1995, BIOMETRY PRINCIPLES, p[58, 72]; Vardeny O, 2011, J AM SOC HYPERTENS, V5, P114, DOI 10.1016/j.jash.2011.01.005; Vassan RS, 2001, NEW ENGL J MED, V345, P1291; Verdecchia P., 1996, BLOOD PRESS MONIT, V1, P3; Wang XL, 2009, J HYPERTENS, V27, P2358, DOI 10.1097/HJH.0b013e328330e84d	51	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	DEC	2014	32	12					2332	2340		10.1097/HJH.0000000000000355		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT6AA	WOS:000345019800006		
J	Yano, Y; Fujimoto, S; Sato, Y; Konta, T; Iseki, K; Iseki, C; Moriyama, T; Yamagata, K; Tsuruya, K; Narita, I; Kondo, M; Kimura, K; Asahi, K; Kurahashi, I; Ohashi, Y; Watanabe, T				Yano, Yuichiro; Fujimoto, Shouichi; Sato, Yuji; Konta, Tsuneo; Iseki, Kunitoshi; Iseki, Chiho; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kimura, Kenjiro; Asahi, Koichi; Kurahashi, Issei; Ohashi, Yasuo; Watanabe, Tsuyoshi			New-onset hypertension and risk for chronic kidney disease in the Japanese general population	JOURNAL OF HYPERTENSION			English	Article						chronic kidney disease; high-normal blood pressure; new-onset hypertension; prehypertension; proteinuria	STAGE RENAL-DISEASE; BLOOD-PRESSURE; MEN; DECLINE; PREHYPERTENSION; COHORT; WOMEN	Objectives: Our aims were to assess the progression rate of normotension and prehypertension to hypertension in Japan, and the effect of the new-onset hypertension on chronic kidney disease (CKD). Methods: This was a nationwide study of 45 378 Japanese aged 40-74 years (mean age 60 years, 37% men) without hypertension or cardiovascular disease at baseline. At baseline and 3-year follow-up, blood pressure (BP) and kidney function were assessed. CKD was defined as an estimated glomerular filtration rate (eGFR) below 60 ml/min per 1.73 m(2) or the presence of proteinuria (>= 1+ by a dipstick). Results: At 3-year follow-up, the incidence rates of hypertension among participants with optimal BP (< 120/80 mmHg, n = 18 724), normal BP (120-129/80-84 mmHg, n = 15 017) and high-normal BP (130-139/85-89 mmHg, n = 11 637) were 8, 23, and 39% in men, and 6, 20, and 37% in women, respectively. Among those without CKD at baseline (n = 42 625), 2142 participants (5%) had developed CKD during follow-up. Irrespective of the baseline BP classifications, participants with new-onset hypertension had a higher risk for proteinuria [odds ratio (95% confidence interval) 1.7 (1.3-2.3) in men and 1.6 (1.2-2.2) in women], but not for eGFR below 60 ml/min per 1.73 m(2), compared with those who maintained optimal BP during follow-up. Men who remained in the high-normal BP range during follow-up showed higher risk for proteinuria [odds ratio (95% confidence interval) 1.6 (1.1-2.3)], but not for eGFR below 60 ml/min per 1.73 m(2). Conclusions: This nationwide longitudinal study suggests that, over 3 years of follow-up, women and men with new-onset hypertension and men with high-normal BP were at higher risk of newly developing proteinuria.	[Yano, Yuichiro] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Fujimoto, Shouichi] Miyazaki Univ, Fac Med, Dept Hemovasc Med & Artificial Organs, Kiyotake, Miyazaki 8891692, Japan; [Sato, Yuji] Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan; [Konta, Tsuneo] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Iseki, Kunitoshi; Iseki, Chiho] Univ Hosp Ryukyus, Dialysis Unit, Okinawa, Japan; [Moriyama, Toshiki] Osaka Univ, Hlth Care Ctr 1, Osaka, Japan; [Yamagata, Kunihiro] Univ Tsukuba, Fac Med, Dept Nephrol, Ibaraki, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan; [Narita, Ichiei] Niigata Univ, Sch Med, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Kondo, Masahide] Univ Tsukuba, Fac Med, Dept Hlth Care Policy & Hlth Econ, Ibaraki, Japan; [Kimura, Kenjiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Asahi, Koichi; Watanabe, Tsuyoshi] Fukushima Med Univ, Sch Med, Dept Nephrol Hypertens Diabetol Endocrinol & Meta, Fukushima, Japan; [Kurahashi, Issei] Univ Tokyo, Sch Med, Dept Med Informat & Econ, Tokyo 113, Japan; [Ohashi, Yasuo] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan	Fujimoto, S (reprint author), Miyazaki Univ, Fac Med, Dept Hemovasc Med & Artificial Organs, Kihara 5200, Kiyotake, Miyazaki 8891692, Japan.	fujimos@med.miyazaki-u.ac.jp			Ministry of Health, Labor and Welfare of Japan	This work was supported by Health and Labor Sciences Research Grants for 'Research on the Positioning of Chronic Kidney Disease (CKD) in Specific Health Check and Guidance in Japan', 'Study on the Appropriate States of Specific Health Checkups and Specific Health Guidance for Prevention of CKD Progression', and 'Design of a Comprehensive Healthcare System for CKD Based on the Individual Risk Assessment by Specific Health Checkups' from the Ministry of Health, Labor and Welfare of Japan.	Kanno A, 2012, NEPHROL DIAL TRANSPL, V27, P3218, DOI 10.1093/ndt/gfs054; Kim J, 2006, J HYPERTENS, V24, P2177, DOI 10.1097/01.hjh.0000249694.81241.7c; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Obermayr RP, 2008, NEPHROL DIAL TRANSPL, V23, P1265, DOI 10.1093/ndt/gfm790; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Paulis L, 2010, NAT REV CARDIOL, V7, P431, DOI 10.1038/nrcardio.2010.85; Hanratty R, 2011, CLIN J AM SOC NEPHRO, V6, P2605, DOI 10.2215/CJN.02240311; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; [Anonymous], 2002, CIRC J, V66, P987; Iseki K, 2008, KIDNEY INT, V74, P415, DOI 10.1038/ki.2008.261; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1917, DOI 10.1681/ASN.2012040390; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Pimenta E, 2010, NAT REV NEPHROL, V6, P21, DOI 10.1038/nrneph.2009.191; Agrawal V, 2009, NAT REV CARDIOL, V6, P301, DOI 10.1038/nrcardio.2009.11; Yano Y, 2012, KIDNEY INT, V81, P293, DOI 10.1038/ki.2011.346; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Chiena KL, 2007, J HYPERTENS, V25, P1355, DOI 10.1097/HJH.0b013e3280d94313; Ito S, 2012, HYPERTENSION, V60, P589, DOI 10.1161/HYPERTENSIONAHA.111.188706; Perticone F, 2010, CIRCULATION, V122, P379, DOI 10.1161/CIRCULATIONAHA.110.940932; Schaeffner ES, 2008, NEPHROL DIAL TRANSPL, V23, P1246, DOI 10.1093/ndt/gfm757; Tohidi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045304; Vupputuri S, 2003, HYPERTENSION, V42, P1144, DOI 10.1161/01.HYP.0000101695.56635.31; Yano Yuichiro, 2007, J Clin Hypertens (Greenwich), V9, P775, DOI 10.1111/j.1524-6175.2007.07321.x	27	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	DEC	2014	32	12					2371	2377		10.1097/HJH.0000000000000344		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT6AA	WOS:000345019800014		
J	Okuda, N; Stamler, J; Brown, IJ; Ueshima, H; Miura, K; Okayama, A; Saitoh, S; Nakagawa, H; Sakata, K; Yoshita, K; Zhao, L; Elliott, P				Okuda, Nagako; Stamler, Jeremiah; Brown, Ian J.; Ueshima, Hirotsugu; Miura, Katsuyuki; Okayama, Akira; Saitoh, Shigeyuki; Nakagawa, Hideaki; Sakata, Kiyomi; Yoshita, Katsushi; Zhao, Liancheng; Elliott, Paul		INTERMAP Res Grp	Individual efforts to reduce salt intake in China, Japan, UK, USA: what did people achieve? The INTERMAP Population Study	JOURNAL OF HYPERTENSION			English	Article						China; hypertension; Japan; population study; reduced salt diet; UK; urinary sodium excretion; USA	URINARY SODIUM-EXCRETION; UNITED-STATES; BLOOD-PRESSURE; HYPERTENSION; WOMEN; MANAGEMENT; KINGDOM; MEN; PREVALENCE; AWARENESS	Objective: Habitual high-salt intake raises blood pressure and risk of cardiovascular diseases. To prevent/control these risks, reduced salt diet (RSD) is recommended in many countries and some people report practicing it; however, little is known about actual achievement. This population-based study assessed level of 24-h dietary sodium intake of participants reporting RSD and others. Method: Participants were 4680 men and women ages 40-59 years randomly selected from 17 populations in People's Republic of China (PRC), Japan, UK and USA, for an observational study on diet and blood pressure (INTERMAP). Daily sodium intake was determined by two timed 24-h urine collections. Antihypertensive treatment status and RSD were ascertained by questionnaire. Results: Participants reporting RSD were few; 3.1% (Japan), 1.3% (PRC), 2.5% (UK), 7.2% (USA); 15.1, 7.9, 16.7 and 16.8% of people with treated hypertension. For those reporting RSD, 24-h urinary sodium excretion was significantly, but only modestly lower than for others, by 17.9 mmol/day (Japan), 56.7 (PRC) and 14.7 (USA), but higher by 10.5 in UK. Sodium intakes for participants reporting RSD remained higher than recommended; 181.0 mmol/day (Japan), 171.5 (PRC), 155.2 (UK) and 148.9 (USA). For these people, as for others, main sources of salt were processed foods in Japan, UK and USA; in PRC, salt added in preparation at home. Conclusion: Enhanced sustained efforts are needed to raise general awareness of the harmful effects of salt on health and the benefits of salt reduction. Population approaches are needed to reduce salt content of processed foods and restaurant meals.	[Okuda, Nagako] Univ Human Arts & Sci, Dept Hlth & Nutr, Saitama 3398539, Japan; [Stamler, Jeremiah] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Brown, Ian J.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Ueshima, Hirotsugu; Miura, Katsuyuki] Shiga Univ Med Sci, Dept Publ Hlth, Otsu, Shiga 52021, Japan; [Ueshima, Hirotsugu; Miura, Katsuyuki] Shiga Univ Med Sci, Ctr Epidemiol Res Asia, Otsu, Shiga 52021, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Tokyo, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Sch Hlth Sci, Div Med & Behav Subjects, Sapporo, Hokkaido, Japan; [Nakagawa, Hideaki] Kanazawa Med Univ, Dept Publ Hlth, Kanazawa, Ishikawa, Japan; [Sakata, Kiyomi] Iwate Med Univ, Dept Hyg & Prevent Med, Morioka, Iwate 020, Japan; [Yoshita, Katsushi] Osaka City Univ, Grad Sch Human Life Sci, Dept Food Sci & Nutr, Osaka 558, Japan; [Zhao, Liancheng] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhao, Liancheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, London, England	Okuda, N (reprint author), Univ Human Arts & Sci, Dept Hlth & Nutr, Iwatsuki Ku, 1288 Umagome, Saitama 3398539, Japan.	nagako_okuda@human.ac.jp			National Institute for Health Research (NIHR) Imperial College Healthcare NHS Trust (ICHNT); Imperial College Biomedical Research Centre (BRC); US National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA [2-RO1-HL50490]; Ministry of Education, Science, Sports, and Culture [090357003]	We thank study staff at local, national and international centres for their efforts; a partial listing of these colleagues is given in reference [12]. P. E. is supported by the National Institute for Health Research (NIHR) Imperial College Healthcare NHS Trust (ICHNT) and Imperial College Biomedical Research Centre (BRC), and is an NIHR Senior Investigator.; This research is supported by grant 2-RO1-HL50490 from the US National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA; and by national and local agencies in China, Japan (the Ministry of Education, Science, Sports, and Culture, Grant-in-Aid for Scientific Research [A], No. 090357003) and the United Kingdom. The sponsors had no role in the design or conduct of the study; the collection, management, analysis or interpretation of the data; or the preparation, review or approval of the manuscript.	Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; Cook NR, 2007, BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Okuda N, 2010, J EPIDEMIOL, V20, pS506, DOI 10.2188/jea.JE20090218; Schakel SF, 2003, J FOOD COMPOS ANAL, V16, P395, DOI 10.1016/S0889-1575(03)00043-7; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1172, DOI 10.3945/ajcn.2010.29367; Dennis B, 2003, J HUM HYPERTENS, V17, P609, DOI 10.1038/sj.jhh.1001604; Primatesta P, 2001, HYPERTENSION, V38, P827; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Tuomilehto J, 2001, LANCET, V357, P848, DOI 10.1016/S0140-6736(00)04199-4; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Nagata C, 2004, STROKE, V35, P1543, DOI 10.1161/01.STR.0000130425.50441.b0; Brinsden HC, 2013, BMJ OPEN, V3; Bruce A, 1984, ANN CLIN RES S43, V16, pS174; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Intersalt Cooperative Research Group, 1988, BMJ, V297, P319; Kawano Y, 2007, HYPERTENS RES, V30, P879, DOI 10.1291/hypres.30.879; Leshem M, 2008, APPETITE, V50, P71, DOI 10.1016/j.appet.2007.05.010; Ministry of Health and Welfare, 1998, NAT HLTH NUTR SURV J; National Centre for Social Research, 2011, SURV 24 H UR SOD EXC; National Centre for Social Research, 2007, ASS DIET SOD LEV AD; National Institute of Health and Nutrition, 2012, NAT HEATH NUTR SURV; Sadler KNS, 2012, NATL DIET NUTR SURVE; The Resources Council, 1998, STAND TABL FOOD COMP; The Resources Council Science and Technology Agency of Japan, 1982, STAND TABL FOOD COMP; Ueshima H, 2000, J HUM HYPERTENS, V14, P765, DOI 10.1038/sj.jhh.1001054; van den Brandt PA, 2003, CANCER CAUSE CONTROL, V14, P427, DOI 10.1023/A:1024979314124	33	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0263-6352	1473-5598		J HYPERTENS	J. Hypertens.	DEC	2014	32	12					2385	2392		10.1097/HJH.0000000000000341		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT6AA	WOS:000345019800016		
J	Chu, H; Shih, CJ; Lee, YJ; Kuo, SC; Hsu, YT; Ou, SM; Shih, YN; Tarng, DC; Li, SY; Chen, YT; Chen, RC				Chu, Hsi; Shih, Chia-Jen; Lee, Yi-Jung; Kuo, Shu-Chen; Hsu, Yen-Tao; Ou, Shuo-Ming; Shih, Yu-Ning; Tarng, Der-Cherng; Li, Szu-Yuan; Chen, Yung-Tai; Chen, Ran-Chou			Risk of tuberculosis among healthcare workers in an intermediate-burden country: A nationwide population study	JOURNAL OF INFECTION			English	Article						Epidemiology; Healthcare worker; Tuberculosis	OCCUPATIONAL TUBERCULOSIS; PULMONARY TUBERCULOSIS; INFECTION; TAIWAN; DIAGNOSIS; DISEASE; STROKE	Objective: The potential association between healthcare workers (HCWs) and the risk of clinically active tuberculosis (TB) in countries with intermediate TB burdens remains unclear. Methods: A nationwide, population-based cohort study was performed by using Taiwan National Health Insurance Database during 2000-2010. We included HCWs and non-HCWs without history of tuberculosis matched at a 1:1 ratio according to age, sex, monthly income, underlying comorbidities, and concomitant medications. All subjects were followed from the date of enrollment until TB occurrence, death, or 31 December 2010. Results: The study population comprised 11,811 healthcare workers and 11,811 matched subjects. 62 HCWs and 38 control subjects developed TB during a median follow-up period of 9.4 years. The incidence of TB was higher among HCWs than among matched subjects (61.08 vs. 37.81 per 100,000 person-years). The risk of TB was also greater among HCWs (adjusted hazard ratio [aHR], 1.62; 95% confidence interval [CI], 1.08-2.43), particularly for pulmonary TB in comparison with extrapulmonary TB (aHR, 1.56; 95% CI, 1.02-2.39). Among different job categories of HCWs, we found that only nurses had a significantly increased risk of developing TB (aHR, 2.55; 95% CI, 1.37-4.72) compared to the matched cohort. Conclusions: HCWs are associated independently with a higher risk of developing TB in this intermediate-burden country. Therefore, the importance of TB surveillance among HCWs should be emphasized. (C) 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Chu, Hsi; Shih, Chia-Jen; Lee, Yi-Jung; Kuo, Shu-Chen; Ou, Shuo-Ming; Shih, Yu-Ning; Tarng, Der-Cherng; Li, Szu-Yuan; Chen, Yung-Tai] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chu, Hsi; Hsu, Yen-Tao; Shih, Yu-Ning] Taipei City Hosp, Dept Chest, Div Resp Med, Heping Fuyou Branch, Tokyo 108, Japan; [Shih, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Yuanshan Branch, Yilan, Taiwan; [Lee, Yi-Jung] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Kuo, Shu-Chen] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Kuo, Shu-Chen] Taipei Vet Gen Hosp, Div Infect Dis, Taipei, Taiwan; [Ou, Shuo-Ming; Tarng, Der-Cherng; Li, Szu-Yuan] Taipei Vet Gen Hosp, Dept Med, Div Nephrol, Taipei, Taiwan; [Chen, Yung-Tai] Taipei City Hosp, Dept Med, Div Nephrol, Heping Fuyou Branch, Tokyo 108, Japan; [Chen, Ran-Chou] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Chen, Ran-Chou] Taipei City Hosp, Dept Radiol, Heping Fuyou Branch, Tokyo 108, Japan	Chen, YT (reprint author), Taipei City Hosp, Dept Med, Div Nephrol, Heping Fuyou Branch, Tokyo 108, Japan.	ytchen0117@gmail.com; DAA60@tpech.gov.tw	Kuo, Shu-Chen/G-9108-2011				SEPKOWITZ KA, 1994, ANN INTERN MED, V120, P71; Cuhadaroglu C, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-14; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Wu CY, 2010, GASTROENTEROLOGY, V139, P1165, DOI 10.1053/j.gastro.2010.06.067; Jelip J, 2004, TUBERCULOSIS, V84, P19, DOI 10.1016/j.tube.2003.08.015; Kruuner A, 2001, INT J TUBERC LUNG D, V5, P170; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; Chen TC, 2010, AM J MED SCI, V340, P367, DOI 10.1097/MAJ.0b013e3181e92b06; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Babus V, 1997, INT J TUBERC LUNG D, V1, P254; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Mathew A, 2013, J CLIN EPIDEMIOL, V66, P67, DOI [10.1016/j.jclinepi.2011.12.010, 10.1016/j.jclinepi.2012.12.010]; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Centers for Disease Control DoH Executive Yuan Taiwan, 2013, TAIW TUB CONTR REP 2; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Jo KW, 2008, INT J TUBERC LUNG D, V12, P436; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kayanja HK, 2005, INT J TUBERC LUNG D, V9, P686; Lin HP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-55; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Raitio M, 2003, INT J TUBERC LUNG D, V7, P556; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; Skodric-Trifunovic V, 2009, INT J TUBERC LUNG D, V13, P640; WHO, 2013, GLOB TUB REP WORLD H; Yanai H, 2003, INT J TUBERC LUNG D, V7, P36; Yen YF, 2012, INT J TUBERC LUNG D, V16, P178, DOI 10.5588/ijtld.11.0034	32	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	DEC	2014	69	6					525	532		10.1016/j.jinf.2014.06.019		8	Infectious Diseases	Infectious Diseases	AU1ZT	WOS:000345416700001		
J	Hang, NTL; Matsushita, I; Shimbo, T; Hong, LT; Tam, DB; Lien, LT; Thuong, PH; Cuong, VC; Hijikata, M; Kobayashi, N; Sakurada, S; Higuchi, K; Harada, N; Endo, H; Keicho, N				Nguyen Thi Le Hang; Matsushita, Ikumi; Shimbo, Takuro; Le Thi Hong; Do Bang Tam; Luu Thi Lien; Pham Huu Thuong; Vu Cao Cuong; Hijikata, Minako; Kobayashi, Nobuyuki; Sakurada, Shinsaku; Higuchi, Kazue; Harada, Nobuyuki; Endo, Hiroyoshi; Keicho, Naoto			Association between tuberculosis recurrence and interferon-gamma response during treatment	JOURNAL OF INFECTION			English	Article						Tuberculosis; Recurrence; Interferon-gamma release assay; Cellular response	T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; RELEASE ASSAYS; LATENT TUBERCULOSIS; IMMUNE-RESPONSES; RISK-FACTORS; IFN-GAMMA; ANTIGENS	Objectives: We investigated the relationship between tuberculosis recurrence and Mycobacterium tuberculosis antigen-stimulated interferon-gamma (IFN-gamma) responses during treatment. Methods: Plasma IFN-gamma levels in active pulmonary tuberculosis patients (n = 407) were analyzed using QuantiFERON-TB Gold In-Tube (TM) (QFT-IT) at 0, 2, and 7 months of the 8 month treatment received from 2007 to 2009 and the patients were followed up for another 16 months after treatment. Risk factors for recurrence were assessed using the log-rank test and Cox proportional hazard models. Random coefficient models were used to compare longitudinal patterns of IFN-gamma levels between groups. Results: QFT-IT showed positive results in 95.6%, 86.2%, and 83.5% at 0, 2, and 7 months, respectively. The antigen-stimulated IFN-gamma responses varied significantly during the treatment course (P < 0.0001). Unexpectedly, positive-to-negative conversion of QFT-IT results between 0 and 2 months was significantly associated with earlier recurrence (adjusted hazard ratio, 5.57; 95% confidence interval, 2.28-13.57). Time-dependent changes in IFN-gamma levels were significantly different between the recurrence and nonrecurrence groups (P < 0.0001). Conclusions: Although the IGRA response varies individually, early response during the treatment course may provide an insight into host immune responses underlying tuberculosis recurrence. (C) 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.	[Nguyen Thi Le Hang] NCGM BMH, Med Collaborat Ctr, Hanoi, Vietnam; [Matsushita, Ikumi; Hijikata, Minako; Keicho, Naoto] JATA, Res Inst TB, Dept Pathophysiol & Host Def, Kiyose, Tokyo 2048533, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Clin Res Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Le Thi Hong; Do Bang Tam] Hanoi Lung Hosp, Dept Biochem Hematol & Blood Transfus, Hanoi, Vietnam; [Luu Thi Lien] Hanoi Dept Hlth, Hanoi, Vietnam; [Pham Huu Thuong; Vu Cao Cuong] Hanoi Lung Hosp, Hanoi, Vietnam; [Hijikata, Minako; Keicho, Naoto] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo 1628655, Japan; [Kobayashi, Nobuyuki] NHO Tokyo Natl Hosp, Kiyose, Tokyo 2048585, Japan; [Sakurada, Shinsaku] Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Shinjuku Ku, Tokyo 1628655, Japan; [Higuchi, Kazue; Harada, Nobuyuki] Res Inst Immune Diag, Tachikawa, Tokyo 1900013, Japan; [Endo, Hiroyoshi] Tokyo Womens Med Univ, Dept Int Affairs & Trop Med, Shinjuku Ku, Tokyo 1628666, Japan	Harada, N (reprint author), Japan AntiTB Assoc, Res Inst TB, Dept Pathophysiol & Host Def, 3-1-24 Matsuyama, Kiyose, Tokyo 2048533, Japan.	nkeicho-tky@umin.ac.jp			Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by a grant from the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Chee CBE, 2010, EUR RESPIR J, V36, P355, DOI 10.1183/09031936.00151309; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Higuchi K, 2008, TUBERCULOSIS, V88, P244, DOI 10.1016/j.tube.2007.11.009; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Chiappini E, 2012, CLIN THER, V34, P1041, DOI 10.1016/j.clinthera.2012.03.006; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Luzze H, 2013, INT J TUBERC LUNG D, V17, P361, DOI 10.5588/ijtld.11.0692; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Ruhwald M, 2012, EXPERT REV MOL DIAGN, V12, P175, DOI [10.1586/erm.11.97, 10.1586/ERM.11.97]; Millington KA, 2007, J IMMUNOL, V178, P5217; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Chappert P, 2010, CURR OPIN IMMUNOL, V22, P552, DOI 10.1016/j.coi.2010.08.005; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Komiya K, 2011, J INFECTION, V63, P48, DOI 10.1016/j.jinf.2011.05.006; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P1146; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Kobashi Y, 2009, J INFECTION, V58, P197, DOI 10.1016/j.jinf.2008.08.009; Bocchino M, 2010, RESP MED, V104, P1551, DOI 10.1016/j.rmed.2010.05.011; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Bugiani M, 2011, Monaldi Arch Chest Dis, V75, P215; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chiacchio T, 2009, CLIN EXP IMMUNOL, V156, P463, DOI 10.1111/j.1365-2249.2009.03908.x; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Hang NTL, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-66; HANG NTL, 2011, PLOS ONE, V0006; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Lee SW, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-300; Pai Madhukar, 2006, J Occup Med Toxicol, V1, P7, DOI 10.1186/1745-6673-1-7; Pang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065496; Theron G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037436, 10.1371/journal.pone.0037436d]; Ringshausen FC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-220; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; WHO, 2013, WHOHTMTB20126	47	1	1	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0163-4453	1532-2742		J INFECTION	J. Infect.	DEC	2014	69	6					616	626		10.1016/j.jinf.2014.06.007		11	Infectious Diseases	Infectious Diseases	AU1ZT	WOS:000345416700010		
J	Kruusamae, K; Mukai, K; Sugino, T; Asaka, K				Kruusamaee, Karl; Mukai, Ken; Sugino, Takushi; Asaka, Kinji			Impact of viscoelastic properties on bucky-gel actuator performance	JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES			English	Article						Bucky-gel; electroactive polymer; viscoelasticity; nanotube; ionic liquid; poly(vinylidene fluoride-co-hexafluoropropylene); thermo-mechanical properties	WALLED CARBON NANOTUBES; COMPOSITES	Due to their soft polymeric backbone and metal-free compositions, bending electromechanically active bucky-gel laminates are attractive candidates for actuators in applications in a variety of fields such as medicine and space technology. However, the soft structure of these materials also proposes challenges to engineering new devices as the unorthodox composition requires that the developer really understands the mechanical nature of these actuators. As the composition of bucky-gel laminates includes porous polymer filled with ionic liquid but also carbon nanotubes, the viscoelastic nature and how it possibly affects actuator performance is of great interest. Several customised mechanical tests are implemented on both electrically active and inactive bending bucky-gel actuators to investigate their mechanical properties. It is reported that these materials are highly viscoelastic and their mechanical relaxation can be described by generalised Maxwell model for solids. Moreover, these viscoelastic effects are shown to depend on the level of input voltage, thus, altering the overall performance of the actuator. Temperature measurements reveal remarkable thermal dissipation during the actuation cycles, which, as the dynamic measurements demonstrate, alters the mechanical properties of bucky-gel actuators.	[Kruusamaee, Karl; Mukai, Ken; Sugino, Takushi; Asaka, Kinji] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka 5638577, Japan	Kruusamae, K (reprint author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	karl.kruusamae@aist.go.jp					Kosidlo U, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/10/104022; Liu Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3432664; Jo C, 2013, PROG POLYM SCI, V38, P1037, DOI 10.1016/j.progpolymsci.2013.04.003; Takeuchi I, 2009, ELECTROCHIM ACTA, V54, P1762, DOI 10.1016/j.electacta.2008.10.007; Yang S, 2013, INT J PLASTICITY, V41, P124, DOI 10.1016/j.ijplas.2012.09.010; Asaka K, 2013, POLYM INT, V62, P1263, DOI 10.1002/pi.4562; Mukai K, 2009, ADV MATER, V21, P1582, DOI 10.1002/adma.200802817; Fukushima T, 2003, SCIENCE, V300, P2072, DOI 10.1126/science.1082289; Sugino T, 2011, CARBON, V49, P3560, DOI 10.1016/j.carbon.2011.04.056; Liu YJ, 2009, COMPOS SCI TECHNOL, V69, P2064, DOI 10.1016/j.compscitech.2008.08.016; Palmre V, 2011, J MATER CHEM, V21, P2577, DOI 10.1039/c0jm01729a; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Wu DF, 2012, IND ENG CHEM RES, V51, P6705, DOI 10.1021/ie2024454; Ceseracciu L, 2011, SENSOR ACTUAT B-CHEM, V156, P949, DOI 10.1016/j.snb.2011.03.012; Chang LF, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/6/065018; Fukushima T., 2005, ANGEW CHEM, V117, P2462, DOI 10.1002/ange.200462318; Ikeda K, 2014, SENSOR ACTUAT B-CHEM, V190, P954, DOI 10.1016/j.snb.2013.09.016; Kruusamae K, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/2/025031; Kruusamae K, 2012, SENSORS-BASEL, V12, P1950, DOI 10.3390/s120201950; Vunder V, 2012, SMART MATER STRUCT, V21, DOI 10.1088/0964-1726/21/11/115023; Wineman A.S., 2000, MECH RESPONSE POLYM	21	4	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1045-389X	1530-8138		J INTEL MAT SYST STR	J. Intell. Mater. Syst. Struct.	DEC	2014	25	18			SI		2235	2245		10.1177/1045389X14538538		11	Materials Science, Multidisciplinary	Materials Science	AU0SX	WOS:000345335900005		
J	Kamo, A; Tominaga, M; Kamata, Y; Kaneda, K; Ko, KC; Matsuda, H; Kimura, U; Ogawa, H; Takamori, K				Kamo, Atsuko; Tominaga, Mitsutoshi; Kamata, Yayoi; Kaneda, Kazuyuki; Ko, Kyi C.; Matsuda, Hironori; Kimura, Utako; Ogawa, Hideoki; Takamori, Kenji			The Excimer Lamp Induces Cutaneous Nerve Degeneration and Reduces Scratching in a Dry-Skin Mouse Model	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article							ATOPIC-DERMATITIS MODEL; ACETONE-TREATED MICE; LIGHT 308 NM; NC/NGA MICE; MECHANISMS; EFFICACY; BEHAVIOR; GROWTH; SYMPTOMS; PRURITUS	Epidermal hyperinnervation, which is thought to underlie intractable pruritus, has been observed in patients with atopic dermatitis (AD). The epidermal expression of axonal guidance molecules has been reported to regulate epidermal hyperinnervation. Previously, we showed that the excimer lamp has antihyperinnervative effects in nonpruritic dry-skin model mice, although epidermal expression of axonal guidance molecules was unchanged. Therefore, we investigated the antipruritic effects of excimer lamp irradiation and its mechanism of action. A single irradiation of AD model mice significantly inhibited itch-related behavior 1 day later, following improvement in the dermatitis score. In addition, irradiation of nerve fibers formed by cultured dorsal root ganglion neurons increased bleb formation and decreased nerve fiber expression of nicotinamide mononucleotide adenylyl transferase 2, suggesting degenerative changes in these fibers. We also analyzed whether attaching a cutoff excimer filter (COF) to the lamp, thus decreasing cytotoxic wavelengths, altered hyperinnervation and the production of cyclobutane pyrimidine dimer (CPD), a DNA damage marker, in dry-skin model mice. Irradiation with COF decreased CPD production in keratinocytes, as well as having an antihyperinnervative effect, indicating that the antipruritic effects of excimer lamp irradiation with COF are due to induction of epidermal nerve degeneration and reduced DNA damage.	[Kamo, Atsuko; Tominaga, Mitsutoshi; Kamata, Yayoi; Ko, Kyi C.; Matsuda, Hironori; Ogawa, Hideoki; Takamori, Kenji] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Chiba 2790021, Japan; [Kamo, Atsuko] Tokai Univ, Sch Hlth Sci, Dept Nursing, Hiratsuka, Kanagawa 25912, Japan; [Kaneda, Kazuyuki] Ushio Inc, Tokyo, Japan; [Kimura, Utako; Takamori, Kenji] Juntendo Univ, Urayasu Hosp, Dept Dermatol, Chiba 2790021, Japan	Takamori, K (reprint author), Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, 2-1-1 Tomioka, Chiba 2790021, Japan.	ktakamor@juntendo.ac.jp			MEXT [S1311011]; KAKENHI [25870728]	This work was partly supported by a grant of Strategic Research Foundation Grant-aided Project for Private Universities from MEXT (S1311011) and by KAKENHI Grant number 25870728.	Baltas E, 2006, J EUR ACAD DERMATOL, V20, P657, DOI 10.1111/j.1468-3083.2006.01495.x; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; Suto H, 1999, INT ARCH ALLERGY IMM, V120, P70, DOI 10.1159/000053599; Ebata T, 1999, BRIT J DERMATOL, V141, P82; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Negi O, 2012, J DERMATOL SCI, V66, P37, DOI 10.1016/j.jdermsci.2012.01.007; Tominaga M, 2013, BIOL PHARM BULL, V36, P1241; Yamaguchi J, 2008, J INVEST DERMATOL, V128, P2842, DOI 10.1038/jid.2008.150; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Tominaga M, 2007, J DERMATOL SCI, V48, P103, DOI 10.1016/j.jdermsci.2007.06.003; Kamo A, 2011, J DERMATOL SCI, V62, P91, DOI 10.1016/j.jdermsci.2011.01.004; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Kabashima K, 2013, J DERMATOL SCI, V70, P3, DOI 10.1016/j.jdermsci.2013.02.001; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Aubin F, 2005, BRIT J DERMATOL, V152, P99, DOI 10.1111/j.1365-2133.2005.06320.X; Kamo A, 2011, J DERMATOL SCI, V62, P64, DOI 10.1016/j.jdermsci.2011.01.008; Urashima R, 1998, VIRCHOWS ARCH, V432, P363, DOI 10.1007/s004280050179; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Hashimoto Y, 2004, LIFE SCI, V76, P783, DOI 10.1016/j.lfs.2004.07.022; Klein PA, 1999, ARCH DERMATOL, V135, P1522, DOI 10.1001/archderm.135.12.1522; Kobayashi K, 2009, PHOTODERMATOL PHOTO, V25, P30, DOI 10.1111/j.1600-0781.2009.00396.x; Nistico SP, 2008, PHOTOMED LASER SURG, V26, P14, DOI 10.1089/pho.2007.2116; Takano N, 2005, J PHARMACOL SCI, V99, P277, DOI 10.1254/jphs.FP0050564; Takano N, 2007, BRIT J DERMATOL, V156, P241, DOI 10.1111/j.1365-2133.2006.07636.x; Tominaga M, 2009, J DERMATOL SCI, V55, P40, DOI 10.1016/j.jdermsci.2009.03.007; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458	27	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	DEC	2014	134	12					2977	2984		10.1038/jid.2014.256		8	Dermatology	Dermatology	AT6NU	WOS:000345056900018		
J	Yanagishita, T; Yajima, I; Kumasaka, M; Iida, M; Xiang, L; Tamada, Y; Matsumoto, Y; Watanabe, D; Kato, M				Yanagishita, Takeshi; Yajima, Ichiro; Kumasaka, Mayuko; Iida, Machiko; Xiang, Li; Tamada, Yasuhiko; Matsumoto, Yoshinari; Watanabe, Daisuke; Kato, Masashi			An Actin-Binding Protein Espin Is a Growth Regulator for Melanoma	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Letter							MALIGNANT-MELANOMA; TUMOR-DEVELOPMENT; TRANSGENIC MICE; MOUSE MODEL; MICROVILLI; EXPRESSION; CELLS		[Yanagishita, Takeshi; Yajima, Ichiro; Kumasaka, Mayuko; Iida, Machiko; Kato, Masashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan; [Yanagishita, Takeshi; Tamada, Yasuhiko; Matsumoto, Yoshinari; Watanabe, Daisuke] Aichi Med Univ, Sch Med, Dept Dermatol, Nagakute, Aichi 48011, Japan; [Yajima, Ichiro; Kumasaka, Mayuko; Iida, Machiko; Xiang, Li; Kato, Masashi] Nagoya Univ, Grad Sch Med, Dept Occupat & Environm Hlth, Nagoya, Aichi 4648601, Japan	Yanagishita, T (reprint author), Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Units Environm Hlth Sci, Kasugai, Aichi 487, Japan.	katomasa@med.nagoya-u.ac.jp					Yajima I, 2012, J DERMATOL SCI, V68, P172, DOI 10.1016/j.jdermsci.2012.09.009; Chen S, 1996, J INVEST DERMATOL, V106, P1145, DOI 10.1111/1523-1747.ep12340194; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Kumasaka MY, 2010, CANCER RES, V70, P24, DOI 10.1158/0008-5472.CAN-09-2838; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Bartles JR, 1996, J CELL SCI, V109, P1229; Hasegawa T, 2008, ONCOGENE, V27, P5684, DOI 10.1038/onc.2008.182; Kato M, 1999, ONCOGENE, V18, P837, DOI 10.1038/sj.onc.1202329; Kato M, 2011, CANCER EPIDEM BIOMAR, V20, P1622, DOI 10.1158/1055-9965.EPI-11-0228; Ohshima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010279; Sekerkova G, 2006, CELL MOL LIFE SCI, V63, P2329, DOI 10.1007/s00018-006-6148-x; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Yanagishita T, 2014, MOL CANCER RES, V12, P440, DOI 10.1158/1541-7786.MCR-13-0468-T	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0022-202X	1523-1747		J INVEST DERMATOL	J. Invest. Dermatol.	DEC	2014	134	12					2996	2999		10.1038/jid.2014.249		4	Dermatology	Dermatology	AT6NU	WOS:000345056900023		
J	Babu, GA; Ravi, G; Navaneethan, M; Arivanandhan, M; Hayakawa, Y				Babu, G. Anandha; Ravi, G.; Navaneethan, M.; Arivanandhan, M.; Hayakawa, Y.			An investigation of flower shaped NiO nanostructures by microwave and hydrothermal route	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							MAGNETIC-PROPERTIES; NICKEL-OXIDE; THERMAL-DECOMPOSITION; TOLUENE COMBUSTION; NANO-PARTICLES; NANOPARTICLES; PERFORMANCE; BEHAVIOR; PRECIPITATION; NANOSHEETS	The face centered cubic phase of NiO nanostructures were successfully synthesized from microwave and hydrothermal methods. The structural properties of the synthesized material were analyzed by X-ray diffraction (XRD) studies. The thermal analysis revealed the transformation of Ni(OH)(2) into NiO at about 380 A degrees C. The obtained scanning electron microscopy images exhibited less agglomerated flowers for hydrothermal reacted NiO than the microwave processed samples. The sheet like morphologies of NiO nanostructures were confirmed by transmission electron microscope and the obtained particles sizes were comparable to the calculated values from XRD data. The UV-Vis and photoluminescence spectra results showed that the absorption edges of the NiO nanoflowers have a blue-shift due to quantum confinement effect. The Raman spectrum exhibited the transformation of antiferromagnetic to superparamagnetic transition confirmed from the absence of magnon peak. The XPS spectrum presented the observation of Ni 2p and O 1s levels with higher intense peak nature for hydrothermal treated NiO than microwave. The hysteresis loops of the NiO samples prepared by both hydrothermal and microwave heating methods revealed the weak ferromagnetic behaviors at room temperature. Based on the experimental observations and analysis, a possible hydrothermal reaction mechanism is proposed to synthesize flower shaped NiO nanostructured materials with improved structural, optical, morphological and magnetic properties compared to microwave synthesis.	[Babu, G. Anandha; Ravi, G.] Alagappa Univ, Dept Phys, Karaikkudi 630004, Tamil Nadu, India; [Navaneethan, M.; Arivanandhan, M.; Hayakawa, Y.] Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan	Ravi, G (reprint author), Alagappa Univ, Dept Phys, Karaikkudi 630004, Tamil Nadu, India.	gravicrc@gmail.com	Arivanandhan, Mukannan/E-5411-2010		DST, India [IF110040]	One of the authors G. Anandha babu gratefully acknowledges DST, India for the financial support under the scheme of INSPIRE Fellowship (Grant No. IF110040) to carry out this work.	Chai H, 2012, MATER RES BULL, V47, P3947, DOI 10.1016/j.materresbull.2012.08.033; Bai GM, 2012, CATAL COMMUN, V27, P148, DOI 10.1016/j.catcom.2012.07.008; Li Q, 2007, MATER LETT, V61, P1615, DOI 10.1016/j.matlet.2006.07.113; Luo YY, 2007, J SOLID STATE CHEM, V180, P2149, DOI 10.1016/j.jssc.2007.05.025; Salavati-Niasari M, 2009, INORG CHIM ACTA, V362, P3691, DOI 10.1016/j.ica.2009.04.025; Cao CY, 2011, J MATER CHEM, V21, P3204, DOI 10.1039/c0jm03749d; Aslani A, 2011, APPL SURF SCI, V257, P4056, DOI 10.1016/j.apsusc.2010.11.174; Varghese B, 2008, CHEM MATER, V20, P3360, DOI 10.1021/cm703512k; Meybodi SM, 2012, ULTRASON SONOCHEM, V19, P841, DOI 10.1016/j.ultsonch.2011.11.017; Al-Sehemi AG, 2014, J MOL STRUCT, V1058, P56, DOI 10.1016/j.molstruc.2013.10.065; Verma V, 2013, THIN SOLID FILMS, V527, P369, DOI 10.1016/j.tsf.2012.12.020; Kavitha T, 2011, J MATER CHEM, V21, P15686, DOI 10.1039/c1jm13278d; Wei ZQ, 2009, J ALLOY COMPD, V479, P855, DOI 10.1016/j.jallcom.2009.01.064; Cheng B, 2011, J HAZARD MATER, V185, P889, DOI 10.1016/j.jhazmat.2010.09.104; Hu LL, 2013, MATER LETT, V108, P92, DOI 10.1016/j.matlet.2013.06.060; Liang K, 2012, J MATER CHEM, V22, P11062, DOI 10.1039/c2jm31526b; Bai GM, 2013, CHEM ENG J, V219, P200, DOI 10.1016/j.cej.2013.01.008; Wang L, 2010, J ALLOY COMPD, V495, P82, DOI 10.1016/j.jallcom.2010.01.091; Song XF, 2008, J AM CERAM SOC, V91, P3465, DOI 10.1111/j.1551-2916.2008.02667.x; Ren Y, 2010, J AM CERAM SOC, V93, P3560, DOI 10.1111/j.1551-2916.2010.04090.x; Davar F, 2009, J ALLOY COMPD, V476, P797, DOI 10.1016/j.jallcom.2008.09.121; Harraz FA, 2010, J ALLOY COMPD, V508, P133, DOI 10.1016/j.jallcom.2010.08.027; Yang Q, 2005, MATER LETT, V59, P1967, DOI 10.1016/j.matlet.2005.02.037; Tian XQ, 2012, J MATER CHEM, V22, P8029, DOI 10.1039/c2jm16057a; Liu SH, 2012, J MAGN MAGN MATER, V324, P2070, DOI 10.1016/j.jmmm.2012.02.017; Yuan CZ, 2013, ELECTROCHIM ACTA, V88, P507, DOI 10.1016/j.electacta.2012.10.115; Pulimi VRR, 2009, J MAGN MAGN MATER, V321, P2556, DOI 10.1016/j.jmmm.2009.03.039; Dong Q, 2014, APPL CATAL B-ENVIRON, V147, P741, DOI 10.1016/j.apcatb.2013.10.007; Beach ER, 2009, MATER CHEM PHYS, V115, P371, DOI 10.1016/j.matchemphys.2008.12.018; Wei AH, 2014, CHEM ENG J, V239, P141, DOI 10.1016/j.cej.2013.10.079; LaGrow AP, 2012, J AM CHEM SOC, V134, P855, DOI 10.1021/ja210209r; Zhu ZF, 2011, ADV POWDER TECHNOL, V22, P422, DOI 10.1016/j.apt.2010.06.008; Meher SK, 2011, ACS APPL MATER INTER, V3, P2063, DOI 10.1021/am200294k; Wang YP, 2005, THERMOCHIM ACTA, V437, P106, DOI 10.1016/j.tca.2005.06.027; Rondinone AJ, 1999, J PHYS CHEM B, V103, P6876, DOI 10.1021/jp9912307; Zhu GX, 2012, RSC ADV, V2, P4236, DOI 10.1039/c2ra01307j; Tadic M, 2014, J ALLOY COMPD, V586, pS322, DOI 10.1016/j.jallcom.2012.10.166; Rakshit S, 2013, RSC ADV, V3, P6106, DOI 10.1039/c3ra21978j; Chander S, 2003, PRAMANA-J PHYS, V61, P617, DOI 10.1007/BF02705484; Chen KF, 2008, J ALLOY COMPD, V454, P447, DOI 10.1016/j.jallcom.2006.12.130; Cui YF, 2011, CRYSTENGCOMM, V13, P4930, DOI 10.1039/c1ce05389b; Das S, 2010, J ALLOY COMPD, V505, pL19, DOI 10.1016/j.jallcom.2010.05.180; Dolia SN, 2006, INDIAN J PURE AP PHY, V44, P169; Farhadi S, 2011, POLYHEDRON, V30, P1244, DOI 10.1016/j.poly.2011.01.028; Khadar MA, 2003, MATER RES BULL, V38, P1341, DOI 10.1016/S0025-5408(03)00139-9; Liu M., 2013, RSC ADV, V3, P8000; Ram SDG, 2010, APPL PHYS A-MATER, V99, P197, DOI 10.1007/s00339-009-5496-4; Salavati-Niasari M, 2009, POLYHEDRON, V28, P1111, DOI 10.1016/j.poly.2009.01.026; Tiwari SD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.104433; Winkler E., 2008, NANOTECHNOLOGY, V19; Xia C., 2011, SENSOR ACTUAT B-CHEM, V153, P434, DOI 10.1016/j.snb.2010.11.011	51	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	DEC	2014	25	12					5231	5240		10.1007/s10854-014-2293-4		10	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	AT3BI	WOS:000344809500008		
J	Yonekura, K; Watanabe, O				Yonekura, Kazuo; Watanabe, Osamu			A Shape Parameterization Method Using Principal Component Analysis in Applications to Parametric Shape Optimization	JOURNAL OF MECHANICAL DESIGN			English	Article							PROPER ORTHOGONAL DECOMPOSITION; HOLE	This paper proposes a shape parameterization method using a principal component analysis (PCA) for shape optimization. The proposed method is used as a preprocessing tool of parametric optimization algorithms, such as genetic algorithms (GAs) or response surface methods (RSMs). When these parametric optimization algorithms are used, the number of parameters should be small while the design space represented by the parameters should be able to represent a variety of shapes. In order to define the parameters, PCA is applied to shapes. In many industrial fields, a large amount of data of shapes and their performance is accumulated. By applying PCA to these shapes included in a database, important features of the shapes are extracted. A design space is defined by basis vectors which are generated from the extracted features. The number of dimensions of the design space is decreased without omitting important features. In this paper, each shape is discretized by a set of points and PCA is applied to it. A shape discretization method is also proposed and numerical examples are provided.	[Yonekura, Kazuo; Watanabe, Osamu] IHI Corp, R&D Technol Ctr, Numer Engn Dept, Yokohama, Kanagawa 2358501, Japan	Yonekura, K (reprint author), IHI Corp, R&D Technol Ctr, Numer Engn Dept, Yokohama, Kanagawa 2358501, Japan.	kazuo_yonekura@ihi.co.jp; osamu_watanabe@ihi.co.jp					Abbot I.H., 1959, THEORY WING SECTIONS; Lee KD, 2010, INT J HEAT MASS TRAN, V53, P2996, DOI 10.1016/j.ijheatmasstransfer.2010.03.032; Borrvall T, 2003, INT J NUMER METH FL, V41, P77, DOI 10.1002/fld.426; Okita Y, 2007, J TURBOMACH, V129, P331, DOI 10.1115/1.2437781; Oyama A, 2010, J AIRCRAFT, V47, P1756, DOI 10.2514/1.C000264; BENDSOE MP, 1988, COMPUT METHOD APPL M, V71, P197, DOI 10.1016/0045-7825(88)90086-2; Chatterjee A, 2000, CURR SCI INDIA, V78, P808; SIROVICH L, 1987, Q APPL MATH, V45, P561; Samareh JA, 2001, AIAA J, V39, P877, DOI 10.2514/2.1391; BendsOe M. P., 2003, TOPOLOGY OPTIMIZATIO; Berkhin P, 2006, GROUPING MULTIDIMENSIONAL DATA: RECENT ADVANCES IN CLUSTERING, P25, DOI 10.1007/3-540-28349-8_2; Brittingham RA, 2000, J TURBOMACH, V122, P133, DOI 10.1115/1.555419; Bunker RS, 2005, J HEAT TRANS-T ASME, V127, P441, DOI 10.1115/1.1860562; Drela M, 1989, LECT NOTES ENG, V54, P1, DOI DOI 10.1007/978-3-642-84010-4; Heidmann J. D., 2008, NASATM2008215209; Jeong MJ, 2005, J MECH DESIGN, V127, P215, DOI 10.1115/1.1830047; Kulfan B. M., 2007, 45 AIAA AER SCI M EX; Naik S., 2008, U.S. Patent No, Patent No. [7,997,866, 7997866]; Samareh J.A., 1999, CEAS AIAA ICASE NASA, P333; Silieti M, 2009, INT J THERM SCI, V48, P2237, DOI 10.1016/j.ijthermalsci.2009.04.007; Song W., 2004, 20044482 AIAA; Vanderplaats G. N., 1979, TP1370 NASA; Vucina D, 2008, LECT NOTES ENG COMP, P111	23	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1050-0472			J MECH DESIGN	J. Mech. Des.	DEC	2014	136	12							121401	10.1115/1.4028273		7	Engineering, Mechanical	Engineering	AU1BM	WOS:000345356000003		
J	Ju, Y; Asahi, T; Sawamura, N				Ju, Ye; Asahi, Toru; Sawamura, Naoya			Arctic mutant A beta 40 aggregates on alpha 7 nicotinic acetylcholine receptors and inhibits their functions	JOURNAL OF NEUROCHEMISTRY			English	Article						Alzheimer's disease; amyloid; calcium; mitogen-activated protein kinases; nicotinic acetylcholine receptors	AMYLOID-BETA-PROTEIN; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; IN-VITRO; PEPTIDE; MUTATION; MICE; PROTOFIBRILS; ANGIOPATHY; PATHOLOGY	Amyloid protein (A beta) plays a central role in the pathogenesis of Alzheimer's disease (AD). Point mutations within the A sequence associated with familial AD (FAD) are clustered around the central hydrophobic core of A. Several types of mutations within the A sequence have been identified, and the Arctic' mutation (E22G) has a purely cognitive phenotype typical of AD. Previous studies have shown that the primary result of the Arctic' mutation is increased formation of A protofibrils. However, the molecular mechanism underlying this effect remains unknown. A42 binds to a neuronal nicotinic acetylcholine receptor subunit, neuronal acetylcholine receptor subunit alpha-7 (CHRNA7), with high affinity and, thus, may be involved in the pathogenesis of AD. Therefore, to clarify the molecular mechanism of Arctic mutation-mediated FAD, we focused on CHRNA7 as a target molecule of Arctic A. We performed an in vitro binding assay using purified CHRNA7 and synthetic Arctic A40, and demonstrated that Arctic A40 specifically bound to CHRNA7. The aggregation of Arctic A40 was enhanced with the addition of CHRNA7. Furthermore, the function of CHRNA7 was detected by measuring Ca2+ flux and phospho-p44/42 MAPK (ERK1/2) activation. Our results indicated that Arctic A40 aggregation was enhanced by the addition of CHRNA7, which destabilized the function of CHRNA7 via inhibition of Ca2+ responses and activation of ERK1/2. These findings indicate that Arctic A mutation may be involved in the mechanism underlying FAD. This mechanism may involve binding and aggregation, leading to the inhibition of CHRNA7 functions.	[Ju, Ye; Asahi, Toru; Sawamura, Naoya] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Asahi, Toru; Sawamura, Naoya] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care ASMeW, Shinjuku Ku, Tokyo 1628480, Japan	Sawamura, N (reprint author), Waseda Univ, Fac Sci & Engn, Shinjuku Ku, 03C309 TWIns,2-2 Wakamatsu, Tokyo 1628480, Japan.	naoya.sawamura@gmail.com			KAKENHI [21700415]; High-Tech Research Center (TWIns); Consolidated Research Institute of Advanced Science and Medical Care (ASMeW); Global COE 'Practical Chemical Wisdom' projects; Leading Graduate Program in Science and Engineering, Waseda University; COI STREAM (Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program), from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by KAKENHI 21700415. This study was also supported by the High-Tech Research Center (TWIns), the Consolidated Research Institute of Advanced Science and Medical Care (ASMeW), the Global COE 'Practical Chemical Wisdom' projects, the Leading Graduate Program in Science and Engineering, Waseda University, and COI STREAM (Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program), from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; BURDICK D, 1992, J BIOL CHEM, V267, P546; Gessel MM, 2012, ACS CHEM NEUROSCI, V3, P909, DOI 10.1021/cn300050d; Dineley KT, 2001, J NEUROSCI, V21, P4125; Basun H, 2008, ARCH NEUROL-CHICAGO, V65, P499, DOI 10.1001/archneur.65.4.499; SEGUELA P, 1993, J NEUROSCI, V13, P596; Paivio A, 2004, J MOL BIOL, V339, P145, DOI 10.1016/j.jmb.2004.03.028; Pettit DL, 2001, J NEUROSCI, V21; LEVINE H, 1993, PROTEIN SCI, V2, P404; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Norlin N, 2012, J STRUCT BIOL, V180, P174, DOI 10.1016/j.jsb.2012.06.010; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; KAMINO K, 1992, AM J HUM GENET, V51, P998; [Anonymous], 2000, ADV IND CON, DOI 10.1046/j.1365-313x.2000.00899.x; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Selkoe DJ, 1999, NATURE, V399, pA23; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Liu QS, 2001, P NATL ACAD SCI USA, V98, P4734, DOI 10.1073/pnas.081553598; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Pifer PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016248; Ronnback A, 2011, NEUROBIOL AGING, V32, P280, DOI 10.1016/j.neurobiolaging.2009.02.021; Sawamura N, 2001, J BIOL CHEM, V276, P10314, DOI 10.1074/jbc.M009733200; Sawamura N, 2005, P NATL ACAD SCI USA, V102, P1187, DOI 10.1073/pnas.0406543102; Soderman A, 2008, BRAIN RES, V1227, P240, DOI 10.1016/j.brainres.2008.06.062; Sureshbabu N, 2010, J MOL NEUROSCI, V41, P368, DOI 10.1007/s12031-010-9380-7; VansBroeckhoven C., 1990, SCIENCE, V248, P1120	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2014	131	5					667	674		10.1111/jnc.12837		8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AU0YQ	WOS:000345348500014		
J	Srimontri, P; Endo, S; Sakamoto, T; Nakayama, Y; Kurosaka, A; Itohara, S; Hirabayashi, Y; Kato, K				Srimontri, Paitoon; Endo, Shogo; Sakamoto, Toshiro; Nakayama, Yoshiaki; Kurosaka, Akira; Itohara, Shigeyoshi; Hirabayashi, Yoshio; Kato, Keiko			Sialyltransferase ST3Gal IV deletion protects against temporal lobe epilepsy	JOURNAL OF NEUROCHEMISTRY			English	Article						amygdala; animal model; anxiety; sialyltransferase; temporal lobe epilepsy; thalamus	MYELIN-ASSOCIATED GLYCOPROTEIN; KINDLED-SEIZURES; GROWTH-HORMONE; PHARMACORESISTANT EPILEPSY; GANGLIOSIDE BIOSYNTHESIS; BRAIN GANGLIOSIDES; STATUS EPILEPTICUS; C57BL/6 MICE; SIALIC ACIDS; GM3 SYNTHASE	Temporal lobe epilepsy (TLE) often becomes refractory, and patients with TLE show a high incidence of psychiatric symptoms, including anxiety and depression. Therefore, it is necessary to identify molecules that were previously unknown to contribute to epilepsy and its associated disorders. We previously found that the sialyltransferase ST3Gal IV is up-regulated within the neural circuits through which amygdala-kindling stimulation propagates epileptic seizures. In contrast, this study demonstrated that kindling stimulation failed to evoke epileptic seizures in ST3Gal IV-deficient mice. Furthermore, approximately 80% of these mice failed to show tonic-clonic seizures with stimulation, whereas all littermate wild-type mice showed tonic-clonic seizures. This indicates that the loss of ST3Gal IV does not cause TLE in mice. Meanwhile, ST3Gal IV-deficient mice exhibited decreased acclimation in the open field test, increased immobility in the forced swim test, enhanced freezing during delay auditory fear conditioning, and sleep disturbances. Thus, the loss of ST3Gal IV modulates anxiety-related behaviors. These findings indicate that ST3Gal IV is a key molecule in the mechanisms underlying anxiety - a side effect of TLE - and may therefore also be an effective target for treating epilepsy, acting through the same circuits.	[Srimontri, Paitoon; Nakayama, Yoshiaki; Kurosaka, Akira; Kato, Keiko] Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan; [Endo, Shogo] Tokyo Metropolitan Inst Gerontol, Aging Regulat Res Team, Itabashi Ku, Tokyo, Japan; [Sakamoto, Toshiro] Kyoto Tachibana Univ, Dept Psychol, Fac Hlth Sci, Yamashina Ku, Kyoto, Japan; [Itohara, Shigeyoshi] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan; [Hirabayashi, Yoshio] RIKEN Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama, Japan	Kato, K (reprint author), Kyoto Sangyo Univ, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	kato@cc.kyoto-su.ac.jp			Kyoto Sangyo University Research Grants [E1106]; Ministry of Education, Culture, Sports, Science, and Technology [22580338]; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	This work was supported by Kyoto Sangyo University Research Grants (E1106); the Ministry of Education, Culture, Sports, Science, and Technology (22580338); and Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST). We thank Ms Yuko Watanabe for assisting in the paperwork, and Mr Hirotaka Nishizaki and Ms Asami Miyauchi for assisting in the experiments. Ms Shigeko Yamada participated as an undergraduate student in the early stages of this research. The authors declare no competing financial interests.	RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; PostelVinay MC, 1997, ENDOCRINOLOGY, V138, P1816, DOI 10.1210/en.138.5.1816; Zhang XM, 2008, NEUROTOXICOLOGY, V29, P406, DOI 10.1016/j.neuro.2008.01.006; Goosens KA, 2001, LEARN MEMORY, V8, P148, DOI 10.1101/lm.37601; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Watanabe S, 2010, GLIA, V58, P1197, DOI 10.1002/glia.20999; TURNER BH, 1991, J COMP NEUROL, V313, P295, DOI 10.1002/cne.903130208; KUPFER DJ, 1976, BIOL PSYCHIAT, V11, P159; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; LEDOUX JE, 1991, NEUROSCI LETT, V134, P139, DOI 10.1016/0304-3940(91)90526-Y; Ma JY, 2004, BRAIN RES, V997, P111, DOI 10.1016/j.brainres.2003.11.004; Bazil CW, 2000, ARCH NEUROL-CHICAGO, V57, P363, DOI 10.1001/archneur.57.3.363; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Ekinci O, 2009, EPILEPSY BEHAV, V14, P8, DOI 10.1016/j.yebeh.2008.08.015; Gastens AM, 2008, EPILEPSIA, V49, P1759, DOI 10.1111/j.1528-1167.2008.01659.x; Wang B, 2003, EUR J CLIN NUTR, V57, P1351, DOI 10.1038/sj.ejcn.1601704; Mortazavi F, 2005, EPILEPSY BEHAV, V7, P629, DOI 10.1016/j.yebeh.2005.08.019; DODRILL CB, 1986, EPILEPSIA, V27, P399, DOI 10.1111/j.1528-1157.1986.tb03559.x; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Spencer SS, 2002, LANCET NEUROL, V1, P375, DOI 10.1016/S1474-4422(02)00163-1; Perini GI, 1996, J NEUROL NEUROSUR PS, V61, P601, DOI 10.1136/jnnp.61.6.601; Patterson MC, 2013, HAND CLINIC, V113, P1707, DOI 10.1016/B978-0-444-59565-2.00039-3; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; BAILEY KR, 2009, METHODS BEHAV ANAL N, P3; Browne TR, 2000, HDB EPILEPSY, p[42, 91], DOI 10.1007/978-1-4939-0659-8_10; DESFREITAS RM, 2010, PHARM BIOCH BEHAV, V94, P341; EICHENBAUM HB, 2002, FUNDAMFNTAL NEUROSCI, P1299; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; Franks RP, 2003, CHILD ADOL PSYCH CL, V12, P551, DOI 10.1016/S0156-4993(03)00029-4; Gemmell C, 2002, NEUROSCIENCE, V109, P401, DOI 10.1016/S0306-4522(01)00554-1; Glauser TA, 2004, EPILEPSY BEHAV, V5, pS25, DOI 10.1016/j.yebeh.2004.06.013; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Kato K, 2001, BRAIN RES, V901, P281, DOI 10.1016/S0006-8993(01)02299-5; Kato K, 2008, NEUROSCI LETT, V441, P286, DOI 10.1016/j.neulet.2008.06.058; Kato K, 2009, J NEUROCHEM, V110, P509, DOI 10.1111/j.1471-4159.2009.06132.x; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Leussis MP, 2007, NEUROSCIENCE, V145, P33, DOI 10.1016/j.neuroscience.2006.11.031; Leussis MP, 2006, EPILEPSIA, V47, P801, DOI 10.1111/j.1528-1167.2006.00525.x; Matsuhashi H, 2003, J NEUROCHEM, V84, P53, DOI 10.1046/j.1471-4159.2003.01257.x; MEIBACH RC, 1977, BRAIN RES, V134, P1, DOI 10.1016/0006-8993(77)90921-0; Midzyanovskaya IS, 2005, EPILEPSY BEHAV, V6, P543, DOI 10.1016/j.yebeh.2005.03.005; Niimi K, 2011, BIOCHEM BIOPH RES CO, V406, P524, DOI 10.1016/j.bbrc.2011.02.071; Okabe A, 2001, J NEUROCHEM, V77, P1185, DOI 10.1046/j.1471-4159.2001.00319.x; Price Joseph L., 1995, P629; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Seyrantepe V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001118; Stromme P, 2011, BRAIN, V134, P3369, DOI 10.1093/brain/awr250; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; SUZUKI J, 1982, EXP NEUROL, V75, P440, DOI 10.1016/0014-4886(82)90172-8; Uchida H, 1999, J MOL ENDOCRINOL, V23, P347, DOI 10.1677/jme.0.0230347; WHITE LE, 1993, J NEUROSCI, V13, P4787; Witter M.P., 2004, RAT NERVOUS SYSTEM, P635; Woolley ML, 2006, BRAIN RES, V1078, P151, DOI 10.1016/j.brainres.2006.01.071; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	70	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2014	131	5					675	687		10.1111/jnc.12838		13	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AU0YQ	WOS:000345348500015		
J	Busby, ER; Soeta, S; Sherwood, NM; Johnston, SD				Busby, E. R.; Soeta, S.; Sherwood, N. M.; Johnston, S. D.			Molecular Analysis of the Koala Reproductive Hormones and Their Receptors: Gonadotrophin-Releasing Hormone (GnRH), Follicle-Stimulating Hormone beta and Luteinising Hormone beta with Localisation of GnRH	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						marsupials; gonadotrophin-releasing hormone; luteinising hormone; follicle-stimulating hormone; receptors; neuropeptides	WALLABY MACROPUS-EUGENII; GLYCOPROTEIN HORMONE; SEQUENCE ALIGNMENT; PROVIDES INSIGHT; BRUSHTAIL POSSUM; LEOPARD GECKO; GREEN ANOLE; 2ND FORM; II GENE; EVOLUTION	During evolution, reproductive hormones and their receptors in the brain-pituitary-gonadal axis have been altered by genetic mechanisms. To understand how the neuroendocrine control of reproduction evolved in mammals, it is important to examine marsupials, the closest group to placental mammals. We hypothesised that at least some of the hormones and receptors found in placental mammals would be present in koala, a marsupial. We examined the expression of koala mRNA for the reproductive molecules. Koala cDNAs were cloned from brain for gonadotrophin-releasing hormones (GnRH1 and GnRH2) or from pituitary for GnRH receptors, types I and II, follicle-stimulating hormone (FSH) and luteinising hormone (LH), and from gonads for FSH and LH receptors. Deduced proteins were compared by sequence alignment and phylogenetic analysis with those of other vertebrates. In conclusion, the koala expressed mRNA for these eight putative reproductive molecules, whereas at least one of these molecules is missing in some species in the amniote lineage, including humans. In addition, GnRH1 and 2 are shown by immunohistochemistry to be expressed as proteins in the brain.	[Busby, E. R.; Sherwood, N. M.] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; [Soeta, S.] Nippon Vet & Life Sci Univ, Sch Vet Med, Tokyo, Japan; [Johnston, S. D.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia	Busby, ER (reprint author), Univ Victoria, Dept Biol, Petch Bldg,3800 Finnerty Rd, Victoria, BC V8W 3N5, Canada.	erbusby@uvic.ca			Canadian NSERC; Dreamworld (Ardent Leisure, Australia)	The present study was supported by Canadian NSERC (NMS) and Research Donation from Dreamworld (Ardent Leisure, Australia) (SDJ). All genetic sequences are deposited in GenBank database. The authors of the manuscript have no conflicts of interest to declare.	Allen CD, 2008, BIOL REPROD, V78, P661, DOI 10.1095/biolreprod.107.064824; Allen CD, 2008, REPROD FERT DEVELOP, V20, P598, DOI 10.1071/RD07214; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Kah O, 2007, GEN COMP ENDOCR, V153, P346, DOI 10.1016/j.ygcen.2007.01.030; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Roch GJ, 2014, GEN COMP ENDOCR, V209, P118, DOI 10.1016/j.ygcen.2014.07.025; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Fan QR, 2008, PROTEINS, V72, P393, DOI 10.1002/prot.21937; Kim DK, 2011, GEN COMP ENDOCR, V170, P68, DOI 10.1016/j.ygcen.2010.10.018; Dos Santos S, 2009, ENDOCRINOLOGY, V150, P3815, DOI 10.1210/en.2008-1743; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Ikemoto T, 2006, GENE, V368, P28, DOI 10.1016/j.gene.2005.10.004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Bousfield GR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1581; Butler AB, 2005, COMP VERTEBRATE NEUR, P361; Cheung TC, 2002, REPROD FERT DEVELOP, V14, P157, DOI 10.1071/RD01124; Crawford JL, 2011, GEN COMP ENDOCR, V170, P424, DOI 10.1016/j.ygcen.2010.10.024; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Dawson TJ, 1989, FAUNA AUSTR B, V1B, P42; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Ikemoto T, 2003, GENE, V316, P157, DOI 10.1016/S0378-1119(03)00758-3; Ikemoto T, 2007, J MOL ENDOCRINOL, V38, P289, DOI 10.1677/JME-06-0010; King JA, 2000, GEN COMP ENDOCR, V117, P439, DOI 10.1006/gcen.1999.7418; KING JA, 1989, ENDOCRINOLOGY, V125, P2244; Lescheid DW, 1997, ENDOCRINOLOGY, V138, P5618, DOI 10.1210/en.138.12.5618; Lescheid DW, 1997, GEN COMP ENDOCR, V108, P247, DOI 10.1006/gcen.1997.6970; LINCOLN GA, 1978, J ENDOCRINOL, V77, P347, DOI 10.1677/joe.0.0770347; LOVEJOY DA, 1992, P NATL ACAD SCI USA, V89, P6373, DOI 10.1073/pnas.89.14.6373; LOVEJOY DA, 1991, REGUL PEPTIDES, V33, P105, DOI 10.1016/0167-0115(91)90206-V; Mattiske D, 2002, MOL REPROD DEV, V63, P24, DOI 10.1002/mrd.10161; Molinia FC, 1998, ANIM REPROD SCI, V53, P253, DOI 10.1016/S0378-4320(98)00117-1; Moore LG, 1997, GEN COMP ENDOCR, V106, P30, DOI 10.1006/gcen.1996.6847; Moore LG, 1997, REPROD FERT DEVELOP, V9, P419, DOI 10.1071/R97004; Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81; Roch GJ, 2014, GENOME BIOL EVOL, V6, P1466, DOI 10.1093/gbe/evu118; Dos Santos S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-332; SCHWANZELFUKUDA M, 1987, ANN NY ACAD SCI, V519, P213, DOI 10.1111/j.1749-6632.1987.tb36299.x; Sherwood NM, 1997, GNRH NEURONS GENE BE, P3; Stewart AJ, 2009, NEUROENDOCRINOLOGY, V90, P416, DOI 10.1159/000233303; THOMAS GB, 1988, NEUROENDOCRINOLOGY, V48, P342, DOI 10.1159/000125033; VansHiel MB, 2012, PEPTIDES, V34, P193; White RB, 1998, P NATL ACAD SCI USA, V95, P305, DOI 10.1073/pnas.95.1.305	56	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	DEC	2014	26	12					870	887		10.1111/jne.12208		18	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	AU0TO	WOS:000345337700005		
J	Watanabe, Y; Uenoyama, Y; Suzuki, J; Takase, K; Suetomi, Y; Ohkura, S; Inoue, N; Maeda, KI; Tsukamura, H				Watanabe, Y.; Uenoyama, Y.; Suzuki, J.; Takase, K.; Suetomi, Y.; Ohkura, S.; Inoue, N.; Maeda, K. -I.; Tsukamura, H.			Oestrogen-Induced Activation of Preoptic Kisspeptin Neurones May be Involved in the Luteinising Hormone Surge in Male and Female Japanese Monkeys	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						GPR54; metastin; nonhuman primates; sex difference	METASTASIS SUPPRESSOR GENE; SEXUAL-DIFFERENTIATION; ARCUATE NUCLEUS; RHESUS-MONKEY; KISS1 GENE; BASAL HYPOTHALAMUS; PITUITARY-FUNCTION; MACACA-MULATTA; GNRH SECRETION; MESSENGER-RNA	The oestrogen-induced luteinising hormone (LH) surge is evident in male primates, including humans, whereas male rodents never show the LH surge, even when treated with a preovulatory level of oestrogen. This suggests that the central mechanism governing reproductive hormones in primates is different from that in rodents. The present study aimed to investigate whether male Japanese monkeys conserve a brain mechanism mediating the oestrogen-induced LH surge via activation of kisspeptin neurones. Adult male and female Japanese monkeys were gonadectomised and then were treated with oestradiol-17 for 2weeks followed by a bolus injection of oestradiol benzoate. Both male and female monkeys showed an oestrogen-induced LH surge. In gonadectomised monkeys sacrificed just before the anticipated time of the LH surge, oestrogen treatment significantly increased the number of KISS1-expressing cells in the preoptic area (POA) and enhanced the expression of c-fos in POA KISS1-positive cells of males and females. The oestrogen treatment failed to induce c-fos expression in the arcuate nucleus (ARC) kisspeptin neurones in both sexes just prior to LH surge onset. Thus, kisspeptin neurones in the POA but not in the ARC might be involved in the positive-feedback action of oestrogen that induces LH surge in male Japanese monkeys, as well as female monkeys. The present results indicate that oestrogen-induced activation of POA kisspeptin neurones may contribute to the LH surge generation in both sexes. The conservation of the LH surge generating system found in adult male primates, unlike rodents, could be a result of the capability of oestrogen to induce POA kisspeptin expression and activation.	[Watanabe, Y.; Uenoyama, Y.; Takase, K.; Suetomi, Y.; Ohkura, S.; Inoue, N.; Tsukamura, H.] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Suzuki, J.] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Maeda, K. -I.] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan	Tsukamura, H (reprint author), Nagoya Univ, Lab Reprod Sci, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	htsukamura@nagoya-u.jp			JSPS KAKENHI [26 .4328, 26252046, 23580402, 24380157]; Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development [REP2002]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Cooperation Research Program of Primate Research Institute, Kyoto University	We are grateful to the National Hormone and Peptide Program for the LH assay kit. We thank Maki Kawahara for her technical support. The RIA was performed at the Nagoya University Radioisotope Centre. This work was supported in part by JSPS KAKENHI Grant Numbers 26 .4328 to YW, 26252046 to H.T., 23580402 to Y.U. and 24380157 to K.M., the Research Program on Innovative Technologies for Animal Breeding, Reproduction, and Vaccine Development (REP2002), and Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry. This study was also supported in part by the Cooperation Research Program of Primate Research Institute, Kyoto University (to H.T.).	Alcin E, 2013, J NEUROENDOCRINOL, V25, P488, DOI 10.1111/jne.12025; Terao Y, 2004, BBA-GENE STRUCT EXPR, V1678, P102, DOI 10.1016/j.bbaexp.2004.02.005; KARSCH FJ, 1973, ENDOCRINOLOGY, V92, P799; Seminara SB, 2008, J NEUROENDOCRINOL, V20, P727, DOI 10.1111/j.1365-2826.2008.01731.x; Plant TM, 2012, FRONT NEUROENDOCRIN, V33, P160, DOI 10.1016/j.yfrne.2012.02.002; Tomikawa J, 2010, BIOL REPROD, V82, P313, DOI 10.1095/biolreprod.109.079863; Tena-Sempere M, 2006, HUM REPROD UPDATE, V12, P631, DOI 10.1093/humupd/dml023; KARSCH FJ, 1973, SCIENCE, V179, P484, DOI 10.1126/science.179.4072.484; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Kim W, 2009, PEPTIDES, V30, P103, DOI 10.1016/j.peptides.2008.06.005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Kauffman AS, 2007, ENDOCRINOLOGY, V148, P1774, DOI 10.1210/en.2006-1540; Kauffman AS, 2009, PEPTIDES, V30, P83, DOI 10.1016/j.peptides.2008.06.014; Yamada S, 2007, ENDOCRINOLOGY, V148, P2226, DOI 10.1210/en.2006-1529; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; Terasawa E, 2010, J NEUROENDOCRINOL, V22, P630, DOI 10.1111/j.1365-2826.2010.02027.x; Adachi S, 2007, J REPROD DEVELOP, V53, P367, DOI 10.1262/jrd.18146; KREY LC, 1975, ENDOCRINOLOGY, V96, P1073; Maeda KI, 2007, REV ENDOCR METAB DIS, V8, P21, DOI 10.1007/s11154-007-9032-6; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Inoue N, 2011, P NATL ACAD SCI USA, V108, P17527, DOI 10.1073/pnas.1113035108; Homma T, 2009, BIOL REPROD, V81, P1216, DOI 10.1095/biolreprod.109.078311; Tsukamura H, 2010, ANN NY ACAD SCI, V1200, P95, DOI 10.1111/j.1749-6632.2010.05645.x; Ohkura S, 2009, PEPTIDES, V30, P49, DOI 10.1016/j.peptides.2008.08.004; Okamura H, 2013, ADV EXP MED BIOL, V784, P297, DOI 10.1007/978-1-4614-6199-9_14; Clarke IJ, 2011, FRONT NEUROENDOCRIN, V32, P367, DOI 10.1016/j.yfrne.2011.01.001; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Merkley CM, 2012, ENDOCRINOLOGY, V153, P5406, DOI 10.1210/en.2012-1357; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; Ducret E, 2010, ENDOCRINOLOGY, V151, P2223, DOI 10.1210/en.2009-1480; GLADUE BA, 1984, SCIENCE, V225, P1496, DOI 10.1126/science.6089349; HODGES JK, 1978, J REPROD FERTIL, V52, P83; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Paxinos G., 2000, RHESUS MONKEY BRAIN; Plant TM, 2009, PEPTIDES, V30, P67, DOI 10.1016/j.peptides.2008.06.029; POMERANTZ SM, 1986, HORM BEHAV, V20, P483, DOI 10.1016/0018-506X(86)90010-3; REYES FI, 1974, J CLIN ENDOCR METAB, V38, P612; Ruka KA, 2013, ENDOCRINOLOGY, V154, P2761, DOI 10.1210/en.2013-1268; Smith JT, 2010, BIOL REPROD, V83, P568, DOI 10.1095/biolreprod.110.085407; STEARNS EL, 1973, J CLIN ENDOCR METAB, V37, P635	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	DEC	2014	26	12					909	917		10.1111/jne.12227		9	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	AU0TO	WOS:000345337700008		
J	Kuwabara, S; Misawa, S				Kuwabara, Satoshi; Misawa, Sonoko			Exercise, dominant hand and neurodegeneration	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS		[Kuwabara, Satoshi; Misawa, Sonoko] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba 2608670, Japan	Kuwabara, S (reprint author), Chiba Univ, Grad Sch Med, Dept Neurol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	kuwabara-s@faculty.chiba-u.jp					Eisen A, 2012, J NEUROL NEUROSUR PS, V83, P399, DOI 10.1136/jnnp-2011-301456; van der Hoorn A, 2012, MOVEMENT DISORD, V27, P206, DOI 10.1002/mds.24007; Turner MR, 2011, J NEUROL NEUROSUR PS, V82, P853, DOI 10.1136/jnnp.2010.208413; JOHNSON E W, 1971, Archives of Physical Medicine and Rehabilitation, V52, P333; Piscosquito G, 2014, J NEUROL NEUROSUR PS, V85, P1343	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	DEC	2014	85	12					1291	1291		10.1136/jnnp-2014-307924		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AT9XF	WOS:000345276400001		
J	Kawachi, I				Kawachi, Izumi			Deep grey matter involvement in multiple sclerosis: key player or bystander?	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material									Niigata Univ, Brain Res Inst, Dept Neurol, Chuo Ku, Niigata 9518585, Japan	Kawachi, I (reprint author), Niigata Univ, Brain Res Inst, Dept Neurol, Chuo Ku, 1-757 Asahimachi, Niigata 9518585, Japan.	ikawachi@bri.niigata-u.ac.jp					Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; Calabrese M, 2013, PRION, V7, P20, DOI 10.4161/pri.22580; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Haider L, 2014, J NEUROL NEUROSUR PS, V85, P1375; Kawachi I, 2014, CLIN EXP NEUROIMMUNO, V5, P69	6	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	DEC	2014	85	12					1293	1293		10.1136/jnnp-2014-308221		1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	AT9XF	WOS:000345276400003		
J	Riku, Y; Ando, T; Goto, Y; Mano, K; Iwasaki, Y; Sobue, G; Yoshida, M				Riku, Yuichi; Ando, Takashi; Goto, Yoji; Mano, Kazuo; Iwasaki, Yasushi; Sobue, Gen; Yoshida, Mari			Early Pathologic Changes in Hereditary Diffuse Leukoencephalopathy With Spheroids	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Autopsy; Axonal spheroids; CSF1R gene; Hereditary diffuse leukoencephalopathy with spheroids; Leukoencephalopathy; MRI; Pigmentary leukodystrophy	NEUROAXONAL SPHEROIDS; AXONAL SPHEROIDS; LEUKODYSTROPHY; HDLS; MUTATIONS; FAMILY	Hereditary diffuse leukoencephalopathy with spheroids (HDLS) is a familial neurodegenerative disease clinically characterized by progressive cognitive and motor dysfunction. Mutations in the colony-stimulating factor 1 receptor (CSF1R) gene have recently been identified in HDLS patients. The presence of diffuse axonal spheroids, myelin loss, and pigmented microglia in the white matter are pathologic hallmarks of HDLS; however, early pathologic findings have not been described inHDLS patients. We report a Japanese family with HDLS. A novel heterozygous c. 653 C>Y mutation in the CSF1R gene was identified in the female proband who died at the age of 63 years; postmortem findings were compatible with HDLS. We also autopsied her sister who was considered to be neurologically asymptomatic and died of tuberculosis at the age of 44 years. Postmortem studies revealed patchy axonal degeneration and myelin loss, predominantly in the subcortical white matter. Pigmented microglia were distributed diffusely throughout the cerebral white matter and expressed CSF1R poorly. In conclusion, our observations suggest that the pathology of HDLS may initially be characterized by multifocal lesions in subcortical white matter regions. Moreover, pigmented microglia poorly express CSF1R and are distributed diffusely throughout the white matter at the early disease stage, preceding axonal damage and myelin loss.	[Riku, Yuichi; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Ando, Takashi; Goto, Yoji; Mano, Kazuo] Nagoya Daiichi Red Cross Hosp, Dept Neurol, Nagoya, Aichi, Japan; [Iwasaki, Yasushi; Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Nagakute, Aichi 48011, Japan	Yoshida, M (reprint author), Aichi Med Univ, Inst Med Sci Aging, Yazakokarimata 9, Nagakute, Aichi 48011, Japan.	myoshida@aichi-med-u.ac.jp			Research Committee for CNS Degenerative Diseases, Ministry of Health, Labour and Welfare, Japan	This study was supported by Grants-in-Aid from the Research Committee for CNS Degenerative Diseases, Ministry of Health, Labour and Welfare, Japan.	Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Kondo Y, 2011, J NEUROSCI, V31, P3610, DOI 10.1523/JNEUROSCI.6344-10.2011; Axelsson R, 1984, Acta Psychiatr Scand Suppl, V314, P1; Browne L, 2003, EUR NEUROL, V50, P85, DOI 10.1159/000072504; Freeman SH, 2008, BRAIN PATHOL, V19, P39; Kinoshita M, 2012, J NEUROL SCI, V318, P115, DOI 10.1016/j.jns.2012.03.012; Konnno T, 2014, NEUROLOGY, V82, P1; Lin WL, 2010, INT J CLIN EXP PATHO, V3, P665; Marotti JD, 2004, ACTA NEUROPATHOL, V107, P481, DOI 10.1007/s00401-004-0847-x; Mitsui J, 2012, AM J MED GENET B, V159B, P951, DOI 10.1002/ajmg.b.32100; Moro-de-Casillas ML, 2004, J NEUROL NEUROSUR PS, V75, P1070, DOI 10.1136/jnnp.2003.028431; Sundal C, 2012, NEUROLOGY, V79, P566, DOI 10.1212/WNL.0b013e318263575a; Sundal C, 2014, J NEUROIMAGING, V24, P444, DOI 10.1111/jon.12037; Van Gerpen JA, 2008, NEUROLOGY, V71, P925, DOI 10.1212/01.wnl.0000325916.30701.21; Wider C, 2009, NEUROLOGY, V72, P1953, DOI 10.1212/WNL.0b013e3181a826c0; Yazawa I, 1997, J NEUROL SCI, V147, P185, DOI 10.1016/S0022-510X(96)05346-4	19	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2014	73	12					1183	1190				8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AU0DQ	WOS:000345294200009		
J	Wu, HS				Wu, Hua-Shan			Predictors of Hyperphagia in Institutionalized Patients With Dementia	JOURNAL OF NURSING RESEARCH			English	Article						dementia; institutionalized; hyperphagic behavior; predictor	ABILITIES SCREENING INSTRUMENT; MANSFIELD AGITATION INVENTORY; COGNITIVE-ABILITIES; CHINESE VERSION; BEHAVIORAL DISTURBANCES; ALZHEIMERS-DISEASE; DISORDERS; SCORES; VOLUME	Background: Hyperphagia, a common eating behavioral change in patients with dementia, is one of the risk factors for institutional placement. No study of hyperphagia has yet been conducted on institutionalized patients with dementia. There is currently no academic consensus over the correlations among hyperphagic behaviors, agitated behaviors, cognitive function, and demographic characteristics in this patient group. Purpose: This study explores the prevalence and predictors of hyperphagic behaviors in institutionalized patients with dementia. Methods: A cross-sectional and correlational design was used. The participants were recruited from seven dementia special care units and assisted living facilities in Taiwan. One hundred seventy-nine patients with dementia agreed to participate. Two research assistants were trained to collect data using the subscale for hyperphagic behaviors, the Cohen-Mansfield Agitation Inventory, the Cognitive Abilities Screening Instrument, and a dementia patient demographic characteristics datasheet. Results: The prevalence of hyperphagic behaviors in institutionalized patients with dementia was 50.8% (91/179). After excluding the variables from the long-term memory, short-term memory, attention, abstraction and judgment, and verbally nonaggressive behavior subscales scores, we found gender, length of institutionalization, category fluency, and physically nonaggressive behavior subscale scores to be significant predictors of hyperphagic behaviors (p < .05). Conclusions/Implications for Practice: Findings suggest that institutionalized male patients with dementia with longer institutionalization who have either a relatively low-fluency task score or a relatively high frequency of physically nonaggressive behaviors are at greater risk for exhibiting hyperphagic behaviors. Once hyperphagic behaviors are found in a patient, a transdisciplinary case meeting should be held to develop an appropriate dietary management plan, and further identification and treatment should be done by a neurologist or a psychiatrist.	[Wu, Hua-Shan] Asia Univ, Sch Nursing, Tokyo, Japan	Wu, HS (reprint author), 500 Liufeng Rd, Taichung 41354, Taiwan.	huashan64@gmail.com			Taiwan Nurses Association [1012005]	This work was supported by the Taiwan Nurses Association (grant number 1012005). The author thanks Chia-Lin Lee and Ruo-Hui Hung for their assistance with data collection.	Andrieu S, 2001, J Nutr Health Aging, V5, P113; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/ldg65.049; LIU HC, 1994, PSYCHOL MED, V24, P763; Lin KN, 2002, DEMENT GERIATR COGN, V14, P176, DOI 10.1159/000066024; MILLER RJ, 1995, J AM GERIATR SOC, V43, P546; Ikeda M, 2002, J NEUROL NEUROSUR PS, V73, P371, DOI 10.1136/jnnp.73.4.371; Whitwell JL, 2007, NEUROIMAGE, V35, P207, DOI 10.1016/j.neuroimage.2006.12.006; Volkers KM, 2011, REV NEUROSCIENCE, V22, P259, DOI 10.1515/RNS.2011.026; Hope T, 1997, INT J GERIATR PSYCH, V12, P1062, DOI 10.1002/(SICI)1099-1166(199711)12:11<1062::AID-GPS675>3.0.CO;2-N; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Callen DJA, 2004, NEUROBIOL AGING, V25, P761, DOI 10.1016/j.neurobiolaging.2003.08.011; Bielemann RM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-45; Chang C. J., 1993, CHINESE PSYCHIAT, V7, P136; Chrisman M, 1991, J Gerontol Nurs, V17, P9; Chung S. Y., 2007, CHINESE J PSYCHOL, V49, P73; Cohen-Mansfields J, 2009, J PSYCHIATR RES, V43, P64, DOI DOI 10.1016/J.JPSYCHIRES.2008.02.003; Cullen P, 1997, INT J GERIATR PSYCH, V12, P559, DOI 10.1002/(SICI)1099-1166(199705)12:5<559::AID-GPS550>3.0.CO;2-W; Gold Carl A, 2008, Expert Rev Neurother, V8, P1879, DOI 10.1586/14737175.8.12.1879; Greenwood CE, 2005, J GERONTOL A-BIOL, V60, P499; Hwang H. C., 2012, FORMOSAN J MED, V16, P382, DOI [10.1007/s11940-012-01669-9, DOI 10.1007/S11940-012-01669-9]; Hwang JP, 1997, INT J GERIATR PSYCH, V12, P902, DOI 10.1002/(SICI)1099-1166(199709)12:9<902::AID-GPS660>3.0.CO;2-Q; Keene J, 1998, INT J GERIATR PSYCH, V13, P700, DOI 10.1002/(SICI)1099-1166(1998100)13:10<700::AID-GPS855>3.0.CO;2-D; Keene JM, 1997, APPETITE, V28, P151, DOI 10.1006/appe.1996.0061; Lin LC, 2007, J ADV NURS, V59, P178, DOI 10.1111/j.1365-2648.2007.04303.x; Nagaratnam N, 2001, ARCH GERONTOL GERIAT, V32, P57, DOI 10.1016/S0167-4943(01)00081-4; Smith G, 1998, NEUROPSY NEUROPSY BE, V11, P97; Tsai RC, 2007, INT PSYCHOGERIATR, V19, P1051, DOI 10.1017/S1041610207005327; Tsang SW, 2010, J NEUROL SCI, V288, P151, DOI 10.1016/j.jns.2009.08.066; White Heidi K, 2004, J Am Med Dir Assoc, V5, P89, DOI 10.1097/01.JAM.0000110646.48753.EF	31	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1682-3141	1948-965X		J NURS RES	J. Nurs. Res.	DEC	2014	22	4					250	258		10.1097/jnr.0000000000000051		9	Nursing	Nursing	AT7PK	WOS:000345129800005		
J	Aoki, K; Wakamatsu, T				Aoki, K.; Wakamatsu, T.			Excitation of optical modes supported by strong absorption in organic thin films at attenuated total reflection geometry	JOURNAL OF OPTICS			English	Article						attenuated total reflection (ATR); electric field enhancement; evanescent field; surface plasmon polariton; surface exiton polariton; organic thin film; copper phthalocyanine (CuPc)	SURFACE-PLASMON RESONANCE; AGGREGATE FILMS; POLARITONS; CRYSTALS; SENSORS; SPECTRA; PHTHALOCYANINES	Reflection dips observed at attenuated total reflection (ATR) geometry for metal thin films are interpreted from excitations of surface plasmon polaritons. We have presented that the absorption induced by enhanced electric fields in a metal film is an origin of this phenomenon (Wakamatsu et al (2007 J. Opt. Soc. Am. B 24 2307)). This viewpoint provides that ATR dips can be generated not only in metals but in other materials. Here, the absorption spectra of copper phthalocyanine (CuPc) thin films were observed at ATR geometry without a metal layer. Only from p-polarized ATR measurements was a strong absorption dip observed in the short wavelength region of the CuPc absorption bands. Kramers-Kronig analyses for the transmittance spectra of a CuPc thin film revealed that the refractive index of the film lowers around the spectral position of the p-polarized ATR dip. Transfer matrix analyses indicated that the lowered refractive index of CuPc induces the enhancement of evanescent fields in the film. These results demonstrate that the ATR dip generation is attributable to the absorption derived from enhanced evanescent fields in the CuPc film.	[Aoki, K.; Wakamatsu, T.] Ibaraki Natl Coll Technol, Dept Elect & Elect Syst Engn, Hitachinaka, Ibaraki 3128508, Japan	Aoki, K (reprint author), Univ Tsukuba, Inst Appl Phys, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	wakamatu@ee.ibaraki-ct.ac.jp			JSPS KAKENHI Grant	We thank Dr S Toyoshima of Fukushima National College of Technology for the experimental support. This work was partly supported by the JSPS KAKENHI Grant.	Cheng CH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3483159; OTTO A, 1968, Z PHYS, V216, P398, DOI 10.1007/BF01391532; DAVIDSON AT, 1982, J CHEM PHYS, V77, P168, DOI 10.1063/1.443636; Farag AAM, 2007, OPT LASER TECHNOL, V39, P728, DOI 10.1016/j.optlastec.2006.03.011; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Wakamatsu T, 2007, J OPT SOC AM B, V24, P2307, DOI 10.1364/JOSAB.24.002307; Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6; Wakamatsu T, 2011, APPL OPTICS, V50, P696, DOI 10.1364/AO.50.000696; EDWARDS L, 1970, J MOL SPECTROSC, V33, P292, DOI 10.1016/0022-2852(70)90040-8; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Piliarik M, 2009, OPT EXPRESS, V17, P16505, DOI 10.1364/OE.17.016505; Born M., 1999, PRINCIPLES OPTICS; BRILLANTE A, 1979, J CHEM PHYS, V70, P5739, DOI 10.1063/1.437401; Harrick N. J., 1967, INTERNAL REFLECTION; HARRISON SE, 1966, J CHEM PHYS, V45, P343, DOI 10.1063/1.1727331; KRETSCHM.E, 1968, Z NATURFORSCH PT A, VA 23, P2135; LAGOIS J, 1976, PHYS REV LETT, V36, P680, DOI 10.1103/PhysRevLett.36.680; PHILPOTT MR, 1978, J CHEM PHYS, V69, P2912, DOI 10.1063/1.436890; PHILPOTT MR, 1980, J CHEM PHYS, V72, P2774, DOI 10.1063/1.439426; Raether H., 1988, SURFACE PLASMONS SMO; Wakamatsu T, 2006, J OPT SOC AM B, V23, P1859, DOI 10.1364/JOSAB.23.001859; Wakamatsu T, 2003, APPL OPTICS, V42, P6929, DOI 10.1364/AO.42.006929; Yang F., 1991, Journal of Modern Optics, V38, DOI 10.1080/09500349114551611; Yuan W, 2007, APPL OPTICS, V46, P8068, DOI 10.1364/AO.46.008068	24	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2040-8978	2040-8986		J OPTICS-UK	J. Opt.	DEC	2014	16	12							125008	10.1088/2040-8978/16/12/125008		6	Optics	Optics	AT4NC	WOS:000344915000009		
J	Okayasu, I; Komiyama, O; Ayuse, T; De Laat, A				Okayasu, I.; Komiyama, O.; Ayuse, T.; De Laat, A.			Tactile sensory and pain thresholds in the face and tongue of subjects asymptomatic for oro-facial pain and headache	JOURNAL OF ORAL REHABILITATION			English	Article						oro-facial pain; sensory threshold; pain threshold; mechanoreceptors; somatosensory function	BURNING MOUTH SYNDROME; ATYPICAL ODONTALGIA; JAW; MANAGEMENT; STIMULATION; REFLEXES; TESTS; WOMEN; SKIN; MEN	The aim of this study was to examine the tactile sensory and pain thresholds in the face, tongue, hand and finger of subjects asymptomatic for pain. Sixteen healthy volunteers (eight men and eight women, mean age 357years, range 27-41) participated. Using Semmes-Weinstein monofilaments, the tactile detection threshold (TDT) and the filament-prick pain detection threshold (FPT) were measured at five sites: on the cheek skin (CS), tongue tip (TT), palm side of the thenar skin (TS), dorsum of the hand (DH) and the finger tip (FT). The difference between the tactile sensory and pain threshold (FPT-TDT) was also calculated. Both for the TDT and FPT, TT and DH had the lowest and highest values, respectively. As for the FPT-TDT, there were no significant differences among the measurement sites. As the difference between FPT and TDT (FPT-TDT) is known to be an important consideration in interpreting QST (quantitative sensory testing) data and can be altered by neuropathology, taking the FPT-TDT as a new parameter in addition to the TDT and FPT separately would be useful for case-control studies on oro-facial pain patients with trigeminal neuralgia, atypical facial pain/atypical odontalgia and burning mouth syndrome/glossodynia.	[Okayasu, I.; Ayuse, T.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Physiol, Nagasaki 8528588, Japan; [Komiyama, O.] Nihon Univ, Sch Dent Matsudo, Dept Oral Funct & Rehabil, Matsudo, Chiba, Japan; [De Laat, A.] Katholieke Univ Leuven, Dept Oral Hlth Sci, Leuven, Belgium; [De Laat, A.] Univ Hosp Leuven, Leuven, Belgium	Okayasu, I (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Physiol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	okayasu@nagasaki-u.ac.jp			Subsidy for dentistry research General Foundation Hojin-kai	This study was supported by a Subsidy for dentistry research General Foundation Hojin-kai for 2012.	Baad-Hansen L, 2013, PAIN, V154, P1287, DOI 10.1016/j.pain.2013.04.005; Isselee H, 2001, EUR J PAIN, V5, P27, DOI 10.1053/eujp.2000.0213; Komiyama O, 2012, J ORAL SCI, V54, P321; Baad-Hansen L, 2008, J ORAL REHABIL, V35, P1, DOI 10.1111/j.1365-2842.2007.01813.x; Eliav E, 2004, J OROFAC PAIN, V18, P339; Michelotti A, 2008, J OROFAC PAIN, V22, P139; Pigg M, 2010, PAIN, V148, P220, DOI 10.1016/j.pain.2009.10.024; Lewis MAO, 2007, ORAL SURG ORAL MED O, V103, pS32, DOI 10.1016/j.tripleo.2006.10.014; Patton LL, 2007, ORAL SURG ORAL MED O, V103, pS39, DOI 10.1016/j.tripleo.2006.11.009; Baad-Hansen L, 2010, J ORAL REHABIL, V37, P313, DOI 10.1111/j.1365-2842.2010.02059.x; De Laat A, 2012, 14 WORLD CONGR PAIN, P251; De Laat A, 1998, J OROFAC PAIN, V12, P260; Isselee H, 2002, J OROFAC PAIN, V16, P105; Jacobs R, 2002, J ORAL REHABIL, V29, P720, DOI 10.1046/j.1365-2842.2002.00952.x; JOHANSSON RS, 1988, EXP BRAIN RES, V72, P204, DOI 10.1007/BF00248518; Komiyama O, 2013, J ORAL SCI, V55, P17; Komiyama O, 2005, PAIN, V115, P308, DOI 10.1016/j.pain.2005.03.006; Komiyama O, 2008, CLIN J PAIN, V24, P16, DOI 10.1097/AJP.0b013e318156d937; Lindblom U, 2005, PATHS OF PAIN 1975-2005, P253; Mashu S, 2004, PAIN RES, V19, P123; Morimoto T, 2008, BASIC PHYSL DENTAL S; Okayasu I, 2009, J ORAL REHABIL, V36, P476, DOI 10.1111/j.1365-2842.2009.01961.x; Okayasu I, 2013, J JPN SOC STOMATOGNA, V20, P48; Okayasu I, 2012, J JPN SOC STOMATOGNA, V18, P204; Okayasu I, 2012, ARCH ORAL BIOL, V57, P1251, DOI 10.1016/j.archoralbio.2012.02.013; Okayasu I, 2012, J PROSTHODONT RES, V56, P87, DOI 10.1016/j.jpor.2011.12.001; Okayasu I, 2012, J JPN SOC STOMATOGNA, V19, P52; Okayasu I, 2013, J JPN SOC STOMATOGNA, V19, P196; RATH EM, 1990, J ORAL MAXIL SURG, V48, P1181, DOI 10.1016/0278-2391(90)90534-9; Sessle BJ, 2005, PATHS OF PAIN 1975-2005, P131; Svensson P, 2004, J OROFAC PAIN, V18, P332; Trulsson M, 2004, CLIN ORAL PHYSL, P165; vansSteenberghe D, 1989, ELECTROMYOGRAPHY JAW, P269; YAMADA Y, 1990, J ORAL REHABIL, V17, P15, DOI 10.1111/j.1365-2842.1990.tb01389.x; YAMADA Y, 1982, ARCH ORAL BIOL, V27, P13, DOI 10.1016/0003-9969(82)90171-6; YAMADA Y, 1985, ARCH ORAL BIOL, V30, P197, DOI 10.1016/0003-9969(85)90115-3; Zakrzewska JM, 2010, PAIN 2010 UPDATED RE, P137	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	DEC	2014	41	12					875	880		10.1111/joor.12213		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT8ZW	WOS:000345218400001		
J	Tomonari, H; Ikemori, T; Kubota, T; Uehara, S; Miyawaki, S				Tomonari, H.; Ikemori, T.; Kubota, T.; Uehara, S.; Miyawaki, S.			First molar cross-bite is more closely associated with a reverse chewing cycle than anterior or pre-molar cross-bite during mastication	JOURNAL OF ORAL REHABILITATION			English	Article						first molar; cross-bite; jaw movement; chewing pattern; malocclusion; mastication	UNILATERAL POSTERIOR CROSSBITE; JAW MOVEMENT; MUSCLE-ACTIVITY; PATTERNS; FORCE; AREA	A posterior cross-bite is defined as an abnormal bucco-lingual relationship between opposing molars, pre-molars or both in centric occlusion. Although it has been reported that patients with unilateral posterior cross-bite often show unique chewing patterns, the relationship between the form of cross-bite and masticatory jaw movement remains unclear in adult patients. The objective of this study was to investigate masticatory jaw movement among different forms of cross-bite. One hundred and one adults were recruited in this study: 27 had unilateral first molar cross-bite (MC group); 28, unilateral pre-molar cross-bite (PC group); 23, anterior cross-bite (AC group); and 23, normal occlusion (control group). Masticatory jaw movement of the lower incisor point was recorded with six degrees of freedom jaw-tracking system during unilateral mastication. Our results showed that the reverse chewing ratio during deliberate unilateral mastication was significantly larger in the MC group than in the PA (P<0001), AC (P<0001) and control (P<0001) groups. These findings suggest that compared to the anterior or pre-molar cross-bite, the first molar cross-bite is more closely associated with a higher prevalence of a reverse chewing cycle.	[Tomonari, H.; Miyawaki, S.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthodont, Kagoshima 8908544, Japan; [Ikemori, T.; Kubota, T.; Uehara, S.] Kagoshima Univ, Dept Orthodont Med & Dent Hosp, Kagoshima 8908544, Japan	Miyawaki, S (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Hlth Res Course, Dept Orthodont,Field Dev Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	miyawaki@dent.kagoshima-u.ac.jp			JSPS KAKENHI [23593036, 24593105, 24390464, 24593104, 21592617]	All authors declare no potential conflict of interests with respect to the research, authorship and/or publication of this article. This study was partially supported by JSPS KAKENHI (Grant numbers 23593036, 24593105, 24390464, 24593104 and 21592617).	Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Piancino MG, 2009, EUR J ORAL SCI, V117, P122, DOI 10.1111/j.1600-0722.2008.00601.x; Wang M, 2013, J ORAL REHABIL, V40, P69, DOI 10.1111/j.1365-2842.2012.02333.x; Sohn BW, 1997, AM J ORTHOD DENTOFAC, V112, P403, DOI 10.1016/S0889-5406(97)70048-9; Hattori Y, 2009, J BIOMECH, V42, P1533, DOI 10.1016/j.jbiomech.2009.03.040; Tsuboi A, 2003, EUR J NEUROSCI, V17, P229, DOI 10.1046/j.1460-9568.2003.02450.x; Tomonari H, 2014, J ORAL REHABIL, V41, P257, DOI 10.1111/joor.12148; van der Bilt A, 2011, J ORAL REHABIL, V38, P754, DOI 10.1111/j.1365-2842.2010.02197.x; Kuninori T, 2014, J ORAL REHABIL, V41, P338, DOI 10.1111/joor.12149; Miyawaki S, 2000, J DENT RES, V79, P1525; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; EGERMARKERIKSSON I, 1990, EUR J ORTHODONT, V12, P399; EHRLICH J, 1992, J ORAL REHABIL, V19, P393, DOI 10.1111/j.1365-2842.1992.tb01581.x; Goto T, 2012, J ORAL REHABIL, V39, P677, DOI 10.1111/j.1365-2842.2012.02318.x; Hidaka O, 1999, J DENT RES, V78, P1336; Kato H, 1996, J JPN SOC STOMATOGNA, V2, P119; KUTIN G, 1969, AMER J ORTHODONTICS, V56, P491, DOI 10.1016/0002-9416(69)90210-3; Miyawaki S, 2004, AM J ORTHOD DENTOFAC, V126, P549, DOI 10.1016/j.ajodo.2003.10.033; Moyers RE, 1988, HDB ORTHODONTICS, P127; Nakatsuka Y, 2010, AUST DENT J, V55, P45, DOI 10.1111/j.1834-7819.2009.01174.x; Nie QO, 2010, AM J ORTHOD DENTOFAC, V138, P323, DOI 10.1016/j.ajodo.2008.10.020; Piancino MG, 2012, EUR J ORTHODONT, V34, P536, DOI 10.1093/ejo/cjr109; Rilo B, 2007, ARCH ORAL BIOL, V52, P474, DOI 10.1016/j.archoralbio.2006.10.001; Tanigawa Y, 2012, AUST DENT J, V57, P171, DOI 10.1111/j.1834-7819.2012.01680.x; Tokiwa H., 2001, J JPN SOC STOMATOGNA, V7, P13; Wang Mei-Qing, 2004, J Contemp Dent Pract, V5, P74	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	DEC	2014	41	12					890	896		10.1111/joor.12222		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT8ZW	WOS:000345218400003		
J	Nakayama, E; Tohara, H; Hino, T; Sato, M; Hiraba, H; Abe, K; Ueda, K				Nakayama, E.; Tohara, H.; Hino, T.; Sato, M.; Hiraba, H.; Abe, K.; Ueda, K.			The effects of ADL on recovery of swallowing function in stroke patients after acute phase	JOURNAL OF ORAL REHABILITATION			English	Article						deglutition disorders; functional independence measure; stroke; nutritional intake	INDEPENDENCE MEASURE; PROLONGED DYSPHAGIA; ASPIRATION; PREDICTORS; REHABILITATION; DISORDERS; RISK; RELIABILITY; INDICATORS; OUTCOMES	This study aimed to examine the association between the degree of recovery from dysphagia and changes in functional independence measure (FIM) items in stroke patients after acute phase by conducting a historical cohort study, because none explains the effects of activities of daily living (ADL) on recovery of swallowing function. Study patients included hospitalised stroke patients after acute phase in whom dysphagia was confirmed (n=72). Change in nutritional intake method score was examined for association with age, days from stroke onset to admission, length of hospital stay and change in FIM score. Moreover, to examine characteristics of patients who were removed from tube feeding, all patients who required tube feeding at the time of admission were divided into two groups comprising those who required tube feeding at discharge and those who did not. A significant and positive association was observed between change in nutritional intake method and FIM for all items other than self-care of bathing, locomotion of stairs and problem solving. Patients who were removed from tube feeding were significantly younger than those who required tube feeding at the time of discharge (P<0041) and also showed significantly higher FIM scores for transfer and all cognitive FIM items at the time of admission (P<005). This study demonstrated that nutritional intake methods improve in conjunction with FIM improvements in patients with dysphagia following the acute phase of stroke. Our results suggest that the age and cognitive function may influence the recovery of patient ability of oral intake.	[Nakayama, E.; Sato, M.; Hiraba, H.; Abe, K.; Ueda, K.] Nihon Univ, Sch Dent, Dept Dysphagia Rehabil, Tokyo 1018310, Japan; [Tohara, H.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Gerontol & Gerodontol, Tokyo, Japan; [Hino, T.] Shinyachiyo Hosp, Chiba, Japan	Nakayama, E (reprint author), Nihon Univ, Sch Dent, Dept Dysphagia Rehabil, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	nakayama.enri@nihon-u.ac.jp			Shinyachiyo Hospital	This study was supported in part by a Grant-in-Aid from Shinyachiyo Hospital. The authors have no conflicts of interest to declare for this study.	Amarasena J, 2003, BRAIN RES, V965, P222, DOI 10.1016/S0006-8993(02)04204-X; Mann G, 1999, STROKE, V30, P744; Parker C, 2004, DYSPHAGIA, V19, P28, DOI 10.1007/s00455-003-0032-8; Smithard DG, 2007, AGE AGEING, V36, P90, DOI 10.1093/ageing/afl149; Hamdy S, 1999, AM J PHYSIOL-GASTR L, V277, pG219; JOHNSON ER, 1993, ARCH PHYS MED REHAB, V74, P973; Daniels SK, 1998, ARCH PHYS MED REHAB, V79, P14, DOI 10.1016/S0003-9993(98)90200-3; Paciaroni M, 2004, EUR NEUROL, V51, P162, DOI 10.1159/000077663; Watanabe Y, 2004, DYSPHAGIA, V19, P100, DOI 10.1007/s00455-003-0509-5; Bagg S, 2002, STROKE, V33, P179, DOI 10.1161/hs0102.101224; Ickenstein GW, 2005, J NEUROL, V252, P1510, DOI 10.1007/s00415-005-0906-9; Falsetti P, 2009, J STROKE CEREBROVASC, V18, P329, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.009; Schroeder MF, 2006, J REHABIL RES DEV, V43, P301, DOI 10.1682/JRRD.2004.12.0154; Smithard DG, 1996, STROKE, V27, P1200; ODDERSON IR, 1995, ARCH PHYS MED REHAB, V76, P1130, DOI 10.1016/S0003-9993(95)80121-9; Hadjikoutis S, 2000, BRAIN, V123, P1863, DOI 10.1093/brain/123.9.1863; Broadley S, 2003, J CLIN NEUROSCI, V10, P300, DOI 10.1016/S0967-5868(03)00022-5; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Han TR, 2008, DYSPHAGIA, V23, P59, DOI 10.1007/s00455-007-9097-0; Leder SB, 2002, DYSPHAGIA, V17, P214, DOI 10.1007/s00455-002-0054-7; Nilsson H, 1998, DYSPHAGIA, V13, P32, DOI 10.1007/PL00009547; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; KIDD D, 1995, QJM-MON J ASSOC PHYS, V88, P409; Mann G, 2000, CEREBROVASC DIS, V10, P380, DOI 10.1159/000016094; Foley NC, 2009, J REHABIL MED, V41, P707, DOI 10.2340/16501977-0415; Broadley S, 2005, DYSPHAGIA, V20, P303, DOI 10.1007/s00455-005-0032-y; Bohannon R W, 1991, J Stroke Cerebrovasc Dis, V1, P190, DOI 10.1016/S1052-3057(10)80016-3; Brosseau L, 1996, AM J PHYS MED REHAB, V75, P422, DOI 10.1097/00002060-199611000-00005; Iizuka M, 2005, ARCH PHYS MED REHAB, V86, P1049, DOI 10.1016/j.apmr.2004.09.021; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; LOGEMANN JA, 1994, OTOLARYNG HEAD NECK, V110, P222; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mann G, 2001, DYSPHAGIA, V16, P208, DOI 10.1007/s00455-001-0069-5; McMicken BL, 2009, DISABIL REHABIL, V31, P2196, DOI 10.3109/09638280902956894; RASLEY A, 1993, AM J ROENTGENOL, V160, P1005; Ronning OM, 1998, STROKE, V29, P779; Samuels R, 2006, J INTELL DISABIL RES, V50, P362, DOI 10.1111/j.1365-2788.2005.00784.x; Smithard DG, 1997, CLIN REHABIL, V11, P73, DOI 10.1177/026921559701100111; Tracy J F, 1989, Dysphagia, V4, P90, DOI 10.1007/BF02407151; Wilkinson TJ, 2002, DYSPHAGIA, V17, P227, DOI 10.1007/s00455-002-0060-9; Yamamura K, 2002, BRAIN RES, V944, P40, DOI 10.1016/S0006-8993(02)02705-1	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	DEC	2014	41	12					904	911		10.1111/joor.12212		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT8ZW	WOS:000345218400005		
J	Okada, T; Ikebe, K; Inomata, C; Takeshita, H; Uota, M; Mihara, Y; Matsuda, K; Kitamura, M; Murakami, S; Gondo, Y; Kamide, K; Masui, Y; Takahashi, R; Arai, Y; Maeda, Y				Okada, T.; Ikebe, K.; Inomata, C.; Takeshita, H.; Uota, M.; Mihara, Y.; Matsuda, K.; Kitamura, M.; Murakami, S.; Gondo, Y.; Kamide, K.; Masui, Y.; Takahashi, R.; Arai, Y.; Maeda, Y.			Association of periodontal status with occlusal force and food acceptability in 70-year-old adults: from SONIC Study	JOURNAL OF ORAL REHABILITATION			English	Article						geriatric dentistry; periodontics; occlusal force; food acceptability; epidemiology; multiple regression analysis	MASTICATORY PERFORMANCE; BITE FORCE; OLDER-ADULTS; CONTACT AREA; BITING FORCE; PRESSURE; AGE; POPULATION; FLOW	This cross-sectional study aimed to investigate the association of periodontal status with occlusal force and food acceptability. We hypothesised that mastication deteriorated with reduced periodontal support, even when posterior occlusal contacts with natural teeth were maintained and the patients remained clinically asymptomatic. Participants were 482 independently living 69-71-year-olds, classified as Eichner's group A, having no mobile teeth and no periodontal symptoms. The periodontal probing depth (PPD) and restoration status of each tooth were examined. Occlusal force in the intercuspal position was measured with pressure-sensitive films. Food acceptability was evaluated from the difficulty experienced in chewing apples, grilled beef, and hard rice crackers. Multivariate regression analysis was performed to investigate the association of periodontal status with occlusal force and food acceptability. A P-value of <005 was considered statistically significant. Multiple linear regression analysis showed that occlusal force had significant negative associations with maximal PPD (standardised partial regression coefficient ()=-0121) after controlling for gender, handgrip strength, number of teeth, and percentage of restored teeth. Approximately 15% of participants were included in the compromised food acceptability group. Logistic regression analyses showed that compromised food acceptability was significantly associated with PPD, after controlling for gender, number of teeth, and percentage of restored teeth. Periodontal probing depth (PPD) was significantly correlated with occlusal force and self-rated food acceptability after controlling for the possible confounding factors in septuagenarians, even those with complete posterior occlusal contacts and no tooth mobility.	[Okada, T.; Ikebe, K.; Inomata, C.; Takeshita, H.; Uota, M.; Mihara, Y.; Matsuda, K.; Maeda, Y.] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan; [Kitamura, M.; Murakami, S.] Osaka Univ, Grad Sch Dent, Dept Periodont, Suita, Osaka 5650871, Japan; [Gondo, Y.] Osaka Univ, Grad Sch Human Sci, Dept Clin Thanatol & Geriatr Behav Sci, Suita, Osaka 5650871, Japan; [Kamide, K.] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka 5650871, Japan; [Masui, Y.; Takahashi, R.] Tokyo Metropolitan Geriatr Hosp, Div Social & Human Sci, Tokyo 173, Japan; [Masui, Y.; Takahashi, R.] Inst Gerontol, Tokyo, Japan; [Arai, Y.] Keio Univ, Sch Med, Dept Geriatr Med, Tokyo, Japan	Ikebe, K (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ikebe@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science [23390440, 23249086, 25293394]	Kazunori Ikebe, Shinya Murakami, Yoshinobu Maeda and Yasuyuki Gondo were responsible for the project concept, design and development of the research plan; Tadashi Okada, Kazunori Ikebe, Chisato Inomata, Hajime Takeshita, Masahiro Uota, Yusuke Mihara, Kenichi Matsuda and Masahiro Kitamura collected data for dental status and oral function; Yasuyuki Gondo and Yukie Masui collected socioeconomic and psychological data; Kei Kamide, Ryutaro Takahashi and Yasumichi Arai collected medical data; Tadashi Okada and Kazunori Ikebe performed statistical analysis; Kazunori Ikebe wrote and had primary responsibility for the final content of the manuscript. All authors have read and approved the final manuscript. None of the authors have any conflict of interest in relation to the publication of this work. This research was supported by Grants-in-Aid for Scientific Research (Nos. 23390440, 23249086, and 25293394) from the Japan Society for the Promotion of Science. None of the authors have any conflict of interest with regard to the publication of this work.	Alkan A, 2006, J PERIODONTOL, V77, P1442, DOI 10.1902/jop.2006.060025; Alkan A, 2006, J AM DENT ASSOC, V137, P978; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; HEATH MR, 1982, INT DENT J, V32, P345; Suzuki T, 1997, INT J PROSTHODONT, V10, P386; Miyaura K, 1999, J ORAL REHABIL, V26, P223, DOI 10.1046/j.1365-2842.1999.00364.x; Okiyama S, 2003, J ORAL REHABIL, V30, P278, DOI 10.1046/j.1365-2842.2003.01009.x; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Hiiemae K, 1996, ARCH ORAL BIOL, V41, P175, DOI 10.1016/0003-9969(95)00112-3; Dental Health Division of Health Policy Bureau Japanese Ministry of Health Labour Welfare, 2011, STAT TABL SURV DEN 1; HANNAM AG, 1976, ARCH ORAL BIOL, V21, P641, DOI 10.1016/0003-9969(76)90137-0; Hidaka O, 1999, J DENT RES, V78, P1336; Ikebe K, 2007, INT J PROSTHODONT, V20, P161; Ikebe K, 2005, J DENT, V33, P131, DOI 10.1016/j.jdent.2004.09.002; Ikebe K, 2010, INT J PROSTHODONT, V23, P521; Ikebe K, 2012, J DENT, V40, P71, DOI 10.1016/j.jdent.2011.10.007; KREHER JM, 1987, J PROSTHET DENT, V57, P631, DOI 10.1016/0022-3913(87)90350-7; Morita M, 2003, J ORAL REHABIL, V30, P260, DOI 10.1046/j.1365-2842.2003.01012.x; Takeuchi N, 2008, J CLIN PERIODONTOL, V35, P215, DOI 10.1111/j.1600-051X.2007.01186.x	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	DEC	2014	41	12					912	919		10.1111/joor.12214		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT8ZW	WOS:000345218400006		
J	Ogawa, K; Matsumura, N; Yoshida, A				Ogawa, Kiyohisa; Matsumura, Noboru; Yoshida, Atsushi			Modified Osteotomy for Symptomatic Malunion of the Humeral Greater Tuberosity	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						greater tuberosity malunion; osteotomy; valgus-impacted fracture	ARTHROSCOPIC TREATMENT; PROXIMAL HUMERUS; FRACTURES	Here, we describe a modified osteotomy for malunion of the greater tuberosity that facilitates bone union and prevents symptom recurrence. The 3 most important features of this technique are: (1) osteotomizing the displaced fragment that includes the bed of the fracture, (2) placing figure-of-eight sutures by passing suture threads from inside the medullary cavity through osseous holes made in the metaphysis, and (3) pushing the distal end of the osteotomized fragment into the medullary cavity and fixing it in place. This procedure was performed on 10 patients who complained of clinical symptoms derived primarily from greater tuberosity malunion after fractures of various morphologies. Eight of these patients were available for follow-up examinations over 2 postoperative years. Constant score ratios comparing the repaired side to the uninjured side ranged from 82% to 100%. These results support the use of this modified osteotomy in achieving favorable bone union and in creating sufficient subacromial space to resolve most symptoms caused by these malunited proximal humeral fractures.	[Ogawa, Kiyohisa] Eiju Gen Hosp, Dept Orthoped Surg, Taito Ku, Taito, Tokyo, Japan; [Matsumura, Noboru] Keio Univ, Dept Orthoped Surg, Sch Med, Shinjuku Ku, Tokyo 108, Japan; [Yoshida, Atsushi] Saitama Natl Hosp, Dept Orthoped Surg, Wakou City, Japan	Ogawa, K (reprint author), 2-3-23 Harayama,Midori Ku, Saitama 3360931, Japan.	ogawa51@jcom.home.ne.jp					Ogawa K, 2003, J TRAUMA, V54, P713, DOI 10.1097/01.TA.0000057230.30979.49; Bono CM, 2001, J BONE JOINT SURG BR, V83B, P1056, DOI 10.1302/0301-620X.83B7.10516; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077; Beredjiklian PK, 1998, J BONE JOINT SURG AM, V80A, P1484; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Craig Edward V., 1995, P289; Craig EV, 2004, MASTER TECHNIQUES OR, P495; GERBER C, 1990, ORTHOPADE, V19, P316; Iannotti Joseph P., 1997, P245; Kim KC, 2010, ORTHOPEDICS, V33, P242, DOI 10.3928/01477447-20100225-13; Martinez AA, 2010, INT ORTHOP, V34, P1207, DOI 10.1007/s00264-009-0900-4; Park Tae-Soo, 1997, Bulletin Hospital for Joint Diseases, V56, P171; Ritzman TF, 2007, DISORDERS SHOULDER D, P907; Russo R, 2005, Chir Organi Mov, V90, P159; Siegel JA, 2000, ORTHOP CLIN N AM, V31, P35, DOI 10.1016/S0030-5898(05)70126-7; Siegel JA, 2003, J SHOULDER ELB SURG, V12, P69, DOI 10.1067/mse.2002.123902; Wirth Michael A, 2003, Instr Course Lect, V52, P13	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	DEC	2014	28	12					E290	E295				6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	AU0TN	WOS:000345337600004		
J	Murakami, H; Okamura, K; Aoki, S; Sakagami, R; Yamazaki, J				Murakami, H.; Okamura, K.; Aoki, S.; Sakagami, R.; Yamazaki, J.			Association of caspase-14 and filaggrin expression with keratinization of the oral mucosa and reconstruction culture rat models	JOURNAL OF PERIODONTAL RESEARCH			English	Article						caspase-14; filaggrin; keratinization; oral mucosa	GREEN TEA; EPIGALLOCATECHIN-3-GALLATE EGCG; EPIDERMAL-KERATINOCYTES; SKIN; DIFFERENTIATION; FIBROBLASTS; HEALTH; CELLS; REGENERATION; PROTEINS	Background and ObjectiveKeratinization of the oral mucosa, such as the gingiva, has been shown to be important for periodontal health. Caspase-14 is a protease that plays a role in keratinization of the epidermis. The objective of this study was to investigate whether the expression of caspase-14 is intimately linked with keratinization and to examine the effect of the main component of green tea on the improvement of keratinization in rat oral mucosal preparations. Material and MethodsHistological and immunohistochemical analyses and quantitative mRNA measurements of caspase-14 and its substrate filaggrin were performed using different types of rat epithelial tissue and organotypic reconstruction culture models derived from epithelial cells and fibroblasts taken from the rat oral mucosa. ResultsIn the skin, palate, buccal mucosa and esophagus, the degree of keratinization appeared to be associated with expression of cytokeratin 10. The relative protein and mRNA expression levels of caspase-14 and filaggrin were consistent with the degree of keratinization in the following order: skin > palate > buccal mucosa > esophagus. The culture models of palatal and buccal mucosa retained a stratified epithelial structure. Expression of caspase-14 appeared to be stronger in the palatal model than in the buccal model. Remarkably, epigallocatechin-3-gallate (EGCG) improved the localization of cytokeratins and increased the expression of caspase-14 and filaggrin. This expression was more intense in the palatal model than in the buccal model, indicating that both models maintain the intrinsic properties of keratinization of the mucosa from where the cultured cells were derived. ConclusionsThese results suggest that keratinization is closely associated with expression of caspase-14 and filaggrin. Our reconstruction models are promising tools for drug evaluation and show that EGCG is beneficial for improving both keratinization and expression of the linked protease in the oral mucosa.	[Murakami, H.; Sakagami, R.] Fukuoka Dent Coll, Dept Odontol, Sawara Ku, Fukuoka 8140193, Japan; [Okamura, K.] Fukuoka Dent Coll, Dept Morphol Biol, Fukuoka 8140193, Japan; [Aoki, S.] Saga Univ, Dept Pathol & Microbiol, Fac Med, Saga 840, Japan; [Yamazaki, J.] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka 8140193, Japan	Yamazaki, J (reprint author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	junyama@college.fdcnet.ac.jp					MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383; Agudio G, 2008, J PERIODONTOL, V79, P587, DOI 10.1902/jop.2008.070414 ; Hsu S, 2007, EXP DERMATOL, V16, P678, DOI 10.1111/j.1600-0625.2007.00585.x; Hsu S, 2003, J PHARMACOL EXP THER, V306, P29, DOI 10.1124/jpet.103.049734; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Eckhart L, 2000, J INVEST DERMATOL, V115, P1148, DOI 10.1046/j.1523-1747.2000.00205.x; Hoste E, 2011, J INVEST DERMATOL, V131, P2233, DOI 10.1038/jid.2011.153; Aoki S, 2009, PATHOL INT, V59, P368, DOI 10.1111/j.1440-1827.2009.02379.x; Sugihara H, 2001, BRIT J DERMATOL, V144, P244, DOI 10.1046/j.1365-2133.2001.04008.x; Wennstrom JL, 2012, CLIN ORAL IMPLAN RES, V23, P136, DOI 10.1111/j.1600-0501.2012.02540.x; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Aoki S, 2004, MOL BIOL CELL, V15, P4647, DOI 10.1091/mbc.E04-01-0038; Block MS, 1990, J ORAL MAXILLOFAC SU, V48, P153; Bloor BK, 1998, LAB INVEST, V78, P787; CLAUSEN H, 1986, J ORAL PATHOL MED, V15, P36, DOI 10.1111/j.1600-0714.1986.tb00561.x; DALE B A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P167; DALE BA, 1982, ARCH ORAL BIOL, V27, P535, DOI 10.1016/0003-9969(82)90067-X; Denecker G, 2008, J CELL BIOL, V180, P451, DOI [10.1083/jcb.200709098, 10.1083/icb.200709098]; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Hsu S, 2005, J PHARMACOL EXP THER, V312, P884, DOI 10.1124/jpet.104.076075; LANG NP, 1972, J PERIODONTOL, V43, P623, DOI 10.1902/jop.1972.43.10.623; Okazaki M, 2003, PLAST RECONSTR SURG, V112, P784, DOI 10.1097/01.PRS.0000069710.48139.4E; Presland Richard B, 2002, J Dent Educ, V66, P564; Rawlings A V, 2004, Dermatol Ther, V17 Suppl 1, P43, DOI 10.1111/j.1396-0296.2004.04S1005.x; Song JM, 2007, EXPERT REV ANTI-INFE, V5, P497, DOI 10.1586/14787210.5.3.497; WARRER K, 1995, CLIN ORAL IMPLAN RES, V6, P131, DOI 10.1034/j.1600-0501.1995.060301.x	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	DEC	2014	49	6					703	710		10.1111/jre.12152		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT7ZC	WOS:000345152300004		
J	Nakatsuka, Y; Nagasawa, T; Yumoto, Y; Nakazawa, F; Furuichi, Y				Nakatsuka, Y.; Nagasawa, T.; Yumoto, Y.; Nakazawa, F.; Furuichi, Y.			Inhibitory effects of sword bean extract on alveolar bone resorption induced in rats by Porphyromonas gingivalis infection	JOURNAL OF PERIODONTAL RESEARCH			English	Article						alveolar bone resorption; Porphyromonas gingivalis; sword bean	GREEN TEA POLYPHENOLS; CYSTEINE PROTEINASE; BIOFILM FORMATION; CANAVANINE; ARGININE; PERIODONTITIS; CYTOTOXICITY; SUPPRESSION; HEMOGLOBIN; ACTIVATION	BackgroundThe domesticated legume, Canavalia gladiata (commonly called the sword bean), is known to contain canavanine. The fruit is used in Chinese and Japanese herbal medicine for treating the discharge of pus, but its pharmacological mechanisms are still unclear. ObjectivesThis study examined the effect of sword bean extract (SBE) on (i) oral bacteria and human oral epithelial cells in vitro, and (ii) the initiation and progression of experimental Porphyromonas gingivalis-induced alveolar bone resorption in rats. Material and MethodsA high-performance liquid chromatography/ultraviolet method was applied to quantitate canavanine in SBE. By assessing oral bacterial growth, we estimated the minimum inhibitory concentration and minimum bactericidal concentration of SBE, canavanine, chlorhexidine gluconate (CHX) solution. The cytotoxicity of SBE, canavanine, CHX, leupeptin and cystatin for KB cells was determined using a trypan blue assay. The effects of SBE, canavanine, leupeptin and cystatin on Arg-gingipain (Rgp) and Lys-gingipain (Kgp) were evaluated by colorimetric assay using synthetic substrates. To examine its effects on P.gingivalis-associated periodontal tissue breakdown, SBE was orally administered to P.gingivalis-infected rats. ResultSword bean extract contained 6.4% canavanine. SBE and canavanine inhibited the growth of P.gingivalis and Fusobacterium nucleatum. The cytotoxicity of SBE, canavanine and cystatin on KB cells was significantly lower than that of CHX. Inhibition of Rgp with SBE was comparable to that with leupeptin, a known Rgp inhibitor, and inhibition of Kgp with SBE was significantly higher than that with leupeptin at 500g/mL ( p<0.05). P.gingivalis-induced alveolar bone resorption was significantly suppressed by administration of SBE, with bone levels remaining comparable to non-infected animals ( p<0.05). ConclusionThe present study suggests that SBE might be effective against P.gingivalis-associated alveolar bone resorption.	[Nakatsuka, Y.; Nagasawa, T.; Yumoto, Y.; Furuichi, Y.] Hlth Sci Univ Hokkaido, Div Periodontol & Endodontol, Dept Oral Rehabil, Sch Dent, Tobetsu, Hokkaido, Japan; [Nakazawa, F.] Hlth Sci Univ Hokkaido, Div Microbiol, Dept Oral Biol, Sch Dent, Tobetsu, Hokkaido, Japan	Furuichi, Y (reprint author), Hlth Sci Univ Hokkaido, Div Periodontol & Endodontol, Dept Oral Rehabil, Sch Dent, 1757 Kanazawa Ishikari Tobetsu, Tobetsu, Hokkaido, Japan.	furuichi@hoku-iryo-u.ac.jp					Abrahamson M, 1997, J CLIN PATHOL-MOL PA, V50, P291; Ekanayake S, 2007, FOOD CHEM TOXICOL, V45, P797, DOI 10.1016/j.fct.2006.10.030; Shimizu M, 2005, MUTAT RES-FUND MOL M, V591, P147, DOI 10.1016/j.mrfmmm.2005.04.010; Guggenheimer J, 2003, J AM DENT ASSOC, V134, P61; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Kadowaki T, 2004, MOL PHARMACOL, V66, P1599, DOI 10.1124/mol.104.004366; Okamoto K, 1998, J BIOL CHEM, V273, P21225, DOI 10.1074/jbc.273.33.21225; Nakajima K, 2006, J PERIODONTAL RES, V41, P527, DOI 10.1111/j.1600-0765.2006.00901.x; Hirasawa M, 2002, J PERIODONTAL RES, V37, P433, DOI 10.1034/j.1600-0765.2002.01640.x; GORDON JM, 1985, J CLIN PERIODONTOL, V12, P697, DOI 10.1111/j.1600-051X.1985.tb00941.x; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244; Suganuma M, 1999, CANCER RES, V59, P44; Mann CM, 2000, LETT APPL MICROBIOL, V30, P294, DOI 10.1046/j.1472-765x.2000.00712.x; Li L, 2008, J AM CHEM SOC, V130, P1918, DOI 10.1021/ja0760877; IMAMURA T, 1994, J CLIN INVEST, V94, P361, DOI 10.1172/JCI117330; Sakanaka S, 1996, BIOSCI BIOTECH BIOCH, V60, P745; Yamanaka A, 2007, J PERIODONTAL RES, V42, P589, DOI 10.1111/j.1600-0765.2007.00982.x; Percival RS, 2006, EUR J ORAL SCI, V114, P343; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; DeCarlo AA, 1999, J BACTERIOL, V181, P3784; Drake David, 2011, J Clin Dent, V22, P1; Guggenheimer J, 2003, J AM DENT ASSOC, V134, P118; HIGUCHI M, 1995, BLOOD, V86, P2248; Johansson A, 1998, EUR J ORAL SCI, V106, P863, DOI 10.1046/j.0909-8836.1998.eos106405.x; Kitano S, 2001, JPN J PHARMACOL, V85, P84, DOI 10.1254/jjp.85.84; Laurena Antonio C., 1994, Journal of Food Composition and Analysis, V7, P194, DOI 10.1006/jfca.1994.1019; Park Hyun, 1995, Korean Journal of Parasitology, V33, P211; TEAS HJ, 1951, J BIOL CHEM, V190, P369; Verma RK, 2010, INTERDISCIP PERSPECT, V2010, DOI DOI 10.1155/2010/605125; WALKER JB, 1955, J BIOL CHEM, V212, P207	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	DEC	2014	49	6					801	809		10.1111/jre.12166		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AT7ZC	WOS:000345152300016		
J	Matsuba, S; Niwa, S; Muraki, K; Kanatsuka, S; Nakazono, Y; Hatano, N; Fujii, M; Zhan, P; Suzuki, T; Ohya, S				Matsuba, Sayo; Niwa, Satomi; Muraki, Katsuhiko; Kanatsuka, Saki; Nakazono, Yurika; Hatano, Noriyuki; Fujii, Masanori; Zhan, Peng; Suzuki, Takayoshi; Ohya, Susumu			Downregulation of Ca2+-Activated Cl- Channel TMEM16A by the Inhibition of Histone Deacetylase in TMEM16A-Expressing Cancer Cells	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							K+-CHANNEL; THERAPEUTIC TARGET; DNA METHYLATION; BREAST-CANCER; EXPRESSION; HDAC3; PROLIFERATION; PROGRESSION; CARCINOMA; ANO1	The Ca2+-activated Cl- channel transmembrane proteins with unknown function 16 A (TMEM16A; also known as anoctamin 1 or discovered on gastrointestinal stromal tumor 1) plays an important role in facilitating the cell growth and metastasis of TMEM16A-expressing cancer cells. Histone deacetylase (HDAC) inhibitors (HDACi) are useful agents for cancer therapy, but it remains unclear whether ion channels are epigenetically regulated by them. Using real-time polymerase chain reaction, Western blot analysis, and whole-cell patch-clamp assays, we found a significant decrease in TMEM16A expression and its functional activity was induced by the vorinostat, a pan-HDACi in TMEM16A-expressing human cancer cell lines, the prostatic cancer cell line PC-3, and the breast cancer cell line YMB-1. TMEM16A downregulation was not induced by the chemotherapy drug paclitaxel in either cell type. Pharmacologic blockade of HDAC3 by 1 mu M T247 [N-(2-aminophenyl)-4-[1-(2-thiophen-3-ylethyl)-1H-[1],[2],[3]triazol-4-yl]benzamide], a HDAC3-selective HDACi, elicited a large decrease in TMEM16A expression and functional activity in both cell types, and pharmacologic blockade of HDAC2 by AATB [4-(acetylamino)N-[2-amino-5-(2-thienyl)phenyl]-benzamide; 300 nM] elicited partial inhibition of TMEM16A expression (similar to 40%) in both. Pharmacologic blockade of HDAC1 or HDAC6 did not elicit any significant change in TMEM16A expression, respectively. In addition, inhibition of HDAC3 induced by small interfering RNA elicited a large decrease in TMEM16A transcripts in both cell types. Taken together, in malignancies with a frequent gene amplification of TMEM16A, HDAC3 inhibition may exert suppressive effects on cancer cell viability via downregulation of TMEM16A.	[Matsuba, Sayo; Niwa, Satomi; Kanatsuka, Saki; Nakazono, Yurika; Fujii, Masanori; Ohya, Susumu] Kyoto Pharmaceut Univ, Dept Pharmacol, Div Pathol Sci, Kyoto 6078414, Japan; [Muraki, Katsuhiko; Hatano, Noriyuki] Aichi Gakuin Univ, Sch Pharm, Lab Cellular Pharmacol, Nagoya, Aichi 464, Japan; [Zhan, Peng; Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan	Ohya, S (reprint author), Kyoto Pharmaceut Univ, Dept Pharmacol, Div Pathol Sci, Yamashina Ku, 5 Misasagi Nakauchi, Kyoto 6078414, Japan.	sohya@mb.kyoto-phu.ac.jp			Japan Society for the Promotion of Science [25460111]; Promotion and Mutual Aid Cooperation for Private Schools of Japan (Kyoto Pharmaceutical University); Promotion and Mutual Aid Cooperation for Private Schools of Japan (Aichi-Gakuin University); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Uehara Memorial Foundation	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25460111); a research grant from the Promotion and Mutual Aid Cooperation for Private Schools of Japan (Kyoto Pharmaceutical University and Aichi-Gakuin University); Mochida Memorial Foundation for Medical and Pharmaceutical Research; and Uehara Memorial Foundation (to S.O.).	AKERVALL JA, 1995, CANCER, V76, P853, DOI 10.1002/1097-0142(19950901)76:5<853::AID-CNCR2820760520>3.0.CO;2-6; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Martin-Trujillo A, 2011, EPIGENETICS-US, V6, P1236, DOI 10.4161/epi.6.10.17654; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Minami J, 2014, LEUKEMIA, V28, P680, DOI 10.1038/leu.2013.231; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Alenghat T, 2013, NATURE, V504, P153, DOI 10.1038/nature12687; Itoh Y, 2007, J MED CHEM, V50, P5425, DOI 10.1021/jm7009217; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Ohya S, 2009, J PHARMACOL SCI, V109, P148, DOI 10.1254/jphs.08208SC; Taylor P, 2012, MOL CANCER THER, V11, P1713, DOI 10.1158/1535-7163.MCT-11-0990; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Li JY, 2013, CURR MED CHEM, V20, P1858; Uchida H, 2010, NEUROSCIENCE, V166, P1, DOI 10.1016/j.neuroscience.2009.12.021; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Munster PN, 2009, BRIT J CANCER, V101, P1044, DOI 10.1038/sj.bjc.6605293; Lang F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0108; Venkatraman A, 2014, HUM MOL GENET, V23, P3733, DOI 10.1093/hmg/ddu081; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Iwamoto M, 2013, CANCER CHEMOTH PHARM, V72, P493, DOI 10.1007/s00280-013-2220-z; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Hatano N, 2013, AM J PHYSIOL-CELL PH, V304, pC354, DOI 10.1152/ajpcell.00096.2012; Jacobsen KS, 2013, PFLUG ARCH EUR J PHY, V465, P1753, DOI 10.1007/s00424-013-1315-z; Komatsu Y, 2006, ANTICANCER RES, V26, P2029; Lin HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020362; Miao LJ, 2014, TUMOR BIOL, V35, P7097, DOI 10.1007/s13277-014-1961-6; Muller BM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-215; Nwaobi SE, 2014, GLIA, V62, P411, DOI 10.1002/glia.22613; Ohshiro J, 2014, BIOCHEM BIOPH RES CO, V443, P518, DOI 10.1016/j.bbrc.2013.11.117; Ohya S, 2013, BRIT J PHARMACOL, V169, P1011, DOI 10.1111/bph.12215; Ohya S, 2011, J PHARMACOL EXP THER, V338, P528, DOI 10.1124/jpet.111.182782; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068669; Yamazaki D, 2006, J BIOL CHEM, V281, P38430, DOI 10.1074/jbc.M603917200; Yang M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00185; Zhu J, 2013, BRAIN RES, V1520, P15, DOI 10.1016/j.brainres.2013.04.061	51	4	4	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	DEC	2014	351	3					510	518		10.1124/jpet.114.217315		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT9AK	WOS:000345219800004		
J	Tsugawa, D; Oya, Y; Masuzaki, R; Ray, K; Engers, DW; Dib, M; Do, N; Kuramitsu, K; Ho, K; Frist, A; Yu, PB; Bloch, KD; Lindsley, CW; Hopkins, CR; Hong, CC; Karp, SJ				Tsugawa, Daisuke; Oya, Yuki; Masuzaki, Ryota; Ray, Kevin; Engers, Darren W.; Dib, Martin; Do, Nhue; Kuramitsu, Kaori; Ho, Karen; Frist, Audrey; Yu, Paul B.; Bloch, Kenneth D.; Lindsley, Craig W.; Hopkins, Corey R.; Hong, Charles C.; Karp, Seth J.			Specific Activin Receptor-Like Kinase 3 Inhibitors Enhance Liver Regeneration	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							PARTIAL-HEPATECTOMY; HEPCIDIN EXPRESSION; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; CELL-CYCLE; IN-VIVO; MICE; DORSOMORPHIN; REPLICATION; FAILURE	Pharmacologic agents to enhance liver regeneration after injury would have wide therapeutic application. Based on previous work suggesting inhibition of bone morphogenetic protein (BMP) signaling stimulates liver regeneration, we tested known and novel BMP inhibitors for their ability to accelerate regeneration in a partial hepatectomy (PH) model. Compounds were produced based on the 3,6-disubstituted pyrazolo[1,5-a] pyrimidine core of the BMP antagonist dorsomorphin and evaluated for their ability to inhibit BMP signaling and enhance liver regeneration. Antagonists of the BMP receptor activin receptor-like kinase 3 (ALK3), including LDN-193189 (LDN; 4-[6-[4-(1-piperazinyl)phenyl] pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline), DMH2 (4-(2-(4-(3-(quinolin-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl)phenoxy)ethyl)morpholine; VU0364849), and the novel compound VU0465350 (7-(4-isopropoxyphenyl)-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridine; VU5350), blocked SMAD phosphorylation in vitro and in vivo, and enhanced liver regeneration after PH. In contrast, an antagonist of the BMP receptor ALK2, VU0469381 (5-(6-(4-methoxyphenyl)pyrazolo[1,5-a] pyrimidin-3-yl)quinolone; 1LWY), did not affect liver regeneration. LDN did not affect liver synthetic or metabolic function. Mechanistically, LDN increased serum interleukin-6 levels and signal transducer and activator of transcription 3 phosphorylation in the liver, and modulated other factors known to be important for liver regeneration, including suppressor of cytokine signaling 3 and p53. These findings suggest that inhibition of ALK3 may be part of a therapeutic strategy for treating human liver disease.	[Tsugawa, Daisuke; Oya, Yuki; Masuzaki, Ryota; Ray, Kevin; Karp, Seth J.] Vanderbilt Univ, Med Ctr, Transplant Ctr, Nashville, TN 37212 USA; [Tsugawa, Daisuke; Oya, Yuki; Masuzaki, Ryota; Ray, Kevin; Karp, Seth J.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37212 USA; [Engers, Darren W.; Lindsley, Craig W.; Hopkins, Corey R.] Vanderbilt Ctr Neurosci Drug Discovery, Dept Pharmacol, Nashville, TN USA; [Dib, Martin; Do, Nhue] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Kuramitsu, Kaori] Kobe Univ, Dept Surg, Kobe, Hyogo 657, Japan; [Ho, Karen] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Yu, Paul B.] Brigham & Womens Hosp, Dept Med, Div Cardiol, Boston, MA 02115 USA; [Bloch, Kenneth D.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Ctr Crit Care Res, Boston, MA 02114 USA; [Lindsley, Craig W.] Vanderbilt Univ, Dept Chem, Nashville, TN 37212 USA; [Frist, Audrey; Hong, Charles C.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA	Karp, SJ (reprint author), Vanderbilt Univ, Sch Med, Dept Surg, 805 Oxford House,1313 21st Ave South, Nashville, TN 37212 USA.	seth.karp@vanderbilt.edu			National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [7R01-DK081387, R01-DK0829710]; Vanderbilt University Medical Center; Foundation LeDucq	This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grants 7R01-DK081387 and R01-DK0829710]; Vanderbilt University Medical Center; and the Foundation LeDucq.	Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Moustakas A, 2001, J CELL SCI, V114, P4359; Engers DW, 2013, BIOORG MED CHEM LETT, V23, P3248, DOI 10.1016/j.bmcl.2013.03.113; Flodby P, 1996, J BIOL CHEM, V271, P24753; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; MICHALOPOULOS G, 1984, CANCER RES, V44, P4414; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Kogure K, 1996, HEPATOLOGY, V24, P361; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Brandoff Jared F, 2008, Am J Orthop (Belle Mead NJ), V37, P410; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Do N, 2012, AM J PHYSIOL-GASTR L, V303, pG1220, DOI 10.1152/ajpgi.00105.2012; GOHDA E, 1988, J CLIN INVEST, V81, P414, DOI 10.1172/JCI113334; Hayashi E, 2003, J SURG RES, V111, P196, DOI 10.1016/S0022-4804(03)00052-0; Piscione TD, 1997, AM J PHYSIOL-RENAL, V273, pF961; Rehman H, 2011, TRANSPLANTATION, V91, P406, DOI 10.1097/TP.0b013e318204bdb2; SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I; Yu Paul B, 2008, Nat Chem Biol, V4, P33, DOI 10.1038/nchembio.2007.54; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	32	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	DEC	2014	351	3					549	558		10.1124/jpet.114.216903		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT9AK	WOS:000345219800008		
J	Sasaki, A; Mizoguchi, S; Kagaya, K; Shiro, M; Sakai, A; Andoh, T; Kino, Y; Taniguchi, H; Saito, Y; Takahata, H; Kuraishi, Y				Sasaki, Atsushi; Mizoguchi, Shizuka; Kagaya, Kenta; Shiro, Mai; Sakai, Akiho; Andoh, Tsugunobu; Kino, Yurika; Taniguchi, Hiroyuki; Saito, Yukako; Takahata, Hiroki; Kuraishi, Yasushi			A Mouse Model of Peripheral Postischemic Dysesthesia: Involvement of Reperfusion-Induced Oxidative Stress and TRPA1 Channel	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							SENSORY NEURONS; N-ACETYLCYSTEINE; MOLECULAR-MECHANISMS; CANCER-PATIENTS; MURINE MODEL; PAIN; NEUROPATHY; RECEPTOR; EXPRESSION; ALLODYNIA	Peripheral postischemic dysesthesia was examined behaviorally in mice and we investigated the underlying molecular mechanism with a focus on oxidative stress. Hind-paw ischemia was induced by tight compression of the ankle with a rubber band, and reperfusion was achieved by cutting the rubber tourniquet. We found that reperfusion after ischemia markedly provoked licking of the reperfused hind paw, which was significantly inhibited by systemic administration of the antioxidant N-acetyl-L-cysteine and the transient receptor potential (TRP) A1 channel blocker HC-030031 [2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide]. Postischemic licking was also significantly inhibited by an intraplantar injection of another antioxidant, phenyl-N-tert-butylnitrone. The TRPV1 channel blocker BCTC [N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) tetrahydropyrazine-1(2H)-carboxamide] did not inhibit postischemic licking. An intraplantar injection of hydrogen peroxide elicited hind-paw licking, which was inhibited by N-acetyl-L-cysteine, phenyl-N-tert-butylnitrone, and HC-030031. Postischemic licking was not affected by chemical depletion of sensory C-fibers, but it was inhibited by morphine, which has been shown to inhibit the C- and A delta-fiber-evoked responses of dorsal horn neurons. Interestingly, postischemic licking was not inhibited by gabapentin and pregabalin, which have been shown to inhibit the C-fiber-but not A delta-fiber-evoked response. The present results suggest that ischemia-reperfusion induces oxidative stress, which activates TRPA1 channels to provoke postischemic licking. It has been suggested that this behavior is mediated by myelinated (probably A delta-type) afferent fibers. Oxidative stress and TRPA1 channels may be potential targets to treat peripheral ischemia-associated dysesthesia.	[Sasaki, Atsushi; Mizoguchi, Shizuka; Shiro, Mai; Andoh, Tsugunobu; Kuraishi, Yasushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama 9300194, Japan; [Kagaya, Kenta; Kino, Yurika; Taniguchi, Hiroyuki] Mitsubishi Tanabe Pharma Corp, Div Res, Pharmacol Res Labs 2, Dept 1, Toda, Saitama, Japan; [Saito, Yukako; Takahata, Hiroki] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Lab Organ & Pharmaceut Chem, Sendai, Miyagi, Japan	Kuraishi, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, 2630 Sugitani, Toyama 9300194, Japan.	kuraisiy@pha.u-toyama.ac.jp			Nakatomi Foundation	This work was supported in part by a Grant-in-Aid from the Nakatomi Foundation (to A.Sas.).	Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; JURNA I, 1979, BRAIN RES, V171, P573, DOI 10.1016/0006-8993(79)91065-5; You HJ, 2009, NEUROSCIENCE, V164, P1845, DOI 10.1016/j.neuroscience.2009.09.047; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Driessen CML, 2012, SUPPORT CARE CANCER, V20, P877, DOI 10.1007/s00520-011-1336-0; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Head KA, 2006, ALTERN MED REV, V11, P294; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Yamamoto J, 2008, NEUROSCIENCE, V151, P843, DOI 10.1016/j.neuroscience.2007.11.025; Fernandes ES, 2013, FASEB J, V27, P1664, DOI 10.1096/fj.12-221218; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Singh R, 2014, PHARMACOL RES, V80, P21, DOI 10.1016/j.phrs.2013.12.005; Bastyr EJ, 2005, CLIN THER, V27, P1278, DOI 10.1016/j.clinthera.2005.08.002; Scherens A, 2009, EUR J PAIN, V13, P711, DOI 10.1016/j.ejpain.2008.07.014; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; OCHOA JL, 1980, BRAIN, V103, P835, DOI 10.1093/brain/103.4.835; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Das A, 2012, BIOCHEM PHARMACOL, V84, P486, DOI 10.1016/j.bcp.2012.04.021; Gauchan P, 2009, J PHARMACOL SCI, V109, P469, DOI 10.1254/jphs.08325SC; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Moran LK, 2001, CURR MED CHEM, V8, P763; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; da Costa DSM, 2010, PAIN, V148, P431, DOI 10.1016/j.pain.2009.12.002; Fidanboylu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025212; Iida H, 2009, MUSCLE NERVE, V40, P582, DOI 10.1002/mus.21388; Jang HJ, 2008, NEUROSCI LETT, V443, P17, DOI 10.1016/j.neulet.2008.07.049; Kamboj SS, 2010, J NEUROCHEM, V112, P77, DOI 10.1111/j.1471-4159.2009.06435.x; Kim HS, 2008, PHARMACOLOGY, V81, P317, DOI 10.1159/000119756; Lin PC, 2006, SUPPORT CARE CANCER, V14, P484, DOI 10.1007/s00520-006-0018-9; Maxfield EK, 1997, J DIABETES COMPLICAT, V11, P47, DOI 10.1016/S1056-8727(96)00112-2; MERRINGTON WR, 1949, J NEUROL NEUROSUR PS, V12, P1, DOI 10.1136/jnnp.12.1.1; Nakano T, 2008, ACTA DERM-VENEREOL, V88, P449, DOI 10.2340/00015555-0479; Sasaki A, 2013, NEUROREPORT, V24, P137, DOI 10.1097/WNR.0b013e32835df4d9; Sasaki A, 2008, NEUROREPORT, V19, P975, DOI 10.1097/WNR.0b013e328302f123; Suarez-Roca H, 2003, J PSYCHOSOM RES, V55, P253, DOI 10.1016/S0022-3999(02)00498-1; Takahashi N, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00058; Takasaki I, 2000, JPN J PHARMACOL, V83, P319, DOI 10.1254/jjp.83.319; Tanabe M, 2006, EXP NEUROL, V202, P280, DOI 10.1016/j.expneurol.2006.06.002; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	47	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	DEC	2014	351	3					568	575		10.1124/jpet.114.217570		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT9AK	WOS:000345219800010		
J	Hiyoshi, T; Marumo, T; Hikichi, H; Tomishima, Y; Urabe, H; Tamita, T; Iida, I; Yasuhara, A; Karasawa, J; Chaki, S				Hiyoshi, Tetsuaki; Marumo, Toshiyuki; Hikichi, Hirohiko; Tomishima, Yasumitsu; Urabe, Hiroki; Tamita, Tomoko; Iida, Izumi; Yasuhara, Akito; Karasawa, Jun-ichi; Chaki, Shigeyuki			Neurophysiologic and Antipsychotic Profiles of TASP0433864, a Novel Positive Allosteric Modulator of Metabotropic Glutamate 2 Receptor	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							PERFORANT PATH INPUTS; METHYL-D-ASPARTATE; PHARMACOLOGICAL CHARACTERIZATION; PREFRONTAL CORTEX; 2-DEOXYGLUCOSE UPTAKE; DENTATE GYRUS; D-AMPHETAMINE; AGONIST; SCHIZOPHRENIA; LY354740	Excess glutamatergic neurotransmission has been implicated in the pathophysiology of schizophrenia, and the activation of metabotropic glutamate 2 (mGlu2) receptor may exert antipsychotic effects by normalizing glutamate transmission. In the present study, we investigated the neurophysiologic and antipsychotic profiles of TASP0433864 [(2S)-2-[(4-tert-butylphenoxy)methyl]-5methyl-2,3-dihydroimidazo[2,1-b][1,3]oxazole-6-carboxamide], a newly synthesized positive allosteric modulator (PAM) of mGlu2 receptor. TASP0433864 exhibited PAM activity at human and rat mGlu2 receptors with EC50 values of 199 and 206 nM, respectively, without exerting agonist activity at rat mGlu2 receptor. TASP0433864 produced a leftward and upward shift in the concentration-response curve of glutamate-increased guanosine 5'-O-(3-[S-35]thio) triphosphate binding to mGlu2 receptor. In contrast, TASP0433864 had negligible activities for other mGlu receptors, including mGlu3 receptor, and did not have any affinity for other receptors or transporters. In hippocampal slices, TASP0433864 potentiated an inhibitory effect of DCG-IV [(2S,2'R,3'R)-2-(2',3'-dicarboxylcyclopropyl)glycine], a mGlu2/3 receptor agonist, on the field excitatory postsynaptic potentials in the dentate gyrus, indicating that TASP0433864 potentiates the mGlu2 receptor-mediated presynaptic inhibition of glutamate release. Moreover, TASP0433864 inhibited both MK-801 [(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate]- and ketamine-increased cortical gamma band oscillation in the rat cortical electroencephalogram, which have been considered to reflect the excess activation of cortical pyramidal neurons. The inhibitory effect of TASP0433864 on cortical activation was also observed in the mouse 2-deoxy-glucose uptake study. In a behavioral study, TASP0433864 significantly inhibited both ketamine- and methamphetamine-increased locomotor activities in mice and rats, respectively. Collectively, these findings indicate that TASP0433864 is a selective mGlu2 receptor PAM with antipsychotic activity, and the attenuation of excess glutamatergic neurotransmission may be involved in the action of TASP0433864.	[Hiyoshi, Tetsuaki; Marumo, Toshiyuki; Hikichi, Hirohiko; Tomishima, Yasumitsu; Karasawa, Jun-ichi; Chaki, Shigeyuki] Taisho Pharmaceut Co Ltd, Pharmacol Labs, Saitama 3319530, Japan; [Urabe, Hiroki; Tamita, Tomoko; Yasuhara, Akito] Taisho Pharmaceut Co Ltd, Chem Labs, Saitama 3319530, Japan; [Iida, Izumi] Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Saitama 3319530, Japan	Hiyoshi, T (reprint author), Taisho Pharmaceut Co Ltd, Pharmacol Labs, Kita Ku, Pharmacol 1,1-403 Yoshino Cho, Saitama 3319530, Japan.	t-hiyoshi@so.taisho.co.jp					Jones NC, 2012, INT J NEUROPSYCHOPH, V15, P657, DOI 10.1017/S1461145711000848; Breier A, 1997, AM J PSYCHIAT, V154, P805; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Tamaru Y, 2001, NEUROSCIENCE, V106, P481, DOI 10.1016/S0306-4522(01)00305-0; Fell MJ, 2012, NEUROPHARMACOLOGY, V62, P1473, DOI 10.1016/j.neuropharm.2011.06.007; Woolley ML, 2008, PSYCHOPHARMACOLOGY, V196, P431, DOI 10.1007/s00213-007-0974-x; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Fell MJ, 2008, J PHARMACOL EXP THER, V326, P209, DOI 10.1124/jpet.108.136861; Fell MJ, 2011, J PHARMACOL EXP THER, V336, P165, DOI 10.1124/jpet.110.172957; Thiel CM, 1999, NEUROSCIENCE, V93, P243, DOI 10.1016/S0306-4522(99)00158-X; Shigemoto R, 1997, J NEUROSCI, V17, P7503; Johnson MP, 2005, PSYCHOPHARMACOLOGY, V179, P271, DOI 10.1007/s00213-004-2099-9; Krystal JH, 2003, PSYCHOPHARMACOLOGY, V169, P215, DOI 10.1007/s00213-003-1582-z; Shoblock JR, 2003, PSYCHOPHARMACOLOGY, V165, P359, DOI 10.1007/s00213-002-1288-7; Kew JNC, 2001, NEUROPHARMACOLOGY, V40, P20; Rorick-Kehn LM, 2007, PSYCHOPHARMACOLOGY, V193, P121, DOI 10.1007/s00213-007-0758-3; Monn JA, 1997, J MED CHEM, V40, P528, DOI 10.1021/jm9606756; Cartmell J, 2000, J NEUROCHEM, V75, P889, DOI 10.1046/j.1471-4159.2000.0750889.x; Galici R, 2006, J PHARMACOL EXP THER, V318, P173, DOI 10.1124/jpet.106.102046; Krystal JH, 2005, PSYCHOPHARMACOLOGY, V179, P303, DOI 10.1007/s00213-004-1982-8; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Galici R, 2005, J PHARMACOL EXP THER, V315, P1181, DOI 10.1124/jpet.105.091074; Gozzi A, 2008, NEUROPSYCHOPHARMACOL, V33, P1690, DOI 10.1038/sj.npp.1301547; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Hiyoshi T, 2014, NEUROPHARMACOLOGY, V85, P384, DOI 10.1016/j.neuropharm.2014.05.037; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Miyamoto S, 2000, NEUROPSYCHOPHARMACOL, V22, P400, DOI 10.1016/S0893-133X(99)00127-X; Wright RA, 2013, NEUROPHARMACOLOGY, V66, P89, DOI 10.1016/j.neuropharm.2012.01.019; Benneyworth MA, 2007, MOL PHARMACOL, V72, P477, DOI 10.1124/mol.107.035170; Saito K, 2011, ANAL BIOCHEM, V412, P9, DOI 10.1016/j.ab.2011.01.022; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Kew JNC, 2002, NEUROPHARMACOLOGY, V43, P215, DOI 10.1016/S0028-3908(02)00084-9; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Lavreysen H, 2013, J PHARMACOL EXP THER, V346, P514, DOI 10.1124/jpet.113.204990; Fraley ME, 2009, EXPERT OPIN THER PAT, V19, P1259, DOI 10.1517/13543770903045009; Chaki S, 2010, EUR J PHARMACOL, V639, P59, DOI 10.1016/j.ejphar.2009.12.041; Cartmell J, 1999, J PHARMACOL EXP THER, V291, P161; Chin CL, 2011, J PHARMACOL EXP THER, V336, P709, DOI 10.1124/jpet.110.173880; Dunayevich E, 2008, NEUROPSYCHOPHARMACOL, V33, P1603, DOI 10.1038/sj.npp.1301531; CAMP DM, 1994, BRAIN RES, V668, P180, DOI 10.1016/0006-8993(94)90523-1; Dedeurwaerdere S, 2011, PSYCHOPHARMACOLOGY, V214, P505, DOI 10.1007/s00213-010-2052-z; Grillon C, 2003, PSYCHOPHARMACOLOGY, V168, P446, DOI 10.1007/s00213-003-1444-8; Homayoun Houman, 2005, Journal of Neurophysiology (Bethesda), V93, P1989; Kellner M, 2005, PSYCHOPHARMACOLOGY, V179, P310, DOI 10.1007/s00213-004-2025-1; Kilbride J, 1998, EUR J PHARMACOL, V356, P149, DOI 10.1016/S0014-2999(98)00526-3; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nakazato A, 2000, J MED CHEM, V43, P4893, DOI 10.1021/jm000346k; Neki A, 1996, NEUROSCI LETT, V202, P197, DOI 10.1016/0304-3940(95)12248-6; Nicoletti F, 2011, Neuropharmacology, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Sanacora G, 2014, MOL PSYCHIATR, V19, P978, DOI 10.1038/mp.2013.130; Schoepp DD, 2003, STRESS, V6, P189, DOI 10.1080/1025389031000146773; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; Tatsuta T, 2005, NEUROCHEM RES, V30, P1377, DOI 10.1007/s11064-005-8390-2; Watson C, 2007, RAT BRAIN STEREOTAXI	57	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	DEC	2014	351	3					642	653		10.1124/jpet.114.218651		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AT9AK	WOS:000345219800017		
J	Yamamiya, I; Yoshisue, K; Ishii, Y; Yamada, H; Yoshida, K				Yamamiya, Ikuo; Yoshisue, Kunihiro; Ishii, Yuji; Yamada, Hideyuki; Yoshida, Ken-ichiro			Species variation in the enantioselective metabolism of tegafur to 5-fluorouracil among rats, dogs and monkeys	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article						biopharmaceutics and drug disposition; other topics; pharmacokinetics and drug disposition	IN-VITRO; THYMIDINE PHOSPHORYLASE; LIVER-MICROSOMES; FTORAFUR; CYTOCHROME-P450; HUMANS; ENZYMES; R,S-1-(TETRAHYDRO-2-FURANYL)-5-FLUOROURACIL; PHARMACOKINETICS; DISPOSITION	ObjectivesTegafur (FT), a pro-drug of 5-fluorouracil (5-FU), is a racemate consisting of two enantiomers, R and S-FT. The aim of this study was to clarify interspecies variation in the enantioselective metabolism of FT. MethodsPlasma concentrations of FT enantiomers were determined in rats, dogs and monkeys following intravenous and oral dosing of the racemate (5mg/kg). In addition, the enzymatic conversion of FT enantiomers to 5-FU was assayed using hepatic preparations. Key findingsMetabolic clearance of R-FT was higher than that of S-FT in rats and monkeys, but S-FT was the preferential substrate for dogs. An inhibition study revealed that cytochrome P450 is primarily responsible for the enantioselective metabolism of FT in rats and dogs. In contrast, in monkeys, thymidine phosphorylase was a determinant of the enantioselectivity in FT metabolism. Although oral bioavailability was not enantioselective, in-vitro and in-vivo kinetic studies suggested that the enantioselectivity in the hepatic intrinsic clearance of FT directly influences the body clearance in all animal species examined. ConclusionsThe interspecies variations were observed in the enantioselective pharmacokinetics of FT, and the in-vivo enantioselectivity could be extrapolated from the in-vitro metabolic activities.	[Yamamiya, Ikuo; Yoshisue, Kunihiro; Yoshida, Ken-ichiro] Taiho Pharmaceut Co Ltd, Pharmacokinet Res Labs, Tsukuba, Ibaraki 3002611, Japan; [Yamamiya, Ikuo; Ishii, Yuji; Yamada, Hideyuki] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan	Yamamiya, I (reprint author), Taiho Pharmaceut Co Ltd, Pharmacokinet Res Labs, 3 Okubo, Tsukuba, Ibaraki 3002611, Japan.	i-yamamiya@taiho.co.jp					Ikeda K, 2000, CLIN CANCER RES, V6, P4409; Naritomi Y, 2003, DRUG METAB DISPOS, V31, P580, DOI 10.1124/dmd.31.5.580; Kraus BLH, 2000, XENOBIOTICA, V30, P575; Komatsu T, 2001, CLIN CANCER RES, V7, P675; Yamamiya I, 2010, DRUG METAB DISPOS, V38, P1267, DOI 10.1124/dmd.110.032797; Semak I, 2008, J PINEAL RES, V45, P515, DOI 10.1111/j.1600-079X.2008.00630.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Uno Y, 2011, DRUG METAB REV, V43, P346, DOI 10.3109/03602532.2010.549492; BENVENUTO JA, 1979, CANCER RES, V39, P3199; BENVENUTO JA, 1978, CANCER RES, V38, P3867; Bogaards JJP, 2000, XENOBIOTICA, V30, P1131; COHEN AM, 1975, DRUG METAB DISPOS, V3, P303; Damle BD, 2001, BIOPHARM DRUG DISPOS, V22, P45, DOI 10.1002/bdd.256; ELSAYED YM, 1982, BIOCHEM PHARMACOL, V31, P3006, DOI 10.1016/0006-2952(82)90279-9; ELSAYED YM, 1983, CANCER RES, V43, P4039; Emoto C, 2013, CURR DRUG METAB, V14, P239; Emoto Chie, 2003, Drug Metab Pharmacokinet, V18, P287, DOI 10.2133/dmpk.18.287; FREUDENTHAL RI, 1977, XENOBIOTICA, V7, P757; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Fukushima Masakazu, 2006, Gan To Kagaku Ryoho, V33 Suppl 1, P19; Haduch A, 2005, PHARMACOL REP, V57, P867; KRENITSK.TA, 1965, J BIOL CHEM, V240, P1281; Laufer R, 2009, DRUG METAB DISPOS, V37, P873, DOI 10.1124/dmd.108.023804; MAEHARA Y, 1989, J SURG ONCOL, V42, P184, DOI 10.1002/jso.2930420311; PEARCE R, 1992, ARCH BIOCHEM BIOPHYS, V298, P211, DOI 10.1016/0003-9861(92)90115-D; Shindoh H, 2011, J TOXICOL SCI, V36, P411; Turan VK, 2001, DRUG METAB DISPOS, V29, P837; Yamamiya I, 2013, PHARM RES PERSPECT, V1, DOI 10.1002/prp2.9; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; YAMASHITA K, 1988, Journal of Toxicological Sciences, V13, P97; Yoshisue K, 2009, J PHARM PHARMACOL, V61, P1643, DOI 10.1211/jpp/61.12.0009; Zhou DS, 2010, DRUG METAB DISPOS, V38, P1015, DOI 10.1124/dmd.110.033068	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3573	2042-7158		J PHARM PHARMACOL	J. Pharm. Pharmacol.	DEC	2014	66	12					1686	1697		10.1111/jphp.12304		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU0KY	WOS:000345312800004		
J	Iseya, K; Miura, S; Mohri, T				Iseya, Kenji; Miura, Seiji; Mohri, Tetsuo			A Quantitative Evaluation of Phase Field Microstructure by the Spectral Analysis	JOURNAL OF PHASE EQUILIBRIA AND DIFFUSION			English	Article						imaging; phase field method; phenomenological free energy; spectral analysis; visualization of microstructure	CLUSTER VARIATION METHOD; MODEL; HOMOGENIZATION; PRECIPITATION; SIMULATION	Two-phase microstructure calculated by Phase Field calculations is perturbed by Gaussian filtration processes to produce a series of deteriorated images. Fourier spectral analysis is, then, performed on the resultant images to derive information of spatial distribution of phases consisting of the microstructure. It is shown that Fourier spectrum is correlated with characteristic length involved in the microstructure. By inverting a particular spectrum peak, one can estimate the spatial distribution of a particular phase.	[Iseya, Kenji; Miura, Seiji] Hokkaido Univ, Grad Sch Engn, Div Mat Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Mohri, Tetsuo] Tohoku Univ, Inst Mat Res, Ctr Computat Mat Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Mohri, T (reprint author), Tohoku Univ, Inst Mat Res, Ctr Computat Mat Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	tmohri@imr.tohoku.ac.jp					Laschet G, 2008, MAT SCI ENG A-STRUCT, V472, P214, DOI 10.1016/j.msea.2007.03.046; ALLEN SM, 1979, ACTA METALL MATER, V27, P1085, DOI 10.1016/0001-6160(79)90196-2; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; Wang Y, 1998, ACTA MATER, V46, P2983, DOI 10.1016/S1359-6454(98)00015-9; Steinbach I, 2009, MODEL SIMUL MATER SC, V17, DOI 10.1088/0965-0393/17/7/073001; [Anonymous], 2014, H ROTH AW S TMS 2014; KIKUCHI R, 1951, PHYS REV, V81, P988, DOI 10.1103/PhysRev.81.988; Hu SY, 2001, ACTA MATER, V49, P1879, DOI 10.1016/S1359-6454(01)00118-5; Chen LQ, 2002, ANNU REV MATER RES, V32, P113, DOI 10.1146/annurev.matsci.32.112001.132041; Bruce A. D., 1989, NEW PHYSICS, P236; Fromm BS, 2012, ACTA MATER, V60, P5984, DOI 10.1016/j.actamat.2012.06.058; Iseya K, 2014, MATER TRANS, V55, P489, DOI 10.2320/matertrans.M2013362; Kitashima T, 2009, ACTA MATER, V57, P2020, DOI 10.1016/j.actamat.2009.01.006; Mohri T., 2014, H ROTH AW S TMS 2014; MORITA T, 1994, PROG THEOR PHYS SUPP, P27; Nixon M., 2008, FEATURE EXTRACTION I; Ohno M, 2004, THESIS HOKKAIDO U; Provatas N., 2010, PHASE FIELD METHODS; Proville L, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054104; Ramanarayan H, 2003, ACTA MATER, V51, P4761, DOI 10.1016/S1359-6454(03)00301-X; Tanaka K, 1996, THEORY AND APPLICATIONS OF THE CLUSTER VARIATION AND PATH PROBABILITY METHODS, P353; TANAKA K, 1995, PHYS LETT A, V203, P122, DOI 10.1016/0375-9601(95)00387-I; WANG Y, 1995, ACTA METALL MATER, V43, P1837, DOI 10.1016/0956-7151(94)00406-8; Yamanaka A, 2008, MAT SCI ENG A-STRUCT, V480, P244, DOI 10.1016/j.msea.2007.08.066; Yao H., 1991, MAT SCI ENG A-STRUCT, V148, P45, DOI 10.1016/0921-5093(91)90864-J	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1547-7037	1863-7345		J PHASE EQUILIB DIFF	J. Phase Equilib. Diffus.	DEC	2014	35	6					788	793		10.1007/s11669-014-0338-2		6	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	AT9ZB	WOS:000345281500014		
J	Chin, T; Ono, S; Hyakusoku, H				Chin, Takafumi; Ono, Shinpei; Hyakusoku, Hiko			Successful repair of flayed tissue in a degloving injury of the hand by arteriovenous anastomosis	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Degloving; arterial-venous shunt; arterialisation; microsurgery; reconstruction; trauma	SKIN FLAP	We report the case of a 43-year-old man who had a degloving injury of the left hand from a printer machine. There was no response to a pin prick test over the peripheral portion of the degloved skin, so a branch of a digital artery was selected for anastomosis to a subcutaneous vein, which resulted in survival of the degloved tissue with no signs of congestion. Postoperative care and rehabilitation were straightforward, and functional results. were satisfactory.	[Chin, Takafumi; Ono, Shinpei; Hyakusoku, Hiko] Nippon Med Coll Hosp, Dept Plast & Reconstruct Surg, Tokyo, Japan	Chin, T (reprint author), Fushimi Dermatol & Aesthet Surg Clin Kyoto, Fushimi Ku, 12-1-1F Fukakusa Shibata Yashikimachi, Kyoto 6128432, Japan.	chin@peach.plala.or.jp					Adani R, 1998, PLAST RECONSTR SURG, V101, P1544, DOI 10.1097/00006534-199805000-00018; Hsu WM, 1996, PLAST RECONSTR SURG, V98, P146, DOI 10.1097/00006534-199607000-00023; Hyakusoku H, 1993, KEISEIGEKA, V36, P1341; INNIS C O, 1957, Br J Plast Surg, V10, P122, DOI 10.1016/S0007-1226(57)80020-4; Jeng SF, 1997, ANN PLAS SURG, V39, P360, DOI 10.1097/00000637-199710000-00006; KURATA T, 1978, BRIT J PLAST SURG, V31, P117, DOI 10.1016/S0007-1226(78)90058-9; MCCRAW JB, 1977, PLAST RECONSTR SURG, V60, P710, DOI 10.1097/00006534-197711000-00006; MCGROUTHER DA, 1980, BRIT J PLAST SURG, V33, P9, DOI 10.1016/0007-1226(80)90046-6; Takeuchi M, 1997, ANN PLAS SURG, V39, P174, DOI 10.1097/00000637-199708000-00010; Watanabe K, 1991, KEISEIGEKA, V34, P659	10	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	DEC	2014	48	6					423	425		10.3109/2000656X.2013.806389		3	Orthopedics; Surgery	Orthopedics; Surgery	AT8YI	WOS:000345214500014		
J	Maegawa, N; Yajima, H; Shigematsu, K; Ota, H; Takakura, Y				Maegawa, Naoki; Yajima, Hiroshi; Shigematsu, Koji; Ota, Hiroyoshi; Takakura, Yoshinori			Functional reconstruction of bilateral injuries to the dorsum of hand using radial forearm tendocutaneous flaps	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Dorsal hand; radial forearm flap; vascularised tendon graft; soft tissue defect	TENDON GRAFTS	We treated a patient with skin and tendon defects of both hands as a result of injury by a heat press. There have been no reports of bilateral hand injuries being treated using simultaneous bilateral tendocutaneous flaps. In this case, we reconstructed the injured tissue using simultaneous bilateral radial forearm tendocutaneous flaps, with satisfactory results.	[Maegawa, Naoki; Yajima, Hiroshi; Shigematsu, Koji; Ota, Hiroyoshi; Takakura, Yoshinori] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 6348522, Japan	Maegawa, N (reprint author), Nara Med Univ, Dept Orthopaed Surg, 840 Shijyoucho, Kashihara, Nara 6348522, Japan.	nmaegawa@naramed-u.ac.jp					MORIYAMA M, 1992, J RECONSTR MICROSURG, V8, P83, DOI 10.1055/s-2007-1006689; Podlewski J, 1988, Acta Chir Plast, V30, P58; REID CD, 1983, BRIT J PLAST SURG, V36, P473, DOI 10.1016/0007-1226(83)90133-9; SINGER DI, 1989, J HAND SURG-AM, V14A, P55, DOI 10.1016/0363-5023(89)90059-2; Tamai S, 1999, HAND CLIN, V15, P555; TAYLOR GI, 1979, BRIT J PLAST SURG, V32, P170; Toschka H, 2001, INT J ORAL MAX SURG, V30, P42, DOI 10.1054/ijom.2000.0005; TSUGE K, 1980, AUST NZ J SURG, V50, P267, DOI 10.1111/j.1445-2197.1980.tb04115.x; Yajima H, 1996, PLAST RECONSTR SURG, V98, P328, DOI 10.1097/00006534-199608000-00019; Yajima H, 2004, SCAND J PLAST RECONS, V38, P112, DOI 10.1080/02844310310014847; Zachary RB., 1946, BRIT J SURG, V23, P350	11	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	DEC	2014	48	6					426	428		10.3109/2000656X.2013.806403		3	Orthopedics; Surgery	Orthopedics; Surgery	AT8YI	WOS:000345214500015		
J	Nakanishi, A; Yajima, H; Kisanuki, O				Nakanishi, Akito; Yajima, Hiroshi; Kisanuki, Osamu			Post-traumatic osteonecrosis of the lunate after fracture of the distal radius	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Kienbock disease; distal radius fracture; vascularised bone graft; posttraumatic osteonecrosis	KIENBOCKS-DISEASE; INTRAOSSEOUS PRESSURE; AVASCULAR CHANGES; DISLOCATION	We present a case of post-traumatic osteonecrosis of the lunate after fracture of the distal radius. Post-traumatic osteonecrosis of the carpal lunate after a fracture of the distal radius has, to our knowledge, not been reported previously. We treated the patient with vascularised bone graft from the distal radius, with a satisfactory result.	[Nakanishi, Akito; Kisanuki, Osamu] Yoshimoto Orthopaed & Surg Hosp, Dept Orthopaed Surg, Yamatotakada, Nara 6350075, Japan; [Yajima, Hiroshi] Nara Med Univ, Dept Orthopaed Surg, Nara, Nara, Japan	Nakanishi, A (reprint author), Yoshimoto Orthopaed & Surg Hosp, Dept Orthopaed Surg, Noguchi 136, Yamatotakada, Nara 6350075, Japan.	yoshimoto-mail@guitar.ocn.ne.jp					Arner M, 1996, J HAND SURG-BRIT EUR, V21B, P384, DOI 10.1016/S0266-7681(05)80210-4; GELBERMAN RH, 1980, J HAND SURG-AM, V5, P272; GELLMAN H, 1988, CLIN ORTHOP RELAT R, P196; Hulten O, 1928, ACTA RADIOL, V9, P155; JENSEN CH, 1993, J HAND SURG-AM, V18A, P355, DOI 10.1016/0363-5023(93)90375-D; Schiltenwolf M, 1996, J HAND SURG-AM, V21A, P754, DOI 10.1016/S0363-5023(96)80187-0; WHITE RE, 1984, J HAND SURG-AM, V9A, P181; Yajima H, 1998, J HAND SURG-AM, V23A, P402, DOI 10.1016/S0363-5023(05)80457-5	8	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	DEC	2014	48	6					434	436		10.3109/2000656X.2013.812763		3	Orthopedics; Surgery	Orthopedics; Surgery	AT8YI	WOS:000345214500018		
J	Shiraishi, T; Park, S; Niu, A; Hasegawa, H				Shiraishi, Tomohiro; Park, Susam; Niu, Atushi; Hasegawa, Hiromi			Congenital hypertrophy of multiple intrinsic muscles of the foot	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Hypertrophy; foot; intrinsic muscle; congenital deformity	UPPER-LIMB HYPERTROPHY; HAND; PSEUDOTUMORS	Congenital hypertrophy of a single intrinsic muscle of the foot is rare, and as far as we know, only six cases have been reported. We describe a case of congenital anomaly that showed hypertrophy of multiple intrinsic muscles of the foot; the affected muscles were all the intrinsic muscles of the foot except the extensor digitorum brevis or extensor hallucis. Other tissues such as adipose tissue, nervous tissue, or osseous tissue showed no abnormalities. To reduce the volume of the foot we removed parts of the enlarged muscles.	[Shiraishi, Tomohiro; Park, Susam; Hasegawa, Hiromi] Shizuoka Childrens Hosp, Dept Plast Surg, Shizuoka, Japan; [Niu, Atushi] Kanto Cent Hosp, Publ Sch Teachers, Mutual Aid Assoc, Dept Plast Surg, Tokyo, Japan	Shiraishi, T (reprint author), Kyorin Univ, Sch Med, Dept Plast & Reconstruct Surg, 6-20-2 Shinkawa, Mitaka, Tokyo, Japan.	shiraishi-tky@umin.ac.jp					ESTERSOHN H S, 1987, Journal of Foot Surgery, V26, P501; Iconomou T, 2003, PLAST RECONSTR SURG, V115, P1223; JAHSS MH, 1974, ORTHOP CLIN N AM, V5, P67; LANZ U, 1994, J HAND SURG-BRIT EUR, V19B, P683, DOI 10.1016/0266-7681(94)90235-6; Montgomery F, 1998, FOOT ANKLE INT, V19, P566; RINGELMAN PR, 1993, FOOT ANKLE, V14, P366; SO YC, 1992, J HAND SURG-BRIT EUR, V17B, P113, DOI 10.1016/0266-7681(92)90025-W; Takka S, 2005, ANN PLAS SURG, V54, P97, DOI 10.1097/01.sap.0000130701.63585.b7; Tanabe K, 1997, J HAND SURG-BRIT EUR, V22B, P253, DOI 10.1016/S0266-7681(97)80075-7; Teoh LC, 2001, J HAND SURG-BRIT EUR, V26, P492, DOI 10.1054/jhsb.2001.0643	10	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	DEC	2014	48	6					437	440		10.3109/2000656X.2013.812765		4	Orthopedics; Surgery	Orthopedics; Surgery	AT8YI	WOS:000345214500019		
J	Fujii, H; Honoki, K; Kobata, Y; Yajima, H; Kido, A; Takakura, Y				Fujii, Hiromasa; Honoki, Kanya; Kobata, Yasunori; Yajima, Hiroshi; Kido, Akira; Takakura, Yoshinori			Ewing sarcoma of the proximal phalanx: case report	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Ewing sarcoma; phlanx; ray amputation; ray transfer; case report	HAND	We report a case of primary Ewing sarcoma of the proximal phalanx of the right middle finger in an 18-year-old boy. He was treated with neoadjuvant chemotherapy, followed by ray amputation. To restore maximum function, the index ray was transferred to the base of the third metacarpal bone and fixed with a plate. The function of his right hand after the operation was excellent and the cosmetic appearance acceptable. There was no evidence of local recurrence or metastasis after 20 months follow up.	[Fujii, Hiromasa; Honoki, Kanya; Kobata, Yasunori; Yajima, Hiroshi; Kido, Akira; Takakura, Yoshinori] Nara Med Univ, Dept Orthoped Surg, Kashihara, Nara 6348521, Japan	Honoki, K (reprint author), Nara Med Univ, Dept Orthoped Surg, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	kahonoki@nmu-gw.cc.naramed-u.ac.jp					MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; HUVOS AG, 1977, ARCH PATHOL LAB MED, V101, P14; BACCI G, 1982, Cancer, V49, P1561, DOI 10.1002/1097-0142(19820415)49:8<1561::AID-CNCR2820490808>3.0.CO;2-K; Baraga JJ, 2001, SKELETAL RADIOL, V30, P121; COLEN L, 1985, J HAND SURG-AM, V10A, P232; Daecke W, 2005, J CANCER RES CLIN, V131, P219, DOI 10.1007/s00432-004-0637-9; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; Freegler EJ, 1980, HAND, V12, P316; KINSELLA TJ, 1983, INT J RADIAT ONCOL, V9, P1115; LACEY SH, 1987, J BONE JOINT SURG AM, V69A, P931	10	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	DEC	2014	48	6					441	443		10.3109/2000656X.2013.814314		3	Orthopedics; Surgery	Orthopedics; Surgery	AT8YI	WOS:000345214500020		
J	Kuriyama, K; Murase, T; Moritomo, H; Yoshikawa, H				Kuriyama, Kohji; Murase, Tsuyoshi; Moritomo, Hisao; Yoshikawa, Hideki			Attritional rupture of the extensor pollicis longus tendon by an osseous spur more than 30 years after wrist injury: A case report	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Extensor pollicis longus tendon; rupture; osseous spur; endochondral bone formation	COLLES FRACTURE	A 46-year-old woman sustained a rupture of the extensor pollicis longus tendon more than 30 years after wrist injury. She was successfully treated with palmaris longus tendon graft and excision of the osseous spur. Attrition of the extensor pollicis longus tendon by a newly formed osseous spur was the major mechanism.	[Kuriyama, Kohji] Hoshigaoka Koseinenkin Hosp, Dept Orthopaed Surg, Hirakata, Osaka 5738511, Japan; [Murase, Tsuyoshi; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan; [Moritomo, Hisao] Yukioka Hosp, Osaka Yukioka Coll Hlth Sci, Hand Ctr, Dept Phys Therapy, Osaka, Japan	Kuriyama, K (reprint author), Hoshigaoka Koseinenkin Hosp, Dept Orthopaed Surg, 4-8-1 Hoshigaoka, Hirakata, Osaka 5738511, Japan.	ronakuri@mx2.canvas.ne.jp					COONEY WP, 1980, J BONE JOINT SURG AM, V62, P613; Nakase T, 2003, OSTEOARTHR CARTILAGE, V11, P278, DOI 10.1016/S1063-4584(03)00004-9; Bonatz E, 1996, Am J Orthop (Belle Mead NJ), V25, P118; BUNATA RE, 1983, J BONE JOINT SURG AM, V65, P401; HARVEY FJ, 1989, J HAND SURG-AM, V14A, P957; HELAL B, 1982, HAND, V14, P41, DOI 10.1016/S0072-968X(82)80038-7; Ikegame M, 2001, J BONE MINER RES, V16, P24, DOI 10.1359/jbmr.2001.16.1.24; Lean J.M., 1995, AM J PHYSIOL-ENDOC M, V268, P318; SADR B, 1984, J HAND SURG-AM, V9, P144; WITTER H, 1960, Bruns Beitr Klin Chir, V201, P448	10	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	DEC	2014	48	6					452	454		10.3109/2000656X.2014.903057		3	Orthopedics; Surgery	Orthopedics; Surgery	AT8YI	WOS:000345214500023		
J	Ikeda, H; Fujino, S				Ikeda, Hiroshi; Fujino, Shigeru			Composition and pH dependence on aggregation of SiO2-PVA suspension for the synthesis of porous SiO2-PVA nanocomposite	JOURNAL OF POROUS MATERIALS			English	Article						Silica glass; Fumed silica; PVA; Mesoporous; Monolith; Adsorption	SILICA GLASS; ADSORPTION; POLYMER; MICROSTRUCTURE; ALCOHOL); BODIES; VOLUME	Porous monolithic SiO2-poly(vinyl alcohol) (PVA) nanocomposites were fabricated by drying an SiO2-PVA suspension. Depending on the amount of added PVA and pH value of the suspension, the Brunauer-Emmett-Teller surface areas, total pore volumes, and mean pore radii of the (100 - x)SiO2-xPVA (x = 0, 10, 20, 30 wt%) nanocomposites were 102-313 m(2) g(-1), 0.61-1.42 cm(3) g(-1), and 8.1-14.7 nm, respectively. Some cracks were observed in the monolithic SiO2-PVA nanocomposite, affected by the pore size. To elucidate crack generation, the correlation between the dispersion/aggregation in the SiO2-PVA suspension and the pore size distribution of the nanocomposite was evaluated in terms of the added PVA amount and pH value. At x = 20 and pH 3, the SiO2 particles and PVA aggregated in the suspension. The preparation of crack-free monolithic SiO2-PVA nanocomposites was possible using the aggregated suspension owing to the low capillary force during drying because of the relatively large pores.	[Ikeda, Hiroshi; Fujino, Shigeru] Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Kasuga, Fukuoka 8168580, Japan	Fujino, S (reprint author), Kyushu Univ, Art Sci & Technol Ctr Cooperat Res, Kasuga, Fukuoka 8168580, Japan.	fujino@astec.kyushu-u.ac.jp	Ikeda, Hiroshi/K-3378-2012	Ikeda, Hiroshi/0000-0002-7187-1722	JSPS KAKENHI Grant [24760564, 24656388]	This work was supported by JSPS KAKENHI Grant Numbers 24760564, 24656388.	Kim S, 2009, LANGMUIR, V25, P6155, DOI 10.1021/la804112b; Kirkbir F, 1996, J SOL-GEL SCI TECHN, V6, P203, DOI 10.1007/BF00402691; GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495; Lue SJ, 2008, J MEMBRANE SCI, V325, P831, DOI 10.1016/j.memsci.2008.09.015; RABINOVICH EM, 1982, J NON-CRYST SOLIDS, V47, P435, DOI 10.1016/0022-3093(82)90221-6; Chrissafis K, 2008, J APPL POLYM SCI, V110, P1739, DOI 10.1002/app.28818; Ikeda H, 2011, J CERAM SOC JPN, V119, P65, DOI 10.2109/jcersj2.119.65; TOKI M, 1988, J NON-CRYST SOLIDS, V100, P479, DOI 10.1016/0022-3093(88)90067-1; CLASEN R, 1987, J NON-CRYST SOLIDS, V89, P335; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Boisvert JP, 2003, J POLYM SCI POL PHYS, V41, P3127, DOI 10.1002/polb.10768; Nakane K, 1999, J APPL POLYM SCI, V74, P133, DOI 10.1002/(SICI)1097-4628(19991003)74:1<133::AID-APP16>3.0.CO;2-N; Kuraoka K, 2008, J CERAM SOC JPN, V116, P832, DOI 10.2109/jcersj2.116.832; Paik U, 1999, J AM CERAM SOC, V82, P833; Peng Z, 2005, J APPL POLYM SCI, V96, P1436, DOI 10.1002/app.21583; Rabinovich EM, 2003, J SOL-GEL SCI TECHN, V28, P19, DOI 10.1023/A:1025624801014; Rachas I, 2000, COLLOID SURFACE A, V161, P307, DOI 10.1016/S0927-7757(99)00378-7; SCHERER GW, 1984, J NON-CRYST SOLIDS, V63, P163, DOI 10.1016/0022-3093(84)90395-8; SRDIC V, 1992, CERAM INT, V18, P73, DOI 10.1016/0272-8842(92)90034-B; TADROS TF, 1968, J ELECTROANAL CHEM, V17, P267, DOI 10.1016/S0022-0728(68)80206-2; TADROS TF, 1978, J COLLOID INTERF SCI, V64, P36, DOI 10.1016/0021-9797(78)90332-6	22	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-2224	1573-4854		J POROUS MAT	J. Porous Mat.	DEC	2014	21	6					1143	1149		10.1007/s10934-014-9866-8		7	Chemistry, Applied; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	AT6XR	WOS:000345080700028		
J	Yamamoto, T; Arii, K; Niimoto, S; Ohata, M; Tagawa, T; Minami, F				Yamamoto, Toshiya; Arii, Kazuaki; Niimoto, Shinta; Ohata, Mitsuru; Tagawa, Tetsuya; Minami, Fumiyoshi			Investigation of Bulging Behavior of Coke Drum-A Practical Analysis of Bulging Under Complex Quench Conditions	JOURNAL OF PRESSURE VESSEL TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article								Coke drums undergo cyclic operations typically in the temperature range from room temperature to about 500 degrees C (930 degrees F). During quenching, the coke drum is inevitably subjected to a rapid drop in temperature because cooling water is injected directly into the coke drum through the bottom inlet nozzle. The temperature profile on the shell surface is uneven during quenching, and can vary in each cycle of the quenching operation. Such a complicated thermal profile induces large strains in the shell portion of the coke drum, and eventually causes damage like bulging and/or cracking. The authors have investigated the bulging behavior of the coke drum by the thermal elastic-plastic finite element (FE)-analysis, considering the existence of the overmatch welds and uneven temperature field during quenching (Ohata et al., 2011, "Investigation of Bulging Behavior of Coke Drum-Feasible Study on Causes of Bulging," ASME PVP2011-57276, Baltimore). In this paper, a practical FE-analysis is developed to estimate the complex strain that leads to bulging under uneven temperature fields during quenching. The actual temperature and strain data during operation are collected by thermocouples and high temperature strain gauges. A thermal analysis model, including an evaluation of boiling heat transfer on the shell's inner surface, is established to simulate the measured shell behavior of the coke drum. By utilizing this FE-analysis model, several parameters thought of as causal factors in bulging can be examined under the uneven temperature profile that is likely to occur during actual operation. This analytical approach can also provide effective technique for improvements in shell durability.	[Yamamoto, Toshiya; Arii, Kazuaki; Niimoto, Shinta] Sumitomo Heavy Ind Proc Equipment Co Ltd, Saijo City, Ehime 7991393, Japan; [Ohata, Mitsuru; Tagawa, Tetsuya; Minami, Fumiyoshi] Osaka Univ, Suita, Osaka 5650871, Japan	Yamamoto, T (reprint author), Sumitomo Heavy Ind Proc Equipment Co Ltd, 1501 Imazaike, Saijo City, Ehime 7991393, Japan.						Allevato C., 1999, ETCE 99 S PLANT FAC; [Anonymous], 2007, ASME BOIL PRESS VESS; BROMLEY LA, 1950, CHEM ENG PROG, V46, P221; LIENHARD JH, 1973, J HEAT TRANS-T ASME, V95, P152; Henry R. E., 1996, 5 INT C SIM METH NUC; Livingston B., 1998, ASME PVP, V376, P33; Nukiyama S., 1934, J JPN SOC MECH ENG, V37, P367; Ohata M., 2011, PVP200157276 ASME; Ramos A., 1998, ANAL DESIGN COMPOSIT, V368, P231; Ramos A., 1997, ASME PVP, V359, P291	10	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-9930	1528-8978		J PRESS VESS-T ASME	J. Press. Vessel Technol.-Trans. ASME	DEC	2014	136	6							061401	10.1115/1.4027591		8	Engineering, Mechanical	Engineering	AT8AD	WOS:000345155300010		
J	Miyoshi, H; Otani, T; Irikura, N; Nagata, M				Miyoshi, Hirokazu; Otani, Tamaki; Irikura, Namiko; Nagata, Motoi			In situ F-18-gamma-ray-induced Ag nanoparticle formation in the presence of SiO2 nanoparticles under air	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Silica nanoparticles; Radiation effect; Silver nanoparticles; In situ gamma-ray	SILICA; INTERFACE	The in situ F-18-gamma-ray irradiation of SiO2 nanoparticles in an aqueous solution containing Ag+ led to the reduction of Ag+ to Ag-0 aggregates or Ag-0 nanoparticles in a small volume (0.1 ml) under air. F-18 was used in the form of F-18-fluorodeoxyglucose, produced by a cyclotron at our University hospital. The in situ average absorbed dose at the distance of 1 A mu m in the solution volume (0.1 ml) was calculated to be 12.2 kGy equivalent to a point source of 20 MBq. The SiO2 nanoparticles had two effects; they enhanced the reduction of Ag+ to Ag-0 aggregates and they acted as reaction sites to prevent aggregation. When Ag+ adsorbed on the surface of the SiO2 nanoparticles, Ag nanoparticles were formed by F-18 gamma-rays. The absorption spectra of Ag nanoparticles and Ag-0 aggregates were markedly different.	[Miyoshi, Hirokazu; Otani, Tamaki; Nagata, Motoi] Univ Tokushima, Radioisotope Res Ctr, Tokushima 7708503, Japan; [Irikura, Namiko] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708503, Japan	Miyoshi, H (reprint author), Univ Tokushima, Radioisotope Res Ctr, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	miyoshi.hirokazu@tokushima-u.ac.jp					Tarasova NP, 2010, CR CHIM, V13, P1028, DOI 10.1016/j.crci.2010.05.013; ENUSTUN BV, 1963, J AM CHEM SOC, V85, P3317, DOI 10.1021/ja00904a001; Schatz T, 1999, J PHYS CHEM B, V103, P10209, DOI 10.1021/jp992269e; Kapoor V, 2004, RADIOGRAPHICS, V24, P523, DOI 10.1148/rg.242025724; Dimitrijevic NM, 1999, J PHYS CHEM B, V103, P7073, DOI 10.1021/jp991378q; Kiefer J., 1990, BIOL RAD EFFECTS; Miyoshi H, 2013, J RADIOANAL NUCL CH, V295, P1903, DOI 10.1007/s10967-012-2161-8; Mozumder A., 1999, FUNDAMENTALS RAD CHE; Schatz T, 1998, J PHYS CHEM B, V102, P7225, DOI 10.1021/jp982129p; Svegborn SL, 2010, RADIAT PROT DOSIM, V139, P208; Vinci JC, 2010, PHOTOCHEM PHOTOBIOL, V86, P806, DOI 10.1111/j.1751-1097.2010.00717.x	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	DEC	2014	302	3					1177	1183		10.1007/s10967-014-3359-8		7	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AT7AQ	WOS:000345088700014		
J	Fukushima, M; Matsue, H; Chatt, A				Fukushima, M.; Matsue, H.; Chatt, A.			A feasibility study to measure low levels of boron in selected Canadian and Japanese foods by prompt gamma activation analysis using the JAEA JRR-3 facility	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article; Proceedings Paper	5th Symposium on Nuclear Analytical Chemistry (NAC)	JAN 20-24, 2014	Mumbai, INDIA	BARC, Dept Atom Energy, Board Res Nucl Sci, Int Atom Energy Agcy, Indian Assoc Nucl Chemists & Allied Scientists		Prompt gamma activation; Boron; Foods	IONIZATION MASS-SPECTROMETRY; GUIDED NEUTRON BEAMS; RAY ANALYSIS; MULTIELEMENT DETERMINATION; ISOTOPIC ANALYSIS; ICP-MS; LITHIUM; SAMPLES; WATER; EMISSION	A feasibility study was carried out to evaluate the potential of the thermal neutron capture prompt-gamma activation analysis (PGAA) for the measurement of low levels of boron in selected Canadian and Japanese foods using the PGA facility at the JRR-3 reactor of the Japan Atomic Energy Agency (JAEA) in Tokai. A method was optimized for this purpose. It is rapid and can be used without any chemical separation. The precision and accuracy of the method are good. The detection limit is around 0.5 mg kg(-1).	[Fukushima, M.] Ishinomaki Senshu Univ, Dept Basic Sci, Ishinomaki, Miyagi, Japan; [Matsue, H.] Japan Atom Energy Agcy, Dept Res Reactor & Tandem Accelerator, Tokai, Ibaraki, Japan; [Chatt, A.] Dalhousie Univ, Dept Chem, Trace Anal Res Ctr, Halifax, NS B3H 4R2, Canada	Fukushima, M (reprint author), Ishinomaki Senshu Univ, Dept Basic Sci, Ishinomaki, Miyagi, Japan.	fukusima@isenshu-u.ac.jp	Chatt, Amares/I-2287-2012				Aggarwal SK, 2009, ANAL CHEM, V81, P7420, DOI 10.1021/ac901224m; Anderson David L., 1994, Journal of Food Composition and Analysis, V7, P59, DOI 10.1006/jfca.1994.1006; ANDERSON DL, 1995, J RADIOAN NUCL CH AR, V194, P351, DOI 10.1007/BF02038434; Anderson DL, 2000, J RADIOANAL NUCL CH, V244, P225, DOI 10.1023/A:1006761525590; Anderson DL, 2005, J RADIOANAL NUCL CH, V263, P683, DOI 10.1007/s10967-005-0643-7; ANDERSON DL, 1993, J RADIOAN NUCL CH AR, V167, P139, DOI 10.1007/BF02035473; ANDERSON DL, 1990, FRESEN J ANAL CHEM, V338, P554, DOI 10.1007/BF00322537; Anderson DL, 1992, T AM NUCL SOC, V65, P141; Yamada S, 2006, PHYSICA B, V385-86, P1243, DOI 10.1016/j.physb.2006.05.420; Dolan SP, 2002, J FOOD COMPOS ANAL, V15, P593, DOI [10.1016/S0889-1575(02)91064-1, 10.1006/jfca.2002.1064]; Sarkar A, 2010, MICROCHIM ACTA, V168, P65, DOI 10.1007/s00604-009-0259-7; Sah RN, 1997, MICROCHEM J, V56, P285, DOI 10.1006/mchj.1997.1428; Madejczyk M, 2008, ANAL CHIM ACTA, V617, P11, DOI 10.1016/j.aca.2008.01.038; Chhillar S, 2012, J RADIOANAL NUCL CH, V293, P437, DOI 10.1007/s10967-012-1764-4; Chhillar S, 2013, J RADIOANAL NUCL CH, V298, P1597, DOI 10.1007/s10967-013-2609-5; Chhillar S, 2014, DAE BRNS 5 S NUCL AN, P224; CLARKE WB, 1987, APPL RADIAT ISOTOPES, V38, P735; Culver BD, 1994, PATTYS IND HYGIENE T, P4411; Economou A, 2004, ANAL CHIM ACTA, V510, P219, DOI 10.1016/j.aca.2004.01.002; FAILEY MP, 1979, ANAL CHEM, V51, P2209, DOI 10.1021/ac50049a035; HEDRICH E, 1981, J RADIOANAL CHEM, V61, P295, DOI 10.1007/BF02517415; Hight Susan C., 1993, Journal of Food Composition and Analysis, V6, P121, DOI 10.1006/jfca.1993.1015; IYENGAR GV, 1990, FRESEN J ANAL CHEM, V338, P562, DOI 10.1007/BF00322539; Magara M, 1998, NUCL INSTRUM METH A, V411, P130, DOI 10.1016/S0168-9002(98)00303-9; Matsue H, 2001, J RADIOANAL NUCL CH, V249, P11; Moir DL, 1995, T AM NUCL SOC, V73, P11; Moir DL, 1989, THESIS DALHOUSIE U H; MOIR DL, 1987, J RADIOAN NUCL CH AR, V116, P389, DOI 10.1007/BF02035783; Molnar GL, 2004, HDB PROMPT GAMMA ACT, P1229; Nakano E, 2008, TALANTA, V74, P533, DOI 10.1016/j.talanta.2007.06.021; NIELSEN HK, 1987, J RADIOAN NUCL CH AR, V114, P237, DOI 10.1007/BF02039797; Resano M, 2007, ANAL CHIM ACTA, V582, P214, DOI 10.1016/j.aca.2006.09.023; Sah RN, 1997, PLANT SOIL, V193, P15, DOI 10.1023/A:1004251606504; Sakai Y, 2005, J RADIOANAL NUCL CH, V265, P287, DOI 10.1007/s10967-005-0822-6; SALES HB, 1981, RADIOCHEM RADIOA LET, V50, P105; Selecki A, 1969, RADIOCHEM RADIOANAL, V1, P247; Shen JJS, 2003, ANAL CHEM, V75, P1972, DOI 10.1021/ac020589f; United Nations, 1958, P 2 UN INT C PEAC US, V16, P11; Vertes A, 2003, HDB NUCL CHEM, V3; YAKIMOVA VP, 1992, J ANAL CHEM+, V47, P1477; Yonezawa C, 2001, J RADIOANAL NUCL CH, V248, P719, DOI 10.1023/A:1010648930039; Yonezawa C, 2000, J RADIOANAL NUCL CH, V244, P373, DOI 10.1023/A:1006739710086; YONEZAWA C, 1995, J RADIOAN NUCL CH AR, V193, P171, DOI 10.1007/BF02041931; YONEZAWA C, 1995, ANAL CHEM, V67, P4466, DOI 10.1021/ac00120a006; Zaijun Li, 2006, Food Chemistry, V94, P310, DOI 10.1016/j.foodchem.2005.01.019	45	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	DEC	2014	302	3					1225	1229		10.1007/s10967-014-3524-0		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	AT7AQ	WOS:000345088700020		
J	Takagi, Y; Oi, T; Tanaka, H; Inui, H; Fujioka, H; Tanaka, J; Yoshiya, S; Nobuhara, K				Takagi, Yohei; Oi, Takanori; Tanaka, Hiroshi; Inui, Hiroaki; Fujioka, Hiroyuki; Tanaka, Juichi; Yoshiya, Shinichi; Nobuhara, Katsuya			Increased horizontal shoulder abduction is associated with an increase in shoulder joint load in baseball pitching	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Throwing shoulder injuries; baseball pitch; 3-dimensional motion analysis; motion capture; horizontal shoulder abduction; joint load; maximum external rotation	PITCHERS; BIOMECHANICS; PATHOLOGY; ROTATION; PLAYERS; INJURY	Background: Soft tissues of the shoulder undergoes substantial stresses due to humeral head movement, and this may contribute to throwing shoulder injuries in baseball pitchers. Prevention and management of throwing shoulder injuries critically rely on reduction of shear force at the shoulder joint. However, the amount and direction of the force applied to the shoulder during the throwing motion have not been clarified. The purpose of this study was to analyze forces applied to the shoulder during a baseball pitch. Methods: We performed biomechanical analysis of 213 baseball pitchers of various ages and skill levels. Throwing motion was analyzed with a 3-dimensional motion capture system. The Euler angle sequence was adopted to describe angular values of the upper arm relative to the trunk for shoulder rotation, and inverse dynamics was used to estimate the resultant joint forces at the shoulder. Results: There was a significant relation between horizontal abduction/adduction angle and resultant anterior/posterior force at the point of maximum external rotation (MER) (r = -0.63, P < .01), whereby increased horizontal abduction was associated with increased resultant anterior force. There was a significant but weak correlation between abduction/adduction angle and superior/inferior force at MER (r = 0.24, P < .01). Comparison among the groups with variable ages and skill levels showed larger horizontal abduction and smaller external rotation angles at MER in the adult amateur player group, whereas normalized compression force and internal rotation torque values at MER were smaller in the junior high school-and elementary school-aged groups. Discussion: These results suggest that excessive horizontal abduction at MER increases anterior shear force in the shoulder and may lead to shoulder injuries. Focusing on reducing horizontal abduction at MER in the throwing motion may be key to preventing and managing shoulder injuries in baseball pitchers. (C) 2014 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Takagi, Yohei; Oi, Takanori; Tanaka, Juichi; Yoshiya, Shinichi] Hyogo Coll Med, Dept Orthopaed Surg, Nishinomiya, Hyogo 6638501, Japan; [Tanaka, Hiroshi; Inui, Hiroaki; Nobuhara, Katsuya] Nobuhara Hosp & Inst Biomech, Tatsuno, Japan; [Fujioka, Hiroyuki] Univ Hyogo, Hlth Sci Sch Rehabil, Dept Phys Therapy, Kobe, Hyogo 6500044, Japan	Takagi, Y (reprint author), Hyogo Coll Med, Dept Orthopaed Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	y.takgi126@gmail.com					Ae M, 1992, BIOMECHANISMS, V11, P23; Andrews JR, 1991, CLIN SPORTS MED, V10, P910; Mihata T, 2004, AM J SPORT MED, V32, P1278, DOI 10.1177/0363546503262188; FLEISIG GS, 1995, AM J SPORT MED, V23, P233, DOI 10.1177/036354659502300218; Mihata T, 2010, AM J SPORT MED, V38, P369, DOI 10.1177/0363546509346408; Sabick MB, 2004, AM J SPORT MED, V32, P892, DOI 10.1177/0363546503259354; JOBE FW, 1991, AM J SPORT MED, V19, P428, DOI 10.1177/036354659101900502; Sabick MB, 2005, AM J SPORT MED, V33, P1716, DOI 10.1177/0363546505275347; Nakamizo H, 2008, J SHOULDER ELB SURG, V17, P795, DOI 10.1016/j.jse.2008.02.013; Laudner KG, 2010, AM J SPORT MED, V38, P2106, DOI 10.1177/0363546510370291; Stodden DF, 2005, J APPL BIOMECH, V21, P44; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; Heyworth BE, 2009, AM J SPORT MED, V37, P1024, DOI 10.1177/0363546508324966; Myers JB, 2013, J SHOULDER ELB SURG, V22, P1154, DOI 10.1016/j.jse.2012.12.029; Miyashita K, 2010, AM J SPORT MED, V38, P363, DOI 10.1177/0363546509347542; Nobuhara K., 2003, SHOULDER FUNCITON CL, P401, DOI 10.1142/9789812388919_0009; NOBUHARA K, 1987, CLIN ORTHOP RELAT R, P44; Walch G, 1992, J Shoulder Elbow Surg, V1, P238, DOI 10.1016/S1058-2746(09)80065-7; Whiteley R, 2007, J SPORT SCI MED, V6, P1, DOI 10.1080/00221340708986165	19	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	DEC	2014	23	12					1757	1762		10.1016/j.jse.2014.03.005		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AT4WL	WOS:000344942300006		
J	Kikukawa, K; Ide, J; Kikuchi, K; Morita, M; Mizuta, H; Ogata, H				Kikukawa, Kenshi; Ide, Junji; Kikuchi, Ken; Morita, Makoto; Mizuta, Hiroshi; Ogata, Hiroomi			Hypertrophic changes of the teres minor muscle in rotator cuff tears: quantitative evaluation by magnetic resonance imaging	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Teres minor muscle; hypertrophic change; rotator cuff tear; MRI evaluation; infraspinatus muscle; atrophy	DORSI TENDON TRANSFER; TOTAL SHOULDER ARTHROPLASTY; LATISSIMUS-DORSI; FATTY INFILTRATION; LONG-TERM; FOLLOW-UP; REPAIR; TENOTOMY; MINIMUM; ATROPHY	Background: Few reports have assessed the teres minor (TM) muscle in rotator cuff tears. This study aimed to quantitatively analyze the morphologic changes of the TM muscle in patients with or without rotator cuff tears by magnetic resonance imaging (MRI). Methods: This retrospective study consisted of 279 subjects classified on the basis of interpretations of conventional MRI observations into 6 groups: no cuff tear; partial-thickness supraspinatus (SSP) tear; full-thickness SSP tear; SSP and subscapularis tears; SSP and infraspinatus (ISP) tears; and SSP, ISP, and subscapularis tears. With use of ImageJ software (National Institutes of Health, Bethesda, MD, USA) for oblique sagittal MRI, we measured the areas of ISP, TM, and anatomic external rotation (ISP + TM) muscles on the most lateral side in which the scapular spine was in contact with the scapular body. The occupational ratios of the TM muscle area to the anatomic external rotation muscle area were calculated. Ratios above the maximum of the 95% confidence intervals of the occupational ratio in the no-tear group were defined as hypertrophy of the TM muscle. Results: Occupational ratios of the TM muscle in the no-tear group followed a normal distribution, and ratios >0.288 were defined as hypertrophic. Hypertrophic changes of the TM muscle were confirmed in rotator cuff tears involving the ISP tendon. A negative correlation was found between the occupational ratios of TM and ISP (P < .001). Conclusion: The TM muscle appeared hypertrophic in rotator cuff tears involving the ISP, and the progression of ISP muscle atrophy seemed to induce the development of this compensatory hypertrophy. (C) 2014 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Kikukawa, Kenshi; Morita, Makoto; Ogata, Hiroomi] Kumamoto Social Insurance Gen Hosp, Dept Orthopaed Surg, Yatsushiro, Kumamoto 8668660, Japan; [Ide, Junji] Kumamoto Univ, Kumamoto Univ Hosp, Dept Adv Joint Reconstruct Surg, Kumamoto, Japan; [Kikuchi, Ken] Kumamoto Univ, Grad Sch Social & Cultural Sci, Negotiat Conflict Resolut & Adm, Kumamoto, Japan; [Mizuta, Hiroshi] Kumamoto Univ, Fac Life Sci, Dept Orthopaed Surg, Kumamoto, Japan	Kikukawa, K (reprint author), Kumamoto Social Insurance Gen Hosp, Dept Orthopaed Surg, 10-10 Tohricho, Yatsushiro, Kumamoto 8668660, Japan.	kikukawakenshi@yahoo.co.jp					Shen PH, 2008, J SHOULDER ELB SURG, V17, p1S, DOI 10.1016/j.jse.2007.04.014; Boughebri O, 2013, ORTHOP TRAUMATOL-SUR, V99, P131, DOI 10.1016/j.otsr.2012.11.014; Boileau P, 2007, J BONE JOINT SURG AM, V89A, P747, DOI 10.2106/JBJS.E.01097; Melis B, 2011, SKELETAL RADIOL, V40, P1335, DOI 10.1007/s00256-011-1178-3; Costouros JG, 2007, J SHOULDER ELB SURG, V16, P727, DOI 10.1016/j.jse.2007.02.128; Gerber C, 2007, J BONE JOINT SURG AM, V89A, P940, DOI 10.2106/JBJS.F.00955; Gladstone JN, 2007, AM J SPORT MED, V35, P719, DOI 10.1177/0363546506297539; Walch G, 1998, J BONE JOINT SURG BR, V80B, P624, DOI 10.1302/0301-620X.80B4.8651; Namdari S, 2012, J BONE JOINT SURG AM, V94A, P891, DOI 10.2106/JBJS.K.00841; Gerber C, 2007, J SHOULDER ELB SURG, V16, P815, DOI 10.1016/j.jse.2007.02.120; Walch G, 2005, J SHOULDER ELB SURG, V14, P238, DOI 10.1016/j.jse.2004.07.008; Boileau P, 2008, CLIN ORTHOP RELAT R, V466, P584, DOI 10.1007/s11999-008-0114-x; Sirveaux F, 2004, J BONE JOINT SURG BR, V86B, P388, DOI 10.1302/0301-620X.86B3.14024; Cofield RH, 2001, J BONE JOINT SURG AM, V83A, P71; Simovitch RW, 2007, J BONE JOINT SURG AM, V89A, P934, DOI 10.2106/JBJS.F.01075; Boileau P, 2006, J SHOULDER ELB SURG, V15, P527, DOI 10.1016/j.jse.2006.01.003; Nove-Josserand L, 2009, ORTHOP TRAUMATOL-SUR, V95, P108, DOI 10.1016/j.otsr.2008.10.002; Boileau Pascal, 2010, J Shoulder Elbow Surg, V19, P20, DOI 10.1016/j.jse.2009.12.011; Cheung S, 2011, ARTHROSCOPY, V27, P463, DOI 10.1016/j.arthro.2010.09.014; COLACHIS S C JR, 1971, Archives of Physical Medicine and Rehabilitation, V52, P22; Pape G, 2013, J SHOULDER ELB SURG, V22, pE1, DOI 10.1016/j.jse.2012.04.006; Yamaguchi H, 2012, ADV ORTHOP, P1	22	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	DEC	2014	23	12					1800	1805		10.1016/j.jse.2014.03.014		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AT4WL	WOS:000344942300012		
J	Nishinaka, N; Tsutsui, H; Yamaguchi, K; Uehara, T; Nagai, S; Atsumi, T				Nishinaka, Naoya; Tsutsui, Hiroaki; Yamaguchi, Ken; Uehara, Taishi; Nagai, Suguru; Atsumi, Takashi			Costal osteochondral autograft for reconstruction of advanced-stage osteochondritis dissecans of the capitellum	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Osteochondritis dissecans of the humeral capitellum; costal osteochondral; autograft transplantation; throwing elbow; baseball; surgical treatment	HUMERAL CAPITELLUM; BASEBALL PLAYERS; FOLLOW-UP; FRAGMENT FIXATION; ELBOW; LESIONS; TRANSPLANTATION; MOSAICPLASTY; CARTILAGE; GRAFT	Background: Advanced-stage osteochondritis dissecans of the capitellum affecting the lateral wall may result in osteoarthritis, and suitable treatment is needed to avoid permanent deformation and impaired function. We aimed to assess postoperative outcomes of costal osteochondral autograft for treatment of this condition. Methods: We included 22 young overhead athletes (mean age, 13.9 years) with advanced osteochondritis dissecans of the humeral capitellum who underwent costal osteochondral autograft. All patients had elbow pain and wide-range articular cartilage lesions. We evaluated clinical and radiographic outcomes at a mean follow-up of 27 months (range, 12-77 months). Results: All patients achieved rapid functional improvement and returned to their former sports activity levels. The baseball players were able to play catch within 62 to 164 days (mean, 107 days) and returned to full pitching activity within 123 to 339 days (mean, 226 days). We assessed mean elbow function by the clinical rating system of Timmerman and Andrews and the Japanese Orthopaedic Association sports score; the scores improved from 121.5 and 53.7 points preoperatively to 169.2 points and 86.1 points, respectively, at the time of follow-up. Four patients required additional minor surgical procedures, including screw removal, loose body removal, and shaving off of spur formation. No patient showed obvious radiographic changes of osteoarthritis. All patients were satisfied with the final outcomes and had good functional recovery. Conclusion: Costal osteochondral autograft gave satisfactory results for advanced osteochondritis dissecans of the humeral capitellum with extensive lesions affecting the lateral wall. (C) 2014 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Nishinaka, Naoya; Yamaguchi, Ken; Uehara, Taishi; Nagai, Suguru; Atsumi, Takashi] Showa Univ, Fujigaoka Hosp, Dept Orthopaed Surg, Yokohama, Kanagawa 2278501, Japan; [Tsutsui, Hiroaki] Showa Univ, Fujigaoka Rehabil Hosp, Dept Orthopaed Surg & Sports Med, Yokohama, Kanagawa 2278501, Japan	Nishinaka, N (reprint author), Showa Univ, Fujigaoka Hosp, Dept Orthopaed Surg, Aoba Ku, 1-30 Fujigaoka, Yokohama, Kanagawa 2278501, Japan.	nissieparadise@pure.ocn.ne.jp					Nobuta S, 2008, UPSALA J MED SCI, V113, P201; Shimada K, 2012, J BONE JOINT SURG AM, V94A, P992, DOI 10.2106/JBJS.J.00228; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58; Takahara M, 1999, CLIN ORTHOP RELAT R, P108; TIMMERMAN LA, 1994, AM J SPORT MED, V22, P230, DOI 10.1177/036354659402200213; HASEGAWA T, 1992, J HAND SURG-BRIT EUR, V17B, P583, DOI 10.1016/S0266-7681(05)80248-7; Oka Y, 1999, INT ORTHOP, V23, P53, DOI 10.1007/s002640050304; BAUER M, 1992, CLIN ORTHOP RELAT R, P156; Kuwahata Y, 1998, ORTHOPEDICS, V21, P449; Takeda H, 2002, AM J SPORT MED, V30, P713; Shimada K, 2005, CLIN ORTHOP RELAT R, P140, DOI 10.1097/01.blo.0000160025.14363.f9; Reddy S, 2007, AM J SPORT MED, V35, P80, DOI 10.1177/0363546506290986; Harada M, 2002, J SHOULDER ELB SURG, V11, P368, DOI 10.1067/mse.2002.123900; NELSON DW, 1990, J COMPUT ASSIST TOMO, V14, P804, DOI 10.1097/00004728-199009000-00026; Matsuura T, 2008, AM J SPORT MED, V36, P868, DOI 10.1177/0363546507312168; Yamamoto Y, 2006, AM J SPORT MED, V34, P714, DOI 10.1177/0363546505282620; Ansah P, 2007, J BONE JOINT SURG AM, V89A, P2188, DOI 10.2106/JBJS.F.00299; Iwasaki N, 2009, J BONE JOINT SURG AM, V91A, P2359, DOI 10.2106/JBJS.H.01266; Mihara K, 2010, J SHOULDER ELB SURG, V19, P31, DOI 10.1016/j.jse.2009.04.007; Iwasaki N, 2006, AM J SPORT MED, V34, P1233, DOI 10.1177/0363546506286343; Iwasaki N, 2007, AM J SPORT MED, V35, P2096, DOI 10.1177/0363546507306465; Takeba J, 2010, KNEE SURG SPORT TR A, V18, P831, DOI 10.1007/s00167-009-0945-3; Ito Y, 2004, J JPN SOC SURG ELBOW, V11, P3; Kitaoka E, 2001, J CELL BIOCHEM, V81, P571, DOI 10.1002/jcb.1075; Kiyoshige Y, 2000, AM J SPORT MED, V28, P534; Nishinaka N, 2011, J JPN ELBOW SOC, V18, P17; Oka Y, 2001, J BONE JOINT SURG BR, V83B, P738, DOI 10.1302/0301-620X.83B5.11767; Okura T, 2011, J JPN ELBOW SOC, V18, P20; Sato K, 2003, J SHOULDER ELB SURG, V12, P403, DOI 10.1016/S1058-2746(02)00045-9; Sato Kazuki, 2008, Tech Hand Up Extrem Surg, V12, P85, DOI 10.1097/BTH.0b013e31815b2e05; Sato K, 2012, OSTEOARTHR CARTILAGE, V20, P172, DOI 10.1016/j.joca.2011.12.001; Takahara M, 1998, J BONE JOINT SURG AM, V80A, P892; Takahara M, 2000, RADIOLOGY, V216, P207; WOODWARD AH, 1975, CLIN ORTHOP RELAT R, P35; Yoshizu T, 1986, SHUJUTSU, V40, P131	35	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	DEC	2014	23	12					1888	1897		10.1016/j.jse.2014.06.047		10	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AT4WL	WOS:000344942300024		
J	Duncan, SFM; Briski, DC; Steinmann, SP; Adams, J; Kakinoki, R				Duncan, Scott F. M.; Briski, David C.; Steinmann, Scott P.; Adams, Julie; Kakinoki, Ryosuke			Unique application of a metacarpophalangeal joint implant as a radial head prosthesis	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article							ESSEX-LOPRESTI INJURY; OXIDE DENTAL IMPLANTS; TERM-FOLLOW-UP; CONGENITAL DISLOCATION; NATURAL-HISTORY; ALUMINUM-OXIDE; LTI CARBON; RECONSTRUCTION; CHILDREN; FOREARM		[Duncan, Scott F. M.; Briski, David C.] Ochsner Hlth Syst, Dept Orthoped Surg, New Orleans, LA USA; [Steinmann, Scott P.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Adams, Julie] Univ Minnesota, Dept Orthopaed Surg, Minneapolis, MN 55455 USA; [Kakinoki, Ryosuke] Kyoto Univ, Dept Orthoped Surg, Kyoto, Japan	Duncan, SFM (reprint author), Ochsner Med Ctr, 1514 Jefferson Hwy, New Orleans, LA 70121 USA.	Duncan.academic@gmail.com					Adams JE, 2010, J HAND SURG-AM, V35A, P129, DOI 10.1016/j.jhsa.2009.10.007; Cook SD, 1999, J BONE JOINT SURG AM, V81A, P635; COOK SD, 1983, ORTHOPEDICS, V6, P952, DOI 10.3928/0147-7447-19830801-03; COOK SD, 1981, J BIOMED MATER RES, V15, P879, DOI 10.1002/jbm.820150612; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P591, DOI 10.1097/01.BPO.0000023140.69745.72; Kepler CK, 2010, J SHOULDER ELB SURG, V19, pE13, DOI 10.1016/j.jse.2009.07.063; LLOYDROBERTS GC, 1977, J BONE JOINT SURG BR, V59, P402; Kim HT, 2002, J PEDIATR ORTHOPED, V22, P583, DOI 10.1097/01.BPO.0000023116.11337.68; McGlinn EP, 2013, J HAND SURG-AM, V38A, P1599, DOI 10.1016/j.jhsa.2013.04.031; Wijk U, 2010, J HAND SURG-AM, V35A, P38, DOI 10.1016/j.jhsa.2009.08.010; BELL SN, 1991, J BONE JOINT SURG AM, V73A, P392; Bell Tawse AJ, 1965, J BONE JOINT SURG BR, V47, P718; CAMPBELL CC, 1992, J BONE JOINT SURG AM, V74A, P726; Chloros GD, 2008, J HAND SURG-AM, V33A, P124, DOI 10.1016/j.jhsa.2007.09.008; COOK SD, 1983, J BIOMED MATER RES, V17, P519, DOI 10.1002/jbm.820170311; Echtler B, 1997, ACTA ORTHOP SCAND, V68, P598, DOI 10.3109/17453679708999034; Fox KW, 1960, CLIN ORTHOP RELAT R, V18, P234; Heijink Andras, 2008, J Shoulder Elbow Surg, V17, pe12, DOI 10.1016/j.jse.2007.04.009; Heijink A, 2010, J SHOULDER ELB SURG, V19, P929, DOI 10.1016/j.jse.2010.03.007; Hotchkiss RN, 1998, AAOS INSTR COURS LEC, V47, P173; Jung M, 2008, J BIOMED MATER RES B, V85B, P427, DOI 10.1002/jbm.b.30961; KELLY DW, 1981, J PEDIATR ORTHOPED, V1, P295; Marcotte AL, 2007, HAND CLIN, V23, P195, DOI 10.1016/j.hcl.2007.01.005; Mardam-Bey T, 1979, J Hand Surg Am, V4, P316; Markolf KL, 1998, J BONE JOINT SURG AM, V80A, P879; McFarland EG, 2004, CLIN SPORT MED, V23, P743, DOI 10.1016/j.csm.2004.06.002; MITAL MA, 1976, ORTHOP CLIN N AM, V7, P375; MIURA T, 1990, J HAND SURG-BRIT EUR, V15B, P477, DOI 10.1016/0266-7681(90)90095-L; Murray Peter M, 2010, Instr Course Lect, V59, P295; Rozental Tamara D, 2003, J Am Acad Orthop Surg, V11, P68; Sachar K, 1998, HAND CLIN, V14, P39; Sferopoulos N K, 1999, Acta Orthop Belg, V65, P378; Steinmann SP, 2011, HAND CLIN, V27, P229, DOI 10.1016/j.hcl.2011.01.006; Wiley J J, 1991, Orthop Rev, V20, P973; Yamazaki H, 2007, J HAND SURG-BRIT EUR, V32E, P93, DOI 10.1016/j.jhsb.2006.09.003	35	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	DEC	2014	23	12					E308	E312		10.1016/j.jse.2014.08.004		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AT4WL	WOS:000344942300003		
J	Kawasaki, T; Maki, N; Shimizu, K; Ota, C; Urayama, S; Moriya, S; Kaketa, T; Kobayashi, H; Kaneko, K				Kawasaki, Takayuki; Maki, Nobukazu; Shimizu, Kyoko; Ota, Chihiro; Urayama, Shingo; Moriya, Shuichi; Kaketa, Takefumi; Kobayashi, Hideo; Kaneko, Kazuo			Do stingers affect scapular kinematics in rugby players?	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Scapular dyskinesis; rugby; collision sports; shoulder; stinger; burner syndrome	IMPINGEMENT SYNDROME; SHOULDER IMPINGEMENT; MUSCLE-ACTIVITY; NERVE INJURY; PART 2; DYSKINESIS; RELIABILITY; CLASSIFICATION; EPIDEMIOLOGY; ORIENTATION	Background: Scapular dyskinesis is observed in subjects with pathologic conditions of the shoulder; however, there is limited information about the factors related to scapular dyskinesis among participants in rugby. The purpose of this study was to investigate the incidence, reliability, and relationships between scapular dyskinesis and variables related to the shoulder in high-school rugby players. Methods: A total of 164 Japanese high-school rugby players were evaluated with questionnaires, physical examinations, and a video analysis during their preseason. After evaluation of the inter-rater reliability of a classification of scapular dyskinesis, the outcomes were analyzed to assess the relationships between scapular dyskinesis and other variables during the preseason. The data were assessed with a logistic regression analysis calculating the odds ratios (OR). Results: The inter-rater reliability among 3 blinded observers based on the Fleiss k value and percentage agreement was .52 and 79.0%, respectively, which indicates that the method is moderately reliable. Scapular dyskinesis was identified in 16 (10.1%) shoulders among 159 players, with type I being prominent. A multivariate logistic regression analysis revealed that a type I dyskinesis was significantly associated with a past history of stingers with projected pain to the affected side of the shoulder (OR, 3.7) and the player's competitive grade at the time of the survey (OR, 3.9). Conclusions: Scapular dyskinesis is significantly associated with a past history of stingers. This suggests that stingers are a causative factor of scapular dyskinesis in the rugby population. Our method of evaluating scapular dyskinesis in collision athletes exhibits moderate reliability. (C) 2014 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Kawasaki, Takayuki; Moriya, Shuichi; Kaketa, Takefumi; Kobayashi, Hideo; Kaneko, Kazuo] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138421, Japan; [Maki, Nobukazu; Shimizu, Kyoko] Mejiro Orthopaed & Internal Med Clin, Toshima Ku, Tokyo, Japan; [Ota, Chihiro] Keio Univ, Rugby Football Club, Yokohama, Kanagawa 223, Japan; [Urayama, Shingo] Int Budo Univ, Dept Sports Med, Katsuura, Chiba, Japan	Kawasaki, T (reprint author), Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	k-saki@luck.ocn.ne.jp					Alpert SW, 2000, J SHOULDER ELB SURG, V9, P47, DOI 10.1016/S1058-2746(00)90009-0; Sim J, 2005, PHYS THER, V85, P257; GREGG JR, 1979, J BONE JOINT SURG AM, V61, P825; Ludewig PM, 2000, PHYS THER, V80, P276; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; McClure P, 2009, J ATHL TRAINING, V44, P160, DOI 10.4085/1062-6050-44.2.160; SILLIMAN JF, 1993, CLIN ORTHOP RELAT R, P7; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Tsai NT, 2003, ARCH PHYS MED REHAB, V84, P1000, DOI 10.1016/S0003-9993(03)00127-8; GOZNA ER, 1979, J BONE JOINT SURG AM, V61, P1230; Safran MR, 2004, AM J SPORT MED, V32, P1063, DOI 10.1177/0363546504265193; Atalar H, 2009, ACTA ORTHOP BELG, V75, P19; Ludewig PM, 1996, J ORTHOP SPORT PHYS, V24, P57; Gumina S, 2009, ARTHROSCOPY, V25, P40, DOI 10.1016/j.arthro.2008.08.019; Uhl TL, 2009, ARTHROSCOPY, V25, P1240, DOI 10.1016/j.arthro.2009.06.007; McClure PW, 2006, PHYS THER, V86, P1075; FIDDIAN NJ, 1984, CLIN ORTHOP RELAT R, P228; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; Ellenbecker TS, 2012, CLIN ORTHOP RELAT R, V470, P1540, DOI 10.1007/s11999-011-2216-0; Ogston JB, 2007, AM J SPORT MED, V35, P1361, DOI 10.1177/0363546507300820; Bahk M, 2007, AM J SPORT MED, V35, P131, DOI 10.1177/0363546506294570; HAWKINS RJ, 1980, AM J SPORT MED, V8, P151, DOI 10.1177/036354658000800302; Shannon B, 2002, CLIN SPORT MED, V21, P29, DOI 10.1016/S0278-5919(03)00055-3; Kawasaki T, 2012, J SHOULDER ELB SURG, V21, P709, DOI 10.1016/j.jse.2011.11.032; Lukasiewicz AC, 1999, J ORTHOP SPORT PHYS, V29, P574; Silva RT, 2010, BRIT J SPORT MED, V44, P407, DOI 10.1136/bjsm.2008.046284; Kon Y, 2008, J SHOULDER ELB SURG, V17, P943, DOI 10.1016/j.jse.2008.05.047; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606; Kibler WB, 2012, J AM ACAD ORTHOP SUR, V20, P364, DOI 10.5435/JAAOS-20-06-364; Burkhart SS, 2003, ARTHROSCOPY, V19, P641, DOI 10.1016/S0749-8063(03)00389-X; BERGFELD JA, 1988, ORTHOP T, V12, P743; Kibler W Ben, 2002, J Shoulder Elbow Surg, V11, P550, DOI 10.1067/mse.2002.126766; MAKIN GJV, 1986, J NEUROL NEUROSUR PS, V49, P640, DOI 10.1136/jnnp.49.6.640; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Seitz AL, 2012, J SHOULDER ELB SURG, V21, P631, DOI 10.1016/j.jse.2011.01.008; Timmons MK, 2012, J SPORT REHABIL, V21, P354; WRIGHT TA, 1975, CLIN ORTHOP RELAT R, P15	38	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	DEC	2014	23	12					E293	E299		10.1016/j.jse.2014.04.009		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AT4WL	WOS:000344942300001		
J	Ohta, S; Kakinoki, R; Noguchi, T; Kaizawa, Y; Matsuda, S				Ohta, Souichi; Kakinoki, Ryosuke; Noguchi, Takashi; Kaizawa, Yukitoshi; Matsuda, Syuichi			Reconstruction of active elbow flexion in patients with radial ray deficiency: report of two cases	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article							MUSCLE		[Ohta, Souichi; Kakinoki, Ryosuke; Noguchi, Takashi; Kaizawa, Yukitoshi; Matsuda, Syuichi] Kyoto Univ, Dept Orthopaed Surg, Kyoto 6068507, Japan	Ohta, S (reprint author), Kyoto Univ, Dept Orthopaed Surg, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	sota@kuhp.kyoto-u.ac.jp					ATKINS RM, 1985, J BONE JOINT SURG BR, V67, P640; D'Arcangelo M, 2000, GROWING HAND DIAGNOS, P147; Doi Kazuteru, 2011, J Bone Joint Surg Am, V93, pe105, DOI 10.2106/JBJS.J.01846; Gagnon E, 2000, PLAST RECONSTR SURG, V106, P1582, DOI 10.1097/00006534-200012000-00022; Goldfarb CA, 2004, J HAND SURG-AM, V29A, P462, DOI 10.1016/j.jhsa.2003.12.011; Lamb DW, 1972, HAND, V4, P22; Lamb DW, 1977, J BONE JOINT SURG AM, V59, P1; Matsuo T., 2001, CEREBRAL PALSY ORTHO; MENELAUS MB, 1976, J BONE JOINT SURG BR, V58, P488; Smith PJ, 2002, PEDIAT LIMB, P153	10	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	DEC	2014	23	12					E313	E317		10.1016/j.jse.2014.08.005		5	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AT4WL	WOS:000344942300004		
J	Otoshi, K; Takegami, M; Sekiguchi, M; Onishi, Y; Yamazaki, S; Otani, K; Shishido, H; Kikuchi, S; Konno, S				Otoshi, Kenichi; Takegami, Misa; Sekiguchi, Miho; Onishi, Yoshihiro; Yamazaki, Shin; Otani, Koji; Shishido, Hiroaki; Kikuchi, Shinichi; Konno, Shinichi			Association between kyphosis and subacromial impingement syndrome: LOHAS study	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article						Epidemiologic study; kyphosis; wall-occiput test; rib-pelvic distance test; subacromial impingement syndrome; scapular dyskinesis; LOHAS	3-DIMENSIONAL SCAPULAR KINEMATICS; ROTATOR CUFF DISEASE; TERM-FOLLOW-UP; SHOULDER IMPINGEMENT; VERTEBRAL DEFORMITIES; LOCOMOTIVE SYNDROME; THORACIC KYPHOSIS; OLDER PERSONS; BACK-PAIN; DISABILITY	Background: Kyphosis is a cause of scapular dyskinesis, which can induce various shoulder disorders, including subacromial impingement syndrome (SIS). This study aimed to clarify the impact of kyphosis on SIS with use of cross-sectional data from the Locomotive Syndrome and Health Outcome in Aizu Cohort Study (LOHAS). Methods: The study enrolled 2144 participants who were older than 40 years and participated in health checkups in 2010. Kyphosis was assessed by the wall-occiput test (WOT) for thoracic kyphosis and the rib-pelvic distance test (RPDT) for lumbar kyphosis. The associations between kyphosis, SIS, and reduction in shoulder elevation (RSE) were investigated. Results: Age-and gender-adjusted logistic regression analysis demonstrated significant association between SIS and WOT (odds ratio, 1.65; 95% confidence interval, 1.02, 2.64; P < .05), whereas there was no significant association between SIS and RPDT. Multivariable logistic regression analysis demonstrated no significant association between SIS and both WOT and RPDT, whereas there was significant association between SIS and RSE. Conclusion: RSE plays a key role in the development of SIS, and thoracic kyphosis might influence the development of SIS indirectly by reducing shoulder elevation induced by the restriction of the thoracic spine extension and scapular dyskinesis. (C) 2014 Journal of Shoulder and Elbow Surgery Board of Trustees.	[Otoshi, Kenichi; Sekiguchi, Miho; Otani, Koji; Shishido, Hiroaki; Kikuchi, Shinichi; Konno, Shinichi] Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima 9601295, Japan; [Takegami, Misa] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Osaka, Japan; [Onishi, Yoshihiro] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan; [Yamazaki, Shin] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan	Otoshi, K (reprint author), Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, 1 Hikarigaoka, Fukushima 9601295, Japan.	kootoshi@fmu.ac.jp					Abe K, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-157; OZAKI J, 1988, J BONE JOINT SURG AM, V70A, P1224; Kibler WB, 1998, AM J SPORT MED, V26, P325; Hebert LJ, 2002, ARCH PHYS MED REHAB, V83, P60, DOI 10.1053/apmr.2002.27471; Ludewig PM, 2000, PHYS THER, V80, P276; Briggs AM, 2007, PHYS THER, V87, P595, DOI 10.2522/ptj.20060119; Jobe CM, 1997, ORTHOP CLIN N AM, V28, P137, DOI 10.1016/S0030-5898(05)70274-1; Baskurt Z, 2011, J BACK MUSCULOSKELET, V24, P173, DOI 10.3233/BMR-2011-0291; Budoff JE, 1998, J BONE JOINT SURG AM, V80A, P733; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; Lewis JS, 2005, J SHOULDER ELB SURG, V14, P385, DOI 10.1016/J.JSE.2004.08.007; WARNER JJP, 1990, AM J SPORT MED, V18, P366, DOI 10.1177/036354659001800406; Kebaetse M, 1999, ARCH PHYS MED REHAB, V80, P945, DOI 10.1016/S0003-9993(99)90088-6; Wang CH, 1999, ARCH PHYS MED REHAB, V80, P923, DOI 10.1016/S0003-9993(99)90084-9; MURRAY PM, 1993, J BONE JOINT SURG AM, V75A, P236; Lukasiewicz AC, 1999, J ORTHOP SPORT PHYS, V29, P574; Nakamura K, 2009, J ORTHOP SCI, V14, P1, DOI 10.1007/s00776-008-1302-y; Di Bari M, 2004, J AM GERIATR SOC, V52, P909, DOI 10.1111/j.1532-5415.2004.52257.x; Kado DM, 2007, ANN INTERN MED, V147, P330; NEER CS, 1972, J BONE JOINT SURG AM, VA 54, P41; Imaeda T, 2006, J ORTHOP SCI, V11, P248, DOI 10.1007/s00776-006-1013-1; BIGLIANI LU, 1991, CLIN SPORT MED, V10, P823; Ryan SD, 1997, J AM GERIATR SOC, V45, P1479; Boyles RE, 2009, MANUAL THER, V14, P375, DOI 10.1016/j.math.2008.05.005; Bullock MP, 2005, MANUAL THER, V10, P28, DOI 10.1016/j.math.2004.07.002; Celli L, 1990, SHOULDER, P28; Crawford Helen J., 1993, Physiotherapy Theory and Practice, V9, P143, DOI 10.3109/09593989309047453; Edelson G, 2000, J SHOULDER ELB SURG, V9, P308, DOI 10.1067/mse.2000.105449; ETTINGER B, 1994, OSTEOPOROSIS INT, V4, P55, DOI 10.1007/BF02352262; Fukuhara S, 2004, MANUAL SF 36V2 JAPAN; Gray J, 2004, PHYS THERAPY SHOULDE, P133; Green AD, 2004, JAMA-J AM MED ASSOC, V292, P2890, DOI 10.1001/jama.292.23.2890; Grimsby O, 1997, PHYS THERAPY SHOULDE, P95; Gumina Stefano, 2008, Chir Organi Mov, V91, P93, DOI 10.1007/s12306-007-0016-1; HORTER TS, 1978, PHYS THER, V58, P184; Ismail AA, 1999, OSTEOPOROSIS INT, V9, P206, DOI 10.1007/s001980050138; Kibler W Ben, 2002, J Shoulder Elbow Surg, V11, P550, DOI 10.1067/mse.2002.126766; Matsen FA, 1990, SHOULDER, V2, P623; MEISTER K, 1993, J ORTHOP SPORT PHYS, V18, P413; Meurer A, 2004, Z ORTHOP GRENZGEB, V142, P415, DOI 10.1055/s-2004-822821; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Otani K, 2012, J ORTHOP SCI, V17, P261, DOI 10.1007/s00776-012-0200-5; Rubin BD, 2002, ARTHROSCOPY, V18, P29, DOI 10.1053/jars.2002.36507; SCHENKMAN M, 1987, Journal of Orthopaedic and Sports Physical Therapy, V8, P438; Siminoski K, 2003, AM J MED, V115, P233, DOI 10.1016/S0002-9343(03)00299-7; Siminoski K, 2011, J MUSCULOSKEL NEURON, V11, P249; SOSLOWSKY LJ, 1994, CLIN ORTHOP RELAT R, P10; Stewart SG, 1995, J MAN MANIP THER, V3, P15; Struyf F, 2013, CLIN RHEUMATOL, V32, P73, DOI 10.1007/s10067-012-2093-2; Theisen C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-135; Uhthoff HK, 1997, ORTHOP CLIN N AM, V28, P31, DOI 10.1016/S0030-5898(05)70262-5; WATSON DH, 1993, CEPHALALGIA, V13, P272, DOI 10.1046/j.1468-2982.1993.1304272.x	52	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	DEC	2014	23	12					E300	E307		10.1016/j.jse.2014.04.010		8	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	AT4WL	WOS:000344942300002		
J	Kageyama, M; Sugiyama, T; Takai, Y; Kanehisa, H; Maeda, A				Kageyama, Masahiro; Sugiyama, Takashi; Takai, Yohei; Kanehisa, Hiroaki; Maeda, Akira			Kinematic and Kinetic Profiles of Trunk and Lower Limbs during Baseball Pitching in Collegiate Pitchers	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Throwing movement; pitching ball velocity; ground-reaction force; lower limbs; pivot and stride legs	BIOMECHANICS; SHOULDER; VELOCITY; MOVEMENT; MOTION	The purpose of this study was to clarify differences in the kinematic and kinetic profiles of the trunk and lower extremities during baseball pitching in collegiate baseball pitchers, in relation to differences in the pitched ball velocity. The subjects were 30 collegiate baseball pitchers aged 18 to 22 yrs, who were assigned to high- (HG, 37.4 +/- 0.8 m.s(-1)) and low-pitched-ball-velocity groups (LG, 33.3 +/- 0.8 m.s(-1)). Three-dimensional motion analysis with a comprehensive lower-extremity model was used to evaluate kinematic and kinetic parameters during baseball pitching. The ground-reaction forces (GRF) of the pivot and stride legs during pitching were determined using two multicomponent force plates. The joint torques of hip, knee, and ankle were calculated using inverse-dynamics computation of a musculoskeletal human model. To eliminate any effect of variation in body size, kinetic and GRF data were normalized by dividing them by body mass. The maxima and minima of GRF (Fy, Fz, and resultant forces) on the pivot and stride leg were significantly greater in the HG than in the LG (p < 0.05). Furthermore, Fy, Fz, and resultant forces on the stride leg at maximum shoulder external rotation and ball release were significantly greater in the HG than in the LG (p < 0.05). The hip abduction, hip internal rotation and knee extension torques of the pivot leg and the hip adduction torque of the stride leg when it contacted the ground were significantly greater in the HG than in the LG (p < 0.05). These results indicate that, compared with low-ball-velocity pitchers, high-ball-velocity pitchers can generate greater momentum of the lower limbs during baseball pitching.	[Kageyama, Masahiro; Sugiyama, Takashi] Natl Inst Fitness & Sports Kanoya, Grad Sch Phys Educ, Kanoya, Kagoshima 8912393, Japan; [Takai, Yohei; Kanehisa, Hiroaki; Maeda, Akira] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima 8912393, Japan	Maeda, A (reprint author), Natl Inst Fitness & Sports Kanoya, 1 Shiromizu, Kanoya, Kagoshima 8912393, Japan.	m127003@sky.nifs-k.ac.jp; m127004@sky.nifs-k.ac.jp; y-takai@nifs-k.ac.jp; hkane@nifs-k.ac.jp; amaeda@nifs-k.ac.jp					Fleisig GS, 1999, J BIOMECH, V32, P1371, DOI 10.1016/S0021-9290(99)00127-X; Matsuo T, 2001, J APPL BIOMECH, V17, P1; MacWilliams BA, 1998, AM J SPORT MED, V26, P66; Campbell BM, 2010, J STRENGTH COND RES, V24, P964, DOI 10.1519/JSC.0b013e3181cb241b; Urbin MA, 2013, AM J SPORT MED, V41, P336, DOI 10.1177/0363546512467952; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; SAKURAI S, 1993, J APPL BIOMECH, V9, P47; Fleisig GS, 1996, J APPL BIOMECH, V12, P207; DILLMAN CJ, 1993, J ORTHOP SPORT PHYS, V18, P402; Escamilla RF, 1998, J APPL BIOMECH, V14, P1; Atwater A E, 1979, Exerc Sport Sci Rev, V7, P43; ELLIOTT B, 1988, INT J SPORT BIOMECH, V4, P59; Ishida K., 2004, INT J SPORT HLTH SCI, V2, P119, DOI 10.5432/ijshs.2.119; Kibler WB, 1991, CONT ORTHOP, V22, P525; Kibler W. Ben, 1995, Arthroscopy, V11, P296, DOI 10.1016/0749-8063(95)90006-3; Kreighbaum E., 1985, BIOMECHANICS QUANTIT, V2nd, P585; Milewski MD, 2012, J APPL BIOMECH, V28, P491; Miller DI, 1973, BIOMECHANICS SPORT R; Myers D., 2000, LOUISVILLE SLUGGER C; Nakamura Y, 2005, IEEE T ROBOT, V21, P58, DOI 10.1109/TRO.2004.833798; Robb AJ, 2010, AM J SPORT MED, V38, P2487, DOI 10.1177/0363546510375535; Stodden DF, 2001, J APPL BIOMECH, V17, P164	22	1	1	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	DEC	2014	13	4					742	750				9	Sport Sciences	Sport Sciences	AT7MM	WOS:000345121400004		
J	Takeuchi, S; Nishida, Y; Mizushima, T				Takeuchi, Shinta; Nishida, Yusuke; Mizushima, Takashi			Effects of Synchronization between Cardiac and Locomotor Rhythms on Oxygen Pulse during Walking	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Heart rate; step rate; coupling; entrainment; oxygen consumption stroke volume	HEART-RATE-VARIABILITY; CARDIOLOCOMOTOR SYNCHRONIZATION; ANALYZING ENTRAINMENT; STROKE VOLUME; GROUP-III; HUMANS; EXERCISE; INHIBITION; AFFERENTS; FAILURE	The objective of the study was to investigate whether the occurrence of cardiac-locomotor synchronization (CLS) affects oxygen pulse (O-2 pulse, mL/beat) during walking. Twelve healthy men were studied under two treadmill protocols. The CLS protocol involved subjects walking at a frequency of their heart rate (HR) to induce CLS. The free protocol (reference) involved subjects walking at a self-selected cadence. The treadmill load was equal between the two protocols and was adjusted so that the subject's HR was maintained at approximately 120 bpm. Electrocardiographic signals, foot switch signals, and oxygen consumption (VO2) were measured continuously for 10 min after the heart rate reached a steady state. VO2, O-2 pulse, and mean HR were calculated. VO2 and O-2 pulse were significantly higher in subjects in the CLS protocol compared to those in the free protocol. However, mean HR was not different between the two groups. The synchronization strength was significantly related to the increase in O-2 pulse in subjects in the CLS protocol compared with those in the free protocol. These results suggest that the occurrence of CLS enhances O-2 pulse by increasing the strength of CLS during walking.	[Takeuchi, Shinta; Mizushima, Takashi] Hamamatsu Univ Sch Med, Univ Hosp, Dept Rehabil, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Takeuchi, Shinta; Mizushima, Takashi] Hamamatsu Univ Sch Med, Univ Hosp, Dept Rehabil, Hamamatsu, Shizuoka 4313192, Japan; [Nishida, Yusuke] Seirei Christopher Univ, Shizuoka 4338558, Japan	Takeuchi, S (reprint author), Hamamatsu Univ Sch Med, Univ Hosp, Dept Rehabil, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	take.shin1110@gmail.com; yuusuke-n@seirei.ac.jp; mizusima@hama-med.ac.jp			JSPS KAKENHI [24650311]	This work was supported by JSPS KAKENHI Grant Numbers 24650311.	BERNARDI L, 1990, CARDIOVASC RES, V24, P969, DOI 10.1093/cvr/24.12.969; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; BHAMBHANI Y, 1994, CAN J APPL PHYSIOL, V19, P49; Schafer C, 1998, NATURE, V392, P239, DOI 10.1038/32567; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; Miller JD, 2005, J PHYSIOL-LONDON, V563, P925, DOI 10.1016/j.physiol.2004.076422; Whipp BJ, 1996, J APPL PHYSIOL, V81, P2674; Blain G, 2009, AM J PHYSIOL-HEART C, V296, pH1651, DOI 10.1152/ajpheart.00881.2008; Casadei B, 1996, J APPL PHYSIOL, V81, P556; CISKE PE, 1986, AM HEART J, V112, P1016, DOI 10.1016/0002-8703(86)90315-7; Dhindsa M.S., 2012, ARTERY RES, V6, P136; DONVILLE JE, 1993, CAN J APPL PHYSIOL, V18, P379; Kimura T, 2010, J ELECTROMYOGR KINES, V20, P572, DOI 10.1016/j.jelekin.2010.03.004; KIRBY RL, 1989, J APPL PHYSIOL, V66, P323; KIRBY RL, 1992, J APPL PHYSIOL, V72, P1368; Legramante JM, 2000, AM J PHYSIOL-HEART C, V278, pH871; MCWILLIAM PN, 1991, AM J PHYSIOL, V260, pH730; NIIZEKI K, 1993, J APPL PHYSIOL, V75, P1815; Niizeki K., 2014, J PHYS FITNESS SPORT, V3, P11; Niizeki K, 2005, AM J PHYSIOL-REG I, V288, pR645, DOI 10.1152/ajpregu.00491.2004; Niizeki K, 1996, FOLIA PRIMATOL, V66, P226, DOI 10.1159/000157197; Nomura K, 2001, EUR J APPL PHYSIOL, V84, P373, DOI 10.1007/s004210100382; Nomura K, 2006, EUR J APPL PHYSIOL, V97, P240, DOI 10.1007/s00421-005-0103-7; Nomura K, 2003, EUR J APPL PHYSIOL, V89, P221, DOI 10.1007/s00421-002-0784-0; Novak V, 2007, J GERONTOL A-BIOL, V62, P86; OROURKE M, 1992, CORONARY ARTERY DIS, V3, P863, DOI 10.1097/00019501-199209000-00014; Phillips B, 2013, J SPORT SCI MED, V12, P381; Rosenblum MG, 1998, IEEE ENG MED BIOL, V17, P46, DOI 10.1109/51.731320; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Seidel H, 1998, IEEE ENG MED BIOL, V17, P54, DOI 10.1109/51.731321; Simmons AD, 1997, AM J PHYSIOL-REG I, V273, pR1352; SULLIVAN M, 1989, J AM COLL CARDIOL, V13, P1138; Vella CA, 2011, EUR J APPL PHYSIOL, V111, P915, DOI 10.1007/s00421-010-1554-z; Wasserman K, 1999, PRINCIPLES EXERCISE, P2	34	1	1	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	DEC	2014	13	4					881	887				7	Sport Sciences	Sport Sciences	AT7MM	WOS:000345121400020		
J	Sugiyama, T; Kameda, M; Kageyama, M; Kiba, K; Kanehisa, H; Maeda, A				Sugiyama, Takashi; Kameda, Mai; Kageyama, Masahiro; Kiba, Kazufusa; Kanehisa, Hiroaki; Maeda, Akira			Asymmetry between the Dominant and Non-Dominant Legs in the Kinematics of the Lower Extremities during a Running Single Leg Jump in Collegiate Basketball Players	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Jump height; symmetry index; bilateral difference; joint kinematics	HIGH-SCHOOL BASKETBALL; VERTICAL JUMP; STIFFNESS; BIOMECHANICS; MOVEMENTS; INJURIES; STRENGTH; PLANTAR; ENERGY; TORQUE	The present study aimed to clarify the asymmetry between the dominant (DL) and non-dominant takeoff legs (NDL) in terms of lower limb behavior during running single leg jumps (RSJ) in collegiate male basketball players in relation to that of the jump height. Twenty-seven players performed maximal RSJ with a 6 m approach. Three-dimensional kinematics data during RSJ was collected using a 12 Raptor camera infrared motion analysis system (MAC 3D system) at a sampling frequency of 500 Hz. The symmetry index in the jump heights and the kinematics variables were calculated as {2 x (DL -NDL) / (DL + NDL)} x 100. The run-up velocity was similar between the two legs, but the jump height was significantly higher in the DL than in the NDL. During the takeoff phase, the joint angles of the ankle and knee were significantly larger in the DL than the NDL. In addition, the contact time for the DL was significantly shorter than that for the NDL. The symmetry index of the kinematics for the ankle joint was positively correlated with that of jump height, but that for the knee joint was not. The current results indicate that, for collegiate basketball players, the asymmetry in the height of a RSJ can be attributed to that in the joint kinematics of the ankle during the takeoff phase, which may be associated with the ability to effectively transmit run-up velocity to jump height.	[Sugiyama, Takashi; Kameda, Mai; Kageyama, Masahiro] Natl Inst Fitness & Sports Kanoya, Grad Sch Phys Educ, Kagoshima 8912393, Japan; [Kiba, Kazufusa; Kanehisa, Hiroaki; Maeda, Akira] Natl Inst Fitness & Sports Kanoya, Kagoshima 8912393, Japan	Maeda, A (reprint author), Natl Inst Fitness & Sports Kanoya, 1 Shiromizu, Kanoya, Kagoshima 8912393, Japan.	m127004@sky.nifs-k.ac.jp; m147002@sky.nifs-k.ac.jp; m127003@sky.nifs-k.ac.jp; bsk-kiba@nifs-k.ac.jp; hkane@nifs-k.ac.jp; amaeda@nifs-k.ac.jp					Ae M., 1986, INT J SPORT BIOMECH, V2, P66; Ae M., NEW STUDIES ATHLETIC, V23, P45; Decker MJ, 2003, CLIN BIOMECH, V18, P662, DOI 10.1016/S0268-0033(03)00090-1; Greig MP, 2000, J APPL BIOMECH, V16, P367; Maulder P, 2005, PHYS THER SPORT, V6, P74, DOI 10.1016/j.ptsp.2005.01.001; Miyaguchi K, 2010, J STRENGTH COND RES, V24, P2516, DOI 10.1519/JSC.0b013e3181e380b5; Laffaye G, 2005, MED SCI SPORT EXER, V37, P536, DOI 10.1249/01.MSS.0000158991.17211.13; Messina DF, 1999, AM J SPORT MED, V27, P294; Schiltz M, 2009, J ATHL TRAINING, V44, P39, DOI 10.4085/1062-6050-44.1.39; de Ruiter CJ, 2010, EUR J APPL PHYSIOL, V108, P247, DOI 10.1007/s00421-009-1209-0; Yu B, 2006, CLIN BIOMECH, V21, P297, DOI 10.1016/j.clinbiomech.2005.11.003; Hewit JK, 2012, PHYS THER SPORT, V13, P238, DOI 10.1016/j.ptsp.2011.12.003; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Farley CT, 1999, J BIOMECH, V32, P267, DOI 10.1016/S0021-9290(98)00170-5; Meylan CMP, 2010, J SPORT SCI, V28, P545, DOI 10.1080/02640411003628048; Wang LI, 2011, J SPORT SCI MED, V10, P151; Swearingen J, 2011, PHYS THER SPORT, V12, P194, DOI 10.1016/j.ptsp.2011.06.001; AURA O, 1989, INT J SPORT BIOMECH, V5, P89; Brumitt Jason, 2013, Int J Sports Phys Ther, V8, P216; Deitch JR, 2006, AM J SPORT MED, V34, P1077, DOI 10.1177/0363546505285383; Ellapen T.J., 2012, AFRICAN J PHYS HLTH, V18, P308; Hay JG, 1999, J SPORT SCI, V17, P159, DOI 10.1080/026404199366262; Ritzdorf W., 2009, NEW STUDIES ATHLETIC, V24, P31; Stefanyshyn DJ, 1998, J SPORT SCI, V16, P177; Theoharopoulos A, 2000, ISOKINET EXERC SCI, V8, P181; Wong PL, 2007, BRIT J SPORT MED, V41, P84, DOI 10.1136/bjsm.2006.030908; Yoon S, 2007, INT J SPORTS MED, V28, P66, DOI 10.1055/s-2006-923903	28	0	0	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	DEC	2014	13	4					951	957				7	Sport Sciences	Sport Sciences	AT7MM	WOS:000345121400029		
J	Yamashita, Y; Ikeda, T; Kurihara, T; Yoshida, Y; Takeishi, K; Itoh, S; Harimoto, N; Kawanaka, H; Shirabe, K; Maehara, Y				Yamashita, Yo-ichi; Ikeda, Tetsuo; Kurihara, Takeshi; Yoshida, Yoshihiro; Takeishi, Kazuki; Itoh, Shinji; Harimoto, Norifumi; Kawanaka, Hirofumi; Shirabe, Ken; Maehara, Yoshihiko			Long-Term Favorable Surgical Results of Laparoscopic Hepatic Resection for Hepatocellular Carcinoma in Patients with Cirrhosis: A Single-Center Experience over a 10-Year Period	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							OPEN LIVER RESECTION; POSTOPERATIVE COMPLICATIONS; COLORECTAL-CANCER; COLON-CANCER; HEPATECTOMY; METAANALYSIS; OUTCOMES; SURVIVAL; POSITION; GASTRECTOMY	BACKGROUND: We first performed laparoscopic hepatic resection (Lap-Hx) for hepatocellular carcinoma (HCC) in 1994. Here we review the long-term surgical results of Lap-Hx for HCC in patients with cirrhosis over a 10-year period at a single institution. STUDY DESIGN: Between January 2000 and December 2013, 99 patients with cirrhosis underwent open hepatic resection (Open-Hx) and 63 underwent Lap-Hx for primary HCC within the Milan criteria. We compared the operative outcomes and patient survival between the 2 groups. RESULTS: There were no significant differences regarding patient background characteristics or tumor-related factors between the 2 groups. The morbidity rate of the Lap-Hx group was significantly lower than that of the Open-Hx group (26% vs 10%; p = 0.0459), and the complication rate of ascites was significantly lower (7% vs 0%; p = 0.0077). The mean duration of hospital stay of the Lap-Hx group was significantly shorter than that of the Open-Hx group (16 vs 10 days; p = 0.0008). There were no significant between-group differences regarding overall or disease-free survival. CONCLUSIONS: Laparoscopic-Hx for HCC in patients with cirrhosis is associated with less morbidity and shorter hospital stays, with no compromise in patient survival. It may be time to consider changing the standard operation for primary HCC within the Milan criteria to Lap-Hx in patients with cirrhosis. ((C) 2014 by the American College of Surgeons)	[Yamashita, Yo-ichi; Ikeda, Tetsuo; Kurihara, Takeshi; Yoshida, Yoshihiro; Takeishi, Kazuki; Itoh, Shinji; Harimoto, Norifumi; Kawanaka, Hirofumi; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Yamashita, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamashi@surg2.med.kyushu-u.ac.jp					Ai JH, 2013, PLOS ONE, V21; Yamamoto S, 2014, ANN SURG, V260, P23, DOI 10.1097/SLA.0000000000000499; Hassoun Z, 2003, CLIN GASTROENTEROL H, V1, P10, DOI 10.1053/jcgh.2003.50003; HASHIZUME M, 1995, SURG ENDOSC-ULTRAS, V9, P1289; Kim H, 2014, SURG ENDOSC, V28, P950, DOI 10.1007/s00464-013-3254-3; Ikeda T, 2014, SURG ENDOSC, V28, P2484, DOI 10.1007/s00464-014-3469-y; Yamashita Y, 2007, J AM COLL SURGEONS, V205, P19, DOI 10.1016/j.jamcollsurg.2007.01.069; Shimada M, 1998, BRIT J SURG, V85, P195; Xiong JJ, 2012, WORLD J GASTROENTERO, V18, P6657, DOI 10.3748/wjg.v18.i45.6657; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Parks KR, 2014, HPB, V16, P109, DOI 10.1111/hpb.12117; Li N, 2012, HEPATOL RES, V42, P51, DOI 10.1111/j.1872-034X.2011.00890.x; Ito H, 2008, ANN SURG, V247, P994, DOI 10.1097/SLA.0b013e31816c405f; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Zhou YM, 2011, DIGEST DIS SCI, V56, P1937, DOI 10.1007/s10620-011-1572-7; Law WL, 2007, ANN SURG ONCOL, V14, P2559, DOI 10.1245/s10434-007-9434-4; Yin Z, 2013, ANN SURG ONCOL, V20, P1203, DOI 10.1245/s10434-012-2705-8; Buell JF, 2009, ANN SURG, V250, P825, DOI 10.1097/SLA.0b013e3181b3b2d8; Buunen M, 2004, SURG ENDOSC, V18, P1022, DOI 10.1007/s00464-003-9169-7; MAKUUCHI M, 1987, SURG GYNECOL OBSTET, V164, P155; Yamashita Y, 2014, AM J SURG, V207, P890, DOI 10.1016/j.amjsurg.2013.07.028; Chan ACY, 2014, WORLD J SURG, V38, P1141, DOI 10.1007/s00268-013-2380-3; Chen YY, 2011, SURG LAPARO ENDO PER, V21, pE41, DOI 10.1097/SLE.0b013e3182078ac3; Cheng QY, 2014, J GASTROINTEST SURG, V18, P1087, DOI 10.1007/s11605-014-2519-z; Han H-S, PROSPECTIVE RANDOMIZ; Ikeda T, 2011, SURG TODAY, V41, P1592, DOI 10.1007/s00595-010-4479-6; Ikeda T, 2013, J HEPATO-BIL-PAN SCI, V20, P145, DOI 10.1007/s00534-012-0558-y; KANEMATSU T, 1989, HEPATOLOGY, V10, P98, DOI 10.1002/hep.1840100119; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Shimada M, 2001, SURG ENDOSC-ULTRAS, V15, P541, DOI 10.1007/s004640080099; Shimada M, 2002, SURGERY, V131, pS312, DOI 10.1067/msy.2002.120116; Theophilus M, 2014, COLORECTAL DIS, V16, pO75, DOI 10.1111/codi.12483; Tokunaga M, 2013, ANN SURG ONCOL, V20, P1575, DOI 10.1245/s10434-012-2720-9; Wang WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088753; Yamashita Y, 2013, SURGERY, V154, P1038, DOI 10.1016/j.surg.2013.04.046	35	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	DEC	2014	219	6					1117	1123		10.1016/j.jamcollsurg.2014.09.003		7	Surgery	Surgery	AU2ET	WOS:000345429900004		
J	Imai, D; Ikegami, T; Toshima, T; Yoshizumi, T; Yamashita, Y; Ninomiya, M; Harimoto, N; Itoh, S; Uchiyama, H; Shirabe, K; Maehara, Y				Imai, Daisuke; Ikegami, Toru; Toshima, Takeo; Yoshizumi, Tomoharu; Yamashita, Yo-ichi; Ninomiya, Mizuki; Harimoto, Norifumi; Itoh, Shinji; Uchiyama, Hideaki; Shirabe, Ken; Maehara, Yoshihiko			Preemptive Thoracic Drainage to Eradicate Postoperative Pulmonary Complications after Living Donor Liver Transplantation	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							RISK-FACTORS; PLEURAL EFFUSIONS; EARLY-ONSET; PNEUMONIA; ATELECTASIS; GRAFT; VENTILATION; CONGESTION; ANESTHESIA; STRATEGIES	BACKGROUND: Thoracic fluid retention after living donor liver transplantation (LDLT) has various negative consequences, including atelectasis, pneumonia, and respiratory distress or failure. STUDY DESIGN: We analyzed the clinical impact of preemptive thoracic drainage in 177 patients undergoing adult-to-adult LDLT for chronic liver diseases at a single center. Recipients were divided into 2 time periods. The earlier cohort (n = 120) was analyzed for risk factors for postoperative atelectasis retrospectively; the later cohort (n = 57), with a risk factor for postoperative atelectasis, underwent preemptive thoracic drainage prospectively. The incidence of postoperative pulmonary complications was compared between these 2 cohorts. RESULTS: Independent risk factors for atelectasis in earlier cohort were body mass index >= 27 kg/m(2) (p < 0.001), performance status >= 3 (p = 0.003) and model for end-stage liver disease score >= 23 (p = 0.005). The rates of atelectasis (21.1% vs 42.5%, p = 0.005) and pneumonia (1.8% vs 10.0%, p = 0.049) were significantly lower in later than in earlier cohort. Moreover, the mean durations of ICU stay (3.6 +/- 0.2 days vs 5.7 +/- 0.6 days, p = 0.038) and postoperative oxygen support (5.1 +/- 0.8 days vs 7.1 +/- 0.5 days, p = 0.037) were significantly shorter in the later than in the earlier cohort. There were no significant differences in the incidence of adverse events associated with thoracic drainages between these 2 cohorts. CONCLUSIONS: Preemptive thoracic drainage for transplant recipients at high risk of postoperative atelectasis could decrease morbidities after LDLT. ((C) 2014 by the American College of Surgeons)	[Imai, Daisuke; Ikegami, Toru; Toshima, Takeo; Yoshizumi, Tomoharu; Yamashita, Yo-ichi; Ninomiya, Mizuki; Harimoto, Norifumi; Itoh, Shinji; Uchiyama, Hideaki; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Ikegami, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan.	tikesurg@surg2.med.kyushu-u.ac.jp					Ahmed SH, 2004, J TRAUMA, V57, P1184, DOI 10.1097/01.TA.0000145074.98431.15; Ikegami T, 2012, J AM COLL SURGEONS, V214, P288, DOI 10.1016/j.jamcollsurg.2011.12.001; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Shander A, 2011, CRIT CARE MED, V39, P2163, DOI 10.1097/CCM.0b013e31821f0522; Lee S, 2001, TRANSPLANTATION, V71, P812, DOI 10.1097/00007890-200103270-00021; FUJITA T, 1995, AM J SURG, V169, P304, DOI 10.1016/S0002-9610(99)80163-9; Lee SO, 2011, LIVER TRANSPLANT, V17, P733, DOI 10.1002/lt.22296; Ikegami T, 2013, J AM COLL SURGEONS, V216, P353, DOI 10.1016/j.jamcollsurg.2012.11.011; Masuda T, 2014, LIVER TRANSPLANT, V20, P401, DOI 10.1002/lt.23811; van Kaam AH, 2004, AM J RESP CRIT CARE, V169, P1046, DOI 10.1164/rccm.200312-1779OC; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Feltracco P, 2013, WORLD J GASTROENTERO, V19, P9271, DOI 10.3748/wjg.v19.i48.9271; BRISMAR B, 1985, ANESTHESIOLOGY, V62, P422, DOI 10.1097/00000542-198504000-00009; Golfieri R, 2000, EUR RADIOL, V10, P1169, DOI 10.1007/s003309900268; HEDENSTIERNA G, 1976, ACTA ANAESTH SCAND, V20, P248; Ikegami T, 2012, LIVER TRANSPLANT, V18, P1060, DOI 10.1002/lt.23483; Kress John P, 2009, Crit Care Med, V37, pS442, DOI 10.1097/CCM.0b013e3181b6f9c0; Kupfer Y, 2011, CHEST, V139, P519, DOI 10.1378/chest.10-1012; LEBEAU G, 1990, SURG GYNECOL OBSTET, V170, P317; Levesque E, 2011, J CRIT CARE, V26, P257, DOI 10.1016/j.jcrc.2010.08.020; Levesque E, 2012, TRANSPLANTATION, V94, P532, DOI 10.1097/TP.0b013e31825c1d41; Lin YH, 2010, J INT MED RES, V38, P1845; MARTIN LF, 1984, ARCH SURG-CHICAGO, V119, P379; Pirat A, 2003, TRANSPL P, V36, P218; Sato Y, 2012, TRANSPL P, V44, P820, DOI 10.1016/j.transproceed.2012.03.031; Schindler MB, 2005, CRIT CARE, V9, P341, DOI 10.1186/cc3766; Toshima T, 2012, TRANSPLANTATION, V93, P929, DOI 10.1097/TP.0b013e3182488bd8; Troisi R, 2003, LIVER TRANSPLANT, V9, pS1, DOI 10.1053/jlts.2003.50193; Weiss E, 2010, LIVER TRANSPLANT, V16, P1178, DOI 10.1002/lt.22132; Yoshiya S, 2012, TRANSPLANTATION, V94, P947, DOI 10.1097/TP.0b013e31826969e6; Yoshizumi T, 2008, TRANSPL INT, V21, P833, DOI 10.1111/j.1432-2277.2008.00678.x	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	DEC	2014	219	6					1134	+		10.1016/j.jamcollsurg.2014.09.006		11	Surgery	Surgery	AU2ET	WOS:000345429900006		
J	Oki, E; Tsuda, Y; Saeki, H; Ando, K; Imamura, Y; Nakashima, Y; Ohgaki, K; Morita, M; Ikeda, T; Maehara, Y				Oki, Eiji; Tsuda, Yasuo; Saeki, Hiroshi; Ando, Koji; Imamura, Yu; Nakashima, Yuichiro; Ohgaki, Kippei; Morita, Masaru; Ikeda, Tetsuo; Maehara, Yoshihiko			Book-Binding Technique for Billroth I Anastomosis During Totally Laparoscopic Distal Gastrectomy	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							TRIANGULATING STAPLING TECHNIQUE; INTRACORPOREAL ANASTOMOSIS; Y RECONSTRUCTION; GASTRIC-CANCER		[Oki, Eiji; Tsuda, Yasuo; Saeki, Hiroshi; Ando, Koji; Imamura, Yu; Nakashima, Yuichiro; Ohgaki, Kippei; Morita, Masaru; Ikeda, Tetsuo; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Oki, E (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okieiji@surg2.med.kyushu-u.ac.jp					Huscher CGS, 2007, AM J SURG, V194, P839, DOI 10.1016/j.amjsurg.2007.08.037; Kim JJ, 2008, SURG ENDOSC, V22, P436, DOI 10.1007/s00464-007-9446-y; [Anonymous], 1999, JAPANESE CLASSIFICAT; Kanaya S, 2002, J AM COLL SURGEONS, V195, P284, DOI 10.1016/S1072-7515(02)01239-5; Noshiro H, 2009, GASTRIC CANCER, V12, P164, DOI 10.1007/s10120-009-0520-0; Guzman EA, 2009, ANN SURG ONCOL, V16, P2218, DOI 10.1245/s10434-009-0508-3; Ikeda O, 2009, SURG ENDOSC, V23, P2374, DOI 10.1007/s00464-009-0360-3; Kanaya S, 2011, GASTRIC CANCER, V14, P365, DOI 10.1007/s10120-011-0054-0; Song KY, 2008, J GASTROINTEST SURG, V12, P1015, DOI 10.1007/s11605-008-0484-0; Ikeda T, 2013, SURG ENDOSC, V27, P325, DOI 10.1007/s00464-012-2433-y; Fukunaga Y, 2011, SURG TODAY, V41, P643, DOI 10.1007/s00595-010-4319-8; Nunobe S, 2010, DIGEST SURG, V27, P359, DOI 10.1159/000315013; Oki E, 2011, SURG LAPARO ENDO PER, V21, P146, DOI 10.1097/SLE.0b013e318219a66b; Oki Eiji, 2012, J Gastric Cancer, V12, P108, DOI 10.5230/jgc.2012.12.2.108; Oki E, 2011, EUR SURG RES, V47, P205, DOI 10.1159/000332850; Saeki H, 2013, J AM COLL SURGEONS, V216, pE43, DOI 10.1016/j.jamcollsurg.2013.02.005; Takaori K, 2005, AM J SURG, V189, P178, DOI 10.1016/j.amjsurg.2004.09.008; Takiguchi S, 2003, SURG TODAY, V33, P371; Toh Y, 2009, SURG TODAY, V39, P201, DOI 10.1007/s00595-008-3827-2; Yoshimatsu K, 2007, HEPATO-GASTROENTEROL, V54, P1988	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	DEC	2014	219	6					E69	E73		10.1016/j.jamcollsurg.2014.09.001		5	Surgery	Surgery	AU2ET	WOS:000345429900001		
J	Machino-Ohtsuka, T; Tajiri, K; Kimura, T; Sakai, S; Sato, A; Yoshida, T; Hiroe, M; Yasutomi, Y; Aonuma, K; Imanaka-Yoshida, K				Machino-Ohtsuka, Tomoko; Tajiri, Kazuko; Kimura, Taizo; Sakai, Satoshi; Sato, Akira; Yoshida, Toshimichi; Hiroe, Michiaki; Yasutomi, Yasuhiro; Aonuma, Kazutaka; Imanaka-Yoshida, Kyoko			Tenascin-C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation	JOURNAL OF THE AMERICAN HEART ASSOCIATION			English	Article						dendritic cell; myocarditis; tenascin-C; Th17; TLR4	ARTHRITIC JOINT DISEASE; REGULATORY T-CELLS; DILATED CARDIOMYOPATHY; EXTRACELLULAR-MATRIX; ADAPTIVE IMMUNITY; HEART-FAILURE; UP-REGULATION; INFLAMMATION; RECEPTOR; EXPRESSION	Background-Tenascin-C (TN-C), an extracellular matrix glycoprotein, appears at several important steps of cardiac development in the embryo, but is sparse in the normal adult heart. TN-C re-expresses under pathological conditions including myocarditis, and is closely associated with tissue injury and inflammation in both experimental and clinical settings. However, the pathophysiological role of TN-C in the development of myocarditis is not clear. We examined how TN-C affects the initiation of experimental autoimmune myocarditis, immunologically. Methods and Results-A model of experimental autoimmune myocarditis was established in BALB/c mice by immunization with murine alpha-myosin heavy chains. We found that TN-C knockout mice were protected from severe myocarditis compared to wild-type mice. TN-C induced synthesis of proinflammatory cytokines, including interleukin (IL)-6, in dendritic cells via activation of a Toll-like receptor 4, which led to T-helper (Th) 17 cell differentiation and exacerbated the myocardial inflammation. In the transfer experiment, dendritic cells loaded with cardiac myosin peptide acquired the functional capacity to induce myocarditis when stimulated with TN-C; however, TN-C-stimulated dendritic cells generated from Toll-like receptor 4 knockout mice did not induce myocarditis in recipients. Conclusions-Our results demonstrated that TN-C aggravates autoimmune myocarditis by driving the dendritic cell activation and Th17 differentiation via Toll-like receptor 4. The blockade of Toll-like receptor 4-mediated signaling to inhibit the proinflammatory effects of TN-C could be a promising therapeutic strategy against autoimmune myocarditis.	[Machino-Ohtsuka, Tomoko; Tajiri, Kazuko; Kimura, Taizo; Sakai, Satoshi; Sato, Akira; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Div Cardiovasc, Tsukuba, Ibaraki 3058575, Japan; [Yoshida, Toshimichi; Imanaka-Yoshida, Kyoko] Mie Univ, Grad Sch Med, Res Ctr Matrix Biol, Tsu, Mie 514, Japan; [Yoshida, Toshimichi; Imanaka-Yoshida, Kyoko] Mie Univ, Grad Sch Med, Dept Pathol & Matrix Biol, Tsu, Mie 514, Japan; [Hiroe, Michiaki] Natl Ctr Global Hlth & Med, Dept Cardiol, Tokyo, Japan; [Yasutomi, Yasuhiro] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Lab Immunoregulat & Vaccine Res, Tsukuba, Ibaraki, Japan	Aonuma, K (reprint author), Univ Tsukuba, Fac Med, Div Cardiovasc, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kaonuma@md.tsukuba.ac.jp	Yoshida, Toshimichi/H-6204-2013	Yoshida, Toshimichi/0000-0001-8935-8217	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [25860581]; Okasan-Kato Foundation	This work was supported by Health Science Research grants from the Ministry of Health, Labor and Welfare of Japan and the Ministry of Education, Culture, Sports, Science and Technology of Japan to Tajiri (No. 25860581), and a research grant for intractable diseases from the Ministry of Health, Labor and Welfare of Japan and The Okasan-Kato Foundation to Imanaka-Yoshida.	Goh FG, 2010, J IMMUNOL, V184, P2655, DOI 10.4049/jimmunol.0903359; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Eriksson U, 2001, J IMMUNOL, V167, P5464; Kawai T, 2001, J IMMUNOL, V167, P5887; Leib C, 2011, CIRC RES, V109, P130, DOI 10.1161/CIRCRESAHA.111.245563; Sato A, 2006, J AM COLL CARDIOL, V47, P2319, DOI 10.1016/j.jacc.2006.03.033; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Goser S, 2005, CIRCULATION, V112, P3400, DOI 10.1161/CIRCULATIONHA.105.572396; Cihakova D, 2008, ADV IMMUNOL, V99, P95, DOI 10.1016/S0065-2776(08)00604-4; Fairweather D, 2001, J AUTOIMMUN, V16, P175, DOI 10.1006/jaut.2000.0492; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Ruppert V, 2008, CARDIOVASC PATHOL, V17, P81, DOI 10.1016/j.carpath.2007.07.004; Yamashita T, 2011, CARDIOVASC RES, V91, P640, DOI 10.1093/cvr/cvr148; Eriksson U, 2003, J EXP MED, V197, P323, DOI 10.1084/jem.20021788; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Levroney EL, 2005, J IMMUNOL, V175, P413; Waldner H, 2009, AUTOIMMUN REV, V8, P400, DOI 10.1016/j.autrev.2008.12.019; Nishioka T, 2010, AM J PHYSIOL-HEART C, V298, pH1072, DOI 10.1152/ajpheart.00255.2009; Fujita S, 2013, HEART VESSELS, V28, P646, DOI 10.1007/s00380-012-0311-0; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Ritzman AM, 2010, INFECT IMMUN, V78, P4593, DOI 10.1128/IAI.00798-10; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Kaisho T, 2001, J IMMUNOL, V166, P5688; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; Imanaka-Yoshida K, 2002, J PATHOL, V197, P388, DOI 10.1002/path.1131; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Twerenbold R, 2012, EUR HEART J, V33, P579, DOI 10.1093/eurheartj/ehr492; Ruhmann M, 2012, ARTHRITIS RHEUM-US, V64, P2179, DOI 10.1002/art.34401; Imanaka-Yoshida K, 2001, LAB INVEST, V81, P1015; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Chiquet-Ehrismann R, 2014, MATRIX BIOL, V37, P112, DOI 10.1016/j.matbio.2014.01.007; El-Karef A, 2007, J PATHOL, V211, P86, DOI 10.1002/path.2099; Eriksson U, 2005, INT J BIOCHEM CELL B, V37, P27, DOI 10.1016/j.biocel.2004.06.014; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Fujimoto Naoki, 2009, J Card Fail, V15, P898, DOI 10.1016/j.cardfail.2009.06.443; Fulcher JA, 2009, J BIOL CHEM, V284, P26860, DOI 10.1074/jbc.M109.037507; Fulcher JA, 2006, J IMMUNOL, V177, P216; Kalembeyi I, 1997, INT J DEV BIOL, V41, P569; Kanayama M, 2009, J IMMUNOL, V182, P8015, DOI 10.4049/jimmunol.0900725; Kanayama M, 2011, J IMMUNOL, V187, P5851, DOI 10.4049/jimmunol.1101524; Kishimoto C, 2001, J VIROL, V75, P1294, DOI 10.1128/JVI.75.3.1294-1300.2001; Leipner C, 2008, CARDIOVASC RES, V79, P118, DOI 10.1093/cvr/cvn063; Li S, 2013, J CLIN CELL IMMUNOL, V4; Liu Y, 2014, CLIN REV ALLERG IMMU, V47, P136, DOI 10.1007/s12016-013-8402-y; Morimoto S, 2005, J PATHOL, V205, P460, DOI 10.1002/path.1730; Nakahara H, 2006, EUR J IMMUNOL, V36, P3334, DOI 10.1002/eji.200636271; Nishioka T, 2007, J CARDIOVASC PHARM, V49, P261, DOI 10.1097/FJC.0b013e318033dfd4; Pinet Eric, 2009, Journal of Sensors, DOI 10.1155/2009/720980; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sato M, 2002, CIRCULATION, V106, P1397, DOI 10.1161/01.CIR.0000027823.07104.86; Schulz G, 2008, J INVEST DERMATOL, V128, P2541, DOI 10.1038/jid.2008.112; Tajiri K, 2012, J IMMUNOL, V189, P2043, DOI 10.4049/jimmunol.1103610; Tsukada B, 2009, HUM PATHOL, V40, P1015, DOI 10.1016/j.humpath.2008.12.017; Valaperti A, 2008, J IMMUNOL, V180, P2686; Yue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018186; Zimmermann O, 2005, INT J CARDIOL, V104, P92, DOI 10.1016/j.ijcard.2005.02.052	65	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-9980			J AM HEART ASSOC	J. Am. Heart Assoc.	DEC	2014	3	6							e001052	10.1161/JAHA.114.001052		15	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT6RY	WOS:000345067600012		
J	Tanaka, A; Yuasa, S; Mearini, G; Egashira, T; Seki, T; Kodaira, M; Kusumoto, D; Kuroda, Y; Okata, S; Suzuki, T; Inohara, T; Arimura, T; Makino, S; Kimura, K; Kimura, A; Furukawa, T; Carrier, L; Node, K; Fukuda, K				Tanaka, Atsushi; Yuasa, Shinsuke; Mearini, Giulia; Egashira, Toru; Seki, Tomohisa; Kodaira, Masaki; Kusumoto, Dai; Kuroda, Yusuke; Okata, Shinichiro; Suzuki, Tomoyuki; Inohara, Taku; Arimura, Takuro; Makino, Shinji; Kimura, Kensuke; Kimura, Akinori; Furukawa, Tetsushi; Carrier, Lucie; Node, Koichi; Fukuda, Keiichi			Endothelin-1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy-Induced Pluripotent Stem Cell-Derived Cardiomyocytes	JOURNAL OF THE AMERICAN HEART ASSOCIATION			English	Article						disease modeling; ET-1; HCM; iPS cells; MYBPC3	ACTIVATED T-CELLS; CARDIAC-HYPERTROPHY; HYPERTENSIVE-RATS; RECEPTOR; CALCINEURIN; MUTATIONS; DISEASE; MYBPC3; SYSTEM; HEART	Background-Despite the accumulating genetic and molecular investigations into hypertrophic cardiomyopathy (HCM), it remains unclear how this condition develops and worsens pathologically and clinically in terms of the genetic-environmental interactions. Establishing a human disease model for HCM would help to elucidate these disease mechanisms; however, cardiomyocytes from patients are not easily obtained for basic research. Patient-specific induced pluripotent stem cells (iPSCs) potentially hold much promise for deciphering the pathogenesis of HCM. The purpose of this study is to elucidate the interactions between genetic backgrounds and environmental factors involved in the disease progression of HCM. Methods and Results-We generated iPSCs from 3 patients with HCM and 3 healthy control subjects, and cardiomyocytes were differentiated. The HCM pathological phenotypes were characterized based on morphological properties and high-speed video imaging. The differences between control and HCM iPSC-derived cardiomyocytes were mild under baseline conditions in pathological features. To identify candidate disease-promoting environmental factors, the cardiomyocytes were stimulated by several cardiomyocyte hypertrophy-promoting factors. Interestingly, endothelin-1 strongly induced pathological phenotypes such as cardiomyocyte hypertrophy and intracellular myofibrillar disarray in the HCM iPSC-derived cardiomyocytes. We then reproduced these phenotypes in neonatal cardi omyocytes from the heterozygous Mybpc3-targeted knock in mice. High-speed video imaging with motion vector prediction depicted physiological contractile dynamics in the iPSC-derived cardiomyocytes, which revealed that self-beating HCM iPSC-derived single cardiomyocytes stimulated by endothelin-1 showed variable contractile directions. Conclusions-Interactions between the patient's genetic backgrounds and the environmental factor endothelin-1 promote the HCM pathological phenotype and contractile variability in the HCM iPSC-derived cardiomyocytes.	[Tanaka, Atsushi; Yuasa, Shinsuke; Egashira, Toru; Seki, Tomohisa; Kusumoto, Dai; Kuroda, Yusuke; Okata, Shinichiro; Suzuki, Tomoyuki; Inohara, Taku; Makino, Shinji; Kimura, Kensuke; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Tanaka, Atsushi; Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 840, Japan; [Okata, Shinichiro; Furukawa, Tetsushi] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Tokyo, Japan; [Arimura, Takuro; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo, Japan; [Mearini, Giulia; Carrier, Lucie] Univ Med Ctr Hamburg Eppendorf, Cardiovasc Res Ctr, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Mearini, Giulia; Carrier, Lucie] DZHK German Ctr Cardiovasc Res, Kiel, Germany	Yuasa, S (reprint author), Keio Univ, Sch Med, Dept Cardiol, 35 Shinanomachi Shinjuku Ku, Tokyo 1608582, Japan.	yuasa@a8.keio.jp			Ministry of Education, Culture, Sports, Science and Technology; Health Labour Sciences Research Grant; New Energy and Industrial Technology Development Organization, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation; Japan Science and Technology Agency; Research Center Network for Realization of Regenerative Medicine "The Program for Intractable Diseases Research utilizing Disease-specific iPS cells"; Nakatomi Foundation; Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology SENSHIN Medical Research Foundation; Kimura Memorial Heart Foundation Research Grant; Japan Intractable Diseases Research Foundation, Japan; Cell Science Research Foundation; Tokyo Biochemical Research Foundation; Suzuken Memorial Foundation; Japan Foundation for Applied Enzymology; Joint Usage/Research Program of Medical Research Institute; Tokyo Medical and Dental University; DZHK (German Center for Cardiovascular Research); German Ministry of Research and Education (BMBF); Association Institut de Myologie (Paris)	This study was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology, Health Labour Sciences Research Grant, the New Energy and Industrial Technology Development Organization, Japan, the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan Science and Technology Agency, Research Center Network for Realization of Regenerative Medicine "The Program for Intractable Diseases Research utilizing Disease-specific iPS cells," The Nakatomi Foundation, Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology SENSHIN Medical Research Foundation, Kimura Memorial Heart Foundation Research Grant, Japan Intractable Diseases Research Foundation, Japan, The Cell Science Research Foundation, The Tokyo Biochemical Research Foundation, Suzuken Memorial Foundation, The Japan Foundation for Applied Enzymology, Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University, the DZHK (German Center for Cardiovascular Research), the German Ministry of Research and Education (BMBF), and the Association Institut de Myologie (Paris).	Marian AJ, 2000, LANCET, V355, P58, DOI 10.1016/S0140-6736(99)06187-5; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; ITO H, 1994, CIRCULATION, V89, P2198; ITO H, 1991, CIRC RES, V69, P209; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Ashrafian H, 2011, CIRC RES, V109, P86, DOI 10.1161/CIRCRESAHA.111.242974; Khan JM, 2013, BRIT J PHARMACOL, V169, P304, DOI 10.1111/j.1476-5381.2012.02118.x; Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; Poirier O, 2003, EUR J HUM GENET, V11, P659, DOI 10.1038/sj.ejhg.5201023; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Jandeleit-Dahm KAM, 2012, CURR OPIN NEPHROL HY, V21, P66, DOI 10.1097/MNH.0b013e32834dde48; Behrens-Gawlik V, 2014, PFLUG ARCH EUR J PHY, V466, P215, DOI 10.1007/s00424-013-1409-7; Egashira T, 2012, CARDIOVASC RES, V95, P419, DOI 10.1093/cvr/cvs206; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Nagueh SF, 2004, J MOL CELL CARDIOL, V36, P663, DOI 10.1016/j.yjmcc.2004.02.010; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Fraysse B, 2012, J MOL CELL CARDIOL, V52, P1299, DOI 10.1016/j.yjmcc.2012.03.009; Hasegawa K, 1996, HYPERTENSION, V27, P259; Seki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085645; Vignier N, 2009, CIRC RES, V105, P239, DOI 10.1161/CIRCRESAHA.109.201251; MARON BJ, 1981, AM J CARDIOL, V48, P418, DOI 10.1016/0002-9149(81)90068-0; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; McConnell BK, 2001, CIRC RES, V88, P383; Ehmke H, 1999, HYPERTENSION, V33, P954; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Coats CJ, 2008, HEART, V94, P1258, DOI 10.1136/hrt.2008.153452; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; Hayakawa T, 2012, TISSUE ENG PART C-ME, V18, P21, DOI [10.1089/ten.TEC.2011.0273, 10.1089/ten.tec.2011.0273]; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Kang M, 2007, PHYSIOLOGY, V22, P174, DOI 10.1152/physio.00051.2006; Kim SJ, 1999, AM J PHYSIOL-HEART C, V276, pH1780; Kirschner SE, 2005, AM J PHYSIOL-HEART C, V288, pH1242, DOI 10.1152/ajpheart.00686.2004; Marian AJ, 2009, J CARDIOVASC TRANSL, V2, P483, DOI 10.1007/s12265-009-9132-7; Members WC, 2011, CIRCULATION, V124, P2761; Molkentin JD, 2013, CIRC RES, V113, P16, DOI 10.1161/CIRCRESAHA.113.301667; Ohnuki M, 2009, CURR PROTOC STEM CEL, V9; Ostman-Smith I, 2000, LANCET, V355, P928, DOI 10.1016/S0140-6736(05)74130-1; PEARCE PC, 1985, BRIT HEART J, V54, P420; Seki T, 2011, CURR PROTOC STEM CEL, V18; TASHIRO A, 1990, VIRCHOWS ARCH A, V416, P473, DOI 10.1007/BF01600297; THIBAULT G, 1995, J MOL CELL CARDIOL, V27, P2327, DOI 10.1016/S0022-2828(95)91911-2; Wilkins BJ, 2002, J PHYSIOL-LONDON, V541, P1, DOI 10.1113/jphysiol.2002.017129; Yang QL, 1998, J CLIN INVEST, V102, P1292, DOI 10.1172/JCI3880	47	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-9980			J AM HEART ASSOC	J. Am. Heart Assoc.	DEC	2014	3	6							e001263	10.1161/JAHA.114.001263		25	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT6RY	WOS:000345067600023		
J	Ueda, T; Kawakami, R; Sugawara, Y; Okada, S; Nishida, T; Onoue, K; Soeda, T; Okayama, S; Takeda, Y; Watanabe, M; Kawata, H; Uemura, S; Saito, Y				Ueda, Tomoya; Kawakami, Rika; Sugawara, Yu; Okada, Sadanori; Nishida, Taku; Onoue, Kenji; Soeda, Tsunenari; Okayama, Satoshi; Takeda, Yukiji; Watanabe, Makoto; Kawata, Hiroyuki; Uemura, Shiro; Saito, Yoshihiko			Worsening of Renal Function During 1 Year After Hospital Discharge Is a Strong and Independent Predictor of All-Cause Mortality in Acute Decompensated Heart Failure	JOURNAL OF THE AMERICAN HEART ASSOCIATION			English	Article						acute decompensated heart failure; prognosis; worsening of renal function after discharge	PROGNOSTIC IMPLICATIONS; CARDIORENAL SYNDROME; CONGESTION; SURVIVAL; OUTCOMES; IMPACT	Background-Renal impairment is a common comorbidity and the strongest risk factor for poor prognosis in acute decompensated heart failure (ADHF). In clinical practice, renal function is labile during episodes of ADHF, and often worsens after discharge. The significance of worsening of renal function (WRF) after discharge has not been investigated as extensively as baseline renal function at admission or WRF during hospitalization. Methods and Results-Among 611 consecutive patients with ADHF emergently admitted to our hospital, 233 patients with 3 measurements of serum creatinine (SCr) level measurements (on admission, at discharge, and 1 year after discharge) were included in the present study. Patients were divided into 2 groups according to the presence or absence of WRF at 1 year after discharge (1y-WRF), defined as an absolute increase in SCr >0.3 mg/dL (>26.5 mu mol/L) plus a >= 25% increase in SCr at 1 year after discharge compared to the SCr value at discharge. All-cause and cardiovascular mortality were assessed as adverse outcomes. During a mean follow-up of 35.4 months, 1y-WRF occurred in 48 of 233 patients. There were 66 deaths from all causes. All-cause and cardiovascular mortality were significantly higher in patients with 1y-WRF (log-rank P<0.0001 and P<0.0001, respectively) according to Kaplan-Meier analysis. In a multivariate Cox proportional hazards model, 1y-WRF was a strong and independent predictor of all-cause and cardiovascular mortality. Hemoglobin and B-type natriuretic peptide at discharge, as well as left ventricular ejection fraction <50%, were independent predictors of 1y-WRF. Conclusions-In patients with ADHF, 1y-WRF is a strong predictor of all-cause and cardiovascular mortality.	[Ueda, Tomoya; Kawakami, Rika; Sugawara, Yu; Okada, Sadanori; Nishida, Taku; Soeda, Tsunenari; Okayama, Satoshi; Takeda, Yukiji; Watanabe, Makoto; Kawata, Hiroyuki; Uemura, Shiro; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med, Kashihara, Nara 6348522, Japan; [Onoue, Kenji; Saito, Yoshihiko] Nara Med Univ, Dept Regulatory Med Blood Pressure, Kashihara, Nara 6348522, Japan	Kawakami, R (reprint author), Nara Med Univ, Dept Internal Med, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	rkawa@naramed-u.ac.jp			Japan Heart Foundation; Naito Foundation	Yoshihiko Saito has the following conflicts of interest to disclose: Honoraria: MSD Co, Ltd; Mitsubishi Tanabe Pharma Corporation; Takeda Pharmaceutical Co; Daiichi Sankyo Company Ltd; Otsuka Pharmaceutical Co, Ltd; Pfizer Japan Inc. Research funding: Japan Heart Foundation, The Naito Foundation. Subsidies or donations: MSD Co, Ltd; Mitsubishi Tanabe Pharma Corporation; Daiichi Sankyo Company Ltd; Takeda Pharmaceutical Co, Ltd; Novartis Pharma K.K.; Shionogi & Co, Ltd; Astellas Pharma Inc; AstraZeneca K.K., Ltd; Otsuka Pharmaceutical Co, Ltd; St. Jude Medical Japan Co, Ltd; Kyowa Hakko Kirin Co Ltd. Endowed departments by commercial entities: MSD Co, Ltd. The other authors have no financial conflicts of interest to disclose. ORIGINAL RESEARCH	McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Damman K, 2009, EUR J HEART FAIL, V11, P847, DOI 10.1093/eurjhf/hfp108; Hillege HL, 2006, CIRCULATION, V113, P671, DOI 10.1161/CIRCULATIONAHA.105.580506; Belziti CA, 2010, REV ESP CARDIOL, V63, P294, DOI 10.1016/S0300-8932(10)70088-9; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; Pang PS, 2010, EUR HEART J, V31, P784, DOI 10.1093/eurheartj/ehq040; Blair JEA, 2011, EUR HEART J, V32, P2563, DOI 10.1093/eurheartj/ehr238; Tang WHW, 2010, HEART, V96, P255, DOI 10.1136/hrt.2009.166256; Voors AA, 2011, EUR J HEART FAIL, V13, P961, DOI 10.1093/eurjhf/hfr060; Damman K, 2011, PROG CARDIOVASC DIS, V54, P144, DOI 10.1016/j.pcad.2011.01.003; Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011; Rossignol P, 2012, CIRCULATION, V125, P271, DOI 10.1161/CIRCULATIONAHA.111.028282; Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386; Krumholz HM, 2000, AM J CARDIOL, V85, P1110, DOI 10.1016/S0002-9149(00)00705-0; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Metra M, 2012, CIRC-HEART FAIL, V5, P54, DOI 10.1161/CIRCHEARTFAILURE.111.963413; Díez Javier, 2009, Expert Rev Cardiovasc Ther, V7, P897, DOI 10.1586/erc.09.74; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6; KRUCK F, 1978, EUR J CLIN PHARMACOL, V14, P153, DOI 10.1007/BF02089953	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2047-9980			J AM HEART ASSOC	J. Am. Heart Assoc.	DEC	2014	3	6							e001174	10.1161/JAHA.114.001174		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AT6RY	WOS:000345067600024		
J	Hussein, H; Ishihara, A; Menendez, M; Bertone, A				Hussein, H.; Ishihara, A.; Menendez, M.; Bertone, A.			Pharmacokinetics and bone resorption evaluation of a novel Cathepsin K inhibitor (VEL-0230) in healthy adult horses	JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS			English	Article							ALENDRONATE TREATMENT; BIOCHEMICAL MARKERS; EQUINE OSTEOCLASTS; IN-VITRO; TILUDRONATE; TURNOVER; OSTEOPOROSIS; BISPHOSPHONATES; EFFICACY; DISEASE	Plasma pharmacokinetic (PK) and bone resorption biomarker [carboxy-terminal cross-linking telopeptide of type I collagen (CTX-1)] analyses were performed following single and multiple oral dose protocols of a Cathepsin K inhibitor (VEL-0230) in horses. Outcomes included plasma and urine drug and CTX-1 concentrations. In the dose range study, 2, 4, and 8mg/kg body weight (b.w.) doses were administered in a Latin square design to three mares and evaluated for 1week. Based on the PK characteristics of VEL-0230, 4mg/kg b.w. was selected for the dose interval study in which 3.25days (d) and 7days dose intervals were evaluated over three administrations using four exercising horses in a Latin square design. The 3.25days and 7days dose intervals provided a rapid inhibition of bone resorption based on plasma CTX-1. CTX-1 inhibition prior to next dose administration was not different from baseline in the 3.25days and 7days protocols, and for the first 3days but the sustained CTX-1 inhibition in the 7days protocol along with the cost and logistic benefits for weekly administration made the 7days protocol preferable. Weekly administration of VEL-0230 may provide effective inhibition of bone resorption in young exercising horses that returns to baseline within 7days after drug withdrawal even after multiple doses.	[Hussein, H.; Menendez, M.; Bertone, A.] Ohio State Univ, Dept Vet Clin Sci, Coll Vet Med, Columbus, OH 43210 USA; [Ishihara, A.] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan	Hussein, H (reprint author), Ohio State Univ, Dept Vet Clin Sci, Comparat Orthoped Res Lab, 601 Tharp St, Columbus, OH 43210 USA.	Hussein.57@osu.edu			FreeStride Therapeutics, Inc. USA; Thoroughbred Charities of America	The present study was partially funded by FreeStride Therapeutics, Inc. USA. We thank Thoroughbred Charities of America for funding pilot data collection.	Denoix JM, 2003, EQUINE VET J, V35, P407, DOI 10.2746/042516403776014226; Kim MK, 2006, J PHARMACOL EXP THER, V318, P555, DOI 10.1124/jpet.106.102798; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Cremers S, 2006, DRUGS, V66, P2031, DOI 10.2165/00003495-200666160-00001; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; LUDDEN TM, 1991, CLIN PHARMACOKINET, V20, P429, DOI 10.2165/00003088-199120060-00001; Delguste C, 2007, BONE, V41, P414, DOI 10.1016/j.bone.2007.05.005; Leung P, 2011, BONE, V49, P623, DOI 10.1016/j.bone.2011.06.014; Filipovic N, 2010, RES VET SCI, V88, P405, DOI 10.1016/j.rvsc.2009.11.008; Coudry V, 2007, AM J VET RES, V68, P329, DOI 10.2460/ajvr.68.3.329; Barrett J, 2004, J CLIN PHARMACOL, V44, P951, DOI 10.1177/0091270004267594; Billinghurst RC, 2003, OSTEOARTHR CARTILAGE, V11, P760, DOI 10.1016/S1063-4584(03)00152-3; Carstanjen B, 2004, AM J VET RES, V65, P104, DOI 10.2460/ajvr.2004.65.104; Delguste C, 2008, J VET PHARMACOL THER, V31, P108, DOI 10.1111/j.1365-2885.2007.00936.x; GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693; Garnero P, 1999, BONE, V24, P603, DOI 10.1016/S8756-3282(99)00087-3; Gray AW, 2002, RES VET SCI, V72, P105, DOI 10.1053/rvsc.2001.0523; Gray AW, 2002, RES VET SCI, V72, P95, DOI 10.1053/rvsc.2001.0522; Inui T, 1997, J BIOL CHEM, V272, P8109; Katzman SA, 2012, JAVMA-J AM VET MED A, V240, P1323, DOI 10.2460/javma.240.11.1323; Kellerhouse PL, 2000, J BONE MINER RES, V15, pS526; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Lasseter KC, 2005, CLIN DRUG INVEST, V25, P107, DOI 10.2165/00044011-200525020-00003; Nieto JE, 2013, AM J VET RES, V74, P550, DOI 10.2460/ajvr.74.4.550; Pollina GF, 2012, J VET PHARMACOL THER, V35, P489, DOI 10.1111/j.1365-2885.2011.01336.x; Vinardell T, 2009, OSTEOARTHR CARTILAGE, V17, P375, DOI 10.1016/j.joca.2008.07.017; Yun MH, 2006, ARCH PHARM RES, V29, P328, DOI 10.1007/BF02968579	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7783	1365-2885		J VET PHARMACOL THER	J. Vet. Pharmacol. Ther.	DEC	2014	37	6					556	564		10.1111/jvp.12131		9	Pharmacology & Pharmacy; Veterinary Sciences	Pharmacology & Pharmacy; Veterinary Sciences	AU0ES	WOS:000345297000005		
J	Uchiyama, J; Gillam, JC; Hosoya, LA; Lindstrom, K; Jordan, P				Uchiyama, Junzo; Gillam, J. Christopher; Hosoya, Leo Aoi; Lindstrom, Kati; Jordan, Peter			Investigating Neolithization of Cultural Landscapes in East Asia: The NEOMAP Project	JOURNAL OF WORLD PREHISTORY			English	Article						European Neolithic; Neolithization; Hunter-gatherers; Transition to farming; Cultural landscape research; East Asia		The Neolithic is regarded as one of the most important developments in prehistory, a major cultural threshold marked by combined shifts in economy, technology, ideology, settlement and social organisation. Many foundational ideas about the Neolithic emerged within the context of European archaeology, and substantial work has now been directed at understanding how this 'package' of innovations appeared first in the Near East, and then dispersed steadily out into the rest of northwest Europe. Papers presented in this special issue are an output of the international NEOMAP Project (Neolithization and Modernization: Landscape History on East Asian Inland Seas) (2005-2012), which sought to apply two key approaches drawn from European Neolithic studies to the archaeology of East Asia: (a) the concept of Neolithization, defined as a long-term and historically-contingent process of culture-change; and (b), the contextual study of this process via the framework of cultural landscape research. This exercise has been highly productive, and provides new insights into a series of unique cultural transformations in East Asia, most of which have a very different sequence and character to those in the European Neolithic. It is hoped that, in turn, these comparative insights into the Neolithization of East Asian cultural landscapes will encourage those working on the European Neolithic to look back over their own regional datasets and critically reflect on some of their deeper assumptions about the internal logic and cultural content of the European Neolithic transition. Given the existence of so many fundamentally different kinds of Neolithic across the broader continent of Eurasia, the overall goal of this special issue is to re-kindle international debates about how best to explain each of these distinctive regional Neolithization trajectories.	[Uchiyama, Junzo] Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan; [Gillam, J. Christopher] Univ S Carolina, Savannah River Archaeol Res Program, South Carolina Inst Archaeol & Anthropol, Columbia, SC 29208 USA; [Hosoya, Leo Aoi] Ochanomizu Univ, Ctr Global Human Resource Dev, Bunkyo Ku, Tokyo 1128610, Japan; [Lindstrom, Kati] KTH Royal Inst Technol, Div Hist Sci Technol & Environm, S-10044 Stockholm, Sweden; [Jordan, Peter] Univ Groningen, GIA, Arctic Ctr, NL-9718 CW Groningen, Netherlands	Jordan, P (reprint author), Univ Groningen, GIA, Arctic Ctr, Aweg 30, NL-9718 CW Groningen, Netherlands.	junzo@chikyu.ac.jp; gillamc@mailbox.sc.edu; hosoya.aoi@ocha.ac.jp; katli@kth.se; p.d.jordan@rug.nl					Ammerman A. J., 1984, NEOLITHIC TRANSITION; Craig OE, 2013, NATURE, V496, P351, DOI 10.1038/nature12109; Zvelebil M, 2008, MESOLITHIC EUROPE, P18; Barrett J. C., 1994, FRAGMENTS ANTIQUITY; Bender B., 1993, LANDSCAPE POLITICS P; Bender B., 2006, HDB MAT CULTURE, P303, DOI DOI 10.4135/9781848607972.N20; Bradley Richard, 1998, SIGNIFICANCE MONUMEN; Carmichael M. L., 1994, SACRED SITES SACRED; CHILDE V.G., 1957, DAWN EUROPEAN CIVILI; Cho Daeyoun, 2009, CERAMICS FARMING DIS, P149; David B., 2014, OXFORD HDB ARCHAEOLO, P1163; David D., 2008, HDB LANDSCAPE ARCHAE; Edmonds M. R., 1999, ANCESTRAL GEOGRAPHIE; Gibbs K., 2013, SIBIRICA, V12, P1, DOI DOI 10.3167/SIB.2013.120101; Habu J., 2014, OXFORD HDB ARCHAEOLO, P507; Habu J., 2004, ANCIENT JOMON JAPAN; HIGGS ES, 1969, ANTIQUITY, V43, P31; Hosoya L. A., 2008, STUDIES PADDY RICE C, P87; Hosoya L. A., 2009, YURASHIA NOKO SHI, P185; Hosoya L. A., 2002, THESIS U CAMBRIDGE; Hosoya L. A., 2010, B RES CTR TRADITIONA, V2, P125; Hosoya L. A., 2008, NEOLITHIC NEOLITHISA, P236; Hosoya L. A., 2009, INTERACTION HUNTER G, V73, P99; Hudson M. J., 2014, OXFORD HDB ARCHAEOLO, P507; Imamura K., 1996, PREHISTORIC JAPAN NE; Ingold T, 2000, PERCEPTION ENV ESSAY; Jordan P., 2011, LANDSCAPE CULTURE NO, P17; JORDAN P., 2009, CERAMICS FARMING DIS; Jordan P., 2014, OXFORD HDB ARCHAEOLO, P903; Kaner Simon, 2009, CERAMICS FARMING DIS, P93; Lubbock John, 1865, PREHISTORIC TIMES; Nakamura O., 2008, JOMON JIDAI KOHKOGAK, P145; Price T. D., 1985, PREHISTORIC HUNTER G; Seguchi S, 2014, J WORLD PREHIST, V27, P225, DOI 10.1007/s10963-014-9078-9; Taavitsainen J.-P., 2014, OXFORD HDB ARCHAEOLO, P1071; Thomas J, 1999, UNDERSTANDING NEOLIT; THOMAS J., 1988, P PREHIST SOC, V54, P59; Tilley C, 1994, PHENOMENOLOGY LANDSC; Tilley C., 1996, ETHNOGRAPHY NEOLITHI; Trigger BG, 2006, HISTORY OF ARCHAEOLOGICAL THOUGHT, 2ND EDITION, P1, DOI 10.2277/ 0521600499; Uchiyama J., 2009, NEOMAP INTERIM REPOR, P139; Uchiyama J, 2011, APPROACH CULT THEOR, V1, P136; Ucko P. J., 1999, ARCHAEOLOGY ANTHR LA; Underhill AP, 2006, BLACKW STUD GLOB ARC, P121, DOI 10.1002/9780470774670.ch7; Whittle A., 2007, GOING MESOLITHIC NEO, P617; Zvelebil M., 2006, J ANTHROPOL ARCHAEOL, V25, P178; Zvelebil M., 2000, ARCHAEOGENETICS DNA, P57; Zvelebil M., 2003, MESOLITHIC MOVE, P65; Zvelebil M., 1986, HUNTERS TRANSITION M; Zvelebil M., 2004, TRACES ANCESTRY STUD, P41; Zvelebil M., 2005, DOCUMENTA PRAEHISTOR, VXXXII, P87	51	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-7537	1573-7802		J WORLD PREHIST	J. World Prehist.	DEC	2014	27	3-4			SI		197	223		10.1007/s10963-014-9079-8		27	Anthropology; Archaeology	Anthropology; Archaeology	AU2BS	WOS:000345421700001		
J	Seguchi, S				Seguchi, Shinji			Landscape 'Neolithization' Among the Hunter-Fisher-Gatherers of Lake Biwa, Central Japan	JOURNAL OF WORLD PREHISTORY			English	Article						Sedentary life; Landscape type; Storage facility; Storage pit; Transportation device; Dugout canoe; Population growth		The concept of Neolithization has been used to examine a wide range of human relationships to the post-glacial environment, including the rise of farming and the invention of new adaptive technologies, like pottery. This paper focuses on understanding the establishment of sedentary life-ways by Jomon hunter-fisher-gatherers living around Lake Biwa, Central Japan, as a key aspect of Neolithization processes. Natural landscapes in this area presented different opportunities for human subsistence and settlement. Focusing on the characteristics and distribution of key aquatic and terrestrial resources, it is clear that two settlement strategies could have been sustained by local hunter-fisher-gatherer populations. The first involved targeting settlement in areas with complementary resources to avoid the risk of seasonal shortfalls; these areas are, however, limited geographically and would have filled up quickly. The second strategy involved a more elaborate approach to the logistics of mobility and food storage to secure the resources to sustain a settled life; this strategy opened up much larger areas for colonization. This analysis demonstrates that early populations initially favored the first strategy, but then shifted to the second, as population pressures generated major landscape shifts toward the end of the Middle Jomon period (4000 cal BP).	Shiga Prefectural Assoc Cultural Heritage, Shiga, Japan	Seguchi, S (reprint author), Shiga Prefectural Assoc Cultural Heritage, Shiga, Japan.	seguchineo@gmail.com					Amemiya M., 1993, J SOC KYUSYU PREHIST, V30, P987; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707; Childe G, 1952, NEW LIGHT MOST ANCIE; Habu J., 2000, ANCIENT CULTURE, V52, P18; Habu J., 2000, ANCIENT CULTURE, V52, P29; Habu J., 2004, ANCIENT JOMON JAPAN; Imamura K., 2002, JOMON YUTAKASA TO GE; Imamura K., 1996, PREHISTORIC JAPAN NE; JORDAN P., 2009, CERAMICS FARMING DIS; [Kansai Joumon Bunka Kenkyukai Study Group of Kansai Jomon Culture], 2001, KANS JOM JID SEIG KA; [Kansai Joumon Bunka Kenkyukai Study Group of Kansai Jomon Culture], 1999, JOM HOUS KANS DISTR; Kobayashi K., 2008, JOMON JIDAI KOKOGAKU, P257; Kobayashi T, 2004, JOMON REFLECTIONS FO; Kobayashi T., 1986, NIHON KOUKOGAKU, P37; Nakamura O., 2006, ASIAN PERSPECT, V45, P290; Nishida M., 1986, SEDENTARY REVOLUTION; Nishida M, 1980, ANTHR Q, V11, P3; Nishida M., 1984, ANTHR Q, V15, P3; Seguchi S., 2009, KYUSYU NI OKERU JOUM, P25; Seguchi S., 2009, JOMON SYURAKU KOUKOG; Shiga-ken Bunkazai Hogo Kyoukai (Shiga Prefectural Cultural Properties Association), 1998, ARCH EXC REP REL DEV; Shiga-ken Bunkazai Hogo Kyoukai (Shiga Prefectural Cultural Properties Association), 2007, EXC REP CONC CONSTR, V1; Shiga-ken Bunkazai Hogo Kyoukai (Shiga Prefectural Cultural Properties Association), 1997, ARCH EXC REP REL DEV; Testart A., 1982, CHASSEURS CUEILLEURS; Tomoda T., 1978, SERIES NIHON YASEI D; Uchiyama J., 2009, NEOLITHISATION LANDS; Uchiyama J., 2007, JOMON DOUBUTSU KOUKO; Woodburn J., 1988, HUNTERS GATHERERS, P31; Yamamoto N., 1995, STUDIES PREHISTORIC, V4, P25; Zvelebil M., 1989, BAD YEAR EC	31	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-7537	1573-7802		J WORLD PREHIST	J. World Prehist.	DEC	2014	27	3-4			SI		225	245		10.1007/s10963-014-9078-9		21	Anthropology; Archaeology	Anthropology; Archaeology	AU2BS	WOS:000345421700002		
J	Onishi, H				Onishi, Hideyuki			The Formation of the Ainu Cultural Landscape: Landscape Shift in a Hunter-Gatherer Society in the Northern Part of the Japanese Archipelago	JOURNAL OF WORLD PREHISTORY			English	Article						Ainu ecosystem; Historical revisionism; Medieval Far East; Subsistence strategy; Trade network	MEDIEVAL WARM PERIOD	Ainu history includes a dramatic socio-cultural transition, reflected in landscape formation, between the Epi-Jomon (third century BC-seventh century AD) and the Satsumon period (seventh-thirteenth centuries AD). This article examines the nature of this landscape shift, revealing, between the Epi-Jomon and the Satsumon, a variety of profound changes in the ways in which land and bio-resources were used for subsistence activities, even though natural and physical environmental cycles underwent no fundamental transformation during this time. These results lead us to conclude that the Ainu landscape-as the product of a system of ecological and socio-cultural adaptation, described in the historical and ethnographic eras-was established in the Satsumon period. This landscape shift is illustrated by a case study of a hunter-gatherer society directly influenced by the market economy and political systems of outside societies and nations during East Asia's medieval stage, before completing its spontaneous process of 'Neolithizaiton'.	Doshisha Womens Coll Liberal Arts, Kyotanabe, Kyoto, Japan	Onishi, H (reprint author), Doshisha Womens Coll Liberal Arts, Kyotanabe, Kyoto, Japan.	honishi@dwc.doshisha.ac.jp					Amano T., 1991, NIHON KODAI NO TETSU, P66; HEADLAND TN, 1989, CURR ANTHROPOL, V30, P43, DOI 10.1086/203710; GROVE JM, 1994, CLIMATIC CHANGE, V26, P143, DOI 10.1007/BF01092411; WILMSEN EN, 1990, CURR ANTHROPOL, V31, P489, DOI 10.1086/203890; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; Asahikawa city, 1996, SHIN AS SHISH, V6; Asahikawashi City, 1990, MED MIR AS NO AYUM; Deriha K., 2009, HUMAN NATURE RELATIO, P101; Deriha K., 1994, ARCTIC STUDIES CTR N, V3, P14; Fujimoto T., 1982, SATSUMON BUNKA; Fujimoto T., 1979, HOKUHEN NO ISEKI; Fukazawa Y., 1998, BRIT ARCHAEOLOGICAL; Harada K., 1994, SHIN ASAHIKAWA SHISH, V1, P753; Hayashi Y., 1969, AINU NO NOKO BUNKA; Hirai Y., 2002, KITA NO IKAI, P34; Hoffman C., 1984, PAST PRESENT HUNTER, P123; Imamura K., 1996, PREHISTORIC JAPAN NE; Kikuchi I., 2003, EZOSHIMA TO HOPPO SE; Kikuchi I., 1994, AINU MINZOKU TO NIHO; Kinase T., 1997, MINZOKUGAKU EKNKYU, V62, P1; Kinase T., 1998, MINZOKUGAKU KENKYU, V63, P182; Kojima K., 2003, AINU MINZOKU SHI NO; Minoshima H., 2001, KODAI KOKKA TO HOPPO; Murakami H., 1959, ASAHIKAWA SHISHI, V1, P156; Onishi H., 2008, HIGASHI ASIA NAIKAI, P237; Onishi H., 2009, TOBINITAI BUNKA KARA; PETERSON JT, 1978, AM ANTHROPOL, V80, P335, DOI 10.1525/aa.1978.80.2.02a00050; Peterson N., 1991, CASH COMMODITISATION; Sasaki S., 2009, HUMAN NATURE RELATIO; Segawa T., 2005, AINU ECOSYSTEM NO KO; Seki H., 2002, SHIN ASAHIKAWA SHISH, V2, P877; Suzuki M., 2003, HOKKAIDO KOKOGAKU, V39, P29; Takakura S., 1960, T AM PHILOS SOC, V50, P1; Takakura S., 1966, AINU KENKYU; Takakura S., 1972, SHINBAN AINU SEISAKU; Tezuka K, 1998, ARCTIC ANTHROPOL, V35, P350; Tezuka K., 2009, HUMAN NATURE RELATIO, P117; Tezuka K., 2011, AINU NO MINZOKU KOKO; Watanabe H., 1972, THE AINU ECOSYSTEM; Wilmsen E. N, 1989, LAND FILLED FLIES; Yamada G., 2000, HOKKAIDO KOKOGAKU, V36, P15; Yamada T., 2003, JAPANESE REV CULTURA, V4, P75; Yamaura K., 1999, AINU SPIRIT NO PEOPL	43	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-7537	1573-7802		J WORLD PREHIST	J. World Prehist.	DEC	2014	27	3-4			SI		277	293		10.1007/s10963-014-9080-2		17	Anthropology; Archaeology	Anthropology; Archaeology	AU2BS	WOS:000345421700005		
J	Makibayashi, K				Makibayashi, Keisuke			The Transformation of Farming Cultural Landscapes in the Neolithic Yangtze Area, China	JOURNAL OF WORLD PREHISTORY			English	Article						Yangtze area; Rice cultivation; Cultivation system; Consumption system; Landscape	REGION; RICE	This paper discusses aspects of landscape formation in the age of Neolithization, with examples of the farming-culture formation process in the Yangtze (e center dot center dot ae +/- Y) area of China. This research systematically links practical archaeological artefacts with farming culture to explore the development of the farming cultural landscape. In addition, differences between farming formation processes in the Lower Yangtze and Middle Yangtze areas are demonstrated from a landscape perspective, moving beyond the present culture-historical understanding of rice cultivation in the greater Yangtze area.	Ehime Univ, Res Ctr Ancient East Asian Iron Culture, Matsuyama, Ehime, Japan	Makibayashi, K (reprint author), Ehime Univ, Res Ctr Ancient East Asian Iron Culture, Matsuyama, Ehime, Japan.	makiba@ehime-u.ac.jp					Fuller DQ, 2010, ENVIRON ARCHAEOL, V15, P139, DOI 10.1179/146141010X12640787648531; Fuller DQ, 2008, ROUTLEDGE STUD EARLY, V5, P40; Fujiwara H., 1998, INASAKU NO KIGEN WO; Hosoya LA, 2011, ARCHAEOL ANTHROP SCI, V3, P7, DOI 10.1007/s12520-011-0059-y; Komoto M., 1992, B NATL MUSEUM JAPANE, V40, P1; Makibayashi K., 2006, KODAI BUNKA, V58, P85; Makibayashi K., 2005, CHUGOKU KOKOGAKU, V5, P149; Makibayashi K., 2004, KOKO RONSHU ESSAYS A, P987; Makibayashi K., 2008, HIGASHI AJIA NO BUNK, P31; Miyamoto K., 2000, CHUGOKU KODAI HOKUCH; Nakamura S., 1986, TOKYO DAIGAKU KOKOGA, V5, P125; Nakamura S., 2004, KANAZAWA DAIGAKU KOK, V27, P131; Nakamura S., 2009, YURASHI NOKOSHI, V1, P61; Nakamura S., 2008, SEKKO SHO YOYO DENRA; Nakamura S., 2002, INE NO KOKOGAKU; Sato Y., 2008, INE NO REKISHI; Sheng D., 2006, AGR ARCHAEOLOGY, V1, P30; The Institute of Archaeology of Hunan Province, 2000, WENWU, V4, P4; Wang J., 1987, AGR ARCHAEOLOGY, V1-2, P1; Watanabe Y., 1994, NIHON KOKOGAKU, V1, P207; Yan W., 1982, AGR ARCHAEOLOGY, V1-2, P1; Zhao H., 2011, TIANLUOSHAN YIZHI ZI; Zhejiang Province Institute of Cultural Relics and Archaeology, 2009, TIANL YIZH HEM WENH	23	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-7537	1573-7802		J WORLD PREHIST	J. World Prehist.	DEC	2014	27	3-4			SI		295	307		10.1007/s10963-014-9082-0		13	Anthropology; Archaeology	Anthropology; Archaeology	AU2BS	WOS:000345421700006		
J	Ito, S				Ito, Shinji			Why did People go up the Hill? Prehistoric Landscape Shifts and Neolithization of the Northern Ryukyu Archipelago, Japan	JOURNAL OF WORLD PREHISTORY			English	Article						Ryukyu-Jomon (Ryukyu-Shell-midden); Neolithization; Landscape shift		The remote Ryukyu archipelago, which runs from southern Japan southwest to Taiwan, is located in the subtropical zone, and consists of small coral and volcanic islands, with mainland Okinawa, the largest island, forming the main centre of settlement. Most of the islands are surrounded by coral reefs, beach sand dunes, and interior terraces lower than 700 m above mean sea level (amsl). Throughout human history, these geographical factors have conditioned the formation of cultural landscapes across the archipelago. Neolithic innovations and developments on these islands resulted in significant cultural landscape shifts, evidencing a unique Ryukyu trajectory of Neolithization that was quite different from those taking place elsewhere in the East Asian Inland Seas. In particular, major settlement and subsistence shifts on the islands mark the change from nomadic lifeways to increasing sedentism in the interior uplands between 4000 and 2500 BP, and a subsequent shift to lower coastal locations.	Seinan Gakuin Univ, Fukuoka, Japan	Ito, S (reprint author), Seinan Gakuin Univ, Fukuoka, Japan.	s-ito@seinan-gu.ac.jp					BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; SPIELMANN KA, 1994, ANNU REV ANTHROPOL, V23, P303; Zvelebil M, 2008, MESOLITHIC EUROPE, P18; Dunn F. L., 1975, RAIN FOREST COLLECTO; Habu J., 2002, FORAGING COLLECTING, P53; Hayden B., 1996, EMERGENT COMPLEXITY, P50; Imamura K., 2002, RICHNESS LIMIT JOMON; Ito S., 2003, B INDOPACIFIC PREHIS, V23, P63; Ito S., 2008, HDB JOMON POTTERY, P814; Ito S., 2010, ARCHAEOLOGY J, V597, P6; Ito S., 2000, BASIC STUDIES RYUKYU; Kelly R. L., 1995, FORAGING SPECTRUM DI; Kurozumi T., 2007, J OKINAWA ARCHAEOLOG, V26, P121; Morrrison K., 2002, FORAGER TRADERS S SE; Peterson J. T., 1978, EVOLUTION SOCIAL BOU; Sasaki S., 2002, HUNTER GATHERER SOC; Takamiya H., 2005, PREHISTORY OKINAWA I; Tsuji S., 2007, IREIBARU SITE, P433	18	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0892-7537	1573-7802		J WORLD PREHIST	J. World Prehist.	DEC	2014	27	3-4			SI		309	323		10.1007/s10963-014-9081-1		15	Anthropology; Archaeology	Anthropology; Archaeology	AU2BS	WOS:000345421700007		
J	Kimura, S; Nakamura, S; Vithana, SB; Sakai, K				Kimura, Sho; Nakamura, Shinya; Vithana, Shriwantha Buddhi; Sakai, Kazuhito			Shearing rate effect on residual strength of landslide soils in the slow rate range	LANDSLIDES			English	Article						Residual strength; Shearing rate; Ring-shear test; Slip surface soils	COHESIVE SOILS; TESTS; CLAYS; JAPAN	In the present study, we investigate the influence of shearing rate on the residual strength parameters, phi(r), in landslide soils using ring-shear tests at two shearing rates (0.01 and 0.5mm/min) under selected effective normal stresses. The landslide soil samples used for this study cover a wide range of soil types and properties. Relationships between the phi(r) and soil properties, such as liquid limit, plasticity index, and the clay fraction show that the phi(r) decreases with increasing soil LL, I-p and CF. The differences in the phi(r) at two shearing rates, phi(r (0.5))-phi(r (0.01)), under different effective normal stresses are either negative or positive values of which the maximum magnitude is generally about 1.0 degrees. The relationships between the phi(r (0.5))-phi(r (0.01)) and the soil properties (LL, I-p, and CF) are not exhibited in a regular pattern. On the other hand, the phi(r (0.5)) and phi(r (0.01)) determined at each effective normal stress suggest that the tendency for increased negative effect of the phi(r) with decreasing effective normal stress is more noticeable in the slow shearing rate range. The absolute value of phi(r (0.5))-phi(r (0.01)) at lower effective normal stress is found to be greater than 1.0 degrees, with the maximum of about 4.0 degrees. The negative shearing rate effect on phi(r) at low effective normal stress is affected by the undulating shear behavior due to poor or no slickenside development.	[Kimura, Sho; Nakamura, Shinya; Vithana, Shriwantha Buddhi; Sakai, Kazuhito] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 9010213, Japan	Nakamura, S (reprint author), Univ Ryukyus, Fac Agr, Senbaru 1, Nishihara, Okinawa 9010213, Japan.	s-naka@agr.u-ryukyu.ac.jp					[Anonymous], 2006, D6467 ASTM; Vithana SB, 2012, ENG GEOL, V131, P29, DOI 10.1016/j.enggeo.2012.01.015; HUNGR O, 1984, GEOTECHNIQUE, V34, P415; Vithana SB, 2012, LANDSLIDES, V9, P305, DOI 10.1007/s10346-011-0301-9; Gibo S, 2002, GEOTECHNIQUE, V52, P683, DOI 10.1680/geot.52.9.683.38837; KANJI MA, 1974, GEOTECHNIQUE, V24, P671; LUPINI JF, 1981, GEOTECHNIQUE, V31, P181; Bhat DR, 2013, ELECT J GEOTECHNICAL, V18, P1387; BISHOP AW, 1971, GEOTECHNIQUE, V21, P273; Egashira K., 2000, Clay Science, V11, P107; Gibo S, 2007, J JPN LANDSLIDE SOC, V40, P156; Gibo S, 2009, J JPN LANDSLIDE SOC, V46, P154; Gibo S, 1997, J JPN LANDSLIDE SOC, V34, P50; Gibo S., 1994, J JPN LANDSLIDE SOC, V31, P24; GIBO S, 1987, CAN GEOTECH J, V24, P456, DOI 10.1139/t87-057; Grelle G, 2010, GEOTECHNIQUE, V60, P91, DOI 10.1680/geot.8.P.019; Hawkins A.W., 1985, GROUND ENG, V18, P22; Holtz RD, 1981, INTRO GEOTECHNICAL E, P88; Japanese Geotechnical Society, 2000, EX IMP STRENGTH MOB, P441; Kimura S, 2009, P 19 2009 INT OFFSH, P156; La Gatta D.P., 1970, HARVARD SOIL MECH SE; LEHANE BM, 1992, GEOTECHNIQUE, V42, P363; Lemos L., 1985, P 11 INT C SOIL MECH, V4, P1955; Meehan CL, 2011, LANDSLIDES, V8, P449, DOI 10.1007/s10346-011-0263-y; Meehan CL, 2010, LANDSLIDES, V7, P157, DOI 10.1007/s10346-010-0199-7; Mesri G, 2003, J GEOTECH GEOENVIRON, V129, P12, DOI 10.1061/(ASCE)1090-0241(2003)129:1(12); Nakamura S, 2004, T JSIDRE, V229, P47; Nakamura S, 2011, P 50 C JPN LANDSL SO, P108; Nakamura S, 2010, GEOLOGY, V38, P743, DOI 10.1130/G30908.1; Nakamura S., 1999, J JPN LANDSLIDE SOC, V36, P28; Nakamura S, 2000, J JPN LANDSLIDE SOC, V37, P18; Nakamura S, 2011, J JPN LANDSLIDE SOC, V48, P9; Nakamura S, 2000, J JPN LANDSLIDE SOC, V37, P10; Nakamura S, 2001, THESIS KAGOSHIMA U K; SKEMPTON AW, 1985, GEOTECHNIQUE, V35, P3; Skempton AW, 1964, GEOTECHNIQUE, V14, P77, DOI DOI 10.1680/GE0T.1964.14.2.77; STARK TD, 1994, J GEOTECH ENG-ASCE, V120, P856, DOI 10.1061/(ASCE)0733-9410(1994)120:5(856); Stark TD, 1997, J GEOTECH GEOENVIRON, V123, P335, DOI 10.1061/(ASCE)1090-0241(1997)123:4(335); Stark TD, 2005, J GEOTECH GEOENVIRON, V131, P575, DOI 10.1061/(ASCE)1090-0241(2005)131:5(575); Sun B, 2004, J JPN SOC NAT DISAST, V23-1, P79; Suzuki M, 2000, J GEOTECHNICAL ENG, V645, P37; Tika TE, 1999, GEOTECH TEST J, V22, P342; Tika TE, 1999, GEOTECHNIQUE, V49, P59; Tika TE, 1996, GEOTECHNIQUE, V46, P197; Tiwari B, 2005, J GEOTECH GEOENVIRON, V131, P1139, DOI 10.1061/(ASCE)1090-0241(2005)131:9(1139); Toyota H, 2009, GEOTECHNIQUE, V59, P649, DOI 10.1680/geot.8.029.3671; Wang G, 2010, J JPN LANDSLIDE SOC, V47, P265; Wang GH, 2010, EARTH SURF PROC LAND, V35, P407, DOI 10.1002/esp.1937; Yamaguchi, 1980, JAP SOC LANDSL NAT C; Yatabe R, 1991, J GEOTECHNICAL ENG, V436, P93; Yokota K, 1997, J JAPANESE SOC CIVIL, V568, P125; Yokota K., 1995, J JAPAN SOC CIVIL EN, V529, P155; Zhou Y, 1997, T JSIDRE, V187, P23	53	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-510X	1612-5118		LANDSLIDES	Landslides	DEC	2014	11	6					969	979		10.1007/s10346-013-0457-6		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	AU0OY	WOS:000345324100003		
J	Motoyama, H; Kobayashi, A; Yokoyama, T; Shimizu, A; Furusawa, N; Sakai, H; Kitagawa, N; Ohkubo, Y; Tsukahara, T; Miyagawa, S				Motoyama, Hiroaki; Kobayashi, Akira; Yokoyama, Takahide; Shimizu, Akira; Furusawa, Norihiko; Sakai, Hiroshi; Kitagawa, Noriyuki; Ohkubo, Yohei; Tsukahara, Teruomi; Miyagawa, Shin-ichi			Liver failure after hepatocellular carcinoma surgery	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Hepatocellular carcinoma; International normalized ratio; Intraoperative packed red blood cell transfusion; Posthepatectomy liver failure; Serum bilirubin level	CIRRHOTIC-PATIENTS; MAJOR LIVER; HEPATIC-DYSFUNCTION; BLOOD-TRANSFUSION; RESECTION; HEPATECTOMY; MORTALITY; TRANSPLANTATION; PREDICTION; MODEL	The aim of this study was to construct a prediction model for posthepatectomy liver failure (PHLF), as defined by the International Study Group of Liver Surgery, and evaluate its accuracy in hepatocellular carcinoma (HCC) patients with cirrhosis or chronic hepatitis. A total of 277 consecutive hepatectomies for HCC between 2005 and 2013 were analyzed retrospectively. Multivariate logistic regression analysis was used to develop a predictive model for PHLF. The sensitivity, specificity, and area under the receiver operating characteristic (AUROC) curve were evaluated. The Hosmer-Lemeshow goodness-of-fit test was used to assess the model calibration. The constructed model was internally validated by k-fold cross-validation (k = 5). PHLF developed in 12.6 % of hepatectomies. Multivariate analysis identified the following variables as predictors of PHLF: elevated preoperative serum bilirubin level, elevated preoperative international normalized ratio, and intraoperative packed red blood cell transfusion. The predictive model allowed discrimination between patients who developed PHLF and those who did not, with a sensitivity of 82.9 %, specificity of 72.3 %, and AUROC curve of 0.81 (95 % CI, 0.74 to 0.89). The Hosmer-Lemeshow test indicated a good fit (P = 0.545). The AUROC curve of the developed model was significantly greater than that of the model for end-stage liver disease (MELD) score (P = 0.014), suggesting that the former model is better at predicting the PHLF than the latter one. The developed model could be useful for predicting the occurrence of PHLF in HCC patients with underlying liver disease.	[Motoyama, Hiroaki; Kobayashi, Akira; Yokoyama, Takahide; Shimizu, Akira; Furusawa, Norihiko; Sakai, Hiroshi; Kitagawa, Noriyuki; Ohkubo, Yohei; Miyagawa, Shin-ichi] Shinshu Univ, Dept Surg 1, Sch Med, Matsumoto, Nagano 3908621, Japan; [Tsukahara, Teruomi] Shinshu Univ, Dept Prevent Med & Publ Hlth, Sch Med, Matsumoto, Nagano 3908621, Japan	Kobayashi, A (reprint author), Shinshu Univ, Dept Surg 1, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kbys@shinshu-u.ac.jp					SITZMANN JV, 1994, ANN SURG, V219, P13, DOI 10.1097/00000658-199401000-00003; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Cucchetti A, 2006, LIVER TRANSPLANT, V12, P966, DOI 10.1002/lt.20761; Northup PG, 2005, ANN SURG, V242, P244, DOI 10.1097/01.sla.0000171327.29262.e0; Fukushima K, 2014, J GASTROINTEST SURG, V18, P729, DOI 10.1007/s11605-013-2423-y; Kubota K, 1997, HEPATOLOGY, V26, P1176; Sarasin FP, 1998, HEPATOLOGY, V28, P436, DOI 10.1002/hep.510280222; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Makuuchi M, 1998, ULTRASOUND MED BIOL, V24, P1229, DOI 10.1016/S0301-5629(98)00112-4; Ribeiro HSC, 2013, EJSO-EUR J SURG ONC, V39, P380, DOI 10.1016/j.ejso.2012.12.020; Nanashima A, 2013, J SURG RES, V185, P127, DOI 10.1016/j.jss.2013.05.021; Yang T, 2011, WORLD J SURG, V35, P2073, DOI 10.1007/s00268-011-1161-0; Ghany MG, 2010, GASTROENTEROLOGY, V138, P136, DOI 10.1053/j.gastro.2009.09.007; Mullen JT, 2007, J AM COLL SURGEONS, V204, P854, DOI 10.1016/j.jamcollsurg.2006.12.032; Allard MA, 2013, ANN SURG, V258, P822, DOI 10.1097/SLA.0b013e3182a64b38; Subramanian J, 2013, CONTEMP CLIN TRIALS, V36, P636, DOI 10.1016/j.cct.2013.06.011; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Chen X, 2012, BRIT J SURG, V99, P1701, DOI 10.1002/bjs.8951; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524; MAKUUCHI M, 1989, WORLD J SURG, V13, P644; Kumar R, 2012, GUT, V61, P1068, DOI 10.1136/gutjnl-2011-301762; Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Kubo S, 2004, ANN SURG, V239, P186, DOI 10.1097/01.sla.0000109152.48425.4d; Teh SH, 2007, GASTROENTEROLOGY, V132, P1261, DOI 10.1053/j.gastro.2007.01.040; Shoup M, 2003, J GASTROINTEST SURG, V7, P325, DOI 10.1016/S1091-255X(02)00370-0; Capussotti L, 2009, BRIT J SURG, V96, P88, DOI 10.1002/bjs.6429; Michel J, 1997, J HEPATOL, V26, P1274, DOI 10.1016/S0168-8278(97)80462-X; Barton JS, 2013, HPB OXFORD; Behrns K E, 1998, J Gastrointest Surg, V2, P292, DOI 10.1016/S1091-255X(98)80025-5; BOLDER U, 1993, SCAND J GASTROENTERO, V28, P949, DOI 10.3109/00365529309098290; Cohnert TU, 1997, WORLD J SURG, V21, P396; Couinaud C., 1957, FOIE ETUDES ANATOMIQ; Dmitrewski J, 1998, J Hepatobiliary Pancreat Surg, V5, P18, DOI 10.1007/PL00009945; Fukumori D, 2011, J HEPATO-BIL-PAN SCI, V18, P724, DOI 10.1007/s00534-011-0394-5; Jarnagin William R, 2002, Ann Surg, V236, P397; Lei JY, 2013, TRANSPL P, V45, P205, DOI 10.1016/j.transproceed.2012.03.063; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92; Nagai S, 2009, BRIT J SURG, V96, P437, DOI 10.1002/bjs.6479; Rahman SH, 2008, ARCH SURG-CHICAGO, V143, P247, DOI 10.1001/archsurg.2007.75; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Squires 3rd MH, 2014, HPB OXFORD; YAMANAKA N, 1984, ANN SURG, V200, P658, DOI 10.1097/00000658-198411000-00018	52	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	DEC	2014	399	8					1047	1055		10.1007/s00423-014-1252-0		9	Surgery	Surgery	AT7EY	WOS:000345100900009		
J	Hirokawa, F; Hayashi, M; Miyamoto, Y; Asakuma, M; Shimizu, T; Komeda, K; Inoue, Y; Uchiyama, K				Hirokawa, Fumitoshi; Hayashi, Michihiro; Miyamoto, Yoshiharu; Asakuma, Mitsuhiro; Shimizu, Tetsunosuke; Komeda, Koji; Inoue, Yoshihiro; Uchiyama, Kazuhisa			Surgical treatment of extrahepatic recurrence of hepatocellular carcinoma	LANGENBECKS ARCHIVES OF SURGERY			English	Article						Extrahepatic recurrence (EHR); Hepatocellular carcinoma; Hepatectomy; Recurrence	LIVER RESECTION; RISK-FACTORS; INTRAHEPATIC RECURRENCE; CURATIVE RESECTION; PROGNOSTIC-FACTORS; CLINICAL-FEATURES; JAPAN-SOCIETY; METASTASIS; HEPATECTOMY; MANAGEMENT	The purpose of this study was to clarify the clinicopathological features of extrahepatic hepatocellular carcinoma (HCC) recurrence after hepatectomy in order to schedule optimal treatment strategies for better long-term outcomes. A cohort of 206 patients who had undergone curative hepatectomy for HCC was analysed; 133 patients had developed relapse. Among them, 101 patients had intrahepatic recurrence only (IHR), and 32 patients had extrahepatic recurrence (EHR). Clinicopathological and survival data were compared between the two groups. The overall survival rate after hepatectomy was better in the IHR than in the EHR group (p < 0.0001). The recurrence-free interval after hepatectomy was significantly shorter in the EHR than in the IHR group (258 vs. 487 days, p < 0.0043). Patients in the EHR group were more likely to have a high PIVKA II, a large tumour, and microscopic portal vein invasion when compared with patients in the IHR group. Microscopic portal vein invasion was the most important independent risk factor for EHR after hepatectomy (p = 0.0295). Patients with more than two risk factors for EHR showed poor prognosis in comparison with patients without any risk factors (p < 0.001). In the EHR group, patients who underwent repeated resection had significantly better survival than patients receiving only the best supportive care (539 vs. 133 days, p = 0.0098). Furthermore, among EHR patients with concomitant IHR, patients with controllable IHR had significantly better survival than those with uncontrollable IHR (524 vs. 147 days, p = 0.0131). EHR of HCC was associated with early recurrence, and risk factors for the occurrence of EHR included the presence of high PIVKA II, large tumours, and microscopic portal vein invasion. Resection of recurrent tumour and local control of concomitant IHR may improve the prognosis of EHR patients.	[Hirokawa, Fumitoshi; Hayashi, Michihiro; Miyamoto, Yoshiharu; Asakuma, Mitsuhiro; Shimizu, Tetsunosuke; Komeda, Koji; Inoue, Yoshihiro; Uchiyama, Kazuhisa] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Takatsuki, Osaka 5698686, Japan	Hirokawa, F (reprint author), Osaka Med Coll, Dept Gen & Gastroenterol Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	sur122@poh.osaka-med.ac.jp					BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Uka K, 2007, WORLD J GASTROENTERO, V13, P414; Sun L, 2007, WORLD J GASTROENTERO, V13, P5413; Taketomi A, 2009, TRANSPLANTATION, V87, P531, DOI 10.1097/TP.0b013e3181943bee; Balsells J, 1996, BRIT J SURG, V83, P758, DOI 10.1002/bjs.1800830610; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Choi D, 2007, ANN SURG ONCOL, V14, P2319, DOI 10.1245/s10434-006-9220-8; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Lin CY, 2012, EUR J RADIOL, V81, P2417, DOI 10.1016/j.ejrad.2011.08.004; Shimada M, 1996, GASTROENTEROLOGY, V111, P720, DOI 10.1053/gast.1996.v111.pm8780578; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; Richly H, 2009, EUR J CANCER, V45, P579, DOI 10.1016/j.ejca.2008.10.039; Yang YB, 2007, SURGERY, V141, P196, DOI 10.1016/j.surg.2006.06.033; Taketomi A, 2010, ANN SURG ONCOL, V17, P2740, DOI 10.1245/s10434-010-1076-2; Takenaka K, 1996, ARCH SURG-CHICAGO, V131, P71; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Marubashi S, 2011, ANN SURG ONCOL, V18, P2200, DOI 10.1245/s10434-011-1577-7; Arii S, 2010, HEPATOL RES, V40, P667, DOI 10.1111/j.1872-034X.2010.00673.x; Chan KM, 2009, WORLD J GASTROENTERO, V15, P5481, DOI 10.3748/wjg.15.5481; Chua TC, 2012, SURG ONCOL, V21, P95, DOI 10.1016/j.suronc.2011.01.005; Hirokawa F, 2011, SURGERY, V149, P438, DOI 10.1016/j.surg.2009.11.015; Ishii H, 2004, JPN J CLIN ONCOL, V34, P733, DOI 10.1093/jjco/hyh135; Kudo M, 2007, ONCOLOGY-BASEL, V72, P2, DOI 10.1159/000111702; Liu Yang, 2002, Hepatobiliary Pancreat Dis Int, V1, P72; Ochiai T, 2012, WORLD J SURG, V36, P136, DOI 10.1007/s00268-011-1317-y; Ogawa M, 2004, HEPATOL RES, V29, P228, DOI 10.1016/j.hepres.2004.04.002; Sano Takanori, 2011, Hepatogastroenterology, V58, P2067, DOI 10.5754/hge11188; Sasaki A, 2007, ANN SURG ONCOL, V14, P3181, DOI 10.1245/s10434-007-9570-x; Si MS, 2003, AM SURGEON, V69, P879; Tanaka K, 2008, WORLD J SURG, V32, P1738, DOI 10.1007/s00268-008-9613-x; Taniai N, 1999, HEPATO-GASTROENTEROL, V46, P2523; Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984; Utsunomiya T, 2001, HEPATO-GASTROENTEROL, V48, P1088; Yoon KT, 2007, ONCOLOGY-BASEL, V72, P104, DOI 10.1159/000111715; Yoon YS, 2010, ANN SURG ONCOL, V17, P2795, DOI 10.1245/s10434-010-1073-5	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1435-2443	1435-2451		LANGENBECK ARCH SURG	Langenbecks Arch. Surg.	DEC	2014	399	8					1057	1064		10.1007/s00423-014-1230-6		8	Surgery	Surgery	AT7EY	WOS:000345100900010		
J	Saito, K; Munro, MJ				Saito, Kazuya; Munro, Murray J.			The Early Phase of /(sic)/ Production Development in Adult Japanese Learners of English	LANGUAGE AND SPEECH			English	Article						L2 pronunciation; English; experience effects; task variation	R-VERTICAL-BAR; PERCEIVED FOREIGN ACCENT; AMERICAN ENGLISH; LANGUAGE EXPERIENCE; NATIVE SPEAKERS; ESL LEARNERS; L2 SPEECH; PERCEPTION; VOWELS; ACQUISITION	Although previous research indicates that Japanese speakers' second language (L2) perception and production of English // may improve with increased L2 experience, relatively little is known about the fine phonetic details of their // productions, especially during the early phase of L2 speech learning. This cross-sectional study examined acoustic properties of word-initial // from 60 Japanese learners with a length of residence of between one month and one year in Canada. Their performance was compared to that of 15 native speakers of English and 15 low-proficiency Japanese learners of English. Formant frequencies (F2 and F3) and F1 transition durations were evaluated under three task conditionsword reading, sentence reading, and timed picture description. Learners with as little as two to three months of residence demonstrated target-like F2 frequencies. In addition, increased LOR was predictive of more target-like transition durations. Although the learners showed some improvement in F3 as a function of LOR, they did so mainly at a controlled level of speech production. The findings suggest that during the early phase of L2 segmental development, production accuracy is task-dependent and is influenced by the availability of L1 phonetic cues for redeployment in L2.	[Saito, Kazuya] Waseda Univ, Tokyo 1698050, Japan; [Munro, Murray J.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada	Saito, K (reprint author), Waseda Univ, Sch Commerce, Shinjuku Ku, 1-6-1 Nishi Waseda, Tokyo 1698050, Japan.	kazuya.saito@waseda.jp			Waseda University	This research was funded by Waseda University Grant for Special Research Projects, awarded to the first author.	FLEGE JE, 1992, J ACOUST SOC AM, V92, P128, DOI 10.1121/1.404278; Flege JE, 1996, J ACOUST SOC AM, V99, P1161, DOI 10.1121/1.414884; FLEGE JE, 1992, J ACOUST SOC AM, V91, P370, DOI 10.1121/1.402780; Munro MJ, 2008, LANG LEARN, V58, P479, DOI 10.1111/j.1467-9922.2008.00448.x; Derwing TM, 2004, LANG LEARN, V54, P655, DOI 10.1111/j.1467-9922.2004.00282.x; Larson-Hall J, 2006, LANG SPEECH, V49, P521; Espy-Wilson CY, 2000, J ACOUST SOC AM, V108, P343, DOI 10.1121/1.429469; FLEGE JE, 1995, J ACOUST SOC AM, V97, P3125, DOI 10.1121/1.413041; Bradlow AR, 1999, J ACOUST SOC AM, V106, P2074, DOI 10.1121/1.427952; Lin YH, 2003, APPL LINGUIST, V24, P439, DOI 10.1093/applin/24.4.439; Yang BG, 1996, J PHONETICS, V24, P245, DOI 10.1006/jpho.1996.0013; Lee B, 2006, STUD SECOND LANG ACQ, V28, P487, DOI 10.1017/S0272263106060207; BOHN OS, 1990, APPL PSYCHOLINGUIST, V11, P303, DOI 10.1017/S0142716400008912; Hattori K, 2009, J ACOUST SOC AM, V125, P469, DOI 10.1121/1.3021295; Spada N, 2010, LANG LEARN, V60, P263, DOI 10.1111/j.1467-9922.2010.00562.x; Kuhl PK, 2000, P NATL ACAD SCI USA, V97, P11850, DOI 10.1073/pnas.97.22.11850; Piske T, 2001, J PHONETICS, V29, P191, DOI 10.1006/jpho.2001.0134; Cebrian J, 2006, J PHONETICS, V34, P372, DOI 10.1016/j.wocn.2005.08.003; McAllister R, 2002, J PHONETICS, V30, P229, DOI 10.1006/jpho.2002.0174; FLEGE JE, 1995, LANG SPEECH, V38, P25; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; Nishi K, 2007, J SPEECH LANG HEAR R, V50, P1496, DOI 10.1044/1092-4388(2007/103); Flege JE, 1997, J PHONETICS, V25, P437, DOI 10.1006/jpho.1997.0052; Gottfried TL, 1997, J PHONETICS, V25, P207, DOI 10.1006/jpho.1997.0042; Kennedy S, 2008, CAN MOD LANG REV, V64, P459, DOI 10.3138/cmlr.64.3.459; Baker W., 2006, IRAL-INT REV APPL LI, V44, P231, DOI DOI 10.1515/IRAL.2006.010; Baker W, 2010, BILING-LANG COGN, V13, P263, DOI 10.1017/S136672890999006X; Best Catherine T., 2007, LANGUAGE EXPERIENCE, P13, DOI DOI 10.1075/LLLT.17.07BES; Boersma Paul, 2012, PRAAT DOING PHONETIC; Bohn O.-S., 1995, SPEECH PERCEPTION LI, P379; Bongaerts T., 1995, AGE FACTOR 2 LANGUAG; Bradlow A.R., 2008, PHONOLOGY 2 LANGUAGE, P287; Cobb T., 2012, COMPLEAT LEXICAL TUT; DeKeyser R, 2003, HDB 2 LANGUAGE ACQUI, P313; DeKeyser RM, 2001, COGNITION 2 LANGUAGE, P125; Derwing TM, 2013, LANG LEARN, V63, P163, DOI 10.1111/lang.12000; Derwing TM, 2008, APPL LINGUIST, V29, P359, DOI 10.1093/applin/amm041; Dohlus K., 2008, ROLE PHONOLOGY PHONE; Ellis R., 2002, STUDIES 2 LANGUAGE A, V24, P223, DOI DOI 10.1017/S0272263102002073; ESPYWILSON CY, 1992, J ACOUST SOC AM, V92, P736, DOI 10.1121/1.403998; FLEGE JE, 1993, J ACOUST SOC AM, V93, P1589, DOI 10.1121/1.406818; Flege J., 1990, J PHONETICS, V17, P299; FLEGE JE, 1988, J ACOUST SOC AM, V84, P70, DOI 10.1121/1.396876; Flege J. E., 2001, STUDIES 2 LANGUAGE A, V23, P527; Flege James Emil, 1995, SPEECH PERCEPTION LI, P233; Flege JE, 2003, PHONETICS PHONOLOGY, P319, DOI DOI 10.1515/9783110895094.319; Guion SG, 2000, J ACOUST SOC AM, V107, P2711, DOI 10.1121/1.428657; Ingvalson EM, 2012, BILING-LANG COGN, V15, P255, DOI 10.1017/S1366728911000447; Iverson P., 2003, COGNITION, V87, P847; Jiang N, 2007, LANG LEARN, V57, P1, DOI 10.1111/j.1467-9922.2007.00397.x; Krashen S, 1981, 2 LANGUAGE ACQUISITI; Ladefoged Peter, 1996, SOUNDS WORLDS LANGUA; Lotto A. J., 2004, SOUND SENSE 50 YEARS, pC381; Major Roy, 2001, FOREIGN ACCENT ONTOG; Moyer A, 1999, STUDIES 2 LANGUAGE A, V21, P81, DOI DOI 10.1017/50272263199001035; Peterson G. E., 1960, J ACOUST SOC AM, V97, P1286; Piske T., 2011, ACHIEVEMENTS PERSPEC, P195; Rau DV, 2009, LANG LEARN, V59, P581; Saito K., APPL PSYCHO IN PRESS; Saito K, 2013, J MEM LANG, V69, P546, DOI 10.1016/j.jm1.2013.07.003; SCHROEDER MR, 1979, J ACOUST SOC AM, V66, P1647, DOI 10.1121/1.383662; Segalowitz N., 2003, HDB 2 LANGUAGE ACQUI, P382, DOI 10.1002/9780470756492.ch13; Statistics Canada, 2008, 2006 CENS CAN TOP BA; TRAUNMULLER H, 1990, J ACOUST SOC AM, V88, P97; Trofimovich P, 2006, STUD SECOND LANG ACQ, V28, P1, DOI 10.1017/S0272263106060013; UNDERBAKKE M, 1988, J ACOUST SOC AM, V84, P90, DOI 10.1121/1.396878; Vance Timothy J., 1987, INTRO JAPANESE PHONO; Yamada R. A., 1995, SPEECH PERCEPTION LI, P305	68	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0023-8309	1756-6053		LANG SPEECH	Lang. Speech	DEC	2014	57	4					451	469		10.1177/0023830913513206		19	Audiology & Speech-Language Pathology; Linguistics; Psychology, Experimental	Audiology & Speech-Language Pathology; Linguistics; Psychology	AU0HQ	WOS:000345304600002		
J	Nakamura, M; Kolinsky, R				Nakamura, Miyoko; Kolinsky, Regine			Multiple Functional Units in the Preattentive Segmentation of Speech in Japanese: Evidence from Word Illusions	LANGUAGE AND SPEECH			English	Review						Speech segmentation; Japanese; mora; syllable; orthographic effects	STATISTICAL INFORMATION; PHONOLOGICAL AWARENESS; MIGRATION PARADIGM; RECOGNITION; PERCEPTION; COARTICULATION; SIMILARITY; MORA; CUES; SYLLABLES	We explored the functional units of speech segmentation in Japanese using dichotic presentation and a detection task requiring no intentional sublexical analysis. Indeed, illusory perception of a target word might result from preattentive migration of phonemes, morae, or syllables from one ear to the other. In Experiment 1, Japanese listeners detected targets presented in hiragana and/or kanji. Phoneme migrations did occur, suggesting that orthography-independent sublexical constituents play some role in segmentation. However, syllable and especially mora migrations were more numerous. This pattern of results was not observed in French speakers (Experiment 2), suggesting that it reflects native segmentation in Japanese. To control for the intervention of kanji representations (many words are written in kanji, and one kanji often corresponds to one syllable), in Experiment 3, Japanese listeners were presented with target loanwords that can be written only in katakana. Again, phoneme migrations occurred, while the first mora and syllable led to similar rates of illusory percepts. No migration occurred for the second, special mora (/J/ or /N/), probably because this constitutes the latter part of a heavy syllable. Overall, these findings suggest that multiple units, such as morae, syllables, and even phonemes, function independently of orthographic knowledge in Japanese preattentive speech segmentation.	[Nakamura, Miyoko] Keio Univ, Grad Sch Media & Governance, Tokyo 108, Japan; [Kolinsky, Regine] Univ Libre Bruxelles, ULB Neurosci Inst UNI, CRCN, Unite Rech Neurosci Cognit UNESCOG, Brussels, Belgium	Kolinsky, R (reprint author), Univ Libre Bruxelles, UNESCOG, CP 191-50,Ave F Roosevelt, B-1050 Brussels, Belgium.	rkolins@ulb.ac.be			Human Frontier Science Program (HFSP) grant	The second author is Research Director of FRS-FNRS. At the time of testing, her team benefited from a Human Frontier Science Program (HFSP) grant ("Processing consequences of contrasting language phonologies"). The first author was Researcher at ULB for Experiments 1 and 2 and a Master's course student at the Graduate School of Media and Governance, Keio University, for Experiment 3.	READ C, 1986, COGNITION, V24, P31, DOI 10.1016/0010-0277(86)90003-X; CHURCH KW, 1987, COGNITION, V25, P53, DOI 10.1016/0010-0277(87)90004-7; Ventura P, 2004, LANG COGNITIVE PROC, V19, P57, DOI 10.1080/01699060344000134; Mattys SL, 2005, J EXP PSYCHOL GEN, V134, P477, DOI 10.1037/0096-3445.134.4.477; Content A, 2001, LANG COGNITIVE PROC, V16, P609; PORT RF, 1987, J ACOUST SOC AM, V81, P1574, DOI 10.1121/1.394510; MORAIS J, 1986, COGNITION, V24, P45, DOI 10.1016/0010-0277(86)90004-1; CUTLER A, 1988, J EXP PSYCHOL HUMAN, V14, P113, DOI 10.1037/0096-1523.14.1.113; MACKAY DG, 1970, NEUROPSYCHOLOGIA, V8, P323, DOI 10.1016/0028-3932(70)90078-3; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; Mattys SL, 2004, J EXP PSYCHOL HUMAN, V30, P397, DOI 10.1037/0096-1523.30.2.397; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; CUTTING JE, 1976, PSYCHOL REV, V83, P114, DOI 10.1037/0033-295X.83.2.114; Murty L, 2007, LANG SPEECH, V50, P77; Ziegler JC, 1998, PSYCHON B REV, V5, P683, DOI 10.3758/BF03208845; Grabe E, 2002, PHONOL PHONET, V4-1, P515; MORAIS J, 1987, Q J EXP PSYCHOL-A, V39, P451; Labrune L, 2012, PHONOLOGY, V29, P113, DOI 10.1017/S095267571200005X; MORAIS J, 1979, COGNITION, V7, P323, DOI 10.1016/0010-0277(79)90020-9; SEIDENBERG MS, 1979, J EXP PSYCHOL-HUM L, V5, P546, DOI 10.1037//0278-7393.5.6.546; CUTLER A, 1994, J MEM LANG, V33, P824, DOI 10.1006/jmla.1994.1039; POSER WJ, 1990, LANGUAGE, V66, P78, DOI 10.2307/415280; CUTLER A, 1983, NATURE, V304, P159, DOI 10.1038/304159a0; Boersma P, 2013, PRAAT DOING PHONETIC; Boersma Paul, 2001, GLOT INT, V5.9-10, P341; Castles A, 2003, Q J EXP PSYCHOL-A, V56, P445, DOI 10.1080/02724980244000486; Castro S.-L., 1995, STUDIES ACQUISITION, P1; Cutler A, 2002, J MEM LANG, V46, P296, DOI 10.1006/jmla.2001.2814; Day R. S., 1968, DISS ABSTR INT B; Dell Gary, 1980, ERRORS LINGUISTIC PE, P273; Dupoux E., 1992, ANAL APPROACHES HUMA, P59; EHRI LC, 1979, J EDUC PSYCHOL, V71, P26, DOI 10.1037//0022-0663.71.1.26; Fernandes T, 2007, PERCEPT PSYCHOPHYS, V69, P856, DOI 10.3758/BF03193922; Fernandes T, 2010, ATTEN PERCEPT PSYCHO, V72, P1522, DOI 10.3758/APP.72.6.1522; FRAUENFELDER UH, 1990, J EXP PSYCHOL HUMAN, V16, P77, DOI 10.1037/0096-1523.16.1.77; FRAZIER L, 1987, COGNITION, V25, P157, DOI 10.1016/0010-0277(87)90008-4; Fromkin V. A, 1973, SPEECH ERRORS LINGUI; Fujimura O., 2007, ONSEIKAGAKU GENRON G; Fukumori T., 2010, KISOKARA NIHONGO ONS; Haraguchi S., 1999, HDB JAPANESE LINGUIS, P1; Hardison DM, 2010, APPL PSYCHOLINGUIST, V31, P81, DOI 10.1017/S0142716409990178; Inaba S., 1998, P LANG INF COMP PACL, P106; Inagaki K, 2000, J EXP CHILD PSYCHOL, V75, P70, DOI 10.1006/jecp.1999.2523; Ito J., 1990, PAR SYLL PHON PHON C, P213; Kasuya H., 1990, KOZA NIHONGO NIHONGO, P178; Kawahara S, 2007, J EAST ASIAN LINGUIS, V16, P113, DOI 10.1007/s10831-007-9009-1; Kawahara S., 2009, ONSEI KENKYUU, V13, P101; Kawahara S, 2009, J LINGUIST, V45, P111, DOI 10.1017/S0022226708005537; Kawahara S., MOUTON HDB IN PRESS; Kolinsky R, 1996, LANG COGNITIVE PROC, V11, P611; KOLINSKY R, 1995, J MEM LANG, V34, P19, DOI 10.1006/jmla.1995.1002; Kolinsky R, 1998, EUR J COGN PSYCHOL, V10, P1, DOI 10.1080/713752266; Kondo Y., 1998, ON IN KENKYUU, V1, P75; Kondo Y, 2006, LANG SPEECH, V49, P393; Kubozono H., 1995, GOKEISEI ONIN KOOZOO; Kubozono H, 2006, LINGUA, V116, P1140, DOI 10.1016/j.lingua.2005.06.010; Kubozono H., 1998, ONSEI KENKYUU, V2, P5; Kubozono H, 2003, SYLLABLE OPTIMALITY, P99, DOI 10.1017/CBO9780511497926.005; KUBOZONO H, 1989, LANG SPEECH, V32, P249; Kubozono H., 1999, BUNPO TO ONSEI, VII, P241; Kubozono H., 1998, ONIN KOOZOO AKUSENTO; Kubozono Haruo, 1999, HDB JAPANESE LINGUIS, P31; Labrune L., 2012, PHONOLOGY JAPANESE; Labrune L., 2006, PHONOLOGIE JAPONAIS; Ladefoged P., 1975, COURSE PHONETICS; LIBERMAN IY, 1974, J EXP CHILD PSYCHOL, V18, P201, DOI 10.1016/0022-0965(74)90101-5; Machida Y., 1962, WARABE UTA; Macmillan N. A., 2005, DETECTION THEORY USE; MANN VA, 1986, COGNITION, V24, P65, DOI 10.1016/0010-0277(86)90005-3; Mattys SL, 2005, LANG SPEECH, V48, P223; Mattys SL, 1997, J MEM LANG, V36, P87, DOI 10.1006/jmla.1996.2472; Mattys SL, 2009, COGNITIVE PSYCHOL, V59, P203, DOI 10.1016/j.cogpsych.2009.04.001; McCawley James D., 1968, PHONOLOGICAL COMPONE; MCCLELLAND JL, 1986, J EXP PSYCHOL HUMAN, V12, P18, DOI 10.1037//0096-1523.12.1.18; McQueen JM, 2001, J MEM LANG, V45, P103, DOI 10.1006/jmla.2000.2763; MEHLER J, 1981, J VERB LEARN VERB BE, V20, P298, DOI 10.1016/S0022-5371(81)90450-3; MESTER A, 1990, LINGUIST INQ, V21, P478; Morais J, 1998, LETRAS HOJE, V33, P61; MORAIS J, 1994, COGNITION, V50, P287, DOI 10.1016/0010-0277(94)90032-9; Muraki M., 1990, KOZA NIHONGO NIHONGO, V3, P139; Muto T, 1987, 9 BIENN M INT SOC ST; Nakamura M, 1998, CAH PSYCHOL COGN, V17, P417; Nasu A, 2006, PHONOLOGICAL STUDIES, V9, P157; NHK (Nippon Hoso Kyokai), 1998, NIHONGO HATSUON AKUS; Ohara A., 1994, NIHON NO WARABE UTA; Otake T, 2001, PHONOLOGICAL STUDIES, V4, P81; Otake T, 1993, J MEM LANG, V32, P358; Otake T., 1996, PHONOLOGICAL STRUCTU, P183; Otake T, 1996, J ACOUST SOC AM, V100, P3831, DOI 10.1121/1.417239; Peereman R, 2009, PSYCHON B REV, V16, P363, DOI 10.3758/PBR.16.2.363; Saito Y., 2003, ONSEI ONIN, P1; Sakamoto Y, 2005, PHONOLOGICAL STUDIES, V8, P89; Sato K., 2001, NIHONGO KYOUIKUGAKU, V3, P47; Scliar-Cabral L., 1997, INT J PSYCHOLINGUIST, V13, P211; Serniclaes W, 2005, COGNITION, V98, pB35, DOI 10.1016/j.cognition.2005.03.002; Shibatani Masayoshi, 1990, LANGUAGES JAPAN; Shinohara S, 2000, J EAST ASIAN LINGUIS, V9, P55, DOI 10.1023/A:1008335811086; Shirota S., 1993, NIHONGO OTO ONSEIGAK; Spagnoletti C., 1989, READ WRIT, V1, P221, DOI [10.1007/bf00377644, DOI 10.1007/BF00377644]; STUDDERTKENNEDY M, 1981, COGNITION, V10, P301, DOI 10.1016/0010-0277(81)90061-5; Takayama T., 2011, ONSEIGAKU KIHON JITE, P490; TAMAOKA K, 1994, JPN J PSYCHOL, V65, P377; Tanaka S., 2008, RIZUMU AKUSENTO YURE; Tanaka S., 2000, SYNCHRONIC DIACHRONI, P521; Tanaka S., 1999, BUNPOO TO ONSEI, VII, P261; Tanaka S, 1998, ONSEI KENKYUU, V2, P50; Tateishi K, 1989, P W COAST C FORM LIN, V8, P384; TREISMAN A, 1984, J EXP PSYCHOL HUMAN, V10, P12, DOI 10.1037/0096-1523.10.1.12; Tsujimura N, 2007, INTRO JAPANESE LINGU; Ujihira A, 1996, NIHONGO NIHON BUNKA, V4, P14; Uwano Z, 2003, ONSEI ON IN, P61; Vance Timothy J., 1987, INTRO JAPANESE PHONO; Vance Timothy J., 2008, SOUNDS JAPANESE; Verdonschot RG, 2011, J EXP PSYCHOL LEARN, V37, P1458, DOI 10.1037/a0024491	114	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0023-8309	1756-6053		LANG SPEECH	Lang. Speech	DEC	2014	57	4					513	543		10.1177/0023830913508077		31	Audiology & Speech-Language Pathology; Linguistics; Psychology, Experimental	Audiology & Speech-Language Pathology; Linguistics; Psychology	AU0HQ	WOS:000345304600005		
J	Kaminskii, AA; Yu, H; Zhang, H; Wang, J; Lux, O; Rhee, H; Eichler, HJ; Yoneda, H; Shirakawa, A; Zhang, J; Tang, G				Kaminskii, A. A.; Yu, H.; Zhang, H.; Wang, J.; Lux, O.; Rhee, H.; Eichler, H. J.; Yoneda, H.; Shirakawa, A.; Zhang, J.; Tang, G.			Monoclinic m-LaVO4-a novel high Raman gain SRS-active crystal	LASER PHYSICS			English	Article						stimulated Raman scattering (SRS); lanthanum vanadate; rare earth vanadates; Raman four-wave mixing; cascaded and cross-cascaded SRS; Raman lasers	TETRAGONAL VANADATES YVO4; STOKES COMB GENERATION; ZIRCON-TYPE LAVO4; LANTHANUM ORTHOVANADATE; SINGLE-CRYSTALS; LASER; GROWTH; GDVO4; NM; CONVERSION	Monoclinic m-LaVO4, having a monazite-type structure and being known as a host crystal for Nd3+-lasants, is an attractive chi((3))-nonlinear optical material for Raman laser converters. This paper presents the stimulated Raman scattering (SRS) spectroscopy of m-LaVO4 in the visible and near-IR spectral range using picosecond laser excitation. High-order SRS and Raman-induced four-wave parametric mixing processes result in an almost two-octave-wide Stokes and anti-Stokes frequency comb. All the measured spectral lines were assigned to the participating molecular vibration modes of the studied vanadate. Finally, an estimation of the steady-state Raman gain coefficient for first Stokes generation in near-IR was performed.	[Kaminskii, A. A.] Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia; [Yu, H.; Zhang, H.; Wang, J.] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Yu, H.; Zhang, H.; Wang, J.] Shandong Univ, Inst Crystal Mat, Jinan 250100, Peoples R China; [Lux, O.; Rhee, H.; Eichler, H. J.] Tech Univ Berlin, Inst Opt & Atom Phys, D-10623 Berlin, Germany; [Yoneda, H.; Shirakawa, A.] Univ Electrocommun, Inst Laser Sci, Tokyo 1828585, Japan; [Zhang, J.; Tang, G.] Jiangsu Normal Univ, Lab Adv Laser Mat & Devices, Xuzhou 221116, Peoples R China	Kaminskii, AA (reprint author), Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia.	kaminalex@mail.ru; haohaiyu@sdu.edu.cn; oliver.lux@physik.tu-berlin.de	Zhang, Jian/G-8296-2011	Zhang, Jian/0000-0001-9061-3940	Russian Foundation for Basic Research; 'Extreme light fields and their applications' Program; Alexander von Humboldt Foundation	The authors wish to note that this work was considerably enhanced through mutual scientific help within the 'Joint Open Laboratory for Laser Crystals and Precise Laser Systems,' and was stimulated by the research programs of the Institute of Crystallography at the Russian Academy of Sciences, by the State Key Laboratory of Crystal Materials and the Institute of Crystal Materials at Shandong University, by the Institute of Optics and Atomic Physics at the Technical University of Berlin, by the Institute for Laser Science of the Tokyo University of Electro-Communications, and by the Laboratory of Advanced Laser Materials and Devices at the Jiangsu Normal University. One of our number (AAK) is grateful to the Russian Foundation for Basic Research and the 'Extreme light fields and their applications' Program for partly their support, as well as to the Alexander von Humboldt Foundation. The authors also thank E Smirnova for her crystallographic help.	Chen YF, 2004, OPT LETT, V29, P2172, DOI 10.1364/OL.29.002172; RICE CE, 1976, ACTA CRYSTALLOGR B, V32, P2232, DOI 10.1107/S0567740876007450; Kaminskii A, 2008, APPL PHYS B-LASERS O, V93, P865, DOI 10.1007/s00340-008-3234-9; Bashir J, 2006, MATER LETT, V60, P470, DOI 10.1016/j.matlet.2005.09.016; Kaminskii AA, 2008, LASER PHYS LETT, V5, P367, DOI 10.1002/lapl.200810005; Sun SQ, 2013, OPT EXPRESS, V21, P31119, DOI 10.1364/OE.21.031119; Jia CJ, 2005, J PHYS CHEM B, V109, P3284, DOI 10.1021/jp045967u; Zhang LZ, 2004, J CRYST GROWTH, V260, P460, DOI 10.1016/j.jcrysgro.2003.08.067; Liu JH, 2003, APPL PHYS LETT, V83, P1289, DOI 10.1063/1.1601673; Chen YF, 2004, OPT LETT, V29, P1915, DOI 10.1364/OL.29.001915; Kaminskii AA, 2001, OPT COMMUN, V194, P201, DOI 10.1016/S0030-4018(01)01274-3; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1579, DOI 10.1002/pssb.201451279; Chen YF, 2004, OPT LETT, V29, P2632, DOI 10.1364/OL.29.002632; OCONNOR JR, 1966, APPL PHYS LETT, V9, P407, DOI 10.1063/1.1754631; Oka Y, 2000, J SOLID STATE CHEM, V152, P486, DOI 10.1006/jssc.2000.8717; Basiev TT, 2004, LASER PHYS LETT, V1, P237, DOI 10.1002/lapl.200410057; KAMINSKII AA, 1987, PHYS STATUS SOLIDI A, V102, P389, DOI 10.1002/pssa.2211020143; Shayeganrad G, 2013, OPT COMMUN, V292, P131, DOI 10.1016/j.optcom.2012.11.060; Chen YF, 2004, OPT LETT, V29, P2279, DOI 10.1364/OL.29.002279; Cong HJ, 2010, J APPL CRYSTALLOGR, V43, P308, DOI 10.1107/S0021889809052339; Ding SH, 2013, OPT EXPRESS, V21, P13052, DOI 10.1364/OE.21.013052; Duan YM, 2011, LASER PHYS, V21, P1859, DOI 10.1134/S1054660X11190108; Kaiser W., 1972, LASER HDB, V2, P1077; Kaminskii A, 2008, LASER PHYS, V18, P1546, DOI 10.1134/S1054660X08120268; Kaminskii A. A, 1996, CRYSTALLINE LASERS P; Kaminskii A A, 2012, PHYS STATUS SOLIDI B, V250, P169; Kaminskii AA, 2014, LASER PHOTONICS REV, V8, P904, DOI 10.1002/lpor.201400058; Kaminskii A A, 2007, LASER PHOTONICS REV, V1, P97; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1045, DOI 10.1002/pssb.201451009; Kaminskii AA, 2009, LASER PHYS LETT, V6, P374, DOI 10.1002/lapl.200910008; Kaminskii AA, 2001, LASER PHYS, V11, P1124; Kaminskii AA, 2015, PHYS STATUS SOLIDI B, V252, P305, DOI 10.1002/pssb.201451413; Kaminskii AA, 2012, APPL PHYS B-LASERS O, V109, P649, DOI 10.1007/s00340-012-5233-0; Khan M. N., 2013, INT J ADV RES, V1, P402; Kisel VE, 2005, APPL PHYS B-LASERS O, V80, P471, DOI 10.1007/s00340-005-1749-x; Li R, 2013, OPT EXPRESS, V21, P17745, DOI 10.1364/OE.21.017745; Lin JP, 2012, OPT EXPRESS, V20, P15180, DOI 10.1364/OE.20.015180; Lisiecki R, 2010, J LUMIN, V130, P131, DOI 10.1016/j.jlumin.2009.07.037; Lu YF, 2010, LASER PHYS LETT, V7, P787, DOI 10.1002/lapl.201010064; MAUNDERS EA, 1971, J OPT SOC AM, V61, P684; Roseau D L, 1981, J RAMAN SPECTROSC, V19, P253; Shuzhen F, 2011, OPT COMMUN, V284, P1642, DOI 10.1016/j.optcom.2010.11.050; Sun LM, 2010, J APPL PHYS, V108, DOI 10.1063/1.3499308; Sun SQ, 2012, J MATER RES, V27, P2528, DOI 10.1557/jmr.2012.290; Yu HH, 2014, LASER PHOTONICS REV, V8, P847, DOI 10.1002/lpor.201400022; Zhang L Z, 2006, MATER RES INNOV, V10, P421; Zhang LZ, 2010, MATER RES INNOV, V14, P119, DOI 10.1179/143307510X12639910071359; Zhong DG, 2014, CRYSTENGCOMM, V16, P8406, DOI 10.1039/c4ce00042k	48	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1054-660X	1555-6611		LASER PHYS	Laser Phys.	DEC	2014	24	12							125803	10.1088/1054-660X/24/12/125803		8	Optics; Physics, Applied	Optics; Physics	AT9CY	WOS:000345226800022		
J	Kaminskii, AA; Lux, O; Hanuza, J; Rhee, H; Eichler, HJ; Zhang, J; Tang, D; Shen, D; Yoneda, H; Shirakawa, A				Kaminskii, A. A.; Lux, O.; Hanuza, J.; Rhee, H.; Eichler, H. J.; Zhang, J.; Tang, D.; Shen, D.; Yoneda, H.; Shirakawa, A.			Trigonal LaF3: a novel SRS-active crystal	LASER PHYSICS			English	Article						stimulated Raman scattering; trigonal LaF3 crystal; Raman four-wave mixing; SRS frequency comb; many-phonon SRS; cascaded and cross-cascaded SRS	STIMULATED RAMAN-SCATTERING; FLUORIDE SINGLE CRYSTALS; LASER OPERATION; EMISSION; ENERGY; SPECTROSCOPY; GROWTH; PRF3; TRANSITION; PARAMETERS	Trigonal fluoride LaF3, widely known as a host crystal for Ln(3+)-lasants, was found to be an attractive many-phonon Raman material and a subject for the investigation of different chi((3))-nonlinear optical effects. We present the manifestation of photon-phonon interactions related to stimulated Raman scattering (SRS) and Raman-induced four-wave mixing (RFWM) processes, initiated by picosecond ex.itation at room temperature. Sesqui-octave-spanning Stokes and anti-Stokes frequency comb generation as well as many-step cascaded and cross-cascaded up-conversion chi((3))-nonlinear processes have been observed. The recorded spectral lines originated by SRS and RFWM are identified and attributed to the three observed SRS-promoting phonon modes. The lower limit of the steady-state Raman gain coefficient for near-IR first Stokes generation was estimated. Moreover, a brief review of known Ln(3+):LaF3 laser crystals and SRS-active fluorides is given.	[Kaminskii, A. A.] Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia; [Lux, O.; Rhee, H.; Eichler, H. J.] Tech Univ Berlin, Inst Opt & Atom Phys, D-10623 Berlin, Germany; [Hanuza, J.] Polish Acad Sci, Inst Low Temp & Struct Res, PL-50950 Wroclaw, Poland; [Zhang, J.; Tang, D.; Shen, D.] Jiangsu Normal Univ, Sch Phys & Elect Engn, Xuzhou 221116, Peoples R China; [Yoneda, H.; Shirakawa, A.] Univ Electrocommun, Inst Laser Sci, Tokyo 1828585, Japan	Kaminskii, AA (reprint author), Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia.	kaminalex@mail.ru; oliver.lux@physik.tu-berlin.de	Zhang, Jian/G-8296-2011	Zhang, Jian/0000-0001-9061-3940			KORCZAK W, 1983, J CRYST GROWTH, V61, P601, DOI 10.1016/0022-0248(83)90188-4; GUGGENHEIM H, 1963, J APPL PHYS, V34, P2482, DOI 10.1063/1.1702768; LAIHO R, 1983, PHILOS MAG A, V47, P235; SOLOMON R, 1963, APPL PHYS LETT, V3, P135, DOI 10.1063/1.1753902; LUPKE G, 1991, APPL PHYS B-PHOTO, V53, P71, DOI 10.1007/BF00325534; Kaminskii AA, 2013, PHYS STATUS SOLIDI B, V250, P169, DOI 10.1002/pssb.201248273; ROBINSON M, 1966, J APPL PHYS, V37, P2072, DOI 10.1063/1.1708673; WIRICK MP, 1966, APPL OPTICS, V5, P1966, DOI 10.1364/AO.5.001966; KAMINSKII AA, 1988, INORG MATER+, V24, P439; Kaminskii AA, 2007, LASER PHOTONICS REV, V1, P93, DOI 10.1002/lpor.200710008; HEGARTY J, 1980, J APPL PHYS, V51, P3545, DOI 10.1063/1.328193; Kaminskii AA, 2000, QUANTUM ELECTRON+, V30, P1035, DOI 10.1070/QE2000v030n12ABEH001880; Bhutta T, 2001, IEEE J QUANTUM ELECT, V37, P1469, DOI 10.1109/3.958380; ZALKIN A, 1966, INORG CHEM, V5, P1466, DOI 10.1021/ic50042a047; Kaminskii AA, 2006, LASER PHYS LETT, V3, P385, DOI 10.1002/lapl.200610029; Kaminskii AA, 2008, LASER PHYS LETT, V5, P304, DOI 10.1002/lapl.200710130; Peijzel PS, 2005, J SOLID STATE CHEM, V178, P448, DOI 10.1016/j.jssc.2004.07.046; Kaminskii AA, 2001, OPT COMMUN, V194, P201, DOI 10.1016/S0030-4018(01)01274-3; Becker P, 2012, PHYS STATUS SOLIDI A, V209, P327, DOI 10.1002/pssa.201127415; Crichton WA, 2010, DALTON T, V39, P4302, DOI 10.1039/b925817e; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1579, DOI 10.1002/pssb.201451279; MANSMANN M, 1964, Z ANORG ALLG CHEM, V331, P98, DOI 10.1002/zaac.19643310115; LIAROKAPIS E, 1985, PHYS REV B, V32, P8346, DOI 10.1103/PhysRevB.32.8346; JOHNSON LF, 1963, J APPL PHYS, V34, P897, DOI 10.1063/1.1729557; Antipenko B. M., 1980, Soviet Journal of Quantum Electronics, V10, DOI 10.1070/QE1980v010n05ABEH010146; BAUMAN RP, 1967, PHYS REV, V161, P842, DOI 10.1103/PhysRev.161.842; Cerdeira P, 1979, PHYS REV B, V19, P5413; Daran E, 1999, ELECTRON LETT, V35, P398, DOI 10.1049/el:19990303; EHRLICH DJ, 1980, OPT LETT, V5, P339, DOI 10.1364/OL.5.000339; Kaiser W., 1972, LASER HDB, V2, P1077; Kaminskii A A, 2013, LASER PHYS LETT, V10; KAMINSKII AA, 1994, J PHYS IV, V4, P297, DOI 10.1051/jp4:1994473; Kaminskii A. A, 1996, CRYSTALLINE LASERS P; Kaminskii A. A., 1973, Inorganic Materials, V9; Kaininskii AA, 2007, LASER PHYS LETT, V4, P668, DOI 10.1002/lapl.200710038; Kaminskii A A, 2014, LASER PHYS; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1045, DOI 10.1002/pssb.201451009; KLEIN PH, 1967, J APPL PHYS, V38, P1603, DOI 10.1063/1.1709730; KRUPKE WF, 1964, J CHEM PHYS, V41, P1225, DOI 10.1063/1.1726054; MACFARLANE RM, 1988, APPL PHYS LETT, V52, P1300, DOI 10.1063/1.99681; OCONNOR JR, 1964, APPL PHYS LETT, V4, P208; Oftedal T, 1931, Z PHYS CHEM, V13, P190; Oftedal T, 1929, Z PHYS CHEM, V5, P273; Rast H E, 1965, PHYS REV, V171, P1051; Reichert F, 2012, OPT EXPRESS, V20, P20387, DOI 10.1364/OE.20.020387; WAYNANT RW, 1985, APPL PHYS LETT, V46, P14, DOI 10.1063/1.95833; Weber M J, 1987, HDB LASER SCI TECH 3, VV; Weber M J, 2000, HDB LASER WAVELENGTH; WEBER MJ, 1978, OPT ENG, V17, P463, DOI 10.1117/12.7972266; Zabokritskii B. Ya., 1972, Ukrayins'kyi Fizychnyi Zhurnal, V17	50	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1054-660X	1555-6611		LASER PHYS	Laser Phys.	DEC	2014	24	12							125401	10.1088/1054-660X/24/12/125401		12	Optics; Physics, Applied	Optics; Physics	AT9CY	WOS:000345226800013		
J	Kaminskii, AA; Zhang, J; Lux, O; Rhee, H; Eichler, HJ; Tang, DV; Yu, HH; Zhang, HJ; Wang, J; Yoneda, H; Shirakawa, A				Kaminskii, A. A.; Zhang, J.; Lux, O.; Rhee, H.; Eichler, H. J.; Tang, D. V.; Yu, H. H.; Zhang, H. J.; Wang, J.; Yoneda, H.; Shirakawa, A.			Stimulated Raman scattering spectroscopy of Y0.4Gd0.6VO4 crystals with partly disordered zircon-type structure-observation of new chi((3))-nonlinear optical interactions	LASER PHYSICS LETTERS			English	Article						stimulated Raman scattering (SRS); partly disordered tetragonal vanadate; Y0.4Gd0.6VO4; Raman crystal; zircon-type crystal; stokes and anti-stokes frequency comb; cross-cascaded nonlinear optical effects; many-phonon SRS; Raman frequency converter	TETRAGONAL VANADATES YVO4; STOKES COMB GENERATION; SRS-ACTIVE CRYSTAL; SINGLE-CRYSTALS; LATTICE-VIBRATIONS; YTTRIUM VANADATE; LASER; GDVO4; CONVERSION; NM	This letter presents the results of stimulated Raman scattering (SRS) spectroscopy of tetragonal Y0.4Gd0.6VO4 vanadate crystals having a partly disordered zircon-type structure. Picosecond laser pumping revealed previously unexplored chi((3))-nonlinear interactions comprising the generation of an almost two-octave spanning Stokes and anti-Stokes frequency comb, self-third harmonic generation as well as cross-cascaded processes involving four different Raman-active modes. The recorded spectral lines have been assigned to the participating molecular vibrational modes of the (VO4)(3-) structural units of the studied crystal. In addition, this work provides a brief review of all known SRS-active tetragonal and monoclinic vanadates of the form REVO4 including their chi((3))-nonlinear properties and steady-state Raman gain coefficients for first Stokes generation.	[Kaminskii, A. A.] Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia; [Zhang, J.; Tang, D. V.] Jiangsu Normal Univ, Sch Phys & Elect Engn, Xuzhou 221116, Peoples R China; [Lux, O.; Rhee, H.; Eichler, H. J.] Tech Univ Berlin, Inst Opt & Atom Phys, D-10623 Berlin, Germany; [Yu, H. H.; Zhang, H. J.; Wang, J.] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China; [Yu, H. H.; Zhang, H. J.; Wang, J.] Shandong Univ, Inst Crystal Mat, Jinan 250100, Peoples R China; [Yoneda, H.; Shirakawa, A.] Univ Electrocommun, Inst Laser Sci, Tokyo 1828585, Japan	Kaminskii, AA (reprint author), Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia.	kaminalex@mail.ru; jzhang@jsnu.edu.cn; oliver.lux@physik.tu-berlin.de	Zhang, Jian/G-8296-2011	Zhang, Jian/0000-0001-9061-3940			Chen YF, 2004, OPT LETT, V29, P2172, DOI 10.1364/OL.29.002172; Kaminskii A, 2008, APPL PHYS B-LASERS O, V93, P865, DOI 10.1007/s00340-008-3234-9; Kaminskii AA, 2008, LASER PHYS LETT, V5, P367, DOI 10.1002/lapl.200810005; DUCLOS SJ, 1989, J PHYS CHEM SOLIDS, V50, P769, DOI 10.1016/0022-3697(89)90055-3; Panchal V, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064111; Kaminskii AA, 2007, LASER PHOTONICS REV, V1, P93, DOI 10.1002/lpor.200710008; Bohaty L, 2012, LASER PHOTONICS REV, V6, P690, DOI 10.1002/lpor.201200028; MILLER SA, 1968, PHYS REV, V168, P964, DOI 10.1103/PhysRev.168.964; Chen YF, 2004, OPT LETT, V29, P1915, DOI 10.1364/OL.29.001915; Kaminskii AA, 2001, OPT COMMUN, V194, P201, DOI 10.1016/S0030-4018(01)01274-3; Kaminskii AA, 2012, LASER PHYS LETT, V9, P879, DOI 10.7452/lapl.201210103; Santos CC, 2007, J APPL PHYS, V101, DOI 10.1063/1.2437676; Piper JA, 2007, IEEE J SEL TOP QUANT, V13, P692, DOI 10.1109/JSTQE.2007.897175; Chen YF, 2004, OPT LETT, V29, P2632, DOI 10.1364/OL.29.002632; OCONNOR JR, 1966, APPL PHYS LETT, V9, P407, DOI 10.1063/1.1754631; Basiev TT, 2004, LASER PHYS LETT, V1, P237, DOI 10.1002/lapl.200410057; Cerny P, 2004, PROG QUANT ELECTRON, V28, P113, DOI 10.1016/j.pquantelec.2003.09.003; Guedes I, 2001, J APPL PHYS, V90, P1843, DOI 10.1063/1.1384858; Shayeganrad G, 2013, OPT COMMUN, V292, P131, DOI 10.1016/j.optcom.2012.11.060; Bohaty L, 2013, PHYS STATUS SOLIDI-R, V7, P429, DOI 10.1002/pssr.201307143; CHAVES A, 1972, SOLID STATE COMMUN, V10, P1075, DOI 10.1016/0038-1098(72)90899-X; Chen YF, 2004, OPT LETT, V29, P2279, DOI 10.1364/OL.29.002279; Duan YM, 2011, LASER PHYS, V21, P1859, DOI 10.1134/S1054660X11190108; HARLEY RT, 1971, SOLID STATE COMMUN, V9, P515, DOI 10.1016/0038-1098(71)90136-0; Jindal R, 2013, SPECTROCHIM ACTA A, V113, P286, DOI 10.1016/j.saa.2013.05.005; Kaminskii A, 2008, LASER PHYS, V18, P1546, DOI 10.1134/S1054660X08120268; Kaminskii A A, 1969, INORG MAT USSR, V5, P763; Kaminskii AA, 2014, PHYS STATUS SOLIDI B, V251, P1045, DOI 10.1002/pssb.201451009; Kaminskii AA, 2009, LASER PHYS LETT, V6, P374, DOI 10.1002/lapl.200910008; Kaminskii AA, 2001, LASER PHYS, V11, P1124; Kaminskii AA, 2015, PHYS STATUS SOLIDI B, V252, P305, DOI 10.1002/pssb.201451413; Kaminskii AA, 2012, APPL PHYS B-LASERS O, V109, P649, DOI 10.1007/s00340-012-5233-0; Kisel VE, 2005, APPL PHYS B-LASERS O, V80, P471, DOI 10.1007/s00340-005-1749-x; Lin JP, 2012, OPT EXPRESS, V20, P15180, DOI 10.1364/OE.20.015180; Lu YF, 2010, LASER PHYS LETT, V7, P787, DOI 10.1002/lapl.201010064; Maunders E A, 1976, J OPT SOC AM, V66, P1405; Rouseau D L, 1968, J RAMAN SPECTROSC, V10, P253; RUBIN JJ, 1966, J APPL PHYS, V37, P2920, DOI 10.1063/1.1782159; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Shuzhen F, 2011, OPT COMMUN, V284, P1642, DOI 10.1016/j.optcom.2010.11.050; Voron'ko YK, 2009, PHYS SOLID STATE+, V51, P1886, DOI 10.1134/S1063783409090200; Weber M.J., 1999, HDB LASER WAVELENGTH; Yu HH, 2014, LASER PHOTONICS REV, V8, P847, DOI 10.1002/lpor.201400022	43	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1612-2011	1612-202X		LASER PHYS LETT	Laser Phys. Lett.	DEC	2014	11	12							125808	10.1088/1612-2011/11/12/125808		8	Optics; Physics, Applied	Optics; Physics	AT9AZ	WOS:000345221300031		
J	Waki, N; Matsumoto, M; Fukui, Y; Suganuma, H				Waki, N.; Matsumoto, M.; Fukui, Y.; Suganuma, H.			Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: an open-label pilot study	LETTERS IN APPLIED MICROBIOLOGY			English	Article						incidence; influenza; Lactobacillus brevis KB290; probiotics; schoolchildren	SSP BULGARICUS OLL1073R-1; RANDOMIZED CONTROLLED-TRIAL; VIRUS INFECTION; DOUBLE-BLIND; EXOPOLYSACCHARIDES; VACCINATION; DURATION; EFFICACY; COLD; MICE	We investigated the efficacy of dietary consumption of Lactobacillus brevis KB290 (KB290) against influenza in humans by a preliminary intervention study on elementary schoolchildren, using a commercially available probiotic drink. Subjects were divided into Groups A and B, and an open-label, parallel-group trial was conducted in two 8-week periods at a 1-month interval in winter 2013/2014. Group A was provided with a bottle of the test drink containing KB290 (about 6billion colony-forming units) every school day in the first period and had no treatment in the second period, and vice versa for Group B. Epidemic influenza was not observed during the first period and only two of 1783 subjects were diagnosed. In the second period, the incidence of influenza in Groups A (no treatment) and B (provided the test drink) was 239 and 157%, respectively, and the difference was statistically significant (P<0001). The reduction in the incidence of influenza by KB290 consumption was especially remarkable in unvaccinated individuals. This is believed to be the first study to show a probiotic food reducing the incidence of influenza in schoolchildren, although further studies are needed to confirm the effectiveness of the probiotic strain KB290.	[Waki, N.; Matsumoto, M.; Fukui, Y.; Suganuma, H.] Kagome Co Ltd, Div Res & Dev, Nasushiobara, Tochigi 3292762, Japan	Waki, N (reprint author), Kagome Co Ltd, Div Res & Dev, 17 Nishitomiyama, Nasushiobara, Tochigi 3292762, Japan.	Naoko_Waki@kagome.co.jp					Makino S, 2010, BRIT J NUTR, V104, P998, DOI 10.1017/S000711451000173X; Neuzil KM, 2001, PEDIATR INFECT DIS J, V20, P733, DOI 10.1097/00006454-200108000-00004; Olivares M, 2007, NUTRITION, V23, P254, DOI 10.1016/j.nut.2007.01.004; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Namba K, 2010, BIOSCI BIOTECH BIOCH, V74, P939, DOI 10.1271/bbb.90749; SUGAYA N, 1994, JAMA-J AM MED ASSOC, V272, P1122, DOI 10.1001/jama.272.14.1122; Guillemard E, 2010, BRIT J NUTR, V103, P58, DOI 10.1017/S0007114509991395; Makino S, 2006, J DAIRY SCI, V89, P2873; Kishi A, 1996, J AM COLL NUTR, V15, P408; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Merenstein D, 2010, EUR J CLIN NUTR, V64, P669, DOI 10.1038/ejcn.2010.65; Kawai S, 2011, CLIN INFECT DIS, V53, P130, DOI 10.1093/cid/cir336; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Suzuki S, 2013, CAN J MICROBIOL, V59, P549, DOI 10.1139/cjm-2013-0115; Waki N, 2014, LETT APPL MICROBIOL, V58, P87, DOI 10.1111/lam.12160; Ujike M, 2010, EMERG INFECT DIS, V16, P926, DOI 10.3201/eid1606.091623; Barik S., 2012, BMC MED, V13, P104; Fukui Y., 2013, BR J NUTR, V2, P1; Fukui Y., 2014, BR J NUTR, V28, P1; Gasparini R, 2013, HUM VACC IMMUNOTHER, V9, P561, DOI 10.4161/hv.23235; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-15; Murakami Katsumi, 2012, Biopsychosoc Med, V6, P16, DOI 10.1186/1751-0759-6-16; Nagai T, 2011, INT IMMUNOPHARMACOL, V11, P2246, DOI 10.1016/j.intimp.2011.09.012; Nobuta Y., 2009, International Journal of Probiotics and Prebiotics, V4, P263; Vouloumanou EK, 2009, INT J ANTIMICROB AG, V34, pe1	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0266-8254	1472-765X		LETT APPL MICROBIOL	Lett. Appl. Microbiol.	DEC	2014	59	6					565	571		10.1111/lam.12340		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AT8ZS	WOS:000345218100001		
J	Imada, K; Tanaka, S; Ibaraki, Y; Yoshimura, K; Ito, S				Imada, K.; Tanaka, S.; Ibaraki, Y.; Yoshimura, K.; Ito, S.			Antifungal effect of 405-nm light on Botrytis cinerea	LETTERS IN APPLIED MICROBIOLOGY			English	Article						aminolevulinic acid; antifungal; Botrytis cinerea; oxidative stress; singlet oxygen; Solanum lycopersicum L; visible blue light	TRICHOPHYTON-RUBRUM; HEME-BIOSYNTHESIS; INACTIVATION; PORPHYRINS; BACTERIA; ACID	There is very little information on the fungistatic or fungicidal effect of visible light. This study investigated the effect of 405-nm light, generated by a light-emitting diode array, on the economically important fungus Botrytis cinerea. The mycelial growth of B.cinerea was inhibited to the greatest extent by light at 405 and 415nm and was negligibly inactivated at 450nm, suggesting the presence of a photosensitizing compound that absorbs light mainly at wavelengths of 405-415nm. Delta-aminolevulinic acid, a precursor of endogenous photosensitizer porphyrins, was used to determine the role of these porphyrins in 405-nm light-mediated photoinactivation of the fungus. Concentration-dependent inhibition of spore germination by delta-aminolevulinic acid and accumulation of singlet oxygen in the spores was observed when the spores were exposed to 405-nm light. These results suggest that the excitation of endogenous porphyrins and subsequent accumulation of singlet oxygen could partially explain the 405-nm light-mediated photoinactivation of B.cinerea. The development of symptoms in detached tomato leaves inoculated with B.cinerea spores was significantly reduced by irradiation with 405-nm light, indicating that 405-nm light has a potential use for controlling plant diseases caused by B.cinerea.	[Imada, K.; Tanaka, S.; Ibaraki, Y.; Ito, S.] Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Yamaguchi 7538515, Japan; [Yoshimura, K.] Yamaguchi Prefectural Ind Technol Inst, Ube, Yamaguchi, Japan	Ito, S (reprint author), Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	shinsan@yamaguchi-u.ac.jp			Regional Innovation Cluster Program (Global Type) 'Yamaguchi Green Materials Cluster'; Ministry of Education, Culture, Sports, Science and Technology, Japan	This research was supported by the Regional Innovation Cluster Program (Global Type) 'Yamaguchi Green Materials Cluster' and a Grant-in-Aid for Scientific Research (B) funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Schobert M, 2002, J MOL MICROB BIOTECH, V4, P287; Maclean M, 2008, FEMS MICROBIOL LETT, V285, P227, DOI 10.1111/j.1574-6968.2008.01233.x; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Keller M, 2003, VITIS, V42, P87; Murdoch LE, 2013, FUNGAL BIOL-UK, V117, P519, DOI 10.1016/j.funbio.2013.05.004; Ashkenazi H, 2003, FEMS IMMUNOL MED MIC, V35, P17, DOI 10.1016/S0928-8244(02)00423-6; Nitzan Y, 1999, LASER MED SCI, V14, P269, DOI 10.1007/s101030050094; Kobayashi Michie, 2013, Environment Control in Biology, V51, P157, DOI 10.2525/ecb.51.157; Kamp H, 2005, MYCOSES, V48, P101, DOI 10.1111/j.1439-0507.2004.01070.x; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Calzavara-Pinton P, 2012, PHOTOCHEM PHOTOBIOL, V88, P512, DOI 10.1111/j.1751-1097.2012.01107.x; Marquenie D, 2002, INT J FOOD MICROBIOL, V74, P27, DOI 10.1016/S0168-1605(01)00719-X; Young AR, 2006, PROG BIOPHYS MOL BIO, V92, P80, DOI 10.1016/j.pbiomolbio.2006.02.005; Franken ACW, 2011, APPL MICROBIOL BIOT, V91, P447, DOI 10.1007/s00253-011-3391-3; Oriel S, 2010, CURR MICROBIOL, V60, P117, DOI 10.1007/s00284-009-9514-8; Endarko E, 2012, PHOTOCHEM PHOTOBIOL, V88, P1280, DOI 10.1111/j.1751-1097.2012.01173.x; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; Baltazar LD, 2013, J ANTIMICROB CHEMOTH, V68, P354, DOI 10.1093/jac/dks414; Canessa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084223; Islam SZ, 1998, PLANT DIS, V82, P850, DOI 10.1094/PDIS.1998.82.8.850; Nakajima M, 2014, J GEN PLANT PATHOL, V80, P15, DOI 10.1007/s10327-013-0492-0; Ranganna B, 1997, CAN J PLANT PATHOL, V19, P30; REDDI E, 1988, REV CHEM INTERMED, V10, P241; Schumacher J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004040; Tan K. K., 1973, T BRIT MYCOLOGICAL S, V61, P145; vansKan J. A., 2006, TRENDS PLANT SCI, V11, P247	27	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0266-8254	1472-765X		LETT APPL MICROBIOL	Lett. Appl. Microbiol.	DEC	2014	59	6					670	676		10.1111/lam.12330		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	AT8ZS	WOS:000345218100016		
J	Magni, P; Como, S; Montani, S; Tsutsumi, H				Magni, P.; Como, S.; Montani, S.; Tsutsumi, H.			Interlinked seasonal variation in biogenic nutrient fluxes and pore-water nutrient concentrations in intertidal sediments	MARINE BIOLOGY			English	Article							SETO INLAND SEA; ARTIFICIAL TIDAL FLAT; INNER TOKYO BAY; RUDITAPES-PHILIPPINARUM; OSAKA BAY; MUSCULISTA-SENHOUSIA; BENTHIC MACROFAUNA; BOTTOM SEDIMENTS; TEMPORAL-CHANGES; NITROGEN BUDGET	The seasonal variation in biogenic fluxes of NH4+, PO43- and SiO2 calculated from the nutrient excretion rates of dominant bivalves (Ruditapes philippinarum and Arcuatula [=Musculista] senhousia), and pore-water nutrient (NH4+, PO43-, SiO2 and NO3- + NO2-), sedimentary acid-volatile sulfide (AVS) and benthic chlorophyll-a (Chl-a) concentrations was assessed on an intertidal sandflat in the Seto Inland Sea (Japan) from summer 1994 to autumn 1995. In spite of the large variability between sampling dates and stations, significant correlations between biogenic nutrient fluxes and pore-water nutrient concentrations were found, suggesting a seasonal linkage between bivalve-mediated biological processes and chemical features of sediments. This linkage was stronger in surface (0-0.5 cm) than subsurface (0.5-2 cm) sediments, consistent with the autoecological characteristics of R. philippinarum and A. senhousia inhabiting the uppermost sediment layer. Significant temporal variation in porewater NO3- + NO2-, sedimentary AVS and benthic Chl-a concentrations was also found, which was related to both occasional extreme events (e. g., dystrophy) and alternating periods of production and decomposition. This study may serve twofold in (1) contributing to unravel the ecological structure and functioning of natural tidal flats, and the scale of seasonal variability in biotic and sedimentary parameters and (2) providing useful information for assessing the effectiveness of the physico-chemical and biological structure of artificial tidal flats which are growing in number and extension worldwide.	[Magni, P.; Como, S.] CNR IAMC, I-09170 Torregrande, Oristano, Italy; [Magni, P.] Consiglio Nazl Ric Ist Sci Marine CNR ISMAR, I-30122 Venice, Italy; [Montani, S.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Tsutsumi, H.] Prefectural Univ Kumamoto, Fac Environm & Symbiot Sci, Kumamoto 8628502, Japan	Magni, P (reprint author), CNR IAMC, I-09170 Torregrande, Oristano, Italy.	paolo.magni@cnr.it	CNR, Ismar/P-1247-2014; Magni, Paolo/F-2691-2012; 	CNR, Ismar/0000-0001-5351-1486; Magni, Paolo/0000-0001-5955-6829	Ministry of Education, Culture, Sports, Science and Technology of Japan [22380102]; Flagship Project RITMARE-The Italian Research for the Sea-Italian Ministry of Education, University and Research	This study was partly supported by a research fund (No. 22380102) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid of Scientific Research) and by the Flagship Project RITMARE-The Italian Research for the Sea-coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research. We gratefully acknowledge the constructive criticisms of two anonymous reviewers which helped us improve manuscript's clarity.	RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.2307/2409177; Yang HY, 2011, BIRD CONSERV INT, V21, P241, DOI 10.1017/S0959270911000086; SCHLUTER L, 1994, HELGOLANDER MEERESUN, V48, P419, DOI 10.1007/BF02366255; Crooks JA, 1998, MAR ECOL PROG SER, V162, P137, DOI 10.3354/meps162137; DAME RF, 1984, J EXP MAR BIOL ECOL, V83, P239, DOI 10.1016/S0022-0981(84)80003-9; DAME R, 1991, ESTUARIES, V14, P130, DOI 10.2307/1351686; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343; Ishii R, 2008, MAR POLLUT BULL, V56, P2059, DOI 10.1016/j.marpolbul.2008.07.022; Magni P, 2000, MAR ECOL PROG SER, V198, P139, DOI 10.3354/meps198139; Spilmont N, 2011, ESTUAR COAST SHELF S, V95, P470, DOI 10.1016/j.ecss.2011.10.021; RYSGAARD S, 1995, MAR ECOL PROG SER, V126, P111, DOI 10.3354/meps126111; Crooks JA, 1999, J EXP MAR BIOL ECOL, V240, P53, DOI 10.1016/S0022-0981(99)00041-6; Welsh DT, 2003, CHEM ECOL, V19, P321, DOI 10.1080/0275754031000155474; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; Kasai A, 2004, FISHERIES SCI, V70, P11, DOI 10.1111/j.1444-2906.2003.00764.x; Ricciardi A, 1998, MAR ECOL PROG SER, V163, P245, DOI 10.3354/meps163245; Gimenez L, 2006, ESTUAR COAST SHELF S, V68, P462, DOI 10.1016/j.eccs.2006.03.001; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; Aldous A, 2005, RESTOR ECOL, V13, P341, DOI 10.1111/j.1526-100X.2005.00043.x; Nizzoli D, 2011, MAR POLLUT BULL, V62, P1276, DOI 10.1016/j.marpolbul.2011.03.009; Zhang L, 2013, ESTUAR COAST SHELF S, V133, P182, DOI 10.1016/j.ecss.2013.08.028; Trimmer M, 1998, MAR ECOL PROG SER, V163, P109, DOI 10.3354/meps163109; Donadi S, 2013, ECOLOGY, V94, P489; MORRISEY DJ, 1992, J EXP MAR BIOL ECOL, V164, P233, DOI 10.1016/0022-0981(92)90177-C; Wang WW, 2011, ENVIRON EARTH SCI, V63, P1067, DOI 10.1007/s12665-010-0782-1; Zainal K, 2012, MAR POLLUT BULL, V64, P1452, DOI 10.1016/j.marpolbul.2012.04.004; MANN R, 1978, ESTUAR COAST MAR SCI, V6, P335, DOI 10.1016/0302-3524(78)90021-X; Aoki S, 2011, NIPPON SUISAN GAKK, V77, P606, DOI 10.2331/suisan.77.606; Asmus H, 1990, BER BIOL ANST HELGOL, V6, P1; Asmus RM, 2000, HYDROBIOLOGIA, V436, P217, DOI 10.1023/A:1026542621512; Bartoli M, 2009, J EXP MAR BIOL ECOL, V381, P105, DOI 10.1016/j.jembe.2009.09.018; Bartoli M, 2001, HYDROBIOLOGIA, V455, P203, DOI 10.1023/A:1011910422400; BAYNE BL, 1977, J MAR BIOL ASSOC UK, V57, P355; CASTEL J, 1989, ESTUAR COAST SHELF S, V28, P71, DOI 10.1016/0272-7714(89)90042-5; Davoult D, 2009, HYDROBIOLOGIA, V620, P163, DOI 10.1007/s10750-008-9626-3; DOERING PH, 1987, MAR BIOL, V94, P377, DOI 10.1007/BF00428243; Eguchi M, 2002, FISHERIES SCI, V68, P596; French K, 2004, ESTUAR COAST SHELF S, V61, P173, DOI 10.1016/j.ecss.2004.04.013; GOULLETQUER P, 1989, J EXP MAR BIOL ECOL, V132, P85, DOI 10.1016/0022-0981(89)90217-7; Guarini JM, 1998, MAR ECOL PROG SER, V166, P131, DOI 10.3354/meps166131; Hatano T, 2013, J JSCE, V1, P145; HUETTEL M, 1990, Marine Ecology Progress Series, V62, P241; Hutchison L, 2015, ESTUAR COAST, V38, pS67, DOI 10.1007/s12237-013-9647-7; Ichimi K, 2012, J PHYCOL, V48, P1284, DOI 10.1111/j.1529-8817.2012.01185.x; Imanaka S, 2002, FISHERIES SCI, V68, P449; Kanaya G, 2013, MAR POLLUT BULL, V71, P179, DOI 10.1016/j.marpolbul.2013.03.018; KLUMP JV, 1989, LIMNOL OCEANOGR, V34, P559; Komorita T, 2010, J EXP MAR BIOL ECOL, V383, P8, DOI 10.1016/j.jembe.2009.10.018; Komorita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086732; Kuwae T, 2003, ESTUAR COAST SHELF S, V57, P929, DOI 10.1016/S0272-7714(02)00423-7; Kuwae T, 1998, MANGROVES SALT MARSH, V2, P167, DOI 10.1023/A:1009973605222; Lee JG, 1998, WATER RES, V32, P2601; LERAT Y, 1990, J EXP MAR BIOL ECOL, V135, P135, DOI 10.1016/0022-0981(90)90012-2; Magni P, 2005, WATER ENCY, P6; Magni P, 1997, LA MER, V35, P137; Magni P, 2002, J OCEANOGR, V58, P389, DOI 10.1023/A:1015826212267; Magni P, 2006, HYDROBIOLOGIA, V571, P297, DOI 10.1007/s10750-006-0242-9; Magni P, 2006, MAR BIOL, V149, P1185, DOI 10.1007/s00227-006-0298-0; Magni P, 2000, HYDROBIOLOGIA, V432, P9, DOI 10.1023/A:1004064917794; Marinelli RL, 1998, LIMNOL OCEANOGR, V43, P1305; Montani S., 1998, J OCEANOGR, V54, P65, DOI 10.1007/BF02744382; Montani S, 2003, MAR ECOL PROG SER, V249, P79, DOI 10.3354/meps249079; Mortimer RJG, 1999, ESTUAR COAST SHELF S, V48, P683, DOI 10.1006/ecss.1999.0479; Nam J, 2010, OCEAN COAST MANAGE, V53, P703, DOI 10.1016/j.ocecoaman.2010.10.002; Nishijima W, 2014, MAR POLLUT BULL, V82, P101, DOI 10.1016/j.marpolbul.2014.03.014; Parsons T.R, 1984, MANUAL CHEM BIOL MET; PRINS TC, 1994, HYDROBIOLOGIA, V283, P413, DOI 10.1007/BF00024645; Sandwell DR, 2009, J EXP MAR BIOL ECOL, V373, P16, DOI 10.1016/j.jembe.2009.02.015; Smith AS, 2014, ENVIRON SCI-PROC IMP, V16, P106, DOI 10.1039/c3em00465a; Stief P, 2013, BIOGEOSCIENCES, V10, P7829, DOI 10.5194/bg-10-7829-2013; Strickland J.D.H., 1972, FISHERIES RES BOARD, V167, P310; Underwood A.J., 1997, EXPT ECOLOGY THEIR L; Winer B. J., 1991, STAT PRINCIPLES EXPT; Yamochi S, 2008, MAR POLLUT BULL, V57, P137, DOI 10.1016/j.marpolbul.2008.04.032; Yamochi S, 2013, ESTUAR COAST SHELF S, V116, P21, DOI 10.1016/j.ecss.2012.07.002; Yamochi S, 2003, INT SER PROG WAT RES, V9, P93; Zar J. H., 2010, BIOSTATISTICAL ANAL	77	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	DEC	2014	161	12					2767	2779		10.1007/s00227-014-2541-4		13	Marine & Freshwater Biology	Marine & Freshwater Biology	AT6LS	WOS:000345050800005		
J	Gould, AL; Harii, S; Dunlap, PV				Gould, Alison L.; Harii, Saki; Dunlap, Paul V.			Host preference, site fidelity, and homing behavior of the symbiotically luminous cardinalfish, Siphamia tubifer (Perciformes: Apogonidae)	MARINE BIOLOGY			English	Article							CORAL-REEF FISH; GREAT-BARRIER-REEF; SEA-URCHIN CARDINALFISH; PHOTOBACTERIUM-MANDAPAMENSIS; SELECTIVE PREDATION; HABITAT; VERSICOLOR; DOEDERLEINI; SETTLEMENT; AUSTRALIA	The sea urchin cardinalfish, Siphamia tubifer (Perciformes: Apogonidae), is unusual among coral reef fishes for its use of bioluminescence, produced by symbiotic bacteria, while foraging at night. As a foundation for understanding the relationship between the symbiosis and the ecology of the fish, this study examined the diel behavior, host urchin preference, site fidelity, and homing of S. tubifer in June and July of 2012 and 2013 at reefs near Sesoko Island, Okinawa, Japan (26 degrees 38'N, 127 degrees 52'E). After foraging, S. tubifer aggregated in groups among the spines of the longspine sea urchin, Diadema setosum, and the banded sea urchin, Echinothrix calamaris. A preference for D. setosum was evident (P < 0.001), especially by larger individuals (>25 mm standard length, P < 0.01), and choice experiments demonstrated the ability of S. tubifer to recognize and orient to a host urchin and to conspecifics. Tagging studies revealed that S. tubifer exhibits daily fidelity to a host urchin; 43-50 and 26-37 % of tagged individuals were associated with the same urchin after 3 and 7 days. Tagged fish also returned to their site of origin after displacement; by day two, 23-43 and 27-33 % of tagged individuals returned from displacement distances of 1 and 2 km. These results suggest that S. tubifer uses various environmental cues for homing and site fidelity; similar behaviors and cues might be used by larvae for recruitment to settlement sites and for the acquisition of luminous symbiotic bacteria.	[Gould, Alison L.; Dunlap, Paul V.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Harii, Saki] Univ Ryukyus, Trop Biosphere Res Ctr, Sesoko Stn, Motobu, Okinawa 9050227, Japan	Gould, AL (reprint author), Univ Michigan, Dept Ecol & Evolutionary Biol, 830 North Univ Ave, Ann Arbor, MI 48109 USA.	algould@umich.edu			University of Michigan's Rackham Graduate School and International Institute; University of Michigan's Department of Ecology and Evolutionary Biology	We thank K. Dougan (University of Michigan) and S. Kadena (Sesoko Station) for technical assistance. This study is a contribution from Sesoko Station, Tropical Biosphere Research Center, University of the Ryukyus. Support was provided by the University of Michigan's Rackham Graduate School and International Institute, and the Department of Ecology and Evolutionary Biology.	ALLEN GR, 1972, COPEIA, P595; Allen Gerald R., 1993, Revue Francaise d'Aquariologie Herpetologie, V20, P9; Okuda N, 1996, ENVIRON BIOL FISH, V45, P397, DOI 10.1007/BF00002532; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Kaeding AJ, 2007, APPL ENVIRON MICROB, V73, P3173, DOI 10.1128/AEM.02212-06; Shima JS, 2001, ECOLOGY, V82, P2190, DOI 10.1890/0012-9658(2001)082[2190:ROACRF]2.0.CO;2; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Marnane MJ, 2000, J FISH BIOL, V57, P1590, DOI 10.1006/jfbi.2000.1422; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Marnane MJ, 2002, MAR ECOL PROG SER, V231, P261, DOI 10.3354/meps231261; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; GREENFIELD DW, 1990, COPEIA, P1107, DOI 10.2307/1446495; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Gardiner NM, 2010, CORAL REEFS, V29, P845, DOI 10.1007/s00338-010-0642-1; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/s003380050025; Dunlap PV, 2011, J MORPHOL, V272, P897, DOI 10.1002/jmor.10956; MANLY BFJ, 1972, AM NAT, V106, P719, DOI 10.1086/282808; Radford C, 2008, MAR ECOL PROG SER, V362, P37, DOI 10.3354/meps07444; Urbanczyk H, 2011, J BACTERIOL, V193, P3144, DOI 10.1128/JB.00370-11; Dunlap PV, 2012, J FISH BIOL, V81, P1340, DOI 10.1111/j.1095-8649.2012.03415.x; BELLWOOD DR, 1995, MAR ECOL PROG SER, V117, P127, DOI 10.3354/meps117127; BREDER C.M., 1966, MODES REPROD FISHES; Brown GE, 2002, ANIM BEHAV, V63, P1175, DOI 10.1006/anbe.2002.3024; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; CHRYSTAL PJ, 1985, MAR BIOL, V85, P185, DOI 10.1007/BF00397437; Doving KB, 2006, CHEM SENSES, V31, P265, DOI 10.1093/chemse/bjj028; Dunlap P, 2009, MAR BIOL, V156, P2011, DOI 10.1007/s00227-009-1232-z; Eibl-Eibesfeldt I., 1961, Zeitschrift fuer Tierpsychologie, V18, P56; Gardiner NM, 2005, MAR ECOL PROG SER, V305, P163, DOI 10.3354/meps305163; Gon O, 2012, ZOOTAXA, P1; Hohenegger J, 1999, MAR MICROPALEONTOL, V36, P109, DOI 10.1016/S0377-8398(98)00030-9; Kingsford MJ, 2014, MAR BIOL, V161, P245, DOI 10.1007/s00227-013-2331-4; Kolm N, 2005, BEHAV ECOL, V16, P521, DOI 10.1093/beheco/ari022; KUWAMURA T, 1985, ENVIRON BIOL FISH, V13, P17, DOI 10.1007/BF00004852; LACHNER ERNEST A., 1955, COPEIA, V1955, P53, DOI 10.2307/1439455; Leis JM, 2003, J FISH BIOL, V63, P724, DOI 10.1046/j.1095-8649.2003.00182.x; Leis J.M., 1986, P703; MAGNUS DIETRICH B. E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P635; Michael SW, 2013, LIONFISH ARE BEAUTIF; NODA M, 1994, ANIM BEHAV, V47, P1413, DOI 10.1006/anbe.1994.1188; R Development Core Team, 2012, R LANG ENV STAT COMP; Radcliffe L, 1911, P US NATL MUS, V41, P245, DOI DOI 10.5479/SI.00963801.41-1853.245; Rogers P.H., 1988, P131; SALE P F, 1978, Environmental Biology of Fishes, V3, P85, DOI 10.1007/BF00006310; Sale P.F., 1978, P313; SHAPIRO DY, 1986, ANIM BEHAV, V34, P865, DOI 10.1016/S0003-3472(86)80072-0; Shima JS, 2012, J EXP MAR BIOL ECOL, V416, P162, DOI 10.1016/j.jembe.2012.02.020; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Stier AC, 2009, CORAL REEFS, V28, P227, DOI 10.1007/s00338-008-0445-9; STRASBUR.DW, 1966, PAC SCI, V20, P338; Tamura R., 1982, Galaxea, V1, P1; Thresher RE, 1984, REPROD REEF FISHES, P399; TOMINAGA YOSHIAKL, 1964, JAP J ICHTHYOL, V12, P10; Weber M., 1909, NOTES LEYDEN MUSEUM, V31, P143; White GE, 2013, MAR BIOL, V160, P1365, DOI 10.1007/s00227-013-2188-6; YOSHIYAMA RM, 1992, J EXP MAR BIOL ECOL, V160, P115, DOI 10.1016/0022-0981(92)90114-P	58	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	DEC	2014	161	12					2897	2907		10.1007/s00227-014-2554-z		11	Marine & Freshwater Biology	Marine & Freshwater Biology	AT6LS	WOS:000345050800015		
J	Ferrandiz, CM				Ferrandiz, Carlos Moraga			Elimination of extremal index zeroes from generic paths of closed -forms	MATHEMATISCHE ZEITSCHRIFT			English	Article						Morse-Novikov theory; Cerf theory; Closed 1-forms; Pseudo-gradients; Pseudo-isotopy; s-cobordism		Let be a Morse closed -form of a smooth -dimensional manifold . The zeroes of of index or are called centers. It is known that every non-vanishing de Rham cohomology class contains a Morse representative without centers. The result of this paper is the one-parameter analogue of the last statement: every generic path of closed -forms in a fixed class such that have no centers, can be modified relatively to its extremities to another such path having no center at all.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Ferrandiz, CM (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	carlos@ms.u-tokyo.ac.jp			ERC GEODYCON project [eOTP: 12GEODYC]; JSPS Postdoctoral Fellowship	I greatly appreciate the comments from the anonymous referee, specially for having pointed out an accident that was not treated in the first version of the paper. The first version was partially written at the University of Nantes under the financial support of the "ERC GEODYCON project" (eOTP: 12GEODYC). The revisions and improvements which have led to this final version were made during a "JSPS Postdoctoral Fellowship" under remarkably good research conditions at The University of Tokyo.	MOSER J, 1965, T AM MATH SOC, V120, P286, DOI 10.2307/1994022; ARNOUX P, 1986, INVENT MATH, V84, P141, DOI 10.1007/BF01388736; Cerf J., 1970, I HAUTES ETUDES SCI, V39, P5, DOI DOI 10.1007/BF02684687; Cerf J., 1968, LECT NOTES MATH, V53; Farber M, 2004, MATH SURVEYS MONOGRA, V108; Golubitsky M., 1973, GRADUATE TEXTS MATH, V14; Hatcher A., 1973, ASTERISQUE, P6; Hirsch M.W., 1994, GRADUATE TEXTS MATH, V33; Kupka I., 1963, CONTRIB DIFFERENTIAL, V2, P457; Latour F., 1995, I HAUTES ETUDES SCI, P135; Laudenbach F, 2013, CR MATH, V351, P483, DOI 10.1016/j.crma.2013.06.009; Laudenbach F., 2010, IMHOTEP AFR J PURE A, V9; Laudenbach F., 2014, ANN FS TOULOUSE, VXXIII, P197; Martinet J., 1982, LONDON MATH SOC LECT, V58; Maumary S., 1967, LNM, V48; Milnor J. W., 1965, LECT H COBORDISM THE; Moraga Ferrandiz C., 2012, THESIS U NANTES; NOVIKOV SP, 1981, DOKL AKAD NAUK SSSR+, V260, P31; Pajitnov A, 2006, DEGRUYTER STUD MATH, V32, P1, DOI 10.1515/9783110197976; Sikorav J.-C., 1987, THESIS PARIS 11 ORSA; Thom R., 1955, ANN I FOURIER GRENOB, V6, P43	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	DEC	2014	278	3-4					743	765		10.1007/s00209-014-1332-4		23	Mathematics	Mathematics	AU0EO	WOS:000345296500005		
J	Miyachi, H				Miyachi, Hideki			Unification of extremal length geometry on Teichmuller space via intersection number	MATHEMATISCHE ZEITSCHRIFT			English	Article						Teichmuller space; Teichmuller distance; Extremal length; Intersection number; Gromov product; Mapping class group	GARDINER-MASUR BOUNDARY; QUADRATIC-DIFFERENTIALS; RIEMANN SURFACES; TRANSFORMATIONS; AUTOMORPHISMS; FOLIATIONS; ISOMETRIES; GEODESICS; THEOREM; CURVES	In this paper, we give a framework for the study of the extremal length geometry of Teichmuller space after S. Kerckhoff, F. Gardiner and H. Masur. There is a natural compactification using extremal length geometry introduced by Gardiner and Masur. The compactification is realized in a certain projective space. We develop the extremal length geometry in the cone which is defined as the inverse image of the compactification via the quotient mapping. The compactification is identified with a subset of the cone by taking an appropriate lift. The cone contains canonically the space of measured foliations in the boundary. We first extend the geometric intersection number on the space of measured foliations to the cone, and observe that the restriction of the intersection number to Teichmuller space is represented by an explicit formula in terms of the Gromov product with respect to the Teichmuller distance. From this observation, we deduce that the Gromov product extends continuously to the compactification. As an application, we obtain an alternative approach to a characterization of the isometry group of Teichmuller space. We also obtain a new realization of Teichmuller space, a hyperboloid model of Teichmuller space with respect to the Teichmuller distance.	Osaka Univ, Grad Sch Sci, Dept Math, Toyonaka, Osaka 5600043, Japan	Miyachi, H (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Machikaneyama 1-1, Toyonaka, Osaka 5600043, Japan.	miyachi@math.sci.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture [21540177]	The author is partially supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C), 21540177.	MINSKY YN, 1993, TOPOLOGY, V32, P625, DOI 10.1016/0040-9383(93)90013-L; BONAHON F, 1988, INVENT MATH, V92, P139, DOI 10.1007/BF01393996; THURSTON WP, 1988, B AM MATH SOC, V19, P417, DOI 10.1090/S0273-0979-1988-15685-6; BONAHON F, 1986, ANN MATH, V124, P71, DOI 10.2307/1971388; Bridson M. R., 1999, GRUNDLEHREN MATH WIS, V319; Douady A., 1991, SOC MATH FRANCE, V66-67; Duchin M, 2010, INVENT MATH, V182, P231, DOI 10.1007/s00222-010-0262-y; EARLE CJ, 1974, DUKE MATH J, V41, P583, DOI 10.1215/S0012-7094-74-04163-5; Earle CJ, 1996, T AM MATH SOC, V348, P1163, DOI 10.1090/S0002-9947-96-01490-0; Earle CJ, 2003, DUKE MATH J, V120, P433, DOI 10.1215/S0012-7094-03-12029-3; Gardiner F., 1991, COMPLEX VARIABLES TH, V16, P209, DOI 10.1080/17476939108814480; Gromov M., 1981, P 1978 STON BROOK C, P182; HUBBARD J, 1979, ACTA MATH-DJURSHOLM, V142, P221, DOI 10.1007/BF02395062; IMAYOSHI Y., 1992, INTRO TEICHMULLER SP; Ivanov N., 2001, AM MATH SOC TRANSL 2, V2, p[202, 131]; Ivanov N. V., 1992, TRANSLATIONS MATH MO, V115; KERCKHOFF SP, 1980, TOPOLOGY, V19, P23, DOI 10.1016/0040-9383(80)90029-4; Korkmaz M, 1999, TOPOL APPL, V95, P85, DOI 10.1016/S0166-8641(97)00278-2; Lakic N, 1997, T AM MATH SOC, V349, P2951, DOI 10.1090/S0002-9947-97-01771-6; Liu L., 2014, HDB TEICHMULLER THEO, VIV, P355; Luo F, 2000, TOPOLOGY, V39, P283, DOI 10.1016/S0040-9383(99)00008-7; Markovic V, 2003, DUKE MATH J, V120, P405, DOI 10.1215/S0012-7094-03-12028-1; MASUR H, 1975, ANN MATH, V102, P205, DOI 10.2307/1971031; MASUR H, 1982, ANN MATH, V115, P169, DOI 10.2307/1971341; Masur H, 2002, GEOMETRIAE DEDICATA, V93, P177, DOI 10.1023/A:1020300413472; Masur H., 2009, SURVEYS DIFFERENTIAL, VXIV, P295; MASUR HA, 1995, ANN ACAD SCI FENN A1, V20, P259; McCarthy JD, 1999, ANN ACAD SCI FENN-M, V24, P147; Miyachi H, 2008, GEOMETRIAE DEDICATA, V137, P113, DOI 10.1007/s10711-008-9289-2; Miyachi H, 2014, IRMA LECT MATH THEOR, V19, P375; Miyachi H., 2008, OCAMI STUDIES, V2, P295; Miyachi H, 2013, GEOMETRIAE DEDICATA, V162, P283, DOI 10.1007/s10711-012-9727-z; Rees M., 1981, ERGOD THEOR DYN SYST, V1, P461; Rieffel M. A., 2002, DOC MATH, V7, P605; Royden H. L., 1971, ANN MATH STUD, V66, P369; VEECH WA, 1982, ANN MATH, V115, P201, DOI 10.2307/1971391; Walsh C., 2012, COMMUNICATION	37	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5874	1432-1823		MATH Z	Math. Z.	DEC	2014	278	3-4					1065	1095		10.1007/s00209-014-1346-y		31	Mathematics	Mathematics	AU0EO	WOS:000345296500020		
J	Tomita, T; Nakamura, M; Hirose, Y; Kitsuda, K; Notogawa, T; Miki, K; Nakamura, K; Ishigaki, T				Tomita, Tsuneyuki; Nakamura, Mitsuhiro; Hirose, Yoshinori; Kitsuda, Kenji; Notogawa, Takuya; Miki, Katsuhito; Nakamura, Kiyonao; Ishigaki, Takashi			Multivariate analysis of factors predicting prostate dose in intensity-modulated radiotherapy	MEDICAL DOSIMETRY			English	Article						Multivariate analysis; lnterfraction displacement; Prostate cancer	CANCER RADIOTHERAPY; RADIATION-THERAPY; DISTENDED RECTUM; ORGAN MOTION; MOVEMENT; CT	We conducted a multivariate analysis to determine relationships between prostate radiation dose and the state of surrounding organs, including organ volumes and the internal angle of the levator ani muscle (LAM), based on cone-beam computed tomography (CBCT) images after bone matching. We analyzed 270 CBCT data sets from 30 consecutive patients receiving intensity-modulated radiation therapy for prostate cancer. With patients in the supine position on a couch with the HipFix system, data for center of mass (COM) displacement of the prostate and the state of individual organs were acquired and compared between planning CT and CBCT scans. Dose distributions were then recalculated based on CBCT images. The relative effects of factors on the variance in COM, dose covering 95% of the prostate volume (D-95%), and percentage of prostate volume covered by the 100% isodose line (V-100%) were evaluated by a backward stepwise multiple regression analysis. COM displacement in the anterior-posterior direction (COMAP) correlated significantly with the rectum volume (delta Vr) and the internal LAM angle (delta theta; R = 0.63). Weak correlations were seen for COM in the left-right (R = 0.18) and superior-inferior directions. (R = 0.31). Strong correlations between COMAP and prostate D-95% and V-100% were observed (R >= 0.69). Additionally, the change ratios in delta Vr and delta theta remained as predictors of prostate D-95% and V-100%. This study shows statistically that maintaining the same rectum volume and LAM state for both the planning CT simulation and treatment is important to ensure the correct prostate dose in the supine position with bone matching. (C) 2014 American Association of Medical Dosimetrists.	[Tomita, Tsuneyuki; Hirose, Yoshinori; Kitsuda, Kenji; Notogawa, Takuya; Miki, Katsuhito] Osaka Red Cross Hosp, Div Radiol, Osaka, Japan; [Nakamura, Mitsuhiro] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Applied Therapy, Sakyo Ku, Kyoto 6068507, Japan; [Nakamura, Kiyonao; Ishigaki, Takashi] Osaka Red Cross Hosp, Dept Radiat Oncol, Osaka, Japan	Nakamura, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Applied Therapy, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	m_nkmr@kuhp.lcyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23791408]; Japanese College of Medical Physics	This work was supported by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (grant no. 23791408) and Grant-in-Aid for Scientific Research from the Japanese College of Medical Physics.	Adamson J, 2009, INT J RADIAT ONCOL, V75, P260, DOI 10.1016/j.ijrobp.2009.03.007; Hatton JA, 2011, RADIOTHER ONCOL, V98, P162, DOI 10.1016/j.radonc.2011.01.006; Zelefsky MJ, 2012, INT J RADIAT ONCOL, V84, P125, DOI 10.1016/j.ijrobp.2011.11.047; De Crevoisier R, 2005, INT J RADIAT ONCOL, V62, P965, DOI 10.1016/.ijrobp.2004.11.032; TENHAKEN RK, 1991, INT J RADIAT ONCOL, V20, P1317; Yoo S, 2006, INT J RADIAT ONCOL, V66, P1553, DOI 10.1016/j.ijrobp.2006.08.031; Song WY, 2007, MED PHYS, V34, P352, DOI 10.1118/1.2405325; Van Lin ENJT, 2005, INT J RADIAT ONCOL, V63, P565, DOI 10.1016/j.ijrobp.2005.05.010; Zelefsky MJ, 2006, J UROLOGY, V176, P1415, DOI 10.1016/j.juro.2006.06.002; vanHerk M, 1995, INT J RADIAT ONCOL, V33, P1311, DOI 10.1016/0360-3016(95)00116-6; Langen KM, 2001, INT J RADIAT ONCOL, V50, P265, DOI 10.1016/S0360-3016(01)01453-5; Kitamura K, 2002, INT J RADIAT ONCOL, V53, P1117, DOI 10.1016/S0360-3016(02)02882-1; Nijkamp J, 2008, INT J RADIAT ONCOL, V70, P75, DOI 10.1016/j.ijrobp.2007.05.046; Kupelian PA, 2006, INT J RADIAT ONCOL, V66, P876, DOI 10.1016/j.ijrobp.2006.06.011; Dunn O.J., 1974, APPL STAT ANAL VARIA, VSecond; Fiorino C, 2008, INT J RADIAT ONCOL, V71, P611, DOI 10.1016/j.ijrobp.2008.01.048; Guckenberger M, 2006, RADIOTHER ONCOL, V79, P59, DOI 10.1016/j.radonc.2006.03.004; Lips IM, 2012, INT J RADIAT ONCOL, V83, P653, DOI 10.1016/j.ijrobp.2011.07.030; Onishi H, 2012, RADIOTHER ONCOL, V104, P390, DOI 10.1016/j.radonc.2012.04.005; Tanyi JA, 2010, INT J RADIAT ONCOL, V78, P1579, DOI 10.1016/j.ijrobp.2010.02.001; Wu J, 2001, RADIOTHER ONCOL, V61, P127, DOI 10.1016/S0167-8140(01)00452-2	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0958-3947	1873-4022		MED DOSIM	Med. Dosim.	WIN	2014	39	4					360	365		10.1016/j.meddos.2014.06.004		6	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	AT3OZ	WOS:000344845100013		
J	Goto, K; Morishima, T				Goto, Kazushige; Morishima, Takuma			Compression Garment Promotes Muscular Strength Recovery after Resistance Exercise	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						RESISTANCE EXERCISE; RECOVERY; MUSCULAR STRENGTH; COMPRESSION; FATIGUE; GARMENT; WHOLE BODY COMPRESSION	INDUCED MUSCLE DAMAGE; SPRINT PERFORMANCE; LOWER-LIMB; RUNNING PERFORMANCE; ECCENTRIC EXERCISE; IMPROVES RECOVERY; PLAYERS; STOCKINGS; SORENESS; MATCH	Purpose: This study aimed to investigate the effects of wearing a compression garment (CG) for 24 h on changes in muscular strength and blood parameters over time after resistance exercise. Methods: Nine trained men conducted resistance exercises (10 repetitions of 3-5 sets at 70% of one-repetition maximum (1RM) for nine exercises) in two trials, wearing either a CG or a normal garment (CON) for 24 h after exercise. Recovery of muscular strength, blood parameters, muscle soreness, and upper arm and thigh circumference were compared between the trials. Results: Both trials showed decreases in maximal strength after the exercise (P < 0.05). However, the CG trial showed faster recovery of one-repetition maximum for the chest press from 3 to 8 h after exercise (P < 0.05). Recovery of maximal knee extension strength was also improved in the CG trial 24 h after exercise (P < 0.05). The CG trial was associated with lower muscle soreness and subjective fatigue scores the following morning (P < 0.05). The upper arm and thigh circumferences were significantly higher during the recovery period in the CON trial, whereas no change was observed in the CG trial. Blood lactate, insulin like growth factor-1, free testosterone, myoglobin, creatine kinase, interleukin 6, and interleukin 1 receptor antagonist concentrations for 24 h after exercise were similar in both trials. Conclusions: Wearing a CG after resistance exercise facilitates the recovery of muscular strength. Recovery for upper body muscles significantly improved within 3-8 h after exercise. However, facilitation of recovery of lower limb muscles by wearing the CG took a longer time.	[Goto, Kazushige] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan; [Goto, Kazushige; Morishima, Takuma] Ritsumeikan Univ, Grad Sch Sport & Hlth Sci, Kusatsu, Shiga 5258577, Japan	Goto, K (reprint author), Ritsumeikan Univ, Fac Sport & Hlth Sci, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	kagoto@fc.ritsumei.ac.jp			Ritsumeikan University; Japan Society for the Promotion of Science	The present study was partially supported by a research grant from Ritsumeikan University and Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Marqueste T, 2008, J APPL PHYSIOL, V105, P299, DOI 10.1152/japplphysiol.00738.2007; MAYBERRY JC, 1991, J VASC SURG, V13, P91; Suzuki M, 2004, BRIT J SPORT MED, V38, P436, DOI 10.1136/bjsm.2002.004309; Kraemer WJ, 2010, J STRENGTH COND RES, V24, P804, DOI 10.1519/JSC.0b013e3181d33025; Jakeman JR, 2010, EUR J APPL PHYSIOL, V109, P1137, DOI 10.1007/s00421-010-1464-0; [Anonymous], 1996, J STRENGTH COND RES; Cleak MJ, 1992, J SPORT SCI, V10, P325, DOI 10.1080/02640419208729932; LAWRENCE D, 1980, BRIT J SURG, V67, P119, DOI 10.1002/bjs.1800670214; FRIDEN J, 1986, J APPL PHYSIOL, V61, P2175; de Glanville KM, 2012, J STRENGTH COND RES, V26, P480, DOI 10.1519/JSC.0b013e318225ff61; Nosaka K, 2011, EUR J APPL PHYSIOL, V111, P2427, DOI 10.1007/s00421-011-2086-x; Kraemer WJ, 2001, J ORTHOP SPORT PHYS, V31, P282; Chapman DW, 2008, EUR J APPL PHYSIOL, V104, P531, DOI 10.1007/s00421-008-0806-7; Davies V, 2009, J STRENGTH COND RES, V23, P1786, DOI 10.1519/JSC.0b013e3181b42589; Pruscino CL, 2013, EUR J APPL PHYSIOL, V113, P1585, DOI 10.1007/s00421-012-2576-5; Beaven CM, 2013, APPL PHYSIOL NUTR ME, V38, P633, DOI 10.1139/apnm-2012-0333; Dascombe BJ, 2011, INT J SPORT PHYSIOL, V6, P160; MacRae BA, 2011, SPORTS MED, V41, P815, DOI 10.2165/11591420-000000000-00000; Duffield R, 2007, BRIT J SPORT MED, V41, P409, DOI 10.1136/bjsm.2006.033753; Gill ND, 2006, BRIT J SPORT MED, V40, P260, DOI 10.1136/bjsm.2005.022483; Scanlan AT, 2008, INTJ SPORT PHYSIOL, V3, P424; Chatard JC, 2004, EUR J APPL PHYSIOL, V93, P347, DOI 10.1007/s00421-004-1163-9; Hill J, 2014, BRIT J SPORT MED, V48, P1340, DOI 10.1136/bjsports-2013-092456; Bahnert A, 2013, J SCI MED SPORT, V16, P151, DOI 10.1016/j.jsams.2012.05.008; BERRY MJ, 1987, AM J PHYS MED REHAB, V66, P121; Burden RJ, 2012, J STRENGTH COND RES, V26, P2837; Faulkner JA, 2013, J STRENGTH COND RES, V27, P669, DOI 10.1519/JSC.0b013e31825c2f50; Hamlin MJ, 2012, J STRENGTH COND RES, V26, P2975, DOI 10.1519/JSC.0b013e3182711e0b; Jayaraman RC, 2004, EUR J APPL PHYSIOL, V93, P30, DOI 10.1007/s00421-004-1153-y; Kraemer WJ, 1998, SPORTS MED TRAIN REH, V8, P163; VIITASALO JT, 1995, EUR J APPL PHYSIOL O, V71, P431, DOI 10.1007/BF00635877	31	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	DEC	2014	46	12					2265	2270		10.1249/MSS.0000000000000359		6	Sport Sciences	Sport Sciences	AT8ZQ	WOS:000345217900009		
J	Cooper, AJL; Kuhara, T				Cooper, Arthur J. L.; Kuhara, Tomiko			alpha-Ketoglutaramate: an overlooked metabolite of glutamine and a biomarker for hepatic encephalopathy and inborn errors of the urea cycle	METABOLIC BRAIN DISEASE			English	Article						omega-Amidase; Ammonia; GlutaminaseII; Hepatic encephalopathy; alpha-ketoglutaramate; Urea cycle disorders	ESSENTIAL AMINO-ACIDS; CONJUGATE BETA-LYASE; BRANCHED-CHAIN AMINO; PORTAL-SYSTEMIC ENCEPHALOPATHY; METHIONINE SALVAGE PATHWAY; TUMOR-SUPPRESSOR NIT2; LIVER OMEGA-AMIDASE; PERFUSED-RAT-LIVER; TRANSAMINASE-K; KETO ANALOGS	Glutamine metabolism is generally regarded as proceeding via glutaminase-catalyzed hydrolysis to glutamate and ammonia, followed by conversion of glutamate to alpha-ketoglutarate catalyzed by glutamate dehydrogenase or by a glutamate-linked aminotransferase (transaminase). However, another pathway exists for the conversion of glutamine to alpha-ketoglutarate that is often overlooked, but is widely distributed in nature. This pathway, referred to as the glutaminase II pathway, consists of a glutamine transaminase coupled to omega-amidase. Transamination of glutamine results in formation of the corresponding alpha-keto acid, namely, alpha-ketoglutaramate (KGM). KGM is hydrolyzed by omega-amidase to aketoglutarate and ammonia. The net glutaminase II reaction is: L-Glutamine+alpha-keto acid+H2O -> alpha-ketoglutarate+L-amino acid+ammonia. In this mini-review the biochemical importance of the glutaminase II pathway is summarized, with emphasis on the key component KGM. Forty years ago it was noted that the concentration of KGM is increased in the cerebrospinal fluid (CSF) of patients with hepatic encephalopathy (HE) and that the level of KGMin the CSF correlates well with the degree of encephalopathy. In more recent work, we have shown that KGM is markedly elevated in the urine of patients with inborn errors of the urea cycle. It is suggested that KGM may be a useful biomarker for many hyperammonemic diseases including hepatic encephalopathy, inborn errors of the urea cycle, citrin deficiency and lysinuric protein intolerance.	[Cooper, Arthur J. L.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA; [Kuhara, Tomiko] Kanazawa Med Univ, Med Res Inst, Div Human Genet, Dept Biochem, Uchinada, Ishikawa 9200293, Japan	Cooper, AJL (reprint author), New York Med Coll, Dept Biochem & Mol Biol, 15 Dana Rd, Valhalla, NY 10595 USA.	arthur_cooper@nymc.edu			NIH [DK 16739]	Some of the author's work mentioned in this review was supported by NIH grant DK 16739.	Abou-Khalil WH, 1983, CANCER RES, V43, P1990; HOFFER LJ, 1993, J NUTR, V123, P1513; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WALKER S, 1982, DIGESTION, V24, P105; Olson KC, 2013, ANAL BIOCHEM, V439, P116, DOI 10.1016/j.ab.2013.05.002; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/nchembio.1141, 10.1038/NCHEMBIO.1141]; Zheng X, 2012, ANAL CHEM, V84, P10044, DOI 10.1021/ac3025202; COOPER AJL, 1987, PHYSIOL REV, V67, P440; Porter LD, 2002, PHYSIOL GENOMICS, V9, P157, DOI 10.1152/physiolgenomics.00017.2002; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; HUTSON SM, 1981, AM J CLIN NUTR, V34, P173; STEELE RD, 1986, FASEB J, V45, P2060; BEAL MF, 1992, DEV BRAIN RES, V68, P136; Barglow KT, 2008, BIOCHEMISTRY-US, V47, P13514, DOI 10.1021/bi801786y; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Chavarria L, 2013, J CEREBR BLOOD F MET, V33, P272, DOI 10.1038/jcbfm.2012.173; Albuquerque EX, 2013, BIOCHEM PHARMACOL, V85, P1027, DOI 10.1016/j.bcp.2012.12.014; Erickson JW, 2010, ONCOTARGET, V1, P734; Desjardins P, 2012, NEUROCHEM INT, V60, P690, DOI 10.1016/j.neuint.2012.02.001; Keiding S, 2013, ARCH BIOCHEM BIOPHYS, V536, P131, DOI 10.1016/j.abb.2013.05.006; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; Jaisson S, 2009, BIOCHIMIE, V91, P1066, DOI 10.1016/j.biochi.2009.07.002; Brusilow SW, 2011, CRIT CARE MED, V39, P2550, DOI 10.1097/CCM.0b013e31822572fd; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; de Baulny HO, 2012, MOL GENET METAB, V106, P12, DOI 10.1016/j.ymgme.2012.02.010; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; Mardini H, 2011, J HEPATOL, V54, P1154, DOI 10.1016/j.jhep.2010.09.030; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; COOPER AJL, 1981, COMP BIOCHEM PHYS B, V69, P137, DOI 10.1016/0305-0491(81)90223-6; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Dai Y, 1999, J BIOL CHEM, V274, P1193, DOI 10.1074/jbc.274.3.1193; Butterworth RF, 2013, NAT REV GASTRO HEPAT, V10, P522, DOI 10.1038/nrgastro.2013.99; Bergmeyer U, 1974, METHODS ENZYMATIC AN, P2285; BOURKE E, 1971, NATURE-NEW BIOL, V233, P249; Bourke E, 1971, BIOCH J, V125, p94P; BOURKE E, 1971, AM J PHYSIOL, V220, P1033; Brusilow SW, 2001, METABOLIC MOL BASES; BUCHLI R, 1995, J BIOL CHEM, V270, P29330; CATHELINEAU L, 1981, J PEDIATR-US, V99, P279, DOI 10.1016/S0022-3476(81)80478-7; Chien CH, 2012, J BIOL CHEM, V287, P25715, DOI 10.1074/jbc.M111.259119; CHOW KW, 1974, J NUTR, V104, P1208; Cooper A. J., 1988, GLUTAMINE GLUTAMATE, V1, P33; COOPER AJL, 1980, ANAL BIOCHEM, V103, P118, DOI 10.1016/0003-2697(80)90245-6; COOPER AJL, 1977, CRC CR REV BIOCH MOL, V4, P281, DOI 10.3109/10409237709102560; COOPER AJL, 1993, J NEUROCHEM, V61, P1731, DOI 10.1111/j.1471-4159.1993.tb09810.x; Cooper AJL, 2011, AMINO ACIDS, V41, P7, DOI 10.1007/s00726-010-0552-0; COOPER AJL, 1974, J BIOL CHEM, V249, P2554; Cooper AJL, 2013, GLUTAMINE H IN PRESS; COOPER AJL, 1985, METHOD ENZYMOL, V113, P350; COOPER AJL, 1977, J NEUROCHEM, V28, P771, DOI 10.1111/j.1471-4159.1977.tb10626.x; Cooper AJL, 2013, METAB BRAIN DIS, V28, P119, DOI 10.1007/s11011-012-9338-2; COOPER AJL, 1972, BIOCHEMISTRY-US, V11, P661; Cudalbu C, 2012, J CEREBR BLOOD F MET, V32, P696, DOI 10.1038/jcbfm.2011.173; Dai Y, 2001, BIOCHEMISTRY-US, V40, P6379, DOI 10.1021/bi010110y; DARMAUN D, 1986, AM J PHYSIOL, V251, pE117; Duffy T E, 1974, Res Publ Assoc Res Nerv Ment Dis, V53, P39; DUFFY TE, 1974, J BIOL CHEM, V249, P7603; Duran RV, 2012, MOL CELL, V47, P349; ERRERA M, 1949, J BIOL CHEM, V178, P495; Filipowicz HR, 2006, MOL GENET METAB, V88, P123, DOI 10.1016/j.ymgme.2005.11.016; GREENSTEIN JP, 1949, J BIOL CHEM, V178, P695; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Halamkova L, 2012, TALANTA, V100, P7, DOI 10.1016/j.talanta.2012.08.022; Han Q, 2008, BIOSCIENCE REP, V28, P205, DOI 10.1042/BSR20080085; Han Q, 2004, EUR J BIOCHEM, V271, P4804, DOI 10.1111/j.1432-1033.2004.04446.x; Han Q, 2009, MOL CELL BIOL, V29, P784, DOI 10.1128/MCB.01272-08; HAUSSINGER D, 1985, BIOL CHEM H-S, V366, P527, DOI 10.1515/bchm3.1985.366.1.527; Heins J, 2010, METAB BRAIN DIS, V25, P81, DOI 10.1007/s11011-010-9170-5; HERLONG HF, 1980, ANN INTERN MED, V93, P545; HERSH LB, 1972, BIOCHEMISTRY-US, V11, P2251, DOI 10.1021/bi00762a007; HERSH LB, 1971, BIOCHEMISTRY-US, V10, P2884, DOI 10.1021/bi00791a014; Holecek M, 2013, METAB BRAIN DIS; Huebner K, 2011, ADV ENZYME REGUL, V51, P208, DOI 10.1016/j.advenzreg.2010.09.003; HUTSON SM, 1985, J BIOL CHEM, V260, P4189; JONES TW, 1988, MOL PHARMACOL, V34, P621; Kim HS, 1997, ARCH TOXICOL, V71, P131, DOI 10.1007/s002040050367; Krasnikov BF, 2009, BIOCHIMIE, V91, P1072, DOI 10.1016/j.biochi.2009.07.003; Kuhara T, 2007, J CHROMATOGR B, V855, P42, DOI 10.1016/j.jchromb.2007.03.031; Kuhara T, 2011, ANAL BIOANAL CHEM, V400, P1843, DOI 10.1007/s00216-011-4688-x; Kuhara T, 2011, ANAL BIOANAL CHEM, V400, P1881, DOI 10.1007/s00216-011-4766-0; LAVOIE J, 1987, J NEUROCHEM, V49, P692, DOI 10.1111/j.1471-4159.1987.tb00949.x; Lin CH, 2007, FEBS J, V274, P2946, DOI 10.1111/j.1742-4658.2007.05828.x; LOCKWOOD AH, 1977, J NEUROCHEM, V28, P673, DOI 10.1111/j.1471-4159.1977.tb10443.x; MADDREY WC, 1976, GASTROENTEROLOGY, V71, P190; MALHERBE P, 1995, FEBS LETT, V367, P141, DOI 10.1016/0014-5793(95)00546-L; MALLET RT, 1986, AM J PHYSIOL, V250, pC191; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; MEISTER A, 1952, J BIOL CHEM, V197, P319; MEISTER A, 1955, J BIOL CHEM, V215, P441; MEISTER A, 1953, J BIOL CHEM, V200, P571; OTANI TT, 1957, J BIOL CHEM, V224, P137; Mena FV, 2005, BRAIN RES, V1052, P88, DOI 10.1016/j.brainres.2005.06.014; MILLER JE, 1971, J BIOL CHEM, V246, P3234; MOSCA M, 1994, FEBS LETT, V353, P21, DOI 10.1016/0014-5793(94)01003-X; NISSIM I, 1991, BIOCHEM J, V277, P33; Notarangelo FM, 2012, ANAL BIOCHEM, V421, P573, DOI 10.1016/j.ab.2011.12.032; OKUNO E, 1991, BRAIN RES, V542, P307, DOI 10.1016/0006-8993(91)91583-M; Pace HC, 2001, GENOME BIOL, V2, P1, DOI DOI 10.1186/GB-2001-2-1-REVIEWS0001; Pailla K, 2000, CLIN CHEM, V46, P848; PAMILJANS V, 1962, BIOCHEMISTRY-US, V1, P153, DOI 10.1021/bi00907a023; Pawlak D, 2003, J PHYSIOL PHARMACOL, V54, P175; PERRY S, 1995, FEBS LETT, V360, P277, DOI 10.1016/0014-5793(95)00123-Q; PERRY SJ, 1993, MOL PHARMACOL, V43, P660; Plum F, 1971, Exp Biol Med, V4, P34; RECORD CO, 1976, EUR J CLIN INVEST, V6, P387, DOI 10.1111/j.1365-2362.1976.tb00533.x; SAHAI A, 1991, AM J PHYSIOL, V261, pF481; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; SAPIR DG, 1974, J CLIN INVEST, V54, P974, DOI 10.1172/JCI107838; Scholl-Burgi S, 2012, J INHERIT METAB DIS, V35, P65, DOI 10.1007/s10545-010-9245-9; SHRAWDER E, 1972, J BIOL CHEM, V247, P2486; Siguira M, 1957, JPN J PHARMACOL, V7, P1; STEGINK LD, 1991, AM J CLIN NUTR, V53, P670; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; VANLEUVEN F, 1975, EUR J BIOCHEM, V58, P153; VANLEUVEN F, 1976, EUR J BIOCHEM, V65, P271; VERGARA F, 1974, SCIENCE, V183, P81, DOI 10.1126/science.183.4120.81; Walser M, 1981, METABOLISM CLIN IMPL; WALSER M, 1973, J CLIN INVEST, V52, P2865, DOI 10.1172/JCI107483; WRAY JW, 1995, J BIOL CHEM, V270, P3147; YOSHIDA TASUKU, 1967, VITAMINS [KYOTO], V35, P227; ZIELKE HR, 1978, J CELL PHYSIOL, V95, P41	125	1	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	DEC	2014	29	4			SI		991	1006		10.1007/s11011-013-9444-9		16	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	AU0BI	WOS:000345287800013		
J	Natsui, S; Kikuchi, T; Suzuki, RO				Natsui, Shungo; Kikuchi, Tatsuya; Suzuki, Ryosuke O.			Numerical Analysis of Carbon Monoxide-Hydrogen Gas Reduction of Iron Ore in a Packed Bed by an Euler-Lagrange Approach	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							FLUID DISPERSION COEFFICIENTS; DISCRETE ELEMENT METHOD; BLAST-FURNACE; MATHEMATICAL-MODEL; COAL COMBUSTION; HEAT-TRANSFER; MASS-TRANSFER; SOLID FLOW; DEM-CFD; PARTICLE	In recent years, various methods to decrease carbon dioxide emissions from iron and steel making industries have been developed. The latest blast furnace operation design is intended to induce the low reducing agent operation, highly reactive material is considered a promising way to improve reaction efficiency. Another method utilizes hydrogen in the blast furnace process for highly efficient reduction. Mathematical modeling may help to predict complex in-furnace phenomena, including momentum, heat, and mass transport. However, the current macroscopic continuum model gives no information on the individual particles. In this work, a new approach based on the discrete element method was introduced to consider the interaction between particles under fluid flow in accordance with the arrangement and properties of individual particles. We used an Euler-Lagrange method to precisely understand the influence of the reaction conditions on the behavior of coke and ore particles in three dimensions. The heterogeneity of the reaction rate and temperature distribution was observed to be influenced by the particle arrangement. The endothermic and exothermic reactions influenced each other in the packed bed. Temperature distributions nearly correlated with the gas velocity distribution because convection processes greatly affected the reaction rate. Although convection heat transfer was not a dominant issue in the packed bed, promotion of the reaction by a gas flow was effective.	[Natsui, Shungo; Kikuchi, Tatsuya; Suzuki, Ryosuke O.] Hokkaido Univ, Div Mat Sci & Engn, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Natsui, S (reprint author), Hokkaido Univ, Div Mat Sci & Engn, Fac Engn, Kita Ku, N13 W8, Sapporo, Hokkaido 0608628, Japan.	natsui@eng.hokudai.ac.jp			Steel Foundation for Environmental Protection Technology (SEPT) of Japan	A part of this research was supported by Steel Foundation for Environmental Protection Technology (SEPT) of Japan.	WAKAO N, 1979, CHEM ENG SCI, V34, P325, DOI 10.1016/0009-2509(79)85064-2; Zhou HS, 2004, CHEM ENG SCI, V59, P4193, DOI 10.1016/j.ces.2004.01.069; Nogami H, 2014, TETSU TO HAGANE, V100, P227, DOI 10.2355/tetsutohagane.100.227; RANZ WE, 1952, CHEM ENG PROG, V48, P141; Austin PR, 1997, ISIJ INT, V37, P748, DOI 10.2355/isijinternational.37.748; SPITZER RH, 1966, T METALL SOC AIME, V236, P1715; Zhou HS, 2004, CHEM ENG SCI, V59, P4205, DOI 10.1016/j.ces.2004.01.070; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; WILKE CR, 1950, J CHEM PHYS, V18, P517, DOI 10.1063/1.1747673; Zhou ZY, 2011, POWDER TECHNOL, V208, P72, DOI 10.1016/j.powtec.2010.12.005; WAKAO N, 1978, CHEM ENG SCI, V33, P1375, DOI 10.1016/0009-2509(78)85120-3; Dong XF, 2010, METALL MATER TRANS B, V41, P330, DOI 10.1007/s11663-009-9327-y; Natsui S, 2012, CHEM ENG SCI, V71, P274, DOI 10.1016/j.ces.2011.12.035; Adema AT, 2010, ISIJ INT, V50, P954, DOI 10.2355/isijinternational.50.954; Natsui S, 2011, ISIJ INT, V51, P41, DOI 10.2355/isijinternational.51.41; ERGUN S, 1952, CHEM ENG PROG, V48, P89; Vargas WL, 2002, INT J HEAT MASS TRAN, V45, P4847, DOI 10.1016/S0017-9310(02)00175-8; Natsui S, 2013, ISIJ INT, V53, P1770, DOI 10.2355/isijinternational.53.1770; Chu M, 2004, ISIJ INT, V44, P801, DOI 10.2355/isijinternational.44.801; Austin PR, 1997, ISIJ INT, V37, P458, DOI 10.2355/isijinternational.37.458; TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7; Wright B, 2011, POWDER TECHNOL, V208, P86, DOI 10.1016/j.powtec.2010.12.006; Kaneko Y, 1999, CHEM ENG SCI, V54, P5809, DOI 10.1016/S0009-2509(99)00153-0; Nogami H, 2006, ISIJ INT, V46, P1759, DOI 10.2355/isijinternational.46.1759; Natsui S, 2011, ISIJ INT, V51, P51, DOI 10.2355/isijinternational.51.51; Bird R.B., 1976, TRANSPORT PHENOMENA, p[23, 274, 525, 866]; Castro A. J., 2002, ISIJ INT, V42, P44, DOI 10.2355/isijinternational.42.44; Hara Y., 1976, TETSU TO HAGANE, V62, P315; Kobayashi S., 1977, TETSU TO HAGANE, V63, P1081; Kubaschewski O., 1979, METALLURGICAL THERMO; Levenspiel O., 1999, CHEM REACTION ENG, P385; Miyasaka N., 1968, TETSU TO HAGANE, V54, P1427; Natsui S, 2012, TETSU TO HAGANE, V98, P341, DOI 10.2355/tetsutohagane.98.341; Nogami H., 2010, TETSU TO HAGANE, V96, P319; Nogami H, 2012, ISIJ INT, V52, P1523, DOI 10.2355/isijinternational.52.1523; Poling B.E., 2000, PROPERTIES GASES LIQ; RIST A, 1967, JOM-J MIN MET MAT S, V19, P50; Sakurai T., 2009, T JPN SOC MECH ENG-B, V75, P1041; Takahashi R., 1983, IRONMAKING C P, V43, P485; USUI T, 1994, TETSU TO HAGANE, V80, P431; YAGI J, 1991, ISIJ INT, V31, P387, DOI 10.2355/isijinternational.31.387; Yu Y. H., 1966, CHEM ENG PROGR S SER, V62, P100; Yu YW, 2012, ISIJ INT, V52, P788; Zhou Z.Y., 2011, ISIJ INT, V50, P515	44	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	DEC	2014	45	6					2395	2413		10.1007/s11663-014-0132-x		19	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT7BA	WOS:000345089900042		
J	Wang, Q; He, Z; Li, BK; Tsukihashi, F				Wang, Qiang; He, Zhu; Li, Baokuan; Tsukihashi, Fumitaka			A General Coupled Mathematical Model of Electromagnetic Phenomena, Two-Phase Flow, and Heat Transfer in Electroslag Remelting Process Including Conducting in the Mold	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							SPIN-RESONANCE SYSTEMS; MAGNETIC-FIELD; ESR PROCESS; FLUID-FLOW; SOLIDIFICATION; INTERFACE; BEHAVIOR; CURRENTS; SLAGS	A transient three-dimensional finite-volume mathematical model has been developed to investigate the coupled physical fields in the electroslag remelting (ESR) process. Through equations solved by the electrical potential method, the electric current, electromagnetic force (EMF), and Joule heating fields are demonstrated. The mold is assumed to be conductive rather than insulated. The volume of fluid approach is implemented for the two-phase flow. Moreover, the EMF and Joule heating, which are the source terms of the momentum and energy sources, are recalculated at each iteration as a function of the phase distribution. The solidification is modeled by an enthalpy-porosity formulation, in which the mushy zone is treated as a porous medium with porosity equal to the liquid fraction. An innovative marking method of the metal pool profile is proposed in the experiment. The effect of the applied current on the ESR process is understood by the model. Good agreement is obtained between the experiment and calculation. The electric current flows to the mold lateral wall especially in the slag layer. A large amount of Joule heating around the metal droplet varies as it falls. The hottest region appears under the outer radius of the electrode tip, close to the slag/metal interface instead of the electrode tip. The metal pool becomes deeper with more power. The maximal temperature increases from 1951 K to 2015 K (1678 A degrees C to 1742 A degrees C), and the maximum metal pool depth increases from 34.0 to 59.5 mm with the applied current ranging from 1000 to 2000 A.	[Wang, Qiang; Li, Baokuan] Northeastern Univ, Sch Met & Mat, Shenyang 110819, Peoples R China; [He, Zhu] Wuhan Univ Sci & Technol, Key Lab Ferrous Met & Resources Utilizat, Minist Educ, Wuhan 430081, Peoples R China; [Tsukihashi, Fumitaka] Univ Tokyo, Dept Adv Mat Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Wang, Q (reprint author), Northeastern Univ, Sch Met & Mat, Wenhua Rd 3-11, Shenyang 110819, Peoples R China.	libk@smm.neu.edu.cn			National Natural Science Foundation of China [51210007]	The authors' gratitude goes to the National Natural Science Foundation of China [No. 51210007].	FERNG YM, 1989, NUMER HEAT TR A-APPL, V16, P429, DOI 10.1080/10407788908944725; DILAWARI AH, 1978, METALL TRANS B, V9, P371, DOI 10.1007/BF02654410; DILAWARI AH, 1978, METALL TRANS B, V9, P77, DOI 10.1007/BF02673432; CHOUDHARY M, 1981, METALL TRANS B, V12, P418, DOI 10.1007/BF02654479; Kharicha A, 2005, MAT SCI ENG A-STRUCT, V413, P129, DOI 10.1016/j.msea.2005.08.212; CHOUDHARY M, 1980, METALL TRANS B, V11, P439, DOI 10.1007/BF02676888; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Mitchell A, 2005, MAT SCI ENG A-STRUCT, V413, P10, DOI 10.1016/j.msea.2005.08.157; Kharicha A, 2009, INT J CAST METAL RES, V22, P155, DOI 10.1179/136404609X367579; JARDY A, 1991, METALL TRANS B, V22, P111, DOI 10.1007/BF02672532; Kharicha A, 2008, STEEL RES INT, V79, P632, DOI 10.2374/SRI08SP016-79-2008-632; JOHNSON AJD, 1972, METALL TRANS, V3, P1016, DOI 10.1007/BF02647688; Meier M, 2002, EUR J MECH B-FLUID, V21, P61, DOI 10.1016/S0997-7546(01)01161-X; Li BK, 2012, ISIJ INT, V52, P1289; MITCHELL A, 1990, METALL TRANS B, V21, P723, DOI 10.1007/BF02654251; Murgas M, 2000, ISIJ INT, V40, P980, DOI 10.2355/isijinternational.40.980; BIRO O, 1989, IEEE T MAGN, V25, P3145, DOI 10.1109/20.34388; SWAMINATHAN CR, 1992, METALL TRANS B, V23, P651, DOI 10.1007/BF02649725; Cefalu S.A., 2004, TMS MULTIPHASE PHENO, P279; CHOUDHARY M, 1982, METALL TRANS B, V13, P35, DOI 10.1007/BF02666953; Dilawari A. H., 1977, Metallurgical Transactions B (Process Metallurgy), V8B, DOI 10.1007/BF02657651; Hernandez-Morales B, 1999, IRONMAK STEELMAK, V26, P423, DOI 10.1179/030192399677275; Hugo M., 2013, METALL MATER TRANS B, P79; Kajikawa K, 2007, IRONMAK STEELMAK, V34, P216, DOI 10.1179/174328107X174690; Kelkar K.M., 2005, INT S LIQ MET PROC C, P137; Kharicha A, 2010, MATER SCI FORUM, V649, P229, DOI 10.4028/www.scientific.net/MSF.649.229; Kharicha A., 2007, INT S LIQ MET PROC C, P107; Kharicha A., 2012, TMS CFD MODELING SIM, P139; Kharicha A., 2011, INT S LIQ MET PROC C, P113; MITCHELL A, 1973, METALL TRANS, V4, P631, DOI 10.1007/BF02643068; Mitchell A, 2009, MATER SCI TECH-LOND, V25, P186, DOI 10.1179/174328408X386989; MIYAZAWA K, 1985, T IRON STEEL I JPN, V25, P386; Nastac L, 1998, JOM-J MIN MET MAT S, V50, P30, DOI 10.1007/s11837-998-0376-5; Patel A.D., 2007, INT S LIQ MET PROC C, P95; Ruckert A., 2008, INT SCI C MOD EL PRO, P27; Sheng YY, 1998, METALL MATER TRANS B, V29, P85, DOI 10.1007/s11663-998-0010-5; Weber V., 2009, METALL MATER TRANS B, V42B, P271	37	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	DEC	2014	45	6					2425	2441		10.1007/s11663-014-0158-0		17	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AT7BA	WOS:000345089900044		
J	Hosoi, A; Koto, H; Ju, Y				Hosoi, Atsushi; Koto, Hisataka; Ju, Yang			Fabrication of AFM probe with CuO nanowire formed by stress-induced method	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							GROWTH; MICROSCOPY; RESOLUTION; DEPOSITION; FILMS; TIPS	A novel method has been proposed to fabricate an atomic force microscope (AFM) probe using CuO nanowire and a stress-induced method that can form the nanowire easily. By heating a commercial AFM probe with a film coating of Ta and Cu, a Cu hillock with CuO nanowires on its surface could be formed at the end of the probe. The thickness of the coating films, the heating temperature, and the heating time were investigated to obtain CuO nanowires with a high aspect ratio for use as an AFM probe tip. It was found that a suitable probe tip can be fabricated using the a Cu film thickness of 700 nm, a heating temperature of 380 A degrees C and a heating time of 6 h. Probe tips (similar to 5 mu m high) and nanowires of similar to 25 nm diameter were obtained successfully. In the range evaluated, the measurement resolution of the CuO nanowire probe was slightly worse than that of a commercial AFM probe. However, both probes had almost the same dimensional measurement precision.	[Hosoi, Atsushi] Waseda Univ, Dept Appl Mech & Aerosp Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Koto, Hisataka; Ju, Yang] Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Ju, Y (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	ju@mech.nagoya-u.ac.jp	Hosoi, Atsushi/F-6060-2015		Japan Society for the Promotion of Science [26249001]	This work was supported by the Japan Society for the Promotion of Science under a Grant-in-Aid for Scientific Research (A) 26249001.	Yuan L, 2011, ACTA MATER, V59, P2491, DOI 10.1016/j.actamat.2010.12.052; Jiang XC, 2002, NANO LETT, V2, P1333, DOI 10.1021/nl0257519; Tang J, 2003, ADV MATER, V15, P1352, DOI 10.1002/adma.200305086; Cheung CL, 2000, P NATL ACAD SCI USA, V97, P3809, DOI 10.1073/pnas.050498597; Skibinski J, 2014, MICRON, V66, P23, DOI 10.1016/j.micron.2014.05.001; Nasibulin AG, 2009, NANO RES, V2, P373, DOI 10.1007/s12274-009-9036-5; Bale M, 2002, J VAC SCI TECHNOL B, V20, P364, DOI 10.1116/1.1447242; Beuret C, 2000, APPL PHYS LETT, V76, P1621, DOI 10.1063/1.126115; Brown J, 2013, ULTRAMICROSCOPY, V133, P62, DOI 10.1016/j.ultramic.2013.05.005; CHEN M, 2012, J APPL PHYS, V111; Hu LJ, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-116; Jason HD, 1996, NATURE, V384, P147, DOI 10.1038/384147a0; Ju Y, 2005, P INTERPACK2005, P1919, DOI 10.1115/IPACK2005-73140; Polyakov B, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30430-6; Saka M, 2007, SCRIPTA MATER, V56, P1031, DOI 10.1016/j.scriptamat.2007.02.036; Saka M, 2006, MATER LETT, V60, P2129, DOI 10.1016/j.matlet.2005.12.107; Settsu N, 2008, STRAIN, V44, P201, DOI 10.1111/j.1475-1305.2007.00370.x; TAN EPS, 2007, APPL PHYS LETT, V90; Tohmyoh H, 2010, SCRIPTA MATER, V63, P289, DOI 10.1016/j.scriptamat.2010.04.013; Yue YM, 2012, SCRIPTA MATER, V66, P81, DOI 10.1016/j.scriptamat.2011.09.041	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	DEC	2014	20	12					2221	2229		10.1007/s00542-014-2317-2		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AT6WN	WOS:000345077600012		
J	Shikida, M; Kitamura, S; Miyake, C; Bessho, K				Shikida, Mitsuhiro; Kitamura, Shingo; Miyake, Chikara; Bessho, Katsuhiko			Micromachined pyramidal shaped biodegradable microneedle and its skin penetration capability	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							PHOTOLITHOGRAPHIC PATTERN TRANSFER; TRANSDERMAL DRUG-DELIVERY; FABRICATION; MICROSTRUCTURES; ARRAY	A biodegradable pyramidal shaped microneedle array made of hyaluronic acid-based material was fabricated by anisotropic wet etching and a molding process. First, pyramidal shaped needles were fabricated on a Si wafer by anisotropic wet etching as an original master and then a mixture of two biodegradable materials, hyaluronic acid and a collagen, were replicated with the same shape as the original Si needle by a molding process. The height and pitch of the needle were 0.21 and 0.62 mm, respectively. The tip radius in the replicated biodegradable needle became 0.005 mm. The penetration capability of the needle arrays was evaluated by applying the load to skin multiple times. Results showed that both the Si and biodegradable needle arrays could successfully penetrate silicone rubber sheets with the applied load of 100 g. The developed biodegradable needle arrays also successfully penetrated mouse skin with the load of 50 g.	[Shikida, Mitsuhiro] Nagoya Univ, Ctr Micronano Mechatron, Nagoya, Aichi 4648601, Japan; [Kitamura, Shingo; Bessho, Katsuhiko] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648601, Japan; [Miyake, Chikara] Nagoya Univ, Dept Micronano Syst Engn, Nagoya, Aichi 4648601, Japan	Shikida, M (reprint author), Nagoya Univ, Ctr Micronano Mechatron, Nagoya, Aichi 4648601, Japan.	shikida@mech.nagoya-u.ac.jp			Centre of Excellence (COE) for Education and Research on Micro-Nano Mechatronics, Japan	This research was supported by the Centre of Excellence (COE) for Education and Research on Micro-Nano Mechatronics, Japan.	Shikida M, 2006, J MICROMECH MICROENG, V16, P2230, DOI 10.1088/0960-1317/16/10/041; Mitragotri S, 2004, ADV DRUG DELIVER REV, V56, P589, DOI 10.1016/j.addr.2003.10.024; Barry B., 2003, ADV DRUG DELIV REV, V56, P603; Davis SP, 2003, 12 INT C SOL STAT SE, P1435; Griss P, 2002, PROC IEEE MICR ELECT, P467; Henry S., 1998, Proceedings MEMS 98. IEEE. Eleventh Annual International Workshop on Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.98CH36176), DOI 10.1109/MEMSYS.1998.659807; Kim J, 2011, PROC IEEE MICR ELECT, P280; LEDGER PW, 1992, ADV DRUG DELIVER REV, V9, P289, DOI 10.1016/0169-409X(92)90027-N; Mansoor I, 2013, 17 INT C SOL STAT SE, P373; Mansoor I, 2011, PROC IEEE MICR ELECT, P1027, DOI 10.1109/MEMSYS.2011.5734603; Paik SJ, 2010, PROC IEEE MICR ELECT, P312; Park JH, 2003, PROC IEEE MICR ELECT, P371; Park JH, 2004, PROC IEEE MICR ELECT, P383; Preat V., 2004, ADV DRUG DELIV REV, V56, P659; Roxhed N, 2005, PROC IEEE MICR ELECT, P742; Roxhed N, 2006, PROC IEEE MICR ELECT, P414; Roxhed N, 2005, 13 INT C SOL STAT SE, P213; Roxhed N, 2007, 14 INT C SOL STAT SE, P493; Shikida M, 2006, J MICROMECH MICROENG, V16, P1740, DOI 10.1088/0960-1317/16/8/039; Shikida M, 2004, SENSOR ACTUAT A-PHYS, V116, P264, DOI 10.1016/j.sna.2004.04.031; Shikida M, 2004, J MICROMECH MICROENG, V14, P1462, DOI 10.1088/0960-1317/14/11/005; Trautmann A, 2006, PROC IEEE MICR ELECT, P434; Trautmann A, 2003, PROC IEEE MICR ELECT, P682; Wang PC, 2011, PROC IEEE MICR ELECT, P1039	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	DEC	2014	20	12					2239	2245		10.1007/s00542-013-1924-7		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AT6WN	WOS:000345077600014		
J	Takamatsu, S; Yamashita, T; Itoh, T				Takamatsu, Seiichi; Yamashita, Takahiro; Itoh, Toshihiro			Development of reel-to-reel microchip mounting system for fabrication of meter-long LED lighting tapes	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							DEVICE PLACEMENT MACHINE; OPTIMIZATION; OFFICE	We have developed a reel-to-reel microchip mounting system that continuously mounts LED chips and other microchips on meter-long flexible printed circuit board (PCB) tape for 1.2-m-long standard LED light tubes. Mounting microchips on meter-long PCBs is difficult because a large chip mounter is expensive and the chip positioning stage is difficult to move in a meter-wide area with an accuracy of hundreds of micrometers. Hence, we developed a new microchip mounting system that utilizes a small chip mounter and reel winding machines. The system repeatedly moves the long PCB tape by a certain length with the reel winding machines and mounts the chips on it. The PCB tape (which is 5 mm wide) is made by fabricating long PCB tapes which are 25 cm x 26.6 m through a roll-to-roll PCB process and slitting them into meter-long tapes. The reel-to-reel system repeatedly mounts chips by adjusting their positions through image processing of the copper wiring pattern on the PCBs. Our constructed system mounted 24 LED chips with a pitch of 5 cm with an accuracy of 0.082 mm to form a 1.2-m-long LED tape. The luminance of the tape is 12.4 lx at a distance of 1 m, which is the luminance of outdoor corridor lighting. Therefore, this system can be used for meter-long tape lighting.	[Takamatsu, Seiichi; Yamashita, Takahiro; Itoh, Toshihiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan	Takamatsu, S (reprint author), Natl Inst Adv Ind Sci & Technol, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	seiichi-takamatsu@aist.go.jp					Chang YF, 2009, COMPUT STAND INTER, V31, P740, DOI 10.1016/j.csi.2008.09.016; Aman MM, 2013, ENERG POLICY, V52, P482, DOI 10.1016/j.enpol.2012.09.068; Humphreys CJ, 2008, MRS BULL, V33, P459, DOI 10.1557/mrs2008.91; Dubois MC, 2011, ENERG BUILDINGS, V43, P2572, DOI 10.1016/j.enbuild.2011.07.001; Taguchi T, 2008, IEEJ T ELECTR ELECTR, V3, P21, DOI 10.1002/tee.20228; Lafont U, 2012, MICROELECTRON RELIAB, V52, P71, DOI 10.1016/j.microrel.2011.08.013; Ayob M, 2008, EUR J OPER RES, V186, P893, DOI 10.1016/j.ejor.2007.03.042; Ayob M, 2009, INT J SYST SCI, V40, P553, DOI 10.1080/00207720902777964; Bessho M, 2012, ELECTR COMMUN JPN, V95, P1, DOI 10.1002/ecj.10394; Byun J, 2013, IEEE T CONSUM ELECTR, V59, P70; Maxfield C, 2009, BEBOP TO THE BOOLEAN BOOGIE: AN UNCONVENTIONAL GUIDE TO ELECTRONICS, 3RD EDITION, P1, DOI 10.1016/B978-1-85617-507-4.00001-2; Mistopoulos J, 1997, US Patent Specification, Patent No. 6113248; Ono K, 2012, ELECTR COMMUN JPN, V95, P54, DOI 10.1002/ecj.10395; Rempel D, 1997, ERGONOMICS, V40, P800, DOI 10.1080/001401397187793; Chan Y Sing, 2011, Journal of Semiconductors, V32, DOI 10.1088/1674-4926/32/1/014005	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	DEC	2014	20	12					2247	2253		10.1007/s00542-013-1925-6		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	AT6WN	WOS:000345077600015		
J	Horise, Y; Matsumoto, T; Ikeda, H; Nakamura, Y; Yamasaki, M; Sawada, G; Tsukao, Y; Nakahara, Y; Yamamoto, M; Takiguchi, S; Doki, Y; Mori, M; Miyazaki, F; Sekimoto, M; Kawai, T; Nishikawa, A				Horise, Yuki; Matsumoto, Toshinobu; Ikeda, Hiroki; Nakamura, Yuta; Yamasaki, Makoto; Sawada, Genta; Tsukao, Yukiko; Nakahara, Yujiro; Yamamoto, Masaaki; Takiguchi, Shuji; Doki, Yuichiro; Mori, Masaki; Miyazaki, Fumio; Sekimoto, Mitsugu; Kawai, Toshikazu; Nishikawa, Atsushi			A novel locally operated master-slave robot system for single-incision laparoscopic surgery	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Article						Local operation; master-slave; laparoscopic surgery; single incision	MINIMALLY INVASIVE SURGERY; CHOLECYSTECTOMY; MODEL	Purpose: Single-incision laparoscopic surgery (SILS) provides more cosmetic benefits than conventional laparoscopic surgery but presents operational difficulties. To overcome this technical problem, we have developed a locally operated master-slave robot system that provides operability and a visual field similar to conventional laparoscopic surgery. Material and methods: A surgeon grasps the master device with the left hand, which is placed above the abdominal wall, and holds a normal instrument with the right hand. A laparoscope, a slave robot, and the right-sided instrument are inserted through one incision. The slave robot is bent in the body cavity and its length, pose, and tip angle are changed by manipulating the master device; thus the surgeon has almost the same operability as with normal laparoscopic surgery. To evaluate our proposed system, we conducted a basic task and an ex vivo experiment. Results: In basic task experiments, the average object-passing task time was 9.50 sec (SILS cross), 22.25 sec (SILS parallel), and 7.23 sec (proposed SILS). The average number of instrument collisions was 3.67 (SILS cross), 14 (SILS parallel), and 0.33 (proposed SILS). In the ex vivo experiment, we confirmed the applicability of our system for single-port laparoscopic cholecystectomy. Conclusion: We demonstrated that our proposed robot system is useful for single-incision laparoscopic surgery.	[Horise, Yuki; Miyazaki, Fumio] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Toyonaka, Osaka 560, Japan; [Matsumoto, Toshinobu; Ikeda, Hiroki; Nakamura, Yuta; Kawai, Toshikazu] Osaka Inst Technol, Fac Engn, Dept Robot, Osaka 535, Japan; [Yamasaki, Makoto; Sawada, Genta; Tsukao, Yukiko; Nakahara, Yujiro; Yamamoto, Masaaki; Takiguchi, Shuji; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Sekimoto, Mitsugu] Osaka Natl Hosp, Osaka, Japan; [Nishikawa, Atsushi] Shinshu Univ, Fac Text Sci & Technol, Div Mech Engn & Robot, Ueda, Nagano 3868567, Japan	Nishikawa, A (reprint author), Shinshu Univ, Fac Text Sci & Technol, Div Mech Engn & Robot, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.	nishikawa@shinshu-u.ac.jp			Japan Society for the Promotion of Science Fellows [A2426910]	This research was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (A2426910). We are grateful to Mr. Takeharu Kobayashi and Mr. Kohei Kazuhara of Daiken Medical Co. Ltd., who supported the development of the master device.	White MA, 2010, EUR UROL, V58, P544, DOI 10.1016/j.eururo.2010.06.040; Park SS, 2012, SURG ENDOSC, V26, P60, DOI 10.1007/s00464-011-1828-5; Romanelli JR, 2009, SURG ENDOSC, V23, P1419, DOI 10.1007/s00464-009-0463-x; Tang BJ, 2012, MINIM INVASIV THER, V21, P46, DOI 10.3109/13645706.2011.627924; Spinoglio G, 2012, SURG ENDOSC, V26, P1648, DOI 10.1007/s00464-011-2087-1; Erbella J, 2010, SURG ENDOSC, V24, P1958, DOI 10.1007/s00464-010-0886-4; Mutter D, 2011, J HEPATO-BIL-PAN SCI, V18, P453, DOI 10.1007/s00534-010-0348-3; Derossis AM, 1998, AM J SURG, V175, P482, DOI 10.1016/S0002-9610(98)00080-4; Autorino R, 2013, EUR UROL, V63, P266, DOI 10.1016/j.eururo.2012.08.028; Kroh M, 2011, SURG ENDOSC, V25, P3566, DOI 10.1007/s00464-011-1759-1; Turchetti G, 2012, SURG ENDOSC, V26, P598, DOI 10.1007/s00464-011-1936-2; Ma J, 2011, ANN SURG, V254, P22, DOI 10.1097/SLA.0b013e3182192f89; Atallah SB, 2011, TECH COLOPROCTOL, V15, P461, DOI 10.1007/s10151-011-0762-9; Pietrabissa A, 2012, ARCH SURG-CHICAGO, V147, P709, DOI 10.1001/archsurg.2012.508; Byrn JC, 2007, AM J SURG, V193, P519, DOI 10.1016/j.amjsurg.2006.06.042; Piccigallo M, 2010, IEEE-ASME T MECH, V15, P871, DOI 10.1109/TMECH.2010.2078512; Field JB, 2007, SURG ENDOSC, V21, P244, DOI 10.1007/s00464-006-0894-6; Horise Y, 2013, T JPN SOC MED BIOL E, V51, P263; Horise Y, 2012, INT J COMPUT ASS RAD, V7, P289, DOI 10.1007/s11548-011-0658-1; Kenngott HG, 2012, LANGENBECK ARCH SURG, V397, P333, DOI 10.1007/s00423-011-0859-7; Kobayashi Y, 2010, INT J MED ROBOT COMP, V6, P454, DOI 10.1002/rcs.355; Natali CD, 2012, INT J COMPUT ASSIST, V7, pS169; Ross S, 2012, SURG ENDOSC, V26, P2711, DOI 10.1007/s00464-012-2478-y; Weinberg L, 2011, OBSTET GYNECOL INT, V2011	24	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.	DEC	2014	23	6					326	332		10.3109/13645706.2014.942321		7	Surgery	Surgery	AT9IH	WOS:000345240900002		
J	Hirano, A; Kurabayashi, N; Nakagawa, T; Shioi, G; Todo, T; Hirota, T; Fukada, Y				Hirano, Arisa; Kurabayashi, Nobuhiro; Nakagawa, Tomoki; Shioi, Go; Todo, Takeshi; Hirota, Tsuyoshi; Fukada, Yoshitaka			In Vivo Role of Phosphorylation of Cryptochrome 2 in the Mouse Circadian Clock	MOLECULAR AND CELLULAR BIOLOGY			English	Article							REVEALS; PERIOD; DEGRADATION; GENES; MCRY2; OSCILLATION; MECHANISMS; EXPRESSION; COMPONENT; MAMMALS	The circadian clock is finely regulated by posttranslational modifications of clock components. Mouse CRY2, a critical player in the mammalian clock, is phosphorylated at Ser557 for proteasome-mediated degradation, but its in vivo role in circadian organization was not revealed. Here, we generated CRY2(S557A) mutant mice, in which Ser557 phosphorylation is specifically abolished. The mutation lengthened free-running periods of the behavioral rhythms and PER2:: LUC bioluminescence rhythms of cultured liver. In livers from mutant mice, the nuclear CRY2 level was elevated, with enhanced PER2 nuclear occupancy and suppression of E-box-regulated genes. Thus, Ser557 phosphorylation-dependent regulation of CRY2 is essential for proper clock oscillation in vivo.	[Hirano, Arisa; Kurabayashi, Nobuhiro; Nakagawa, Tomoki; Hirota, Tsuyoshi; Fukada, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Kurabayashi, Nobuhiro] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 113, Japan; [Shioi, Go] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuou ku, Kobe, Hyogo, Japan; [Todo, Takeshi] Osaka Univ, Grad Sch Med, Dept Radiat Biol & Med Genet, Suita, Osaka, Japan	Fukada, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	sfukada@mail.ecc.u-tokyo.ac.jp	Hirota, Tsuyoshi/D-8158-2015; KURABAYASHI, NOBUHIRO/G-4891-2014		Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan; MEXT, Japan; JSPS research fellowships for young scientists	This work was supported in part by grants-in-aid for scientific research and by the Global COE program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan. A. H. and N.K. were supported by JSPS research fellowships for young scientists.	Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Reischl S, 2011, FEBS LETT, V585, P1393, DOI 10.1016/j.febslet.2011.02.038; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kurabayashi N, 2010, MOL CELL BIOL, V30, P1757, DOI 10.1128/MCB.01047-09; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Gao P, 2013, J BIOL CHEM, V288, P35277, DOI 10.1074/jbc.M113.509604; Harada Y, 2005, J BIOL CHEM, V280, P31714, DOI 10.1074/jbc.M506225200; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Sakakida Y, 2005, J BIOL CHEM, V280, P13272, DOI 10.1074/jbc.M413236200; Schibler U, 2006, PROG BRAIN RES, V153, P271, DOI 10.1016/S0079-6123(06)53016-X; St John PC, 2014, P NATL ACAD SCI USA, V111, P2040, DOI 10.1073/pnas.1323618111; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542	33	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	DEC	2014	34	24					4464	4473		10.1128/MCB.00711-14		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AT9BN	WOS:000345223000008		
J	Okudaira, H; Oka, S; Ono, M; Nakanishi, T; Schuster, DM; Kobayashi, M; Goodman, MM; Tamai, I; Kawai, K; Shirakami, Y				Okudaira, Hiroyuki; Oka, Shuntaro; Ono, Masahiro; Nakanishi, Takeo; Schuster, David M.; Kobayashi, Masato; Goodman, Mark M.; Tamai, Ikumi; Kawai, Keiichi; Shirakami, Yoshifumi			Accumulation of Trans-1-Amino-3-[F-18]Fluorocyclobutanecarboxylic Acid in Prostate Cancer due to Androgen-Induced Expression of Amino Acid Transporters	MOLECULAR IMAGING AND BIOLOGY			English	Article						anti-FACBC; Prostate cancer; Androgen; Amino acid transporter; ASCT2	ANTI-1-AMINO-3-F-18-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; CELL-GROWTH; PET/CT; CARCINOMA; RECEPTOR; PROGRESSION; IDENTIFICATION; MECHANISMS; ASCT2; LAT1	Androgens play a crucial role in prostate cancer progression, and trans-1-amino-3-[F-18]fluorocyclobutanecarboxylic acid (anti-[(18) F]FACBC) are used for visualization of prostate cancer. We examined the effect of androgen on the expression of amino acid transporters related to anti-[F-18]FACBC transport and uptake of trans-1-amino-3-fluoro-[1-C-14]cyclobutanecarboxylic acid (anti-[C-14]FACBC). Expression of amino acid transporters and uptake of anti-[C-14]FACBC in androgen receptor (AR)-positive LNCaP and AR-negative DU145 human prostate cancer cells cultured with/without 5 alpha-dihydrotestosterone (DHT) and the effect of bicalutamide, an AR antagonist, on DHT-associated changes were investigated. DHT stimulated the expression of amino acid transporters ASCT2, SNAT5, 4F2 heavy chain, and LAT3 in LNCaP but not in DU145 cells. Anti-[C-14]FACBC uptake was enhanced, in a DHT-dependent manner, in LNCaP cells only. DHT enhanced the expression of ASCT2, the transporter responsible for anti-[F-18]FACBC uptake, thereby increasing anti-[C-14]FACBC uptake in AR-positive LNCaP cells. Androgen-mediated induction may contribute to the distinct anti-[F-18]FACBC accumulation pattern in prostate cancer.	[Okudaira, Hiroyuki; Oka, Shuntaro; Ono, Masahiro; Shirakami, Yoshifumi] Nihon Medi Phys Co Ltd, Res Ctr, Chiba 2990266, Japan; [Ono, Masahiro; Kobayashi, Masato; Kawai, Keiichi] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa 9201192, Japan; [Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa 9201192, Japan; [Schuster, David M.; Goodman, Mark M.] Emory Univ, Dept Radiol & Imaging Sci, Div Nucl Med & Mol Imaging, Atlanta, GA 30322 USA; [Kawai, Keiichi] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan	Okudaira, H (reprint author), Nihon Medi Phys Co Ltd, Res Ctr, 3-1 Kitasode, Chiba 2990266, Japan.	hiroyuki_okudaira@nmp.co.jp	Nakanishi, Takeo/C-3891-2015; TAMAI, Ikumi/D-8412-2015	Nakanishi, Takeo/0000-0002-6561-7138; 			Amaral JS, 2008, MOL CELL BIOCHEM, V313, P1, DOI 10.1007/s11010-008-9735-3; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Jadvar H, 2013, J NUCL MED, V54, P1685, DOI 10.2967/jnumed.113.126094; Wang Q, 2013, JNCI-J NATL CANCER I, V105, P1463, DOI 10.1093/jnci/djt241; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Schuster DM, 2014, J UROLOGY, V191, P1446, DOI 10.1016/j.juro.2013.10.065; Schuster DM, 2007, J NUCL MED, V48, P56; Schuster DM, 2011, RADIOLOGY, V259, P852, DOI 10.1148/radiol.11102023; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Asano Y, 2011, ANN NUCL MED, V25, P414, DOI 10.1007/s12149-011-0477-z; Babu E, 2003, J BIOL CHEM, V278, P43838, DOI 10.1074/jbc.M305221200; Jadvar H, 2013, J NUCL MED, V54, P1195, DOI 10.2967/jnumed.112.114116; Wang Q, 2011, CANCER RES, V71, P7525, DOI 10.1158/0008-5472.CAN-11-1821; Arakawa H, 2012, BIOCHEM PHARMACOL, V84, P1070, DOI 10.1016/j.bcp.2012.07.026; Oka S, 2012, NUCL MED BIOL, V39, P109, DOI 10.1016/j.nucmedbio.2011.06.008; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Okudaira H, 2013, NUCL MED BIOL, V40, P670, DOI 10.1016/j.nucmedbio.2013.03.009; Okudaira H, 2011, J NUCL MED, V52, P822, DOI 10.2967/jnumed.110.086074; Nanni C, 2013, EUR J NUCL MED MOL I, V40, pS11, DOI 10.1007/s00259-013-2373-3; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Cantor JM, 2012, J CELL SCI, V125, P1373, DOI 10.1242/jcs.096040; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI [10.2217/fon.09.117, 10.2217/FON.09.117]; Todorova VK, 2011, CANCER CHEMOTH PHARM, V67, P285, DOI 10.1007/s00280-010-1316-y; Trapman J, 1997, SEMIN CANCER BIOL, V8, P29, DOI 10.1006/scbi.1997.0050; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Galsky MD, 2012, CA-CANCER J CLIN, V62, P299, DOI 10.3322/caac.21141; Chauvin TR, 2004, BIOL REPROD, V71, P560, DOI 10.1095/biolreprod.103.026302; Chuaqui RF, 1997, UROLOGY, V50, P302, DOI 10.1016/S0090-4295(97)00194-5; JANSSEN T, 1995, INT J ONCOL, V7, P1219; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; Schwarzenbock S, 2012, THERANOSTICS, V2, P318, DOI 10.7150/thno.4008; Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003; Wolfgang CL, 2003, J GASTROINTEST SURG, V7, P149, DOI 10.1016/S1091-255X(02)00130-0	34	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1536-1632	1860-2002		MOL IMAGING BIOL	Mol. Imaging. Biol.	DEC	2014	16	6					756	764		10.1007/s11307-014-0756-x		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT9ZC	WOS:000345281600002		
J	Furutani, S; Ihara, M; Nishino, Y; Akamatsu, M; Jones, AK; Sattelle, DB; Matsuda, K				Furutani, Shogo; Ihara, Makoto; Nishino, Yuri; Akamatsu, Miki; Jones, Andrew K.; Sattelle, David B.; Matsuda, Kazuhiko			Exon 3 Splicing and Mutagenesis Identify Residues Influencing Cell Surface Density of Heterologously Expressed Silkworm (Bombyx mori) Glutamate-Gated Chloride Channels	MOLECULAR PHARMACOLOGY			English	Article							DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; GENE SUPERFAMILY; PHOTORECEPTOR SYNAPSE; APIS-MELLIFERA; RECEPTOR; RNA; IDENTIFICATION; TRAFFICKING	Glutamate-gated chloride channels (GluCls) mediate fast inhibitory neurotransmission in invertebrate nervous systems. Insect GluCls show alternative splicing, and, to determine its impact on channel function and pharmacology, we isolated GluCl cDNAs from larvae of the silkworm (Bombyx mori). We show that six B. mori glutamate-gated chloride channel variants are generated by splicing in exons 3 and 9 and that exons 3b and 3c are common in the brain and third thoracic ganglion. When expressed in Xenopus laevis oocytes, the three functional exon 3 variants (3a, b, c) all had similar EC50 values for L-glutamate and ivermectin (IVM); however, I-max (the maximum L-glutamate- and IVM-induced response of the channels at saturating concentrations) differed strikingly between variants, with the 3c variant showing the largest L-glutamate- and IVM-induced responses. By contrast, a partial deletion detected in exon 9 had a much smaller impact on L-glutamate and IVM actions. Binding assays using [H-3] IVM indicate that diversity in IVM responses among the GluCl variants is mainly due to the impact on channel assembly, altering receptor cell surface numbers. GluCl variants expressed in HEK293 cells show that structural differences influenced B-max but not K-d values of [H-3] IVM. Domain swapping and site-directed mutagenesis identified four amino acids in exon 3c as hot spots determining the highest amplitude of the L-glutamate and IVM responses. Modeling the GluCl 3a and 3c variants suggested that three of the four amino acids contribute to intersubunit contacts, whereas the other interacts with the TM2-TM3 linker, influencing the receptor response.	[Furutani, Shogo; Ihara, Makoto; Matsuda, Kazuhiko] Kinki Univ, Fac Agr, Dept Appl Biol Chem, Nara 6318505, Japan; [Nishino, Yuri] Univ Hyogo, Grad Sch Life Sci, Koto Ku, Kamigori, Hyogo, Japan; [Akamatsu, Miki] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Jones, Andrew K.] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Sattelle, David B.] UCL, Wolfson Inst Biomed Res, Dept Med, London, England	Matsuda, K (reprint author), Kinki Univ, Fac Agr, Dept Appl Biol Chem, 3327-204 Nakamachi, Nara 6318505, Japan.	kmatsuda@nara.kindai.ac.jp		Ihara, Makoto/0000-0002-6403-0781	Japan Society for the Promotion of Science [21310147, 26292031]; Ministry of Agriculture, Forestry, and Fisheries of Japan [1302]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1101035]	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [Grants 21310147, 26292031]; the Integrated Research Project for Plants, Insects, and Animals using Genome Technology from the Ministry of Agriculture, Forestry, and Fisheries of Japan [Grant 1302]; and the Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grant S1101035].	Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; Jones Andrew K., 2006, Invertebrate Neuroscience, V6, P123, DOI 10.1007/s10158-006-0026-y; FFRENCHCONSTANT RH, 1993, J NEUROCHEM, V60, P2323, DOI 10.1111/j.1471-4159.1993.tb03523.x; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Jones AK, 2010, HEREDITY, V104, P247, DOI 10.1038/hdy.2009.97; Jones Andrew K., 2008, Invertebrate Neuroscience, V8, P41, DOI 10.1007/s10158-008-0068-4; Gisselmann G, 2002, NAT NEUROSCI, V5, P11, DOI 10.1038/nn787; Jones AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-327; Putrenko I, 2005, J BIOL CHEM, V280, P6392, DOI 10.1074/jbc.M412644200; Jones AK, 2009, J NEUROSCI, V29, P4287, DOI 10.1523/JNEUROSCI.5251-08.2009; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200; Raymond V, 2002, NAT REV DRUG DISCOV, V1, P427, DOI 10.1038/nrd821; Saragoza PA, 2003, MOL BRAIN RES, V117, P15, DOI 10.1016/S0169-328X(03)00261-4; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Cully DF, 1996, J BIOL CHEM, V271, P20187; Kita T, 2014, INSECT BIOCHEM MOLEC, V45, P1, DOI 10.1016/j.ibmb.2013.11.004; Daniel C, 2011, J BIOL CHEM, V286, P2031, DOI 10.1074/jbc.M110.130096; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Buckingham SD, 2005, MOL PHARMACOL, V68, P942, DOI 10.1124/mol.105.015313; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V255, P449; Demares F, 2013, INSECT BIOCHEM MOLEC, V43, P115, DOI 10.1016/j.ibmb.2012.10.003; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Grauso M, 2002, GENETICS, V160, P1519; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Keegan LP, 2005, EMBO J, V24, P2183, DOI 10.1038/sj.emboj.7600691; Lees K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097468; Penn AC, 2009, RNA BIOL, V6, P517; Raymond-Delpech Valerie, 2005, Invertebrate Neuroscience, V5, P119, DOI 10.1007/s10158-005-0004-9; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; WAFFORD KA, 1986, NEUROSCI LETT, V63, P135, DOI 10.1016/0304-3940(86)90050-9; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Wolstenholme AJ, 1997, BIOCHEM SOC T, V25, P830; Wolstenholme Adrian J., 2007, Invertebrate Neuroscience, V7, P179, DOI 10.1007/s10158-007-0061-3; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218	43	2	2	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	DEC	2014	86	6					686	695		10.1124/mol.114.095869		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU0AG	WOS:000345284800008		
J	Ihara, M; Okajima, T; Yamashita, A; Oda, T; Asano, T; Matsui, M; Sattelle, DB; Matsuda, K				Ihara, Makoto; Okajima, Toshihide; Yamashita, Atsuko; Oda, Takuma; Asano, Takuya; Matsui, Mikana; Sattelle, David B.; Matsuda, Kazuhiko			Studies on an Acetylcholine Binding Protein Identify a Basic Residue in Loop G on the beta 1 Strand as a New Structural Determinant of Neonicotinoid Actions	MOLECULAR PHARMACOLOGY			English	Article							XENOPUS-LAEVIS OOCYTES; NICOTINIC RECEPTORS; DIVERSE ACTIONS; MOLECULAR REPLACEMENT; CRYSTAL-STRUCTURES; COCKROACH NEURONS; DIFFRACTION DATA; INSECTICIDES; ALPHA-7; ACHBP	Neonicotinoid insecticides target insect nicotinic acetylcholine receptors (nAChRs). Their widespread use and possible risks to pollinators make it extremely urgent to understand the mechanisms underlying their actions on insect nAChRs. We therefore elucidated X-ray crystal structures of the Lymnaea stagnalis acetylcholine binding protein (Ls-AChBP) and its Gln55Arg mutant, more closely resembling insect nAChRs, in complex with a nitromethylene imidacloprid analog (CH-IMI) and desnitro-imidacloprid metabolite (DN-IMI) as well as commercial neonicotinoids, imidacloprid, clothianidin, and thiacloprid. Unlike imidacloprid, clothianidin, and CH-IMI, thiacloprid did not stack with Tyr185 in the wild-type Ls-AChBP, but did in the Gln55Arg mutant, interacting electrostatically with Arg55. In contrast, DN-IMI lacking the NO2 group was directed away from Lys34 and Arg55 to form hydrogen bonds with Tyr89 in loop A and the main chain carbonyl of Trp143 in loop B. Unexpectedly, we found that several neonicotinoids interacted with Lys34 in loop G on the beta 1 strand in the crystal structure of the Gln55Arg mutant. Basic residues introduced into the alpha 7 nAChR at positions equivalent to AChBP Lys34 and Arg55 enhanced agonist actions of neonicotinoids, while reducing the actions of acetylcholine, (-)-nicotine, and DN-IMI. Thus, not only the basic residues in loop D, but also those in loop G determine the actions of neonicotinoids. These novel findings provide new insights into the modes of action of neonicotinoids and emerging derivatives.	[Ihara, Makoto; Okajima, Toshihide; Asano, Takuya; Matsui, Mikana; Matsuda, Kazuhiko] Kinki Univ, Fac Agr, Dept Appl Biol Chem, Nara 6318505, Japan; [Okajima, Toshihide] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka, Japan; [Yamashita, Atsuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama, Japan; [Sattelle, David B.] UCL, Dept Med, Wolfson Inst Biomed Res, London, England	Ihara, M (reprint author), Kinki Univ, Fac Agr, Dept Appl Biol Chem, 3327-204 Nakamachi, Nara 6318505, Japan.	makoto_i@nara.kindai.ac.jp; kmatsuda@nara.kindai.ac.jp		Ihara, Makoto/0000-0002-6403-0781	Ministry of Agriculture, Forestry, and Fisheries of Japan Genomics-based Technology [PRM-3002]; Ministry of Education, Culture, Sports, Science and Technology of Japan [S1101035]	This study was supported by the Ministry of Agriculture, Forestry, and Fisheries of Japan Genomics-based Technology for Agricultural Improvement [Grant PRM-3002], and the Strategic Project to Support the Formation of Research Bases at Private Universities: Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant S1101035].	Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Ihara Makoto, 2008, Invertebrate Neuroscience, V8, P71, DOI 10.1007/s10158-008-0069-3; Matsuda K, 2005, BIOSCI BIOTECH BIOCH, V69, P1442, DOI 10.1271/bbb.69.1442; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ihara M, 2004, BIOSCI BIOTECH BIOCH, V68, P761, DOI 10.1271/bbb.68.761; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Shimomura M, 2002, BRIT J PHARMACOL, V137, P162, DOI 10.1038/sj.bjp.0704848; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Matsuda K, 2009, MOL PHARMACOL, V76, P1, DOI 10.1124/mol.109.055186; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; NGUYEN M, 1995, GENETICS, V140, P527; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Talley TT, 2008, P NATL ACAD SCI USA, V105, P7606, DOI 10.1073/pnas.0802197105; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Shimomura M, 2006, MOL PHARMACOL, V70, P1255, DOI 10.1124/mol.106.026815; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Changeux JP, 2012, J BIOL CHEM, V287, P40207, DOI 10.1074/jbc.R112.407668; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Ihara M, 2003, NEUROPHARMACOLOGY, V45, P133, DOI 10.1016/S0028-3908(03)00134-5; Ihara M, 2006, J PESTIC SCI, V31, P35, DOI 10.1584/jpestics.31.35; Latli B, 1996, J LABELLED COMPD RAD, V38, P971; Leslie AGW, 2007, NATO SCI SER II MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maus Christian, 2003, Bulletin of Insectology, V56, P51; McDougall Phillips, 2013, AGRIREFERENCE; Nishio M., 2006, TOP STEREOCHEM, V25, P255, DOI 10.1002/0471785156.ch8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shimomura M, 2004, NEUROSCI LETT, V363, P195, DOI 10.1016/j.neulet.2003.12.115; Shimomura M, 2003, BRAIN RES, V991, P71, DOI 10.1016/j.brainres.2003.08.005; Toshima K, 2009, NEUROPHARMACOLOGY, V56, P264, DOI 10.1016/j.neuropharm.2008.08.022; Yoshimura M, 2007, AIP CONF PROC, V879, P1916	49	3	3	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0026-895X	1521-0111		MOL PHARMACOL	Mol. Pharmacol.	DEC	2014	86	6					736	746		10.1124/mol.114.094698		11	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU0AG	WOS:000345284800013		
J	Ohtsu, M; Shibata, Y; Ojika, M; Tamura, K; Hara-Nishimura, I; Mori, H; Kawakita, K; Takemoto, D				Ohtsu, Mina; Shibata, Yusuke; Ojika, Makoto; Tamura, Kentaro; Hara-Nishimura, Ikuko; Mori, Hitoshi; Kawakita, Kazuhito; Takemoto, Daigo			Nucleoporin 75 Is Involved in the Ethylene-Mediated Production of Phytoalexin for the Resistance of Nicotiana benthamiana to Phytophthora infestans	MOLECULAR PLANT-MICROBE INTERACTIONS			English	Article							NUCLEAR-PORE COMPLEX; ACTIVATED PROTEIN-KINASE; DISEASE RESISTANCE; ARABIDOPSIS-THALIANA; LOTUS-JAPONICUS; INNATE IMMUNITY; SYNTHASE GENE; RNA EXPORT; BIOSYNTHESIS; EXPRESSION	Mature Nicotiana benthamiana shows stable resistance to the oomycete pathogen Phytophthora infestans. Induction of phytoalexin (capsidiol) production is essential for the resistance, which is upregulated via a mitogen-activated protein kinase (MAPK) cascade (NbMEK2-WIPK/SIPK) followed by ethylene signaling. In this study, NbNup75 (encodes a nuclear pore protein Nucleoporin75) was identified as an essential gene for resistance of N. benthamiana to P. infestans. In NbNup75-silenced plants, initial events of elicitor-induced responses such as phosphorylation of MAPK and expression of defense-related genes were not affected, whereas induction of later defense responses such as capsidiol production and cell death induction was suppressed or delayed. Ethylene production induced by either INF1 or NbMEK2 was reduced in NbNup75-silenced plants, whereas the expression of NbEAS (a gene for capsidiol biosynthesis) induced by ethylene was not affected, indicating that Nup75 is required for the induction of ethylene production but not for ethylene signaling. Given that nuclear accumulation of polyA RNA was increased in NbNup75-silenced plants, efficient export of mRNA from nuclei via nuclear pores would be important for the timely upregulation of defense responses. Collectively, Nup75 is involved in the induction of a later stage of defense responses, including the ethylene-mediated production of phytoalexin for the resistance of N. benthamiana to P. infestans.	[Ohtsu, Mina; Shibata, Yusuke; Ojika, Makoto; Mori, Hitoshi; Kawakita, Kazuhito; Takemoto, Daigo] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Tamura, Kentaro; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan	Takemoto, D (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	dtakemo@agr.nagoya-u.ac.jp			Japan Society for the Promotion of Science [23780041, 26292024]; Sumitomo Foundation	We thank D. C. Baulcombe (University of Cambridge, U.S.A.) for providing pTV00 and pBINTRA6 vectors, S. Kamoun (The Sainsbury Laboratory, U.K.) for pFB53 vector, S. Seo (National Institute of Agrobiological Sciences, Japan) for SIPK and WIPK antibodies, G. B. Martin (Cornell University, U.S.A.) for access to the N. benthamiana genome database, D. Jones (The Australian National University, Australia) for N. benthamiana seed, K. Shirai (Hokkaido Central Agricultural Experiment Station, Japan) for providing P. infestans isolate, R. Terauchi and S. Natsume (Iwate Biotechnology Research Center, Japan) for the analysis of RNAseq data, M. Mori and S. Tsuda (National Agricultural Research Center for Hokkaido Region, Japan) and Y. Tahara (Nagoya University) for providing potato tubers, and N. Skoulding for English editing of the manuscript. This work was supported by a Grant-in-Aid for Young Scientists (B) (23780041) and Grant-in-Aid for Scientific Research (B) (26292024) from the Japan Society for the Promotion of Science and by Grant for Basic Science Research Projects from The Sumitomo Foundation.	YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Nakazato Y, 2000, BIOSCI BIOTECH BIOCH, V64, P577, DOI 10.1271/bbb.64.577; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Dong CH, 2006, MOL CELL BIOL, V26, P9533, DOI 10.1128/MCB.01063-06; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Ahlfors R, 2004, PLANT J, V40, P512, DOI 10.1111/j.1365-313X.2004.02229.x; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Kim CY, 2003, PLANT CELL, V15, P2707, DOI 10.1105/tpc.011411; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Han L, 2010, PLANT J, V64, P114, DOI 10.1111/j.1365-313X.2010.04318.x; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Lee J, 2004, J BIOL CHEM, V279, P22440, DOI 10.1074/jbc.M401099200; Parry G, 2006, PLANT CELL, V18, P1590, DOI 10.1105/tpc.106.041566; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Groth M, 2010, PLANT CELL, V22, P2509, DOI 10.1105/tpc.109.069807; Wiermer M, 2012, PLANT J, V70, P796, DOI 10.1111/j.1365-313X.2012.04928.x; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; ZAREMBINSKI TI, 1994, PLANT MOL BIOL, V26, P1579, DOI 10.1007/BF00016491; DOYE V, 1994, EMBO J, V13, P6062; Raices M, 2012, NAT REV MOL CELL BIO, V13, P687, DOI 10.1038/nrm3461; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; BAILEY JA, 1975, PHYTOCHEMISTRY, V14, P597, DOI 10.1016/0031-9422(75)85148-X; Chung IM, 2001, MOL CELLS, V12, P353; FACCHINI PJ, 1992, P NATL ACAD SCI USA, V89, P11088, DOI 10.1073/pnas.89.22.11088; Gao HH, 2003, J BIOL CHEM, V278, P25331, DOI 10.1074/jbc.M301607200; Germain H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001250; Goldstein AL, 1996, MOL BIOL CELL, V7, P917; Ishigaki E, 2004, BIOL PHARM BULL, V27, P1308, DOI 10.1248/bpb.27.1308; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Matsukawa M, 2013, MOL PLANT MICROBE IN, V26, P880, DOI 10.1094/MPMI-12-12-0301-R; Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Saito K, 2007, PLANT CELL, V19, P610, DOI 10.1105/tpc.106.046938; Seo S., 2000, PLANT CELL, V270, P1988; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Shibata Y, 2011, PHYSIOL MOL PLANT P, V75, P120, DOI 10.1016/j.pmpp.2010.10.001; Takemoto D, 2012, MOL PLANT MICROBE IN, V25, P379, DOI 10.1094/MPMI-11-10-0272; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Uruma S, 2009, J GEN PLANT PATHOL, V75, P257, DOI 10.1007/s10327-009-0176-y	54	2	2	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0894-0282	1943-7706		MOL PLANT MICROBE IN	Mol. Plant-Microbe Interact.	DEC	2014	27	12					1318	1330		10.1094/MPMI-06-14-0181-R		13	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Plant Sciences	AT7PO	WOS:000345130200002		
J	Aubert, N; Rondelez, Y; Fujii, T; Hagiya, M				Aubert, Nathanael; Rondelez, Yannick; Fujii, Teruo; Hagiya, Masami			Enforcing logical delays in DNA computing systems	NATURAL COMPUTING			English	Article						DNA computing; Delay mechanism; Sequentiality; Concurrency; DNA toolbox		DNA computing has the potential to create powerful devices, but, in the context of well-mixed systems, sequentiality of operations is hard to achieve. To enforce such sequentiality, we propose a generic delay gate that can be interfaced with virtually any DNA system. Since it is system-independent, our delay gate can be used as an off-the-shelf library to accelerate the design of increasingly complex systems. Additionally, we checked the feasibility of our design by testing various in vitro implementations. We also present a theoretical proof of concept of its applicability by using it to complement an existing DNA module library, the DNA toolbox, to design new systems.	[Aubert, Nathanael; Hagiya, Masami] Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan; [Rondelez, Yannick; Fujii, Teruo] Univ Tokyo, Inst Ind Sci, LIMMS CNRS IIS, Tokyo, Japan	Aubert, N (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Tokyo, Japan.	naubert@is.s.u-tokyo.ac.jp; rondelez@iis.u-tokyo.ac.jp; hagiya@is.s.u-tokyo.ac.jp					Genot AJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208102; Fujii T, 2013, ACS NANO, V7, P27, DOI 10.1021/nn3043572; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s; Padirac A, 2012, P NATL ACAD SCI USA, V109, pE3212, DOI 10.1073/pnas.1212069109; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; LAMPORT L, 1977, IEEE T SOFTWARE ENG, V3, P125, DOI 10.1109/TSE.1977.229904; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Genot AJ, 2011, J AM CHEM SOC, V133, P2177, DOI 10.1021/ja1073239; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Pei RJ, 2010, NAT NANOTECHNOL, V5, P773, DOI [10.1038/nnano.2010.194, 10.1038/NNANO.2010.194]; Genot AJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0212; Condon A, 2012, INTERFACE FOCUS, V2, P512, DOI 10.1098/rsfs.2011.0106; Hagiya M, 1999, DIMACS SERIES DISCRE, V48, P57; LAMPORT L, 1977, COMMUN ACM, V20, P806, DOI 10.1145/359863.359878; Montagne K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.120; Montagne K, 2011, 17 INT C DNA COMP MO; Padirac A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks621; Thachuk C, 2012, LNCS, V7433, P135	20	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-7818	1572-9796		NAT COMPUT	Nat. Comput.	DEC	2014	13	4	1-2		SI		559	572		10.1007/s11047-014-9450-9		14	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods	Computer Science	AT4PI	WOS:000344922100011		
J	Kan, A; Sakai, Y; Shohda, K; Suyama, A				Kan, Anton; Sakai, Yoko; Shohda, Koh-ichiroh; Suyama, Akira			A DNA based molecular logic gate capable of a variety of logical operations	NATURAL COMPUTING			English	Article						Biomolecular computing; DNA computing; Logic gate; SNP genotyping	REVERSE-TRANSCRIPTASE; VIRUS; RNA	In this paper we report on a module in the RTRACS (Reverse-transcription and TRanscription-based Autonomous Computing System) molecular computing system, constructed with DNA, RNA and enzymes. The module is a 2-input logic gate that receives input and produces output in the form of RNA molecules. Each of the two input molecules is chosen from a set of two, and the logic gate produces an output molecule for each of the four possible input combinations. Two output RNA molecules can be produced by this module, one for only one combination of inputs, whilst the remaining three combinations lead to the production of the other output. Since the RNA strands can be arbitrarily assigned logical values, this module is capable performing multiple logical operations, including AND, NAND, OR and NOR, given the appropriate mapping of RNA molecules to logical values. We performed numerical simulations of the logic gate reaction scheme, revealing the details of the kinetics of the production of output molecules and the theoretical input-output characteristics. We experimentally demonstrated the proper functioning of the logic gate and the real time production of output molecules. Furthermore, we demonstrate an implementation of the logic gate in diagnosing single nucleotide polymorphism patterns on samples of human genomic DNA. We believe this versatile logic gate has significant advantages as a basic module of RTRACS due to the wide variety of possible logical operations.	[Kan, Anton; Sakai, Yoko; Shohda, Koh-ichiroh; Suyama, Akira] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Kan, Anton; Sakai, Yoko; Shohda, Koh-ichiroh; Suyama, Akira] Univ Tokyo, Grad Sch Arts & Sci, Inst Phys, Meguro Ku, Tokyo 1538902, Japan	Suyama, A (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	aik26@cam.ac.uk; sakai@genta.c.u-tokyo.ac.jp; shohda@genta.c.u-tokyo.ac.jp; suyama@dna.c.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23119007]	The authors gratefully acknowledge Prof. Katsushi Tokunaga and Dr. Nao Nishida, Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, for their help with the preparation of encoding products from the human genomic DNA samples. This work was partly supported by Grant-in-Aid for Scientific Research on Innovative Areas 23119007 to AS from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Hirano N, 2000, BIOCHEMISTRY-US, V39, P13285, DOI 10.1021/bi0015008; Kitajima T, 2008, LECT NOTES COMPUT SC, V4848, P119; KRUG MS, 1991, BIOCHEMISTRY-US, V30, P10614, DOI 10.1021/bi00108a003; MARTIN CT, 1987, BIOCHEMISTRY-US, V26, P2690, DOI 10.1021/bi00384a006; Nishida N, 2005, ANAL BIOCHEM, V346, P281, DOI 10.1016/j.ab.2005.08.007; Nitta Nao, 2005, Natural Computing, V4, P127, DOI 10.1007/s11047-004-4008-X; Sakai Y, 2009, LECT NOTES COMPUT SC, V5877, P137, DOI 10.1007/978-3-642-10604-0_14; Takinoue M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041921; YU H, 1992, J BIOL CHEM, V267, P10888	10	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-7818	1572-9796		NAT COMPUT	Nat. Comput.	DEC	2014	13	4	1-2		SI		573	581		10.1007/s11047-013-9394-5		9	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods	Computer Science	AT4PI	WOS:000344922100012		
J	Akter, F; Ishikawa, H				Akter, Fatima; Ishikawa, Hirohiko			Synoptic features and environmental conditions of the tornado outbreak on March 22, 2013 at Brahmanbaria in the east-central region of Bangladesh	NATURAL HAZARDS			English	Article						Thunderstorms; Severe local storms; Tornado; Bangladesh disaster; Brahmanbaria tornado; Dryline	PREMONSOON SEASON; CONVECTIVE STORMS; PART I; DRYLINE; INDIA; CLIMATOLOGY; INITIATION; LINE; THUNDERSTORMS; CUMULONIMBUS	This study evaluates the synoptic features and environmental conditions of Brahmanbaria tornado event that caused 36 fatalities, 388 injuries and huge damages of properties on 22 March, 2013. Various factors for initiation of that terrific event are investigated through analysis JRA-55 reanalysis (50 km horizontal resolution) data and Multi-functional Transport Satellite images by Japan Meteorological Agency. In addition, radar images, radiosonde data and three hourly synoptic data of Bangladesh Meteorological Department are used to verify the reanalysis data. The genesis of the tornadic storm is identifiable in the most unstable part of the study region. The satellite observations are found to useful to identify the location of convection occurrence region. The half hourly satellite images identify that the convection initiation started at the convergence area and the systems intensify and organize by the continuous moisture supply from the Bay of Bengal. Lower-level convergence coupled with strong wind shear and humidity gradient lift moist air aloft to trigger deep convection and the severe storm occurred. Energy Helicity Index seems a good predictor parameter for this specific case study.		Akter, F (reprint author), Kyoto Univ, Disaster Prevent Res Inst, Kyoto 6110011, Japan.	fatima_a@storm.dpri.kyoto-u.ac.jp; ishikawa@storm.dpri.kyoto-u.ac.jp					Mukhopadhyay P, 2009, J EARTH SYST SCI, V118, P441; MONCRIEFF MW, 1976, Q J ROY METEOR SOC, V102, P373, DOI 10.1002/qj.49710243208; Ziegler CL, 1998, WEATHER FORECAST, V13, P1106, DOI 10.1175/1520-0434(1998)013<1106:TIOMCA>2.0.CO;2; Ebita A, 2011, SOLA, V7, P149, DOI 10.2151/sola.2011-038; Rasmussen EN, 1998, WEATHER FORECAST, V13, P1148, DOI 10.1175/1520-0434(1998)013<1148:ABCOSD>2.0.CO;2; Yamane Y, 2010, ATMOS RES, V95, P400, DOI 10.1016/j.atmosres.2009.11.004; Yamane Y, 2010, ATMOS RES, V95, P407, DOI 10.1016/j.atmosres.2009.11.003; Yamane Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026823; Dalal S, 2012, ATMOS RES, V106, P120, DOI 10.1016/j.atmosres.2011.12.002; WESTON KJ, 1972, Q J ROY METEOR SOC, V98, P519, DOI 10.1002/qj.49709841704; Murphey HV, 2006, MON WEATHER REV, V134, P406, DOI 10.1175/MWR3063.1; Romatschke U, 2010, J CLIMATE, V23, P419, DOI 10.1175/2009JCLI3140.1; WEISMAN ML, 1982, MON WEATHER REV, V110, P504, DOI 10.1175/1520-0493(1982)110<0504:TDONSC>2.0.CO;2; FUELBERG HE, 1994, WEATHER FORECAST, V9, P316, DOI 10.1175/1520-0434(1994)009<0316:TPEOST>2.0.CO;2; BLUESTEIN HB, 1993, MON WEATHER REV, V121, P1354, DOI 10.1175/1520-0493(1993)121<1354:MOISCS>2.0.CO;2; COLBY FP, 1984, MON WEATHER REV, V112, P2239, DOI 10.1175/1520-0493(1984)112<2239:CIAAPO>2.0.CO;2; Davis J. K., 1993, Proceedings. Third Great Lakes Symposium on VLSI Design Automation of High Performance VLSI Systems (Cat. No.93TH0506-6), DOI 10.1109/GLSV.1993.224469; Davis J. M., 1993, GEOPHYS MONOGR SER, V79, P573, DOI DOI 10.1029/GM079P0573; Fujita T. T., 1958, B AM METEOROL SOC, V39, P574; Galway J.G., 1956, B AM METEOROL SOC, V37, P528; Ghosh A, 2008, ATMOS RES, V87, P116, DOI 10.1016/j.atmosres.2007.08.001; Hane CE, 1997, MON WEATHER REV, V125, P231, DOI 10.1175/1520-0493(1997)125<0231:STDIRT>2.0.CO;2; Hart JA, 1991, SHARP WORKSTATION V1, P30; Huschke RE, 1959, GLOSSARY METEOROLOGY, P638; LOHAR D, 1995, J CLIMATE, V8, P2567, DOI 10.1175/1520-0442(1995)008<2567:TEOIOP>2.0.CO;2; Miller RC, 1959, B AM METEOROL SOC, V40, P465; Murata F, 2011, J METEOROL SOC JPN, V89A, P167, DOI 10.2151/jmsj.2011-A11; Ono Y, 2001, THESIS KENT STATE U; PETERSON RE, 1981, ARCH METEOR GEOPHY B, V29, P345, DOI 10.1007/BF02263310; Rasmussen EN, 1983, P 13 C SEV LOC STORM, pJ5; Rhea J. O., 1966, J APPL METEOROL, V5, P58, DOI 10.1175/1520-0450(1966)005<lessthan>0058:ASOTFA<greaterthan>2.0.CO;2; Sadowski AF, 1977, TECHNICAL PROCEDURES, P8; Showalter AK., 1953, B AM METEOROL SOC, V34, P250; Yamane Y, 2012, INT J CLIMATOL, V33, P725	34	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	DEC	2014	74	3					1309	1326		10.1007/s11069-014-1252-y		18	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AT7DK	WOS:000345096800001		
J	Luo, Y; Shaw, R; Lin, HL; Joerin, J				Luo, Yuner; Shaw, Rajib; Lin, Hanliang; Joerin, Jonas			Assessing response behaviour of debris-flows affected communities in Kaohsiung, Taiwan	NATURAL HAZARDS			English	Article						Response behaviour; Risk perception; Debris-flow; Typhoon Morakot	DISASTER MANAGEMENT; RISK PERCEPTION; FLOOD; PREPAREDNESS; MITIGATION; HAZARD	During Typhoon Morakot which hit Taiwan from 6 to 9 August, 2009, Kaohsiung City was highly affected by devastating debris-flows and flooding. Recorded casualties were 699 deaths and 1,766 damaged homes, mostly in the mountainous areas of Kaohsiung City. Due to a largely malfunctioning or absent early-warning system, residents in those mountainous villages were required to rely on individual- and/or community-based capacities to evacuate and respond to debris-flow-related disasters. Hence, this study investigates the response behaviour of selected debris-flow-affected communities in Kaohsiung City, based on a preparedness awareness action and affect model. Key results from the survey highlight that only 13.8 % of the households received formal (institutional) early warning, whereas 86.2 % households had to rely on their intrinsic senses and indigenous knowledge to recognise the onset of debris-flows in their villages during Typhoon Morakot. Among those households who did not receive formal early warning, 10 % of the households received previous disaster education, 17 % had previous disaster experience, and 73 % did have neither disaster education nor disaster experience. Furthermore, households with disaster education were among those who were best prepared and knew best how to evacuate and respond to debris-flow-related disasters followed by households with disaster experiences. Finally, findings from the survey and selected key informants' interviews identified that the response behaviour of communities ought to be enhanced through the following measures: conduction of hydro-meteorological-related disaster education, improved participatory risk communication and enhanced recognition of communities as vital actors during a disaster to provide local knowledge and support to relief operations.	[Luo, Yuner; Shaw, Rajib] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Lin, Hanliang] Natl Cheng Kung Univ, Dept Urban Planning, Tainan 70101, Taiwan; [Joerin, Jonas] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Luo, Y (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan.	luo.yuner@gmail.com			Kyoto University and the Independent Administrative Institution Japan Student Services Organization (JASSO)	The authors thank the residents from the survey areas in Kaohsiung for their kind support and cooperation to reply the questionnaires. The first author acknowledges the financial support to this research from the Global 30 Project at Kyoto University and the Independent Administrative Institution Japan Student Services Organization (JASSO).	Allen KM, 2006, DISASTERS, V30, P81, DOI 10.1111/j.1467-9523.2006.00308.x; SLOVIC P, 1986, RISK ANAL, V6, P403, DOI 10.1111/j.1539-6924.1986.tb00953.x; Kang JE, 2007, J APPL SOC PSYCHOL, V37, P887, DOI 10.1111/j.1559-1816.2007.00191.x; Lindell MK, 2000, ENVIRON BEHAV, V32, P461, DOI 10.1177/00139160021972621; MILETI DS, 1992, RISK ANAL, V12, P393, DOI 10.1111/j.1539-6924.1992.tb00691.x; Parker DJ, 2009, METEOROL APPL, V16, P103, DOI 10.1002/met.119; Ho MC, 2008, RISK ANAL, V28, P635, DOI 10.1111/j.1539-6924.2008.01040.x; Baum R, 2010, LANDSLIDES, V7, P259, DOI 10.1007/s10346-009-0177-0; Grothmann T, 2006, NAT HAZARDS, V38, P101, DOI 10.1007/s11069-005-8604-6; Perry RW, 2003, DISASTERS, V27, P336, DOI 10.1111/j.0361-3666.2003.00237.x; Paton D, 2008, J VOLCANOL GEOTH RES, V172, P179, DOI 10.1016/j.jvolgeores.2007.12.026; Chen LC, 2006, NAT HAZARDS, V37, P209, DOI 10.1007/s11069-005-4669-5; Tunstall Sylvia, 2006, Journal of Water and Health, V4, P365, DOI 10.2166/wh.2006.031; Chen CY, 2008, NAT HAZARDS, V47, P245, DOI 10.1007/s11069-008-9217-7; Chen L-C., 2010, TAIWANS DISASTER PRE; Chen L-C, 2005, INT WORKSH EM RESP R; Chen LC, 2006, J CHIN INST ENG, V29, P633, DOI 10.1080/02533839.2006.9671159; Control Yuan Republic of China (Taiwan), 2009, INV REP HUM RIGHTS; Dynes R., 1994, INT J MASS EMERGENCI, V12, P141; Fitzpatrick C, 1991, INT J MASS EMERGENCI, V9, P137; Gladwin C, 2001, INT J MASS EMERGENCI, V19, P117; Johnston D, 2004, VOLC SOC WORKSH WAIR; Lin SY, 2008, NAT HAZARDS, V44, P305, DOI 10.1007/s11069-007-9136-z; Lindell M. K., 2005, NAT HAZARDS REV, V6, P171, DOI DOI 10.1061/(ASCE)1527-6988(2005)6:4(171); Mileti D. S., 1995, INT J MASS EMERGENCI, V13, P119; Morakot Post-Disaster Reconstruction Council (MPDRC), 2011, REB SUST HOM INN UN; National Fire Agency (NFA), 2011, LOSS CAUS NAT DIS 19; National Fire Agency (NFA), 2011, LOSS NAT HAZ TAIW; Paton D, 2000, J AM SOC PROF EMERG, V7, P109; Paton D., 2003, DISASTER PREVENTION, V12, P210, DOI 10.1108/09653560310480686; Perry Ronald W., 2004, J CONTING CRISIS MAN, V12, P64, DOI 10.1111/j.0966-0879.2004.00436.x; Shaw R, 2012, COMM ENV DISAST RISK, V10, P1; Shaw R, 2004, DISASTER PREVENTION, V13, P39, DOI 10.1108/09653560410521689; Shiwaku K, 2007, DISASTER PREV MANAG, V16, P576, DOI DOI 10.1108/09653560710817057; Smith K., 1993, ENV HAZARDS ASSESSIN; Solomon S, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19; Taiwan Climate Change Projection & Information Platform (TCCIP), 2011, TAIW CLIM CHANG SCI; WAECKERLE JF, 1991, NEW ENGL J MED, V324, P815; WALLACE WA, 1985, PUBLIC ADMIN REV, V45, P134, DOI 10.2307/3135008; Water Resource Agency (WRA), 2009, MAJ FLOOD DROUGHT DI; Weichselgartner J, 2001, DISASTER PREVENTION, V10, P85, DOI DOI 10.1108/09653560110388609; World Bank, 2005, NATURAL DISASTER HOT; Wu TY, 2012, HYDROL PROCESS, V26, P2421, DOI 10.1002/hyp.9346; Yen CL, 2006, NAT HAZARDS, V37, P3, DOI 10.1007/s11069-005-4652-1; Zhang Y, 2004, NAT HAZARDS REV, V5, P115, DOI DOI 10.1061/(ASCE)1527-6988(2004)5:3(115)	45	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	DEC	2014	74	3					1429	1448		10.1007/s11069-014-1258-5		20	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AT7DK	WOS:000345096800007		
J	Shimokawa, S; Murakami, T; Iizuka, S; Yoshino, J; Yasuda, T				Shimokawa, Shinya; Murakami, Tomokazu; Iizuka, Satoshi; Yoshino, Jun; Yasuda, Takashi			A new typhoon bogussing scheme to obtain the possible maximum typhoon and its application for assessment of impacts of the possible maximum storm surges in Ise and Tokyo Bays in Japan	NATURAL HAZARDS			English	Article						Typhoon bogussing scheme; Maximum potential intensity; Storm surge; Global warming	CLIMATE; MODEL; FREQUENCY; INTENSITY; CYCLONE	We developed the new typhoon bogussing scheme to obtain the possible maximum typhoon approaching any region under any climatic conditions by using a potential vorticity inversion method. Numerical simulations with the new typhoon bogussing scheme are conducted for assessment of storm surges by possible maximum typhoons under the present-day and global warming climatic conditions in Ise and Tokyo Bays in Japan. The results suggest that the storm tide higher than the maximum storm tide in recorded history can occur in Ise and Tokyo Bays even for the present-day climate and the storm tide higher than the design sea level can cause severe damage to Nagoya and Tokyo megacities, in particular, airport facilities in Ise Bay for the global warming climate. These results suggest that the new typhoon bogussing scheme we developed is useful for assessment of impacts of storm surge by the possible maximum typhoons.	[Shimokawa, Shinya; Murakami, Tomokazu; Iizuka, Satoshi] Natl Inst Earth Sci & Disaster Prevent, Storm Flood & Landslide Res Unit, Tsukuba, Ibaraki 3050006, Japan; [Yoshino, Jun] Gifu Univ, Grad Sch Engn, Environm & Renewable Energy Syst Div, Gifu 5011193, Japan; [Yasuda, Takashi] Aichi Univ Technol, Gamagori 4430047, Japan	Shimokawa, S (reprint author), Natl Inst Earth Sci & Disaster Prevent, Storm Flood & Landslide Res Unit, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	simokawa@bosai.go.jp			Japan Society for the Promotion of Science [24360199, 25400465]; National Research Institute for Earth Science and Disaster Prevention	The authors would like to thank Dr. A. Ukai for useful comments and discussions. This research was supported by the Japan Society for the Promotion of Science through Grants Nos. 24360199 and 25400465, and by the National Research Institute for Earth Science and Disaster Prevention through a research project on the coastal disaster.	Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; EMANUEL KA, 1995, J ATMOS SCI, V52, P3969, DOI 10.1175/1520-0469(1995)052<3969:SOTCTS>2.0.CO;2; Knutson TR, 2008, NAT GEOSCI, V1, P359, DOI 10.1038/ngeo202; McDonald RE, 2005, CLIM DYNAM, V25, P19, DOI 10.1007/s00382-004-0491-0; Booij N., 1996, P 25 INT C COAST ENG, V1, P668; DAVIDSON NE, 1993, J METEOROL SOC JPN, V71, P437; DUDHIA J, 1993, MON WEATHER REV, V121, P1493, DOI 10.1175/1520-0493(1993)121<1493:ANVOTP>2.0.CO;2; Ishikawa H, 2013, HYDROL PROCESS, V27, P3292, DOI 10.1002/hyp.9830; Japan Meteorological Agency (JMA), 2005, REP EXTR WEATH; Kawasaki K, 2012, ANN J CIVIL ENG OC B, V3-68, P852; Munich Re, 2005, TOPICS GEO ANNUAL RE; Murakami Tomokazu, 2008, Proceedings of the 31st International Conference on Coastal Engineering 2008; Murakami T, 2011, ASIAN J ENV DISASTER, V3, P217; Science Council of Japan (SCJ), 2008, SUST ASS NAT HUM LAN; Ueno M, 1989, 28 JMANPD; Ueno M, 1991, WGNE M NCAR; United Nations Environment Programme (UNEP), 2007, GLOB ENV OUTL 4; Yoshino J, 2008, SOL COAST DIS C, V2008, P256	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	DEC	2014	74	3					2037	2052		10.1007/s11069-014-1277-2		16	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AT7DK	WOS:000345096800039		
J	Han, Z; Chen, GQ; Li, YG; Xu, LR; Zheng, L; Zhang, YB				Han, Zheng; Chen, Guangqi; Li, Yange; Xu, Linrong; Zheng, Lu; Zhang, Yingbing			A new approach for analyzing the velocity distribution of debris flows at typical cross-sections	NATURAL HAZARDS			English	Article						Debris flow; Generalized model of cross-section; Velocity; Distribution profile	MANNING COEFFICIENT; EROSION; CHINA; MODEL; ALPS	The asymmetrical distribution of debris-flow velocity in a cross-section has long been observed and is currently regarded as one of the most essential issues in debris-flow research. Due to a lack of quantitative models for the velocity distributions of debris flows, most studies consider only the mean velocity. However, to optimize countermeasure structures, to estimate the erosion rate, or to evaluate the constitutive equations for shear behavior, it is beneficial to know the velocity profile in a cross-section. In this paper, a generalized model of typical channel geometries (e. g., rectangular, trapezoid, or V-shape) is proposed. A description of the velocity distribution that optimizes the Manning-Strickler velocity equation for transverse distribution and Egashira's velocity equation for vertical distribution is presented; thus, the debris-flow velocity at any point in the cross-section can be calculated and the distribution profile therefore obtained. A well-documented debris-flow reference case and the Jiasikou debris flow in the high-seismic-intensity zone of the Wenchuan earthquake are selected as case studies to demonstrate the model. Analyses of both cases confirm the asymmetrical distribution of debris-flow velocity in cross-section, as originally expected. This shows that the velocity at the top surface in the middle of the channel is much larger than that at each sidewall and than the mean value calculated by former equations. The obtained velocity distribution profile is a better approximation of the observed field profiles.	[Han, Zheng; Chen, Guangqi; Li, Yange; Zheng, Lu; Zhang, Yingbing] Kyushu Univ, Dept Civil & Struct Engn, Nishi Ku, Fukuoka 8190395, Japan; [Li, Yange; Xu, Linrong] Cent S Univ, Sch Civil Engn, Changsha, Hunan, Peoples R China	Li, YG (reprint author), Cent S Univ, Sch Civil Engn, Changsha, Hunan, Peoples R China.	hankzzz@163.com; liyange1984@gmail.com			Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; JSPS KAKENHI [22310113]; Global Environment Research Found of Japan [S-8]; National Natural Science Foundation of China [41272376]	This study has received financial support from Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; JSPS KAKENHI Grant Number 22310113 and the Global Environment Research Found of Japan (S-8); and the National Natural Science Foundation of China (Grant No. 41272376, L. Xu). These financial supports are gratefully acknowledged. We also thank Mohammad Reza Ghulami for revising the manuscript. And we thank Dr. Glade and two anonymous reviewers for providing helpful comments and revisions on the earlier draft of this paper.	HUNGR O, 1984, CAN GEOTECH J, V21, P663, DOI 10.1139/t84-073; Hurlimann M, 2003, CAN GEOTECH J, V40, P161, DOI 10.1139/T02-087; Stock JD, 2006, GEOL SOC AM BULL, V118, P1125, DOI 10.1130/B25902.1; Chen NS, 2007, GEOMORPHOLOGY, V84, P44, DOI 10.1016/j.geomorph.2006.07.007; Prochaska A, 2008, LANDSLIDES, V5, P431, DOI 10.1007/s10346-008-0137-0; Breien H, 2008, LANDSLIDES, V5, P271, DOI 10.1007/s10346-008-0118-3; Brayshaw D, 2009, GEOMORPHOLOGY, V109, P122, DOI 10.1016/j.geomorph.2009.02.021; Iverson RM, 2001, GEOLOGY, V29, P115, DOI 10.1130/0091-7613(2001)029<0115:NVOGMF>2.0.CO;2; Berger C, 2011, GEOMORPHOLOGY, V125, P421, DOI 10.1016/j.geomorph.2010.10.019; Rickenmann D, 1999, NAT HAZARDS, V19, P47, DOI 10.1023/A:1008064220727; Arattano M, 2000, DEBRIS-FLOW HAZARDS MITIGATION: MECHANICS, PREDICTION, AND ASSESSMENT, P273; AZMON B, 1992, J HYDROL, V132, P361, DOI 10.1016/0022-1694(92)90186-Y; Berti M, 2000, PHYS CHEM EARTH PT B, V25, P707, DOI 10.1016/S1464-1909(00)00090-3; Chen J, 2003, J NANJING U TECHNOL, V25, P92, DOI [10.3969/j.issn.1671-7627.2003.05.023, DOI 10.3969/J.ISSN.1671-7627.2003.05.023]; China Digital Science and Technology Museum, 2013, SCI COL MOUNT HAZ; Diaz RG, 2005, HYDROL PROCESS, V19, P3221, DOI 10.1002/hyp.5820; Doncker LD, 2009, ENVIRON FLUID MECH, V9, P549, DOI 10.1007/s10652-009-9149-0; Downie W, 1858, REPORT GOVERNOR DOUG; Drago M, 2002, OCEAN ENG, V29, P1769, DOI 10.1016/S0029-8018(02)00008-2; Egashira S, 1989, ANN DISASTER PREVE B, V32, P487; Han Z, 2012, ROCK SOIL MECH, V12, P3715; Hotta N, 1998, J JPN SOC EROS CONTR, V50, P11, DOI [10.4408/IJEGE.2011-03.B-037, DOI 10.4408/IJEGE.2011-03.B-037]; HUNGR O, 1995, CAN GEOTECH J, V32, P610, DOI 10.1139/t95-063; Itakura Y, 1997, DEBRIS-FLOW HAZARDS MITIGATION: MECHANICS, PREDICTION & ASSESSMENT, P747; Itakura Y, 1989, P JAP CHIN S LANDSL, P199; Iverson R. M., 1994, EOS T AM GEOPHYS UN, V75, P274; Jakob M., 2005, DEBRIS FLOW HAZARDS; Johnson AM, 1984, SLOPE INSTABILITY, P257; Kang ZC, 2004, DEBRIS FLOW RES CHIN, P159; Koch T, 1998, TESTING VARIOUS CONS; Li Y, 2012, NAT HAZARDS, V60, P689, DOI 10.1007/s11069-011-0033-0; Lo DOK, 2000, 104 GEO GOV HONG KON; Logan M, 2007, 20071315 USGS US DEP; McClung DM, 2001, J GEOPHYS RES, V106, P489, DOI [10.1029/2001JB000266, DOI 10.1029/2001JB000266]; Hotta N, 2000, PHYS CHEM EARTH PT B, V25, P381, DOI 10.1016/S1464-1909(00)00030-7; PWRI, 1988, 2632 PWRI MIN CONSTR; Schneider V. R., 1989, 2339 US GEOL SURV; Suwa H, 2000, DEBRIS-FLOW HAZARDS MITIGATION: MECHANICS, PREDICTION, AND ASSESSMENT, P293; Takahashi T, 1991, IAHR MONOGRAPHY SERI; Takahashi T, 2003, DEBRIS FLOW MECH PRE; Takahashi T., 2009, INT J EROSION CONTRO, V2, P1; Tecca PR, 2003, DEBRIS-FLOW HAZARDS MITIGATION: MECHANICS, PREDICTION, AND ASSESSMENT, VOLS 1 AND 2, P905; Uddin MS, 1999, APPL OPTICS, V38, P6714, DOI 10.1364/AO.38.006714; Wang JK, 1996, DEBRIS FLOW MITIGATI; Wu Jian, 2013, [Frontiers of Structural and Civil Engineering, 结构与土木工程前沿], V7, P206; Wu JS, 1993, DEBRIS FLOS ITS COMP; Zeng X, 1999, J YANGTZE RIVER SCI, V16, P1; Zhao G, 2012, DEBRIS FLOW XINYUAN	48	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	DEC	2014	74	3					2053	2070		10.1007/s11069-014-1276-3		18	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AT7DK	WOS:000345096800040		
J	Ono, K; Kazama, S; Ekkawatpanit, C				Ono, Keisuke; Kazama, So; Ekkawatpanit, Chaiwat			Assessment of rainfall-induced shallow landslides in Phetchabun and Krabi provinces, Thailand	NATURAL HAZARDS			English	Article						Hazard mapping; Physically based model; Factor of safety; Extreme rainfall; Stability analysis; Sensitivity analysis	EARLY-WARNING SYSTEM; HAZARD ASSESSMENT; LOGISTIC-REGRESSION; CLIMATE-CHANGE; RIVER-BASIN; MODEL; SUSCEPTIBILITY; SCALE; AREA; WASHINGTON	Shallow landslides are a common type of rainfall-induced landslide, and various methods are currently used to predict their occurrence on a regional scale. Physically based models, such as the shallow landslide instability prediction (SLIP) model, have many advantages because these models can assess the hazards of shallow landslides dynamically, based on physical stability equations that consider rainfall as a triggering factor. The main objective of this research is to test the SLIP model's potential to predict shallow landslide hazards in Thailand. To achieve this goal, the SLIP model was applied to two massive landslide events in Thailand. The results predicted by the SLIP model for the two study areas are outlined, and the model prediction capabilities were evaluated using the receiver operating characteristic plot. The Phetchabun results showed that the western part of the catchment had the lowest factor of safety (F-S) value, whereas the Krabi results showed that the slopes surrounding the peak of Khao Panom Mountain had the lowest F-S value, explaining the highest potentials for shallow landslides in each area. The SLIP model showed good performance: The global accuracies were 0.828 for the Phetchabun area and 0.824 for the Krabi area. The SLIP model predicted the daily time-varying percentage of unstable areas over the analyzed periods. The SLIP model simulated a negligible percentage of unstable areas over all considered periods, except for expected dates, suggesting that the prediction capability is reasonably accurate.	[Ono, Keisuke] CTI Engn Co Ltd, Chuo Ku, Tokyo 1038430, Japan; [Kazama, So] Tohoku Univ, Dept Civil Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Ekkawatpanit, Chaiwat] King Mongkuts Univ Technol Thonburi, Fac Engn, Dept Civil Engn, Bangkok 10140, Thailand	Ono, K (reprint author), CTI Engn Co Ltd, Chuo Ku, 3-21-1 Nihonbashihamacho, Tokyo 1038430, Japan.	ono@kaigan.civil.tohoku.ac.jp			Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-8]; JST/JICA, SATREPS, Japan	This research was supported by the Environment Research and Technology Development Fund (S-8) of the Ministry of the Environment, Japan. This research was conducted by the IMPACT project supported by JST/JICA, SATREPS, Japan. We wish to thank Dr. Suttisak Soralump at Kasetsert University in Thailand for his helpful support. Part of this research was supported by a Grant-in-Aid for JSPS (Japan Society for the Promotion of Science) Fellows.	Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Ewen J, 2000, J HYDROL ENG, V5, P250, DOI 10.1061/(ASCE)1084-0699(2000)5:3(250); Iverson RM, 2000, WATER RESOUR RES, V36, P1897, DOI 10.1029/2000WR900090; Montrasio L, 2011, NAT HAZARD EARTH SYS, V11, P1927, DOI 10.5194/nhess-11-1927-2011; Chung CJF, 1999, PHOTOGRAMM ENG REM S, V65, P1389; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Devkota KC, 2013, NAT HAZARDS, V65, P135, DOI 10.1007/s11069-012-0347-6; Pradhan B, 2010, ADV SPACE RES, V45, P1244, DOI 10.1016/j.asr.2010.01.006; Nichol J, 2005, INT J REMOTE SENS, V26, P1913, DOI 10.1080/01431160512331314047; Glenn NF, 2006, GEOMORPHOLOGY, V73, P131, DOI 10.1016/j.geomorph.2005.07.006; WU TH, 1979, CAN GEOTECH J, V16, P19; Baum RL, 2005, LANDSLIDES, V2, P266, DOI 10.1007/s10346-005-0023-y; Tarolli P, 2011, GEOMORPHOLOGY, V133, P199, DOI 10.1016/j.geomorph.2011.02.033; Liao ZH, 2012, ENVIRON EARTH SCI, V66, P1697, DOI 10.1007/s12665-011-0997-9; MONTGOMERY DR, 1994, WATER RESOUR RES, V30, P1153, DOI 10.1029/93WR02979; Cervi F, 2010, LANDSLIDES, V7, P433, DOI 10.1007/s10346-010-0207-y; Bui DT, 2011, NAT HAZARDS, V59, P1413, DOI 10.1007/s11069-011-9844-2; Kirschbaum DB, 2010, NAT HAZARDS, V52, P561, DOI 10.1007/s11069-009-9401-4; Hong Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028010; Wang HB, 2013, NAT HAZARDS, V69, P1281, DOI 10.1007/s11069-011-0008-1; Begueria S, 2006, NAT HAZARDS, V37, P315, DOI 10.1007/s11069-005-5182-6; Guzzetti F, 1999, GEOMORPHOLOGY, V31, P181, DOI 10.1016/S0169-555X(99)00078-1; Crosta G, 1998, ENVIRON GEOL, V35, P131; WU WM, 1995, WATER RESOUR RES, V31, P2097, DOI 10.1029/95WR01136; Montgomery DR, 1998, HYDROL PROCESS, V12, P943, DOI 10.1002/(SICI)1099-1085(199805)12:6<943::AID-HYP664>3.0.CO;2-Z; Collison A, 2000, ENG GEOL, V55, P205, DOI 10.1016/S0013-7952(99)00121-0; Chiang SH, 2011, GEOMORPHOLOGY, V133, P143, DOI 10.1016/j.geomorph.2010.12.028; Jakob M, 2009, GEOMORPHOLOGY, V107, P275, DOI 10.1016/j.geomorph.2008.12.009; Catani F, 2005, LANDSLIDES, V2, P329, DOI 10.1007/s10346-005-0021-0; Massonnet D, 1998, REV GEOPHYS, V36, P441, DOI 10.1029/97RG03139; Guns M, 2012, NAT HAZARD EARTH SYS, V12, P1937, DOI 10.5194/nhess-12-1937-2012; Arnone E, 2011, GEOMORPHOLOGY, V133, P121, DOI 10.1016/j.geomorph.2011.03.019; Pradhan B, 2011, INT J REMOTE SENS, V32, P4075, DOI 10.1080/01431161.2010.484433; Baum RL, 2002, 02424 USGS; Bednarik M, 2012, NAT HAZARDS, V64, P547, DOI 10.1007/s11069-012-0257-7; Calcaterra D, 2004, LANDSLIDES EVALUTION, P177; Casadel M, 2003, EARTH SURF PROC LAND, V28, P925, DOI 10.1002/esp.470; Chiang SH, 2009, GEOMORPHOLOGY, V103, P299, DOI 10.1016/j.geomorph.2008.06.012; Dhakal AS, 2003, EARTH SURF PROC LAND, V28, P853, DOI 10.1002/esp.499; Godt JW, 2008, REV ENG GEOL, V20, P137, DOI 10.1130/2008.4020(08); Guzzetti F, 2007, LANDSLIDES, V5, P3, DOI [10.1007/s10346-007-0112-1, DOI 10.1007/S10346-007-0112-1]; Hong Y, 2007, INT J REMOTE SENS, V28, P3713; Jotisankasa A, 2008, P 7 INT C MAN LANDSL, P383; Kawagoe S, 2010, HYDROL EARTH SYST SC, V14, P1047, DOI 10.5194/hess-14-1047-2010; Liao ZH, 2010, LANDSLIDES, V7, P317, DOI 10.1007/s10346-010-0219-7; Lin Y-P, 2010, HYDROL EARTH SYST SC, V7, P3423, DOI 10.5194/hessd-7-3423-2010; Montrasio L., 2010, International Journal of Geosciences, V1, P58; Montrasio L, 2008, NAT HAZARD EARTH SYS, V8, P1149; Montrasio L, 2012, NAT HAZARDS, V60, P1231, DOI 10.1007/s11069-011-9906-5; Morrisey MM, 2001, 010067 USGS; Nguyen HT, 2013, NAT HAZARDS, V65, P635, DOI 10.1007/s11069-012-0387-y; O'loughlin C. L., 1976, B INT ASS ENG GEOLOG, V13, P41, DOI DOI 10.1007/BF02634757; Oh H-J, 2008, ENVIRON GEOL, V57, P641, DOI 10.1007/s00254-008-1342-9; PACHAURI AK, 1992, ENG GEOL, V32, P81, DOI 10.1016/0013-7952(92)90020-Y; Pack RT, 2001, P 15 ANN C GIS BRIT, P56; Pack RT, 1998, TERRAIN STABILITY MA; Soralump S, 2010, GEOTECH ENG J SEAGS, V41, P1; Soralump S, 2011, P EIT JAP S 2011 HUM, P29; Tanavud C, 2008, P 7 INT C MAN LANDSL, P109; Vieira BC, 2010, NAT HAZARD EARTH SYS, V10, P1829, DOI 10.5194/nhess-10-1829-2010; Yumuang S, 2006, ENVIRON GEOL, V51, P545, DOI 10.1007/s00254-006-0351-9	61	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	DEC	2014	74	3					2089	2107		10.1007/s11069-014-1292-3		19	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AT7DK	WOS:000345096800042		
J	Zhang, XQ; Yamaguchi, Y				Zhang, X. Q.; Yamaguchi, Y.			Characterization and evaluation of MODIS-derived Drought Severity Index (DSI) for monitoring the 2009/2010 drought over southwestern China	NATURAL HAZARDS			English	Article						Drought; Drought Severity Index; SPI; MODIS; Southwestern China	EVAPOTRANSPIRATION ALGORITHM; VEGETATION; PRECIPITATION; CLIMATE; STRESS; SPACE	This article investigates whether the Moderate Resolution Imaging Spectro-radiometer (MODIS)-derived global terrestrial Drought Severity Index (DSI) had the capability of detecting regional drought over subtropical southwestern China. Monthly, remotely sensed DSI data with 0.05 degrees spatial resolution were used to characterize the extent, duration, and severity of drought from 2000 to 2010. We reported that southwestern China suffered from incipient to extreme droughts from November 2009 to March 2010 (referred to as the "drought period"). The area affected by drought occupied approximately 74 % of the total area of the study region, in which a moderate drought, severe drought, and an extreme drought accounted for 20, 12.7, and 13.2 % of the total area, respectively; particularly in March 2010, droughts of severe and extreme intensity covered the largest areas of drought, which were 16.1 and 18.6 %, respectively. Spatially, eastern Yunnan, western Guizhou, and Guangxi suffered from persistent droughts whose intensities ranged from mild to extreme during the drought period. Pearson's correlation analyses were performed between DSI and the in situ meteorological station-based Standardized Precipitation Index (SPI) for validating the monitoring results of the DSI. The results showed that the DSI corresponded favorably with the time scales of the SPI; meanwhile, the DSI showed its highest correlation (mean: r = 0.58) with a three-month SPI. Furthermore, similar spatial patterns and temporal variations were found between the DSI and the three-month SPI, as well as the agro-meteorological drought observation data, when monitoring drought. Our analysis suggests that the DSI can be used for near-real-time drought monitoring with fine resolution across subtropical southwestern China, or other similar regions, based solely on MODIS-derived evapotranspiration/potential evapotranspiration and Normalized Difference Vegetation Index data.	[Zhang, X. Q.; Yamaguchi, Y.] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Environm Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Zhang, XQ (reprint author), Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Environm Sci, Chikusa Ku, D2-1 510, Nagoya, Aichi 4648601, Japan.	dr.xqzhang@gmail.com; yasushi@nagoya-u.jp			China Scholarship Council (CSC)	This study is financially supported by the China Scholarship Council (CSC). We thank the Numerical Terradynamical Simulation Group (NTSG) at the University of Montana for providing MODIS Global Terrestrial DSI data. We also thank the National Drought Mitigation Center (NDMC) at the University of Nebraska-Lincoln for providing the program to calculate the SPI. Thanks are given to the Chinese Meteorological Data Service of China Meteorological Administration for sharing the meteorological data and drought observation data.	Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Wang L, 2010, INT J CLIMATOL, V30, P153, DOI 10.1002/joc.1876; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Chen MY, 2002, J HYDROMETEOROL, V3, P249, DOI 10.1175/1525-7541(2002)003<0249:GLPAYM>2.0.CO;2; KOGAN FN, 1995, ADV SPACE RES, V15, P91, DOI 10.1016/0273-1177(95)00079-T; Kogan F, 2013, REMOTE SENS LETT, V4, P364, DOI 10.1080/2150704X.2012.736033; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1192666; KOGAN FN, 1995, B AM METEOROL SOC, V76, P655, DOI 10.1175/1520-0477(1995)076<0655:DOTLIT>2.0.CO;2; Mu QZ, 2013, B AM METEOROL SOC, V94, P83, DOI 10.1175/BAMS-D-11-00213.1; Caccamo G, 2011, REMOTE SENS ENVIRON, V115, P2626, DOI 10.1016/j.rse.2011.05.018; Rouault M, 2003, WATER SA, V29, P489; Zhang AZ, 2013, REMOTE SENS ENVIRON, V134, P12, DOI 10.1016/j.rse.2013.02.023; McVicar TR, 1998, AGR SYST, V57, P399, DOI 10.1016/S0308-521X(98)00026-2; Brown JF, 2008, GISCI REMOTE SENS, V45, P16, DOI 10.2747/1548-1603.45.1.16; Zhang L, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045706; Guttman NB, 1999, J AM WATER RESOUR AS, V35, P311, DOI 10.1111/j.1752-1688.1999.tb03592.x; Mu Q, 2007, REMOTE SENS ENVIRON, V111, P519, DOI 10.1016/j.rse.2007.04.015; Sandholt I, 2002, REMOTE SENS ENVIRON, V79, P213, DOI 10.1016/S0034-4257(01)00274-7; Yang J, 2012, METEOROL ATMOS PHYS, V115, P173, DOI 10.1007/s00703-011-0172-6; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Gibbs WJ, 1967, AUSTR BUREAU METEORO, V48, P37; [黄荣辉 HUANG RongHui], 2006, [大气科学, Chinese Journal of Atmospheric Sciences], V30, P730; Kogan FN, 1997, B AM METEOROL SOC, V78, P621, DOI 10.1175/1520-0477(1997)078<0621:GDWFS>2.0.CO;2; Kogan F.N., 2002, EOS T AM GEOPHYS UN, V83, DOI [10.1029/2002EO000382, DOI 10.1029/2002E0000382]; [李强子 Li Qiangzi], 2010, [地理学报, Acta Geographica Sinica], V65, P771; Liu J., 2010, CHINA WATER RESOUR, V9, P17; McKee T. B., 1993, P 8 C APPL CLIM, V17, P179; Mckee T.B., 1995, P 9 C APPL CLIM, P233; Palmer W.C., 1965, 45 US DEP COMM WEATH; Shakya N, 2010, INT J REMOTE SENS, V31, P903, DOI 10.1080/01431160902902617; Song L. C., 2003, DROUGHT; [索渺清 Suo Miaoqing], 2008, [应用气象学报, Journal of Applied Meteorolgical Science], V19, P731; Wilhite D. A., 1985, Water International, V10, P111	34	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0921-030X	1573-0840		NAT HAZARDS	Nat. Hazards	DEC	2014	74	3					2129	2145		10.1007/s11069-014-1278-1		17	Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences; Water Resources	Geology; Meteorology & Atmospheric Sciences; Water Resources	AT7DK	WOS:000345096800044		
J	Cheng, J; Ji, HL; Qiu, JH; Takagi, T; Uchimoto, T; Hu, N				Cheng, Jun; Ji, Hongli; Qiu, Jinhao; Takagi, Toshiyuki; Uchimoto, Tetsuya; Hu, Ning			Role of interlaminar interface on bulk conductivity and electrical anisotropy of CFRP laminates measured by eddy current method	NDT & E INTERNATIONAL			English	Article						Carbon fiber reinforced polymer; Eddy current testing; Finite element analysis; Bulk conductivity; Electric anisotropy	REINFORCED POLYMER COMPOSITES; SIMULATION; PLASTICS	The purpose of this paper is to deal with the characterization of bulk electrical conductivity in multilayer carbon fiber reinforced polymer (CFRP) laminate by using eddy current method. The correlation between probe signals and conductivities in different directions of unidirectional CFRP is obtained with the aid of numerical code, which is based on finite element method in terms of magnetic vector potential. The effect of interlaminar interface on the bulk conductivity of CFRP laminate is investigated by visualizing the lift-off curves of probe signal in complex plane. It is found out that the cross-ply laminate has much better electrical conductance than unidirectional plate, and the bulk conductivity of CFRP laminate depends mainly on the number of current paths produced by the overlapped fibers at the interfaces between two angled layers. In addition the polar diagrams of T R probe signals at multiple angular positions are depicted to characterize the anisotropy of CFRP laminate. (C) 2014 Elsevier Ltd. All rights reserved.	[Cheng, Jun; Ji, Hongli; Qiu, Jinhao] Nanjing Univ Aeronaut & Astronaut, State Key Lab Mech & Control Mech Struct, Nanjing 210016, Jiangsu, Peoples R China; [Takagi, Toshiyuki; Uchimoto, Tetsuya] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Hu, Ning] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan	Qiu, JH (reprint author), Nanjing Univ Aeronaut & Astronaut, State Key Lab Mech & Control Mech Struct, 29 Yudao St, Nanjing 210016, Jiangsu, Peoples R China.	qiu@nuaa.edu.cn			Doctoral Fund of Youth Scholars of Ministry of Education of China [20123218120035]; NUAA Fundamental Research Funds [NS2013008]; State Key Laboratory Program [MCMS-0513G01, MCMS-0514K01]; PAPD; JSPS; Institute of Fluid Science, Tohoku University [J13R03]	This research is supported by Doctoral Fund of Youth Scholars of Ministry of Education of China No. 20123218120035, the NUAA Fundamental Research Funds No. NS2013008, the State Key Laboratory Program under Grant Nos. MCMS-0513G01 and MCMS-0514K01 and PAPD. In addition, it is also partially supported by the JSPS Core-to-Core Program, A. Advanced Research Networks, "International research core on smart layered materials and structures for energy saving", Collaborative Research Project of the Institute of Fluid Science, Tohoku University (J13R03).	Abu-Nabah BA, 2007, NDT&E INT, V40, P555, DOI 10.1016/j.ndteint.2007.06.001; Park JB, 2007, SMART MATER STRUCT, V16, P57, DOI 10.1088/0964-1726/16/1/006; Wasselynck G, 2011, IEEE T MAGN, V47, P1114, DOI 10.1109/TMAG.2010.2073456; Holloway CL, 2005, IEEE T ELECTROMAGN C, V47, P833, DOI 10.1109/TEMC.2005.854101; Menana H, 2011, EUR PHYS J-APPL PHYS, V53, DOI 10.1051/epjap/2010100255; Todoroki A, 2004, JSME INT J A-SOLID M, V47, P357, DOI 10.1299/jsmea.47.357; Bensaid S, 2005, IEEE T MAGN, V41, P1568, DOI 10.1109/TMAG.2005.845047; Cheng J, 2012, INT J APPL ELECTROM, V39, P251, DOI 10.3233/JAE-2012-1468; Cheng J, 2014, J COMPOS MAT; Mook G, 2001, COMPOS SCI TECHNOL, V61, P865, DOI 10.1016/S0266-3538(00)00164-0; Ma X, 2004, P 21 IEEE INSTR MEAS, V1, P127; Chen ZM, 2005, RES NONDESTRUCT EVAL, V16, P35, DOI 10.1080/09349840590961670; Perez M. A., 2011, Ultragarsas, V66, DOI 10.5755/j01.u.66.2.526; Pratap SB, 1996, IEEE T MAGN, V32, P437; Takahashi K, 2011, J COMPOS MATER, V45, P2603, DOI 10.1177/0021998311416683; Todoroki A, 2012, T JPN SOC AERONAUT S, V55, P237, DOI 10.2322/tjsass.55.237; Wang SK, 2000, J MATER SCI, V35, P91, DOI 10.1023/A:1004744600284; Yin WL, 2009, IEEE T INSTRUM MEAS, V58, P738, DOI 10.1109/TIM.2008.2005072	18	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0963-8695	1879-1174		NDT&E INT	NDT E Int.	DEC	2014	68						1	12		10.1016/j.ndteint.2014.07.001		12	Materials Science, Characterization & Testing	Materials Science	AT8ML	WOS:000345187200001		
J	Tohmyoh, H; Ikarashi, H; Hasegawa, Y; Obara, S; Matsui, Y				Tohmyoh, Hironori; Ikarashi, Hidetomo; Hasegawa, Yuta; Obara, Satoshi; Matsui, Yoichi			Inspection of the physical contact between two steel sheets by means of a potential drop technique	NDT & E INTERNATIONAL			English	Article						Resistance spot welding; Steel sheet; Cu electrode; Physical contacts; Potential drop technique	CLOSELY COUPLED PROBES; SPOT-WELDS; DCPD TECHNIQUE; CRACK; NDE; RESISTANCE; SURFACE	In this paper, we propose a potential drop technique for inspecting the physical contact between two steel sheets. One of the important targets in this study is the examination of spot welds in the steel sheets and we evaluated this using the electrical circuit in a welding machine. First, we used numerical analysis to analyze the changes in the potential drop due to the size of the physical contact between the steel sheets. In the conventional setup for spot welding, two steel sheets are inserted between two Cu electrodes. In the analysis, the current is supplied through two terminals, one on the surface of each electrode, and the potential drop is measured between two other terminals, again, one on the surface of each electrode. The validity of the analysis was confirmed experimentally where the physical contact between the steel sheets was modified by inserting shims between the sheets. (C) 2014 Elsevier Ltd. All rights reserved.	[Tohmyoh, Hironori; Ikarashi, Hidetomo] Tohoku Univ, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Hasegawa, Yuta; Obara, Satoshi; Matsui, Yoichi] Toyota Motor East Japan Inc, Kanegasaki, Iwate 0294503, Japan	Tohmyoh, H (reprint author), Tohoku Univ, Dept Nanomech, Aoba Ku, Aoba 6-6-01, Sendai, Miyagi 9808579, Japan.	tohmyoh@ism.mech.tohoku.ac.jp					Akamatsu S, 2011, Japan patent, Patent No. [P4822545, 4822545]; JOHNSON HH, 1965, MATER RES STANDARD, V5, P442; Tsukada K, 2011, NDT&E INT, V44, P101, DOI 10.1016/j.ndteint.2010.09.012; Denisov AA, 2004, J RES NATL INST STAN, V109, P233, DOI 10.6028/jres.109.015; Khan MI, 2007, SCI TECHNOL WELD JOI, V12, P175, DOI 10.1179/174329307X159801; BENDEC F, 1984, ULTRASONICS, V22, P78, DOI 10.1016/0041-624X(84)90025-8; COOPER JF, 1985, INT J FATIGUE, V7, P137, DOI 10.1016/0142-1123(85)90023-4; GHAJARIEH R, 1994, NDT&E INT, V27, P143, DOI 10.1016/0963-8695(94)90605-X; MANSOUR TM, 1988, MATER EVAL, V46, P650; Mozurkewich G, 2008, ULTRASONICS, V48, P343, DOI 10.1016/j.ultras.2008.01.004; Pereira AM, 2010, MATER DESIGN, V31, P2454, DOI 10.1016/j.matdes.2009.11.052; Saka M, 1996, J PRESS VESS-T ASME, V118, P198, DOI 10.1115/1.2842181; Saka M, 1998, J PRESS VESS-T ASME, V120, P374, DOI 10.1115/1.2842346; Takada H, 2011, MATER TRANS, V52, P539, DOI 10.2320/matertrans.M2010336; Tohmyoh H, 2012, PHYSICA E, V46, P33, DOI 10.1016/j.physe.2012.09.003; Wang G, 2004, EXP MECH, V44, P512, DOI 10.1177/0014485104047383; Zhao YY, 2013, J MANUF SCI E-T ASME, V135, DOI 10.1115/1.4023367; Zhenhua Chen, 2009, Journal of Materials Processing Technology, V209, DOI 10.1016/j.jmatprotec.2008.05.030	18	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0963-8695	1879-1174		NDT&E INT	NDT E Int.	DEC	2014	68						28	32		10.1016/j.ndteint.2014.08.003		5	Materials Science, Characterization & Testing	Materials Science	AT8ML	WOS:000345187200004		
J	Ishigami, J; Iimori, S; Kuwahara, M; Sasaki, S; Tsukamoto, Y				Ishigami, Junichi; Iimori, Soichiro; Kuwahara, Michio; Sasaki, Sei; Tsukamoto, Yusuke			Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients	NEPHROLOGY			English	Article						B-type natriuretic peptide; cardiovascular disease; chronic kidney disease; haemodialysis; ultrasound cardiography	VENTRICULAR EJECTION FRACTION; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEART-FAILURE; DIALYSIS PATIENTS; PROGNOSTIC VALUE; TERMINAL PROBNP; BLOOD-PRESSURE; VOLUME STATUS; ASSOCIATION	Aim: Estimating fluid balance in haemodialysis patients is essential when determining dry weight, but limited methods are currently available. B-type natriuretic peptide (BNP) is a useful surrogate marker in patients with congestive heart failure (CHF), but whether its validity could be generalized to haemodialysis patients has not been studied well. Methods: A total of 457 haemodialysis patients at a dialysis centre were analyzed. Determinants of BNP were assessed in connection with ultrasound cardiography (UCG) records, Kt/V, ultrafiltration rate (UFR), and demographic factors. All-cause death and cardiovascular (CV) events were recorded as the main outcome. Results: Among the UCG records, left atrial diameter (LAD), left ventricular ejection fraction (LVEF), were determinants of log-transformed (ln) BNP; UFR, age and sex were also significant. There was a positive correlation between BNP and LAD (r = 0.285, P < 0.001). Receiver operating characteristic (ROC) analysis revealed that BNP had 90% and 80% sensitivity to predict the presence of LA enlargement of 77.9 pg/mL and 133.2 pg/mL, respectively. Higher BNP and lower LVEF were associated with higher risk for developing all-cause death and CVD. In the adjusted model, patients with BNP higher than 471 pg/mL had hazard ratio of 2.18 (95% confidence interval (CI) 1.20-3.96, P = 0.01), compared to those with BNP <109 pg/mL. Conclusion: B-type natriuretic peptide was determined by LAD, LVEF, UFR, age and sex. BNP and LAD had positive correlation and BNP could become a useful tool for estimating the presence of LA enlargement. BNP and LVEF was a strong risk factor for predicting all-cause death and CV events among patients undergoing haemodialysis.	[Ishigami, Junichi; Iimori, Soichiro; Kuwahara, Michio] Shuuwa Gen Hosp, Dept Nephrol, Saitama, Japan; [Ishigami, Junichi; Iimori, Soichiro; Sasaki, Sei] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo 1130034, Japan; [Tsukamoto, Yusuke] Itabashi Chuo Gen Hosp, Dept Nephrol, Tokyo, Japan	Ishigami, J (reprint author), Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1130034, Japan.	junichi_ishigami@hotmail.com					Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Booth J, 2010, CLIN J AM SOC NEPHRO, V5, P1036, DOI 10.2215/CJN.09001209; Chazot C, 2012, NEPHROL DIAL TRANSPL, V27, P2404, DOI 10.1093/ndt/gfr678; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Kumar S, 2012, NEPHRON CLIN PRACT, V122, P33, DOI 10.1159/000348510; Vickery S, 2005, AM J KIDNEY DIS, V46, P610, DOI 10.1053/j.ajkd.2005.06.017; Leypoldt JK, 2002, KIDNEY INT, V61, P266, DOI 10.1046/j.1523-1755.2002.00099.x; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Daimon M, 2008, CIRC J, V72, P1859, DOI 10.1253/circj.CJ-08-0171; Tripepi G, 2009, HYPERTENSION, V54, P818, DOI 10.1161/HYPERTENSIONAHA.109.136804; Yamada S, 2010, CLIN J AM SOC NEPHRO, V5, P1793, DOI 10.2215/CJN.00050110; Davenport A, 2008, KIDNEY INT, V73, P759, DOI 10.1038/sj.ki.5002745; Madsen LH, 2007, KIDNEY INT, V71, P548, DOI 10.1038/sj.ki.5002087; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792; McCullough PA, 2003, AM J KIDNEY DIS, V41, P571, DOI 10.1053/ajkd.2003.50118; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Winkler K, 2008, EUR HEART J, V29, P2092, DOI 10.1093/eurheartj/ehn278; David S, 2008, NEPHROL DIAL TRANSPL, V23, P1370, DOI 10.1093/ndt/gfm700; [Anonymous], 2012, NAT I DIAB DIG KIDN; Curtis JP, 2003, J AM COLL CARDIOL, V42, P736, DOI 10.1016/S0735-1097(03)00789-7; Zoccali C, 2001, J AM SOC NEPHROL, V12, P1508; Yasuda K, 2012, NEPHROL DIAL TRANSPL, V27, P3885, DOI 10.1093/ndt/gfs365; Charra Bernard, 2007, Hemodial Int, V11, P21, DOI 10.1111/j.1542-4758.2007.00148.x; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Group KDIGOKCW, 2013, KIDNEY INT S, V3, P1; Koch M, 2010, CLIN NEPHROL, V73, P21; Roberts MA, 2008, CLIN J AM SOC NEPHRO, V3, P1057, DOI 10.2215/CJN.05151107; Takami Y, 2004, AM J KIDNEY DIS, V44, P420, DOI 10.1053/j.ajkd.2004.05.023	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	DEC	2014	19	12					777	783		10.1111/nep.12329		7	Urology & Nephrology	Urology & Nephrology	AU0MZ	WOS:000345318400007		
J	Fukasawa, H; Ishigaki, S; Kinoshita-Katahashi, N; Niwa, H; Yasuda, H; Kumagai, H; Furuya, R				Fukasawa, Hirotaka; Ishigaki, Sayaka; Kinoshita-Katahashi, Naoko; Niwa, Hiroki; Yasuda, Hideo; Kumagai, Hiromichi; Furuya, Ryuichi			Plasma levels of fibroblast growth factor-23 are associated with muscle mass in haemodialysis patients	NEPHROLOGY			English	Article						fibroblast growth factor-23; haemodialysis; malnutrition; protein-energy wasting; soluble Klotho (s-Klotho)	LEFT-VENTRICULAR HYPERTROPHY; CHRONIC KIDNEY-DISEASE; VITAMIN-D METABOLISM; DIALYSIS PATIENTS; MORTALITY; KLOTHO; FGF23; MALNUTRITION; INFLAMMATION; PHOSPHATE	Aim: Malnutrition is highly prevalent in haemodialysis (HD) patients, and it contributes to morbidity and mortality. Fibroblast growth factor-23 (FGF-23) and Klotho contribute to chronic kidney disease-mineral and bone disorder (CKD-MBD) in HD patients, but the role that these molecules play in determining nutritional status is currently unknown. Methods: A cross-sectional study examining 77 HD patients was performed. The plasma concentrations of FGF-23 and soluble Klotho (s-Klotho) were studied to evaluate their association with muscle mass, which was investigated by abdominal muscle areas measured using computed tomography and by creatinine (Cr) production estimated using the Cr kinetic model. Results: Plasma FGF-23 concentrations were significantly and positively correlated with abdominal muscle areas and Cr production (rho = 0.301, P < 0.01 and rho = 0.345, P < 0.01, respectively). In contrast, s-Klotho was not significantly correlated with these muscle mass indices and plasma FGF-23 concentrations. Multiple regression analyses showed that FGF-23 was a significant independent predictor of both muscle mass indices (P < 0.01 and P < 0.05, respectively). Conclusion: Plasma FGF-23 concentrations were associated with muscle mass indices in HD patients. Our findings suggest that FGF-23 and nutritional status are linked and this link is most likely independent of s-Klotho.	[Fukasawa, Hirotaka; Ishigaki, Sayaka; Kinoshita-Katahashi, Naoko; Niwa, Hiroki; Furuya, Ryuichi] Iwata City Hosp, Div Renal, Dept Internal Med, Iwata, Shizuoka 4388550, Japan; [Yasuda, Hideo] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Kumagai, Hiromichi] Univ Shizuoka, Sch Food & Nutr Sci, Dept Clin Nutr, Shizuoka 4228526, Japan	Fukasawa, H (reprint author), Iwata City Hosp, Div Renal, Dept Internal Med, 512-3 Ohkubo, Iwata, Shizuoka 4388550, Japan.	hfukasawaucsd@gmail.com			Japanese Association of Dialysis Physicians (JADP) [2011-08]	We thank Ms. Kozue Sakuma for measuring abdominal muscle areas. This work was supported by grants from the Japanese Association of Dialysis Physicians (JADP Grant 2011-08, to H.F.).	Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.11114245; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Scialla JJ, 2013, KIDNEY INT, V83, P1159, DOI 10.1038/ki.2013.3; Komaba H, 2012, NAT REV NEPHROL, V8, P484, DOI 10.1038/nrneph.2012.116; Kopple JD, 1999, KIDNEY INT, V56, P1136, DOI 10.1046/j.1523-1755.1999.00615.x; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V35, P1192; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Park J, 2013, NEPHROL DIAL TRANSPL, V28, P2146, DOI 10.1093/ndt/gft213; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Tieland M, 2013, EUR J CLIN NUTR, V67, P1050, DOI 10.1038/ejcn.2013.144; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Cabezas-Rodriguez I, 2013, CLIN J AM SOC NEPHRO, V8, P1725, DOI 10.2215/CJN.10951012; Foundation NK, 2000, AM J KIDNEY DIS, V35, pS17; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Kaizu Y, 2002, NEPHROL DIAL TRANSPL, V17, P442, DOI 10.1093/ndt/17.3.442; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Sogos V, 1998, DEV DYNAM, V211, P362, DOI 10.1002/(SICI)1097-0177(199804)211:4<362::AID-AJA7>3.0.CO;2-F; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1320-5358	1440-1797		NEPHROLOGY	Nephrology	DEC	2014	19	12					784	790		10.1111/nep.12333		7	Urology & Nephrology	Urology & Nephrology	AU0MZ	WOS:000345318400008		
J	Kinoshita, M; Numata, S; Tajima, A; Ohi, K; Hashimoto, R; Shimodera, S; Imoto, I; Takeda, M; Ohmori, T				Kinoshita, Makoto; Numata, Shusuke; Tajima, Atsushi; Ohi, Kazutaka; Hashimoto, Ryota; Shimodera, Shinji; Imoto, Issei; Takeda, Masatoshi; Ohmori, Tetsuro			Aberrant DNA Methylation of Blood in Schizophrenia by Adjusting for Estimated Cellular Proportions	NEUROMOLECULAR MEDICINE			English	Article						Epigenetics; DNA methylation; Schizophrenia; Microarray; Leukocyte; Blood; Cell heterogeneity	TRANSCRIPTION FACTOR-1 MYT1; SURROGATE VARIABLE ANALYSIS; EPIGENOME-WIDE ASSOCIATION; OLIGODENDROCYTE LINEAGE; BIPOLAR DISORDER; GENE PROMOTER; EXPRESSION; MICROARRAY; SIGNATURES; NEURONS	DNA methylation, which is the transference of a methyl group to the 5'-carbon position of the cytosine in a CpG dinucleotide, is one of the major mechanisms of epigenetic modifications. A number of studies have demonstrated altered DNA methylation of peripheral blood cells in schizophrenia (SCZ) in previous studies. However, most of these studies have been limited to the analysis of the CpG sites in CpG islands in gene promoter regions, and cell-type proportions of peripheral leukocytes, which may be one of the potential confounding factors for DNA methylation, have not been adjusted in these studies. In this study, we performed a genome-wide DNA methylation profiling of the peripheral leukocytes from patients with SCZ and from non-psychiatric controls (N = 105; 63 SCZ and 42 control subjects) using a quantitative high-resolution DNA methylation microarray which covered across the whole gene region (485,764 CpG dinucleotides). In the DNA methylation data analysis, we first estimated the cell-type proportions of each sample with a published algorithm. Next, we performed a surrogate variable analysis to identify potential confounding factors in our microarray data. Finally, we conducted a multiple linear regression analysis in consideration of these factors, including estimated cell-type proportions, and identified aberrant DNA methylation in SCZ at 2,552 CpG loci at a 5 % false discovery rate correction. Our results suggest that altered DNA methylation may be involved in the pathophysiology of SCZ, and cell heterogeneity adjustments may be necessary for DNA methylation analysis.	[Kinoshita, Makoto; Numata, Shusuke; Ohmori, Tetsuro] Univ Tokushima, Grad Sch, Dept Psychiat, Course Integrated Brain Sci,Inst Hlth Biosci, Tokushima 7708503, Japan; [Tajima, Atsushi; Imoto, Issei] Univ Tokushima, Grad Sch, Dept Human Genet, Inst Hlth Biosci, Tokushima 7708503, Japan; [Ohi, Kazutaka; Hashimoto, Ryota] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka 5650871, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Suita, Osaka 5650871, Japan; [Shimodera, Shinji] Kochi Med Sch, Dept Neuropsychiat, Nankoku, Kochi 7838505, Japan	Numata, S (reprint author), Univ Tokushima, Grad Sch, Dept Psychiat, Course Integrated Brain Sci,Inst Hlth Biosci, 3-8-15 Kuramoto Cho, Tokushima 7708503, Japan.	knst5511mkt@sunny.ocn.ne.jp; shu-numata@umin.ac.jp; tajima.atsushi@tokushima-u.ac.jp; ohi@psy.med.osaka-u.ac.jp; hashimor@psy.med.osaka-u.ac.jp; shimodes@kochi-u.ac.jp; issehgen@tokushima-u.ac.jp; mtakeda@psy.med.osaka-u.ac.jp; tohmori@clin.med.tokushima-u.ac.jp	Tajima, Atsushi/C-1053-2008; Hashimoto, Ryota/P-8572-2014	Tajima, Atsushi/0000-0001-6808-5491; Hashimoto, Ryota/0000-0002-5941-4238	Japanese Ministry of Education, Culture, Sports, Science and Technology [24791216]; SEN-SHIN Medical Research Foundation; Research Group for Schizophrenia	The authors thank Dr. Jorg Tost for his valuable comments and suggestions on SNP-associated probes in the Illumina HumanMethylation450 platform. The authors would also like to thank Mrs. Akemi Okada and Mrs. Kumiko Kikuchi for their technical assistance. The authors appreciate all the volunteers who understood our study purpose and participated in this study, and the physicians who helped us to collect clinical data and blood samples at the mental hospitals. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Grant Number 24791216), SEN-SHIN Medical Research Foundation, and the Research Group for Schizophrenia.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; Aberg KA, 2014, JAMA PSYCHIAT, V71, P255, DOI 10.1001/jamapsychiatry.2013.3730; Li W, 2012, GENES BRAIN BEHAV, V11, P87, DOI 10.1111/j.1601-183X.2011.00734.x; Nishioka M, 2013, J HUM GENET, V58, P91, DOI 10.1038/jhg.2012.140; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Langevin SM, 2014, EPIGENETICS-US, V9, P884, DOI 10.4161/epi.28575; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Lambert SR, 2013, ACTA NEUROPATHOL, V126, P291, DOI 10.1007/s00401-013-1124-7; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Gejman PV, 2011, ANNU REV GENOM HUM G, V12, P121, DOI 10.1146/annurev-genom-082410-101459; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/epi.11.105, 10.2217/EPI.11.105]; Carrard A, 2011, J AFFECT DISORDERS, V132, P450, DOI 10.1016/j.jad.2011.03.018; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Nakatani N, 2006, HUM MOL GENET, V15, P1949, DOI 10.1093/hmg/ddl118; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Kinoshita M, 2013, NEUROMOL MED, V15, P95, DOI 10.1007/s12017-012-8198-6; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Kordi-Tamandani DM, 2013, GENE, V515, P163, DOI 10.1016/j.gene.2012.10.075; Teschendorff AE, 2011, BIOINFORMATICS, V27, P1496, DOI 10.1093/bioinformatics/btr171; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Lee Y, 2012, PSYCHIAT GENET, V22, P206, DOI 10.1097/YPG.0b013e328353ae3d; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Roth TL, 2011, J CHILD PSYCHOL PSYC, V52, P398, DOI 10.1111/j.1469-7610.2010.02282.x; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Kordi-Tamandani DM, 2012, MOL BIOL REP, V39, P10889, DOI 10.1007/s11033-012-1986-0; Tsai GE, 2010, CURR PHARM DESIGN, V16, P522; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Bonsch D., 2012, PSYCHIAT RES, V198, P533; Chen YB, 2012, HUM GENET, V131, P1081, DOI 10.1007/s00439-011-1131-5; Harvey Robert J, 2008, Front Mol Neurosci, V1, P1, DOI 10.3389/neuro.02.001.2008; Houseman E. A., 2012, BMC BIOINFORMATICS, V13, P1471; Huang da W., 2009, NAT PROTOC, V4, P44, DOI [DOI 10.1038/NPR0T.2008.211, 10.1038/nprot.2008.211]; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Khojasteh-Fard M, 2011, MED HYPOTHESES, V77, P573, DOI 10.1016/j.mehy.2011.06.034; Murata Y, 2014, NEUROSCI LETT, V563, P123, DOI 10.1016/j.neulet.2014.01.038; Petronis A, 2000, MOL PSYCHIATR, V5, P342, DOI 10.1038/sj.mp.4000750; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Tolosa A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-114; Van Den Bossche MJ, 2013, AM J MED GENET B, V162B, P273, DOI 10.1002/ajmg.b.32146; Xu HQ, 2012, PSYCHIAT RES, V200, P1079, DOI 10.1016/j.psychres.2012.07.003; Cheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089128; Zouridis H., 2012, SCI TRANSL MED, V4, P156, DOI DOI 10.1126/SCITRANSLMED.3004504	58	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	DEC	2014	16	4					697	703		10.1007/s12017-014-8319-5		7	Neurosciences	Neurosciences & Neurology	AT7WR	WOS:000345145700005		
J	Tsukabe, A; Watanabe, Y; Tanaka, H; Kunitomi, Y; Nishizawa, M; Arisawa, A; Yoshiya, K; Shimazu, T; Tomiyama, N				Tsukabe, Akio; Watanabe, Yoshiyuki; Tanaka, Hisashi; Kunitomi, Yuki; Nishizawa, Mitsuo; Arisawa, Atsuko; Yoshiya, Kazuhisa; Shimazu, Takeshi; Tomiyama, Noriyuki			Prevalence and diagnostic performance of computed tomography angiography spot sign for intracerebral hematoma expansion depend on scan timing	NEURORADIOLOGY			English	Article						CTA spot sign; CT angiography; Acute stroke; Intracerebral hematoma; ICH	ACUTE CEREBRAL-HEMORRHAGE; CONTRAST EXTRAVASATION; POSTCONTRAST CT; HIGHEST RISK; GROWTH; MORTALITY; VOLUME	The computed tomography angiography (CTA) spot sign correlates with intracerebral hemorrhage (ICH) expansion; however, various diagnostic performances for hematoma expansion, especially in sensitivity, have been reported. We aimed to assess the impact of scan timing of CTA on the diagnostic performance of the CTA spot sign for ICH expansion in two different arterial phases within patients. Eighty-three consecutive patients with primary ICH who received two sequential CTAs were recruited. Two neuroradiologists reviewed CTAs for CTA spot signs, while one reviewed initial and follow-up non-contrast CT for measuring ICH volume. The time interval between two phases was then calculated, and the diagnostic performance of CTA spot sign in each phase was evaluated. CTA spot signs were observed in 20/83 (24.1 %) patients in the early phase and 44/83 (53.0 %) patients in the late phase. The mean time interval between the two phases was 12.7 s. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for hematoma progression of CTA spot sign were 48.1, 87.5, 65.0, 77.8, and 74.7 %, respectively, in early phase and 92.6, 66.1, 56.8, 94.9, and 74.7 %, respectively, in late phase. The CTA spot sign was significantly associated with ICH expansion in early (P < 0.001) and late (P < 0.00001) phases (Pearson's chi-square test). A mere 10-s difference in scan timing could make a difference on prevalence and diagnostic performance of the CTA spot sign, suggesting a need for the standardization of the CTA protocol to generalize the approach for effective clinical application.	[Tsukabe, Akio; Watanabe, Yoshiyuki; Tanaka, Hisashi; Kunitomi, Yuki; Nishizawa, Mitsuo; Arisawa, Atsuko; Tomiyama, Noriyuki] Osaka Univ, Dept Diagnost & Intervent Radiol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Yoshiya, Kazuhisa; Shimazu, Takeshi] Osaka Univ, Dept Traumatol & Acute Crit Med, Grad Sch Med, Suita, Osaka 5650871, Japan	Tsukabe, A (reprint author), Osaka Univ, Dept Diagnost & Intervent Radiol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	a-tsukabe@radiol.med.osaka-u.ac.jp					van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; BRODERICK JP, 1993, STROKE, V24, P987; Huynh TJ, 2013, STROKE, V44, P972, DOI 10.1161/STROKEAHA.111.000410; Almandoz JED, 2009, STROKE, V40, P2994, DOI 10.1161/STROKEAHA.109.554667; Brott T, 1997, STROKE, V28, P1; Brouwers HB, 2012, STROKE, V43, P3427, DOI 10.1161/STROKEAHA.112.664003; Thompson AL, 2009, CAN J NEUROL SCI, V36, P456; Wang YH, 2011, EUR NEUROL, V65, P150, DOI 10.1159/000324153; Kim J, 2008, AM J NEURORADIOL, V29, P520, DOI 10.3174/ajnr.A0859; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Hallevi H, 2010, CEREBROVASC DIS, V29, P217, DOI 10.1159/000267842; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Koculym A, 2013, AM J NEURORADIOL, V34, P965, DOI 10.3174/ajnr.A3338; Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators, 2010, CRIT CARE MED, V38, P637, DOI DOI 10.1097/CCM.0B013E3181B9E1A5; Becker K, 2009, NAT REV NEUROL, V5, P526, DOI 10.1038/nrneurol.2009.152; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090431; Ederies A, 2009, STROKE, V40, P1672, DOI 10.1161/STROKEAHA.108.541201; Kothari Rashmi U., 1996, Stroke, V27, P1304; Mayer SA, 2007, STROKE, V38, P763, DOI 10.1161/01.STR.0000254499.46122.22; Rodriguez-Luna D, 2014, STROKE, V45, P734, DOI 10.1161/STROKEAHA.113.003007; Sun SJ, 2013, EUR RADIOL, V23, P1846, DOI 10.1007/s00330-013-2803-4	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	DEC	2014	56	12					1039	1045		10.1007/s00234-014-1430-3		7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AU0ET	WOS:000345297100003		
J	Takigawa, T; Suzuki, K; Sugiura, Y; Suzuki, R; Takano, I; Shimizu, N; Tanaka, Y; Hyodo, A				Takigawa, Tomoji; Suzuki, Kensuke; Sugiura, Yoshiki; Suzuki, Ryotaro; Takano, Issei; Shimizu, Nobuyuki; Tanaka, Yoshihiro; Hyodo, Akio			Thromboembolic events associated with single balloon-, double balloon-, and stent-assisted coil embolization of asymptomatic unruptured cerebral aneurysms: evaluation with diffusion-weighted MR imaging	NEURORADIOLOGY			English	Article						Unruptured aneurysm; Coil embolization; Balloon-assisted technique; Stent-assisted technique; Diffusion-weighted imaging	GUGLIELMI DETACHABLE COILS; WIDE-NECKED ANEURYSMS; INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; ASPIRIN RESISTANCE; ANTIPLATELET THERAPY; PART II; COMPLICATIONS; SAFETY; ARTERIOGRAPHY	The introduction of the balloon remodeling and stent-assisted technique has revolutionized the approach to coil embolization for wide-neck aneurysms. The purpose of this study was to determine the frequency of thromboembolic events associated with single balloon-assisted, double balloon-assisted, and stent-assisted coil embolization for asymptomatic unruptured aneurysms. A retrospective review was undertaken by 119 patients undergoing coiling with an adjunctive technique for unruptured saccular aneurysms (64 single balloon, 12 double balloon, 43 stent assisted). All underwent diffusion-weighted imaging (DWI) within 24 h after the procedure. DWI showed hyperintense lesions in 48 (40 %) patients, and ten (21 %) of these patients incurred neurological deterioration (permanent, two; transient, eight). Hyperintense lesions were detected significantly more often in procedures with the double balloon-assisted technique (7/12, 58 %) than with the single balloon-assisted technique (16/64, 25 %, p = 0.05). Occurrence of new lesions was significantly higher with the use of stent-assisted technique (25/43, 58 %) than with the single balloon-assisted technique (p = 0.001). Symptomatic ischemic rates were similar between the three groups. The increased number of microcatheters was significantly related to the DWI abnormalities (two microcatheters, 15/63 (23.8 %); three microcatheters, 20/41 (48.8 %) (p = 0.008); four microcatheters, 12/15 (80 %) (p = 0.001)). Thromboembolic events detected on DWI related to coil embolization for unruptured aneurysms are relatively common, especially in association with the double balloon-assisted and stent-assisted techniques. Furthermore, the number of microcatheters is highly correlated with DWI abnormalities. The high rate of thromboembolic events suggests the need for evaluation of platelet reactivity and the addition or change of antiplatelet agents.	[Takigawa, Tomoji; Suzuki, Kensuke; Sugiura, Yoshiki; Suzuki, Ryotaro; Takano, Issei; Shimizu, Nobuyuki; Tanaka, Yoshihiro; Hyodo, Akio] Dokkyo Med Univ, Dept Neurosurg, Koshigaya Hosp, Koshigaya, Saitama 3438555, Japan	Takigawa, T (reprint author), Dokkyo Med Univ, Dept Neurosurg, Koshigaya Hosp, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	tomojy33@yahoo.co.jp					Albayram S, 2004, AM J NEURORADIOL, V25, P1768; EARNEST F, 1984, AM J ROENTGENOL, V142, P247; Spiotta AM, 2011, STROKE, V42, P1051, DOI 10.1161/STROKEAHA.110.602276; Pierot L, 2008, STROKE, V39, P2497, DOI 10.1161/STROKEAHA.107.512756; Kang HS, 2010, AM J NEURORADIOL, V31, P1206, DOI 10.3174/ajnr.A2051; Krasopoulos G, 2008, BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Tan LA, 2015, J NEUROINTERV SURG, V7, P217, DOI 10.1136/neurintsurg-2014-011111; Raymond J, 2003, STROKE, V34, P1398, DOI 10.1161/01.STR.0000073841.88563.E9; Soeda A, 2003, AM J NEURORADIOL, V24, P127; Cottier JP, 2001, AM J NEURORADIOL, V22, P345; Moret J, 1997, J NEURORADIOLOGY, V24, P30; Qureshi AI, 2000, NEUROSURGERY, V46, P1360, DOI 10.1097/00006123-200006000-00014; Pelz DM, 1998, AM J NEURORADIOL, V19, P1541; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Heller RS, 2013, J NEUROSURG, V119, P1603, DOI 10.3171/2013.7.JNS122178; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; GEREMIA G, 1994, AM J NEURORADIOL, V15, P1223; Lee DH, 2008, AM J NEURORADIOL, V29, P1389, DOI 10.3174/ajnr.A1070; Lanterna LA, 2004, NEUROSURGERY, V55, P767, DOI 10.1227/01.NEU.0000137653.93173.1C; GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; Shapiro M, 2008, AM J NEURORADIOL, V29, P1777, DOI 10.3174/ajnr.A1216; Altay T, 2011, J NEUROINTERV SURG, V3, P147, DOI 10.1136/jnis.2010.003616; Brooks NP, 2008, J NEUROSURG, V108, P1095, DOI 10.3171/JNS/2008/108/6/1095; Cronqvist M, 2005, NEURORADIOLOGY, V47, P855, DOI 10.1007/s00234-005-1408-2; Delgado Almandoz JE, 2013, J NEUROINTERV SUR S3, V5, piii3; Derdeyn CP, 2002, J NEUROSURG, V96, P837, DOI 10.3171/jns.2002.96.5.0837; EISENBERG RL, 1980, NEUROLOGY, V30, P895; Feher Gergely, 2010, World J Cardiol, V2, P171, DOI 10.4330/wjc.v2.i7.171; MANI RL, 1978, AM J ROENTGENOL, V131, P861; Ishibashi T, 2006, INTERV NEURORADIOL, V12, P112; KERBER CW, 1978, AM J ROENTGENOL, V130, P1097; Lefkowitz MA, 1999, NEUROSURGERY, V45, P531, DOI 10.1097/00006123-199909000-00024; Lubicz B, 2008, NEURORADIOLOGY, V50, P769, DOI 10.1007/s00234-008-0397-3; Malek AM, 2000, NEUROSURGERY, V46, P1397, DOI 10.1097/00006123-200006000-00022; Murthy SB, 2014, J CLIN NEUROSCI, V21, P6, DOI 10.1016/j.jocn.2013.03.014; Nelson PK, 2001, AM J NEURORADIOL, V22, P19; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Rordorf G, 2001, AM J NEURORADIOL, V22, P5; Ross IB, 2005, SURG NEUROL, V64, P12, DOI 10.1016/j.surneu.2004.09.045; SAINTGEORGES G, 1985, AM J ROENTGENOL, V144, P235; Schneider PA, 2005, J VASC SURG, V41, P238, DOI 10.1016/j.jvs.2004.11.024; Tran HA, 2007, THROMB RES, V120, P337, DOI 10.1016/j.thromres.2006.08.014; WOLFEL DA, 1984, RADIOLOGY, V153, P363	45	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	DEC	2014	56	12					1079	1086		10.1007/s00234-014-1421-4		8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AU0ET	WOS:000345297100008		
J	Sai, A; Shimono, T; Yamamoto, A; Takeshita, T; Ohsawa, M; Wakasa, K; Miki, Y				Sai, Asari; Shimono, Taro; Yamamoto, Akira; Takeshita, Toru; Ohsawa, Masahiko; Wakasa, Kenichi; Miki, Yukio			Incidence of abnormal retropharyngeal lymph nodes in sinonasal malignancies among adults	NEURORADIOLOGY			English	Article						Retropharyngeal lymph node; Sinonasal malignancies; Computed tomography; Magnetic resonance imaging	NASOPHARYNGEAL CARCINOMA; COMPUTED-TOMOGRAPHY; STAGING CATEGORIES; PROGNOSTIC VALUE; NORMAL ANATOMY; NECK-CANCER; METASTASIS; HEAD; ADENOPATHY; VARIANTS	The aim of this study is to investigate the relationship between abnormal retropharyngeal lymph nodes (RPLNs) and sinonasal malignancies among adults. Magnetic resonance and computed tomography images from 89 patients over 20 years old who were all histopathologically confirmed to have sinonasal malignancies from September 2001 to April 2014 were assessed retrospectively. Abnormal RPLNs were determined as those > 5 mm in shortest axis or showing heterogeneous enhancement on axial images. Locations of sinonasal malignancies were categorized using the anterior border of the pterygopalatine fossa as a boundary: (a) anterior lesions, only present anterior to the boundary, or (b) posterior lesions, present or extending posterior to the boundary. Fisher's exact test was used for the analysis of the relationship between frequency of abnormal RPLNs and lesion location. Abnormal RPLNs were present in 13 of 89 patients (15 %), including 6 of 41 squamous cell carcinomas (15 %), 4 of 24 malignant lymphomas (17 %), 3 of 5 olfactory neuroblastomas (60 %), and 0 of 19 others (0 %). Four of the 39 patients (10 %) with anterior lesions showed abnormal RPLNs, compared to 9 of 50 patients (18 %) with posterior lesions. No significant difference in frequency of abnormal RPLNs was apparent between anterior and posterior lesions (P = 0.37). In primary sinonasal malignancies among adults, the highest incidence of abnormal RPLNs was seen with olfactory neuroblastoma. The frequency of abnormal RPLNs was unaffected by the location of sinonasal malignancies among adults.	[Sai, Asari; Shimono, Taro; Yamamoto, Akira; Takeshita, Toru; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Abeno Ku, Osaka 5458585, Japan; [Ohsawa, Masahiko; Wakasa, Kenichi] Osaka City Univ, Dept Diagnost Pathol, Grad Sch Med, Osaka 558, Japan	Sai, A (reprint author), Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	m2076193@med.osaka-cu.ac.jp					Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; Zhang GY, 2010, RADIOLOGY, V255, P605, DOI 10.1148/radiol.10090289; Tang LL, 2008, CANCER, V113, P347, DOI 10.1002/cncr.23555; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Werner JA, 2003, HEAD NECK-J SCI SPEC, V25, P322, DOI 10.1002/hed.10257; Som PM, 2000, AM J ROENTGENOL, V174, P837; Gunn GB, 2013, CANCER-AM CANCER SOC, V119, P3162, DOI 10.1002/cncr.28195; MANCUSO AA, 1983, RADIOLOGY, V148, P715; MANCUSO AA, 1983, RADIOLOGY, V148, P709; Holbrook EH, 2011, LARYNGOSCOPE, V121, P1687, DOI 10.1002/lary.21856; Edge S, 2009, AJCC CANC STAGING MA; Ferlito A, 2002, ACTA OTO-LARYNGOL, V122, P556, DOI 10.1080/00016480260092408; Howell MC, 2011, AM J NEURORADIOL, V32, P929, DOI 10.3174/ajnr.A2401; Ichimura Keiichi, 1993, Auris Nasus Larynx, V20, P117; King AD, 2000, HEAD NECK-J SCI SPEC, V22, P275; Lam WWM, 1997, HEAD NECK-J SCI SPEC, V19, P176, DOI 10.1002/(SICI)1097-0347(199705)19:3<176::AID-HED2>3.0.CO;2-#; Liu LZ, 2006, INT J RADIAT ONCOL, V66, P721, DOI 10.1016/j.ijrobp.2006.05.054; NAKASHIMA T, 1984, ARCH OTOLARYNGOL, V110, P641; Ogura I, 2004, ORAL SURG ORAL MED O, V98, P355, DOI 10.1016/j.tripleo.2004.06.067; Pan WR, 2009, HEAD NECK-J SCI SPEC, V31, P52, DOI 10.1002/hed.20926; Rouviere H, 1938, ANATOMY HUMAN LYMPHA, P16; Som PM, 2011, HEAD NECK IMAGING, V2, P2287; Zollinger LV, 2008, AM J NEURORADIOL, V29, P1561, DOI 10.3174/ajnr.A1114	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	DEC	2014	56	12					1097	1102		10.1007/s00234-014-1428-x		6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AU0ET	WOS:000345297100010		
J	Taniguchi, T				Taniguchi, Takeshi			Global existence of a weak solution to 3d stochastic Navier-Stokes equations in an exterior domain	NODEA-NONLINEAR DIFFERENTIAL EQUATIONS AND APPLICATIONS			English	Article							UNBOUNDED-DOMAINS; 2D	In this paper we consider the existence of a weak solution to a 3d stochastic Navier-Stokes equation perturbed by a noise g(X(t)) dW, where W(t) is a cylindrical Wiener process, in an exterior domain D: dX(t) = [-AX(t) + B (X(t))]dt + g(X(t)) dW(t), where A = -P-2 Delta is the Stokes operator and g satisfies some conditions.	Kurume Univ, Grad Sch Comparat Culture, Div Math Sci, Kurume, Fukuoka 8398502, Japan	Taniguchi, T (reprint author), Kurume Univ, Grad Sch Comparat Culture, Div Math Sci, Kurume, Fukuoka 8398502, Japan.	takeshi_taniguchi@kurume-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan [24540198]	The author would like to strongly appreciate to referees for their kind comments and nice advises. This research is partly supported by the Grant-in-Aid for Scientific Research (N0. 24540198) from Japan Society for the Promotion of Science (JSPS), Japan.	Brzezniak Z, 2006, T AM MATH SOC, V358, P5587, DOI 10.1090/S0002-9947-06-03923-7; FUJITA H, 1964, ARCH RATION MECH AN, V16, P269, DOI 10.1007/BF00276188; MIYAKAWA T, 1988, MATH Z, V199, P455, DOI 10.1007/BF01161636; Sritharan SS, 2006, STOCH PROC APPL, V116, P1636, DOI 10.1016/j.spa.2006.04.001; Mikulevicius R, 2005, ANN PROBAB, V33, P137, DOI 10.1214/009117904000000630; GIGA Y, 1991, J FUNCT ANAL, V102, P72, DOI 10.1016/0022-1236(91)90136-S; Brzezniak Z., 2011, GLOBAL STOCH ANAL, V1, P175; Brzezniak Z., 1999, INFIN DIMENS ANAL QU, P85; Brzezniak Z, 2013, J DIFFER EQUATIONS, V254, P1627, DOI 10.1016/j.jde.2012.10.009; Capinski M, 2001, NONLINEAR ANAL-THEOR, V44, P141, DOI 10.1016/S0362-546X(99)00255-2; Da Prato G., 1992, STOCHASTIC EQUATIONS; Farwig R, 2010, NODEA-NONLINEAR DIFF, V17, P303, DOI 10.1007/s00030-010-0055-4; Flandoli F, 2008, LECT NOTES MATH, V1942, P51; Flandoli F., 1995, PROBA THEORY RELAT F, V102, P365; KATO T, 1984, MATH Z, V187, P471, DOI 10.1007/BF01174182; Kato T, 1962, REND SEMIN MAT U PAD, V32, P243; Kim JU, 2008, APPL MATH OPT, V58, P29, DOI 10.1007/s00245-007-9029-2; Miyakawa T., 1982, HIROSHIMA MATH J, V12, P115; Pazy A, 1983, SEMIGROUPS LINEAR OP; Seidler J, 2003, J LOND MATH SOC, V67, P245, DOI 10.1112/S0024610702003745; Shreve S.E., 1991, BROWNIAN MOTION STOC; Sohr H, 2001, NAVIER STOKES EQUATI; Taniguchi T., DISCRETE CO IN PRESS; Taniguchi T, 2011, J DIFFER EQUATIONS, V251, P3329, DOI 10.1016/j.jde.2011.07.029; Temam R., INFINITE DIMENSIONAL; Temam R., 1977, NAVIER STOKES EQUATI; van Neerven J, 2012, SIAM J MATH ANAL, V44, P1372, DOI 10.1137/110832525; Zabczyk J., 1996, ERGODICITY INFINITE	28	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1021-9722	1420-9004		NODEA-NONLINEAR DIFF	NoDea-Nonlinear Differ. Equ. Appl.	DEC	2014	21	6					813	840		10.1007/s00030-014-0268-z		28	Mathematics, Applied	Mathematics	AU0FA	WOS:000345297700003		
J	Naimen, D				Naimen, Daisuke			Positive solutions of Kirchhoff type elliptic equations involving a critical Sobolev exponent	NODEA-NONLINEAR DIFFERENTIAL EQUATIONS AND APPLICATIONS			English	Article						Kirchhoff; Elliptic; Critical; Variational method	CRITICAL GROWTH; STANDING WAVES; EXISTENCE; MULTIPLICITY; COMPACTNESS; STABILITY	In this paper we investigate the following Kirchhoff type elliptic boundary value problem involving a critical nonlinearity: here is a bounded domain with smooth boundary and a + b > 0. Under several conditions on and , we prove the existence and nonexistence of solutions of (K1). This is some extension of a part of Brezis-Nirenberg's result in 1983.	Osaka City Univ, Grad Sch Sci, Dept Math, Sumiyoshi Ku, Osaka 5588585, Japan	Naimen, D (reprint author), Osaka City Univ, Grad Sch Sci, Dept Math, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	d12sax0J51@ex.media.osaka-cu.ac.jp					Alves CO, 2005, COMPUT MATH APPL, V49, P85, DOI 10.1016/j.camwa.2005.01.008; Alves C.O., 2010, DIFFER EQU APPL, V2, P409; Li YH, 2012, J DIFFER EQUATIONS, V253, P2285, DOI 10.1016/j.jde.2012.05.017; Azzollini A, 2011, ANN MAT PUR APPL, V190, P507, DOI 10.1007/s10231-010-0160-3; Figueiredo GM, 2012, DIFFER INTEGRAL EQU, V25, P853; Kikuchi H, 2007, ADV NONLINEAR STUD, V7, P403; Liang SH, 2013, NONLINEAR ANAL-THEOR, V81, P31, DOI 10.1016/j.na.2012.12.003; CARRIER GF, 1945, Q APPL MATH, V3, P157; CLARK DC, 1972, INDIANA U MATH J, V22, P65, DOI 10.1512/iumj.1972.22.22008; DANCONA P, 1992, INVENT MATH, V108, P247, DOI 10.1007/BF02100605; Figueiredo GM, 2013, J MATH ANAL APPL, V401, P706, DOI 10.1016/j.jmaa.2012.12.053; Arosio A, 1996, T AM MATH SOC, V348, P305, DOI 10.1090/S0002-9947-96-01532-2; Perera K, 2006, J DIFFER EQUATIONS, V221, P246, DOI 10.1016/j.jde.2005.03.006; Wang J, 2012, J DIFFER EQUATIONS, V253, P2314, DOI 10.1016/j.jde.2012.05.023; Jeanjean L, 2006, ADV DIFFERENTIAL EQU, V11, P813; Ma TF, 2003, APPL MATH LETT, V16, P243, DOI 10.1016/S0893-9659(03)80038-1; Alves CO, 2012, NONLINEAR ANAL-THEOR, V75, P2750, DOI 10.1016/j.na.2011.11.017; OPLINGER DW, 1960, J ACOUST SOC AM, V32, P1529, DOI 10.1121/1.1907948; Arosio A., 1993, FUNCTIONAL ANAL METH, P220; Bernstein S., 1940, IZV AKAD NAUK SSSR M, V4, P17; BREZIS H, 1986, P SYMP PURE MATH, V45, P165; BREZIS H, 1983, COMMUN PUR APPL MATH, V36, P437, DOI 10.1002/cpa.3160360405; CARRIER GF, 1949, Q APPL MATH, V7, P97; Gilbarg D., 2001, ELLIPTIC PARTIAL DIF; Kirchhoff G., 1876, VORLESUNGEN MATH PHY; Liang Z., 2013, ANN I H POI IN PRESS; Lions J.L., 1978, CONTEMPORARY DEV CON; Lions P. L., 1985, REV MAT IBEROAM, V1, P145; NARASIMH.R, 1968, J SOUND VIB, V8, P134, DOI 10.1016/0022-460X(68)90200-9; Pohozaev S.I., 1965, SOV MATH DOKL, V6, P1408; Pohozhaev S.I., 1975, MATH USSR SB, V25, P145, DOI 10.1070/SM1975v025n01ABEH002203; Schlesinger K., 1931, Zeitschrift fur Technische Physik, V12; Struwe M, 2008, ERGEB MATH GRENZGEB, V34, P1; Sun Y., 2012, J PARTIAL DIFFER EQU, V25, P187; Willem M., 1996, MINIMAX THEOREMS	35	5	5	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1021-9722	1420-9004		NODEA-NONLINEAR DIFF	NoDea-Nonlinear Differ. Equ. Appl.	DEC	2014	21	6					885	914		10.1007/s00030-014-0271-4		30	Mathematics, Applied	Mathematics	AU0FA	WOS:000345297700006		
J	Hirooka, K; Saito, W; Noda, K; Ishida, S				Hirooka, Kiriko; Saito, Wataru; Noda, Kousuke; Ishida, Susumu			Enhanced-depth Imaging Optical Coherence Tomography and Laser Speckle Flowgraphy in a Patient with Acute Macular Neuroretinopathy	OCULAR IMMUNOLOGY AND INFLAMMATION			English	Letter							KOYANAGI-HARADA-DISEASE; CENTRAL SEROUS CHORIORETINOPATHY; BLOOD-FLOW-VELOCITY		[Hirooka, Kiriko; Saito, Wataru; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido 0608638, Japan; [Saito, Wataru; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Sapporo, Hokkaido 0608638, Japan	Saito, W (reprint author), Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Kita Ku, Nishi 7,Kita 15, Sapporo, Hokkaido 0608638, Japan.	wsaito@med.hokudai.ac.jp					Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Usui S, 2012, INVEST OPHTH VIS SCI, V53, P2300, DOI 10.1167/iovs.11-8383; Rao Narsing A., 2007, International Ophthalmology, V27, P81, DOI 10.1007/s10792-006-9029-2; Sarraf D, 2013, JAMA OPHTHALMOL, V131, P1275, DOI 10.1001/jamaophthalmol.2013.4056; Yeh S, 2011, ARCH OPHTHALMOL-CHIC, V129, P365, DOI 10.1001/archophthalmol.2011.22; Hirose S, 2008, ACTA OPHTHALMOL, V86, P902, DOI 10.1111/j.1755-3768.2008.01384.x; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; BOS PJM, 1975, AM J OPHTHALMOL, V80, P573; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P510, DOI 10.1097/IAE.0b013e3181eef053; Fong AHC, 2011, RETINA-J RET VIT DIS, V31, P502, DOI 10.1097/IAE.0b013e3182083beb; Hashimoto Yuki, 2012, Clin Ophthalmol, V6, P1645, DOI 10.2147/OPTH.S35854; Hirooka Kiriko, 2013, Clin Ophthalmol, V7, P1447, DOI 10.2147/OPTH.S47045; Neuhann IM, 2010, GRAEF ARCH CLIN EXP, V248, P1041, DOI 10.1007/s00417-010-1324-y; Saito M, 2013, BRIT J OPHTHALMOL, V97, P775, DOI 10.1136/bjophthalmol-2012-302349; Sanjari N, 2013, OSLI RETINA, V44, pS36, DOI 10.3928/23258160-20131101-07; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7	16	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0927-3948	1744-5078		OCUL IMMUNOL INFLAMM	Ocul. Immunol. Inflamm.	DEC	2014	22	6					485	489		10.3109/09273948.2014.916305		5	Ophthalmology	Ophthalmology	AT8WG	WOS:000345209300011		
J	Tanaka, N; Sakamoto, K; Okabe, H; Fujioka, A; Yamamura, K; Nakagawa, F; Nagase, H; Yokogawa, T; Oguchi, K; Ishida, K; Osada, A; Kazuno, H; Yamada, Y; Matsuo, K				Tanaka, Nozomu; Sakamoto, Kazuki; Okabe, Hiroyuki; Fujioka, Akio; Yamamura, Keisuke; Nakagawa, Fumio; Nagase, Hideki; Yokogawa, Tatsushi; Oguchi, Kei; Ishida, Keiji; Osada, Akiko; Kazuno, Hiromi; Yamada, Yuikari; Matsuo, Kenichi			Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models	ONCOLOGY REPORTS			English	Article						TAS-102; trifluridine; tipiracil hydrochloride; Lonsurf	METASTATIC COLORECTAL-CANCER; PHASE-III TRIAL; PLUS IRINOTECAN; FLUOROURACIL; LEUCOVORIN; 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE; 5-FLUOROURACIL; OXALIPLATIN; COMBINATION; BEVACIZUMAB	TAS-102 is a novel oral nucleoside antitumor agent containing trifluridine (FTD) and tipiracil hydrochloride (TPI). The compound improves overall survival of colorectal cancer (CRC) patients who are insensitive to standard chemotherapies. FTD possesses direct antitumor activity since it inhibits thymidylate synthase (TS) and is itself incorporated into DNA. However, the precise mechanisms underlying the incorporation into DNA and the inhibition of TS remain unclear. We found that FTD-dependent inhibition of TS was similar to that elicited by fluorodeoxyuridine (FdUrd), another clinically used nucleoside analog. However, washout experiments revealed that FTD-dependent inhibition of TS declined rapidly, whereas FdUrd activity persisted. The incorporation of FTD into DNA was significantly higher than that of other antitumor nucleosides. Additionally, orally administered FTD had increased antitumor activity and was incorporated into DNA more effectively than continuously infused FTD. When TAS-102 was administered, FTD gradually accumulated in tumor cell DNA, in a TPI-independent manner, and significantly delayed tumor growth and prolonged survival, compared to treatment with 5-FU derivatives. TAS-102 reduced the Ki-67-positive cell fraction, and swollen nuclei were observed in treated tumor tissue. The amount of FTD incorporation in DNA and the antitumor activity of TAS-102 in xenograft models were positively and significantly correlated. These results suggest that TAS-102 exerts its antitumor activity predominantly due to its DNA incorporation, rather than as a result of TS inhibition. The persistence of FTD in the DNA of tumor cells treated with TAS-102 may underlie its ability to prolong survival in cancer patients.	[Tanaka, Nozomu; Sakamoto, Kazuki; Okabe, Hiroyuki; Fujioka, Akio; Yamamura, Keisuke; Yokogawa, Tatsushi; Oguchi, Kei; Ishida, Keiji; Osada, Akiko; Kazuno, Hiromi; Yamada, Yuikari; Matsuo, Kenichi] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Tsukuba, Ibaraki 3002611, Japan; [Nakagawa, Fumio; Nagase, Hideki] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Kawaguchi, Tokushima 7710194, Japan; [Tanaka, Nozomu] Kanazawa Univ, Canc Res Inst, Div Mol Virol & Oncol, Kanazawa, Ishikawa 9201192, Japan	Sakamoto, K (reprint author), Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Drug Discovery & Dev 1, 3 Okubo, Tsukuba, Ibaraki 3002611, Japan.	ka-sakamoto@taiho.co.jp					Skevaki CL, 2011, DRUGS, V71, P331, DOI 10.2165/11585330-000000000-00000; DEXTER DL, 1972, CANCER RES, V32, P247; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Bijnsdorp IV, 2010, INT J CANCER, V126, P2457, DOI 10.1002/ijc.24943; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Pettersen HS, 2011, NUCLEIC ACIDS RES, V39, P8430, DOI 10.1093/nar/gkr563; FUJIWARA Y, 1970, MOL PHARMACOL, V6, P273; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; HEIDELBERGER C, 1964, J MED CHEM, V7, P1, DOI 10.1021/jm00331a001; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5; ANSFIELD FJ, 1971, CANCER CHEMOTH REP 1, V55, P205; Emura T, 2004, INT J MOL MED, V13, P249; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; LANGENBA.RJ, 1972, BIOCHEM BIOPH RES CO, V48, P1565, DOI 10.1016/0006-291X(72)90892-3; Markley JC, 2001, BIOORG MED CHEM LETT, V11, P2453, DOI 10.1016/S0960-894X(01)00461-9; MILLER EM, 1992, CANCER RES, V52, P1687; Quesada-Soriano I, 2010, BIOCHIMIE, V92, P178, DOI 10.1016/j.biochi.2009.10.008; Suzuki N, 2011, INT J ONCOL, V39, P263, DOI 10.3892/ijo.2011.1003	23	10	10	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2319	2326		10.3892/or.2014.3487		8	Oncology	Oncology	AT4JE	WOS:000344904900003		
J	Jiang, X; Kanda, T; Nakamoto, S; Haga, Y; Sasaki, R; Nakamura, M; Wu, S; Mikata, R; Yokosuka, O				Jiang, Xia; Kanda, Tatsuo; Nakamoto, Shingo; Haga, Yuki; Sasaki, Reina; Nakamura, Masato; Wu, Shuang; Mikata, Rintaro; Yokosuka, Osamu			Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stress	ONCOLOGY REPORTS			English	Article						apoptosis; ER stress; GRP78/Bip; pancreatic cancer; resistance; UPR	ER STRESS; HEPATOCELLULAR-CARCINOMA; ANDROGEN RECEPTOR; BREAST-CANCER; APOPTOSIS; GRP78; HEPATOCARCINOGENESIS; INVOLVEMENT; ACTIVATION; PATHWAY	The present study examined the expression of glucose-regulated protein 78 (GRP78/Bip) in human pancreatic cancer cell lines and the effect of knockdown of GRP78 on the cleavage of poly(ADP-ribose) polymerase (PARP). Human pancreatic cancer cell lines (KP-2, MIAPaCa-2, Panc-1 and SUIT-2), constitutively expressed GRP78. We also demonstrated that ER stress induced by thapsigargin upregulated protein levels of GRP78. In the presence of thapsigargin, knockdown of GRP78 enhanced the PARP cleavage in the human pancreatic cancer cells. These results provide evidence that GRP78 is a potential therapeutic target for 'difficult-to-treat' pancreatic cancer, in which ER stress signaling in part falls into disorder.	[Jiang, Xia; Kanda, Tatsuo; Nakamoto, Shingo; Haga, Yuki; Sasaki, Reina; Nakamura, Masato; Wu, Shuang; Mikata, Rintaro; Yokosuka, Osamu] Chiba Univ, Dept Gastroenterol & Nephrol, Grad Sch Med, Chuo Ku, Chiba 2608677, Japan; [Nakamoto, Shingo] Chiba Univ, Dept Mol Virol, Grad Sch Med, Chuo Ku, Chiba 2608677, Japan	Kanda, T (reprint author), Chiba Univ, Dept Gastroenterol & Nephrol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	kandat-cib@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24590955]	The present study was supported by Grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (24590955 to T.K.).	Wang J, 2009, J CELL MOL MED, V13, P3888, DOI 10.1111/j.1582-4934.2009.00873.x; Miyazaki M, 2014, SURGERY, V155, P58, DOI 10.1016/j.surg.2013.06.050; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Lennon AM, 2014, CANCER RES, V74, P3381, DOI 10.1158/0008-5472.CAN-14-0734; Mahadevan NR, 2011, P NATL ACAD SCI USA, V108, P6561, DOI 10.1073/pnas.1008942108; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Kanda T, 2014, WORLD J GASTROENTERO, V20, P9229, DOI 10.3748/wjg.v20.i28.9229; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Sudo K, 2014, CANCER CHEMOTH PHARM, V73, P389, DOI 10.1007/s00280-013-2368-6; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Tsai HY, 2013, ONCOGENE, V32, P4921, DOI 10.1038/onc.2012.514; Mujumdar N, 2014, AM J PHYSIOL-GASTR L, V306, pG1011, DOI 10.1152/ajpgi.00466.2013; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; EHRENFRIED JA, 1995, SURG ONCOL, V4, P197; Jiang X, 2014, EXP CELL RES, V323, P326, DOI 10.1016/j.yexcr.2014.02.017; Jiang X, 2013, IMMUNOL LETT, V152, P8, DOI 10.1016/j.imlet.2013.03.006; Kanda T, 2005, DNA CELL BIOL, V24, P805, DOI 10.1089/dna.2005.24.805; Kuroda T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-134; Lei Y, 2014, ONCOGENE; Okitsu Kohichiroh, 2010, Genes Cancer, V1, P859, DOI 10.1177/1947601910383417; Roller C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00010; Visioli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101053; Wang R, 2013, CHEM-BIOL INTERACT, V205, P1, DOI 10.1016/j.cbi.2013.06.007	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2343	2348		10.3892/or.2014.3533		6	Oncology	Oncology	AT4JE	WOS:000344904900006		
J	Nonaka, R; Nishimura, J; Kagawa, Y; Osawa, H; Hasegawa, J; Murata, K; Okamura, S; Ota, H; Uemura, M; Hata, T; Takemasa, I; Mizushima, T; Okuzaki, D; Yamamoto, H; Doki, Y; Mori, M				Nonaka, Ryoji; Nishimura, Junichi; Kagawa, Yoshinori; Osawa, Hideki; Hasegawa, Junichi; Murata, Kohei; Okamura, Shu; Ota, Hirofumi; Uemura, Mamoru; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Okuzaki, Daisuke; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki			Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer	ONCOLOGY REPORTS			English	Article						miR-199a-3p; circulating miR; colorectal cancer	COLON-CANCER; EXPRESSION; MICRORNAS; MARKERS; UPDATE; PLASMA	Serum microRNAs (miRNAs) have been shown to have potential for cancer diagnosis. The main objective of the present study was to identify a novel serum miRNA biomarker from patients with colorectal cancer (CRC). Microarray analysis of miRNA expression was performed using paired pre-operative and post-operative serum from 10 CRC patients. Expression of two miRNAs (let-7a and miR-199a-3p) was significantly decreased in the post-operative serum when compared to levels in the pre-operative serum (P=0.015 and 0.029, respectively). Quantitative real-time polymerase chain reaction (qRT-PCR) confirmed the decrease in the miRNAs in an extended number (n=30) of paired serum samples. Next, we examined the serum let-7a level in 32 non-cancer patients and 84 CRC patients but we found no significant difference (P=0.120). In contrast, miR199a-3p expression was significantly higher in the CRC patients than that in the non-cancer patients (P=0.016). Furthermore, clinical and pathological survey indicated that high expression of miR-199a-3p was significantly associated with deep wall invasion. Our data suggest that circulating miR-199a-3p could be a novel serum biomarker for CRC.	[Nonaka, Ryoji; Nishimura, Junichi; Kagawa, Yoshinori; Osawa, Hideki; Uemura, Mamoru; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Hasegawa, Junichi] Osaka Rosai Hosp, Dept Surg, Osaka, Japan; [Murata, Kohei; Okamura, Shu] Suita Municipal Hosp, Dept Surg, Osaka, Japan; [Ota, Hirofumi] Saiseikai Senri Hosp, Dept Surg, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Special Res Facil, Suita, Osaka 5650871, Japan	Yamamoto, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hyamamoto@gesurg.med.osaka-u.ac.jp	Nishimura, Junichi/K-8390-2015	Nishimura, Junichi/0000-0001-8220-3423	 [24390315]	This study was supported by a Grant-in-Aid for Scientific Research (B) (24390315 to H.Y.)	Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1288, DOI 10.1001/jama.289.10.1288; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ahmed FE, 2013, CANCER GENOM PROTEOM, V10, P93; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; O'Connell JB, 2004, J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Cheng H, 2010, PLOS ONE, V6; Jemel A, 2011, CA-CANCER J CLIN, V61, P69; Wan DW, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0378-6	19	6	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2354	2358		10.3892/or.2014.3515		5	Oncology	Oncology	AT4JE	WOS:000344904900008		
J	Tawada, M; Hayashi, SI; Ikegame, Y; Nakashima, S; Yoshida, K				Tawada, Masahiro; Hayashi, Shin-Ichiro; Ikegame, Yuka; Nakashima, Shigeru; Yoshida, Kazuhiro			Possible involvement of tumor-producing VEGF-A in the recruitment of lymphatic endothelial progenitor cells from bone marrow	ONCOLOGY REPORTS			English	Article						human adenocarcinoma; lymphangiogenesis; VEGF-A; bone marrow; lymphatic endothelial progenitor cells	HEPATOCYTE GROWTH-FACTOR; REGULATORY T-CELLS; VESSEL FORMATION; LYMPHANGIOGENESIS; PROMOTES; CANCER; METASTASIS; ANGIOGENESIS; INDUCTION; NEOVASCULARIZATION	Lymphatic metastasis of human malignant adenocarcinomas is a critical determinant of prognosis. Lymphangiogenesis, the growth of lymphatic vessels, is closely involved in lymphatic metastasis. However, the mechanisms of tumor lymphangiogenesis are not clearly understood. In a previous study, we showed that human gastric cancer MKN45 cells organize neighboring lymphatic vessels via recruitment of bone marrow-derived lymphatic endothelial progenitor cells in a nude mouse xenograft model. The present results also indicated that human colorectal cancer LS174T and breast cancer SK-BR-3 cells promoted lymphangiogenesis as well as the recruitment of lymphatic endothelial progenitor cells from bone marrow. Among growth factors, which are reported to be involved in lymphangiogenesis, only vascular endothelial growth factor (VEGF)-A was extensively secreted by these three types of adenocarcinoma cells in culture. The well-characterized lymphangiogenic factors VEGF-C and VEGF-D in the culture medium of these three types of adenocarcinoma cells were below the detectable levels in ELISA assay. Secretion of epidermal growth factor (EGF) and hepatocyte growth factor (HGF) was not detected. In in vitro culture assay, VEGF-A directly induced the differentiation of bone marrow mononuclear cells into LYVE-1-positive lymphatic endothelial lineage cells. These data collectively suggest the possibility that VEGF-A-rich human adenocarcinomas induce tumor lymphangiogenesis via recruitment of lymphangiogenic endothelial progenitor cells from bone marrow.	[Tawada, Masahiro; Yoshida, Kazuhiro] Gifu Univ, Grad Sch Med, Dept Surg Oncol, Gifu 5011194, Japan; [Hayashi, Shin-Ichiro; Ikegame, Yuka; Nakashima, Shigeru] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu 5011194, Japan; [Tawada, Masahiro] Gifu Prefectural Gen Med Ctr, Dept Surg, Gifu 5008717, Japan; [Hayashi, Shin-Ichiro] Natl Cerebral & Cardiovasc Ctr, Div Nephrol & Hypertens, Suita, Osaka 5658565, Japan	Tawada, M (reprint author), Gifu Prefectural Gen Med Ctr, Dept Surg, 4-6-1 Noisshiki, Gifu 5008717, Japan.	tawada0316@yahoo.co.jp			NaSNeLC research grant from Gifu University Graduate School of Medicine	This study was supported in part by an NaSNeLC research grant from Gifu University Graduate School of Medicine. The authors thank Ryoko Hayashi for her technical assistance.	Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Wada J, 2009, ANTICANCER RES, V29, P881; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Asahara T, 1999, CIRC RES, V85, P221; Gavalas NG, 2012, BRIT J CANCER, V107, P1869, DOI 10.1038/bjc.2012.468; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Achen MG, 2006, BRIT J CANCER, V94, P1355, DOI 10.1038/sj.bjc.6603120; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; IMAI Y, 1982, CANCER RES, V42, P4394; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Li B, 2006, CLIN CANCER RES, V12, P6808, DOI 10.1158/1078-0432.CCR-06-1558; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; GUADAGNI F, 1990, CANCER RES, V50, P6248; Hayashi S, 1999, CIRCULATION, V100, P301; KOSHIKAWA N, 1992, CANCER RES, V52, P5046; Tawada M, 2012, J GASTROENTEROL, V47, P1057, DOI 10.1007/s00535-012-0638-4; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	35	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2359	2364		10.3892/or.2014.3499		6	Oncology	Oncology	AT4JE	WOS:000344904900009		
J	Yamamoto, K; Seike, M; Takeuchi, S; Soeno, C; Miyanaga, A; Noro, R; Minegishi, Y; Kubota, K; Gemma, A				Yamamoto, Kazuo; Seike, Masahiro; Takeuchi, Susumu; Soeno, Chie; Miyanaga, Akihiko; Noro, Rintaro; Minegishi, Yuji; kubota, Kaoru; Gemma, Akihiko			miR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma	ONCOLOGY REPORTS			English	Article						IL-18; miR-379; miR-411; mesothelioma; histone deacetylase inhibitor	LUNG-CANCER; PHASE-I; EXPRESSION PROFILES; GAMMA PRODUCTION; COMBINATION; CELLS; INTERLEUKIN-18; CISPLATIN; ADENOCARCINOMA; VORINOSTAT	Malignant pleural mesothelioma (MPM) is a rapidly fatal malignancy that is increasing in incidence in Japan. In this study, we performed gene and microRNA (miRNA) expression profiling to identify novel therapeutic targets in MPM cells. Based on relative sensitivities to pemetrexed (PEM) and the histone deacetylase (HDAC) inhibitor, vorinostat (SAHA), 211H cells were determined to be the only sensitive MPM cell line out of the 6 tested. On the same series of cell lines, we performed whole genome transcriptomic profiling via DNA microarrays and pathway analysis of the derived data. Of particular note, IL-18 gene expression levels were significantly higher in the cell lines that were either drug resistant or displayed intermediate sensitivity, compared to the sensitive 211H cell line. Pathway analysis revealed IL-18 as an important gene associated with drug sensitivity of MPM cells. A relationship between IL-18 overexpression and drug resistance was also observed following targeted assessment of 10 cytokine genes using quantitative RT-PCR. miRNA expression profiles were evaluated in the MPM cell line panel in order to discern the mechanism of IL-18 induction in the drug-resistant lines. We found that miR-379 and miR-411 belonged to the same cluster of miRNAs located on chromosome 14q32 that commonly target the IL-18 gene. Luciferase reporter assays revealed that miR-379 and miR-411 directly target the IL-18 gene. Introduction of miR-379 plus miR-411, as well as IL-18 silencing, significantly suppressed the invasive capacity of MES01 cells in vitro. Furthermore, the use of either PEM or SAHA together with miR-379 plus miR-411 mimics mediated increased sensitivity to these drugs in MES01 cells. These results suggest that the miR-379/411 cluster may provide new therapeutic opportunities for advanced MPM patients, depending on the nature of IL-18 gene expression.	[Yamamoto, Kazuo; Seike, Masahiro; Takeuchi, Susumu; Soeno, Chie; Miyanaga, Akihiko; Noro, Rintaro; Minegishi, Yuji; kubota, Kaoru; Gemma, Akihiko] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 1138603, Japan	Seike, M (reprint author), Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	mseike@nms.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24591179, 25461172]; Clinical Rebiopsy Bank Project for Comprehensive Cancer Therapy Development; Smoking Research Foundation	We would like to thank Ms. Shoko Tanaka for assistance with the cytokine gene expression analysis. We would like to thank Mrs. Haruka Isobe of MediBic for assistance with the Pathway analysis. This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant no. 24591179 to M.S.; grant no. 25461172 to A.G.), the Clinical Rebiopsy Bank Project for Comprehensive Cancer Therapy Development (to M.S and A.G.) and the Smoking Research Foundation (to A.G.).	Vandermeers F, 2009, CLIN CANCER RES, V15, P2818, DOI 10.1158/1078-0432.CCR-08-1579; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936; Seike M, 2007, J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Son YI, 2001, CANCER RES, V61, P884; Dinarello CA, 2006, CANCER METAST REV, V25, P307, DOI 10.1007/s10555-006-9000-8; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Miyanaga A, 2008, MOL CANCER THER, V7, P1923, DOI 10.1158/1535-7163.MCT-07-2140; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; Shimokawa T, 2012, BRIT J CANCER, V106, P867, DOI 10.1038/bjc.2012.7; Gemma A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-174; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Pass HI, 2010, CANCER RES, V70, P1916, DOI 10.1158/0008-5472.CAN-09-3993; Fakih MG, 2009, CLIN CANCER RES, V15, P3189, DOI 10.1158/1078-0432.CCR-08-2999; Cioce M, 2014, ONCOGENE, V33, P5319, DOI 10.1038/onc.2013.476; Coughlin CM, 1998, J CLIN INVEST, V101, P1441, DOI 10.1172/JCI1555; Hansen J, 1998, AM J RESP CRIT CARE, V157, P69; Hurwitz JL, 2012, EUR J CANCER, V48, P1096, DOI 10.1016/j.ejca.2011.11.009; Kaufman AJ, 2008, EXPERT REV ANTICANC, V8, P293, DOI 10.1586/14737140.8.2.293; Khan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068753; Kitamura K, 2014, MOL CANCER THER, V13, P444, DOI 10.1158/1535-7163.MCT-13-0448; Park S, 2007, CELL MOL IMMUNOL, V4, P329; Pollari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037361; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Sugarbaker DJ, 1999, J THORAC CARDIOV SUR, V117, P54, DOI 10.1016/S0022-5223(99)70469-1; Thodtmann R, 1999, J CLIN ONCOL, V17, P3009; Yao L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024684	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2365	2372		10.3892/or.2014.3481		8	Oncology	Oncology	AT4JE	WOS:000344904900010		
J	Qin, W; Akutsu, Y; Andocs, G; Suganami, A; Hu, X; Yusup, G; Komatsu-Akimoto, A; Hoshino, I; Hanari, N; Mori, M; Isozaki, Y; Akanuma, N; Tamura, Y; Matsubara, H				Qin, Wei; Akutsu, Yasunori; Andocs, Gabor; Suganami, Akiko; Hu, Xin; Yusup, Gulbostan; Komatsu-Akimoto, Aki; Hoshino, Isamu; Hanari, Naoyuki; Mori, Mikito; Isozaki, Yuka; Akanuma, Naoki; Tamura, Yutaka; Matsubara, Hisahiro			Modulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice	ONCOLOGY REPORTS			English	Article						dendritic cells; hyperthermia; abscopal effect; cancer therapy; immunotherapy	HEAT-SHOCK PROTEINS; HEPATOCELLULAR-CARCINOMA; RADIATION-THERAPY; CANCER; TUMOR; RADIOTHERAPY; IRRADIATION; REGRESSION; LYMPHOMA; CHEMOTHERAPY	The aim of this study was to assess whether modulated electro-hyperthermia (mEHT) can induce an abscopal effect and thereby enhance the antitumor effects of immunotherapy. We used an intratumoral dendritic cell (DC) injection and mEHT to treat C3H/He mice inoculated with squamous cell carcinoma SCCVII cells in the left leg, and we assessed the whole body antitumor effects. Tumors were examined every two or three days in order to assess growth inhibition. The tumor-draining lymph nodes were removed to enable flow cytometric analysis of CD3(+) and CD8(+) cells, whereas immunohistochemistry was used to assess CD8, S100 and Foxp3 expression in the tumors. Additionally, GP96 expression in the tumors from the different treatment groups was measured. In the control group, the mean tumor volume was larger than that in other groups. These results indicated that the combination therapy of an intratumoral DC injection and mEHT evoked systemic antitumor activity. A larger number of CD3(+) and CD8(+) cells were detected by flow cytometric analysis in the DC plus mEHT treatment group. Tumor tissue immunostaining showed that CD8 and S100 were more strongly expressed in the DC plus mEHT treatment group, although Foxp3 expression was much higher in the control group. The GP96 gene expression level in the mEHT group was significantly different from the expression level in the control group. An abscopal effect may be induced by mEHT, and the effect of immunotherapy with DCs was strongly enhanced by the overexpression of GP96. GP96 is thought to be one of the molecules explaining the abscopal effect. Direct intratumoral administration of DCs and mEHT may be a feasible future treatment strategy.	[Qin, Wei; Akutsu, Yasunori; Hu, Xin; Yusup, Gulbostan; Komatsu-Akimoto, Aki; Hoshino, Isamu; Hanari, Naoyuki; Mori, Mikito; Isozaki, Yuka; Akanuma, Naoki; Matsubara, Hisahiro] Chiba Univ, Dept Frontier Surg, Grad Sch Med, Chiba 2408470, Japan; [Andocs, Gabor] Tottori Univ, Fac Vet Sci, Dept Vet Clin Med, Tottori 6808553, Japan; [Suganami, Akiko; Tamura, Yutaka] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba 2608670, Japan	Akutsu, Y (reprint author), Chiba Univ, Dept Frontier Surg, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2408470, Japan.	yakutsu@faculty.chiba-u.jp			JSPS KAKENHI [24501328]	This study was supported by the JSPS KAKENHI (grant no. 24501328).	Feyerabend T, 2001, INT J RADIAT ONCOL, V49, P1317, DOI 10.1016/S0360-3016(00)01514-5; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Akutsu Y, 2007, INT J ONCOL, V31, P509; Khurana D, 2001, HEAD NECK-J SCI SPEC, V23, P899, DOI 10.1002/hed.1130; Andocs G, 2009, ELECTROMAGN BIOL MED, V28, P148, DOI 10.1080/15368370902724633; Andocs G, 2009, STRAHLENTHER ONKOL, V185, P120, DOI 10.1007/s00066-009-1903-1; Segal BH, 2006, DRUG DISCOV TODAY, V11, P534, DOI 10.1016/j.drudis.2006.04.016; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Ohba K, 1998, GUT, V43, P575; Candido KA, 2001, CANCER RES, V61, P228; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; REES GJG, 1983, BRIT J RADIOL, V56, P63; Lugade AA, 2005, J IMMUNOL, V174, P7516; NOBLER MP, 1969, RADIOLOGY, V93, P410; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Fiorentini G, 2006, IN VIVO, V20, P721; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Bollschweiler E, 2006, ENDOSCOPY, V38, P149, DOI 10.1055/s-2006-924993; Demaria S, 2004, INT J RADIAT ONCOL, V58, P862, DOI 10.1016/j.ijrobp.2003.09.012; Schmidt T, 2003, CANCER RES, V63, P8962; Bogovic J, 2001, ONKOLOGIE, V24, P55, DOI 10.1159/000050283; Demine R, 2005, J BIOL CHEM, V280, P17573, DOI 10.1074/jbc.M501233200; Facciponte JG, 2006, CANCER IMMUNOL IMMUN, V55, P339, DOI 10.1007/s00262-005-0020-y; Hegyi G, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/672873; Liu SL, 2005, CANCER RES, V65, P9126, DOI 10.1158/0008-5472.CAN-05-0945; MACKLIS RM, 1992, CANCER, V69, P778, DOI 10.1002/1097-0142(19920201)69:3<778::AID-CNCR2820690327>3.0.CO;2-E; Mayinger B, 2001, GASTROINTEST ENDOSC, V54, P195, DOI 10.1067/mge.2001.116563; MOLE RH, 1953, BRIT J RADIOL, V26, P234; Okuma Kae, 2011, J Med Case Rep, V5, P111, DOI 10.1186/1752-1947-5-111; Perego D, 2000, HAEMATOLOGICA, V85, P211; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Ramirez SR, 2005, CELL STRESS CHAPERON, V10, P221, DOI 10.1379/CSC-117R.1; REES GJG, 1981, CLIN RADIOL, V32, P475, DOI 10.1016/S0009-9260(81)80310-8; SHAM RL, 1995, AM J MED, V98, P307, DOI 10.1016/S0002-9343(99)80380-5; Triozzi PL, 2000, CANCER, V89, P2646, DOI 10.1002/1097-0142(20001215)89:12<2646::AID-CNCR18>3.0.CO;2-A; Wang XH, 2005, CANCER IMMUNOL IMMUN, V54, P971, DOI 10.1007/s00262-005-0662-9	36	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2373	2379		10.3892/or.2014.3500		7	Oncology	Oncology	AT4JE	WOS:000344904900011		
J	Hatakeyama, H; Mizumachi, T; Sakashita, T; Kano, S; Homma, A; Fukuda, S				Hatakeyama, Hiromitsu; Mizumachi, Takatsugu; Sakashita, Tomohiro; Kano, Satoshi; Homma, Akihiro; Fukuda, Satoshi			Epithelial-mesenchymal transition in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma	ONCOLOGY REPORTS			English	Article						epithelial-mesenchymal transition; human papillomavirus; oropharyngeal squamous cell carcinoma	E-CADHERIN; NECK-CANCER; IMPROVED SURVIVAL; HEAD; EXPRESSION; P53; HPV; HETEROGENEITY; PROGNOSIS; GENE	High-risk human papillomavirus (HPV) infection is associated with carcinogenesis in oropharyngeal squamous cell carcinoma (OPSCC) and patients with HPV-positive tumors have a significantly favorable prognosis. However, the underlying mechanism of this favorable clinical outcome remains unclear. Epithelial-mesenchymal transition (EMT) causes aggressiveness of cancer cells and we investigated the expression of the EMT markers and analyzed their correlation with HPV status and prognosis in order to examine the treatment response of HPV-positive OPSCCs. A total of 79 patients with OPSCC were examined in the present study. All high-risk HPV infections were determined with the multiplex PCR kit from each formalin-fixed paraffin-embedded (FFPE) sample. We performed immunohistochemical staining for E-cadherin and vimentin. Expression of the markers was graded and we statistically analyzed the correlation between tumor, node, metastasis (TNM) stages and prognosis. High-risk HPV-positive tumors were detected in 23 cases. The five-year survival rate in HPV-positive and -negative tumors was 82.7 and 48.3%, respectively. High E-cadherin expression rate in HPV-negative samples was 76.7% and 43.4% in HPV-positive samples (p=0.007). Vimentin expression did not show a difference between HPV-positive and -negative tumors. HPV-negative patients presented significantly greater heterogeneity of E-cadherin expression compared to HPV-positive patients (p=0.0349). HPV-positive OPSCCs originally lost their epithelial cell phenotype compared with HPV-negative tumors. Therefore, the paradoxical favorable prognosis of HPV-positive OPSCC may be due to the intratumor homogeneity in EMT.	[Hatakeyama, Hiromitsu; Mizumachi, Takatsugu; Sakashita, Tomohiro; Kano, Satoshi; Homma, Akihiro; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Hatakeyama, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	htkym@med.hokudai.ac.jp					Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Zhao ZG, 2012, ORAL ONCOL, V48, P761, DOI 10.1016/j.oraloncology.2012.02.024; Jung YS, 2013, BIOCHEM BIOPH RES CO, V435, P339, DOI 10.1016/j.bbrc.2013.04.060; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Haraf DJ, 1996, CLIN CANCER RES, V2, P755; Fakhry C, 2008, J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; VESSEY CJ, 1995, J PATHOL, V176, P151, DOI 10.1002/path.1711760208; Nishiwaki M, 2008, J CLIN MICROBIOL, V46, P1161, DOI 10.1128/JCM.00793-07; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; Mizumachi T, 2013, INT J CLIN ONCOL, V18, P824, DOI 10.1007/s10147-012-0469-6; Mroz EA, 2013, ORAL ONCOL, V49, P211, DOI 10.1016/j.oraloncology.2012.09.007; Nijkamp MM, 2011, RADIOTHER ONCOL, V99, P344, DOI 10.1016/j.radonc.2011.05.066; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Perrone F, 2006, CLIN CANCER RES, V12, P6643, DOI 10.1158/1078-0432.CCR-06-1759; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Weinberger PM, 2006, J CLIN ONCOL, V24, P736, DOI 10.1200/JCO.2004.00.3335; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; Andrews NA, 1997, BRIT J CANCER, V75, P1474, DOI 10.1038/bjc.1997.252; Worden FP, 2008, J CLIN ONCOL, V26, P3138, DOI 10.1200/JCO.2007.12.7597; Braakhuis BJM, 2004, J NATL CANCER I, V96, P998, DOI 10.1093/jnci/djh183; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Baumann JL, 2009, LARYNGOSCOPE, V119, P1531, DOI 10.1002/lary.20509; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hashimoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047899; Mroz EA, 2012, J CLIN ONCOL, V30, P4053, DOI 10.1200/JCO.2012.44.8050; Olshan AF, 1997, ONCOGENE, V14, P811, DOI 10.1038/sj.onc.1200892; Westra William H, 2012, Head Neck Pathol, V6 Suppl 1, pS48, DOI 10.1007/s12105-012-0371-6	36	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2673	2679		10.3892/or.2014.3509		7	Oncology	Oncology	AT4JE	WOS:000344904900048		
J	Sato, S; Tsuchikawa, T; Nakamura, T; Sato, N; Tamoto, E; Okamura, K; Shichinohe, T; Hirano, S				Sato, Shoki; Tsuchikawa, Takahiro; Nakamura, Toru; Sato, Nagato; Tamoto, Eiji; Okamura, Keisuke; Shichinohe, Toshiaki; Hirano, Satoshi			Impact of the tumor microenvironment in predicting postoperative hepatic recurrence of pancreatic neuroendocrine tumors	ONCOLOGY REPORTS			English	Article						pancreatic neuroendocrine tumor; postoperative hepatic recurrence; tumor-infiltrating lymphocytes; ATRX/DAXX; p-mTOR	GROWTH-FACTOR RECEPTOR; ENDOCRINE TUMORS; PROGNOSTIC-FACTORS; CANCER; CELLS; EXPRESSION; SURVIVAL; THERAPY; MTOR	The disease frequency of pancreatic neuroendocrine tumors (PNETs) has been growing, and postoperative hepatic recurrence (PHR) is one of the factors affecting patient prognosis. The present study aimed to investigate biomarkers of PNETs in the primary disease site to predict PHR using immunohistochemical analysis for tumor-infiltrating lymphocytes (TILs: CD3, CD8 and CD45RO), human leukocyte antigen (HLA) class I, alpha-thalassemia/mental retardation X-linked (ATRX), death domain-associated protein (DAXX), mammalian target of rapamycin (mTOR) and phospho-mTOR (p-mTOR). Correlations were analyzed between TILs and the biomarkers, clinicopathological features and prognosis. Sixteen patients with PNETs who underwent radical surgery at our hospital were reviewed. We analyzed the correlation between PHR and immunohistochemical characteristics, and also between disease-free survival (DFS) or overall survival (OS) and the immunohistochemical characteristics. We found that PHR was associated with the expression patterns of DAXX and p-mTOR. No association was found between PHR and patient background, TILs or other biomarkers. DFS was found to be associated with ATRX, DAXX and p-mTOR. OS was associated only with p-mTOR. In conclusion, ATRX, DAXX and p-mTOR are useful molecular biomarkers for predicting PHR in patients who undergo radical surgery for PNETs. Use of these biomarkers will enable earlier decisions on which patients may benefit from adjuvant therapy.	[Sato, Shoki; Tsuchikawa, Takahiro; Nakamura, Toru; Sato, Nagato; Tamoto, Eiji; Okamura, Keisuke; Shichinohe, Toshiaki; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido 0600815, Japan	Sato, S (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, N-15 W-17, Sapporo, Hokkaido 0600815, Japan.	a02m033@yahoo.co.jp					Panzuto F, 2005, ENDOCR-RELAT CANCER, V12, P1083, DOI 10.1677/ERC1.01017; Cho Y, 2003, CANCER RES, V63, P1555; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Han X, 2013, TUMOR BIOL, V34, P2871, DOI 10.1007/s13277-013-0849-1; Scarpa A, 2010, MODERN PATHOL, V23, P824, DOI 10.1038/modpathol.2010.58; de Wilde RF, 2012, NAT REV GASTRO HEPAT, V9, P199, DOI 10.1038/nrgastro.2012.9; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Metz DC, 2008, GASTROENTEROLOGY, V135, P1469, DOI 10.1053/j.gastro.2008.05.047; Bloomston M, 2006, J GASTROINTEST SURG, V10, P1361, DOI 10.1016/j.gassur.2006.09.004; Tsuchikawa T, 2013, CANCER SCI, V104, P531, DOI 10.1111/cas.12119; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; de Wilde RF, 2012, MODERN PATHOL, V25, P1033, DOI 10.1038/modpathol.2012.53; La Rosa S, 2009, HUM PATHOL, V40, P30, DOI 10.1016/j.humpath.2008.06.005; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Crippa S, 2012, ANN ONCOL, V23, P1928, DOI 10.1093/annonc/mds166; Garcia I, 2003, ANN SURG ONCOL, V10, P234, DOI 10.1245/ASO.2003.05.010; Inada S, 1999, SURG TODAY, V29, P493; Katz SC, 2010, HPB, V12, P674, DOI 10.1111/j.1477-2574.2010.00231.x; Marinoni I, 2014, GASTROENTEROLOGY, V146	23	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	DEC	2014	32	6					2753	2759		10.3892/or.2014.3530		7	Oncology	Oncology	AT4JE	WOS:000344904900058		
J	Yamashita, S; Martinez, A; Xu, B				Yamashita, Shinji; Martinez, Amos; Xu, Bo			Short pulse fiber lasers mode-locked by carbon nanotubes and graphene	OPTICAL FIBER TECHNOLOGY			English	Article						Carbon nanotube; Graphene; Mode-locked fiber laser	NONLINEAR-OPTICAL RESPONSE; D-SHAPED FIBER; SATURABLE ABSORBERS; WAVELENGTH CONVERSION; FEMTOSECOND; DEPOSITION; DISPERSION; END; COMPOSITES; ABSORPTION	One and two dimensional forms of carbon, carbon nanotubes and graphene, have interesting and useful, not only electronic but also photonic, properties. For fiber lasers, they are very attractive passive mode lockers for ultra-short pulse generation, since they have saturable absorption with inherently fast recovery time (<1 ps). In this paper, we review the photonic properties of graphene and CNT and our recent works on fabrication of fiber devices and applications to ultra-short pulse mode-locked fiber lasers. (C) 2014 Published by Elsevier Inc.	[Yamashita, Shinji; Martinez, Amos; Xu, Bo] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan	Yamashita, S (reprint author), Univ Tokyo, RCAST, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	syama@ee.t.u-tokyo.ac.jp			Funding Program for Next Generation World-Leading Researchers (NEXT Program) of the Japan Society for the Promotion of Science (JSPS)	A part of this work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) of the Japan Society for the Promotion of Science (JSPS).	Agrawal GP, 2008, APPLICATIONS OF NONLINEAR FIBER OPTICS, 2ND EDITION, P1; Yamashita S, 2012, J LIGHTWAVE TECHNOL, V30, P427, DOI 10.1109/JLT.2011.2172574; Song YW, 2007, OPT LETT, V32, P148, DOI 10.1364/OL.32.000148; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Collins PG, 2000, SCI AM, V283, P62; Zhao CJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767919; Bao QL, 2009, ADV FUNCT MATER, V19, P3077, DOI 10.1002/adfm.200901007; Chow KK, 2009, OPT EXPRESS, V17, P15608, DOI 10.1364/OE.17.015608; Nair RR, 2008, SCIENCE, V320, P1308, DOI 10.1126/science.1156965; Hendry E, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.097401; Wise FW, 2008, LASER PHOTONICS REV, V2, P58, DOI 10.1002/lpor.200710041; Renninger WH, 2012, IEEE J SEL TOP QUANT, V18, P389, DOI 10.1109/JSTQE.2011.2157462; Yamashita S, 2005, IEEE PHOTONIC TECH L, V17, P750, DOI 10.1109/LPT.2005.843932; Set SY, 2004, IEEE J SEL TOP QUANT, V10, P137, DOI 10.1109/JSTQE.2003.822912; Martinez A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3641419; Fermann ME, 2009, IEEE J SEL TOP QUANT, V15, P191, DOI 10.1109/JSTQE.2008.2010246; Martinez A, 2013, OPT EXPRESS, V21, P4665, DOI 10.1364/OE.21.004665; Lin GR, 2011, LASER PHYS LETT, V8, P880, DOI 10.1002/lapl.201110078; Martinez A, 2008, OPT EXPRESS, V16, P15425, DOI 10.1364/OE.16.015425; Chow KK, 2009, OPT EXPRESS, V17, P7664, DOI 10.1364/OE.17.007664; Martinez A, 2013, NAT PHOTONICS, V7, P842, DOI 10.1038/nphoton.2013.304; Kumar S, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3264964; Murakami Y, 2004, CHEM PHYS LETT, V385, P298, DOI 10.1016/j.cplett.2003.12.095; Hasan T, 2009, ADV MATER, V21, P3874, DOI 10.1002/adma.200901122; Keller U, 1996, IEEE J SEL TOP QUANT, V2, P435, DOI 10.1109/2944.571743; Oktem B, 2010, NAT PHOTONICS, V4, P307, DOI [10.1038/nphoton.2010.33, 10.1038/NPHOTON.2010.33]; Lauret JS, 2004, APPL PHYS LETT, V85, P3572, DOI 10.1063/1.1808226; Grelu P, 2012, NAT PHOTONICS, V6, P84, DOI [10.1038/nphoton.2011.345, 10.1038/NPHOTON.2011.345]; Set SY, 2004, J LIGHTWAVE TECHNOL, V22, P51, DOI 10.1109/JLT.2003.822205; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/nphoton.2010.186, 10.1038/NPHOTON.2010.186]; Xu J, 2012, OPT EXPRESS, V20, P15474, DOI 10.1364/OE.20.015474; Murakami Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.087402; Yamashita S, 2004, OPT LETT, V29, P1581, DOI 10.1364/OL.29.001581; Cho WB, 2010, ADV FUNCT MATER, V20, P1937, DOI 10.1002/adfm.200902368; Kashiwagi K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2338779; Saraceno CJ, 2012, IEEE J SEL TOP QUANT, V18, P29, DOI 10.1109/JSTQE.2010.2092753; Xu B, 2013, OPT EXPRESS, V21, P3651, DOI 10.1364/OE.21.003651; Lin YH, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/5/055105; Kashiwagi K, 2009, OPT EXPRESS, V17, P18364, DOI 10.1364/OE.17.018364; Xu B, 2012, IEEE PHOTONIC TECH L, V24, P1792, DOI 10.1109/LPT.2012.2210035; Martinez A, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739512; Martinez A, 2010, OPT EXPRESS, V18, P23054, DOI 10.1364/OE.18.023054; Xing GC, 2010, OPT EXPRESS, V18, P4564, DOI 10.1364/OE.18.004564; Keller U, 2003, NATURE, V424, P831, DOI 10.1038/nature01938; Sun ZP, 2010, ACS NANO, V4, P803, DOI 10.1021/nn901703e; Nicholson JW, 2007, OPT EXPRESS, V15, P9176, DOI 10.1364/OE.15.009176; Martinez A, 2008, OPT EXPRESS, V16, P11337, DOI 10.1364/OE.16.011337; Lee CC, 2012, APPL PHYS B-LASERS O, V108, P129, DOI 10.1007/s00340-012-5095-5; Margulis VA, 1998, PHYSICA B, V245, P173, DOI 10.1016/S0921-4526(97)00676-5; Keller U, 2010, APPL PHYS B-LASERS O, V100, P15, DOI 10.1007/s00340-010-4045-3; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Choi SY, 2009, OPT EXPRESS, V17, P21788, DOI 10.1364/OE.17.021788; Chow K.K., 2010, APPL PHYS LETT, V96; Dawlaty J.M., 2008, APPL PHYS LETT, V92; Dinh K. T., 2008, APPL PHYS EXPRESS, V22; Hasegawa Y., 2013, P C LAS EL OPT CLEO; Hongzhi Y., 2012, THESIS NATL U SINGAP; Kashiwagi K., 2007, P SPIE PHOT W; Kashiwagi K, 2007, JPN J APPL PHYS 2, V46, pL988, DOI 10.1143/JJAP.46.L988; Kashiwagi K., 2006, P C LAS EL OPT CLEO; Lauret JS, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.057404; Lee C.-C., 2013, ULTRAFAST OPT; Martinez A., 2014, J SEL TOP QUANTUM EL, V20, P1; Martinez A., 2011, OPT EXPRESS, V19, P6156; Martinez A, 2010, OPT EXPRESS, V18, P11008, DOI 10.1364/OE.18.011008; Reich S., 2004, CARBON NANOTUBES BAS; Saito R, 1998, PHYS PROPERTIES CARB; Shimamoto D., 2008, APPL PHYS LETT, V92; Song YW, 2010, OPT COMMUN, V283, P3740, DOI 10.1016/j.optcom.2010.05.020; Song Y.W., 2006, P C LAS EL OPT CLEO; Song Y.W., 2007, APPL PHYS LETT, V90; Song Y.W., 2008, APPL PHYS LETT, V92; Tan WD, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292018; Travers JC, 2011, LASER PHYS LETT, V8, P144, DOI 10.1002/lapl.201010112; Uchida S, 2009, OPT LETT, V34, P3077, DOI 10.1364/OL.34.003077; Wang F., 2012, P CLAS EL OPT CLEO 2; Xu B., 2014, LASER PHYS LETT, V11; Xu B., 2014, PHOTONICS TECHNOL LE, V26; Yamashita S., 2013, SPIE ACTIVE PHOTONIC, P25; Martinez A, 2013, WOODH PUB SER ELECT, P121, DOI 10.1533/9780857098627.2.121	81	8	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	DEC	2014	20	6					702	713		10.1016/j.yofte.2014.08.013		12	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	AT4SY	WOS:000344933400016		
J	Yokoyama, Y; Takada, K; Kageyama, T; Tanaka, S; Kondo, H; Kanbe, S; Maeda, Y; Mochida, R; Nishi, K; Yamamoto, T; Takemasa, K; Sugawara, M; Arakawa, Y				Yokoyama, Yoshitaka; Takada, Kan; Kageyama, Takeo; Tanaka, Shin; Kondo, Hayato; Kanbe, Satoshi; Maeda, Yasunari; Mochida, Reio; Nishi, Kenichi; Yamamoto, Tsuyoshi; Takemasa, Keizo; Sugawara, Mitsuru; Arakawa, Yasuhiko			1064-nm DFB laser diode modules applicable to seeder for pulse-on-demand fiber laser systems	OPTICAL FIBER TECHNOLOGY			English	Article						Semiconductor DFB laser; Pulse-on-demand; Fiber laser; Gain-switching	OSCILLATOR-POWER-AMPLIFIER; HIGH-REPETITION-RATE; HIGH AVERAGE POWER; PEAK-POWER; PS PULSES; NM; AMPLIFICATION; INJECTION; JITTER	Semiconductor DFB (Distributed feedback) laser diodes with an operating wavelength of 1064 nm, which is suitable for pulse-on-demand fiber laser, have been developed. The stable performance of CW and nanosecond/picosecond pulsed operation is reviewed. By applying gain-switching operation with a simple direct modulation technique, 50-ps pulse generation with a stable spectral single-mode property was obtained. For the efficient amplification of the obtained 50-ps pulse, a monolithic semiconductor optical amplifier (SOA) was integrated into the DFB lasers. An improved peak power of 300 mW at 50-ps pulse was observed with limited optical noise injection when the synchronous modulation technique of the DFB and the SOA was employed. Short cavity lasers showed a high-frequency response compared to the original DFB lasers and achieved a short pulse width of 13 ps by standard gain-switched operation. (C) 2014 Elsevier Inc. All rights reserved.	[Yokoyama, Yoshitaka; Takada, Kan; Kanbe, Satoshi; Yamamoto, Tsuyoshi; Takemasa, Keizo; Sugawara, Mitsuru] QD Laser Inc, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Yamamoto, Tsuyoshi] Fujitsu Labs Ltd, Atsugi, Kanagawa 2430197, Japan; [Kageyama, Takeo; Tanaka, Shin; Kondo, Hayato; Maeda, Yasunari; Mochida, Reio; Nishi, Kenichi; Takemasa, Keizo; Sugawara, Mitsuru; Arakawa, Yasuhiko] Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan; [Arakawa, Yasuhiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Yokoyama, Y (reprint author), QD Laser Inc, Kawasaki Ku, 1-1 Minamiwataridacho, Kawasaki, Kanagawa 2100855, Japan.	yokoyama@qdlaser.com		Kageyama, Takeo/0000-0003-4416-5360			Abrardi Laura, 2012, P SOC PHOTO-OPT INS, V8237; Schmidt O, 2007, OPT LETT, V32, P1551, DOI 10.1364/OL.32.001551; Ancona A, 2008, OPT EXPRESS, V16, P8958, DOI 10.1364/OE.16.008958; Di Teodoro F, 2013, OPT LETT, V38, P2162, DOI 10.1364/OL.38.002162; Carlson CG, 2009, IEEE J SEL TOP QUANT, V15, P451, DOI 10.1109/JSTQE.2009.2012403; LAU KY, 1988, APPL PHYS LETT, V52, P257, DOI 10.1063/1.99486; Roser F, 2007, OPT LETT, V32, P3495, DOI 10.1364/OL.32.003495; Wang JH, 2012, OPT EXPRESS, V20, P28373, DOI 10.1364/OE.20.028373; Gunning P, 1996, ELECTRON LETT, V32, P1010, DOI 10.1049/el:19960649; WEBER AG, 1992, IEEE J QUANTUM ELECT, V28, P441, DOI 10.1109/3.123271; Krehlik P, 2006, OPTO-ELECTRON REV, V14, P123; Deladurantaye P, 2011, PROC SPIE, V7914, DOI 10.1117/12.875265; Desbiens Louis, 2013, Review of Laser Engineering, V41; DiGiovanni DJ, 1999, OPT PHOTONICS NEWS, V10, P26; Dupriez P, 2006, IEEE PHOTONIC TECH L, V18, P1013, DOI 10.1109/LPT.2006.873486; Feng Y, 2004, JPN J APPL PHYS 2, V43, pL722, DOI 10.1143/JJAP.43.L722; Kageyama T., 2012, 17 INT C MOL BEAM EP; Kanzelmeyer S, 2011, OPT EXPRESS, V19, P1854, DOI 10.1364/OE.19.001854; McComb TS, 2014, PROC SPIE, V8961, DOI 10.1117/12.2037974; Pataca D.M., 1997, J MICROWAVES OPTOEL, V1, P47; Schwertfeger S, 2013, APPL OPTICS, V52, P3364, DOI 10.1364/AO.52.003364; Takada K., 2010, 10 3 GB S OPERATION; Tunnermann A, 2010, APPL OPTICS, V49, pF71, DOI 10.1364/AO.49.000F71; WICHT T, 1991, IEEE J QUANTUM ELECT, V27, P1682, DOI 10.1109/3.89993; Zhang YB, 2010, LASER PHYS, V20, P1580, DOI 10.1134/S1054660X10130207	25	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1068-5200	1095-9912		OPT FIBER TECHNOL	Opt. Fiber Technol.	DEC	2014	20	6					714	724		10.1016/j.yofte.2014.08.004		11	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	AT4SY	WOS:000344933400017		
J	Ebina, K; Hashimoto, J; Shi, K; Kashii, M; Hirao, M; Yoshikawa, H				Ebina, K.; Hashimoto, J.; Shi, K.; Kashii, M.; Hirao, M.; Yoshikawa, H.			Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients	OSTEOPOROSIS INTERNATIONAL			English	Article						Postmenopausal osteoporosis; Prednisolone; Rheumatoid arthritis; Teriparatide; Under-carboxylated osteocalcin	BONE-MINERAL DENSITY; PARATHYROID-HORMONE; CONTROLLED-TRIAL; FRACTURE RISK; DOUBLE-BLIND; WOMEN; TURNOVER; INCREASES; MARKERS	Patients with rheumatoid arthritis showed greater response to 18-month administration of daily teriparatide especially in the increase of bone formation markers at 1 month and femoral neck bone mineral density at 18 months compared to postmenopausal osteoporosis patients. The aim of this study was to evaluate the effects of 18-month administration of daily teriparatide (TPTD) in osteoporosis patients with rheumatoid arthritis (RA) by comparing that of postmenopausal osteoporosis patients (Porosis). The effects of TPTD were examined between RA (n = 70; age 68.4 years; disease activity score assessing 28 joints with CRP [DAS28-CRP] 2.8; rheumatoid factor [RF] positivity 75.5 %) with 77.1 % of prior bisphosphonate (BP), 84.3 % of oral prednisolone (PSL) (4.4 mg/day at baseline), 25.7 % of biologics, and Porosis (n = 62; age 71.3 years) with 77.4 % of prior BP. Femoral neck (FN) bone mineral density (BMD) increase at 18 months was significantly greater in RA compared to Porosis (4.7 vs. 0.7 %, P = 0.038), whereas it was 9.7 versus 7.9 % (P = 0.736) in the lumbar spine (LS). The increase of bone formation markers (bone alkaline phosphatase [bone ALP] and N-terminal type I procollagen propeptide [PINP]) at 1 month were all significantly greater in RA compared to Porosis. A multivariate logistic regression analysis revealed that the significant indicator of 18-month BMD increase in RA was a 3-month increase of under-carboxylated osteocalcin (ucOC) for LS (beta = 0.446, P = 0.005) and baseline ucOC for FN (beta = 0.554, P = 0.001), in which both showed significant negative correlation with baseline PSL dose. RA showed greater response to daily TPTD administration, especially in the increase of bone formation markers at 1 month and FN BMD increase at 18 months compared to Porosis.	[Ebina, K.; Shi, K.; Kashii, M.; Hirao, M.; Yoshikawa, H.] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; [Hashimoto, J.] Natl Hosp Org, Osaka Minami Med Ctr, Dept Rheumatol, Kawachi Nagano, Osaka 5868521, Japan	Ebina, K (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	k-ebina@umin.ac.jp			Japan Osteoporosis Foundation	This work was supported by grants from the Japan Osteoporosis Foundation. The funding organization had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen PQ, 2005, J BONE MINER RES, V20, P962, DOI 10.1359/JBMR.050105; Guler-Yuksel M, 2009, ANN RHEUM DIS, V68, P330, DOI 10.1136/ard.2007.086348; Drake MT, 2010, J CLIN ENDOCR METAB, V95, P5056, DOI 10.1210/jc.2010-0720; Garnero P, 2010, ARTHRITIS RHEUM-US, V62, P33, DOI 10.1002/art.25053; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; PEEL NFA, 1995, ANN RHEUM DIS, V54, P801, DOI 10.1136/ard.54.10.801; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; van Staa TP, 2000, RHEUMATOLOGY, V39, P1383, DOI 10.1093/rheumatology/39.12.1383; Wright NC, 2011, J RHEUMATOL, V38, P1680, DOI 10.3899/jrheum.101196; Gifre L, 2013, BONE, V57, P272, DOI 10.1016/j.bone.2013.08.016; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Cosman F, 2009, J CLIN ENDOCR METAB, V94, P3772, DOI 10.1210/jc.2008-2719; Burshell AL, 2010, BONE, V46, P935, DOI 10.1016/j.bone.2009.12.032; Binkley N, 2009, J BONE MINER RES, V24, P983, DOI [10.1359/jbmr.081254, 10.1359/JBMR.081254]; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; van Staa TP, 2006, ARTHRITIS RHEUM, V54, P3104, DOI 10.1002/art.22117; Lange U, 2005, RHEUMATOLOGY, V44, P1546, DOI 10.1093/rheumatology/kei082; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Boonen S, 2008, J CLIN ENDOCR METAB, V93, P852, DOI 10.1210/jc.2007-0711; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Braun T, 2012, CURR OSTEOPOROS REP, V10, P101, DOI 10.1007/s11914-012-0104-5; Cortet B, 2000, CLIN EXP RHEUMATOL, V18, P683; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Guler-Yuksel M, 2007, ANN RHEUM DIS, V66, P1508, DOI 10.1136/ard.2007.070839; Mokuda S, 2011, J ENDOCRINOLOGICAL I, V35, P661; Terpos E, 2011, CLIN EXP RHEUMATOL, V29, P921; Tsujimoto M, 2011, BONE, V48, P798, DOI 10.1016/j.bone.2010.12.006	31	3	3	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	DEC	2014	25	12					2755	2765		10.1007/s00198-014-2819-x		11	Endocrinology & Metabolism	Endocrinology & Metabolism	AT3BM	WOS:000344810100008		
J	Behr, R; Colletti, V; Matthies, C; Morita, A; Nakatomi, H; Dominique, L; Darrouzet, V; Brill, S; Shehata-Dieler, W; Lorens, A; Skarzynski, H				Behr, Robert; Colletti, Vittorio; Matthies, Cordula; Morita, Akio; Nakatomi, Hirofumi; Dominique, Liguoro; Darrouzet, Vincent; Brill, Stefan; Shehata-Dieler, W.; Lorens, Artur; Skarzynski, Henryk			New Outcomes With Auditory Brainstem Implants in NF2 Patients	OTOLOGY & NEUROTOLOGY			English	Article						Auditory brainstem implant; NF2; Speech recognition; Vestibular schwannoma	COCHLEAR NUCLEUS; NEUROFIBROMATOSIS TYPE-2; ELECTRICAL-STIMULATION; SPEECH-PERCEPTION; SITTING POSITION; HEARING; PERFORMANCE	Objective: To determine factors related to high levels of speech recognition in patients with the auditory brainstem implant (ABI). Study Design: Retrospective case review. Setting: International multicenter data from hospitals and tertiary referral facilities. Patients: Patients with neurofibromatosis type 2 (NF2) and bilateral vestibular schwannomas. Intervention: ABIs were placed after the removal of vestibular schwannomas. Main Outcome Measures: Demographic and surgical data were collected from 26 patients with ABIs who achieved scores of better than 30% correct identification of sentences presented in quiet listening conditions and without lipreading cues. Results: Scores better than 30% speech recognition of standard sentence test materials (HINT or equivalent) in quiet listening conditions were obtained in 26 of the 84 NF2 patients (31%). ABI speech recognition was correlated with surgical position, length of deafness, the number of distinct pitch electrodes, perceptual levels, and ABI stimulation rate, but not correlated with tumor size, tumor stage, the number of electrodes used, or electrophysiological recordings. This paper presents the consensus opinion from a meeting of surgeons to compare outcomes across ABI surgical centers. Conclusions: The consensus opinion was that brainstem trauma is a primary factor in the variability of outcomes in NF2 patients. The significant co-factors in outcomes implied that ABI surgery should be accomplished with great care to minimize physical and venous trauma to the brainstem. It is clear that high levels of speech recognition, including high levels of open-set speech recognition, are possible with the ABI even in patients with NF2 and large tumors.	[Behr, Robert] Univ Marburg, Klinikum Fulda gAG, Acad Hosp, Fulda, Germany; [Colletti, Vittorio] Univ Verona, I-37100 Verona, Italy; [Matthies, Cordula; Brill, Stefan; Shehata-Dieler, W.] Univ Wurzburg, D-97070 Wurzburg, Germany; [Morita, Akio] NTT Med Ctr Tokyo, Tokyo, Japan; [Nakatomi, Hirofumi] Univ Tokyo, Tokyo, Japan; [Dominique, Liguoro; Darrouzet, Vincent] Univ Bordeaux, Bordeaux, France; [Lorens, Artur; Skarzynski, Henryk] Inst Physiol & Pathol Hearing, Warsaw, Poland	Behr, R (reprint author), Klinikum Fulda gAG, Neurochirurg Klin, Pacelliallee 4, D-36043 Fulda, Germany.	r.behr.neurochir@klinikum-fulda.de					EDGERTON BJ, 1982, ANN OTO RHINOL LARYN, V91, P117; Koos WT, 1998, J NEUROSURG, V88, P506, DOI 10.3171/jns.1998.88.3.0506; Behr R, 2007, SKULL BASE-INTERD AP, V17, P91, DOI 10.1055/s-2006-950390; O'Driscoll M, 2011, EAR HEARING, V32, P300, DOI 10.1097/AUD.0b013e3181fc9f17; Matthies C, 2014, J NEUROSURG, V120, P546, DOI 10.3171/2013.9.JNS12686; BRACKMANN DE, 1993, OTOLARYNG HEAD NECK, V108, P624; Nevison B, 2002, EAR HEARING, V23, P170, DOI 10.1097/00003446-200206000-00002; Colletti V, 2009, OTOL NEUROTOL, V30, P614, DOI 10.1097/MAO.0b013e3181a864f2; Colletti V, 2005, LARYNGOSCOPE, V115, P1974, DOI 10.1097/01.mlg.0000178327.42926.ec; Lenarz T, 2001, OTOL NEUROTOL, V22, P823, DOI 10.1097/00129492-200111000-00019; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Otto SR, 2002, J NEUROSURG, V96, P1063, DOI 10.3171/jns.2002.96.6.1063; Colletti V, 1998, AUDIOLOGY, V37, P27; Colletti Vittorio, 2006, Adv Otorhinolaryngol, V64, P167; HITSELBERGER WE, 1984, OTOLARYNG HEAD NECK, V92, P52; Laszig R, 1997, AM J OTOL, V18, P160; Matthies C, 2000, J LARYNGOL OTOL, V114, P32; O'Driscoll M, 2011, EAR HEARING, V32, P286, DOI 10.1097/AUD.0b013e3181fc9d72; OTTO SR, 1990, ANN OTO RHINOL LARYN, V99, P789; Porter JM, 1999, BRIT J ANAESTH, V82, P117; Shannon RV, 1993, OTOLARYNGOL HEAD NEC, V108, P635; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; Shannon RV, 1997, IEEE T REHABIL ENG, V5, P1; Skarzynski H, 2009, MED SCI MONITOR, V15, pCS100; Skarzynski H, 2000, J LARYNGOL OTOL, V114, P44; Waring M D, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P33; Waring MD, 1996, EVOKED POTENTIAL, V100, P538, DOI 10.1016/S0921-884X(96)96061-0; Wong AYC, 2005, ANAESTHESIA, V60, P811, DOI 10.1111/j.1365-2044.2005.04237.x	28	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	DEC	2014	35	10					1844	1851				8	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AT8AX	WOS:000345157200042		
J	Kitahara, T; Horii, A; Imai, T; Ohta, Y; Morihana, T; Inohara, H; Sakagami, M				Kitahara, Tadashi; Horii, Arata; Imai, Takao; Ohta, Yumi; Morihana, Tetsuo; Inohara, Hidenori; Sakagami, Masafumi			Effects of Endolymphatic Sac Decompression Surgery on Vertigo and Hearing in Patients With Bilateral Meniere's Disease	OTOLOGY & NEUROTOLOGY			English	Article						Bilateral Meniere's disease; Endolymphatic sac drainage; Local steroid treatment; Surgical effects	PSYCHOLOGICAL CONDITION; VEIN DECOMPRESSION; MANAGEMENT; STEROIDS; DRAINAGE; SHUNT	Objective: The aim of the present study, which involved a 2-year observation period and a nonsurgical control group, was to determine whether endolymphatic sac decompression surgery (ESDS) has the potential to prevent the progression of vertigo and hearing loss in patients with intractable bilateral Meniere's disease (MD). Study Design: Prospective case-control study. Setting: Tertiary referral center. Methods: Between 1996 and 2008, we subjected 67 patients with intractable bilateral MD to ESDS and local corticosteroid treatment. Another 34 patients with intractable bilateral MD who declined ESDS were treated with the best available medical therapies. All of the patients underwent regular follow-up examinations for at least 2 years. Results: Vertigo was resolved in 22 of 34 patients in the non-ESDS group and 60 of 67 patients in the ESDS group (p = 0.055, Fisher's exact test). Of the 24 patients in the non-ESDS group and 55 patients in the ESDS group in whom the ipsilateral ear (the treated ear) exhibited worse hearing function than the contralateral ear, the hearing level of the former ear was preserved in 13 and 52 patients, respectively (p = 0.007, Fisher's exact test). Of the 10 patients in the nonsurgical group and 12 patients in the surgical group in whom the ipsilateral ear exhibited better hearing function than the contralateral ear, the hearing level of the former ear was preserved in 2 and 11 patients, respectively (p = 0.035, Fisher's exact test). Conclusion: The present findings suggest that ESDS combined with local corticosteroid treatment can control progressive hearing loss in both ears in patients with bilateral MD at least during the first 2 postoperative years.	[Kitahara, Tadashi; Horii, Arata; Imai, Takao; Ohta, Yumi; Morihana, Tetsuo; Inohara, Hidenori; Sakagami, Masafumi] Osaka Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, Suita, Osaka 5650871, Japan	Kitahara, T (reprint author), Osaka Univ, Grad Sch Med, Dept Otolaryngol & Head & Neck Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	tkitahara@ent.med.osaka-u.ac.jp			Health Science Research Grant for Specific Disease from Japan's Ministry of Health, Labour and Welfare	This study was supported in part by a Health Science Research Grant for Specific Disease from Japan's Ministry of Health, Labour and Welfare (2011-2013).	STAHLE J, 1978, ARCH OTOLARYNGOL, V104, P99; Sakagsami M, 2006, J LARYNGOL OTOL, V120, P972, DOI 10.1017/S0022215106002556; Sajjadi H, 2008, LANCET, V372, P406, DOI 10.1016/S0140-6736(08)61161-7; Ostrowski VB, 2003, OTOLARYNG HEAD NECK, V128, P550, DOI 10.1016/mhn.2003.113; Kitahara T, 2008, LARYNGOSCOPE, V118, P854, DOI 10.1097/MLG.0b013e3181651c4a; Kitahara T, 2013, AURIS NASUS LARYNX, V40, P425, DOI 10.1016/j.anl.2012.11.008; Claes J, 2000, ACTA OTO-LARYNGOL, P34; Committee on Hearing and Equilibrium, 1995, OTOLARYNGOL HEAD NEC, V113, P181; Furukawa M, 2013, ACTA OTO-LARYNGOL, V133, P584, DOI 10.3109/00016489.2012.759274; Gianoli GJ, 1998, OTOLARYNG HEAD NECK, V118, P22, DOI 10.1016/S0194-5998(98)70370-5; Gibson WPR, 1996, J LARYNGOL OTOL, V110, P1008; Havia M, 2004, ARCH OTOLARYNGOL, V130, P431, DOI 10.1001/archotol.130.4.431; Hio S, 2013, ACTA OTO-LARYNGOL, V133, P42, DOI 10.3109/00016489.2012.709322; HUANG TS, 1994, ANN OTO RHINOL LARYN, V103, P389; KITAHARA M, 1991, ACTA OTO-LARYNGOL, P74; MOFFAT DA, 1994, CLIN OTOLARYNGOL, V19, P261, DOI 10.1111/j.1365-2273.1994.tb01228.x; NAGUIB MB, 1994, SKULL BASE SURG, V4, P32, DOI 10.1055/s-2008-1058986; PAPARELLA MM, 1984, ACTA OTO-LARYNGOL, V97, P233, DOI 10.3109/00016488409130984; Stahle J, 1991, Acta Otolaryngol Suppl, V485, P78; THOMSEN J, 1981, ARCH OTOLARYNGOL, V107, P271; WATANABE I, 1980, ORL J OTO-RHINO-LARY, V42, P20; Welling DB, 2000, OTOLARYNG HEAD NECK, V122, P340, DOI 10.1016/S0194-5998(00)70044-1	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	DEC	2014	35	10					1852	1857				6	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AT8AX	WOS:000345157200043		
J	Fujimoto, C; Kamogashira, T; Kinoshita, M; Egami, N; Sugasawa, K; Demura, S; Yamasoba, T; Iwasaki, S				Fujimoto, Chisato; Kamogashira, Teru; Kinoshita, Makoto; Egami, Naoya; Sugasawa, Keiko; Demura, Shinichi; Yamasoba, Tatsuya; Iwasaki, Shinichi			Power Spectral Analysis of Postural Sway During Foam Posturography in Patients With Peripheral Vestibular Dysfunction	OTOLOGY & NEUROTOLOGY			English	Article						Posture; Vestibular diseases; Vestibule	IDIOPATHIC BILATERAL VESTIBULOPATHY; EVOKED MYOGENIC POTENTIALS; BODY SWAY; STANCE; INSTABILITY; SUPPORT; LESIONS	Objective: To assess the frequency-domain characteristics of postural instability caused by peripheral vestibular dysfunction by performing a power spectral analysis of the center of pressure (COP) sway during foam posturography. Methods: Data were obtained from 78 patients and 163 controls. Two-legged stance tasks were performed in 4 conditions: eyes open with and without foam rubber, and eyes closed with and without foam rubber. We estimated the power spectrum of the acceleration signal using the maximum entropy method. The areas under the curve (AUCs) of power spectral density of the COP were calculated across low-frequency (0.02 to 0.1 Hz, LF-AUC), middle-frequency (0.1 to 1Hz, MF-AUC), and high-frequency (1 to 10 Hz, HF-AUC) ranges. We performed binomial logistic regression analyses to see whether the AUCs of selected bandwidths of COP have a stronger association with the presence of peripheral vestibular dysfunction in comparison with the velocity and area in the eyes closed/foam rubber condition. Results: In both the controls and patients, the MF-AUC was significantly larger than the LF-AUC or HF-AUC in the eyes closed/foam rubber condition. In this condition, the presence of peripheral vestibular dysfunction had a significantly positive relationship with MF-AUC and HF-AUC (p < 0.05) and the MF-AUC of the anteriorposterior axis showed a stronger association with the presence of peripheral vestibular dysfunction than area. Conclusion: An increase in activity at middle frequency movements could be characteristic of peripheral vestibular dysfunction when standing on foam rubber with the eyes closed.	[Fujimoto, Chisato; Kamogashira, Teru; Kinoshita, Makoto; Egami, Naoya; Sugasawa, Keiko; Yamasoba, Tatsuya; Iwasaki, Shinichi] Univ Tokyo, Dept Otolaryngol, Fac Med, Tokyo 113, Japan; [Demura, Shinichi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Fujimoto, C (reprint author), Univ Tokyo, Dept Otolaryngol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	cfujimoto-tky@umin.ac.jp					Fujimoto C, 2013, ACTA OTO-LARYNGOL, V133, P454, DOI 10.3109/00016489.2012.742565; MORI S, 1973, J NEUROPHYSIOL, V36, P458; NASHNER LM, 1982, J NEUROSCI, V2, P536; MAURITZ KH, 1980, EXP BRAIN RES, V38, P117; Schmal F, 2005, J VESTIBUL RES-EQUIL, V15, P215; Fujimoto C, 2009, J NEUROL, V256, P1488, DOI 10.1007/s00415-009-5147-x; Iwasaki S, 2005, ARCH OTOLARYNGOL, V131, P857, DOI 10.1001/archotol.131.10.857; Fujimoto C, 2009, CLIN NEUROPHYSIOL, V120, P1408, DOI 10.1016/j.clinph.2009.05.002; Horak FB, 2001, J NEUROPHYSIOL, V86, P575; Fujimoto C, 2012, OTOL NEUROTOL, V33, P432, DOI 10.1097/MAO.0b013e3182487f48; BLACK FO, 1983, ACTA OTO-LARYNGOL, V95, P199, DOI 10.3109/00016488309130936; Chiang JH, 1997, GAIT POSTURE, V5, P239, DOI 10.1016/S0966-6362(96)01091-0; Fujimoto C, 2010, CLIN NEUROPHYSIOL, V121, P1279, DOI 10.1016/j.clinph.2010.02.149; MAURITZ KH, 1979, BRAIN, V102, P461, DOI 10.1093/brain/102.3.461; Baloh RW, 1998, ARCH NEUROL-CHICAGO, V55, P649, DOI 10.1001/archneur.55.5.649; Davison A., 1997, BOOTSTRAP METHODS TH; DIENER HC, 1982, EXP BRAIN RES, V45, P126; Efron B., 1994, INTRO BOOTSTRAP; ENBOM H, 1991, ANN OTO RHINOL LARYN, V100, P472; FREUND HJ, 1983, PHYSIOL REV, V63, P387; FURMAN JM, 1995, OTOLARYNG HEAD NECK, V112, P8, DOI 10.1016/S0194-5998(95)70300-4; KAPTEYN TS, 1972, ACTA OTO-LARYNGOL, V73, P104, DOI 10.3109/00016487209138918; KAY SM, 1981, P IEEE, V69, P1380, DOI 10.1109/PROC.1981.12184; Massion J., 2004, CLIN DISORDERS BALAN, P1; Nakagawa H, 1993, Acta Otolaryngol Suppl, V504, P112; NASHNER LM, 1971, ACTA OTO-LARYNGOL, V72, P429, DOI 10.3109/00016487109122504; Patel M, 2008, GAIT POSTURE, V28, P649, DOI 10.1016/j.gaitpost.2008.04.018; Pepe M., 2004, STAT EVALUATION MED; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; YONEDA S, 1986, ACTA OTO-LARYNGOL, V102, P87, DOI 10.3109/00016488609108650	30	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	DEC	2014	35	10					E317	E323				7	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	AT8AX	WOS:000345157200010		
J	Gong, HY; Qin, SQ; Wan, XH; Zhang, HS; Zhou, YZ; Cao, J; Xuan, XN; Suzuki, H; Zhou, JL				Gong, Haiyan; Qin, Shunqing; Wan, Xiuhong; Zhang, Houshuang; Zhou, Yongzhi; Cao, Jie; Xuan, Xuenan; Suzuki, Hiroshi; Zhou, Jinlin			Immunoglobulin G binding protein (IGBP) from Rhipicephalus haemaphysaloides: identification, expression, and binding specificity	PARASITOLOGY RESEARCH			English	Article						Immunoglobulin G binding protein (IGBP); Rhipicephalus haemaphysaloides; Binding specificity	TICK-BORNE DISEASES; SALIVARY-GLANDS; VACCINE; CATTLE; INFESTATIONS; APPENDICULATUS; LONGICORNIS; PERFORMANCE	As the second most important human ectoparasite, ranked only after mosquitoes, the tick threatens the development of husbandry and even the health of humans worldwide. Immunoglobulin G binding proteins (IGBPs) are considered to be the major factors used by ticks to evade the host immune system and the damage caused by host antibodies. In this study, an IGBP-MB homologue was identified in the tick Rhipicephalus haemaphysaloides, which was predominantly detected in the salivary glands and hemolymph of male ticks. Recombinant IGBP (rIGBP/His) displayed significant binding activity to IgGs from rabbits and pigs, and bound to the F(ab)'2 but not the Fc fragment of rabbit IgG. Although the silencing of IGBP expression in ticks had no obvious effect on their blood-feeding and subsequent oviposition, antibodies raised to rIGBP/GST reduced the replete body weight (218.9 +/- 20 mg in the control group vs. 142.5 +/- 43.3 mg in the test group, P<0.05 by Student's ttest) and increased the mortality of the ticks. This study extends our understanding of the immunoevasive function of IGBPs and is a step towards the development of a vaccine against ticks.	[Gong, Haiyan; Qin, Shunqing; Wan, Xiuhong; Zhang, Houshuang; Zhou, Yongzhi; Cao, Jie; Zhou, Jinlin] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Minist Agr, Key Lab Anim Parasitol, Shanghai 200241, Peoples R China; [Xuan, Xuenan; Suzuki, Hiroshi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Zhou, Jinlin] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Peoples R China	Zhou, JL (reprint author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Minist Agr, Key Lab Anim Parasitol, Shanghai 200241, Peoples R China.	jinlinzhou@hotmail.com			National Natural Science Foundation of China [31172095, 31311140167]	This work was supported by grants (No. 31172095 and 31311140167) from the National Natural Science Foundation of China.	Zhou JL, 2006, GENE, V372, P191, DOI 10.1016/j.gene.2005.12.020; Mulenga A, 1999, INFECT IMMUN, V67, P1652; de la Fuente Jose, 2007, Animal Health Research Reviews, V8, P23; Zhou JL, 2006, PARASITOL RES, V100, P77, DOI 10.1007/s00436-006-0243-7; Wang H, 1998, NATURE, V391, P753, DOI 10.1038/35773; Singh SK, 2003, CURR SCI INDIA, V85, P1284; Nuttall PA, 2006, PARASITE IMMUNOL, V28, P155, DOI 10.1111/j.1365-3024.2006.00806.x; George JE, 2004, PARASITOLOGY, V129, pS353, DOI 10.1017/S0031182003004682; Tavassoli M, 2012, PARASITOL RES, V111, P1779, DOI 10.1007/s00436-012-3023-6; Fragoso H, 1998, VACCINE, V16, P1990, DOI 10.1016/S0264-410X(98)00116-9; Carvalho WA, 2011, IMMUNOGENETICS, V63, P319, DOI 10.1007/s00251-011-0515-y; Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119; Gong HY, 2008, VET PARASITOL, V151, P268, DOI 10.1016/j.vetpar.2007.11.015; Rechav Y, 2000, EXP APPL ACAROL, V24, P569, DOI 10.1023/A:1026531926109; Rodriguez-Valle M, 2012, VACCINE, V30, P3453, DOI 10.1016/j.vaccine.2012.03.020; Sonenshine D.E., 1993, BIOL TICKS, V2; Wang H, 2013, US Pat, Patent No. [8:343,504, 8343504]; WANG H, 1995, PARASITE IMMUNOL, V17, P517, DOI 10.1111/j.1365-3024.1995.tb00882.x; Wang H, 2007, WO Patent, Patent No. [2,007,051,975, 2007051975]; WANG H, 1994, PARASITOLOGY, V109, P525; Wang H, 1999, CELL MOL LIFE SCI, V56, P286, DOI 10.1007/s000180050430; WANG H, 1995, PARASITOLOGY, V111, P161; Willadsen P, 2004, PARASITOLOGY, V129, pS367, DOI 10.1017/S0031182003004657; Xiang FY, 2009, AGR SCI CHINA, V8, P121, DOI 10.1016/S1671-2927(09)60017-1	24	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	DEC	2014	113	12					4387	4395		10.1007/s00436-014-4115-2		9	Parasitology	Parasitology	AT3XB	WOS:000344866500009		
J	Onishi, I; Nakagawa, Y; Murayama, T; Hidaka, M; Yamamoto, K; Abe-Suzuki, S; Abe, S; Kurata, M; Kitagawa, M				Onishi, Iichiroh; Nakagawa, Yasunori; Murayama, Toshihiko; Hidaka, Michihiro; Yamamoto, Kouhei; Abe-Suzuki, Shiho; Abe, Shinya; Kurata, Morito; Kitagawa, Masanobu			l Expression of multidrug resistance 1 gene in association with CXCL12 in chronic myelogenous leukaemia	PATHOLOGY			English	Article						ATP-binding cassette transporters; chronic myelogenous leukaemia; CXCL12; K562; MDR1	CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; IMATINIB MESYLATE; P-GLYCOPROTEIN; MDR1; INHIBITION; ACTIVATION; APOPTOSIS; EFFLUX; NICHES	Even though the BCR-ABL tyrosine kinase inhibitor imatinib significantly improves the prognosis of chronic myelogenous leukaemia (CML) patients, drug resistance is a major obstacle to better management. We examined the interaction of recently defined bone marrow microenvironment factors CXCL12 and ATP-binding cassette (ABC) transporters in the bone marrow of CML patients in the chronic phase and blast crisis. Expression levels of mRNA extracted from frozen specimens of CML patients were measured by real-time polymerase chain reaction. The expression of the ABC transporters MDR1, ABCC1, ABCG2, and CXCL12 was significantly higher in the bone marrow samples of CML blast crisis than in those of CML chronic phase. Immunohistochemical staining for CXCL12 revealed that the proportion of CXCL12 positive reticular cell areas correlated well with the mRNA levels of CXCL12 in CML bone marrow. Finally, co-culture experiments of K562 CML cells with CXCL12 expressing mesenchymal cells (OP9 cells or human CXCL12 transfected 3T3 cells) revealed enhanced mRNA levels for MDR1 in a CXCL12 rich environment. These results suggest that imatinib treatment restores the bone marrow microenvironment in CML with the presence of CXCL12 expressing reticular cells but in turn induces the overexpression of MDR1 in haematopoietic cells due to up-regulated expression of CXCL12.	[Onishi, Iichiroh; Yamamoto, Kouhei; Abe-Suzuki, Shiho; Abe, Shinya; Kurata, Morito; Kitagawa, Masanobu] Tokyo Med & Dent Univ, Dept Comprehens Pathol, Grad Sch Med & Dent Sci, Tokyo 1138519, Japan; [Nakagawa, Yasunori] Japan Red Cross Med Ctr, Dept Internal Med, Tokyo, Japan; [Murayama, Toshihiko] Natl Hosp Org Kumamoto, Med Ctr, Dept Pathol, Kumamoto, Japan; [Hidaka, Michihiro] Natl Hosp Org Kumamoto, Med Ctr, Dept Internal Med, Kumamoto, Japan	Kurata, M (reprint author), Tokyo Med & Dent Univ, Dept Comprehens Pathol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	kurata.pth2@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors state that there are no conflicts of interest to disclose.	Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; SATO H, 1990, LEUKEMIA RES, V14, P11, DOI 10.1016/0145-2126(90)90141-U; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Yagi K, 2013, HISTOPATHOLOGY, V62, P414, DOI 10.1111/his.12035; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Jin LH, 2008, MOL CANCER THER, V7, P48, DOI 10.1158/1535-7163.MCT-07-0042; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cashman J, 2002, BLOOD, V99, P792, DOI 10.1182/blood.V99.3.792; Damiano JS, 2001, LEUKEMIA, V15, P1232, DOI 10.1038/sj.leu.2402179; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Avecilla ST, 2004, NAT MED, V10, P4; Giles FJ, 1999, CANCER, V86, P805, DOI 10.1002/(SICI)1097-0142(19990901)86:5<805::AID-CNCR16>3.0.CO;2-E; Holtz M, 2007, CANCER RES, V67, P1113, DOI 10.1158/0008-5472.CAN-06-2014; Kurata M, 2006, EXP MOL PATHOL, V81, P249, DOI 10.1016/j.yexmp.2006.01.004; Kurata M, 2013, WORLD J HEMATOL, V2, P1; Mendez-Ferrer S, 2010, NATURE, V66, P29; Mowafi F, 2008, PEDIATR BLOOD CANCER, V50, P812, DOI 10.1002/pbc.21370; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Swerdlow SH, 2008, WHO CLASSIFICATION T, P32; Yamada O, 2011, CELL SIGNAL, V23, P1119, DOI 10.1016/j.cellsig.2011.02.005	25	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0031-3025	1465-3931		PATHOLOGY	Pathology	DEC	2014	46	7					623	629		10.1097/PAT.0000000000000180		7	Pathology	Pathology	AT9NO	WOS:000345254100008		
J	Tamiya, J; Ide, R; Takahashi, M; Saiki, C				Tamiya, Junko; Ide, Ryoji; Takahashi, Masayuki; Saiki, Chikako			Effects of dexmedetomidine on cardiorespiratory regulation in spontaneously breathing newborn rats	PEDIATRIC ANESTHESIA			English	Article						alpha(2)-adrenoceptor; atipamezole; breathing pattern; dexmedetomidine; heart rate; immature	RESPIRATORY RHYTHM GENERATOR; VENTILATORY RESPONSES; CHILDREN; MEDETOMIDINE; ATIPAMEZOLE; MODULATION; ANESTHESIA; ISOFLURANE; MIDAZOLAM; SEDATION	Background Dexmedetomidine, a selective alpha(2)-adrenoceptor agonist, is a new sedative agent. Objective To examine the dexmedetomidine-associated changes in cardiorespiratory indices in spontaneously breathing newborn rats. Methods An abdominal catheter to administer drugs and subcutaneous electrodes to record electrocardiographic data were inserted into 2- to 4-day-old rats under isoflurane anesthesia; the rats were then placed in individual chambers. After recovery from the anesthesia, the rats received intraperi-toneal administrations of normal saline (NS, vehicle), dexmedetomidine (50 mu g center dot kg(-1)), or dexmedetomidine (50 mu g center dot kg(-1)) followed 5min later with NS or the selective (2)-adrenoceptor antagonist atipamezole (1mg center dot kg(-1)) (n=10 in each group). Cardiorespiratory indices were recorded for each animal throughout the experiment. Results Dexmedetomidine administration significantly decreased heart rate (HR) and minute ventilation (V-E) (P<0.05) compared with control, whereas NS administration did not. The decrease in HR and V-E after dexmedetomidine administration was significantly less in rats that received atipamezole (P<0.05) than in those that received NS after dexmedetomidine administration. The dexmedetomidine-associated V-E depression was attributed to a significant decrease in respiratory frequency (f(R)) but not tidal volume (V-T). The change in f(R) was reversed by atipamezole administration, which itself induced no significant changes in HR and f(R). Conclusion In spontaneously breathing immature rats, dexmedetomidine administration significantly reduced HR and V-E. Because atipamezole fully reversed decreases in f(R) and therefore V-E, dexmedetomidine-related respiratory suppression occurs predominantly through (2)-adrenoceptor-related suppression of f(R).	[Tamiya, Junko; Ide, Ryoji; Takahashi, Masayuki; Saiki, Chikako] Nippon Dent Univ Tokyo, Dept Physiol, Sch Life Dent Tokyo, Chiyoda Ku, Tokyo 1028159, Japan	Tamiya, J (reprint author), Nippon Dent Univ Tokyo, Dept Physiol, Sch Life Dent Tokyo, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1028159, Japan.	tamiya-j@tky.ndu.ac.jp					Akada S, 2008, ANESTH ANALG, V107, P167, DOI 10.1213/ane.0b013e3181732dc2; Almaraz L, 1997, AM J PHYSIOL-CELL PH, V272, pC628; Mason KP, 2011, ANESTH ANALG, V113, P1129, DOI 10.1213/ANE.0b013e31822b8629; SAETTA M, 1985, J APPL PHYSIOL, V58, P1988; Gerlach AT, 2009, ANN PHARMACOTHER, V43, P2064, DOI 10.1345/aph.1M310; Granholm M, 2006, VET ANAESTH ANALG, V33, P214, DOI 10.1111/j.1467-2995.2005.00259.x; Candiotti KA, 2010, ANESTH ANALG, V110, P47, DOI 10.1213/ane.0b013e3181ae0856; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Sharp DB, 2014, BRAIN RES, V1574, P1, DOI 10.1016/j.brainres.2014.06.010; Kaczynska K, 2006, EXP PHYSIOL, V91, P269, DOI 10.1113/expphysiol.2005.031914; Lubisch N, 2009, PEDIATR NEUROL, V41, P88, DOI 10.1016/j.pediatrneurol.2009.02.006; Murrell JC, 2005, VET ANAESTH ANALG, V32, P117, DOI 10.1111/j.1467-2995.2005.00233.x; Barton KP, 2008, PEDIATR CRIT CARE ME, V9, P612, DOI 10.1097/PCC.0b013e31818d320d; Chang C, 2009, ANESTH ANALG, V109, P84, DOI 10.1213/ane.0b013e3181a2ad5f; Fernandes FC, 2006, RESP PHYSIOL NEUROBI, V154, P342, DOI 10.1016/j.resp.2006.02.002; Filbey WA, 2014, SLEEP, V37, P871, DOI 10.5665/sleep.3650; Hayward LF, 2001, AM J PHYSIOL-REG I, V281, pR1464; Hilaire G, 2004, RESP PHYSIOL NEUROBI, V143, P187, DOI 10.1016/j.resp.2004.04.016; Koroglu A, 2005, BRIT J ANAESTH, V94, P821, DOI 10.1093/bja/aei119; MATSUOKA T, 1994, J APPL PHYSIOL, V77, P1067; NGUYEN D, 1992, ANESTHESIOLOGY, V76, P573, DOI 10.1097/00000542-199204000-00014; Nishida T, 2002, INTENS CARE MED, V28, P969, DOI 10.1007/s00134-002-1338-y; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Saiki C, 1996, J PHYSIOL-LONDON, V491, P261; Tachibana K, 2012, PEDIATR ANESTH, V22, P713, DOI 10.1111/j.1460-9592.2012.03810.x; Voituron N, 2012, RESP PHYSIOL NEUROBI, V180, P132, DOI 10.1016/j.resp.2011.11.003; ZORNOW MH, 1991, NEUROPHARMACOLOGY, V30, P1065, DOI 10.1016/0028-3908(91)90135-X	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645	1460-9592		PEDIATR ANESTH	Pediatr. Anesth.	DEC	2014	24	12					1245	1251		10.1111/pan.12530		7	Anesthesiology; Pediatrics	Anesthesiology; Pediatrics	AT7YX	WOS:000345151700008		
J	Nagasawa, H; Kohno, Y; Yamamoto, Y; Kondo, M; Sugawara, M; Koyama, T; Terazawa, D; Miura, R				Nagasawa, Hiroyuki; Kohno, Yoshinori; Yamamoto, Yutaka; Kondo, Masashi; Sugawara, Masami; Koyama, Toshinari; Terazawa, Daisuke; Miura, Ryosuke			Methodologic Comparison of Left Ventricular Stroke Volumes in the Early Neonatal Period by Echocardiography	PEDIATRIC CARDIOLOGY			English	Article						Left ventricle; End-diastolic volume; End-systolic volume; Stroke volume; Normal neonate; Three-dimensional echocardiography; Comparison	RECOMMENDATIONS; CHILDREN; INFANTS	Several methods for evaluating left ventricular stroke volume (SV) in neonates using echocardiography have been reported. However, no studies on methodologic comparison of SV with three-dimensional (3D) echocardiography are available. This is the first detailed report on a methodologic comparison of SV in the early neonatal period. The study group included 70 normal neonates (35 boys and 35 girls). An iE33 echocardiograph and Q-LAB supplied by Philips Electronics were used to examine and calculate volumes. Comparisons of SV were performed using Teichholz (T), the velocity time integral (VTI), Pombo (P), modified Simpson (MS), and 3D methods with normal neonates who had no persistent ductus arteriosus less than 7 days after birth. The mean SVs were 33.7 mL/m(2) (T), 30.6 mL/m(2) (VTI), 22.0 mL/m(2) (P), 17.5 mL/m(2) (3D), and 14.9 mL/m(2) (MS) using Haycock's formula of body surface area. The stroke volumes differed significantly depending on the different methods. The correlation coefficient was highest between the MS and 3D methods. The SVs of the T and VTI methods were significantly greater than those previously reported, and it seemed inappropriate to evaluate volumes in neonates. The 3D and MS methods were appropriate for measuring SV in neonates during the early neonatal period.	[Nagasawa, Hiroyuki; Kohno, Yoshinori; Yamamoto, Yutaka; Kondo, Masashi; Sugawara, Masami; Koyama, Toshinari; Terazawa, Daisuke; Miura, Ryosuke] Gifu Prefectural Gen Med Ctr, Dept Neonatol, Gifu 5008717, Japan	Nagasawa, H (reprint author), Gifu Prefectural Gen Med Ctr, Dept Neonatol, 4-6-1 Noisshiki, Gifu 5008717, Japan.	hironag@ccn2.aitai.ne.jp					Acar P, 2001, PEDIATR CARDIOL, V22, P116, DOI 10.1007/s002460010173; Mertens L, 2011, J AM SOC ECHOCARDIOG, V24, P1057, DOI 10.1016/j.echo.2011.07.014; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Mor-Avi V, 2004, CIRCULATION, V110, P1814, DOI 10.1161/01.CIR.0000142670.65971.5F; POMBO JF, 1971, CIRCULATION, V43, P480; Cohen J, 1988, STAT POWER ANAL BEHA, P52; Foran AM, 2007, PEDIATRICS, V120, P78, DOI 10.1542/peds.2006-3305; Ichihashi K, 1999, PEDIATR INT, V41, P8, DOI 10.1046/j.1442-200x.1999.01008.x; Jurko A Jr, 2004, Bratisl Lek Listy, V105, P78; Nagasawa H, 2014, CARDIOL YOUNG, V24, P685, DOI 10.1017/S1047951113000954; Nagasawa H, 2010, CARDIOL YOUNG, V20, P525	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0172-0643	1432-1971		PEDIATR CARDIOL	Pediatr. Cardiol.	DEC	2014	35	8					1415	1420		10.1007/s00246-014-0944-0		6	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	AU0RY	WOS:000345333100015		
J	Yorifuji, T; Hashimoto, Y; Kawakita, R; Hosokawa, Y; Fujimaru, R; Hatake, K; Tamagawa, N; Nakajima, H; Fujii, M				Yorifuji, Tohru; Hashimoto, Yukiko; Kawakita, Rie; Hosokawa, Yuki; Fujimaru, Rika; Hatake, Kazue; Tamagawa, Nobuyoshi; Nakajima, Hisakazu; Fujii, Masayo			Relapsing 6q24-related transient neonatal diabetes mellitus successfully treated with a dipeptidyl peptidase-4 inhibitor: a case report	PEDIATRIC DIABETES			English	Article						dipeptidyl peptidase 4 inhibitors; transient neonatal diabetes		The most common form of transient neonatal diabetes mellitus (TNDM) is 6q24-related TNDM. Patients are treated with insulin during the neonatal period until spontaneous remission. However, diabetes often recurs in adolescence, and there is no standard therapy for patients with a relapse. A paternal duplication at the 6q24 critical region spanning the pleiomorphic adenoma gene-like 1 PLAGL1 gene was found in a Japanese patient with TNDM relapse. The patient was treated with a dipeptidyl peptidase-4 (DPP4) inhibitor, alogliptin, at a dose of 25mg per day. Immediately after treatment initiation, his hemoglobin A1c (HbA1c) levels dropped from 7.0-7.5% (52-58mmol/mol) to 6.0-6.5% (41-47mmol/mol) and remained stable for over a year. We reported the successful treatment of relapsed 6q24-related TNDM with a DPP4 inhibitor. Although insulin has been the conventional treatment for such patients, treatments targeting the GLP1 pathway can be a useful alternative because these patients retain the cell mass and responsiveness through G protein-coupled pathways.	[Yorifuji, Tohru; Hashimoto, Yukiko; Kawakita, Rie; Hosokawa, Yuki; Fujimaru, Rika] Osaka City Gen Hosp, Dept Pediat Endocrinol & Metab, Childrens Med Ctr, Osaka 5340021, Japan; [Yorifuji, Tohru; Hatake, Kazue; Tamagawa, Nobuyoshi] Osaka City Gen Hosp, Clin Res Ctr, Osaka 5340021, Japan; [Nakajima, Hisakazu] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 602, Japan; [Fujii, Masayo] Fujii Childrens Clin, Osaka, Japan	Yorifuji, T (reprint author), Osaka City Gen Hosp, Dept Pediat Endocrinol & Metab, Childrens Med Ctr, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	t-yorifuji@hospital.city.osaka.jp			National Center for Child Health and Development [25-10]	This work was supported, in part, by a Grant for National Center for Child Health and Development (25-10).	Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Sovik O, 2012, PEDIATR DIABETES, V13, P155, DOI 10.1111/j.1399-5448.2011.00776.x; Hoffmann A, 2012, MOL CELL BIOL, V32, P2549, DOI 10.1128/MCB.06637-11; TEMPLE IK, 1995, NAT GENET, V9, P110, DOI 10.1038/ng0295-110; Mackay DJG, 2005, HUM GENET, V116, P255, DOI 10.1007/s00439-004-1236-1; Mackay DJG, 2010, AM J MED GENET C, V154C, P335, DOI 10.1002/ajmg.c.30272; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Docherty LE, 2010, DIABETOLOGIA, V53, P2347, DOI 10.1007/s00125-010-1853-2; Docherty LE, 2013, DIABETOLOGIA, V56, P758, DOI 10.1007/s00125-013-2832-1; Greeley SAW, 2010, TRENDS ENDOCRIN MET, V21, P464, DOI 10.1016/j.tem.2010.03.004; Narita T, 2009, DIABETIC MED, V26, P667; Schimmel Ulf, 2009, Diabetes Care, V32, pe9, DOI 10.2337/dc08-1813; Shield JPH, 2004, ARCH DIS CHILD, V89, pF341, DOI 10.1136/adc.2003.030502; Valerio G, 2004, DIABETES CARE, V27, P2405, DOI 10.2337/diacare.27.10.2405	14	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-543X	1399-5448		PEDIATR DIABETES	Pediatr. Diabetes	DEC	2014	15	8					606	610		10.1111/pedi.12123		5	Endocrinology & Metabolism; Pediatrics	Endocrinology & Metabolism; Pediatrics	AT6FU	WOS:000345035600008		
J	Koike, Y; Uchida, K; Tanaka, K; Ide, S; Otake, K; Okita, Y; Inoue, M; Araki, T; Mizoguchi, A; Kusunoki, M				Koike, Yuhki; Uchida, Keiichi; Tanaka, Koji; Ide, Shozo; Otake, Kohei; Okita, Yoshiki; Inoue, Mikihiro; Araki, Toshimitsu; Mizoguchi, Akira; Kusunoki, Masato			Dynamic pathology for circulating free DNA in a dextran sodium sulfate colitis mouse model	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Green fluorescent protein; Multiphoton fluorescence microscopy; Circulating free DNA, neutrophils; Sepsis; Time-lapse imaging	CELL-FREE DNA; LASER-SCANNING MICROSCOPY; MULTIPHOTON MICROSCOPY; PROGNOSTIC MARKER; IN-VIVO; METASTASIS; MICE; INFLAMMATION; THROMBOSIS; SEPSIS	In sepsis, circulating free DNA (cf-DNA) is increased, and is a marker of severity and prognosis of septic patients. This study aimed to evaluate cf-DNA in a dextran sodium sulfate-induced colitis mouse model, and its clinical implications. Dynamic pathology of the cecum wall in the DSS-induced colitis mouse model was analyzed using multiphoton microscopy (MPM). Plasma cf-DNA concentrations in colitis mouse were quantified using PicoGreen dsDNA Assay Kit. Plasma cf-DNA was also measured in 123 human ulcerative colitis (UC) patients [mean age: 35.9 years (3-75 years) with 20 pediatric patients] to assess its relationships with clinical severity and Matt's grade. Real-time images of cf-DNA were detected in the colitis model. The amount of labeled cf-DNA in the circulation of the colitis mice group was significantly higher compared with that in the control group (P < 0.05). In human UC blood samples, plasma cf-DNA concentrations in UC patients were significantly positively correlated with the clinical severity of UC and Matt's grade (P < 0.05, P < 0.05, respectively). Using MPM, we observed and analyzed real-time images of cf-DNA in a colitis mouse model. Plasma cf-DNA is a potential non-invasive blood marker for reflecting clinical severity and mucosal damage in UC patients.	[Koike, Yuhki; Uchida, Keiichi; Tanaka, Koji; Ide, Shozo; Otake, Kohei; Okita, Yoshiki; Inoue, Mikihiro; Araki, Toshimitsu; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan; [Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie 5148507, Japan	Koike, Y (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	koikyon@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 25462771]	This work was partly supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI 25462771 to Y. K.). No additional external funding was received for this study.	Rainer TH, 2007, CLIN CHIM ACTA, V376, P190, DOI 10.1016/j.cca.2006.08.025; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Butt AN, 2008, ANN NY ACAD SCI, V1137, P236, DOI 10.1196/annals.1448.002; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Atamaniuk J, 2012, NEPHROL DIAL TRANSPL, V27, P902, DOI 10.1093/ndt/gfr695; Lo YMD, 2000, CLIN CHEM, V46, P319; Savchenko AS, 2011, PATHOL INT, V61, P290, DOI 10.1111/j.1440-1827.2011.02651.x; Keshari RS, 2012, CYTOM PART A, V81A, P238, DOI 10.1002/cyto.a.21178; Koike Y, 2011, J THROMB THROMBOLYS, V32, P138, DOI 10.1007/s11239-011-0600-y; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Pittet MJ, 2011, CELL, V147, P983, DOI 10.1016/j.cell.2011.11.004; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Toiyama Y, 2010, J GASTROENTEROL, V45, P544, DOI 10.1007/s00535-009-0187-7; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Ustione A, 2011, J MICROSC-OXFORD, V243, P221, DOI 10.1111/j.1365-2818.2011.03532.x; Jylhava J, 2013, AGING CELL, V12, P388, DOI 10.1111/acel.12058; Yang D, 2004, ARTHRITIS RHEUM, V50, P3401, DOI 10.1002/art.20604; Tanaka K, 2014, AM J TRANSL RES, V6, P179; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700; Kohlova M, 2013, HEMODIAL INT, V17, P664, DOI 10.1111/hdi.12055; Morimoto Y, 2011, J GASTROINTEST SURG, V15, P1842, DOI 10.1007/s11605-011-1632-5; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Obermayer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097784; Rhodes A, 2012, CRIT CARE, V16, DOI 10.1186/cc11508; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Tanaka K, 2013, SURG TODAY, V43, P123, DOI 10.1007/s00595-012-0283-9; Tanaka K, 2012, MICROSC RES TECHNIQ, V75, P307, DOI 10.1002/jemt.21059; Tanaka K, 2012, J ONCOL, V2012	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	DEC	2014	30	12					1199	1206		10.1007/s00383-014-3607-6		8	Pediatrics; Surgery	Pediatrics; Surgery	AT6TN	WOS:000345072200004		
J	Koga, H; Yamoto, M; Okazaki, T; Okawada, M; Doi, T; Miyano, G; Fukumoto, K; Lane, GJ; Urushihara, N; Yamataka, A				Koga, Hiroyuki; Yamoto, Masaya; Okazaki, Tadaharu; Okawada, Manabu; Doi, Takashi; Miyano, Go; Fukumoto, Koji; Lane, Geoffrey J.; Urushihara, Naoto; Yamataka, Atsuyuki			Factors affecting postoperative respiratory tract function in type-C esophageal atresia. Thoracoscopic versus open repair	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Thoracoscopic repair; Esophageal atresia; Tracheoesophageal fistula; Respiratory tract-related complications	TRACHEOESOPHAGEAL FISTULA; PAIN; SURGERY	We assessed the outcome of 72 cases of type-C esophageal atresia (EAc) treated by open (OR) or thoracoscopic (TR) repair from 2000 to 2013. During OR, direct lung retraction (DLR) is required but during TR, CO2 insufflation causes lung collapse so DLR is unnecessary. Patient demographics, operative time, respiratory tract impact (RTI: incidence of atelectasis, timing of extubation, need for reintubation, and duration of chest tube insertion), narcotic usage, commencement of oral feeding, and length of hospitalization (LOH) were compared. Seven long-gap cases were excluded, leaving 65 EAc subjects (TR = 25, OR = 40). Patient demographics, operative time, and duration of chest tube insertion were similar. No TR case required DLR. Significant differences were found in TR for narcotic usage (1.6 vs. 3.1 days), commencement of feeding (7.8 vs. 10.5 days), incidence of atelectasis (8 vs. 30 %), initial extubation (2.8 vs. 5.6 days), and LOH (33 vs. 46 days), (all p < 0.05, respectively). Postoperative tracheal tube blockage caused by excessive secretions (4 vs. 10 %) and reintubation (4 vs. 17.5 %) were less in TR but not significant. There were three anastomotic leakages in TR, one in OR. TR is less traumatic than OR because DLR is unnecessary, resulting in lower RTI and smooth recovery.	[Koga, Hiroyuki; Okazaki, Tadaharu; Okawada, Manabu; Doi, Takashi; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Dept Pediat Surg, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Yamoto, Masaya; Miyano, Go; Fukumoto, Koji; Urushihara, Naoto] Shizuoka Childrens Hosp, Dept Pediat Surg, Shizuoka, Japan	Koga, H (reprint author), Juntendo Univ, Dept Pediat Surg, Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	h-koga@juntendo.ac.jp					Rogers ML, 2000, EUR J CARDIO-THORAC, V18, P711, DOI 10.1016/S1010-7940(00)00569-8; Holcomb GW, 2005, ANN SURG, V242, P422, DOI 10.1097/01.sla.0000179649.15576.db; Perttunen K, 1999, ACTA ANAESTH SCAND, V43, P563; Stevens B, 1996, CLIN J PAIN, V12, P13, DOI 10.1097/00002508-199603000-00004; Findik G, 2008, PEDIATR SURG INT, V24, P721, DOI 10.1007/s00383-008-2144-6; MCKINNON LJ, 1990, J PEDIATR SURG, V25, P778; Kalfa N, 2005, PEDIATRICS, V116, pE785, DOI 10.1542/peds.2005-0650; Krosnar S, 2005, PEDIATR ANESTH, V15, P541, DOI 10.1111/j.1460-9592.2005.01594.x; LEHANE JR, 1980, BRIT J ANAESTH, V52, P773, DOI 10.1093/bja/52.8.773; Nguyen T, 2006, J LAPAROENDOSC ADV S, V16, P174, DOI 10.1089/lap.2006.16.174; Rothenberg SS, 2002, J PEDIATR SURG, V37, P869, DOI 10.1053/jpsu.2002.32891; Rothenberg SS, 2000, PEDIAT ENDOSURG INNO, P150; Shimotakahara A, 2010, PEDIATR SURG INT, V26, P443, DOI 10.1007/s00383-010-2560-2; Szavay PO, 2011, J LAPAROENDOSC ADV S, V21, P439, DOI 10.1089/lap.2010.0349; van der Zee DC, 2003, SURG ENDOSC, V17, P1065, DOI 10.1007/s00464-002-9177-z; Yamataka A, 2014, VID SESS 51 ANN M JA	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	DEC	2014	30	12					1273	1277		10.1007/s00383-014-3618-3		5	Pediatrics; Surgery	Pediatrics; Surgery	AT6TN	WOS:000345072200013		
J	Tiwari, S; Tripathy, BC; Jajoo, A; Das, AB; Murata, N; Sane, PV; Govindjee				Tiwari, Swati; Tripathy, Baishnab Charan; Jajoo, Anjana; Das, Anath Bandhu; Murata, Norio; Sane, Prafullachandra Vishnu; Govindjee			Prasanna K. Mohanty (1934-2013): a great photosynthetiker and a wonderful human being who touched the hearts of many	PHOTOSYNTHESIS RESEARCH			English	Article						Chlorophyll; Cyanobacteria; Chlorophyll fluorescence; Electron transport; Photosynthesis	ELECTRON-TRANSPORT ACTIVITIES; CUCUMIS-SATIVUS COTYLEDONS; CYANOBACTERIUM SYNECHOCOCCUS-CEDRORUM; OXYGEN-EVOLVING COMPLEX; ULTRAVIOLET-B RADIATION; DETACHED BARLEY LEAVES; DELAYED LIGHT-EMISSION; ALTERS ENERGY-TRANSFER; MODERATE HEAT-STRESS; PHOTOSYSTEM-II	Prasanna K. Mohanty, a great scientist, a great teacher and above all a great human being, left us more than a year ago (on March 9, 2013). He was a pioneer in the field of photosynthesis research; his contributions are many and wide-ranging. In the words of Jack Myers, he would be a "photosynthetiker" par excellence. He remained deeply engaged with research almost to the end of his life; we believe that generations of researchers still to come will benefit from his thorough and enormous work. We present here his life and some of his contributions to the field of Photosynthesis Research. The response to this tribute was overwhelming and we have included most of the tributes, which we received from all over the world. Prasanna Mohanty was a pioneer in the field of "Light Regulation of Photosynthesis", a loving and dedicated teacher-unpretentious, idealistic, and an honest human being.	[Tiwari, Swati] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Tripathy, Baishnab Charan] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Jajoo, Anjana] Devi Ahilya Univ, Sch Life Sci, Indore, Madhya Pradesh, India; [Das, Anath Bandhu] Orissa Univ Agr & Technol, Dept Agr Biotechnol, Bhubaneswar 751003, Odisha, India; [Murata, Norio] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Sane, Prafullachandra Vishnu] Jain Irrigat Syst Ltd, Jain Hills 425001, Jalgaon, India; [Govindjee] Univ Illinois, Dept Plant Biol, Dept Biochem, Urbana, IL 61801 USA; [Govindjee] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA	Tiwari, S (reprint author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India.	swatijnubt@gmail.com; gov@illinois.edu			Department of Biotechnology Grant (DBT at the Jawaharlal Nehru University) [102/IFD/SAN/2002/2013-2014]	We thank Savita (one name only), supported by Department of Biotechnology Grant (DBT grant 102/IFD/SAN/2002/2013-2014 to ST, at the Jawaharlal Nehru University), for her secretarial help. More than forty people helped us prepare this Tribute and we thank them all; and George C. Papageorgiou read, and corrected, the final version of this tribute before it was uploaded for publication. Special thanks go to those who provided photographs (too many to list). We are highly thankful to all those who provided individual Tributes. We mention here just a few: Basanti and Udaya Biswal, James Bolton & John Boyer (their texts are in the main portion of this paper), Usha Andley (who had worked with Prasanna in India), Lalit Mohan Das (brother-in-law of Prasanna), Walter Mangel (who provided his memories from days when Prasanna was a PhD student), Michael Seibert (with whom Prasanna spent a sabbatical), and Sadanand Torasia (who knew Prasanna the longest) for their contributions to this Tribute. We regret that we were unable to locate Bacon Ke with whom Prasanna had worked once. Govindjee thanks the staff of the Life Science Information Technology office for their constant help.	Abrol YP, 1993, PHOTOSYNTHESIS PHOTO; Alia, 1992, Physiologia Plantarum, V86, P189; Alia, 2001, AMINO ACIDS, V21, P195; ALIA, 1993, PLANT SOIL, V155, P497, DOI 10.1007/BF00025092; Alia, 1997, J PHOTOCH PHOTOBIO B, V38, P253, DOI 10.1016/S1011-1344(96)07470-2; ALIA, 1991, BIOCHEM BIOPH RES CO, V181, P1238; Alia A, 1992, BIOCH PHYSL PFLANZEN, V188, P1; Allakhverdiev SI, 2003, BIOCHEMISTRY-US, V42, P14277, DOI 10.1021/bi035205+; Allakhverdiev SI, 2012, PHOTOSYNTHESIS OVERV, P189; Allakhverdiev SI, 2005, BBA-BIOENERGETICS, V1708, P342, DOI 10.1016/j.bbabio.2005.05.006; Andley UP, 1977, BIOPHYS STRUCT MECH, V3, P259; ANDLEY UP, 1981, PHOTOCHEM PHOTOBIOL, V33, P235, DOI 10.1111/j.1751-1097.1981.tb05330.x; Andley UP, 2005, PHOTOSYNTH RES, V85, P145, DOI 10.1007/s11120-005-4912-7; Vani B, 2001, J PLANT PHYSIOL, V158, P583, DOI 10.1078/0176-1617-00260; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P541, DOI 10.1007/s11120-008-9331-0; TRIPATHY BC, 1980, PLANT PHYSIOL, V66, P1174, DOI 10.1104/pp.66.6.1174; Allakhverdiev SI, 2007, BBA-BIOENERGETICS, V1767, P1363, DOI 10.1016/j.bbabio.2007.10.005; MOHANTY P, 1993, BIOCHIM BIOPHYS ACTA, V1144, P92, DOI 10.1016/0005-2728(93)90035-E; Eaton-Rye JJ, 2013, PHOTOSYNTH RES, V116, P111, DOI 10.1007/s11120-013-9921-3; Matysik J, 2002, CURR SCI INDIA, V82, P525; MURATA N, 1992, FEBS LETT, V296, P187, DOI 10.1016/0014-5793(92)80376-R; ATAL N, 1991, PLANT CELL PHYSIOL, V32, P943; Sireesha K, 2012, BBA-BIOENERGETICS, V1817, P1525, DOI 10.1016/j.bbabio.2012.04.016; Nellaepalli S, 2011, BBA-BIOENERGETICS, V1807, P1177, DOI 10.1016/j.bbabio.2011.05.016; Parida AK, 2004, J PLANT PHYSIOL, V161, P531, DOI 10.1078/0176-1617-01084; BISWAL UC, 1976, PLANT CELL PHYSIOL, V17, P323; MAMEDOV MD, 1991, FEBS LETT, V294, P271, DOI 10.1016/0014-5793(91)81446-F; Sah JF, 1998, BIOCHEM MOL BIOL INT, V44, P245; PAPAGEORGIOU GC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P361, DOI 10.1016/S0005-2728(05)80148-3; Biswal B, 2013, ADV PHOTOSYNTHESIS R, V36, P685; BISWAL UC, 1976, PLANT SCI LETT, V7, P371, DOI 10.1016/0304-4211(76)90094-8; BISWAL UC, 1988, INT REV CYTOL, V113, P271; BISWAL UC, 1978, PHYSIOL PLANTARUM, V44, P127, DOI 10.1111/j.1399-3054.1978.tb01626.x; BONAVENT.C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; BRAND JJ, 1983, FEBS LETT, V155, P120, DOI 10.1016/0014-5793(83)80222-1; Chopra RK, 2002, CURR SCI INDIA, V83, P514; Das AB, 2013, ADV TOPICS SCI TECHN, P650; Das AB, 2014, MANGROVES BIOL BIOGE; Dawar S, 1998, INT J ENERG RES, V22, P1019, DOI 10.1002/(SICI)1099-114X(19981010)22:12<1019::AID-ER416>3.0.CO;2-U; Fork DC, 1986, LIGHT EMISSION PLANT, P451; FORK DC, 1985, PHYSIOL VEG, V23, P511; Ghirardi ML, 2010, CURR SCI INDIA, V98, P499; Ghosh AK, 2004, PHOTOSYNTH RES, V80, P427, DOI 10.1023/B:PRES.0000030765.62805.fb; Govindjee, 1986, LIGHT EMISSION PLANT; Govindjee Mohanty P, 1971, FLUORESCENCE NEWS, V6, P1; Govindjee Mohanty PK, 1972, BIOL TAXONOMY BLUE G, P171; Govindjee Papageorgiou GC, 1973, PRACTICAL FLUORESCEN, P543; GROVER A, 1986, PHOTOSYNTH RES, V10, P223, DOI 10.1007/BF00118287; HOSHINA S, 1984, PHOTOSYNTH RES, V5, P347, DOI 10.1007/BF00034979; Itoh S, 2012, PHOTOSYNTHESIS OVERV, V280; Jajoo A, 2009, PHOTOSYNTH RES, V100, P49, DOI 10.1007/s11120-009-9409-3; Jajoo A, 2001, PHOTOSYNTHETICA, V39, P321, DOI 10.1023/A:1015125008028; Jha IB, 2000, INDIAN J BIOCHEM BIO, V37, P486; JOSHI MK, 1994, J PHOTOCH PHOTOBIO B, V23, P63, DOI 10.1016/1011-1344(93)06981-8; Karapetyan N V, 2014, Photosynth Res, V120, P347, DOI 10.1007/s11120-014-9971-1; Kolli BK, 1998, Z NATURFORSCH C, V53, P369; MOHANTY P, 1972, PLANT CELL PHYSIOL, V13, P81; Mohanty P, 1997, INDIAN J BIOCHEM BIO, V34, P241; Mohanty P, 2012, ADV PHOTOSYNTH RESP, V34, P251, DOI 10.1007/978-94-007-1579-0_12; MOHANTY P, 1972, FEBS LETT, V20, P273, DOI 10.1016/0014-5793(72)80085-1; MOHANTY P, 1973, BIOCHIM BIOPHYS ACTA, V305, P95, DOI 10.1016/0005-2728(73)90235-1; Mohanty P, 2002, Z NATURFORSCH C, V57, P836; MOHANTY P, 1971, PHOTOCHEM PHOTOBIOL, V14, P667, DOI 10.1111/j.1751-1097.1971.tb06206.x; MOHANTY P, 1973, BIOCHIM BIOPHYS ACTA, V292, P459, DOI 10.1016/0005-2728(73)90051-0; MOHANTY P, 1974, Plant Biochemical Journal, V1, P78; MOHANTY P, 1974, PLANT CELL PHYSIOL, V15, P213; Mohanty P, 1971, BIOCHIM BIOPHYS ACTA, V223, P198; MOHANTY P, 1985, PHOTOSYNTH RES, V6, P349, DOI 10.1007/BF00054108; MOHANTY P, 1976, PLANT PHYSIOL, V57, P704, DOI 10.1104/pp.57.5.704; Mohanty P, 2007, PHOTOSYNTH RES, V94, P217, DOI 10.1007/s11120-007-9184-y; MOHANTY P, 1985, PHOTOCHEM PHOTOBIOL, V41, P589, DOI 10.1111/j.1751-1097.1985.tb03531.x; MOHANTY P, 1971, BIOCHIM BIOPHYS ACTA, V253, P213, DOI 10.1016/0005-2728(71)90247-7; MOHANTY P, 1973, PLANT CELL PHYSIOL, V14, P611; MOHANTY PK, 1963, NATURE, V200, P909, DOI 10.1038/200909b0; MOHANTY PK, 1962, SCIENCE, V138, P902, DOI 10.1126/science.138.3543.902; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; MURTHY SDS, 1990, J PHOTOCH PHOTOBIO B, V6, P373, DOI 10.1016/1011-1344(90)85111-9; MURTHY SDS, 1995, BIOMETALS, V8, P237; Ogren WL, 2003, PHOTOSYNTH RES, V76, P53, DOI 10.1023/A:1024913925002; Parida AK, 2004, PLANT GROWTH REGUL, V42, P213, DOI 10.1023/B:GROW.0000026508.63288.39; Prakash J. S. S., 2013, Physiology and Molecular Biology of Plants, V19, P301, DOI 10.1007/s12298-013-0183-5; Prakash JSS, 2001, Z NATURFORSCH C, V56, P585; Prakash JSS, 2003, J PLANT PHYSIOL, V160, P175, DOI 10.1078/0176-1617-00529; Prakash JSS, 2001, PHOTOSYNTH RES, V68, P153, DOI 10.1023/A:1011876412537; Raghavendra S, 2003, PHOTOSYNTH RES, V76, P435; Rajagopal S, 2005, PHOTOSYNTH RES, V85, P181, DOI 10.1007/s11120-005-2439-6; Rajagopal S, 2000, J PHOTOCH PHOTOBIO B, V54, P61, DOI 10.1016/S1011-1344(99)00156-6; Rajagopal S, 1999, PHOTOSYNTHETICA, V36, P617, DOI 10.1023/A:1007060625055; SABAT SC, 1991, Z NATURFORSCH C, V46, P87; SABAT SC, 1991, BIOCHEM BIOPH RES CO, V179, P1127, DOI 10.1016/0006-291X(91)91937-8; Sabat S. C., 1989, Photosynthesis: molecular biology and bioenergetics., P343; SABAT SC, 1989, J PHOTOCH PHOTOBIO B, V3, P175, DOI 10.1016/1011-1344(89)80060-0; SAYEED SA, 1988, P INDIAN AS-PLANT SC, V98, P157; Singhal G, 1989, PHOTOSYNTHESIS MOL B; SRIVASTAVA M, 1994, BBA-BIOENERGETICS, V1186, P1, DOI 10.1016/0005-2728(94)90128-7; TIWARI S, 1993, PHOTOSYNTH RES, V38, P463, DOI 10.1007/BF00046775; Tiwari S, 1996, PHOTOSYNTH RES, V50, P243, DOI 10.1007/BF00033123; TRIPATHY BC, 1981, BIOCHIM BIOPHYS ACTA, V638, P217, DOI 10.1016/0005-2728(81)90230-9; TRIPATHY BC, 1983, BIOCHIM BIOPHYS ACTA, V722, P88, DOI 10.1016/0005-2728(83)90160-3; WARDEN JT, 1974, BIOCHEM BIOPH RES CO, V59, P872, DOI 10.1016/S0006-291X(74)80060-4; WAVARE RA, 1982, PHOTOBIOCH PHOTOBIOP, V3, P327; YADAV PK, 1984, BIOCHEM PHYSIOL PFL, V179, P45	102	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0166-8595	1573-5079		PHOTOSYNTH RES	Photosynth. Res.	DEC	2014	122	3					235	260		10.1007/s11120-014-0033-5		26	Plant Sciences	Plant Sciences	AT7WY	WOS:000345146300001		
J	Allakhverdiev, SI; Tomo, T; Govindjee				Allakhverdiev, Suleyman I.; Tomo, Tatsuya; Govindjee			International conference on "photosynthesis research for sustainability-2014: in honor of Vladimir A. Shuvalov", held on June 2-7, 2014, in Pushchino, Russia	PHOTOSYNTHESIS RESEARCH			English	Article						Young investigator awardees; Azat Abdullatypov; Maria Borisova-Mubarakshina; Anastasia I. Gavrisheva; Shu Ikehira; Shin Nakamura; Laszlo Sass; Franz-Josef Schmitt; Toshiyuki Shinoda; Sepideh Skandary	PRIMARY CHARGE SEPARATION; II REACTION CENTERS; PHOTOSYSTEM-II; BACTERIAL PHOTOSYNTHESIS; PHOTOCHEMICAL-REACTION; PICOSECOND DETECTION; INTERMEDIATE; COMPLEX	In this article, we provide a News Report on an international conference "Photosynthesis Research for Sustainability-2014" that was held in honor of Vladimir A. Shuvalov at the Biological Research Center of the Russian Academy of Sciences, in Pushchino, Russia, during June 2-7, 2014 (http://photosynthesis2014. We begin this report with a short description of Vladimir A. Shuvalov, the honored scientist. We then provide some information on the conference, and the program. A special feature of this conference was awards given to nine young investigators; they are recognized in this Report. We have also included several photographs to show the pleasant ambiance at this conference. We invite the readers to the next two conferences on ''Photosynthesis Research for Sustainability-2015: the first one to be held in Baku in May or June, 2015, and the second one, which will honor George C. Papageorgiou, will be held in Greece (in Colymbari, near Chania in Crete) during September 21-26, 2015. Information will be posted at: http://photosynthesis2015.cellreg.org/.	[Allakhverdiev, Suleyman I.] Russian Acad Sci, Inst Plant Physiol, Moscow 127276, Russia; [Allakhverdiev, Suleyman I.] Russian Acad Sci, Inst Basic Biol Problems, Pushchino 142290, Moscow Region, Russia; [Tomo, Tatsuya] Tokyo Univ Sci, Dept Biol, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan; [Govindjee] Univ Illinois, Dept Plant Biol, Dept Biochem, Urbana, IL 61801 USA; [Govindjee] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	Allakhverdiev, SI (reprint author), Russian Acad Sci, Inst Plant Physiol, Botanicheskaya St 35, Moscow 127276, Russia.	suleyman.allakhverdiev@gmail.com; gov@life.illinois.edu			Russian Foundation for Basic Research [14-04-06026]; International Society of Photosynthesis Research (ISPR); LabInstruments- laboratory equipment, analytical instruments, consumables and more ...; BioLogic Science Instruments -Rapid Kinetics and Spectroscopy Instruments/Photosynthesis; Agrisera-Antibodies for Plant Sciences, PP Systems-Portable Photosynthesis Systems, quality instrumentation for Life Sciences,(IAHE); Russian Foundation for Basic Research; "Molecular and Cell Biology" Programs of the Russian Academy of Sciences	We express our appreciation to all the attendees for valuable discussions on various aspects of photosynthesis at the Pushchino conference. We thank all the members of the International organizing committee for their help with the various sections, and the committees, mentioned in this report for the selection of the Awardees; further, we are grateful to all the chairpersons of the poster sessions for their help; and thank all the sponsors: The Russian Foundation for Basic Research (grant # 14-04-06026); International Society of Photosynthesis Research (ISPR); LabInstruments- laboratory equipment, analytical instruments, consumables and more ... ; BioLogic Science Instruments -Rapid Kinetics and Spectroscopy Instruments/Photosynthesis; Agrisera-Antibodies for Plant Sciences, PP Systems-Portable Photosynthesis Systems, quality instrumentation for Life Sciences, Hansatech Instruments: Instrumentation for Photosynthesis and Respiration Studies, and the International Association for Hydrogen Energy (IAHE). We also thank Ineke Ravesloot of Springer, for mailing books to Suleyman Allakhverdiev (in Pushchino) for awards for the best posters. We thank Maria Leonova (registration, infrastructure managing), Marina Kozuleva (transportation), Zinaida Eltsova (accommodation), Evgeny Shastik (bonfire and coffee breaks), Ilya Naydov (adstract book formatting), Alexander Shitov (who painstakingly took many of the photographs at the conference), Konstantin Neverov and his wonderful associate guides for showing the participants sights in Pushchino and in Moscow, and many others for their wonderful help in Pushchino that made this conference a memorable event. We thank Anatoly A. Tsygankov, chairman of the local organizing committee, and all members of his committee, for their wonderful work that led to a very smooth running of our conference. Special thanks to Dmitry A. Los for the creation and support for the conference Web site. SIA is grateful for support by grants from the Russian Foundation for Basic Research, and by "Molecular and Cell Biology" Programs of the Russian Academy of Sciences. Messages received by one of the authors (SIA) and the national organizing committee are available below in the Appendix.	Allakhverdiev SI, 2012, PHOTOSYNTH RES, V110, P205, DOI 10.1007/s11120-011-9713-6; Allakhverdiev SI, 2013, PHOTOSYNTH RES, V118, P297, DOI 10.1007/s11120-013-9901-7; WASIELEWSKI MR, 1989, P NATL ACAD SCI USA, V86, P524, DOI 10.1073/pnas.86.2.524; Greenfield SR, 1997, J PHYS CHEM B, V101, P2251, DOI 10.1021/jp962982t; Shelaev IV, 2011, J PHOTOCH PHOTOBIO B, V104, P44, DOI 10.1016/j.jphotobiol.2011.02.003; Shelaev IV, 2008, PHOTOSYNTH RES, V98, P95, DOI 10.1007/s11120-008-9371-5; SHUVALOV VA, 1978, FEBS LETT, V91, P135, DOI 10.1016/0014-5793(78)80034-9; Shelaev IV, 2010, BBA-BIOENERGETICS, V1797, P1410, DOI 10.1016/j.bbabio.2010.02.026; Ciamician G, 1912, Science, V36, P385, DOI 10.1126/science.36.926.385; Fenton JM, 1978, FEBS LETT, V100, P1; Khatypov RA, 2012, BBA-BIOENERGETICS, V1817, P1392, DOI 10.1016/j.bbabio.2011.12.007; PARSON WW, 1975, BIOCHIM BIOPHYS ACTA, V416, P105, DOI 10.1016/0304-4173(75)90014-2; ROCKLEY MG, 1975, P NATL ACAD SCI USA, V72, P2251, DOI 10.1073/pnas.72.6.2251; SHUVALOV VA, 1976, BIOCHIM BIOPHYS ACTA, V440, P587, DOI 10.1016/0005-2728(76)90044-X; WASIELEWSKI MR, 1987, PHOTOSYNTH RES, V12, P181, DOI 10.1007/BF00047947	15	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0166-8595	1573-5079		PHOTOSYNTH RES	Photosynth. Res.	DEC	2014	122	3					337	347		10.1007/s11120-014-0032-6		11	Plant Sciences	Plant Sciences	AT7WY	WOS:000345146300008		
J	Okada, Y; Teramura, K; Takahashi, KH				Okada, Yasukazu; Teramura, Kohei; Takahashi, Kazuo H.			Heat shock proteins mediate trade-offs between early-life reproduction and late survival in Drosophila melanogaster	PHYSIOLOGICAL ENTOMOLOGY			English	Article						Antagonistic pleiotropy; early reproduction; hsp; life-history trade-off; longevity	DIETARY RESTRICTION; NATURAL-SELECTION; OXIDATIVE STRESS; GENOME-WIDE; SPAN; EVOLUTION; FEMALE; COSTS; MECHANISMS; EXPRESSION	Ageing and the resulting increased likelihood mortality are the inescapable fate of organisms because selection pressures on genes that exert their function late in life is weak, promoting the evolution of genes that enhance early-life reproductive performance at the same time as sacrificing late survival. Heat shock proteins (HSP) are known to buffer various environmental stresses and are also involved in protein homeostasis and longevity. The characteristics of genes for HSPs (hsp) imply that they affect various life-history traits, which in turn affect longevity; however, little is known about the effects of hsp genes on life-history traits and their interaction with longevity. In the present study, the effects of hsp genes on multiple fitness traits, such as locomotor activity, total fecundity, early fecundity and survival time, are investigated in Drosophila melanogasterMeigen using RNA interference (RNAi). In egg-laying females, RNAi knockdown of six hsp genes (hsp22, hsp23, hsp67Ba, hsp67Bb, hsp67Bc and hsp27-like) does not shorten survival but rather increases it. Knockdown of five of those genes on an individual basis reduces early-life reproduction, suggesting that several hsp genes mediate the trade-off between early reproduction and late survival. The data indicate a positive effect of hsp genes on early reproduction and also negative effects on survival time, supporting the antagonistic pleiotropic effects predicted by the optimality theory of ageing.	[Okada, Yasukazu; Teramura, Kohei] Okayama Univ, Res Core Interdisciplinary Sci, Okayama 7008530, Japan; [Okada, Yasukazu] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan; [Teramura, Kohei; Takahashi, Kazuo H.] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Takahashi, KH (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Tsushima Naka 1-1-1, Okayama 7008530, Japan.	kaz_tak@cc.okayama-u.ac.jp	TAKAHASHI, Kazuo/B-2425-2011		Ministry of Education, Sport, Culture, Science and Technology of Japan	We thank Hisao Moriya, Ayako Chino, Akira Satoh, Ayano Satoh and Yuka Kuroda for kindly providing experimental equipment and technical advice. Special Coordination Funds for Promoting Sciences and Technology of The Ministry of Education, Sport, Culture, Science and Technology of Japan were provided to K.H.T.	Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.2307/2406060; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; WOLF TJ, 1989, FUNCT ECOL, V3, P417, DOI 10.2307/2389615; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Timakov B, 2001, CELL STRESS CHAPERON, V6, P71, DOI 10.1379/1466-1268(2001)006<0071:THGODM>2.0.CO;2; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Liao PC, 2008, BIOCHEM BIOPH RES CO, V376, P637, DOI 10.1016/j.bbrc.2008.08.161; Jokela J, 1995, EVOLUTION, V49, P1268, DOI 10.2307/2410451; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Minois N, 2001, EXP GERONTOL, V36, P1137, DOI 10.1016/S0531-5565(00)00263-1; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Bell G., 1986, Oxford Surveys in Evolutionary Biology, V3, P83; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; Fisher R.A., 1930, GENETICAL THEORY NAT; GADGIL M, 1970, American Naturalist, V104, P1, DOI 10.1086/282637; Kleinbaum DG, 2012, STAT BIOL HEALTH, P55, DOI 10.1007/978-1-4419-6646-9_2; LAFFERTY KD, 1993, OIKOS, V68, P3, DOI 10.2307/3545303; LAW R, 1979, AM NAT, V113, P3, DOI 10.1086/283361; MARIN R, 1993, DEV GENET, V14, P69, DOI 10.1002/dvg.1020140109; Marin R, 1996, CHROMOSOMA, V105, P142, DOI 10.1007/BF02509495; Medawar P.B., 1952, UNSOLVED PROBLEM BIO; Morrow G, 2003, SEMIN CELL DEV BIOL, V14, P291, DOI 10.1016/j.semcdb.2003.09.023; R Development Core Team R, 2006, R LANG ENV STAT COMP; Silbermann R, 2000, EVOLUTION, V54, P2038; Soliman M.H., 1988, P46; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Vos M. J., 2009, THESIS U GRONINGEN	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6962	1365-3032		PHYSIOL ENTOMOL	Physiol. Entomol.	DEC	2014	39	4					304	312		10.1111/phen.12076		9	Entomology	Entomology	AT4AP	WOS:000344879900005		
J	Tokumoto, I; Heilman, JL; Schwinning, S; McInnes, KJ; Litvak, ME; Morgan, CLS; Kamps, RH				Tokumoto, Ieyasu; Heilman, James L.; Schwinning, Susanne; McInnes, Kevin J.; Litvak, Marcy E.; Morgan, Cristine L. S.; Kamps, Ray H.			Small-scale variability in water storage and plant available water in shallow, rocky soils	PLANT AND SOIL			English	Article						Karst; Soil water storage capacity; Root distribution; Root water access	FUNCTIONAL DIFFERENCES; BEDROCK; SENSITIVITY; ECOSYSTEMS; VEGETATION; RANGELANDS; LIMESTONE; MOISTURE; SYSTEMS; DEPTH	Background and aims We quantified spatial variability in water storage and plant access to water in the rocky soils of a karst savanna dominated by Ashe juniper (Juniperus ashei) and honey mesquite (Prosopis glandulosa). Methods In a 25x25 m grid with 5-m node spacing, water content and bulk density profiles were measured to a depth of 1.6 m by a combination of time domain reflectometry, neutron thermalization and gamma ray densitometry. Changes in water content were used to infer recharge and plant uptake of soil water. Predawn water potentials of trees were sampled periodically to evaluate individual differences in water access. Results Pore volume and maximum water storage varied between 0.24 and 0.42 m(3) m(-3), and 198 to 431 mm, respectively, across the 36 individual profiles. Porosity accounted for 19 and 20% and depth for 35 and 61% of the variation in uptake and recharge, respectively. Predawn water potentials were consistently different among individual trees over multiple dry seasons. Conclusions Unequal water status among trees was consistent with the variability of recharge and uptake in the rooting zone, suggesting that trees cannot fully compensate for spatial variability in soil properties by roots foraging for water.	[Tokumoto, Ieyasu] Tottori Univ, Arid Land Res Ctr, Tottori 680001, Japan; [Heilman, James L.; McInnes, Kevin J.; Morgan, Cristine L. S.; Kamps, Ray H.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Schwinning, Susanne] SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Litvak, Marcy E.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	Heilman, JL (reprint author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	j-heilman@tamu.edu	Schwinning, Susanne/G-6412-2015; Morgan, Cristine`/A-1555-2013	Schwinning, Susanne/0000-0002-9740-0291; Morgan, Cristine`/0000-0001-9836-0669	southeastern region of the National Institute for Climate Change Research (NICCR) through the Office of Biological and Environmental Research, US Dept. of Energy; Texas State University	The research was supported by a grant from the southeastern region of the National Institute for Climate Change Research (NICCR) through the Office of Biological and Environmental Research, US Dept. of Energy. The excavation study was funded through a research enhancement grant from Texas State University. We would also like to thank J. P. Bach, Manager of Freeman Ranch, for his assistance in establishing and maintaining our research sites.	EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Gerke HH, 2006, J PLANT NUTR SOIL SC, V169, P382, DOI 10.1002/jpln.200521955; Fies JC, 2002, EUR J SOIL SCI, V53, P95, DOI 10.1046/j.1365-2389.2002.00431.x; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; Scott RL, 2010, AGR FOREST METEOROL, V150, P219, DOI 10.1016/j.agrformet.2009.11.002; Dasgupta S, 2006, VADOSE ZONE J, V5, P1076, DOI 10.2136/vzj2005.0073; Pockman WT, 2000, AM J BOT, V87, P1287, DOI 10.2307/2656722; Estrada-Medina H, 2013, PLANT SOIL, V362, P37, DOI 10.1007/s11104-012-1175-x; Sauer TJ, 2002, SOIL SCI SOC AM J, V66, P1947; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Taucer PI, 2008, T ASABE, V51, P1951; Seyfried MS, 2006, HYDROL PROCESS, V20, P3261, DOI 10.1002/hyp.6331; Laio F, 2001, ADV WATER RESOUR, V24, P707, DOI 10.1016/S0309-1708(01)00005-7; Schenk HJ, 2008, NEW PHYTOL, V178, P223, DOI 10.1111/j.1469-8137.2008.02427.x; Lenahan MJ, 2011, CHEM GEOL, V284, P182, DOI 10.1016/j.chemgeo.2011.02.018; Arbel Y, 2010, EARTH SURF PROC LAND, V35, P1682, DOI 10.1002/esp.2010; Lee XH, 2004, ATMOS OCEAN SCI LIB, V29, P33; Elkington RJ, 2014, ECOHYDROLOGY, V7, P278, DOI 10.1002/eco.1344; Federer CA, 2003, J HYDROMETEOROL, V4, P1276, DOI 10.1175/1525-7541(2003)004<1276:SOAETS>2.0.CO;2; Grigg AM, 2010, PLANT SOIL, V326, P75, DOI 10.1007/s11104-009-9957-5; Guswa AJ, 2002, WATER RESOUR RES, DOI [10.1016/jadvsatres.2004.03.001, DOI 10.1016/JADVSATRES.2004.03.001]; Katsura S, 2009, VADOSE ZONE J, V8, P557, DOI 10.2136/vzj2008.0142; Kukowski K, 2012, OECOLOGIA, V171, P819; Massman WJ, 2000, AGR FOREST METEOROL, V104, P185, DOI 10.1016/S0168-1923(00)00164-7; MILLY PCD, 1994, J CLIMATE, V7, P506, DOI 10.1175/1520-0442(1994)007<0506:SOTGWC>2.0.CO;2; Querejeta JI, 2006, PLANT SOIL, V287, P187, DOI 10.1007/s11104-006-9065-8; Ryel Ronald J., 2008, V69, P397, DOI 10.1007/978-3-540-72954-9_16; Ryel RJ, 2010, VADOSE ZONE J, V9, P548, DOI 10.2136/vzj2010.0022; Tokumoto I, 2011, SOIL SCI SOC AM J, V75, P1922, DOI 10.2136/sssaj2011.0032n; Tokumoto I, 2012, SOIL SCI SOC AM J, V76, P2136, DOI 10.2136/sssaj2012.0167; Wilcox BP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033696	31	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0032-079X	1573-5036		PLANT SOIL	Plant Soil	DEC	2014	385	1-2					193	204		10.1007/s11104-014-2224-4		12	Agronomy; Plant Sciences; Soil Science	Agriculture; Plant Sciences	AT9ZR	WOS:000345283400014		
J	Baba-Kasai, A; Hara, N; Takano, M				Baba-Kasai, Akiko; Hara, Naho; Takano, Makoto			Tissue-specific and light-dependent regulation of phytochrome gene expression in rice	PLANT CELL AND ENVIRONMENT			English	Article						light-induced repression; Oryza sativaL; phytochrome gene; tissue-specific expression	HIGHER-PLANTS; BIOLOGICAL-ACTIVITY; BETA-GLUCURONIDASE; TERMINAL REGION; BINDING PROTEIN; PISUM-SATIVUM; RED LIGHT; ARABIDOPSIS; PROMOTER; MUTANTS	Phytochromes are red- and far red light photoreceptors in higher plants. Rice (Oryza sativaL.) has three phytochromes (phyA, phyB and phyC), which play distinct as well as cooperative roles in light perception. To gain a better understanding of individual phytochrome functions in rice, expression patterns of three phytochrome genes were characterized using promoter-GUS fusion constructs. The phytochrome genes PHYA and PHYB showed distinct patterns of tissue- and developmental stage-specific expression in rice. The PHYA promoter-GUS was expressed in all leaf tissues in etiolated seedlings, while its expression was restricted to vascular bundles in expanded leaves of light-grown seedlings. These observations suggest that light represses the expression of the PHYA gene in all cells except vascular bundle cells in rice seedlings. Red light was effective, but far red light was ineffective in gene repression, and red light-induced repression was not observed in phyB mutants. These results indicate that phyB is involved in light-dependent and tissue-specific repression of the PHYA gene in rice. In order to characterize the tissue-specific expression of PHYTOCHROME genes in rice, we examined the expression patterns of rice PHYTOCHROME promoter-GUS fusion genes. The results demonstrated PHYA expression was restricted to vascular bundles in light-grown seedlings as a result of light-mediated down-regulation of the PHYA gene in the other tissues and that the repression of PHYA is mediated by phyB signals in a tissue-specific manner. Commentary:	[Baba-Kasai, Akiko; Hara, Naho; Takano, Makoto] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan	Baba-Kasai, A (reprint author), Genet Resources Ctr, Austin, TX 78759 USA.	akikoba@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries, Genomics for Agricultural Innovation [GPN0003]	We thank Dr. H. Ichikawa (National Institute of Agrobiological Sciences) for kindly providing the pSMAH binary vector. We also thank Ms. A. Tagiri for technical advice regarding in situ hybridization. This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries, Genomics for Agricultural Innovation GPN0003.	Adam E, 1996, PLANT PHYSIOL, V110, P1081; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Takano M, 2009, P NATL ACAD SCI USA, V106, P14705, DOI 10.1073/pnas.0907378106; Takano M, 2001, PLANT CELL, V13, P521, DOI 10.1105/tpc.13.3.521; NAGATANI A, 1993, PLANT PHYSIOL, V102, P269; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Trupkin SA, 2007, PLANT MOL BIOL, V63, P669, DOI 10.1007/s11103-006-9115-x; Neff MM, 2000, GENE DEV, V14, P257; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; ADAM E, 1994, PLANT J, V6, P283, DOI 10.1046/j.1365-313X.1994.06030283.x; SOMERS DE, 1995, PLANT J, V7, P413, DOI 10.1046/j.1365-313X.1995.7030413.x; Goosey L, 1997, PLANT PHYSIOL, V115, P959, DOI 10.1104/pp.115.3.959; Endo M, 2005, PLANT CELL, V17, P1941, DOI 10.1105/tpc.105.032342; REED JW, 1994, PLANT PHYSIOL, V104, P1139; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; Basu D, 2000, PLANT MOL BIOL, V44, P27, DOI 10.1023/A:1006488119301; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; DEHESH K, 1991, MOL GEN GENET, V225, P305, DOI 10.1007/BF00269863; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; KOSUGI S, 1990, PLANT SCI, V70, P133, DOI 10.1016/0168-9452(90)90042-M; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; JEFFERSON RA, 1987, EMBO J, V6, P3901; Iwamoto M, 2009, PLANT CELL ENVIRON, V32, P592, DOI 10.1111/j.1365-3040.2009.01954.x; PARKS BM, 1993, PLANT CELL, V5, P39; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109; Heijde M, 2012, TRENDS PLANT SCI, V17, P230, DOI 10.1016/j.tplants.2012.01.007; BRUCE WB, 1990, PLANT CELL, V2, P1081; BRUCE WB, 1991, EMBO J, V10, P3015; CHERRY JR, 1992, P NATL ACAD SCI USA, V89, P5039, DOI 10.1073/pnas.89.11.5039; CHRISTENSEN AH, 1989, GENE, V85, P381, DOI 10.1016/0378-1119(89)90431-9; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; DEHESH K, 1990, SCIENCE, V250, P1397, DOI 10.1126/science.2255908; JORDAN ET, 1995, PLANT PHYSIOL, V107, P797, DOI 10.1104/pp.107.3.797; KAY SA, 1989, NUCLEIC ACIDS RES, V17, P2865, DOI 10.1093/nar/17.7.2865; KAY SA, 1989, PLANT CELL, V1, P351; KOMEDA Y, 1991, PLANT CELL PHYSIOL, V32, P737; Li J., 2011, ARABIDOPSIS BOOK, V9; LISSEMORE JL, 1987, PLANT MOL BIOL, V8, P485, DOI 10.1007/BF00017994; LISSEMORE JL, 1988, MOL CELL BIOL, V8, P4840; Martinez-Garcia JF, 1999, PLANT J, V18, P173, DOI 10.1046/j.1365-313X.1999.00440.x; Nagatani A, 2004, CURR OPIN PLANT BIOL, V7, P708, DOI 10.1016/j.ppi.2004.09.010; NIETOSOTELO J, 1994, PLANT CELL, V6, P287; Quail P. H., 1987, MOL BIOL PHYTOCHROME; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; SATO N, 1988, PLANT MOL BIOL, V11, P697, DOI 10.1007/BF00017469; SEELEY KA, 1992, PLANT CELL, V4, P29; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; STOCKHAUS J, 1992, GENE DEV, V6, P2364, DOI 10.1101/gad.6.12a.2364; Tilbrook K., 2013, ARABIDOPSIS BOOK, V11; TOMIZAWA K, 1986, PLANT CELL PHYSIOL, V27, P1101; vansTuinen A., 1995, MOL GEN GENET, V246, P133; Wang HY, 2003, TRENDS PLANT SCI, V8, P172, DOI 10.1016/S1360-1385(03)00049-9; WEINMANN P, 1994, PLANT J, V5, P559; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yu X. H., 2010, Arabidopsis Book, V8, pe0135	57	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	DEC	2014	37	12					2654	2666		10.1111/pce.12354		13	Plant Sciences	Plant Sciences	AT8UN	WOS:000345207400005		
J	Yamada, T; Mori, Y; Yasue, K; Maruyama, N; Kitamura, K; Abe, J				Yamada, Tetsuya; Mori, Yoshihiro; Yasue, Kazuho; Maruyama, Nobuyuki; Kitamura, Keisuke; Abe, Jun			Knockdown of the 7S globulin subunits shifts distribution of nitrogen sources to the residual protein fraction in transgenic soybean seeds	PLANT CELL REPORTS			English	Article						Glycine max; AmiRNA; Gene silencing; Storage protein; Protein content; Amino acids	BY-PRODUCT OKARA; GLYCINE-MAX L; BETA-CONGLYCININ; STORAGE PROTEINS; ARTIFICIAL MICRORNAS; VIRUS-RESISTANCE; ALPHA-SUBUNITS; MAJOR PROTEINS; OIL CONTENT; GENES	Key message A platform of gene silencing by amiRNA had been established in fertile transgenic soybean. We demonstrated that knockdown of storage protein shifted the distribution of nitrogen sources in soybean seeds. Artificial microRNAs (amiRNAs) were designed using the precursor sequence of the endogenous soybean (Glycine max L. Merrill) miRNA gma-miR159a and expressed in transgenic soybean plants to suppress the biosynthesis of 7S globulin, which is one of the major storage proteins. Seed-specific expression of these amiRNAs (amiR-7S) resulted in a strong suppression of 7S globulin subunit genes and decreased accumulation of the 7S globulin subunits in seeds. Thus, the results demonstrate that a platform for gene silencing by amiRNA was first developed in fertile transgenic soybean plants. There was no difference in nitrogen, carbon, and lipid contents between amiR-7S and control seeds. Four protein fractions were collected from defatted mature seeds on the basis of solubility at different pH to examine the distribution of nitrogen sources and compensatory effects. In the whey and lipophilic fractions, nitrogen content was similar in amiR-7S and control seeds. Nitrogen content was significantly decreased in the major soluble protein fraction and increased in the residual fraction (okara) of the amiR-7S seeds. Amino acid analysis revealed that increased nitrogen compounds in okara were proteins or peptides rather than free amino acids. Our study indicates that the decrease in 7S globulin subunits shifts the distribution of nitrogen sources to okara in transgenic soybean seeds.	[Yamada, Tetsuya; Mori, Yoshihiro; Kitamura, Keisuke; Abe, Jun] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Yasue, Kazuho] Hokkaido Univ, Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Maruyama, Nobuyuki] Kyoto Univ, Grad Sch Agr, Uji, Kyoto 611011, Japan	Yamada, T (reprint author), Hokkaido Univ, Grad Sch Agr, Kita Ku, Kita9 Nishi9, Sapporo, Hokkaido 0608589, Japan.	tetsuyay@res.agr.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23580002]; CREST of the Japan Science and Technology Agency (JAT)	We thank Y. Kitsui and M. Suzuki (Hokkaido University), and E. Okuda (Kyoto University) for technical assistance. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23580002) and by CREST of the Japan Science and Technology Agency (JAT).	Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Ai T, 2011, PLANT BIOLOGY, V13, P304, DOI 10.1111/j.1438-8677.2010.00374.x; DIERS BW, 1992, THEOR APPL GENET, V83, P608, DOI 10.1007/BF00226905; Mori T, 2004, PLANT J, V40, P238, DOI 10.1111/j.1365-313X.2004.02204.x; Herman EM, 1999, PLANT CELL, V11, P601; Kinney AJ, 2001, PLANT CELL, V13, P1165, DOI 10.1105/tpc.13.5.1165; Prak K, 2005, J AGR FOOD CHEM, V53, P3650, DOI 10.1021/jf047811x; Wadahama H, 2012, PLANT PHYSIOL, V158, P1395, DOI 10.1104/pp.111.189621; Toppino L, 2011, PLANT BIOTECHNOL J, V9, P684, DOI 10.1111/j.1467-7652.2010.00567.x; Mansur LM, 1996, CROP SCI, V36, P1327; Schmidt MA, 2008, PLANT BIOTECHNOL J, V6, P832, DOI 10.1111/j.1467-7652.2008.00364.x; Li C, 2011, HEREDITY, V106, P633, DOI 10.1038/hdy.2010.97; Shi A, 2010, PLANT BREEDING, V129, P250, DOI 10.1111/j.1439-0523.2010.01766.x; THANH VH, 1976, J AGR FOOD CHEM, V24, P1117, DOI 10.1021/jf60208a030; Mateos-Aparicio I, 2010, INNOV FOOD SCI EMERG, V11, P445, DOI 10.1016/j.ifset.2010.02.003; NIELSEN NC, 1989, PLANT CELL, V1, P313, DOI 10.1105/tpc.1.3.313; Redondo-Cuenca A, 2008, FOOD CHEM, V108, P1099, DOI 10.1016/j.foodchem.2007.11.061; MORI T, 1981, J AGR FOOD CHEM, V29, P20, DOI 10.1021/jf00103a006; NAKAMURA T, 1984, J AGR FOOD CHEM, V32, P647, DOI 10.1021/jf00123a055; BRIM CA, 1979, CROP SCI, V19, P494; Shi R, 2010, PLANTA, V232, P1281, DOI 10.1007/s00425-010-1253-3; Shibata M, 2008, BREEDING SCI, V58, P361, DOI 10.1270/jsbbs.58.361; Krishnan HB, 2007, J AGR FOOD CHEM, V55, P1839, DOI 10.1021/jf062497n; Tezuka M, 2000, J AGR FOOD CHEM, V48, P1111, DOI 10.1021/jf990560l; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; Sebolt AM, 2000, CROP SCI, V40, P1438; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Allen DK, 2013, PLANT PHYSIOL, V161, P1458, DOI 10.1104/pp.112.203299; Cober ER, 2000, CROP SCI, V40, P39; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Maruyama N, 2004, J AGR FOOD CHEM, V52, P8197, DOI 10.1021/jf048786y; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; OGAWA T, 1989, JPN J BREED, V39, P137; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Dwiyanti MS, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-152; Fahim M, 2012, PLANT BIOTECHNOL J, V10, P150, DOI 10.1111/j.1467-7652.2011.00647.x; Fernandez AI, 2009, PLANT PHYSIOL, V151, P1729, DOI 10.1104/pp.109.147546; FISCHER RL, 1982, CELL, V29, P651, DOI 10.1016/0092-8674(82)90181-7; Goto K, 2003, PLANT MOL BIOL REP, V21, P51, DOI 10.1007/BF02773396; Hajika M, 1996, BREEDING SCI, V46, P385; KITAMURA K, 1984, THEOR APPL GENET, V68, P253, DOI 10.1007/BF00266899; Kwanyuen P, 1997, J AM OIL CHEM SOC, V74, P983, DOI 10.1007/s11746-997-0015-2; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Narikawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P1976, DOI 10.1271/bbb.100479; Nishizawa K, 2010, PLANT BIOTECHNOL-NAR, V27, P409, DOI 10.5511/plantbiotechnology.10.0823a; Nishizawa K, 2003, PLANT J, V34, P647, DOI 10.1046/j.1365-313X.2003.01754.x; Ohtake N, 1997, SOIL SCI PLANT NUTR, V43, P247; Pathan SM, 2013, CROP SCI, V53, P765, DOI 10.2135/cropsci2012.03.0153; Samoto M, 1998, BIOSCI BIOTECH BIOCH, V62, P935, DOI 10.1271/bbb.62.935; Samoto M, 2007, FOOD CHEM, V102, P317, DOI 10.1016/j.foodchem.2006.05.054; Sato H, 2007, PLANT BIOTECHNOL, V5, P533; SCALLON B, 1985, THEOR APPL GENET, V70, P510, DOI 10.1007/BF00305984; Sorgentini DA, 1999, J FOOD BIOCHEM, V23, P489, DOI 10.1111/j.1745-4514.1999.tb00033.x; TAKAHASHI K, 1994, BREEDING SCI, V44, P65; Takahashi M, 2003, PLANTA, V217, P577, DOI 10.1007/s00425-003-1026-3; THANH VH, 1978, J AGR FOOD CHEM, V26, P695, DOI 10.1021/jf60217a027; Tsubokura Y, 2012, PLANT MOL BIOL, V78, P301, DOI 10.1007/s11103-011-9865-y; VANDERRIET WB, 1989, FOOD CHEM, V34, P193, DOI 10.1016/0308-8146(89)90140-4; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Yamada T, 2010, PLANT BIOTECHNOL, V27, P217, DOI 10.5511/plantbiotechnology.27.217; Yamada T, 2002, THEOR APPL GENET, V104, P308, DOI 10.1007/s001220100736; IWABUCHI S, 1987, J AGR FOOD CHEM, V35, P205, DOI 10.1021/jf00074a010; Zhang B, 2010, EUPHYTICA, V173, P387, DOI 10.1007/s10681-010-0126-y	64	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	DEC	2014	33	12					1963	1976		10.1007/s00299-014-1671-y		14	Plant Sciences	Plant Sciences	AT6TQ	WOS:000345072500003		
J	Okamoto, H; Kusaka, K				Okamoto, Hiroyuki; Kusaka, Kosuke			Design of Strain-Sensing Devices in Microscale by Using Surface Plasmon Polaritons	PLASMONICS			English	Article						Surface plasmons; Multimode interference; Strain sensors; Finite-difference time-domain method	METAL WAVE-GUIDES; SENSOR; SENSITIVITY; SPLITTERS; FILM	We have presented a strain-sensing device in microscale by using surface plasmon polaritons and multimode interference effects. The device is numerically investigated by the finite-difference time-domain method. Optimum depths and length of the structure are designed for sensing a strain. The size of the designed structure is several micrometers and is about a thousandth compared with a fiber Bragg grating strain sensor. The sensitivity of the designed structure is 11.34 pm/mu oee- that is about ten times larger than that of a fiber Bragg grating strain sensor. The temperature sensitivity of the designed structure is 34.43 pm/ C-a similar to. This temperature sensitivity is three times larger than that of a fiber Bragg grating strain sensor. Therefore, temperature compensation techniques are needed for the structure. The presented structure has a simple design such as a plasmonic waveguide with a trench structure. The simple structural design device has a capability of being used in micro- and nano-electromechanical systems.	[Okamoto, Hiroyuki; Kusaka, Kosuke] Anan Natl Coll Technol, Dept Syst & Control Engn, Anan, Tokushima 7740017, Japan	Okamoto, H (reprint author), Anan Natl Coll Technol, Dept Syst & Control Engn, 265 Aoki Minobayashi, Anan, Tokushima 7740017, Japan.	okamoto@anan-nct.ac.jp			Japan Keirin and Autorace Foundation (JKA) [25-119]	This work was supported by the Japan Keirin and Autorace Foundation (JKA) (25-119). This work was carried out using equipment provided by the Cybermedia Center, Osaka University.	JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Han ZH, 2007, OPT COMMUN, V278, P199, DOI 10.1016/j.optcom.2007.05.058; Tanaka K, 2003, APPL PHYS LETT, V82, P1158, DOI 10.1063/1.1557323; Wang Q, 2006, OPT LETT, V31, P317, DOI 10.1364/OL.31.000317; Ma T, 2013, OPT EXPRESS, V21, P11994, DOI 10.1364/OE.21.011994; SOLDANO LB, 1995, J LIGHTWAVE TECHNOL, V13, P615, DOI 10.1109/50.372474; Bozhevolnyi SI, 2006, OPT EXPRESS, V14, P9467, DOI 10.1364/OE.14.009467; Min BK, 2009, NATURE, V457, P455, DOI 10.1038/nature07627; Chen CH, 2013, OPT EXPRESS, V21, P4036, DOI 10.1364/OE.21.004036; Hu N, 2013, CARBON, V51, P202, DOI 10.1016/j.carbon.2012.08.029; Kersey AD, 1997, J LIGHTWAVE TECHNOL, V15, P1442, DOI 10.1109/50.618377; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Yanai A, 2009, OPT EXPRESS, V17, P924, DOI 10.1364/OE.17.000924; Mohammed AAS, 2008, SENSORS-BASEL, V8, P2642, DOI 10.3390/s8042642; Zoo Y, 2006, THIN SOLID FILMS, V513, P170, DOI 10.1016/j.tsf.2006.002.005; Cochrane C, 2007, SENSORS-BASEL, V7, P473, DOI 10.3390/s7040473; Gunendi MC, 2013, OPT EXPRESS, V21, P18344, DOI 10.1364/OE.21.018344; Kou Y, 2011, OPT EXPRESS, V19, P6042, DOI 10.1364/OE.19.006042; Li E, 2008, APPL PHYS LETT, V92, P10117; Noh JS, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-441; Okamoto H, 2012, APPL PHYS B-LASERS O, V108, P149, DOI 10.1007/s00340-012-5081-y; Tahir BA, 2011, CHINESE J PHYS, V49, P1035; Tsai YJ, 2009, OPT EXPRESS, V17, P17471, DOI 10.1364/OE.17.017471; ULRICH R, 1975, OPT COMMUN, V13, P259, DOI 10.1016/0030-4018(75)90095-4	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1955	1557-1963		PLASMONICS	Plasmonics	DEC	2014	9	6					1351	1354		10.1007/s11468-014-9748-6		4	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	AT7XD	WOS:000345146800012		
J	Yakabi, K; Harada, Y; Takayama, K; Ro, S; Ochiai, M; Iizuka, S; Hattori, T; Wang, LX; Tache, Y				Yakabi, Koji; Harada, Yumi; Takayama, Kiyoshige; Ro, Shoki; Ochiai, Mitsuko; Iizuka, Seiichi; Hattori, Tomohisa; Wang, Lixin; Tache, Yvette			Peripheral alpha(2)-beta(1) adrenergic interactions mediate the ghrelin response to brain urocortin 1 in rats	PSYCHONEUROENDOCRINOLOGY			English	Article						Atylated ghrelin; Adrenergit receptors; Food intake; Urocortin 1; Stress; Rikkunshito	CORTICOTROPIN-RELEASING-FACTOR; EDINGER-WESTPHAL NUCLEUS; AUTONOMIC NERVOUS-SYSTEM; DES-ACYL GHRELIN; FOOD-INTAKE; CRF2 RECEPTORS; GASTROINTESTINAL-TRACT; CIRCULATING GHRELIN; ENERGY-METABOLISM; INDUCED ANOREXIA	The autonomic nervous system (ANS) conveys neuronal input from the brain to the stomach. We investigated mechanisms through which urocortin 1 (UCN1) injected intracerebroventricularly (ICV, 300 pmol/rat) inhibits circulating ghrelin in rats. This was achieved by assessing (1) the induction of c-fos gene expression as a marker of neuronal activation in specific hypothalamic and caudal brainstem regulating ANS; (2) the influence of vagotomy and pharmacological blockade of central and peripheral alpha- and beta-adrenergic receptor (AR) on ICY UCN1-induced reduction of plasma ghrelin levels (determined by ELISA); and (3) the relevance of this pathway in the feeding response to a fast in rats. UCN1 increased c-fos mRNA expression in key brain sites influencing sympathetic activity namely the hypothalamic paraventricular and ventromedial nuclei, locus coeruleus, nucleus of the solitary tract, and rostral ventrolateral medulla, by 16-, 29-, 6-, 37-, and 13-fold, respectively. In contrast, the dorsal motor nucleus of the vagus had little c-fos mRNA expression and ICY UCN1 induced a similar reduction in acylated ghrelin in the sham-operated (31%) and vagotomized (41%) rats. An intraperitoneal (IP) injection of either a non-selective alpha- or selective alpha(2)-AR antagonist reduced, while a selective alpha(2)-AR agonist enhanced ICV UCN1-induced suppression of plasma acylated ghrelin levels. In addition, IP injection of a non-selective beta- or selective beta(1)-AR agonist blocked, and selective beta(1)-AR antagonist augmented, the ghrelin response to ICV UCN1. The IP injections of a selective alpha(1)- or non-selective beta or beta(2)-AR antagonists, or any of the pretreatments given ICV had no effect. ICV UCN1 reduced the 2-h food intake in response to a fast by 80%, and this effect was partially prevented by a selective alpha(2)-AR antagonist. These data suggest that ICV UCN1 reduces plasma ghrelin mainly through the brain sympathetic component of the ANS and peripheral AR specifically alpha(2)-AR activation and inactivation of beta(1)-AR. The alpha(2)-AR pathway contributes to the associated reduction in food intake. (C) 2014 The Authors. Published by Elsevier Ltd.	[Yakabi, Koji; Harada, Yumi; Takayama, Kiyoshige; Ro, Shoki; Ochiai, Mitsuko] Saitama Med Univ, Dept Gastroenterol & Hepatol, Saitama Med Ctr, Saitama 3508550, Japan; [Harada, Yumi; Iizuka, Seiichi; Hattori, Tomohisa] Tsumura & Co, Tsumura Res Labs, Ami, Ibaraki 3001192, Japan; [Takayama, Kiyoshige] Gunma Univ, Sch Hlth Sci, Dept Lab Sci, Gunma 3718511, Japan; [Ro, Shoki] Teikyo Univ, Chiba Med Ctr, Cent Res Labs, Chiba 2990111, Japan; [Wang, Lixin; Tache, Yvette] Univ Calif Los Angeles, CURE Digest Dis Ctr, Dept Med, Div Digest Dis, Los Angeles, CA 90078 USA; [Wang, Lixin; Tache, Yvette] Univ Calif Los Angeles, Ctr Neurobiol Stress, Dept Med, Div Digest Dis, Los Angeles, CA 90078 USA; [Wang, Lixin; Tache, Yvette] VA Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90078 USA	Harada, Y (reprint author), Tsumura & Co, Tsumura Res Labs, 3586 Yoshiwara, Ami, Ibaraki 3001192, Japan.	harada_yumi@mail.tsumura.co.jp			Saitama Medical Center, Saitama Medical University (Japan); Tsumura Co. (Japan); Senior Research Career Scientist Award	This work was supported in part by Saitama Medical Center, Saitama Medical University (Japan), a grant from Tsumura & Co. (Japan) and the Senior Research Career Scientist Award (YT).	Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Toth ZE, 1999, J COMP NEUROL, V414, P255; Gyires K, 2007, NEUROCHEM INT, V51, P289, DOI 10.1016/j.neuint.2007.07.001; Takeda H, 2008, GASTROENTEROLOGY, V134, P2004, DOI 10.1053/j.gastro.2008.02.078; Quinson N, 2001, ARCH HISTOL CYTOL, V64, P281, DOI 10.1679/aohc.64.281; Takeda H, 2012, METHOD ENZYMOL, V514, P333, DOI 10.1016/B978-0-12-381272-8.00021-0; Stengel A, 2010, PEPTIDES, V31, P2229, DOI 10.1016/j.peptides.2010.08.026; Wang LX, 2006, AM J PHYSIOL-GASTR L, V291, pG611, DOI 10.1152/ajpgi.00533.2005; Stengel A, 2011, AM J PHYSIOL-GASTR L, V301, pG239, DOI 10.1152/ajpgi.00018.2011; Shah NS, 2013, J CHEM NEUROANAT, V52, P25, DOI 10.1016/j.jchemneu.2013.04.004; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Czimmer J, 2006, AM J PHYSIOL-GASTR L, V290, pG511, DOI 10.1152/ajpgi.00289.2005; Saper CB, 2002, ANNU REV NEUROSCI, V25, P433, DOI 10.1146/annurev.neuro.25.032502.111311; Gaszner B, 2004, J COMP NEUROL, V480, P170, DOI 10.1002/cne.20343; Mundinger TO, 2006, ENDOCRINOLOGY, V147, P2893, DOI 10.1210/en.2005-1182; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Hosoda H, 2008, REGUL PEPTIDES, V146, P12, DOI 10.1016/j.regpep.2007.07.005; Phillips RJ, 1996, AM J PHYSIOL-REG I, V271, pR766; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Spina M, 1996, SCIENCE, V273, P1561, DOI 10.1126/science.273.5281.1561; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Kozicz T, 1998, J COMP NEUROL, V391, P1, DOI 10.1002/(SICI)1096-9861(19980202)391:1<1::AID-CNE1>3.0.CO;2-6; Martinez V, 2004, J PHYSIOL-LONDON, V556, P221, DOI 10.1113/jphysiol.2003.059659; Yakabi K, 2011, AM J PHYSIOL-ENDOC M, V301, pE72, DOI 10.1152/ajpendo.00695.2010; Shrestha YB, 2009, PEPTIDES, V30, P1187, DOI 10.1016/j.peptides.2009.02.001; Bittencourt JC, 1999, J COMP NEUROL, V415, P285; Smagin GN, 1998, NEUROREPORT, V9, P1601, DOI 10.1097/00001756-199805110-00063; Benoit SC, 2000, PEPTIDES, V21, P345, DOI 10.1016/S0196-9781(00)00153-4; Bakshi VP, 2007, J NEUROSCI, V27, P10568, DOI 10.1523/JNEUROSCI.3044-06.2007; Becker C, 1999, NEUROPHARMACOLOGY, V38, P525, DOI 10.1016/S0028-3908(98)00209-3; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200; Chen Peilin, 2012, Front Endocrinol (Lausanne), V3, P180, DOI 10.3389/fendo.2012.00180; Currie PJ, 2001, BRAIN RES, V916, P222, DOI 10.1016/S0006-8993(01)02851-7; Daniels D, 2004, J NEUROSCI, V24, P11457, DOI 10.1523/JNEUROSCI.2702-04.2004; De Fanti BA, 2002, BRAIN RES, V930, P37, DOI 10.1016/S0006-8993(01)03401-1; de la Cour CD, 2007, REGUL PEPTIDES, V143, P118, DOI 10.1016/j.regpep.2007.05.001; Grill HJ, 2000, BRAIN RES, V867, P19, DOI 10.1016/S0006-8993(00)02193-4; Hosoda Hiroshi, 2002, Mol Interv, V2, P494, DOI 10.1124/mi.2.8.494; KRUKOFF TL, 1993, MOL NEUROBIOL, V7, P247, DOI 10.1007/BF02769178; Li X, 2010, AUTON NEUROSCI-BASIC, V154, P108, DOI 10.1016/j.autneu.2009.12.004; Mizutani M, 2009, AM J PHYSIOL-GASTR L, V297, pG974, DOI 10.1152/ajpgi.00147.2009; Muller TD, 2013, ENDOCR DEV, V25, P91, DOI 10.1159/000346590; Ohata H, 2000, BRAIN RES, V861, P1, DOI 10.1016/S0006-8993(99)02378-1; Patterson ZR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00130; Paxinos G, 1998, RAT BRAIN STEREOTAXI; Saegusa Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE685, DOI 10.1152/ajpendo.00121.2011; Stengel A., 2014, FRONT NEUROSCI, P8; SZEMEREDI K, 1991, BRAIN RES, V542, P8, DOI 10.1016/0006-8993(91)90990-D; UHLEN S, 1994, J PHARMACOL EXP THER, V271, P1558; Uhlen S, 1998, EUR J PHARMACOL, V343, P93, DOI 10.1016/S0014-2999(97)01521-5; Wang LX, 2013, PEPTIDES, V39, P164, DOI 10.1016/j.peptides.2012.11.009; Weitemier AZ, 2006, NEUROSCIENCE, V137, P1439, DOI 10.1016/j.neuroscience.2005.10.021; Zhao T.J., 2010, P NATL ACAD SCI US	53	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	DEC	2014	50						300	310		10.1016/j.psyneuen.2014.09.003		11	Endocrinology & Metabolism; Neurosciences; Psychiatry	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	AT6PJ	WOS:000345061000029		
J	Nishiyama, R				Nishiyama, Ryoji			Active maintenance of semantic representations	PSYCHONOMIC BULLETIN & REVIEW			English	Article						Semantic representations; Active maintenance; Verbal working memory	SHORT-TERM-MEMORY; IMMEDIATE SERIAL-RECALL; WORKING-MEMORY; ARTICULATORY SUPPRESSION; RETENTION; INFORMATION; LONG; INTERFERENCE; DISSOCIATIONS; RECOGNITION	In research on verbal working memory, articulatory rehearsal, a maintenance mechanism for phonological representations, has undergone intensive and excellent study. Possible mechanisms for semantic representation have received less attention. However, several studies have reported a double dissociation in types of memory deficits (semantic memory difficulties vs. phonological memory difficulties). This suggests the separability of two maintenance mechanisms. The present study focused on this separability in individuals with normal memory abilities, using a dual-task interference paradigm. The results indicate a crossover interaction between memory and interference task effects: Preventing articulatory rehearsal more strongly disrupted the phonological memory task, whereas performing a tapping task that interfered with attentional control more strongly disrupted semantic memory. These results suggest that semantic representations are actively maintained by a mechanism other than phonological maintenance.	Kwansei Gakuin Univ, Dept Psychol Sci, Nishinomiya, Hyogo 6628501, Japan	Nishiyama, R (reprint author), Kwansei Gakuin Univ, Dept Psychol Sci, 1-155 Uegahara Ichibancho, Nishinomiya, Hyogo 6628501, Japan.	ryoji.nishiyama@gmail.com					Alloway TP, 2010, EUR J COGN PSYCHOL, V22, P297, DOI 10.1080/09541440902793731; Amano S., 2000, NIHONGO NO GOITOKUSE, V7; Amano S., 2005, NIHONGO NO GOITOKUSE, V8; Hamilton AC, 2005, COGN AFFECT BEHAV NE, V5, P1; Romani C, 2008, Q J EXP PSYCHOL, V61, P292, DOI 10.1080/17470210601147747; Oberauer K, 2003, J MEM LANG, V49, P469, DOI 10.1016/S0749-596X(03)00080-9; MCLEOD P, 1984, ATTENTION PERFORM, V10, P55; Allen CM, 2012, APHASIOLOGY, V26, P428, DOI 10.1080/02687038.2011.617436; Oberauer K, 2008, PSYCHOL REV, V115, P544, DOI 10.1037/0033-295X.115.3.544; Shivde G, 2004, COGN AFFECT BEHAV NE, V4, P10, DOI 10.3758/CABN.4.1.10; BADDELEY AD, 1966, Q J EXP PSYCHOL, V18, P362, DOI 10.1080/14640746608400055; Howard D, 2005, COGN NEUROPSYCHOL, V22, P42, DOI 10.1080/02643290342000582; Hamilton AC, 2009, COGN NEUROPSYCHOL, V26, P685, DOI 10.1080/02643291003665688; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709; BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; Larsen JD, 2003, Q J EXP PSYCHOL-A, V56, P1249, DOI 10.1080/02724980244000765; Haarmann H, 2001, PSYCHON B REV, V8, P568, DOI 10.3758/BF03196193; Martin RC, 2003, J NEUROLINGUIST, V16, P341, DOI 10.1016/S0911-6044(03)00025-3; Majerus S, 2004, COGN NEUROPSYCHOL, V21, P491, DOI 10.1080/02643290342000104; Shivde G, 2011, J EXP PSYCHOL LEARN, V37, P1342, DOI 10.1037/a0024832; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D, 1986, WORKING MEMORY; CERMAK LS, 1976, MEM COGNITION, V4, P172, DOI 10.3758/BF03213161; Guerard K, 2009, EXP PSYCHOL, V56, P367, DOI 10.1027/1618-3169.56.5.367; LEVY BA, 1975, Q J EXP PSYCHOL, V27, P33, DOI 10.1080/14640747508400462; LOGIE RH, 1990, ACTA PSYCHOL, V75, P55, DOI 10.1016/0001-6918(90)90066-O; MARTIN RC, 1994, J MEM LANG, V33, P83, DOI 10.1006/jmla.1994.1005; Martin R., 1994, NEUROPSYCHOLOGY, V8, P506, DOI [10.1037/0894-4105.8.4.506, DOI 10.1037/0894-4105.8.4.506]; NELSON DL, 1979, MEM COGNITION, V7, P257, DOI 10.3758/BF03197598; Nishiyama R, 2013, J EXP PSYCHOL LEARN, V39, P642, DOI 10.1037/a0029160; O'Donnell R. D., 1986, HDB PERCEPTION PERFO, V2; Saint-Aubin J, 2005, PSYCHON B REV, V12, P171, DOI 10.3758/BF03196364; SHULMAN HG, 1972, J VERB LEARN VERB BE, V11, P221, DOI 10.1016/S0022-5371(72)80080-X; SHULMAN HG, 1970, J VERB LEARN VERB BE, V9, P499, DOI 10.1016/S0022-5371(70)80093-7; TELL PM, 1972, J VERB LEARN VERB BE, V11, P455, DOI 10.1016/S0022-5371(72)80027-6; WICKELGR.WA, 1973, PSYCHOL BULL, V80, P425, DOI 10.1037/h0035255; Witt ST, 2013, BRAIN IMAGING BEHAV, V7, P260, DOI 10.1007/s11682-013-9224-5	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1069-9384	1531-5320		PSYCHON B REV	Psychon. Bull. Rev.	DEC	2014	21	6					1583	1589		10.3758/s13423-014-0618-1		7	Psychology, Mathematical; Psychology, Experimental	Psychology	AT6XY	WOS:000345081400024		
J	Yamamura, E				Yamamura, Eiji			Impact of natural disaster on public sector corruption	PUBLIC CHOICE			English	Article						Corruption; Institution; Disasters; Risk	RENT-SEEKING; POLITICAL-ECONOMY; RESOURCE CURSE; GROWTH; RELIEF; FATALITIES; GOVERNMENT; KATRINA; INCOME; MODEL	This paper uses inter-country panel data from 1990 through 2010 to examine how the occurrence of natural disasters affects corruption within the public sector. For a closer analysis, disaster is classified into various categories, including general floods, other floods, tropical storms, other storms, earthquakes, volcanic eruptions, and landslides. Furthermore, this paper explores whether natural disasters have different impacts on corruption levels in developed and developing countries. The study reveals a number of novel findings. (1) Natural disasters that cause substantial damage increase public sector corruption in both developing and developed countries. (2) Natural disasters have a greater impact on public sector corruption in developed countries than in developing countries. (3) In developed countries, natural disaster frequency has a significant impact on the level of corruption. Hence, foreseeable disasters increase corruption in general. In developed countries, an incentive may exist to live within disaster-prone areas because of the potential for disaster compensation payments.	Seinan Gakuin Univ, Dept Econ, Fukuoka 8148511, Japan	Yamamura, E (reprint author), Seinan Gakuin Univ, Dept Econ, 6-2-92 Nishijin Sawara Ku, Fukuoka 8148511, Japan.	yamaei@seinan-gu.ac.jp					Ades A, 1999, AM ECON REV, V89, P982, DOI 10.1257/aer.89.4.982; Albala-Bertrand JM, 1993, POLITICAL EC LARGE N; Anbarci N, 2006, KYKLOS, V59, P327, DOI 10.1111/j.1467-6435.2006.00335.x; Svensson J, 2000, J INT ECON, V51, P437, DOI 10.1016/S0022-1996(99)00014-8; Shughart WF, 2006, PUBLIC CHOICE, V127, P31, DOI 10.1007/s11127-006-7731-2; Baland JM, 2000, J DEV ECON, V61, P527, DOI 10.1016/S0304-3878(00)00067-5; Cuaresma JC, 2008, ECON INQ, V46, P214, DOI 10.1111/j.1465-7295.2007.00063.x; Toya H, 2007, ECON LETT, V94, P20, DOI 10.1016/j.econlet.2006.06.020; Shughart WF, 2011, INDEP REV, V15, P519; La Porta R, 1999, J LAW ECON ORGAN, V15, P222, DOI 10.1093/jleo/15.1.222; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Torvik R, 2002, J DEV ECON, V67, P455, DOI 10.1016/S0304-3878(01)00195-X; Dreher A, 2010, PUBLIC CHOICE, V144, P215, DOI 10.1007/s11127-009-9513-0; Brollo F, 2013, AM ECON REV, V103, P1759, DOI 10.1257/aer.103.5.1759; Paldam M, 2001, KYKLOS, V54, P383, DOI 10.1111/j.0023-5962.2001.00160.x; [Anonymous], 2013, DAILY YOMIURI   0512; Luechinger S, 2009, J PUBLIC ECON, V93, P620, DOI 10.1016/j.jpubeco.2008.10.003; Escaleras M, 2007, PUBLIC CHOICE, V132, P209, DOI 10.1007/s11127-007-9148-y; Gokcekus O, 2008, ECON LETT, V99, P59, DOI 10.1016/j.econlet.2007.05.029; Anbarci N, 2005, J PUBLIC ECON, V89, P1907, DOI 10.1016/j.jpubeco.2004.08.002; Jain AK, 2001, J ECON SURV, V15, P71, DOI 10.1111/1467-6419.00133; Djankov S, 2008, J ECON GROWTH, V13, P169, DOI 10.1007/s10887-008-9032-8; Garrett TA, 2003, ECON INQ, V41, P496, DOI 10.1093/ei/cbg023; Strobl E, 2011, REV ECON STAT, V93, P575, DOI 10.1162/REST_a_00082; Serra D, 2006, PUBLIC CHOICE, V126, P225, DOI 10.1007/s11127-006-0286-4; Leeson PT, 2008, J LAW ECON, V51, P667, DOI 10.1086/590129; Sobel RS, 2006, PUBLIC CHOICE, V127, P55, DOI 10.1007/s11127-006-7730-3; Shiue CH, 2004, J ECON HIST, V64, P100; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Robinson JA, 2006, J DEV ECON, V79, P447, DOI 10.1016/j.jdeveco.2006.01.008; Kellenberg DK, 2008, J URBAN ECON, V63, P788, DOI 10.1016/j.jue.2007.05.003; Apergis N, 2010, PUBLIC CHOICE, V145, P125, DOI 10.1007/s11127-009-9557-1; Boettke P, 2007, SOUTH ECON J, V74, P363; Chamlee-Wright E., 2010, CULTURAL POLITICAL E; Davoodi H., 1997, WP97139 IMF; Djankov S, 2003, Q J ECON, V118, P453, DOI 10.1162/003355303321675437; Easterly W, 1997, Q J ECON, V112, P1203, DOI 10.1162/003355300555466; Eisensee T, 2007, Q J ECON, V122, P693, DOI 10.1162/qjec.122.2.693; Escaleras M, 2010, PUBLIC CHOICE, V145, P435, DOI 10.1007/s11127.009.9574.0; Escaleras MP, 2008, SOUTH ECON J, V74, P1017; Glaeser E. L., 2006, J PUBLIC ECON, V90, P1407; JIJI, 2012, JAPAN TIMES; Johnson ND, 2011, PUBLIC CHOICE, V147, P377, DOI 10.1007/s11127-010-9634-5; Kurosaki T., 2013, CTR EC I WORKING PAP, V2012-10; Leff N., 1964, AM BEHAV SCI, V82, P337; LUI FT, 1985, J POLIT ECON, V93, P760, DOI 10.1086/261329; MAURO P, 1995, Q J ECON, V110, P681, DOI 10.2307/2946696; Niskanen W. A., 1971, BUREAUCRACY REPRESEN; Pedro V., 2010, J DEV ECON, V92, P28; Pellegrini L., 2008, ECON GOV, V9, P245, DOI 10.1007/s10101-007-0033-4; Russell T., 2008, RISKING HOUSE HOME D; SHLEIFER A, 1993, Q J ECON, V108, P599, DOI 10.2307/2118402; Simmons KM, 2002, SOUTH ECON J, V68, P660, DOI 10.2307/1061724; Skidmore M., 2013, CESIFO WORKING PAPER, V3905; SWALEHEEN M, 2011, PUBLIC CHOICE, V146, P23; Treisman D, 2000, J PUBLIC ECON, V76, P399, DOI 10.1016/S0047-2727(99)00092-4; Vigdor JL, 2009, J ECON LIT, V47, P1156; World Bank, 2010, WORLD DEV IND 2010 C; Yamamura E, 2013, ECON GOV, V14, P233, DOI 10.1007/s10101-013-0125-2; Zanjani G., 2008, RISKING HOUSE HOME D	60	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0048-5829	1573-7101		PUBLIC CHOICE	Public Choice	DEC	2014	161	3-4					385	405		10.1007/s11127-014-0154-6		21	Economics; Political Science	Business & Economics; Government & Law	AT7XF	WOS:000345147000007		
J	Bayad, A; Hamahata, Y				Bayad, Abdelmejid; Hamahata, Yoshinori			Multiple Dedekind-Rademacher sums in finite fields	RAMANUJAN JOURNAL			English	Article						Dedekind sums; Cotangent sums; Higher-dimensional Dedekind sums; Finite fields		In this paper, we introduce multiple Dedekind-Rademacher sums in finite fields and establish the reciprocity law. Our Dedekind-Rademacher sums generalize the higher-dimensional Dedekind sums introduced in our previous paper (Bayad and Hamahata in Finite Fields Appl. 18:19-25, 2012).	[Bayad, Abdelmejid] Univ Evry Val dEssonne, Dept Math, F-91037 Evry, France; [Hamahata, Yoshinori] Ritsumeikan Univ, Inst Teaching & Learning, Kusatsu, Shiga 5258577, Japan	Hamahata, Y (reprint author), Ritsumeikan Univ, Inst Teaching & Learning, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	abayad@maths.univ-evry.fr; hamahata@fc.ritsumei.ac.jp			Japan Society for the Promotion of Science [20540026]	The second named author was supported by the Grant-in-Aid for Scientific Research (No. 20540026), Japan Society for the Promotion of Science.	Bayad A, 2012, J NUMBER THEORY, V132, P332, DOI 10.1016/j.jint.2011.05.020; ZAGIER D, 1973, MATH ANN, V202, P149, DOI 10.1007/BF01351173; Beck M, 2003, ACTA ARITH, V109, P109, DOI 10.4064/aa109-2-1; Bayad A, 2012, FINITE FIELDS TH APP, V18, P19, DOI 10.1016/j.ffa.2011.05.001; Gekeler EU, 2001, FINITE FIELDS TH APP, V7, P553, DOI 10.1006/ffta.2000.0314; Hamahata Y, 2008, LECT NOTES COMPUT SC, V5130, P11, DOI 10.1007/978-3-540-69499-1_2; Rademacher H., 1972, DEDEKIND SUMS	7	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1382-4090	1572-9303		RAMANUJAN J	Ramanujan J.	DEC	2014	35	3					493	502		10.1007/s11139-013-9527-6		10	Mathematics	Mathematics	AT3CN	WOS:000344813400009		
J	Hirai, M; Gunji, A; Inoue, Y; Kita, Y; Hayashi, T; Nishimaki, K; Nakamura, M; Kakigi, R; Inagaki, M				Hirai, Masahiro; Gunji, Atsuko; Inoue, Yuki; Kita, Yosuke; Hayashi, Takashi; Nishimaki, Kengo; Nakamura, Miho; Kakigi, Ryusuke; Inagaki, Masumi			Differential electrophysiological responses to biological motion in children and adults with and without autism spectrum disorders	RESEARCH IN AUTISM SPECTRUM DISORDERS			English	Article						Point-light walker; Biological motion; Event-related potential (ERP); Autism spectrum disorder; Development; Children	VISUAL-EVOKED-POTENTIALS; EVENT-RELATED POTENTIALS; COHERENT MOTION; BRAIN ACTIVITY; OBJECT MOTION; SPATIOTEMPORAL DYNAMICS; SOCIAL-PERCEPTION; CORTEX; ONSET; BODY	Although atypical processing of biological motion (BM) in individuals with autism spectrum disorder (ASD) has been reported, the temporal profile of the neural response to BM is not well explored. In the current study, event-related potentials (ERPs) were measured in 12 individuals with ASD, aged 8-22 years, and 12 age- and gender-matched normal controls, to investigate the electrophysiological response to BM and a control visual stimulus. By introducing a novel experimental paradigm that can dissociate the electrophysiological responses to motion processing and the global shape processing of BM, we found that: (1) the timing of the response was preserved in ASD groups, whereas (2) the ERP response to BM was significantly enhanced compared with scrambled point-light motion (SM) in normal controls; the responses to both BM and SM were not significantly different in subjects with ASD. Because we did not find a significant group effect on the peak and mean amplitude induced by BM, it is presumed that this atypical response in individuals with ASD was due to over-sensitivity to the local motion signals. This experimental paradigm showed atypical local motion processing of BM in individuals with ASD. (C) 2014 Elsevier Ltd. All rights reserved.	[Hirai, Masahiro; Kakigi, Ryusuke] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 4448585, Japan; [Hirai, Masahiro; Gunji, Atsuko; Inoue, Yuki; Kita, Yosuke; Hayashi, Takashi; Inagaki, Masumi] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Dev Disorders, Kodaira, Tokyo 1878553, Japan; [Gunji, Atsuko] Yokohama Natl Univ, Coll Educ & Human Sci, Yokohama, Kanagawa 2408501, Japan; [Hirai, Masahiro] Aichi Human Serv Ctr, Inst Dev Res, Dept Functioning Sci, Kasugai, Aichi 4800392, Japan; [Inoue, Yuki] Shimada Ryoiku Ctr Hachioji, Tokyo 1930931, Japan; [Hayashi, Takashi] Nishikawa Clin, Dept Dev Med, Ube, Yamaguchi 7550151, Japan; [Nishimaki, Kengo] Natl Rehabil Ctr Persons Disabil, Dept Med Treatment 3, Pediat & Child Psychiat Sect, Tokorozawa, Saitama 3598555, Japan	Hirai, M (reprint author), Jichi Med Univ, Ctr Dev Adv Med Technol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	hirai@jichi.ac.jp	Gunji, Atsuko/O-6323-2014	Gunji, Atsuko/0000-0001-8908-8739			Annaz D., 2011, DEVELOPMENTAL SCI, V13, P826; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; Santi A, 2003, J COGNITIVE NEUROSCI, V15, P800, DOI 10.1162/089892903322370726; Hirai M, 2009, NEUROSCIENCE, V161, P311, DOI 10.1016/j.neuroscience.2009.03.026; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Nakamura H, 2003, NEUROSCI RES, V46, P423, DOI 10.1016/S0168-0102(03)00119-6; Bonda E, 1996, J NEUROSCI, V16, P3737; Kaiser MD, 2012, DEV COGN NEUROS-NETH, V2, P25, DOI 10.1016/j.dcn.2011.05.005; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Koldewyn K, 2011, DEVELOPMENTAL SCI, V14, P1075, DOI 10.1111/j.1467-7687.2011.01058.x; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Thierry G, 2006, NEUROIMAGE, V32, P871, DOI 10.1016/j.neuroimage.2006.03.060; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; CUTTING JE, 1978, BEHAV RES METH INSTR, V10, P91, DOI 10.3758/BF03205105; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Kaiser MD, 2010, P NATL ACAD SCI USA, V107, P21223, DOI 10.1073/pnas.1010412107; Safford AS, 2010, J NEUROSCI, V30, P9064, DOI 10.1523/JNEUROSCI.1779-10.2010; Greimel E, 2013, BEHAV BRAIN RES, V251, P168, DOI 10.1016/j.bbr.2013.05.055; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Kuba M, 2007, VISION RES, V47, P189, DOI 10.1016/j.visres.2006.09.020; Servos P, 2002, CEREB CORTEX, V12, P772, DOI 10.1093/cercor/12.7.772; KUBA M, 1992, DOC OPHTHALMOL, V80, P83, DOI 10.1007/BF00161234; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; Michels L, 2009, NEUROIMAGE, V45, P151, DOI 10.1016/j.neuroimage.2008.10.063; Moore DG, 1997, BRIT J DEV PSYCHOL, V15, P401; Grossman ED, 2004, J COGNITIVE NEUROSCI, V16, P1669, DOI 10.1162/0898929042568569; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Jokisch D, 2005, BEHAV BRAIN RES, V157, P195, DOI 10.1016/j.bbr.2004.06.025; Stekelenburg JJ, 2004, NEUROREPORT, V15, P777, DOI 10.1097/01.wnr.0000119730.93564.e8; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; Koldewyn K, 2010, BRAIN, V133, P599, DOI 10.1093/brain/awp272; Murphy P, 2009, NEUROPSYCHOLOGIA, V47, P3225, DOI 10.1016/j.neuropsychologia.2009.07.026; Pavlova M, 2006, ANN NEUROL, V59, P415, DOI 10.1002/ana.20762; Jokisch D, 2005, EUR J NEUROSCI, V21, P3439, DOI 10.1111/j.1460-9568.2005.04145.x; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; Heinrich SP, 2004, J VISION, V4, P469, DOI 10.1167/4.6.6; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Pelphrey KA, 2003, J NEUROSCI, V23, P6819; Aspell JE, 2005, EUR J NEUROSCI, V22, P2937, DOI 10.1111/j.1460-9568.2005.04473.x; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004; Herrington JD, 2007, RES AUTISM SPECT DIS, V1, P14, DOI 10.1016/j.rasd.2006.07.002; Hirai M, 2005, COGNITIVE BRAIN RES, V23, P387, DOI 10.1016/j.cogbrainres.2004.11.005; Cook J, 2009, NEUROPSYCHOLOGIA, V47, P3275, DOI 10.1016/j.neuropsychologia.2009.07.010; Hirai M, 2008, CLIN NEUROPHYSIOL, V119, P2775, DOI 10.1016/j.clinph.2008.09.008; Hirai M, 2009, NEUROREPORT, V20, P267, DOI 10.1097/WNR.0b013e32832000de; Hoffmann M, 1999, VISION RES, V39, P437, DOI 10.1016/S0042-6989(98)00186-2; Ito H, 2012, RES AUTISM SPECT DIS, V6, P1265, DOI 10.1016/j.rasd.2012.04.002; JOHANSSO.G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kaiser MD, 2010, AUTISM RES, V3, P191, DOI 10.1002/aur.137; Kroger A., 2013, SOCIAL COGNITIVE AFF; Lam K, 2000, NEUROSCIENCE, V97, P1, DOI 10.1016/S0306-4522(00)00037-3; MEASSO G, 1993, ACTA NEUROL SCAND, V88, P70; Milne E, 2005, CAH PSYCHOL COGN, V23, P3; Patzwahl DR, 1996, NEUROREPORT, V7, P469, DOI 10.1097/00001756-199601310-00022; Pavlova M., 2011, CEREBRAL CORTEX; Saygin AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013491; Spileers W, 1996, EVOKED POTENTIAL, V100, P287, DOI 10.1016/0168-5597(96)94750-4; Sugishita M., 1993, RAVENS COLOURED PROG; Troje N. F., 2008, SENSES COMPREHENSIVE, P231; Uno A., 2005, ONSEIGENGOIGAKU, P185; Virji-Babul N, 2007, NEUROREPORT, V18, P1125, DOI 10.1097/WNR.0b013e32821c5470	68	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-9467	1878-0237		RES AUTISM SPECT DIS	Res. Autism Spectr. Disord.	DEC	2014	8	12					1623	1634		10.1016/j.rasd.2014.08.014		12	Education, Special; Psychology, Developmental; Psychiatry; Rehabilitation	Education & Educational Research; Psychology; Psychiatry; Rehabilitation	AT8MG	WOS:000345186700001		
J	Asano, R; Tsuchiya, KJ; Takei, N; Harada, T; Kugizaki, Y; Nakahara, R; Nakayasu, C; Okumura, A; Suzuki, Y; Takagai, S; Mori, N				Asano, Ryosuke; Tsuchiya, Kenji J.; Takei, Nori; Harada, Taeko; Kugizaki, Yumeno; Nakahara, Ryuji; Nakayasu, Chikako; Okumura, Akemi; Suzuki, Yukiko; Takagai, Shu; Mori, Norio		HBC Study Team	Broader autism phenotype as a risk factor for postpartum depression: Hamamatsu Birth Cohort (HBC) Study	RESEARCH IN AUTISM SPECTRUM DISORDERS			English	Article						Postpartum depression; Broader autism phenotype; Epidemiology; Birth cohort; Pregnant women; Japan	SEROTONIN TRANSPORTER; POSTNATAL DEPRESSION; SPECTRUM DISORDERS; CHILDREN; FAMILIES; PARENTS; MOOD; MOTHERS; TRAITS; BRAIN	The broader autism phenotype (BAP), which refers to the expression of behavioral and cognitive propensities that are milder but qualitatively similar to those defining autism spectrum disorder, can play a crucial role in postpartum depression (PPD). We investigated whether pregnant women's BAP would increase the risk for PPD, using a representative birth cohort in Japan. Pregnant women were enrolled in the Hamamatsu Birth Cohort (HBC) Study during their mid-gestation (N = 841) and were followed up until 3 months after delivery. BAP was measured mainly during the 2nd trimester of the pregnancy by using the Broader Phenotype Autism Symptoms Scale. Participants scoring 9 points or higher on the Edinburgh Postnatal Depression Scale at least once during the first 3 months after childbirth were diagnosed with PPD. Among participants, 128 (15.2%) women were found to have PPD. Multiple logistic regression analyses showed that BAP were associated with PPD (OR = 1.19, 95% CI [1.07-1.31]), even after controlling for other potential confounders. In addition, the association was not moderated by history of depression and/or anxiety disorders, including concurrent depressive and anxiety symptoms during pregnancy. The findings suggest that pregnant women with BAP have an elevated risk for PPD. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).	[Asano, Ryosuke; Tsuchiya, Kenji J.; Takei, Nori; Harada, Taeko; Kugizaki, Yumeno; Nakahara, Ryuji; Nakayasu, Chikako; Okumura, Akemi; Suzuki, Yukiko; Takagai, Shu; Mori, Norio] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Tsuchiya, Kenji J.; Takei, Nori; Takagai, Shu] Osaka Univ, Dept Child Dev, United Grad Sch Child Dev, Suita, Osaka 565, Japan; [Tsuchiya, Kenji J.; Takei, Nori; Takagai, Shu] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Tsuchiya, Kenji J.; Takei, Nori; Takagai, Shu] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan; [Tsuchiya, Kenji J.; Takagai, Shu; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka 4313192, Japan; [Takei, Nori] Kings Coll London, Inst Psychiat, Div Psychol Med, London WC2R 2LS, England	Tsuchiya, KJ (reprint author), Handayama 1 Higashiku, Hamamatsu, Shizuoka 4313192, Japan.	tsuchiya@hama-med.ac.jp					American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Murray EA, 2011, BIOL PSYCHIAT, V69, pE43, DOI 10.1016/j.biopsych.2010.09.041; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Piven J, 1999, AM J PSYCHIAT, V156, P557; Paulson JF, 2006, PEDIATRICS, V118, P659, DOI 10.1542/peds.2005-2948; Hay DF, 2008, J CHILD PSYCHOL PSYC, V49, P1079, DOI 10.1111/j.1469-7610.2008.01959.x; Gjerdingen DK, 2007, J AM BOARD FAM MED, V20, P280, DOI 10.3122/jabfm.2007.03.060171; Ingersoll B, 2011, RES AUTISM SPECT DIS, V5, P337, DOI 10.1016/j.rasd.2010.04.017; Dawson G, 2002, DEV PSYCHOPATHOL, V14, P581, DOI 10.1017/S0954579402003103; Matsumoto K, 2011, J AFFECT DISORDERS, V133, P607, DOI 10.1016/j.jad.2011.04.024; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Yamashita H, 2000, J AFFECT DISORDERS, V58, P145, DOI 10.1016/S0165-0327(99)00108-1; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Mori T, 2011, J AFFECT DISORDERS, V135, P341, DOI 10.1016/j.jad.2011.07.012; Davey HL, 2011, MATERN CHILD HLTH J, V15, P866, DOI 10.1007/s10995-008-0314-8; Piven J, 1997, AM J PSYCHIAT, V154, P185; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Sanjuan J, 2008, BRIT J PSYCHIAT, V193, P383, DOI 10.1192/bjp.bp.107.045427; Dawson G, 2005, DEV PSYCHOPATHOL, V17, P679, DOI 10.1017/S0954579405050327; Cook Edwin H. Jr., 1996, Current Opinion in Pediatrics, V8, P348, DOI 10.1097/00008480-199608000-00008; Dawson G, 2007, J AUTISM DEV DISORD, V37, P523, DOI 10.1007/s10803-006-0182-2; Dennis C-L, 2004, Arch Womens Ment Health, V7, P183; Devlin B, 2005, MOL PSYCHIATR, V10, P1110, DOI 10.1038/sj.mp.4001724; Doornbos B, 2009, PROG NEURO-PSYCHOPH, V33, P1250, DOI 10.1016/j.pnpbp.2009.07.013; First M., 1997, STRUCTURED CLINICAL; Gerdts J, 2011, AUTISM RES TREAT, V2011, DOI DOI 10.1155/2011/545901; Gerdts JA, 2013, J AUTISM DEV DISORD, V43, P1597, DOI 10.1007/s10803-012-1706-6; Holden J., 2003, PERINATAL MENTAL HEA; Kanne SM, 2012, J AUTISM DEV DISORD, V42, P769, DOI 10.1007/s10803-011-1308-8; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; Matson JL, 2007, RES DEV DISABIL, V28, P567, DOI 10.1016/j.ridd.2006.08.001; Riccio O, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.49; Skalkidou Alkistis, 2012, Womens Health (Lond Engl), V8, P659, DOI 10.2217/whe.12.55; Tamaki R, 1997, PSYCHIAT CLIN NEUROS, V51, P93, DOI 10.1111/j.1440-1819.1997.tb02368.x; Tsuchiya KJ, 2010, J DEV ORIG HLTH DIS, V1, P158, DOI 10.1017/S2040174410000140; Wan EY, 2009, INT J GYNECOL OBSTET, V104, P209, DOI 10.1016/j.ijgo.2008.10.016; Yirmiya N, 2005, J CHILD PSYCHOL PSYC, V46, P69, DOI 10.1111/j.1469-7610.2004.00334.x	42	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1750-9467	1878-0237		RES AUTISM SPECT DIS	Res. Autism Spectr. Disord.	DEC	2014	8	12					1672	1678		10.1016/j.rasd.2014.08.010		7	Education, Special; Psychology, Developmental; Psychiatry; Rehabilitation	Education & Educational Research; Psychology; Psychiatry; Rehabilitation	AT8MG	WOS:000345186700006		
J	Takahara, M; Shimomura, I				Takahara, Mitsuyoshi; Shimomura, Iichiro			Metabolic syndrome and lifestyle modification	REVIEWS IN ENDOCRINE & METABOLIC DISORDERS			English	Review						Metabolic syndrome; Visceral fat accumulation; Lifestyle modification; Health promotion program in healthcare field	CORONARY-HEART-DISEASE; VISCERAL FAT ACCUMULATION; BODY-MASS INDEX; SIMPLE ANTHROPOMETRIC INDEXES; CARDIOVASCULAR RISK-FACTORS; EPICARDIAL ADIPOSE-TISSUE; TYPE-2 DIABETES-MELLITUS; Y GASTRIC BYPASS; IMPROVE INSULIN SENSITIVITY; BETA-CELL FUNCTION	A clustering of metabolic abnormalities such as dyslipidemia, hypertension, and diabetes mellitus, all of which are major risk factors for cardiovascular disease (CVD), occurs more often than by chance. Numerous epidemiological studies, as well as basic researches, have revealed that visceral fat accumulation is closely involved in this risk clustering. This morbid condition is now well recognized as the metabolic syndrome. The concept of the metabolic syndrome, i.e., the involvement of visceral adiposity in the clustering of CVD risk factors, implies that an effective CVD risk reduction will be accomplished by an intervention to reduce visceral fat deposits. The primary strategy of the intervention is lifestyle modification, which can be put into practice in healthcare fields, without necessity of medical treatment. Now that CVD is a leading global health burden, the metabolic syndrome attracts increasing attention in the world. To take global action against the syndrome, several working groups developed its internationally unified diagnostic criteria. Most recently, the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) jointly proposed the criteria, although some cautions will be needed in their practical use. In this review, we mainly focus on the findings observed in clinical and epidemiological studies, to discuss a practical strategy of the management of the metabolic syndrome in healthcare fields.	[Takahara, Mitsuyoshi; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan	Shimomura, I (reprint author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	shimomura@endmet.med.osaka-u.ac.jp					Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anderson PJ, 1997, DIABETES CARE, V20, P1854, DOI 10.2337/diacare.20.12.1854; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; KANNEL WB, 1961, ANN INTERN MED, V55, P33; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Borel AL, 2012, OBESITY, V20, P1223, DOI 10.1038/oby.2011.396; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Bosy-Westphal A, 2010, OBESITY, V18, P2111, DOI 10.1038/oby.2010.49; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Chan EW, 2013, OBES REV, V14, P383, DOI 10.1111/obr.12015; Wilson PWF, 1998, CIRCULATION, V97, P1837; Bradley D, 2012, J CLIN INVEST, V122, P4667, DOI 10.1172/JCI64895; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Okauchi Y, 2007, DIABETES CARE, V30, P2392, DOI 10.2337/dc07-0218; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Yim JE, 2007, INT J OBESITY, V31, P1400, DOI 10.1038/sj.ijo.0803621; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629; Hippisley-Cox J, 2007, BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Cameron AJ, 2008, J INTERN MED, V264, P177, DOI 10.1111/j.1365-2796.2008.01935.x; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; KANAI H, 1990, HYPERTENSION, V16, P484; Fabbrini E, 2010, GASTROENTEROLOGY, V139, P448, DOI 10.1053/j.gastro.2010.04.056; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Hiuge-Shimizu A, 2012, ANN MED, V44, P82, DOI 10.3109/07853890.2010.526138; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; [Anonymous], 2001, JAMA, V285, P2486; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Despres JP, 2000, ARTERIOSCL THROM VAS, V20, P1932; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Miller GD, 2011, DIABETES OBES METAB, V13, P189, DOI 10.1111/j.1463-1326.2010.01338.x; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Stern MP, 2002, ANN INTERN MED, V136, P575; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Nazare JA, 2013, J NUTR, V143, P1074, DOI 10.3945/jn.113.175273; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Alssema M, 2011, DIABETOLOGIA, V54, P1004, DOI 10.1007/s00125-010-1990-7; Iacobellis G, 2005, J CLIN ENDOCR METAB, V90, P6300, DOI 10.1210/jc.200-1087; Byrne CD, 2014, ARTERIOSCL THROM VAS, V34, P1155, DOI 10.1161/ATVBAHA.114.303034; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; TOKUNAGA K, 1983, INT J OBESITY, V7, P437; Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075; Toledo-Corral CM, 2013, J CLIN ENDOCR METAB, V98, P1115, DOI 10.1210/jc.2012-3806; Borel AL, 2012, METABOLISM, V61, P262, DOI 10.1016/j.metabol.2011.06.024; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Ai M, 2011, ATHEROSCLEROSIS, V217, P543, DOI 10.1016/j.atherosclerosis.2011.05.035; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Viner RM, 2010, OBES REV, V11, P593, DOI 10.1111/j.1467-789X.2009.00651.x; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Liu JK, 2010, J CLIN ENDOCR METAB, V95, P5419, DOI 10.1210/jc.2010-1378; Lin WY, 2002, INT J OBESITY, V26, P1232, DOI 10.1038/sj.ijo.0802040; Takahara M, 2012, J ATHEROSCLER THROMB, V19, P767; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; NAKAMURA T, 1994, ATHEROSCLEROSIS, V107, P239, DOI 10.1016/0021-9150(94)90025-6; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129; VAGUE J, 1947, PRESSE MED, V55, P339; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361; Nishimura A, 2006, CLIN CHIM ACTA, V371, P163, DOI 10.1016/j.cca.2006.03.008; Balkau B, 1999, DIABETIC MED, V16, P442; Barba C, 2004, LANCET, V363, P157; Chilton M, 2014, DIABETES OBES METAB, V16, P237, DOI 10.1111/dom.12198; Csendes A, 2009, OBES SURG, V19, P490, DOI 10.1007/s11695-008-9660-2; Dillard TH, 2013, SURG OBES RELAT DIS, V9, P269, DOI 10.1016/j.soard.2011.09.027; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Herrera MF, 2010, DIABETES CARE, V33, P1413, DOI 10.2337/dc09-1833; Hippisley-Cox J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b880; Kim MK, 2014, J DIABETES INVEST, V5, P221, DOI 10.1111/jdi.12137; Kim MK, 2009, NUTR METAB CARDIOVAS, V19, P760, DOI 10.1016/j.numecd.2009.01.010; LEAN MEJ, 1995, BRIT MED J, V311, P158; Lear SA, 2003, METABOLISM, V52, P1295, DOI 10.1016/S0026-0495(03)00196-3; Lima MMO, 2013, OBESITY, V21, pE182, DOI 10.1002/oby.20030; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsumoto S, 2002, BIOCHEM BIOPH RES CO, V292, P781, DOI 10.1006/bbrc.2002.6720; Muramoto A, 2010, J JPN SOC STUDY OBES, V16, P182; Oka R, 2010, OBESITY, V18, P153, DOI 10.1038/oby.2009.180; Okauchi Yukiyoshi, 2009, Diabetes Care, V32, pe122, DOI 10.2337/dc09-1130; Okauchi Y, 2010, ATHEROSCLEROSIS, V212, P698, DOI 10.1016/j.atherosclerosis.2010.06.011; Padwal R, 2004, COCHRANE DB SYST REV, V3; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pelletier-Beaumont E, 2012, ATHEROSCLEROSIS, V221, P577, DOI 10.1016/j.atherosclerosis.2012.01.023; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Rabkin SW, 2014, METAB SYNDR RELAT D, V12, P31, DOI 10.1089/met.2013.0107; Ryo M, 2011, INTERNAL MED, V50, P1643, DOI 10.2169/internalmedicine.50.5039; Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Takahara M, 2013, J ATHEROSCLER THROMB, V20, P310; Takahara M, 2014, J ATHEROSCLER THROMB, V21, P543; Tamboli RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028577; The Examination Committee for Criteria of Metabolic Syndrome in Japan, 2005, J JPN SOC INTERN MED, V94; Vissers D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056415; Wang CY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000297; Wannamethee SG, 2008, INT J OBESITY, V32, pS25, DOI 10.1038/ijo.2008.32; World Health Organization, 2008, 2008 2013 ACT PLAN G	109	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-9155	1573-2606		REV ENDOCR METAB DIS	Rev. Endocr. Metab. Disord.	DEC	2014	15	4					317	327		10.1007/s11154-014-9294-8		11	Endocrinology & Metabolism	Endocrinology & Metabolism	AU0TW	WOS:000345338400008		
J	Sakai, R; Cho, SK; Nanki, T; Koike, R; Watanabe, K; Yamazaki, H; Nagasawa, H; Amano, K; Tanaka, Y; Sumida, T; Ihata, A; Yasuda, S; Nakajima, A; Sugihara, T; Tamura, N; Fujii, T; Dobashi, H; Miura, Y; Miyasaka, N; Harigai, M				Sakai, Ryoko; Cho, Soo-Kyung; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Yamazaki, Hayato; Nagasawa, Hayato; Amano, Koichi; Tanaka, Yoshiya; Sumida, Takayuki; Ihata, Atsushi; Yasuda, Shinsuke; Nakajima, Atsuo; Sugihara, Takahiko; Tamura, Naoto; Fujii, Takao; Dobashi, Hiroaki; Miura, Yasushi; Miyasaka, Nobuyuki; Harigai, Masayoshi		REAL Study Grp	The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database	RHEUMATOLOGY INTERNATIONAL			English	Article						Rheumatoid arthritis; Epidemiology; Tumor necrosis factor inhibitor; Infection; Risk	MODIFYING ANTIRHEUMATIC DRUGS; POSTMARKETING SURVEILLANCE; EULAR RECOMMENDATIONS; MANAGEMENT; THERAPY; AGENTS; RATES	To investigate changes in the risk for serious infections (SIs) over time in Japanese rheumatoid arthritis (RA) patients treated with tumor necrosis factor inhibitors (TNFIs). This prospective cohort study included Japanese RA patients who began treatment with a TNFI from 2005 to 2007 (2005 group, n = 716, 634.2 patient years [PY]) and from 2008 to 2011 (2008 group, n = 352, 270.1 PY) at the time or after their enrollment in the registry of Japanese RA patients on biologics for long-term safety (REAL) database. Patients were observed for 12 months or until discontinuation of their initial TNFI in the REAL database. Drug discontinuation reasons and retention rates were analyzed. Incidence rates of serious adverse events (SAEs) were calculated with 95 % confidence intervals (CIs). The Cox proportional hazard model was applied to estimate the risk for SIs. The retention rate in the 2008 group was significantly lower than the 2005 group (p < 0.001). Discontinuation rates due to lack of efficacy or good control for the 2008 group were significantly higher than the 2005 group (p < 0.001). The crude incidence rate ratios comparing the 2008 group with the 2005 group for SAEs were 0.93 (95 % CI 0.65-1.34) and for SIs were 0.50 (0.24-1.03). The 2008 group had significantly lower risk for SIs than the 2005 group after adjusting for covariates (hazard ratio: 0.43 [0.20-0.93]). These results indicate significant decrease of the risk for SIs with TNFI treatment over time; this may be explained by evidence-based risk management of RA patients given TNFIs.	[Sakai, Ryoko; Cho, Soo-Kyung; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Yamazaki, Hayato; Harigai, Masayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pharmacovigilance, Bunkyo Ku, Tokyo 1138519, Japan; [Sakai, Ryoko; Nanki, Toshihiro; Koike, Ryuji; Watanabe, Kaori; Yamazaki, Hayato; Miyasaka, Nobuyuki; Harigai, Masayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med & Rheumatol, Bunkyo Ku, Tokyo 1138519, Japan; [Cho, Soo-Kyung] Hanyang Univ, Hosp Rheumat Dis, Seoul 133792, South Korea; [Koike, Ryuji; Harigai, Masayoshi] Tokyo Med & Dent Univ Hosp, Clin Res Ctr, Fac Med, Bunkyo Ku, Tokyo 1138519, Japan; [Nagasawa, Hayato; Amano, Koichi] Saitama Med Univ, Dept Rheumatol Clin Immunol, Saitama Med Ctr, Kawagoe, Saitama 3508550, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Dept Internal Med 1, Yahatanishi Ku, Fukuoka 8070804, Japan; [Sumida, Takayuki] Univ Tsukuba, Dept Internal Med, Tsukuba, Ibaraki 3050006, Japan; [Ihata, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Yasuda, Shinsuke] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Nakajima, Atsuo] Tokyo Metropolitan Police Hosp, Dept Rheumatol, Nakano Ku, Tokyo 1648541, Japan; [Sugihara, Takahiko] Tokyo Metropolitan Geriatr Hosp, Dept Med & Rheumatol, Itabashi Ku, Tokyo 1730015, Japan; [Tamura, Naoto] Juntendo Univ, Dept Internal Med & Rheumatol, Fac Med, Bunkyo Ku, Tokyo 1138421, Japan; [Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Sakyo Ku, Kyoto 6068507, Japan; [Dobashi, Hiroaki] Kagawa Univ, Fac Med, Dept Internal Med 1, Div Endocrinol & Metab Hematol Rheumatol & Resp M, Miki, Kagawa 7610793, Japan; [Miura, Yasushi] Kobe Univ, Dept Orthopaed Surg, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Miyasaka, Nobuyuki] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1138519, Japan	Harigai, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pharmacovigilance, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	mharigai.mpha@tmd.ac.jp			Ministry of Health, Labor and Welfare, Japan [H22- meneki-ippann-001]; Japan Society for the Promotion of Science [20390158, 19590530]; Abbott Laboratories; Bristol-Myers Squibb; Eisai Co. Ltd.; Chugai Pharmaceutical Co. Ltd.; Mitsubishi-Tanabe Pharma Co.; Takeda Pharmaceutical Co. Ltd.; Pfizer Japan Inc.; Japanese Ministry of Education; Global Center of Excellence (GCOE) Program	This work was supported by a grant-in-aid from the Ministry of Health, Labor and Welfare, Japan (H19-menekiippan-009 to N. Miyasaka, H22- meneki-ippann-001 to M. Harigai) and by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (# 20390158 to M. Harigai, # 19590530 to R. Koike). This work was also supported by grants for pharmacovigilance research on biologicals from Abbott Laboratories, Bristol-Myers Squibb, Eisai Co. Ltd., Chugai Pharmaceutical Co. Ltd., Mitsubishi-Tanabe Pharma Co., Takeda Pharmaceutical Co. Ltd., and Pfizer Japan Inc. (to M. Harigai), and by a grant from the Japanese Ministry of Education, Global Center of Excellence (GCOE) Program, " International Research Center for Molecular Science in Tooth and Bone Diseases".	Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Takeuchi T, 2010, NAT REV RHEUMATOL, V6, P644, DOI 10.1038/nrrheum.2010.154; Au K, 2011, ANN RHEUM DIS, V70, P785, DOI 10.1136/ard.2010.128637; Sakai R, 2012, ARTHRIT CARE RES, V64, P1125, DOI 10.1002/acr.21666; Listing J, 2005, ARTHRITIS RHEUM, V52, P3403, DOI 10.1002/art.21386; Koike T, 2012, MOD RHEUMATOL, V22, P498, DOI 10.1007/s10165-011-0541-5; Strangfeld A, 2011, ANN RHEUM DIS, V70, P1914, DOI 10.1136/ard.2011.151043; Hetland ML, 2008, ANN RHEUM DIS, V67, P1023, DOI 10.1136/ard.2007.087262; Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748; Dixon WG, 2006, ARTHRITIS RHEUM, V54, P2368, DOI 10.1002/art.21978; Koike T, 2009, J RHEUMATOL, V36, P898, DOI 10.3899/jrheum.080791; Favalli EG, 2009, AUTOIMMUN REV, V8, P266, DOI 10.1016/j.autrev.2008.11.002; Castro-Rueda Hernan, 2008, Curr Opin Rheumatol, V20, P314, DOI 10.1097/BOR.0b013e3282f5fcf6; Japan College of Rheumatology, 2012, 2012 UP JAP GUID US; Koike Ryuji, 2007, Mod Rheumatol, V17, P451, DOI 10.1007/s10165-007-0626-3; Lobo Francis S, 2006, Res Social Adm Pharm, V2, P143, DOI 10.1016/j.sapharm.2005.12.001; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Singh JA, 2013, ARTHRIT CARE RES, V65, P832, DOI 10.1002/acr.21872	19	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0172-8172	1437-160X		RHEUMATOL INT	Rheumatol. Int.	DEC	2014	34	12					1729	1736		10.1007/s00296-014-3045-8		8	Rheumatology	Rheumatology	AU0TY	WOS:000345338700014		
J	Endo, K; Hayashi, K; Ida, T; Takemura, T				Endo, Kazunaka; Hayashi, Koichiro; Ida, Tomonori; Takemura, Tetsuo			IR and Py-GC/MS Spectral Simulation of Polymer Film by Quantum Chemical and Quantum Molecular Dynamics Calculations Using the Polymer Models	RUSSIAN JOURNAL OF PHYSICAL CHEMISTRY A			English	Article						polymers; IR spectra; MS; quantum chemical calculations; QMD calculations	REACTIVE FORCE-FIELD; THERMAL-DECOMPOSITION; PARTICLE BOMBARDMENT; VAPOR-DEPOSITION; HYDROCARBONS; POLYSTYRENE; DENSITY; REAXFF	We have simulated IR and pyrolysis gas chromatography mass spectrometry (Py-GCMS) spectra of six polymers (PE, PP, PS, PET, N6, PVDF) with the density-functional theory and quantum molecular dynamics calculations on model oligomers. In the former calculations, experimental harmonic frequencies of the polymers have been assigned from the simulated IR spectra. In the latter QMD calculations on thermal decomposition of polymer models, the approximated mass spectra of six (PE, PP, PS, PET, N6, PVDF) polymers were almost in good accordance with the experimental results in Py-GC/MS, although we adjusted the decomposition temperatures to 2240, 2520, and 2800 K as the average absolute deviation of 8%.	[Endo, Kazunaka; Takemura, Tetsuo] Tokyo Univ Sci, Res Inst Sci & Technol, Shinjuku Ku, Kagurazaka 1628601, Japan; [Hayashi, Koichiro; Ida, Tomonori] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Chem,Fac Sci, Kanazawa, Ishikawa 9201192, Japan	Endo, K (reprint author), Tokyo Univ Sci, Res Inst Sci & Technol, Shinjuku Ku, Kagurazaka 1628601, Japan.	endo_kz@nifty.com					HAILE JM, 1983, J CHEM PHYS, V79, P3067, DOI 10.1063/1.446137; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; BECKE AD, 1992, J CHEM PHYS, V97, P9173, DOI 10.1063/1.463343; Stuart SJ, 2000, J CHEM PHYS, V112, P6472, DOI 10.1063/1.481208; [Anonymous], 1985, J AM CHEM SOC; Nyden MR, 2004, MAT SCI ENG A-STRUCT, V365, P114, DOI 10.1016/j.msea.2003.09.060; Sinnott SB, 1999, CHEM PHYS LETT, V315, P25, DOI 10.1016/S0009-2614(99)01216-6; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Stoliarov SI, 2003, POLYMER, V44, P883, DOI 10.1016/S0032-3861(02)00761-9; Chenoweth K, 2005, J AM CHEM SOC, V127, P7192, DOI 10.1021/ja050980t; van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Brenner DW, 2000, PHYS STATUS SOLIDI B, V217, P23, DOI 10.1002/(SICI)1521-3951(200001)217:1<23::AID-PSSB23>3.0.CO;2-N; BRENNER DW, 1991, THIN SOLID FILMS, V206, P220, DOI 10.1016/0040-6090(91)90425-W; Chatterjee R, 1999, J PHYS CHEM B, V103, P151, DOI 10.1021/jp9833045; Delcorte A, 2000, J PHYS CHEM B, V104, P2673, DOI 10.1021/jp993539w; IR Polymers, 2006, IR POLYMERS FTIR SPE; KELCHNER CL, 1994, SURF SCI, V310, P425, DOI 10.1016/0039-6028(94)91405-2; Liu KSS, 1999, J PHYS CHEM B, V103, P3195, DOI 10.1021/jp984071k; Nyden M. R., 2000, FIRE RETARDANCY POLY, P501; Nyden M. R., 1998, PROCEEDINGS OF THE I; NYDEN MR, 1992, MACROMOLECULES, V25, P1658, DOI 10.1021/ma00032a007; Nyden MR, 1997, POLYM ENG SCI, V37, P1496, DOI 10.1002/pen.11798; RAEKER TJ, 1991, INT REV PHYS CHEM, V10, P1, DOI 10.1080/01442359109353253; Rappe A. K., 1997, MOL ENG, V7, P385, DOI 10.1023/A:1008264127580; STAVE MS, 1990, J CHEM PHYS, V93, P4413, DOI 10.1063/1.458724; TAYLOR RS, 1995, LANGMUIR, V11, P1220, DOI 10.1021/la00004a030	29	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0036-0244	1531-863X		RUSS J PHYS CHEM A+	Russ. J. Phys. Chem. A	DEC	2014	88	13					2370	2379		10.1134/S0036024414130081		10	Chemistry, Physical	Chemistry	AT4AA	WOS:000344877400015		
J	Terada, Y				Terada, Yoshikazu			Strong Consistency of Reduced K-means Clustering	SCANDINAVIAN JOURNAL OF STATISTICS			English	Article						clustering; dimension reduction; k-means	CENTRAL-LIMIT-THEOREM; FACTORIAL	Reduced k-means clustering is a method for clustering objects in a low-dimensional subspace. The advantage of this method is that both clustering of objects and low-dimensional subspace reflecting the cluster structure are simultaneously obtained. In this paper, the relationship between conventional k-means clustering and reduced k-means clustering is discussed. Conditions ensuring almost sure convergence of the estimator of reduced k-means clustering as unboundedly increasing sample size have been presented. The results for a more general model considering conventional k-means clustering and reduced k-means clustering are provided in this paper. Moreover, a consistent selection of the numbers of clusters and dimensions is described.	Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Terada, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.	terada@sigmath.es.osaka-u.ac.jp			 [24 . 2466]	The author wishes to express his thanks to the associate editor and the reviewer for their valuable comments that have significantly improved the paper. The author also thanks Professor Yutaka Kano and Assistant Professor Kengo Kamatani for their supervision of this research. This work was supported by Grant-in-Aid for JSPS Fellows Number 24 . 2466.	Timmerman ME, 2010, COMPUT STAT DATA AN, V54, P1858, DOI 10.1016/j.csda.2010.02.009; Sun W, 2012, ELECTRON J STAT, V6, P148, DOI 10.1214/12-EJS668; Abraham C, 2003, SCAND J STAT, V30, P581, DOI 10.1111/1467-9469.00350; Yang YH, 2006, STAT SINICA, V16, P635; LINDER T, 1994, IEEE T INFORM THEORY, V40, P1728, DOI 10.1109/18.340451; Vichi M, 2001, COMPUT STAT DATA AN, V37, P49, DOI 10.1016/S0167-9473(00)00064-5; POLLARD D, 1981, ANN STAT, V9, P135, DOI 10.1214/aos/1176345339; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Arabie P., 1994, ADV METHODS MARKETIN, P160; Chang W., 1983, APPL STAT-J ROY ST C, V32, P267, DOI 10.2307/2347949; Cheng RCH, 2001, SCAND J STAT, V28, P603, DOI 10.1111/1467-9469.00257; De Soete G., 1994, NEW APPROACHES CLASS, P212; DEHARDT J, 1971, ANN MATH STAT, V42, P2050, DOI 10.1214/aoms/1177693073; Garcia-Escudero LA, 1999, ANN STAT, V27, P1061; Peskir G., 2000, UNIFORM LAWS LARGE N; Pfanzagl J., 1994, PARAMETRIC STAT THEO; POLLARD D, 1982, ANN PROBAB, V10, P919, DOI 10.1214/aop/1176993713; Shamir O., 2007, ADV NEURAL INF PROCE, V20, P1297; Terada Y., 2013, STRONG CONSISTENCY F; van der Vaart A.W., 1998, ASYMPTOTIC STAT; vons Luxburg U., 2008, ANN STAT, V36, P555; Wang JH, 2010, BIOMETRIKA, V97, P893, DOI 10.1093/biomet/asq061	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-6898	1467-9469		SCAND J STAT	Scand. J. Stat.	DEC	2014	41	4					913	931		10.1111/sjos.12074		19	Statistics & Probability	Mathematics	AT3UO	WOS:000344860800004		
J	Phartyal, SS; Kondo, T; Fuji, A; Hidayati, SN; Walck, JL				Phartyal, Shyam S.; Kondo, Tetsuya; Fuji, Akinori; Hidayati, Siti N.; Walck, Jeffrey L.			A comprehensive view of epicotyl dormancy in Viburnum furcatum: combining field studies with laboratory studies using temperature sequences	SEED SCIENCE RESEARCH			English	Article						cotyledon emergence; epicotyl dormancy; morphophysiological dormancy; radicle emergence; temperature sequences; Viburnum	SEED DORMANCY; MORPHOPHYSIOLOGICAL DORMANCY; GERMINATION; CAPRIFOLIACEAE; EMERGENCE; PHENOLOGY; JAPAN; ECOPHYSIOLOGY; REQUIREMENTS; LILIACEAE	Seeds with epicotyl dormancy reside in soil up to 15 months (or longer), being exposed to a sequence of temperatures, before seedlings completely emerge (i.e. with both roots and shoots). Heretofore, few studies have examined precise temperatures, especially in sequences, for promotion of radicle and cotyledon emergence and how they relate to environmental cues in nature. Viburnum is the best known genus to exhibit epicotyl dormancy and, as such, we investigated the Japanese V. furcatum, hypothesizing a similar kind and level of dormancy. The under-developed embryos in mature seeds in October were spatulate shaped, unlike those in other Viburnum species, and they elongated from late June to August of the following year. Radicles emerged after embryo growth until mid-October, followed by cotyledons from mid-April to mid-May. Temperatures required for embryo growth, radicle and cotyledon emergence in the laboratory approximated closely those in the field. Embryo elongation and radicle emergence occurred at warm temperature regimes, and gibberellic acid (GA(3)) did not substitute for this warm temperature requirements. Following a 120-d cold stratification of seeds with an emerged radicle, shoots emerged from seeds at 10, 15, 15/5, 20/10 and 25/15 degrees C. We identified that seeds of V. furcatum have deep simple epicotyl morphophysiological dormancy like the majority of other Viburnum species. For propagation of the species from seeds, the nearly 2-year period for seedling emergence could be shortened to 8 months: start fresh seeds at 25/15 degrees C (60 d) and then move them through a sequence of 15/5 degrees C (30 d) -> 0 degrees C (120 d) -> 20/10 degrees C (30 d).	[Phartyal, Shyam S.; Kondo, Tetsuya; Fuji, Akinori] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Phartyal, Shyam S.] Garhwal Cent Univ, Dept Forestry, Srinagar, Uttarakhand, India; [Phartyal, Shyam S.] Garhwal Cent Univ, NR, HNB, Srinagar, Uttarakhand, India; [Hidayati, Siti N.; Walck, Jeffrey L.] Middle Tennessee State Univ, Dept Biol, Evolut & Ecol Grp, Murfreesboro, TN 37132 USA	Phartyal, SS (reprint author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan.	shyamphartyal@gmail.com			Japanese Society for the Promotion of Science (JSPS) [P06195]	The senior author thanks the Japanese Society for the Promotion of Science (JSPS) for a Postdoctoral Fellowship (P06195).	Kondo T, 2011, AM J BOT, V98, P215, DOI 10.3732/ajb.1000151; Mattana E, 2012, PLANT BIOLOGY, V14, P77, DOI 10.1111/j.1438-8677.2011.00476.x; Jayasuriya KMGG, 2010, AM J BOT, V97, P15, DOI 10.3732/ajb.0900213; BASKIN JM, 1985, B TORREY BOT CLUB, V112, P253, DOI 10.2307/2996540; Baskin CC, 2009, PROPAG ORNAM PLANTS, V9, P115; Kondo T, 2005, CAN J BOT, V83, P571, DOI [10.1139/B05-027, 10.1139/b05-027]; Baskin CC, 2008, SEED SCI RES, V18, P179, DOI 10.1017/S0960258508042177; Kondo T, 2006, AM J BOT, V93, P849, DOI 10.3732/ajb.93.6.849; Adams CA, 2003, J TORREY BOT SOC, V130, P11, DOI 10.2307/3557520; MARTIN AC, 1946, AM MIDL NAT, V36, P513, DOI 10.2307/2421457; Hidayati SN, 2000, AM J BOT, V87, P1669, DOI 10.2307/2656744; Takagi H, 2001, J JPN SOC HORTIC SCI, V70, P424; Baskin CC, 2009, INT J PLANT SCI, V170, P174, DOI 10.1086/595283; Hidayati SN, 2005, AM MIDL NAT, V153, P232, DOI 10.1674/0003-0031(2005)153[0232:EDIVAC]2.0.CO;2; Bremer B, 2009, BOT J LINN SOC, V161, P105; Barton L.V., 1958, P PLANT PROPAGATORS, V8, P126; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Chien CT, 2011, ANN BOT-LONDON, V108, P13, DOI 10.1093/aob/mcr096; Copete E, 2011, ANN BOT-LONDON, V107, P1003, DOI 10.1093/aob/mcr030; Dhyani A, 2013, J BIOSCIENCES, V38, P13, DOI 10.1007/s12038-012-9284-5; Giersbach J, 1937, CONTRIBUTIONS B THOM, V9, P79; Hara M., 1990, NAT HIST RES, V1, P49; Hara M., 1991, SAITO HO ON KAI MUSE, V59, P43; Hukusima Tukasa, 1995, Japanese Journal of Ecology (Sendai), V45, P79; Jayasuriya KMGG, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls044; Karlsson LM, 2005, ANN BOT-LONDON, V95, P323, DOI 10.1093/aob/mci029; Kondo T, 2004, SEED SCI RES, V14, P371, DOI 10.1079/SSR2004182; Mondoni A, 2009, SEED SCI RES, V19, P137, DOI 10.1017/S0960258509990067; Moura M, 2010, PROPAG ORNAM PLANTS, V10, P129; Nozaki E., 1983, INT C BEAR RES MANAG, V5, P106; Ohwi J., 1965, FLORA JAPAN; Phartyal SS, 2012, ECOL RES, V27, P677, DOI 10.1007/s11284-012-0940-x; Phartyal SS, 2009, AM J BOT, V96, P1086, DOI 10.3732/ajb.0800379; Stokes P, 1965, ENCY PLANT PHYSL, V15, P746; USDA-ARS, 2011, NAT GEN RES PROGR; Vandelook F, 2007, ANN BOT-LONDON, V100, P233, DOI 10.1093/aob/mcm090; Walck JL, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls007; Yamanaka N., 1986, B KYOTO U FOR, V57, P26	38	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0960-2585	1475-2735		SEED SCI RES	Seed Sci. Res.	DEC	2014	24	4					281	292		10.1017/S0960258514000257		12	Plant Sciences	Plant Sciences	AT4TR	WOS:000344935900002		
J	Takashima, K; Sugitani, K; Morimoto, N; Sakaguchi, S; Noritsugu, T; Mukai, T				Takashima, Kazuto; Sugitani, Kazuhiro; Morimoto, Naohiro; Sakaguchi, Seiya; Noritsugu, Toshiro; Mukai, Toshiharu			Pneumatic artificial rubber muscle using shape-memory polymer sheet with embedded electrical heating wire	SMART MATERIALS AND STRUCTURES			English	Article						shape-memory polymer; pneumatic rubber muscle; shape fixity; Joule heat; shape recovery; glass transition temperature	MEDICAL APPLICATIONS; POLYURETHANE; COMPOSITES	Shape-memory polymer (SMP) can be deformed by applying a small load above its glass transition temperature (T-g). Shape-memory polymer maintains its shape after it has cooled below T-g and returns to a predefined shape when subsequently heated above T-g. The reversible change in the elastic modulus between the glassy and rubbery states of an SMP can be on the order of several hundred times. Based on the change in stiffness of the SMP in relation to the change in temperature, the present study attempts to evaluate the application of the SMP to soft actuators of a robot. In order to control the temperature of the SMP, we developed an SMP sheet with an embedded electrical heating wire. We formed a uniform, thin SMP sheet without air bubbles using a heat press. The SMP sheet with a heating wire can be heated quickly and can be maintained at a constant temperature. Moreover, the effects of the embedded wire on the mechanical properties in bending and tensile tests were small. Then, we applied the SMP sheet with the embedded electrical heating wire to a pneumatic artificial rubber muscle. The enhanced versatility of SMP sheet applications is demonstrated through a series of experiments conducted using a prototype. The initial shape and bending displacement of the pneumatic artificial rubber muscle can be changed by controlling the temperature of the SMP sheet.	[Takashima, Kazuto; Sugitani, Kazuhiro; Morimoto, Naohiro; Sakaguchi, Seiya] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan; [Takashima, Kazuto; Mukai, Toshiharu] RIKEN, Innovat Ctr, Moriyama Ku, Nagoya, Aichi 4630003, Japan; [Noritsugu, Toshiro] Tsuyama Natl Coll Technol, Tsuyama 7088509, Japan	Takashima, K (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	ktakashima@life.kyutech.ac.jp			Mazda Foundation	The present study was supported by a research grant from The Mazda Foundation.	Meng H, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/9/093001; Baer G, 2007, J APPL POLYM SCI, V103, P3882, DOI 10.1002/app.25567; Yang B, 2005, EUR POLYM J, V41, P1123, DOI 10.1016/j.eurpolymj.2004.11.029; Cho JW, 2005, MACROMOL RAPID COMM, V26, P412, DOI 10.1002/marc.200400492; Shahinpoor M, 2005, SMART MATER STRUCT, V14, P197, DOI 10.1088/0964-1726/14/1/020; Takashima K, 2010, SENSOR ACTUAT A-PHYS, V164, P116, DOI 10.1016/j.sna.2010.09.010; Behl M, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70047-0; Higuchi T, 2010, NEXT-GENERATION ACTUATORS LEADING BREAKTHROUGHS, P1, DOI 10.1007/978-1-84882-991-6; Li ZF, 2011, J INTEL MAT SYST STR, V22, P1605, DOI 10.1177/1045389X11406763; Rossiter J, 2012, SMART MATER STRUCT, V21, P1; Rossiter J, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/4/045007; Sagawa H, 1988, J ROBOTICS SOC JAPAN, V6, P109; Sasaki D, 2006, J ROBOTICS SOC JAPAN, V24, P640; Takashima K, 2012, J ROBOTICS MECHATRON, V24, P472; Takashima K, 2010, JOJUNAL ROBOTICS SOC, V28, P905; Tobushi H, 2007, T JSME, V73, P1150; Yamano M, 2013, P IEEE SICE INT S SY, P647	17	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0964-1726	1361-665X		SMART MATER STRUCT	Smart Mater. Struct.	DEC	2014	23	12							125005	10.1088/0964-1726/23/12/125005		9	Instruments & Instrumentation; Materials Science, Multidisciplinary	Instruments & Instrumentation; Materials Science	AT9WU	WOS:000345275400006		
J	Sato, N				Sato, Norihisa			A characterization result for approval voting with a variable set of alternatives	SOCIAL CHOICE AND WELFARE			English	Article							MATHEMATICAL STRUCTURE	In this paper, we present a new result for axiomatic characterization of approval voting. Having defined a model in which the actual set of alternatives becomes known only after a vote has been taken, we characterize approval voting as the only voting procedure (to be precise, "family of ballot aggregation functions") that satisfies faithfulness (F), consistency (C), stability on selected alternatives (SSA), and independence of dropped alternatives (IDA). SSA, which is a version of the property introduced by Arrow (Economica 16:121-127, 1959), states that if the actual set of alternatives is smaller than the original set, we should select those alternatives, if any, that would have been selected on the first vote and that are still feasible. On the other hand, IDA suggests that we should select alternatives based on the outcome of the second vote. Therefore, given F and C, approval voting is the only voting procedure that selects the same set of alternatives irrespective of which vote counts, that is, the first or second vote.	Nagoya Gakuin Univ, Fac Econ, Atsuta Ku, Nagoya, Aichi 4568612, Japan	Sato, N (reprint author), Nagoya Gakuin Univ, Fac Econ, Atsuta Ku, 1-25 Atsuta Nishimachi, Nagoya, Aichi 4568612, Japan.	nrsato@gmail.com					Alcalde-Unzu J, 2014, J MATH ECON, V50, P69, DOI 10.1016/j.jmateco.2013.09.004; Alcalde-Unzu J, 2011, WORKING PAPER; Alos-Ferrer C, 2006, SOC CHOICE WELFARE, V27, P621, DOI 10.1007/s00355-006-0145-8; FISHBURN PC, 1978, J ECON THEORY, V19, P180, DOI 10.1016/0022-0531(78)90062-5; ARROW KJ, 1959, ECONOMICA, V26, P121, DOI 10.2307/2550390; BAIGENT N, 1991, MATH SOC SCI, V21, P21, DOI 10.1016/0165-4896(91)90037-R; BRAMS SJ, 1978, AM POLIT SCI REV, V72, P831, DOI 10.2307/1955105; Fishburn P. C, 1978, AGGREGATION REVELATI; Masso J, 2008, ECON THEOR, V36, P129, DOI 10.1007/s00199-007-0263-2; Nurmi H, 1987, COMPARING VOTING SYS; Nurmi H., 1999, VOTING PARADOXES DEA; Saari DG, 2000, ECON THEOR, V15, P55; Saari DG, 2000, ECON THEOR, V15, P1, DOI 10.1007/s001990050001; SERTEL MR, 1988, J ECON THEORY, V45, P207, DOI 10.1016/0022-0531(88)90262-1; Vorsatz M, 2007, SOC CHOICE WELFARE, V28, P127, DOI 10.1007/s00355-006-0149-4; Xu J, 2010, HDB APPROVAL VOTING	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	DEC	2014	43	4					809	825		10.1007/s00355-014-0811-1		17	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	AU0UC	WOS:000345339100002		
J	Guerci, E; Hanaki, N; Watanabe, N; Esposito, G; Lu, XY				Guerci, Eric; Hanaki, Nobuyuki; Watanabe, Naoki; Esposito, Gabriele; Lu, Xiaoyan			A methodological note on a weighted voting experiment	SOCIAL CHOICE AND WELFARE			English	Article							POWER	We conducted a sensitivity analysis of the results of weighted voting experiments by varying two features of the experimental protocol by Montero et al. (Soc Choice Welf 30(1):69-87, 2008): (1) the way in which the roles of subjects are reassigned in each round [random role (RR) vs. fixed role (FR)] and (2) the number of proposals that subjects can simultaneously approve [multiple approval (MA) vs. single approval (SA)]. It was observed that the differences in these protocols had impacts on the relative frequencies of minimum winning coalitions (MWCs) as well as how negotiations proceed. 3-player MWCs were more frequently observed, negotiations were much longer, subjects made less mistakes, and proposal-objection dynamics were more frequently observed, under the protocol with FR and SA than under the protocol with RR and MA.	[Guerci, Eric] Univ Nice Sophia Antipolis, ISEM, F-06189 Nice, France; [Guerci, Eric] CNRS, GREDEG, UMR 7321, F-06034 Nice, France; [Hanaki, Nobuyuki] Aix Marseille Univ, Aix Marseille Sch Econ, CNRS, EHESS, Marseille, France; [Hanaki, Nobuyuki] IUF, Marseille, France; [Watanabe, Naoki] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki 3058573, Japan; [Esposito, Gabriele] Commiss European Communities, Joint Res Ctr, Inst Prospect Technol Studies, Seville, Spain; [Lu, Xiaoyan] Janssen Pharmaceut NV, Beerse, Belgium	Watanabe, N (reprint author), Univ Tsukuba, Fac Engn Informat & Syst, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058573, Japan.	eric.guerci@gredeg.cnrs.fr; nobuyuki.HANAKI@univ-amu.fr; naoki50@sk.tsukuba.ac.jp; gabriele.esposito@ec.europa.eu; xlu2@its.jnj.com					Aleskerov F, 2009, POWER PREFERENCES EX; Frechette G, 2005, J PUBLIC ECON, V89, P1497, DOI 10.1016/j.jpubeco.2004.02.009; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.3102/10769986017004315; BARON DP, 1989, AM POLIT SCI REV, V83, P1181, DOI 10.2307/1961664; Montero M, 2008, SOC CHOICE WELFARE, V30, P69, DOI 10.1007/s00355-007-0222-7; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Shapley LS, 1954, AM POLIT SCI REV, V48, P787, DOI 10.2307/1951053; AUMANN RJ, 1964, ANN MATH STUD, V52, P443; Banzhaf J.F., 1965, RUTGERS LAW REV, V19, P317; Deegan J., 1978, International Journal of Game Theory, V7, DOI 10.1007/BF01753239; Drouvelis M, 2010, GAME ECON BEHAV, V69, P274, DOI 10.1016/j.geb.2009.12.002; Esposito G, 2012, EXPT STUDY MEA UNPUB; Felsenthal D.S., 1998, MEASUREMENT VOTING P; Frechette GR, 2005, GAME ECON BEHAV, V51, P365, DOI 10.1016/j.geb.2004.11.003; Kagel JH, 2010, EXP ECON, V13, P167, DOI 10.1007/s10683-010-9234-8; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Morelli M, 1999, AM POLIT SCI REV, V93, P809, DOI 10.2307/2586114; PACKEL EW, 1980, PUBLIC CHOICE, V35, P229, DOI 10.1007/BF00140846; Rao MM, 1960, SOME ASYMPTOTIC RESU, P60; Riker W. H., 1962, THEORY POLITICAL COA; Winer B.J., 1971, STAT PRINCIPLES EXPT	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	DEC	2014	43	4					827	850		10.1007/s00355-014-0814-y		24	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	AU0UC	WOS:000345339100003		
J	Shinohara, R				Shinohara, Ryusuke			Participation and demand levels for a joint project	SOCIAL CHOICE AND WELFARE			English	Article							EXCLUDABLE PUBLIC GOOD; VOLUNTARY PARTICIPATION; GOODS; ALLOCATIONS; PROVISION; GAME	We examine a voluntary participation game in public good provision in which each agent has a demand level for the public good. The agent's demand level is the minimum level of the public good from which she can receive a positive benefit. In this game, there exists a subgame perfect Nash equilibrium at which the (Pareto) efficient allocation is achieved. The voluntary participation game may also have a subgame perfect Nash equilibrium with underprovision of the public good. However, some subgame perfect Nash equilibrium with the efficient allocation satisfies strong perfection, introduced by Rubinstein (Int J Game Theory 9:1-12, 1980), and strong perfection is satisfied only by the subgame perfect Nash equilibrium with the efficient allocation. Furthermore, all payoffs at strong perfect equilibria belong to the core of the enterprise game. By these results, we conclude that in our case, the voluntary participation problem is not as serious as the earlier studies report. We also discuss the extensibility of these results.	Hosei Univ, Dept Econ, Machida, Tokyo 1940298, Japan	Shinohara, R (reprint author), Hosei Univ, Dept Econ, 4342 Aihara Machi, Machida, Tokyo 1940298, Japan.	ryusukes@hosei.ac.jp					Saijo T, 1999, J ECON THEORY, V84, P227, DOI 10.1006/jeth.1998.2476; Furusawa T, 2011, THEOR ECON, V6, P219, DOI 10.3982/TE567; Dixit A, 2000, J PUBLIC ECON, V76, P309, DOI 10.1016/S0047-2727(99)00089-4; Aumann R., 1959, CONTRIBUTIONS THEORY, V4, P287; Branzei R, 2005, J PUBLIC ECON THEORY, V7, P623, DOI 10.1111/j.1467-9779.2005.00237.x; DASPREMONT C, 1983, CAN J ECON, V16, P17, DOI 10.2307/134972; GROVES T, 1977, ECONOMETRICA, V45, P783, DOI 10.2307/1912672; Healy PJ, 2010, REV ECON DES, V14, P27, DOI 10.1007/s10058-009-0090-y; LITTLECH.SC, 1973, MANAGE SCI, V20, P370, DOI 10.1287/mnsc.20.3.370; Nishimura Y, 2013, SOC CHOICE WELFARE, V40, P793, DOI 10.1007/s00355-011-0644-0; PALFREY TR, 1984, J PUBLIC ECON, V24, P171, DOI 10.1016/0047-2727(84)90023-9; Rubinstein A., 1980, International Journal of Game Theory, V9, DOI 10.1007/BF01784792; Saijo T, 2010, REV ECON DES, V14, P51, DOI 10.1007/s10058-009-0100-0; Konishi H, 2014, J PUBLIC ECON THEORY, V16, P173, DOI 10.1111/jpet.12054; Shinohara R, 2009, SOC CHOICE WELFARE, V32, P367, DOI 10.1007/s00355-008-0329-5; Shinohara R, 2007, WORKING PAPER; WALKER M, 1981, ECONOMETRICA, V49, P65, DOI 10.2307/1911126	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0176-1714	1432-217X		SOC CHOICE WELFARE	Soc Choice Welf.	DEC	2014	43	4					925	952		10.1007/s00355-014-0806-y		28	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	AU0UC	WOS:000345339100007		
J	Patrascu, M; Stancu, AF; Pop, F				Patrascu, Monica; Stancu, Alexandra Florentina; Pop, Florin			HELGA: a heterogeneous encoding lifelike genetic algorithm for population evolution modeling and simulation	SOFT COMPUTING			English	Article						Evolutionary computing; Genetic algorithms; Modeling; Simulation; Human race evolution	OPTIMIZATION; CONVERGENCE	Today, there is a substantial need for population evolution modeling in multidisciplinary research areas, such as social sciences (sociology, anthropology etc.), which can neither be solved formally, nor empirically at global scale, thus requiring the development of heuristic techniques, like evolutionary algorithms. Therefore, existent methodologies of social simulation can be extended from microenvironments to large scale modeling of extremely complex systems, as it is the case of human evolution. The modeling of population evolution prediction is currently used in high interest areas, from migration flows, to financial crisis simulation, to the free-market economy models, as well as multi-national family dynamics and cultural aspects. The high performance of evolutionary computing has been already proven in the context of virus population evolution, be they biological or cybernetic, thus making them the perfect method for our endeavour. This paper presents the design and implementation of a soft computing application, namely HELGA-heterogeneous encoding lifelike genetic algorithm. HELGA was designed for the modeling and simulation of Earth population evolution, on a global scale, throughout multiple historical eras. The model shows the tendency of human evolution towards one mixed race. The algorithm takes into account the influence of social factors, such as the Industrial Revolution or the discovery of the New World. Our method, for which all constraints have been based on validated research, has aligned precisely to real historical events: it anticipated the end of antiquity, the industrial era, the baby boom phenomenon and so on. For example, the poor health conditions of the Middle Ages have caused a drastic drop in population size. The presented model shows the valiant result of one final race, and although this theory cannot be formally proved in the present, we consider that our results can be used as hypothesis for future social science research. Also, HELGA can be extended with new capabilities and constraints.	[Patrascu, Monica] Univ Politehn Bucuresti, Automat Control & Syst Engn Dept, Fac Automat Control & Comp, Bucharest, Romania; [Stancu, Alexandra Florentina] Univ Tokyo, Grad Sch Engn, Dept Syst Innovat, Tokyo, Japan; [Stancu, Alexandra Florentina] Makino Milling Machine CO LTD, Tokyo, Japan; [Pop, Florin] Univ Politehn Bucuresti, Dept Comp Sci, Fac Automat Control & Comp, Bucharest, Romania	Pop, F (reprint author), Univ Politehn Bucuresti, Dept Comp Sci, Fac Automat Control & Comp, Bucharest, Romania.	monica.patrascu@acse.pub.ro; stancu@makino.co.jp; florin.pop@cs.pub.ro	Patrascu, Monica/H-9868-2014	Patrascu, Monica/0000-0003-2201-2312			Albano P., 2011, Proceedings of the 2011 Third International Conference on Intelligent Networking and Collaborative Systems (INCoS 2011), DOI 10.1109/INCoS.2011.129; Castiglione A, 2012, COMPUT MATH APPL, V63, P437, DOI 10.1016/j.camwa.2011.07.068; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Alcala-Fdez J, 2009, FUZZY SET SYST, V160, P905, DOI 10.1016/j.fss.2008.05.012; Hrstka O, 2004, ADV ENG SOFTW, V35, P237, DOI 10.1016/S0965-9978(03)00113-3; [Anonymous], 2002, SER JOINT FAO WHO UN; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Schilling MF, 2002, AM STAT, V56, P223, DOI 10.1198/0031300265; Woodley MA, 2012, PERS INDIV DIFFER, V53, P152, DOI 10.1016/j.paid.2011.03.028; Lassig J, 2013, SOFT COMPUT, V17, P1121, DOI 10.1007/s00500-013-0991-0; [Anonymous], DAT SMITHS I HUM OR; Chang PC, 2010, EXPERT SYST APPL, V37, P1863, DOI 10.1016/j.eswa.2009.07.066; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Zheng YJ, 2013, SOFT COMPUT, V17, P1301, DOI 10.1007/s00500-012-0968-4; Gibbs MS, 2008, INFORM SCIENCES, V178, P2857, DOI 10.1016/j.ins.2008.03.012; Garai G, 2007, PATTERN RECOGN, V40, P212, DOI 10.1016/j.patcog.2006.04.023; [Anonymous], 2014, HUMAN EVOLUTION ENTR; Togan V, 2008, COMPUT STRUCT, V86, P1204, DOI 10.1016/j.compstruc.2007.11.006; Bickford L, 2013, EYE COLOUR; Castiglione A., 2011, P BROADB WIR COMP CO, P392; Castiglione A, 2014, J NETW COMPUT APPL, V38, P22, DOI 10.1016/j.jnca.2013.05.002; Castiglione A, 2010, J SYST SOFTWARE, V83, P1813, DOI 10.1016/j.jss.2010.04.062; Castiglione A, 2013, J AMB INTEL HUM COMP, V4, P265, DOI 10.1007/s12652-011-0070-2; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; De Santis A, 2013, J AMB INTEL HUM COMP, V4, P223, DOI 10.1007/s12652-011-0069-8; Dean L, 2005, BLOOD GROUPS RED CEL; Embretson S. E., 2000, ITEM RESPONSE THEORY; He HM, 2007, J PARALLEL DISTR COM, V67, P229, DOI 10.1016/j.jpdc.2006.08.002; Javadi AA, 2005, ADV ENG INFORM, V19, P255, DOI 10.1016/j.aei.2005.07.003; John P, 1884, LIB WONDERS CURIOSIT; Keely B, 2010, OECD INSIGHTS INT MI; Lewontin Richard, 2011, STANFORD ENCY PHILOS; Library of The University of Chicago, 2014, ETHN MAPS 19 CENT; Mansoori EG, 2014, SOFT COMPUT, V18, P905, DOI 10.1007/s00500-013-1105-8; Palmieri F, 2014, CONCURR COMP-PRACT E, V26, P1113, DOI 10.1002/cpe.3061; Rodgers JL, 2001, CHANCE, V14, P8; SOPHIE STUDY, 2014, STUD PHARM ETHN DIV; Tao Q, 2004, APPL MATH COMPUT, V150, P811, DOI 10.1016/S0096-3003(03)00309-6; Toffoli T., 1987, CELLULAR AUTOMATA MA; Vatolkin I, 2012, SOFT COMPUT, V16, P2027, DOI 10.1007/s00500-012-0874-9; Wai J, 2011, INTELLIGENCE, V39, P443, DOI 10.1016/j.intell.2011.07.006	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-7643	1433-7479		SOFT COMPUT	Soft Comput.	DEC	2014	18	12					2565	2576		10.1007/s00500-014-1401-y		12	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	AT7DN	WOS:000345097100017		
J	Pons, A; Jouin, J; Bechade, E; Julien, I; Masson, O; Geffroy, PM; Mayet, R; Thomas, P; Fukuda, K; Kagomiya, I				Pons, A.; Jouin, J.; Bechade, E.; Julien, I.; Masson, O.; Geffroy, P. M.; Mayet, R.; Thomas, P.; Fukuda, K.; Kagomiya, I.			Study of the formation of the apatite- type phases La9.33+x(SiO4)(6)O2+3x/2 synthesized from a lanthanum oxycarbonate La2O2CO3	SOLID STATE SCIENCES			English	Review						Oxyapatite; Powders-solid state reaction; Lanthanum carbonate; Ionic conductivity; Fuel cells	OXIDE-ION CONDUCTIVITY; ELECTRICAL-PROPERTIES; FUEL-CELLS; CRYSTAL-STRUCTURE; SINGLE-CRYSTALS; C-AXIS; SILICATE; LA-9.33(SIO4)(6)O-2; OXYAPATITE; CONDUCTORS	Lanthanum silicated apatites with nominal composition La9.33+x(SiO4)(6)O2+3x/2 (-0.2 < x < 0.27) have been successfully synthesized by solid state reaction using a new reagent La2O2CO3 and amorphous SiO2 precursors. The formation mechanism of La2O2CO3 reagent, which cannot be purchased, has been followed by in-situ temperature depend XRD of La2O3 under CO2 atmosphere. The stability of this reagent during the synthesis step allowed to limit the formation of secondary phase La2Si2O7 and made the weighting of the reagent easier. High purity powders could be synthesized at the temperature of 1400 degrees C. Dense pellets (more than 98.5%) were obtained by isostatic pressing of powders calcined at 1200 degrees C and then sintered at 1550 degrees C. Traces of La2SiO5 secondary phase present in synthesized powder disappeared after densification and pure oxyapatite materials were obtained for all the compositions. Electrical measurements confirmed that conductivity behaviors of the sintered pellets were dependent to the oxygen over-stoichiometry. Indeed, a relatively high conductivity of 1 x 10(-2) S cm(-1) was exhibited at 800 degrees C for the nominal composition La-9.60(SiO4)(6)O-2.405 with low activation energy around 0.79 eV. The ionic conductivity properties were comparable with that of the earlier obtained materials. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Pons, A.; Jouin, J.; Bechade, E.; Julien, I.; Masson, O.; Geffroy, P. M.; Mayet, R.; Thomas, P.] ENSCI, Fac Sci & Tech, Ctr Europeen Ceram, UMR CNRS 7315, F-87068 Limoges, France; [Fukuda, K.; Kagomiya, I.] Nagoya Inst Technol, Dept Environm & Mat Engn, Nagoya, Aichi 4668555, Japan	Bechade, E (reprint author), ENSCI, Fac Sci & Tech, Ctr Europeen Ceram, UMR CNRS 7315, 12 Rue Atlantis, F-87068 Limoges, France.	aenor.pons@uniliom.fr; jenny.jouin@unilim.fr; emilie.bechade@unilim.fr; isabelle.julien@unilim.fr; olivier.masson@unilim.fr; pierre-marie.geffroy@unilim.fr; richard.mayet@unilim.fr; philippe.thomas@unilim.fr; fukuda.koichiro@nitech.ac.jp; kagomiya@nitech.ac.jp		PONS, Aenor/0000-0002-1948-1540	Limousin Region	The authors wish to thank R. Kaneko and Y. Shimono for their help during the synthesis process. Limousin Region is gratefully acknowledged for its financial support.	Fukuda K, 2013, CHEM MATER, V25, P2154, DOI 10.1021/cm400892p; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Minh NQ, 2004, SOLID STATE IONICS, V174, P271, DOI 10.1016/j.ssi.2004.07.042; Steele BCH, 2001, J MATER SCI, V36, P1053, DOI 10.1023/A:1004853019349; Fukuda K, 2012, SOLID STATE IONICS, V217, P40, DOI 10.1016/j.ssi.2012.04.018; Kobayashi K, 2008, SOLID STATE IONICS, V179, P2209, DOI 10.1016/j.ssi.2008.07.023; Nakayama S, 1998, J EUR CERAM SOC, V18, P1413, DOI 10.1016/S0955-2219(98)00032-6; Liu W, 2014, J POWER SOURCES, V248, P685, DOI 10.1016/j.jpowsour.2013.10.011; Tolchard JR, 2003, J MATER CHEM, V13, P1956, DOI 10.1039/b302748c; Belous A, 2004, CHEM MATER, V16, P407, DOI 10.1021/cm034820x; Fukuda K, 2011, CHEM MATER, V23, P5474, DOI 10.1021/cm2029905; Yoshioka H, 2006, J ALLOY COMPD, V408, P649, DOI 10.1016/j.jallcom.2004.12.180; Marrero-Lopez D, 2014, J POWER SOURCES, V245, P107, DOI 10.1016/j.jpowsour.2013.06.111; Marques FMB, 2006, SOLID STATE IONICS, V177, P1697, DOI 10.1016/j.ssi.2006.04.036; Yoshioka H, 2007, J AM CERAM SOC, V90, P3099, DOI 10.1111/j.1551-2916.2007.01862.x; Fukuda K, 2012, CHEM MATER, V24, P4623, DOI 10.1021/cm3034643; Sansom JEH, 2004, SOLID STATE IONICS, V167, P17, DOI 10.1016/j.ssi.2003.12.014; Porras-Vazquez JM, 2009, J AM CERAM SOC, V92, P1062, DOI 10.1111/j.1551-2916.2009.03032.x; Nakayama S, 2013, J EUR CERAM SOC, V33, P207, DOI 10.1016/j.jeurceramsoc.2012.09.013; Panteix PJ, 2008, CERAM INT, V34, P1579, DOI 10.1016/j.ceramint.2007.05.004; Kendrick E, 2007, J MATER CHEM, V17, P3104, DOI 10.1039/b704426g; Bechade E, 2009, CHEM MATER, V21, P2508, DOI 10.1021/cm900783j; Bakiz B, 2010, ADV MATER SCI ENG, DOI 10.1155/2010/360597; Beaudet-Savignat S, 2007, J MATER CHEM, V17, P2078, DOI 10.1039/b615104c; Bechade E, 2008, J EUR CERAM SOC, V28, P2717, DOI 10.1016/j.jeurceramsoc.2008.03.045; Nakayama S, 2001, J MATER SCI LETT, V20, P913, DOI 10.1023/A:1010928800227; Okudera H, 2005, SOLID STATE IONICS, V176, P1473, DOI 10.1016/j.ssi.2005.02.014; Panteix PJ, 2006, MATER CHEM PHYS, V95, P313, DOI 10.1016/j.matchemphys.2005.06.040; Yamamoto O, 2000, ELECTROCHIM ACTA, V45, P2423, DOI 10.1016/S0013-4686(00)00330-3; Yao HC, 2010, SOLID STATE IONICS, V181, P41, DOI 10.1016/j.ssi.2009.12.004	30	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1293-2558	1873-3085		SOLID STATE SCI	Solid State Sci.	DEC	2014	38						150	155		10.1016/j.solidstatesciences.2014.10.013		6	Chemistry, Inorganic & Nuclear; Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	AT7ZS	WOS:000345154100025		
J	Funar-Timofei, S; Iliescu, S; Suzuki, T				Funar-Timofei, Simona; Iliescu, Smaranda; Suzuki, Takahiro			Correlations of limiting oxygen index with structural polyphosphoester features by QSPR approaches	STRUCTURAL CHEMISTRY			English	Article						Limiting oxygen index (LOI); Polyphosphoesters; Quantitative structure-property; Relationships (QSPR); Multiple linear regression (MLR); Artificial neural network (ANN)	LIQUID INTERFACIAL POLYCONDENSATION; FLASH-POINT TEMPERATURE; QSAR MODELS; PHYSICOCHEMICAL PROPERTIES; CORRELATION-COEFFICIENT; CONDENSATION POLYMERS; CONFORMER GENERATION; ORGANIC-COMPOUNDS; PURE COMPOUNDS; PREDICTION	Fire retardant materials diminish the hazard to life from fire. Polyphosphonates and polyphosphates display good flame retardancy and attractive plasticizing properties, being an important class of organophosphorus based polymer additives. Properties of previously synthesized polyphosphoesters are presented here, being simulated as monomers. In this quantitative structure-property relationship work, the flammability was expressed by limiting oxygen index (LOI) values, which were determined experimentally. Two types of chiral structures were found by molecular mechanics calculations using the MMFF94s force field for half of the monomers, consequently, two datasets were built. Structural parameters were calculated for the minimum energy structures and were related to the LOI values by multiple linear regression (MLR), artificial neural networks (ANNs), and support vector machines (SVMs). MLR calculations were combined with a genetic algorithm for variable selection. Stable and predictive MLR models in terms of 2D autocorrelation parameters weighed by atomic polarizabilities and of 3D-Morse descriptors were obtained. Somewhat inferior fits were found in the nonlinear modeling by ANNs and SVMs with the same set of descriptors. Monomers including R chiral structures gave more stable and predictive models compared to the S isomers in all approaches. Monomer geometry influences the flame retardancy, being favorable for R isomers.	[Funar-Timofei, Simona; Iliescu, Smaranda] Timisoara Romanian Acad, Inst Chem, Timisoara 300223, Romania; [Suzuki, Takahiro] Toyo Univ, Nat Sci Lab, Bunkyo Ku, Tokyo 1128606, Japan	Funar-Timofei, S (reprint author), Timisoara Romanian Acad, Inst Chem, B Dul Mihai Viteazul 24, Timisoara 300223, Romania.	timofei@acad-icht.tm.edu.ro	FUNAR-TIMOFEI, SIMONA/C-3369-2011; 	Funar-Timofei, Simona/0000-0002-6786-6584	Project 1.1 of the Institute of Chemistry Timisoara of the Romanian Academy	This project was financially supported by Project 1.1 of the Institute of Chemistry Timisoara of the Romanian Academy. The authors are indebted to Chemaxon Ltd., OpenEye Ltd. and Prof. Paola Gramatica from The University of Insubria (Varese, Italy) for giving access to their software.	Annakutty S, 1988, POLYMER, V29, P1273; Pan Y, 2010, AICHE J, V56, P690, DOI 10.1002/aic.12007; Chirico N, 2011, J CHEM INF MODEL, V51, P2320, DOI 10.1021/ci200211n; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Gramatica P, 2013, J COMPUT CHEM, V34, P2121, DOI 10.1002/jcc.23361; Goodarzi M, 2009, QSAR COMB SCI, V28, P1487, DOI 10.1002/qsar.200960074; Gharagheizi F, 2012, J THERM ANAL CALORIM, V110, P1005, DOI 10.1007/s10973-011-1951-5; Katritzky AR, 2000, J CHEM INF COMP SCI, V40, P1, DOI 10.1021/ci9903206; Katritzky AR, 2007, J MOL GRAPH MODEL, V26, P529, DOI 10.1016/j.jmgm.2007.03.006; Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151; ANNAKUTTY KS, 1988, POLYMER, V29, P756, DOI 10.1016/0032-3861(88)90096-1; Iliescu S, 2007, PURE APPL CHEM, V79, P1879, DOI 10.1351/pac200779111879; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946; Lindgren F, 1996, J CHEMOMETR, V10, P521; Le T, 2012, CHEM REV, V112, P2889, DOI 10.1021/cr200066h; Gramatica P, 2012, MOL INFORM, V31, P817, DOI 10.1002/minf.201200075; Lu SY, 2002, PROG POLYM SCI, V27, P1661, DOI 10.1016/S0079-6700(02)00018-7; KANNAN P, 1991, EUR POLYM J, V27, P1017, DOI 10.1016/0014-3057(91)90072-V; Schuurmann G, 2008, J CHEM INF MODEL, V48, P2140, DOI 10.1021/ci800253u; Consonni V, 2009, J CHEM INF MODEL, V49, P1669, DOI 10.1021/ci900115y; Gharagheizi F, 2012, FLUID PHASE EQUILIBR, V329, P71, DOI 10.1016/j.fluid.2012.05.015; Shi LM, 2001, J CHEM INF COMP SCI, V41, P186, DOI 10.1021/ci000066d; Todeschini R, 1999, CHEMOMETR INTELL LAB, V46, P13, DOI 10.1016/S0169-7439(98)00124-5; BURDEN FR, 1989, J CHEM INF COMP SCI, V29, P225, DOI 10.1021/ci00063a011; Chang C.C., 2001, LIBSVM LIB SUPPORT V; Chatterjee S., 1991, REGRESSION ANAL EXAM; Chen CC, 2009, J HAZARD MATER, V162, P746, DOI 10.1016/j.jhazmat.2008.05.137; Chirico N., 2012, QSAR RES UNIT ENV CH; Frank I. E., 1994, DATA ANAL HDB; Gharagheizi F, 2011, J HAZARD MATER, V189, P211, DOI 10.1016/j.jhazmat.2011.02.014; Gharagheizi F, 2009, J HAZARD MATER, V167, P507, DOI 10.1016/j.jhazmat.2009.01.002; Gharagheizi F, 2008, QSAR COMB SCI, V27, P679, DOI 10.1002/qsar.200730110; Gharagheizi F, 2009, J HAZARD MATER, V169, P217, DOI 10.1016/j.jhazmat.2009.03.083; Gramatica P, 1999, TRAC-TREND ANAL CHEM, V18, P461, DOI 10.1016/S0165-9936(99)00115-6; Gramatica P, 2004, FRESEN ENVIRON BULL, V13, P1258; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Iliescu S, 2007, CHEM B POLITEHNICA U, V52, P74; Iliescu S, 2008, P 15 S AN ENV PROBL, P186; Iliescu S, 2011, CR CHIM, V146, P47; Iliescu S., 2004, Molecular Crystals and Liquid Crystals, V418, DOI 10.1080/15421400490479299; Iliescu S, 2001, CHEM B POLITECHNICA, V46, P141; Iliescu S, 2003, REV CHIM-BUCHAREST, V54, P689; Iliescu S, 2011, MACROMOL RES, V19, P1186, DOI 10.1007/s13233-011-1111-6; Iliescu S, 2010, P 4 ED S INT PART NE, P101; Iliescu S, 2012, MOLECULES, V17, P9090, DOI 10.3390/molecules17089090; Iliescu S, 2002, POLYM BULL, V48, P451, DOI 10.1007/s00289-002-0054-7; Iliescu S, 2002, PHOSPHORUS SULFUR, V177, P2051, DOI 10.1080/10426500290094783; Iliescu S, 2005, REV ROUM CHIM, V50, P609; Iliescu S, 2009, POLYM BULL, V63, P485, DOI 10.1007/s00289-009-0107-2; Iliescu S, 2006, OARA SER CHEM, V15, P21; Katritzky AR, 2010, CHEM REV, V110, P5714, DOI 10.1021/cr900238d; KISHORE K, 1988, POLYMER, V29, P762, DOI 10.1016/0032-3861(88)90097-3; Lomakin SM, 1999, ECOLOGICAL ASPECTS P; Massarelli I, 2009, BIOORGAN MED CHEM, V17, P3543, DOI 10.1016/j.bmc.2009.04.014; Neter J., 1985, APPL LINEAR STAT MOD; Ronova I, 2010, STRUCT CHEM, V21, P541, DOI 10.1007/s11224-010-9584-z; Roy S, 2004, J POLYM MATER, V21, P39; Suzuki T, 1994, FIRE MATER, V18, P81, DOI 10.1002/fam.810180204; VanKrevelen DW, 2009, PROPERTIES OF POLYMERS: THEIR CORRELATION WITH CHEMICAL STRUCTURE; THEIR NUMERICAL ESTIMATION AND PREDICTION FROM ADDITIVE GROUP CONTRIBUTIONS, P1; Tresadern G, 2009, J MOL GRAPH MODEL, V27, P860, DOI 10.1016/j.jmgm.2009.01.003; Vapnik V. N., 1995, NATURE STAT LEARNING; Weil ED, 1999, PHOSPHORUS SULFUR, V144, P17, DOI 10.1080/10426509908546171; WOLD S, 1983, J CHEM INF COMP SCI, V23, P6, DOI 10.1021/ci00037a002; Zupan J, 1995, NEURAL NETWORKS CHEM	65	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-0400	1572-9001		STRUCT CHEM	Struct. Chem.	DEC	2014	25	6					1847	1863		10.1007/s11224-014-0474-7		17	Chemistry, Multidisciplinary; Chemistry, Physical; Crystallography	Chemistry; Crystallography	AT3CF	WOS:000344812400026		
J	Ebina, A; Sugitani, I; Fujimoto, Y; Yamada, K				Ebina, Aya; Sugitani, Iwao; Fujimoto, Yoshihide; Yamada, Keiko			Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: Is thyroid lobectomy the treatment of choice for low-risk patients?	SURGERY			English	Article							PROGNOSTIC SCORING SYSTEM; FOLLOW-UP; RADIOACTIVE IODINE; CANCER; SURGERY; RECURRENCE; VARIABLES; POLICY; JAPAN	Background. Our original system for risk group classification for predicting cause-specific death from papillary thyroid carcinoma (PTC) defined patients with distant metastasis and older patients >= 50 years) with either massive extrathyroidal extension or large (>= 3 cm) lymph node metastasis as high risk; all others are low risk. For unilateral, low-risk PTC, the extent of thyroidectomy (less-than-total thyroidectomy vs total or near-total thyroidectomy) has been determined based on the choice of the patient since 2005. Patients. Of 1,187 patients who underwent initial thyroidectomy for PTC (tumor size IT] >1 cm) between 1993 and 2010, 967 (82%) were classified as low risk. Among low-risk patients, 791 (82%) underwent less than total thyroidectomy. Results. The 10-year cause-specific survival and disease-free survival rates did not differ between patients who underwent total thyroidectomy versus less than total thyroidectomy (cause-specific survival, 99% vs 99% [P = .61]; disease-free survival, 91% vs 87% [P = .90]). Age >= 60 years, T >= 3cm, and lymph node metastases >3cm represented significant risk factors for distant recurrence. Conclusion. The favorable overall survival of low-risk patients, regardless of the extent of thyroidectomy, supports patient autonomy in treatment-related decision making. Low-risk patients possessing risk factors for distant recurrence would be likely to benefit from total thyroidectomy followed by radioactive iodine.	[Ebina, Aya; Sugitani, Iwao; Fujimoto, Yoshihide] Japanese Fdn Canc Res, Canc Inst Hosp, Div Head & Neck, Tokyo, Japan; [Sugitani, Iwao] Nippon Med Sch, Dept Surg, Div Endocrine Surg, Tokyo 113, Japan; [Yamada, Keiko] Japanese Fdn Canc Res, Canc Inst Hosp, Div Ultrasonog Examinat, Tokyo, Japan	Sugitani, I (reprint author), Nippon Med Sch, Dept Surg, Div Endocrine Surg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	isugitani@jfcr.or.jp					Bilimoria KY, 2007, ANN SURG, V246, P375, DOI 10.1097/SLA.0b013e31814697d9; Sugitani I, 2010, J CLIN ENDOCR METAB, V95, P4576, DOI 10.1210/jc.2010-0161; Hotomi M, 2012, WORLD J SURG, V36, P1231, DOI 10.1007/s00268-012-1518-z; Shaha AR, 1996, ANN SURG ONCOL, V3, P534, DOI 10.1007/BF02306085; HAY ID, 1987, SURGERY, V102, P1088; CADY B, 1988, SURGERY, V104, P947; Sugitani I, 2004, SURGERY, V135, P139, DOI 10.1016/S0039-6060(03)00384-2; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Mendelsohn AH, 2010, ARCH OTOLARYNGOL, V136, P1055, DOI 10.1001/archoto.2010.181; Sugitani I, 2010, WORLD J SURG, V34, P1222, DOI 10.1007/s00268-009-0359-x; Cady B, 1998, SURGERY, V124, P947, DOI 10.1016/S0039-6060(98)70034-0; Fujimoto Y, 1998, ENDOCR J, V45, P475, DOI 10.1507/endocrj.45.475; HAY ID, 1993, SURGERY, V114, P1050; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; Imai T, 2010, JAPANESE CLIN GUIDEL, P107; Ito Y, 2010, WORLD J SURG, V34, P2570, DOI 10.1007/s00268-010-0710-2; Matsuzu K, 2014, WORLD J SURG, V38, P68, DOI 10.1007/s00268-013-2224-1; Brennan T, 2002, LANCET, V359, P520; Nixon IJ, 2012, SURGERY, V151, P571, DOI 10.1016/j.surg.2011.08.016; Shigematsu N, 2006, ENDOCR J, V53, P829, DOI 10.1507/endocrj.K06-105; Sugitani I, 2008, WORLD J SURG, V32, P2494, DOI 10.1007/s00268-008-9711-9; Sugitani I, 2010, SURG TODAY, V40, P199, DOI 10.1007/s00595-009-4034-5; Tuttle RM, 2008, J SURG ONCOL, V97, P712, DOI 10.1002/jso.21010	25	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	DEC	2014	156	6					1579	1589		10.1016/j.surg.2014.08.060		11	Surgery	Surgery	AT9OF	WOS:000345255700039		
J	Emoto, S; Sunami, E; Yamaguchi, H; Ishihara, S; Kitayama, J; Watanabe, T				Emoto, Shigenobu; Sunami, Eiji; Yamaguchi, Hironori; Ishihara, Soichiro; Kitayama, Joji; Watanabe, Toshiaki			Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer	SURGERY TODAY			English	Review						Colorectal cancer; Gastric cancer; Intraperitoneal chemotherapy; Peritoneal carcinomatosis; Pharmacokinetics	ADVANCED GASTRIC-CANCER; COMPLETE CYTOREDUCTIVE SURGERY; INCORPORATING MICELLAR NANOPARTICLE; ALBUMIN-BOUND PACLITAXEL; PHASE-III TRIAL; TRIFUNCTIONAL ANTIBODY CATUMAXOMAB; OXALIPLATIN PLUS IRINOTECAN; GYNECOLOGIC-ONCOLOGY-GROUP; ENDOTHELIAL GROWTH-FACTOR; COLORECTAL-CANCER	Intraperitoneal (IP) chemotherapy for peritoneal carcinomatosis (PC) from gastrointestinal cancer has been investigated and applied clinically for several decades. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy have been considered to be the optimal treatment options for selected patients with colorectal and gastric cancers with PC. Accumulating evidence suggests that the administration of IP paclitaxel for patients with PC from gastric cancer may improve the patient survival. The pharmacokinetics of such treatment should be considered to optimize IP chemotherapy. In addition, newly emerging molecular-targeted therapies and research into new drug delivery systems, such as nanomedicine or controlled absorption/release methods, are essential to improve the effects of IP chemotherapy. This review summarizes the current status and future prospects of IP chemotherapy for the treatment of gastrointestinal cancer.	[Emoto, Shigenobu; Sunami, Eiji; Yamaguchi, Hironori; Ishihara, Soichiro; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan	Watanabe, T (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	toshwatanabe@yahoo.co.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Public Trust Surgery Research Fund, Tokyo, Japan	This work was funded by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Ministry of Health, Labor and Welfare of Japan, and by a grant-in-aid from the Public Trust Surgery Research Fund, Tokyo, Japan.	Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; Sadeghi B, 2000, CANCER, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Verwaal VJ, 2008, ANN SURG ONCOL, V15, P2426, DOI 10.1245/s10434-008-9966-2; Ishigami H, 2010, ONCOLOGY-BASEL, V79, P269, DOI 10.1159/000323272; Cashin PH, 2012, EJSO-EUR J SURG ONC, V38, P509, DOI 10.1016/j.ejso.2012.03.001; Wang YY, 2010, RES J BIOTECHNOL, V5, P5; Franko J, 2010, CANCER-AM CANCER SOC, V116, P3756, DOI 10.1002/cncr.25116; PAZDUR R, 1994, ANN ONCOL, V5, P468; Cashin PH, 2012, ANN ONCOL, V23, P647, DOI 10.1093/annonc/mdr301; Petrelli F, 2010, EXPERT OPIN PHARMACO, V11, P1413, DOI 10.1517/14656561003796562; Yang XJ, 2010, J SURG ONCOL, V101, P457, DOI 10.1002/jso.21519; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; Shimizu A, 2014, SURG TODAY, V44, P314, DOI 10.1007/s00595-013-0530-8; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Elias D, 2007, ANN SURG ONCOL, V14, P509, DOI 10.1245/s10434-006-9167-9; Verwaal VJ, 2005, ANN SURG ONCOL, V12, P65, DOI 10.1245/ASO.2005.03.039; Markman M, 2003, LANCET ONCOL, V4, P277, DOI 10.1016/S1470-2045(03)01074-X; Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Matsumura Y, 2009, CANCER SCI, V100, P572, DOI 10.1111/j.1349-7006.2009.01103.x; Liu YT, 2010, INT J PHARMACEUT, V395, P243, DOI 10.1016/j.ijpharm.2010.05.008; Wimberger P, 2012, ANN ONCOL, V23, P1979, DOI 10.1093/annonc/mds178; Ishigami H, 2009, ONCOLOGY-BASEL, V76, P311, DOI 10.1159/000209277; Elias D, 2004, ANN SURG ONCOL, V11, P518, DOI 10.1245/ASO.2004.09.008; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Verwaal VJ, 2003, J CLIN ONCOL, V21, P3737, DOI 10.1200/JCO.2003.04.187; Heiss MM, 2010, INT J CANCER, V127, P2209, DOI 10.1002/ijc.25423; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Fujimoto S, 1997, CANCER, V79, P884, DOI 10.1002/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C; Yang XJ, 2011, ANN SURG ONCOL, V18, P1575, DOI 10.1245/s10434-011-1631-5; Dedrick RL, 1997, J NATL CANCER I, V89, P480, DOI 10.1093/jnci/89.7.480; Glehen O, 2004, J CLIN ONCOL, V22, P3284, DOI 10.1200/JCO.2004.10.012; Wu W, 2011, INT J PHARMACEUT, V416, P104, DOI 10.1016/j.ijpharm.2011.06.015; Kato K, 2012, INVEST NEW DRUG, V30, P1621, DOI 10.1007/s10637-011-9709-2; Ayantunde AA, 2007, ANN ONCOL, V18, P945, DOI 10.1093/annonc/mdl499; Quenet F, 2011, ANN SURG, V254, P294, DOI 10.1097/SLA.0b013e3182263933; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021; Singla AK, 2002, INT J PHARM, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Desai N, 2006, CLIN CANCER RES, V12, P1317, DOI 10.1158/1078-0432.CCR-05-1634; Negishi T, 2006, BRIT J CANCER, V95, P601, DOI 10.1038/sj.bjc.6603311; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Schmitt M, 2004, INT J ONCOL, V25, P841; Cai S, 2008, J SURG RES, V147, P247, DOI 10.1016/j.jss.2008.02.048; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Elias D, 2007, ANN SURG ONCOL, V14, P1818, DOI 10.1245/s10434-007-9348-1; Bajaj G, 2012, J CONTROL RELEASE, V158, P386, DOI 10.1016/j.jconrel.2011.12.001; Urano M, 1999, INT J HYPERTHER, V15, P79, DOI 10.1080/026567399285765; Ruf P, 2007, BRIT J CANCER, V97, P315, DOI 10.1038/sj.bjc.6603881; Elias D, 2010, J CLIN ONCOL, V28, P63, DOI 10.1200/JCO.2009.23.9285; Morgan RJ, 2011, J NATL COMPR CANC NE, V9, P82; Jacquet P, 1998, ONCOLOGY-BASEL, V55, P130, DOI 10.1159/000011847; Yonemura Y, 2005, BRIT J SURG, V92, P370, DOI 10.1002/bjs.4695; Elias D, 2002, ANN ONCOL, V13, P267, DOI 10.1093/annonc/mdf019; Ceelen WP, 2010, NAT REV CLIN ONCOL, V7, P108, DOI 10.1038/nrclinonc.2009.217; Yonemura Y, 2006, EJSO, V32, P661, DOI 10.1016/j.ejso.2006.03.007; BOUCHER Y, 1990, CANCER RES, V50, P4478; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Markman M, 2006, J CLIN ONCOL, V24, P988, DOI 10.1200/JCO.2005.05.2456; Sugarbaker PH, 2012, LANCET ONCOL, V13, pE362, DOI 10.1016/S1470-2045(12)70210-3; Auzenne E, 2007, NEOPLASIA, V9, P479, DOI 10.1593/neo.07229; Yamada J, 2008, CANCER LETT, V272, P307, DOI 10.1016/j.canlet.2008.07.024; Kianmanesh R, 2007, ANN SURG, V245, P597, DOI 10.1097/01.sla.0000255561.87771.11; Glehen O, 2010, ANN SURG ONCOL, V17, P2370, DOI 10.1245/s10434-010-1039-7; Elias D, 2009, J CLIN ONCOL, V27, P681, DOI 10.1200/JCO.2008.19.7160; Xiao K, 2009, BIOMATERIALS, V30, P6006, DOI 10.1016/j.biomaterials.2009.07.015; Hribaschek A, 2007, CHEMOTHERAPY, V53, P410, DOI 10.1159/000110005; MARKMAN M, 1992, J CLIN ONCOL, V10, P1485; Hamaguchi T, 2005, BRIT J CANCER, V92, P1240, DOI 10.1038/sj.bjc.6602479; Vicent MJ, 2006, TRENDS BIOTECHNOL, V24, P39, DOI 10.1016/j.tibtech.2005.11.006; Yagi Y, 2010, CANCER CHEMOTH PHARM, V66, P745, DOI 10.1007/s00280-009-1219-y; Bokemeyer C, 2010, EXPERT OPIN BIOL TH, V10, P1259, DOI 10.1517/14712598.2010.504706; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Chua TC, 2012, J CLIN ONCOL, V30, P2449, DOI 10.1200/JCO.2011.39.7166; Elias Dominique M, 2003, Surg Oncol Clin N Am, V12, P755, DOI 10.1016/S1055-3207(03)00051-6; DEDRICK RL, 1978, CANCER TREAT REP, V62, P1; Zebrowski BK, 1999, ANN SURG ONCOL, V6, P373, DOI 10.1007/s10434-999-0373-0; Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n; Emoto S, 2012, CANCER SCI, V103, P1304, DOI 10.1111/j.1349-7006.2012.02274.x; Glehen O, 2008, J SURG ONCOL, V98, P242, DOI 10.1002/jso.21061; Kobold S, 2009, ONCOLOGIST, V14, P1242, DOI 10.1634/theoncologist.2009-0109; Markman M, 2001, J CLIN ONCOL, V19, P1001; Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043; Aoyagi Keishiro, 2005, Gastric Cancer, V8, P155, DOI 10.1007/s10120-005-0329-4; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z; Beaujard AC, 2000, CANCER, V88, P2512, DOI 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J; Bijelic L, 2008, J SURG ONCOL, V98, P295, DOI 10.1002/jso.21084; Cheong JH, 2007, ANN SURG ONCOL, V14, P61, DOI 10.1245/s10434-006-9205-7; Chua TC, 2012, SURG ONCOL CLIN N AM, V21, P635, DOI 10.1016/j.soc.2012.07.010; Colson YL, 2011, BIOMATERIALS, V32, P832, DOI 10.1016/j.biomaterials.2010.09.059; Echarri Gonzalez MJ, 2011, ONCOLOGY WILLISTON P, V25, P170; Echarri Gonzalez MJ, 2011, ONCOLOGY WILLISTON P, V25, P156; Einzig AI, 1996, AM J THER, V3, P750, DOI 10.1097/00045391-199611000-00003; Elias D, 2004, ANN ONCOL, V15, P781, DOI 10.1093/annone/mdh186; Elias D, 2010, ANN SURG, V251, P896, DOI 10.1097/SLA.0b013e3181d9765d; Elias D, 2004, ANN ONCOL, V15, P1558, DOI 10.1093/annonc/mdh398; Elias DM, 2003, SURG ONCOL CLIN N AM, V12, pxiv; Emoto S, 2013, SURG TODAY; FLESSNER MF, 1985, AM J PHYSIOL, V248, pH26; Fujiwara Y, 2011, ANN SURG ONCOL, V18, P3726, DOI 10.1245/s10434-011-1770-8; Fushida S, 2013, CANCER CHEMOTH PHARM, V71, P1265, DOI 10.1007/s00280-013-2122-0; Fushida S, 2008, ONCOL REP, V19, P1305; Glehen O, 2010, CANCER-AM CANCER SOC, V116, P5608, DOI 10.1002/cncr.25356; Glehen O, 2004, ARCH SURG-CHICAGO, V139, P20, DOI 10.1001/archsurg.139.1.20; Hall JY, 2004, J GASTROINTEST SURG, V8, P454, DOI 10.1016/j.gassur.2003.12.014; Howell SB, 2008, INT J GYNECOL CANCER, V18, P20, DOI 10.1111/j.1525-1438.2007.01099.x; Hribaschek A, 2003, ONCOL REP, V10, P1793; Imaizumi T, 2010, SURG TODAY, V40, P851, DOI 10.1007/s00595-009-4154-y; Imano M, 2012, J SURG ONCOL, V105, P43, DOI 10.1002/jso.22065; Jacquet P, 1996, Cancer Treat Res, V82, P53; Kamei T, 2010, CANCER SCI, V102, P200; Kodera Y, 2007, HEPATO-GASTROENTEROL, V54, P960; Kondo A, 1996, BRIT J CANCER, V73, P1166, DOI 10.1038/bjc.1996.225; Konno T, 2003, J BIOMED MATER RES A, V65A, P209, DOI 10.1002/jbm.a.10481; Kwak MK, 2010, INVEST NEW DRUG, V28, P284, DOI 10.1007/s10637-009-9253-5; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X; Mahteme H, 2004, BRIT J CANCER, V90, P403, DOI 10.1038/sj.bjc.6601586; Matsui Akira, 2003, Surg Oncol Clin N Am, V12, P795, DOI 10.1016/S1055-3207(03)00033-4; Matsui A, 2003, SURG ONCOL CLIN N AM, V12, pxv; Nakajima TE, 2008, CANCER RES, V68, P9318, DOI 10.1158/0008-5472.CAN-08-2822; Ninomiya S, 2009, J SURG RES, V154, P196, DOI 10.1016/j.jss.2008.08.017; Parson SL, 1996, BRIT J SURG, V83, P6, DOI 10.1002/bjs.1800830104; Piso P, 2011, DTSCH ARZTEBL INT, V108, P802, DOI 10.3238/arztebl.2011.0802; Reddy LH, 2006, AAPS J, V8, pE254, DOI 10.1208/aapsj080229; Riesenberg R, 2001, J HISTOCHEM CYTOCHEM, V49, P911; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004; Ruf P, 2001, BLOOD, V98, P2526, DOI 10.1182/blood.V98.8.2526; Shah DK, 2011, CANCER CHEMOTH PHARM, V68, P951, DOI 10.1007/s00280-011-1566-3; Shen P, 2008, ANN SURG ONCOL, V15, P3422, DOI 10.1245/s10434-008-0127-4; Shinohara S, 2013, SURG TODAY, V43, P40, DOI 10.1007/s00595-012-0230-9; Soma D, 2009, CANCER SCI, V100, P1979, DOI 10.1111/j.1349-7006.2009.01265.x; Soma D, 2009, J SURG RES, V155, P142, DOI 10.1016/j.jss.2008.06.049; STERNBERG CN, 1994, BRIT J CANCER, V70, P376, DOI 10.1038/bjc.1994.309; Strohlein MA, 2010, FUTURE ONCOL, V6, P1387, DOI [10.2217/fon.10.111, 10.2217/FON.10.111]; Sugarbaker PH, 2005, ONCOLOGIST, V10, P112, DOI 10.1634/theoncologist.10-2-112; SUGARBAKER PH, 1985, SURGERY, V98, P414; Tsujitani S, 1999, ONCOLOGY-BASEL, V57, P77, DOI 10.1159/000012004; Wang ZB, 2010, ANAT REC, V293, P754, DOI 10.1002/ar.21101; Yan Tristan D, 2010, World J Gastrointest Oncol, V2, P109, DOI 10.4251/wjgo.v2.i2.109; Yonemura Yutaka, 2010, World J Gastrointest Oncol, V2, P85, DOI 10.4251/wjgo.v2.i2.85; Yonemura Y, 2010, EJSO-EUR J SURG ONC, V36, P1131, DOI 10.1016/j.ejso.2010.09.006; Yonemura Y, 2009, J SURG ONCOL, V100, P311, DOI 10.1002/jso.21324; Yu J, 2012, INVEST NEW DRUG, V30, P1, DOI 10.1007/s10637-010-9499-y	152	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2209	2220		10.1007/s00595-014-0848-x		12	Surgery	Surgery	AT7DP	WOS:000345097300001		
J	Yoshimura, N; Fukahara, K; Yamashita, A; Doki, Y; Takeuchi, K; Higuma, T; Senda, K; Toge, M; Matsuo, T; Nagura, S; Aoki, M; Sakata, K; Obi, H				Yoshimura, Naoki; Fukahara, Kazuaki; Yamashita, Akio; Doki, Yoshinori; Takeuchi, Katsunori; Higuma, Tomonori; Senda, Kazutaka; Toge, Masayoshi; Matsuo, Tatsuro; Nagura, Saori; Aoki, Masaya; Sakata, Kimimasa; Obi, Hayato			Current topics in surgery for isolated total anomalous pulmonary venous connection	SURGERY TODAY			English	Review						Total anomalous pulmonary venous connection; Sutureless repair; Multidetector computed tomography	PRIMARY SUTURELESS REPAIR; SURGICAL-MANAGEMENT; VEIN STENOSIS; OBSTRUCTION; DRAINAGE; ECHOCARDIOGRAPHY; ANGIOGRAPHY; MORTALITY; CHILDREN; OUTCOMES	Surgical correction of total anomalous pulmonary venous connection (TAPVC) remains a challenge, with reported early mortality rates of up to 20 %. In this review article, we describe several topics, including surgery for neonates, diagnoses with multidetector computed tomography (MDCT), and primary sutureless repair. Several studies have reported mortality rates of around 10 %, and demonstrated unchanged hospital mortality in neonates, despite improvement of the overall mortality of cohorts including older patients. Previous reports identified a low body weight at the time of the operation, preoperative pulmonary venous obstruction (PVO), and a prolonged cardiopulmonary bypass time as risk factors for hospital mortality. With the development of new technologies, MDCT has become a good diagnostic modality for use in the pre- and post-operative evaluation. MDCT delineates the drainage site of the vertical vein and the atypical vessel into the systemic vein, and it can also evaluate the existence of obstruction in the vertical vein. Following favorable experiences with post-repair PVO, the indications for sutureless repair as a primary operation have been expanded for infants, including those at risk of developing PVO after the repair of TAPVC. Primary sutureless repair has proven especially useful for difficult patient groups, such as those with congenital PVO, infracardiac TAPVC with small pulmonary veins, or mixed-type TAPVC.	[Yoshimura, Naoki; Fukahara, Kazuaki; Yamashita, Akio; Doki, Yoshinori; Takeuchi, Katsunori; Higuma, Tomonori; Senda, Kazutaka; Toge, Masayoshi; Matsuo, Tatsuro; Nagura, Saori; Aoki, Masaya; Sakata, Kimimasa; Obi, Hayato] Toyama Univ, Grad Sch Med, Dept Surg 1, Toyama 9300194, Japan	Yoshimura, N (reprint author), Toyama Univ, Grad Sch Med, Dept Surg 1, 2630 Sugitani, Toyama 9300194, Japan.	ynaoki@med.u-toyama.ac.jp					Yun TJ, 2005, J THORAC CARDIOV SUR, V129, P167, DOI 10.1016/j.jtcvs.2004.08.043; Chowdhury UK, 2008, J THORAC CARDIOV SUR, V135, P106, DOI 10.1016/j.jtcvs.2007.08.028; WANG JK, 1993, PEDIATR CARDIOL, V14, P28; Oh KH, 2009, PEDIATR RADIOL, V39, P950, DOI 10.1007/s00247-009-1309-3; Kelle AM, 2010, J THORAC CARDIOV SUR, V139, P1387, DOI 10.1016/j.jtcvs.2010.02.024; Yong MS, 2011, ANN THORAC SURG, V91, P1921, DOI 10.1016/j.athoracsur.2010.12.069; Kirshbom PM, 2002, ANN THORAC SURG, V74, P1616, DOI 10.1016/S0003-4975(02)03935-8; Kim TH, 2000, AM J ROENTGENOL, V175, P1381; Mukhopadhyay S, 2006, CIRCULATION, V114, P1807, DOI 10.1161/CIRCULATIONAHA.105.603001; Karamlou T, 2007, CIRCULATION, V115, P1591, DOI 10.1161/CIRCULATIONAHA.106.635441; Chowdhury UK, 2007, J THORAC CARDIOV SUR, V133, P1286, DOI 10.1016/j.jtcvs.2006.08.010; Seale AN, 2010, CIRCULATION, V122, P2718, DOI 10.1161/CIRCULATIONAHA.110.940825; Ricci M, 2003, EUR J CARDIO-THORAC, V24, P28, DOI 10.1016/S1010-7940(03)00180-5; Ucar T, 2008, INT J CARDIOVAS IMAG, V24, P229, DOI 10.1007/s10554-007-9246-4; Apostolopoulou SC, 2007, HEART, V93, P350, DOI 10.1136/hrt.2006.100388; Azakie A, 2011, ANN THORAC SURG, V92, P666, DOI 10.1016/j.athoracsur.2011.04.024; Bando K, 1996, CIRCULATION, V94, P12; Buitrago E, 2008, ANN THORAC SURG, V86, P320, DOI 10.1016/j.athoracsur.2008.01.093; Caldarone CA, 1998, ANN THORAC SURG, V66, P1514, DOI 10.1016/S0003-4975(98)00952-7; Devaney EJ, 2006, SEMIN THORAC CARDIOV, V9, P51, DOI 10.1053/j.pcsu.2006.02.023; Hasegawa Tomomi, 2013, Gen Thorac Cardiovasc Surg, V61, P528, DOI 10.1007/s11748-012-0188-y; Hickey Edward J, 2011, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V14, P101, DOI 10.1053/j.pcsu.2011.01.007; Hirono K, 2010, J THORAC CARDIOV SUR, V140, P346, DOI 10.1016/j.jtcvs.2010.03.023; Honjo O, 2010, ANN THORAC SURG, V90, P862, DOI 10.1016/j.athoracsur.2010.05.007; Husain SA, 2012, ANN THORAC SURG, V94, P825, DOI 10.1016/j.athoracsur.2012.04.026; JONAS RA, 1987, AM J CARDIOL, V59, P431, DOI 10.1016/0002-9149(87)90951-9; Kan CD, 2011, ANN THORAC SURG, V91, P2003, DOI 10.1016/j.athoracsur.2010.11.070; Kouchoukos NT, 2013, KIRKLIN BARRAT BOYES, P1182; Kuwano Hiroyuki, 2012, Gen Thorac Cardiovasc Surg, V60, P680, DOI 10.1007/s11748-012-0119-y; Lacour-Gayet F, 2006, SEMIN THORAC CARDIOV, V9, P45, DOI 10.1053/j.pcsu.2006.02.010; Lacour-Gayet F, 1999, J THORAC CARDIOV SUR, V117, P679, DOI 10.1016/S0022-5223(99)70287-4; MASUI T, 1991, RADIOLOGY, V181, P645; Matsuhisa H, 2013, ANN THORAC SURG, V95, P729, DOI 10.1016/j.athoracsur.2012.09.080; MULLER WH, 1951, ANN SURG, V134, P683, DOI 10.1097/00000658-195113440-00015; Perloff JK, 1994, CLIN RECOGNITION CON, P334; Sakata R, 2011, GEN THORAC CARDIOVAS, V59, P636; St Louis James D, 2012, Ann Thorac Surg, V94, P133, DOI 10.1016/j.athoracsur.2012.03.006; Suarez MR, 2009, J CARDIAC SURG, V24, P564, DOI 10.1111/j.1540-8191.2009.00886.x; Yoshimura N, 2010, INTERACT CARDIOV TH, V10, P675, DOI 10.1510/icvts.2009.221440; Yoshimura Naoki, 2012, Gen Thorac Cardiovasc Surg, V60, P785, DOI 10.1007/s11748-012-0154-8	40	3	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2221	2226		10.1007/s00595-014-0877-5		6	Surgery	Surgery	AT7DP	WOS:000345097300002		
J	Hida, J; Okuno, K; Tokoro, T				Hida, Jin-ichi; Okuno, Kiyotaka; Tokoro, Tadao			Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer	SURGERY TODAY			English	Review						Rectal cancer; Total mesorectal excision; Distal intramural and mesorectal spread; Preoperative chemoradiotherapy; Lateral lymph node dissection	CIRCUMFERENTIAL RESECTION MARGIN; SPHINCTER-SAVING RESECTION; PELVIC SIDEWALL DISSECTION; COMBINED-MODALITY THERAPY; LOCAL RECURRENCE RATES; ANTERIOR RESECTION; ABDOMINOPERINEAL RESECTION; PROGNOSTIC-SIGNIFICANCE; CURATIVE RESECTION; ONCOLOGIC OUTCOMES	The local recurrence rate after total mesorectal excision (TME) appears to be markedly lower than that after conventional operations. We reviewed all relevant articles identified from the MEDLINE databases and clarified the rationale for TME. It is clear that distal intramural spread is rare. Even when present, such spread is not likely to extend beyond 2 cm. Data with attention to mesorectal cancer deposits suggest that mesorectal clearance of at least 4-5 cm distal to the tumor should be sufficient. TME should be performed for most tumors of the mid- and lower rectum. This does not mean that the gut tube needs to be divided at the same level in every case. Dissection of the distal mesorectum off the gut tube can be performed, so the distal line of division of the bowel wall can be made at a minimum of 2 cm below the tumor if such a maneuver would ensure that the sphincters are preserved. In cases with cancer in the upper third of the rectum, the mesorectum and gut tube can safely be divided 5 cm below the tumor without jeopardizing the recurrence rates. Our findings indicate that TME is an essential treatment approach for rectal cancer, and lateral lymph node dissection and preoperative chemoradiotherapy are additional therapies that should be considered for advanced rectal cancer.	[Hida, Jin-ichi; Okuno, Kiyotaka; Tokoro, Tadao] Kinki Univ, Sch Med, Dept Surg, Osaka 5898511, Japan	Hida, J (reprint author), Kinki Univ, Sch Med, Dept Surg, 377-2 Ohno Higashi, Osaka 5898511, Japan.	hida@surg.med.kindai.ac.jp					Akagi Y, 2012, INT J CANCER, V131, P1220, DOI 10.1002/ijc.27315; Akasu T, 2008, ANN SURG ONCOL, V15, P2668, DOI 10.1245/s10434-008-0047-3; Andreola S, 2001, ANN SURG ONCOL, V8, P611, DOI 10.1245/aso.2001.8.7.611; Kockerling F, 1998, J CLIN ONCOL, V16, P324; Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Akiyoshi T, 2014, ANN SURG ONCOL, V21, P189, DOI 10.1245/s10434-013-3216-y; ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Ueno M, 2005, BRIT J SURG, V92, P756, DOI 10.1002/bjs.4975; Kim YW, 2009, ANN SURG, V249, P965, DOI 10.1097/SLA.0b013e3181a6cc25; WILLIAMS NS, 1983, BRIT J SURG, V70, P150, DOI 10.1002/bjs.1800700305; Ishihara S, 2010, INT J COLORECTAL DIS, V25, P1417, DOI 10.1007/s00384-010-1051-1; Wibe A, 2004, DIS COLON RECTUM, V47, P48, DOI 10.1007/s10350-003-0012-y; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Patel UB, 2011, J CLIN ONCOL, V29, P3753, DOI 10.1200/JCO.2011.34.9068; Ueno H, 2004, ANN SURG, V239, P34, DOI 10.1097/01.sla.0000103070.13030.eb; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Birbeck KF, 2002, ANN SURG, V235, P449, DOI 10.1097/00000658-200204000-00001; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kobayashi H, 2009, DIS COLON RECTUM, V52, P567, DOI 10.1007/DCR.0b013e3181a1d994; Trakarnsanga A, 2013, ANN SURG ONCOL, V20, P1179, DOI 10.1245/s10434-012-2722-7; SCOTT N, 1995, BRIT J SURG, V82, P1031, DOI 10.1002/bjs.1800820808; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Kusters M, 2009, ANN SURG, V249, P229, DOI 10.1097/SLA.0b013e318190a664; Arbman G, 1996, BRIT J SURG, V83, P375, DOI 10.1002/bjs.1800830326; Rullier E, 2005, ANN SURG, V241, P465, DOI 10.1097/01.sla.0000154551.06768.e1; Reynolds JV, 1996, BRIT J SURG, V83, P1112, DOI 10.1002/bjs.1800830826; Nash GM, 2010, DIS COLON RECTUM, V53, P1365, DOI 10.1007/DCR.0b013e3181f052d4; Peng JJ, 2011, CANCER-AM CANCER SOC, V117, P1415, DOI 10.1002/cncr.25620; Ceyhan GO, 2010, ANN SURG, V252, P797, DOI 10.1097/SLA.0b013e3181fcab8d; Kusters M, 2010, EJSO-EUR J SURG ONC, V36, P470, DOI 10.1016/j.ejso.2009.11.011; Kennelly RP, 2013, BRIT J SURG, V100, P160, DOI 10.1002/bjs.9001; Zaheer S, 1998, ANN SURG, V227, P800, DOI 10.1097/00000658-199806000-00003; KROOK JE, 1991, NEW ENGL J MED, V324, P709, DOI 10.1056/NEJM199103143241101; Silberfein EJ, 2010, ANN SURG ONCOL, V17, P2863, DOI 10.1245/s10434-010-1119-8; Nagawa H, 2001, DIS COLON RECTUM, V44, P1274, DOI 10.1007/BF02234784; Shirouzu K, 2004, DIS COLON RECTUM, V47, P1442, DOI 10.1007/s10350-004-0618-8; GRINNELL RS, 1950, ANN SURG, V131, P494, DOI 10.1097/00000658-195004000-00004; Frasson M, 2011, CANCER-AM CANCER SOC, V117, P3118, DOI 10.1002/cncr.25866; Nelson H, 2001, J NATL CANCER I, V93, P583, DOI 10.1093/jnci/93.8.583; Akiyoshi T, 2012, ANN SURG, V255, P1129, DOI 10.1097/SLA.0b013e3182565d9d; Ueno H, 2002, CANCER, V94, P2882, DOI 10.1002/cncr.10551; Marijnen CAM, 2003, INT J RADIAT ONCOL, V55, P1311, DOI 10.1016/S0360-3016(02)04291-8; Reshef A, 2012, DIS COLON RECTUM, V55, P51, DOI 10.1097/DCR.0b013e3182351c1f; Wibe A, 2002, DIS COLON RECTUM, V45, P857, DOI 10.1097/01.DCR.0000019492.53207.70; Shirouzu K, 2011, ANN SURG, V253, P704, DOI 10.1097/SLA.0b013e3182119331; Bernstein TE, 2009, BRIT J SURG, V96, P1348, DOI 10.1002/bjs.6739; Ueno H, 2002, HISTOPATHOLOGY, V40, P127, DOI 10.1046/j.1365-2559.2002.01324.x; Kapiteijn E, 2002, BRIT J SURG, V89, P1142, DOI 10.1046/j.1365-2168.2002.02196.x; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; CAWTHORN SJ, 1990, LANCET, V335, P1055, DOI 10.1016/0140-6736(90)92631-Q; QUIRKE P, 1986, LANCET, V2, P996; Engelen SME, 2013, EUR J CANCER, V49, P2311, DOI 10.1016/j.ejca.2013.03.006; Saito N, 1998, AM J SURG, V175, P277, DOI 10.1016/S0002-9610(98)00018-X; Marr R, 2005, ANN SURG, V242, P74, DOI 10.1097/01.sla.0000167926.60908.15; Law WL, 2004, ANN SURG, V240, P260, DOI 10.1097/01.sla.0000133185.23514.32; Stewart D, 2008, COLORECTAL DIS, V10, P879, DOI 10.1111/j.1463-1318.2008.01508.x; Nesbakken A, 2002, EUR J SURG ONCOL, V28, P126, DOI 10.1053/ejso.2001.1231; HEALD RJ, 1986, LANCET, V1, P1479; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; POLLETT WG, 1983, ANN SURG, V198, P159, DOI 10.1097/00000658-198308000-00008; HIDA J, 1994, J AM COLL SURGEONS, V178, P223; Andreola S, 1997, DIS COLON RECTUM, V40, P25, DOI 10.1007/BF02055677; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; GALANDIUK S, 1992, SURG GYNECOL OBSTET, V174, P27; Kim JC, 2007, ANN SURG, V246, P754, DOI 10.1097/SLA.0b013e318070d587; MACFARLANE JK, 1993, LANCET, V341, P457; KARANJIA ND, 1990, BRIT J SURG, V77, P510, DOI 10.1002/bjs.1800770512; Block WA, 1948, SURG GYNECOL OBSTET, V87, P457; Bulow S, 2003, BRIT J SURG, V90, P974, DOI 10.1002/bjs.4137; Cecil TD, 2004, DIS COLON RECTUM, V47, P1145, DOI 10.1007/s10350-004-0086-6; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Corman MR, 2005, COLON RECTAL SURG, P5; Dahlberg M, 1999, BRIT J SURG, V86, P379; deHaasKock DFM, 1996, BRIT J SURG, V83, P781, DOI 10.1002/bjs.1800830617; Du CZ, 2012, HUM PATHOL, V43, P1061, DOI 10.1016/j.humpath.2011.07.026; Enker WE, 1995, CANC COLON RECTUM AN, P561; Fitzgerald TL, 2011, J AM COLL SURGEONS, V213, P589, DOI 10.1016/j.jamcollsurg.2011.07.020; Garcia-Granero E, 2011, COLORECTAL DIS, V13, P650, DOI 10.1111/j.1463-1318.2010.02249.x; Gijn W, 2011, LANCET ONCOL, V12, P575; GLOVER RP, 1946, SURG GYNECOL OBSTET, V82, P434; Glynne-Jones R, 2006, COLORECTAL DIS, V8, P800, DOI 10.1111/j.1463-1318.2006.01139.x; GOLDBERG PA, 1995, BRIT J SURG, V82, P1054, DOI 10.1002/bjs.1800820818; GOLIGHER JC, 1951, BRIT J SURG, V39, P199, DOI 10.1002/bjs.18003915504; GRINNELL RS, 1954, SURG GYNECOL OBSTET, V99, P421; Guillem JG, 2007, ANN SURG, V245, P88, DOI 10.1097/01.sla.0000232540.82364.43; Hall NR, 1998, DIS COLON RECTUM, V41, P979, DOI 10.1007/BF02237384; Hardy K J, 1971, Aust N Z J Surg, V41, P44; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; HEIMANN TM, 1986, DIS COLON RECTUM, V29, P862, DOI 10.1007/BF02555364; Hida J, 1997, J AM COLL SURGEONS, V184, P475; Hida J, 1997, J AM COLL SURGEONS, V184, P584; Hida JI, 1996, DIS COLON RECTUM, V39, P74, DOI 10.1007/BF02048273; HOJO K, 1986, DIS COLON RECTUM, V29, P11, DOI 10.1007/BF02555276; Japanese Research Society for Cancer of the Colon and Rectum, 1990, MULT REG LARG BOW CA, V5, P56; Keighley MRB, 2008, SURG ANUS RECTUM COL, P1149; Kelly SB, 2011, BRIT J SURG, V98, P573, DOI 10.1002/bjs.7372; Killingback M, 2001, DIS COLON RECTUM, V44, P473, DOI 10.1007/BF02234317; Kiran RP, 2011, DIS COLON RECTUM, V54, P157, DOI 10.1007/DCR.0b013e3181fc9378; Kobayashi H, 2011, INT J COLORECTAL DIS, V26, P891, DOI 10.1007/s00384-011-1173-0; Kulu Y, 2012, DIGEST DIS, V30, P118, DOI 10.1159/000342040; Kwok SPY, 1996, BRIT J SURG, V83, P969, DOI 10.1002/bjs.1800830726; Law WL, 2005, DIS COLON RECTUM, V48, P218, DOI 10.1007/s10350-004-0813-7; Law WL, 2001, BRIT J SURG, V88, P1607, DOI 10.1046/j.0007-1323.2001.01929.x; Leo E, 2000, ANN SURG ONCOL, V7, P125, DOI 10.1007/s10434-000-0125-7; Liang JT, 2011, ANN SURG ONCOL, V18, P153, DOI 10.1245/s10434-010-1238-2; Liebig C, 2010, J CLIN ONCOL, V28, pe361; Lin HH, 2013, AM J SURG, V206, P771, DOI 10.1016/j.amjsurg.2013.03.009; Lopez-Kostner F, 1998, SURGERY, V124, P612, DOI 10.1067/msy.1998.91361; Fowler JM, 2007, RADIOLOGY, V243, P132, DOI 10.1148/radiol.2431051825; Mezhir JJ, 2005, SURGERY, V138, P658, DOI 10.1016/j.surg.2005.06.048; Morita T., 1992, Journal of the Japan Society of Coloproctology, V45, P1113; NG IOL, 1993, CANCER, V71, P1972, DOI 10.1002/1097-0142(19930315)71:6<1972::AID-CNCR2820710608>3.0.CO;2-V; Ono C, 2002, DIS COLON RECTUM, V45, P744, DOI 10.1097/01.DCR.0000017586.54619.75; PATY PB, 1994, ANN SURG, V219, P365, DOI 10.1097/00000658-199404000-00007; Pricolo VE, 2010, DIGEST SURG, V27, P185, DOI 10.1159/000274464; QUER EA, 1953, SURG GYNECOL OBSTET, V96, P24; Quirke P, 1992, SURG ONCOL CLIN N AM, V1, P1; Rogers AC, 2014, MODERN PATHOL, V27, P156, DOI 10.1038/modpathol.2013.124; Rutkowski A, 2008, ANN SURG ONCOL, V15, P3124, DOI 10.1245/s10434-008-0125-6; SHIROUZU K, 1995, CANCER, V76, P388, DOI 10.1002/1097-0142(19950801)76:3<388::AID-CNCR2820760307>3.0.CO;2-Y; Syk E, 2011, COLORECTAL DIS, V13, P255, DOI 10.1111/j.1463-1318.2009.02119.x; Syk E, 2010, DIS COLON RECTUM, V53, P744, DOI 10.1007/DCR.0b013e3181cf8841; Tinley HS, 2009, DIS COLON RECTUM, V52, P1723; Tocchi A, 2001, ARCH SURG-CHICAGO, V136, P216, DOI 10.1001/archsurg.136.2.216; Topor B, 2003, DIS COLON RECTUM, V46, P779, DOI 10.1097/01.DCR.0000069955.51592.56; TWOMEY P, 1989, ARCH SURG-CHICAGO, V124, P1174; VERNAVA AM, 1992, SURG GYNECOL OBSTET, V175, P333; Vironen JH, 2002, EUR J SURG, V168, P158, DOI 10.1080/110241502320127775; Watanabe T, 2002, SURGERY, V132, P27, DOI 10.1067/msy.2002.125357; WILSON SM, 1976, ANN SURG, V183, P556, DOI 10.1097/00000658-197605000-00013; WOLMARK N, 1986, ANN SURG, V204, P480, DOI 10.1097/00000658-198610000-00016; Yao YF, 2011, J CLIN PATHOL, V64, P1073, DOI 10.1136/jclinpath-2011-200190; Zhao GP, 2005, WORLD J GASTROENTERO, V11, P319	134	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2227	2242		10.1007/s00595-013-0811-2		16	Surgery	Surgery	AT7DP	WOS:000345097300003		
J	Kanzaki, R; Inoue, M; Minami, M; Shintani, Y; Nakagiri, T; Funaki, S; Sawabata, N; Okumura, M				Kanzaki, Ryu; Inoue, Masayoshi; Minami, Masato; Shintani, Yasushi; Nakagiri, Tomoyuki; Funaki, Soichiro; Sawabata, Noriyoshi; Okumura, Meinoshin			Feasibility of aspirin continuation during the perioperative period for pulmonary resection in lung cancer patients: a retrospective study at a single institute in Japan	SURGERY TODAY			English	Article						Lung cancer; Aspirin; Surgery	ANTIPLATELET THERAPY; NONCARDIAC SURGERY; COMPLICATIONS; GUIDELINES; MANAGEMENT; THROMBOSIS; ANALGESIA	To evaluate the feasibility of aspirin continuation during the perioperative period for pulmonary resection in lung cancer patients. A retrospective study was conducted in 46 patients who were taking aspirin and underwent pulmonary resection. The indications for aspirin were generally a cardiovascular or cerebrovascular comorbidity. Whether to continue or discontinue aspirin was determined based on the severity of the cardiovascular or cerebrovascular comorbidity, along with the patient's overall condition. The intraoperative and postoperative outcomes were compared between patients continuing and those discontinuing aspirin. Twenty patients continued (group C) and 26 patients discontinued (group D) aspirin. The length of the operation (226 +/- A 97 min in group C vs. 189 +/- A 90 min in group D), intraoperative bleeding (234 +/- A 232 vs. 204 +/- A 367 g) and average pleural discharge on postoperative days 1, 2 and 3 (331, 230 and 215 vs. 304, 210 and 174 ml/day) showed no significant differences between the two groups. The postoperative complication rates were also not significantly different between the two groups [eight patients (40 %) in group C vs. nine patients (35 %) in group D]. Continuous administration of aspirin during the perioperative period for pulmonary resection in lung cancer patients appears to be clinically feasible in the Japanese population.	[Kanzaki, Ryu; Inoue, Masayoshi; Minami, Masato; Shintani, Yasushi; Nakagiri, Tomoyuki; Funaki, Soichiro; Sawabata, Noriyoshi; Okumura, Meinoshin] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Suita, Osaka 5650871, Japan	Inoue, M (reprint author), Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, L5-2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	rkanzaki@tj8.so-net.ne.jp; mi@thoracic.med.osaka-u.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Saunders E, 2008, CARDIOL REV, V16, P82, DOI 10.1097/CRD.0b013e31815685fa; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Beattie WS, 2003, ANESTH ANALG, V97, P919, DOI 10.1213/01.ANE.0000074660.05733.10; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Endoh H, 2013, SURG TODAY, V43, P514, DOI 10.1007/s00595-012-0401-8; Liu SS, 2007, ANESTH ANALG, V104, P689, DOI 10.1213/01.ane.0000255040.71600.41; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P71; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Fleisher LA, 2007, CIRCULATION, V116, P1971, DOI 10.1161/CIRCULATIONAHA.107.185700; Kato K, 2011, J JPN SOC CLIN ANEST, V31, P986; Kobayashi H, 2010, J CATARACT REFR SURG, V36, P1115, DOI 10.1016/j.jcrs.2010.01.017; Murase A, 2011, CENTRAL JPN J ORTHOP, V54, P291; Ohmiya H, 2007, ORTHOP TRAUMATOL, V56, P214; Shinkai A, 2011, GANNKA RINSHO KIYO F, V4, P433; Sonobe Makoto, 2011, Gen Thorac Cardiovasc Surg, V59, P477, DOI 10.1007/s11748-011-0775-3; Stafford-Smith Mark, 1996, Canadian Journal of Anaesthesia, V43, pR129; Tsukahara A, 67 GEN M JAP SOC GAS, P3; Yokoyama M, 2010, J JPN SOC CLIN ANEST, V30, P142	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2243	2248		10.1007/s00595-014-0843-2		6	Surgery	Surgery	AT7DP	WOS:000345097300004		
J	Uramoto, H; Shimokawa, H; Hanagiri, T; Ichiki, Y; Tanaka, F				Uramoto, Hidetaka; Shimokawa, Hidehiko; Hanagiri, Takeshi; Ichiki, Yoshinobu; Tanaka, Fumihiro			Factors predicting the surgical outcome in patients with T3/4 lung cancer	SURGERY TODAY			English	Article						Lung cancer; T3/4; Surgery; Predictive factor; Prognosis	CHEST-WALL; CELL; RESECTION; RISK; INVASION; SURGERY	Locally advanced lung cancer, such as T3/4 tumors, is considered to have a significantly worse prognosis than lower-stage disease, and the treatment of these tumors is difficult. Nevertheless, the information regarding the optimal treatment of T3/4 lung cancers after an operation is still limited. This study evaluated the prognostic factors for the postoperative outcome in patients with T3/4 lung cancers. The results of the surgical treatments were retrospectively analyzed for 212 patients with pathological T3 and 197 patients with T4 disease. The global 5-year survival rate was 30.7 % in this series. The 5-year overall survival (OS) rate in patients with T3 disease was 36.1 %, while that in patients with T4 disease was 24.8 %. The prognosis in females, those with N0-1 disease and those who underwent a complete resection was better than that of the other patients in both the T3 and T4 subgroups. The examination of the OS according to a time series showed that the rate was higher in more recent versus less recent years. From the standpoint of pulmonary metastasis (PM), the 5-year OS rates in T4 patients with PM and without PM were 38.6 and 17.4 %, respectively. Multivariate analyses demonstrated that female gender, T3 disease, N0-1 disease and postoperative treatment were significant favorable prognostic predictors for OS. These findings suggest that surgical resection remains an important treatment option, especially in cases having the aforementioned factors.	[Uramoto, Hidetaka; Shimokawa, Hidehiko; Hanagiri, Takeshi; Tanaka, Fumihiro] Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Ichiki, Yoshinobu] Onga Hosp, Onga Nakama Med Assoc, Dept Chest Surg, Onga, Japan	Uramoto, H (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Surg 2, Yahatanishi Ku, I-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	hidetaka@med.uoeh-u.ac.jp			JPJS KAKENHI Grant [25462202]; UOEH Research Grant for Promotion of Occupational Health	The authors thank Ayano Tadano for her valuable technical assistance. This study was supported, in part, by JPJS KAKENHI Grant Number 25462202 and by a UOEH Research Grant for Promotion of Occupational Health.	Rusch VW, 2007, J CLIN ONCOL, V25, P313, DOI 10.1200/JCO.2006.08.2826; Kim YT, 2013, J THORAC ONCOL, V8, P171, DOI 10.1097/JTO.0b013e318277a3bb; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Yang HX, 2009, ANN THORAC SURG, V88, P372, DOI 10.1016/j.athoracsur.2009.04.018; Endoh H, 2013, SURG TODAY, V43, P514, DOI 10.1007/s00595-012-0401-8; Yoshino I, 2012, J THORAC ONCOL, V7, P850, DOI 10.1097/JTO.0b013e31824c945b; Yildizeli B, 2008, ANN THORAC SURG, V86, P1065, DOI 10.1016/j.athoracsur.2008.07.004; Doddoli C, 2005, ANN THORAC SURG, V80, P2032, DOI 10.1016/j.athoracsur.2005.03.088; Di Perna CA, 2005, CLIN CANCER RES, V11, p5038S, DOI 10.1158/1078-0432.CCR-05-9007; Farjah F, 2009, J THORAC ONCOL, V4, P355, DOI 10.1097/JTO.0b013e318197f4d9; Hanagiri T, INDIAN J SU IN PRESS; Lococo F, 2012, ANN THORAC SURG, V93, P1633, DOI 10.1016/j.athoracsur.2012.01.109; Nagai K, 2007, J THORAC ONCOL, V2, P282; Shien K, 2012, ANN SURG ONCOL, V19, P2685, DOI 10.1245/s10434-012-2302-x; Suzuki M, 2010, INTERACT CARDIOV TH, V11, P420, DOI 10.1510/icvts.2010.242743; Uramoto H, 2010, J THORAC ONCOL, V5, P1136, DOI 10.1097/JTO.0b013e3181e0b993	16	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2249	2254		10.1007/s00595-014-0861-0		6	Surgery	Surgery	AT7DP	WOS:000345097300005		
J	Hayashi, Y; Miyata, K; Yuasa, N; Takeuchi, E; Goto, Y; Miyake, H; Nagai, H; Kobayashi, Y				Hayashi, Yuki; Miyata, Kanji; Yuasa, Norihiro; Takeuchi, Eiji; Goto, Yasutomo; Miyake, Hideo; Nagai, Hidemasa; Kobayashi, Yoichiro			Short- and long-term outcomes of open inguinal hernia repair: comparison of the Prolene Hernia System and the Mesh Plug method	SURGERY TODAY			English	Article						Inguinal hernia; Prolene Hernia System; Mesh Plug	GROIN HERNIA; RISK-FACTOR; RECURRENCE; SURGERY; INFECTION; TRIAL; HERNIORRHAPHY; SUTURELESS; TIME	Tension-free mesh repair of adult inguinal hernias has become a standard procedure, but there have been few comparisons of the postoperative outcome after hernia repair using the Prolene Hernia System (PHS) vs. the Mesh Plug (MP) method in a large number of patients from a single institution. We reviewed the medical records of patients to investigate the short- and long-term outcomes of the different types of hernia repair. Late symptoms were evaluated by questionnaire. A total of 1,141 repairs performed from 1999 to 2008 (PHS in 957 and MP in 184 repairs) were evaluated. There were 93 early postoperative complications (8.2 %). A subcutaneous hematoma was found more frequently after MP repair compared with after PHS repair (3.8 vs. 1.3 %, P = 0.013). Seven hundred and ten patients (62.2 %) could be followed up for more than 2 years. Recurrence was detected in 14 patients with PHS repair and two patients with MP repair (1.5 vs. 1.1 %, P = 0.956). Wound infections occurred in three patients (0.3 %) with PHS repair vs. none with MP repair (P > 0.999). Patients with PHS and MP repair showed no significant differences in the long-term wound pain. The recurrence and wound infection rates were similar after hernia repair using the PHS and MP methods. Patients undergoing PHS repair developed fewer subcutaneous hematomas. An older age (a parts per thousand yen65 years) was a significant independent risk factor for recurrence.	[Hayashi, Yuki; Miyata, Kanji; Yuasa, Norihiro; Takeuchi, Eiji; Goto, Yasutomo; Miyake, Hideo; Nagai, Hidemasa; Kobayashi, Yoichiro] Japanese Red Cross Nagoya Dai Ichi Hosp, Dept Surg, Nakamura Ku, Nagoya, Aichi, Japan	Hayashi, Y (reprint author), Japanese Red Cross Nagoya Dai Ichi Hosp, Dept Surg, Nakamura Ku, 3-35 Michishita Cho, Nagoya, Aichi, Japan.	cdt00630@syd.odn.ne.jp					LICHTENSTEIN IL, 1986, INT SURG, V71, P1; Kald A, 1998, EUR J SURG, V164, P45; Zhao G, 2009, ANN SURG, V250, P35, DOI 10.1097/SLA.0b013e3181ad63cc; Nienhuijs SW, 2005, BRIT J SURG, V92, P33, DOI 10.1002/bjs.4702; Rosemar A, 2010, ANN SURG, V252, P397, DOI 10.1097/SLA.0b013e3181e985a1; Pessaux P, 2006, AM J SURG, V192, P165, DOI 10.1016/j.amjsurg.2006.05.003; van der Linden W, 2011, ARCH SURG-CHICAGO, V146, P1198, DOI 10.1001/archsurg.2011.268; Kugel RD, 1999, AM J SURG, V178, P298, DOI 10.1016/S0002-9610(99)00181-6; Praveen S, 2009, ASIAN J SURG, V32, P59, DOI 10.1016/S1015-9584(09)60011-7; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; Arvidsson D, 2005, BRIT J SURG, V92, P1085, DOI 10.1002/bjs.5137; Awad SS, 2007, AM J SURG, V193, P697, DOI 10.1016/j.amjsurg.2006.08.087; Berende C A S, 2007, Hernia, V11, P303, DOI 10.1007/s10029-007-0218-3; [陈杰 Chen Jie], 2003, [中华普通外科杂志, Chinese Journal of General Surgery], V18, P543; Dalenback J, 2009, HERNIA, V13, P121, DOI 10.1007/s10029-008-0443-4; Esposito S, 2006, J CHEMOTHERAPY, V18, P278; Faraj D, 2010, HERNIA, V14, P155, DOI 10.1007/s10029-009-0576-0; Gilbert AI, 1999, HERNIA, V3, P161, DOI 10.1007/BF01195319; Gilbert A I, 2004, Hernia, V8, P203; Gilbert AI, 1997, CAN J SURG, V40, P209; Hasegawa S, 2006, SURG TODAY, V36, P1058, DOI 10.1007/s00595-006-3311-9; Huang C S, 2005, Hernia, V9, P167, DOI 10.1007/s10029-005-0318-x; Jansen PL, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-18; Junge K, 2006, Hernia, V10, P309, DOI 10.1007/s10029-006-0096-0; Just E, 2010, INT J SURG, V8, P462, DOI 10.1016/j.ijsu.2010.06.006; Kehlet H, 2008, HERNIA, V12, P507, DOI 10.1007/s10029-008-0371-3; Kingsnorth A N, 2002, Hernia, V6, P113; Mayagoitia J C, 2006, Hernia, V10, P147, DOI 10.1007/s10029-005-0057-z; Mayagoitia J C, 2004, Hernia, V8, P64, DOI 10.1007/s10029-003-0180-7; Mesci A, 2012, SURG TODAY, V42, P157, DOI 10.1007/s00595-011-0017-4; Sorensen LT, 2002, WORLD J SURG, V26, P397, DOI 10.1007/s00268-001-0238-6; Taylor EW, 2004, BRIT J SURG, V91, P105, DOI 10.1002/bjs.4365	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2255	2262		10.1007/s00595-014-0867-7		8	Surgery	Surgery	AT7DP	WOS:000345097300006		
J	Yunoki, J; Kuratani, T; Shirakawa, Y; Torikai, K; Shimamura, K; Kin, K; Sawa, Y				Yunoki, Junji; Kuratani, Toru; Shirakawa, Yukitoshi; Torikai, Kei; Shimamura, Kazuo; Kin, Keiwa; Sawa, Yoshiki			Clinical experience with the RELAY NBS PLUS stent-graft for aortic arch pathology	SURGERY TODAY			English	Article						Aortic arch pathology; Aneurysm; Endovascular repair; TEVAR; RELAY	ENDOVASCULAR TREATMENT; ENDOLEAK FORMATION; REPAIR; DISSECTION; ANEURYSMS; TEVAR; RISK	To assess the safety, efficacy and performance of the RELAY NBS PLUS stent-graft in patients with aortic arch pathology. From July 2010 to December 2011, the RELAY NBS PLUS was used to treat 13 patients (eight males; mean age 59.8 years, range 29-78 years) suffering from aortic arch pathology. The distribution of the proximal landing zone was Zone 0 in one case, Zone 1 in three cases and Zone 2 in nine cases. Bypass of the cervical branches was performed in 11 patients. The surgery-related mortality within 30 days and postoperative morbidity were 0 %. Postoperative computed tomography at discharge confirmed 100 % clinical success without any endoleaks. The mean radius of the inner curve in the aortic arch was 16.2 mm (range 5.8-25.7 mm). We detected two bird-beak configurations with a severely angulated aortic arch with a radius of the inner curve < 15 mm. At the mid-term follow-up (mean 22.1 months; range 13.8-28.2 months), all patients were alive without aorta- or device-related complications. RELAY NBS PLUS stent-grafts can be safely and effectively implanted with controlled deployment to satisfactorily repair aortic arch pathology, even in the cases considered to present with an unfavorable anatomy for the first generation commercially available stent-graft devices. These encouraging outcomes will need to be confirmed in a larger series with a longer follow-up.	[Yunoki, Junji; Kuratani, Toru; Shirakawa, Yukitoshi; Torikai, Kei; Shimamura, Kazuo; Kin, Keiwa; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan	Yunoki, J (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	zunzy0120@hotmail.com; sawa@surg1.med.osaka-u.ac.jp					Makaroun MS, 2008, J VASC SURG, V47, P912, DOI 10.1016/j.jvs.2007.12.006; Ueda T, 2010, RADIOLOGY, V255, P645, DOI 10.1148/radiol.10091468; Murphy EH, 2012, ANN VASC SURG, V26, P55, DOI 10.1016/j.avsg.2011.08.009; Bavaria JE, 2007, J THORAC CARDIOV SUR, V133, P369, DOI 10.1016/j.jtcvs.2006.07.040; Melissano G, 2012, EUR J VASC ENDOVASC, V43, P269, DOI 10.1016/j.ejvs.2011.12.009; Ferro C, 2011, CARDIOVASC INTER RAD, V34, P401, DOI 10.1007/s00270-010-9852-8; Haw SW, 2011, J VASC SURG, V54, P30; Hughes GC, 2010, ANN THORAC SURG, V90, P83, DOI 10.1016/j.athoracsur.2010.03.052; Igarashi T, 2013, SURG TODAY, V43, P103, DOI 10.1007/s00595-012-0335-1; Kuratani Toru, 2010, Gen Thorac Cardiovasc Surg, V58, P393, DOI 10.1007/s11748-009-0578-y; Riambau V, 2011, J VASC SURG, V53, P565, DOI 10.1016/j.jvs.2010.09.050; Shigemura N, 2000, J THORAC CARDIOV SUR, V120, P406, DOI 10.1067/mtc.2000.107279; Sze DY, 2009, CIRC-CARDIOVASC INTE, V2, P105, DOI 10.1161/CIRCINTERVENTIONS.108.819722; Zipfel B, 2011, J ENDOVASC THER, V18, P131, DOI 10.1583/10-3233MR.1	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2263	2268		10.1007/s00595-014-0851-2		6	Surgery	Surgery	AT7DP	WOS:000345097300007		
J	Hatanaka, A; Nakahara, S; Takeyama, E; Iwanaka, T; Ishida, K				Hatanaka, Akira; Nakahara, Saori; Takeyama, Eriko; Iwanaka, Tadashi; Ishida, Kazuo			Management of extremely low birth weight neonates with bowel obstruction within 2 weeks after birth	SURGERY TODAY			English	Article						Extremely low birth weight infant; Meconium obstruction; Meconium-related ileus; Gastrografin enema	MECONIUM-RELATED ILEUS; PREMATURE-INFANT; MUCOVISCIDOSIS; DIAGNOSIS; ABSENCE; DISEASE; ENEMA	The majority of bowel obstructions in extremely low birth weight (ELBW) neonates are meconium-related ileus (MRI). ELBW neonates with bowel obstruction may recover by conservative treatment, but some do not. Considering the high surgical morbidity rates, unnecessary surgery should be avoided. We sought to identify a reasonable treatment strategy under these conditions. ELBW neonates who started to have bowel obstruction with an unclear cause within 14 days of age were enrolled. The study period was from January 2009 to August 2011. The enrolled patients had daily Gastrografin(A (R)) enemas until 14 days of age or until the obstruction resolved. If the obstruction lasted beyond around 14 days of age, the patient underwent surgical intervention. The clinical data of the patients were collected and analyzed. Fourteen patients were enrolled. Twelve patients had MRI, which resolved within 14 days without surgery. Two patients with persistent obstruction underwent surgery, and they were found to have Hirschsprung's disease and ileal volvulus, respectively. For ELBW neonates with bowel obstruction of unclear etiology, the early and frequent administration of a Gastrografin(A (R)) enema is reasonable. Surgery should be considered if the obstruction lasts beyond approximately 14 days after birth.	[Hatanaka, Akira; Nakahara, Saori; Takeyama, Eriko; Ishida, Kazuo] Japanese Red Cross Med Ctr, Dept Pediat Surg, Tokyo 1508935, Japan; [Hatanaka, Akira; Iwanaka, Tadashi] Univ Tokyo, Grad Sch Med, Dept Pediat Surg, Tokyo 1138655, Japan	Hatanaka, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Pediat Surg, 7-3-1 Hongo, Tokyo 1138655, Japan.	hatanakaa-psu@h.u-tokyo.ac.jp					Greenholz SK, 1996, J PEDIATR SURG, V31, P117, DOI 10.1016/S0022-3468(96)90332-2; Emil S, 2004, J PEDIATR SURG, V39, P731, DOI 10.1016/j.jpedsurg.2004.01.027; NOBLETT HR, 1969, J PEDIATR SURG, V4, P190, DOI 10.1016/0022-3468(69)90390-X; Kubota A, 2011, PEDIATR INT, V53, P887, DOI 10.1111/j.1442-200X.2011.03381.x; CLATWORTHY HW, 1956, SURGERY, V39, P131; Kim YJ, 2012, NEONATOLOGY, V101, P172, DOI 10.1159/000330850; Nakaoka T, 2009, PEDIATR SURG INT, V25, P273, DOI 10.1007/s00383-009-2334-x; Garza-Cox S, 2004, PEDIATRICS, V114, P285, DOI 10.1542/peds.114.1.285; VINOGRAD I, 1983, J PEDIATR-US, V103, P963, DOI 10.1016/S0022-3476(83)80732-X; Chan KL, 2003, PEDIATR SURG INT, V19, P573, DOI 10.1007/s00383-003-0979-4; Copeland DR, 2009, J PEDIATR SURG, V44, P2130, DOI 10.1016/j.jpedsurg.2009.06.005; Dimmitt R A, 2000, Semin Pediatr Surg, V9, P79; Haiden N, 2007, J PEDIATR GASTR NUTR, V44, P270, DOI 10.1097/MPG.0b013e31802c685a; Kubota A, 1999, EUR J PEDIATR SURG, V9, P392, DOI 10.1055/s-2008-1072290; Paradiso VF, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-55; RICKHAM PP, 1965, AM J SURG, V109, P173; SHIGEMOTO H, 1978, J PEDIATR SURG, V13, P475, DOI 10.1016/S0022-3468(78)80308-X; Shinohara T, 2007, PEDIATR INT, V49, P641, DOI 10.1111/j.1442-200X.2007.02457.x	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2269	2274		10.1007/s00595-013-0824-x		6	Surgery	Surgery	AT7DP	WOS:000345097300008		
J	Tagawa, T; Yamasaki, N; Tsuchiya, T; Miyazaki, T; Morino, S; Akamine, S; Nagayasu, T				Tagawa, Tsutomu; Yamasaki, Naoya; Tsuchiya, Tomoshi; Miyazaki, Takuro; Morino, Shigeyuki; Akamine, Shinji; Nagayasu, Takeshi			Thoracoscopic versus transsternal resection for early stage thymoma: long-term outcomes	SURGERY TODAY			English	Article						VATS; Thymoma; Thymectomy	MYASTHENIA-GRAVIS; THYMECTOMY	This study was undertaken to investigate the efficacy of a video-assisted thoracoscopic (VATS) approach for stage I and II thymoma through comparisons with the transsternal approach. The indications for VATS resection were clinical stage I or II thymoma, a tumor less than 50 mm, located within the thymic lobes and separated from the brachiocephalic vein. Data were collected between 1995 and 2007. Twenty-seven patients underwent total thymectomy (15 by VATS and 12 by the transsternal approach). The mean tumor size was 36.3 (22-50) mm for VATS and 37.6 (15-55) mm for the transsternal group (p = 0.7862). The mean lengths of the operation were 249.8 min and 227.9 min (p = 0.2728), respectively. The mean intraoperative blood loss was significantly lower in VATS, at 92.3 ml, than the 225.1 ml lost in the transsternal group (p = 0.0020). The morbidity rates were 13.3 and 8.3 % (p = 0.6812), respectively. There was no mortality in either group. The mean follow-up periods were 109.0 (37-145) months following VATS and 102.0 (44-175) months following the transsternal approach. One stage II patient developed pleural dissemination three years after VATS resection. Other patients survived with no recurrence. VATS resection of early stage thymoma can be performed with less bleeding and with a comparable prognosis to the transsternal approach. VATS resection should thus be considered as a viable option for treatment.	[Tagawa, Tsutomu; Yamasaki, Naoya; Tsuchiya, Tomoshi; Miyazaki, Takuro; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Translat Med Sci, Div Surg Oncol, Nagasaki 8528501, Japan; [Morino, Shigeyuki; Akamine, Shinji] Oita Prefectural Hosp, Div Gen Thorac Surg, Oita, Japan	Tagawa, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Translat Med Sci, Div Surg Oncol, I-7-1 Sakamoto, Nagasaki 8528501, Japan.	tomtgw@nagasaki-u.ac.jp					Andou A, 1996, J JPN ASS CHEST SURG, V10, P107; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Cheng YJ, 2005, CHEST, V128, P3010, DOI 10.1378/chest.128.4.3010; Ito S, 1997, J JPN ASS CHEST SURG, V11, P181; Kondo K, 2003, ANN THORAC SURG, V76, P878, DOI 10.1016/S0003-4975(03)00555-1; LANDRENEAU RJ, 1992, ANN THORAC SURG, V54, P142; Meyer DM, 2009, ANN THORAC SURG, V87, P385, DOI 10.1016/j.athoracsur.2008.11.040; Onuki T, 2010, LUNG CANCER, V68, P460, DOI 10.1016/j.lungcan.2009.08.001; Pennathur A, 2011, J THORAC CARDIOV SUR, V141, P694, DOI 10.1016/j.jtcvs.2010.09.003; SABBAGH MN, 1995, MUSCLE NERVE, V18, P1475, DOI 10.1002/mus.880181220; Sakamaki Y, 2008, SURG ENDOSC, V22, P1272, DOI 10.1007/s00464-007-9606-0; SUGARBAKER DJ, 1993, ANN THORAC SURG, V56, P653; Tagawa T, 2000, JPN J CHEST SURG, V14, P178	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2275	2280		10.1007/s00595-013-0829-5		6	Surgery	Surgery	AT7DP	WOS:000345097300009		
J	Fujita, T; Hata, H; Shimahara, Y; Sato, S; Kobayashi, J				Fujita, Tomoyuki; Hata, Hiroki; Shimahara, Yusuke; Sato, Shunsuke; Kobayashi, Junjiro			Initial experience with internal mammary artery harvesting with the da Vinci Surgical System for minimally invasive direct coronary artery bypass	SURGERY TODAY			English	Article						da Vinci Surgical System; Minimally invasive direct coronary artery bypass; Robot surgery; Coronary artery disease	FOLLOW-UP; GRAFT-SURGERY; REVASCULARIZATION; DISEASE; TRIAL; PREDICTORS; CABG	We evaluated the feasibility of off-pump minimally invasive direct coronary artery bypass (MIDCAB) in combination with robotic harvesting of the left internal mammary artery (LIMA). Since 2004, 33 patients [average age, 64 years; 27 males (82 %)] have undergone MIDCAB with robotic LIMA harvesting performed through the fourth or fifth intercostal space with guidance by enhanced computed tomography (CT). No deaths or major adverse cardiac events occurred. Robotic LIMA harvesting was completed in 30 cases (91 %), while three cases (9 %) required conversion to a median sternotomy due to bleeding. The risk of LIMA injury significantly increased with age (p = 0.0012). For the 30 successful cases, the average harvest time was 68 min, and the average intraoperative blood loss was 306 ml, with only three patients (9 %) requiring a transfusion. The graft flow was measurable in all cases (average, 34 ml/minute). All grafts were shown to be patent in postoperative evaluations, although CT revealed that the LIMA in one patient was anastomosed to an untargeted artery. Off-pump MIDCAB in combination with robotic harvesting of the LIMA is a reasonable and less invasive procedure than the standard procedures. Potential problems include difficulty controlling bleeding from the graft, especially in elderly patients, and proper identification of the target artery.	[Fujita, Tomoyuki; Hata, Hiroki; Shimahara, Yusuke; Sato, Shunsuke; Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan	Fujita, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	tomofujita@nifty.com	Kobayashi, Junjiro/J-8547-2015				Argenziano M, 2006, ANN THORAC SURG, V81, P1666, DOI 10.1016/j.athoracsur.2005.11.007; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Loulmet D, 1999, J THORAC CARDIOV SUR, V118, P4, DOI 10.1016/S0022-5223(99)70133-9; Kiaii B, 2008, J THORAC CARDIOV SUR, V136, P702, DOI 10.1016/j.jtcvs.2008.02.081; Taggart DP, 2012, EUR HEART J, V33, P1181, DOI 10.1093/eurheartj/ehr374; Gao CQ, 2011, J THORAC CARDIOV SUR, V142, P843, DOI 10.1016/j.jtcvs.2011.01.051; Bonaros N, 2009, CARDIOLOGY, V114, P59, DOI 10.1159/000212115; Srivastava S, 2006, ANN THORAC SURG, V81, P800, DOI 10.1016/j.athoracsur.2005.08.044; Argenziano M, 2006, ANN THORAC SURG, V81, p[1666, 1674]; Balkhy HH, 2011, ANN THORAC SURG, V92, P821, DOI 10.1016/j.athoracsur.2011.04.103; Blazek S, 2013, JACC-CARDIOVASC INTE, V6, P20, DOI 10.1016/j.jcin.2012.09.008; Bonaros N, 2013, ANN THORAC SURG, V95, P803, DOI 10.1016/j.athoracsur.2012.09.071; Dogan S, 2002, Interact Cardiovasc Thorac Surg, V1, P30, DOI 10.1016/S1569-9293(02)00008-7; Sabik JF, 2011, ANN THORAC SURG, V92, P1701; Halkos ME, 2011, ANN THORAC SURG, V92, P1695, DOI 10.1016/j.athoracsur.2011.05.090; Kobayashi J, 2013, GEN THORAC CARDIOVAS; Kuwano Hiroyuki, 2012, Gen Thorac Cardiovasc Surg, V60, P680, DOI 10.1007/s11748-012-0119-y; Nakajima H, 2011, EUR J CARDIO-THORAC, V40, P399, DOI 10.1016/j.ejcts.2010.11.057; Repossini A, 2013, EUR J CARDIOTHORAC S; Schachner T, 2011, ANN THORAC SURG, V91, P647, DOI 10.1016/j.athoracsur.2010.10.072; Srivastava S, 2012, ANN THORAC SURG, V94, P1463, DOI 10.1016/j.athoracsur.2012.05.028	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2281	2286		10.1007/s00595-013-0830-z		6	Surgery	Surgery	AT7DP	WOS:000345097300010		
J	Miyamoto, Y; Watanabe, M; Sakamoto, Y; Shigaki, H; Murata, A; Sugihara, H; Etoh, K; Ishimoto, T; Iwatsuki, M; Baba, Y; Iwagami, S; Yoshida, N; Baba, H				Miyamoto, Yuji; Watanabe, Masayuki; Sakamoto, Yasuo; Shigaki, Hironobu; Murata, Asuka; Sugihara, Hidetaka; Etoh, Kojiro; Ishimoto, Takatsugu; Iwatsuki, Masaaki; Baba, Yoshifumi; Iwagami, Shiro; Yoshida, Naoya; Baba, Hideo			Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer	SURGERY TODAY			English	Article						Colorectal cancer; Chemotherapy; Surgery	NONOPERATIVE MANAGEMENT; LIVER METASTASES; COLON-CANCER; LARGE-BOWEL; PHASE-III; CHEMOTHERAPY; FLUOROURACIL; COMBINATION; LEUCOVORIN; BEVACIZUMAB	We evaluated the need for primary tumor resection in patients with colorectal cancer (CRC) and synchronous unresectable metastases who underwent chemotherapy, and identified the associations between the primary tumor characteristics and risk of intestinal obstruction or perforation. We retrospectively analyzed the survival and complication rates of patients with synchronous metastatic CRC treated between April 2005 and December 2011. Of 131 patients, 68 underwent primary tumor resection before chemotherapy, and 63 were treated without resection before chemotherapy. The overall survival (OS) did not significantly differ between the two groups (log-rank P = 0.53). In the resection group, 12 patients (17.6 %) developed postoperative complications. In the non-resection group, 16 patients (25.4 %) required surgical intervention owing to obstruction or perforation during their treatment. Surgical intervention did not affect the OS. A circumferential tumor was a risk factor for obstruction or perforation of the colorectum in non-resected patients (odds ratio = 11.163; P = 0.006). Resection of primary tumors before chemotherapy is unnecessary in selected patients with synchronous metastatic colorectal cancer. A circumferential tumor is a risk factor for obstruction or perforation during chemotherapy in cases without primary tumor resection.	[Miyamoto, Yuji; Watanabe, Masayuki; Sakamoto, Yasuo; Shigaki, Hironobu; Murata, Asuka; Sugihara, Hidetaka; Etoh, Kojiro; Ishimoto, Takatsugu; Iwatsuki, Masaaki; Baba, Yoshifumi; Iwagami, Shiro; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, I-1-1 Honjo, Kumamoto 8608556, Japan.	yuji-miyamoto@live.jp; hdobaba@kumamoto-u.ac.jp					Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Poultsides GA, 2009, J CLIN ONCOL, V27, P3379, DOI 10.1200/JCO.2008.20.9817; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Tebbutt NC, 2003, GUT, V52, P568, DOI 10.1136/gut.52.4.568; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Ruo L, 2003, J AM COLL SURGEONS, V196, P722, DOI 10.1016/S1072-7515(03)00136-4; Scoggins CR, 1999, ANN SURG ONCOL, V6, P651, DOI 10.1007/s10434-999-0651-x; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Galizia G, 2008, ARCH SURG-CHICAGO, V143, P352, DOI 10.1001/archsurg.143.4.352; Tilney HS, 2007, SURG ENDOSC, V21, P225, DOI 10.1007/s00464-005-0644-1; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; McCahill LE, 2012, J CLIN ONCOL, V30, P3223, DOI 10.1200/JCO.2012.42.4044; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Venderbosch S, 2011, ANN SURG ONCOL, V18, P3252, DOI 10.1245/s10434-011-1951-5; Douillard JY, 2002, J CLIN ONCOL, V20, P3605, DOI 10.1200/JCO.2002.04.123; Ferrand F, 2013, EUR J CANCER, V49, P90, DOI 10.1016/j.ejca.2012.07.006; BACON HARRY E., 1964, DIS COLON RECTUM, V7, P211, DOI 10.1007/BF02633635; Cheynel N, 2007, DIS COLON RECTUM, V50, P1568, DOI 10.1007/s10350-007-9007-4; Costi R, 2011, SURG TODAY, V41, P222, DOI 10.1007/s00595-009-4253-9; Karoui M, 2007, ARCH SURG-CHICAGO, V142, P619, DOI 10.1001/archsurg.142.7.619; OXLEY EM, 1969, BRIT J SURG, V56, P149, DOI 10.1002/bjs.1800560217; Saeki H, 2013, SURG TODAY, DOI [10.1007/S00595-013-0716-0, DOI 10.1007/S00595-013-0716-0.]; Sarela AI, 2001, BRIT J SURG, V88, P1352, DOI 10.1046/j.0007-1323.2001.01915.x; Verhoef C, 2011, EJC SUPPL, V3, pS61	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2287	2292		10.1007/s00595-014-0869-5		6	Surgery	Surgery	AT7DP	WOS:000345097300011		
J	Endo, K; Iida, T; Yagi, S; Yoshizawa, A; Fujimoto, Y; Ogawa, K; Ogura, Y; Mori, A; Kaido, T; Uemoto, S				Endo, Kosuke; Iida, Taku; Yagi, Shintaro; Yoshizawa, Atsushi; Fujimoto, Yasuhiro; Ogawa, Kohei; Ogura, Yasuhiro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji			Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation	SURGERY TODAY			English	Article						Hepatic hydrothorax; Liver transplantation; Massive ascites; Bacteremia; Mortality	CIRRHOTIC-PATIENTS; REFRACTORY ASCITES; HEPATORENAL-SYNDROME; TOTAL PARACENTESIS; MELD SCORE; MANAGEMENT; RECIPIENTS; MODEL; SURVIVAL; TENSE	Uncontrollable hepatic hydrothorax and massive ascites (H&MA) requiring preoperative drainage are sometimes encountered in liver transplantation (LT). We retrospectively analyzed the characteristics of such patients and the impact of H&MA on the postoperative course. We evaluated 237 adult patients who underwent LT in our institute between April 2006 and October 2010. Recipients with uncontrollable H&MA (group HA: n = 36) had more intraoperative bleeding, higher Child-Pugh scores, lower serum albumin concentrations and higher blood urea nitrogen concentrations than those without uncontrollable H&MA (group C: n = 201). They were also more likely to have preoperative hepatorenal syndrome and infections. The incidence of postoperative bacteremia was higher (55.6 vs. 46.7 %, P = 0.008) and the 1- and 3-year survival rates were lower (1 year: 58.9 vs. 82.9 %; 3 years: 58.9 vs. 77.7 %; P = 0.003) in group HA than in group C. The multivariate proportional regression analyses revealed that uncontrollable H&MA and the Child-Pugh score were independent risk factors for the postoperative prognosis. Postoperative infection control may be an important means of improving the outcome for patients with uncontrollable H&MA undergoing LT, and clinicians should strive to perform surgery before H&MA becomes uncontrollable.	[Endo, Kosuke; Iida, Taku; Yagi, Shintaro; Yoshizawa, Atsushi; Fujimoto, Yasuhiro; Ogawa, Kohei; Ogura, Yasuhiro; Mori, Akira; Kaido, Toshimi; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, Kyoto 6068507, Japan	Iida, T (reprint author), Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	kosukee@kuhp.kyoto-u.ac.jp; itaku@kuhp.kyoto-u.ac.jp					POZZI M, 1994, GASTROENTEROLOGY, V106, P709; Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; Iida T, 2010, LIVER TRANSPLANT, V16, P1379, DOI 10.1002/lt.22165; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122; Sanyal AJ, 2003, GASTROENTEROLOGY, V124, P634, DOI 10.1053/gast.2003.50088; Selzner M, 2010, ANN SURG, V251, P153, DOI 10.1097/SLA.0b013e3181bc9c6a; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; MORROW CS, 1958, ANN INTERN MED, V49, P193; RUNYON BA, 1986, ARCH INTERN MED, V146, P2259, DOI 10.1001/archinte.146.11.2259; Somsouk M, 2011, LIVER TRANSPLANT, V17, P129, DOI 10.1002/lt.22218; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Salerno F, 2004, HEPATOLOGY, V40, P629, DOI 10.1002/hep.20364; Cardenas A, 2007, BEST PRACT RES CL GA, V21, P55, DOI 10.1016/j.bpg.2006.07.012; Gines P, 1999, J AM SOC NEPHROL, V10, P1833; Hayashi PH, 2003, LIVER TRANSPLANT, V9, P737, DOI 10.1053/jlts.2003.50122; Ishigami M, 2008, J GASTROENTEROL, V43, P363, DOI 10.1007/s00535-008-2168-7; Liu LU, 2004, CHEST, V126, P142, DOI 10.1378/chest.126.1.142; LUCA A, 1994, HEPATOLOGY, V20, P30, DOI 10.1016/0270-9139(94)90130-9; Orman ES, 2009, HEPATOL INT, V3, P582, DOI 10.1007/s12072-009-9136-z; Serste T, 2010, EUR J GASTROEN HEPAT, V22, P207, DOI 10.1097/MEG.0b013e3283311140; Taketomi A, 2012, SURG TODAY, V42, P559, DOI 10.1007/s00595-011-0086-4; Xiol X, 2005, TRANSPLANT INT, V18, P672, DOI 10.1111/j.1432-2277.2005.00116.x; Xiol X, 1996, HEPATOLOGY, V23, P719, DOI 10.1002/hep.510230410	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2293	2299		10.1007/s00595-014-0839-y		7	Surgery	Surgery	AT7DP	WOS:000345097300012		
J	Asai, K; Watanabe, M; Kusachi, S; Matsukiyo, H; Saito, T; Kodama, H; Kiribayashi, T; Enomoto, T; Nakamura, Y; Okamoto, Y; Saida, Y; Nagao, J				Asai, Koji; Watanabe, Manabu; Kusachi, Shinya; Matsukiyo, Hiroshi; Saito, Tomoaki; Kodama, Hajime; Kiribayashi, Takaharu; Enomoto, Toshiyuki; Nakamura, Yoichi; Okamoto, Yasushi; Saida, Yoshihisa; Nagao, Jiro			Risk factors for conversion of laparoscopic cholecystectomy to open surgery associated with the severity characteristics according to the Tokyo guidelines	SURGERY TODAY			English	Article						Tokyo guidelines; Acute cholecystitis; Early laparoscopic cholecystectomy; Conversion to open surgery	RANDOMIZED CLINICAL-TRIAL; ACUTE CHOLECYSTITIS; PREDICTIVE FACTORS; COMPLICATIONS; MANAGEMENT	The aim of this retrospective study was to identify the risk factors associated with the severity characteristics in the Tokyo guidelines for conversion to open surgery in patients with acute cholecystitis (AC) who underwent laparoscopic cholecystectomy. A total of 225 patients were enrolled in the study. The patients were classified into two groups: a conversion group and a no-conversion group. The preoperative characteristics and therapeutic strategy were analyzed as risk factors for conversion to open surgery. The postoperative outcomes were also analyzed. Conversion to open surgery occurred in 29 patients (12.9 %), including seven patients (6.7 %) with mild AC and 22 patients (18.5 %) with moderate AC. A univariate analysis showed that the risk factors for conversion to open surgery included a duration of symptoms longer than 72 h, an elevated C-reactive protein (CRP) value and the Tokyo guidelines 2013 (TG 13) severity classification. The multivariate analysis showed that the risk factors for conversion to open surgery included a duration of symptoms longer than 72 h and a CRP value > 11.5 mg/dl. A duration of symptoms longer than 72 h, which is included in the criterion for moderate AC severity in the TG 13, was an independent risk factor for conversion to open surgery. In addition, adoption of a high CRP value as an additional criterion for moderate AC may increase the utility of the TG 13.	[Asai, Koji; Watanabe, Manabu; Kusachi, Shinya; Matsukiyo, Hiroshi; Saito, Tomoaki; Kodama, Hajime; Kiribayashi, Takaharu; Enomoto, Toshiyuki; Nakamura, Yoichi; Okamoto, Yasushi; Saida, Yoshihisa; Nagao, Jiro] Toho Univ, Ohashi Med Ctr, Dept Surg, Tokyo 1538515, Japan	Asai, K (reprint author), Toho Univ, Ohashi Med Ctr, Dept Surg, 2-17-6 Ohashi, Tokyo 1538515, Japan.	k-asai@mvg.biglobe.ne.jp					Lo CM, 1998, ANN SURG, V227, P461, DOI 10.1097/00000658-199804000-00001; Yokoe M, 2013, J HEPATO-BIL-PAN SCI, V20, P35, DOI 10.1007/s00534-012-0568-9; Wevers KP, 2013, SURG LAPARO ENDO PER, V23, P163, DOI 10.1097/SLE.0b013e31826d7fb0; Brodsky A, 2000, SURG ENDOSC, V14, P755, DOI 10.1007/s004640000182; Teckchandani N, 2010, INT J SURG, V8, P623, DOI 10.1016/j.ijsu.2010.05.014; Schafer M, 2001, AM J SURG, V182, P291, DOI 10.1016/S0002-9610(01)00702-4; Takada T, 2013, J HEPATO-BIL-PAN SCI, V20, P1, DOI 10.1007/s00534-012-0566-y; Yamashita Y, 2013, J HEPATO-BIL-PAN SCI, V20, P89, DOI 10.1007/s00534-012-0567-x; Lo CM, 1997, AM J SURG, V173, P513, DOI 10.1016/S0002-9610(97)00005-6; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Johansson M, 2003, J GASTROINTEST SURG, V7, P642, DOI 10.1016/S1091-255X(03)00065-9; Kolla SB, 2004, SURG ENDOSC, V18, P1323, DOI 10.1007/s00464-003-9230-6; Asai K, 2012, J HEPATO-BIL-PAN SCI, V19, P476, DOI 10.1007/s00534-011-0463-9; Lai PBS, 1998, BRIT J SURG, V85, P764; Banz V, 2011, ANN SURG, V254, P964, DOI 10.1097/SLA.0b013e318228d31c; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; Yamashita Y, 2007, J HEPATO-BILIARY-PAN, V14, P91, DOI 10.1007/s00534-006-1161-x; Popkharitov AI, 2008, LANGENBECK ARCH SURG, V393, P935, DOI 10.1007/s00423-008-0313-7; GRACIE WA, 1982, NEW ENGL J MED, V307, P798, DOI 10.1056/NEJM198209233071305; Asai K, 2013, J HEPATO-BIL-PAN SCI, V20, P348, DOI 10.1007/s00534-012-0536-4; Hadad SM, 2007, WORLD J SURG, V31, P1302; Hadad SM, 2007, WORLD J SURG, V31, P1298, DOI 10.1007/s00268-007-9050-2; Halachmi S, 2000, EUR J SURG, V166, P136; Johansson M, 2005, BRIT J SURG, V92, P44, DOI 10.1002/bjs.4836; Kum CK, 1996, WORLD J SURG, V20, P48; Kum CK, 1996, WORLD J SURG, V20, P43; Lee SW, 2010, J HEPATO-BIL-PAN SCI, V17, P879, DOI 10.1007/s00534-010-0289-x; Moyson J, 2008, HEPATO-GASTROENTEROL, V55, P1975; Reibetanz J, 2013, SURG TODAY, V43, P1025, DOI 10.1007/s00595-012-0393-4; Takada T, 2007, J HEPATO-BILIARY-PAN, V14, P1, DOI 10.1007/s00534-006-1150-0	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2300	2304		10.1007/s00595-014-0838-z		5	Surgery	Surgery	AT7DP	WOS:000345097300013		
J	Fukata, S; Kawabata, Y; Fujisiro, K; Katagawa, Y; Kuroiwa, K; Akiyama, H; Terabe, Y; Ando, M; Kawamura, T; Hattori, H				Fukata, Shinji; Kawabata, Yasuji; Fujisiro, Ken; Katagawa, Yuichi; Kuroiwa, Kojiro; Akiyama, Hirotoshi; Terabe, Yasuhito; Ando, Masahiko; Kawamura, Takashi; Hattori, Hideyuki			Haloperidol prophylaxis does not prevent postoperative delirium in elderly patients: a randomized, open-label prospective trial	SURGERY TODAY			English	Article						Haloperidol prophylaxis; Postoperative delirium; Elderly patients; Randomized open-label prospective trial; NEECHAM	NEECHAM CONFUSION SCALE; MINI-MENTAL-STATE; PERIOPERATIVE HALOPERIDOL; REDUCING DELIRIUM; CARDIAC-SURGERY; RISK; RISPERIDONE; MANAGEMENT	Postoperative delirium is the most common postoperative complication in the elderly. The purpose of this study was to evaluate the safety and effectiveness of the preventive administration of low-dose haloperidol on the development of postoperative delirium after abdominal or orthopedic surgery in elderly patients. A total of 119 patients aged 75 years or older who underwent elective surgery for digestive or orthopedic disease were included in this study. Patients were divided into those who did (intervention group, n = 59) and did not (control group, n = 60) receive 2.5 mg of haloperidol at 18:00 daily for 3 days after surgery; a randomized, open-label prospective study was performed on these groups. The primary endpoint was the incidence of postoperative delirium during the first 7 days after the operation. The incidence of postoperative delirium in all patients was 37.8 %. No side effects involving haloperidol were noted; however, the incidences of postoperative delirium were 42.4 and 33.3 % in the intervention and control groups, respectively, which were not significantly different (p = 0.309). No significant effect of the treatment was observed on the severity or persistence of postoperative delirium. The preventive administration of low-dose haloperidol did not induce any adverse events, but also did not significantly decrease the incidence or severity of postoperative delirium or shorten its persistence.	[Fukata, Shinji; Kawabata, Yasuji; Fujisiro, Ken; Katagawa, Yuichi] Natl Ctr Geriatr & Gerontol, Dept Surg, Obu, Aichi 4748511, Japan; [Kuroiwa, Kojiro] Natl Ctr Geriatr & Gerontol, Dept Perioperat Med Care, Obu, Aichi 4748511, Japan; [Kuroiwa, Kojiro] Tokyo Metropolitan Geriatr Hosp, Dept Surg, Tokyo 173, Japan; [Akiyama, Hirotoshi] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; [Terabe, Yasuhito] Natl Ctr Geriatr & Gerontol, Dept Restorat Med, Obu, Aichi 4748511, Japan; [Ando, Masahiko] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4648601, Japan; [Kawamura, Takashi] Kyoto Univ, Hlth Serv, Kyoto, Japan; [Hattori, Hideyuki] Natl Ctr Geriatr & Gerontol, Dept Psychiat, Obu, Aichi 4748511, Japan	Fukata, S (reprint author), Natl Ctr Geriatr & Gerontol, Dept Perioperat Med Care, 35 Gengo, Obu, Aichi 4748511, Japan.	fukatash@ncgg.go.jp			Research Grant for Longevity Sciences from the Ministry of Health, Labour and Welfare [17C-3, 21-13]; Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan [23-28]	This work was supported by a Research Grant for Longevity Sciences (17C-3, 21-13) from the Ministry of Health, Labour and Welfare and The Research Funding for Longevity Sciences (23-28) from National Center for Geriatrics and Gerontology (NCGG), Japan.	American Psychiatric Association, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 1999, AM J PSYCHIAT S, V156, P1; Colombo R, 2012, MINERVA ANESTESIOL, V78, P1026; Matsushita T, 2004, GEN HOSP PSYCHIAT, V26, P158, DOI 10.1016/j.genhosppsych.2003.08.011; McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; Blansfield JA, 2004, J GASTROINTEST SURG, V8, P539, DOI 10.1016/j.gassur.2004.03.009; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Wang W, 2012, CRIT CARE MED, V40, P731, DOI 10.1097/CCM.0b013e3182376e4f; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Demeure MJ, 2006, J AM COLL SURGEONS, V203, P752, DOI 10.1016/j.jamcollsurg.2006.07.032; Larsen KA, 2010, PSYCHOSOMATICS, V51, P409, DOI 10.1176/appi.psy.51.5.409; Teslyar P, 2013, PSYCHOSOMATICS, V54, P124, DOI 10.1016/j.psym.2012.12.004; Amemiya T, 2007, ANN SURG, V246, P222, DOI 10.1097/SLA.0b013e3180caa3fb; ANTHONY JC, 1982, PSYCHOL MED, V12, P397; Prakanrattana U, 2007, ANAESTH INTENS CARE, V35, P714; Robinson TN, 2008, CLIN INTERV AGING, V3, P351; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Hattori H, 2009, INT J GERIATR PSYCH, V24, P1304, DOI 10.1002/gps.2262; Cole MG, 2004, AM J GERIAT PSYCHIAT, V12, P2; Cole MG, 1996, CAN MED ASSOC J, V155, P1263; Hagino H, 2004, J ORTHOP SCI, V9, P1, DOI 10.1007/s00776-003-0741-8; FORSMAN A, 1976, CURR THER RES CLIN E, V20, P319; Goldenberg G., 2006, PSYCHOGERIATRICS, V6, P43, DOI 10.1111/j.1479-8301.2006.00146.x; Hakim SM, 2012, ANESTHESIOLOGY, V116, P987, DOI 10.1097/ALN.0b013e31825153cc; Immers Henny E M, 2005, BMC Nurs, V4, P7, DOI 10.1186/1472-6955-4-7; Isobe Hideki, 2007, Nihon Ronen Igakkai Zasshi, V44, P599, DOI 10.3143/geriatrics.44.599; Kaneko Tetsuya, 1999, Yonago Acta Medica, V42, P179; MAHONEY F I, 1965, Md State Med J, V14, P61; Neelon VJ, 1996, NURS RES, V45, P324, DOI 10.1097/00006199-199611000-00002; Olin K, 2005, BRIT J SURG, V92, P1559, DOI 10.1002/bjs.5053; Santana SF, 2005, DEMENTIA GERIATRIC C, V20, P231; Schrader SLP, 2008, NEUROLOGIST, V14, P134, DOI 10.1097/NRL.0b013e318166b88c; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P207, DOI 10.1891/rtnp.17.3.207.53186; Seitz D, 2006, J AM GERIATR SOC, V54, P861, DOI 10.1111/j.1532-5415.2006.00714.x; Tagarakis GI, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-25; Wang MD, 2006, J AM GERIATR SOC, V54, P860, DOI 10.1111/j.1532-5415.2006.00713.x; Wang MD, 2006, J AM GERIATR SOC, V54, P861	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2305	2313		10.1007/s00595-014-0859-7		9	Surgery	Surgery	AT7DP	WOS:000345097300014		
J	Tsunoda, A; Nakagi, M; Kano, N; Mizutani, M; Yamaguchi, K				Tsunoda, Akira; Nakagi, Masafumi; Kano, Nobuyasu; Mizutani, Masahiko; Yamaguchi, Kenji			Serum aluminum levels in dialysis patients after sclerotherapy of internal hemorrhoids with aluminum potassium sulfate and tannic acid	SURGERY TODAY			English	Article						Internal hemorrhoids; Aluminum potassium sulfate and tannic acid (ALTA); Sclerotherapy; Hemodialysis	ENCEPHALOPATHY; HEMODIALYSIS; CITRATE; AGENT	Aluminum potassium sulfate and tannic acid (ALTA) is an effective sclerosing agent for internal hemorrhoids. However, it is contraindicated for patients with chronic renal failure on dialysis, because the aluminum in ALTA can cause aluminum encephalopathy when it is not excreted effectively. We conducted this study to measure the serum aluminum concentrations and observe for symptoms relating to aluminum encephalopathy in dialysis patients after ALTA therapy. Ten dialysis patients underwent ALTA therapy for hemorrhoids. We measured their serum aluminum concentrations and observed them for possible symptoms of aluminum encephalopathy. The total injection volume of ALTA solution was 31 mL (24-37). The median serum aluminum concentration before ALTA therapy was 9 mu g/L, which increased to 741, 377, and 103 mu g/L, respectively, 1 h, 1 day, and 1 week after ALTA therapy. These levels decreased rapidly, to 33 mu g/L by 1 month and 11 mu g/L by 3 months after ALTA therapy. No patient suffered symptoms related to aluminum encephalopathy. Although the aluminum concentrations increased temporarily after ALTA therapy, dialysis patients with levels below 150 mu g/L by 1 week and thereafter are considered to be at low risk of the development of aluminum encephalopathy.	[Tsunoda, Akira; Kano, Nobuyasu] Kameda Med Ctr, Dept Surg, Kamogawa, Chiba 2968602, Japan; [Tsunoda, Akira; Nakagi, Masafumi; Mizutani, Masahiko] Awa Reg Med Ctr, Dept Surg, Tateyama, Toyama, Japan; [Yamaguchi, Kenji] Awa Reg Med Ctr, Dept Nephrol, Tateyama, Toyama, Japan	Tsunoda, A (reprint author), Kameda Med Ctr, Dept Surg, 929 Higasicho, Kamogawa, Chiba 2968602, Japan.	a.tsunoda@kameda.jp					Nakamura H, 2000, J CLIN PHARMACOL, V40, P296, DOI 10.1177/00912700022008847; Jaffe JA, 2005, AM J KIDNEY DIS, V46, P316, DOI 10.1053/j.ajkd.2005.04.020; Yokel RA, 2001, TOXICOL SCI, V64, P77; Takano M, 2006, INT J COLORECTAL DIS, V21, P44, DOI 10.1007/s00384-005-0771-0; Harris WR, 2003, INORG CHEM, V42, P3262, DOI 10.1021/ic026027w; ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402; Bondy SC, 2010, NEUROTOXICOLOGY, V31, P575, DOI 10.1016/j.neuro.2010.05.009; Priest ND, 1998, HUM EXP TOXICOL, V17, P296, DOI 10.1191/096032798678908783; CHAZAN JA, 1989, AM J KIDNEY DIS, V13, P284; Deguchi H, 2010, J HYOGO MED ASSOC, V52, P48; EgbunaOI Bosde A, 2005, INTERNET J NEPHROL, V2, P2; FLENDRIG JA, 1976, LANCET, V1, P1235; Hachiro Y, 2011, SURG TODAY, V41, P806, DOI 10.1007/s00595-010-4386-x; KIRSCHBAUM BB, 1989, AM J MED SCI, V297, P9; Kosugi M, 2008, J JPN SOC COLOPROCTO, V61, P71; Malaki Majid, 2013, J Pediatr Neurosci, V8, P81, DOI 10.4103/1817-1745.111439; National Kidney Foundation, 2003, AM J KIDNEY DIS S, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Ono T, 2005, J PHARMACOL SCI, V99, P353, DOI 10.1254/jphs.FPJ05026X; Rob PM, 2001, CNS DRUGS, V15, P691, DOI 10.2165/00023210-200115090-00003; SHEIKH F, 1992, DIS COLON RECTUM, V35, P56, DOI 10.1007/BF02053339; Shi Z, 1998, Zhongguo Zhong Xi Yi Jie He Za Zhi, V18, P201; Takamura H, 2004, JPN PHARMACOL THER, V32, P355; Takamura H., 2001, Journal of the Japan Society of Coloproctology, V54, P910; Yamamoto Y, 2013, SURG TODAY, V43, P698, DOI 10.1007/s00595-012-0429-9	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2314	2317		10.1007/s00595-014-0914-4		4	Surgery	Surgery	AT7DP	WOS:000345097300015		
J	Seishima, R; Okabayashi, K; Hasegawa, H; Sugiyama, D; Ishii, Y; Tsuruta, M; Takebayashi, T; Kitagawa, Y				Seishima, Ryo; Okabayashi, Koji; Hasegawa, Hirotoshi; Sugiyama, Daisuke; Ishii, Yoshiyuki; Tsuruta, Masashi; Takebayashi, Toru; Kitagawa, Yuko			Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population	SURGERY TODAY			English	Article						Body mass index; Obesity; Postoperative recurrence; Rectal cancer	BODY-MASS-INDEX; TREATMENT-RELATED TOXICITY; GROWTH-FACTOR-I; COLORECTAL-CANCER; COLON-CANCER; RISK-FACTORS; LAPAROSCOPIC SURGERY; VISCERAL OBESITY; PERIOPERATIVE OUTCOMES; GENERAL-SURGERY	Obesity contributes to the technical difficulty of rectal surgery and is considered to be a risk factor for postoperative complications. The impact of obesity on the long-term outcomes of rectal cancer surgery remains unclear. A total of 263 consecutive rectal cancer patients who underwent surgery were categorized into two groups according to the body mass index (BMI) based on the Asian BMI classification: non-obese (BMI < 25 kg/m(2)) and obese (BMI a parts per thousand yen25 kg/m(2)). The postoperative survival and recurrence rates and oncological surgical quality indicators were compared between groups using the univariate and multivariate analyses. The differences in recurrence patterns were assessed by a competing risk regression analysis. 64 (24 %) patients were included in the obese group. The number of retrieved lymph nodes was significantly greater in the non-obese group than in the obese group (22.4 vs. 16.0, P < 0.01). The 5-year disease-free survival (DFS) rates were 86.5 and 68.8 % in the obese and non-obese groups, respectively (P = 0.01). The multivariate analysis demonstrated that obesity significantly decreased the postoperative recurrence rate (P = 0.04). Moreover, the BMI was significantly associated with distant metastasis (P = 0.04). Obese rectal cancer patients have high DFS rates and a decreased incidence of distant metastases compared to non-obese patients. The BMI may be a key factor for predicting the postoperative prognosis and determination of an appropriate strategy for the treatment of rectal cancer patients.	[Seishima, Ryo; Okabayashi, Koji; Hasegawa, Hirotoshi; Ishii, Yoshiyuki; Tsuruta, Masashi; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Sugiyama, Daisuke; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo 1608582, Japan	Hasegawa, H (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	hasegawa@z8.keio.jp					Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679; Merkow RP, 2009, J AM COLL SURGEONS, V208, P53, DOI 10.1016/j.jamcollsurg.2008.08.032; Kayani B, 2012, WORLD J SURG, V36, P1785, DOI 10.1007/s00268-012-1582-4; Meyerhardt JA, 2004, J CLIN ONCOL, V22, P648, DOI 10.1200/JCO.2004.07.121; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S; Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8; Quirke P, 2007, HISTOPATHOLOGY, V50, P103, DOI 10.1111/j.1365-2559.2006.02543.x; Makino T, 2012, ANN SURG, V255, P228, DOI 10.1097/SLA.0b013e31823dcbf7; Zervoudakis A, 2011, J NATL CANCER I, V103, P826, DOI 10.1093/jnci/djr101; Meyerhardt JA, 2003, CANCER, V98, P484, DOI 10.1002/cncr.11544; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; Lascano CA, 2006, AM J SURG, V192, P357, DOI 10.1016/j.amjsurg.2006.04.011; Kurmann A, 2011, SURG ENDOSC, V25, P3531, DOI 10.1007/s00464-011-1753-7; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; Ishii Y, 2005, BRIT J SURG, V92, P1261, DOI 10.1002/bjs.5069; Inui A, 2002, CA-CANCER J CLIN, V52, P72; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; Murono K, 2013, INT J COLORECTAL DIS, V28, P1065, DOI 10.1007/s00384-013-1656-2; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Campbell PT, 2012, J CLIN ONCOL, V30, P42, DOI 10.1200/JCO.2011.38.0287; Moon HG, 2008, ANN SURG ONCOL, V15, P1918, DOI 10.1245/s10434-008-9891-4; Mullen JT, 2008, ANN SURG ONCOL, V15, P2164, DOI 10.1245/s10434-008-9990-2; Linebarger JH, 2010, AM J SURG, V200, P478, DOI 10.1016/j.amjsurg.2009.12.012; Benoist S, 2000, AM J SURG, V179, P275, DOI 10.1016/S0002-9610(00)00337-8; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; Chern H, 2010, J AM COLL SURGEONS, V211, P55, DOI 10.1016/j.jamcollsurg.2010.03.010; Consultation WHOE, 2004, LANCET, V363, P157, DOI DOI 10.1016/S0140-6736(03)15268-3; Gil A, 2007, BRIT J NUTR, V98, pS121, DOI 10.1017/S0007114507838050; Gorog Denes, 2003, Pathology & Oncology Research, V9, P180; Ma J, 2004, J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Min YW, 2012, ANN SURG ONCOL, V19, P3460, DOI 10.1245/s10434-012-2436-x; Nakamura T, 2013, SURG TODAY, V43, P763, DOI 10.1007/s00595-012-0352-0; Nitori N, 2009, SURG LAPARO ENDO PER, V19, P324, DOI 10.1097/SLE.0b013e3181ae5442; Palma S, 2007, BRIT J SURG, V94, P369, DOI 10.1002/bjs.5626; PRASAD US, 1991, EUR J CARDIO-THORAC, V5, P67, DOI 10.1016/1010-7940(91)90003-3; Rullier E, 1998, BRIT J SURG, V85, P355	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2324	2331		10.1007/s00595-014-0899-z		8	Surgery	Surgery	AT7DP	WOS:000345097300017		
J	Takayama, T; Matsumoto, S; Wakatsuki, K; Tanaka, T; Migita, K; Ito, M; Nakajima, Y				Takayama, Tomoyoshi; Matsumoto, Sohei; Wakatsuki, Kohei; Tanaka, Tetsuya; Migita, Kazuhiro; Ito, Masahiro; Nakajima, Yoshiyuki			A novel laparoscopic procedure for treating proximal early gastric cancer: laparoscopy-assisted pylorus-preserving nearly total gastrectomy	SURGERY TODAY			English	Article						Proximal gastric cancer; Laparoscopic surgery; Pylorus-preserving gastrectomy	LYMPH-NODE DISSECTION	Pylorus-preserving nearly total gastrectomy (PPNTG) is a function-preserving gastrectomy for treating proximal early gastric cancer that prevents rapid gastric emptying and reflux. In this report, we present a surgical technique for performing laparoscopy-assisted PPNTG (LAPPNTG). The resection of the stomach was similar to that during conventional total gastrectomy, with the key difference being that the pyloric cuff was preserved to a length of 3-4 cm. Compared with standard total gastrectomy, the lymph node dissection along the right gastric vessels and the infrapyloric vessels were omitted. Reconstruction was performed with a jejunal interposition that was 30 cm in length, with preservation of the marginal vessels in a retrocolic fashion. Thirteen patients with cT1 cN0 proximal gastric cancer underwent LAPPNTG at our institution. The median length of the operation and estimated blood loss were 329 min and 138 ml, respectively. All resected specimens had tumor-free margins, and the median number of removed lymph nodes was 40. There were no serious postoperative complications and no patients underwent conversion to laparotomy. Performing LAPPNTG with a jejunal interposition is feasible and might be an appropriate treatment for proximal early gastric cancer.	[Takayama, Tomoyoshi; Matsumoto, Sohei; Wakatsuki, Kohei; Tanaka, Tetsuya; Migita, Kazuhiro; Ito, Masahiro; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan	Takayama, T (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	t-taka@naramed-u.ac.jp					Aihara R, 2010, SURG ENDOSC, V24, P2343, DOI 10.1007/s00464-010-0947-8; SALVONHARMAN JC, 1994, ARCH SURG-CHICAGO, V129, P381; MAKI T, 1967, SURGERY, V61, P838; Nunobe S, 2007, WORLD J SURG, V31, P2335, DOI 10.1007/s00268-007-9262-5; Mochiki E, 2008, SURG ENDOSC, V22, P1997, DOI 10.1007/s00464-008-0015-9; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kitano S, 1999, SURG TODAY, V29, P389; KODAMA M, 1991, WORLD J SURG, V15, P628; Kodera K, 2011, WORLD J SURG, V35, P1469; MAKI T, 1977, LANGENBECK ARCH CHIR, V343, P183, DOI 10.1007/BF01267990; Tanaka T, 2013, HEPATO-GASTROENTEROL, V60, P200, DOI 10.5754/hge12500	14	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2332	2338		10.1007/s00595-014-0928-y		7	Surgery	Surgery	AT7DP	WOS:000345097300018		
J	Kawamura, H; Takahashi, N; Takahashi, M; Taketomi, A				Kawamura, Hideki; Takahashi, Norihiko; Takahashi, Masahiro; Taketomi, Akinobu			The differences in microorganism growth on various dressings used to cover injection sites: inspection of the risk of catheter-related bloodstream infections caused by Gram-negative bacilli	SURGERY TODAY			English	Article						Gram-negative bacillus; Catheter-related bloodstream infection; Dressing; Sepsis	RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL ADULTS; EPIDEMIOLOGY; PREVENTION	Sepsis caused by Gram-negative bacilli (GNB) is the most serious catheter-related bloodstream infection. However, the cause(s) of GNB propagation on the skin around needle or catheter insertion sites remain unclear. This observational study aimed to assess the differences in the microbial growth among various types of dressings used to cover injection sites, with a particular focus on GNB. We analyzed the bacterial populations on three types of surgical dressings; Tegaderm I.V. (semi-permeable, 27 sheets), IV3000 (highly permeable, 34 sheets) and Tegaderm CHG (chlorhexidine-impregnated, 26 sheets). The peripheral catheter site dressing was replaced every 3 days or when there was leakage or pain at the catheter site. Bacterial growth was observed in all Tegaderm I.V. and IV3000 sheets and in only one (3.8 %) Tegaderm CHG sheet. The GNB detection rate was significantly lower in the IV3000 group (2.9 %) than in the Tegaderm I.V. group (63.0 %). No GNB growth was identified in the Tegaderm CHG group. Semi-permeable dressings were insufficient to prevent GNB infections, whereas highly permeable or chlorhexidine-impregnated dressings could prevent GNB infections. Chlorhexidine-impregnated dressings can control almost all bacterial growth.	[Kawamura, Hideki; Takahashi, Masahiro] JA Sapporo Kosei Hosp, Dept Surg, Chuo Ku, Sapporo, Hokkaido 0600033, Japan; [Takahashi, Norihiko; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg I, Sapporo, Hokkaido, Japan	Kawamura, H (reprint author), JA Sapporo Kosei Hosp, Dept Surg, Chuo Ku, N3,E8, Sapporo, Hokkaido 0600033, Japan.	h.kawamura@med.hokudai.ac.jp					Velasco E, 2004, EUR J CLIN MICROBIOL, V23, P596, DOI 10.1007/s10096-004-1181-x; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Humphreys H, 2008, J HOSP INFECT, V69, P249, DOI 10.1016/j.jhin.2008.04.021; Higgins CS, 2001, CLIN MICROBIOL INFEC, V7, P308, DOI 10.1046/j.1198-743x.2001.00253.x; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Raad II, 2002, ARCH INTERN MED, V162, P871, DOI 10.1001/archinte.162.8.871; Mermel LA, 2011, CLIN INFECT DIS, V52, P211, DOI 10.1093/cid/ciq108; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Pujol M, 2007, J HOSP INFECT, V67, P22, DOI 10.1016/j.jhin.2007.06.017; Ball C, 2001, Intensive Crit Care Nurs, V17, P249, DOI 10.1054/iccn.2001.1597; Crosby CT, 2009, BRIT J HOSP MED, V70, P579; Jones A., 2004, JAVA, V9, P26; Keenlyside D, 1993, Prof Nurse, V8, P288; Koerner RJ, 1997, J HOSP INFECT, V36, P285, DOI 10.1016/S0195-6701(97)90055-4; O'Grady NP, 2002, MMWR RECOMM REP, V9, P1; Periti P, 2000, Expert Opin Pharmacother, V1, P1203, DOI 10.1517/14656566.1.6.1203; Reynolds M G, 1997, Intensive Crit Care Nurs, V13, P26, DOI 10.1016/S0964-3397(97)80688-X; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; Vu-Thien H, 1998, EUR J CLIN MICROBIOL, V17, P626; Zingg W, 2009, INT J ANTIMICROB AG, V34, P38	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2339	2344		10.1007/s00595-014-0935-z		6	Surgery	Surgery	AT7DP	WOS:000345097300019		
J	Nii, A; Utsunomiya, T; Shimada, M; Ikegami, T; Ishibashi, H; Imura, S; Morine, Y; Ikemoto, T; Sasaki, H; Kawashima, A				Nii, Akira; Utsunomiya, Tohru; Shimada, Mitsuo; Ikegami, Toru; Ishibashi, Hiroki; Imura, Satoru; Morine, Yuji; Ikemoto, Tetsuya; Sasaki, Hajime; Kawashima, Akihiro			A hydrolyzed whey peptide-based diet ameliorates hepatic ischemia-reperfusion injury in the rat nonalcoholic fatty liver	SURGERY TODAY			English	Article						Nonalcoholic fatty liver disease; Ischemia-reperfusion injury; Hydrolyzed whey peptide; Steatosis; Rat	ISCHEMIA/REPERFUSION INJURY; NITRIC-OXIDE; STEATOHEPATITIS; STEATOSIS; MICE; TRANSPLANTATION; DONORS; MODEL; HEPATOCYTES; POPULATION	The number of patients with nonalcoholic fatty liver disease (NAFLD) is increasing. Hepatic steatosis is a major risk factor for hepatic failure after ischemia-reperfusion (I/R) injury. Hydrolyzed whey peptide (HWP) is a functional liquid-type nutritional diet containing whey peptide, which has previously been shown to exert anti-inflammatory effects. In the present study, we examined the effects of HWP on the hepatic I/R injury in a rat NAFLD model. Rats fed a methionine/choline-deficient diet for 4 weeks were divided into two groups after 30 min of whole liver ischemia. In Group-M, HWP was given immediately after reperfusion and every 6 h thereafter. In Group-C, the vehicle was given in the same manner. The liver function tests and microscopic findings of the liver after reperfusion were compared between the two groups. The serum transaminase levels in Group-M were significantly lower than those in Group-C after reperfusion. The gene expression levels of IL-6 and inducible nitric oxide synthase (iNOS) were significantly lower in Group-M compared to Group-C. The TNF-alpha and uncoupling protein-2 (UCP-2) expression levels were also markedly lower in Group-M. The hepatic necrotic areas in Group-M were significantly smaller than those in Group-C. The administration of a HWP diet ameliorated the hepatic I/R injury in rats with NAFLD.	[Nii, Akira; Utsunomiya, Tohru; Shimada, Mitsuo; Ikegami, Toru; Ishibashi, Hiroki; Imura, Satoru; Morine, Yuji; Ikemoto, Tetsuya] Univ Tokushima, Dept Surg, Tokushima 7708503, Japan; [Sasaki, Hajime; Kawashima, Akihiro] Meiji Dairies Corp, Inst Food Sci, Div Res & Dev, Odawara, Kanagawa 2500862, Japan	Nii, A (reprint author), Univ Tokushima, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	akiranii2000@yahoo.co.jp; mshimada@clin.med.tokushima-u.ac.jp			Research Support Foundation of The University of Tokushima; Food Science Institute, Division of Research and Development, Meiji Dairies Corporation; Japan Society for the Promotion of Science	Grant support was provided by the Research Support Foundation of The University of Tokushima and the Food Science Institute, Division of Research and Development, Meiji Dairies Corporation, and the Grants-in-Aid for Scientific Research of the Japan Society for the Promotion of Science.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Selzner M, 2000, HEPATOLOGY, V32, P1280, DOI 10.1053/jhep.2000.20528; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Arribas B, 2009, BRIT J NUTR, V101, P51, DOI 10.1017/S0007114508986876; Zamboni F, 2001, CLIN TRANSPLANT, V15, P53, DOI 10.1034/j.1399-0012.2001.150109.x; HILDEN M, 1977, SCAND J GASTROENTERO, V12, P593; Chen Y, 2005, BIOCHEM BIOPH RES CO, V326, P45, DOI 10.1016/j.bbrc.2004.10.202; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Kooby DA, 2003, J GASTROINTEST SURG, V7, P1034, DOI 10.1016/j.gassur.2003.09.012; Behrns K E, 1998, J Gastrointest Surg, V2, P292, DOI 10.1016/S1091-255X(98)80025-5; Hanaoka J, 2014, HEPATOL RES, V44, P114, DOI 10.1111/hepr.12097; Hara K, 2002, HEPATOL RES, V24, P228, DOI 10.1016/S1386-6346(02)00088-8; HORNBOLL P, 1982, ACTA PATH MICRO IM A, V90, P199; Imeryuz N, 2007, J HEPATOL, V47, P851, DOI 10.1016/j.jhep.2007.06.018; Kume H, 2006, BIOSCI BIOTECH BIOCH, V70, P1281, DOI 10.1271/bbb.70.1281; Marshall Keri, 2004, Altern Med Rev, V9, P136; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Oner OZ, 2006, SURG TODAY, V36, P376, DOI 10.1007/s00595-005-3166-5; Rinella ME, 2001, LIVER TRANSPLANT, V7, P409, DOI 10.1053/jlts.2001.23787; Sun CK, 2001, TRANSPLANTATION, V72, P1625, DOI 10.1097/00007890-200111270-00008; Takeda Y, 1999, TRANSPLANTATION, V67, P820, DOI 10.1097/00007890-199903270-00007; Urena MAG, 1998, WORLD J SURG, V22, P837; Wan CD, 2008, WORLD J GASTROENTERO, V14, P590, DOI 10.3748/wjg.14.590; Yamaguchi M., 2007, Inflammopharmacology, V15, P43, DOI 10.1007/s10787-006-1558-9; Zhang BH, 1999, J GASTROEN HEPATOL, V14, P133, DOI 10.1046/j.1440-1746.1999.01822.x	28	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2354	2360		10.1007/s00595-014-0853-0		7	Surgery	Surgery	AT7DP	WOS:000345097300021		
J	Asahi, Y; Kamiyama, T; Nakanishi, K; Yokoo, H; Tahara, M; Usui, A; Funakoshi, T; Sato, M; Sasaki, A; Matsuno, Y; Taketomi, A; Todo, S				Asahi, Yoh; Kamiyama, Toshiya; Nakanishi, Kazuaki; Yokoo, Hideki; Tahara, Munenori; Usui, Akihiro; Funakoshi, Tohru; Sato, Masanori; Sasaki, Ayami; Matsuno, Yoshihiro; Taketomi, Akinobu; Todo, Satoru			Chondroma of the diaphragm mimicking a giant liver tumor with calcification: report of a case	SURGERY TODAY			English	Article						Chondroma; Extraskeletal; Diaphragmatic tumor; Calcification	EXTRASKELETAL CHONDROMA; BONE-TUMORS	Extraskeletal chondroma is an unusual benign tumor, which rarely arises in the diaphragm. We report a case of chondroma of the diaphragm in a 31-year-old woman. Initially, a benign liver tumor with calcification was suspected, based on pre and intraoperative examination findings. Although parts of the tumor were contiguous with the diaphragm, its connections with the diaphragm were much narrower than its connection with the liver, which suggested a liver tumor. Pathological examination subsequently revealed that the chondroma was contiguous with the diaphragm and that there was a distinct border between the tumor and the liver; thus, the tumor was diagnosed as a chondroma of the diaphragm.	[Asahi, Yoh; Kamiyama, Toshiya; Nakanishi, Kazuaki; Yokoo, Hideki; Tahara, Munenori; Usui, Akihiro; Funakoshi, Tohru; Sato, Masanori; Sasaki, Ayami; Taketomi, Akinobu] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg I, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Pathol, Sapporo, Hokkaido 060, Japan; [Todo, Satoru] Hokkaido Univ Hosp, Dept Transplantat Surg, Sapporo, Hokkaido 060, Japan	Kamiyama, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg I, Kita Ku, Nishi 5, Sapporo, Hokkaido 0608648, Japan.	yoh-hibana@yk2.so-net.ne.jp; t-kamiya@med.hokudai.ac.jp					Stoupis C, 1998, RADIOGRAPHICS, V18, P675; Altay M, 2007, J ORTHOP SCI, V12, P415, DOI 10.1007/s00776-007-1152-z; Aslam MB, 2006, HISTOPATHOLOGY, V48, P465, DOI 10.1111/j.1365-2559.2005.02257.x; CLAGETT OT, 1949, AM J SURG, V78, P526, DOI 10.1016/0002-9610(49)90219-6; Cumming D, 2005, Hand Surg, V10, P327, DOI 10.1142/S0218810405002954; Falleti J, 2009, INT J ORAL MAX SURG, V38, P895, DOI 10.1016/j.ijom.2009.02.020; FRIED RH, 1992, GASTROENTEROLOGY, V103, P678; Furuya K, 1993, HOKKAIDO U MED LIB S, V83, P75; Haruki K, 2012, SURG TODAY, V42, P391, DOI 10.1007/s00595-011-0079-3; ITAKURA M, 1990, ENDOSCOPY, V22, P276, DOI 10.1055/s-2007-1012870; Kwon H, 2010, J CRANIOFAC SURG, V21, P1990, DOI 10.1097/SCS.0b013e3181f504f5; Lee KCY, 2002, CLIN RADIOL, V57, P18, DOI 10.1053/crad.2001.0719; Papagelopoulos PJ, 2007, JOINT BONE SPINE, V74, P285, DOI 10.1016/j.jbspin.2006.06.014; Sera H, 2005, INT J ORAL MAX SURG, V34, P99, DOI 10.1016/j.ijom.2004.03.011; Singh AP, 2011, ACTA ORTHOP TRAUMATO, V45, P130, DOI 10.3944/AOTT.2011.2419; Watanabe F., 2012, CASE REP MED, V2012; Woertler K, 2003, EUR RADIOL, V13, P1820, DOI 10.1007/s00330-003-1902-z; Yokoo H, 2012, HEPATO-GASTROENTEROL, V59, P831, DOI 10.5754/hge10337; Yoshida T, 2010, J HEPATO-BIL-PAN SCI, V17, P152, DOI 10.1007/s00534-009-0114-6; Zhang Y, 2012, PEDIATR SURG INT, V28, P1157, DOI 10.1007/s00383-012-3173-8	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2361	2365		10.1007/s00595-014-0949-6		5	Surgery	Surgery	AT7DP	WOS:000345097300022		
J	Sofue, K; Takeuchi, Y; Shibamoto, K; Sugimoto, K; Sugimura, K; Arai, Y				Sofue, Keitaro; Takeuchi, Yoshito; Shibamoto, Kentaro; Sugimoto, Koji; Sugimura, Kazuro; Arai, Yasuaki			Infusion of 50 % glucose solution to occlude an intrahepatic portosystemic venous shunt before percutaneous transhepatic portal embolization: report of a case	SURGERY TODAY			English	Article						Percutaneous transhepatic portal embolization; Intrahepatic portovenous shunt; Glucose solution	VEIN EMBOLIZATION; RANDOMIZED-TRIAL; OBLITERATION; INJECTION	A 68-year-old man with cholangiocarcinoma underwent percutaneous transhepatic portal embolization to expand the indication for hepatic resection. Selective right posterior portography revealed an intrahepatic portosystemic venous shunt (IPSVS) connecting the segment VII branch to the right hepatic venous branch. An infusion of 50 % glucose solution was given to occlude the shunt. This is novel management for IPSVSs when they are numerous, small, or torturous, and makes the subsequent procedures simpler, shorter, and less expensive.	[Sofue, Keitaro; Takeuchi, Yoshito; Shibamoto, Kentaro; Arai, Yasuaki] Natl Canc Ctr, Dept Radiol, Tokyo 1040045, Japan; [Sofue, Keitaro; Sugimoto, Koji; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo, Japan	Sofue, K (reprint author), Natl Canc Ctr, Dept Radiol, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	keitarosofue@yahoo.co.jp					Ito K, 2009, CLIN RADIOL, V64, P200, DOI 10.1016/j.crad.2008.05.016; Yamagami T, 2007, AUSTRALAS RADIOL, V51, P334, DOI 10.1111/j.1440-1673.2007.01746.x; PARK JH, 1990, AM J ROENTGENOL, V155, P527; Chang KY, 1996, ENDOSCOPY, V28, P481, DOI 10.1055/s-2007-1005527; Chevallier P, 2000, J RADIOL, V81, P597; Di Stefano DR, 2005, RADIOLOGY, V234, P625, DOI 10.1148/radiol.2342031996; Kuo MJ, 2007, ENDOSCOPY, V39, P487, DOI 10.1055/s-2007-966267; Le Baleur A, 1983, PHLEBOLOGIE, V36, P349; Lee YJ, 2012, KOREAN J RADIOL, V13, P827, DOI 10.3348/kjr.2012.13.6.827; Madoff DC, 2005, J VASC INTERV RADIOL, V16, P779, DOI 10.1097/RVI.0000159543.28222.73; Wakabayashi H, 1996, SURG TODAY, V26, P49; Yoshimatsu R, 2006, Br J Radiol, V79, pe162, DOI 10.1259/bjr/10360703	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2366	2368		10.1007/s00595-013-0745-8		3	Surgery	Surgery	AT7DP	WOS:000345097300023		
J	Makiguchi, T; Horiguchi, J; Nagaoka, R; Yokoo, S; Terashi, H; Oyama, T; Takeyoshi, I				Makiguchi, Takaya; Horiguchi, Jun; Nagaoka, Rin; Yokoo, Satoshi; Terashi, Hiroto; Oyama, Tetsunari; Takeyoshi, Izumi			Huge myoid hamartoma of the breast treated with reduction mammaplasty: report of a case	SURGERY TODAY			English	Article						Breast; Myoid hamartoma; Muscular hamartoma; Reduction mammaplasty; Reconstruction	THE-LITERATURE	Breast hamartoma is an uncommon benign tumor characterized by the variety of component tissues. Adipose tissue, mammary glands, and fibrous tissue in various proportions are the main components and form a well-circumscribed mass. Myoid (muscular) hamartoma is an extremely rare subtype of breast hamartoma, which contains an additional smooth muscle component. Inadequate breast contour and nipple-areola complex malposition and expansion can occur after resection of a large myoid hamartoma. Immediate mammaplasty for the affected breast, using the dermoglandular flap technique, is required to provide symmetry of the bilateral breasts. We report a case of myoid hamartoma that was larger than ever documented before. An acceptable aesthetic result was achieved by resection and application of reduction mammaplasty in a single-stage operation.	[Makiguchi, Takaya; Yokoo, Satoshi] Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, Maebashi, Gunma 3718511, Japan; [Horiguchi, Jun; Nagaoka, Rin; Oyama, Tetsunari; Takeyoshi, Izumi] Gunma Univ, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Terashi, Hiroto] Kobe Univ, Grad Sch Med, Dept Plast Surg, Kobe, Hyogo, Japan	Makiguchi, T (reprint author), Gunma Univ, Grad Sch Med, Dept Stomatol & Maxillofacial Surg, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	takayamakiguchi@gmail.com					Ogawa T, 2012, J BREAST CANCER, V15, P468, DOI 10.4048/jbc.2012.15.4.468; ARRIGONI MG, 1971, SURG GYNECOL OBSTETR, V133, P577; Kajo K, 2010, BREAST CARE, V5, P331, DOI 10.1159/000321341; RIBEIRO L, 1975, PLAST RECONSTR SURG, V55, P330, DOI 10.1097/00006534-197555030-00010; Yamamoto Y, 1998, BRIT J PLAST SURG, V51, P109, DOI 10.1054/bjps.1997.0093; Bayar S, 2010, BREAST J, V16, P86, DOI 10.1111/j.1524-4741.2009.00858.x; DAVIES JD, 1973, J PATHOL, V111, P209, DOI 10.1002/path.1711110309; Filho Osvaldo Giannotti, 2004, Int J Surg Pathol, V12, P151, DOI 10.1177/106689690401200211; Kijima Y, 2010, BREAST CANC; Kijima Y, 2013, SURG TODAY; Mathers Marie E, 2004, Breast J, V10, P58, DOI 10.1111/j.1524-4741.2004.09620.x; Mizuta N, 2012, WORLD J SURG ONCOL, V16, P10; Murugesan JR, 2006, CLIN BREAST CANCER, V7, P345, DOI 10.3816/CBC.2006.n.050; Takahara A, 2012, J JPN PRS, V32, P571; Takeuchi M, 2001, Breast Cancer, V8, P243, DOI 10.1007/BF02967516	15	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2369	2373		10.1007/s00595-014-0833-4		5	Surgery	Surgery	AT7DP	WOS:000345097300024		
J	Nakagawa, A; Sugawara, G; Ebata, T; Yokoyama, Y; Igami, T; Shingu, Y; Nagino, M				Nakagawa, Akifumi; Sugawara, Gen; Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Shingu, Yuji; Nagino, Masato			Hepatopancreatoduodenectomy with arterial reconstruction for extrahepatic cholangiocarcinoma with celiac axis obstruction: report of a case	SURGERY TODAY			English	Article						Celiac axis obstruction; Bile duct carcinoma; Hepatopancreatoduodenectomy	PANCREATICODUODENECTOMY; STENOSIS; COMPRESSION; MANAGEMENT; OCCLUSION	We report a case of successful right hepatectomy plus pancreatoduodenectomy (Rt-HPD) with arterial reconstruction for extrahepatic bile duct carcinoma with obstruction of the celiac axis in a 76-year-old man. Obstruction of the celiac axis resulted in arterial blood supply to the upper abdominal organs coming from the pancreatic head arcade. The patient underwent arterial reconstruction before the Rt-HPD to maintain the blood supply from the pancreatic head arcade for as long as possible. His postoperative course was uneventful and he was well with no sign of recurrence when last seen, 64 months after surgery. To our knowledge, this is the first description of this modified HPD with arterial reconstruction. Thus, rational surgical planning based on careful preoperative assessment would expand the indications for HPD, even for patients with celiac axis obstruction requiring arterial reconstruction.	[Nakagawa, Akifumi; Sugawara, Gen; Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Shingu, Yuji; Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, Nagoya, Aichi 4668550, Japan	Nagino, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nakagawa13101975@yahoo.co.jp; nagino@med.nagoya-u.ac.jp					Gaujoux S, 2009, ANN SURG, V249, P111, DOI 10.1097/SLA.0b013e3181930249; Ebata T, 2012, ANN SURG, V256, P297, DOI 10.1097/SLA.0b013e31826029ca; Berney T, 1998, AM J SURG, V176, P352, DOI 10.1016/S0002-9610(98)00195-0; Farma JM, 2007, AM J SURG, V193, P341, DOI 10.1016/j.amjsurg.2006.09.027; Hasegawa K, 2003, SURGERY, V133, P440, DOI 10.1067/msy.2003.103; Pfeiffenberger J, 2002, LANGENBECK ARCH SURG, V387, P210, DOI 10.1007/s00423-002-0310-1; Shima Y, 2005, SURG TODAY, V35, P86, DOI 10.1007/s00595-004-2864-8; Sugae T, 2012, SURGERY, V151, P543, DOI 10.1016/j.surg.2011.08.012; TREDE M, 1985, SURGERY, V97, P28	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2374	2377		10.1007/s00595-013-0760-9		4	Surgery	Surgery	AT7DP	WOS:000345097300025		
J	Nakamura, Y; Shikata, F; Ryugo, M; Okamura, T; Yasugi, T; Izutani, H				Nakamura, Yuki; Shikata, Fumiaki; Ryugo, Masahiro; Okamura, Toru; Yasugi, Takumi; Izutani, Hironori			Redo cardiac surgery for active prosthetic valve endocarditis associated with hereditary hemorrhagic telangiectasia: report of a case	SURGERY TODAY			English	Article						Hereditary hemorrhagic telangiectasia; Prosthetic valve endocarditis; Cardiac surgery	AORTIC-VALVE; PATIENT; REPLACEMENT; DISEASE	Hereditary hemorrhagic telangiectasia (HHT) is caused by an autosomal dominant gene and characterized by multiple arteriovenous malformations in several organs, leading to bleeding or shunting. These patients often suffer severe infections and heart failure, which should be managed in the perioperative period, when open heart surgery is indicated. We report a case of successful aortic root replacement for active prosthetic valve endocarditis and ventricular septal perforation in a patient with HHT, who had severe heart failure.	[Nakamura, Yuki; Shikata, Fumiaki; Ryugo, Masahiro; Okamura, Toru; Yasugi, Takumi; Izutani, Hironori] Ehime Univ Hosp, Dept Cardiovasc Surg, Toon, Ehime 7910295, Japan	Nakamura, Y (reprint author), Ehime Univ Hosp, Dept Cardiovasc Surg, Toon, Ehime 7910295, Japan.	yukihtky@yahoo.co.jp; izutani@m.ehime-u.ac.jp					Sharathkumar AA, 2008, HAEMOPHILIA, V14, P1269, DOI 10.1111/j.1365-2516.2008.01774.x; Benzadon MN, 2009, ANN THORAC SURG, V88, pE3, DOI 10.1016/j.athoracsur.2009.02.014; Gungor H, 2012, CARDIOVASC J AFR, V23, pE5, DOI 10.5830/CVJA-2011-002; Ishikawa S, 2004, JPN HEART J, V45, P885, DOI 10.1536/jhj.45.885; Jayawardena Suriya, 2006, Am J Ther, V13, P460, DOI 10.1097/01.mjt.0000209683.99205.4f; Sakata Y, 1992, Kyobu Geka, V45, P1024; Seike Yoshimasa, 2005, Kyobu Geka, V58, P1141; Shikata F, 2010, ANN THORAC SURG, V89, P2072; Wilson Walter, 2007, Circulation, V116, P1736, DOI 10.1161/CIRCULATIONAHA.106.183095	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2378	2381		10.1007/s00595-014-0876-6		4	Surgery	Surgery	AT7DP	WOS:000345097300026		
J	Arima, K; Watanabe, M; Iwatsuki, M; Ida, S; Ishimoto, T; Nagai, Y; Iwagami, S; Baba, Y; Sakamoto, Y; Miyamoto, Y; Baba, H				Arima, Kota; Watanabe, Masayuki; Iwatsuki, Masaaki; Ida, Satoshi; Ishimoto, Takatsugu; Nagai, Yohei; Iwagami, Shiro; Baba, Yoshifumi; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo			Volvulus of an ileal pouch-rectal anastomosis after subtotal colectomy for ulcerative colitis: report of a case	SURGERY TODAY			English	Article						Ileal J-pouch rectal anastomosis; Ileal pouch volvulus; Subtotal colectomy; Pouchpexy	SMALL-BOWEL OBSTRUCTION; ANAL ANASTOMOSIS	Ileal J-pouch rectal anastomosis is a commonly performed procedure for patients who have undergone subtotal colectomy for ulcerative colitis or familial adenomatous polyposis without rectal involvement. We herein report the case of a patient with ileal pouch volvulus that developed 15 years after subtotal colectomy for ulcerative colitis. A 62-year-old female visited our emergency room with complaints of abdominal pain and nausea that had persisted for 12 h. Abdominal radiography and contrast-enhanced computed tomography detected segmental distention of the small intestine around the staples. We diagnosed volvulus of the ileal pouch-rectal anastomosis and performed emergency laparotomy. We released the volvulus and performed pouchpexy. The patient was discharged on postoperative day 10, and recurrence of the volvulus has not been observed for 5 months since the procedure was performed. Our study indicates that an early diagnosis and intervention are needed to avoid serious complications, such as pouch necrosis and perforation, in such cases.	[Arima, Kota; Watanabe, Masayuki; Iwatsuki, Masaaki; Ida, Satoshi; Ishimoto, Takatsugu; Nagai, Yohei; Iwagami, Shiro; Baba, Yoshifumi; Sakamoto, Yasuo; Miyamoto, Yuji; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Kumamoto 8608556, Japan	Arima, K (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, I-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	kota84115@gmail.com; hdobaba@kumamoto-u.ac.jp					Aberg H, 2007, INT J COLORECTAL DIS, V22, P637, DOI 10.1007/s00387-006-0215-5; MARCELLO PW, 1993, DIS COLON RECTUM, V36, P1105, DOI 10.1007/BF02052257; MacLean AR, 2002, ANN SURG, V235, P200, DOI 10.1097/00000658-200202000-00007; FRAZEE RC, 1988, ANN SURG, V208, P565, DOI 10.1097/00000658-198811000-00004; Catalano O, 1996, EUR J RADIOL, V23, P115, DOI 10.1016/0720-048X(96)01065-0; Delaini G G, 2005, Tech Coloproctol, V9, P187, DOI 10.1007/s10151-005-0225-2; FRANCOIS Y, 1989, ANN SURG, V209, P46, DOI 10.1097/00000658-198901000-00007; Ikeda T, 2012, SURG TODAY, V42, P41, DOI 10.1007/s00595-011-0003-x; Liu LJ, 2011, INT J COLORECTAL DIS, V26, P1051, DOI 10.1007/s00384-011-1186-8; Patel Sandeep, 2008, World J Emerg Surg, V3, P18, DOI 10.1186/1749-7922-3-18; Warren C, 2010, COL DIS, V13, P105	11	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2382	2384		10.1007/s00595-013-0724-0		3	Surgery	Surgery	AT7DP	WOS:000345097300027		
J	Iwaki, R; Nakagiri, K; Morimoto, N; Murakami, H; Honda, T; Yoshida, M; Mukohara, N				Iwaki, Ryuma; Nakagiri, Keitaro; Morimoto, Naoto; Murakami, Hirohisa; Honda, Tasuku; Yoshida, Masato; Mukohara, Nobuhiko			A false aneurysm with an aorto-superior vena cava fistula after replacement of the ascending aorta: report of a case	SURGERY TODAY			English	Article						Aortic operation; CHD; Valve; CABG; Venous grafts	SURGICAL-TREATMENT; TAKAYASUS-ARTERITIS; PSEUDOANEURYSM; SURGERY	A 58-year-old female presenting with congestive heart failure due to a fistula between an aortic false aneurysm and the superior vena cava (SVC) is described. She had a history of Takayasu's arteritis (TA) and she had undergone aortic valve and ascending aorta replacement and coronary artery bypass grafting 6 years before. The false aneurysm had occurred 1 year after the surgery, and she had been conservatively managed. The operation revealed that the cause of the false aneurysm was the detachment of the two proximal saphenous vein anastomoses to the ascending aortic graft. After the surgery, the patient made an uneventful recovery. A false aneurysm of the ascending aorta is one of the most serious complications after replacement of the ascending aorta for patients with TA (Miyata et al. in J Vasc Surg 27:438-445, 1998). We herein present the exceptional case of a fistula between an aortic false aneurysm and the SVC that occurred after ascending aorta graft replacement.	[Iwaki, Ryuma; Nakagiri, Keitaro; Morimoto, Naoto; Murakami, Hirohisa; Honda, Tasuku; Yoshida, Masato; Mukohara, Nobuhiko] Hyogo Brain & Heart Ctr, Div Cardiovasc Surg, Dept Surg, Himeji, Hyogo 6700981, Japan	Iwaki, R (reprint author), Hyogo Brain & Heart Ctr, Div Cardiovasc Surg, Dept Surg, 520 Saisho Kou, Himeji, Hyogo 6700981, Japan.	rryuma.0619@gmail.com					Ogino H, 2008, CIRCULATION, V118, P2738, DOI 10.1161/CIRCULATIONAHA.107.759589; Miyata T, 2003, CIRCULATION, V108, P1474, DOI 10.1161/01.CIR.0000089089.42153.5E; Katsumata T, 2000, ANN THORAC SURG, V70, P547, DOI 10.1016/S0003-4975(00)01300-X; Miyata T, 1998, J VASC SURG, V27, P438, DOI 10.1016/S0741-5214(98)70318-0; Ogawa T, 2013, SURG TODAY, V43, P566, DOI 10.1007/s00595-012-0194-9; SULLIVAN KL, 1988, CHEST, V93, P138, DOI 10.1378/chest.93.1.138	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2385	2387		10.1007/s00595-013-0723-1		3	Surgery	Surgery	AT7DP	WOS:000345097300028		
J	Mizoguchi, H; Sakaki, M; Inoue, K; Kobayashi, Y; Iwata, T; Suehiro, Y; Miura, T				Mizoguchi, Hiroki; Sakaki, Masayuki; Inoue, Kazushige; Kobayashi, Yasuhiko; Iwata, Takashi; Suehiro, Yasuo; Miura, Takuya			Quadricuspid aortic valve complicated with infective endocarditis: report of a case	SURGERY TODAY			English	Article						Quadricuspid aortic valve; Infective endocarditis; Vegetation; Aortic regurgitation; Aortic valve replacement		Congenital quadricuspid aortic valve is a rare cardiac malformation with an unknown risk of infective endocarditis. We report a case of quadricuspid aortic valve complicated with infective endocarditis. A 53-year-old Japanese woman was hospitalized with leg edema and a fever of unknown origin. Corynebacterium striatum was detected in the blood culture. Echocardiography demonstrated a quadricuspid aortic valve with vegetation and severe functional regurgitation. The condition was diagnosed as a quadricuspid aortic valve with infective endocarditis, for which surgery was performed. The quadricuspid aortic valve had three equal-sized cusps and one smaller cusp (type B according to Hurwitz classification). We dissected the vegetation and infectious focus and implanted a mechanical valve. Following the case report, we review the literature.	[Mizoguchi, Hiroki; Sakaki, Masayuki; Inoue, Kazushige; Kobayashi, Yasuhiko; Iwata, Takashi; Suehiro, Yasuo; Miura, Takuya] Kansai Rosai Hosp, Dept Cardiovasc Surg, Amagasaki, Hyogo 6608511, Japan	Mizoguchi, H (reprint author), Kansai Rosai Hosp, Dept Cardiovasc Surg, 3-1-69 Inabasou, Amagasaki, Hyogo 6608511, Japan.	hmizo131@hotmail.co.jp					Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; HURWITZ LE, 1973, AM J CARDIOL, V31, P623, DOI 10.1016/0002-9149(73)90332-9; Ozaki S, 2014, J THORAC CARDIOV SUR, V147, P301, DOI 10.1016/j.jtcvs.2012.11.012; Asami H, 1998, Kyobu Geka, V51, P216; Bauer F, 2008, EUR J ECHOCARDIOGR, V9, P386, DOI 10.1016/j.euje.2006.12.001; FELDMAN BJ, 1990, AM J CARDIOL, V65, P937, DOI 10.1016/0002-9149(90)91446-D; FINCH A, 1994, ECHOCARDIOGR-J CARD, V11, P369, DOI 10.1111/j.1540-8175.1994.tb01379.x; MATSUKAWA T, 1988, JPN CIRC J, V52, P437; Schmidt KI, 2008, ANN THORAC SURG, V85, P1087, DOI 10.1016/j.athoracsur.2007.09.016; Simonds JP, 1923, AM J MED SCI, V166, P584, DOI 10.1097/00000441-192310000-00013; Takeda N, 2003, JPN HEART J, V44, P441, DOI 10.1536/jhj.44.441; Timperley J, 2002, CLIN CARDIOL, V25, P548, DOI 10.1002/clc.4950251203; Watanabe Y, 2003, CIRC J, V67, P275	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	DEC	2014	44	12					2388	2391		10.1007/s00595-014-0844-1		4	Surgery	Surgery	AT7DP	WOS:000345097300029		
J	Yamada, H; Yamamoto, A; Okada, T; Kanagaki, M; Fushimi, Y; Mehemed, TM; Porter, DA; Togashi, K				Yamada, Hirofumi; Yamamoto, Akira; Okada, Tomohisa; Kanagaki, Mitsunori; Fushimi, Yasutaka; Mehemed, Taha Mohamed; Porter, David A.; Togashi, Kaori			Diffusion tensor imaging analysis of optic radiation using readout-segmented echo-planar imaging	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Readout-segmented echo-planar imaging; Optic radiation; Diffusion tensor imaging; Magnetic resonance imaging	WHITE-MATTER; TEMPORAL-LOBE; FIBER TRACTS; HUMAN BRAIN; TRACTOGRAPHY; VISUALIZATION; DISSECTION; PATHWAYS; LAYERS; NERVE	To investigate the diffusion tensor imaging parameters of the optic radiation and surrounding structures using the high-resolution readout-segmented diffusion tensor imaging method. Coronal readout-segmented diffusion tensor images were acquired in 15 healthy volunteers. On three slices of each image, eigenvalue 1, fractional anisotropy, radial diffusivity, apparent diffusion coefficient, and signal intensity on T2-weighted images were measured in the lateral inferior longitudinal fasciculus, external and internal layers of the optic radiation, and the tapetum within regions of interest delineated by two independent observers. Profile curve analysis of regions of interest across the optic radiation and surrounding structures was performed for a representative typical case. Significant differences in fractional anisotropy, radial diffusivity and apparent diffusion coefficient were observed between external and internal layers of the optic radiation, while there was no significant difference in eigenvalue 1. In fractional anisotropy maps, two low signal bands were observed between the inferior longitudinal fasciculus, the optic radiation and the tapetum. Profile curve analysis showed a minimum on the fractional anisotropy and eigenvalue 1 images and a maximum in the radial diffusivity image. Readout-segmented diffusion tensor imaging revealed significant differences in the diffusion tensor imaging parameters between internal and external layers of the optic radiation.	[Yamada, Hirofumi; Yamamoto, Akira; Okada, Tomohisa; Kanagaki, Mitsunori; Fushimi, Yasutaka; Mehemed, Taha Mohamed; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, Kyoto 6068507, Japan; [Porter, David A.] Siemens AG, Healthcare Sect, D-91054 Erlangen, Germany	Yamamoto, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	yakira@kuhp.kyoto-u.ac.jp			Siemens AG	David A Porter has received a payment from Siemens AG registering US patents related to this work. The rest of the authors declare that they have no conflict of interest.	Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Powell HWR, 2005, NEUROLOGY, V65, P596, DOI 10.1212/01.wnl.0000172858.20354.73; Holdsworth SJ, 2008, EUR J RADIOL, V65, P36, DOI 10.1016/j.ejrad.2007.09.016; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Yamamoto T, 2005, AM J OPHTHALMOL, V140, P781, DOI 10.1016/j.ajo.2005.05.018; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Winston GP, 2011, EPILEPSY RES, V97, P124, DOI 10.1016/j.eplepsyres.2011.07.019; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92; CURNES JT, 1988, AM J NEURORADIOL, V9, P1061; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Burgel U, 1997, J BRAIN RES, V38, P397; Caroline A, 2012, NATURE METHODS, V9, P671; Frost R, 2012, MAGN RESON MED, V68, P441, DOI 10.1002/mrm.23242; Hosoya T, 1998, NEURORADIOLOGY, V40, P477; Iima M, 2012, AM J NEURORADIOL, V33, P1321, DOI 10.3174/ajnr.A2969; Kenichi Oishi AVF, 2010, MRI ATLAS HUMAN WHIT; Kitajima M, 1996, AM J NEURORADIOL, V17, P1379; Mori N, 2009, INVEST RADIOL, V44, P140, DOI 10.1097/RLI.0b013e318193ff25; Porter DA, 2004, P INT SOC MAG RESON, V11, P442; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Sincoff EH, 2004, J NEUROSURG, V101, P739, DOI 10.3171/jns.2004.101.5.0739; Tamura H, 2003, AM J NEURORADIOL, V24, P401; WOODWARD WR, 1984, NEUROSCIENCE, V12, P1089, DOI 10.1016/0306-4522(84)90005-8	29	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	DEC	2014	36	10					973	980		10.1007/s00276-014-1299-1		8	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AU0FD	WOS:000345298000003		
J	Inui, H; Tanaka, H; Nobuhara, K				Inui, Hiroaki; Tanaka, Hiroshi; Nobuhara, Katsuya			Glenohumeral relationships at different angles of abduction	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Shoulder; Glenohumeral joint; Abduction; Function; MRI	IN-VIVO; SHOULDER; JOINT; INSTABILITY; ELEVATION; MECHANICS; POSITION; HUMERUS; MOTION	The objective of this study was to clarify the relationships among anatomical landmarks of the glenohumeral joint at different angles of abduction. Fifteen volunteers (ten men, five women; mean age 29 years) were enrolled in this study. Images of externally and internally rotated positions at 45A degrees, 90A degrees, and 135A degrees of abduction in the plane 30A degrees anterior to the trunk were taken using an open magnetic resonance imaging system. Landmarks including the glenoidal long axis with its center, bicipital groove, center of the head, and humeral shaft axis were determined. Using a line set on the surface of the head in the plane parallel to the humeral axis (including the head center and bicipital groove with its parallel and perpendicular lines), the glenoid location and rotational relationships were investigated in each position. The average angles of axial rotation were 48A degrees A A +/- A 27A degrees at 45A(0) of abduction, 71A degrees A A +/- A 20A degrees at 90A degrees of abduction, and 40A degrees A A +/- A 27A degrees at 135A degrees of abduction. The trajectories of the glenoid center primarily extended over the anterior portion of the humeral head at 45A degrees of abduction and over the posterior portion at 90A degrees of abduction, while those at 135A degrees of abduction were localized on a small upper portion of the head. The glenohumeral relationships demonstrated that arm abduction might influence shoulder function through its effects on the portion of the humeral surface in contact with the glenoid during rotation and the resultant changes in the glenohumeral relationships.	[Inui, Hiroaki; Tanaka, Hiroshi; Nobuhara, Katsuya] Nobuhara Hosp, Tatsunoshi, Hyogo 6794017, Japan; [Inui, Hiroaki; Tanaka, Hiroshi; Nobuhara, Katsuya] Inst Biomech, Tatsunoshi, Hyogo 6794017, Japan	Inui, H (reprint author), Nobuhara Hosp, 720 Haze, Tatsunoshi, Hyogo 6794017, Japan.	inuhiro123@yahoo.co.jp					Huffman GR, 2006, AM J SPORT MED, V34, P1662, DOI 10.1177/0363546506287740; Boileau P, 1997, J BONE JOINT SURG BR, V79B, P857, DOI 10.1302/0301-620X.79B5.7579; IANNOTTI JP, 1992, J BONE JOINT SURG AM, V74A, P491; HOWELL SM, 1988, J BONE JOINT SURG AM, V70A, P227; Graichen H, 2000, CLIN ORTHOP RELAT R, P154; Robertson DD, 2000, J BONE JOINT SURG AM, V82A, P1594; Bey MJ, 2011, AM J SPORT MED, V39, P2117, DOI 10.1177/0363546511412164; SOSLOWSKY LJ, 1992, J ORTHOPAED RES, V10, P524, DOI 10.1002/jor.1100100407; Codman EA., 1934, SHOULDER; GAGEY O, 1987, SURG RADIOL ANAT, V9, P19, DOI 10.1007/BF02116850; Inui H, 2002, J SHOULDER ELB SURG, V11, P510, DOI 10.1067/mse.2002.126768; Inui H, 2014, SURG RADIOL ANAT, V36, P755, DOI 10.1007/s00276-014-1257-y; Koishi H, 2011, INT ORTHOP, V35, P1503, DOI 10.1007/s00264-011-1219-5; Matsen III FA, 2003, SHOULDER, P655; Nobuhara K, 2003, SHOULDER ITS FUNCTIO, P49, DOI 10.1142/9789812388919_0005; Pearl ML, 2009, J SHOULDER ELB SURG, V18, P366, DOI 10.1016/j.jse.2009.01.011; Schiffern SC, 2002, AM J SPORT MED, V30, P382; Shafer BL, 2008, J BONE JOINT SURG AM, V90A, P136, DOI 10.2106/JBJS.F.00841	18	1	1	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	DEC	2014	36	10					1009	1014		10.1007/s00276-014-1315-5		6	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AU0FD	WOS:000345298000008		
J	Ishiyama, G; Hinata, N; Kinugasa, Y; Murakami, G; Fujimiya, M				Ishiyama, Gentaro; Hinata, Nobuyuki; Kinugasa, Yusuke; Murakami, Gen; Fujimiya, Mineko			Nerves supplying the internal anal sphincter: an immunohistochemical study using donated elderly cadavers	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Internal anal sphincter; Pelvic plexus; Nerve; Anatomy; Immunohistochemistry	QUALITY-OF-LIFE; LOCALIZED PROSTATE-CANCER; LOW RECTAL-CANCER; NITRIC-OXIDE; INTERSPHINCTERIC RESECTION; SMOOTH-MUSCLE; BRANCHES; FASCIA; HYSTERECTOMY; ANORECTUM	Nerves serving the internal anal sphincter (NIAS) have been described as the lower rectal branches of the pelvic autonomic nerve plexus. However, their topographical anatomy and fiber components have remained unclear. Using histological sections from ten elderly donated cadavers, we investigated the topographical anatomy and composite fibers of the NIAS using immunohistochemistry for S100 protein, neuronal nitric oxide synthase (nNOS), vasoactive intestinal polypeptide (VIP) and tyrosine hydroxylase (TH). At the 2-3 o'clock position in the lower rectum, the NIAS originated from nerves at the posterolateral corner of the prostate in males or in the lower paracolpium in females. The nerves ran inferiorly along the internal aspect of the levator ani muscle, and joined branches of the myenteric plexus at a level slightly above the epithelial junction. The NIAS contained both nNOS-positive parasympathetic nerve fibers and TH-positive sympathetic fibers, but VIP-positive fibers were few in number. The origin of the NIAS at the posterolateral corner of the prostate as well as in the lower paracolpium might be sacrificed or damaged during radical prostatectomy or tension-free vaginal tape insertion. Low anterior resection of rectal cancer will most likely render damage to the NIAS because of its intersphincteric course. Although the nerve composition of the NIAS is characterized by a higher proportion of sympathetic nerve fibers than the myenteric plexus in the large intestine, their role is unclear. However, evaluation of sphincteric function after surgery would appear to be difficult because of the complex control mechanism independent of nerve supply.	[Ishiyama, Gentaro; Fujimiya, Mineko] Sapporo Med Univ, Dept Anat, Sch Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Hinata, Nobuyuki] Kobe Univ, Grad Sch Med, Dept Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kinugasa, Yusuke] Shizuoka Canc Inst, Div Colorectal Canc, Nagaizumi, Shizuoka 4118777, Japan; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa 0680833, Japan	Hinata, N (reprint author), Kobe Univ, Grad Sch Med, Dept Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hinata@med.kobe-u.ac.jp	Hinata, Nobuyuki/M-9421-2015	Hinata, Nobuyuki/0000-0001-7014-6812			Akita K, 2003, SURG RADIOL ANAT, V25, P387, DOI 10.1007/s00276-003-0151-9; Pardo Y, 2010, J CLIN ONCOL, V28, P4687, DOI 10.1200/JCO.2009.25.3245; Ji GJ, 2002, J GEN PHYSIOL, V119, P533, DOI 10.1085/jgp.20028514; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717; Schiessel R, 2005, DIS COLON RECTUM, V48, P1858, DOI 10.1007/s10350-005-0134-5; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Zhang C, 2010, DIS COLON RECTUM, V53, P1315, DOI 10.1007/DCR.0b013e3181e74525; Zhai LD, 2009, DIS COLON RECTUM, V52, P1564, DOI 10.1007/DCR.0b013e3181a8f75c; Stefanski L, 2008, SURG RADIOL ANAT, V30, P675, DOI 10.1007/s00276-008-0379-5; Rullier E, 2003, BRIT J SURG, V90, P445, DOI 10.1002/bjs.4052; van Tol-Geerdink JJ, 2013, BRIT J CANCER, V108, P1784, DOI 10.1038/bjc.2013.181; Ball TP, 1997, J UROLOGY, V158, P827, DOI 10.1016/S0022-5347(01)64329-5; Beck M, 2009, CELL TISSUE RES, V338, P37, DOI 10.1007/s00441-009-0852-4; DONKER PJ, 1986, NEUROUROL URODYNAM, V5, P185, DOI 10.1002/nau.1930050207; Hieda K, 2013, CLIN ANAT, V26, P843, DOI 10.1002/ca.22227; Hirata E, 2011, CLIN ANAT, V24, P469, DOI 10.1002/ca.21042; HORSCH D, 1993, J COMP NEUROL, V335, P381, DOI 10.1002/cne.903350308; Jones OM, 2003, DIS COLON RECTUM, V46, P963, DOI 10.1097/01.DCR.0000074735.71720.01; Katahira A, 2008, INT J GYNECOL CANCER, V18, P193, DOI 10.1111/j.1525-1438.2007.00973.x; Kato M, 2008, INT UROGYNECOL J, V19, P1687, DOI 10.1007/s00192-008-0713-9; Mattei A, 2007, EUR UROL, V52, P687, DOI 10.1016/j.eururo.2007.05.029; Nagai K, 1974, J ASS COLON ANUS DIS, V27, P7; Nelson MT, 1998, J PHYSIOL-LONDON, V507, P629, DOI 10.1111/j.1469-7793.1998.629bs.x; Sato K, 1981, J JPN SOC COLOPROCTO, V34, P515; Stavreva G, 2012, ACTA NEUROBIOL EXP, V72, P185; Stebbing JF, 1998, ANN ROY COLL SURG, V80, P137; Takeyama M, 2008, INT UROGYNECOL J, V19, P559, DOI 10.1007/s00192-007-0467-9; Terauchi A, 2005, AM J PHYSIOL-GASTR L, V289, pG291, DOI 10.1152/ajpgi.00005.2005; Williams P.L., 1995, GRAYS ANATOMY, V58	30	2	2	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	DEC	2014	36	10					1033	1042		10.1007/s00276-014-1289-3		10	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AU0FD	WOS:000345298000011		
J	Ishikawa, K; Nakao, S; Murakami, G; Rodriguez-Vazquez, JF; Matsuoka, T; Nakamuro, M; Shimazu, T				Ishikawa, Kazuo; Nakao, Shota; Murakami, Gen; Francisco Rodriguez-Vazquez, Jose; Matsuoka, Tetsuya; Nakamuro, Makoto; Shimazu, Takeshi			Preliminary embryological study of the radiological concept of retroperitoneal interfascial planes: what are the interfascial planes?	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						Retroperitoneal space; Interfascial planes; Fetal development; Multidetector computed tomography	RENAL FASCIA; PANCREATIC EFFUSIONS; ADIPOSE-TISSUE; SPACE; EXTENSION; ADULT; CT	Recently, the radiological concept of retroperitoneal interfascial planes has been widely accepted to explain the extension of retroperitoneal pathologies. This study aimed to explore embryologically based corroborative evidence, which remains to be elucidated, for this concept. Using serial or semi-serial transverse sections from 29 human fetuses at the 5th-25th week of fetal age, we microscopically observed the development of the retroperitoneal fasciae and other structures in the retroperitoneal connective tissue. A hypothesis for the formation of the interfascial planes was generated from the developmental study and analysis of retroperitoneal fasciae in computed tomography images from 224 patients. Whereas the loose connective tissue was uniformly distributed in the retroperitoneum by the 9th week, the primitive renal and transversalis fasciae appeared at the 10th-12th week, as previous research has noted. By the 23rd week, the renal fascia, transversalis fascia, and primitive adipose tissue of the flank pad emerged. In addition, the primitive lateroconal fascia, which runs parallel to and close to the posterior renal fascia, emerged between the renal fascia and the adipose tissue of the flank pad. Conversely, pre-existing loose connective tissue was sandwiched between the opposing fasciae and was compressed and narrowed by the developing organs and fatty tissues. Through this developmental study, we provided the hypothesis that the compressed loose connective tissue and both opposed fasciae compose the interfascial planes. Analysis of the thickened retroperitoneal fasciae in computed tomography images supported this hypothesis. Further developmental or histological studies are required to verify our hypothesis.	[Ishikawa, Kazuo; Nakao, Shota; Matsuoka, Tetsuya] Rinku Gen Med Ctr, Senshu Trauma & Crit Care Ctr, Izumisano, Osaka 5980048, Japan; [Murakami, Gen] Iwamizawa Kojin Kai Hosp, Div Internal Med, Iwamizawa, Hokkaido 0680833, Japan; [Francisco Rodriguez-Vazquez, Jose] Univ Complutense, Fac Med, Dept Anat & Embryol 2, E-28040 Madrid, Spain; [Nakamuro, Makoto] Seikeikai Hosp, Dept Surg, Sakai Ku, Sakai, Osaka 5900024, Japan; [Shimazu, Takeshi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka 5650871, Japan	Ishikawa, K (reprint author), Rinku Gen Med Ctr, Senshu Trauma & Crit Care Ctr, 2-23 Rinku Ourai Kita, Izumisano, Osaka 5980048, Japan.	ishikawa@sccmc.izumisano.osaka.jp		Rodriguez-Vazquez, Jose Francisco/0000-0001-5423-4492	Marumo Research Foundation for Emergency Medicine in Japan	This work was supported by a grant from Marumo Research Foundation for Emergency Medicine in Japan.	Aizenstein RI, 1997, AM J ROENTGENOL, V168, P639; Congdon ED, 1942, AM J ANAT, V70, P251, DOI 10.1002/aja.1000700204; HAYES MA, 1950, AM J ANAT, V87, P119, DOI 10.1002/aja.1000870105; Grodinsky M, 1938, AM J ANAT, V63, P367, DOI 10.1002/aja.1000630303; POISSONNET CM, 1984, EARLY HUM DEV, V10, P1, DOI 10.1016/0378-3782(84)90106-3; Gore RM, 2000, AM J ROENTGENOL, V175, P363; Balfe DM, 1998, COMPUTED BODY TOMOGR, V3rd, P573; BAUMANN JA, 1945, ACTA ANAT, V1, P15; Cho BH, 2009, J HEPATO-BILIARY-PAN, V16, P824, DOI 10.1007/s00534-009-0126-2; Congdon ED, 1941, ANAT REC, V80, P289, DOI 10.1002/ar.1090800303; DODDS WJ, 1986, AM J ROENTGENOL, V147, P1155; FRITSCH H, 1992, EARLY HUM DEV, V28, P79, DOI 10.1016/0378-3782(92)90008-5; Gerota D, 1895, ARCH ANAT ENTWICK, V2, P265; Ishikawa K, 2005, J TRAUMA, V59, P595, DOI 10.1097/01.ta.0000177712.88653.c0; Ishikawa K, 2006, EUR J RADIOL, V60, P445, DOI 10.1016/j.ejrad.2006.06.014; Lee Su Lim, 2010, Emerg Radiol, V17, P3, DOI 10.1007/s10140-009-0809-7; MARKS SC, 1986, SURG RADIOL ANAT, V8, P89, DOI 10.1007/BF02421375; Matsubara A, 2009, CELLS TISSUES ORGANS, V190, P286, DOI 10.1159/000209231; MEYERS MA, 1972, RADIOLOGY, V104, P249; Meyers MA, 1976, DYNAMIC RADIOLOGY AB, P113; Molmenti EP, 1996, RADIOLOGY, V200, P95; Nsiah-Sarbeng P, 2012, EPOS ECR 2012, DOI [10.1594/ecr2012/C-0635, DOI 10.1594/ECR2012/C-0635]; PARIENTY RA, 1981, RADIOLOGY, V139, P119; RAPTOPOULOS V, 1986, RADIOLOGY, V158, P367; Raptopoulos V, 1997, RADIOLOGY, V205, P777; Tobin CE, 1944, ANAT REC, V89, P295, DOI 10.1002/ar.1090890304; Wassermann F, 1965, HDB PHYSL 5, P87; Wolfram-Gabel R, 2000, CLIN ANAT, V13, P168, DOI 10.1002/(SICI)1098-2353(2000)13:3<168::AID-CA2>3.0.CO;2-C	28	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0930-1038	1279-8517		SURG RADIOL ANAT	Surg. Radiol. Anat.	DEC	2014	36	10					1079	1087		10.1007/s00276-014-1301-y		9	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	AU0FD	WOS:000345298000017		
J	Kumara, HMCS; Gaita, DJ; Miyagaki, H; Yan, XH; Herath, SAC; Cekic, V; Whelan, RL				Kumara, H. M. C. Shantha; Gaita, David J.; Miyagaki, Hiromichi; Yan, Xiaohong; Herath, Sonali A. C.; Cekic, Vesna; Whelan, Richard L.			Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Matrix metalloproteinase 3; Minimally invasive colorectal surgery	INCREASED TUMOR ESTABLISHMENT; ENDOTHELIAL-CELL-GROWTH; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER RESECTION; HEPATOCELLULAR-CARCINOMA; COLON RESECTION; BREAST-CANCER; MURINE MODEL; ANGIOGENESIS; MICE	MMP-3, a member of the matrix metalloproteinase (MMP) family, is involved in the breakdown of the extracellular matrix in tissue remodeling and may also play a role in cancer progression and metastasis. Minimally invasive colorectal resection (MICR) may increase plasma MMP-3 levels directly via surgical trauma or indirectly due to surgery-associated elevations in TNF-alpha and IL1 which are regulators of MMP-3. This study's purpose was to evaluate plasma MMP-3 levels during the first month after MICR for colorectal cancer. Patients enrolled in an IRB approved data/plasma bank who underwent elective MICR for CRC. Blood plasma samples had been collected preoperatively, on postoperative day (POD) 1, 3 and at varying postoperative time points and were stored at -80 A degrees C. The late samples (POD 7-41) were bundled into 7 day time blocks and considered as single time points. MMP-3 levels were analyzed in duplicate via ELISA and the results reported as mean +/- A SD. The paired t test was used for analysis (significance, p < 0.008 after Bonferroni's correction). A total of 73 CRC patients who underwent MICR met the inclusion criteria. The mean PreOp MMP-3 level was 14.9 +/- A 7.8 ng/ml (n = 73). Significantly elevated mean plasma levels were noted on POD 1 (21.4 +/- A 14.7 ng/ml, n = 73, p < 0.0001), POD 3 (37.9 +/- A 21.5 ng/ml, n = 72, p < 0.0001), POD 7-13 (22.0 +/- A 13.0 ng/ml, n = 56, p < 0.0001), POD 14-20 (21.9 +/- A 10.3 ng/ml, n = 20, p = 0.003), and on POD 21-27 (21.9 +/- A 11.43 ng/ml, n = 20, p = 0.002) when compared to PreOp levels. Plasma levels returned to the PreOp baseline at the POD 28-41 time point (n = 16, p = 0.07). Plasma MMP-3 levels remained significantly elevated from baseline for 4 weeks after MICR for CRC. The early postoperative increase in MMP-3 levels may be due to the surgery-related acute inflammatory response; the elevation noted during weeks 2-3 may be related to wound healing. Increased MMP-3 levels may promote metastases or the growth of residual cancer.	[Kumara, H. M. C. Shantha; Gaita, David J.; Miyagaki, Hiromichi; Yan, Xiaohong; Herath, Sonali A. C.; Cekic, Vesna; Whelan, Richard L.] St Lukes Roosevelt Hosp, Div Colon & Rectal Surg, Dept Surg, New York, NY 10019 USA; [Miyagaki, Hiromichi] Osaka Univ, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan; [Whelan, Richard L.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Whelan, RL (reprint author), St Lukes Roosevelt Hosp, Div Colon & Rectal Surg, Dept Surg, Suite 7B,425 West,59th St, New York, NY 10019 USA.	hmsach_6@yahoo.com; rwhelan@chpnet.org					Allendorf JDF, 1999, SURG ENDOSC-ULTRAS, V13, P233, DOI 10.1007/s004649900952; Tang CH, 2010, BIOCHEM PHARMACOL, V79, P209, DOI 10.1016/j.bcp.2009.08.006; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kumara HMCS, 2011, SURG ENDOSC, V25, P2153, DOI 10.1007/s00464-010-1514-z; Kumara HMCS, 2012, SURG ENDOSC, V26, P1759, DOI 10.1007/s00464-011-2112-4; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Crawford SE, 1998, HUM PATHOL, V29, P1039, DOI 10.1016/S0046-8177(98)90410-5; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Kumara HMCS, 2012, SURG ENDOSC, V26, P790, DOI 10.1007/s00464-011-1953-1; KATZ MH, 1991, J AM ACAD DERMATOL, V25, P1054, DOI 10.1016/0190-9622(91)70306-M; Ben-Eliyahu S, 2003, BRAIN BEHAV IMMUN, V17, pS27; Kumara HMCS, 2009, ANN SURG, V249, P973, DOI 10.1097/SLA.0b013e3181a6cd72; Orlichenko LS, 2008, CLIN EXP METASTAS, V25, P593, DOI 10.1007/s10585-008-9143-9; LANGE PH, 1980, CANCER, V45, P1498, DOI 10.1002/1097-0142(19800315)45:6<1498::AID-CNCR2820450633>3.0.CO;2-7; Peeters CFJM, 2006, INT J CANCER, V119, P1249, DOI 10.1002/ijc.21928; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; ALLENDORF JDF, 1995, ARCH SURG-CHICAGO, V130, P649; Allendorf JDF, 1998, SURG ENDOSC-ULTRAS, V12, P1035, DOI 10.1007/s004649900775; Mendes O, 2005, CLIN EXP METASTAS, V22, P237, DOI 10.1007/s10585-005-8115-6; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Belizon A, 2008, SURG ENDOSC, V22, P287, DOI 10.1007/s00464-007-9725-7; Carter JJ, 2003, SURGERY, V134, P432, DOI 10.1067/S0039-6060(03)00136-3; Ceelen W, 2014, CRIT REV ONCOL HEMAT, V89, P16, DOI 10.1016/j.critrevonc.2013.07.008; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; GUTMAN M, 1995, WORLD J SURG, V19, P226; Ishii Y, 2003, J EXP CLIN CANC RES, V22, P461; Jung K, 1997, INT J CANCER, V74, P220, DOI 10.1002/(SICI)1097-0215(19970422)74:2<220::AID-IJC14>3.0.CO;2-H; Karayiannakis AJ, 2003, EUR SURG RES, V35, P492, DOI 10.1159/000073388; Lee EJ, 2010, CHEM-BIOL INTERACT, V185, P18, DOI 10.1016/j.cbi.2010.02.037; Liu HQ, 2011, ONCOL LETT, V2, P1319, DOI 10.3892/ol.2011.399; Mels AK, 2001, BRIT J SURG, V88, P539, DOI 10.1046/j.1365-2168.2001.01722.x; Okamoto K, 2010, INTERNAL MED, V49, P887, DOI 10.2169/internalmedicine.49.3268; Kumara HMCS, 2009, EJSO-EUR J SURG ONC, V35, P295, DOI 10.1016/j.ejso.2008.07.012; Shantha Kumara HMC, 2009, ANN SURG, V250, P1046; Wu FPK, 2004, DIS COLON RECTUM, V47, P1670, DOI 10.1007/s10350-004-0660-6; Wu F. P. K., 2003, Angiogenesis, V6, P255, DOI 10.1023/B:AGEN.0000029410.32264.b0; Yamamura Y, 1998, JPN J SURG, V28, P1175; Yeh YC, 2010, DIGEST DIS SCI, V55, P1649, DOI 10.1007/s10620-009-0926-x	43	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	DEC	2014	28	12					3322	3328		10.1007/s00464-014-3612-9		7	Surgery	Surgery	AT7XK	WOS:000345147500009		
J	Nakahira, S; Takeda, Y; Katsura, Y; Kato, T; Hatanaka, N; Tamura, S				Nakahira, Shin; Takeda, Yutaka; Katsura, Yoshiteru; Kato, Takeshi; Hatanaka, Nobutaka; Tamura, Shigeyuki			Laparoscopic left hepatectomy with tumor thrombectomy in patients with hepatocellular carcinoma concomitant with advanced portal vein tumor thrombus	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Hepatocellular carcinoma; Portal vein tumor thrombus; Laparoscopic hepatectomy; Tumor thrombectomy		Although laparoscopic hepato-biliary-pancreatic surgery has been widely adopted, use of laparoscopic resection for hepatocellular carcinoma (HCC) with advanced portal vein tumor thrombus (PVTT) is uncommon because of the complications involved. From June 2010 through November 2013, 200 laparoscopic hepatectomies were performed. We report the short-term outcome of laparoscopic hepatectomy for HCC with advanced PVTT in 3 patients. Video presentation is a demonstration of the operative procedures employed in Case 3. In this case, the left hepatic artery and left hepatic duct were divided before tumor thrombectomy, and the bifurcation of the portal vein was clearly visible. Three female patients with HCC concomitant with PVTT in the portal trunk or the opposite branch underwent laparoscopic left hepatectomy with tumor thrombectomy using a laparoscopy-assisted technique (1 patient) or pure laparoscopic technique (2 patients). The median operative time was 592 min (range, 555-891 min), and median estimated blood loss was 1182 ml (range, minimal amount-4800 ml). The median length of hospital stay was 19 days (range, 9-22 days), and there was no postoperative mortality. In Case 1, recurrent tumors developed in the residual lobe after curative resection, and the patient died 10 months after the surgery despite treatment with sorafenib and transcatheter arterial chemoembolization. In Case 2, the patient survived for 10 months after curative resection without tumor recurrence. In Case 3, the patient was treated with sorafenib 1 month after palliative resection; she survived for 4 postoperative months, during which decreased tumor marker levels were observed. Laparoscopic hepatectomy for HCC with advanced PVTT is a safe and feasible procedure in selected patients, when performed by surgeons with expertise in hepatic surgery and minimally invasive techniques. Although these patients cannot be cured by surgery alone, early adjuvant therapy followed by laparoscopic surgery might contribute to a good outcome.	[Nakahira, Shin; Hatanaka, Nobutaka] Natl Hosp Org Kure Med Ctr, Dept Digest Surg, Kure, Hiroshima 7370023, Japan; [Nakahira, Shin; Hatanaka, Nobutaka] Chugoku Canc Ctr, Kure, Hiroshima 7370023, Japan; [Nakahira, Shin; Takeda, Yutaka; Katsura, Yoshiteru; Kato, Takeshi; Tamura, Shigeyuki] Kansai Rosai Hosp, Dept Digest Surg, Amagasaki, Hyogo, Japan	Nakahira, S (reprint author), Natl Hosp Org Kure Med Ctr, Dept Digest Surg, 3-1 Aoyama Cho, Kure, Hiroshima 7370023, Japan.	snakahira-gi@umin.ac.jp						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	DEC	2014	28	12					3505	3505		10.1007/s00464-014-3729-x		1	Surgery	Surgery	AT7XK	WOS:000345147500036		
J	Fuse, S; Nakamura, K; Mifune, Y; Marubayashi, H; Hijikuro, I; Nojima, S; Tanaka, H; Takahashi, T				Fuse, Shinichiro; Nakamura, Kentarou; Mifune, Yuto; Marubayashi, Hironori; Hijikuro, Ichiro; Nojima, Shuichi; Tanaka, Hiroshi; Takahashi, Takashi			Rapid Library Synthesis of Amphiphiles Based On a Dioxinone Scaffold and Identification of Nonlamellar Liquid Crystals	SYNLETT			English	Article						multicomponent reaction; combinatorial chemistry; alkylation; nucleophilic addition; palladium	MEMBRANE-PROTEIN CRYSTALLIZATION; CATALYZED COUPLING REACTIONS; DRUG-DELIVERY; CUBIC PHASES; AQUEOUS DISPERSIONS; EFFICIENT; 1,3-DIOXIN-4-ONES; DERIVATIVES; MESOPHASES; BGLATION	Linear and branched amphiphiles with different lengths of lipids and different numbers of hydroxyl groups were rapidly synthesized based on a dioxinone scaffold. The liquid crystalline (LC) properties of the synthesized amphiphiles in excess water were investigated by polarizing optical microscopy and small-angle X-ray scattering (SAXS) analysis. Novel -keto ester based amphiphiles that formed non-lamellar, inverted LC phases were identified.	[Fuse, Shinichiro; Nakamura, Kentarou; Mifune, Yuto; Tanaka, Hiroshi] Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, Tokyo 1528552, Japan; [Marubayashi, Hironori; Nojima, Shuichi] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan; [Hijikuro, Ichiro] ChemGenesis Inc, Chuo Ku, Tokyo 1030023, Japan; [Takahashi, Takashi] Yokohama Coll Pharm, Yokohama, Kanagawa 2450066, Japan	Fuse, S (reprint author), Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	sfuse@apc.titech.ac.jp; ihijikuro@chemgenesis.com; snojima@polymer.titech.ac.jp; ttak@ym.hamayaku.ac.jp	Fuse, Shinichiro/B-9396-2015; Nojima, Shuichi/D-4245-2015; Tanaka, Hiroshi/I-2402-2012	Fuse, Shinichiro/0000-0002-6836-4180; 	New Energy and Industrial Development Organization (NEDO)	The authors thank Mr. Shintaro Nakagawa, Tokyo Institute of Technology, for helping with the SAXS analysis, and Ms. Saki Nakamura, Tokyo Institute of Technology, for helping with the initial synthetic study. The authors also thank the New Energy and Industrial Development Organization (NEDO) for financial support.	Angelova A., 2010, ACCOUNTS CHEM RES, V44, P147; LARSSON K, 1983, NATURE, V304, P664, DOI 10.1038/304664c0; Guo CY, 2010, DRUG DISCOV TODAY, V15, P1032, DOI 10.1016/j.drudis.2010.09.006; Fuse S, 2010, CHEM-ASIAN J, V5, P2459, DOI 10.1002/asia.201000534; Takahashi T, 2003, ANGEW CHEM INT EDIT, V42, P5230, DOI 10.1002/anie.20035229; Shah JC, 2001, ADV DRUG DELIVER REV, V47, P229, DOI 10.1016/S0169-409X(01)00108-9; Spicer PT, 2005, CURR OPIN COLLOID IN, V10, P274, DOI 10.1016/j.cocis.2005.09.004; Caffrey M, 2000, CURR OPIN STRUC BIOL, V10, P486, DOI 10.1016/S0959-440X(00)00119-6; Caffrey M, 2003, J STRUCT BIOL, V142, P108, DOI 10.1016/S1047-8477(03)00043-1; Mulet X, 2013, J COLLOID INTERF SCI, V393, P1, DOI 10.1016/j.jcis.2012.10.014; Drummond CJ, 1999, CURR OPIN COLLOID IN, V4, P449, DOI 10.1016/S1359-0294(00)00020-0; Fuse S, 2014, EUR J MED CHEM, V85, P228, DOI 10.1016/j.ejmech.2014.07.095; Barauskas J, 2005, NANO LETT, V5, P1615, DOI 10.1021/nl050678i; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Cramer N, 2006, CHEM-EUR J, V12, P2488, DOI 10.1002/chem.200501274; TSUJI J, 1985, J ORG CHEM, V50, P1523, DOI 10.1021/jo00209a032; Fuse S, 2014, ACS COMB SCI, V16, P494, DOI 10.1021/co500071x; Guzman-Martinez A, 2010, J AM CHEM SOC, V132, P10634, DOI 10.1021/ja104254d; Yaghmur A, 2009, ADV COLLOID INTERFAC, V147-48, P333, DOI 10.1016/j.cis.2008.07.007; LANDH T, 1995, FEBS LETT, V369, P13, DOI 10.1016/0014-5793(95)00660-2; Caffrey M, 2008, CRYST GROWTH DES, V8, P4244, DOI 10.1021/cg800693r; TROST BM, 1973, J AM CHEM SOC, V95, P292, DOI 10.1021/ja00782a080; Heinemann C, 1997, J AM CHEM SOC, V119, P1129, DOI 10.1021/ja962479u; Barauskas J, 2008, PHYS CHEM CHEM PHYS, V10, P6483, DOI 10.1039/b811251g; Fuse S, 2014, CHEM-EUR J, V20, P10685, DOI 10.1002/chem.201402093; [Anonymous], 2012, ECONOMIST, V401, P1; Fuse S, 2012, ACS COMB SCI, V14, P545, DOI 10.1021/co3000665; Aoki Y, 2011, CHEM LETT, V40, P1192, DOI 10.1246/cl.2011.1192; CARROLL MF, 1953, J AM CHEM SOC, V75, P5400, DOI 10.1021/ja01117a076; Doi T, 2008, J COMB CHEM, V10, P135, DOI 10.1021/cc7000925; FONG C, 2012, J CHEM SOC, V41, P1297, DOI DOI 10.1039/C1CS15148G; Fuse S, 2014, EUR J ORG CHEM, P4854, DOI 10.1002/ejoc.201402478; Fuse S., 2011, ACS COMB SCI, V14, P17; Graalfs H, 1999, EUR J ORG CHEM, P1057; Hattori H, 2012, SYNTHESIS-STUTTGART, V44, P2365, DOI 10.1055/s-0031-1289809; Holmberg K., 1998, SURFACTANTS POLYM AQ; Holmberg K., 2002, HDB APPL SURFACE COL, P465; Itami K, 2006, CHEM-EUR J, V12, P3966, DOI 10.1002/chem.200500958; KANEKO C, 1990, J HETEROCYCLIC CHEM, V27, P25; Larsson K, 2000, CURR OPIN COLLOID IN, V5, P64, DOI 10.1016/S1359-0294(00)00040-6; Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9; Nemoto H, 2012, BIOORG MED CHEM LETT, V22, P6425, DOI 10.1016/j.bmcl.2012.08.057; Nemoto H, 2012, BIOORG MED CHEM LETT, V22, P5051, DOI 10.1016/j.bmcl.2012.06.019; Nemoto H, 2010, CHEM LETT, V39, P856, DOI 10.1246/cl.2010.856; NEMOTO H, 1992, J ORG CHEM, V57, P435, DOI 10.1021/jo00028a010; PADIAS AB, 1987, J ORG CHEM, V52, P5305, DOI 10.1021/jo00233a002; TSUJI J, 1965, TETRAHEDRON LETT, P4387; Wadsater M, 2013, SOFT MATTER, V9, P8815, DOI 10.1039/c3sm51385h; Yoshida M, 2009, CHEM COMMUN, P2756, DOI 10.1039/b901788g	49	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	DEC	2014	25	19					2806	2813		10.1055/s-0034-1379184		8	Chemistry, Organic	Chemistry	AU0QM	WOS:000345328700026		
J	Kobayashi, Y; Kashiwa, M; Sonoda, M; Kirihata, M; Tanimori, S				Kobayashi, Yasuyuki; Kashiwa, Mitsuhiro; Sonoda, Motohiro; Kirihata, Mitsunori; Tanimori, Shinji			Regioselective Monoarylation of 2-Phenylbenzimidazole via Ruthenium-Catalyzed C-H Bond Functionalization	SYNTHESIS-STUTTGART			English	Article						C-H bond activation; benzimidazole; arylation; ruthenium catalyst; directing group	DIRECT ORTHO ARYLATION; BENZIMIDAZOLE DERIVATIVES; ORGANIC HALIDES; ACTIVATION; CLEAVAGE; INHIBITORS; DESIGN; ALKENYLATION	The highly regioselective monoarylation of 1-methyl-2-phenyl-1H-benzimidazole has been demonstrated. The reaction of 1-methyl-2-phenyl-1H-benzimidazole with 4-iodoanisole provided 2-(4-methoxybiphenyl-2-yl)-1-methyl-1H-benzimidazole as the sole product in 96% isolated yield in the presence of [RuCl2(p-cymene)](2) and triphenylphosphine as precatalysts. A series of novel 2-(biphenyl-2-yl)benzimidazoles have been synthesized in good to excellent yields.	[Kobayashi, Yasuyuki; Kashiwa, Mitsuhiro; Sonoda, Motohiro; Kirihata, Mitsunori; Tanimori, Shinji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Biosci & Informat, Naka Ku, Sakai, Osaka 5998531, Japan	Tanimori, S (reprint author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Dept Biosci & Informat, Naka Ku, 1-1 Gakuencho, Sakai, Osaka 5998531, Japan.	tanimori@bioinfo.osakafu-u.ac.jp					Panda SS, 2012, CURR ORG CHEM, V16, P1905; Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Sezen B, 2003, J AM CHEM SOC, V125, P10580, DOI 10.1021/ja036157j; Oi S, 2001, ORG LETT, V3, P2579, DOI 10.1021/ol016257z; Ackermann L, 2008, ORG LETT, V10, P3081, DOI [10.1021/ol801078r, 10.1021/ol102187e]; Bastien D, 2012, J MED CHEM, V55, P3182, DOI 10.1021/jm201645r; Gaba M, 2014, EUR J MED CHEM, V76, P494, DOI 10.1016/j.ejmech.2014.01.030; Zimmermann G, 2014, J MED CHEM, V57, P5435, DOI 10.1021/jm500632s; Ackermann L, 2005, ORG LETT, V7, P3123, DOI 10.1021/ol051216e; Oi S, 2002, ORG LETT, V4, P1783, DOI 10.1021/ol025851l; Bischoff F, 2012, J MED CHEM, V55, P9089, DOI 10.1021/jm201710f; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Xu LM, 2010, CHEM SOC REV, V39, P712, DOI 10.1039/b809912j; Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Arockiam PB, 2012, CHEM REV, V112, P5879, DOI [10.1021/cr300153j, 10.1021/cr300153J]; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Giri R, 2009, CHEM SOC REV, V38, P3242, DOI 10.1039/b816707a; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Seregin IV, 2007, CHEM SOC REV, V36, P1173, DOI 10.1039/b606984n; Miyamura S, 2008, J ORGANOMET CHEM, V693, P2438, DOI 10.1016/j.jorganchem.2008.04.029; Charton J, 2006, BIOORGAN MED CHEM, V14, P4490, DOI 10.1016/j.bmc.2006.02.028; Chen LH, 2013, MOL DIVERS, V17, P641, DOI 10.1007/s11030-013-9460-z; Feng J, 2013, SYNLETT, V24, P2153, DOI 10.1055/s-0033-1339516; Kakiuchi F, 2008, SYNTHESIS-STUTTGART, P3013, DOI 10.1055/s-2008-1067256; Li BJ, 2008, SYNLETT, P949, DOI 10.1055/s-2008-1042907; Oi S, 2008, CHEM LETT, V37, P994, DOI 10.1246/cl.2008.994; Richards ML, 2006, EUR J MED CHEM, V41, P950, DOI 10.1016/j.ejmech.2006.03.014; Satoh T, 2007, TOP ORGANOMETAL CHEM, V24, P61, DOI 10.1007/3418_2007_066; Tuncbilek M, 2009, EUR J MED CHEM, V44, P1024, DOI 10.1016/j.ejmech.2008.06.026; Yoon YK, 2014, BIOORGAN MED CHEM, V22, P703, DOI 10.1016/j.bmc.2013.12.029	30	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2014	46	23					3185	3190		10.1055/s-0034-1379013		6	Chemistry, Organic	Chemistry	AU0QQ	WOS:000345329100004		
J	Seki, M				Seki, Masahiko			Novel and Efficient Debenzylation of N-Benzyltetrazole Derivatives with the Rosenmund Catalyst	SYNTHESIS-STUTTGART			English	Article						palladium; cleavage; hydrogen transfer; heterocycles; protecting groups	II RECEPTOR ANTAGONISTS; C-H ACTIVATION; PRACTICAL SYNTHESIS; BLOCKERS; SERIES; SYSTEM; POTENT	The Rosenmund catalyst (Pd/BaSO4) was found to efficiently catalyze debenzylation of N-benzyltetrazole derivatives with ammonium formate by catalytic transfer hydrogenation under mild conditions. The protocol has been applied to functionalized substrates to provide various angiotensin II receptor blockers in excellent yields.	API Corp, Proc R&D Dept, Healthcare Business Div 2, Chuo Ku, Tokyo 1030027, Japan	Seki, M (reprint author), API Corp, Proc R&D Dept, Healthcare Business Div 2, Chuo Ku, 2-3-4 Nihonbashi, Tokyo 1030027, Japan.	seki.masahiko@mm.api-corp.co.jp					Anderson N. G., 2000, PRACTICAL PROCESS RE; KUBO K, 1993, J MED CHEM, V36, P2343, DOI 10.1021/jm00068a011; Seki M, 2011, J ORG CHEM, V76, P10198, DOI 10.1021/jo202041e; BERNHART CA, 1993, J MED CHEM, V36, P3371, DOI 10.1021/jm00074a018; MCEWEN AB, 1983, J ORG CHEM, V48, P4436, DOI 10.1021/jo00171a069; CARINI DJ, 1991, J MED CHEM, V34, P2525, DOI 10.1021/jm00112a031; Wexler RR, 1996, J MED CHEM, V39, P625, DOI 10.1021/jm9504722; Kurup A, 2001, CHEM REV, V101, P2727, DOI 10.1021/cr000025g; Seki M, 2011, ACS CATAL, V1, P607, DOI 10.1021/cs200044t; Dunn P. J., 2010, GREEN CHEM PHARM IND; Graul A., 1997, Drugs of the Future, V22, P1205; Kocienski P, 2013, SYNFACTS, V9, P0006; Seki M, 2014, [No title captured], Patent No. [WO 2014034868, 2014034868]; Seki M, 2012, SYNTHESIS-STUTTGART, V44, P3231, DOI 10.1055/s-0032-1317131; Seki M, 2012, J SYN ORG CHEM JPN, V70, P1295; SEKI M, 1995, SYNLETT, P609; Seki M., SCI SYNTHESIS CATALY; Seki M., 2014, [No title captured], Patent No. [WO 2014051008, 2014051008]; Yasuda N., 2011, ART PROCESS CHEM	19	3	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881	1437-210X		SYNTHESIS-STUTTGART	Synthesis	DEC	2014	46	23					3249	3255		10.1055/s-0034-1378585		7	Chemistry, Organic	Chemistry	AU0QQ	WOS:000345329100013		
J	Honma, Y; Taguchi, K; Hiyama, H; Yui-Kurino, R; Mikami, T; Kubo, T				Honma, Yujiro; Taguchi, Kazunori; Hiyama, Hajime; Yui-Kurino, Rika; Mikami, Tetsuo; Kubo, Tomohiko			Molecular mapping of restorer-of-fertility 2 gene identified from a sugar beet (Beta vulgaris L. ssp vulgaris) homozygous for the non-restoring restorer-of-fertility 1 allele	THEORETICAL AND APPLIED GENETICS			English	Article							CYTOPLASMIC MALE-STERILITY; POLLEN RESTORER; FERTILITY; INHERITANCE; LINKAGE; RESTORATION; REGIONS; MARKERS	By genetically eliminating the major restorer - of - fertility gene ( Rf ), a weak Rf gene was unveiled. It is an allele of Z , long known as an elusive Rf gene in sugar beet. In the hybrid breeding of sugar beet, maintainer-genotype selection is a laborious process because of the dependence on test crossing, despite the very low occurrence of this genotype. Marker-assisted selection (MAS) of the maintainer genotype is highly desired by sugar beet breeders. The major restorer-of-fertility gene (Rf) was identified as Rf1, and its non-restoring allele (rf1) was discriminated at the DNA level; however, some of the rf1rf1 selections retained an as yet unidentified Rf, another target locus for MAS. The objective of this study was to identify this Rf. An rfrf1 plant was crossed to a cytoplasmic male-sterile sugar beet and then backcrossed to obtain progeny segregating the unidentified Rf. The progeny exhibited partial male-fertility restoration that was unstable in single plants. The segregation ratio of restored vs. non-restored plants suggested the involvement of a single Rf in this male-fertility restoration, designated as Rf2. We confirmed the feasibility of molecular tagging of Rf2 by identifying four shared amplified fragment length polymorphism (AFLP) fragments specific to 17 restored plants. Bulked segregant analysis also was performed to screen the Rf2-linked AFLP markers, which were subsequently converted into 17 sequence-tagged site markers. All the markers, as well two additional chromosome-IV-assigned markers, were linked to each other to form a single linkage map, on which Rf2 was located. Our data suggested that Rf2 is likely an allele of Z, long known as an elusive Rf gene in sugar beet. We also discuss the importance of Rf2 for sugar beet breeding.	[Honma, Yujiro; Hiyama, Hajime; Yui-Kurino, Rika; Mikami, Tetsuo; Kubo, Tomohiko] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Taguchi, Kazunori] Natl Agr & Food Res Org NARO, HARC, Memuro, Hokkaido 0820081, Japan	Kubo, T (reprint author), Hokkaido Univ, Res Fac Agr, Kita Ku, N-9,W-9, Sapporo, Hokkaido 0608589, Japan.	tomohiko@abs.agr.hokudai.ac.jp	Kubo, Tomohiko/B-7738-2012		Bio-oriented Industry (BRAIN); Grants-in-Aid for Science and technology research promotion program for agriculture, forestry, fisheries and food industry, Japan; JSPS [25292001]	This work was supported in part by: Grants-in-Aid for Scientific Research from the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Grants-in-Aid for Science and technology research promotion program for agriculture, forestry, fisheries and food industry, Japan; and JSPS KAKENHI Grant Number 25292001. YH is a Research Fellow of the JSPS.	Matsuhira H, 2012, GENETICS, V192, P1347, DOI 10.1534/genetics.112.145409; Bosemark N. O., 2006, Sugar beet, P50, DOI 10.1002/9780470751114.ch4; Wise RP, 2002, P NATL ACAD SCI USA, V99, P10240, DOI 10.1073/pnas.172388899; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Schondelmaier J, 1997, THEOR APPL GENET, V95, P590, DOI 10.1007/s001220050600; Moritani M, 2013, MOL BREEDING, V32, P91, DOI 10.1007/s11032-013-9854-8; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Schneider K, 1999, MOL GEN GENET, V262, P515, DOI 10.1007/s004380051113; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; BLISS FREDRICK A., 1965, CROP SCI, V5, P403; BOSEMARK NO, 1993, SUGAR BEET CROP, P66; Budar F, 2006, ANNU PLANT REV, V20, P147; CHEN L, 2014, ANNU REV PLANT BIOL, V65; Doyle JJ, 1990, FOCUS, V12, P13; FOOLAD MR, 1993, THEOR APPL GENET, V87, P184, DOI 10.1007/BF00223763; Hjerdin-Panagopoulos A, 2002, CROP SCI, V42, P540; HOGABOAM G. J., 1957, JOUR AMER SOC SUGAR BEET TECHNOL, V9, P457, DOI 10.5274/jsbr.9.5.457; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; Kikuchi S, 2003, THEOR APPL GENET, V108, P73, DOI 10.1007/s00122-003-1413-y; KOSAMBI DD, 1944, ANN EUGENIC, V12, P505; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lincoln S, 1993, MAPPING GENES CONTRO; NAGAO S., 1962, Journal of the Faculty of Agriculture, Hokkaido University, V52, P51; Navabi A, 2009, THEOR APPL GENET, V118, P347, DOI 10.1007/s00122-008-0904-2; Owen F. V., 1945, JOUR AGRIC RES, V71, P423; OWEN F. V., 1942, American Journal of Botany, V29, pp; Panella L., 2005, GENETICS BREEDING SU, P34; PILLEN K, 1993, PLANT BREEDING, V111, P265, DOI 10.1111/j.1439-0523.1993.tb00641.x; R Development Core Team, 2011, R LANG ENV STAT COMP; ROUNDY TE, 1974, CROP SCI, V14, P230; SAVITSKY VF, 1963, P 11 INT C GEN, V1, P215; Taguchi K, 2014, CROP SCI, V54, P1407, DOI 10.2135/cropsci2013.11.0731; THEURER JC, 1971, J AM SOC SUGAR BEET, V16, P354; THEURER JC, 1969, J AM SOC SUGAR BEET, V15, P538; WANG S, 2007, WINDOWS QTL CARTGRAP	35	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	DEC	2014	127	12					2567	2574		10.1007/s00122-014-2398-4		8	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	AU0TB	WOS:000345336300004		
J	Kagawa, S; Mihara, K; Nakamura, A; Nemoto, K; Suzuki, T; Nagai, G; Kondo, T				Kagawa, Shoko; Mihara, Kazuo; Nakamura, Akifumi; Nemoto, Kenji; Suzuki, Takeshi; Nagai, Goyo; Kondo, Tsuyoshi			Relationship Between Plasma Concentrations of Lamotrigine and Its Early Therapeutic Effect of Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder	THERAPEUTIC DRUG MONITORING			English	Article						lamotrigine; plasma concentration; augmentation therapy; treatment-resistant; early response	BIPOLAR DEPRESSION; TOLERABILITY; EFFICACY; LITHIUM	Background: The relationship between plasma concentrations of lamotrigine and its therapeutic effects was prospectively studied on 34 (9 men and 25 women) inpatients with treatment-resistant depressive disorder during an 8-week treatment of lamotrigine augmentation using an open-study design. Methods: The subjects were depressed patients who had already shown insufficient response to at least 3 psychotropics, including antidepressants, mood stabilizers, and atypical antipsychotics. The diagnoses were major depressive disorder (n = 12), bipolar I disorder (n = 7), and bipolar II disorder (n = 15). The final doses of lamotrigine were 100 mg/d for 18 subjects who were not taking valproate and 75 mg/d for 16 subjects taking valproate. Depressive symptoms were evaluated by the Montgomery Asberg Depression Rating Scale (MADRS) before and after the 8-week treatment. Blood sampling was performed at week 8. Plasma concentrations of lamotrigine were measured by high-performance liquid chromatography. Results: There was a significant linear relationship between the plasma concentrations of lamotrigine and percentage improvements at week 8 (r = 0.418, P < 0.05). A stepwise multiple regression analysis showed that plasma lamotrigine concentrations alone had a significant effect on the percentage improvements at week 8 (standardized partial correlation coefficients = 0.454, P < 0.001). The receiver operating characteristics analysis indicated that a plasma lamotrigine concentration of 12.7 mu mol/L or greater was significantly (P < 0.001) predictive of response (50% or more reduction in the MADRS score). The proportion of the responders was significantly higher in the groups with a lamotrigine concentration >12.7 mu mol/L (11/15 versus 4/19, P < 0.01). Conclusions: The present study suggests that an early therapeutic response to lamotrigine is dependent on its plasma concentration and that a plasma lamotrigine concentration of 12.7 mu mol/L may be a threshold for a good therapeutic response in treatment-resistant depressive disorder.	[Kagawa, Shoko; Mihara, Kazuo; Nakamura, Akifumi; Nemoto, Kenji; Suzuki, Takeshi; Nagai, Goyo; Kondo, Tsuyoshi] Univ Ryukyus, Grad Sch Med, Dept Neuropsychiat, Nishihara, Okinawa 9030215, Japan; [Suzuki, Takeshi] Univ Ryukyus, Grad Sch Med, Dept Pharm, Nishihara, Okinawa 9030215, Japan	Mihara, K (reprint author), Univ Ryukyus, Grad Sch Med, Dept Neuropsychiat, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	miharak@med.u-ryukyu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [16790696, 19591366, 25461736]	Supported by Grant-in Aids from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#16790696, #19591366 and #25461736).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Geddes JR, 2009, BRIT J PSYCHIAT, V194, P4, DOI 10.1192/bjp.bp.107.048504; Shelton RC, 2010, CNS DRUGS, V24, P131, DOI 10.2165/11530280-000000000-00000; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; van der Loos MLM, 2009, J CLIN PSYCHIAT, V70, P223; Sachs GS, 2007, NEW ENGL J MED, V356, P1711, DOI 10.1056/NEJMoa064135; Reimers A, 2009, PHARMACOEPIDEM DR S, V18, P132, DOI 10.1002/pds.1690; Barbee JG, 2011, J CLIN PSYCHIAT, V72, P1405, DOI 10.4088/JCP.09m05355gre; Brzakovic BB, 2012, J CLIN PHARM THER, V37, P693, DOI 10.1111/j.1365-2710.2012.01351.x; Hirsch LJ, 2004, NEUROLOGY, V63, P1022; Ivkovic M, 2009, PSYCHIAT DANUB, V21, P187; Kagawa S, 2010, CLIN NEUROPSYCHOPHAR, V1, P35; Thase ME, 2005, PSYCHOPHARMACOLOGY 4, P1081	14	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0163-4356	1536-3694		THER DRUG MONIT	Ther. Drug Monit.	DEC	2014	36	6					730	733				4	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	AT8BG	WOS:000345158200008		
J	Nakamura, A; Mihara, K; Nemoto, K; Nagai, G; Kagawa, S; Suzuki, T; Kondo, T				Nakamura, Akifumi; Mihara, Kazuo; Nemoto, Kenji; Nagai, Goyo; Kagawa, Shoko; Suzuki, Takeshi; Kondo, Tsuyoshi			Lack of Correlation Between the Steady-State Plasma Concentrations of Aripiprazole and Haloperidol in Japanese Patients With Schizophrenia	THERAPEUTIC DRUG MONITORING			English	Article						aripiprazole; dehydroaripiprazole; haloperidol; steady-state plasma concentration	SERUM CONCENTRATIONS; REDUCED HALOPERIDOL; CYP2D6 GENOTYPE; DEHYDROARIPIPRAZOLE; CARBAMAZEPINE; METABOLITE	Background: Both aripiprazole and haloperidol have been used in the treatment of schizophrenia, and are metabolized by the cytochrome P450 (CYP) 2D6 and CYP3A4. The authors studied the correlations between the steady-state plasma concentrations (C-ss) of aripiprazole and its active metabolite, dehydroaripiprazole, and those of haloperidol in 19 Japanese patients with schizophrenia, together with the effects of CYP2D6 genotypes on the steady-state kinetics of these compounds. Methods: All the patients received first 24 mg/d of aripiprazole for 3 weeks and later received 6 mg/d of haloperidol for 2 weeks. Blood samplings were performed at least 2 weeks after the initiation of each treatment. The C-ss values of aripiprazole and dehydroaripiprazole were measured using liquid chromatography with mass spectrometric detection, and those of haloperidol were measured by using an enzyme immunoassay. CYP2D6 genotypes were determined by using polymerase chain reaction analysis. Results: None of the correlations between the C-ss of aripiprazole (r = 0.286) or the sum of aripiprazole plus dehydroaripiprazole (r = 0.344) and those of haloperidol were significant. The mean C-ss of aripiprazole was significantly higher (P < 0.05) in the subjects with 1 *10 allele of CYP2D6 (n = 6) than in those with no mutated alleles (n = 13), whereas there were no significant differences in those of haloperidol between the 2 groups. Conclusions: This study suggests that the C-ss of aripiprazole and that of aripiprazole plus dehydroaripiprazole do not correlate with that of haloperidol in the same individual, because of the greater involvement of CYP2D6 in the metabolism of aripiprazole than in that of haloperidol.	[Nakamura, Akifumi; Mihara, Kazuo; Nemoto, Kenji; Nagai, Goyo; Kagawa, Shoko; Suzuki, Takeshi; Kondo, Tsuyoshi] Univ Ryukyus, Grad Sch Med, Dept Neuropsychiat, Nishihara, Okinawa 9030215, Japan; [Suzuki, Takeshi] Univ Ryukyus, Grad Sch Med, Dept Pharm, Nishihara, Okinawa 9030215, Japan	Mihara, K (reprint author), Univ Ryukyus, Grad Sch Med, Dept Neuropsychiat, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	miharak@med.u-ryukyu.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [16790696, 19591366, 25461736]	Supported by Grant-in Aids from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#16790696, #19591366, and #25461736). Authentic aripiprazole and dehydroaripiprazole were kindly provided by Otsuka Pharmaceutical, Co, Ltd, Tokyo, Japan.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Yasui-Furukori N, 2003, J CLIN PSYCHOPHARM, V23, P435, DOI 10.1097/01.jcp.0000088902.24613.63; Sakuyama K, 2008, DRUG METAB DISPOS, V36, P2460, DOI 10.1124/dmd.108.023242; Harrison TS, 2004, DRUGS, V64, P1715; Citrome L, 2007, J CLIN PSYCHOPHARM, V27, P279, DOI 10.1097/jcp.0b013e318056f309; Nakamura A, 2009, THER DRUG MONIT, V31, P575, DOI 10.1097/FTD.0b013e3181b6326a; Kubo M, 2005, J CHROMATOGR B, V822, P294, DOI 10.1016/j.jchromb.2005.06.023; Ulrich S, 1998, CLIN PHARMACOKINET, V34, P227, DOI 10.2165/00003088-199834030-00005; Hendset M, 2007, EUR J CLIN PHARMACOL, V63, P1147, DOI 10.1007/s00228-007-0373-6; Kirschbaum KM, 2008, WORLD J BIOL PSYCHIA, V9, P212, DOI 10.1080/15622970701361255; Shim JC, 2007, AM J PSYCHIAT, V164, P1404, DOI 10.1176/appi.apj.2007.06071075; Suzuki A, 1997, PHARMACOGENETICS, V7, P415, DOI 10.1097/00008571-199710000-00013; Caccia S, 2007, CURR DRUG METAB, V8, P612; DANIEL DG, 1994, J CLIN PSYCHOPHARM, V14, P340; Mihara K, 2011, CLIN NEUROPSYCHOPHAR, V1, P1; Mihara K, 1999, CLIN PHARMACOL THER, V65, P291, DOI 10.1016/S0009-9236(99)70108-6; Nagai G, 2012, PSYCHIAT CLIN NEUROS, V66, P518, DOI 10.1111/j.1440-1819.2012.02391.x; Nemoto K, 2012, THER DRUG MONIT, V34, P188, DOI 10.1097/FTD.0b013e31824a31e6; Suzuki T, 2011, THER DRUG MONIT, V33, P21, DOI 10.1097/FTD.0b013e3182031021; Yasui N, 1999, J CLIN PSYCHOPHARM, V19, P149, DOI 10.1097/00004714-199904000-00010	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0163-4356	1536-3694		THER DRUG MONIT	Ther. Drug Monit.	DEC	2014	36	6					815	818				4	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	AT8BG	WOS:000345158200020		
J	Bukbuk, DN; Fukushi, S; Tani, H; Yoshikawa, T; Taniguchi, S; Iha, K; Fukuma, A; Shimojima, M; Morikawa, S; Saijo, M; Kasolo, F; Baba, SS				Bukbuk, David Nadeba; Fukushi, Shuetsu; Tani, Hideki; Yoshikawa, Tomoki; Taniguchi, Satoshi; Iha, Koichiro; Fukuma, Aiko; Shimojima, Masayuki; Morikawa, Shigeru; Saijo, Masayuki; Kasolo, Francis; Baba, Saka Saheed			Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, Nigeria	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Nigeria; Rift Valley fever; Seroprevalence	IMMUNOGLOBULIN-G ANTIBODIES; LINKED-IMMUNOSORBENT-ASSAY; RECOMBINANT NUCLEOPROTEIN; MONOCLONAL-ANTIBODIES; NUCLEOCAPSID PROTEIN; IGM ANTIBODIES; INDIRECT ELISA; LASSA FEVER; N-PROTEIN; VIRUS	Background: Rift Valley fever (RVF) is endemic to the tropical regions of eastern and southern Africa. The seroprevalence of RVF was investigated among the human population in Borno State, Nigeria to determine the occurrence of the disease in the study area in comparison with that of Lassa fever and Crimean-Congo Hemorrhagic fever. Methods: Recombinant nucleoprotein (rNP)-based IgG-ELISAs for the detection of serum antibodies against RVF virus (RVFV), Lassa fever virus (LASV), and Crimean-Congo hemorrhagic fever virus (CCHFV) were used to test human sera in Borno State, Nigeria. The presence of neutralizing antibody against the RVFV-glycoprotein-bearing vesicular stomatitis virus pseudotype (RVFVpv) was also determined in the human sera. Results: Of the 297 serum samples tested, 42 (14.1%) were positive for the presence of RVFV-IgG and 22 (7.4%) and 7 (2.4%) of the serum samples were positive for antibodies against LASV and CCHFV, respectively. There was a positive correlation between the titers of neutralizing antibodies obtained using RVFVpv and those obtained using the conventional neutralization assay with the attenuated RVFV-MP12 strain. Conclusions: The seroprevalence of RVF was significantly higher than that of LASV and CCHF in Borno State, Nigeria. The RVFVpv-based neutralization assay developed in this study has the potential to replace the traditional assays based on live viruses for the diagnosis and seroepidemiological studies of RVF.	[Bukbuk, David Nadeba; Baba, Saka Saheed] Univ Maiduguri, Fac Vet Med, Dept Microbiol & Parasitol, Maiduguri, Nigeria; [Fukushi, Shuetsu; Tani, Hideki; Yoshikawa, Tomoki; Taniguchi, Satoshi; Iha, Koichiro; Fukuma, Aiko; Shimojima, Masayuki; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Tokyo, Japan; [Kasolo, Francis] WHO, Reg Off Africa, Dis Prevent & Control Cluster, Brazzaville, DEM REP CONGO	Fukushi, S (reprint author), Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.	fukushi@nih.go.jp			Ministry of Health Labor and Welfare of Japan; Japan Society for the Promotion of Science [H22-Shinko-Ippan-009, H22-Shinko-Ippan-006, H25 Shinko-Ippan-004]	This work was supported in part by a grant-in-aid from the Ministry of Health Labor and Welfare of Japan and the Japan Society for the Promotion of Science [H22-Shinko-Ippan-009, H22-Shinko-Ippan-006, and H25 Shinko-Ippan-004].	Fukushi S, 2012, J VIROL METHODS, V180, P68, DOI 10.1016/j.jviromet.2011.12.013; Andriamandimby SF, 2010, EMERG INFECT DIS, V16, P963, DOI 10.3201/eid1606.091266; Kaku Y, 2009, J VIROL METHODS, V160, P7, DOI 10.1016/j.jviromet.2009.04.037; Clements ACA, 2007, PREV VET MED, V82, P72, DOI 10.1016/j.prevetmed.2007.05.006; Nderitu L, 2011, J INFECT DIS, V203, P655, DOI 10.1093/infdis/jiq004; Saijo M, 2002, J CLIN MICROBIOL, V40, P372, DOI 10.1128/JCM.40.2.372-375.2002; Saijo M, 2005, J VIROL METHODS, V125, P181, DOI 10.1016/j.jviromet.2005.01.028; ZWEIG MH, 1993, CLIN CHEM, V39, P561; Saijo M, 2002, J CLIN MICROBIOL, V40, P1587, DOI 10.1128/JCM.40.5.1587-1591.2002; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Faye O, 2007, EMERG INFECT DIS, V13, P1016, DOI 10.3201/eid1307.061487; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Kaku Y, 2012, J VIROL METHODS, V179, P226, DOI 10.1016/j.jviromet.2011.11.003; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415; Ehichioya DU, 2011, J CLIN MICROBIOL, V49, P1157, DOI 10.1128/JCM.01891-10; Archer BN, 2011, SAMJ S AFR MED J, V101, P263; EZEIFEKA GO, 1982, INT J ZOONOSES, V9, P147; Fafetine JM, 2007, VET MICROBIOL, V121, P29, DOI 10.1016/j.vetmic.2006.11.008; Fukushi S, 2012, VIRUSES-BASEL, V4, P2097, DOI 10.3390/v4102097; Fukushi S, 2006, J MED VIROL, V78, P1509, DOI 10.1002/jmv.20732; Gachohi JM, 2012, REV SCI TECH OIE, V31, P877; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557; Jäckel S, 2013, Res Vet Sci, V95, P725, DOI 10.1016/j.rvsc.2013.04.015; MONATH TP, 1975, B WORLD HEALTH ORGAN, V52, P577; Nakauchi M, 2009, CLIN VACCINE IMMUNOL, V16, P1132, DOI 10.1128/CVI.00163-09; Olaleye OD, 1996, REV SCI TECH OIE, V15, P937; Olaleye OD, 1996, REV SCI TECH OIE, V15, P923; Saijo M, 2007, CLIN VACCINE IMMUNOL, V14, P1182, DOI 10.1128/CVI.00101-07; van Vuren PJ, 2007, J VIROL METHODS, V140, P106, DOI 10.1016/j.jviromet.2006.11.005	30	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	DEC	2014	108	12					768	773		10.1093/trstmh/tru163		6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	AU0XM	WOS:000345345500005		
J	Kitagawa, M				Kitagawa, Masatoshi			STABILITY OF BRANCHING LAWS FOR HIGHEST WEIGHT MODULES	TRANSFORMATION GROUPS			English	Article							VISIBLE ACTIONS; SPACES; REPRESENTATIONS; RESTRICTIONS; VARIETIES; SUBGROUPS; RESPECT	In this paper, we study the irreducible decomposition of a (a",[X];G)-module M for a quasi-affine spherical variety X of a connected reductive algebraic group G over a",. We show that for sufficiently large parameters, the decomposition of M with respect to G is reduced to the decomposition of the 'fiber' M/(x (0))M with respect to some reductive subgroup L of G. In particular, we obtain a method to compute the maximum value of multiplicities in M. Our main result is a generalization of earlier work by F. SatAi in [17]. We apply this result to branching laws of holomorphic discrete series representations with respect to symmetric pairs of holomorphic type. We give a necessary and sufficient condition for multiplicity-freeness of the branching laws.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Kitagawa, M (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	kitamasa@ms.u-tokyo.ac.jp					Kobayashi T, 2005, PUBL RES I MATH SCI, V41, P497, DOI 10.2977/prims/1145475221; JAKOBSEN HP, 1979, J FUNCT ANAL, V34, P29, DOI 10.1016/0022-1236(79)90023-5; Kobayashi T, 2008, PROG MATH, V255, P45; KOBAYASHI T, 1994, INVENT MATH, V117, P181, DOI 10.1007/BF01232239; BRION M, 1986, INVENT MATH, V84, P617, DOI 10.1007/BF01388749; GROSSHANS FD, 1983, INVENT MATH, V73, P1, DOI 10.1007/BF01393822; GROSSHANS FD, 1992, INVENT MATH, V107, P127, DOI 10.1007/BF01231884; Heckman G., 2013, ARXIV13105134; Helgason S., 1994, MATH SURVEYS MONOGRA, V39; Hua L. K., 1963, HARMONIC ANAL FUNCTI; JOSEPH A, 1992, ANN SCI ECOLE NORM S, V25, P1; Knapp A. W., 2002, PROGR MATH, V140; Kobayashi T, 2007, TRANSFORM GROUPS, V12, P671, DOI 10.1007/s00031-007-0057-4; Kobayashi T, 1998, J FUNCT ANAL, V152, P100, DOI 10.1006/jfan.1997.3128; Kobayashi T, 2007, J MATH SOC JPN, V59, P669, DOI 10.2969/jmsj/05930669; Kostant B., 2004, PROGR MATH, V220, P291; Sato F., 1993, COMMENT MATH U ST PA, V42, P189; SCHMID W, 1969, INVENT MATH, V9, P61, DOI 10.1007/BF01389889; Tanaka Y, 2012, P JPN ACAD A-MATH, V88, P91, DOI 10.3792/pjaa.88.91; Timashev D., 2011, ENCY MATH SCI, V8; Vogan D. A., 1991, PROGR MATH, V101, P315; Wallach N., 1973, PURE APPL MATH, V19; Yamashita H., 2002, REPRESENTATIONS NONC, P62; Yamashita H, 2001, ASTERISQUE, P81; Yamashita H., 2005, INFIN DIMENS ANAL QU, VIII, P325	25	0	0	SPRINGER BIRKHAUSER	NEW YORK	233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA	1083-4362	1531-586X		TRANSFORM GROUPS	Transform. Groups	DEC	2014	19	4					1027	1050		10.1007/s00031-014-9284-7		24	Mathematics	Mathematics	AU0FG	WOS:000345298300005		
J	Miyata, Y; Kanda, S; Mitsunari, K; Asai, A; Sakai, H				Miyata, Yasuyoshi; Kanda, Shigeru; Mitsunari, Kensuke; Asai, Akihiro; Sakai, Hideki			Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity	TRANSLATIONAL RESEARCH			English	Article							TRANSITIONAL-CELL CARCINOMA; UPPER URINARY-TRACT; GROWTH-FACTOR-C; FACTOR-KAPPA-B; COX-2 EXPRESSION; LUNG-CANCER; SURVIVAL; ANGIOGENESIS; METASTASIS; LYMPHANGIOGENESIS	Heme oxygenase (HO)-1 is upregulated in malignancies and, in turn, regulates other cancer-related factors. Although HO-1 expression has been associated with cigarette smoking under various pathologic conditions, little is known about their association in patients with bladder cancer. HO-1 expression was assessed in 215 formalin-fixed bladder cancer specimens by immunohistochemistry. Microvessel density, lymph vessel density (LVD), proliferation index (PI), and expression of the vascular endothelial growth factor (VEGF)-A, -C, and -D, cyclooxygenase (COX)-2, matrix metalloproteinase (MMP)-2, and MMP-9 were investigated by similar methods. Multivariate analyses were performed to evaluate the pathologic role and predictive value of HO-1 expression. Our results demonstrated that HO-1 expression was positively associated with T stage, lymph node metastasis, and grade. HO-1 expression was also positively correlated with PI, LVD, and expression levels of VEGF-D, COX-2, MMP-2, and MMP-9 (P < 0.001). In addition, multivariate analyses showed that HO-1 expression positively correlated with smoking intensity. Positive HO-1 expression was a significant predictor of subsequent metastasis (P = 0.008) and poor cause-specific survival (P < 0.001). Similarly, multivariate analyses showed that HO-1 expression was a predictor of cause-specific survival (hazard ratio = 3.13, P = 0.013). In conclusion, pathologic changes of HO-1-related factors were dependent on smoking intensity. Smoking upregulated HO-1 expression, and HO-1 was associated with malignant behavior of bladder cancer. Cancer cell proliferation, lymphangiogenesis, and expression levels of VEGF-D, COX-2, and MMP-2 played important roles in these HO-1-related effects. The clinical correlations of HO-1 were regulated by a complex mechanism that depended on smoking intensity.	[Miyata, Yasuyoshi; Kanda, Shigeru; Mitsunari, Kensuke; Asai, Akihiro; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 8528501, Japan	Miyata, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	int.doc.miya@m3.dion.ne.jp			Japanese Government [25462487]	This study was supported by Grant-in-Aid for Scientific Research from the Japanese Government (No. 25462487 to Y.M.). It was not supported by any private or public company or organization.	Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Lin CW, 2008, MOL CANCER THER, V7, P1195, DOI 10.1158/1535-7163.MCT-07-2199; Birrane G, 2013, INT J ONCOL, V42, P1919, DOI 10.3892/ijo.2013.1910; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Degese MS, 2012, LUNG CANCER, V77, P168, DOI 10.1016/j.lungcan.2012.02.016; Strope SA, 2008, J UROLOGY, V180, P31, DOI 10.1016/j.juro.2008.03.045; Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284; Masini E, 2003, EXP BIOL MED, V228, P546; Mitra AP, 2013, CANCER-AM CANCER SOC, V119, P756, DOI 10.1002/cncr.27763; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Li MY, 2008, EUR RESPIR J, V32, P911, DOI 10.1183/09031936.00064508; Miyata Y, 2003, CLIN CANCER RES, V9, P1741; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Na HK, 2014, FREE RADICAL BIO MED, V67, P353, DOI 10.1016/j.freeradbiomed.2013.10.819; Yin YJ, 2012, EXP BIOL MED, V237, P362, DOI 10.1258/ebm.2011.011193; Lin HY, 2014, NEUROBIOL AGING, V35, P191, DOI 10.1016/j.neurobiolaging.2013.06.020; Ferrando M, 2011, ANGIOGENESIS, V14, P467, DOI 10.1007/s10456-011-9230-4; Yan YL, 2014, TUMOR BIOL, V35, P3047, DOI 10.1007/s13277-013-1395-6; Liu PL, 2010, MOL NUTR FOOD RES, V54, pS196, DOI 10.1002/mnfr.200900550; Miyake M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1020, DOI 10.1111/j.1751-1097.2009.00543.x; Miyake M, 2010, ANTICANCER RES, V30, P2145; Lane D, 2005, AM J REPROD IMMUNOL, V53, P153, DOI 10.1111/j.1600-0897.2005.00259.x; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Kamat AM, 2007, MOL CANCER THER, V6, P1022, DOI 10.1158/1535-7163.MCT-06-0545; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Miyata Y, 2004, UROLOGY, V63, P602, DOI 10.1016/j.urology.2003.09.035; Becker JC, 2007, SCAND J GASTROENTERO, V42, P852, DOI 10.1080/00365520701192383; Costa F, 2009, LIFE SCI, V84, P785, DOI 10.1016/j.lfs.2009.03.002; D'Souza AM, 2012, VIRCHOWS ARCH, V461, P467, DOI 10.1007/s00428-012-1249-4; Gontero P, 2014, UROL INT, V92, P136, DOI 10.1159/000351961; He YL, 2004, BBA-REV CANCER, V1654, P3, DOI 10.1016/j.bbcan.2003.07.003; Hilmy M, 2006, BRIT J CANCER, V95, P1234, DOI 10.1038/sj.bjc.6603415; Huang SK, 2008, UROL INT, V80, P405, DOI 10.1159/000132699; Hung RY, 2011, BIOCHIM BIOPHYS ACTA, V1815, P158; Jazkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2009; Marcon F, 2013, MUTAGENESIS, V28, P135, DOI 10.1093/mutage/ges062; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Miyake M, 2010, UROL INT, V85, P355, DOI 10.1159/000317785; Miyata Y, 2006, J UROLOGY, V176, P348, DOI 10.1016/S0022-5347(06)00520-9; Park SY, 2014, ONCOL REP, V31, P497, DOI 10.3892/or.2013.2843; Sasaki T, 2005, VIRCHOWS ARCH, V446, P523; Tanni SE, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-45; Yanagawa T, 2004, ORAL ONCOL, V40, P21, DOI 10.1016/S1368-8375(03)00128-3; Yin M-S, 2011, J UROLOGY, V185, P701	49	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1931-5244	1878-1810		TRANSL RES	Transl. Res.	DEC	2014	164	6					468	476		10.1016/j.trsl.2014.06.010		9	Medical Laboratory Technology; Medicine, General & Internal; Medicine, Research & Experimental	Medical Laboratory Technology; General & Internal Medicine; Research & Experimental Medicine	AT8QK	WOS:000345197100005		
J	Yoshimoto, A; Surovy, P; Konoshima, M; Kurth, W				Yoshimoto, Atsushi; Surovy, Peter; Konoshima, Masashi; Kurth, Winfried			Constructing tree stem form from digitized surface measurements by a programming approach within discrete mathematics	TREES-STRUCTURE AND FUNCTION			English	Article						3D shape reconstruction; Shape from contour; Tree stem shape; Discrete optimization	MECHANICAL DESIGN; ALLOMETRY; RECONSTRUCTION; PLANTS; SHAPE; SIZE; ALGORITHM; DIAMETER; CONTOURS; HEIGHT	Key message The main message of this work is the demonstration of possibility of creation of stem shape from digitized points using integer-programming approach. The points are digitized by magnetic motion tracker which in contrast to the laser scanning allows the reconstruction of complete cross-section of stem even in the "hidden (invisible)" part. Three-dimensional information on tree stem form plays an important role in understanding the structure and strength of a standing tree against the forces of wind, snow, and other natural pressure. It also contributes to precision in volume measurement compared to conventional two-dimensional measurement. We investigate approaches for obtaining three-dimensional information of tree stem form from partially organized surface measurements, acquired using a three-dimensional digitizing device (Polhemus FASTRAK(A (R)) motion tracking device). We then propose a new programming approach from discrete mathematics to construct tree stem form. Our method is based on an optimal connection of neighbor triangles for surface construction, which is created by locally possible combination of three digitized points on the stem surface. We compare the proposed method to the existing heuristic methods of contour tracing and region growing. Our analysis shows that the proposed method provides a consistent construction of tree stem form, for even stems with extremely irregular structure such as those from bent trees and mangrove trees with unique root spread, while the other methods are incapable for constructing such tree stems.	[Yoshimoto, Atsushi; Surovy, Peter] Inst Stat Math, Dept Math Anal & Stat Inference, Tachikawa, Tokyo 1908562, Japan; [Konoshima, Masashi] Univ Ryukyus, Fac Agr, Nishihara, Okinawa 9030213, Japan; [Kurth, Winfried] Univ Gottingen, Dept Ecoinformat Biometr & Forest Growth, D-37077 Gottingen, Germany	Yoshimoto, A (reprint author), Inst Stat Math, Dept Math Anal & Stat Inference, 10-3 Midori Cho, Tachikawa, Tokyo 1908562, Japan.	yoshimoa@ism.ac.jp			JSPS KAKENHI [22252002, 23.01400]; JSPS [P11400]	This work was supported by JSPS KAKENHI Grant Numbers 22252002, 23.01400. The second author would like to thank JSPS for funding the post-doctoral fellowship No. P11400.	Bernardini F, 1999, IEEE T VIS COMPUT GR, V5, P349, DOI 10.1109/2945.817351; WEINER J, 1992, ECOLOGY, V73, P648, DOI 10.2307/1940771; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; BOISSONNAT JD, 1984, ACM T GRAPHIC, V3, P266, DOI 10.1145/357346.357349; HOLBROOK NM, 1989, AM J BOT, V76, P1740, DOI 10.2307/2444473; Lin HW, 2004, COMPUT AIDED DESIGN, V36, P1, DOI 10.1016/S0010-4485(03)00064-2; KEPPEL E, 1975, IBM J RES DEV, V19, P2; Danjon F, 2008, PLANT SOIL, V303, P1, DOI 10.1007/s11104-007-9470-7; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; FUCHS H, 1977, COMMUN ACM, V20, P693, DOI 10.1145/359842.359846; HOPPE H, 1992, COMP GRAPH, V26, P71; BONSER SP, 1994, AM J BOT, V81, P400, DOI 10.2307/2445488; Bernardini F, 1996, COMPUT GEOM APPL, V9, P27; Bertram JEA, 1989, TREES-STRUCT FUNCT, V3, P241; Constant T, 2003, ANN FOR SCI, V60, P371, DOI 10.1051/forest:2003028; Cormen Thomas H., 2001, INTRO ALGORITHMS, P955; DEAN TJ, 1986, ANN BOT-LONDON, V58, P833; FigueiredoFilho A, 1996, CAN J FOREST RES, V26, P1113, DOI 10.1139/x26-124; FORMATH Group, 2013, FASTRAKDIGITIZER V1; KING D, 1978, RADIAT ENVIRON BIOPH, V15, P141, DOI 10.1007/BF01323263; Koizumi A, 2011, J WOOD SCI, V57, P276, DOI 10.1007/s10086-011-1174-1; KUPPERS M, 1989, TRENDS ECOL EVOL, V4, P375, DOI 10.1016/0169-5347(89)90103-1; Lahtinen A, 1979, FORSTL, V95, P1; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Pulkkinen M, 2012, SILVA FENNICA, V46, P749; Qiang W, 2007, COMPUT SCI ENG, V9, P32, DOI 10.1109/MCSE.2007.18; RICH PM, 1986, B TORREY BOT CLUB, V113, P241, DOI 10.2307/2996362; Sloboda B, 1970, MITTEILUNGEN BADEN W, V24, P18; Surovy P, 2011, AGROFOREST SYST, V82, P105, DOI 10.1007/s10457-010-9344-5	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-1890	1432-2285		TREES-STRUCT FUNCT	Trees-Struct. Funct.	DEC	2014	28	6					1577	1588		10.1007/s00468-014-1065-3		12	Forestry	Forestry	AT7WL	WOS:000345145100003		
J	Watanabe, J; Mizukami, M; Kurihara, K				Watanabe, Junichi; Mizukami, Masashi; Kurihara, Kazue			Resonance Shear Measurement of Confined Alkylphenyl Ether Lubricants	TRIBOLOGY LETTERS			English	Article						Resonance shear measurement; Phenyl ether; Lubricants; Confined space; Tribology	MOLECULARLY THIN-LAYERS; LIQUID-FILMS; FORCES; SURFACES; TRANSITIONS	The tribological properties of four phenyl ether lubricants, monoalkydiphenyl ether (MADE), dialkyldiphenyl ether (DADE), m-phenoxyphenoxy m-biphenyl (m-4P2E), and m-bis(m-phenoxyphenoxy) benzene (m-5P4E), confined between mica surfaces have been investigated using the resonance shear measurement (RSM). The RSM study revealed that the viscous parameter of these lubricants increased when they were confined in a nano-space. The viscous parameter b (2) values of these lubricants confined in a gap smaller than ca. 2-3 nm were in the order of MADE > DADE > m-4P2E a parts per thousand m-5P4E, while their bulk viscosities were in the order of m-5P4E > m-4P2E > DADE > MADE. Further, the MADE, which has better hydrodynamic lubrication property because of the lowest bulk viscosity, was relatively easily squeezed out from the gap compared to others. These results have demonstrated that phenyl ether lubricants confined in a nano-space behave quite differently from those of the bulk phase, and the direct characterization of confined lubricants is imperative for designing efficient lubricants, especially for boundary lubrication.	[Watanabe, Junichi; Mizukami, Masashi; Kurihara, Kazue] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Kurihara, Kazue] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Kurihara, K (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.	jun.watanabe.1123@gmail.com; mizukami@tagen.tohoku.ac.jp; kurihara@tagen.tohoku.ac.jp	Kurihara, Kazue/E-5018-2010		Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported by the "Green Tribology Innovation Network'' in the area of Advanced Environmental Materials of Green Network of Excellence (GRENE) program and "Ultra-low Friction Technology Area'' in the Tohoku Innovative Materials Technology Initiatives for Reconstruction from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	GRANICK S, 1991, SCIENCE, V253, P1374, DOI 10.1126/science.253.5026.1374; Kumacheva E, 1998, J CHEM PHYS, V108, P7010, DOI 10.1063/1.476115; HORN RG, 1981, J CHEM PHYS, V75, P1400, DOI 10.1063/1.442146; PEACHEY J, 1991, REV SCI INSTRUM, V62, P463, DOI 10.1063/1.1142089; Dushkin CD, 1998, REV SCI INSTRUM, V69, P2095, DOI 10.1063/1.1148904; Mizukami M, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3012811; Klein J, 1998, J CHEM PHYS, V108, P6996, DOI 10.1063/1.476114; HORN RG, 1981, J PHYS-PARIS, V42, P39, DOI 10.1051/jphys:0198100420103900; ISRAELACHVILI JN, 1988, SCIENCE, V240, P189, DOI 10.1126/science.240.4849.189; Dushkin CD, 1997, COLLOID SURFACE A, V129, P131, DOI 10.1016/S0927-7757(97)00031-9; GEE ML, 1990, J CHEM PHYS, V93, P1895, DOI 10.1063/1.459067; Gao JP, 1997, J CHEM PHYS, V106, P4309, DOI 10.1063/1.473132; Fujii Y., 1997, J JPN SOC TRIBOLOGIS, V47, P187; Hayashi S, 2002, LANGMUIR, V18, P3932, DOI 10.1021/la0114979; ISRAELAC.JN, 1973, J COLLOID INTERF SCI, V44, P259, DOI 10.1016/0021-9797(73)90218-X; Kawai H, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2903404; Kayano Y., 2007, T MRS J, V32, P367; Kayano Y, 2007, LANGMUIR, V23, P8365, DOI 10.1021/la701466n; Matsubara H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.197801; Mizukami M, 2004, PROG COLL POL SCI S, V128, P105, DOI 10.1007/b97098; Sakuma H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.046104; Sakuma H, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3062862; Trivedi HK, 2004, TRIBOL LETT, V17, P1, DOI 10.1023/B:TRIL.0000017412.45588.17	23	3	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1023-8883	1573-2711		TRIBOL LETT	Tribol. Lett.	DEC	2014	56	3					501	508		10.1007/s11249-014-0427-8		8	Engineering, Chemical; Engineering, Mechanical	Engineering	AU0UE	WOS:000345339300011		
J	Chen, B; Mokume, M; Liu, CJ; Hayashi, K				Chen, Bin; Mokume, Masami; Liu, Chuanjun; Hayashi, Kenshi			Structure and localized surface plasmon tuning of sputtered Au nano-islands through thermal annealing	VACUUM			English	Article						Localized surface plasmon resonance; Au nano-islands; Structure tuning; Refractive index sensitivity	GOLD NANOPARTICLES; SILVER NANOPARTICLES; OPTICAL-PROPERTIES; REFRACTIVE-INDEX; RESONANCE SPECTROSCOPY; NANOSPHERE LITHOGRAPHY; MOLECULAR RESONANCES; SPECTRA; FILMS; PARTICLES	Localized surface plasmon resonance of noble metallic nanoparticles has been widely used in the fabrication of various sensors. Turning the nanostructure of localized surface plasmon resonance is significant because the resonance induced localized surface plasmon resonance shift is found to be strongly dependent on the structural characteristics, and thus the performance of the sensors. A simple sputtering, annealing, re-sputtering, and re-annealing process was proposed to tune the structural and optical characteristics of Au nano-islands deposited on the glass substrate. It was found that the size and inter-particle distance of nano-islands depend on annealing time and temperature. High temperature annealing tended to increase the size and inter-islands distance of Au islands. Re-sputtering and re-annealing under different conditions made size and inter-particle distance further tuning possible. Investigations on the optical characteristics of Au nano-islands demonstrated that the surface plasmon resonance peak and the spectral bandwidth of islands were tunable from 510 nm to 620 nm and from 50 nm to approximately 400 nm, respectively. The refractive index sensitivity of Au nano-islands determined by the surface plasmon band position change in different surrounding medium was compared. 500 degrees C 5 h annealing increased the value of refractive index sensitivity to approximately 58 nm/RIU from 26 nm/RIU under 100 C 5 h annealing. Besides, Au nano-islands with the same re-sputtering condition but different re-annealing conditions showed the maximum value when the re-annealing temperature is at 500 degrees C for 5 h. In addition, the refractive index sensitivity, surface plasmon band position, and figure of merit were dependent with each other. These results suggest that the scheme "sputtering, annealing, re-sputtering, and re-annealing" is an effective method to adjust the structure and increase the refractive index sensitivity of sputtered Au islands. (C) 2014 Elsevier Ltd. All rights reserved.	[Chen, Bin; Mokume, Masami; Liu, Chuanjun; Hayashi, Kenshi] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Dept Elect, Fukuoka 812, Japan	Hayashi, K (reprint author), Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Dept Elect, Fukuoka 812, Japan.	hayashi@ed.kyushu-u.ac.jp		Liu, Chuanjun/0000-0002-7232-2573	Strategic Information and Communication R&D Promotion Program, Ministry of Internal Affairs and communications	The work is partly supported by the Strategic Information and Communication R&D Promotion Program, Ministry of Internal Affairs and communications.	Jensen TR, 2000, J PHYS CHEM B, V104, P10549, DOI 10.1021/jp002435e; Mayer KM, 2011, CHEM REV, V111, P3828, DOI 10.1021/cr100313v; Lee KS, 2005, J PHYS CHEM B, V109, P20331, DOI 10.1021/jp054385p; Mock JJ, 2003, NANO LETT, V3, P485, DOI 10.1021/nl0340475; Rechberger W, 2003, OPT COMMUN, V220, P137, DOI 10.1016/S0030-4018(03)01357-9; Karakouz T, 2008, ADV MATER, V20, P3893, DOI 10.1002/adma.200703092; Karakouz T, 2009, CHEM MATER, V21, P5875, DOI 10.1021/cm902676d; Chen HJ, 2008, LANGMUIR, V24, P5233, DOI 10.1021/la800305j; Saha K, 2012, CHEM REV, V112, P2739, DOI 10.1021/cr2001178; Tesler AB, 2011, J PHYS CHEM C, V115, P24642, DOI 10.1021/jp209114j; Miller MM, 2005, J PHYS CHEM B, V109, P21556, DOI 10.1021/jp054227y; Zhang XY, 2005, NANO LETT, V5, P1503, DOI 10.1021/nl050873x; GRANQVIST CG, 1977, PHYS REV B, V16, P3513, DOI 10.1103/PhysRevB.16.3513; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Haes AJ, 2006, J AM CHEM SOC, V128, P10905, DOI 10.1021/ja063575q; Coronado EA, 2003, J CHEM PHYS, V119, P3926, DOI 10.1063/1.1587686; Sherry LJ, 2005, NANO LETT, V5, P2034, DOI 10.1021/nl0515753; Rycenga M, 2011, CHEM REV, V111, P3669, DOI 10.1021/cr100275d; Funston AM, 2009, NANO LETT, V9, P1651, DOI 10.1021/nl900034v; Hubenthal F, 2010, APPL PHYS B-LASERS O, V100, P225, DOI 10.1007/s00340-010-4064-0; Tseng AA, 2003, IEEE T ELECTRON PACK, V26, P141, DOI 10.1109/TEPM.2003.817714; Tamaru H, 2002, APPL PHYS LETT, V80, P1826, DOI 10.1063/1.1461072; Nath N, 2004, ANAL CHEM, V76, P5370, DOI 10.1021/ac049741z; Oldfield G, 2000, ADV MATER, V12, P1519, DOI 10.1002/1521-4095(200010)12:20<1519::AID-ADMA1519>3.0.CO;2-W; Jain PK, 2007, NANO LETT, V7, P2080, DOI 10.1021/nl071008a; Zhao J, 2006, J AM CHEM SOC, V128, P11004, DOI 10.1021/ja0636082; Karakouz T, 2013, PHYS CHEM CHEM PHYS, V15, P4656, DOI 10.1039/c3cp50198a; Ghosh SK, 2007, CHEM REV, V107, P4797, DOI 10.1021/cr0680282; Zhao J, 2007, J AM CHEM SOC, V129, P7647, DOI 10.1021/ja0707106; Reinhard BM, 2005, NANO LETT, V5, P2246, DOI 10.1021/nl051592s; Hartland GV, 2011, CHEM REV, V111, P3858, DOI 10.1021/cr1002547; Yang SM, 2006, SMALL, V2, P458, DOI 10.1002/smll.200500390; Brandt T, 1997, APPL PHYS B-LASERS O, V65, P793, DOI 10.1007/s003400050349; Chen B, 2013, IEEE SENS J, V13, P1307, DOI 10.1109/JSEN.2012.2231672; Chen B, 2013, IEEJ T SENSORS MICRO, V133, P90; Chumanov G, 1996, J PHYS CHEM-US, V100, P5166, DOI 10.1021/jp9536716; Grigorchuk NI, 2012, J OPT SOC AM B, V29, P3404; Langhammer C, 2007, J CHEM PHYS, V126; Maier S. A., 2006, PLASMONICS FUNDAMENT; NORRMAN S, 1978, PHYS REV B, V18, P674, DOI 10.1103/PhysRevB.18.674; Pavaskar P, 2013, J APPL PHYS, V113	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		94	101		10.1016/j.vacuum.2014.09.005		8	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300016		
J	Kobayashi, A				Kobayashi, Akira			On the ISAPS '13 in Istanbul & Sakarya Preface	VACUUM			English	Editorial Material									[Kobayashi, Akira] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Kobayashi, A (reprint author), UTM, MJIIT, Jalan Semarak 54100, Kuala Lumpur, Malaysia.	kobayashi@nucl.eng.osaka-u.ac.jp						0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		146	148		10.1016/j.vacuum.2014.08.008		3	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300024		
J	Ono, N; Yamamoto, M; Koike, K				Ono, Norifumi; Yamamoto, Masami; Koike, Kazuo			Detection of shock structure around Mach disk in axisymmetric plasma jet	VACUUM			English	Article						Plasma jet; Magnetic field; Mach disk; Image analysis; Abel-inversion	STRONG MAGNETIC-FIELD; FLOW; GAS	Plasma jets have been used widely in various fields such as materials and aerospace engineering. The understanding of the shock structure is important to control a supersonic jet using a magnetic field. An experiment of axisymmetric argon plasma jet under strong magnetic field was carried out to detect the shock structure around the Mach disk precisely. A magnetic field was applied to the jet using a pair of identical superconducting coils. The jet images in a vacuum chamber were taken by a digital single-lens reflex camera with high spatial and color resolution through a viewing window. The distribution of light intensity from photographic data was converted to the radial intensity, relevant to plasma density, using Abel-inversion. The radial shock structure, that is not apparent on the ordinary photos, can be detected from the converted distributions. The software for the analysis was developed to detect the shock structure in the plasma jet. The method of shock detection was also detailed. The hidden shock characteristics such as triple point were found using the radial intensity obtained from the data with high color resolution. The shock lines upstream of the Mach disk under the magnetic field were indicated in detail. The reflected shock location could be determined. The intensity distribution downstream of the Mach disk was significantly changed by applying the magnetic field. The interaction between plasma density and magnetic field clearly occurs at higher density region downstream of the Mach disk. (C) 2014 Elsevier Ltd. All rights reserved.	[Ono, Norifumi; Koike, Kazuo] Tohoku Gakuin Univ, Dept Mech Engn & Intelligent Syst, Tagajo, Miyagi 9858537, Japan; [Yamamoto, Masami] Tohoku Gakuin Univ, Grad Sch, Tagajo, Miyagi 9858537, Japan	Ono, N (reprint author), Tohoku Gakuin Univ, Dept Mech Engn & Intelligent Syst, 1-13-1 Chuo, Tagajo, Miyagi 9858537, Japan.	norifumi@mail.tohoku-gakuin.ac.jp					Cristofolini A, 2008, J SPACECRAFT ROCKETS, V45, P438, DOI 10.2514/1.29919; Gribben BJ, 2000, AIAA J, V38, P275, DOI 10.2514/2.954; Katsurayama H, 2008, J SPACECRAFT ROCKETS, V45, P248, DOI 10.2514/1.31702; Kobayashi A, 2002, VACUUM, V65, P475, DOI 10.1016/S0042-207X(01)00459-6; Kobayashi A, 2006, VACUUM, V80, P1294, DOI 10.1016/j.vacuum.2006.01.064; Koike K, 2009, VACUUM, V83, P25; Koike K, 2004, VACUUM, V73, P353, DOI 10.1016/j.vacuum.2003.12.055; Nishiyama H, 2004, VACUUM, V73, P691, DOI 10.1016/j.vacuum.2003.12.091; Ono N, 2005, JSME INT J B-FLUID T, V48, P411, DOI 10.1299/jsmeb.48.411; Ono N, 2006, VACUUM, V80, P1179, DOI 10.1016/j.vacuum.2006.01.052; Ono N, 2007, J VISUAL-JAPAN, V10, P237; Ono N., 2008, J IAPS, V16, P3; Ono N, 2010, VACUUM, V85, P569, DOI 10.1016/j.vacuum.2010.08.013; Schoenberg KF, 1998, PHYS PLASMAS, V5, P2090, DOI 10.1063/1.872880	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		149	153		10.1016/j.vacuum.2014.05.010		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300025		
J	Fujita, D; Kawashima, R; Ito, Y; Akagi, S; Suzuki, J; Schonherr, T; Koizumi, H; Komurasaki, K				Fujita, Daiki; Kawashima, Rei; Ito, Yuki; Akagi, Shohei; Suzuki, Jun; Schoenherr, Tony; Koizumi, Hiroyuki; Komurasaki, Kimiya			Operating parameters and oscillation characteristics of an anode-layer Hall thruster with argon propellant	VACUUM			English	Article						Electric propulsion; Anode-layer Hall thruster; Argon; Discharge oscillation		Currently, the propellant most often used in Hall effect thrusters is xenon and in recent years occasionally krypton. However, both noble gases are extremely scarce on Earth and missions with high propellant demand, e.g., high-power operation, are defied due to the limited annual production. Therefore, alternative abundant propellants like argon need to be considered. In this paper, the operation characteristics of the anode-layer Hall thruster (TAL) UT-58 with argon propellant are evaluated. Further, the guidelines of high-power operation with argon propellant have been investigated by discussing the discharge stability in each propellant using the same performance map. Finally, it is shown by these maps that optimum magnetic lines by magnetic shielding can be applied to the anode-layer Hall thruster with argon propellant. As a result, three regions were determined by comparing the oscillation amplitude using both xenon and argon, and it was discovered that the optimum operating points with argon propellant are in a region with low magnetic flux density. (C) 2014 Elsevier Ltd. All rights reserved.	[Fujita, Daiki; Ito, Yuki; Akagi, Shohei; Suzuki, Jun; Komurasaki, Kimiya] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan; [Kawashima, Rei; Schoenherr, Tony; Koizumi, Hiroyuki] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan	Fujita, D (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan.	d.fujita@al.t.u-tokyo.ac.jp	Schonherr, Tony/E-8777-2010	Schonherr, Tony/0000-0003-1545-3822			Nagao N, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2815336; Cambel AB, 1963, PLASMA PHYSICS AND M; Conversano RW, 2013, IEPC PAPER 2013 201; Garrigues L, 2013, IEPC PAPER 2013 250; Jankovsky R, 1999, AIAA PAPER 99 2949; Mikellides IG, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3551583; Osuga H, 2010, IAC PAPER 2010 C4 4; Osuga H, 2011, IEPC PAPE 2011 182; Osuga H, 2010, PROCEEDINGS OF 14TH; Schonherr T, 2012, PROCEEDINGS OF THE M; Tamida T, 2007, IEPC PAPER 2007 88; Yamamoto N, 2005, J PROPUL POWER, V21, P870, DOI 10.2514/1.12759; Yamarnoto N, 2013, IEPC PAPER 2013 244	13	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		159	164		10.1016/j.vacuum.2014.07.022		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300027		
J	Kakami, A; Ishibashi, T; Ideta, K; Tachibana, T				Kakami, Akira; Ishibashi, Takuya; Ideta, Keisuke; Tachibana, Takeshi			One-Newton class thruster using arc discharge assisted combustion of nitrous oxide/ethanol bipropellant	VACUUM			English	Article						Space propulsion; Plasma assisted combustion; Nitrous oxide; Ethanol		This paper discusses a 1-N class thruster using nitrous oxide (N2O)/ethanol bipropellant thruster using arc discharge assisted combustion. Bipropellant thruster, which is mainly used in spacecraft for orbit transfer and station keeping, utilizes toxic propellants: hydrazine and nitrogen tetroxide despite relatively high specific impulse. Then a new bipropellant thruster with arc plasma assisted combustion was proposed to develop a non-toxic eco-friendly bipropellant thruster. Both N2O and ethanol, which can be stored in a liquid form, have neither toxicity nor reactivity to materials such as metal and polymer. Arcjet was utilized to initiate and sustain N2O/ethanol chemical reaction at 0.4 MPa thrust chamber pressure. A prototyped thruster shows that combustion was successfully started and sustained with the assistance of a 1-kW arc discharge. Thrust measurements at atmospheric ambient pressure yielded a specific impulse of 55 s with a characteristic exhaust velocity efficiency of 60%. (C) 2014 Elsevier Ltd. All rights reserved.	[Kakami, Akira] Miyazaki Univ, Dept Mech Design Syst Engn, Miyazaki 8892192, Japan; [Ishibashi, Takuya; Ideta, Keisuke; Tachibana, Takeshi] Kyushu Inst Technol, Dept Mech Engn, Kitakyushu, Fukuoka 8048550, Japan	Kakami, A (reprint author), Miyazaki Univ, Dept Mech Design Syst Engn, 1-1 Gakuenkibanadai Sakura, Miyazaki 8892192, Japan.	kakami@cc.miyazaki-u.ac.jp					Aoyagi J, 2010, PLASMA APPL HYBRID F, V19, P26; Hisatsune K, 2004, INT C GREEN PROP SPA; Jankovsky RS, 1996, P 32 AIAA ASME SAE A; Kakami A, 2010, P 46 AIAA ASME SAE A; Kakami A, 2009, J JPN SOC AERONAUTIC, V57, P190; Katsumi T, 2008, INT J ENERGETIC MAT, V2, P123; Nagase S, 2004, P 24 INT S SPAC TECH; Spores RA, 2013, P 49 AIAA ASME SAE A; Sutton GP, 2001, ROCKET PROPULSION EL	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		172	176		10.1016/j.vacuum.2014.08.003		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300029		
J	Yugeswaran, S; Kobayashi, A				Yugeswaran, Subramaniam; Kobayashi, Akira			Metallic glass coatings fabricated by gas tunnel type plasma spraying	VACUUM			English	Article						Metallic glass; Surface coating; Gas tunnel type plasma torch; Amorphous; Microstructure	COMPOSITE COATINGS; WEAR BEHAVIOR; JET; RESISTANCE; ALLOYS	Gas tunnel type plasma spraying is a renowned technique due to its greater advantages than other conventional plasma spraying followed by high speed and high energy density plasma jet. Furthermore, this is a simple and novel process for producing dense metallic coatings with and without secondary phases such as oxides and intermetallic phases under selective operating parameters. The present work was undertaken to study the formation mechanism and for examining the metallic glass coating properties formed through gas tunnel type plasma spraying process. For this purpose, Fe based, Zr based and Ni based metallic glass coatings were individually deposited by gas tunnel type plasma spray torch at optimum operating conditions with two different input currents (300 and 400 A). Phase and microstructure formations were examined and the results were correlated with the input current. Similarly, mechanical properties and electrochemical corrosion properties of each coating were examined and the results were correlated with the existing phase and the microstructures of the coatings. The examined results revealed that the Fe based metallic glass coatings have relatively less porosity (3-4%) and crystalline phase fraction (9-14%). These coatings also exhibit excellent sliding wear resistance (2.77 x 10(-6) mm(3)/nm(-1)) and electrochemical corrosion resistance against 3.5% NaCl solution. (C) 2014 Elsevier Ltd. All rights reserved.	[Yugeswaran, Subramaniam] Univ Toronto, Ctr Adv Coating Technol, Toronto, ON M5S 3G8, Canada; [Kobayashi, Akira] Univ Teknol Malaysia Kuala Lumpur, MJIIT, Kuala Lumpur 54100, Malaysia; [Kobayashi, Akira] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Yugeswaran, S (reprint author), Univ Toronto, Ctr Adv Coating Technol, Toronto, ON M5S 3G8, Canada.	yugeswaran@gmail.com					Yugeswaran S, 2013, J ALLOY COMPD, V551, P168, DOI 10.1016/j.jallcom.2012.09.111; Zhou Z, 2009, SURF COAT TECH, V204, P563, DOI 10.1016/j.surfcoat.2009.08.025; Guo RQ, 2011, CORROS SCI, V53, P2351, DOI 10.1016/j.corsci.2010.12.022; ARATA Y, 1987, J APPL PHYS, V62, P4884, DOI 10.1063/1.338995; Greer AL, 2002, INT MATER REV, V47, P87, DOI 10.1179/095066001225001067; Inoue A, 2001, MATER TRANS, V42, P970, DOI 10.2320/matertrans.42.970; ARATA Y, 1986, JPN J APPL PHYS 1, V25, P1697, DOI 10.1143/JJAP.25.1697; Wang AP, 2007, MAT SCI ENG A-STRUCT, V449, P277, DOI 10.1016/j.msea.2006.02.366; Inoue A, 2004, ADV MATER, V16, P2189, DOI 10.1002/adma.200400301; Kobayashi A, 2008, MATER SCI ENG B-ADV, V148, P110, DOI 10.1016/j.mseb.2007.09.035; Zhang C, 2011, ELECTROCHIM ACTA, V56, P6380, DOI 10.1016/j.electacta.2011.05.020; ARATA Y, 1986, J APPL PHYS, V59, P3038, DOI 10.1063/1.337047; Kim J, 2011, SURF COAT TECH, V205, P3020, DOI 10.1016/j.surfcoat.2010.11.012; Kobayashi A, 2006, VACUUM, V80, P1294, DOI 10.1016/j.vacuum.2006.01.064; Suresh K, 2013, VACUUM, V88, P114, DOI 10.1016/j.vacuum.2012.02.010; Yugeswaran S, 2012, J EUR CERAM SOC, V32, P823, DOI 10.1016/j.jeurceramsoc.2011.10.049; Yugeswaran S, 2012, APPL SURF SCI, V258, P8460, DOI 10.1016/j.apsusc.2012.04.047	17	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		177	182		10.1016/j.vacuum.2014.04.016		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300030		
J	Ando, Y; Noda, Y; Kobayashi, A				Ando, Yasutaka; Noda, Yoshimasa; Kobayashi, Akira			Photo-catalytic titanium oxide film deposition by atmospheric TPCVD using vortex Ar plasma jet	VACUUM			English	Article						Titanium oxide; Thermal plasma chemical vapor deposition (TPCVD); MOCVD; Photo-catalyst; Surface modification; Vortex flow; Spray pyrolysis	CHEMICAL-VAPOR-DEPOSITION; THERMAL PLASMA; COATINGS; DIAMOND; GAS; GROWTH; AIR; CVD	In order to generate the vortex plasma jet, the vortex flow creation nozzle (vortex nozzle) was equipped at the head of the plasma torch. Consequently, by equipment of the vortex nozzle, plasma jet released from the plasma torch ran along the inner wall of the vortex nozzle and the plasma jet was changed into vortex plasma jet in the vortex nozzle. As for the titanium oxide film deposition, anatase rich titanium oxide film with uniform thickness distribution could be obtained on the 304 stainless steel substrate. The film deposition rate at the center on the condition of 30 mm in deposition distance was approximately 8 mu m/min. Besides, since the anatase rich film indicated hydrophilic and methylene-blue droplet on the film was decolored by UV irradiation in cases of methylene-blue wettability and decoloration tests, it was proved that the anatase rich film have photocatalytic properties. Especially, in case of the film deposited on the condition of 30 mm in deposition distance, methylene-blue droplet was perfectly decolored by 48 h UV irradiation. From these results, this technique was found to have high potential for uniform film deposition by TPCVD. (C) 2014 Elsevier Ltd. All rights reserved.	[Ando, Yasutaka] Ashikaga Inst Technol, Div Renewable Energy & Environm, Ashikaga, Tochigi 3268558, Japan; [Noda, Yoshimasa] Ashikaga Inst Technol, Collaborat Res Ctr, Ashikaga, Tochigi 3268558, Japan; [Kobayashi, Akira] Univ Technol Malaysia, Malaysia Japan Int Inst Technol, Kuala Lumpur 54100, Malaysia; [Kobayashi, Akira] Osaka Univ, Grad Sch Eng, Suita, Osaka 5650871, Japan	Ando, Y (reprint author), Ashikaga Inst Technol, Div Renewable Energy & Environm, 268-1 Omae, Ashikaga, Tochigi 3268558, Japan.	yando@ashitech.ac.jp					Ando Y, 2006, IEEE T PLASMA SCI, V34, P1229, DOI [10.1109/TPS.2006.878437, 10.1009/TPS.2006.878437]; Ando Y, 2012, P 9 INT C FLOW DYN, P690; Ando Y, 2006, VACUUM, V80, P1278, DOI 10.1016/j.vacuum.2006.01.066; Ando Y, 2013, IEEE T PLASMA SCI, V41, P1850, DOI 10.1109/TPS.2013.2247066; Shimada S, 2007, SURF COAT TECH, V201, P7194, DOI 10.1016/j.surfcoat.2007.01.041; Jang J, 2013, J THERM SPRAY TECHN, V22, P974, DOI 10.1007/s11666-013-9941-8; Arata Y., 1985, J HIGH TEMP SOC, V11-3, P124; Bouyer E, 2001, APPL ORGANOMET CHEM, V15, P833, DOI 10.1002/aoc.237; Higa A, 1996, JPN J APPL PHYS 1, V35, P216, DOI 10.1143/JJAP.35.216; Jang J, 2013, J PHYS CONF SER, V441, DOI 10.1088/1742-6596/441/1/012032; Kobayashi A, 2000, VACUUM, V59, P194, DOI 10.1016/S0042-207X(00)00270-0; Kobayashi A, 2000, SURF COAT TECH, V132, P152, DOI 10.1016/S0257-8972(00)00725-8; Kobayashi A, 2008, J PHYS CONF SER, V133, DOI 10.1088/1742-6596/133/1/012019; Kobayashi A., 1990, SURF COAST TECHNOL, V90, P197; KURIHARA K, 1988, APPL PHYS LETT, V52, P437, DOI 10.1063/1.99435; MATSUMOTO S, 1992, J MATER SCI, V27, P5905, DOI 10.1007/BF01119758; MURAKAMI H, 1988, ADV CERAM MATER, V3, P423; OHTAKE N, 1993, JPN J APPL PHYS 1, V32, P2067, DOI 10.1143/JJAP.32.2067; Okayama H, 1997, T I ELECT ENG JPN A, V9, P936; Saito T, 2007, J ENV ENG, V2, P429, DOI 10.1299/jee.2.429; Yagi H., 2000, T MAT RES SOC JPN, V25, P313; Yasutaka Ando, 2009, IEEE T PLASMA SCI, V37, P2202	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		190	195		10.1016/j.vacuum.2014.07.002		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300032		
J	Unal, O; Karaoglanli, AC; Varol, R; Kobayashi, A				Unal, Okan; Karaoglanli, A. Cahit; Varol, Remzi; Kobayashi, Akira			Microstructure evolution and mechanical behavior of severe shot peened commercially pure titanium	VACUUM			English	Article						Severe shot peening; Nanoindentation; CP titanium; Nanostructure; Elastic modulus	NANOSTRUCTURED SURFACE-LAYER; LOW-CARBON STEEL; ELASTIC-MODULUS; ALLOY-STEEL	Severe plastic deformation methods such as equal channel angular pressing (ECAP), high pressure torsion (HPT) and constrained groove pressing (CGP) have been increased in importance due to superior mechanical properties evolution and nanostructured grains build up. Besides, severe shot peening has been using as a severe plastic deformation method in recent years and applied converting microstructure to nanostructure just below the surface. Not only enhancement of fatigue, fretting fatigue and corrosion strength of materials but also altering the surface microstructure gathers much interest for severe shot peening application. In this study, severe shot peening with different Almen intensities (A28-30, A30 -32, A32-34, A34-36, C4-6, C6-8, C8-10) was performed on commercially pure (CP) titanium (grade 2) and the specimens surfaces were investigated according to Almen intensity (plastic deformation rate). Also mechanical properties such as hardness and elastic modulus have been investigated by performing nanoindentation tests. Results have shown the work hardened layer is approximately 160 mu m and has nanograin size distributions with much higher nanohardness and elastic modulus with compared to those of inside the bulk material. (C) 2014 Elsevier Ltd. All rights reserved.	[Unal, Okan] Bartin Univ, Dept Mech Engn, TR-74100 Bartin, Turkey; [Karaoglanli, A. Cahit] Bartin Univ, Dept Met & Mat Engn, TR-74100 Bartin, Turkey; [Varol, Remzi] Suleyman Demirel Univ, Dept Mech Engn, TR-32200 Isparta, Turkey; [Kobayashi, Akira] Malaysia Japan Int Inst Technol, UTM KL, Kuala Lumpur 54100, Malaysia; [Kobayashi, Akira] Osaka Univ, Grad Sch Engn, Ibaraki, Osaka 5650871, Japan	Unal, O (reprint author), Bartin Univ, Dept Mech Engn, TR-74100 Bartin, Turkey.	unalokan78@gmail.com					Zheng CY, 2011, APPL SURF SCI, V257, P5634, DOI 10.1016/j.apsusc.2011.01.062; Mai YJ, 2010, APPL SURF SCI, V256, P1972, DOI 10.1016/j.apsusc.2009.09.030; Wang YM, 2004, ACTA MATER, V52, P1699, DOI 10.1016/j.actamat.2003.12.022; Unal O, 2014, APPL SURF SCI, V290, P40, DOI 10.1016/j.apsusc.2013.10.184; Dai FZ, 2012, VACUUM, V86, P1482, DOI 10.1016/j.vacuum.2012.02.001; Li D, 2009, APPL SURF SCI, V255, P3811, DOI 10.1016/j.apsusc.2008.10.037; Shuman DJ, 2007, MATER CHARACT, V58, P380, DOI 10.1016/j.matchar.2006.06.005; Sivasankaran S, 2011, MATER CHARACT, V62, P661, DOI 10.1016/j.matchar.2011.04.017; Child DJ, 2011, ACTA MATER, V59, P4825, DOI 10.1016/j.actamat.2011.04.025; Mordyuk BN, 2012, SURF COAT TECH, V210, P54, DOI 10.1016/j.surfcoat.2012.08.063; Bagherifard S, 2012, ENG FRACT MECH, V81, P56, DOI 10.1016/j.engfracmech.2011.06.011; Bagherifard S, 2010, SURF COAT TECH, V204, P54; Bagherifard S, 2009, FRATTURA INTEGRITA S, V7, P3; Carek GA, 1987, 2711 NASA; Ni ZC, 2003, PHYSICA B, V334, P221, DOI 10.1016/S0921-4526(03)00069-3; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Unal O, 2013, MATER RES INNOV, V17, P519, DOI 10.1179/1433075X13Y.0000000106; Yang HP, 2013, SURF COAT TECH, V228, P229, DOI 10.1016/j.surfcoat.2013.04.033; Zehetbauer M.J., 2009, BULK NANOSTRUCTURED	19	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		202	206		10.1016/j.vacuum.2014.08.004		5	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300034		
J	Itarashiki, T; Hayashi, N; Yonesu, A				Itarashiki, Tomomasa; Hayashi, Nobuya; Yonesu, Akira			Sterilization effect of nitrogen oxide radicals generated by microwave plasma using air	VACUUM			English	Article						Microwave plasma; Medical sterilization; Active oxygen species; RF plasma	OXYGEN PLASMA	Plasma sterilization has attracted attention as a safe and low cost sterilization method compared to conventional sterilization methods such as EOG (ethylene oxide gas) sterilization and high-pressure steam sterilization. In this research, a plasma is generated by irradiating air with microwaves. Sterilization is caused by O-radicals and NO-radicals. In order to carry out sterilization efficiently, optimal setting of equipment conditions is required. The pressure required for optimal conditions of the equipment, the microwave output, and the equipment used have been examined. A biological indicator (BI), Geobacillus stearothermophilus (ATCC7953), was used. It was found that sterilization was successful when the pressure in the vacuum chamber for microwave output of 280 W was 60 Pa. (C) 2014 Elsevier Ltd. All rights reserved.	[Itarashiki, Tomomasa; Hayashi, Nobuya] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Itarashiki, Tomomasa] Saraya Co Ltd, Higashisumiyoshi Ku, Osaka 5460013, Japan; [Yonesu, Akira] Univ Ryukyus, Fac Engn, Okinawa 9030213, Japan	Itarashiki, T (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	itarashiki@saraya.com					Nagatsu M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1931050; Fumagalli F, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/13/135203; Zhao Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3588036; Hayashi N, 2008, IEEE T PLASMA SCI, V36, P1302, DOI 10.1109/TPS.2008.924453; Stapelmann K, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/192005; Rossi F, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115017; Yoshino K, 2013, VACUUM, V93, P84, DOI 10.1016/j.vacuum.2013.01.009; Bol'shakov A.A., AIAA J, V42, P823; Hayashi N, 2011, IEEE T PLASMA SCI, V39, P2976, DOI 10.1109/TPS.2011.2145004; Liu H, 2008, APPL SURF SCI, V254, P1815, DOI 10.1016/j.apsusc.2007.07.152; Moreira AJ, 2004, APPL SURF SCI, V235, P151, DOI 10.1016/j.apsusc.2004.05.128; Nagatsu M, 2005, IEEE PLASMA SCI, V87; SAKUDO N, 1978, REV SCI INSTRUM, V49, P940, DOI 10.1063/1.1135499; Singh MK, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115027; Xu L, 2006, J PHYS D APPL PHYS, V39, P148, DOI 10.1088/0022-3727/39/1/022	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		213	216		10.1016/j.vacuum.2014.06.018		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300036		
J	Kitazaki, S; Tanaka, A; Hayashi, N				Kitazaki, Satoshi; Tanaka, Akimasa; Hayashi, Nobuya			Sterilization of narrow tube inner surface using discharge plasma, ozone, and UV light irradiation	VACUUM			English	Article						Atmospheric pressure plasma; Dielectric barrier discharge; Plasma sterilization; Oxygen radical; Hydroxyl radical; UV		Sterilization of medical equipment is an important procedure in the field of medicine. However, methods for sterilizing medical equipment such as catheters or endoscopes have yet to be established. We developed novel sterilization methods to sterilize the inner surface of a tube using low-pressure discharge plasma, atmospheric pressure ozone, and ultraviolet (UV) light irradiation. Generation of active oxygen and hydroxyl (OH) radicals were measured by a chemical indicator and a spectrum analysis of light emission from the plasma. A biological indicator with Geobacillus stearothermophilus was used to evaluate the sterilizing ability. A tube 1000 mm long and 4 mm in diameter was successfully sterilized for 30 min using air and water vapor discharge. Furthermore, the atmospheric pressure method sterilized the tube in 1 min. Compared to conventional methods, sterilization using discharge plasma, ozone, and UV light irradiation is safe for the human body and harmless to the environment. (C) 2014 Elsevier Ltd. All rights reserved.	[Kitazaki, Satoshi; Tanaka, Akimasa; Hayashi, Nobuya] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Kitazaki, S (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasuga Kouen, Kasuga, Fukuoka 8168580, Japan.	kitazaki@aees.kyushu-u.ac.jp					Alkawareek MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044289; Laroussi M, 2006, PLASMA PROCESS POLYM, V3, P470, DOI 10.1002/ppap.200600005; Hayashi N, 2008, IEEE T PLASMA SCI, V36, P1302, DOI 10.1109/TPS.2008.924453; Adler S, 1998, J HOSP INFECT, V40, P125, DOI 10.1016/S0195-6701(98)90091-3; Fujiyama H, 2000, J PLASMA FUSION RES, V76, P465; Lerouge S., 2001, PLASMAS POLYM, V6, P175, DOI 10.1023/A:1013196629791; Sato T, 2006, IEEE T IND APPL, V42, P399, DOI 10.1109/TIA.2006.870039; Singh MK, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115027; Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012	9	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		217	220		10.1016/j.vacuum.2014.06.014		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300037		
J	Matsutani, T; Kawasaki, T; Kodama, T; Hisaka, M; Takai, Y; Ikuta, T				Matsutani, Takaomi; Kawasaki, Tadahiro; Kodama, Tetsuji; Hisaka, Masaki; Takai, Yoshizo; Ikuta, Takashi			Development of focused ion beam system attached to floating type low energy ion gun for surface finishing	VACUUM			English	Article						Low-energy ion gun; Electron impact ionization cell; Floating source; Retarding immersion lens; Focused ion beam; Damage removal	DAMAGE; BOMBARDMENT; AR+	Ion beams of several tens of keV are widely used for the analysis and materials processing, but the occurrence of damage to the surface is of concern. For surface treatment of the ion beam processed sample to remove the damaged layer, a floating-type low-energy ion gun (FUG) producing 100-500 eV ions at a high current intensity has been developed. This ion gun consists of a permanent magnet-aided electron impact-type ionization cell, an extractor, and a cylindrical retarding immersion lens. The gun produced current intensities of order 1.81 mu A (current density of 7.9 mu A/cm(2)) for 100 eV ions. The entire system has been compactly constructed with an ionization cell that has an outer diameter of less than 3.3 cm and a lens system that has a length of 24 cm. In addition, a focused ion beam (FIB) system attached to the FLIG has been developed to remove damaged layers formed by previous high energy etching. The thickness of the damaged layer induced on a GaAs (111) surface by 25 kV Ga+ ions was of order 24 nm, assessed using a transmission electron microscope (TEM). This damaged layer was reduced to similar to 2.6 nm by subsequent bombardment by low energy 200 eV Ar+ ions. Published by Elsevier Ltd.	[Matsutani, Takaomi] Kindai Univ, Dept Elect & Elect Engn, Higashiosaka, Osaka 5778502, Japan; [Kawasaki, Tadahiro] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Hisaka, Masaki] Osaka Electrocommun Univ, Dept Biomed Engn, Shijyonawate, Osaka 5750063, Japan; [Takai, Yoshizo] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Ikuta, Takashi] Osaka Electrocommun Univ, Dept Elect Engn, Neyagawa, Osaka 5728530, Japan	Matsutani, T (reprint author), Kindai Univ, Dept Elect & Elect Engn, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	matutani@ele.kindai.ac.jp			Japan Society for the Promotion of Science [24360020]	The work was supported by a Grant-in-Aid for Scientific Research (B) #24360020 from the Japan Society for the Promotion of Science. The authors are very grateful to Professor Emeritus R. Shimizu of Osaka University.	CHASON E, 1993, APPL PHYS LETT, V62, P363, DOI 10.1063/1.108957; ALBAYATI AH, 1990, SURF SCI, V237, P213, DOI 10.1016/0039-6028(90)90533-E; BASILE DP, 1992, MATER RES SOC SYMP P, V254, P23; DAY ME, 1993, J APPL PHYS, V74, P5217, DOI 10.1063/1.354261; KONOMI I, 1989, SURF SCI, V207, P427, DOI 10.1016/0039-6028(89)90133-7; Nishihara S, 1985, P 9 S ION SOURC ION, P543; Shimizu R., 1984, Technology Reports of the Osaka University, V34; SHIMIZU R, 1988, SURF INTERFACE ANAL, V11, P510, DOI 10.1002/sia.740111004; Tarutani M., 1993, Technology Reports of the Osaka University, V43; YAMAGUCHI A, 1995, J VAC SCI TECHNOL B, V13, P962, DOI 10.1116/1.588213; Zhao Q, 2000, J VAC SCI TECHNOL A, V18, P2271, DOI 10.1116/1.1286103	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	DEC	2014	110				SI		228	231		10.1016/j.vacuum.2014.07.020		4	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AT8LR	WOS:000345185300039		
J	Azuma, N; Iida, O; Takahara, M; Soga, Y; Kodama, A				Azuma, Nobuyoshi; Iida, Osamu; Takahara, Mitsuyoshi; Soga, Yoshimitsu; Kodama, Akio			Surgical reconstruction versus peripheral intervention in patients with critical limb ischemia - a prospective multicenter registry in Japan: The SPINACH study design and rationale	VASCULAR			English	Article						Critical limb ischemia; peripheral arterial disease; distal bypass; endovascular treatment; diabetic atherosclerosis; dialysis-dependent renal failure	LOWER-EXTREMITY BYPASS; LEG BASIL TRIAL; ENDOVASCULAR THERAPY; ARTERIAL-DISEASE; RISK STRATIFICATION; AMPUTATION-FREE; ANGIOPLASTY; SURVIVAL; REVASCULARIZATION; OUTCOMES	Clinical evidence reflecting the recent development of treatments for patients with critical limb ischemia is mandatory to guide the decision-making process for the selection of revascularization procedures, including bypass or endovascular treatment. This paper describes the protocol for a clinical study that is designed and carried out by both vascular surgeons and interventional cardiologists collaboratively, and will investigate current treatment for critical limb ischemia in Japan. The registry aimed to recruit approximately 450 patients with critical limb ischemia, including approximately 150 patients who underwent bypass surgery and approximately 300 patients who underwent endovascular treatment in 23 institutions. The primary endpoint of this study is amputation-free survival at 36 months, and the secondary endpoints include major amputation, cardiovascular events, re-intervention, death, ulcer healing, and their composite outcomes. The SPINACH study aims to provide a suitable patient model for each revascularization procedure, bypass and endovascular treatment, and will expound on the role of each approach for critical limb ischemia treatment (Clinical trial registration UMIN000007050).	[Azuma, Nobuyoshi] Asahikawa Med Univ, Dept Vasc Surg, Asahikawa, Hokkaido 0788510, Japan; [Iida, Osamu] Kansai Rosai Hosp, Dept Cardiol, Amagasaki, Hyogo, Japan; [Takahara, Mitsuyoshi] Osaka Univ, Dept Metab Med, Grad Sch Med, Osaka, Japan; [Soga, Yoshimitsu] Kokura Mem Hosp, Dept Cardiol, Kitakyushu, Fukuoka, Japan; [Kodama, Akio] Nagoya Univ, Div Vasc Surg, Dept Surg, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Azuma, N (reprint author), Asahikawa Med Univ, 2-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	nazuma@asahikawa-med.ac.jp			Abbott Vascular Japan Co., Ltd; Boston Scientific Japan K.K.; Cook Japan Incorporated; Goodman Co., Ltd; Johnson Johnson K.K.; Kaken Pharmaceutical Co., Ltd; Kaneka Medix Corporation; Medicon Inc.; Medikit Co., Ltd; Medtronic Japan Co., Ltd; Mitsubishi Tanabe Pharma Corporation; MSD K.K.; St. Jude Medical Japan Co., Ltd; Taisho Toyama Pharmaceutical Co., Ltd; Terumo Corp.; W.L. Gore & Associates, Co., Ltd	The SPINACH Study is sponsored by the following companies; Abbott Vascular Japan Co., Ltd, Boston Scientific Japan K.K., Cook Japan Incorporated, Goodman Co., Ltd, Johnson & Johnson K.K., Kaken Pharmaceutical Co., Ltd, Kaneka Medix Corporation, Medicon Inc., Medikit Co., Ltd, Medtronic Japan Co., Ltd, Mitsubishi Tanabe Pharma Corporation, MSD K.K., St. Jude Medical Japan Co., Ltd, Taisho Toyama Pharmaceutical Co., Ltd, Terumo Corp., W.L. Gore & Associates, Co., Ltd (The companies are listed in alphabetical order).	Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Alexandrescu VA, 2009, J ENDOVASC THER, V15, P580; Alpert JS, 2000, EUR HEART J, V21, P1399, DOI 10.1053/euhj.2000.2265; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Nolan BW, 2011, J VASC SURG, V54, P730, DOI 10.1016/j.jvs.2011.03.236; Okamoto K, 2006, AM J KIDNEY DIS, V48, P269, DOI 10.1053/j.ajkd.200604.075; Iida O, 2010, CATHETER CARDIO INTE, V75, P830, DOI 10.1002/ccd.22319; Iida O, 2013, CIRC-CARDIOVASC INTE, V6, P68, DOI 10.1161/CIRCINTERVENTIONS.112.975318; Neville RF, 2009, ANN VASC SURG, V23, P367, DOI 10.1016/j.avsg.2008.08.022; Azuma N, 2012, EUR J VASC ENDOVASC, V43, P322, DOI 10.1016/j.ejvs.2011.12.001; Takahara M, 2010, DIABETES CARE, V33, P2538, DOI [10.2337/dc10-0939, 10.2337/dc10.0939]; Goodney PP, 2009, J VASC SURG, V49, P1431, DOI 10.1016/j.jvs.2009.02.014; Schanzer A, 2008, J VASC SURG, V48, P1464, DOI 10.1016/j.jvs.2008.07.062; Ramdev P, 2002, J VASC SURG, V36, P969, DOI 10.1067/mva.2002.128297; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Conte MS, 2009, J VASC SURG, V50, P1462, DOI 10.1016/j.jvs.2009.09.044; Yamada T, 2008, J VASC SURG, V47, P318, DOI 10.1016/j.jvs.2007.10.045; Iida O, 2013, J VASC SURG, V57, P974, DOI 10.1016/j.jvs.2012.10.096; Soga Y, 2011, J VASC SURG, V54, P1058, DOI 10.1016/j.jvs.2011.03.286; Attinger CE, 2006, PLAST RECONSTR SURG, V117, p261S, DOI 10.1097/01.prs.0000222582.84385.54; Bradbury AW, 2010, J VASC SURG, V51, p52S, DOI 10.1016/j.jvs.2010.01.077; Bradbury AW, 2010, J VASC SURG, V51, p18S, DOI 10.1016/j.jvs.2010.01.074; Houbballah R, 2012, EUR J VASC ENDOVASC, V44, P116, DOI 10.1016/j.ejvs.2012.06.012; Iida O, 2012, EUR J VASC ENDOVASC, V43, P313, DOI 10.1016/j.ejvs.2011.11.025; Lavery L A, 1996, J Foot Ankle Surg, V35, P528; Lepantalo MJA, 2012, EUR J VASC ENDOVASC, V44, P112, DOI 10.1016/j.ejvs.2012.06.011; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Soga Y, 2011, J VASC SURG, V54, P1659, DOI 10.1016/j.jvs.2011.06.024	29	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1708-5381	1708-539X		VASCULAR	Vascular	DEC	2014	22	6					411	420		10.1177/1708538113518204		10	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AT7GI	WOS:000345104400003		
J	Sasayama, M; Benjathummarak, S; Kawashita, N; Rukmanee, P; Sangmukdanun, S; Masrinoul, P; Pitaksajjakul, P; Puiprom, O; Wuthisen, P; Kurosu, T; Chaichana, P; Maneekan, P; Ikuta, K; Ramasoota, P; Okabayashi, T; Singhasivanon, P; Luplertlop, N				Sasayama, Mikiko; Benjathummarak, Surachet; Kawashita, Norihito; Rukmanee, Prasert; Sangmukdanun, Suntaree; Masrinoul, Promsin; Pitaksajjakul, Pannamthip; Puiprom, Orapim; Wuthisen, Pitak; Kurosu, Takeshi; Chaichana, Panjaporn; Maneekan, Pannamas; Ikuta, Kazuyoshi; Ramasoota, Pongrama; Okabayashi, Tamaki; Singhasivanon, Pratap; Luplertlop, Natthanej			Chikungunya virus was isolated in Thailand, 2010	VIRUS GENES			English	Article						Chikungunya virus; Thailand; Virus replication; Genetic variation	AEDES-ALBOPICTUS; INFECTION; EMERGENCE; OUTBREAK; MOSQUITO; AEGYPTI; DISEASE; REGION	Chikungunya fever (CHIKF) is an acute febrile illness caused by a mosquito-borne alphavirus, chikungunya virus (CHIKV). This disease re-emerged in Kenya in 2004, and spread to the countries in and around the Indian Ocean. The re-emerging epidemics rapidly spread to regions like India and Southeast Asia, and it was subsequently identified in Europe in 2007, probably as a result of importation of chikungunya cases. On the one hand, chikungunya is one of the neglected diseases and has only attracted strong attention during large outbreaks. In 2008-2009, there was a major outbreak of chikungunya fever in Thailand, resulting in the highest number of infections in any country in the region. However, no update of CHIKV circulating in Thailand has been published since 2009. In this study, we examined the viral growth kinetics and sequences of the structural genes derived from CHIKV clinical isolates obtained from the serum specimens of CHIKF-suspected patients in Central Thailand in 2010. We identified the CHIKV harboring two mutations E1-A226V and E2-I211T, indicating that the East, Central, and South African lineage of CHIKV was continuously circulating as an indigenous population in Thailand.	[Sasayama, Mikiko; Masrinoul, Promsin; Puiprom, Orapim; Chaichana, Panjaporn; Okabayashi, Tamaki] Mahidol Osaka Ctr Infect Dis, Bangkok 10400, Thailand; [Sasayama, Mikiko; Okabayashi, Tamaki] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Benjathummarak, Surachet; Pitaksajjakul, Pannamthip; Ramasoota, Pongrama] Mahidol Univ, Fac Trop Med, Ctr Excellence Antibody Res, Bangkok 10400, Thailand; [Kawashita, Norihito] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Environm Pharmacometr, Suita, Osaka 5650871, Japan; [Rukmanee, Prasert; Sangmukdanun, Suntaree; Wuthisen, Pitak; Maneekan, Pannamas; Singhasivanon, Pratap; Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok 10400, Thailand; [Kurosu, Takeshi; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 5650871, Japan	Ramasoota, P (reprint author), Mahidol Univ, Fac Trop Med, Ctr Excellence Antibody Res, Bangkok 10400, Thailand.	pongrama.ram@mahidol.ac.th; natthanej.lup@mahidol.ac.th			program of Japan Initiative for Global Research Network on Infectious Diseases by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Faculty of Tropical Medicine, Mahidol University; MEXT of Japan [25860407]	We would like to thank Naokazu Takeda, Surapee Anantapreecha and Yoshiharu Matsuura for their help with this study. This study was supported by the program of Japan Initiative for Global Research Network on Infectious Diseases by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a TropMed Grant and Dean fund year 2010 from the Faculty of Tropical Medicine, Mahidol University, and by a Grant-in-Aid for Young Scientists (B) (No. 25860407) from the MEXT of Japan.	Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002; Rianthavorn P, 2010, INT J INFECT DIS, V14, pE161, DOI 10.1016/j.ijid.2010.01.001; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Centers for disease control and prevention, 2014, CHIK CAR; Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446; Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786; Sreekumar E, 2010, VIRUS GENES, V40, P14, DOI 10.1007/s11262-009-0411-9; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	DEC	2014	49	3					485	489		10.1007/s11262-014-1105-5		5	Genetics & Heredity; Virology	Genetics & Heredity; Virology	AT7CH	WOS:000345093600014		
J	Watanabe, J; Saito, H; Otani, S; Ikeguchi, M				Watanabe, Joji; Saito, Hiroaki; Otani, Shinji; Ikeguchi, Masahide			Maintaining a Surgery Service for Local Hospitals Under the Situation of a Decreasing Number of Surgeons in a Region of Japan	WORLD JOURNAL OF SURGERY			English	Article								The number of surgeons is decreasing in Japan, leading to the problem of how to maintain a surgery service in local hospitals. We introduce our strategy for supporting ongoing surgical services in regional hospitals by dispatching surgeons temporarily to assist in operations. We conducted a questionnaire-based survey at three local hospitals in Tottori and a neighboring prefecture to which surgeons from our department were temporarily dispatched over 5 years from January 2008 to March 2013. We supported 686 operations at three hospitals over 5 years. The average age of the patients was 72.4 years. Of the diseases treated, 45.1 % were malignant, and 54.9 % were benign. The emergency operation rate was 17.3 %. Our strategy has produced a continuous surgical service at local hospitals in the face of diminishing numbers of surgeons. We recommend that such a strategy be adopted in other regions in which there are a decreasing number of surgeons and where it is not easy to move patients elsewhere for care.	[Watanabe, Joji; Saito, Hiroaki; Otani, Shinji; Ikeguchi, Masahide] Tottori Univ Hosp, Div Surg Oncol, Dept Surg, Yonago, Tottori 6838504, Japan	Watanabe, J (reprint author), Tottori Univ Hosp, Div Surg Oncol, Dept Surg, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	watanabe.j@med.tottori-u.ac.jp					American College of Surgeons, 2014, OP GIV BACK; Journal of the American Medical Association, 2014, CAR CTR VOL OPP; Meier D, 2010, WORLD J SURG, V34, P941, DOI 10.1007/s00268-010-0454-z; Morimoto Shinya, 2011, Fukuoka Acta Medica, V102, P267; Nakano T, 2011, NEUROSURG EMERG, V16, P125; Yoshida K, 2011, B SHIMANE U FACULTY, V34, P49	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3063	3066		10.1007/s00268-014-2779-5		4	Surgery	Surgery	AT7GD	WOS:000345103900006		
J	Inada, T; Yoshida, M; Ikeda, M; Yumiba, T; Matsumoto, H; Takagane, A; Kunisaki, C; Fukushima, R; Yabusaki, H; Nakada, K				Inada, Takao; Yoshida, Masashi; Ikeda, Masami; Yumiba, Takeyoshi; Matsumoto, Hideo; Takagane, Akinori; Kunisaki, Chikara; Fukushima, Ryoji; Yabusaki, Hiroshi; Nakada, Koji			Evaluation of QOL After Proximal Gastrectomy Using a Newly Developed Assessment Scale (PGSAS-45)	WORLD JOURNAL OF SURGERY			English	Article							QUALITY-OF-LIFE; QUESTIONNAIRE SURVEY; SYMPTOMS; CANCER; ESOPHAGOGASTROSTOMY; RECONSTRUCTION; PYLOROPLASTY; CARCINOMA; JAPAN	Proximal gastrectomy with esophagogastrostomy (PGEG) has been widely applied as a comparatively simple method. In this study, we used a questionnaire survey to evaluate the influence of various surgical factors on post-operative quality of life (QOL) after PGEG. In this post-gastrectomy syndrome assessment study, we analyzed QOL in 2,368 cases. Among these, 193 had undergone proximal gastrectomy and 115 had undergone PGEG. The Post-Gastrectomy Syndrome Assessment Scale (PGSAS)-45 is a questionnaire consisting of 45 items, including the SF-8, the Gastrointestinal Symptom Rating Scale (GSRS), and other symptom items seemed to be specific to post-gastrectomy. The 23 symptom items were composed of seven symptom subscales (SS), including esophageal reflux, abdominal pain, and meal-related distress. These seven SS, total symptom score, ingested amount of food per meal, necessity for additional meals, quality of ingestion SS, ability to work, dissatisfaction with symptoms, dissatisfaction with the meal, dissatisfaction with working, dissatisfaction with daily life SS and change in body weight were evaluated as main outcome measures. In PGEG cases, we evaluated the influence on QOL of various surgical factors, such as procedures to prevent gastroesophageal regurgitation and size of the remnant stomach. The scores for esophageal reflux and dissatisfaction with the meal were higher in patients who had not undergone an anti-reflux procedure. In most cases, the preserved remnant stomach was more than two-thirds the size of the pre-operative stomach. When comparing patients with a remnant stomach two-thirds the pre-operative size and those with more than three-quarters, the diarrhea SS and necessity for additional meals scores were lower in the group with more than three-quarters. The indigestion, constipation, and abdominal pain subscales, and the total symptom score, were higher in patients who had not undergone pyloric bougie than in those who had. These results indicated that QOL was better in patients with a large remnant stomach. Procedures to prevent gastroesophageal reflux, and the use of pyloric bougie as a complementary drainage procedure, were considered effective ways to reduce the deterioration of QOL.	[Inada, Takao] Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan; [Inada, Takao; Yoshida, Masashi; Ikeda, Masami; Yumiba, Takeyoshi; Matsumoto, Hideo; Takagane, Akinori; Kunisaki, Chikara; Fukushima, Ryoji; Yabusaki, Hiroshi; Nakada, Koji] Japan Postgastrect Syndrome Working Party, Tokyo, Japan; [Yoshida, Masashi] Int Univ Hlth & Welf, Mita Hosp, Ctr Digest Dis, Tokyo, Japan; [Ikeda, Masami] Asama Gen Hosp, Dept Surg, Saku, Japan; [Yumiba, Takeyoshi] Osaka Kosei Nenkin Hosp, Dept Surg, Osaka, Japan; [Matsumoto, Hideo] Kawasaki Med Univ, Dept Digest Surg, Kurashiki, Okayama, Japan; [Takagane, Akinori] Hakodate Goryokaku Hosp, Dept Surg, Hakodate, Hokkaido, Japan; [Kunisaki, Chikara] Yokohama City Univ, Med Ctr, Dept Surg, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Fukushima, Ryoji] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan; [Yabusaki, Hiroshi] Niigata Canc Ctr Hosp, Dept Surg, Niigata, Japan; [Nakada, Koji] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan	Inada, T (reprint author), Tochigi Canc Ctr, Dept Surg, Utsunomiya, Tochigi, Japan.	tinada@tcc.pref.tochigi.lg.jp					Okabayashi T, 2000, CANCER, V89, P2555, DOI 10.1002/1097-0142(20001215)89:12<2555::AID-CNCR6>3.0.CO;2-R; Katai H, 2010, BRIT J SURG, V97, P558, DOI 10.1002/bjs.6944; SALVONHARMAN JC, 1994, ARCH SURG-CHICAGO, V129, P381; Kumagai K, 2012, SURG TODAY, V42, P411, DOI 10.1007/s00595-012-0159-z; Shiraishi N, 2002, WORLD J SURG, V26, P1150, DOI 10.1007/s00268-002-6369-6; Turner-Bowker DM, 2003, QUAL LIFE RES, V12, P1003; Tokunaga M, 2009, LANGENBECK ARCH SURG, V394, P637, DOI 10.1007/s00423-008-0442-z; HAI AA, 1986, INT SURG, V71, P87; Ichikawa D, 2013, LANGENBECK ARCH SURG, V398, P697, DOI 10.1007/s00423-012-0921-0; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kunisaki S, 2005, J AM COLL SURGEONS, V200, P15; Kuwabara Kazuaki, 2012, Case Rep Gastroenterol, V6, P400, DOI 10.1159/000339715; Lei W, 2012, HEPATO-GASTROENTEROL, V59, P633; MATSUSHIRO T, 1986, AM J SURG, V152, P314, DOI 10.1016/0002-9610(86)90265-5; Nakada K, 2013, GASTROENTEROLOGY, V144, pS1111; Nakane Y, 2004, HEPATO-GASTROENTEROL, V51, P1867; Sun YF, 2011, HEPATO-GASTROENTEROL, V58, P669; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Velanovich V, 2003, DIS ESOPHAGUS, V16, P243, DOI 10.1046/j.1442-2050.2003.00337.x; Yamashita Y, 1999, SURG TODAY, V29, P107	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3152	3162		10.1007/s00268-014-2712-y		11	Surgery	Surgery	AT7GD	WOS:000345103900019		
J	Igami, T; Nakamura, Y; Hirose, T; Ebata, T; Yokoyama, Y; Sugawara, G; Mizuno, T; Mori, K; Nagino, M				Igami, Tsuyoshi; Nakamura, Yoshihiko; Hirose, Tomoaki; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Mori, Kensaku; Nagino, Masato			Application of a Three-dimensional Print of a Liver in Hepatectomy for Small Tumors Invisible by Intraoperative Ultrasonography: Preliminary Experience	WORLD JOURNAL OF SURGERY			English	Article							TRANSPLANTATION	Hepatectomy for an invisible small tumor using intraoperative ultrasonography requires technical ingenuity. We used a 3D print of a liver to perform a hepatectomy on two patients with synchronous multiple liver metastases from colorectal cancer. Because of preoperative chemotherapy, one of the tumors became smaller and invisible to ultrasonography in each case. We present our procedure here. Multidetector-row computed tomography images of anatomical structures were digitally segmented using the original software "PLUTO," which was developed at the Graduate School of Information Science, Nagoya University. After converting the final segmentation data to stereolithography files, a 3D printed liver at a 70 % scale was produced. The support material was washed and the mold charge was removed from the 3D-printed hepatic veins. The surface of the 3D-printed model was abraded and coated with urethane resin paint. After air-drying, the 3D-printed hepatic veins were colored by injecting a dye. The 3D printed portal veins were whitish because mold charge remained. All procedures after 3D printing were performed by hand. Hepatectomy for the small tumor that is invisible to intraoperative ultrasonography was performed by referring to a 3D-printed model. The planned resections were successful with histologically negative surgical margins. The application of a 3D-printed liver to perform a hepatectomy for a small tumor that is invisible to intraoperative ultrasonography is an easy and feasible procedure. Use of 3D-printing technology in hepatectomy requires further improvement and automation of hand work after the 3D print has been made.	[Igami, Tsuyoshi; Hirose, Tomoaki; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato] Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nakamura, Yoshihiko; Mori, Kensaku] Nagoya Univ, Informat Strategy Off, Nagoya, Aichi 4668550, Japan; [Mori, Kensaku] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4668550, Japan	Igami, T (reprint author), Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	igami@med.nagoya-u.ac.jp; nagino@med.nagoya-u.ac.jp					Zein NN, 2013, LIVER TRANSPLANT, V19, P1304, DOI 10.1002/lt.23729; Ikegami T, 2013, NAT REV GASTRO HEPAT, V10, P697, DOI 10.1038/nrgastro.2013.195; Lorensen W. E., 1987, P SIGGRAPH 87, V21, P163, DOI DOI 10.1145/37401.37422; Nimura Yukitaka, 2008, Medical Imaging Technology, V26	4	2	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3163	3166		10.1007/s00268-014-2740-7		4	Surgery	Surgery	AT7GD	WOS:000345103900020		
J	Sato, F; Igami, T; Ebata, T; Yokoyama, Y; Sugawara, G; Mizuno, T; Nagino, M				Sato, Fumiya; Igami, Tsuyoshi; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato			A Study of the Right Intersectional Plane (Right Portal Scissura) of the Liver Based on Virtual Left Hepatic Trisectionectomy	WORLD JOURNAL OF SURGERY			English	Article							ADVANCED PERIHILAR CHOLANGIOCARCINOMA; HEPATOBILIARY MALIGNANCY; SEGMENTAL ANATOMY; LEFT-HEPATECTOMY; RESECTION; APPRAISAL; SURGERY; CT	Left hepatic trisectionectomy is a challenging procedure. For an anatomically correct resection, it is necessary to have understanding of the right intersectional plane; however, little is known on this issue. The purpose of this study was to investigate the 3D anatomy of the right intersectional plane and to enable safe and precise left trisectionectomy. A virtual left trisectionectomy was performed using 3D-processing software, in patients who underwent computed tomography. The reconstructed images were reviewed, and attention was paid to the extent of the right hepatic vein (RHV) exposure on the transected plane and the type of the inferior right hepatic vein (IRHV). Of the 200 study patients, 109 (54.5 %) patients showed complete exposure of the RHV on the transected plane, whereas the remaining 91 exhibited partial exposure. In the 109 patients with complete exposure, 58 (53.2 %) patients had no IRHV and the remaining 51 had a small IRHV. None of the patients had a large IRHV. In contrast, of the 91 patients with partial exposure, only 10 (11.0 %) patients had no IRHV, 35 (38.5 %) had a small IRHV, and 46 (50.5 %) patients had a large IRHV. The incidence of IRHV types was significantly different between the two groups (P < 0.001). The RHV does not always run along the right intersectional plane, i.e., the vein is not always fully exposed on the transected plane even after anatomically correct left trisectionectomy. The extent of the RHV exposure is closely related to the type of the IRHV.	[Sato, Fumiya; Igami, Tsuyoshi; Ebata, Tomoki; Yokoyama, Yukihiro; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato] Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, Nagoya, Aichi 4668550, Japan	Nagino, M (reprint author), Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nagino@med.nagoya-u.ac.jp					VANLEEUWEN MS, 1994, AM J ROENTGENOL, V163, P1395; Shindoh J, 2010, ANN SURG, V251, P917, DOI 10.1097/SLA.0b013e3181d773ae; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; Esaki M, 2013, BRIT J SURG, V100, P801, DOI 10.1002/bjs.9099; Takamoto T, 2013, AM J SURG, V206, P530, DOI 10.1016/j.amjsurg.2013.01.041; Ariizumi S, 2013, J HEPATO-BIL-PAN SCI, V20, P396, DOI 10.1007/s00534-012-0573-z; Saito S, 2005, HEPATOLOGY, V41, P1297, DOI 10.1002/hep.20684; Radtke A, 2010, ANN SURG, V252, P876, DOI 10.1097/SLA.0b013e3181fdd012; Mise Y, 2013, J HEPATO-BIL-PAN SCI, V20, P157, DOI 10.1007/s00534-012-0574-y; BISMUTH H, 1982, WORLD J SURG, V6, P3; Natsume S, 2012, ANN SURG, V255, P754, DOI 10.1097/SLA.0b013e31824a8d82; Couinaud C, 1989, SUGICAL ANATOMY LIVE; Lang H, 2006, J AM COLL SURGEONS, V203, P311, DOI 10.1016/j.jamcollsurg.2006.05.290; Nishio H, 2005, ANN SURG, V242, P267, DOI 10.1097/01.sla.0000171304.70678.11; Ohashi I, 1996, RADIOLOGY, V200, P779; Povoski SP, 1999, WORLD J SURG, V23, P1289; STARZL TE, 1982, SURG GYNECOL OBSTET, V155, P21; Vauthey JN, 2004, ANN SURG, V239, P722, DOI 10.1097/01.sia.0000124385.83887.d5	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3181	3185		10.1007/s00268-014-2718-5		5	Surgery	Surgery	AT7GD	WOS:000345103900024		
J	Shimizu, H; Hosokawa, I; Ohtsuka, M; Kato, A; Yoshitomi, H; Miyazaki, M				Shimizu, Hiroaki; Hosokawa, Isamu; Ohtsuka, Masayuki; Kato, Atsushi; Yoshitomi, Hideyuki; Miyazaki, Masaru			Clinical Significance of Anatomical Variant of the Left Hepatic Artery for Perihilar Cholangiocarcinoma Applied to Right-Sided Hepatectomy	WORLD JOURNAL OF SURGERY			English	Article							HILAR CHOLANGIOCARCINOMA; PORTAL-VEIN; LEFT-TRISECTIONECTOMY; SURGICAL ANATOMY; CT ANGIOGRAPHY; RESECTION; LIVER	Full understanding of the hilar anatomy is crucial for successful surgical resection of perihilar cholangiocarcinoma (PHC). The three-dimensional positional relationship between the left hepatic artery (LHA) and the umbilical portion of the left portal vein (UP) was evaluated using multidetector-row computed tomography (CT) in 58 consecutive patients who underwent right-sided hepatectomy for Bismuth-Corlette IIIa or IV tumors. The positional relationship of the LHA related to UP was classified into the following three types: L-UP type, LHA runs into the left lateral section (LLS) from the left caudal side of the UP; R-UP type, LHA runs into the LLS from the right cranial side of the UP; and combined type, one branch of the LHA runs into the LLS from the right cranial side of the UP, and the other from the left caudal side of the UP. L-UP-type LHA was observed in 53 cases (91.4 %), R-UP type in three cases (5.2 %), and combined type in two cases (3.4 %). No cancer involvement of the LHA was seen in any cases with L-UP type. In one case with R-UP type (one of three; 33.3 %) and one case with combined type (one of two, 50 %), cancer invasion to the LHA was observed at the right side of the UP, requiring combined resection of the involved LHA. R-UP-type LHA running just along the left hepatic duct may be easily involved by right-side predominant PHC when extending to the left hepatic duct. Hepatobiliary surgeons should recognize this anatomical variant and carefully evaluate the running courses of LHA to successfully perform R0 resection in right-sided hepatectomy for PHC.	[Shimizu, Hiroaki; Hosokawa, Isamu; Ohtsuka, Masayuki; Kato, Atsushi; Yoshitomi, Hideyuki; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Chiba 2608677, Japan	Shimizu, H (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan.	h-shimizu@faculty.chiba-u.jp					Nagino M, 2006, ANN SURG, V243, P28, DOI 10.1097/01.sla.0000193604.72436.63; Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016; Suda K, 2009, AM J SURG, V197, P752, DOI 10.1016/j.amjsurg.2008.05.007; HIATT JR, 1994, ANN SURG, V220, P50, DOI 10.1097/00000658-199407000-00008; Shimizu H, 2010, ANN SURG, V251, P281, DOI 10.1097/SLA.0b013e3181be0085; Endo I, 2007, SURGERY, V142, P666, DOI 10.1016/j.surg.2007.05.018; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; Boudjema K, 2013, J GASTROINTEST SURG, V17, P1247, DOI 10.1007/s11605-013-2215-4; Hosokawa I, 2014, ANN SURG, V259, P1178, DOI 10.1097/SLA.0000000000000584; Machado MA, 2012, ANN SURG ONCOL, V19, P1324, DOI 10.1245/s10434-011-2072-x; Song SY, 2010, RADIOLOGY, V255, P278, DOI 10.1148/radiol.09090389; Neuhaus P, 2012, ANN SURG ONCOL, V19, P1602, DOI 10.1245/s10434-011-2077-5; Yoshioka Y, 2011, WORLD J SURG, V35, P1340, DOI 10.1007/s00268-011-1075-x; BISMUTH H, 1982, WORLD J SURG, V6, P3; Natsume S, 2012, ANN SURG, V255, P754, DOI 10.1097/SLA.0b013e31824a8d82; Hirano S, 2008, J HEPATOBILIARY PANC, V16, P796; Ibukuro K, 2013, AM J ROENTGENOL, V200, P1160, DOI 10.2214/AJR.12.8918; Nagino M, 2013, ANN SURG, V258, P129, DOI 10.1097/SLA.0b013e3182708b57; Ozden I, 2002, WORLD J SURG, V26, P1441, DOI 10.1007/s00268-002-6544-9; Sakai H, 2005, TRANSPLANT INT, V18, P499, DOI 10.1111/j.1432-2277.2004.00009.x; Seda-Neto J, 2008, TRANSPLANTATION, V86, P697, DOI 10.1097/TP.0b013e318183ed22; Shimizu H, 2009, ANN SURG, V249, P435, DOI 10.1097/SLA.0b013e31819a6c10; Uesaka K, 2012, J HEPATO-BIL-PAN SCI, V19, P195, DOI 10.1007/s00534-011-0474-6	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3210	3214		10.1007/s00268-014-2715-8		5	Surgery	Surgery	AT7GD	WOS:000345103900029		
J	Ito, T; Ebata, T; Yokoyama, Y; Igami, T; Sugawara, G; Mizuno, T; Shimoyama, Y; Nagino, M				Ito, Takaaki; Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Sugawara, Gen; Mizuno, Takashi; Shimoyama, Yoshie; Nagino, Masato			The Pathologic Correlation Between Liver and Portal Vein Invasion in Perihilar Cholangiocarcinoma: Evaluating the Oncologic Rationale for the American Joint Committee on Cancer Definitions of T2 and T3 Tumors	WORLD JOURNAL OF SURGERY			English	Article							HILAR CHOLANGIOCARCINOMA; STAGING SYSTEM; RESECTION; MANAGEMENT; CLASSIFICATION; HEPATECTOMY; OUTCOMES; IMPACT; SPREAD; DEPTH	The American Joint Committee on Cancer (AJCC) has recommended that cancers with liver involvement be graded T2b and those with portal vein involvement be graded T3, although the value of staging as prognostic factors remains unclear. We evaluated the current definition of the T2/3 tumors for perihilar cholangiocarcinoma. A total of 202 patients with perihilar cholangiocarcinoma who underwent hepatectomy without vascular resection were enrolled. Clinicopathologic data about invasion of the liver and the unilateral portal vein were evaluated. The liver and the unilateral portal vein were involved in 100 (49.5 %) and 38 (18.8 %) patients, respectively. The survival rates were not significantly different between patients with and without liver invasion (48.6 vs. 52.2 %, respectively, at 5 years, P = 0.157) and between patients with or without unilateral portal vein invasion (43.2 vs. 52.1 %, respectively, at 5 years, P = 0.363). The survival rate of patients with tumors staged pT2b was not significantly different from the rate of patients with pT2a (63.4 vs. 55.6 % at 5 years, P = 0.912), and the pT2b tumor patient survival rate was better than the rate of patients with pT3 (34.9 % at 5 years, P = 0.011). Using multivariate analysis, nodal metastasis (P = 0.003), positive surgical margin (P = 0.010), and Bismuth type IV tumor (P = 0.039) were identified as independent prognostic factors. The liver and the unilateral portal vein are frequently involved in perihilar cholangiocarcinoma. The determinants of the current AJCC T2/3 tumor classifications are rational; however, subdivision of T2 tumors may be of less clinical value.	[Ito, Takaaki; Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Sugawara, Gen; Mizuno, Takashi; Nagino, Masato] Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Shimoyama, Yoshie] Nagoya Univ, Grad Sch Med, Dept Pathol & Clin Labs, Nagoya, Aichi 4668550, Japan	Nagino, M (reprint author), Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nagino@med.nagoya-u.ac.jp					Matsuo K, 2012, J AM COLL SURGEONS, V215, P343, DOI 10.1016/j.jamcollsurg.2012.05.025; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; BISMUTH H, 1992, ANN SURG, V215, P31; Ebata T, 2009, BRIT J SURG, V96, P926, DOI 10.1002/bjs.6655; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Hemming AW, 2011, J AM COLL SURGEONS, V212, P604, DOI 10.1016/j.jamcollsurg.2010.12.028; de Jong MC, 2011, ARCH SURG-CHICAGO, V146, P697, DOI 10.1001/archsurg.2011.122; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Ito F, 2008, ANN SURG, V248, P273, DOI 10.1097/SLA.0b013e31817f2bfd; Ebata T, 2003, ANN SURG, V238, P720, DOI 10.1097/01.sla.0000094437.68038.a3; DeOliveira ML, 2011, HEPATOLOGY, V53, P1363, DOI 10.1002/hep.24227; Ito F, 2009, ANN SURG, V250, P210, DOI 10.1097/SLA.0b013e3181afe0ab; Ebata T, 2014, BRIT J SURG, V101, P79, DOI 10.1002/bjs.9379; Juntermanns B, 2013, ANN SURG ONCOL, V20, P277, DOI 10.1245/s10434-012-2486-0; de Jong MC, 2012, CANCER-AM CANCER SOC, V118, P4737, DOI 10.1002/cncr.27492; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Ohkubo M, 2004, ANN SURG, V239, P82, DOI 10.1097/01.sla.0000102934.93029.89; Edge SB, 2010, AJCC CANC STAGING MA; Hayashi S, 2008, J HEPATO-BILIARY-PAN, V15, P640, DOI 10.1007/s00534-008-1336-8; Jarnagin W, 2011, J AM COLL SURGEONS, V212, P613; Hong SM, 2009, SURGERY, V146, P250, DOI 10.1016/j.surg.2009.02.023; Japanese Society of Biliary Surgery, 1993, GEN RUL SURG PATH ST; Kawarada Y, 2000, J Hepatobiliary Pancreat Surg, V7, P580, DOI 10.1007/s005340070007; Nakanishi Y, 2009, J HEPATO-BILIARY-PAN, V16, P869, DOI 10.1007/s00534-009-0070-1; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; Sato H, 2013, INT J CLIN EXP PATHO, V6, P318; Wakai T, 2005, CANCER, V103, P1210, DOI 10.1002/cncr.20906	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3215	3221		10.1007/s00268-014-2719-4		7	Surgery	Surgery	AT7GD	WOS:000345103900030		
J	Shigeta, K; Ishii, Y; Hasegawa, H; Okabayashi, K; Kitagawa, Y				Shigeta, Kohei; Ishii, Yoshiyuki; Hasegawa, Hirotoshi; Okabayashi, Koji; Kitagawa, Yuko			Evaluation of 5-Fluorouracil Metabolic Enzymes as Predictors of Response to Adjuvant Chemotherapy Outcomes in Patients with Stage II/III Colorectal Cancer: A Decision-Curve Analysis	WORLD JOURNAL OF SURGERY			English	Article							DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY; THYMIDYLATE SYNTHASE EXPRESSION; III COLON-CANCER; THYMIDINE PHOSPHORYLASE; PROTEIN EXPRESSION; PROGNOSTIC-SIGNIFICANCE; FOLLOW-UP; FLUOROURACIL; LEUCOVORIN; CARCINOMA	The effectiveness of 5-fluorouracil (5-FU)-based adjuvant chemotherapy is reported in patients with colorectal cancer (CRC), but the usefulness of 5-FU metabolic enzymes as predictive biomarkers of the efficacy of this chemotherapy remains unclear. This study aims to verify whether 5-FU metabolic enzymes are predictive biomarkers in the clinical setting of adjuvant chemotherapy for stage II/III CRC. In total, 179 patients with stage II/III CRC who were treated at our institute between 2000 and 2010 were enrolled. Messenger RNA (mRNA) expression of major 5-FU metabolic enzymes, namely thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase (TP), orotate phosphoribosyl transferase, and beta-actin (control) was evaluated using the Danenberg Tumor Profile method. mRNA expression and other clinicopathological data were investigated with regard to CRC relapse. A total of 78 patients underwent surgery alone, while 101 underwent adjuvant chemotherapy (5-FU plus leucovorin [LV] or tegafur plus uracil /LV) following surgery. Relapse-free survival was longer and risk of recurrence was lower in association with high TP mRNA expression than in association with low TP mRNA expression in the adjuvant chemotherapy group (hazard ratio 0.66; 95 % confidence interval 0.47-0.92; p = 0.016), but not in the surgery alone group. mRNA expression of no other enzymes was associated with relapse in both groups. In decision-curve analyses, the predictive efficiency of TP mRNA expression plus clinicopathological factors was slightly better than that of clinicopathological factors only. TP mRNA expression in tumors predicted the effects of adjuvant chemotherapy for stage II/III CRC, although the beneficial effects were marginal.	[Shigeta, Kohei; Hasegawa, Hirotoshi; Okabayashi, Koji; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Ishii, Yoshiyuki] Kitasato Univ, Kitasato Inst Hosp, Dept Digest Surg, Minato Ku, Tokyo 1088642, Japan	Ishii, Y (reprint author), Kitasato Univ, Kitasato Inst Hosp, Dept Digest Surg, Minato Ku, 9-1 Shirokane 5 Chome, Tokyo 1088642, Japan.	ohlkoh@gmail.com; yishii@insti.kitasato-u.ac.jp		Shigeta, Kohei/0000-0003-1596-4200			Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Punt CJA, 2004, ANN ONCOL, V15, P1453, DOI 10.1093/annonc/mdh383; DIASIO RB, 1994, J CLIN ONCOL, V12, P2239; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Lenz HJ, 1998, CLIN CANCER RES, V4, P1243; Soong R, 2008, ANN ONCOL, V19, P915, DOI 10.1093/annonc/mdm599; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc.1074; Twelves C, 2005, NEW ENGL J MED, V352, P2696, DOI 10.1056/NEJMoa043116; Labianca R, 2010, ANN ONCOL, V21, pv70, DOI 10.1093/annonc/mdq168; SCHEITHAUER W, 1993, BRIT MED J, V306, P752; van Triest B, 2000, CLIN CANCER RES, V6, P1063; Ichikawa W, 2003, BRIT J CANCER, V89, P1486, DOI 10.1038/sj.bjc.6601335; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; Boskos CS, 2010, J SURG ONCOL, V102, P408, DOI 10.1002/jso.21423; Cascinu S, 1999, CLIN CANCER RES, V5, P1996; Donada M, 2011, J CANCER RES CLIN, V137, P201, DOI 10.1007/s00432-010-0872-1; Hobday Timothy J, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS11, DOI 10.3816/CCC.2005.s.002; Ikeguchi M, 2002, LANGENBECK ARCH SURG, V387, P240, DOI 10.1007/s00423-002-0313-y; Jensen SA, 2008, ACTA ONCOL, V47, P1054, DOI 10.1080/02841860801942158; Kumamoto K, 2012, ONCOL LETT, V3, P983, DOI 10.3892/ol.2012.598; Lassmann S, 2006, INT J COLORECTAL DIS, V21, P238, DOI 10.1007/s00384-005-0767-9; Leichman CG, 1997, J CLIN ONCOL, V15, P3223; Lokich J, 1998, ONCOLOGY-NY, V12, P19; Mayer RJ, 2000, NEW ENGL J MED, V343, P963, DOI 10.1056/NEJM200009283431309; Nii A, 2009, HEPATOL RES, V39, P274, DOI 10.1111/j.1872-034X.2008.00457.x; Oka H, 2006, MUTAT RES-GEN TOX EN, V606, P52, DOI 10.1016/j.mrgentox.2006.02.001; Paradiso A, 2000, BRIT J CANCER, V82, P560, DOI 10.1054/bjoc.1999.0964; Ruckhaberle E, 2010, EUR J CANCER, V46, P549, DOI 10.1016/j.ejca.2009.11.020; Sadahiro S, 2012, CANCER CHEMOTH PHARM, V70, P285, DOI 10.1007/s00280-012-1909-8; Tokunaga Y, 2007, SURGERY, V141, P346, DOI 10.1016/j.surg.2006.06.025; Vignoli M, 2011, PHARMACOL RES, V64, P242, DOI 10.1016/j.phrs.2011.04.006; Westra JL, 2005, ANN ONCOL, V16, P1646, DOI 10.1093/annonc/mdi316; Yamada H, 2008, ONCOL REP, V19, P729	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3248	3256		10.1007/s00268-014-2738-1		9	Surgery	Surgery	AT7GD	WOS:000345103900034		
J	Shinto, E; Tsuda, H; Ueno, H; Shimazaki, H; Yamamoto, J; Hase, K				Shinto, Eiji; Tsuda, Hitoshi; Ueno, Hideki; Shimazaki, Hideyuki; Yamamoto, Junji; Hase, Kazuo			Prognostic Value of the Number and Size of Venous Invasions in pT3 Colorectal Cancer: A Prospective Observational Study	WORLD JOURNAL OF SURGERY			English	Article							BLOOD-VESSEL INVASION; CLINICAL-SIGNIFICANCE; STEM-CELLS; PERIPHERAL-BLOOD; COLON-CANCER; TUMOR-CELLS; CARCINOMA; SURVIVAL	Although venous invasion is reportedly a clinically useful prognostic marker for colorectal cancer, suitable grading criteria have not been established. This prospective observational study aimed to investigate the prognostic value of the number and size of venous invasions in patients with pT3 colorectal cancer. We recruited 139 consecutive patients with pT3 colorectal carcinomas resected between October 2001 and August 2003. We used slides of whole-tissue sections stained with Elastica van Gieson. Venous invasion was classified according to the number of veins with carcinoma infiltration per slide with most venous invasions (V-number classification): V(n)-low 0-3 and V(n)-high a parts per thousand yen4. Additionally, the findings were classified according to the maximal size of veins containing carcinoma infiltration (V-size classification): V(s)-low < 1 mm and V(s)-high a parts per thousand yen1 mm. The grades of venous invasions were evaluated just after surgery. The 5-year survival rate of V(n)-low and V(n)-high were 89.9 and 59.1 %, respectively (p < 0.0001). Comparisons between overall survival curves revealed that V-number classification (but not V-size classification) had a significant prognostic value in patients with pT3 cancer, especially in stage II patients (98.2 and 64.2 %, respectively; p < 0.0001). Multivariate analysis revealed distant metastasis, age, and V-number classification (hazard ratio 3.1; p = 0.0071) as independent prognostic indicators. V-number classification may be a useful prognostic system when evaluating and sub-grouping patients with pT3 colorectal cancer.	[Shinto, Eiji; Ueno, Hideki; Yamamoto, Junji; Hase, Kazuo] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Pathol, Tokorozawa, Saitama 3598513, Japan; [Shimazaki, Hideyuki] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 3598513, Japan	Shinto, E (reprint author), Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	eiji-c@zf6.so-net.ne.jp			National Cancer Center Research and Development Fund [23-A-11, 23-A-26]; Japan Society for the Promotion of Science KAKENHI [23501302, 25462074, 26462032]	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-11 and 23-A-26) and by the Japan Society for the Promotion of Science KAKENHI (23501302, 25462074, and 26462032).	Willis ND, 2008, J ANAT, V213, P59, DOI 10.1111/j.1469-7580.2008.00917.x; Ouchi K, 1996, CANCER, V78, P2313, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2313::AID-CNCR7>3.0.CO;2-N; Iinuma H, 2011, J CLIN ONCOL, V29, P1547, DOI 10.1200/JCO.2010.30.5151; KRASNA MJ, 1988, CANCER, V61, P1018, DOI 10.1002/1097-0142(19880301)61:5<1018::AID-CNCR2820610527>3.0.CO;2-H; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; van Wyk HC, 2014, CRIT REV ONCOL HEMAT, V90, P77, DOI 10.1016/j.critrevonc.2013.11.004; Betge J, 2012, CANCER-AM CANCER SOC, V118, P628, DOI 10.1002/cncr.26310; Petersen VC, 2002, GUT, V51, P65, DOI 10.1136/gut.51.1.65; Iinuma H, 2006, INT J ONCOL, V28, P297; TALBOT IC, 1980, BRIT J SURG, V67, P439, DOI 10.1002/bjs.1800670619; Bugg WG, 2014, CLIN RADIOL, V69, P619, DOI 10.1016/j.crad.2014.01.010; MINSKY BD, 1988, J CLIN ONCOL, V6, P119; Chafai N, 2005, COLORECTAL DIS, V7, P176, DOI 10.1111/j.1463-1318.2004.00744.x; Japanese Society for Cancer of Colon and Rectum, 2009, JAP CLASS COL CARC, P27; Sato T, 2006, JPN J GASTROENTEROL, V39, P1571; Sato T, 2010, AM J SURG PATHOL, V34, P454, DOI 10.1097/PAS.0b013e3181d296ef; Sobin LH, 2009, TNM CLASSIFICATION M; Sternberg A, 2006, J CLIN PATHOL, V59, P207, DOI 10.1136/jcp.2004.023333; Yeung TM, 2009, DIS COLON RECTUM, V52, P1788, DOI 10.1007/DCR.0b013e3181a8738c	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	DEC	2014	38	12					3257	3264		10.1007/s00268-014-2734-5		8	Surgery	Surgery	AT7GD	WOS:000345103900035		
J	Saleh, AA; Hayashi, K; Ijiri, D; Ohtsuka, A				Saleh, A. A.; Hayashi, K.; Ijiri, D.; Ohtsuka, A.			Beneficial effects of Aspergillus awamori in broiler nutrition	WORLDS POULTRY SCIENCE JOURNAL			English	Article						Aspergillus awamori; growth performance; fatty acids; digestibility; broiler	DISTILLERY BY-PRODUCT; FATTY-ACID PROFILE; DIETARY SUPPLEMENTATION; GROWTH-PERFORMANCE; PROTEIN-DEGRADATION; PROBIOTIC SUPPLEMENTATION; OXIDATIVE STABILITY; ALPHA-TOCOPHEROL; MUSCLE ATROPHY; VITAMIN-E	Since January 2006, the use of antibiotics for domestic animals as feed additives has been banned within the European Union, influenced by the consumers' demands for products free of antimicrobial residues. As an alternative, probiotics in animal nutrition have attracted attention for their potential roles as growth promoters as well as antibiotics. Recently, much research data has been gathered and suggests a potential role for probiotics from fungi as natural growth promoters in broiler nutrition. One such fungi, Aspergillus awamori, has been shown to improve the growth performance and meat quality of broiler chickens. This review examines the current scientific data on the use of A. awamori as a probiotic in broiler nutrition. From the available literature, it can be concluded that A. awamori may provide an effective alternative to antibiotics in the production of broilers.	[Saleh, A. A.] Kafrelsheikh Univ, Dept Poultry Prod, Fac Agr, Kafr Al Sheikh 333516, Egypt; [Hayashi, K.] Biogenkoji Res Inst, Kirishima 8996404, Japan; [Saleh, A. A.; Ijiri, D.; Ohtsuka, A.] Kagoshima Univ, Dept Biochem Sci & Technol, Fac Agr, Kagoshima 8900065, Japan	Ohtsuka, A (reprint author), Kagoshima Univ, Dept Biochem Sci & Technol, Fac Agr, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	ohtsuka@chem.agri.kagoshima-u.ac.jp					Al-Kassie G. A. M., 2008, International Journal of Poultry Science, V7, P1182; AMSAL A., 1999, FOOD SCI TECHNOL RES, V5, P153, DOI DOI 10.3136/FSTR.5.153; Gracia MI, 2003, POULTRY SCI, V82, P436; MOHAN B, 1995, BRIT POULTRY SCI, V36, P799, DOI 10.1080/00071669508417824; Simopoulos AP, 2000, POULTRY SCI, V79, P961; SUZUKI K, 1995, BIOL CHEM H-S, V376, P523; ENDO A, 1985, J MED CHEM, V28, P401, DOI 10.1021/jm00382a001; Brigelius-Flohe R, 1999, FASEB J, V13, P1145; Ohtsuka A, 2011, J POULT SCI, V48, P92, DOI 10.2141/jpsa.010093; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Maraschiello C, 1999, J AGR FOOD CHEM, V47, P867, DOI 10.1021/jf980824o; Verstegen MWA, 2002, ANIM BIOTECHNOL, V13, P113, DOI 10.1081/ABIO-120005774; Botsoglou NA, 1997, J AGR FOOD CHEM, V45, P3711, DOI 10.1021/jf9703009; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; STUTZ MW, 1984, POULTRY SCI, V63, P2036; Patterson JA, 2003, POULTRY SCI, V82, P627; Panda Arun K., 2006, Journal of Poultry Science, V43, P235, DOI 10.2141/jpsa.43.235; Khan RU, 2011, WORLD POULTRY SCI J, V67, P297, DOI 10.1017/S0043933911000316; Mersmann HJ, 1998, J ANIM SCI, V76, P1396; Smith IJ, 2007, EXP PHYSIOL, V92, P561, DOI 10.1113/expphysiol.2006.035790; Okada S, 1996, PATHOL INT, V46, P311, DOI 10.1111/j.1440-1827.1996.tb03617.x; [Anonymous], 1991, J CHEM SOC CHEM COMM; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Hong KJ, 2004, J MED FOOD, V7, P430, DOI 10.1089/jmf.2004.7.430; Betti M, 2009, POULTRY SCI, V88, P1740, DOI 10.3382/ps.2008-00449; Bhat MK, 2001, ENZYMES FARM ANIMAL, P11; Bibel DJ, 1988, ASM NEWS, V54, P661; Chang GB, 2011, J ANIM VET ADV, V10, P1785, DOI 10.3923/javaa.2011.1785.1788; El-Deep MH, 2014, J POULT SCI, V51, P281, DOI 10.2141/jpsa.0130154; Garcia-Maroto F, 2002, LIPIDS, V37, P417, DOI 10.1007/s1145-002-0910-6; Hajjaj H, 2005, FEMS MICROBIOL LETT, V242, P155, DOI 10.1016/j.femsle.2004.11.001; Jin LZ, 1997, WORLD POULTRY SCI J, V53, P351, DOI 10.1079/WPS19970028; Kamizono T, 2010, BIOSCI BIOTECH BIOCH, V74, P92, DOI 10.1271/bbb.90587; Kamizono T, 2013, J POULT SCI, V50, P37, DOI 10.2141/jpsa.0120063; Kim S. H., 2003, Korean Journal of Poultry Science, V30, P151; MADHAVI D.L., 2005, FOOD ANTIOXIDANTS TE, P159; MOHAMED A.B., 2011, RES OPINIONS ANIMAL, V1, P279; Mohan B, 1996, BRIT POULTRY SCI, V37, P395, DOI 10.1080/00071669608417870; Morrissey PA, 1997, BRIT POULTRY SCI, V38, P84, DOI 10.1080/00071669708417945; Ohtsuka A, 1998, J NUTR SCI VITAMINOL, V44, P237; Piray A. H., 2008, Journal of Biological Sciences, V8, P818; RICHARD A., 2004, MICROBIOLOGY, V150, P2881; SAFALAOH A.C.L., 2006, AFRICAN J FOOD AGR N, V6, P1; Sahin T, 2008, J ANIM VET ADV, V7, P1370; Saleh AA, 2012, ANIM SCI J, V83, P594, DOI 10.1111/j.1740-0929.2011.00999.x; Saleh AA, 2013, J POULT SCI, V50, P242, DOI 10.2141/jpsa.0120153; Saleh AA, 2013, BIOMED RES INT, DOI 10.1155/2013/594393; Saleh AA, 2012, BRIT J NUTR, V108, P1596, DOI 10.1017/S0007114511007069; Saleh AA, 2011, J POULT SCI, V48, P201, DOI 10.2141/jpsa.011019; Saleh F, 2005, BRIT POULTRY SCI, V46, P602, DOI 10.1080/00071660500255661; SALLH N.R., 2009, IRAQI J VET SCI, V23, P239; SHEN T., 1991, BIOCHEMISTRY; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; Srianta I., 2010, Asian Journal of Food and Agro-Industry, V3, P293; Thongsong B, 2008, THAI J VET MED, V38, P17; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Yamamoto Masahiro, 2007, Journal of Poultry Science, V44, P291, DOI 10.2141/jpsa.44.291; YOON C., 2004, KOREAN J POULTRY SCI, V3, P229	61	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0043-9339	1743-4777		WORLD POULTRY SCI J	Worlds Poult. Sci. J.	DEC	2014	70	4					857	864		10.1017/S0043933914000907		8	Agriculture, Dairy & Animal Science	Agriculture	AT8EU	WOS:000345167600014		
J	Takubo, H; Ishikawa, T; Kuhlmann, O; Nemoto, H; Noguchi, T; Nanayama, T; Komura, H; Kogayu, M				Takubo, Hiroaki; Ishikawa, Tomohiro; Kuhlmann, Olaf; Nemoto, Hiroyuki; Noguchi, Tomoyuki; Nanayama, Toyomichi; Komura, Hiroshi; Kogayu, Motohiro			Pharmacokinetics and disposition of dalcetrapib in rats and monkeys	XENOBIOTICA			English	Article						CETP; covalent binding; JTT-705; metabolites; mixed disulfide; RO4607381; thioester	ESTER TRANSFER PROTEIN; AVERAGE CHOLESTEROL LEVELS; CORONARY EVENTS; IN-VITRO; PRAVASTATIN; PREVENTION; INHIBITOR; THIOL; MEN	1. The pharmacokinetics and metabolism of dalcetrapib (JTT-705/RO4607381), a novel cholesteryl ester transfer protein inhibitor, were investigated in rats and monkeys. 2. In in vitro stability studies, dalcetrapib was extremely unstable in plasma, liver S9 and small intestinal mucosa, and the pharmacologically active form (dalcetrapib thiol) was detected as major component. Most of the active form in plasma was covalently bound to plasma proteins via mixed disulfide bond formation. 3. Following oral administration of C-14-dalcetrapib to rats and monkeys, active form was detected in plasma. The active form was mainly metabolized to the glucuronide conjugate and the methyl conjugate at the thiol group. Several minor metabolites including mono- and di-oxidized forms of the glucuronide are also detected in the plasma and urine. 4. The administered radioactivity was widely distributed to all tissues and mainly excreted into the feces (85.7 and 62.7% of the dose in rats and monkeys, respectively). Most of the radioactivity was recovered by 168 h. Although the absorbed dalcetrapib was hydrolyzed to the active form and was bound to endogenous thiol via formation of disulfide bond, it was relatively rapidly eliminated from the body and was not retained.	[Takubo, Hiroaki; Nanayama, Toyomichi; Komura, Hiroshi; Kogayu, Motohiro] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Drug Metab & Pharmacokinet Res Labs, Osaka, Japan; [Ishikawa, Tomohiro] Japan Tobacco Inc, Div Pharmaceut, Clin Res Planning Dept, Tokyo, Japan; [Kuhlmann, Olaf] F Hoffmann La Roche Ltd, Nonclin Drug Safety Pharma Res & Early Dev, Basel, Switzerland; [Nemoto, Hiroyuki; Noguchi, Tomoyuki] Sekisui Med Co Ltd, Tokyo, Japan	Takubo, H (reprint author), Japan Tobacco Inc, Cent Pharmaceut Res Inst, 1-1 Murasaki Cho, Takatsuki, Osaka 5691125, Japan.	hiroaki.takubo@jt.com					SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; TALL AR, 1993, J LIPID RES, V34, P1255; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Bentley D, 2012, J CARDIOVASC PHARM, V60, P390, DOI 10.1097/FJC.0b013e31826731ff; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; Derks M, 2009, CLIN THER, V31, P586, DOI 10.1016/j.clinthera.2009.02.011; Derks M, 2010, CLIN PHARMACOL THER, V87, pP1; Gross G, 2012, INT J PHARMACEUT, V437, P103, DOI 10.1016/j.ijpharm.2012.07.071; Heinig K, 2012, J PHARMACEUT BIOMED, V66, P314, DOI 10.1016/j.jpba.2012.03.056; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Kuhlmann O, 2011, XENOBIOTICA, V41, P430, DOI 10.3109/00498254.2010.551223; LAGROST L, 1994, BBA-LIPID LIPID MET, V1215, P209, DOI 10.1016/0005-2760(94)90047-7; PARK BK, 1982, BIOCHEM PHARMACOL, V31, P1755, DOI 10.1016/0006-2952(82)90680-3; Phelan M, 2013, CLIN PHARMACOKINET, V52, P255, DOI 10.1007/s40262-013-0035-z; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHIMADA K, 1994, J CHROMATOGR B, V659, P227, DOI 10.1016/0378-4347(93)E0444-U	19	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	DEC	2014	44	12					1117	1126		10.3109/00498254.2014.932471		10	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AT3XJ	WOS:000344867400007		
J	Haraya, K; Tachibana, T; Nanami, M; Ishigai, M				Haraya, Kenta; Tachibana, Tatsuhiko; Nanami, Masahiko; Ishigai, Masaki			Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody	XENOBIOTICA			English	Article						FcRn; monoclonal antibody; preclinical pharmacokinetic screening; transgenic mice	ENDOTHELIAL GROWTH-FACTOR; ADVANCED SOLID TUMORS; POPULATION PHARMACOKINETICS; THERAPEUTIC ANTIBODIES; CYNOMOLGUS MONKEYS; RHEUMATOID-ARTHRITIS; HEALTHY-VOLUNTEERS; FUSION PROTEIN; HUMAN IGG1; HALF-LIFE	1. For drug discovery, useful screening tools are essential to select superior candidates. Here, we evaluated the applicability of transgenic mice expressing human neonatal Fc receptor (FcRn) (hFcRn Tgm) as a pharmacokinetic screening tool of therapeutic monoclonal antibodies (mAbs) and Fc-fusion proteins that overcomes the species difference in FcRn binding. 2. Marketed 11 mAbs and 2 Fc-fusion proteins were intravenously administered to hFcRn Tgm and WT mice. The half-lives in hFcRn Tgm and WT mice were compared with those in human obtained from literature. The linear half-lives in human and monkey were also calculated by nonlinear pharmacokinetic analysis. For comparison, correlations of half-lives between monkey and human were also evaluated. 3. The half-lives of mAbs and Fc-fusion proteins after intravenous administration ranged from 1.1 to 13.2 days in hFcRn Tgm and from 1.2 to 30.3 days in WT mice. The half-lives in human correlated more closely with those in hFcRn Tgm than in WT mice and monkey. 4. Our results suggest that hFcRn Tgm are a valuable and useful tool for pharmacokinetic screening of mAbs and Fc-fusion proteins in the preclinical stage. Furthermore, we believe that hFcRn Tgm are broadly applicable to preclinical pharmacokinetic screening of mAbs-based therapeutics.	[Haraya, Kenta; Tachibana, Tatsuhiko] Chugai Pharmabody Res Pte Ltd, Singapore 138623, Singapore; [Haraya, Kenta; Tachibana, Tatsuhiko; Nanami, Masahiko; Ishigai, Masaki] Chugai Pharmaceut Co Ltd, Div Res, Gotemba, Shizuoka, Japan	Haraya, K (reprint author), Chugai Pharmabody Res Pte Ltd, 3 Biopolis Dr,04-11 to 17, Singapore 138623, Singapore.	haraya.k@chugai-pharmabody.com					Amano J, 2010, DRUG METAB DISPOS, V38, P2339, DOI 10.1124/dmd.110.035709; Mori K, 2007, CYTOTECHNOLOGY, V55, P109, DOI 10.1007/s10616-007-9103-2; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Bumbaca D, 2011, MABS-AUSTIN, V3, P376, DOI 10.4161/mabs.3.4.15786; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Korth-Bradley JM, 2000, ANN PHARMACOTHER, V34, P161; Betts AM, 2010, J PHARMACOL EXP THER, V333, P2, DOI 10.1124/jpet.109.164129; Klotz U, 2007, CLIN PHARMACOKINET, V46, P645, DOI 10.2165/00003088-200746080-00002; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Black RS, 2010, ALZ DIS ASSOC DIS, V24, P198, DOI 10.1097/WAD.0b013e3181c53b00; Nishimoto N, 2003, J RHEUMATOL, V30, P1426; Doi T, 2009, INT J CLIN ONCOL, V14, P307, DOI 10.1007/s10147-008-0855-2; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; RODEWALD R, 1973, J CELL BIOL, V58, P189, DOI 10.1083/jcb.58.1.189; Dong JQ, 2011, CLIN PHARMACOKINET, V50, P131, DOI 10.2165/11537430-000000000-00000; Rojas JR, 2005, J PHARMACOL EXP THER, V313, P578, DOI 10.1124/jpet.104.079277; Yu M, 2012, MABS-AUSTIN, V4, P475, DOI 10.4161/mabs.20737; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Stein C, 2012, MAMM GENOME, V23, P259, DOI 10.1007/s00335-011-9379-6; Herbst RS, 2005, J CLIN ONCOL, V23, P2544, DOI 10.1200/JCO.2005.02.477; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Ling J, 2009, J CLIN PHARMACOL, V49, P1382, DOI 10.1177/0091270009337134; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Deng R, 2011, MABS-AUSTIN, V3, P61, DOI 10.4161/mabs.3.1.13799; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; MCMAHON FG, 1990, BLOOD, V76, P1718; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Luu KT, 2012, J PHARMACOL EXP THER, V341, P702, DOI 10.1124/jpet.112.191999; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Hayashi N, 2007, BRIT J CLIN PHARMACO, V63, P548, DOI 10.1111/j.1365-2125.2006.02803.x; Saez-Llorens X, 2004, PEDIATR INFECT DIS J, V23, P707, DOI 10.1097/01.inf.0000133165.85909.08; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; Ma PM, 2009, J CLIN PHARMACOL, V49, P1142, DOI 10.1177/0091270009344989; Richter WF, 2012, AAPS J, V14, P559, DOI 10.1208/s12248-012-9367-0; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Bernett MJ, 2013, MABS-AUSTIN, V5, P384, DOI 10.4161/mabs.23976; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Lopez EL, 2010, ANTIMICROB AGENTS CH, V54, P239, DOI 10.1128/AAC.00343-09; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Ng CM, 2006, PHARM RES, V23, P95, DOI 10.1007/s11095-005-8814-3; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Karmiris K, 2009, GASTROENTEROLOGY, V137, P1628, DOI 10.1053/j.gastro.2009.07.062; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Ma Y, 2009, ACTA PHARMACOL SIN, V30, P364, DOI 10.1038/aps.2009.13; Israel EJ, 1997, IMMUNOLOGY, V92, P69, DOI 10.1046/j.1365-2567.1997.00326.x; BELLDEGRIN A, 1980, BIOMED EXPRESS, V33, P8; Roopenian DC, 2010, METHODS MOL BIOL, V602, P93, DOI 10.1007/978-1-60761-058-8_6; Israel EJ, 1996, IMMUNOLOGY, V89, P573, DOI 10.1046/j.1365-2567.1996.d01-775.x; Vugmeyster Y, 2011, PHARM RES-DORDR, V28, P1696, DOI 10.1007/s11095-011-0405-x; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; Zhou HH, 2007, J CLIN PHARMACOL, V47, P383, DOI 10.1177/0091270006298188; Stephenson JJ, 2009, CLIN COLORECTAL CANC, V8, P29, DOI 10.3816/CCC.2009.n.005; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; Bauer RJ, 1999, J PHARMACOKINET BIOP, V27, P397, DOI 10.1023/A:1020917122093; Cosson VF, 2014, CANCER CHEMOTH PHARM, V73, P737, DOI 10.1007/s00280-014-2400-5; Gibiansky Leonid, 2012, Clin Pharmacokinet, V51, P247, DOI 10.2165/11598090-000000000-00000; Hernandez-Bernal F, 2005, BIOPHARM DRUG DISPOS, V26, P151, DOI 10.1002/bdd.445; Kloft C, 2004, INVEST NEW DRUG, V22, P39, DOI 10.1023/B:DRUG.0000006173.72210.1c; Kumagai Y, 2011, BONE, V49, P1101, DOI 10.1016/j.bone.2011.08.007; Lee JH, 2013, BIOLOGICALS, V41, P77, DOI 10.1016/j.biologicals.2012.09.001; Marathe A, 2008, J PHARMACOL EXP THER, V326, P555, DOI 10.1124/jpet.108.137703; Mould DR, 2007, BRIT J CLIN PHARMACO, V64, P278, DOI 10.1111/j.1365-2125.2007.02914.x; PMDA, 2009, XOL INF NEW DRUG APP; PMDA, 2011, STEL INF NEW DRUG AP; PMDA, 2011, SIMP INF NEW DRUG AP; PMDA, 2012, RANM INF NEW DRUG AP; PMDA, 2005, ACT INF NEW DRUG APP; PMDA, 2001, HERC INF NEW DRUG AP; PMDA, 2002, SYN INF NEW DRUG APP; Tam SH, 2013, MABS-AUSTIN, V5, P397, DOI 10.4161/mabs.23836; Tanaka T, 1999, ENDOCR J, V46, P605, DOI 10.1507/endocrj.46.605; Tobinai K, 1998, ANN ONCOL, V9, P527, DOI 10.1023/A:1008265313133; Tokuda Y, 1999, BRIT J CANCER, V81, P1419, DOI 10.1038/sj.bjc.6690343; Vaidyanathan A, 2011, TOXICOL SCI, V119, P116, DOI 10.1093/toxsci/kfq316	83	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	DEC	2014	44	12					1127	1134		10.3109/00498254.2014.941963		8	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AT3XJ	WOS:000344867400008		
J	Umeyama, Y; Fujioka, Y; Okuda, T				Umeyama, Yukari; Fujioka, Yasushi; Okuda, Teruaki			Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information	XENOBIOTICA			English	Article						CYP3A; drug-drug interaction; P-glycoprotein	RENAL-TRANSPLANT RECIPIENTS; CYTOCHROME P4503A CYP3A; HIV PROTEASE INHIBITORS; BLOOD-BRAIN-BARRIER; HEALTHY-VOLUNTEERS; PLASMA-CONCENTRATIONS; ORAL BIOAVAILABILITY; PHARMACOKINETIC INTERACTIONS; GRAPEFRUIT JUICE; CYCLOSPORINE-A	1. Recently, the Food and Drug Administration (FDA) and European Medicines Agency have shown decision trees to determine whether a drug candidate is an inhibitor of P-glycoprotein (P-gp). However, there has been no clear information on whether P-gp inhibition can be significant in clinical drug-drug interactions (DDIs). The purpose of this study was to confirm the effect of P-gp inhibition through comprehensive analysis of the clinical DDI studies. 2. Clinical information on P-gp inhibition was collected using the University of Washington Metabolism and Transport Drug Interaction Database (TM). The risks of P-gp inhibition-related DDI were qualitatively evaluated in terms of the contribution of CYP3A inhibition. The degrees of DDI risk were categorized using the area under the plasma concentration-time curve increase ratio (AUCR), according to the FDA DDI criteria. 3. When both P-gp and CYP3A were inhibited, the DDI risks were potent in 25% of the studies. When CYP3A inhibition did not contribute to the DDI, no study was categorized as potent DDI risk, and the detailed analysis revealed that AUCRs were basically <3.0. The DDI risk caused by P-gp inhibition solely would be limited, although the use of P-gp substrates with narrow therapeutic range should be carefully controlled.	[Umeyama, Yukari; Fujioka, Yasushi; Okuda, Teruaki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, Fujisawa, Kanagawa 2518555, Japan	Umeyama, Y (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Drug Metab & Pharmacokinet Res Labs, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	yukari.umeyama@takeda.com					Alffenaar JWC, 2010, ANTIMICROB AGENTS CH, V54, P3878, DOI 10.1128/AAC.00099-10; Lee J, 2013, CLIN DRUG INVEST, V33, P429, DOI 10.1007/s40261-013-0084-y; Wind S, 2014, CLIN DRUG INVEST, V34, P173, DOI 10.1007/s40261-013-0161-2; Reitman ML, 2011, CLIN PHARMACOL THER, V89, P234, DOI 10.1038/clpt.2010.271; Kovarik JM, 1999, CLIN PHARMACOL THER, V66, P391, DOI 10.1053/cp.1999.v66.a101462; Kharasch ED, 2008, CLIN PHARMACOL THER, V84, P506, DOI 10.1038/clpt.2008.102; Potter JM, 2004, THER DRUG MONIT, V26, P408, DOI 10.1097/00007691-200408000-00011; Tateishi T, 2008, BRIT J CLIN PHARMACO, V65, P693, DOI 10.1111/j.1365-2125.2008.03116.x; Gurley BJ, 2006, DRUG METAB DISPOS, V34, P69, DOI 10.1124/dmd.105.006312; Kharasch ED, 2003, CLIN PHARMACOL THER, V74, P543, DOI 10.1016/j.clpt.2003.08.011; Kharasch ED, 2012, ANESTHESIOLOGY, V116, P432, DOI 10.1097/ALN.0b013e3182423478; Annaert P, 2010, XENOBIOTICA, V40, P163, DOI 10.3109/00498250903509375; Smith DA, 2009, BRIT J CLIN PHARMACO, V67, P421, DOI 10.1111/j.1365-2125.2009.03370.x; Shimizu M, 2006, BRIT J CLIN PHARMACO, V61, P538, DOI 10.1111/j.1365-2125.2006.02613.x; Sansone-Parsons A, 2007, PHARMACOTHERAPY, V27, P825, DOI 10.1592/phco.27.6.825; Mendell J, 2013, AM J CARDIOVASC DRUG, V13, P331, DOI 10.1007/s40256-013-0029-0; Kusuhara H, 2013, DRUG METAB DISPOS, V41, P206, DOI 10.1124/dmd.112.048330; Terkeltaub RA, 2011, ARTHRITIS RHEUM-US, V63, P2226, DOI 10.1002/art.30389; Rengelshausen J, 2003, BRIT J CLIN PHARMACO, V56, P32, DOI 10.1046/j.1365-2125.2003.01824.x; Shon JH, 2005, CLIN PHARMACOL THER, V78, P191, DOI 10.1016/j.clpt.2005.04.012; Croft M, 2012, CLIN PHARMACOKINET, V51, P237, DOI 10.2165/11597070-000000000-00000; Tsuruoka S, 2006, CLIN PHARMACOL THER, V79, P389, DOI 10.1016/j.clpt.2005.12.302; Siedlik PH, 1999, J CLIN PHARMACOL, V39, P501; Yoshizato T, 2012, EUR J CLIN PHARMACOL, V68, P1287, DOI 10.1007/s00228-012-1258-x; Amsden GW, 2000, J CLIN PHARMACOL, V40, P1522; Jalava KM, 1997, THER DRUG MONIT, V19, P609, DOI 10.1097/00007691-199712000-00001; Kirby BJ, 2012, DRUG METAB DISPOS, V40, P610, DOI 10.1124/dmd.111.042705; Muck W, 1999, CLIN PHARMACOL THER, V65, P251, DOI 10.1016/S0009-9236(99)70104-9; Tachibana T, 2010, CURR DRUG METAB, V11, P762, DOI 10.2174/138920010794328922; Malingre MM, 2001, J CLIN ONCOL, V19, P1160; McCance-Katz EF, 2006, CLIN INFECT DIS, V43, pS235, DOI 10.1086/508188; Lilja JJ, 2003, CLIN PHARMACOL THER, V73, P192, DOI 10.1067/mcp.2003.26; Clucas AT, 2007, CLIN PHARMACOKINET, V46, P757, DOI 10.2165/00003088-200746090-00003; Dumond JB, 2010, CLIN PHARMACOL THER, V87, P735, DOI 10.1038/clpt.2009.253; Fenner KS, 2009, CLIN PHARMACOL THER, V85, P173, DOI 10.1038/clpt.2008.195; Kharasch ED, 2013, DRUG METAB DISPOS, V41, P2166, DOI 10.1124/dmd.113.053991; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gurley BJ, 2007, DRUG METAB DISPOS, V35, P240, DOI 10.1124/dmd.106.012708; Wyen C, 2008, CLIN PHARMACOL THER, V84, P75, DOI 10.1038/sj.clpt.6100452; Asberg A, 2001, AM J TRANSPLANT, V1, P382, DOI 10.1034/j.1600-6143.2001.10415.x; Lee JE, 2011, ANTIMICROB AGENTS CH, V55, P4569, DOI 10.1128/AAC.00653-11; Sakugawa T, 2009, BRIT J CLIN PHARMACO, V67, P535, DOI 10.1111/j.1365-2125.2009.03396.x; Tapaninen T, 2011, J CLIN PHARMACOL, V51, P359, DOI 10.1177/0091270010365885; Ma JD, 2010, CLIN PHARMACOKINET, V49, P223, DOI 10.2165/11318000-000000000-00000; Garg V, 2012, J CLIN PHARMACOL, V52, P1566, DOI 10.1177/0091270011419850; Kalvass JC, 2013, CLIN PHARMACOL THER, V94, P80, DOI 10.1038/clpt.2013.34; Hsyu PH, 2001, ANTIMICROB AGENTS CH, V45, P3445, DOI 10.1128/AAC.45.12.3445-3450.2001; Schwarz UI, 2000, INT J CLIN PHARM TH, V38, P161; Tweedie D, 2013, CLIN PHARMACOL THER, V94, P113, DOI 10.1038/clpt.2013.77; Delavenne X, 2013, BRIT J CLIN PHARMACO, V76, P107, DOI 10.1111/bcp.12055; Schmitt C, 2010, INT J CLIN PHARM TH, V48, P192; Nakagami T, 2005, CLIN PHARMACOL THER, V78, P43, DOI 10.1016/j.clpt.2005.03.008; Gupta S, 2001, CLIN THER, V23, P451, DOI 10.1016/S0149-2918(01)80049-7; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Hartter S, 2013, BRIT J CLIN PHARMACO, V75, P1053, DOI 10.1111/j.1365-2125.2012.04453.x; Kakuda TN, 2011, ANTIMICROB AGENTS CH, V55, P2290, DOI 10.1128/AAC.01046-10; Kharasch ED, 2009, ANESTHESIOLOGY, V110, P660, DOI 10.1097/ALN.0b013e3181986a9a; Sugimoto H, 2013, DRUG METAB DISPOS, V41, P683, DOI 10.1124/dmd.112.049577; Cao YJ, 2008, ANTIMICROB AGENTS CH, V52, P1630, DOI 10.1128/AAC.01460-07; Yasui-Furukori N, 2005, CLIN PHARMACOL THER, V77, P17, DOI 10.1016/j.clpt.2004.08.026; Choi DH, 2008, EUR J CLIN PHARMACOL, V64, P445, DOI 10.1007/s00228-007-0447-5; Sadeque AJM, 2000, CLIN PHARMACOL THER, V68, P231, DOI 10.1067/mcp.2000.109156; Morris CA, 2012, AM J TROP MED HYG, V86, P489, DOI 10.4269/ajtmh.2012.11-0558; Zimmerman JJ, 2003, J CLIN PHARMACOL, V43, P1168, DOI 10.1177/0091270003257227; Baris N, 2006, EUR J CLIN PHARMACOL, V62, P535, DOI 10.1007/s00228-006-0138-7; Beringer PM, 2008, PHARMACOTHERAPY, V28, P883, DOI 10.1592/phco.28.7.883; Boffito M, 2004, AIDS, V18, P1291, DOI 10.1097/01.aids.0000125991.25023.f4; Boffito M, 2006, AIDS RES HUM RETROV, V22, P749, DOI 10.1089/aid.2006.22.749; Brandhorst G, 2008, THER DRUG MONIT, V30, P113, DOI 10.1097/FTD.0b013e318161a335; Buss N, 2001, BRIT J CLIN PHARMACO, V52, P255, DOI 10.1046/j.0306-5251.2001.01452.x; Cha YJ, 2013, BASIC CLIN PHARMACOL, V113, P419, DOI 10.1111/bcpt.12108; Chittick GE, 2006, ANTIMICROB AGENTS CH, V50, P1304, DOI 10.1128/AAC.50.4.1304-1310.2006; Choi DH, 2010, EUR J CLIN PHARMACOL, V66, P285, DOI 10.1007/s00228-009-0757-x; Davis MW, 2014, CLIN DRUG INVEST, V34, P259, DOI 10.1007/s40261-013-0168-8; Dorani H, 2007, EUR J CLIN PHARMACOL, V63, P571, DOI 10.1007/s00228-007-0292-6; Elsby R, 2011, DRUG METAB DISPOS, V39, P275, DOI 10.1124/dmd.110.035881; EMA, 2012, GUID INV DRUG INT; Eriksson UG, 2006, DRUG METAB DISPOS, V34, P775, DOI 10.1124/dmd.105.008607; FDA, 2012, DRUG INT STUD STUD D; Frassetto Lynda, 2003, Drug Metab Pharmacokinet, V18, P114, DOI 10.2133/dmpk.18.114; Gurley BJ, 2008, MOL NUTR FOOD RES, V52, P772, DOI 10.1002/mnfr.200700081; Ieiri I, 2013, J CLIN PHARMACOL, V53, P654, DOI 10.1002/jcph.62; Kaijser M, 1997, CLIN TRANSPLANT, V11, P577; Kantola T, 1998, CLIN PHARMACOL THER, V64, P177, DOI 10.1016/S0009-9236(98)90151-5; Kaukonen KM, 1997, CLIN PHARMACOL THER, V62, P510, DOI 10.1016/S0009-9236(97)90046-1; Khaliq Y, 2000, CLIN PHARMACOL THER, V68, P637, DOI 10.1067/mcp.2000.112363; Kharasch ED, 2004, J CLIN PHARMACOL, V44, P224, DOI 10.1177/0091270003262075; Kovarik JM, 2010, BIOPHARM DRUG DISPOS, V31, P331, DOI 10.1002/bdd.715; Krishna R, 2007, J CLIN PHARMACOL, V47, P165, DOI 10.1177/0091270006296523; la Porte CJL, 2007, CLIN PHARMACOL THER, V82, P389, DOI 10.1038/sj.clpt.6100157; Lemahieu WPD, 2005, AM J TRANSPLANT, V5, P2236, DOI 10.1111/j.1600-6143.2005.01005.x; Lemma GL, 2006, CLIN PHARMACOL THER, V79, P218, DOI 10.1016/j.clpt.2005.11.001; Lilja JJ, 2007, BRIT J CLIN PHARMACO, V63, P732, DOI 10.1111/j.1365-2125.2006.02836.x; Machavaram Krishna K., 2006, Drug Metabolism and Drug Interactions, V22, P47; Malingre MM, 2001, EUR J CLIN PHARMACOL, V57, P305, DOI 10.1007/s002280100315; Misaka S, 2013, J CLIN PHARMACOL, V53, P738, DOI 10.1002/jcph.95; Niemi M, 2006, EUR J CLIN PHARMACOL, V62, P463, DOI 10.1007/s00228-006-0133-z; Oswald S, 2010, CLIN PHARMACOL THER, V87, P663, DOI 10.1038/clpt.2009.266; PEDERSEN KE, 1983, EUR J CLIN PHARMACOL, V24, P41, DOI 10.1007/BF00613925; Penzak SR, 2005, JAIDS-J ACQ IMM DEF, V40, P573, DOI 10.1097/01.qai.0000187444.38461.70; Pescovitz MD, 2009, AM J TRANSPLANT, V9, P2324, DOI 10.1111/j.1600-6143.2009.02768.x; Pham PA, 2009, ANTIMICROB AGENTS CH, V53, P4385, DOI 10.1128/AAC.00449-09; Philip DH, 2010, TOP 100 DRUG INTERAC; Prakash J, 2003, CLIN DRUG INVEST, V23, P463, DOI 10.2165/00044011-200323070-00005; RAMEIS H, 1985, INT J CLIN PHARM TH, V23, P145; Ramesh Srirangam, 2006, Drug Metabolism and Drug Interactions, V22, P67; Rao N, 2008, J CLIN PHARMACOL, V48, P1092, DOI 10.1177/0091270008320924; Rebello S, 2011, J CLIN PHARMACOL, V51, P218, DOI 10.1177/0091270010365717; Rebello S, 2011, J CLIN PHARMACOL, V51, P1549, DOI 10.1177/0091270010385934; Saruwatari J, 2012, J CLIN PSYCHOPHARM, V32, P195, DOI 10.1097/JCP.0b013e318248ddb9; Shimizu M, 2006, BRIT J CLIN PHARMACO, V62, P372, DOI 10.1111/j.1365-2125.2006.02689.x; Skarke Carsten, 2003, Pharmacogenetics, V13, P651, DOI 10.1097/00008571-200311000-00001; Soyinka JO, 2010, EUR J PHARM SCI, V39, P213, DOI 10.1016/j.ejps.2009.11.012; Spence R, 2010, CLIN PHARMACOL THER, V88, P513, DOI 10.1038/clpt.2010.120; Tachibana T, 2009, XENOBIOTICA, V39, P430, DOI 10.1080/00498250902846252; Tayrouz Y, 2001, CLIN PHARMACOL THER, V70, P405, DOI 10.1067/mcp.2001.119212; Tuteja S, 2001, TRANSPLANTATION, V71, P1303, DOI 10.1097/00007890-200105150-00021; Uno T, 2006, DRUG METAB DISPOS, V34, P1875, DOI 10.1124/dmd.106.011023; Vaidyanathan S, 2008, J CLIN PHARMACOL, V48, P1323, DOI 10.1177/0091270008323258; van Haarst AD, 2009, J CLIN PHARMACOL, V49, P560, DOI 10.1177/0091270009332812; van Heeswijk RPG, 2006, J CLIN PHARMACOL, V46, P758, DOI 10.1177/0091270006288733; von Hentig N, 2007, ANTIMICROB AGENTS CH, V51, P1431, DOI 10.1128/AAC.00854-06; WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302; Wason S, 2012, POSTGRAD MED, V124, P189, DOI 10.3810/pgm.2012.07.2579; Winston A, 2006, AIDS, V20, P1401, DOI 10.1097/01.aids.0000233573.41597.8a; Yasui-Furukori N, 2007, THER DRUG MONIT, V29, P45, DOI 10.1097/FTD.0b013e31802bb20d	126	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0049-8254	1366-5928		XENOBIOTICA	Xenobiotica	DEC	2014	44	12					1135	1144		10.3109/00498254.2014.928958		10	Pharmacology & Pharmacy; Toxicology	Pharmacology & Pharmacy; Toxicology	AT3XJ	WOS:000344867400009		
J	Tomaschitz, R				Tomaschitz, Roman			High-index asymptotics of spherical Bessel products averaged with modulated Gaussian power laws	ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK			English	Article						Spherical Bessel functions; Airy functions; High-index asymptotics; Nicholson approximation; Lommel polynomials; Hankel series; Gaussian power-law densities; Kummer distributions	AIRY FUNCTIONS; INTEGRAL-REPRESENTATIONS	Bessel integrals of type are investigated, where the kernel g(k) is a modulated Gaussian power-law distribution , and the j (l) ((m)) are multiple derivatives of spherical Bessel functions. These integrals define the multipole moments of Gaussian random fields on the unit sphere, arising in multipole fits of temperature and polarization power spectra of the cosmic microwave background. Two methods allowing efficient numerical calculation of these integrals are presented, covering Bessel indices l in the currently accessible multipole range 0 a parts per thousand currency sign l a parts per thousand currency sign 10(4) and beyond. The first method is based on a representation of spherical Bessel functions by Lommel polynomials. Gaussian power-law averages can then be calculated in closed form as finite Hankel series of parabolic cylinder functions, which allow high-precision evaluation. The second method is asymptotic, covering the high-l regime, and is applicable to general distribution functions g(k) in the integrand; it is based on the uniform Nicholson approximation of the Bessel derivatives in conjunction with an integral representation of squared Airy functions. A numerical comparison of these two methods is performed, employing Gaussian power laws and Kummer distributions to average the Bessel products.	Hiroshima Univ, Dept Phys, Higashihiroshima 7398526, Japan	Tomaschitz, R (reprint author), Hiroshima Univ, Dept Phys, 1-3-1 Kagami Yama, Higashihiroshima 7398526, Japan.	tom@geminga.org					Jackson J. D., 1999, CLASSICAL ELECTRODYN; LAURENZI BJ, 1993, Z ANGEW MATH PHYS, V44, P891, DOI 10.1007/BF00942815; Magnus W., 1966, FORMULAS THEOREMS SP; Newton R. G., 1982, SCATTERING THEORY WA; Olver F. W. J., 2010, NIST HDB MATH FUNCTI; REID WH, 1995, Z ANGEW MATH PHYS, V46, P159, DOI 10.1007/BF00944750; Reid WH, 1997, Z ANGEW MATH PHYS, V48, P656, DOI 10.1007/PL00001482; Reid WH, 1997, Z ANGEW MATH PHYS, V48, P646, DOI 10.1007/PL00001481; Soares M., 2010, AIRY FUNCTIONS APPL; Tomaschitz R, 2012, MON NOT R ASTRON SOC, V427, P1363, DOI 10.1111/j.1365-2966.2012.22024.x; Tomaschitz R, 2013, APPL MATH COMPUT, V225, P228, DOI 10.1016/j.amc.2013.09.035; Tomaschitz R, 2014, MATH METHOD APPL SCI, V37, P1249, DOI 10.1002/mma.2882; Watson G N, 1996, TREATISE THEORY BESS; Weinberg S, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.123512	14	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	0044-2275	1420-9039		Z ANGEW MATH PHYS	Z. Angew. Math. Phys.	DEC	2014	65	6					1077	1105		10.1007/s00033-013-0370-9		29	Mathematics, Applied	Mathematics	AU0TI	WOS:000345337000002		
J	Ben Yahia, H; Shikano, M; Kobayashi, H				Ben Yahia, Hamdi; Shikano, Masahiro; Kobayashi, Hironori			The new disordered triplite polymorph of Co-2[PO4]F	ZEITSCHRIFT FUR KRISTALLOGRAPHIE			English	Article						disorder; polymorphism; single crystal; triplite - triploidite structural relationship	LI-ION BATTERIES; BOND-VALENCE PARAMETERS; CRYSTAL-STRUCTURE; CATHODE MATERIALS; FLUOROPHOSPHATE; LIFESO4F; ELECTROCHEMISTRY	The new polymorph of Co-2[PO4]F has been synthesized by a hydrothermal route. Its crystal structure was determined from single-crystal X-ray diffraction data. CoCo2[PO4]F crystallizes with the triplite-type structure, space group C2/c, a=12.856(2), b=6.4369(10), c=9.6742(16) angstrom, beta=117.40(1)degrees, V=710.7(2) angstrom(3) and Z=8. The structure consists of a 3D-framework buildup of condensed PO4 tetrahedra, and cobalt(II) polyhedra which form chains running along the [101] and [010] directions. The coordination of the cobalt cations and the connectivity between the cobalt polyhedra are not well defined due to the disorder of the fluoride anions which form zig-zag chains along [001]. The theoretical ordering of the fluoride anions led to two different structural models, very similar to the triplite Cc-CoFe[PO4]F and the triploidite P2(1)/c-CoCo2[PO4]F, and in which the cobalt atoms are five and six coordinated.	[Ben Yahia, Hamdi; Shikano, Masahiro; Kobayashi, Hironori] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan	Ben Yahia, H (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	benyahia.hamdi@aist.go.jp; shikano.masahiro@aist.go.jp			 [24.02506]	This work was supported by Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows Grant Number 24.02506. We are thankful to Professor M. Leblanc for having corrected the atomic positions of the triploidite P2<INF>1</INF>/c-Co<INF>2</INF>[PO<INF>4</INF>]F [13].	Liu L, 2011, PROG NAT SCI, V21, P211; Recham N, 2010, CHEM MATER, V22, P1142, DOI 10.1021/cm9021497; Petricek V, 2014, Z KRISTALLOGR, V229, P345, DOI 10.1515/zkri-2014-1737; Ati M, 2011, ELECTROCHEM COMMUN, V13, P1280, DOI 10.1016/j.elecom.2011.08.023; Ben Yahia M, 2012, ENERG ENVIRON SCI, V5, P9584, DOI 10.1039/c2ee22699e; Masquelier C, 2013, CHEM REV, V113, P6552, DOI 10.1021/cr3001862; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; Subban CV, 2013, J AM CHEM SOC, V135, P3653, DOI 10.1021/ja3125492; Tripathi R, 2010, ANGEW CHEM INT EDIT, V49, P8738, DOI 10.1002/anie.201003743; BRESE NE, 1991, ACTA CRYSTALLOGR B, V47, P192, DOI 10.1107/S0108768190011041; CODA A, 1967, ATTI ACCAD NAZ LIN, V43, P212; Dordevic T, 2013, MINER PETROL, V107, P243, DOI 10.1007/s00710-012-0235-5; ENGEL G, 1989, J LESS-COMMON MET, V154, P367, DOI 10.1016/0022-5088(89)90221-X; Leblanc M, 1997, J MAGN MAGN MATER, V167, P71, DOI 10.1016/S0304-8853(97)80011-X; Marx N, 2010, DALTON T, V39, P5108, DOI 10.1039/b922640k; Ramesh TN, 2010, ELECTROCHEM SOLID ST, V13, pA43, DOI 10.1149/1.3298353; REA JR, 1976, ACTA CRYSTALLOGR B, V32, P1944, DOI 10.1107/S0567740876006821; REA JR, 1972, ACTA CRYSTALL B-STRU, VB 28, P2525, DOI 10.1107/S0567740872006417; Richmond WE, 1940, AM MINERAL, V25, P441; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Spek A.L., 2008, PLATON MULTIPURPOSE; Waldrop A. L., 1969, THESIS MIT; WALDROP L, 1969, Z KRISTALLOGR KRIST, V130, P1, DOI 10.1524/zkri.1969.130.1-6.1; Yakubovich O. V., 1978, DOKL AKAD NAUK SSSR, V238, P576; Yu R., 2002, J SOC INORG MAT JPN, V9, P99	25	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0044-2968			Z KRISTALLOGR	Z. Kristall.	DEC	2014	229	12					775	781		10.1515/zkri-2014-1747		7	Crystallography	Crystallography	AU2FZ	WOS:000345433200001		
J	Yasin, NHM; Sanchez-Torres, V; Maeda, T				Yasin, Nazlina Haiza Mohd; Sanchez-Torres, Viviana; Maeda, Toshinari			Enhanced reduction of waste activated sludge at a low temperature by locally isolated strains Pseudomonas sp. VNT and Aeromonas sp. VNT	BIORESOURCE TECHNOLOGY			English	Article						Waste activated sludge (WAS); Psychrophilic; Pseudomonas; Aeromonas	STATIC MAGNETIC-FIELD; BIOHYDROGEN PRODUCTION; AEROBIC DIGESTION; PURIFICATION; SYSTEM; WATER	Appropriate control of waste activated sludge (WAS) is required to solve the annual increment of WAS volume. The low bacterial activity at low temperatures poses a difficulty in reducing or utilizing WAS in cold weather regions and/or during the winter season. This study reveals a practical method to enhance sludge reduction at a low temperature using isolated strains of Pseudomonas and Aeromonas species. The effect of inoculating each strain into WAS was examined at different temperatures (4 degrees C, 10 degrees C, 12 degrees C, 15 degrees C, 20 degrees C, and 30 degrees C) and under an aerobic condition. Sludge reduction showed 2-to 8-fold improvement at the temperature range from 4 degrees C to 15 degrees C. Both strains are psychrophilic and can produce protease and lipase for sludge degradation even at low temperatures. Thus, biological WAS treatment at a psychrophilic temperature can be enhanced by inoculating these promising strains. (C) 2014 Elsevier Ltd. All rights reserved.	[Yasin, Nazlina Haiza Mohd; Maeda, Toshinari] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan; [Sanchez-Torres, Viviana] Univ Ind Santander, Escuela Ingn Quim, Bucaramanga 678, Colombia; [Maeda, Toshinari] Kyushu Inst Technol, Res Ctr Adv Ecofitting Technol, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan	Maeda, T (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Biol Funct Engn, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	toshi.maeda@life.kyutech.ac.jp			Japan Students Services Organization; Sasakawa Scientific Research Grant; Japan Science Society [25-457]; Research Center for Advanced Eco-fitting Technology of Kyushu Institute of Technology; City of Kitakyushu	The authors would like to acknowledge Japan Students Services Organization for the scholarship of N.H. Mohd Yasin during this study. This research was supported by Sasakawa Scientific Research Grant, The Japan Science Society (25-457), the Research Center for Advanced Eco-fitting Technology of Kyushu Institute of Technology, and the City of Kitakyushu.	Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Li XS, 2009, BIORESOURCE TECHNOL, V100, P2475, DOI 10.1016/j.biortech.2008.12.019; Gallert C, 1997, APPL MICROBIOL BIOT, V48, P405; Vackova L, 2011, BIORESOURCE TECHNOL, V102, P4661, DOI 10.1016/j.biortech.2011.01.024; Cavinato C, 2013, RENEW ENERG, V55, P260, DOI 10.1016/j.renene.2012.12.044; Feng LY, 2009, J ENVIRON SCI-CHINA, V21, P589, DOI 10.1016/S1001-0742(08)62312-8; Yasin NHM, 2013, J ENVIRON MANAGE, V130, P375, DOI 10.1016/j.jenvman.2013.09.009; Lee HK, 2003, J MICROBIOL, V41, P22; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Niu C, 2014, BIORESOURCE TECHNOL, V159, P48, DOI 10.1016/j.biortech.2014.01.131; Guo P, 2010, J MICROBIOL BIOTECHN, V20, P254, DOI 10.4014/jmb.0906.06035; Bose A., 2013, BIOCATAL AGR BIOTECH, V2, P255; Ichinari T, 2008, PROCESS BIOCHEM, V43, P722, DOI 10.1016/j.procbio.2008.02.016; KOERS DA, 1977, J WATER POLLUT CON F, V49, P460; Li TL, 2012, BIORESOURCE TECHNOL, V108, P28, DOI 10.1016/j.biortech.2011.12.141; Maeda T, 2009, J HAZARD MATER, V168, P656, DOI 10.1016/j.jhazmat.2009.02.067; Maeda T, 2011, BIORESOURCE TECHNOL, V102, P10650, DOI 10.1016/j.biortech.2011.08.098; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Moreno R., 2014, ENV MICROBIOL REP; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Niu C, 2013, BIORESOURCE TECHNOL, V150, P156, DOI 10.1016/j.biortech.2013.08.139; Niu C, 2012, BIORESOURCE TECHNOL, V123, P66, DOI 10.1016/j.biortech.2012.06.110; Pianetti A, 2008, INT J FOOD MICROBIOL, V127, P252, DOI 10.1016/j.ijfoodmicro.2008.07.024; Prorot A., 2011, Biochemical Engineering Journal, V54, P178, DOI 10.1016/j.bej.2011.02.016; Saha A.K., 1994, CARBOHYD RES, V254, P157, DOI 10.1016/0008-6215(94)84249-3; Sheng YX, 2010, J HAZARD MATER, V179, P918, DOI 10.1016/j.jhazmat.2010.03.093; Uma R.R., 2012, BIORESOURCE TECHNOL, V103, P415; Yasin NHM, 2013, INT J HYDROGEN ENERG, V38, P10277, DOI 10.1016/j.ijhydene.2013.06.065	28	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	DEC	2014	174						134	141		10.1016/j.biortech.2014.10.005		8	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	AT5YD	WOS:000345014900018		
J	Shu, JB; Lv, XQ; Jiang, SZ; Zhang, YQ; Zhang, CH; Meng, YT; Situ, AM; Xu, HQ; Song, L				Shu, Jianbo; Lv, Xiqian; Jiang, Shuzhen; Zhang, Yuqin; Zhang, Chunhua; Meng, Yingtao; Situ, Aiming; Xu, Haiquan; Song, Li			Genetic analysis of the UPB1 gene in two new Chinese families with beta-ureidopropionase deficiency and the carrier frequency of the mutation c. 977G > A in Northern China	CHILDS NERVOUS SYSTEM			English	Article						beta-ureidopropionase deficiency; Carrier frequency; Genetic analysis; Mutation; UPB1	ALTERED URACIL CATABOLISM; PYRIMIDINE DEGRADATION; AMINOISOBUTYRIC ACID; INHIBITION; DIAGNOSIS; OBESITY; URINE	Purpose The purpose of the study was to investigate mutations of the UPB1 gene in two Chinese families with beta-ureidopropionase deficiency and the heterozygous carrier frequency in Chinese. Methods Genomic DNA was extracted from peripheral blood leukocytes from all available family members and 500 unrelated healthy controls. Then, all exons and flanking intron regions of the UPB1 gene were amplified by PCR and analyzed by direct sequencing in two patient-families. Finally, the carrier frequency of the c. 977G> A (p. R326Q) mutation was identified by PCR restriction fragment length polymorphism in 500 healthy controls. Results The two patients had the same homozygous missense mutation in exon 9 (c. 977G> A; p. R326Q), and the carrier frequency of this mutation was 2.8 % in the Northern Chinese population, which suggests that about 1: 5,102 Chinese are expected to suffer from UPB1 deficiency. Conclusions The c. 977G> A (p. R326Q) is the most common mutation of the UPB1 gene in Chinese. The predicted incidence indicates that beta-ureidopropionase deficiency is significantly underdiagnosed in the Chinese population. It should be necessary to add beta-ureidopropionase deficiency to highrisk screening for the symptomatic patients group.	[Shu, Jianbo; Lv, Xiqian; Jiang, Shuzhen; Meng, Yingtao; Song, Li] Tianjin Childrens Hosp, Tianjin Pediat Res Inst, Tianjin, Peoples R China; [Zhang, Chunhua] MILS Int, Dept Res & Dev, Kanazawa, Ishikawa, Japan; [Zhang, Yuqin; Xu, Haiquan] Tianjin Childrens Hosp, Dept Neurol, Tianjin, Peoples R China; [Situ, Aiming] Tianjin Childrens Hosp, Dept Gastroenterol, Tianjin, Peoples R China	Song, L (reprint author), Tianjin Childrens Hosp, Tianjin Pediat Res Inst, Tianjin, Peoples R China.	lisong_tj@sina.com					Assmann B, 2006, NEUROPEDIATRICS, V37, P20, DOI 10.1055/s-2006-923933; Begriche K, 2010, FUND CLIN PHARMACOL, V24, P269, DOI 10.1111/j.1472-8206.2009.00765.x; Begriche K, 2008, OBESITY, V16, P2053, DOI 10.1038/oby.2008.337; Fidlerova J, 2012, PHARMACOL REP, V64, P1234; Kolker S, 2001, J NEUROSCI RES, V66, P666, DOI 10.1002/jnr.10012; Kuhara T, 2009, J MASS SPECTROM, V44, P214, DOI 10.1002/jms.1500; NAKAJIMA Y, 2014, J INHERIT METAB DIS, V14; Ohse M, 2002, J MASS SPECTROM, V37, P954, DOI 10.1002/jms.354; Sakamoto T, 2001, J NUTR SCI VITAMINOL, V47, P132; Schmieden V, 1999, MOL PHARMACOL, V56, P464; Thomas HR, 2007, PHARMACOGENET GENOM, V17, P973, DOI 10.1097/FPC.0b013e3282f01788; Thomas HR, 2008, PHARMACOGENET GENOM, V18, P25, DOI 10.1097/FPC.0b013e3282f2f134; VANGENNIP AH, 1993, CLIN CHEM, V39, P380; vanGennip AH, 1997, J INHERIT METAB DIS, V20, P379, DOI 10.1023/A:1005338230321; van Kuilenburg ABP, 2012, BBA-MOL BASIS DIS, V1822, P1096, DOI 10.1016/j.bbadis.2012.04.001; van Kuilenburg ABP, 2004, HUM MOL GENET, V13, P2793, DOI 10.1093/hmg/ddh303; Vreken P, 1999, BBA-GENE STRUCT EXPR, V1447, P251, DOI 10.1016/S0167-4781(99)00182-7	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2014	30	12					2109	2114		10.1007/s00381-014-2541-1		6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	AT4AO	WOS:000344879700020		
J	Xu, Z; Chang, P; Richter, I; Kim, W; Tang, GL				Xu, Zhao; Chang, Ping; Richter, Ingo; Kim, Who; Tang, Guanglin			Diagnosing southeast tropical Atlantic SST and ocean circulation biases in the CMIP5 ensemble	CLIMATE DYNAMICS			English	Article						Southeast tropical Atlantic; SST bias; Coupled general circulation model; Ocean circulation	LOW-LEVEL JET; SEASONAL CYCLE; COUPLED OCEAN; HEAT FLUXES; WEST-COAST; PACIFIC; VARIABILITY; MODELS; ERRORS; STRATUS	Warm sea-surface temperature (SST) biases in the southeastern tropical Atlantic (SETA), which is defined by a region from 5 degrees E to the west coast of southern Africa and from 10 degrees S to 30 degrees S, are a common problem in many current and previous generation climate models. The Coupled Model Intercomparison Project Phase 5 (CMIP5) ensemble provides a useful framework to tackle the complex issues concerning causes of the SST bias. In this study, we tested a number of previously proposed mechanisms responsible for the SETA SST bias and found the following results. First, the multi-model ensemble mean shows a positive shortwave radiation bias of degrees 20 W m(-2), consistent with models' deficiency in simulating low-level clouds. This shortwave radiation error, however, is overwhelmed by larger errors in the simulated surface turbulent heat and longwave radiation fluxes, resulting in excessive heat loss from the ocean. The result holds for atmosphere-only model simulations from the same multi-model ensemble, where the effect of SST biases on surface heat fluxes is removed, and is not sensitive to whether the analysis region is chosen to coincide with the maximum warm SST bias along the coast or with the main SETA stratocumulus deck away from the coast. This combined with the fact that there is no statistically significant relationship between simulated SST biases and surface heat flux biases among CMIP5 models suggests that the shortwave radiation bias caused by poorly simulated low-level clouds is not the leading cause of the warm SST bias. Second, the majority of CMIP5 models underestimate upwelling strength along the Benguela coast, which is linked to the unrealistically weak alongshore wind stress simulated by the models. However, a correlation analysis between the model simulated vertical velocities and SST biases does not reveal a statistically significant relationship between the two, suggesting that the deficient coastal upwelling in the models is not simply related to the warm SST bias via vertical heat advection. Third, SETA SST biases in CMIP5 models are correlated with surface and subsurface ocean temperature biases in the equatorial region, suggesting that the equatorial temperature bias remotely contributes to the SETA SST bias. Finally, we found that all CMIP5 models simulate a southward displaced Angola-Benguela front (ABF), which in many models is more than 10 degrees south of its observed location. Furthermore, SETA SST biases are most significantly correlated with ABF latitude, which suggests that the inability of CMIP5 models to accurately simulate the ABF is a leading cause of the SETA SST bias. This is supported by simulations with the oceanic component of one of the CMIP5 models, which is forced with observationally derived surface fluxes. The results show that even with the observationally derived surface atmospheric forcing, the ocean model generates a significant warm SST bias near the ABF, underlining the important role of ocean dynamics in SETA SST bias problem. Further model simulations were conducted to address the impact of the SETA SST biases. The results indicate a significant remote influence of the SETA SST bias on global model simulations of tropical climate, underscoring the importance and urgency to reduce the SETA SST bias in global climate models.	[Xu, Zhao] Ocean Univ China, Phys Oceanog Lab, Qingdao, Peoples R China; [Xu, Zhao; Chang, Ping; Kim, Who] Texas A&M Univ, Dept Oceanog, College Stn, TX 77840 USA; [Chang, Ping; Tang, Guanglin] Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77840 USA; [Richter, Ingo] JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa, Japan; [Richter, Ingo] JAMSTEC, Applicat Lab, Yokohama, Kanagawa, Japan	Chang, P (reprint author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77840 USA.	ping@tamu.edu			U.S. National Science Foundation [OCE-1334707, AGS-1067937]; Department of Energy [DE-SC0006824]; National Oceanic and Atmospheric Administration [NA11OAR4310154]; National Science Foundation of China [41028005, 40921004, 40930844]	We are grateful to Paquita Zuidema and C. Roberto Mechoso for their insightful comments, which improved this paper significantly. This research is supported by the U.S. National Science Foundation Grants, OCE-1334707 and AGS-1067937, and Department of Energy Grant DE-SC0006824, as well as National Oceanic and Atmospheric Administration Grant NA11OAR4310154. PC acknowledges the support from the National Science Foundation of China (41028005, 40921004 and 40930844).	Deser C, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043321; Richter I, 2008, CLIM DYNAM, V31, P587, DOI 10.1007/s00382-008-0364-z; Richter I, 2014, CLIM DYNAM, V42, P171, DOI 10.1007/s00382-012-1624-5; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Richter I, 2012, CLIM DYNAM, V38, P985, DOI 10.1007/s00382-011-1038-9; Grodsky SA, 2012, J CLIMATE, V25, P3684, DOI 10.1175/JCLI-D-11-00315.1; Huang BH, 2007, CLIM DYNAM, V28, P661, DOI 10.1007/s00382-006-0223-8; Kirtman BP, 2012, CLIM DYNAM, V39, P1303, DOI 10.1007/s00382-012-1500-3; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Danabasoglu G, 2012, J CLIMATE, V25, P1361, DOI 10.1175/JCLI-D-11-00091.1; Davey MK, 2002, CLIM DYNAM, V18, P403, DOI 10.1007/s00382-001-0188-6; Doi T, 2012, J CLIMATE, V25, P5494, DOI 10.1175/JCLI-D-11-00360.1; Toniazzo T, 2010, CLIM DYNAM, V35, P1309, DOI 10.1007/s00382-009-0703-8; Fennel W, 2012, CONT SHELF RES, V45, P65, DOI 10.1016/j.csr.2012.06.004; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Huang B, 2004, CLIM DYNAM, V23, P133, DOI 10.1007/s00382-004-0443-8; Colberg F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027463; Large WG, 2009, CLIM DYNAM, V33, P341, DOI 10.1007/s00382-008-0441-3; De Szoeke SP, 2008, J CLIMATE, V21, P2573, DOI 10.1175/2007JCLI1975.1; Yu LS, 2004, J CLIMATE, V17, P2096, DOI 10.1175/1520-0442(2004)017<2096:MAVOTW>2.0.CO;2; Ma CC, 1996, J CLIMATE, V9, P1635, DOI 10.1175/1520-0442(1996)009<1635:PSCATT>2.0.CO;2; Large WG, 2006, J CLIMATE, V19, P2325, DOI 10.1175/JCLI3740.1; Lass HU, 2000, J PHYS OCEANOGR, V30, P2589, DOI 10.1175/1520-0485(2000)030<2589:HACMIT>2.0.CO;2; Xu Z, 2014, CLIM DYNAM, V43, P2915, DOI 10.1007/s00382-013-1901-y; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Chang CY, 2007, J CLIMATE, V20, P1053, DOI 10.1175/JCLI4047.1; Nicholson SE, 2010, CLIMATIC CHANGE, V99, P613, DOI 10.1007/s10584-009-9678-z; Bretherton CS, 2004, B AM METEOROL SOC, V85, P967, DOI 10.1175/BAMS-85-7-967; Toniazzo T, 2014, CLIM DYNAM, V43, P2889, DOI 10.1007/s00382-013-1691-2; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; CARTON JA, 2005, J GEOPHYS RES-OCEANS, V110, DOI DOI 10.1029/200; Colbo K, 2007, J MAR RES, V65, P607, DOI 10.1357/002224007783649510; DAI AC, 2006, J CLIMATOL, V9, P4605; de Szoeke SP, 2012, J CLIMATE, V25, P8542, DOI 10.1175/JCLI-D-11-00618.1; de Szoeke SP, 2010, J CLIMATE, V23, P4152, DOI 10.1175/2010JCLI3411.1; DeWitt D, 2005, GEOPHYS RES LETT, V32; Garreaud RD, 2005, MON WEATHER REV, V133, P2246, DOI 10.1175/MWR2972.1; Hu ZZ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009514; LARGE WG, 2004, TECHNICAL REPORT; MECHOSO, 2014, B AM METEOROL SOC, V95, P357, DOI DOI 10.1175/BAMS-D-11-00246.1; MECHOSO CR, 1995, MON WEATHER REV, V123, P2825, DOI 10.1175/1520-0493(1995)123<2825:TSCOTT>2.0.CO;2; MECHOSO CM, 2010, CLIVAR EXCHANGES, P3; Munoz RC, 2005, MON WEATHER REV, V133, P3661, DOI 10.1175/MWR3074.1; Nigam S, 1997, J CLIMATE, V10, P2447, DOI 10.1175/1520-0442(1997)010<2447:TAWTCP>2.0.CO;2; PATRICOLA CM, 2011, CLIM DYNAM, V39, P2443; Penven P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002945; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Richter I, 2008, J CLIMATE, V21, P214, DOI 10.1175/2007JCLI1802.1; SEO H, 2006, GEOPHYS RES LETT, V33; WACONGNE S, 1992, DEEP-SEA RES, V39, P1273, DOI 10.1016/0198-0149(92)90069-6; Wahl S, 2009, CLIM DYNAM, V36, P891; YAMAGATA T, 1995, J PHYS OCEANOGR, V25, P2129, DOI 10.1175/1520-0485(1995)025<2129:SOTTTD>2.0.CO;2; Yu JY, 1999, J CLIMATE, V12, P416, DOI 10.1175/1520-0442(1999)012<0416:ADOTEI>2.0.CO;2	53	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	DEC	2014	43	11			SI		3123	3145		10.1007/s00382-014-2247-9		23	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AT3UY	WOS:000344862200014		
J	Masuda, T; Funama, Y; Imada, N; Sato, T; Yamagami, T; Tatsugami, F; Awai, K				Masuda, Takanori; Funama, Yoshinori; Imada, Naoyuki; Sato, Tomoyasu; Yamagami, Takuji; Tatsugami, Fuminari; Awai, Kazuo			Prediction of Aortic Enhancement on Coronary CTA Images Using a Test Bolus of Diluted Contrast Material	ACADEMIC RADIOLOGY			English	Article						Test bolus technique; contrast material; aortic enhancement; coronary CTA	PATIENT WEIGHT; ANGIOGRAPHY; INJECTION; PROTOCOL; MDCT; ATTENUATION; ACCURACY; EXPOSURE; DURATION; PHANTOM	Rationale and Objectives: The purpose of our study was to compare test bolus techniques using undiluted or diluted contrast material for, their ability to predict aortic enhancement on coronary computed tomographic angiography (c-CTA) images. Materials and Methods: We divided 200 consecutive-patients who underwent c-CTA on a 64-MDCT scanner into two groups. In group A (n = 100), we used a test bolus of undiluted contrast material and in group B (n. = 100), the contrast material was diluted. The injection volume was body weight x 0.2 (contrast material 100%) in group A and body weight x 0.7 (contrast material 30%, saline 70%) in group B. We then compared the CT number in the ascending aorta on c-CTA images obtained with undiluted and diluted contrast media to the CT number on c-CTA images. Results: The mean CT number in the ascending aorta was significantly higher in group B than group A (217.1 vs. 157.4 HU, P < .001). There was a significant difference in the correlation between the CT number of the ascending aorta on c-CTA images and on images acquired with the test bolus using undiluted or diluted test bolus (P < .001). In group B, the correlation had a strong positive linear relationship (r = 0.72, P < .001), whereas in group A the positive linear relationship was weak (r = 0.36). Conclusions: The test bolus with diluted. contrast material was useful for predicting aortic enhancement before c-CTA scanning.	[Masuda, Takanori; Imada, Naoyuki] Tsuchiya Gen Hosp, Dept Radiol Technol, Naka Ku, Hiroshima 7308655, Japan; [Masuda, Takanori; Yamagami, Takuji; Tatsugami, Fuminari; Awai, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan; [Funama, Yoshinori] Kumamoto Univ, Fac Life Sci, Dept Med Phys, Kumamoto, Japan; [Sato, Tomoyasu] Tsuchiya Gen Hosp, Dept Diagnost Radiol, Hiroshima 7308655, Japan	Masuda, T (reprint author), Tsuchiya Gen Hosp, Dept Radiol Technol, Naka Ku, Nakajima Cho 3-30, Hiroshima 7308655, Japan.	takanorimasuda@yahoo.co.jp					Nakaura T, 2008, INVEST RADIOL, V43, P512, DOI 10.1097/RLI.0b013e3181727505; Fleischmann D, 1999, J COMPUT ASSIST TOMO, V23, P474, DOI 10.1097/00004728-199905000-00026; Fleischmann D, 2010, RADIOL CLIN N AM, V48, P237, DOI 10.1016/j.rcl.2010.02.002; Vrachliotis TG, 2007, RADIOLOGY, V243, P368, DOI 10.1148/radiol.2432060447; Layritz C, 2013, J CARDIOVASC COMPUT, V7, P303, DOI 10.1016/j.jcct.2013.08.010; Bae KT, 2008, AM J ROENTGENOL, V190, P777, DOI 10.2214/AJR.07.2765; Funama Y, 2013, PHYS MEDICA, V29, P39, DOI 10.1016/j.ejmp.2011.11.004; Yamamuro M, 2007, J COMPUT ASSIST TOMO, V31, P272, DOI 10.1097/01.rct.0000236422.35761.a1; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Hittmair K, 2001, J COMPUT ASSIST TOMO, V25, P287, DOI 10.1097/00004728-200103000-00024; Awai K, 2003, EUR RADIOL, V13, P2155, DOI 10.1007/s00330-003-1904-x; Awai K, 2006, AM J ROENTGENOL, V186, P379, DOI 10.2214/AJR.04.1591; Cademartiri Filippo, 2006, AJR Am J Roentgenol, V187, pW430, DOI 10.2214/AJR.05.1406; Cademartiri F, 2008, EUR RADIOL, V18, P576, DOI 10.1007/s00330-007-0773-0; Kerl JM, 2012, EUR J RADIOL, V81, P2887, DOI 10.1016/j.ejrad.2011.09.018; Kidoh M, 2013, JPN J RADIOL, V31, P115, DOI 10.1007/s11604-012-0158-4; Nakaura T, 2011, JPN J RADIOL, V29, P457, DOI 10.1007/s11604-011-0579-5; Svensson A, 2010, ACTA RADIOL, V51, P722, DOI 10.3109/02841851.2010.488249	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1076-6332	1878-4046		ACAD RADIOL	Acad. Radiol.	DEC	2014	21	12					1542	1546		10.1016/j.acra.2014.07.002		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AT3OR	WOS:000344844400007		
J	Sasahara, T				Sasahara, T.			CLASSIFICATION RESULTS FOR lambda-BIMINIMAL SURFACES IN 2-DIMENSIONAL COMPLEX SPACE FORMS	ACTA MATHEMATICA HUNGARICA			English	Article						lambda-biharmonic map; lambda-biharmonic surface; lambda-biminimal surface; slant surface; Lagrangian surface; complex space form	PURELY REAL SURFACES; SUBMANIFOLDS	We completely classify lambda-biharmonic slant surfaces and lambda-biminimal Lagrangian surfaces in 2-dimensional complex space forms, under the condition that the mean curvature is nonzero constant. In addition, we provide some examples of lambda-biminimal slant surfaces with nonzero constant mean curvature, which are neither Lagrangian nor lambda-biharmonic.	Hachinohe Inst Technol, Div Math, Ctr Liberal Arts & Sci, Hachinohe, Aomori 0318501, Japan	Sasahara, T (reprint author), Hachinohe Inst Technol, Div Math, Ctr Liberal Arts & Sci, Hachinohe, Aomori 0318501, Japan.	sasahara@hi-tech.ac.jp					Chen BY, 1997, ISRAEL J MATH, V99, P69, DOI 10.1007/BF02760677; Chen BY, 2000, GLASGOW MATH J, V42, P439, DOI 10.1017/S0017089500030111; Loubeau E, 2008, P EDINBURGH MATH SOC, V51, P421, DOI 10.1017/S00130915060000394; Caddeo R, 2001, INT J MATH, V12, P867, DOI 10.1142/S0129167X01001027; Fetcu D, 2010, MATH Z, V266, P505, DOI 10.1007/s00209-009-0582-z; Chen BY, 1999, TAIWAN J MATH, V3, P163; Chen B. Y., 1998, RESULTS MATH, V33, P63; Chen B. Y., 1998, TSUKUBA J MATH, V22, P657; Chen B. Y., 1997, RESULTS MATH, V31, P28; Chen B. Y., 2001, RESULTS MATH, V39, P18; Chen BY, 2010, INT J MATH, V21, P665, DOI 10.1142/S0129167X10006276; Chen B.-Y., 1996, SOOCHOW J MATH, V22, P117; Chen BY, 2010, KYUSHU J MATH, V64, P153, DOI 10.2206/kyushujm.64.153; Chen B.-Y., 1984, TOTAL MEAN CURVATURE; Chen BY, 1990, GEOMETRY SLANT SUBMA; Chen BY, 2010, TURK J MATH, V34, P275, DOI 10.3906/mat-0809-44; Eliasson H.I., 1974, GLOBAL ANAL ITS APPL, VII, P113; Lemaire L., 1981, LECT NOTES MATH, V838, P187; Sasahara T, 2010, J GEOM PHYS, V60, P884, DOI 10.1016/j.geomphys.2010.02.005; Sasahara T, 2007, GLASGOW MATH J, V49, P497, DOI 10.1017/S0017089507003886; Sasahara T, 2009, DIFFER GEOM APPL, V27, P647, DOI 10.1016/j.difgeo.2009.07.001; Yang J., 1997, J GEOM, V59, P184, DOI 10.1007/BF01229576	22	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5294	1588-2632		ACTA MATH HUNG	Acta Math. Hung.	DEC	2014	144	2					433	448		10.1007/s10474-014-0431-3		16	Mathematics	Mathematics	AS9RA	WOS:000344578100008		
J	Takikawa, Y; Matsuda, Y; Nonomura, T; Kakutani, K; Kimbara, J; Osamura, K; Kusakari, S; Toyoda, H				Takikawa, Yoshihiro; Matsuda, Yoshinori; Nonomura, Teruo; Kakutani, Koji; Kimbara, Junji; Osamura, Kazumi; Kusakari, Shin-ichi; Toyoda, Hideyoshi			Electrostatic guarding of bookshelves for mould-free preservation of valuable library books	AEROBIOLOGIA			English	Article						Electric field screen; Penicillium digitatum; Creeping discharge	SPORE PRECIPITATOR; CONIDIA; INSULATORS; HORDEI; FUNGI	Old books are highly susceptible to mould infection, and an effective method for avoiding moulding is needed to safely preserve valuable books in library stack rooms. Guarding a bookshelf with an electric field screen is a physical method that prevents airborne spores from entering the space used for book preservation. In this study, insulated conductor wires (ICWs) were used as electrodes to form electric fields. The ICWs were arrayed in parallel and linked to each other and to a direct current voltage generator. The electric field screen consisted of two layers of ICWs, which were negatively and positively charged with equal voltages to make dipoles, ICW(-) and ICW(+). Both ICWs generated an attractive force that captured airborne spores of Penicillium digitatum that were blown inside the screen. The attractive force was directly proportional to the applied voltage. At a parts per thousand 0.9 kV, the screen exerted sufficient force to capture all airflow-carried spores, but a few spores that were once captured were repulsed out of the electric field when subsequent spores were attracted to positions proximal to them. This phenomenon was explained by creeping discharge between spores located close to each other on the ICW surface. This spore-repulsion problem was resolved by adding an additional ICW layer to the electric field screen, namely an electric field screen with an ICW(-) layer on both sides of an ICW(+) layer. The present study demonstrated that the three-layered electric field screen remained mould-free inside a screen-guarded bookshelf, irrespective of continuous spore exposure.	[Takikawa, Yoshihiro] Kinki Univ, Inst Adv Technol, Plant Ctr, Wakayama 6420017, Japan; [Matsuda, Yoshinori; Nonomura, Teruo] Kinki Univ, Lab Phytoprotect Sci & Technol, Fac Agr, Nara 6318505, Japan; [Kakutani, Koji] Kinki Univ, Pharmaceut Res & Technol Inst, Osaka 5778502, Japan; [Kimbara, Junji] Kagome Co Ltd, Div Res & Dev, Nasushiobara, Tochigi 3292762, Japan; [Osamura, Kazumi] Panason Environm Syst & Engn Co Ltd, Tech Dev Unit, Osaka 5640062, Japan; [Kusakari, Shin-ichi] Agr Food & Environm Sci Res Ctr Osaka Prefecture, Osaka 5830862, Japan; [Toyoda, Hideyoshi] Kinki Univ, Lab Phytoprotect Sci & Technol, Nara 6318505, Japan; [Toyoda, Hideyoshi] Kinki Univ, Agr Fac Lib, Nara 6318505, Japan	Matsuda, Y (reprint author), Kinki Univ, Lab Phytoprotect Sci & Technol, Fac Agr, Nara 6318505, Japan.	ymatsuda@nara.kindai.ac.jp			JSPS KAKENHI Grant [25450375]	This work was supported by JSPS KAKENHI Grant Number 25450375.	Matsuda Y, 2006, PHYTOPATHOLOGY, V96, P967, DOI 10.1094/PHYTO-96-0967; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Kanetis L, 2010, PHYTOPATHOLOGY, V100, P738, DOI 10.1094/PHYTO-100-8-0738; Sequeira S, 2012, INT BIODETER BIODEGR, V74, P67, DOI 10.1016/j.ibiod.2012.07.011; da Silva M, 2006, INT BIODETER BIODEGR, V57, P163, DOI 10.1016/j.ibiod.2006.02.003; Cross J. A., 1987, ELECTROSTATICS PRINC, P269; Halliday D., 2005, FUNDAMENTALS PHYS, P580; Jonassen N, 2002, ELECTROSTATICS, P101; Kebbabi L, 2006, J PHYS D APPL PHYS, V39, P177, DOI 10.1088/0022-3727/39/1/026; Lamford W. A, 2002, MCGRAW HILL ENCY SCI, P442; LEACH CM, 1976, MYCOLOGIA, V68, P63, DOI 10.2307/3758898; Lourenco MJL, 2009, INT BIODETER BIODEGR, V63, P496, DOI 10.1016/j.ibiod.2008.10.011; Matsuda Y., 2012, J APPL PHYS, V112; Mizuno A., 1995, HDB ELECTROSTATIC PR, P653; Moriura N, 2006, MYCOL RES, V110, P18, DOI 10.1016/j.mycres.2005.09.007; Moriura N, 2006, PLANT PATHOL, V55, P367, DOI 10.1111/j.1635-3059.2006.01356.x; Nonomura T, 2009, MYCOL RES, V113, P364, DOI 10.1016/j.mycres.2008.11.012; Shimizu K, 2007, PLANT PATHOL, V56, P987, DOI 10.1111/j.1365-3059.2007.01681.x; Wegner H. E., 2002, MCGRAW HILL ENCY SCI, P42	19	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0393-5965	1573-3025		AEROBIOLOGIA	Aerobiologia	DEC	2014	30	4					435	444		10.1007/s10453-014-9340-8		10	Biology; Environmental Sciences	Life Sciences & Biomedicine - Other Topics; Environmental Sciences & Ecology	AT0KT	WOS:000344625800008		
J	Eid, EM; Shaltout, KH; Asaeda, T				Eid, Ebrahem M.; Shaltout, Kamal H.; Asaeda, Takashi			Growth dynamics of Potamogeton pectinatus L. in Lake Burullus, Egypt: a modelling approach	AFRICAN JOURNAL OF ECOLOGY			English	Article						coastal lagoons; material translocation; numerical growth model; sago pondweed; seasonal biomass; submerged macrophytes	PHRAGMITES-AUSTRALIS; BIOMASS PRODUCTION; SHALLOW LAKES; LIFE-CYCLES; MACROPHYTES; COMPETITION; ECOSYSTEMS; ALLOCATION; LAGOON; TYPHA	In this study, we used a macrophyte model to describe the growth production and the interaction between above- and below-ground organs of Potamogeton pectinatus in Lake Burullus, Egypt. Above- and below-ground biomass of P. pectinatus was sampled on a monthly basis from April to December 2011 at three sites of Lake Burullus. Shoots started to grow in April, reached the maximum biomass in September and then rapidly decreased in October when they moved into the senescence stage. Tubers biomass reduced in August due to the upward translocation to shoots, but sharply increased to the maximum in October by downward translocation from shoots and roots. Potamogeton pectinatus allocated approximately 82.3% of its total biomass to shoots, 15.5% to tubers and 2.2% to roots.	[Eid, Ebrahem M.] Kafr El Sheikh Univ, Fac Sci, Dept Bot, Kafr Al Sheikh 33516, Egypt; [Shaltout, Kamal H.] Tanta Univ, Dept Bot, Fac Sci, Tanta 31527, Egypt; [Asaeda, Takashi] Saitama Univ, IEST, Sakura Ku, Saitama 3388750, Japan	Eid, EM (reprint author), Kafr El Sheikh Univ, Fac Sci, Dept Bot, Kafr Al Sheikh 33516, Egypt.	ebrahem.eid@sci.kfs.edu.eg	Asaeda, Takashi/C-5278-2008		Egyptian Ministry of Higher Education	We thank Dr. A. H. Salama for English revision. The Egyptian Ministry of Higher Education funded the senior author for a six-month postdoctoral fellowship at Saitama University (Saitama, Japan), where part of this work was conducted.	ALEEM A A, 1969, Internationale Revue der Gesamten Hydrobiologie, V54, P491, DOI 10.1002/iroh.19690540403; Allen SE, 1989, CHEM ANAL ECOLOGICAL; ANDERSON MG, 1978, ECOLOGY, V59, P154, DOI 10.2307/1936642; Pineiro G, 2008, ECOL MODEL, V216, P316, DOI 10.1016/j.ecolmodel.2008.05.006; JORGENSEN SE, 1981, ECOL MODEL, V13, P111, DOI 10.1016/0304-3800(81)90009-0; HOWARDWILLIAMS C, 1981, OECOLOGIA, V49, P56, DOI 10.1007/BF00376898; Asaeda T, 2001, ECOL ENG, V16, P341, DOI 10.1016/S0925-8574(00)00120-8; MADSEN JD, 1988, FRESHWATER BIOL, V20, P41, DOI 10.1111/j.1365-2427.1988.tb01715.x; Asaeda T, 2000, AQUAT BOT, V67, P301, DOI 10.1016/S0304-3770(00)00095-4; Shaltout Kamal H., 2010, Ecologia Mediterranea, V36, P77; Asaeda T, 2000, AQUAT BOT, V68, P217, DOI 10.1016/S0304-3770(00)00123-6; Shaltout Kamal H., 2008, Wetlands Ecology and Management, V16, P421, DOI 10.1007/s11273-008-9079-5; Asaeda T, 1997, ECOL MODEL, V104, P261, DOI 10.1016/S0304-3800(97)00129-4; Asaeda T, 2005, ANN BOT-LONDON, V96, P299, DOI 10.1093/aob/mci178; Boulos L., 2005, FLORA EGYPT, V4; Butcher J. C., 2008, NUMERICAL METHODS OR; Casagranda C, 2007, FUND APPL LIMNOL, V168, P243, DOI 10.1127/1863-9135/2007/0168-0243; Clesceri LS, 1999, STANDARD METHODS EXA; COLLINS CD, 1989, AQUAT BOT, V33, P191, DOI 10.1016/0304-3770(89)90037-5; Eid EM, 2010, WETLANDS, V30, P240, DOI 10.1007/s13157-010-0023-0; Eid EM, 2012, ECOL MODEL, V243, P63, DOI 10.1016/j.ecolmodel.2012.05.028; Eid EM, 2010, AQUAT BOT, V92, P86, DOI 10.1016/j.aquabot.2009.10.010; HO YB, 1979, HYDROBIOLOGIA, V62, P7, DOI 10.1007/BF00012558; HOGEWEG P., 1969, Tropical Ecology, V10, P139; Hootsmans MJM, 1999, HYDROBIOLOGIA, V415, P7, DOI 10.1023/A:1003889504338; Hootsmans M.J.M, 1994, GEOBOTANY, V21, P250; Howard-Williams C., 1978, VERH INT VEREIN THEO, V20, P1153; HOWARDWILLIAMS C, 1979, FRESHWATER BIOL, V9, P13, DOI 10.1111/j.1365-2427.1979.tb01482.x; Kantrud H.A., 1990, US FISH WILDLIFE SER, V176; Kassas M., 2002, MANAGEMENT PLAN BURU; KAUTSKY L, 1987, AQUAT BOT, V27, P177, DOI 10.1016/0304-3770(87)90065-9; KRASKA M, 1990, FOLIA GEOBOT PHYTOTX, V25, P257; LUTHER H, 1983, Acta Botanica Fennica, V123, P1; LYTLE CM, 1995, GREAT BASIN NAT, V55, P164; Mader E, 1998, AQUAT BOT, V62, P147, DOI 10.1016/S0304-3770(98)00096-5; MADSEN JD, 1989, AQUAT BOT, V36, P23, DOI 10.1016/0304-3770(89)90088-0; MENENDEZ M, 1989, Scientia Marina, V53, P633; MOEN RA, 1989, AQUAT BOT, V33, P257, DOI 10.1016/0304-3770(89)90041-7; Obrador B, 2007, SCI MAR, V71, P57; OZIMEK T, 1986, EKOL POL-POL J ECOL, V34, P125; Pilon J., 2002, PLANT ECOL, V165, P247; Samaan A.A., 1988, B NAT I OCEANO, V14, P133; Santamaria L, 2004, AQUAT BOT, V79, P51, DOI 10.1016/j.aquabot.2004.01.006; Shaltout K.H., 2012, ETHNOBOT RES APPL, V10, P403; Shaltout K.H., 2005, PUBLICATION NATL BIO; Spencer DF, 2010, AQUAT BOT, V92, P239, DOI 10.1016/j.aquabot.2010.01.001; Statsoft, 2007, STAT VERS 7 1; Van den Berg MS, 1997, PHYCOLOGIA, V36, P115; VANDIJK GM, 1993, J AQUAT PLANT MANAGE, V31, P128; VANWIJCK C, 1994, VEGETATIO, V113, P171; VANWIJK RJ, 1988, AQUAT BOT, V32, P239, DOI 10.1016/0304-3770(88)90119-2; VANWIJK RJ, 1988, AQUAT BOT, V31, P211, DOI 10.1016/0304-3770(88)90015-0; VANWIJK RJ, 1989, AQUAT BOT, V35, P301, DOI 10.1016/0304-3770(89)90004-1	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-6707	1365-2028		AFR J ECOL	Afr. J. Ecol.	DEC	2014	52	4					414	426		10.1111/aje.12135		13	Ecology	Environmental Sciences & Ecology	AS6JH	WOS:000344369400004		
J	Sipe, JD; Benson, MD; Buxbaum, JN; Ikeda, S; Merlini, G; Saraiva, MJM; Westermark, P				Sipe, Jean D.; Benson, Merrill D.; Buxbaum, Joel N.; Ikeda, Shu-ichi; Merlini, Giampaolo; Saraiva, Maria J. M.; Westermark, Per			Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis	AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS			English	Editorial Material							SENILE SYSTEMIC AMYLOIDOSIS; INTERNATIONAL-SOCIETY; COMMITTEE; RECOMMENDATIONS; TRANSTHYRETIN		[Sipe, Jean D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02114 USA; [Benson, Merrill D.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Buxbaum, Joel N.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ikeda, Shu-ichi] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 390, Japan; [Merlini, Giampaolo] Univ Pavia, Amyloid Res & Treatment Ctr, I-27100 Pavia, Italy; [Merlini, Giampaolo] IRCCS Policlin San Matteo, Pavia, Italy; [Saraiva, Maria J. M.] Univ Porto, Amyloid Unit, Inst Mol & Cellular Biol, P-4100 Oporto, Portugal; [Westermark, Per] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden		jdsipe@msn.com	Merlini, Giampaolo/A-3817-2008	Merlini, Giampaolo/0000-0001-7680-3254			Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; den Dunnen JT, 2000, HUM MUTAT, V15, P7; D'Souza A, 2014, AMYLOID, V21, P71, DOI 10.3109/13506129.2013.876984; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Benditt EP, 1980, AMYLOID AMYLOIDOSIS, pXI; Benson MD, 2014, 14 INT S AM APR 27 M; Cohen AS, 1976, AMYLOIDOSIS, pix; HUSBY G, 1991, AMYLOID AND AMYLOIDOSIS 1990, P7; Kalkunte SS, 2013, AM J PATHOL, V183, P1425, DOI 10.1016/j.ajpath.2013.07.022; PITKANEN P, 1984, AM J PATHOL, V117, P391; Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508; Westermark P, 2002, AMYLOID, V9, P197; Westermark P, 1997, AMYLOID, V4, P216, DOI 10.3109/13506129709014387; KAZATCHKINE MD, 1993, B WORLD HEALTH ORGAN, V71, P105	19	38	39	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1350-6129	1744-2818		AMYLOID	Amyloid-J. Protein Fold. Disord.	DEC	2014	21	4					221	224		10.3109/13506129.2014.964858		4	Biochemistry & Molecular Biology; Medicine, General & Internal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; General & Internal Medicine; Research & Experimental Medicine	AS7ZQ	WOS:000344470800001		
J	Ikeda, M; Tashiro, Y; Takai, E; Kurose, S; Fugami, N; Tsuda, K; Arisaka, Y; Kodaira, S; Fujita, Y; Makioka, K; Mizuno, Y; Shimada, H; Harigaya, Y; Takatama, M; Amari, M; Yamazaki, T; Yamaguchi, H; Higuchi, T; Okamoto, K; Tsushima, Y; Ikeda, Y				Ikeda, Masaki; Tashiro, Yuichi; Takai, Eriko; Kurose, Sachiko; Fugami, Naoko; Tsuda, Kazuhisa; Arisaka, Yukiko; Kodaira, Sayaka; Fujita, Yukio; Makioka, Kouki; Mizuno, Yuji; Shimada, Hirotaka; Harigaya, Yasuo; Takatama, Masamitsu; Amari, Masakuni; Yamazaki, Tsuneo; Yamaguchi, Haruyasu; Higuchi, Tetsuya; Okamoto, Koichi; Tsushima, Yoshito; Ikeda, Yoshio			CSF levels of A beta 1-38/A beta 1-40/A beta 1-42 and C-11 PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease	AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS			English	Article						C-11 PiB-PET; amyloid beta protein; Alzheimer's disease; cerebrospinal fluid; primary progressive aphasia	FRONTOTEMPORAL LOBAR DEGENERATION; PITTSBURGH COMPOUND-B; CEREBROSPINAL-FLUID; PHOSPHORYLATED TAU; LATE-ONSET; ATROPHY; QUANTIFICATION; BIOMARKERS; CONSENSUS; DEMENTIA	Primary progressive aphasia (PPA) is a cognitive syndrome characterized by progressive and isolated language impairments due to neurodegenerative diseases. Recently, an international group of experts published a Consensus Classification of the three PPA clinical variants (naPPA, svPPA and lvPPA). We analyzed 24 patients with PPA by cognitive functions, neuroimaging (MRI, Tc-99m ECD-SPECT, C-11 PiB-PET and FDG-PET) and cerebrospinal fluid (CSF) analysis (ptau-181, A beta 1-42, A beta 1-40 and A beta 1-38), to elucidate relationships between neuroimaging studies and biochemical findings in the three PPA clinical variants. Cognitive and speech functions were measured by mini-mental state examination and standard language test of aphasia. The patients with lvPPA showed significant decreases in CSF A beta 1-42 and ratios of A beta 1-42/A beta 1-40 and A beta 1-42/A beta 1-38, and significant increases in CSF ptau-181 and ratios of ptau-181/A beta 1-42 and ptau-181/A beta 1-38; these findings were similar to those of patients with Alzheimer's disease (AD). We observed a higher frequency of the ApoE epsilon 4 allele in the lvPPA patients relative to the two other PPA variants. In C-11 PiB-PET of lvPPA patients, PiB positive findings were detected in cortices of frontal, temporal and parietal lobes and the posterior cingulate, where massive A beta may accumulate due to AD. Our results of AD-CSF markers including A beta 1-38 and C-11 PiB-PET in the lvPPA patients demonstrate a common pathological mechanism with the occurrence of AD.	[Ikeda, Masaki; Tashiro, Yuichi; Takai, Eriko; Kurose, Sachiko; Fugami, Naoko; Fujita, Yukio; Makioka, Kouki; Mizuno, Yuji; Ikeda, Yoshio] Gunma Univ, Grad Sch Med, Dept Neurol, Maebashi, Gunma 3718511, Japan; [Tashiro, Yuichi] Natl Hosp Mito Med Ctr, Dept Neurol, Mito, Ibaraki, Japan; [Tsuda, Kazuhisa; Shimada, Hirotaka] Gunma Univ Hosp, Dept Radiol, Maebashi, Gunma, Japan; [Arisaka, Yukiko; Kodaira, Sayaka; Higuchi, Tetsuya; Tsushima, Yoshito] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gunma 3718511, Japan; [Harigaya, Yasuo] Maebashi Red Cross Hosp, Dept Neurol, Maebashi, Gunma, Japan; [Takatama, Masamitsu; Amari, Masakuni; Okamoto, Koichi] Geriatr Res Inst & Hosp, Dept Neurol, Maebashi, Gunma, Japan; [Yamazaki, Tsuneo] Gunma Univ, Sch Hlth Sci, Dept Occupat Therapy, Maebashi, Gunma 3718511, Japan; [Yamaguchi, Haruyasu] Gunma Univ, Sch Hlth Sci, Dept Phys Therapy, Maebashi, Gunma 3718511, Japan	Ikeda, M (reprint author), Gunma Univ, Grad Sch Med, Dept Neurol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	mikeda@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23591231, 21591108, 23500426, 23300197, 24591263]; "Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI)'' of the New Energy and Industrial Technology Development Organization (NEDO) in Japan; "Dominantly Inherited Alzheimer's Network-Japan (DIAN-J)'' of the Ministry of Health, Labour and Welfare	This study received a Grant-in-Aid for Scientific Research (C) (MI: 23591231, YF: 21591108, TY: 23500426, HY: 23300197, YI: 24591263) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a funding from the "Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI)'' of the New Energy and Industrial Technology Development Organization (NEDO) in Japan, and a research grant of "Dominantly Inherited Alzheimer's Network-Japan (DIAN-J)'' of the Ministry of Health, Labour and Welfare. Dr Tashiro, Dr Takatama, Dr Amari and Dr Harigaya report no disclosures.	Magnin E, 2013, J NEUROL, V260, P528, DOI 10.1007/s00415-012-6671-7; Schoonenboom NSM, 2004, NEUROLOGY, V62, P1580; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; Mimura M, 1998, BRAIN, V121, P2083, DOI 10.1093/brain/121.11.2083; Neary D, 1998, NEUROLOGY, V51, P1546; Rohrer JD, 2012, NEUROBIOL AGING, V33, P744, DOI 10.1016/j.neurobiolaging.2010.05.020; Ogar JM, 2007, ALZ DIS ASSOC DIS, V21, pS23; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; YOSHIZAWA T, 1994, ANN NEUROL, V36, P656, DOI 10.1002/ana.410360416; Rabinovici GD, 2008, ANN NEUROL, V64, P388, DOI 10.1002/ana.21451; Gorno-Tempini ML, 2008, NEUROLOGY, V71, P1227, DOI 10.1212/01.wnl.0000320506.79811.da; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Rogalski E, 2011, NEUROLOGY, V76, P1804, DOI 10.1212/WNL.0b013e31821ccd3c; Migliaccio R, 2009, NEUROLOGY, V73, P1571, DOI 10.1212/WNL.0b013e3181c0d427; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mesulam MM, 2001, ANN NEUROL, V49, P425, DOI 10.1002/ana.91; Josephs KA, 2010, ARCH NEUROL-CHICAGO, V67, P596, DOI 10.1001/archneurol.2010.78; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; Bibl M, 2011, DEMENT GERIATR COGN, V31, P37, DOI 10.1159/000322370; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Ikeda M, 2013, AMYLOID, V20, P107, DOI 10.3109/13506129.2013.790810; Vanmechelen E, 2000, NEUROSCI LETT, V285, P49, DOI 10.1016/S0304-3940(00)01036-3; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Grossman M, 2012, LANCET NEUROL, V11, P545, DOI 10.1016/S1474-4422(12)70099-6; Grossman M, 2010, NAT REV NEUROL, V6, P88, DOI 10.1038/nrneurol.2009.216; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Funayama M, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-158; Gil-Navarro S, 2013, DEMENT GERIATR COGN, V35, P106, DOI 10.1159/000346289; Holsinger T, JAMA, V297, P2391; Ikeda M, 2012, AMYLOID, V19, P186, DOI 10.3109/13506129.2012.725113; Irwin DJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00006; Kas A, 2012, J NEUROL NEUROSUR PS, V83, P695, DOI 10.1136/jnnp-2012-302165; MCKHANN G, 1984, NEUROLOGY, V34, P939; UEKI A, 1993, NEUROSCI LETT, V163, P166, DOI 10.1016/0304-3940(93)90373-S	36	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1350-6129	1744-2818		AMYLOID	Amyloid-J. Protein Fold. Disord.	DEC	2014	21	4					238	245		10.3109/13506129.2014.949231		8	Biochemistry & Molecular Biology; Medicine, General & Internal; Medicine, Research & Experimental	Biochemistry & Molecular Biology; General & Internal Medicine; Research & Experimental Medicine	AS7ZQ	WOS:000344470800004		
J	Tanimukai, H; Hirai, K; Adachi, H; Kishi, A				Tanimukai, Hitsohi; Hirai, Kei; Adachi, Hiroyoshi; Kishi, Akane			Sleep problems and psychological distress in family members of patients with hematological malignancies in the Japanese population	ANNALS OF HEMATOLOGY			English	Article						Hematological malignancy; Family member; Insomnia; Depressive symptom; Worry	SYMPTOM ASSESSMENT SCALE; CANCER-PATIENTS; BREAST-CANCER; PSYCHIATRIC-DISORDERS; CIRCADIAN-RHYTHMS; RISK-FACTOR; DEPRESSION; INSOMNIA; CAREGIVERS; PREVALENCE	Patients with cancer frequently suffer from insomnia symptoms, and additionally, their family members also often experience these symptoms. The aim of this study was to investigate the prevalence of insomnia symptoms in both family members and patients with hematological malignancies. We conducted an observational cross-sectional study using a clinical self-reported questionnaire for sleep conditions, depressive symptoms (two-question method), and worries (five items that originated from the Brief Cancer Worry Inventory). One hundred twelve family members and 153 patients were investigated. A t test and Chi-square test were used to compare the prevalence of insomnia and depressive symptoms between family members and patients. Logistic regression was used to determine whether insomnia symptoms or worries related to patients' disease had an impact on depressive symptoms. The presence of insomnia symptoms in family members (87 %) was significantly higher than that in patients (60 %, p < 0.001). The prevalence of depressive mood and anhedonia in family members were 55 and 34 %, respectively, and these values were higher than those in patients (43 and 28 %, respectively). Insomnia symptoms and worries about present/prospective disease conditions were significantly associated with depressive mood (insomnia symptoms, odds ratios (OR) 4.3, confidence intervals (CI) 1.2-15.2, p = 0.025; worries, OR 4.4, CI 1.0-19.3, p = 0.048). Taken together, our results demonstrated that insomnia symptoms and depressive symptoms are highly prevalent in family members as well as in patients with hematological malignancies.	[Tanimukai, Hitsohi] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka 5650871, Japan; [Tanimukai, Hitsohi] Osaka Univ Hosp, Ctr Oncol, Osaka 553, Japan; [Hirai, Kei] Osaka Univ, Ctr Study Commun Design, Suita, Osaka 5650871, Japan; [Hirai, Kei] Osaka Univ, Support Off Large Scale Educ & Res Projects, Suita, Osaka 5650871, Japan; [Tanimukai, Hitsohi; Adachi, Hiroyoshi] Osaka Univ, Dept Psychiat, Hlth Care Ctr, Suita, Osaka 5650871, Japan; [Kishi, Akane] Kansai Univ, Grad Sch Psychol, Osaka, Japan	Tanimukai, H (reprint author), Osaka Univ, Dept Psychiat, Grad Sch Med, 2-2,D3, Suita, Osaka 5650871, Japan.	tanimuki@psy.med.osaka-u.ac.jp					American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Kim K, 2000, SLEEP, V23, P41; Davidson JR, 2002, SOC SCI MED, V54, P1309, DOI 10.1016/S0277-9536(01)00043-0; Fife BL, 2009, BONE MARROW TRANSPL, V43, P959, DOI 10.1038/bmt.2008.405; Mitchell AJ, 2012, J AFFECT DISORDERS, V140, P149, DOI 10.1016/j.jad.2011.12.043; Segrin C, 2007, PSYCHO-ONCOL, V16, P634, DOI 10.1002/pon.1111; van den Berg JF, 2009, SLEEP, V32, P1367; Ancoli-Israel S, 2006, SUPPORT CARE CANCER, V14, P201, DOI 10.1007/s00520-005-0861-0; GROND S, 1994, J PAIN SYMPTOM MANAG, V9, P372, DOI 10.1016/0885-3924(94)90174-0; WEYERER S, 1991, SLEEP, V14, P392; Allart P, 2013, PSYCHO-ONCOLOGY, V22, P241, DOI 10.1002/pon.3026; Fadul NA, 2008, J PALLIAT MED, V11, P422, DOI 10.1089/jpm.2007.0184; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Neckelmann D, 2007, SLEEP, V30, P873; Zimmermann C, 2013, LEUKEMIA RES, V37, P731, DOI 10.1016/j.leukres.2013.02.009; Walsh D, 2000, SUPPORT CARE CANCER, V8, P175, DOI 10.1007/s005200050281; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Hagedoorn M, 2008, PSYCHOL BULL, V134, P1, DOI 10.1037/0033-2909.134.1.1; Braun M, 2007, J CLIN ONCOL, V25, P4829, DOI 10.1200/JCO.2006.10.0909; Manitta V, 2011, J PAIN SYMPTOM MANAG, V42, P432, DOI 10.1016/j.jpainsymman.2010.12.008; Berger AM, 2007, J PAIN SYMPTOM MANAG, V33, P398, DOI 10.1016/j.jpainsymman.2006.09.022; Arroll B, 2003, BMJ-BRIT MED J, V327, P1144, DOI 10.1136/bmj.327.7424.1144; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; Vanderwerker LC, 2005, J CLIN ONCOL, V23, P6899, DOI 10.1200/JCO.2005.01.370; Beattie S, 2011, PSYCHO-ONCOLOGY, V20, P1137, DOI 10.1002/pon.1962; Berger Ann Malone, 2008, J Natl Compr Canc Netw, V6, P3; Byar Katherine L, 2006, Oncol Nurs Forum, V33, pE18, DOI 10.1188/06.ONF.E18-E26; Carney S, 2011, J CLIN ONCOL, V29, P1001, DOI 10.1200/JCO.2010.30.9104; Carter PA, 2000, CANCER NURS, V23, P410, DOI 10.1097/00002820-200012000-00002; Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y; Doi Yuriko, 2009, Nihon Rinsho, V67, P1463; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Fujisawa D, 2010, SUPPORT CARE CANCER, V18, P1393, DOI 10.1007/s00520-009-0761-9; Futterman AD, 1996, PSYCHOSOM MED, V58, P472; Gibbins J, 2009, J PAIN SYMPTOM MANAG, V38, P860, DOI 10.1016/j.jpainsymman.2009.04.025; GINSBURG ML, 1995, CAN MED ASSOC J, V152, P701; Hirai K, 2008, PSYCHO-ONCOL, V17, P1172, DOI 10.1002/pon.1348; Kozachik SL, 2008, CANCER NURS, V31, P334, DOI 10.1097/01.NCC.0000305769.27227.67; KRECH RL, 1991, J PAIN SYMPTOM MANAG, V6, P360, DOI 10.1016/0885-3924(91)90027-2; Matthews B Alex, 2003, Oncol Nurs Forum, V30, P493; O'Donnell Joseph F, 2004, Clin Cornerstone, V6 Suppl 1D, pS6, DOI 10.1016/S1098-3597(05)80002-X; Rocha FL, 2005, SLEEP MED, V6, P549, DOI 10.1016/j.sleep.2005.04.008; Tendas A, 2010, INTERNAL MED, V49, P1689, DOI 10.2169/internalmedicine.49.3747; Tranmer JE, 2003, J PAIN SYMPTOM MANAG, V25, P420, DOI 10.1016/S0885-3924(03)00074-5; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Wielgus KK, 2009, ONCOL NURS FORUM, V36, P38, DOI 10.1188/09.ONF.38-48	48	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	DEC	2014	93	12					2067	2075		10.1007/s00277-014-2139-4		9	Hematology	Hematology	AT2ZJ	WOS:000344803100015		
J	Yamamoto, R; Yokoyama, A; Yoneda, M; Ohashi, K; Hosoda, T; Kagoo, T; Boku, S; Ueno, H; Yano, T				Yamamoto, Ryusuke; Yokoyama, Akihiro; Yoneda, Mie; Ohashi, Kota; Hosoda, Toru; Kagoo, Toshiya; Boku, Saigen; Ueno, Hironori; Yano, Takahiro			Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia	ANNALS OF HEMATOLOGY			English	Letter									[Yamamoto, Ryusuke; Yokoyama, Akihiro; Yoneda, Mie; Ohashi, Kota; Hosoda, Toru; Kagoo, Toshiya; Boku, Saigen; Ueno, Hironori; Yano, Takahiro] Natl Hosp Org, Tokyo Med Ctr, Dept Internal Med, Div Hematol,Meguro Ku, Tokyo, Japan	Yokoyama, A (reprint author), Natl Hosp Org, Tokyo Med Ctr, Dept Internal Med, Div Hematol,Meguro Ku, 2-5-1 Higashigaoka, Tokyo, Japan.	ayokoyama@ntmc.hosp.go.jp					Al-Ali HK, 2012, LEUKEMIA LYMPHOMA, V53, P110, DOI 10.3109/10428194.2011.606382; Thepot S, 2014, AM J HEMATOL, V89, P410, DOI 10.1002/ajh.23654; Tawfik B, 2014, ANN HEMATOL, V93, P47, DOI 10.1007/s00277-013-1940-9; Maurillo L, 2012, CANCER-AM CANCER SOC, V118, P1014, DOI 10.1002/cncr.26354; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	DEC	2014	93	12					2081	2082		10.1007/s00277-014-2119-8		2	Hematology	Hematology	AT2ZJ	WOS:000344803100017		
J	Li, TT; Liao, XY; Lochhead, P; Morikawa, T; Yamauchi, M; Nishihara, R; Inamura, K; Kim, SA; Mima, K; Sukawa, Y; Kuchiba, A; Imamura, Y; Baba, Y; Shima, K; Meyerhardt, JA; Chan, AT; Fuchs, CS; Ogino, S; Qian, ZR				Li, Tingting; Liao, Xiaoyun; Lochhead, Paul; Morikawa, Teppei; Yamauchi, Mai; Nishihara, Reiko; Inamura, Kentaro; Kim, Sun A.; Mima, Kosuke; Sukawa, Yasutaka; Kuchiba, Aya; Imamura, Yu; Baba, Yoshifumi; Shima, Kaori; Meyerhardt, Jeffrey A.; Chan, Andrew T.; Fuchs, Charles S.; Ogino, Shuji; Qian, Zhi Rong			SMO Expression in Colorectal Cancer: Associations with Clinical, Pathological, and Molecular Features	ANNALS OF SURGICAL ONCOLOGY			English	Article							ISLAND METHYLATOR PHENOTYPE; HEDGEHOG SIGNALING PATHWAY; COLON-CANCER; MICROSATELLITE INSTABILITY; BRAF MUTATION; LINE-1 HYPOMETHYLATION; PROMOTER METHYLATION; PIK3CA MUTATION; ACTIVATION; DIFFERENTIATION	Smoothened, frizzled family receptor (SMO) is an important component of the hedgehog signaling pathway, which has been implicated in various human carcinomas. However, clinical, molecular, and prognostic associations of SMO expression in colorectal cancer remain unclear. Using a database of 735 colon and rectal cancers in the Nurse's Health Study and the Health Professionals Follow-up Study, we examined the relationship of tumor SMO expression (assessed by immunohistochemistry) to prognosis, and to clinical, pathological, and tumor molecular features, including mutations of KRAS, BRAF, and PIK3CA, microsatellite instability, CpG island methylator phenotype (CIMP), LINE-1 methylation, and expression of phosphorylated AKT and CTNNB1. SMO expression was detected in 370 tumors (50 %). In multivariate logistic regression analysis, SMO expression was independently inversely associated with phosphorylated AKT expression [odds ratio (OR) 0.48; 95 % confidence interval (CI) 0.34-0.67] and CTNNB1 nuclear localization (OR 0.48; 95 % CI 0.35-0.67). SMO expression was not significantly associated with colorectal cancer-specific or overall survival. However, in CIMP-high tumors, but not CIMP-low/0 tumors, SMO expression was significantly associated with better colorectal cancer-specific survival (log-rank P = 0.012; multivariate hazard ratio, 0.36; 95 % CI 0.13-0.95; P (interaction) = 0.035, for SMO and CIMP status). Our data reveal novel potential associations between the hedgehog, the WNT/CTNNB1, and the PI3K (phosphatidylinositol-4,5-bisphosphonate 3-kinase)/AKT pathways, supporting pivotal roles of SMO and hedgehog signaling in pathway networking. SMO expression in colorectal cancer may interact with tumor CIMP status to affect patient prognosis, although confirmation by future studies is needed.	[Li, Tingting; Liao, Xiaoyun; Lochhead, Paul; Yamauchi, Mai; Nishihara, Reiko; Inamura, Kentaro; Kim, Sun A.; Mima, Kosuke; Sukawa, Yasutaka; Kuchiba, Aya; Imamura, Yu; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji; Qian, Zhi Rong] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Li, Tingting; Liao, Xiaoyun; Lochhead, Paul; Yamauchi, Mai; Nishihara, Reiko; Inamura, Kentaro; Kim, Sun A.; Mima, Kosuke; Sukawa, Yasutaka; Kuchiba, Aya; Imamura, Yu; Meyerhardt, Jeffrey A.; Fuchs, Charles S.; Ogino, Shuji; Qian, Zhi Rong] Harvard Univ, Sch Med, Boston, MA USA; [Li, Tingting] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Gastroenterol, Beijing, Peoples R China; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Nishihara, Reiko; Kuchiba, Aya] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Inamura, Kentaro] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; [Baba, Yoshifumi] Kumamoto Univ, Dept Surg Gastroenterol, Kumamoto, Japan; [Shima, Kaori] Kagoshima Univ, Dept Oral Pathol, Kagoshima 890, Japan; [Chan, Andrew T.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Li, TT (reprint author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	shuji_ogino@dfci.harvard.edu; zhirong_qian@dfci.harvard.edu			USA National Institute of Health (NIH) [P01 CA87969, UM1 CA167552, P01 CA55075, R01 CA137178, P50 CA127003, R01 CA151993]; Bennett Family Fund for Targeted Therapies Research; Entertainment Industry Foundation through National Colorectal Cancer Research Alliance; Harvard University Frank Knox Memorial Fellowship; Chief Scientist Office, Scotland	Supported in part by USA National Institute of Health (NIH) [P01 CA87969 (to S. E. Hankinson), UM1 CA167552 and P01 CA55075 (to W. C. Willett), R01 CA137178 (to A. T. C.), P50 CA127003 (to C. S. F.), and R01 CA151993 (to S.O.)]; the Bennett Family Fund for Targeted Therapies Research; and the Entertainment Industry Foundation through National Colorectal Cancer Research Alliance. PL was supported by a Harvard University Frank Knox Memorial Fellowship and a fellowship from the Chief Scientist Office, Scotland. A. T. C is a Damon Runyon Clinical Investigator. We would like to thank the participants and staff of the Nurses' Health Study and the Health Professionals Follow-Up Study for their valuable contributions, as well as the following state cancer registries for their help: AL, AZ, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, NE, NH, NJ, NY, NC, ND, OH, OK, OR PA, RI, SC, TN, TX, VA, WA, and WY. In addition, this study was approved by the Connecticut Department of Public Health (DPH) Human Investigations Committee. Certain data used in this publication were obtained from the DPH. The authors assume full responsibility for analyses and interpretation of these data. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. Funding agencies did not have any role in the design of the study; the collection, analysis, or interpretation of the data; the decision to submit the article for publication; or the writing of the article.	Alinger B, 2009, VIRCHOWS ARCH, V454, P369, DOI 10.1007/s00428-009-0753-7; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/j.moldx.2006.060082; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031; Chatel G, 2007, INT J CANCER, V121, P2622, DOI 10.1002/ijc.22998; Lochhead P, 2013, JNCI-J NATL CANCER I, V105, P1151, DOI 10.1093/jnci/djt173; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Ding YL, 2012, ASIAN PAC J CANCER P, V13, P4001, DOI 10.7314/APJCP.2012.13.8.4001; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; Kim JH, 2014, WORLD J GASTROENTERO, V20, P4230, DOI 10.3748/wjg.v20.i15.4230; Domingo E, 2013, J PATHOL, V229, P441, DOI 10.1002/path.4139; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Baba Y, 2011, CANCER-AM CANCER SOC, V117, P1399, DOI 10.1002/cncr.25630; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/erm.12.46, 10.1586/ERM.12.46]; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Madhala-Levy D, 2012, J CELL PHYSIOL, V227, P1455, DOI 10.1002/jcp.22861; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Rosty C, 2013, J GASTROENTEROL, V48, P287, DOI 10.1007/s00535-012-0720-y; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Arimura S, 2009, GASTROENTEROLOGY, V137, P629, DOI 10.1053/j.gastro.2009.04.059; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Saqui-Salces M, 2010, BBA-MOL CELL RES, V1803, P786, DOI 10.1016/j.bbamcr.2010.03.008; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Funkhouser WK, 2012, J MOL DIAGN, V14, P91, DOI 10.1016/j.jmoldx.2011.11.001; Wu KL, 2013, J GASTROENTEROL, V48, P350, DOI 10.1007/s00535-012-0663-3; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Beggs AD, 2013, J PATHOL, V229, P697, DOI 10.1002/path.4132; Morikawa T, 2011, JAMA-J AM MED ASSOC, V305, P1685, DOI 10.1001/jama.2011.513; Hayashi Y, 2010, NEOPLASIA, V12, P1013, DOI 10.1593/neo.10780; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Akiyoshi T, 2006, GUT, V55, P991, DOI 10.1136/gut.2005.080333; Zlobec I, 2011, J PATHOL, V225, P336, DOI 10.1002/path.2879; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Hughes LAE, 2012, BBA-REV CANCER, V1825, P77, DOI 10.1016/j.bbcan.2011.10.005; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Fendrich V, 2011, NEOPLASIA, V13, P923, DOI 10.1593/neo.11088; Kawasaki T, 2007, NEOPLASIA, V9, P1091, DOI 10.1593/neo.07760; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Soerjomataram I, 2012, J GASTROENTEROL, V47, P999, DOI 10.1007/s00535-012-0567-2; Wang Dingzhi, 2011, Cancers (Basel), V3, P3894, DOI 10.3390/cancers3043894; Yang Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2209; Zhang YM, 2009, NEOPLASIA, V11, P96, DOI 10.1593/neo.81264	69	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21	13					4164	4173		10.1245/s10434-014-3888-y		10	Oncology; Surgery	Oncology; Surgery	AT0LA	WOS:000344626400019		
J	Matsuo, K; Cahoon, SS; Gualtieri, M; Scannell, CA; Jung, CE; Takano, T; Paulson, RJ; Muderspach, LI; Roman, LD				Matsuo, Koji; Cahoon, Sigita S.; Gualtieri, Marc; Scannell, Christopher A.; Jung, Carrie E.; Takano, Tadao; Paulson, Richard J.; Muderspach, Laila I.; Roman, Lynda D.			Significance of Adenomyosis on Tumor Progression and Survival Outcome of Endometrial Cancer	ANNALS OF SURGICAL ONCOLOGY			English	Article							CLEAR-CELL ADENOCARCINOMA; UTERINE ADENOMYOSIS; MYOMETRIAL INVASION; IMMUNOHISTOCHEMICAL ANALYSIS; STROMAL CELLS; TNF-ALPHA; CARCINOMA; GRADE; WOMEN; RISK	To examine the effects of adenomyosis on tumor progression and survival outcome of endometrial cancer patients. This is a retrospective study examining stage I-IV endometrial cancer patients who underwent hysterectomy-based surgical staging (n = 571), and endometrial hyperplasia patients who underwent hysterectomy (n = 213). Clinical demographics, histopathological factors, and survival outcomes were analyzed based on the presence or absence of adenomyosis. Among the endometrial cancer cohort, adenomyosis was observed in 47.5 % of cases and was significantly associated with lower grade (grade 1-2 tumors, 81.2 vs. 73.3 %; p = 0.028), earlier stage (stage I disease, 74.8 vs. 64.3 %; p = 0.023), and lower likelihood of deep myometrial invasion (19.2 vs. 28.2 %; p = 0.039) and cervical invasion (13.7 vs. 21.2 %; p = 0.024) than those without adenomyosis. In survival analysis, endometrial cancer coexisting with adenomyosis was associated with a significantly better disease-free survival (5-year rate, 89.2 vs. 78.2 %; p < 0.001) and overall survival (91.8 vs. 83.9 %; p = 0.004) after hysterectomy. In multivariate analysis, controlling for other significant variables in univariate analysis, presence of adenomyosis remained an independent prognostic factor associated with decreased risk of disease recurrence after surgery (hazard ratio [HR] 0.53; 95 % confidence interval [CI] 0.30-0.92; p = 0.023). Endometrial hyperplasia had a significantly increased incidence of adenomyosis when compared with type I endometrial cancer (grade 1-2 endometrioid adenocarcinoma, n = 411) on multivariate analysis (62.9 vs. 48.9 %; HR 1.88; 95 % CI 1.32-2.69; p < 0.001). Adenomyosis appears to be associated with less aggressive tumor behavior of endometrial cancer, suggesting that it may have inhibitory effects on the progression of this disease.	[Matsuo, Koji; Cahoon, Sigita S.; Jung, Carrie E.; Muderspach, Laila I.; Roman, Lynda D.] Univ So Calif, Los Angeles Cty Med Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Gualtieri, Marc; Paulson, Richard J.] Univ So Calif, Los Angeles Cty Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Los Angeles, CA 90033 USA; [Scannell, Christopher A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Matsuo, Koji; Muderspach, Laila I.; Roman, Lynda D.] Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Takano, Tadao] Tohoku Univ, Clin Res Innovat & Educ Ctr, Sendai, Miyagi 980, Japan	Matsuo, K (reprint author), Univ So Calif, Los Angeles Cty Med Ctr, Div Gynecol Oncol, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA.	koji.matsuo@gmail.com					Abushahin N, 2011, INT J GYNECOL PATHOL, V30, P271, DOI 10.1097/PGP.0b013e318200868e; Palena C, 2012, FUTURE ONCOL, V8, P713, DOI [10.2217/fon.12.59, 10.2217/FON.12.59]; Yang JH, 2007, HUM REPROD, V22, P945, DOI 10.1093/humrep/del493; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224; Wang F, 2009, FERTIL STERIL, V91, P1681, DOI 10.1016/j.fertnstert.2008.02.164; Vercellini P, 2006, BEST PRACT RES CL OB, V20, P465, DOI 10.1016/j.bpobgyn.2006.01.017; Garcia L, 2011, J MINIM INVAS GYN, V18, P428, DOI 10.1016/j.jmig.2011.04.004; Benagiano G, 2012, FERTIL STERIL, V98, P572, DOI 10.1016/j.fertnstert.2012.06.044; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Sotnikova N, 2002, AM J REPROD IMMUNOL, V47, P251, DOI 10.1034/j.1600-0897.2002.01040.x; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; Boes AS, 2011, EUR J GYNAECOL ONCOL, V32, P431; Couto D, 2004, ACTA OBSTET GYN SCAN, V83, P406, DOI 10.1111/j.0001-6349.2004.00025b.x; Gun I, 2012, MED GLAS, V9, P268; HALL JB, 1984, GYNECOL ONCOL, V17, P32, DOI 10.1016/0090-8258(84)90057-X; Hanley KZ, 2010, INT J GYNECOL PATHOL, V29, P445, DOI 10.1097/PGP.0b013e3181d81de6; HAYATA T, 1994, INT J GYNECOL OBSTET, V44, P76, DOI 10.1016/0020-7292(94)90030-2; HERNANDEZ E, 1980, AM J OBSTET GYNECOL, V138, P827; Hirabayashi K, 2009, INT J GYNECOL PATHOL, V28, P262, DOI 10.1097/PGP.0b013e31818e101f; Hsu Ming-I, 2006, Taiwan J Obstet Gynecol, V45, P346; Ichikawa Y, 2001, INT J GYNECOL CANCER, V11, P488, DOI 10.1046/j.1525-1438.2001.01066.x; Ismiil N, 2007, ANN DIAGN PATHOL, V11, P252, DOI 10.1016/j.anndiagpath.2006.08.011; Ismiil ND, 2007, INT J GYNECOL PATHOL, V26, P278, DOI 10.1097/01.pgp.0000235064.93182.ec; Izadi-Mood N, 2007, ARCH IRAN MED, V10, P258; JACQUES SM, 1990, GYNECOL ONCOL, V37, P401, DOI 10.1016/0090-8258(90)90376-V; Kairi-Vassilatou E, 2004, EUR J GYNAECOL ONCOL, V25, P222; Kazandi M, 2010, EUR J GYNAECOL ONCOL, V31, P719; Koike N, 2013, ONCOL REP, V29, P861, DOI 10.3892/or.2012.2184; Koshiyama M, 2004, CANCER DETECT PREV, V28, P94, DOI 10.1016/j.cdp.2003.12.008; Koshiyama M, 2002, INT J GYNECOL PATHOL, V21, P239, DOI 10.1097/00004347-200207000-00006; Kucera E, 2011, EUR J GYNAECOL ONCOL, V32, P182; Kuwashima Y., 1994, European Journal of Gynaecological Oncology, V15, P418; Mehasseb MK, 2011, GYNECOL OBSTET INVES, V71, P217, DOI 10.1159/000318205; MITTAL KR, 1993, GYNECOL ONCOL, V49, P197, DOI 10.1006/gyno.1993.1107; Motohara K, 2008, INT J CLIN ONCOL, V13, P266, DOI 10.1007/s10147-007-0725-3; Musa F, 2012, AM J OBSTET GYNECOL, V207; Ohta Y, 2008, PATHOL RES PRACT, V204, P677, DOI 10.1016/j.prp.2008.02.005; Puppa G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-103; Quick CM, 2012, INT J GYNECOL PATHOL, V31, P337, DOI 10.1097/PGP.0b013e31823ff422; Sasaki T, 2001, PATHOL INT, V51, P308, DOI 10.1046/j.1440-1827.2001.01200.x; Tagashira Y, 2009, FERTIL STERIL, V91, P2185, DOI 10.1016/j.fertnstert.2008.04.052; Takai N, 1999, GYNECOL OBSTET INVES, V48, P141, DOI 10.1159/000010139; Takeuchi K, 2004, INT J GYNECOL CANCER, V14, P1004, DOI 10.1111/j.1048-891X.2004.14541.x; WINKELMA.J, 1966, CANCER, V19, P901, DOI 10.1002/1097-0142(196607)19:7<901::AID-CNCR2820190703>3.0.CO;2-0; WOODRUFF JD, 1986, OBSTET GYNECOL, V67, P145	48	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21	13					4246	4255		10.1245/s10434-014-3880-6		10	Oncology; Surgery	Oncology; Surgery	AT0LA	WOS:000344626400030		
J	Liu, Y; Endo, Y; Fujita, T; Ishibashi, H; Nishioka, T; Canbay, E; Li, Y; Ogura, S; Yonemura, Y				Liu, Yang; Endo, Yoshio; Fujita, Takuji; Ishibashi, Haruaki; Nishioka, Toshihiro; Canbay, Emel; Li, Yan; Ogura, Shun-ichiro; Yonemura, Yutaka			Cytoreductive Surgery Under Aminolevulinic Acid-Mediated Photodynamic Diagnosis Plus Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Ovarian Cancer and Primary Peritoneal Carcinoma: Results of a Phase I Trial	ANNALS OF SURGICAL ONCOLOGY			English	Article							5-AMINOLEVULINIC ACID; GASTRIC-CANCER; MOUSE MODEL; THERAPY; ALA; CHEMOHYPERTHERMIA; DISSEMINATION; METASTASES	We conducted a phase I clinical trial to evaluate the sensitivity, specificity, and safety of cytoreductive surgery (CRS) under aminolevulinic acid-mediated photodynamic diagnosis (ALA-PDD) plus hyperthermic intraperitoneal chemotherapy (HIPEC) on 20 patients with peritoneal carcinomatosis (PC) from ovarian cancer and primary peritoneal carcinoma (PPC). Patients took 5-aminolevulinic acid (5-ALA) at a dose of 20 mg/kg orally with 50 mL of water 2 h before surgery. During surgery, the abdominal cavity was observed under blue light (wavelength of 440 nm) before and after CRS plus HIPEC. Specimens were excised and submitted for pathological examination to evaluate the specificity of ALA-PDD. Postoperative course was closely monitored and detailed information was recorded. CRS under ALA-PDD plus HIPEC was performed 21 times in 20 patients with PC (16 ovarian cancer, 4 PPC) between June 2011 and October 2013. With the exception of 1 (5 %) patient, strong red fluorescence was detected in 19 patients with ovarian cancer, with a sensitivity of 95 %. All specimens from red fluorescent lesions were invaded by cancer cells, with a specificity of 100 %. No severe adverse events occurred during the perioperative period, with the exception of some abnormal laboratory results and mild complications. All patients were alive until the last follow-up. ALA-PDD provided a high sensitivity and specificity in detecting peritoneal metastasis in patients with PC from ovarian serous carcinoma and PPC. CRS under ALA-PDD plus HIPEC was a feasible and safe treatment option for patients with PC from ovarian cancer and PPC.	[Liu, Yang; Fujita, Takuji; Ishibashi, Haruaki; Nishioka, Toshihiro; Canbay, Emel; Yonemura, Yutaka] NPO Support Peritoneal Disseminat Treatment, Osaka, Japan; [Liu, Yang; Yonemura, Yutaka] Kishiwada Tokushukai Hosp, Peritoneal Disseminat Ctr, Kishiwada, Japan; [Endo, Yoshio] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 920, Japan; [Li, Yan] Zhongnan Hosp, Dept Oncol, Wuhan, Peoples R China; [Ogura, Shun-ichiro] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan	Liu, Y (reprint author), NPO Support Peritoneal Disseminat Treatment, Osaka, Japan.	y.yonemura@coda.ocn.ne.jp	ENDO, Yoshio/D-8428-2015	ENDO, Yoshio/0000-0003-0785-2006			Allison RR, 2013, PHOTODIAGN PHOTODYN, V10, P331, DOI 10.1016/j.pdpdt.2013.03.011; Hino H, 2013, J SURG RES, V185, P119, DOI 10.1016/j.jss.2013.05.048; Nokes B, 2013, J SURG RES, V181, P262, DOI 10.1016/j.jss.2013.02.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Kishi K, 2012, J SURG ONCOL, V106, P294, DOI 10.1002/jso.23075; Yang XJ, 2011, ANN SURG ONCOL, V18, P1575, DOI 10.1245/s10434-011-1631-5; Waidelich R, 2001, J UROLOGY, V165, P1904, DOI 10.1016/S0022-5347(05)66239-8; Chang SJ, 2012, ANN SURG ONCOL, V19, P4059, DOI 10.1245/s10434-012-2446-8; Glehen O, 2004, LANCET ONCOL, V5, P219, DOI 10.1016/S1470-2045(04)01425-1; Loning M, 2004, CANCER, V100, P1650, DOI 10.1002/cncr.20155; Yonemura Y, 2005, BRIT J SURG, V92, P370, DOI 10.1002/bjs.4695; Mroz P, 2011, NANOMED-NANOTECHNOL, V7, P965, DOI 10.1016/j.nano.2011.04.007; Bakrin N, 2012, ANN SURG ONCOL, V19, P4052, DOI 10.1245/s10434-012-2510-4; Chung IWH, 2013, PHOTODIAGN PHOTODYN, V10, P362, DOI 10.1016/j.pdpdt.2013.03.007; Glehen O, 2003, J CLIN ONCOL, V21, P799, DOI 10.1200/JCO.2003.06.139; Chua TC, 2012, J CLIN ONCOL, V30, P2449, DOI 10.1200/JCO.2011.39.7166; Yano S, 2011, J PHOTOCH PHOTOBIO C, V12, P46, DOI 10.1016/j.jphotochemrev.2011.06.001; Bakrin N, 2013, EJSO-EUR J SURG ONC, V39, P742, DOI 10.1016/j.ejso.2013.02.018; Hahn SM, 2006, CLIN CANCER RES, V12, P2517, DOI 10.1158/1078-0432.CCR-05-1625; Hendren SK, 2001, ANN SURG ONCOL, V8, P65, DOI 10.1245/aso.2001.8.1.65; McCuire WP, 1996, NEW ENGL J MED, V334, P1; Sugarbaker P H, 1996, Cancer Treat Res, V82, P235; Takahashi K, 2013, ANTICANCER RES, V33, P2861	23	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21	13					4256	4262		10.1245/s10434-014-3901-5		7	Oncology; Surgery	Oncology; Surgery	AT0LA	WOS:000344626400031		
J	Saiura, A; Yamamoto, J; Koga, R; Takahashi, Y; Takahashi, M; Inoue, Y; Ono, Y; Kokudo, N				Saiura, Akio; Yamamoto, Junji; Koga, Rintaro; Takahashi, Yu; Takahashi, Michiro; Inoue, Yosuke; Ono, Yoshihiro; Kokudo, Norihiro			Favorable Outcome After Repeat Resection for Colorectal Liver Metastases	ANNALS OF SURGICAL ONCOLOGY			English	Article							LONG-TERM SURVIVAL; HEPATIC RESECTION; EXPANDING CRITERIA; CANCER; HEPATECTOMY; SURGERY; RESECTABILITY; RECURRENCE; PATTERNS; COHORT	The rate of recurrence after liver resection for colorectal liver metastases (CLM) is high, and repeat resection (RR) is reserved with curative intent in selected patients. This study evaluated the benefit of RR for recurrence after liver resection for CLM. Data were collected on 287 consecutive patients who underwent primary curative hepatectomy between January 1999 and October 2008 for CLM at our institution. After median follow-up of 63 months, 211 patients (73 %) developed recurrence and RR was conducted in 102 (48 %) patients. Five-year overall survival (OS) was significantly higher in the RR group than in those patients not selected for RR (70 vs. 45 %, P = 0.002). On multivariate analyses, RR was identified as an independent factor for good prognosis. According to the first recurrence sites, 5-year OS after recurrence was significantly better in patients with liver or lung only recurrence (55, 51 %, respectively) than in locoregional/lymph node metastases and other/multiple sites recurrence (33, 9.0 %, respectively). In patients with liver- or lung-only recurrence, 5-year OS after recurrence was significantly higher in RR patients than in those without RR (liver; 67 and 0 %, lung; 88 and 24 %, respectively; P < 0.001). Given similar indication criteria as the primary CLM, nearly half of all recurrence cases after liver resection for CLM could be salvaged by RR. In patients with liver-or lung-only recurrence, RR warrants a favorable outcome.	[Saiura, Akio; Koga, Rintaro; Takahashi, Yu; Takahashi, Michiro; Inoue, Yosuke; Ono, Yoshihiro] Japanese Fdn Canc Res, Dept Surg Gastroenterol, Canc Inst Hosp, Tokyo, Japan; [Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 359, Japan; [Kokudo, Norihiro] Univ Tokyo, Dept Surg, Grad Sch Med, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, Tokyo, Japan	Saiura, A (reprint author), Japanese Fdn Canc Res, Dept Surg Gastroenterol, Canc Inst Hosp, Tokyo, Japan.	akio.saiura@jfcr.or.jp					de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Wicherts DA, 2013, BRIT J SURG, V100, P808, DOI 10.1002/bjs.9088; Kulik U, 2013, BRIT J SURG, V100, P926, DOI 10.1002/bjs.9132; de Haas RJ, 2011, ANN SURG, V253, P1069, DOI 10.1097/SLA.0b013e318217e898; Shaw IM, 2006, BRIT J SURG, V93, P457, DOI 10.1002/bjs.5323; Brouquet A, 2011, J AM COLL SURGEONS, V213, P62, DOI 10.1016/j.jamcollsurg.2011.05.001; D'Angelica M, 2011, ANN SURG ONCOL, V18, P1096, DOI 10.1245/s10434-010-1409-1; Adair RA, 2012, BRIT J SURG, V99, P1278, DOI 10.1002/bjs.8845; Minagawa M, 2000, ANN SURG, V231, P487, DOI 10.1097/00000658-200004000-00006; Mise Y, 2010, ANN SURG, V251, P902, DOI 10.1097/SLA.0b013e3181c9868a; House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Saiura A, 2006, AM J SURG, V192, P41, DOI 10.1016/j.amjsurg.2006.01.025; Adam R, 2012, ONCOLOGIST, V17, P1225, DOI 10.1634/theoncologist.2012-0121; Pawlik TM, 2008, ONCOLOGIST, V13, P51, DOI 10.1634/theoncologist.2007-0142; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Gold JS, 2008, ANN SURG, V247, P109, DOI 10.1097/SLA.0b013e3181557e47; Brouquet A, 2011, J AM COLL SURGEONS, V213, P69; House MG, 2010, J AM COLL SURGEONS, V210, P752; Jones RP, 2013, BRIT J SURG, V99, P477; Quan D, 2012, SURGERY, V151, P860, DOI 10.1016/j.surg.2011.12.018; Saiura A, 2012, WORLD J SURG, V36, P2171, DOI 10.1007/s00268-012-1616-y; Vauthey JN, 2013, ANN SURG, V258, P619, DOI 10.1097/SLA.0b013e3182a5025a	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21	13					4293	4299		10.1245/s10434-014-3863-7		7	Oncology; Surgery	Oncology; Surgery	AT0LA	WOS:000344626400036		
J	Higuchi, R; Ota, T; Araida, T; Kajiyama, H; Yazawa, T; Furukawa, T; Yoshikawa, T; Takasaki, K; Yamamoto, M				Higuchi, Ryota; Ota, Takehiro; Araida, Tatsuo; Kajiyama, Hideki; Yazawa, Takehisa; Furukawa, Toru; Yoshikawa, Tatsuya; Takasaki, Ken; Yamamoto, Masakazu			Surgical Approaches to Advanced Gallbladder Cancer A 40-Year Single-Institution Study of Prognostic Factors and Resectability	ANNALS OF SURGICAL ONCOLOGY			English	Article							EXTRAHEPATIC BILE-DUCT; BILIARY SURGERY SURVEY; RADICAL SURGERY; COMBINED RESECTION; ADVANCED-CARCINOMA; JAPANESE SOCIETY; PANCREATICODUODENECTOMY; PATTERNS; SURVIVAL; LYMPHADENECTOMY	The aim was to evaluate prognostic factors and factors associated with the resectability of advanced gallbladder cancer (GBC). This was a single-institution retrospective review of 274 consecutive surgically-treated cases of advanced GBC (excluding incidental GBC and early GBC). Univariate and multivariate analysis were performed to assess prognostic variables. R0 resection and survival rates were investigated for each local extension factor. Long-term survival was uncommon among patients with multiple liver metastases (H2-3: n = 22; 2-year survival, 0 %), dissemination (P1-3: n = 16; 3-year survival, 0 %), invasion through the hepatoduodenal ligament (Binf(3): n = 45; 5-year survival, 4.6 %), or group 3 lymph node (LN) metastasis including of the para-aortic LN (N-3: n = 52; 13.7 %). Long-term survival rates did not differ significantly between patients who did and did not undergo bile duct resection or pancreaticoduodenectomy. Survival did not differ significantly according to the type of hepatectomy performed. Surgery may not be indicated for patients with multiple liver metastasis, dissemination, Binf(3), or visible para-aortic LN metastasis. Furthermore, it is important to achieve R0 surgery in cases of GBC.	[Higuchi, Ryota; Ota, Takehiro; Kajiyama, Hideki; Yazawa, Takehisa; Yoshikawa, Tatsuya; Takasaki, Ken; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan; [Araida, Tatsuo] Tokyo Womens Med Univ, Div Gastroenterol Surg, Dept Surg, Yachiyo Med Ctr, Tokyo, Japan; [Furukawa, Toru] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan; [Furukawa, Toru] Tokyo Womens Med Univ, Int Res & Educ Inst Integrated Med Sci, Tokyo, Japan	Higuchi, R (reprint author), Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan.	yamamoto@ige.twmu.ac.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; D'Hondt M, 2013, EJSO-EUR J SURG ONC, V39, P548, DOI 10.1016/j.ejso.2013.02.010; Kondo S, 2000, BRIT J SURG, V87, P418, DOI 10.1046/j.1365-2168.2000.01384.x; Pilgrim CHC, 2013, DIGEST DIS SCI, V58, P2455, DOI 10.1007/s10620-013-2713-y; Hawkins WG, 2004, ANN SURG ONCOL, V11, P310, DOI 10.1245/ASO.2004.03.011; Kiran RP, 2007, ANN SURG ONCOL, V14, P827, DOI 10.1245/s10434-006-9224-4; Lim H, 2013, J CLIN GASTROENTEROL, V47, P443, DOI 10.1097/MCG.0b013e3182703409; Miyakawa S, 2009, J HEPATO-BILIARY-PAN, V16, P1, DOI 10.1007/s00534-008-0015-0; Birnbaum DJ, 2014, EJSO-EUR J SURG ONC, V40, P1008, DOI 10.1016/j.ejso.2013.10.014; Agarwal AK, 2007, ANN SURG ONCOL, V14, P2831, DOI 10.1245/s10434-007-9456-y; Nishio H, 2011, ANN SURG, V253, P953, DOI 10.1097/SLA.0b013e318216f5f3; Balachandran P, 2006, J GASTROINTEST SURG, V10, P848, DOI 10.1016/j.gassur.2005.12.002; D'Angelica M, 2009, ANN SURG ONCOL, V16, P806, DOI 10.1245/s10434-008-0189-3; Horiguchi A, 2013, J HEPATO-BIL-PAN SCI, V20, P518, DOI 10.1007/s00534-012-0584-9; Wakai T, 2010, AM J SURG PATHOL, V34, P65, DOI 10.1097/PAS.0b013e3181c467d4; Araida T, 2004, J HEPATO-BILIARY-PAN, V11, P45, DOI 10.1007/s00534-003-0867-2; Araida T, 2009, J HEPATO-BILIARY-PAN, V16, P204, DOI 10.1007/s00534-009-0044-3; Araida T, 2009, SURG TODAY, V39, P770, DOI 10.1007/s00595-009-3960-6; Chapman WC, 2010, J AM COLL SURGEONS, V210, P814; Benoist S, 1998, AM J SURG, V175, P118, DOI 10.1016/S0002-9610(97)00269-9; Chan KM, 2005, WORLD J SURG, V29, P72, DOI 10.1007/s00268-004-7544-8; Ebata T, 2007, J HEPATO-BILIARY-PAN, V14, P131, DOI 10.1007/s00534-006-1106-4; Endo I, 2001, J Hepatobiliary Pancreat Surg, V8, P505, DOI 10.1007/s005340100017; Fong YM, 2006, ANN SURG, V243, P767, DOI 10.1097/01.sla.0000219737.81943.4e; Fong Y, 2006, ANN SURG, V243, P771, DOI DOI 10.1097/01.SLA.0000219737.81943.4E; Hemming AW, 2010, J AM COLL SURGEONS, V210, P808, DOI 10.1016/j.jamcollsurg.2009.12.007; Japanese Society of Biliary Surgery (JSBS), 2004, CLASS BIL TRACT CARC; Jin LAX, 2013, SURGERY, V154, P266, DOI 10.1016/j.surg.2013.04.022; Kaneoka Y, 2003, WORLD J SURG, V27, P260, DOI 10.1007/s00268-002-6702-0; Kang MJ, 2012, HPB, V14, P805, DOI 10.1111/j.1477-2574.2012.00544.x; Kayahara M, 2008, ANN SURG, V248, P807, DOI 10.1097/SLA.0b013e31818a1561; Kenjo A, 2014, J AM COLL SURGEONS, V218, P412; Kishi Y, 2012, ANN SURG ONCOL, V19, P3567, DOI 10.1245/s10434-012-2599-5; Kohya N, 2008, J SURG ONCOL, V97, P498, DOI 10.1002/jso.20982; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P741, DOI 10.1001/archsurg.138.7.741; Kondo S, 2001, J Hepatobiliary Pancreat Surg, V8, P511, DOI 10.1007/s005340100018; Ota T, 2007, J HEPATO-BILIARY-PAN, V14, P155, DOI 10.1007/s00534-006-1110-8; Regimbeau JM, 2011, EJSO-EUR J SURG ONC, V37, P505, DOI 10.1016/j.ejso.2011.03.135; Sakamoto Y, 2013, SURGERY, V153, P794, DOI 10.1016/j.surg.2012.11.024; Shimizu Y, 2004, SURGERY, V136, P1012, DOI 10.1016/j.surg.2004.04.032; Shirai Y, 1997, HEPATO-GASTROENTEROL, V44, P376; Shukla PJ, 2008, ANN SURG ONCOL, V15, P3132, DOI 10.1245/s10434-008-9917-y; Sobin LH, 2009, TNM CLASSIFICATION M; Takada T, 1977, Jpn J Surg, V7, P10, DOI 10.1007/BF02469402; Wiggers JK, 2014, HPB, V16, P635, DOI 10.1111/hpb.12188; Yagi H, 2006, J HEPATO-BILIARY-PAN, V13, P530, DOI 10.1007/s00534-006-1104-6	46	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	DEC	2014	21	13					4308	4316		10.1245/s10434-014-3885-1		9	Oncology; Surgery	Oncology; Surgery	AT0LA	WOS:000344626400038		
J	Fukuda, T; Sugiyama, S; Sawagaki, T; Nakamura, K				Fukuda, Takehiro; Sugiyama, Shin; Sawagaki, Takanobu; Nakamura, Kazuki			Recent variations in the terminus position, ice velocity and surface elevation of Langhovde Glacier, East Antarctica	ANTARCTIC SCIENCE			English	Article						calving; ice shelf; outlet glacier; satellite image; sea ice	PINE ISLAND GLACIER; WEST ANTARCTICA; SOYA COAST; SHEET; STABILITY; PENINSULA; TERRAIN; RETREAT; DRIVEN; IMAGES	To improve the understanding of the mechanism driving recent changes in outlet glaciers in East Antarctica, we measured changes in the terminus position, ice flow velocity and surface elevation of the Langhovde Glacier located on the Soya Coast. From satellite images from 2000-12 and field measurements taken in 2012 the glacier terminus position and flow velocity showed little change between 2003 and 2007. After this quiescent period, the glacier progressively advanced by 380m and the flow velocity increased near the calving front by 10m a(-1) from 2007-10. No significant change was observed in surface elevation during the study period. The changes in the terminus position and flow velocity imply a reduction in the calving rate from 93m a(-1) (2003-07) to 16m a(-1) (2007-10). This suggests that calving was inhibited by stable sea ice conditions in the ocean. Theses results indicate that the Langhovde Glacier was in a relatively stable condition during the study period, and its terminus position was controlled by the rate of calving under the influence of sea ice conditions.	[Fukuda, Takehiro; Sugiyama, Shin] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Fukuda, Takehiro] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0600810, Japan; [Sawagaki, Takanobu] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan; [Nakamura, Kazuki] Nihon Univ, Coll Engn, Koriyama, Fukushima 9631165, Japan	Sugiyama, S (reprint author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan.	sugishin@lowtem.hokudai.ac.jp	Sugiyama, Shin/C-2511-2012		National Institute of Polar Research; JSPS KAKENHI [23651002 (2011-14)]	This research was carried out as a part of the JARE53 programme. We thank the members of JARE53 and 52 for their help in the field. The field activity was financially supported by the National Institute of Polar Research, and the research project was funded by JSPS KAKENHI Grant Number 23651002 (2011-14). We used ASTER data beta processed by AIST GEO Grid, using ASTER data owned by METI and NASA. We thank D. White and C. Stokes for providing insightful comments, and the Scientific Editor R. Bingham for handling the paper.	MacGregor JA, 2012, J GLACIOL, V58, P458, DOI 10.3189/2012JoG11J262; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Herman F, 2011, J GLACIOL, V57, P197; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Yu JY, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007456; Scherler D, 2008, REMOTE SENS ENVIRON, V112, P3806, DOI 10.1016/j.rse.2008.05.018; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Stearns LA, 2008, NAT GEOSCI, V1, P827, DOI 10.1038/ngeo356; Leprince S, 2007, IEEE T GEOSCI REMOTE, V45, P1529, DOI 10.1109/TGRS.2006.888937; Whitworth T, 1998, ANTARCT RES SER, V75, P1; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Scott JBT, 2009, CRYOSPHERE, V3, P125, DOI 10.5194/tc-3-125-2009; Miles BWJ, 2013, NATURE, V500, P563, DOI 10.1038/nature12382; Lamsal D, 2011, J MT SCI-ENGL, V8, P390, DOI 10.1007/s11629-011-2064-0; Reeh N, 2001, ANN GLACIOL, V33, P474, DOI 10.3189/172756401781818554; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; Berthier E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051755; Callens D., 2013, CRYOSPHERE DISCUSSIO, V7, P4913; Fox AJ, 2005, J GLACIOL, V51, P555, DOI 10.3189/172756505781829043; Frezzotti M, 2002, ANN GLACIOL, V34, P235, DOI 10.3189/172756402781817897; Iizuka Y, 2001, J GLACIOL, V47, P223, DOI 10.3189/172756501781832359; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; Komazawa K., 2014, THESIS HOKKAIDO U; Lee H, 2012, EARTH PLANET SC LETT, V321, P74, DOI 10.1016/j.epsl.2011.12.040; Miura H, 1998, ANN GLACIOL, V27, P297; Moon T, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000927; Nakamura K., 2007, POLAR SCI, V1, P73, DOI DOI 10.1016/J.P0LAR.2007.09.002); Nakawo M., 1978, MEM NATL I POLAR RES, V7, P235; Ohshima KI, 1996, J GEOPHYS RES-OCEANS, V101, P20617, DOI 10.1029/96JC01752; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Shuman CA, 2011, J GLACIOL, V57, P737; Sugiyama S., 2014, EARTH PLANET SC LETT, V399, DOI [10.1016/j.espl.2014.05.001, DOI 10.1016/J.ESPL.2014.05.001]; Toutin T, 2002, IEEE T GEOSCI REMOTE, V40, P2241, DOI 10.1109/TGRS.2002.802878; Ushio S., 2006, J JAPANESE SOC SNOW, V68, P299, DOI 10.5331/seppyo.68.299; Ushio S., 2010, SUMM JSSI JSSE JOINT, VB3-15, P209; Ushio S., 2012, SUMM JSSI JSSE JOINT, VC3-1, P72	38	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0954-1020	1365-2079		ANTARCT SCI	Antarct. Sci.	DEC	2014	26	6			SI		636	645		10.1017/S0954102014000364		10	Environmental Sciences; Geography, Physical; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Physical Geography; Geology	AT2BO	WOS:000344736100006		
J	Kudo, N; Shinohara, H; Kodama, H				Kudo, Naoko; Shinohara, Hitomi; Kodama, Hideya			Heart Rate Variability Biofeedback Intervention for Reduction of Psychological Stress During the Early Postpartum Period	APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK			English	Article						Heart rate variability; Biofeedback; Edinburgh Postnatal Depression Scale; Early postpartum period; Psychological stress	POSTNATAL DEPRESSION SCALE; AUTONOMIC NERVOUS ACTIVITY; ANXIETY DISORDERS; VAGAL TONE; PREGNANCY; PREVALENCE; RECOVERY; SCREEN; SLEEP; WOMEN	This study examined the effectiveness of heart rate variability (HRV) biofeedback intervention for reduction of psychological stress in women in the early postpartum period. On postpartum day 4, 55 healthy subjects received a brief explanation about HRV biofeedback using a portable device. Among them, 25 mothers who agreed to implement HRV biofeedback at home were grouped as the biofeedback group, and other 30 mothers were grouped as the control group. At 1 month postpartum, there was a significant decrease in total Edinburgh Postnatal Depression Scale score (P < 0.001) in the biofeedback group; this change was brought about mainly by decreases in items related to anxiety or difficulty sleeping. There was also a significant increase in standard deviation of the normal heartbeat interval (P < 0.01) of the resting HRV measures in the biofeedback group after adjusting for potential covariates. In conclusion, postpartum women who implemented HRV biofeedback after delivery were relatively free from anxiety and complained less of difficulties sleeping at 1 month postpartum. Although the positive effects of HRV biofeedback may be partly attributable to intervention effects, due to its clinical outcome, HRV biofeedback appears to be recommendable for many postpartum women as a feasible health-promoting measure after childbirth.	[Kudo, Naoko; Shinohara, Hitomi; Kodama, Hideya] Akita Grad Sch Med, Sch Hlth Sci, Dept Matern Child Nursing, Akita 0108543, Japan; [Kudo, Naoko; Shinohara, Hitomi; Kodama, Hideya] Fac Med, Akita 0108543, Japan	Kodama, H (reprint author), Akita Grad Sch Med, Sch Hlth Sci, Dept Matern Child Nursing, 1-1-1 Hondo, Akita 0108543, Japan.	kodamah@hs.akita-u.ac.jp					Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1193/annals.1314.001; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Matthey S, 2008, DEPRESS ANXIETY, V25, P926, DOI 10.1002/da.20415; Beckham AJ, 2013, ARCH WOMEN MENT HLTH, V16, P59, DOI 10.1007/s00737-012-0318-7; Siepmann M, 2008, APPL PSYCHOPHYS BIOF, V33, P195, DOI 10.1007/s10484-008-9064-z; Henriques G, 2011, APPL PSYCHOPHYS BIOF, V36, P101, DOI 10.1007/s10484-011-9151-4; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Weber CS, 2010, EUR J APPL PHYSIOL, V109, P201, DOI 10.1007/s00421-009-1341-x; Hassett AL, 2007, APPL PSYCHOPHYS BIOF, V32, P1, DOI 10.1007/s10484-006-9028-0; Wheat AL, 2010, APPL PSYCHOPHYS BIOF, V35, P229, DOI 10.1007/s10484-010-9133-y; Grassi G, 1999, J HYPERTENS, V17, P719, DOI 10.1097/00004872-199917060-00001; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Reiner R, 2008, APPL PSYCHOPHYS BIOF, V33, P55, DOI 10.1007/s10484-007-9046-6; COX JL, 1993, BRIT J PSYCHIAT, V163, P27, DOI 10.1192/bjp.163.1.27; Matthey S, 2013, J AFFECT DISORDERS, V146, P224, DOI 10.1016/j.jad.2012.09.009; Hallman DM, 2011, APPL PSYCHOPHYS BIOF, V36, P71, DOI 10.1007/s10484-011-9147-0; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Swanson KS, 2009, APPL PSYCHOPHYS BIOF, V34, P71, DOI 10.1007/s10484-009-9077-2; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Klainin P, 2009, INT J NURS STUD, V46, P1355, DOI 10.1016/j.ijnurstu.2009.02.012; Tan G, 2011, APPL PSYCHOPHYS BIOF, V36, P27, DOI 10.1007/s10484-010-9141-y; Lee KA, 2000, OBSTET GYNECOL, V95, P14, DOI 10.1016/S0029-7844(99)00486-X; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Dorheim SK, 2009, SLEEP, V32, P847; Zucker TL, 2009, APPL PSYCHOPHYS BIOF, V34, P135, DOI 10.1007/s10484-009-9085-2; Del Pozo Jessica M, 2004, Am Heart J, V147, pE11, DOI 10.1016/j.ahj.2003.08.013; Ebben MR, 2009, APPL PSYCHOPHYS BIOF, V34, P245, DOI 10.1007/s10484-009-9086-1; Kuo CD, 2000, BRIT J ANAESTH, V84, P323; Lehrer P, 2013, APPL PSYCHOPHYS BIOF, V38, P143, DOI 10.1007/s10484-013-9217-6; Matsuo H, 2007, CLIN EXP OBSTET GYN, V34, P73; McLay RN, 2009, APPL PSYCHOPHYS BIOF, V34, P319, DOI 10.1007/s10484-009-9104-3; Ratanasiripong P., 2012, RANDOMIZED CONTROLLE, V2012; Ross LE, 2009, J WOMENS HEALTH, V18, P475, DOI 10.1089/jwh.2008.0953; Sakakibara M, 2013, APPL PSYCHOPHYS BIOF, V38, P265, DOI 10.1007/s10484-013-9232-7; Stein G. S., 1980, J PSYCHOSOM RES, V24, P1165; Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996, EUROPEAN HEART J, V17, P354, DOI DOI 10.1161/01.CIR.93.5.1043; Walther T, 2005, HYPERTENS RES, V28, P113, DOI 10.1291/hypres.28.113; Whited A, 2014, APPL PSYCHOPHYS BIOF, V39, P75, DOI 10.1007/s10484-014-9243-z	40	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1090-0586	1573-3270		APPL PSYCHOPHYS BIOF	Appl. Psychophysiol. Biofeedback	DEC	2014	39	3-4					203	211		10.1007/s10484-014-9259-4		9	Psychology, Clinical	Psychology	AT2PI	WOS:000344776300006		
J	Bazilevs, Y; Takizawa, K; Tezduyar, TE; Hsu, MC; Kostov, N; McIntyre, S				Bazilevs, Yuri; Takizawa, Kenji; Tezduyar, Tayfun E.; Hsu, Ming-Chen; Kostov, Nikolay; McIntyre, Spenser			Aerodynamic and FSI Analysis of Wind Turbines with the ALE-VMS and ST-VMS Methods	ARCHIVES OF COMPUTATIONAL METHODS IN ENGINEERING			English	Review							FLUID-STRUCTURE INTERACTION; FINITE-ELEMENT FORMULATIONS; INCOMPRESSIBLE-FLOW COMPUTATIONS; DIRICHLET BOUNDARY-CONDITIONS; VARIATIONAL MULTISCALE METHOD; MODIFIED GEOMETRIC POROSITY; LARGE-EDDY SIMULATION; SPACE-TIME PROCEDURE; SLIP MESH UPDATE; ISOGEOMETRIC ANALYSIS	We provide an overview of the aerodynamic and FSI analysis of wind turbines the first three authors' teams carried out in recent years with the ALE-VMS and ST-VMS methods. The ALE-VMS method is the variational multiscale version of the Arbitrary Lagrangian-Eulerian (ALE) method. The VMS components are from the residual-based VMS (RBVMS) method. The ST-VMS method is the VMS version of the deforming-spatial-domain/stabilized space-time (DSD/SST) method. The techniques complementing these core methods include weak enforcement of the essential boundary conditions, NURBS-based isogeometric analysis, using NURBS basis functions in temporal representation of the rotor motion, mesh motion and also in remeshing, rotation representation with constant angular velocity, Kirchhoff-Love shell modeling of the rotor-blade structure, and full FSI coupling. The analysis cases include the aerodynamics of standalone wind-turbine rotors, wind-turbine rotor and tower, and the FSI that accounts for the deformation of the rotor blades. The specific wind turbines considered are NREL 5MW, NREL Phase VI and Micon 65/13M, all at full scale, and our analysis for NREL Phase VI and Micon 65/13M includes comparison with the experimental data.	[Bazilevs, Yuri] Univ Calif San Diego, La Jolla, CA 92093 USA; [Takizawa, Kenji] Waseda Univ, Waseda Inst Adv Study, Dept Modern Mech Engn, Shinjuku Ku, Tokyo 1698050, Japan; [Tezduyar, Tayfun E.; Kostov, Nikolay; McIntyre, Spenser] Rice Univ, Houston, TX 77005 USA; [Hsu, Ming-Chen] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA	Bazilevs, Y (reprint author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jbazilevs@ucsd.edu	Hsu, Ming-Chen/J-1881-2012; Tezduyar, Tayfun/F-6134-2012; Takizawa, Kenji/E-2245-2013	Hsu, Ming-Chen/0000-0001-8062-8612; Tezduyar, Tayfun/0000-0001-8707-3162; Takizawa, Kenji/0000-0003-1172-113X	NSF CAREER Award; NSF [CBET-1306869]; Air Force Office of Scientific Research [FA9550-12-1-0005]; ARO [W911NF-09-1-0346, W911NF-12-1-0162]; Rice-Waseda Research Agreement	We wish to thank the Texas Advanced Computing Center (TACC) and the San Diego Supercomputing Center (SDSC) for providing HPC resources that have contributed to the research results reported in this paper. The first author acknowledges the support of the NSF CAREER Award, the NSF Award CBET-1306869, and the Air Force Office of Scientific Research Award FA9550-12-1-0005. The ST-VMS part of the work was supported by ARO grants W911NF-09-1-0346 and W911NF-12-1-0162 (third author) and Rice-Waseda Research Agreement (second author).	Zhang YJ, 2007, COMPUT METHOD APPL M, V196, P2943, DOI 10.1016/j.cma.2007.02.009; Tezduyar TE, 2000, COMPUT METHOD APPL M, V190, P411; Rispoli F, 2007, COMPUT FLUIDS, V36, P121, DOI 10.1016/j.compfluid.2005.07.004; Isaksen JG, 2008, STROKE, V39, P3172, DOI 10.1161/STROKEAHA.107.503698; Benson DJ, 2011, COMPUT METHOD APPL M, V200, P1367, DOI 10.1016/j.cma.2010.12.003; Takizawa K, 2012, ARCH COMPUT METHOD E, V19, P125, DOI 10.1007/s11831-012-9070-4; Bazilevs Y, 2010, COMPUT METHOD APPL M, V199, P229, DOI 10.1016/j.cma.2009.02.036; Tezduyar TE, 2006, COMPUT METHOD APPL M, V195, P2002, DOI 10.1016/j.cma.2004.09.014; Onate E, 2006, COMPUT MECH, V38, P440, DOI 10.1007/s00466-006-0060-y; Bazilevs Y, 2010, COMPUT METHOD APPL M, V199, P780, DOI 10.1016/j.cma.2008.11.020; JOHNSON AA, 1994, COMPUT METHOD APPL M, V119, P73, DOI 10.1016/0045-7825(94)00077-8; Wall WA, 2008, COMPUT METHOD APPL M, V197, P2976, DOI 10.1016/j.cma.2008.01.025; Akkerman I, 2008, COMPUT MECH, V41, P371, DOI 10.1007/s00466-007-0193-7; Tezduyar TE, 2007, INT J NUMER METH FL, V54, P855, DOI 10.1002/fld.1430; Bazilevs Y, 2008, COMPUT MECH, V43, P143, DOI 10.1007/s00466-008-0277-z; Corsini A, 2006, COMPUT MECH, V38, P356, DOI 10.1007/s00466-006-0045-x; Tezduyar TE, 2003, INT J NUMER METH FL, V43, P555, DOI 10.1002/fld.505; Behr M, 2001, COMPUT METHOD APPL M, V190, P3189, DOI 10.1016/S0045-7825(00)00388-1; Bazilevs Y, 2007, COMPUT FLUIDS, V36, P12, DOI 10.1016/j.compfluid.2005.07.012; Benson DJ, 2010, INT J NUMER METH ENG, V83, P765, DOI 10.1002/nme.2864; Kiendl J, 2010, COMPUT METHOD APPL M, V199, P2403, DOI 10.1016/j.cma.2010.03.029; Jensen FM, 2006, COMPOS STRUCT, V76, P52, DOI 10.1016/j.compstruct.2006.06.008; Takizawa K, 2011, INT J NUMER METH FL, V65, P286, DOI 10.1002/fld.2359; Cirak F, 2001, INT J NUMER METH ENG, V51, P813, DOI 10.1002/nme.182.abs; Bazilevs Y, 2007, COMPUT METHOD APPL M, V197, P173, DOI 10.1016/j.cma.2007.07.016; Hughes TJR, 2005, COMPUT METHOD APPL M, V194, P4135, DOI 10.1016/j.cma.2004.10.008; Kiendl J, 2009, COMPUT METHOD APPL M, V198, P3902, DOI 10.1016/j.cma.2009.08.013; Arnold DN, 2002, SIAM J NUMER ANAL, V39, P1749, DOI 10.1137/S0036142901384162; Bazilevs Y, 2010, J COMPUT PHYS, V229, P3402, DOI 10.1016/j.jcp.2010.01.008; Akin JE, 2004, COMPUT METHOD APPL M, V193, P1909, DOI 10.1016/j.cma.2003.12.050; Cirak F, 2002, COMPUT AIDED DESIGN, V34, P137, DOI 10.1016/S0010-4485(01)00061-6; Hughes TJR, 1998, COMPUT METHOD APPL M, V166, P3, DOI 10.1016/S0045-7825(98)00079-6; Hsu MC, 2014, WIND ENERGY, V17, P461, DOI 10.1002/we.1599; Tezduyar TE, 2001, ARCH COMPUT METHOD E, V8, P83, DOI 10.1007/BF02897870; TEZDUYAR TE, 1992, COMPUT METHOD APPL M, V94, P339, DOI 10.1016/0045-7825(92)90059-S; Govindjee S, 1996, COMPUT METHOD APPL M, V136, P47, DOI 10.1016/0045-7825(96)01045-6; Bazilevs Y, 2008, COMPUT MECH, V43, P3, DOI 10.1007/s00466-008-0315-x; Kalro V, 2000, COMPUT METHOD APPL M, V190, P321; Zahle F, 2009, WIND ENERGY, V12, P594, DOI 10.1002/we.327; Benson DJ, 2010, COMPUT METHOD APPL M, V199, P276, DOI 10.1016/j.cma.2009.05.011; Cottrell JA, 2006, COMPUT METHOD APPL M, V195, P5257, DOI 10.1016/j.cma.2005.09.027; Akin JE, 2003, J APPL MECH-T ASME, V70, P2, DOI 10.1115/1.1526569; Kong C, 2005, ENERGY, V30, P2101, DOI 10.1016/j.energy.2004.08.016; Dorfel MR, 2010, COMPUT METHOD APPL M, V199, P264, DOI 10.1016/j.cma.2008.07.012; Evans JA, 2009, COMPUT METHOD APPL M, V198, P1726, DOI 10.1016/j.cma.2009.01.021; Cottrell JA, 2007, COMPUT METHOD APPL M, V196, P4160, DOI 10.1016/j.cma.2007.04.007; Bazilevs Y, 2007, COMPUT METHOD APPL M, V196, P4853, DOI 10.1016/j.cma.2007.06.026; Bazilevs Y, 2012, INT J NUMER METH ENG, V89, P323, DOI 10.1002/nme.3244; Tezduyar TE, 2006, COMPUT METHOD APPL M, V195, P5743, DOI 10.1016/j.cma.2005.08.023; Bazilevs Y, 2011, INT J NUMER METH FL, V65, P207, DOI 10.1002/fld.2400; Takizawa K, 2013, COMPUT FLUIDS, V85, P125, DOI 10.1016/j.compfluid.2012.11.008; Lipton S, 2010, COMPUT METHOD APPL M, V199, P357, DOI 10.1016/j.cma.2009.01.022; Hsu MC, 2010, COMPUT METHOD APPL M, V199, P828, DOI 10.1016/j.cma.2009.06.019; Hughes TJR, 2007, SIAM J NUMER ANAL, V45, P539, DOI 10.1137/050645646; BROOKS AN, 1982, COMPUT METHOD APPL M, V32, P199, DOI 10.1016/0045-7825(82)90071-8; Takizawa K, 2012, COMPUT MECH, V50, P743, DOI 10.1007/s00466-012-0759-x; Hsu MC, 2012, COMPUT MECH, V50, P821, DOI 10.1007/s00466-012-0772-0; Li YW, 2012, RENEW ENERG, V37, P285, DOI 10.1016/j.renene.2011.06.029; Elguedj T, 2008, COMPUT METHOD APPL M, V197, P2732, DOI 10.1016/j.cma.2008.01.012; Bazilevs Y, 2006, COMPUT MECH, V38, P310, DOI 10.1007/s00466-006-0084-3; Hughes TJR, 2001, PHYS FLUIDS, V13, P1784, DOI 10.1063/1.1367868; TEZDUYAR T, 1993, COMPUTER, V26, P27, DOI 10.1109/2.237441; Cohen E, 2010, COMPUT METHOD APPL M, V199, P334, DOI 10.1016/j.cma.2009.09.010; Karypis G, 1998, SIAM J SCI COMPUT, V20, P359, DOI 10.1137/S1064827595287997; Cirak F, 2000, INT J NUMER METH ENG, V47, P2039, DOI 10.1002/(SICI)1097-0207(20000430)47:12<2039::AID-NME872>3.0.CO;2-1; Behr M, 1999, COMPUT METHOD APPL M, V174, P261, DOI 10.1016/S0045-7825(98)00299-0; Bazilevs Y, 2012, COMPUT METHOD APPL M, V249, P28, DOI 10.1016/j.cma.2012.03.028; Auricchio F, 2010, COMPUT METHOD APPL M, V199, P314, DOI 10.1016/j.cma.2008.06.004; Bazilevs Y, 2012, MATH MOD METH APPL S, V22, DOI 10.1142/S0218202512300025; Bazilevs Y, 2006, MATH MOD METH APPL S, V16, P1031, DOI 10.1142/S0218202506001455; Bazilevs Y, 2011, INT J NUMER METH FL, V65, P236, DOI 10.1002/fld.2454; Bazilevs Y, 2013, COMPUTATIONAL FLUID; Belytschko T., 2000, NONLINEAR FINITE ELE; Berry D., 2007, DESIGN 9 METER CARBO; Bischoff M., 2004, ENCY COMPUTATIONAL M, V2; Bletzinger K.-U., 1991, Computing Systems in Engineering, V2, DOI 10.1016/0956-0521(91)90051-6; Brenner S. C., 2002, MATH THEORY FINITE E; Corsini A, 2012, COMPUT MECH, V50, P695, DOI 10.1007/s00466-012-0789-4; Corsini A, 2011, INT J NUMER METH FL, V65, P254, DOI 10.1002/fld.2451; Corsini A, 2010, COMPUT MECH, V46, P159, DOI 10.1007/s00466-009-0441-0; Corsini A, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005060; Cottrell J., 2009, ISOGEOMETRIC ANAL IN; Ern A., 2004, THEORY PRACTICE FINI; Guttierez E, 2003, TECHNICAL REPORT; Hand M., 2001, NRELTP50029955; Hansen MOL, 2006, PROG AEROSP SCI, V42, P285, DOI 10.1016/j.paerosci.2006.10.002; HUGHES TJR, 1981, COMPUT METHOD APPL M, V29, P329, DOI 10.1016/0045-7825(81)90049-9; HUGHES TJR, 1986, COMPUT METHOD APPL M, V59, P85, DOI 10.1016/0045-7825(86)90025-3; Hughes T. J. R, 1987, FINITE ELEMENT METHO; HUGHES TJR, 1995, COMPUT METHOD APPL M, V127, P387, DOI 10.1016/0045-7825(95)00844-9; HUGHES TJR, 1984, COMPUT METHOD APPL M, V45, P217, DOI 10.1016/0045-7825(84)90157-9; Johnson C., 1987, NUMERICAL SOLUTION P; Jonkman J., 2009, NRELTP50038060; Jonkman J. M., 2005, NRELEL50038230; Kooijman HJT, 2003, DOWECF1W2HKJ010469; Korobenko A, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S0218202513400034; Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, DOI 10.1016/0045-7825(74)90029-2; Manguoglu M, 2011, COMPUT MECH, V48, P377, DOI 10.1007/s00466-011-0619-0; Manguoglu M, 2011, INT J NUMER METH FL, V65, P135, DOI 10.1002/fld.2415; Marinone T, 2012, C P SOC EXPT MECH SE, V2, P27; Melbo H, 2003, COMPUT METHOD APPL M, V192, P613, DOI 10.1016/S0045-7825(02)00575-3; MITTAL S, 1992, INT J NUMER METH FL, V15, P1073, DOI 10.1002/fld.1650150911; MITTAL S, 1995, INT J NUMER METH FL, V21, P933, DOI 10.1002/fld.1650211011; Nitsche J., 1971, ABH MATH SEM HAMBURG, V36, P9, DOI DOI 10.1007/BF02995904; Pape AL, 2004, WIND ENERGY, V7, P309, DOI 10.1002/we.129; Reddy J N, 2004, MECH LAMINATED COMPO; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Shield RT, 1967, Z ANGEW MATH PHYS, V18, P381; Sorensen N. N., 2002, WIND ENERGY, V5, P151, DOI DOI 10.1002/WE.64; Spera DA, 1994, WIND TURBINE TECHNOL, P47; Srinivasan V, 2010, COMPUT METHOD APPL M, V199, P392, DOI 10.1016/j.cma.2008.08.021; Sutherland J. H., 2001, P 2001 ASME WIND EN, P162; Takizawa K, 2010, COMPUT MECH, V46, P31, DOI 10.1007/s00466-009-0425-0; Takizawa K, 2014, COMPUT MECH, V53, P1, DOI 10.1007/s00466-013-0888-x; Takizawa K, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005073; Takizawa K, 2011, COMPUT MECH, V48, P647, DOI 10.1007/s00466-011-0614-5; Takizawa K, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S0218202513400058; Takizawa K, 2012, COMPUT MECH, V50, P761, DOI 10.1007/s00466-012-0758-y; Takizawa K, 2011, INT J NUMER METH FL, V65, P271, DOI 10.1002/fld.2348; Takizawa K, 2013, COMPUT MECH, V51, P1061, DOI 10.1007/s00466-012-0790-y; Takizawa K, 2012, COMPUT MECH, V50, P675, DOI 10.1007/s00466-012-0760-4; Takizawa K, 2012, MATH MOD METH APPL S, V22, DOI 10.1142/S0218202512300013; Takizawa K., 2010, LECT NOTES COMPUTATI, V73, P53; Takizawa K, 2011, COMPUT MECH, V48, P247, DOI 10.1007/s00466-011-0571-z; Takizawa K, 2012, COMPUT MECH, V50, P835, DOI 10.1007/s00466-012-0761-3; Takizawa K, 2011, COMPUT MECH, V48, P333, DOI 10.1007/s00466-011-0589-2; Takizawa K, 2012, ARCH COMPUT METHOD E, V19, P171, DOI 10.1007/s11831-012-9071-3; Takizawa K, 2013, COMPUT MECH, V52, P1351, DOI 10.1007/s00466-013-0880-5; Tezduyar T, 1996, COMPUT MECH, V18, P397, DOI 10.1007/BF00350249; TEZDUYAR TE, 1986, COMPUT METHOD APPL M, V59, P307, DOI 10.1016/0045-7825(86)90003-4; TEZDUYAR TE, 1992, COMPUT METHOD APPL M, V95, P221, DOI 10.1016/0045-7825(92)90141-6; TEZDUYAR TE, 1992, ADV APPL MECH, V28, P1, DOI 10.1016/S0065-2156(08)70153-4; Tezduyar TE, 2011, INT J NUMER METH BIO, V27, P1665, DOI 10.1002/cnm.1433; TEZDUYAR TE, 1992, COMPUT METHOD APPL M, V94, P353, DOI 10.1016/0045-7825(92)90060-W; Tezduyar TE, 1992, NEW METHODS TRANSIEN, V143, P7; van Brummelen EH, 2011, J APPL MECH, V79; WHITE J, 2011, ROUTL FILM GUIDEBOOK, P1; Wilcox D. C., 1998, TURBULENCE MODELING; Zayas J.R., 2008, 3X 100 BLADE FIELD T	139	12	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1134-3060	1886-1784		ARCH COMPUT METHOD E	Arch. Comput. Method Eng.	DEC	2014	21	4					359	398		10.1007/s11831-014-9119-7		40	Computer Science, Interdisciplinary Applications; Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Computer Science; Engineering; Mathematics	AT0FM	WOS:000344612600002		
J	Takizawa, K; Bazilevs, Y; Tezduyar, TE; Hsu, MC; Oiseth, O; Mathisen, KM; Kostov, N; McIntyre, S				Takizawa, Kenji; Bazilevs, Yuri; Tezduyar, Tayfun E.; Hsu, Ming-Chen; Oiseth, Ole; Mathisen, Kjell M.; Kostov, Nikolay; McIntyre, Spenser			Engineering Analysis and Design with ALE-VMS and Space-Time Methods	ARCHIVES OF COMPUTATIONAL METHODS IN ENGINEERING			English	Review							FLUID-STRUCTURE-INTERACTION; FINITE-ELEMENT COMPUTATION; NAVIER-STOKES EQUATIONS; INCOMPRESSIBLE-FLOW COMPUTATIONS; LAGRANGIAN INTERFACE TECHNIQUE; MODIFIED GEOMETRIC POROSITY; CAPTURING TECHNIQUE MITICT; INVISCID SUPERSONIC FLOWS; GENERALIZED-ALPHA METHOD; LARGE-EDDY SIMULATION	Flow problems with moving boundaries and interfaces include fluid-structure interaction (FSI) and a number of other classes of problems, have an important place in engineering analysis and design, and offer some formidable computational challenges. Bringing solution and analysis to them motivated the Deforming-Spatial-Domain/Stabilized Space-Time (DSD/SST) method and also the variational multiscale version of the Arbitrary Lagrangian-Eulerian method (ALE-VMS). Since their inception, these two methods and their improved versions have been applied to a diverse set of challenging problems with a common core computational technology need. The classes of problems solved include free-surface and two-fluid flows, fluid-object and fluid-particle interaction, FSI, and flows with solid surfaces in fast, linear or rotational relative motion. Some of the most challenging FSI problems, including parachute FSI, wind-turbine FSI and arterial FSI, are being solved and analyzed with the DSD/SST and ALE-VMS methods as core technologies. Better accuracy and improved turbulence modeling were brought with the recently-introduced VMS version of the DSD/SST method, which is called DSD/SST-VMST (also ST-VMS). In specific classes of problems, such as parachute FSI, arterial FSI, ship hydrodynamics, fluid-object interaction, aerodynamics of flapping wings, and wind-turbine aerodynamics and FSI, the scope and accuracy of the FSI modeling were increased with the special ALE-VMS and ST FSI techniques targeting each of those classes of problems. This article provides an overview of the core ALE-VMS and ST FSI techniques, their recent versions, and the special ALE-VMS and ST FSI techniques. It also provides examples of challenging problems solved and analyzed in parachute FSI, arterial FSI, ship hydrodynamics, aerodynamics of flapping wings, wind-turbine aerodynamics, and bridge-deck aerodynamics and vortex-induced vibrations.	[Takizawa, Kenji] Waseda Univ, Dept Modern Mech Engn, Shinjuku Ku, Tokyo 1698050, Japan; [Takizawa, Kenji] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698050, Japan; [Bazilevs, Yuri] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA; [Tezduyar, Tayfun E.; Kostov, Nikolay; McIntyre, Spenser] Rice Univ, Houston, TX 77005 USA; [Hsu, Ming-Chen] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Oiseth, Ole; Mathisen, Kjell M.] Norwegian Univ Sci & Technol, Dept Struct Engn, N-7491 Trondheim, Norway	Takizawa, K (reprint author), Waseda Univ, Dept Modern Mech Engn, Shinjuku Ku, I-6-1 Nishi Waseda, Tokyo 1698050, Japan.	Kenji.Takizawa@tafsm.org	Hsu, Ming-Chen/J-1881-2012; Tezduyar, Tayfun/F-6134-2012; Takizawa, Kenji/E-2245-2013	Hsu, Ming-Chen/0000-0001-8062-8612; Tezduyar, Tayfun/0000-0001-8707-3162; Takizawa, Kenji/0000-0003-1172-113X	NASA JSC [NNX13AD87G]; ARO [W911NF-12-1-0162, W911NF-11-1-0083]; Rice-Waseda research agreement	This work was supported in part by NASA JSC grant NNX13AD87G. Method development and evaluation components of the work on aerodynamics of flapping wings and wind-turbine aerodynamics were supported in part by ARO Grant W911NF-12-1-0162 (TT) and Rice-Waseda research agreement (KT). The development and application of FOI techniques for bridge aerodynamics was supported by the program for preferred research areas at the Faculty of Engineering Science and Technology, the Norwegian University of Science and Technology. The research work on free-surface FOI was supported by the ARO Grant W911NF-11-1-0083 (YB). We wish to thank the Texas Advanced Computing Center (TACC) at the University of Texas at Austin, the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, and the Norwegian Metacenter for Computational Science (Notur) for providing some of the HPC resources used. We thank Professor Fabrizio Gabbiani and Dr. Raymond Chan (Baylor College of Medicine) for providing us the digital data extracted from the wind-tunnel videos of the locust.	Akin JE, 2007, COMPUT FLUIDS, V36, P2, DOI 10.1016/j.compfluid.2005.07.008; Torii R, 2008, COMPUT MECH, V43, P151, DOI 10.1007/s00466-008-0325-8; Bazilevs Y, 2009, COMPUT METHOD APPL M, V198, P3534, DOI 10.1016/j.cma.2009.04.015; Rispoli F, 2007, COMPUT FLUIDS, V36, P121, DOI 10.1016/j.compfluid.2005.07.004; Takizawa K, 2012, ARCH COMPUT METHOD E, V19, P125, DOI 10.1007/s11831-012-9070-4; Torii R, 2007, COMPUT FLUIDS, V36, P160, DOI 10.1016/j.compfluid.2005.07.014; Tezduyar TE, 2006, COMPUT METHOD APPL M, V195, P2002, DOI 10.1016/j.cma.2004.09.014; CHUNG J, 1993, J APPL MECH-T ASME, V60, P371, DOI 10.1115/1.2900803; Bazilevs Y, 2010, COMPUT METHOD APPL M, V199, P780, DOI 10.1016/j.cma.2008.11.020; HUGHES TJR, 1980, INT J NUMER METH ENG, V15, P1862, DOI 10.1002/nme.1620151210; JOHNSON AA, 1994, COMPUT METHOD APPL M, V119, P73, DOI 10.1016/0045-7825(94)00077-8; Akkerman I, 2008, COMPUT MECH, V41, P371, DOI 10.1007/s00466-007-0193-7; Tezduyar TE, 2007, INT J NUMER METH FL, V54, P855, DOI 10.1002/fld.1430; Bazilevs Y, 2008, COMPUT MECH, V43, P143, DOI 10.1007/s00466-008-0277-z; Bazilevs Y, 2007, INT J NUMER METH FL, V54, P593, DOI 10.1002/fld.1484; Tezduyar TE, 2003, INT J NUMER METH FL, V43, P555, DOI 10.1002/fld.505; Ohayon R, 2001, COMPUT METHOD APPL M, V190, P3009, DOI 10.1016/S0045-7825(00)00379-0; Bazilevs Y, 2007, COMPUT FLUIDS, V36, P12, DOI 10.1016/j.compfluid.2005.07.012; Tezduyar TE, 2007, INT J NUMER METH FL, V54, P901, DOI 10.1002/fld.1443; Takizawa K, 2011, INT J NUMER METH FL, V65, P286, DOI 10.1002/fld.2359; Bazilevs Y, 2007, COMPUT METHOD APPL M, V197, P173, DOI 10.1016/j.cma.2007.07.016; Hughes TJR, 2005, COMPUT METHOD APPL M, V194, P4135, DOI 10.1016/j.cma.2004.10.008; Johnson AA, 1996, COMPUT METHOD APPL M, V134, P351, DOI 10.1016/0045-7825(95)00988-4; Stein K, 2000, COMPUT METHOD APPL M, V190, P373, DOI 10.1016/S0045-7825(00)00208-5; Bazilevs Y, 2010, J COMPUT PHYS, V229, P3402, DOI 10.1016/j.jcp.2010.01.008; Torii R, 2006, COMPUT MECH, V38, P482, DOI 10.1007/s00466-006-0065-6; Hsu MC, 2014, WIND ENERGY, V17, P461, DOI 10.1002/we.1599; Tezduyar TE, 2001, ARCH COMPUT METHOD E, V8, P83, DOI 10.1007/BF02897870; Tezduyar TE, 2010, INT J NUMER METH FL, V64, P1201, DOI 10.1002/fld.2221; TEZDUYAR TE, 1992, COMPUT METHOD APPL M, V94, P339, DOI 10.1016/0045-7825(92)90059-S; Bazilevs Y, 2008, COMPUT MECH, V43, P3, DOI 10.1007/s00466-008-0315-x; Kalro V, 2000, COMPUT METHOD APPL M, V190, P321; Torii R, 2009, COMPUT METHOD APPL M, V198, P3613, DOI 10.1016/j.cma.2008.08.020; Torii R, 2010, INT J NUMER METH BIO, V26, P336, DOI 10.1002/cnm.1289; Torii R, 2006, COMPUT METHOD APPL M, V195, P1885, DOI 10.1016/j.cma.2005.05.050; Bazilevs Y, 2010, BIOMECH MODEL MECHAN, V9, P481, DOI 10.1007/s10237-010-0189-7; Jansen KE, 2000, COMPUT METHOD APPL M, V190, P305; Akkerman I, 2011, J COMPUT PHYS, V230, P4137, DOI 10.1016/j.jcp.2010.11.044; Khurram RA, 2006, COMPUT MECH, V38, P403, DOI 10.1007/s00466-006-0059-4; Bazilevs Y, 2012, INT J NUMER METH ENG, V89, P323, DOI 10.1002/nme.3244; Tezduyar TE, 2006, COMPUT METHOD APPL M, V195, P5743, DOI 10.1016/j.cma.2005.08.023; Akkerman I, 2012, COMPUT MECH, V50, P719, DOI 10.1007/s00466-012-0770-2; Bazilevs Y, 2011, INT J NUMER METH FL, V65, P207, DOI 10.1002/fld.2400; Takizawa K, 2013, COMPUT FLUIDS, V85, P125, DOI 10.1016/j.compfluid.2012.11.008; Tezduyar TE, 2008, COMPUT MECH, V43, P133, DOI 10.1007/s00466-008-0260-8; Kees CE, 2011, J COMPUT PHYS, V230, P4536, DOI 10.1016/j.jcp.2011.02.030; Cruchaga MA, 2007, COMPUT MECH, V39, P453, DOI 10.1007/s00466-006-0043-z; Longo J, 2005, J SHIP RES, V49, P55; Tezduyar T, 2001, COMPUT METHOD APPL M, V191, P717, DOI 10.1016/S0045-7825(01)00311-5; Larese A, 2012, COMPUT MECH, V50, P805, DOI 10.1007/s00466-012-0768-9; BROOKS AN, 1982, COMPUT METHOD APPL M, V32, P199, DOI 10.1016/0045-7825(82)90071-8; Bazilevs Y, 2010, COMPUT MECH, V46, P3, DOI 10.1007/s00466-009-0421-4; Takizawa K, 2012, COMPUT MECH, V50, P743, DOI 10.1007/s00466-012-0759-x; Hsu MC, 2012, COMPUT MECH, V50, P821, DOI 10.1007/s00466-012-0772-0; Takizawa K, 2011, COMPUT MECH, V48, P345, DOI 10.1007/s00466-011-0590-9; Longo J, 2007, J FLUID ENG-T ASME, V129, P524, DOI 10.1115/1.2717618; Hsu MC, 2012, COMPUT MECH, V50, P499, DOI 10.1007/s00466-012-0686-x; Kleefsman KMT, 2005, J COMPUT PHYS, V206, P363, DOI 10.1016/j.jcp.2004.12.007; Yao JY, 2012, COMPUT MECH, V50, P789, DOI 10.1007/s00466-012-0781-z; Bazilevs Y, 2006, COMPUT MECH, V38, P310, DOI 10.1007/s00466-006-0084-3; Johnson AA, 1999, COMPUT MECH, V23, P130, DOI 10.1007/s004660050393; Hughes TJR, 2001, PHYS FLUIDS, V13, P1784, DOI 10.1063/1.1367868; Tezduyar TE, 2006, COMPUT METHOD APPL M, V195, P1621, DOI 10.1016/j.cma.2005.05.032; TEZDUYAR T, 1993, COMPUTER, V26, P27, DOI 10.1109/2.237441; Van Brummelen EH, 2005, SIAM J SCI COMPUT, V27, P599, DOI 10.1137/S1064827503431430; Torii R, 2007, INT J NUMER METH FL, V54, P995, DOI 10.1002/fld.1497; Akkerman I, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005072; Bazilevs Y, 2012, MATH MOD METH APPL S, V22, DOI 10.1142/S0218202512300025; Bazilevs Y, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S0218202513400010; Bazilevs Y, 2011, INT J NUMER METH FL, V65, P236, DOI 10.1002/fld.2454; Bazilevs Y, 2013, COMPUTATIONAL FLUID; Bazilevs Y, 2009, COMPUT MECH, V45, P77, DOI 10.1007/s00466-009-0419-y; Belytschko T., 2000, NONLINEAR FINITE ELE; Bletzinger K.-U., 2006, LECT NOTES COMPUTATI, V53, P336; Calderer R, 2010, COMPUT MECH, V46, P185, DOI 10.1007/s00466-010-0487-z; Cruchaga M, 2002, COMMUN NUMER METH EN, V18, P483, DOI 10.1002/cnm.506; Cruchaga MA, 2007, INT J NUMER METH FL, V54, P1021, DOI 10.1002/fld.1498; Cruchaga M, 2001, COMPUT METHOD APPL M, V191, P525, DOI 10.1016/S0045-7825(01)00300-0; Cruchaga MA, 2005, INT J NUMER METH FL, V47, P451, DOI 10.1002/fld.825; Dettmer WG, 2008, COMPUT MECH, V43, P81, DOI 10.1007/s00466-008-0254-6; Fridsma G, 1968, SYSTEMATIC STUDY ROU, P1275; Garcia J, 2003, J APPL MECH-T ASME, V70, P18, DOI 10.1115/1.1530631; Hsu MC, 2011, FINITE ELEM ANAL DES, V47, P593, DOI 10.1016/j.finel.2010.12.015; HUGHES TJR, 1981, COMPUT METHOD APPL M, V29, P329, DOI 10.1016/0045-7825(81)90049-9; HUGHES TJR, 1995, COMPUT METHOD APPL M, V127, P387, DOI 10.1016/0045-7825(95)00844-9; Johnson AA, 1997, COMPUT METHOD APPL M, V145, P301, DOI 10.1016/S0045-7825(96)01223-6; Kamran K, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S021820251340006X; Korobenko A, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S0218202513400034; Korobenko A, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4024415; Lohner R, 2006, LECT NOTES COMPUTATI, V53, P82; Manguoglu M, 2011, COMPUT MECH, V48, P377, DOI 10.1007/s00466-011-0619-0; Manguoglu M, 2009, J APPL MECH-T ASME, V76, DOI 10.1115/1.3059576; Manguoglu M, 2011, INT J NUMER METH FL, V65, P135, DOI 10.1002/fld.2415; Manguoglu M, 2010, COMPUT MECH, V46, P83, DOI 10.1007/s00466-009-0426-z; Manguoglu M, 2008, COMPUT MECH, V43, P73, DOI 10.1007/s00466-008-0276-0; McCormick Michael E., 2010, OCEAN ENG MECH APPL; Minami S, 2012, COMPUT MECH, V50, P707, DOI 10.1007/s00466-012-0776-9; Miras T, 2012, COMPUT MECH, V50, P729, DOI 10.1007/s00466-012-0786-7; MITTAL S, 1992, INT J NUMER METH FL, V15, P1073, DOI 10.1002/fld.1650150911; MITTAL S, 1995, INT J NUMER METH FL, V21, P933, DOI 10.1002/fld.1650211011; Nagaoka S, 2011, COMPUT MECH, V48, P269, DOI 10.1007/s00466-011-0620-7; Rispoli F, 2007, INT J NUMER METH FL, V54, P695, DOI 10.1002/fld.1447; Rispoli F, 2009, J APPL MECH-T ASME, V76, DOI 10.1115/1.3057496; Sathe S, 2008, COMPUT MECH, V43, P51, DOI 10.1007/s00466-008-0299-6; Sethian J. A., 1999, LEVEL SET METHODS FA; Svend Ole Hansen APS, 2006, TECHNICAL REPORT; Takase S, 2011, COMPUT MECH, V48, P293, DOI 10.1007/s00466-011-0618-1; Takizawa K, 2007, COMPUT MECH, V40, P167, DOI 10.1007/s00466-006-0093-2; Takizawa K, 2010, COMPUT MECH, V46, P31, DOI 10.1007/s00466-009-0425-0; Takizawa K, 2012, MECH ENG, V134, P34; Takizawa K, 2014, COMPUT MECH, V53, P1, DOI 10.1007/s00466-013-0888-x; Takizawa K, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005073; Takizawa K, 2011, COMPUT MECH, V48, P647, DOI 10.1007/s00466-011-0614-5; Takizawa K, 2014, COMPUT MECH, V53, P91, DOI 10.1007/s00466-013-0895-y; Takizawa K, 2010, INT J NUMER METH BIO, V26, P101, DOI 10.1002/cnm.1241; Takizawa K, 2014, COMPUT MECH, V54, P955, DOI 10.1007/s00466-013-0935-7; Takizawa K, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S0218202513400058; Takizawa K, 2012, COMPUT MECH, V50, P761, DOI 10.1007/s00466-012-0758-y; Takizawa K, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005071; Takizawa K, 2011, INT J NUMER METH FL, V65, P271, DOI 10.1002/fld.2348; Takizawa K, 2007, INT J NUMER METH FL, V54, P1011, DOI 10.1002/fld.1466; Takizawa K, 2012, MATH MOD METH APPL S, V22, DOI 10.1142/S0218202512300013; Takizawa K, 2011, INT J NUMER METH FL, V65, P308, DOI 10.1002/fld.2360; Takizawa K, 2011, COMPUT MECH, V48, P247, DOI 10.1007/s00466-011-0571-z; Takizawa K, 2012, COMPUT MECH, V50, P835, DOI 10.1007/s00466-012-0761-3; Takizawa K, 2011, COMPUT MECH, V48, P333, DOI 10.1007/s00466-011-0589-2; Takizawa K, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005070; Takizawa K, 2012, ARCH COMPUT METHOD E, V19, P171, DOI 10.1007/s11831-012-9071-3; Takizawa K, 2013, COMPUT MECH, V52, P1351, DOI 10.1007/s00466-013-0880-5; Tezduyar T, 1996, COMPUT MECH, V18, P397, DOI 10.1007/BF00350249; Tezduyar T, 2001, COMPUT METHOD APPL M, V191, P705, DOI 10.1016/S0045-7825(01)00310-3; TEZDUYAR TE, 1992, COMPUT METHOD APPL M, V95, P221, DOI 10.1016/0045-7825(92)90141-6; Tezduyar TE, 2008, COMPUT MECH, V43, P39, DOI 10.1007/s00466-008-0261-7; Tezduyar TE, 2006, COMPUT MECH, V38, P469, DOI 10.1007/s00466-005-0025-6; Tezduyar TE, 2007, COMPUT FLUIDS, V36, P147, DOI 10.1016/j.compfluid.2005.07.009; TEZDUYAR TE, 1992, ADV APPL MECH, V28, P1, DOI 10.1016/S0065-2156(08)70153-4; Tezduyar TE, 2011, INT J NUMER METH BIO, V27, P1665, DOI 10.1002/cnm.1433; TEZDUYAR TE, 1992, COMPUT METHOD APPL M, V94, P353, DOI 10.1016/0045-7825(92)90060-W; Tezduyar TE, 2009, COMPUT METHOD APPL M, V198, P3524, DOI 10.1016/j.cma.2008.05.024; TEZDUYAR TE, 1994, COMPUT METHOD APPL M, V119, P157, DOI 10.1016/0045-7825(94)00082-4; Tezduyar TE, 2010, COMPUT MECH, V46, P17, DOI 10.1007/s00466-009-0423-2; Tezduyar TE, 2007, COMPUT FLUIDS, V36, P191, DOI 10.1016/j.compfluid.2005.02.011; Tezduyar TE, 1992, NEW METHODS TRANSIEN, V143, P7; Tezduyar TE, 2008, INT J NUMER METH FL, V57, P1189, DOI 10.1002/fld.1743; Torii R, 2010, COMPUT MECH, V46, P43, DOI 10.1007/s00466-009-0439-7; Torii R, 2011, INT J NUMER METH FL, V65, P324, DOI 10.1002/fld.2448; van Opstal TM, 2012, COMPUT MECH, V50, P779, DOI 10.1007/s00466-012-0794-7; Yao JY, 2013, MATH MOD METH APPL S, V23, DOI 10.1142/S0218202513400046	148	11	11	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1134-3060	1886-1784		ARCH COMPUT METHOD E	Arch. Comput. Method Eng.	DEC	2014	21	4					481	508		10.1007/s11831-014-9113-0		28	Computer Science, Interdisciplinary Applications; Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Computer Science; Engineering; Mathematics	AT0FM	WOS:000344612600004		
J	Utsugi, C; Miyazono, S; Osada, K; Matsuda, M; Kashiwayanagi, M				Utsugi, Chizuru; Miyazono, Sadaharu; Osada, Kazumi; Matsuda, Mitsuyoshi; Kashiwayanagi, Makoto			Impaired mastication reduced newly generated neurons at the accessory olfactory bulb and pheromonal responses in mice	ARCHIVES OF ORAL BIOLOGY			English	Article						Soft diet; Hard diet; Mastication; Olfactory function; Pheromone	PERIODONTAL MECHANOSENSITIVE NEURONS; VOMERONASAL ORGAN; SOMATOSENSORY CORTEX; CELL-PROLIFERATION; PARIETAL CORTEX; SPATIAL MEMORY; SAMP8 MICE; TOOTH LOSS; RAT; NUCLEUS	Objectives: A large number of neurons are generated at the subventricular zone (SVZ) even during adulthood. In a previous study, we have shown that a reduced mastication impairs both neurogenesis in the SVZ and olfactory functions. Pheromonal signals, which are received by the vomeronasal organ, provide information about reproductive and social states. Vomeronasal sensory neurons project to the accessory olfactory bulb (AOB) located on the dorso-caudal surface of the main olfactory bulb. Newly generated neurons at the SVZ migrate to the AOB and differentiate into granule cells and periglomerular cells. This study aimed to explore the effects of changes in mastication on newly generated neurons and pheromonal responses. Design: Bromodeoxyuridine-immunoreactive (BrdU-ir; a marker of DNA synthesis) and Fosir (a marker of neurons excited) structures in sagittal sections of the AOB after exposure to urinary odours were compared between the mice fed soft and hard diets. Results: The density of BrdU-ir cells in the AOB in the soft-diet-fed mice after 1 month was essentially similar to that of the hard-diet-fed mice, while that was lower in the soft-diet-fed mice for 3 or 6 months than in the hard-diet-fed mice. The density of Fos-ir cells in the soft-diet-fed mice after 2 months was essentially similar to that in the hard-diet-fed mice, while that was lower in the soft-diet-fed mice for 4 months than in the hard-diet-fed mice. Conclusions: The present results suggest that impaired mastication reduces newly generated neurons at the AOB, which in turn impairs olfactory function at the AOB. (C) 2014 Elsevier Ltd. All rights reserved.	[Utsugi, Chizuru; Matsuda, Mitsuyoshi] Asahikawa Med Coll, Dept Oral & Maxillofacial Surg, Asahikawa, Hokkaido 0788510, Japan; [Utsugi, Chizuru; Miyazono, Sadaharu; Kashiwayanagi, Makoto] Asahikawa Med Coll, Dept Sensory Physiol, Asahikawa, Hokkaido 0788510, Japan; [Osada, Kazumi] Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Biol, Ishikari, Hokkaido 0610293, Japan	Kashiwayanagi, M (reprint author), Asahikawa Med Coll, Dept Sensory Physiol, Asahikawa, Hokkaido 0788510, Japan.	yanagi@asahikawa-med.ac.jp			Asahikawa Medical University	This work was supported by Asahikawa Medical University.	LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; LYDELL K, 1972, HORM BEHAV, V3, P205, DOI 10.1016/0018-506X(72)90033-5; Yamamoto T, 2001, BRAIN RES, V902, P255, DOI 10.1016/S0006-8993(01)02410-6; Miura H, 2003, J ORAL REHABIL, V30, P808, DOI 10.1046/j.1365-2842.2003.01124.x; Stein PS, 2007, J AM DENT ASSOC, V138, P1314; Kato T, 1997, BEHAV BRAIN RES, V83, P239, DOI 10.1016/S0166-4328(97)86078-0; Patel RC, 2009, NEUROBIOL AGING, V30, P829, DOI 10.1016/j.neurobiolaging.2007.08.007; FUTAMI T, 1995, NEUROSCI RES, V21, P331, DOI 10.1016/0168-0102(94)00869-H; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Onozuka M, 1999, BRAIN RES, V826, P148, DOI 10.1016/S0006-8993(99)01255-X; Weiler E, 1999, EUR J NEUROSCI, V11, P700, DOI 10.1046/j.1460-9568.1999.00476.x; Aoki H, 2005, GERONTOLOGY, V51, P369, DOI 10.1159/000088700; Lexomboon D, 2012, J AM GERIATR SOC, V60, P1951, DOI 10.1111/j.1532-5415.2012.04154.x; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; KEVERNE EB, 1986, CHEM SENSES, V11, P119, DOI 10.1093/chemse/11.1.119; Onozuka M, 2002, BEHAV BRAIN RES, V131, P125, DOI 10.1016/S0166-4328(01)00378-3; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; MCCLINTOCK MK, 1978, HORM BEHAV, V10, P264, DOI 10.1016/0018-506X(78)90071-5; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; BARBER PC, 1974, BRAIN RES, V81, P21, DOI 10.1016/0006-8993(74)90476-4; Bonfanti L, 1997, NEUROSCIENCE, V81, P489, DOI 10.1016/S0306-4522(97)00090-0; Bortolanza M, 2010, NEUROBIOL LEARN MEM, V94, P229, DOI 10.1016/j.nlm.2010.05.011; BRENNAN P, 1990, SCIENCE, V250, P1223, DOI 10.1126/science.2147078; Farkas T, 1999, NEUROSCIENCE, V90, P353, DOI 10.1016/S0306-4522(98)00451-5; Honda N, 2008, EUR J NEUROSCI, V27, P1980, DOI 10.1111/j.1460-9568.2008.06169.x; Honda N, 2009, BIOL PHARM BULL, V32, P627; Inamura K, 1999, EUR J NEUROSCI, V11, P2254, DOI 10.1046/j.1460-9568.1999.00646.x; Itoh S, 2002, ARCH ORAL BIOL, V47, P481, DOI 10.1016/S0003-9969(02)00027-4; Koyama S, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00101; Martinez-Marcos A, 2001, DEV BRAIN RES, V127, P95, DOI 10.1016/S0165-3806(01)00106-7; Matsuoka M, 1999, NEUROSCI RES, V35, P189, DOI 10.1016/S0168-0102(99)00082-6; Paxinos G, 2008, MOUSE BRAIN STEREOTA; Pfaff DW, 1969, OLFACTION TASTE, VIII, P258; TABATA T, 1991, EXP BRAIN RES, V84, P583; Tabata T, 2001, ARCH ORAL BIOL, V46, P881, DOI 10.1016/S0003-9969(01)00059-0; Tsutsui K, 2007, BIOMED RES-TOKYO, V28, P1, DOI 10.2220/biomedres.28.1; Utsugi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097309; Weijenberg RAF, 2011, NEUROSCI BIOBEHAV R, V35, P483, DOI 10.1016/j.neubiorev.2010.06.002; Wysocki C.J., 1987, P125; Yamamoto Tetsu, 2008, Bull Tokyo Dent Coll, V49, P185; Yamamoto Tetsu, 2009, Bull Tokyo Dent Coll, V50, P117	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	DEC	2014	59	12					1272	1278		10.1016/j.archoralbio.2014.07.018		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS7LG	WOS:000344437000004		
J	Terayama, R; Maruhama, K; Tsuchiya, H; Mizutani, M; Iida, S; Sugimoto, T				Terayama, Ryuji; Maruhama, Kotaro; Tsuchiya, Hiroki; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada			Assessment of intraoral mucosal pain induced by the application of capsaicin	ARCHIVES OF ORAL BIOLOGY			English	Article						Capsaicin; Behaviour; c-Fos; Medullary dorsal horn; Immunohistochemistry; Nerve injury	FOS-LIKE IMMUNOREACTIVITY; DORSAL-HORN NEURONS; INTRADERMAL INJECTION; CENTRAL PROJECTION; NUCLEUS CAUDALIS; NEUROPATHIC PAIN; FORMALIN TEST; FACIAL-PAIN; SPINAL-CORD; RAT MODEL	Objective: To develop an objective method for assessing nociceptive behaviour in an animal model of capsaicin-induced intraoral pain. Changes in nociceptive responses were also examined after injury to the inferior alveolar nerve (IAN). Design: Nociceptive responses evoked by the intraoral application of various doses of capsaicin were analyzed in lightly anaesthetized rats. The number of c-Fos protein-like immunoreactive (Fos-LI) neurons in the medullary dorsal horn (MDH) induced by the intraoral application of capsaicin was measured. Behavioural and c-Fos responses were also examined 14 days after injury to the IAN. Results: Larger doses of intraoral capsaicin (1, 10 and 100 mu g) induced vigorous licking behaviour and c-Fos response in the MDH in a reproducible manner. The magnitudes of both behavioural activity and the c-Fos response from the 10 and 100 mu g doses of capsaicin were significantly greater than that by the 1 mu g dose. Injury to the IAN exaggerated the behavioural and c-Fos responses evoked by intraoral capsaicin. Conclusions: The intraoral application of capsaicin is a valid and reliable method for studying intraoral pain and hyperalgesia following nerve injury. (C) 2014 Elsevier Ltd. All rights reserved.	[Terayama, Ryuji; Maruhama, Kotaro; Tsuchiya, Hiroki; Sugimoto, Tomosada] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Funct & Anat, Okayama 7008525, Japan; [Mizutani, Masahide; Iida, Seiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Okayama 7008525, Japan; [Terayama, Ryuji; Maruhama, Kotaro; Mizutani, Masahide; Iida, Seiji; Sugimoto, Tomosada] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan; [Tsuchiya, Hiroki] ASAHI Med Coll Okayama, Okayama 7000028, Japan	Terayama, R (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Funct & Anat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	ryujit@md.okayama-u.ac.jp			Japan Society for the Promotion of Science [24592764]	This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (24592764). All authors report no financial relationship related to any product involved in this study.	Anderson EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089137; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; CLAVELOU P, 1989, NEUROSCI LETT, V103, P349, DOI 10.1016/0304-3940(89)90125-0; Sugimoto T, 1997, J COMP NEUROL, V378, P425, DOI 10.1002/(SICI)1096-9861(19970217)378:3<425::AID-CNE9>3.0.CO;2-5; GREEN BG, 1993, PAIN, V53, P323, DOI 10.1016/0304-3959(93)90228-H; WALL PD, 1974, NATURE, V248, P740, DOI 10.1038/248740a0; Caterina MJ, 1997, NATURE, V389, P816; DUBNER R, 1983, ANNU REV NEUROSCI, V6, P381, DOI 10.1146/annurev.ne.06.030183.002121; TAKEMURA M, 1991, EXP NEUROL, V111, P324, DOI 10.1016/0014-4886(91)90099-X; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; Ringkamp M, 2001, J NEUROSCI, V21, P4460; LAMOTTE RH, 1992, J PHYSIOL-LONDON, V448, P749; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Woda A, 2003, J DENT RES, V82, P764; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; CLAVELOU P, 1995, PAIN, V62, P295, DOI 10.1016/0304-3959(94)00273-H; EISENBERG E, 1993, PAIN, V54, P301, DOI 10.1016/0304-3959(93)90029-O; Eisenberg E, 1996, NEUROSCIENCE, V72, P519, DOI 10.1016/0306-4522(95)00565-X; Fujisawa N, 2012, EXP BRAIN RES, V219, P191, DOI 10.1007/s00221-012-3078-8; Green BG, 1998, PHYSIOL BEHAV, V65, P141, DOI 10.1016/S0031-9384(98)00162-0; KORENMAN EMD, 1981, EXP NEUROL, V72, P63, DOI 10.1016/0014-4886(81)90127-8; Ngom PI, 2001, NEUROSCI LETT, V316, P149, DOI 10.1016/S0304-3940(01)02401-6; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; Pelissier T, 2002, PAIN, V96, P81, DOI 10.1016/S0304-3959(01)00432-8; Pertens E, 1999, J COMP NEUROL, V410, P73; SAKURADA T, 1992, NEUROPHARMACOLOGY, V31, P1279, DOI 10.1016/0028-3908(92)90057-V; SANDKUHLER J, 1984, BRAIN RES, V305, P67, DOI 10.1016/0006-8993(84)91120-X; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; STRASSMAN AM, 1993, J COMP NEUROL, V331, P495, DOI 10.1002/cne.903310406; STRASSMAN AM, 1993, J NEUROPHYSIOL, V70, P1811; Sugimoto T, 1997, NEUROSCI RES, V28, P361, DOI 10.1016/S0168-0102(97)00064-3; SUGIMOTO T, 1994, BRAIN RES, V642, P348, DOI 10.1016/0006-8993(94)90942-3; SUGIMOTO T, 1993, BRAIN RES, V621, P161, DOI 10.1016/0006-8993(93)90314-D; TAKEMURA M, 1987, EXP NEUROL, V96, P540, DOI 10.1016/0014-4886(87)90217-2; Terayama R, 2002, PAIN, V97, P171, DOI 10.1016/S0304-3959(02)00017-9; Terayama R, 1997, BRAIN RES, V768, P135, DOI 10.1016/S0006-8993(97)00633-1; Terayama R, 2000, NEUROREPORT, V11, P1915, DOI 10.1097/00001756-200006260-00022; Williams S, 1990, NEUROSCIENCE, V36, P73; Zhao NN, 2012, J OROFAC PAIN, V26, P277	42	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	DEC	2014	59	12					1334	1341		10.1016/j.archoralbio.2014.08.008		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS7LG	WOS:000344437000012		
J	Ikeda, Y; Yonemitsu, I; Takei, M; Shibata, S; Ono, T				Ikeda, Yuhei; Yonemitsu, Ikuo; Takei, Maki; Shibata, Shunichi; Ono, Takashi			Mechanical loading leads to osteoarthritis-like changes in the hypofunctional temporomandibular joint in rats	ARCHIVES OF ORAL BIOLOGY			English	Article						Temporomandibular joint hypofunction; TMJ-osteoarthritis; Growth; Mechanical loading; Matrix metalloproteinase-13	MANDIBULAR CONDYLAR CARTILAGE; CREATED DISORDERED OCCLUSION; SUBCHONDRAL BONE LOSS; ARTICULAR-CARTILAGE; CANCELLOUS BONE; EXTRACELLULAR-MATRIX; RESORPTION; KNEE; CHONDROCYTES; MODELS	Objectives: Temporomandibular joint (TMJ) hypofunction secondary to feeding a liquid diet in the growing period leads to morphological hypoplasia. However, few studies have evaluated the results of mechanical loading on the hypoplastic TMJ. This study investigated whether TMJ hypofunction in rats causes osteoarthritis (OA)-like changes when exposed to mechanical loading. Design: Male 21-day-old Wistar rats were divided into four groups. The first group (C) served as the control. In the second group (W), mechanical loading was applied to the TMJ by continuous steady mouth opening (3 h/day for 5 days) from 63 days of age. A jaw-opening device was used to hold the mandible open in the maximal mouth-opening position with a cobalt chromium (Co-Cr) wire (phi: 0.9 mm). Groups C and W both received a normal hard diet. The third group (L) and fourth group (LW) were fed a liquid diet and group LW were subjected to the same loading as group W. We evaluated the TMJ using micro-CT, toluidine blue staining and immunohistochemistry of matrix metalloproteinase (MMP)-13. Results: In group LW in the superior and posterior regions of the condyle, bone volume fraction, trabecular thickness and trabecular number were significantly decreased and trabecular spacing was significantly increased. The ratio of MMP-13 immunopositive cells was significantly higher than in the other groups. OA-like changes were also observed, including reduced thickness of the cartilage, irregularities in the chondrocytic layer, and cell-free areas. Conclusions: TMJ hypofunction in rats is likely to lead to OA-like changes when exposed to mechanical loading. (C) 2014 Elsevier Ltd. All rights reserved.	[Ikeda, Yuhei; Yonemitsu, Ikuo; Takei, Maki; Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch, Div Oral Hlth Sci, Dept Orofacial Dev & Funct, Tokyo, Japan; [Shibata, Shunichi] Tokyo Med & Dent Univ, Grad Sch, Div Maxillofacial Neck Reconstruct, Dept Maxillofacial Biol, Tokyo, Japan	Yonemitsu, I (reprint author), Tokyo Med & Dent Univ, Grad Sch, Div Oral Hlth Sci, Dept Orofacial Dev & Funct, Tokyo, Japan.	yoneman.orts@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23792422, 25463171]	This study was financially supported by Grants-in-Aid for Scientific Research (23792422 and 25463171) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Wang GW, 2010, ARCH ORAL BIOL, V55, P887, DOI 10.1016/j.archoralbio.2010.07.013; Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/01.BOR.0000022355.07263.81; KILIARIDIS S, 1985, EUR J ORTHODONT, V7, P273; Thomas CM, 2007, OSTEOARTHR CARTILAGE, V15, P27, DOI 10.1016/j.joca.2006.06.012; Shlopov BV, 2000, ARTHRITIS RHEUM, V43, P195, DOI 10.1002/1529-0131(200001)43:1<195::AID-ANR24>3.0.CO;2-G; Sharawy MM, 2002, CRANIO, V20, P111; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; Embree MC, 2010, AM J PATHOL, V176, P812, DOI 10.2353/ajpath.2010.090450; Kuroda S, 2009, OSTEOARTHR CARTILAGE, V17, P1408, DOI 10.1016/j.joca.2009.04.025; Wang QY, 2012, ARCH ORAL BIOL, V57, P620, DOI 10.1016/j.archoralbio.2011.12.006; Jiao K, 2010, ARCH ORAL BIOL, V55, P155, DOI 10.1016/j.archoralbio.2009.11.012; Zhu SS, 2013, BONE, V53, P340, DOI 10.1016/j.bone.2012.12.044; Chappard C, 2006, OSTEOARTHR CARTILAGE, V14, P215, DOI 10.1016/j.joca.2005.09.008; Jiao K, 2009, APOPTOSIS, V14, P22, DOI 10.1007/s10495-008-0279-5; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Xu L, 2009, OSTEOARTHR CARTILAGE, V17, P917, DOI 10.1016/j.joca.2009.01.002; Kuroda Y, 2011, ANGLE ORTHOD, V81, P975, DOI 10.2319/122810-749.1; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Bobinac D, 2003, BONE, V32, P284, DOI 10.1016/S8756-3282(02)00982-1; Arnett GW, 1996, AM J ORTHOD DENTOFAC, V110, P8, DOI 10.1016/S0889-5406(96)70081-1; Tanaka E, 2005, HISTOCHEM CELL BIOL, V123, P275, DOI 10.1007/s00418-005-0773-6; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Lee YJ, 2003, RHEUMATOL INT, V23, P282, DOI 10.1007/s00296-003-0312-5; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Teramoto M, 2003, J BONE MINER METAB, V21, P276, DOI 10.1007/s00774-003-0421-y; Chen K, 2014, INT J ORAL MAX SURG, V43, P996, DOI 10.1016/j.ijom.2014.04.003; Arnett GW, 1996, AM J ORTHOD DENTOFAC, V110, P117, DOI 10.1016/S0889-5406(96)70099-9; BIRD HA, 1978, ANN RHEUM DIS, V37, P203, DOI 10.1136/ard.37.3.203; Blair-Levy JM, 2008, ARTHRITIS RHEUM, V58, P1096, DOI 10.1002/art.23277; Cledes G, 2006, INT J ORAL MAX SURG, V35, P1026, DOI 10.1016/j.ijom.2006.05.003; Fujisawa T, 2003, J DENT RES, V82, P731; Fujita Y, 1999, J JAPAN SOC TEMPOROM, V11, P182; Giesen EBW, 2000, J DENT RES, V79, P957; Henriksen M, 2012, KNEE, V19, P392, DOI 10.1016/j.knee.2011.07.003; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Kawai N, 2008, J OROFAC PAIN, V22, P153; Kobayashi T, 2012, BRIT J ORAL MAX SURG, V50, P176, DOI 10.1016/j.bjoms.2011.02.006; Kuroe K., 1991, J JAPAN ORTHODONTIC, V50, P196; Newton PM, 1997, AM J SPORT MED, V25, P282, DOI 10.1177/036354659702500302; Ozaki M, 2008, ANGLE ORTHOD, V78, P819, DOI 10.2319/072407-342.1; Reynolds J J, 1996, Oral Dis, V2, P70; SCHELLHAS KP, 1990, AM J ROENTGENOL, V155, P373; Takatsuka S, 1996, J ORAL MAXIL SURG, V54, P1216, DOI 10.1016/S0278-2391(96)90355-9; Takei M, 2008, ORTHOD WAVES, V67, P15, DOI 10.1016/j.odw.2007.10.005; van Strijen PJ, 2001, J ORAL MAXILLOFAC SU, V59, P1107; van Strijen PJ, 2001, J ORAL MAXIL SURG, V59, P1104, DOI 10.1053/joms.2001.25860; Wadhwa S, 2005, CELLS TISSUES ORGANS, V181, P136, DOI 10.1159/000091375; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045036; Wu CW, 2002, J BONE MINER RES, V17, P639, DOI 10.1359/jbmr.2002.17.4.639; Yamada K, 2002, OSTEOARTHR CARTILAGE, V10, P360, DOI 10.1053/joca.2002.0525; Yonemitsu Ikuo, 2007, Arch Oral Biol, V52, P487, DOI 10.1016/j.archoralbio.2006.10.019	51	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	DEC	2014	59	12					1368	1376		10.1016/j.archoralbio.2014.08.010		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS7LG	WOS:000344437000016		
J	Murakami, D; Inada, E; Saitoh, I; Takemoto, Y; Morizono, K; Kubota, N; Iwasaki, T; Oku, T; Yamasaki, Y				Murakami, Daisuke; Inada, Emi; Saitoh, Issei; Takemoto, Yoshihiko; Morizono, Ken; Kubota, Naoko; Iwasaki, Tomonori; Oku, Takeshi; Yamasaki, Youichi			Morphological differences of facial soft tissue contours from child to adult of Japanese males: A three-dimensional cross-sectional study	ARCHIVES OF ORAL BIOLOGY			English	Article						Facial soft tissue; Children; Three-dimensional; Optoelectronic system	PROFILE CHANGES; HUMAN-FACE; GROWTH; DIMENSIONS; OCCLUSION; SKELETAL; AGE	Objective: To evaluate morphological differences of the facial soft tissue surface between male Japanese adults and children. Design: 20 adult Japanese males (average age 28 years) and 20 Japanese boys (average age 5.5 years) with normal occlusion were selected for this study. The images of the subjects' facial surface were obtained with a 3-D laser scanner. To evaluate the three-dimensional morphological differences of the facial soft tissue, we transformed the coordinates of 16 facial landmarks to a new reference plane and compared the adults' and children's facial form drawn to the same scale in the same coordinate system. Results: The morphological difference ratio of the lower facial area was higher than in the upper facial area, and the nose and lower face changed more forward than downward. The morphological difference ratio of the mid face width was smaller than other areas. Conclusion: Our study suggests that the morphological facial soft tissue differences between Japanese adults and children are more forward and downward than laterally, manifesting in a facial form of adults that is deeper and narrow. (C) 2014 Elsevier Ltd. All rights reserved.	[Murakami, Daisuke; Inada, Emi; Takemoto, Yoshihiko; Morizono, Ken; Kubota, Naoko; Iwasaki, Tomonori; Yamasaki, Youichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, Kagoshima 8908544, Japan; [Saitoh, Issei] Niigata Univ, Grad Sch Med & Dent Sci, Div Pediat Dent, Chuo Ku, Niigata 9518514, Japan; [Oku, Takeshi] Oku Pediat & Orthodont Dent Clin, Kagoshima 8900034, Japan	Inada, E (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	inada@dent.kagoshima-u.ac.jp			KAKENHI from Japan Society for the Promotion of Science [25463193, 24792298]	This work was supported by KAKENHI from Japan Society for the Promotion of Science (Nos. 25463193, 24792298).	Simpson E, 2002, AM J PHYS ANTHROPOL, V118, P121, DOI 10.1002/ajpa.10073; Inada E, 2008, CRANIO, V26, P170; Kau CH, 2006, ANGLE ORTHOD, V76, P773, DOI 10.2319/081605-287; Kau CH, 2008, AM J ORTHOD DENTOFAC, V134, P751, DOI 10.1016/j.ajodo.2007.01.037; SNODELL SF, 1993, AM J ORTHOD DENTOFAC, V104, P471, DOI 10.1016/0889-5406(93)70073-W; Baik HS, 2007, AM J ORTHOD DENTOFAC, V131, P759, DOI 10.1016/j.ajodo.2005.08.038; Bishara SE, 1998, AM J ORTHOD DENTOFAC, V114, P698, DOI 10.1016/S0889-5406(98)70203-3; Bravo LA, 1994, ANGLE ORTHOD, V64, P31; BURKE PH, 1988, J ANAT, V158, P115; BURKE PH, 1967, AMER J ORTHODONTICS, V53, P769, DOI 10.1016/0002-9416(67)90121-2; BURKE PH, 1971, HUM BIOL, V43, P536; Ferrario VF, 1997, CLEFT PALATE-CRAN J, V34, P309, DOI 10.1597/1545-1569(1997)034<0309:TDSOGA>2.3.CO;2; Ferrario VF, 1997, EUR J ORTHODONT, V19, P669, DOI 10.1093/ejo/19.6.669; Ferrario VF, 2003, CLIN ANAT, V16, P420, DOI 10.1002/ca.10154; Foley TF, 1997, ANGLE ORTHOD, V67, P373; Halazonetis DJ, 2007, AM J ORTHOD DENTOFAC, V132, P450, DOI 10.1016/j.ajodo.2005.10.033; Inada E, 2009, FORENSIC SCI INT, V191, P111, DOI 10.1016/j.forsciint.2009.06.015; Kau C H, 2004, Orthod Craniofac Res, V7, P198, DOI 10.1111/j.1601-6343.2004.00289.x; Kau C H, 2006, Orthod Craniofac Res, V9, P10, DOI 10.1111/j.1601-6343.2006.00359.x; Kau C H, 2006, Orthod Craniofac Res, V9, P31, DOI 10.1111/j.1601-6343.2006.00341.x; Kushimoto K, 1990, Gifu Shika Gakkai Zasshi, V17, P100; Moorrees CF, 1976, AM J ORTHOD, V69, P57; Nojima Kunihiko, 2002, Bull Tokyo Dent Coll, V43, P163, DOI 10.2209/tdcpublication.43.163; Nute S J, 2000, J Orthod, V27, P31, DOI 10.1093/ortho/27.1.31; Ruf S, 2001, ANGLE ORTHOD, V71, P4; Strajnic L, 2008, COLLEGIUM ANTROPOL, V32, P535; Yip E, 2004, INT J ORAL MAX SURG, V33, P179, DOI 10.1016/j.ijom.2003.0501	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	DEC	2014	59	12					1391	1399		10.1016/j.archoralbio.2014.08.004		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AS7LG	WOS:000344437000019		
J	Nemoto, M; Oue, Y; Morita, Y; Kanno, T; Kinoshita, Y; Niwa, H; Ueno, T; Katayama, Y; Bannai, H; Tsujimura, K; Yamanaka, T; Kondo, T				Nemoto, Manabu; Oue, Yasuhiro; Morita, Yoshinori; Kanno, Toru; Kinoshita, Yuta; Niwa, Hidekazu; Ueno, Takanori; Katayama, Yoshinari; Bannai, Hiroshi; Tsujimura, Koji; Yamanaka, Takashi; Kondo, Takashi			Experimental inoculation of equine coronavirus into Japanese draft horses	ARCHIVES OF VIROLOGY			English	Article							INFECTION; CALVES; COWS; PCR	Recently, outbreaks associated with equine coronavirus (ECoV) have occurred in Japan and the United States. While ECoV is likely to be pathogenic to horses, it has not been shown that experimental inoculation of horses with ECoV produces clinical signs of disease. In this study, we inoculated three Japanese draft horses with an ECoV-positive diarrheic fecal sample to confirm infection after inoculation and to investigate the clinical course and virus shedding patterns of ECoV. Virus neutralization tests showed that all three horses became infected with ECoV. Two of the three horses developed clinical signs similar to those observed during ECoV outbreaks, including fever, anorexia, and gastrointestinal dysfunction. All horses excreted a large amount of virus into their feces for more than 9 days after inoculation regardless of the presence or absence of clinical signs, which suggests that feces are an important source of ECoV infection. ECoV was also detected in nasal swabs from all horses, suggesting that respiratory transmission of ECoV may occur. Both symptomatic horses developed viremia, while the asymptomatic horse did not. White blood cell counts and serum amyloid A concentrations changed relative to the clinical condition of the inoculated horses; these may be useful markers for monitoring the clinical status of horses infected with ECoV. This is the first report of induction of clinical signs of ECoV infection in horses by experimental inoculation. These clinical and virological findings should aid further investigation of the pathogenesis of ECoV.	[Nemoto, Manabu; Kinoshita, Yuta; Niwa, Hidekazu; Ueno, Takanori; Katayama, Yoshinari; Bannai, Hiroshi; Tsujimura, Koji; Yamanaka, Takashi; Kondo, Takashi] Japan Racing Assoc, Equine Res Inst, Epizoot Res Ctr, Shimotsuke, Tochigi 3290412, Japan; [Oue, Yasuhiro] Hokkaido Kushiro Livestock Hyg Serv Ctr, Kushiro, Hokkaido 0840917, Japan; [Morita, Yoshinori] Tokachi Draft Horse Clin, Obihiro, Hokkaido 0800023, Japan; [Kanno, Toru] Natl Inst Anim Hlth, Exot Dis Res Div, Kodaira, Tokyo 1870022, Japan	Nemoto, M (reprint author), Japan Racing Assoc, Equine Res Inst, Epizoot Res Ctr, 1400-4 Shiba, Shimotsuke, Tochigi 3290412, Japan.	nemoto_manabu@epizoo.equinst.go.jp					Guy JS, 2000, J CLIN MICROBIOL, V38, P4523; Traven M, 2001, VET MICROBIOL, V81, P127, DOI 10.1016/S0378-1135(01)00337-6; Jacobsen S, 2007, EQUINE VET EDUC, V19, P38, DOI 10.2746/095777307X177235; SAIF LJ, 1986, AM J VET RES, V47, P1426; Oue Y, 2013, J VET MED SCI, V75, P1261, DOI 10.1292/jvms.13-0056; Niwa H, 2013, VET REC, V173, P607, DOI 10.1136/vr.101960; Belgrave RL, 2013, JAVMA-J AM VET MED A, V243, P113, DOI 10.2460/javma.243.1.113; Tsunemitsu H, 1999, ARCH VIROL, V144, P167, DOI 10.1007/s007050050493; Hobo S, 2007, J VET MED SCI, V69, P827, DOI 10.1292/jvms.69.827; Pusterla N, 2013, VET MICROBIOL, V162, P228, DOI 10.1016/j.vetmic.2012.10.014; Oue Y, 2011, VET MICROBIOL, V150, P41, DOI 10.1016/j.vetmic.2011.01.004; Miszczak F, 2014, VET MICROBIOL, V171, P206, DOI 10.1016/j.vetmic.2014.03.031; de Groot R.J., 2011, VIRUS TAXONOMY CLASS, P806; Kanno T., 2012, Journal of Disaster Research, V7, P297; Magdesian KG, 2014, EQUINE INFECT DIS, V2nd, P198; Narita M., 2011, Journal of the Japan Veterinary Medical Association, V64, P535; Nemoto M, 2010, J VET MED SCI, V72, P823	17	4	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	DEC	2014	159	12					3329	3334		10.1007/s00705-014-2205-1		6	Virology	Virology	AT2ZS	WOS:000344804200015		
J	Saikruang, W; Khamrin, P; Suantai, B; Okitsu, S; Hayakawa, S; Ushijima, H; Maneekarn, N				Saikruang, Wilaiporn; Khamrin, Pattara; Suantai, Boonpa; Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi; Maneekarn, Niwat			Detection of diarrheal viruses circulating in adult patients in Thailand	ARCHIVES OF VIROLOGY			English	Article						Diarrheal viruses; Adult; Epidemiology; Thailand	ACUTE GASTROENTERITIS; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; STOOL SAMPLES; UNITED-STATES; AICHI VIRUS; SAPOVIRUS; INFECTIONS; ROTAVIRUS; CHILDREN	A total of 332 fecal specimens collected during January-December 2008 from adult patients with diarrhea were screened for group A and C rotaviruses, noroviruses GI and GII, sapovirus, Aichi virus, human parechovirus, enterovirus, adenovirus and astrovirus by RT-multiplex PCR. The detection rate for diarrheal viruses was 4.2 %. Adenovirus and enterovirus were equally detected as the most predominant viruses, with prevalence of 1.2 %, followed by Aichi virus (0.9 %) and norovirus GII (0.6 %). Mixed infection with norovirus GII and human parechovirus was also detected (0.3 %). This study provides epidemiological data for a wide variety of diarrheal viruses circulating in adult patients with diarrhea in Chiang Mai, Thailand.	[Saikruang, Wilaiporn; Khamrin, Pattara; Suantai, Boonpa; Maneekarn, Niwat] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai 50200, Thailand; [Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo, Japan	Maneekarn, N (reprint author), Chiang Mai Univ, Dept Microbiol, Fac Med, 110 Intawarorose, Chiang Mai 50200, Thailand.	niwat.m@cmu.ac.th			Faculty of Medicine, Chiang Mai. University (Medical Research Fund); Graduate School of Chiang Mai University, Chiang Mai, Thailand	This research was supported by Grants from the Faculty of Medicine, Chiang Mai. University (Medical Research Fund) and the Graduate School of Chiang Mai University, Chiang Mai, Thailand.	Ambert-Balay K, 2008, J CLIN MICROBIOL, V46, P1252, DOI 10.1128/JCM.02140-07; Khamrin P, 2011, J VIROL METHODS, V173, P390, DOI 10.1016/j.jviromet.2011.02.012; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Pham NTK, 2010, J CLIN MICROBIOL, V48, P115, DOI 10.1128/JCM.01015-09; Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x; Kittigul L, 2010, J MED VIROL, V82, P854, DOI 10.1002/jmv.21746; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Haustein T, 2009, CLIN INFECT DIS, V49, P1890, DOI 10.1086/648440; Huhulescu S, 2009, INFECTION, V37, P103, DOI 10.1007/s15010-008-8106-z; Khamrin P, 2013, INFECT GENET EVOL, V13, P339, DOI 10.1016/j.meegid.2012.11.004; Phan TG, 2005, J MED VIROL, V77, P257, DOI 10.1002/jmv.20445; Chaimongkol N, 2012, CLIN LAB, V58, P117; Chieochansin T, 2011, VIROLOGY, V421, P159, DOI 10.1016/j.virol.2011.09.021; Li CY, 2010, J CLIN MICROBIOL, V48, P4306, DOI 10.1128/JCM.00797-10; Dey SK, 2009, INFECT GENET EVOL, V9, P518, DOI 10.1016/j.meegid.2009.02.001; Faruque ASG, 2004, SCAND J INFECT DIS, V36, P204, DOI 10.1080/00365540410019219; Gonzalez-Losa MD, 2001, ARCH MED RES, V32, P164; Johansson PJH, 2005, SCAND J INFECT DIS, V37, P200, DOI 10.1080/0365540410020974; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129; Khamrin P, 2012, VIRUS GENES, V44, P244, DOI 10.1007/s11262-011-0700-y; Kittigul L, 2009, J MED VIROL, V81, P345, DOI 10.1002/jmv.21380; Pham NTK, 2007, J CLIN MICROBIOL, V45, P2287, DOI 10.1128/JCM.00525-07; Rubilar-Abreu E, 2005, J CLIN MICROBIOL, V43, P1374, DOI 10.1128/JCM.43.3.1374-1376.2005; Saikruang W, 2014, J MED VIROL, V86, P983, DOI 10.1002/jmv.23904; Wang G, 2014, J CLIN VIROL, V59, P250, DOI 10.1016/j.jcv.2014.01.007; Wold W.S.M., 2013, FIELDS VIROLOGY, P1732; Yamashita T, 2000, J CLIN MICROBIOL, V38, P2955; Yan Hainian, 2004, Kansenshogaku Zasshi, V78, P699; ZOLL GJ, 1992, J CLIN MICROBIOL, V30, P160	32	2	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	DEC	2014	159	12					3371	3375		10.1007/s00705-014-2191-3		5	Virology	Virology	AT2ZS	WOS:000344804200020		
J	Dong, JB; Cook, FR; Haga, T; Horii, Y; Norimine, J; Misawa, N; Goto, Y; Zhu, W				Dong, Jianbao; Cook, Frank R.; Haga, Takeshi; Horii, Yoichiro; Norimine, Junzo; Misawa, Naoaki; Goto, Yoshitaka; Zhu, Wei			Comparative analysis of LTR and structural genes in an equine infectious anemia virus strain isolated from a feral horse in Japan	ARCHIVES OF VIROLOGY			English	Article						EIAV; Japanese isolate; Comparative analysis; LTR; Structural genes	LONG TERMINAL REPEAT; FUNCTIONAL DOMAINS; VIRAL REPLICATION; CRYSTAL-STRUCTURE; 2006 OUTBREAK; FIELD STRAIN; IN-VITRO; S2 GENE; GAG P9; PROTEIN	Although equine infectious anemia virus (EIAV) poses a major threat to the equine industry worldwide, the molecular epidemiology of this virus is poorly understood. Recently, an EIAV strain (EIAV(Miyazaki2011-A)) representing a new monophyletic group was discovered in feral horses in southern Japan. In the present study, the EIAV(Miyazaki2011-A) proviral genome is compared with evolutionarily divergent EIAV isolates to investigate conservation of functional elements or motifs within the long terminal repeats (LTRs) and structural genes. This analysis represents a significant step forward in increasing understanding of the molecular conservation and variation between geographically distinct strains of this equine lentivirus.	[Dong, Jianbao; Norimine, Junzo; Misawa, Naoaki] Miyazaki Univ, Ctr Anim Dis Control, Miyazaki 8892192, Japan; [Cook, Frank R.] Univ Kentucky, Gluck Equine Res Ctr, Dept Vet Sci, Lexington, KY 40546 USA; [Haga, Takeshi] Univ Tokyo, Div Infect Control & Dis Prevent, Dept Vet Med Sci, Tokyo 1138657, Japan; [Horii, Yoichiro] Miyazaki Univ, Lab Vet Parasit Dis, Miyazaki 8892192, Japan; [Goto, Yoshitaka; Zhu, Wei] Miyazaki Univ, Lab Vet Microbiol, Miyazaki 8892192, Japan; [Zhu, Wei] Japan Soc Promot Sci, Tokyo 1028472, Japan	Zhu, W (reprint author), Miyazaki Univ, Lab Vet Microbiol, Miyazaki 8892192, Japan.	weizhu@cc.miyazaki-u.ac.jp					Amodeo P, 2006, BIOCHEMISTRY-US, V45, P5517, DOI 10.1021/bi0524924; Eijkelenboom APAM, 1997, CURR BIOL, V7, P739, DOI 10.1016/S0960-9822(06)00332-0; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Dauter Z, 1999, J MOL BIOL, V285, P655, DOI 10.1006/jmbi.1998.2332; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; Leroux C, 2004, VET RES, V35, P485, DOI 10.1051/vetres:2004020; ENGELMAN A, 1992, J VIROL, V66, P6361; Leroux C, 1997, J VIROL, V71, P9627; Baccam P, 2003, J VIROL, V77, P12122, DOI 10.1128/JVI.77.2212122-12131.2003; Belshan M, 2001, VIROLOGY, V279, P185, DOI 10.1006/viro.2000.0696; Belshan M, 1998, J VIROL, V72, P4421; Capomaccio S, 2012, VET MICROBIOL, V157, P320, DOI 10.1016/j.vetmic.2012.01.015; CARROLL R, 1991, J VIROL, V65, P3460; CARVALHO M, 1993, J VIROL, V67, P2064; Chen CP, 2001, J VIROL, V75, P9762, DOI 10.1128/JVI.75.20.9762-9770.2001; Covaleda L, 2010, VIRUS RES, V151, P235, DOI 10.1016/j.virusres.2010.04.007; Covaleda L, 2010, VIROLOGY, V397, P217, DOI 10.1016/j.virol.2009.11.005; Craigo JK, 2007, P NATL ACAD SCI USA, V104, P15105, DOI 10.1073/pnas.0706449104; Craigo JK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-95; Cullinane A, 2007, VET REC, V161, P647; DERSE D, 1987, J VIROL, V61, P743; Dong JB, 2012, ARCH VIROL, V157, P2105, DOI 10.1007/s00705-012-1406-8; Dong JB, 2013, J GEN VIROL, V94, P360, DOI 10.1099/vir.0.047498-0; Eizert H, 2008, J VIROL, V82, P10111, DOI 10.1128/JVI.00418-08; GRUND CH, 1994, J GEN VIROL, V75, P657, DOI 10.1099/0022-1317-75-3-657; Harris ME, 1998, MOL CELL BIOL, V18, P3889; Hatanaka H, 2002, J VIROL, V76, P1876, DOI 10.1128/JVI.76.4.1876-1883.2002; Hines R, 2004, J VIROL, V78, P3407, DOI 10.1128/JVI.78.7.3407-3418.2004; HUSSAIN KA, 1988, J GEN VIROL, V69, P1719, DOI 10.1099/0022-1317-69-7-1719; KEMENY LJ, 1971, CORNELL VET, V61, P687; Lee JH, 2006, J VIROL, V80, P3844, DOI 10.1128/JVI.80.8.3844-3852.2006; Li F, 2002, J VIROL, V76, P1569, DOI 10.1128/JVI.76.4.1569-1577.2002; Li F, 1998, J VIROL, V72, P8344; Li F, 2000, J VIROL, V74, P573; Lignee M., 1843, REC MED VET EC ALFOR, V20, P30; MAURY W, 1994, J VIROL, V68, P6270; MCGEOCH DJ, 1990, NUCLEIC ACIDS RES, V18, P4105, DOI 10.1093/nar/18.14.4105; Payne SL, 1998, J VIROL, V72, P483; Puffer BA, 1997, J VIROL, V71, P6541; Quinlivan M, 2013, J GEN VIROL, V94, P612, DOI 10.1099/vir.0.047191-0; Rungrotmongkol T, 2007, J MOL GRAPH MODEL, V26, P1, DOI 10.1016/j.jmgm.2006.09.004; SALINOVICH O, 1986, J VIROL, V57, P71; Sparks WO, 2008, J GEN VIROL, V89, P1043, DOI 10.1099/vir.0.83195-0; Sponseller BA, 2007, VIROLOGY, V363, P156, DOI 10.1016/j.virol.2007.01.037; STEAGALL WK, 1995, VIROLOGY, V210, P302, DOI 10.1006/viro.1995.1347; STEPHENS RM, 1986, SCIENCE, V231, P589, DOI 10.1126/science.3003905; Tu YB, 2007, ARCH VIROL, V152, P209, DOI 10.1007/s00705-006-0830-z; WEBER IT, 1993, BIOCHEMISTRY-US, V32, P3354, DOI 10.1021/bi00064a019; Zhang XY, 2007, J GEN VIROL, V88, P998, DOI 10.1099/vir.0.82416-0; Zheng YH, 1997, J GEN VIROL, V78, P807	51	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	DEC	2014	159	12					3413	3420		10.1007/s00705-014-2206-0		8	Virology	Virology	AT2ZS	WOS:000344804200027		
J	Di Serio, F; Flores, R; Verhoeven, JTJ; Li, SF; Pallas, V; Randles, JW; Sano, T; Vidalakis, G; Owens, RA				Di Serio, F.; Flores, R.; Verhoeven, J. Th. J.; Li, S-F.; Pallas, V.; Randles, J. W.; Sano, T.; Vidalakis, G.; Owens, R. A.			Current status of viroid taxonomy	ARCHIVES OF VIROLOGY			English	Article							HEPATITIS-DELTA VIRUS; INFECTED TOMATO PLANTS; SMALL RNAS; SECONDARY STRUCTURE; SATELLITE RNAS; COLEUS-BLUMEI; NUCLEOTIDE-SEQUENCE; HOST INTERACTIONS; CIRCULAR RNAS; IN-VIVO	Viroids are the smallest autonomous infectious nucleic acids known so far. With a small circular RNA genome of about 250-400 nt, which apparently does not code for any protein, viroids replicate and move systemically in host plants. Since the discovery of the first viroid almost forty-five years ago, many different viroids have been isolated, characterized and, frequently, identified as the causal agents of plant diseases. The first viroid classification scheme was proposed in the early 1990s and adopted by the International Committee on Taxonomy of Viruses (ICTV) a few years later. Here, the current viroid taxonomy scheme and the criteria for viroid species demarcation are discussed, highlighting the main taxonomic questions currently under consideration by the ICTV Viroid Study Group. The impact of correct taxonomic annotation of viroid sequence variants is also addressed, taking into consideration the increasing application of next-generation sequencing and bioinformatics for known and previously unrecognized viroids.	[Di Serio, F.] CNR, Inst Sustainable Plant Protect, I-70126 Bari, Italy; [Flores, R.; Pallas, V.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; [Verhoeven, J. Th. J.] Natl Plant Protect Org, Natl Reference Ctr, NL-6700 HC Wageningen, Netherlands; [Li, S-F.] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pest, Beijing 100193, Peoples R China; [Randles, J. W.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA 5064, Australia; [Sano, T.] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Vidalakis, G.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Owens, R. A.] ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD 20705 USA	Di Serio, F (reprint author), CNR, Inst Sustainable Plant Protect, I-70126 Bari, Italy.	f.diserio@ba.ivv.cnr.it	Flores, Ricardo/K-2788-2014; 	Flores, Ricardo/0000-0002-3033-5077; Di Serio, Francesco/0000-0003-2822-704X			Flores R, 1997, SEMIN VIROL, V8, P65, DOI 10.1006/smvy.1997.0107; Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Verhoeven JTJ, 2013, J GEN VIROL, V94, P711, DOI 10.1099/vir.0.048751-0; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Ling KS, 2009, PLANT DIS, V93, P1216, DOI 10.1094/PDIS-93-11-1216A; Verhoeven JTJ, 2011, ARCH VIROL, V156, P1433, DOI 10.1007/s00705-011-0975-2; GROSS HJ, 1978, NATURE, V273, P203, DOI 10.1038/273203a0; Hammann C, 2012, RNA BIOL, V9, P809, DOI 10.4161/rna.19810; Ito T, 2013, ARCH VIROL, V158, P2629, DOI 10.1007/s00705-013-1772-x; KEESE P, 1985, P NATL ACAD SCI USA, V82, P4582, DOI 10.1073/pnas.82.14.4582; Flores R, 2012, SEMIN LIVER DIS, V32, P201, DOI 10.1055/s-0032-1323624; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034; Gas ME, 2007, PLOS PATHOG, V3, P1813, DOI 10.1371/journal.ppat.0030182; HERNANDEZ C, 1992, P NATL ACAD SCI USA, V89, P3711, DOI 10.1073/pnas.89.9.3711; Tsagris EM, 2008, CELL MICROBIOL, V10, P2168, DOI 10.1111/j.1462-5822.2008.01231.x; SANO T, 1992, P NATL ACAD SCI USA, V89, P10104, DOI 10.1073/pnas.89.21.10104; Flores R, 1998, ARCH VIROL, V143, P623, DOI 10.1007/s007050050318; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Gozmanova M, 2003, NUCLEIC ACIDS RES, V31, P5534, DOI 10.1093/nar/gkg777; Nohales MA, 2012, P NATL ACAD SCI USA, V109, P13805, DOI 10.1073/pnas.1206187109; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Martinez G, 2010, MOL PLANT PATHOL, V11, P347, DOI [10.1111/j.1364-3703.2009.00608.x, 10.1111/J.1364-3703.2009.00608.X]; DIENER TO, 1971, VIROLOGY, V45, P411, DOI 10.1016/0042-6822(71)90342-4; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Navarro B, 2012, BIOCHIMIE, V94, P1474, DOI 10.1016/j.biochi.2012.02.020; DIENER TO, 1989, P NATL ACAD SCI USA, V86, P9370, DOI 10.1073/pnas.86.23.9370; Zhong XH, 2008, PLANT CELL, V20, P35, DOI 10.1105/tpc.107.056606; Wu QF, 2012, P NATL ACAD SCI USA, V109, P3938, DOI 10.1073/pnas.1117815109; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Bussiere F, 2000, J VIROL, V74, P2647, DOI 10.1128/JVI.74.6.2647-2654.2000; Chiumenti M, 2014, VIRUS RES, V188, P54, DOI 10.1016/j.virusres.2014.03.026; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; Singh RP, 2009, EUR J PLANT PATHOL, V123, P111, DOI 10.1007/s10658-008-9344-8; EFSA, 2011, EFSA J, V9, P2330, DOI DOI 10.2903/J.EFSA.2011.2330; ELENA SF, 1991, P NATL ACAD SCI USA, V88, P5631, DOI 10.1073/pnas.88.13.5631; Elena SF, 2001, J MOL EVOL, V53, P155; Fadda Z, 2003, VIRUS RES, V97, P145, DOI 10.1016/j.virusres.2003.08.002; Flores R., 2000, VIRUS TAXONOMY, P1009; Flores R, 2011, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0000434.pub3, DOI 10.1002/9780470015902.A0000434.PUB3]; Flores R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00217; Flores R., 2005, VIRUS TAXONOMY, P1145; Flores R, 1995, VIRUS TAXONOMY, P495; Flores R, 2011, STUDIES VIRAL ECOLOG, V1, P307; Di Serio F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007539; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; HAMMOND R, 1989, NUCLEIC ACIDS RES, V17, P10083, DOI 10.1093/nar/17.23.10083; HASELOFF J, 1982, NATURE, V299, P316, DOI 10.1038/299316a0; Hou WY, 2009, ARCH VIROL, V154, P315, DOI 10.1007/s00705-008-0276-6; Hou WY, 2009, ARCH VIROL, V154, P993, DOI 10.1007/s00705-009-0388-7; Jenkins GM, 2000, J MOL EVOL, V50, P98; Jiang DM, 2014, VIRUS RES, V180, P97, DOI 10.1016/j.virusres.2013.11.014; JUKES T H, 1969, P21; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; MartinezSoriano JP, 1996, P NATL ACAD SCI USA, V93, P9397, DOI 10.1073/pnas.93.18.9397; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; Owens R.A., 2012, VIRUS TAXONOMY, P1221; Owens RA, 2007, MOL PLANT PATHOL, V8, P549, DOI [10.1111/j.1364-3703.2007.00418.x, 10.1111/J.1364-3703.2007.00418.X]; REZAIAN MA, 1990, NUCLEIC ACIDS RES, V18, P1813, DOI 10.1093/nar/18.7.1813; Rubino L., 2003, Viroids, P76; Semancik JS, 2005, ARCH VIROL, V150, P1059, DOI 10.1007/s00705-005-0499-8; Singh RP, 1999, J GEN VIROL, V80, P2823; Spieker RL, 1996, J GEN VIROL, V77, P2839, DOI 10.1099/0022-1317-77-11-2839; Szychowski JA, 2005, J GEN VIROL, V86, P473, DOI 10.1099/vir.0.80699-0; Verhoeven JThJ, 2010, THESIS WAGENINGEN U, P136; Verhoeven JTJ, 2010, PLANT PATHOL, V59, P3, DOI 10.1111/j.1365-3059.2009.02173.x	68	8	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	DEC	2014	159	12					3467	3478		10.1007/s00705-014-2200-6		12	Virology	Virology	AT2ZS	WOS:000344804200037		
J	Nakamura, M; Inari, N; Hiura, T				Nakamura, Masahiro; Inari, Naoki; Hiura, Tsutom			Spatial variation in leaf traits and herbivore community within the beech canopy between two different latitudes	ARTHROPOD-PLANT INTERACTIONS			English	Article						Canopy foliage; Chewers; Feeding types; Gallers, miners; Scaffolding system	TROPICAL FOREST; CLIMATE-CHANGE; FAGUS-CRENATA; ASSEMBLAGES; GRADIENTS; PATTERNS; DIVERSITY; INSECTS; IMPACTS; DAMAGE	To understand how the herbivore community on beech canopies varies between two different latitudes, we assessed leaf traits and herbivory by three major feeding types (chewing, mining, and galling) at different positions in the canopy using a scaffolding system along a 1,400-km latitudinal gradient between Kuromatsunai (north) and Shiiba (south) in Japan. The chemical and morphological traits of the canopy foliage differed significantly between latitudes and between canopy parts. The leaf mass per area (LMA), leaf nitrogen, and carbon/nitrogen (CN) ratio were higher at south latitude than at north latitude. The upper canopy had a greater LMA, leaf nitrogen, and CN ratio than the lower canopy at both latitudes. On the other hand, herbivory by the three major feeding types differed significantly between latitudes and between canopy parts. The miner and galler densities were higher at south latitude than at north latitude, while the chewing herbivory was lower, showing different latitudinal patterns among feeding types. Among these feeding types, only chewing herbivory was higher in the lower canopy than in the upper canopy at both latitudes. The stepwise regression models showed that LMA and CN ratio explained spatial variation in chewing herbivory. Our study demonstrates that the latitudinal and spatial variations in leaf traits can play an important role in determining the latitudinal and spatial variations in the herbivore community on beech canopies via different responses of each feeding type.	[Nakamura, Masahiro] Hokkaido Univ, Nakagawa Expt Forest, Field Sci Ctr Northern Biosphere, Otoineppu, Nakagawa 0982501, Japan; [Nakamura, Masahiro; Hiura, Tsutom] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Tomakomai Expt Forest, Takaoka, Tomakomai 0530035, Japan; [Inari, Naoki] Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan	Nakamura, M (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Tomakomai Expt Forest, Takaoka, Tomakomai 0530035, Japan.	masahiro@fsc.hokudai.ac.jp			Japan Society for the Promotion of Science [26450188, 19657007, 21248017]; Ministry of Environment [D-0909]; Environment Research and Technology Development Fund [S-9-3]	This work was supported by grants from the Japan Society for the Promotion of Science (No. 26450188 to MN and Nos. 19657007 and 21248017 to TH), the Ministry of Environment (No. D-0909 to TH), and the Environment Research and Technology Development Fund (S-9-3). We thank two anonymous reviewers for useful suggestions.	Andrew Nigel R., 2012, Open Journal of Ecology, V2, P202, DOI 10.4236/oje.2012.24024; Andrew NR, 2004, ECOL ENTOMOL, V29, P527, DOI 10.1111/j.0307-6946.2004.00639.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Nakamura M, 2008, CAN J FOREST RES, V38, P1603, DOI 10.1139/X08-006; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.ecolsys.22.1.115; Marczak LB, 2011, ECOLOGY, V92, P276, DOI 10.1890/10-0760.1; Hikosaka K, 2004, J PLANT RES, V117, P481, DOI 10.1007/s10265-004-0174-2; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Adams JM, 2009, J ECOL, V97, P933, DOI 10.1111/j.1365-2745.2009.01523.x; Hiura T, 2013, BASIC APPL ECOL, V14, P480, DOI 10.1016/j.baae.2013.06.004; Clissold FJ, 2009, ECOLOGY, V90, P3393, DOI 10.1890/09-0130.1; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Connor EF, 1997, OIKOS, V79, P6, DOI 10.2307/3546085; Simpson Stephen J, 2010, Trends Ecol Evol, V25, P53, DOI 10.1016/j.tree.2009.06.012; Andrew NR, 2005, OIKOS, V108, P176, DOI 10.1111/j.0030-1299.2005.13457.x; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Yamasaki M, 2003, OECOLOGIA, V137, P226, DOI 10.1007/s00442-003-1337-x; Bairstow KA, 2010, OECOLOGIA, V163, P437, DOI 10.1007/s00442-010-1606-4; Basset Y, 2003, STUDYING FOREST CANO, P71; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Feath SH, 1981, OIKOS, V37, P238; FOX LR, 1983, AUST J ECOL, V8, P139, DOI 10.1111/j.1442-9993.1983.tb01601.x; Hagiwara S., 1977, SPECIES BIOL RES, V1, P39; Hiura T, 1998, TREES-STRUCT FUNCT, V12, P274, DOI 10.1007/PL00009717; Hiura T, 1993, THESIS HOKKAIDO U SA; Koike T, 1990, T HOKKAIDO BR JPN FO, V38, P20; KOMATSU T, 1995, ECOL ENTOMOL, V20, P33, DOI 10.1111/j.1365-2311.1995.tb00426.x; Korner C., 1999, ALPINE PLANT LIFE FU; Kozlov VM, 2008, CLIMATIC CHANGE, V87, P107, DOI [10.1007/s10584-007-9348-y, DOI 10.1007/S10584-007-9348-Y]; KUULUVAINEN T, 1992, OIKOS, V65, P275, DOI 10.2307/3545019; LANDSBERG J, 1989, TRENDS ECOL EVOL, V4, P96, DOI 10.1016/0169-5347(89)90054-2; Majer JD, 2001, BIOTROPICA, V33, P643; Moran CV, 1982, J ANIM ECOL, V51, P289; Mulkey SS, 1996, TRENDS ECOL EVOL, V11, P408, DOI 10.1016/0169-5347(96)10043-4; Murakami M, 2005, ECOL ENTOMOL, V30, P521, DOI 10.1111/j.0307-6946.2005.00724.x; Parkhurst EF, 1972, J ECOL, V60, P505; Rhoades D. F., 1976, BIOCH INTERACTIONS P, P168; Roininen H, 2006, Galling Arthropods and Their Associates: Ecology and Evolution, P3, DOI 10.1007/4-431-32185-3_1; Schoonhoven L. M., 1998, INSECT PLANT BIOL PH; Simpson S.J., 2012, NATURE NUTR UNIFYING; Slansky F. Jr, 1985, P87; Stork NE, 1997, CANOPY ARTHROPODS; Strong DR, 1984, INSECTS PLANTS COMMU, P313; Suzuki SN, 2012, ECOL RES, V27, P989, DOI 10.1007/s11284-012-0980-2; Toda MJ, 2002, BIODIVERSITY RES MET, P27; Yukawa J, 1997, INSECT MITE GALLS JA	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1872-8855	1872-8847		ARTHROPOD-PLANT INTE	Arthropod-Plant Interact.	DEC	2014	8	6					571	579		10.1007/s11829-014-9346-8		9	Ecology; Entomology	Environmental Sciences & Ecology; Entomology	AT2AL	WOS:000344732900010		
J	Yamanoi, J; Cao, Q				Yamanoi, Junichi; Cao, Qing			Competition and termination of the alliances between asymmetric partners: The case of Japanese department stores	ASIA PACIFIC JOURNAL OF MANAGEMENT			English	Article						Alliance termination; Alliance portfolio; Relative capability; Intra-portfolio competition; Asymmetric partners	STRATEGIC MANAGEMENT RESEARCH; INTERFIRM COOPERATION; PERFORMANCE; DYNAMICS; NETWORKS; ASSETS; COMPLEMENTARITY; BIOTECHNOLOGY; EXPLOITATION; EXPLORATION	To enrich the literature on alliance termination, we recognize that the dynamics of individual alliances are subject to the structural characteristics of the alliance portfolios in which they are embedded. We anchor our study in the context of large industry leaders partnering with multiple small partners, the latter of which can be viewed as competing for access to the formers' resources. We expect that a small partner's relative capability in relation to peer partners within a leader's alliance portfolio is negatively related to the likelihood of alliance termination, since the leader acknowledges that partners with inferior capability do not deserve to be supported. Furthermore, this relationship would be moderated by alliance portfolio size, market overlap with peer partners, and with industry leaders. Using a unique dataset of 145 alliances between leading and small department stores in Japan in the period 1977-93, we found general support for the hypothesized relationships.	[Yamanoi, Junichi] Chuo Univ, Fac Policy Studies, Hachioji, Tokyo 1920393, Japan; [Cao, Qing] Univ Connecticut, Sch Business, Dept Management, Storrs, CT 06269 USA	Yamanoi, J (reprint author), Chuo Univ, Fac Policy Studies, 42-1-11551 Higashinakano, Hachioji, Tokyo 1920393, Japan.	yamanoi@fps.chuo-u.ac.jp; qcao@business.uconn.edu					AMIT R, 1993, STRATEGIC MANAGE J, V14, P33, DOI 10.1002/smj.4250140105; Rothaermel FT, 2004, STRATEGIC MANAGE J, V25, P201, DOI 10.1002/smj.376; Zollo M, 2002, ORGAN SCI, V13, P339, DOI 10.1287/orsc.13.3.339.2780; Gulati R, 1999, AM J SOCIOL, V104, P1439, DOI 10.1086/210179; Lavie D, 2007, STRATEG MANAGE J, V28, P1187, DOI 10.1002/smj.637; HANNAN MT, 1977, AM J SOCIOL, V82, P929, DOI 10.1086/226424; Stuart TE, 1999, ADMIN SCI QUART, V44, P315, DOI 10.2307/2666998; Greve HR, 2013, ORGAN SCI, V24, P79, DOI 10.1287/orsc.1110.0733; Kale P, 2002, STRATEGIC MANAGE J, V23, P747, DOI 10.1002/smj.248; Mowery DC, 1996, STRATEGIC MANAGE J, V17, P77; Gulati R, 2000, STRATEGIC MANAGE J, V21, P203, DOI 10.1002/(SICI)1097-0266(200003)21:3<203::AID-SMJ102>3.0.CO;2-K; Kale P, 2000, STRATEGIC MANAGE J, V21, P217, DOI 10.1002/(SICI)1097-0266(200003)21:3<217::AID-SMJ95>3.3.CO;2-P; Hoffmann WH, 2007, STRATEG MANAGE J, V28, P827, DOI 10.1002/smj.607; Priem RL, 2001, ACAD MANAGE REV, V26, P22, DOI 10.5465/AMR.2001.27879279; Rothaermel FT, 2001, STRATEGIC MANAGE J, V22, P687, DOI 10.1002/smj.180; PARKHE A, 1993, ACAD MANAGE J, V36, P794, DOI 10.2307/256759; Sampson RC, 2005, STRATEGIC MANAGE J, V26, P1009, DOI 10.1002/smj.493; Lavie D, 2006, ACAD MANAGE J, V49, P797; Lane PJ, 1998, STRATEGIC MANAGE J, V19, P461, DOI 10.1002/(SICI)1097-0266(199805)19:5<461::AID-SMJ953>3.3.CO;2-C; BARNETT WP, 1987, ADMIN SCI QUART, V32, P400, DOI 10.2307/2392912; Chung S, 2000, STRATEGIC MANAGE J, V21, P1; DELACROIX J, 1989, AM SOCIOL REV, V54, P245, DOI 10.2307/2095793; Reuer JJ, 2002, STRATEGIC MANAGE J, V23, P135, DOI 10.1002/smj.214; Wiersema MF, 2009, STRATEG MANAGE J, V30, P679, DOI 10.1002/smj.758; Inkpen AC, 1997, ACAD MANAGE REV, V22, P177, DOI 10.5465/AMR.1997.9707180263; Hoetker G, 2007, STRATEGIC MANAGE J, V28, P331, DOI 10.1002/smj.582; Khanna T, 1998, STRATEGIC MANAGE J, V19, P193, DOI 10.1002/(SICI)1097-0266(199803)19:3<193::AID-SMJ949>3.3.CO;2-3; Gulati R, 1998, STRATEGIC MANAGE J, V19, P293, DOI 10.1002/(SICI)1097-0266(199804)19:4<293::AID-SMJ982>3.0.CO;2-M; Chen MJ, 1996, ACAD MANAGE REV, V21, P100; Olk P, 1997, STRATEGIC MANAGE J, V18, P855, DOI 10.1002/(SICI)1097-0266(199712)18:11<855::AID-SMJ923>3.0.CO;2-Q; Ketchen DJ, 2004, J MANAGE, V30, P779, DOI 10.1016/j.jm.2004.06.002; Das TK, 2000, ORGAN SCI, V11, P77, DOI 10.1287/orsc.11.1.77.12570; Kim WC, 2005, CALIF MANAGE REV, V47, P105; Baum JAC, 2000, STRATEGIC MANAGE J, V21, P267, DOI 10.1002/(SICI)1097-0266(200003)21:3<267::AID-SMJ89>3.0.CO;2-8; Adner R, 2006, HARVARD BUS REV, V84, P98; Saxton T, 1997, ACAD MANAGE J, V40, P443, DOI 10.2307/256890; Berman B., 2006, RETAIL MANAGEMENT ST; Burt RS, 1992, STRUCTURAL HOLES SOC; Cameron A. C., 2009, MICROECONOMETRICS US; Carroll G. R., 2000, DEMOGRAPHY CORPORATI; Doz Y. L., 1988, COOPERATIVE STRATEGI, P317; Greve HR, 2010, ACAD MANAGE J, V53, P302; Gulati R, 1995, ADMIN SCI QUART, V40, P619, DOI 10.2307/2393756; Hannan M. T., 1989, ORG ECOLOGY; Hannan M. T., 1986, TECHNICAL REPORT; HANNAN MT, 1984, AM SOCIOL REV, V49, P149, DOI 10.2307/2095567; Leland A., 2005, MOTOROLA BUILDING PA; McCutchen Jr W. W., 2008, J HIGH TECHNOLOGY MA, V18, P191, DOI 10.1016/j.hitech.2007.12.001; Mitsuhashi H, 2009, ACAD MANAGE J, V52, P975; Nelson R., 1982, EVOLUTIONARY THEORY; Pangarkar N, 2009, J MANAGE STUD, V46, P982, DOI 10.1111/j.1467-6486.2009.00844.x; PETERSEN T, 1991, SOCIOL METHODOL, V21, P263, DOI 10.2307/270938; Sadowski B, 2008, J ENG TECHNOL MANAGE, V25, P305, DOI 10.1016/j.jengtecman.2008.10.002; Triola M. F., 2009, ESSENTIALS STAT; Tucker D., 1988, ECOLOGICAL MODELS OR, P127; Wassmer U, 2010, J MANAGE, V36, P141, DOI 10.1177/0149206308328484	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0217-4561	1572-9958		ASIA PAC J MANAG	Asia Pac. J. Manag.	DEC	2014	31	4					949	971		10.1007/s10490-014-9383-y		23	Management	Business & Economics	AT2BK	WOS:000344735700003		
J	Yabushita, NW; Suehiro, A				Yabushita, Natenapha Wailerdsak; Suehiro, Akira			Family business groups in Thailand: coping with management critical points	ASIA PACIFIC JOURNAL OF MANAGEMENT			English	Article						Family business groups; Managerial enterprises; Management critical point; Employed managers; Late industrializing country; Thailand	EMERGING MARKETS; FIRM	Using insights drawn from business history and business group literature, we develop a model to analyze how family business groups in late industrializing countries cope with management resource limitations that plague them in their pursuit of growth and diversification. A field study was conducted analyzing 215 family business groups in Thailand. Results suggest that family business groups will survive, and even prosper, if they are able to adapt their strategies and modernize their management styles to overcome three management resource limitations (or "management critical points")-fund raising, production technology, and human resources. There is a detailed discussion of the different strategies that help to extend these upper limits or management critical points. We then divide family business groups into four types, which are based on their diversification and management strategies. We argue that their performances vary and that the modernized single business type and the modernized conglomerate type will be the future forms of family business groups, which will ensure that they remain competitive in the new global economy. Using our model, we conclude that family business groups in Thailand are still disinclined to make the transition to managerial enterprises, according to the conventional Anglo-Saxon model.	[Yabushita, Natenapha Wailerdsak] Thammasat Univ, Thammasat Business Sch, Bangkok 10200, Thailand; [Suehiro, Akira] Univ Tokyo, Inst Social Sci, Bunkyo Ku, Tokyo 113003, Japan	Yabushita, NW (reprint author), Thammasat Univ, Thammasat Business Sch, 2 Prachan Rd, Bangkok 10200, Thailand.	wailerdsak@hotmail.com; asuehiro@iss.u-tokyo.ac.jp					Amsden A. H., 2003, LATE DEV TAIWANS UPG; Carney M, 2011, ACAD MANAGE J, V54, P437; Bunkanwanicha P, 2013, J FINANC QUANT ANAL, V48, P611, DOI 10.1017/S0022109013000148; Bertrand M, 2008, J FINANC ECON, V88, P466, DOI 10.1016/j.jfineco.2008.04.002; Khanna T, 2007, J ECON LIT, V45, P331, DOI 10.1257/jel.45.2.331; Khanna T, 1997, HARVARD BUS REV, V75, P41; Gomez-Mejia LR, 2011, ACAD MANAG ANN, V5, P653, DOI 10.1080/19416520.2011.593320; Guillen MF, 2000, ACAD MANAGE J, V43, P362, DOI 10.2307/1556400; Gedajlovic E, 2012, J MANAGE, V38, P1010, DOI 10.1177/0149206311429990; Chung HM, 2012, ASIA PAC J MANAG, V29, P303, DOI 10.1007/s10490-011-9281-5; ARIP, 2012, BUS PLUS TOP 1000 CO; ARIP, 2013, BUS PLUS TOP 1000 CO; BERLE A.A., 1932, MODERN CORPORATION P; Brooker Group P. L. C., 2003, THAI BUS GROUPS UN G; Carney M, 2008, ASIA PAC J MANAG, V25, P595, DOI 10.1007/s10490-008-9092-5; Chandler A. D., 1977, VISIBLE HAND MANAGER; Chandler A.D., 1990, SCALE SCOPE DYNAMICS; Chang S.-J., 2006, BUSINESS GROUPS E AS; CHURCH R, 1993, BUS HIST, V35, P17, DOI 10.1080/00076799300000127; Claessens S., 1999, 2089 WORLD BANK; Claessens S, 1999, 2054 WORLD BANK; Herman E.S, 1981, CORPORATE CONTROL CO; Hoshino T., 2004, FAMILI BIJINESU NO K; Jiang Y, 2011, ASIA PAC J MANAG, V28, P15, DOI 10.1007/s10490-010-9228-2; Lansberg I., 1991, FAMILY BUSINESS REV, V4, P127, DOI 10.1111/j.1741-6248.1991.00127.x; LEFF NH, 1978, ECON DEV CULT CHANGE, V26, P661, DOI 10.1086/451052; Peng M. W., 2006, Asia Pacific Journal of Management, V23, DOI 10.1007/s10490-006-9021-4; Pratruangkrai P., 2013, NATION; Rose M. B., 1993, ENTREPRENEURSHIP NET; Suehiro A., 2006, FAMILI BIJINESU RON; Suehiro A., 2014, OXFORD HDB ASIAN BUS; Suehiro A., 2004, ASEAN EC B, V21, P81, DOI 10.1355/AE21-1E; Suehiro A., 1989, CAPITAL ACCUMULATION; Suehiro Akira, 2008, CATCH UP IND TRAJECT; Wailerdsak N., 2008, THAI CAPITAL 1997 CR, P17; Wailerdsak N., 2006, KLUM THUN THURAKIT K; Wailerdsak N., 2005, MANGERIAL CAREERS TH; Wailerdsak N., 2014, CHULALONGKORN BUSINE, V36, P62; Wailerdsak N., 2010, OXFORD HDB BUSINESS; Wailerdsak N., 2013, S E ASIA J CONT BUSI, V2, P1; Wailerdsak N., 2012, J HR INTELLIGENCE, V7, P18; Yui D. W., 2007, J MANAGE STUD, V44, P1551	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0217-4561	1572-9958		ASIA PAC J MANAG	Asia Pac. J. Manag.	DEC	2014	31	4					997	1018		10.1007/s10490-014-9388-6		22	Management	Business & Economics	AT2BK	WOS:000344735700005		
J	Shimoda, T; Mitsunaga, T; Uefune, M; Abe, J; Kugimiya, S; Nagasaka, K; Sano, K; Urano, S; Suzuki, Y; Yano, E; Takabayashi, J				Shimoda, Takeshi; Mitsunaga, Takayuki; Uefune, Masayoshi; Abe, Junichiro; Kugimiya, Soichi; Nagasaka, Koukichi; Sano, Kota; Urano, Satoru; Suzuki, Yoshito; Yano, Eizi; Takabayashi, Junji			A food-supply device for maintaining Cotesia vestalis, a larval parasitoid of the diamondback moth Plutella xylostella, in greenhouses	BIOCONTROL			English	Article						Parasitoid; Biological control; Sugar food; Feeding device; Longevity	HALIDAY HYMENOPTERA-BRACONIDAE; BIOLOGICAL-CONTROL; MICROPLITIS-CROCEIPES; SUGAR CONCENTRATION; NATURAL ENEMIES; HONEYDEW SUGARS; LONGEVITY; NECTAR; WASPS; MANAGEMENT	The limited availability of sugar sources (e.g., flowers) in greenhouses may affect biological pest control by parasitoid wasps. However, few studies have focused on feeding devices to provide parasitoids with sugar foods. We investigated the accessibility of a yellow-colored bottle-type feeding device to adult Cotesia vestalis (Halliday), a larval endoparasitoid of the diamondback moth Plutella xylostella (L.). All parasitoids died within four days in a room with no sugar source, whereas 66.7 % of individuals survived if a bottle-type feeding device providing honey solution was installed. We also investigated female longevity in response to different sugar solutions presented in a bottle-type feeding device. Honey and sugar mixtures (glucose and fructose) improved female longevity (38.4 and 39.2 days, respectively) much more than water (3.1 days), indicating these feeding devices containing sugar foods to be potentially useful for maintaining C. vestalis in greenhouses where natural food sources are limited.	[Shimoda, Takeshi; Mitsunaga, Takayuki; Nagasaka, Koukichi; Suzuki, Yoshito; Yano, Eizi] Natl Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Uefune, Masayoshi; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Abe, Junichiro; Nagasaka, Koukichi] Natl Agr Res Ctr Western Reg, Ayabe 6230035, Japan; [Kugimiya, Soichi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Sano, Kota] Soda Aromat Co Ltd, Tokyo 1030023, Japan; [Urano, Satoru] Natl Agr Res Ctr Kyushu Okinawa Reg, Kumamoto 8611192, Japan	Shimoda, T (reprint author), Natl Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan.	oligota@affrc.go.jp	Takabayashi, Junji/G-2212-2010		Bio-oriented Technology Research Advancement Institution; JSPS KAKENHI [24780049, 19380188, 22380038]	We thank Ms. Kimiko Kanbe, Ms. Yumiko Togashi and Ms. Yoshiko Ishimura for rearing the insects and growing the plants. This research was supported by the Bio-oriented Technology Research Advancement Institution and JSPS KAKENHI Grant Numbers (24780049 for SK, 19380188 and 22380038 for TS).	Abe J, 2007, B NAT AGR RES CTR W, V6, P125; Bianchi FJJA, 2008, BIOL CONTROL, V46, P400, DOI 10.1016/j.biocontrol.2008.04.010; Azzouz H, 2004, BIOL CONTROL, V31, P445, DOI 10.1016/j.biocontrol.2004.07.013; Lucchetta P, 2008, ANIM COGN, V11, P525, DOI 10.1007/s10071-008-0144-5; Cortesero AM, 2000, BIOL CONTROL, V17, P35, DOI 10.1006/bcon.1999.0777; TAKASU K, 1993, BIOL CONTROL, V3, P70, DOI 10.1006/bcon.1993.1011; Wackers FL, 2008, BIOL CONTROL, V45, P176, DOI 10.1016/j.biocontrol.2008.01.007; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; Jacob HS, 1998, ENVIRON ENTOMOL, V27, P1563; Uefune M, 2013, BIOCONTROL, V58, P187, DOI 10.1007/s10526-012-9483-x; Winkler K, 2009, ECOL ENTOMOL, V34, P221, DOI 10.1111/j.1365-2311.2008.01059.x; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Wade MR, 2008, BIOL CONTROL, V45, P185, DOI 10.1016/j.biocontrol.2007.10.024; Rose USR, 2006, FUNCT ECOL, V20, P67, DOI 10.1111/j.1365-2435.2006.01071.x; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; Kugimiya S, 2010, ECOL ENTOMOL, V35, P538, DOI 10.1111/j.1365-2311.2010.01207.x; Wackers FL, 2007, ANNU REV ENTOMOL, V52, P301, DOI 10.1146/annurev.ento.52.110405.091352; Mitsunaga T, 2004, APPL ENTOMOL ZOOL, V39, P691, DOI 10.1303/aez.2004.691; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; BENSAAD AA, 1976, ENVIRON ENTOMOL, V5, P453; Harvey JA, 2012, J INSECT PHYSIOL, V58, P816, DOI 10.1016/j.jinsphys.2012.03.002; Hirose Y, 2009, APPL ENTOMOL ZOOL, V44, P175, DOI 10.1303/aez.2009.175; Kawaguchi M, 1999, APPL ENTOMOL ZOOL, V34, P213; Kugimiya S, 2010, APPL ENTOMOL ZOOL, V45, P369, DOI 10.1303/aez.2010.369; Lewis WJ, 1998, BIOL CONTROL, V11, P175, DOI 10.1006/bcon.1997.0588; Meyhofer R, 2000, ENTOMOL EXP APPL, V97, P115, DOI 10.1046/j.1570-7458.2000.00722.x; Mills N.J., 2008, BEHAV ECOLOGY INSECT, P3; Mitsunaga T, 2006, APPL ENTOMOL ZOOL, V41, P277, DOI 10.1303/aez.2006.277; Mitsunaga T, 2012, JARQ-JPN AGR RES Q, V46, P161; Romeis J, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P178, DOI 10.1017/CBO9780511542220.008; Siekmann G, 2001, OIKOS, V95, P425, DOI 10.1034/j.1600-0706.2001.950307.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Tang BZ, 2014, BIOCONTROL, V59, P647, DOI 10.1007/s10526-014-9600-0; WACKERS FL, 1994, J INSECT PHYSIOL, V40, P641, DOI 10.1016/0022-1910(94)90091-4; Winkler K, 2005, ENTOMOL EXP APPL, V115, P187, DOI 10.1111/j.1570-7458.2005.00254.x; Witting-Bissinger BE, 2008, BIOL CONTROL, V47, P180, DOI 10.1016/j.biocontrol.2008.07.013	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1386-6141	1573-8248		BIOCONTROL	Biocontrol	DEC	2014	59	6					681	688		10.1007/s10526-014-9611-x		8	Entomology	Entomology	AT2AS	WOS:000344733700004		
J	Nakajima, R; Otagaki, S; Yamada, K; Shiratake, K; Matsumoto, S				Nakajima, R.; Otagaki, S.; Yamada, K.; Shiratake, K.; Matsumoto, S.			Molecular cloning and expression analyses of FaFT, FaTFL, and FaAP1 genes in cultivated strawberry: their correlation to flower bud formation	BIOLOGIA PLANTARUM			English	Article						flowering; Fragaria x ananassa; F. vesca; photoperiod; temperature	X-ANANASSA DUCH.; FLORAL INDUCTION; LOCUS-T; ARABIDOPSIS; FT; PROTEIN; SIGNAL; TEMPERATURE; RICE; TERMINAL-FLOWER1	In this study, we cloned flowering-related genes FLOWERING LOCUS T (FT) and TERMINAL FLOWER1 (TFL1) from domesticated octaploid strawberries (Fragaria x ananassa) and analyzed their expression patterns in cultivars Tochiotome and Akihime. The floral meristem generation was induced under the short day and low temperature (SDLT), but not under the long day and high temperature (LDHT). We found that FaFT1, which is an orthologue of the Arabidopsis floral activator FT, was highly expressed in leaves under LDHT but not expressed in leaves under SDLT. On the other hand, the expression of FaTFL2, which belongs to the TFL1 family of flowering repressing genes, decreased in crowns (stem tissue including meristem) under SDLT. These results suggest that FaTFL2, as opposed to FvTFL1 in wild diploid strawberry Fragaria vesca, is related to flowering of the cultivated strawberry. Moreover, the FaTFL2 expression might be regulated by temperature rather than by photoperiod. We demonstrated that a reduction of the FaTFL2 expression is a key signal for flowering in domesticated strawberries.	[Nakajima, R.; Otagaki, S.; Shiratake, K.; Matsumoto, S.] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yamada, K.] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan	Matsumoto, S (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	shogo@agr.nagoya-u.ac.jp	Shiratake, Katsuhiro/I-6888-2014		Japan Society for the Promotion of Science [17580024, 23658026]	We are indebted to Mrs. S. Niwa and K. Kato for their valuable technical assistance. This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 17580024 and 23658026).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Sonsteby A, 1998, J HORTIC SCI BIOTECH, V73, P730; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Bradford E, 2010, J AM SOC HORTIC SCI, V135, P102; Conti L, 2007, PLANT CELL, V19, P767, DOI 10.1105/tpc.106.049767; Verheul MJ, 2006, SCI HORTIC-AMSTERDAM, V107, P164, DOI 10.1016/j.scienta.2005.07.004; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Yeung K, 1999, NATURE, V401, P173; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wigge PA, 2011, CURR BIOL, V21, pR374, DOI 10.1016/j.cub.2011.03.038; Sonsteby A, 2007, J HORTIC SCI BIOTECH, V82, P875; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Iwata H, 2012, PLANT J, V69, P116, DOI 10.1111/j.1365-313X.2011.04776.x; Koskela EA, 2012, PLANT PHYSIOL, V159, P1043, DOI 10.1104/pp.112.196659; Mimida N, 2012, BIOL PLANTARUM, V56, P465, DOI 10.1007/s10535-012-0113-3; Mouhu K, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-122; Taylor DR, 2002, ACTA HORTIC, P245; Weebadde CK, 2008, PLANT BREEDING, V127, P94, DOI 10.1111/j.1439-0523.2007.01430.x	33	1	1	ACAD SCIENCES CZECH REPUBLIC, INST EXPERIMENTAL BOTANY	PRAHA 6	ROZVOJOVA 263, PRAHA 6, CZ-165 02, CZECH REPUBLIC	0006-3134	1573-8264		BIOL PLANTARUM	Biol. Plant.	DEC	2014	58	4					641	648		10.1007/s10535-014-0452-3		8	Plant Sciences	Plant Sciences	AS9ZM	WOS:000344596800005		
J	Alam, MM; Nahar, K; Hasanuzzaman, M; Fujita, M				Alam, M. M.; Nahar, K.; Hasanuzzaman, M.; Fujita, M.			Alleviation of osmotic stress in Brassica napus, B. campestris, and B. juncea by ascorbic acid application	BIOLOGIA PLANTARUM			English	Article						abiotic stress tolerance; antioxidants; AsA-GSH cycle; methylglyoxal; oxidative stress; polyethylene glycol	DROUGHT STRESS; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; SALINITY STRESS; WATER-DEFICIT; SALT STRESS; SPINACH-CHLOROPLASTS; PROLINE ACCUMULATION; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION	The roles of ascorbic acid (AsA, 1 mM) under an osmotic stress [induced by 15 % (m/v) polyethylene glycol, PEG-6000] were investigated by examining morphological and physiological attributes in Brassica species. The osmotic stress reduced the fresh and dry masses, leaf relative water content (RWC), and chlorophyll (Chl) content, whereas increased the proline (Pro), malondialdehyde (MDA), and H2O2 content, and lipoxygenase (LOX) activity. The ascorbate content in B. napus, B. campestris, and B. juncea decreased, increased, and remained unaltered, respectively. The dehydroascorbate (DHA) content increased only in B. napus. The AsA/DHA ratio was reduced by the osmotic stress in all the species except B. juncea. The osmotic stress increased the glutathione (GSH) content only in B. juncea, but increased the glutathione disulfide (GSSG) content and decreased the GSH/GSSG ratio in all the species. The osmotic stress increased the activities of ascorbate peroxidase (APX) (except in B. napus), glutathione reductase (GR) (except in B. napus), glutathione S-transferase (GST) (except in B. juncea), and glutathione peroxidase (GPX), and decreased the activities of catalase (CAT) and monodehydroascorbate reductase (MDHAR) (only in B. campestris). The osmotic stress decreased the glyoxalase I (Gly I) and increased glyoxalase II (Gly II) activities. The application of AsA in combination with PEG improved the fresh mass, RWC, and Chl content, whereas decreased the Pro, MDA, and H2O2 content in comparison with PEG alone. The AsA addition improved AsA-GSH cycle components and improved the activities of all antioxidant and glyoxalase enzymes in most of the cases. So, exogenous AsA improved physiological adaptation and alleviated oxidative damage under the osmotic stress by improving the antioxidant and glyoxalase systems. According to measured parameters, B. juncea can be recognized as more drought tolerant than B. napus and B. campestris.	[Alam, M. M.; Nahar, K.; Fujita, M.] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, Miki, Kagawa 7610795, Japan; [Nahar, K.] Sher e Bangla Agr Univ, Dept Agr Bot, Fac Agr, Dhaka 1207, Bangladesh; [Hasanuzzaman, M.] Sher e Bangla Agr Univ, Dept Agron, Fac Agr, Dhaka 1207, Bangladesh	Fujita, M (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, Miki, Kagawa 7610795, Japan.	fujita@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	The first author is grateful to the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan for financial supports. We acknowledge Dr. Motiar Rohman, the Bangladesh Agricultural Research Institute for his help during enzyme assays.	Alam M. M., 2013, Australian Journal of Crop Science, V7, P1053; Al-Ghamdi AA, 2009, INT J AGRIC BIOL, V11, P7; Amin B., 2009, Research Journal of Biological Sciences, V4, P380; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Hameed A, 2013, BIOL PLANTARUM, V57, P370, DOI 10.1007/s10535-012-0286-9; Wang H, 2009, BIOCHEM PHARMACOL, V77, P1709, DOI 10.1016/j.bcp.2009.02.024; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Hasanuzzaman M, 2013, ECOTOXICOLOGY, V22, P584, DOI 10.1007/s10646-013-1050-4; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Hossain Mohammad Anwar, 2010, Physiology and Molecular Biology of Plants, V16, P259, DOI 10.1007/s12298-010-0028-4; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; Hossain MZ, 2006, BIOL PLANTARUM, V50, P210, DOI 10.1007/s10535-006-0009-1; Dolatabadian A, 2009, NOT BOT HORTI AGROBO, V37, P165; Yang SL, 2009, J PLANT PHYSIOL, V166, P1694, DOI 10.1016/j.jplph.2009.04.006; Hasanuzzaman M, 2011, BIOL TRACE ELEM RES, V143, P1758, DOI 10.1007/s12011-011-8998-9; BARRS HD, 1962, AUST J BIOL SCI, V15, P413; LINDAHL M, 1995, EUR J BIOCHEM, V231, P503, DOI 10.1111/j.1432-1033.1995.tb20725.x; Hussain M, 2009, J AGRON CROP SCI, V195, P98, DOI 10.1111/j.1439-037X.2008.00354.x; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Hasanuzzaman M, 2011, BIOL TRACE ELEM RES, V143, P1704, DOI 10.1007/s12011-011-8958-4; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; DeSouza PI, 1997, AGRON J, V89, P807; Hasanuzzaman M, 2011, PLANT BIOTECHNOL REP, V5, P353, DOI 10.1007/s11816-011-0189-9; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Hasanuzzaman M, 2012, CROP STRESS AND ITS MANAGEMENT: PERSPECTIVES AND STRATEGIES, P261, DOI 10.1007/978-94-007-2220-0_8; Fabro G, 2004, MOL PLANT MICROBE IN, V17, P343, DOI 10.1094/MPMI.2004.17.4.343; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Mullineaux PM, 2005, PHOTOSYNTH RES, V86, P459, DOI 10.1007/s11120-005-8811-8; Yadav SK, 2005, FEBS LETT, V579, P6265, DOI 10.1016/j.febslet.2005.10.006; Athar HUR, 2008, ENVIRON EXP BOT, V63, P224, DOI 10.1016/j.envexpbot.2007.10.018; Jaleel CA, 2009, INT J AGRIC BIOL, V11, P100; PRINCIPATO GB, 1987, BIOCHIM BIOPHYS ACTA, V911, P349, DOI 10.1016/0167-4838(87)90076-8; Dolatabadian A, 2009, J AGRON CROP SCI, V195, P347, DOI 10.1111/j.1439-037X.2009.00382.x; Khan Taqi Ahmed, 2011, Journal of Agrobiology, V28, P97, DOI 10.2478/v10146-011-0011-x; Bybordi A, 2012, J INTEGR AGR, V11, P1610, DOI 10.1016/S2095-3119(12)60164-6; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Singla-Pareek SL, 2003, P NATL ACAD SCI USA, V100, P14672, DOI 10.1073/pnas.2034667100; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Deeba F, 2012, PLANT PHYSIOL BIOCH, V53, P6, DOI 10.1016/j.plaphy.2012.01.002; Shalata A, 2001, J EXP BOT, V52, P2207; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Alves AAC, 2004, ANN BOT-LONDON, V94, P605, DOI 10.1093/aob/mch179; Sharma P, 2005, PLANT GROWTH REGUL, V46, P209, DOI 10.1007/s10725-005-0002-2; Manivannan P, 2007, COLLOID SURFACE B, V59, P141, DOI 10.1016/j.colsurfb.2007.05.002; Elia AC, 2003, ECOTOX ENVIRON SAFE, V55, P162, DOI 10.1016/S0147-6513(02)00123-9; Paradiso A, 2008, PLANT CELL PHYSIOL, V49, P362, DOI 10.1093/pcp/pcn013; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; Mittova V, 2003, FEBS LETT, V554, P417, DOI 10.1016/S0014-5793(03)01214-6; Dreesen FE, 2012, ENVIRON EXP BOT, V79, P21, DOI 10.1016/j.envexpbot.2012.01.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Hasanuzzaman M, 2012, BIOL TRACE ELEM RES, V149, P248, DOI 10.1007/s12011-012-9419-4; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Liu FL, 2004, FIELD CROP RES, V86, P1, DOI 10.1016/S0378-4290(03)00165-5; Noctor G, 2002, ANN BOT-LONDON, V89, P841, DOI 10.1093/aob/mcf096; Asadi K.Z.H., 2010, IRAN J MED AROM PLAN, V25, P469; Aziz A, 1998, J PLANT PHYSIOL, V153, P754; Baghizadeh A., 2011, J STRESS PHYSL BIOCH, V7, P55; Baghizadeh A.M., 2009, RES J BIOL SCI, V4, P380; Bashor CJ, 1999, NEW PHYTOL, V142, P19, DOI 10.1046/j.1469-8137.1999.00370.x; Costa L. dalla, 1997, Potato Research, V40, P19, DOI 10.1007/BF02407559; Darvishan M, 2013, MAYDICA, V58, P195; De Tullio M.C, 2004, VITAMIN C ITS FUNCTI, P176; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; DODERER A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P97, DOI 10.1016/0167-4838(92)90429-H; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Guo ZF, 2005, PLANT PHYSIOL BIOCH, V43, P955, DOI 10.1016/j.plaphy.2005.08.007; Gupta M, 2009, CHEMOSPHERE, V74, P1201, DOI 10.1016/j.chemosphere.2008.11.023; Halimeh R., 2013, Middle East Journal of Scientific Research, V13, P522; Hasanuzzaman M., 2012, Australian Journal of Crop Science, V6, P1314; Hasanuzzaman M., 2014, CLIMATE CHANGE PLANT, P209; Hoque M.A., 2007, J PLANT PHYSL, V165, P813; Kabiri R., 2012, American-Eurasian Journal of Agricultural & Environmental Sciences, V12, P1420; Kadioglu A, 2011, PLANT GROWTH REGUL, V64, P27, DOI 10.1007/s10725-010-9532-3; Moaveni P., 2011, AGR SCI RES J, V1, P64; Molassiotis A, 2006, ENVIRON EXP BOT, V56, P54, DOI 10.1016/j.envexpbot.2005.01.002; NavariIzzo F, 1997, PHYSIOL PLANTARUM, V99, P23, DOI 10.1034/j.1399-3054.1997.990104.x; Pattanagul Wattana, 2011, Asian Journal of Plant Sciences, V10, P212, DOI 10.3923/ajps.2011.212.219; Razaji A., 2012, Annals of Biological Research, V3, P3984; Sakhabutdinova A.R., 2003, BULG J PLANT PHYSL, V2003, P314; Sanchez-Rodriguez E, 2012, PLANT SCI, V188, P89, DOI 10.1016/j.plantsci.2011.12.019; TAIZ L., 2006, PLANT PHYSL; Vander J.D.L., 1993, BIOCHEM SOC T, V21, P522; Wu G., 2007, BIOINTERFACES, V59, P113; Yang JW, 2013, COMPUT BIOL CHEM, V46, P48, DOI 10.1016/j.compbiolchem.2013.04.006	91	0	0	ACAD SCIENCES CZECH REPUBLIC, INST EXPERIMENTAL BOTANY	PRAHA 6	ROZVOJOVA 263, PRAHA 6, CZ-165 02, CZECH REPUBLIC	0006-3134	1573-8264		BIOL PLANTARUM	Biol. Plant.	DEC	2014	58	4					697	708		10.1007/s10535-014-0447-0		12	Plant Sciences	Plant Sciences	AS9ZM	WOS:000344596800012		
J	Hasanuzzaman, M; Nahar, K; Alam, MM; Fujita, M				Hasanuzzaman, Mirza; Nahar, Kamrun; Alam, Md Mahabub; Fujita, Masayuki			Modulation of Antioxidant Machinery and the Methylglyoxal Detoxification System in Selenium-Supplemented Brassica napus Seedlings Confers Tolerance to High Temperature Stress	BIOLOGICAL TRACE ELEMENT RESEARCH			English	Article						Abiotic stress; Antioxidant metabolism; AsA-GSH cycle; Reactive oxygen species; Thermotolerance; Trace elements	HYDROGEN-PEROXIDE; SPINACH-CHLOROPLASTS; PLANTS; GLUTATHIONE; ASCORBATE; PROLINE; DEFENSE; MECHANISMS; REDUCTASE; LEAVES	We investigated the protective role of selenium (Se) in minimizing high temperature-induced damages to rapeseed (Brassica napus L. cv. BINA Sarisha 3) seedlings. Ten-day-old seedlings which had been supplemented with Se (25 mu M Na2SeO4) or not were grown separately under control temperature (25 A degrees C) or high temperature (38 A degrees C) for a period of 24 or 48 h in nutrient solution. Heat stress caused decrease in chlorophyll and leaf relative water content (RWC) and increased malondialdehyde (MDA), hydrogen peroxide (H2O2), proline (Pro), and methylglyoxal (MG) contents. Ascorbate (AsA) content decreased at any duration of heat treatment. The content of reduced glutathione (GSH) increased only at 24 h of stress, while glutathione disulfide (GSSG) markedly increased at both duration of heat exposure with associated decrease in GSH/GSSG ratio. Upon heat treatment the activities of ascorbate peroxidase (APX), glutathione S-transferase (GST) and glyoxalase I (Gly I) were increased, while the activities of monodehydroascorbate reductase (MDHAR), dehydroascorbate reductase (DHAR), and catalase (CAT) were decreased. The activities of glutathione reductase (GR) and glutathione peroxidase (GPX) remained unchanged under heat stress. However, heat-treated seedlings which were supplemented with Se significantly decreased the lipid peroxidation, H2O2, and MG content and enhanced the content of chlorophyll, Pro, RWC, AsA, and GSH as well as the GSH/GSSG ratio. Selenium supplemented heat-treated seedlings also showed enhanced activities of MDHAR, DHAR, GR, GPX, CAT, Gly I, and Gly II as compared to heat-treated seedlings without Se supplementation. This study concludes that exogenous Se application confers heat stress tolerance in rapeseed seedlings by upregulating the antioxidant defense mechanism and methylglyoxal detoxification system.	[Hasanuzzaman, Mirza; Nahar, Kamrun; Alam, Md Mahabub; Fujita, Masayuki] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, Miki, Kagawa 7610795, Japan; [Hasanuzzaman, Mirza] Sher E Bangla Agr Univ, Dept Agron, Fac Agr, Dhaka 1207, Bangladesh; [Nahar, Kamrun] Sher E Bangla Agr Univ, Dept Agr Bot, Fac Agr, Dhaka 1207, Bangladesh	Fujita, M (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, 2393 Ikenobe, Miki, Kagawa 7610795, Japan.	mhzsauag@yahoo.com; fujita@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The authors are grateful to the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, for financial supports. We thankfully acknowledge Mr. Jubayer-Al-Mahmud, Department of Agroforestry and Environmental Science, Sher-e-Bangla Agricultural University, Dhaka, Bangladesh, for critical reading of the manuscript.	Anjum NA, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P1, DOI 10.1007/978-90-481-9404-9; Hoque MA, 2008, J PLANT PHYSIOL, V165, P813, DOI 10.1016/j.jplph.2007.07.013; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Hasanuzzaman M, 2013, ECOTOXICOLOGY, V22, P584, DOI 10.1007/s10646-013-1050-4; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Yao XQ, 2010, BIOL TRACE ELEM RES, V136, P96, DOI 10.1007/s12011-009-8520-9; Hossain MZ, 2006, BIOL PLANTARUM, V50, P210, DOI 10.1007/s10535-006-0009-1; Hasanuzzaman M, 2011, BIOL TRACE ELEM RES, V143, P1758, DOI 10.1007/s12011-011-8998-9; Yao XQ, 2009, BIOL TRACE ELEM RES, V130, P283, DOI 10.1007/s12011-009-8328-7; BARRS HD, 1962, AUST J BIOL SCI, V15, P413; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Hasanuzzaman M, 2011, BIOL TRACE ELEM RES, V143, P1704, DOI 10.1007/s12011-011-8958-4; Srivastava M, 2009, BIORESOURCE TECHNOL, V100, P1115, DOI 10.1016/j.biortech.2008.08.026; Hasanuzzaman M, 2012, CROP STRESS AND ITS MANAGEMENT: PERSPECTIVES AND STRATEGIES, P261, DOI 10.1007/978-94-007-2220-0_8; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; El-Shabrawi H, 2010, PROTOPLASMA, V245, P85, DOI 10.1007/s00709-010-0144-6; Havaux M, 1998, TRENDS PLANT SCI, V3, P147; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Wild R, 2012, ANAL BIOANAL CHEM, V403, P2577, DOI 10.1007/s00216-012-6086-4; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Gill SS, 2013, PLANT PHYSIOL BIOCH, V70, P204, DOI 10.1016/j.plaphy.2013.05.032; Hawrylak-Nowak B, 2009, BIOL TRACE ELEM RES, V132, P259, DOI 10.1007/s12011-009-8402-1; Kumar S, 2011, ACTA PHYSIOL PLANT, V33, P2091, DOI 10.1007/s11738-011-0748-2; Djanaguiraman M, 2005, PLANT SOIL, V272, P77, DOI 10.1007/s11104-004-4039-1; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Elia AC, 2003, ECOTOX ENVIRON SAFE, V55, P162, DOI 10.1016/S0147-6513(02)00123-9; Djanaguiraman M, 2010, PLANT PHYSIOL BIOCH, V48, P999, DOI 10.1016/j.plaphy.2010.09.009; Filek M, 2008, J PLANT PHYSIOL, V165, P833, DOI 10.1016/j.jplph.2007.06.006; Rasheed R, 2011, PLANT GROWTH REGUL, V65, P35, DOI 10.1007/s10725-011-9572-3; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Hasanuzzaman M, 2012, BIOL TRACE ELEM RES, V149, P248, DOI 10.1007/s12011-012-9419-4; Hawrylak-Nowak B, 2010, BIOL TRACE ELEM RES, V138, P307, DOI 10.1007/s12011-010-8613-5; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Feng R, 2013, ENVIRON EXP BOT, V87, P58; Hasanuzzaman M., 2012, Australian Journal of Crop Science, V6, P1314; Mantri N, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P1, DOI 10.1007/978-1-4614-0634-1_1; Mustafiz A, 2010, METHODS MOL BIOL, V639, P95, DOI 10.1007/978-1-60761-702-0_6; Veena Reddy VS, 1999, PLANT J, V17, P385; Wang W, 2007, PLANTA, V218, P1; Xue T., 2001, PLANT SOIL, V27, P55, DOI [10.1023/A:1013369804867, DOI 10.1023/A:1013369804867]; Yao XQ, 2013, ECOTOX ENVIRON SAFE, V92, P320, DOI 10.1016/j.ecoenv.2013.03.024; Zrobek-sokolnik A., 2012, ENV ADAPTATIONS STRE, P113	46	3	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0163-4984	1559-0720		BIOL TRACE ELEM RES	Biol. Trace Elem. Res.	DEC	2014	161	3			SI		297	307		10.1007/s12011-014-0120-7		11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	AT2HR	WOS:000344755100007		
